Citrus Sinensis ID: 014849
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | 2.2.26 [Sep-21-2011] | |||||||
| Q9LZW4 | 442 | CBL-interacting serine/th | yes | no | 0.954 | 0.900 | 0.662 | 1e-147 | |
| O22932 | 435 | CBL-interacting serine/th | no | no | 0.942 | 0.903 | 0.633 | 1e-141 | |
| Q9SN43 | 489 | CBL-interacting serine/th | no | no | 0.913 | 0.779 | 0.546 | 1e-127 | |
| O80902 | 431 | CBL-interacting serine/th | no | no | 0.954 | 0.923 | 0.587 | 1e-125 | |
| Q9LP51 | 520 | CBL-interacting serine/th | no | no | 0.940 | 0.753 | 0.521 | 1e-123 | |
| Q9FJ55 | 483 | CBL-interacting serine/th | no | no | 0.892 | 0.770 | 0.516 | 1e-121 | |
| Q7X996 | 443 | CBL-interacting protein k | yes | no | 0.906 | 0.853 | 0.525 | 1e-117 | |
| Q9LWM4 | 461 | CBL-interacting protein k | no | no | 0.952 | 0.861 | 0.504 | 1e-116 | |
| Q9FJ54 | 439 | CBL-interacting serine/th | no | no | 0.911 | 0.865 | 0.511 | 1e-114 | |
| O22971 | 502 | CBL-interacting serine/th | no | no | 0.920 | 0.764 | 0.488 | 1e-114 |
| >sp|Q9LZW4|CIPKE_ARATH CBL-interacting serine/threonine-protein kinase 14 OS=Arabidopsis thaliana GN=CIPK14 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 521 bits (1343), Expect = e-147, Method: Compositional matrix adjust.
Identities = 275/415 (66%), Positives = 333/415 (80%), Gaps = 17/415 (4%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
+R LFGKYEVGK++GCGAFAKVYHGR+ TGQSVAIK VSKQ++ +GGL +++REI+
Sbjct: 13 NRRGQLFGKYEVGKLVGCGAFAKVYHGRSTATGQSVAIKVVSKQRLQKGGLNGNIQREIA 72
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
IM RLRHP+IV+L+EVLATK+KI+FVMEFAKGGELFAK+SKGRF E LSRRYFQQLISAV
Sbjct: 73 IMHRLRHPSIVRLFEVLATKSKIFFVMEFAKGGELFAKVSKGRFCEDLSRRYFQQLISAV 132
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
YCHSRG+FHRDLK ENLLLDE DLKISDFGLSA+ +QIRPDG+LHTLCGTPAYVAPE+
Sbjct: 133 GYCHSRGIFHRDLKPENLLLDEKLDLKISDFGLSALTDQIRPDGLLHTLCGTPAYVAPEV 192
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248
LAKKGYDGAK+D+WSCG++LFVLNAGYLPFND NLM MYRKIYKGE+R PKWTSPDL+
Sbjct: 193 LAKKGYDGAKIDIWSCGIILFVLNAGYLPFNDHNLMVMYRKIYKGEFRIPKWTSPDLRRL 252
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKER--KFPHEDFDLK---DSVGCNVGSEKYLN 303
+ RLLDT+P TRIT++EI+ DPWFK+ Y +R KF ED D+K D +G+ + +N
Sbjct: 253 LTRLLDTNPQTRITIEEIIHDPWFKQGYDDRMSKFHLEDSDMKLPADETDSEMGARR-MN 311
Query: 304 AFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAV 363
AFDIIS S GFNLSGLF D D ERF+S T E+++E++EE + + L V
Sbjct: 312 AFDIISGSPGFNLSGLFGDARKYDRV---ERFVSAWTAERVVERLEE----IVSAENLTV 364
Query: 364 TKKE-WGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMR---RGEENWKDKLRP 414
KKE WG K+EGQ GNF MV+ I++LTD+LV++E++K R G + W D LRP
Sbjct: 365 AKKETWGMKIEGQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRP 419
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O22932|CIPKB_ARATH CBL-interacting serine/threonine-protein kinase 11 OS=Arabidopsis thaliana GN=CIPK11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 500 bits (1288), Expect = e-141, Method: Compositional matrix adjust.
Identities = 259/409 (63%), Positives = 319/409 (77%), Gaps = 16/409 (3%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-GLTAHVKREISIMSR 72
LFGKYE+GK++GCGAFAKV+H R+ RTGQSVA+K ++K+K+L L ++KREISIM R
Sbjct: 17 LFGKYELGKLLGCGAFAKVFHARDRRTGQSVAVKILNKKKLLTNPALANNIKREISIMRR 76
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYC 131
L HPNIVKL+EV+ATK+KI+F MEF KGGELF KISK GR SE LSRRYFQQLISAV YC
Sbjct: 77 LSHPNIVKLHEVMATKSKIFFAMEFVKGGELFNKISKHGRLSEDLSRRYFQQLISAVGYC 136
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK 191
H+RGV+HRDLK ENLL+DEN +LK+SDFGLSA+ +QIRPDG+LHTLCGTPAYVAPEIL+K
Sbjct: 137 HARGVYHRDLKPENLLIDENGNLKVSDFGLSALTDQIRPDGLLHTLCGTPAYVAPEILSK 196
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251
KGY+GAKVD+WSCG+VLFVL AGYLPFNDPN+M MY+KIYKGEYR P+W SPDLK F+ R
Sbjct: 197 KGYEGAKVDVWSCGIVLFVLVAGYLPFNDPNVMNMYKKIYKGEYRFPRWMSPDLKRFVSR 256
Query: 252 LLDTDPATRITVDEILRDPWF-KKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDIISL 310
LLD +P TRIT+DEIL+DPWF + +K+ KF H+D V ++ + K LNAFD+IS
Sbjct: 257 LLDINPETRITIDEILKDPWFVRGGFKQIKF-HDDEIEDQKVESSLEAVKSLNAFDLISY 315
Query: 311 SSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKK---E 367
SSG +LSGLF +N+ +ERFLS ++PE + E+VE AR + L + KK E
Sbjct: 316 SSGLDLSGLFAGCSNSSGE--SERFLSEKSPEMLAEEVEGFAR----EENLRMKKKKEEE 369
Query: 368 WGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGE---ENWKDKLR 413
+G ++EGQNG F + I I RL D LVVVE ++ G+ E W KLR
Sbjct: 370 YGFEMEGQNGKFGIGICISRLNDLLVVVEARRRGGDGDCYKEMWNGKLR 418
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SN43|CIPKC_ARATH CBL-interacting serine/threonine-protein kinase 12 OS=Arabidopsis thaliana GN=CIPK12 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 453 bits (1166), Expect = e-127, Method: Compositional matrix adjust.
Identities = 233/426 (54%), Positives = 296/426 (69%), Gaps = 45/426 (10%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
S + + G+YE+GK++G G FAKVY RNV+T +SVAIK + K+K+L+GGL AH+KREIS
Sbjct: 17 SPQALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREIS 76
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
I+ R+RHPNIV+L+EV+ATKAKIYFVME+ +GGELF K++KGR E+++R+YFQQLISAV
Sbjct: 77 ILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAV 136
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
+CH+RGV+HRDLK ENLLLDEN +LK+SDFGLSAV +QIR DG+ HT CGTPAYVAPE+
Sbjct: 137 TFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 196
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248
LA+KGYD AKVD+WSCGV+LFVL AGYLPF+D N+MAMY+KIY+GE+RCP+W S +L
Sbjct: 197 LARKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRL 256
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDL----------KDSVGCN--- 295
+ +LL+T+P R T EI+ + WFKK +K KF ED L DSV +
Sbjct: 257 LSKLLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKLCNVVDDDELESDSVESDRDS 316
Query: 296 VGSEK------------------YLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLS 337
SE LNAFDIIS S GF+LSGLFDD RF+S
Sbjct: 317 AASESEIEYLEPRRRVGGLPRPASLNAFDIISFSQGFDLSGLFDDDGEGS------RFVS 370
Query: 338 NETPEKILEKVEEVARLVADGDRLAVTKKEWGAKLEGQ----NGNFTMVIGIDRLTDDLV 393
KI+ K+EE+A++V+ V KK+ LEG G T+ I LT LV
Sbjct: 371 GAPVSKIISKLEEIAKVVS----FTVRKKDCRVSLEGSRQGVKGPLTIAAEIFELTPSLV 426
Query: 394 VVEIKK 399
VVE+KK
Sbjct: 427 VVEVKK 432
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O80902|CIPKM_ARATH CBL-interacting serine/threonine-protein kinase 22 OS=Arabidopsis thaliana GN=CIPK22 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 448 bits (1153), Expect = e-125, Method: Compositional matrix adjust.
Identities = 245/417 (58%), Positives = 311/417 (74%), Gaps = 19/417 (4%)
Query: 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHV 63
TGD ++ LFGKY++GK++G GAFAKVY +++ G +SVAIK V K++ L+ GLTAHV
Sbjct: 16 TGDDNKSA-LFGKYDLGKLLGSGAFAKVYQAEDLQNGGESVAIKVVQKKR-LKDGLTAHV 73
Query: 64 KREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQ 123
KREIS+M RLRHP+IV L EVLATK KIYFVME AKGGELF++++ RF+E LSR+YF+Q
Sbjct: 74 KREISVMRRLRHPHIVLLSEVLATKTKIYFVMELAKGGELFSRVTSNRFTESLSRKYFRQ 133
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
LISAV YCH+RGVFHRDLK ENLLLDEN DLK+SDFGLSA+KEQI PDGMLHTLCGTPAY
Sbjct: 134 LISAVRYCHARGVFHRDLKPENLLLDENRDLKVSDFGLSAMKEQIHPDGMLHTLCGTPAY 193
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSP 243
VAPE+L KKGYDG+K D+WSCGVVLF+LNAGYLPF DPN+M +YRKI+K +Y+ P WTS
Sbjct: 194 VAPELLLKKGYDGSKADIWSCGVVLFLLNAGYLPFRDPNIMGLYRKIHKAQYKLPDWTSS 253
Query: 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK---FPHEDFDLKDSVGCNVGSEK 300
DL+ + RLL+ +P RITV+EIL+DPWF + +D+DL++ + K
Sbjct: 254 DLRKLLRRLLEPNPELRITVEEILKDPWFNHGVDPSEIIGIQADDYDLEE-------NGK 306
Query: 301 YLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDR 360
LNAFD+IS +S NLSGLF +F D C++ F+S+E+ I+ KVEEVA+ + R
Sbjct: 307 ILNAFDLISSASSSNLSGLFGNFVTPD--HCDQ-FVSDESTAVIMRKVEEVAKQL--NLR 361
Query: 361 LAVTKKEWGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEENWKDKLRPAAR 417
+A KKE KLEG +G +V+ + RLT++LV+VE+K R W D LR R
Sbjct: 362 IA-KKKERAIKLEGPHGVANVVVKVRRLTNELVMVEMKNKQRDVGLVWADALRQKLR 417
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LP51|CIPKI_ARATH CBL-interacting serine/threonine-protein kinase 18 OS=Arabidopsis thaliana GN=CIPK18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 442 bits (1136), Expect = e-123, Method: Compositional matrix adjust.
Identities = 228/437 (52%), Positives = 292/437 (66%), Gaps = 45/437 (10%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L GKYE+GK++G G FAKVY +N+++G VAIK + K+KI++ GL AH+KREISI+ R+
Sbjct: 70 LMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILRRV 129
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHP IV L+EV+ATK+KIYFVME+ GGELF ++KGR E+ +RRYFQQLIS+V +CH
Sbjct: 130 RHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFCHG 189
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRDLK ENLLLD +LK+SDFGLSAV EQ+R DG+ HT CGTPAY+APE+L +KG
Sbjct: 190 RGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTRKG 249
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YD AK D+WSCGV+LFVL AG++PF D N+M MY+KIYKGE+RCP+W S DL + RLL
Sbjct: 250 YDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTRLL 309
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHED---------------------------- 285
DT+P TRIT+ EI+++ WFKK +K KF ED
Sbjct: 310 DTNPDTRITIPEIMKNRWFKKGFKHVKFYIEDDKLCREDEDEEEEASSSGRSSTVSESDA 369
Query: 286 -FDLKDSVGCNVGSEKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKI 344
FD+K ++ LNAFDIIS SSGF+LSGLF++ RF+S KI
Sbjct: 370 EFDVKRMGIGSMPRPSSLNAFDIISFSSGFDLSGLFEEEGGEGT-----RFVSGAPVSKI 424
Query: 345 LEKVEEVARLVADGDRLAVTKKEWGAKL----EGQNGNFTMVIGIDRLTDDLVVVEIKKS 400
+ K+EE+A++V+ V KKEW +L EG G T+ I LT LVVVE+KK
Sbjct: 425 ISKLEEIAKIVS----FTVRKKEWSLRLEGCREGAKGPLTIAAEIFELTPSLVVVEVKKK 480
Query: 401 ---MRRGEENWKDKLRP 414
EE +LRP
Sbjct: 481 GGDREEYEEFCNKELRP 497
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ55|CIPKJ_ARATH CBL-interacting serine/threonine-protein kinase 19 OS=Arabidopsis thaliana GN=CIPK19 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 436 bits (1122), Expect = e-121, Method: Compositional matrix adjust.
Identities = 221/428 (51%), Positives = 289/428 (67%), Gaps = 56/428 (13%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
+ GKYE+G+++G G FAKVY RN ++G+SVAIK + K+K+L+ GL AH+KREISI+ R+
Sbjct: 24 ILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRRV 83
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPNIV+L+EV+ATK+KIYFVME+ KGGELF K++KGR E+++R+YFQQLISAV +CH
Sbjct: 84 RHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAVSFCHF 143
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRDLK ENLLLDEN +LK+SDFGLSAV +QIR DG+ HT CGTPAYVAPE+LA+KG
Sbjct: 144 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 203
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAKVD+WSCGV+LFVL AG+LPF+D N+MAMY+KIY+G++RCP+W ++ + R+L
Sbjct: 204 YDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRML 263
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSE-------------- 299
+T P R T+ +I+ WFKK +K KF ED D CNV +
Sbjct: 264 ETKPERRFTMPDIMETSWFKKGFKHIKFYVED----DHQLCNVADDDEIESIESVSGRSS 319
Query: 300 -----------------------KYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFL 336
LNAFD+IS S GF+LSGLF+D RF+
Sbjct: 320 TVSEPEDFESFDGRRRGGSMPRPASLNAFDLISFSPGFDLSGLFEDDGEGS------RFV 373
Query: 337 SNETPEKILEKVEEVARLVADGDRLAVTKKEWGAKLEGQ-----NGNFTMVIGIDRLTDD 391
S +I+ K+EE+AR+V+ V KK+ LEG G ++ I LT
Sbjct: 374 SGAPVGQIISKLEEIARIVS----FTVRKKDCKVSLEGSREGSMKGPLSIAAEIFELTPA 429
Query: 392 LVVVEIKK 399
LVVVE+KK
Sbjct: 430 LVVVEVKK 437
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7X996|CIPK2_ORYSJ CBL-interacting protein kinase 2 OS=Oryza sativa subsp. japonica GN=CIPK2 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 422 bits (1085), Expect = e-117, Method: Compositional matrix adjust.
Identities = 213/405 (52%), Positives = 289/405 (71%), Gaps = 27/405 (6%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L KYE+GK++G G FAKVYH RN T +SVAIK + K+K+L+GGL +KREIS+M +
Sbjct: 9 LMKKYEMGKLLGQGTFAKVYHARNTETSESVAIKMIDKEKVLKGGLMDQIKREISVMKLV 68
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPNIV+LYEV+ATK KIYFV+E KGGELF K+ +GR E +R+YFQQLI AV++CHS
Sbjct: 69 RHPNIVQLYEVMATKTKIYFVLEHVKGGELFNKVQRGRLKEDAARKYFQQLICAVDFCHS 128
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRDLK ENLLLDEN +LK+SDFGLSA+ + R DG+LHT CGTPAYVAPE++ ++G
Sbjct: 129 RGVYHRDLKPENLLLDENSNLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRRG 188
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAK D+WSCGV+LFVL AGYLPF+D NLM MY+KI K E++CP W + D++ + R+L
Sbjct: 189 YDGAKADIWSCGVILFVLLAGYLPFHDKNLMDMYKKIGKAEFKCPSWFNTDVRRLLLRIL 248
Query: 254 DTDPATRITVDEILRDPWFKK--DYKERKF---PHE--------DFDLKDSVGCNVGSEK 300
D +P+TRI++D+I+ +PWF+K D K ++ P + DFD +S
Sbjct: 249 DPNPSTRISMDKIMENPWFRKGLDAKLLRYNLQPKDAIPVDMSTDFDSFNSAPTLEKKPS 308
Query: 301 YLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDR 360
LNAFDIISLS+G +LSG+F++ + ++ +F S T I+ K+E++A+ G R
Sbjct: 309 NLNAFDIISLSTGLDLSGMFEESDKKES-----KFTSTSTASTIISKIEDIAK----GLR 359
Query: 361 LAVTKKEWG-AKLEGQNGNFTMVIGID----RLTDDLVVVEIKKS 400
L +TKK+ G K+EG V+GID +T + +VE+KK+
Sbjct: 360 LKLTKKDGGLLKMEGSKPGRKGVMGIDAEIFEVTPNFHLVELKKT 404
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LWM4|CIPK5_ORYSJ CBL-interacting protein kinase 5 OS=Oryza sativa subsp. japonica GN=CIPK5 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 417 bits (1073), Expect = e-116, Method: Compositional matrix adjust.
Identities = 217/430 (50%), Positives = 291/430 (67%), Gaps = 33/430 (7%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L +YE+G+++G G FAKVYH RN+ + QSVAIK + K+K+LR G+ +KREISIM +
Sbjct: 8 LMNRYELGRMLGQGTFAKVYHARNLASNQSVAIKVIDKEKVLRVGMIDQIKREISIMRLV 67
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPNIV+L+EV+A+K+KIYF ME+ +GGELF+++++GR E +R+YFQQLI AV++CHS
Sbjct: 68 RHPNIVQLHEVMASKSKIYFAMEYVRGGELFSRVARGRLKEDAARKYFQQLIGAVDFCHS 127
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRDLK ENLL+DEN +LK+SDFGLSA KE + DG+LHT CGTPAYVAPEI+ K+G
Sbjct: 128 RGVYHRDLKPENLLVDENGNLKVSDFGLSAFKECQKQDGLLHTTCGTPAYVAPEIINKRG 187
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAK D+WSCGV+LFVL AGYLPF+D NLM MYRKI KG+ + P+W + D++ + RLL
Sbjct: 188 YDGAKADIWSCGVILFVLLAGYLPFHDSNLMEMYRKISKGDVKFPQWFTTDVRRLLSRLL 247
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKF---PHEDFDLKDSVGC-------NVGSEK--- 300
D +P RITV++++ PWFKK YK P+E +LKD N G K
Sbjct: 248 DPNPNIRITVEKLVEHPWFKKGYKPAVMLSQPNESNNLKDVHTAFSADHKDNEGKAKEPA 307
Query: 301 ------YLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARL 354
LNAFDIISLS GF+LSGLF+ N+ + RF++ + I+ K+E+
Sbjct: 308 SSLKPVSLNAFDIISLSKGFDLSGLFE---NDKEQKADSRFMTQKPASAIVSKLEQ---- 360
Query: 355 VADGDRLAVTKKEWGAKL----EGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEENWK- 409
+A+ + V K++ KL EG+ G + I +T VVE+KKS E K
Sbjct: 361 IAETESFKVKKQDGLVKLQGSKEGRKGQLAIDAEIFEVTPSFFVVEVKKSAGDTLEYEKF 420
Query: 410 --DKLRPAAR 417
LRP+ R
Sbjct: 421 CNKGLRPSLR 430
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Oryza sativa subsp. japonica (taxid: 39947) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FJ54|CIPKK_ARATH CBL-interacting serine/threonine-protein kinase 20 OS=Arabidopsis thaliana GN=CIPK20 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-114, Method: Compositional matrix adjust.
Identities = 205/401 (51%), Positives = 288/401 (71%), Gaps = 21/401 (5%)
Query: 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
+ L KYE+G+++G G FAKVYH RN++TG+SVAIK + KQK+ + GL +KREIS+M
Sbjct: 6 IVLMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMR 65
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
+RHP++V L+EV+A+K KIYF ME+ KGGELF K+SKG+ E ++R+YFQQLI A++YC
Sbjct: 66 LVRHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYC 125
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK 191
HSRGV+HRDLK ENLLLDEN DLKISDFGLSA++E + DG+LHT CGTPAYVAPE++ K
Sbjct: 126 HSRGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGK 185
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251
KGYDGAK D+WSCGVVL+VL AG+LPF++ NL+ MYRKI KGE++CP W P++K + R
Sbjct: 186 KGYDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSR 245
Query: 252 LLDTDPATRITVDEILRDPWFKKDYKERKFP-----HEDFDLKDSVGC--NVGSEKYLNA 304
+LD +P +RI +++I+ + WF+K +K+ + P H+ L V +V Y NA
Sbjct: 246 ILDPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMSY-NA 304
Query: 305 FDII-SLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAV 363
FD+I SLS GF+LSGLF+ +++ +F + + ++I+ K EE+A +R +
Sbjct: 305 FDLISSLSQGFDLSGLFEKEERSES-----KFTTKKDAKEIVSKFEEIA---TSSERFNL 356
Query: 364 TKKEWGAKL----EGQNGNFTMVIGIDRLTDDLVVVEIKKS 400
TK + G K+ EG+ G+ + + I +T+ +VE KKS
Sbjct: 357 TKSDVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKS 397
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner (By similarity). Required for the abscisic acid-mediated (ABA) signaling pathway involved in seed germination and growth elongation inhibition. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O22971|CIPKD_ARATH CBL-interacting serine/threonine-protein kinase 13 OS=Arabidopsis thaliana GN=CIPK13 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 413 bits (1062), Expect = e-114, Method: Compositional matrix adjust.
Identities = 216/442 (48%), Positives = 290/442 (65%), Gaps = 58/442 (13%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L KYE+GK++G G+FAKVY RN+ +G+ VAIK + K+KI++ GL H+KREISI+ R+
Sbjct: 53 LMDKYEIGKLLGHGSFAKVYLARNIHSGEDVAIKVIDKEKIVKSGLAGHIKREISILRRV 112
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHP IV L EV+ATK KIY VME+ +GGEL+ +++GR E +RRYFQQLIS+V +CHS
Sbjct: 113 RHPYIVHLLEVMATKTKIYIVMEYVRGGELYNTVARGRLREGTARRYFQQLISSVAFCHS 172
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRDLKLENLLLD+ ++K+SDFGLS V EQ++ +G+ T CGTPAY+APE+L +KG
Sbjct: 173 RGVYHRDLKLENLLLDDKGNVKVSDFGLSVVSEQLKQEGICQTFCGTPAYLAPEVLTRKG 232
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
Y+GAK D+WSCGV+LFVL AGYLPF+D N++ MY KIYKG+++CPKW SP+L + R+L
Sbjct: 233 YEGAKADIWSCGVILFVLMAGYLPFDDKNILVMYTKIYKGQFKCPKWFSPELARLVTRML 292
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHE----------------------------- 284
DT+P TRIT+ EI++ WFKK +K KF E
Sbjct: 293 DTNPDTRITIPEIMKHRWFKKGFKHVKFYIENDKLCREDDDNDDDDSSSLSSGRSSTASE 352
Query: 285 ---DFDLK--DSVGCNVGSEKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNE 339
+FD+K DS + LNAFDI+S S +LSGLF++ RF+S
Sbjct: 353 GDAEFDIKRVDS----MPRPASLNAFDILSFS---DLSGLFEEGGQ------GARFVSAA 399
Query: 340 TPEKILEKVEEVARLVADGDRLAVTKKEWGAKL----EGQNGNFTMVIGIDRLTDDLVVV 395
KI+ K+EE+A+ V + V KK+W +L EG G T+ + I LT LVVV
Sbjct: 400 PMTKIISKLEEIAKEV----KFMVRKKDWSVRLEGCREGAKGPLTIRVEIFELTPSLVVV 455
Query: 396 EIKK---SMRRGEENWKDKLRP 414
E+KK ++ EE +LRP
Sbjct: 456 EVKKKGGNIEEYEEFCNKELRP 477
|
CIPK serine-threonine protein kinases interact with CBL proteins. Binding of a CBL protein to the regulatory NAF domain of CIPK protein lead to the activation of the kinase in a calcium-dependent manner. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | ||||||
| 255588237 | 446 | CBL-interacting serine/threonine-protein | 0.928 | 0.867 | 0.704 | 1e-162 | |
| 449532559 | 432 | PREDICTED: CBL-interacting serine/threon | 0.947 | 0.914 | 0.691 | 1e-161 | |
| 225439649 | 435 | PREDICTED: CBL-interacting serine/threon | 0.959 | 0.919 | 0.688 | 1e-161 | |
| 449464410 | 432 | PREDICTED: CBL-interacting serine/threon | 0.947 | 0.914 | 0.688 | 1e-160 | |
| 224993584 | 430 | CBL-interacting protein kinase 21 [Popul | 0.983 | 0.953 | 0.672 | 1e-160 | |
| 147865635 | 435 | hypothetical protein VITISV_039900 [Viti | 0.959 | 0.919 | 0.685 | 1e-160 | |
| 224140583 | 430 | predicted protein [Populus trichocarpa] | 0.983 | 0.953 | 0.684 | 1e-158 | |
| 225434363 | 436 | PREDICTED: CBL-interacting serine/threon | 0.959 | 0.917 | 0.695 | 1e-153 | |
| 329025152 | 436 | CBL-interacting protein kinase [Solanum | 0.978 | 0.935 | 0.669 | 1e-151 | |
| 347953954 | 438 | CBL-interacting protein kinase 14 [Solan | 0.973 | 0.926 | 0.664 | 1e-150 |
| >gi|255588237|ref|XP_002534545.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] gi|223525074|gb|EEF27838.1| CBL-interacting serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 578 bits (1491), Expect = e-162, Method: Compositional matrix adjust.
Identities = 288/409 (70%), Positives = 338/409 (82%), Gaps = 22/409 (5%)
Query: 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
+NLF KYE+GK++GCGAFAKVYH RNVRTGQ+VAIKAVSKQK+++GG A VKREISIM
Sbjct: 27 INLFDKYELGKLLGCGAFAKVYHARNVRTGQAVAIKAVSKQKVVKGGFVAQVKREISIMR 86
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
LRHPN+VKL EVLATK KIYFVMEFAKGGELF K++KGRFSE LSRRYFQQLI+AV YC
Sbjct: 87 LLRHPNVVKLLEVLATKTKIYFVMEFAKGGELFTKVAKGRFSENLSRRYFQQLITAVGYC 146
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK 191
H+RGVFHRDLK ENLLLDENWDLK+SDFGLSAVK+Q+RPDG+LHTLCGTPAYVAPEILAK
Sbjct: 147 HARGVFHRDLKPENLLLDENWDLKVSDFGLSAVKDQVRPDGLLHTLCGTPAYVAPEILAK 206
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251
KGYDGAKVD+WSCGV+L+VL AGYLPFND NLMAMYRKIY+G+++CPKWTSP+L+ F+ R
Sbjct: 207 KGYDGAKVDVWSCGVILYVLIAGYLPFNDTNLMAMYRKIYRGQFKCPKWTSPELRSFLSR 266
Query: 252 LLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLK---DSVGCNVGSEKYLNAFDII 308
LLDT+P TRIT++EIL DPWFKKDYK+ F EDFD K D+ C LNAF II
Sbjct: 267 LLDTNPETRITMEEILHDPWFKKDYKQINFNAEDFDFKPREDNQNC-------LNAFHII 319
Query: 309 SLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKKEW 368
S SSGF+LS LF++ + +D RF+S+ETP KI E+VEE+A VA+ +++ K W
Sbjct: 320 SFSSGFDLSCLFNESDISD------RFVSSETPAKITERVEEIA--VAENVKVS-KNKNW 370
Query: 369 GAKLEGQNGNFTMVIGIDRLTDDLVVVEIKK---SMRRGEENWKDKLRP 414
GAKLEG NGNF M I I +LTD LVVVE+K ++ G+ WKDKLRP
Sbjct: 371 GAKLEGPNGNFNMSIEIYQLTDKLVVVEMKGKEVNVIPGQGIWKDKLRP 419
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449532559|ref|XP_004173248.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 14-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 280/405 (69%), Positives = 334/405 (82%), Gaps = 10/405 (2%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
LFGKYE+GK++GCGAFAKVYHGRNV TGQSVAIKAV+K K+L+GG TAHVKREI+IM RL
Sbjct: 24 LFGKYELGKLLGCGAFAKVYHGRNVLTGQSVAIKAVNKLKVLKGGFTAHVKREIAIMRRL 83
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPN+V+L+EVLATK KIYFVME+AKGGELF K+SKGRFSE LSRRYFQQLI+AV YCHS
Sbjct: 84 RHPNVVRLFEVLATKTKIYFVMEYAKGGELFGKVSKGRFSENLSRRYFQQLITAVGYCHS 143
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RG+FHRDLK ENLLLD+N+DL++SDFGLSA+ +QIRPDG+LHTLCGTPAYVAPEILAKKG
Sbjct: 144 RGIFHRDLKPENLLLDDNFDLRVSDFGLSALADQIRPDGLLHTLCGTPAYVAPEILAKKG 203
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAK+D+WSCG++L+VL AGYLPFND NLMAMYRKIY+G++RCPKWTSPDL+ FI RLL
Sbjct: 204 YDGAKIDVWSCGIILYVLTAGYLPFNDSNLMAMYRKIYRGDFRCPKWTSPDLQRFISRLL 263
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDS-VGCNVGSEKYLNAFDIISLSS 312
DT+P TRITVDEI RDPWF K ++E KF ++ D S V +V + K LNAFD+IS S
Sbjct: 264 DTNPETRITVDEIQRDPWFVKGFQEEKFQFQELDDSASDVYGDVNNAKCLNAFDLISFSP 323
Query: 313 GFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKKEWGAKL 372
GF+L+GL + + C ERFLS E+PEKI+ VEEV + + AV K WG K+
Sbjct: 324 GFDLTGLIKE--ETEFSSCVERFLSAESPEKIIVTVEEVTK----SENAAVEKNGWGMKV 377
Query: 373 EGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEEN---WKDKLRP 414
EG +G F +VI I RLT++LVVVEIK +R E++ WKD LRP
Sbjct: 378 EGLDGGFVVVIDIFRLTEELVVVEIKNRVREIEQDRQIWKDVLRP 422
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225439649|ref|XP_002269923.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 14 isoform 1 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 573 bits (1476), Expect = e-161, Method: Compositional matrix adjust.
Identities = 285/414 (68%), Positives = 339/414 (81%), Gaps = 14/414 (3%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
DI E+ LFGKY VGK++G GAFAKVYH RN+RTGQSVAIKAVSK+K+++GGLTAHVKRE
Sbjct: 14 DIQPEITLFGKYAVGKLLGYGAFAKVYHARNIRTGQSVAIKAVSKKKVMKGGLTAHVKRE 73
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126
ISIM RLRHP+IVKLYEVLATK KIYFVME+AKGGELF KI+KGRFSE LSRRYFQQLIS
Sbjct: 74 ISIMRRLRHPHIVKLYEVLATKTKIYFVMEYAKGGELFTKIAKGRFSEDLSRRYFQQLIS 133
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
A+ YCHSRGVFHRDLK ENLLLDENW+LK+SDFGLSAVK+QIR DG+LHTLCGTPAYVAP
Sbjct: 134 AIGYCHSRGVFHRDLKPENLLLDENWNLKVSDFGLSAVKDQIRADGLLHTLCGTPAYVAP 193
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLK 246
EILAKKGYDG KVD+W+CG++L+VLNAGYLPFNDPNLM MYRKIYKGE+RCPKWTSPD++
Sbjct: 194 EILAKKGYDGTKVDIWTCGIILYVLNAGYLPFNDPNLMGMYRKIYKGEFRCPKWTSPDMR 253
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFD 306
+ RLLDT+P TRITVDEI+RDPWF+K YKE KF H + + + +Y+NAF
Sbjct: 254 RLLSRLLDTNPETRITVDEIIRDPWFQKGYKEIKF-HVEDFDFKDHDDDDDNAEYMNAFH 312
Query: 307 IISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKK 366
IIS SSGF S + +D + ERF+S E+PEKI+EKVE+VA+ + + VT+K
Sbjct: 313 IISFSSGFEFSSMLND---SGISVAGERFVSAESPEKIIEKVEDVAK----KENVTVTRK 365
Query: 367 E-WGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKK-----SMRRGEENWKDKLRP 414
E WG LEGQNGNF +++ I RLT+ LV+VE++K + G+E W+D LRP
Sbjct: 366 ENWGVMLEGQNGNFALIMEIYRLTEKLVLVEVRKKEVDAGLGPGKEIWRDTLRP 419
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449464410|ref|XP_004149922.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 14-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 572 bits (1473), Expect = e-160, Method: Compositional matrix adjust.
Identities = 279/405 (68%), Positives = 334/405 (82%), Gaps = 10/405 (2%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
LFGKYE+GK++GCGAFAKVYHGRNV TGQSVAIKAV+K K+L+GG TAHVKREI+IM RL
Sbjct: 24 LFGKYELGKLLGCGAFAKVYHGRNVLTGQSVAIKAVNKLKVLKGGFTAHVKREIAIMRRL 83
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPN+V+L+EVLATK KIYFVME+AKGGELF K+SKGRFSE LSRRYFQQLI+AV YCHS
Sbjct: 84 RHPNVVRLFEVLATKTKIYFVMEYAKGGELFGKVSKGRFSENLSRRYFQQLITAVGYCHS 143
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RG+FHRDLK ENLLLD+N+DL++SDFGLSA+ +QIRPDG+LHTLCGTPAYVAPEILAKKG
Sbjct: 144 RGIFHRDLKPENLLLDDNFDLRVSDFGLSALADQIRPDGLLHTLCGTPAYVAPEILAKKG 203
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAK+D+WSCG++L+VL AGYLPFND NLMAMYRKIY+G++RCPKWTSPDL+ FI RLL
Sbjct: 204 YDGAKIDVWSCGIILYVLTAGYLPFNDSNLMAMYRKIYRGDFRCPKWTSPDLQRFISRLL 263
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDS-VGCNVGSEKYLNAFDIISLSS 312
DT+P +RITVDEI RDPWF K ++E KF ++ D S V +V + K LNAFD+IS S
Sbjct: 264 DTNPESRITVDEIQRDPWFVKGFQEEKFQFQELDDSASDVYGDVNNAKCLNAFDLISFSP 323
Query: 313 GFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKKEWGAKL 372
GF+L+GL + + C ERFLS E+PEKI+ VEEV + + AV K WG K+
Sbjct: 324 GFDLTGLIKE--ETEFSSCVERFLSAESPEKIIVTVEEVTK----SENAAVEKNGWGMKV 377
Query: 373 EGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEEN---WKDKLRP 414
EG +G F +VI I RLT++LVVVEIK +R E++ WKD LRP
Sbjct: 378 EGLDGGFVVVIDIFRLTEELVVVEIKNRVREIEQDRQIWKDVLRP 422
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224993584|gb|ACN76471.1| CBL-interacting protein kinase 21 [Populus euphratica] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1470), Expect = e-160, Method: Compositional matrix adjust.
Identities = 283/421 (67%), Positives = 339/421 (80%), Gaps = 11/421 (2%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT 60
+G+ + EVNL GKYE+GK++G GAFAKVYH RNV TGQSVAIKAVSK K+++GG
Sbjct: 4 VGETPPASAGEVNLLGKYELGKLLGYGAFAKVYHARNVSTGQSVAIKAVSKAKVMKGGFV 63
Query: 61 AHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRY 120
AHVKREISIMSRLRH +IV+L+EVLATK K+YFVME+AKGGELF +ISKGRFSE LSRRY
Sbjct: 64 AHVKREISIMSRLRHAHIVRLHEVLATKGKVYFVMEYAKGGELFTRISKGRFSEDLSRRY 123
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
FQQLI+AV YCH+RGVFHRDLK ENLLLDEN++LKI+DFGLSAV +Q+RPDG+LHTLCG
Sbjct: 124 FQQLITAVGYCHARGVFHRDLKPENLLLDENFNLKITDFGLSAVTDQVRPDGLLHTLCGA 183
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240
PAYVAPE+LAKKGYDGAKVD+WSCGVVLFVL AGYLPFND NLMAMYRKIYKG+YRCPKW
Sbjct: 184 PAYVAPELLAKKGYDGAKVDIWSCGVVLFVLIAGYLPFNDTNLMAMYRKIYKGQYRCPKW 243
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED-FDLKDSVGCNVGSE 299
TSP+LK + RLLD +P TRIT+D I+ DPWFKK +KE K + D FD + E
Sbjct: 244 TSPELKRLLSRLLDANPDTRITIDMIINDPWFKKGFKEEKNLYLDEFDFDKGFEED-EDE 302
Query: 300 KYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGD 359
K LNAFDIIS SSG++LS + FN +D ERF+S E PEK++E++EEVAR +G
Sbjct: 303 KSLNAFDIISFSSGYDLSRM---FNESDTMILTERFVSAEKPEKVMERIEEVAR--KEGL 357
Query: 360 RLAVTKKEWGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKK---SMRRGEENWKDKLRPAA 416
+A +K WGAKLEG NGNF M+I + RLTD LV++E+K+ M G+E W+D+L+P
Sbjct: 358 EIA-KRKNWGAKLEGWNGNFIMIIEVHRLTDHLVMIEVKEKKFKMGPGQETWEDQLKPQL 416
Query: 417 R 417
R
Sbjct: 417 R 417
|
Source: Populus euphratica Species: Populus euphratica Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147865635|emb|CAN83248.1| hypothetical protein VITISV_039900 [Vitis vinifera] gi|229609817|gb|ACQ83524.1| CBL-interacting protein kinase 08 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 570 bits (1469), Expect = e-160, Method: Compositional matrix adjust.
Identities = 284/414 (68%), Positives = 338/414 (81%), Gaps = 14/414 (3%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
DI E+ LFGKY VGK++G GAFAKVYH RN+RTGQSVAIKAVSK+K+++GGLTAHVKRE
Sbjct: 14 DIQPEITLFGKYAVGKLLGYGAFAKVYHARNIRTGQSVAIKAVSKKKVMKGGLTAHVKRE 73
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126
ISIM RLRHP+IVKLYEVLATK KIYFVME+AKGGELF KI+KGRFSE LSRRYFQQLIS
Sbjct: 74 ISIMRRLRHPHIVKLYEVLATKTKIYFVMEYAKGGELFTKIAKGRFSEDLSRRYFQQLIS 133
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
A+ YCHSRGVFHRDLK ENLLLDENW+LK+SDFGLSAVK+QIR DG+LHTLCGTPAYVAP
Sbjct: 134 AIGYCHSRGVFHRDLKPENLLLDENWNLKVSDFGLSAVKDQIRADGLLHTLCGTPAYVAP 193
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLK 246
EILAKKGYDG KVD+W+CG++L+VLNAGYLPFNDPNLM MYRKIYKGE+RCPKWTSPD++
Sbjct: 194 EILAKKGYDGTKVDIWTCGIILYVLNAGYLPFNDPNLMGMYRKIYKGEFRCPKWTSPDMR 253
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFD 306
+ RLLDT+P TRITVDEI+RDPWF+K YKE KF H + + + +Y+NAF
Sbjct: 254 RLLSRLLDTNPETRITVDEIIRDPWFQKGYKEIKF-HVEDFDFKDHDDDDDNAEYMNAFH 312
Query: 307 IISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKK 366
IIS SSGF S + +D + ERF+S E+PEKI+EKVE+VA+ + + VT+K
Sbjct: 313 IISFSSGFEFSSMLND---SGISVAGERFVSAESPEKIIEKVEDVAK----KENVTVTRK 365
Query: 367 E-WGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKK-----SMRRGEENWKDKLRP 414
E WG LEGQNGNF +++ I RLT+ LV+VE++K + +E W+D LRP
Sbjct: 366 ENWGVMLEGQNGNFALIMEIYRLTEKLVLVEVRKKEVDAGLGPXKEIWRDTLRP 419
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224140583|ref|XP_002323661.1| predicted protein [Populus trichocarpa] gi|116265958|gb|ABJ91227.1| CBL-interacting protein kinase 21 [Populus trichocarpa] gi|222868291|gb|EEF05422.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 563 bits (1450), Expect = e-158, Method: Compositional matrix adjust.
Identities = 288/421 (68%), Positives = 341/421 (80%), Gaps = 11/421 (2%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT 60
+G+ + EVNLFGKYE+GK++G GAFAKVYH RNV TGQSVAIKAVSK K+++ G
Sbjct: 4 VGETPPASAGEVNLFGKYELGKLLGYGAFAKVYHARNVSTGQSVAIKAVSKAKVMKEGFV 63
Query: 61 AHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRY 120
AHVKREISIMSRLRH +IV+L+EVLATK K+YFVME+AKGGELF+KISKGRFSE LSRRY
Sbjct: 64 AHVKREISIMSRLRHAHIVRLHEVLATKGKVYFVMEYAKGGELFSKISKGRFSEDLSRRY 123
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
FQQLI+AV YCH+RGVFHRDLK ENLLLDEN++LKI+DFGLSAV EQ+RPDG+LHTLCGT
Sbjct: 124 FQQLITAVGYCHARGVFHRDLKPENLLLDENFNLKITDFGLSAVTEQVRPDGLLHTLCGT 183
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240
PAYVAPE+LAKKGYDGAKVD+WSCGVVLFVL AGYLPFND NLMAMYRKIYKG+YRCPKW
Sbjct: 184 PAYVAPELLAKKGYDGAKVDIWSCGVVLFVLIAGYLPFNDTNLMAMYRKIYKGQYRCPKW 243
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED-FDLKDSVGCNVGSE 299
TSPDLK + RLLD +P TRIT+D I+ DPWFKK +KE K + D FD D E
Sbjct: 244 TSPDLKRLLSRLLDANPETRITIDMIINDPWFKKGFKEEKKLYLDEFDF-DKGFEEEEDE 302
Query: 300 KYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGD 359
K LNAFDIIS SSG++LS + FN +D ERF+S E PEK++E++EEVAR +G
Sbjct: 303 KSLNAFDIISFSSGYDLSRM---FNESDTMILTERFVSAEKPEKVMERIEEVAR--KEGL 357
Query: 360 RLAVTKKEWGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRR---GEENWKDKLRPAA 416
+A +K WGAKLEG NGNF M+I + RLTD LV++E+K+ + G+E W+DKL+P
Sbjct: 358 EIA-KRKNWGAKLEGCNGNFIMIIEVHRLTDHLVMIEVKEKKFKIGPGQETWEDKLKPQL 416
Query: 417 R 417
R
Sbjct: 417 R 417
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225434363|ref|XP_002268622.1| PREDICTED: CBL-interacting serine/threonine-protein kinase 11 [Vitis vinifera] gi|229609821|gb|ACQ83526.1| CBL-interacting protein kinase 10 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 548 bits (1412), Expect = e-153, Method: Compositional matrix adjust.
Identities = 286/411 (69%), Positives = 326/411 (79%), Gaps = 11/411 (2%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
S E LFGKYE+G+++GCGAFAKVYH RN+RTGQSVAIKA+ K+KI+ L A+VKREIS
Sbjct: 17 SSEKALFGKYELGRLLGCGAFAKVYHARNIRTGQSVAIKAICKKKIVGSNLMANVKREIS 76
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
IM RL+HP+IVKLYEVLATK KIY VMEF KGGELFAK++KGRFSE LSRRYFQQLISAV
Sbjct: 77 IMRRLQHPHIVKLYEVLATKTKIYCVMEFVKGGELFAKVAKGRFSEDLSRRYFQQLISAV 136
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
YCHSRGVFHRDLK ENLL+DEN LK+SDFGLSA+ +QIR DG+LHTLCGTPAYVAPEI
Sbjct: 137 GYCHSRGVFHRDLKPENLLVDENGCLKVSDFGLSALTDQIRLDGLLHTLCGTPAYVAPEI 196
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248
L KKGYDGAKVD+WSCGV+LFVLNAGYLPFNDPNLMAMY+KIYKGE+RCPKW SPDLK F
Sbjct: 197 LTKKGYDGAKVDVWSCGVILFVLNAGYLPFNDPNLMAMYKKIYKGEFRCPKWMSPDLKRF 256
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDII 308
+ RLLDT+P TRITVDEIL+DPWF+K YKE KF EDF LK S LNAFDII
Sbjct: 257 LSRLLDTNPNTRITVDEILQDPWFRKGYKEVKFHEEDFGLKSEK--EDRSPTNLNAFDII 314
Query: 309 SLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVT-KKE 367
S SSG NLSGLF+D + + +ERF+S E +EK+ E +A+G+ L V KKE
Sbjct: 315 SFSSGLNLSGLFNDSSKSSPDD-DERFVSAEP----VEKIIEKIEEIAEGENLTVNWKKE 369
Query: 368 WGAKLEGQNGNFTMVIGIDRLTDDLVVVEI---KKSMRRGEENWKDKLRPA 415
WG L+G NGNF + + IDRLT DLVVVE+ WKDKLRPA
Sbjct: 370 WGVDLQGPNGNFIIGVQIDRLTHDLVVVEVRRRAGDAAAYAAAWKDKLRPA 420
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|329025152|gb|AEB71559.1| CBL-interacting protein kinase [Solanum chacoense] | Back alignment and taxonomy information |
|---|
Score = 542 bits (1396), Expect = e-151, Method: Compositional matrix adjust.
Identities = 279/417 (66%), Positives = 332/417 (79%), Gaps = 9/417 (2%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
G TG ++NLFGKYEVGK++GCGAFAKVYH R+VRT QSVAIK VSKQKIL+GG
Sbjct: 18 GTITGAGDFKLNLFGKYEVGKLLGCGAFAKVYHARDVRTRQSVAIKTVSKQKILKGGFME 77
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYF 121
HVKREISIM RLRHP+IV+L+EVLATK KIY+VMEFAKGGELF K+SKGRFSE LSRRYF
Sbjct: 78 HVKREISIMRRLRHPHIVRLHEVLATKTKIYYVMEFAKGGELFTKVSKGRFSEDLSRRYF 137
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
QQLISAV+YCHSRGV+HRDLKLENLLLDENWDLK++DFGLSAV +QIRPDG+LHTLCGTP
Sbjct: 138 QQLISAVDYCHSRGVYHRDLKLENLLLDENWDLKVTDFGLSAVTDQIRPDGLLHTLCGTP 197
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT 241
AYVAPEIL KKGY+GAKVD+WSCG++LFVLNAGYLPF D NLMAMYRKIYKGE+RCPKWT
Sbjct: 198 AYVAPEILEKKGYNGAKVDIWSCGIILFVLNAGYLPFTDANLMAMYRKIYKGEFRCPKWT 257
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED-FDLKDSVGCNVGSEK 300
S LK + RLLDT+P TRI++++I DPWF+K YKE K D F+LK++ N K
Sbjct: 258 SHGLKLLLTRLLDTNPETRISIEQIRNDPWFRKGYKEVKSHFGDEFELKNNSDVNRDG-K 316
Query: 301 YLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDR 360
+LNAF IISLSSG NLSGL + ERF+S +PE+I +++EEVA+ A+G R
Sbjct: 317 FLNAFHIISLSSGVNLSGLLKSLGGKETVDV-ERFVSASSPERITQRIEEVAK--AEGIR 373
Query: 361 LAVTKKEWGAKLEGQNGNFTMVIGIDRLTDDLVVVEIK-KSMRRGE--ENWKDKLRP 414
+ K G ++EGQNG F + I+RLT+ +V+VE+K K + G E WK K +P
Sbjct: 374 VT-GKNSAGVRVEGQNGKFVLATEINRLTEKVVIVEVKRKEIGAGPDGELWKLKFKP 429
|
Source: Solanum chacoense Species: Solanum chacoense Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|347953954|gb|AEP33597.1| CBL-interacting protein kinase 14 [Solanum lycopersicum] | Back alignment and taxonomy information |
|---|
Score = 538 bits (1385), Expect = e-150, Method: Compositional matrix adjust.
Identities = 277/417 (66%), Positives = 330/417 (79%), Gaps = 11/417 (2%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
G TGD ++N+FGKYEVGK++GCGAFAKVYH R+VRT QSVAIK VSKQKIL+GG T
Sbjct: 22 GAGTGDF--KLNIFGKYEVGKLLGCGAFAKVYHARDVRTRQSVAIKTVSKQKILKGGFTE 79
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYF 121
HVKREISIM RLRHP+IV+L+EVLATK K+Y+VMEFAKGGELF K+SKGRFSE LSRRYF
Sbjct: 80 HVKREISIMRRLRHPHIVRLHEVLATKTKVYYVMEFAKGGELFTKVSKGRFSEDLSRRYF 139
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
QQLISAV+YCHSRGV+HRDLKLENLLLDENWDLK++DFGLSAV +QIRPDG LHTLCGTP
Sbjct: 140 QQLISAVDYCHSRGVYHRDLKLENLLLDENWDLKVTDFGLSAVTDQIRPDGFLHTLCGTP 199
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT 241
AYVAPEIL KKGY+GAKVD+WSCG++LFVLNAGYLPF D NLMAMYRKIYKGE+RCPKWT
Sbjct: 200 AYVAPEILEKKGYNGAKVDIWSCGIILFVLNAGYLPFTDANLMAMYRKIYKGEFRCPKWT 259
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED-FDLKDSVGCNVGSEK 300
S LK + RLLDT+P TRI++++I DPWF+K YKE K D F+LK S N K
Sbjct: 260 SHGLKLLLTRLLDTNPDTRISIEQIRNDPWFRKGYKEVKSHFGDEFELKSSSDLNRDG-K 318
Query: 301 YLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDR 360
+LNAF IISLSSG NLSGL + ERF+S E+I +++EE+A+ A+G R
Sbjct: 319 FLNAFHIISLSSGVNLSGLLKSLGGKETVDV-ERFVSASPAERITQRIEEIAK--AEGMR 375
Query: 361 LAVTKKEWGAKLEGQNGNFTMVIGIDRLTDDLVVVEIK-KSMRRGE--ENWKDKLRP 414
+ K G ++EGQNG F + I+RLT+ +V+VE+K K + G E W+ K +P
Sbjct: 376 VT-GKNGAGVRVEGQNGKFVLATEINRLTEKVVIVEVKRKEIGAGADGEVWELKFKP 431
|
Source: Solanum lycopersicum Species: Solanum lycopersicum Genus: Solanum Family: Solanaceae Order: Solanales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 417 | ||||||
| TAIR|locus:2181057 | 442 | SR1 "serine/threonine protein | 0.954 | 0.900 | 0.609 | 4.8e-133 | |
| TAIR|locus:2065781 | 435 | SIP4 "SOS3-interacting protein | 0.944 | 0.905 | 0.585 | 1.3e-118 | |
| TAIR|locus:2124072 | 489 | CIPK12 "CBL-interacting protei | 0.697 | 0.595 | 0.587 | 1.3e-105 | |
| TAIR|locus:2029974 | 520 | CIPK18 "CBL-interacting protei | 0.652 | 0.523 | 0.599 | 6.5e-104 | |
| UNIPROTKB|Q84XC0 | 516 | Q84XC0 "Calcineurin B-like-int | 0.671 | 0.542 | 0.594 | 2.8e-103 | |
| TAIR|locus:2040824 | 502 | CIPK13 "CBL-interacting protei | 0.642 | 0.533 | 0.570 | 1.1e-97 | |
| TAIR|locus:2152380 | 439 | CIPK20 "CBL-interacting protei | 0.908 | 0.863 | 0.459 | 1.3e-93 | |
| TAIR|locus:2126749 | 441 | SIP3 "SOS3-interacting protein | 0.908 | 0.859 | 0.463 | 2.7e-93 | |
| TAIR|locus:2152370 | 483 | CIPK19 "CBL-interacting protei | 0.738 | 0.637 | 0.538 | 3.4e-93 | |
| TAIR|locus:2161273 | 479 | SIP1 "SOS3-interacting protein | 0.640 | 0.557 | 0.539 | 6.3e-89 |
| TAIR|locus:2181057 SR1 "serine/threonine protein kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 4.8e-133, P = 4.8e-133
Identities = 253/415 (60%), Positives = 311/415 (74%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
+R LFGKYEVGK++GCGAFAKVYHGR+ TGQSVAIK VSKQ++ +GGL +++REI+
Sbjct: 13 NRRGQLFGKYEVGKLVGCGAFAKVYHGRSTATGQSVAIKVVSKQRLQKGGLNGNIQREIA 72
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
IM RLRHP+IV+L+EVLATK+KI+FVMEFAKGGELFAK+SKGRF E LSRRYFQQLISAV
Sbjct: 73 IMHRLRHPSIVRLFEVLATKSKIFFVMEFAKGGELFAKVSKGRFCEDLSRRYFQQLISAV 132
Query: 129 EYCHSRGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
YCHSRG+FHRD ISDFGLSA+ +QIRPDG+LHTLCGTPAYVAPE+
Sbjct: 133 GYCHSRGIFHRDLKPENLLLDEKLDLKISDFGLSALTDQIRPDGLLHTLCGTPAYVAPEV 192
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248
LAKKGYDGAK+D+WSCG++LFVLNAGYLPFND NLM MYRKIYKGE+R PKWTSPDL+
Sbjct: 193 LAKKGYDGAKIDIWSCGIILFVLNAGYLPFNDHNLMVMYRKIYKGEFRIPKWTSPDLRRL 252
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKER--KFPHEDFDLK---DSVGCNVGSEKYLN 303
+ RLLDT+P TRIT++EI+ DPWFK+ Y +R KF ED D+K D +G+ + +N
Sbjct: 253 LTRLLDTNPQTRITIEEIIHDPWFKQGYDDRMSKFHLEDSDMKLPADETDSEMGARR-MN 311
Query: 304 AFDIIXXXXXXXXXXXXDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAV 363
AFDII D D ERF+S T E+++E++EE+ + L V
Sbjct: 312 AFDIISGSPGFNLSGLFGDARKYDRV---ERFVSAWTAERVVERLEEIV----SAENLTV 364
Query: 364 TKKE-WGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRR---GEENWKDKLRP 414
KKE WG K+EGQ GNF MV+ I++LTD+LV++E++K R G + W D LRP
Sbjct: 365 AKKETWGMKIEGQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRP 419
|
|
| TAIR|locus:2065781 SIP4 "SOS3-interacting protein 4" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1168 (416.2 bits), Expect = 1.3e-118, P = 1.3e-118
Identities = 239/408 (58%), Positives = 300/408 (73%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-GLTAHVKREISIMSR 72
LFGKYE+GK++GCGAFAKV+H R+ RTGQSVA+K ++K+K+L L ++KREISIM R
Sbjct: 17 LFGKYELGKLLGCGAFAKVFHARDRRTGQSVAVKILNKKKLLTNPALANNIKREISIMRR 76
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYC 131
L HPNIVKL+EV+ATK+KI+F MEF KGGELF KISK GR SE LSRRYFQQLISAV YC
Sbjct: 77 LSHPNIVKLHEVMATKSKIFFAMEFVKGGELFNKISKHGRLSEDLSRRYFQQLISAVGYC 136
Query: 132 HSRGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK 191
H+RGV+HRD +SDFGLSA+ +QIRPDG+LHTLCGTPAYVAPEIL+K
Sbjct: 137 HARGVYHRDLKPENLLIDENGNLKVSDFGLSALTDQIRPDGLLHTLCGTPAYVAPEILSK 196
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251
KGY+GAKVD+WSCG+VLFVL AGYLPFNDPN+M MY+KIYKGEYR P+W SPDLK F+ R
Sbjct: 197 KGYEGAKVDVWSCGIVLFVLVAGYLPFNDPNVMNMYKKIYKGEYRFPRWMSPDLKRFVSR 256
Query: 252 LLDTDPATRITVDEILRDPWFKKD-YKERKFPHEDFDLKDS-VGCNVGSEKYLNAFDIIX 309
LLD +P TRIT+DEIL+DPWF + +K+ KF H+D +++D V ++ + K LNAFD+I
Sbjct: 257 LLDINPETRITIDEILKDPWFVRGGFKQIKF-HDD-EIEDQKVESSLEAVKSLNAFDLIS 314
Query: 310 XXXXXXXXXXXDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKKE-W 368
+N+ +ERFLS ++PE + E+VE AR + R+ K+E +
Sbjct: 315 YSSGLDLSGLFAGCSNSSGE--SERFLSEKSPEMLAEEVEGFAR--EENLRMKKKKEEEY 370
Query: 369 GAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGE---ENWKDKLR 413
G ++EGQNG F + I I RL D LVVVE ++ G+ E W KLR
Sbjct: 371 GFEMEGQNGKFGIGICISRLNDLLVVVEARRRGGDGDCYKEMWNGKLR 418
|
|
| TAIR|locus:2124072 CIPK12 "CBL-interacting protein kinase 12" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 949 (339.1 bits), Expect = 1.3e-105, Sum P(2) = 1.3e-105
Identities = 174/296 (58%), Positives = 226/296 (76%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
S + + G+YE+GK++G G FAKVY RNV+T +SVAIK + K+K+L+GGL AH+KREIS
Sbjct: 17 SPQALILGRYEMGKLLGHGTFAKVYLARNVKTNESVAIKVIDKEKVLKGGLIAHIKREIS 76
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
I+ R+RHPNIV+L+EV+ATKAKIYFVME+ +GGELF K++KGR E+++R+YFQQLISAV
Sbjct: 77 ILRRVRHPNIVQLFEVMATKAKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLISAV 136
Query: 129 EYCHSRGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
+CH+RGV+HRD +SDFGLSAV +QIR DG+ HT CGTPAYVAPE+
Sbjct: 137 TFCHARGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEV 196
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248
LA+KGYD AKVD+WSCGV+LFVL AGYLPF+D N+MAMY+KIY+GE+RCP+W S +L
Sbjct: 197 LARKGYDAAKVDIWSCGVILFVLMAGYLPFHDRNVMAMYKKIYRGEFRCPRWFSTELTRL 256
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNA 304
+ +LL+T+P R T EI+ + WFKK +K KF ED L CNV + L +
Sbjct: 257 LSKLLETNPEKRFTFPEIMENSWFKKGFKHIKFYVEDDKL-----CNVVDDDELES 307
|
|
| TAIR|locus:2029974 CIPK18 "CBL-interacting protein kinase 18" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 912 (326.1 bits), Expect = 6.5e-104, Sum P(2) = 6.5e-104
Identities = 163/272 (59%), Positives = 209/272 (76%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L GKYE+GK++G G FAKVY +N+++G VAIK + K+KI++ GL AH+KREISI+ R+
Sbjct: 70 LMGKYELGKLLGHGTFAKVYLAQNIKSGDKVAIKVIDKEKIMKSGLVAHIKREISILRRV 129
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHP IV L+EV+ATK+KIYFVME+ GGELF ++KGR E+ +RRYFQQLIS+V +CH
Sbjct: 130 RHPYIVHLFEVMATKSKIYFVMEYVGGGELFNTVAKGRLPEETARRYFQQLISSVSFCHG 189
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRD +SDFGLSAV EQ+R DG+ HT CGTPAY+APE+L +KG
Sbjct: 190 RGVYHRDLKPENLLLDNKGNLKVSDFGLSAVAEQLRQDGLCHTFCGTPAYIAPEVLTRKG 249
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YD AK D+WSCGV+LFVL AG++PF D N+M MY+KIYKGE+RCP+W S DL + RLL
Sbjct: 250 YDAAKADVWSCGVILFVLMAGHIPFYDKNIMVMYKKIYKGEFRCPRWFSSDLVRLLTRLL 309
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHED 285
DT+P TRIT+ EI+++ WFKK +K KF ED
Sbjct: 310 DTNPDTRITIPEIMKNRWFKKGFKHVKFYIED 341
|
|
| UNIPROTKB|Q84XC0 Q84XC0 "Calcineurin B-like-interacting protein kinase" [Pisum sativum (taxid:3888)] | Back alignment and assigned GO terms |
|---|
Score = 934 (333.8 bits), Expect = 2.8e-103, Sum P(2) = 2.8e-103
Identities = 170/286 (59%), Positives = 223/286 (77%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L G++E+GK++G G FAKV+ +N++TG++VAIK +SK KIL+ GL +H+KREISI+ R+
Sbjct: 22 LLGRFELGKLLGHGTFAKVHLAKNIKTGEAVAIKIISKDKILKSGLVSHIKREISILRRV 81
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPNIV+L+EV+ATK KIYFVME+ +GGELF K++KGR E+++R+YFQQLI AVE+CH+
Sbjct: 82 RHPNIVQLFEVMATKTKIYFVMEYVRGGELFNKVAKGRLKEEVARKYFQQLICAVEFCHA 141
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGVFHRD +SDFGLSAV ++I+ DG+ HT CGTPAYVAPE+L++KG
Sbjct: 142 RGVFHRDIKPENLLLDENGNLKVSDFGLSAVSDEIKQDGLFHTFCGTPAYVAPEVLSRKG 201
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252
YDG KVD+WSCGVVLFVL AGYLPF+DPN +M MY+KIYKG++RCP+W SP+L + RL
Sbjct: 202 YDGGKVDIWSCGVVLFVLMAGYLPFHDPNNVMVMYKKIYKGDFRCPRWFSPELVNLLTRL 261
Query: 253 LDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGS 298
LDT P TRI++ EI+ + WFK +K KF ED V CN+ S
Sbjct: 262 LDTKPQTRISIPEIMENRWFKIGFKRIKFYVED-----DVVCNLDS 302
|
|
| TAIR|locus:2040824 CIPK13 "CBL-interacting protein kinase 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 873 (312.4 bits), Expect = 1.1e-97, Sum P(2) = 1.1e-97
Identities = 153/268 (57%), Positives = 203/268 (75%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L KYE+GK++G G+FAKVY RN+ +G+ VAIK + K+KI++ GL H+KREISI+ R+
Sbjct: 53 LMDKYEIGKLLGHGSFAKVYLARNIHSGEDVAIKVIDKEKIVKSGLAGHIKREISILRRV 112
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHP IV L EV+ATK KIY VME+ +GGEL+ +++GR E +RRYFQQLIS+V +CHS
Sbjct: 113 RHPYIVHLLEVMATKTKIYIVMEYVRGGELYNTVARGRLREGTARRYFQQLISSVAFCHS 172
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRD +SDFGLS V EQ++ +G+ T CGTPAY+APE+L +KG
Sbjct: 173 RGVYHRDLKLENLLLDDKGNVKVSDFGLSVVSEQLKQEGICQTFCGTPAYLAPEVLTRKG 232
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
Y+GAK D+WSCGV+LFVL AGYLPF+D N++ MY KIYKG+++CPKW SP+L + R+L
Sbjct: 233 YEGAKADIWSCGVILFVLMAGYLPFDDKNILVMYTKIYKGQFKCPKWFSPELARLVTRML 292
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKF 281
DT+P TRIT+ EI++ WFKK +K KF
Sbjct: 293 DTNPDTRITIPEIMKHRWFKKGFKHVKF 320
|
|
| TAIR|locus:2152380 CIPK20 "CBL-interacting protein kinase 20" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 932 (333.1 bits), Expect = 1.3e-93, P = 1.3e-93
Identities = 183/398 (45%), Positives = 262/398 (65%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L KYE+G+++G G FAKVYH RN++TG+SVAIK + KQK+ + GL +KREIS+M +
Sbjct: 8 LMRKYELGRLLGQGTFAKVYHARNIKTGESVAIKVIDKQKVAKVGLIDQIKREISVMRLV 67
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHP++V L+EV+A+K KIYF ME+ KGGELF K+SKG+ E ++R+YFQQLI A++YCHS
Sbjct: 68 RHPHVVFLHEVMASKTKIYFAMEYVKGGELFDKVSKGKLKENIARKYFQQLIGAIDYCHS 127
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRD ISDFGLSA++E + DG+LHT CGTPAYVAPE++ KKG
Sbjct: 128 RGVYHRDLKPENLLLDENGDLKISDFGLSALRESKQQDGLLHTTCGTPAYVAPEVIGKKG 187
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAK D+WSCGVVL+VL AG+LPF++ NL+ MYRKI KGE++CP W P++K + R+L
Sbjct: 188 YDGAKADVWSCGVVLYVLLAGFLPFHEQNLVEMYRKITKGEFKCPNWFPPEVKKLLSRIL 247
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFP-----HE-DFDLKD-SVGCNVGSEKYLNAFD 306
D +P +RI +++I+ + WF+K +K+ + P H+ D + D +V Y NAFD
Sbjct: 248 DPNPNSRIKIEKIMENSWFQKGFKKIETPKSPESHQIDSLISDVHAAFSVKPMSY-NAFD 306
Query: 307 IIXXXXXXXXXXXXDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKK 366
+I F + +F + + ++I+ K EE+A +R +TK
Sbjct: 307 LISSLSQGFDLSGL--FEKEERS--ESKFTTKKDAKEIVSKFEEIA---TSSERFNLTKS 359
Query: 367 EWGAKLE----GQNGNFTMVIGIDRLTDDLVVVEIKKS 400
+ G K+E G+ G+ + + I +T+ +VE KKS
Sbjct: 360 DVGVKMEDKREGRKGHLAIDVEIFEVTNSFHMVEFKKS 397
|
|
| TAIR|locus:2126749 SIP3 "SOS3-interacting protein 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 929 (332.1 bits), Expect = 2.7e-93, P = 2.7e-93
Identities = 185/399 (46%), Positives = 258/399 (64%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L G+YE+G+++G G FAKVYH RN++TG+SVA+K V K+K+++ G+ +KREIS+M +
Sbjct: 20 LHGRYELGRLLGHGTFAKVYHARNIQTGKSVAMKVVGKEKVVKVGMVDQIKREISVMRMV 79
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
+HPNIV+L+EV+A+K+KIYF ME +GGELFAK++KGR E ++R YFQQLISAV++CHS
Sbjct: 80 KHPNIVELHEVMASKSKIYFAMELVRGGELFAKVAKGRLREDVARVYFQQLISAVDFCHS 139
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRD ++DFGLSA E ++ DG+LHT CGTPAYVAPE++ KKG
Sbjct: 140 RGVYHRDLKPENLLLDEEGNLKVTDFGLSAFTEHLKQDGLLHTTCGTPAYVAPEVILKKG 199
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAK D+WSCGV+LFVL AGYLPF D NL+ MYRKIY+G+++CP W S D + + +LL
Sbjct: 200 YDGAKADLWSCGVILFVLLAGYLPFQDDNLVNMYRKIYRGDFKCPGWLSSDARRLVTKLL 259
Query: 254 DTDPATRITVDEILRDPWFKKDY-KERKFP--------HEDFDLKDSVGCNVGSEKYLNA 304
D +P TRIT+++++ PWFKK + R P ED D V + + LNA
Sbjct: 260 DPNPNTRITIEKVMDSPWFKKQATRSRNEPVAATITTTEEDVDFL--VHKSKEETETLNA 317
Query: 305 FDIIXXXXXXXXXXXXDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVT 364
F II ++ + RF ++ ++ +EE AR+ G++ V
Sbjct: 318 FHIIALSEGFDLSPLFEEKKKEEKR--EMRFATSRPASSVISSLEEAARV---GNKFDVR 372
Query: 365 KKEWGAKLEG-QNGN---FTMVIGIDRLTDDLVVVEIKK 399
K E ++EG QNG + I + VVVE+KK
Sbjct: 373 KSESRVRIEGKQNGRKGKLAVEAEIFAVAPSFVVVEVKK 411
|
|
| TAIR|locus:2152370 CIPK19 "CBL-interacting protein kinase 19" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 928 (331.7 bits), Expect = 3.4e-93, P = 3.4e-93
Identities = 169/314 (53%), Positives = 228/314 (72%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
+ GKYE+G+++G G FAKVY RN ++G+SVAIK + K+K+L+ GL AH+KREISI+ R+
Sbjct: 24 ILGKYEMGRLLGHGTFAKVYLARNAQSGESVAIKVIDKEKVLKSGLIAHIKREISILRRV 83
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPNIV+L+EV+ATK+KIYFVME+ KGGELF K++KGR E+++R+YFQQLISAV +CH
Sbjct: 84 RHPNIVQLFEVMATKSKIYFVMEYVKGGELFNKVAKGRLKEEMARKYFQQLISAVSFCHF 143
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
RGV+HRD +SDFGLSAV +QIR DG+ HT CGTPAYVAPE+LA+KG
Sbjct: 144 RGVYHRDLKPENLLLDENGNLKVSDFGLSAVSDQIRQDGLFHTFCGTPAYVAPEVLARKG 203
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDGAKVD+WSCGV+LFVL AG+LPF+D N+MAMY+KIY+G++RCP+W ++ + R+L
Sbjct: 204 YDGAKVDIWSCGVILFVLMAGFLPFHDRNVMAMYKKIYRGDFRCPRWFPVEINRLLIRML 263
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDIIXXXXX 313
+T P R T+ +I+ WFKK +K KF ED D CNV + + + + +
Sbjct: 264 ETKPERRFTMPDIMETSWFKKGFKHIKFYVED----DHQLCNVADDDEIESIESVSGRSS 319
Query: 314 XXXXXXXDDFNNND 327
+DF + D
Sbjct: 320 TVSEP--EDFESFD 331
|
|
| TAIR|locus:2161273 SIP1 "SOS3-interacting protein 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 805 (288.4 bits), Expect = 6.3e-89, Sum P(2) = 6.3e-89
Identities = 145/269 (53%), Positives = 199/269 (73%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L KY+VG+++G G FAKVY+GR++ T QSVAIK + K+K+++ GL +KREIS+M
Sbjct: 8 LTDKYDVGRLLGQGTFAKVYYGRSILTNQSVAIKMIDKEKVMKVGLIEQIKREISVMRIA 67
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
RHPN+V+LYEV+ATK +IYFVME+ KGGELF K++KG+ + ++ +YF QLI+AV++CHS
Sbjct: 68 RHPNVVELYEVMATKTRIYFVMEYCKGGELFNKVAKGKLRDDVAWKYFYQLINAVDFCHS 127
Query: 134 RGVFHRDXXXXXXXXXXXXXXXISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
R V+HRD +SDFGLSA+ + R DG+LHT CGTPAYVAPE++ +KG
Sbjct: 128 REVYHRDIKPENLLLDDNENLKVSDFGLSALADCKRQDGLLHTTCGTPAYVAPEVINRKG 187
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
YDG K D+WSCGVVLFVL AGYLPF+D NLM MYRKI K +++ P W +P+++ + ++L
Sbjct: 188 YDGTKADIWSCGVVLFVLLAGYLPFHDSNLMEMYRKIGKADFKAPSWFAPEVRRLLCKML 247
Query: 254 DTDPATRITVDEILRDPWFKKDY--KERK 280
D +P TRIT+ I WF+K K++K
Sbjct: 248 DPNPETRITIARIRESSWFRKGLHMKQKK 276
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| Q9LZW4 | CIPKE_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.6626 | 0.9544 | 0.9004 | yes | no |
| Q7X996 | CIPK2_ORYSJ | 2, ., 7, ., 1, 1, ., 1 | 0.5259 | 0.9064 | 0.8532 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.991 |
| 3rd Layer | 2.7.11 | 0.976 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 417 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-107 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 7e-95 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-84 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 3e-76 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-70 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-69 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-69 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-68 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-67 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-61 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-57 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-56 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-56 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-55 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-55 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-55 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-55 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-54 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-52 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-52 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 3e-51 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 3e-50 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 5e-50 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-49 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-49 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 3e-49 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 6e-49 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 1e-47 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 2e-47 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 5e-47 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-46 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-46 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 2e-46 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-46 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 1e-45 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-45 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 7e-45 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-44 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-44 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 7e-44 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-43 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 4e-43 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-42 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-42 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-42 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 8e-42 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-42 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-41 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 2e-41 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-41 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-41 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 4e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-41 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 6e-40 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 7e-40 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 9e-40 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-39 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-39 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-39 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-39 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 3e-39 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-39 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 8e-39 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-38 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-38 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 7e-38 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 8e-38 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 8e-38 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 2e-37 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-37 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 3e-37 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 4e-37 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 4e-37 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 1e-36 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 2e-36 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 3e-36 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-36 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 4e-36 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 1e-35 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 3e-35 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 4e-35 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-35 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 9e-35 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-34 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 3e-34 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-34 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-34 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-34 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 5e-34 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 5e-34 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 8e-34 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 9e-34 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-33 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-33 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-33 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-33 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-33 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-33 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 3e-33 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-33 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-33 | |
| cd12195 | 116 | cd12195, CIPK_C, C-terminal regulatory domain of C | 4e-33 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-33 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 4e-33 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 6e-33 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-33 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-33 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-33 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-32 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-32 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 2e-32 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-32 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 3e-32 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-32 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-31 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-31 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-31 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-31 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-31 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-30 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-30 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-30 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-30 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-30 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 6e-30 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 7e-30 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 8e-30 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 1e-29 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-29 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-29 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-29 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-29 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 3e-29 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 4e-29 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 7e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-29 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-28 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-28 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-28 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-28 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-27 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-27 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-27 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-27 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-27 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 6e-27 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 8e-27 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-27 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-26 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 3e-26 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-26 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 5e-26 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-25 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-25 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-25 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 6e-25 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-24 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 2e-24 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-24 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-23 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-23 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-23 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 4e-23 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 8e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 8e-23 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 1e-22 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-22 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 3e-22 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 3e-22 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 4e-22 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-22 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 5e-22 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 6e-22 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-22 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-21 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-21 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-21 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-21 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-21 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 3e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-21 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-21 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 7e-21 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 8e-21 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 3e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 6e-20 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 1e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-19 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 3e-19 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-19 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 4e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 4e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-19 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-18 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-18 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 3e-18 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-18 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 4e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 5e-18 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 5e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 7e-18 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-17 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-17 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 1e-17 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 1e-17 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 2e-17 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 5e-17 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-17 | |
| pfam03822 | 58 | pfam03822, NAF, NAF domain | 5e-17 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 6e-17 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-16 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 1e-16 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-16 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-16 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 5e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 6e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 2e-15 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 3e-15 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 3e-15 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-15 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-14 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-14 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-14 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-14 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 3e-14 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 3e-14 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-14 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 7e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-14 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 1e-13 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-13 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-13 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 4e-13 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-13 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 9e-13 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 9e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-12 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-12 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-12 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-12 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-12 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-12 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 1e-11 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-11 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-11 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-11 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 4e-11 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 4e-11 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-11 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-11 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-10 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-10 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 3e-10 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-10 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 5e-10 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 6e-10 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 8e-10 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-09 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 1e-09 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-09 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-09 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-09 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 1e-08 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-08 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-08 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-08 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 3e-08 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 5e-08 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 6e-08 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 1e-07 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-07 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 5e-07 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 9e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 1e-06 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-06 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-06 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 5e-06 | |
| PHA02882 | 294 | PHA02882, PHA02882, putative serine/threonine kina | 1e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 3e-04 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 5e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.001 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 0.001 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.002 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 0.002 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 0.003 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 315 bits (809), Expect = e-107
Identities = 116/260 (44%), Positives = 168/260 (64%), Gaps = 11/260 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YE+ + +G G+F KVY R+ +TG+ VAIK + K+KI + REI I+ +L+HPN
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIK--KDRERILREIKILKKLKHPN 58
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV+LY+V + K+Y VME+ +GG+LF + +GR SE +R Y +Q++SA+EY HS+G+
Sbjct: 59 IVRLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGI 118
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
HRDLK EN+LLDE+ +K++DFGL+ Q+ P L T GTP Y+APE+L KGY
Sbjct: 119 VHRDLKPENILLDEDGHVKLADFGLAR---QLDPGEKLTTFVGTPEYMAPEVLLGKGYGK 175
Query: 197 AKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKGEYRCPKWT---SPDLKWFIGRL 252
VD+WS GV+L+ L G PF D L+ +++KI K + P SP+ K I +L
Sbjct: 176 -AVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRKL 234
Query: 253 LDTDPATRITVDEILRDPWF 272
L DP R+T +E L+ P+F
Sbjct: 235 LVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 284 bits (730), Expect = 7e-95
Identities = 103/263 (39%), Positives = 152/263 (57%), Gaps = 11/263 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YE+ + +G G+F VY ++ TG+ VA+K + K+ REI I+ RL HPN
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTAR-REIRILRRLSHPN 59
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV+L + K +Y VME+ +GG+LF +S+ G SE +++ Q++ +EY HS G+
Sbjct: 60 IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGI 119
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
HRDLK EN+LLDEN +KI+DFGL+ K+ ++ L T GTP Y+APE+L G
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLA--KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYG 177
Query: 197 AKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCPKWT----SPDLKWFI 249
KVD+WS GV+L+ L G PF N + + + R+I + S + K I
Sbjct: 178 PKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLI 237
Query: 250 GRLLDTDPATRITVDEILRDPWF 272
+ L+ DP+ R T +EIL+ PWF
Sbjct: 238 KKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 258 bits (661), Expect = 2e-84
Identities = 108/253 (42%), Positives = 155/253 (61%), Gaps = 7/253 (2%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G+F KV R TG+ A+K + K+KI++ H E +I+SR+ HP IVKL+
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60
Query: 84 VLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
T+ K+Y V+E+A GGELF+ +SK GRFSE+ +R Y +++ A+EY HS G+ +RDLK
Sbjct: 61 AFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMW 202
EN+LLD + +K++DFGL+ KE +T CGTP Y+APE+L KGY A VD W
Sbjct: 121 PENILLDADGHIKLTDFGLA--KELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKA-VDWW 177
Query: 203 SCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRIT 262
S GV+L+ + G PF + +Y KI K R P++ SP+ + I LL DP R+
Sbjct: 178 SLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237
Query: 263 ---VDEILRDPWF 272
+EI P+F
Sbjct: 238 SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 238 bits (609), Expect = 3e-76
Identities = 109/262 (41%), Positives = 156/262 (59%), Gaps = 12/262 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E K +G G+F +V R+ +G+ A+K +SK KI++ HV E I+ +RHP
Sbjct: 3 FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
+V LY + +Y VME+ GGELF+ + K GRF E ++R Y Q++ A+EY HS +
Sbjct: 63 LVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK ENLLLD + +KI+DFG + R G +TLCGTP Y+APEI+ KGY
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGTPEYLAPEIILSKGYGK 177
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
A VD W+ G++++ + AGY PF D N + +Y KI +G+ R P + SPD K I LL D
Sbjct: 178 A-VDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQVD 236
Query: 257 PATRI-----TVDEILRDPWFK 273
R+ V++I PWF
Sbjct: 237 LTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 222 bits (569), Expect = 2e-70
Identities = 98/279 (35%), Positives = 150/279 (53%), Gaps = 25/279 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHP 76
++ GKIIG G+F+ V + T + AIK + K+++++ +VK E +++RL HP
Sbjct: 3 FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG 135
I+KLY + +YFV+E+A GEL I K G E+ +R Y +++ A+EY HS+G
Sbjct: 63 GIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAV------KEQIRPDGMLH------------TL 177
+ HRDLK EN+LLD++ +KI+DFG + V E + D +
Sbjct: 123 IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASF 182
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC 237
GT YV+PE+L +K G D+W+ G +++ + G PF N ++KI K EY
Sbjct: 183 VGTAEYVSPELLNEK-PAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF 241
Query: 238 PKWTSPDLKWFIGRLLDTDPATRITV----DEILRDPWF 272
P PD K I +LL DP R+ V DE+ P+F
Sbjct: 242 PPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 220 bits (563), Expect = 1e-69
Identities = 97/266 (36%), Positives = 141/266 (53%), Gaps = 22/266 (8%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVS------KQKILRGGLTAHVKREISIM 70
KYE+ K IG G+F KVY R G+ +K + K++ E+ I+
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKER-------EDALNEVKIL 53
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLI 125
+L HPNI+K YE K K+ VME+A GG+L KI K + F E+ +F QL
Sbjct: 54 KKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLC 113
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
A++Y HSR + HRD+K +N+ L N +K+ DFG+S V + T+ GTP Y++
Sbjct: 114 LALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYYLS 171
Query: 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPD 244
PE+ K Y+ K D+WS G VL+ L PF NL+ + KI KG+Y P S +
Sbjct: 172 PELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSE 230
Query: 245 LKWFIGRLLDTDPATRITVDEILRDP 270
L+ + LL DP R ++ +IL+ P
Sbjct: 231 LRNLVSSLLQKDPEERPSIAQILQSP 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 5e-69
Identities = 96/250 (38%), Positives = 131/250 (52%), Gaps = 38/250 (15%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G F VY R+ +TG+ VAIK + K+ L + REI I+ +L HPNIVKLY
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKED--SSSLLEELLREIEILKKLNHPNIVKLYG 58
Query: 84 VLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL 141
V + +Y VME+ +GG L + + G+ SE R Q++ +EY HS G+ HRDL
Sbjct: 59 VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDL 118
Query: 142 KLENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
K EN+LLD N +K++DFGLS K +L T+ GTPAY+APE+L KGY K D
Sbjct: 119 KPENILLDSDNGKVKLADFGLS--KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSD 176
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
+WS GV+L+ L P+LK I ++L DP R
Sbjct: 177 IWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205
Query: 261 ITVDEILRDP 270
+ EIL
Sbjct: 206 PSAKEILEHL 215
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 217 bits (554), Expect = 2e-68
Identities = 86/262 (32%), Positives = 145/262 (55%), Gaps = 8/262 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
++ G+++G G+F VY + TG+ +A+K+V L A ++REI I+S L+HP
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEA-LEREIRILSSLQHP 59
Query: 77 NIVKLY--EVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS 133
NIV+ Y E K + +E+ GG L + + K G+ E + R+Y +Q++ + Y HS
Sbjct: 60 NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
G+ HRD+K N+L+D + +K++DFG + I ++ GTP ++APE++ +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMA-MYRKIYKGEY-RCPKWTSPDLKWFIG 250
Y G D+WS G + + G P+++ N MA +Y+ GE P+ S + K F+
Sbjct: 180 Y-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238
Query: 251 RLLDTDPATRITVDEILRDPWF 272
+ L DP R T DE+L+ P+
Sbjct: 239 KCLRRDPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 215 bits (550), Expect = 1e-67
Identities = 88/262 (33%), Positives = 138/262 (52%), Gaps = 13/262 (4%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
I GA+ +V+ + TG AIK + K ++R V E I+S+ + P +VKLY
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYY 60
Query: 84 VLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
K +Y VME+ GG+L + + G E ++R Y +++ A+EY HS G+ HRDLK
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLK 120
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGML------HTLCGTPAYVAPEILAKKGYDG 196
+N+L+D N LK++DFGLS V R + + GTP Y+APE++ +G+
Sbjct: 121 PDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH-S 179
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK--WTSPDLKWFIGRLLD 254
VD WS G +L+ G PF+ +++ I G+ P+ S + I +LL
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239
Query: 255 TDPATRI---TVDEILRDPWFK 273
DP R+ +++EI P+FK
Sbjct: 240 PDPEKRLGAKSIEEIKNHPFFK 261
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 199 bits (508), Expect = 2e-61
Identities = 95/259 (36%), Positives = 138/259 (53%), Gaps = 14/259 (5%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G F +V + ++ A+K V K+ I+ G H+ E I+ HP IVKLY
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 84 VLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
K IY +ME+ GGEL+ + G F E +R Y ++ A EY H+RG+ +RDLK
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLK 120
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMW 202
ENLLLD N +K+ DFG + ++++ T CGTP YVAPEI+ KGYD + VD W
Sbjct: 121 PENLLLDSNGYVKLVDFGFA---KKLKSGQKTWTFCGTPEYVAPEIILNKGYDFS-VDYW 176
Query: 203 SCGVVLFVLNAGYLPFNDPNL--MAMYRKIYKGEYRC--PKWTSPDLKWFIGRLLDTDPA 258
S G++L+ L G PF + + M +Y I KG + P + K I +LL +P
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236
Query: 259 TRI-----TVDEILRDPWF 272
R+ + +I + WF
Sbjct: 237 ERLGNLKGGIKDIKKHKWF 255
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 191 bits (487), Expect = 1e-57
Identities = 98/262 (37%), Positives = 149/262 (56%), Gaps = 14/262 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+G+ +G G+F +V ++ TG+ AIK + K++IL+ HV +E SI+ L HP
Sbjct: 20 FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV + + ++YF++EF GGELF + K GRF +++ Y +L+ A EY HS+ +
Sbjct: 80 IVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSA-VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
+RDLK ENLLLD +K++DFG + V ++ TLCGTP Y+APE++ KG+
Sbjct: 140 IYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT------FTLCGTPEYLAPEVIQSKGHG 193
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
A VD W+ GV+L+ AGY PF D +Y KI G + P W + + LL T
Sbjct: 194 KA-VDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQT 252
Query: 256 DPATRI-----TVDEILRDPWF 272
D R+ V ++ P+F
Sbjct: 253 DHTKRLGTLKGGVADVKNHPYF 274
|
Length = 329 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 185 bits (473), Expect = 2e-56
Identities = 90/258 (34%), Positives = 141/258 (54%), Gaps = 6/258 (2%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y++G +IG GAF VY G N+ TG VAIK +S +KI L + + +EI ++ L+HP
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKS-IMQEIDLLKNLKHP 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG 135
NIVK + T +Y ++E+A+ G L I K G F E L Y Q++ + Y H +G
Sbjct: 60 NIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG 119
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V HRD+K N+L ++ +K++DFG++ + ++ GTP ++APE++ G
Sbjct: 120 VIHRDIKAANILTTKDGVVKLADFGVAT--KLNDVSKDDASVVGTPYWMAPEVIEMSGAS 177
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254
D+WS G + L G P+ D N M A++R + P+ SP+LK F+ +
Sbjct: 178 -TASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236
Query: 255 TDPATRITVDEILRDPWF 272
DP R T ++L+ PW
Sbjct: 237 KDPNLRPTAKQLLKHPWI 254
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 186 bits (474), Expect = 4e-56
Identities = 87/263 (33%), Positives = 143/263 (54%), Gaps = 12/263 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
E K +G G F +V+ R+ + A+K ++ +++R HV E ++ + HP
Sbjct: 3 LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
I++L+ + +Y +ME+ GGELF+ + + GRFS Y +++ A+EY HS+ +
Sbjct: 63 IIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK EN+LLD+ +K++DFG + K+ TLCGTP Y+APE++ KG++
Sbjct: 123 VYRDLKPENILLDKEGHIKLTDFGFA--KKLR---DRTWTLCGTPEYLAPEVIQSKGHNK 177
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
A VD W+ G++++ + GY PF D N +Y KI G+ P+ K I +LL D
Sbjct: 178 A-VDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLVVD 236
Query: 257 PATRI-----TVDEILRDPWFKK 274
R+ D++ WFK
Sbjct: 237 RTRRLGNMKNGADDVKNHRWFKS 259
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 187 bits (475), Expect = 2e-55
Identities = 95/335 (28%), Positives = 145/335 (43%), Gaps = 29/335 (8%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y + + +G G+F +VY R+ + VA+K ++K+ + REI I++ L HP
Sbjct: 1 SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 77 -NIVKLYEVLATKAKIYFVMEFAKGGELFAKI----SKGRFSEQLSRRYFQQLISAVEYC 131
NIVKLY+ + +Y VME+ GG L + KG SE + Q++SA+EY
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYL 117
Query: 132 HSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAV----KEQIRPDGMLHTLCGTPAYVAP 186
HS+G+ HRD+K EN+LLD + +K+ DFGL+ + + T GTP Y+AP
Sbjct: 118 HSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177
Query: 187 EIL--AKKGYDGAKVDMWSCGVVLFVLNAGYLPF----NDPNLMAMYRKIYKGEYRC-PK 239
E+L Y + D+WS G+ L+ L G PF N + I +
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237
Query: 240 WTSPDLKW--------FIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDS 291
SP + +LL DP R++ L K ++ D D
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLL-AHLKLKESDLSDLLKPDD 296
Query: 292 VGCNVGSEKYLNAFDIISLSSGFNLSGLFDDFNNN 326
S I SL+S ++N
Sbjct: 297 SAPLRLSLPPSLEALISSLNSLAISGSDLKLDDSN 331
|
Length = 384 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 3e-55
Identities = 91/272 (33%), Positives = 138/272 (50%), Gaps = 27/272 (9%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSR 72
YEV + IG G+F V R G+ + K + G +T K+ E++I+
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEID-----YGNMTEKEKQQLVSEVNILRE 55
Query: 73 LRHPNIVKLY--EVLATKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLI 125
L+HPNIV+ Y + + +Y VME+ +GG+L I K E+ R QL+
Sbjct: 56 LKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLL 115
Query: 126 SAVEYCHSRG-----VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML-HTLCG 179
A+ CH+R V HRDLK N+ LD N ++K+ DFGL+ + + D T G
Sbjct: 116 LALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI---LGHDSSFAKTYVG 172
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-P 238
TP Y++PE L YD K D+WS G +++ L A PF N + + KI +G++R P
Sbjct: 173 TPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP 231
Query: 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDP 270
S +L I +L+ DP R + +E+L+ P
Sbjct: 232 YRYSSELNEVIKSMLNVDPDKRPSTEELLQLP 263
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 182 bits (465), Expect = 3e-55
Identities = 90/266 (33%), Positives = 143/266 (53%), Gaps = 24/266 (9%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV------SKQKILRGGLTAHVKREISIM 70
+E+ + IG G F +VY R+ RTG+ VAIK + K+KI+ EI I+
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---------EIQIL 51
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAV 128
+ +HPNIVK Y K +++ VMEF GG L K + +E ++L+ +
Sbjct: 52 KKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGL 111
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
EY HS G+ HRD+K N+LL + ++K+ DFGLSA + +T+ GTP ++APE+
Sbjct: 112 EYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR---NTMVGTPYWMAPEV 168
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKG--EYRCPKWTSPDL 245
+ K YD K D+WS G+ L G P+++ M A+++ G R P+ S +
Sbjct: 169 INGKPYDY-KADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEF 227
Query: 246 KWFIGRLLDTDPATRITVDEILRDPW 271
K F+ + L +P R T +++L+ P+
Sbjct: 228 KDFLKKCLQKNPEKRPTAEQLLKHPF 253
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 183 bits (468), Expect = 3e-55
Identities = 88/274 (32%), Positives = 147/274 (53%), Gaps = 18/274 (6%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKA--VSKQKILRGGLTAHVKREISIMSRLR 74
Y+ + IG GA +VY + TG+ VAIK + KQ + EI IM +
Sbjct: 20 LYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKEL------IINEILIMKDCK 73
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYCH 132
HPNIV Y+ +++ VME+ GG L I + R +E ++++ +EY H
Sbjct: 74 HPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLH 133
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI-RPDGMLHTLCGTPAYVAPEILAK 191
S+ V HRD+K +N+LL ++ +K++DFG +A Q+ + +++ GTP ++APE++ +
Sbjct: 134 SQNVIHRDIKSDNILLSKDGSVKLADFGFAA---QLTKEKSKRNSVVGTPYWMAPEVIKR 190
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWF 248
K Y KVD+WS G++ + G P +P L A++ KG + P+ SP+ K F
Sbjct: 191 KDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFKDF 249
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
+ + L DP R + +E+L+ P+ KK + +F
Sbjct: 250 LNKCLVKDPEKRPSAEELLQHPFLKKACPKEEFA 283
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 183 bits (466), Expect = 1e-54
Identities = 100/257 (38%), Positives = 142/257 (55%), Gaps = 9/257 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G F KV R TG+ A+K + K+ I+ AH E ++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTAL 60
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
T ++ FVME+A GGELF +S+ R FSE +R Y +++SA+ Y HS V +RD
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRD 120
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
LKLENL+LD++ +KI+DFGL KE I + T CGTP Y+APE+L Y G VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGL--CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
W GVV++ + G LPF + + ++ I E R P+ SP+ K + LL DP R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 261 I-----TVDEILRDPWF 272
+ EI+ +F
Sbjct: 238 LGGGPEDAKEIMEHRFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 178 bits (452), Expect = 1e-52
Identities = 97/241 (40%), Positives = 140/241 (58%), Gaps = 4/241 (1%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G F KV R TG+ A+K + K+ I+ AH E ++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 60
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
T ++ FVME+A GGELF +S+ R F+E+ +R Y +++SA+EY HSR V +RD
Sbjct: 61 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 120
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
+KLENL+LD++ +KI+DFGL KE I + T CGTP Y+APE+L Y G VD
Sbjct: 121 IKLENLMLDKDGHIKITDFGL--CKEGISDGATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
W GVV++ + G LPF + + ++ I E R P+ SP+ K + LL DP R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237
Query: 261 I 261
+
Sbjct: 238 L 238
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 3e-52
Identities = 97/291 (33%), Positives = 141/291 (48%), Gaps = 35/291 (12%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+EV K+IG GAF +V+ R+ TGQ A+K + K +++ AHV+ E I++ P
Sbjct: 3 FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELF-AKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
IVKLY + +Y VME+ GG+L I K F E+ +R Y +L+ A++ H G
Sbjct: 63 IVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSA-----------------------VKEQIRPDGM 173
HRD+K +N+L+D + +K++DFGL V + R
Sbjct: 123 IHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQ 182
Query: 174 LHTLC----GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK 229
GTP Y+APE+L Y + D WS GV+L+ + G+ PF L Y K
Sbjct: 183 RRVRANSTVGTPDYIAPEVLRGTPYGL-ECDWWSLGVILYEMLYGFPPFYSDTLQETYNK 241
Query: 230 I--YKGEYRCP--KWTSPDLKWFIGRLLDTDPATRIT-VDEILRDPWFKKD 275
I +K R P SP+ I RLL DP R+ +EI P+FK
Sbjct: 242 IINWKESLRFPPDPPVSPEAIDLICRLL-CDPEDRLGSFEEIKSHPFFKGI 291
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 172 bits (438), Expect = 3e-51
Identities = 83/261 (31%), Positives = 141/261 (54%), Gaps = 10/261 (3%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ ++IG GAF KV + T + A+K ++KQK + G +V E I+ L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPF 61
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+V L+ + +Y V++ GG+L +S K +FSE+ + + +++ A+EY HS+G+
Sbjct: 62 LVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
HRD+K +N+LLDE + I+DF ++ ++ PD + + GTP Y+APE+L ++GY
Sbjct: 122 IHRDIKPDNILLDEQGHVHITDFNIAT---KVTPDTLTTSTSGTPGYMAPEVLCRQGY-S 177
Query: 197 AKVDMWSCGVVLFVLNAGYLPF--NDPNLMAMYR-KIYKGEYRCPKWTSPDLKWFIGRLL 253
VD WS GV + G P+ + + R K + P S + I +LL
Sbjct: 178 VAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKLL 237
Query: 254 DTDPATRI--TVDEILRDPWF 272
+ DP R+ + ++ P+F
Sbjct: 238 ERDPQKRLGDNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 3e-50
Identities = 92/265 (34%), Positives = 136/265 (51%), Gaps = 20/265 (7%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVK 80
G IG G F KVY N+ TG+ +A+K + Q + E+ ++ L+HPN+VK
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQD-NDPKTIKEIADEMKVLELLKHPNLVK 63
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGRF-SEQLSRRYFQQLISAVEYCHSRGVFHR 139
Y V + K+Y ME+ GG L + GR E + R Y QL+ + Y HS G+ HR
Sbjct: 64 YYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHR 123
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQ---IRPDGMLHTLCGTPAYVAPEILAK---KG 193
D+K N+ LD N +K+ DFG AVK + + +L GTPAY+APE++ KG
Sbjct: 124 DIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFN--DPNLMAMYRKIYKGEYRCPKW-----TSPDLK 246
+ A D+WS G V+ + G P++ D M+ + G P SP+ K
Sbjct: 183 HGRA-ADIWSLGCVVLEMATGKRPWSELDNEFQIMF-HVGAGH--KPPIPDSLQLSPEGK 238
Query: 247 WFIGRLLDTDPATRITVDEILRDPW 271
F+ R L++DP R T E+L+ P+
Sbjct: 239 DFLDRCLESDPKKRPTASELLQHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 169 bits (432), Expect = 5e-50
Identities = 90/294 (30%), Positives = 141/294 (47%), Gaps = 51/294 (17%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YE + +G G + VY R+ +TG+ VA+K + + G+ + REIS++ L+HPN
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKI-RLDNEEEGIPSTALREISLLKELKHPN 59
Query: 78 IVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
IVKL +V+ T+ K+Y V E+ K + G S L + QL+ + YCHS
Sbjct: 60 IVKLLDVIHTERKLYLVFEYCDMDLKK---YLDKRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILAK- 191
+ HRDLK +N+L++ + LK++DFGL+ A +R H + T Y APEIL
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRT--YTHEVV-TLWYRAPEILLGS 173
Query: 192 KGYDGAKVDMWSCGVVLF-VLNAGYL-------------------PFND--PNLMAMYRK 229
K Y A VD+WS G + ++ L P + P + +
Sbjct: 174 KHYSTA-VDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL--P 230
Query: 230 IYKGEYRCPKWTSPDLKWFIG-----------RLLDTDPATRITVDEILRDPWF 272
YK + PK+ DL+ + ++L +PA RI+ E L+ P+F
Sbjct: 231 DYKPTF--PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 170 bits (432), Expect = 1e-49
Identities = 90/261 (34%), Positives = 144/261 (55%), Gaps = 14/261 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLRHPNI 78
K++G G+F KV T + A+K + K IL+ T KR +++ + HP +
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGK--HPFL 58
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+L+ TK +++FVME+ GG+L I + GRF E +R Y +++ +++ H RG+
Sbjct: 59 TQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGII 118
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLKL+N+LLD +KI+DFG+ KE I T CGTP Y+APEIL+ + Y G
Sbjct: 119 YRDLKLDNVLLDSEGHIKIADFGMC--KEGILGGVTTSTFCGTPDYIAPEILSYQPY-GP 175
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
VD W+ GV+L+ + AG PF + +++ I + E R P+W S + K + L +P
Sbjct: 176 AVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNP 235
Query: 258 ATRITV-----DEILRDPWFK 273
R+ +I P+F+
Sbjct: 236 EKRLGCLPTGEQDIKGHPFFR 256
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 169 bits (431), Expect = 2e-49
Identities = 94/262 (35%), Positives = 146/262 (55%), Gaps = 13/262 (4%)
Query: 22 KIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGL-TAHVKREISIMSRLRHPN 77
K++G G + KV+ R V TG+ A+K + K I+R TAH K E +I+ ++HP
Sbjct: 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV L T K+Y ++E+ GGELF + + G F E + Y ++ A+E+ H +G+
Sbjct: 62 IVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGI 121
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK EN+LLD +K++DFGL KE I + HT CGT Y+APEIL + G+ G
Sbjct: 122 IYRDLKPENILLDAQGHVKLTDFGL--CKESIHEGTVTHTFCGTIEYMAPEILMRSGH-G 178
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
VD WS G +++ + G PF N KI KG+ P + +P+ + + +LL +
Sbjct: 179 KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKRN 238
Query: 257 PATRI-----TVDEILRDPWFK 273
P++R+ E+ P+F+
Sbjct: 239 PSSRLGAGPGDAAEVQSHPFFR 260
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (424), Expect = 3e-49
Identities = 86/262 (32%), Positives = 139/262 (53%), Gaps = 14/262 (5%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA--HVK---REISIMS 71
++ G+++G G+F VY G N+ G A+K VS + G T VK +EI+++S
Sbjct: 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVS---LADDGQTGQEAVKQLEQEIALLS 57
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEY 130
+L+HPNIV+ + +Y +E GG L + K G F E + R Y +Q++ +EY
Sbjct: 58 KLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEY 117
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
H R HRD+K N+L+D N +K++DFG++ +Q+ + G+P ++APE++A
Sbjct: 118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMA---KQVVEFSFAKSFKGSPYWMAPEVIA 174
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPKWTSPDLKWF 248
++G G D+WS G + + G P++ +A KI K P S + K F
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDF 234
Query: 249 IGRLLDTDPATRITVDEILRDP 270
I + L DP+ R T E+L P
Sbjct: 235 ILKCLQRDPSLRPTAAELLEHP 256
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 6e-49
Identities = 102/271 (37%), Positives = 151/271 (55%), Gaps = 14/271 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G F KV + TG+ A+K + K+ I+ AH E ++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 60
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHS-RGVFHR 139
T ++ FVME+A GGELF +S+ R FSE +R Y +++SA++Y HS + V +R
Sbjct: 61 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKLENL+LD++ +KI+DFGL KE I+ + T CGTP Y+APE+L Y G V
Sbjct: 121 DLKLENLMLDKDGHIKITDFGL--CKEGIKDGATMKTFCGTPEYLAPEVLEDNDY-GRAV 177
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W GVV++ + G LPF + + ++ I E R P+ SP+ K + LL DP
Sbjct: 178 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237
Query: 260 RI-----TVDEILRDPWFK----KDYKERKF 281
R+ EI++ +F +D E+K
Sbjct: 238 RLGGGPDDAKEIMQHKFFAGIVWQDVYEKKL 268
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 1e-47
Identities = 97/257 (37%), Positives = 143/257 (55%), Gaps = 9/257 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G F KV R +G+ A+K + K+ I+ AH E ++ RHP + L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
TK ++ FVME+ GGELF +S+ R FSE +R Y +++SA++Y HS + +RD
Sbjct: 61 KYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRD 120
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
LKLENL+LD++ +KI+DFGL KE I + T CGTP Y+APE+L Y G VD
Sbjct: 121 LKLENLMLDKDGHIKITDFGL--CKEGITDAATMKTFCGTPEYLAPEVLEDNDY-GRAVD 177
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
W GVV++ + G LPF + + ++ I + + P+ S D K + LL DP R
Sbjct: 178 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237
Query: 261 I-----TVDEILRDPWF 272
+ EI+R +F
Sbjct: 238 LGGGPDDAKEIMRHSFF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 164 bits (417), Expect = 2e-47
Identities = 86/242 (35%), Positives = 128/242 (52%), Gaps = 5/242 (2%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVK 80
K+IG G+F KV ++ G+ A+K + K+ IL+ H+ E +++ ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T K+YFV+++ GGELF + + R F E +R Y ++ SA+ Y HS + +R
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLK EN+LLD + ++DFGL KE I T CGTP Y+APE+L K+ YD V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL--CKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRT-V 177
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W G VL+ + G PF + MY I R S + + LL D
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237
Query: 260 RI 261
R+
Sbjct: 238 RL 239
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 5e-47
Identities = 95/260 (36%), Positives = 140/260 (53%), Gaps = 13/260 (5%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR---LRHPNIVK 80
IG G F +VY R T + A+K +SK++I+ AH E +I+ R P IV
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L T + +Y V ++ GGELF + K GRFSE ++ Y +L+ A+E+ H + +R
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI-LAKKGYDGAK 198
DLK EN+LLD + + DFGLS K + + +T CGT Y+APE+ L +KGY
Sbjct: 121 DLKPENILLDATGHIALCDFGLS--KANLTDNKTTNTFCGTTEYLAPEVLLDEKGY-TKH 177
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT-SPDLKWFIGRLLDTDP 257
VD WS GV++F + G+ PF + MYR I G+ R PK S + + F+ LL+ +P
Sbjct: 178 VDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNP 237
Query: 258 ATRI----TVDEILRDPWFK 273
R+ E+ P+F
Sbjct: 238 QHRLGAHRDAVELKEHPFFA 257
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 160 bits (407), Expect = 1e-46
Identities = 85/259 (32%), Positives = 129/259 (49%), Gaps = 12/259 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++V K +G G++ VY + + Q A+K V + + V EI I++ + HPN
Sbjct: 2 FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVNHPN 60
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLISAVEYCH 132
I+ E K+ VME+A G+L ISK + EQ R F QL+ ++ H
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ + HRDLK N+LL N +KI D G+S V ++ M T GTP Y+APE+ +
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKK----NMAKTQIGTPHYMAPEVWKGR 176
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251
Y K D+WS G +L+ + PF ++ + K+ +G+Y P S DL+ FI
Sbjct: 177 PYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIRS 235
Query: 252 LLDTDPATRITVDEILRDP 270
+L P R D+IL P
Sbjct: 236 MLQVKPKLRPNCDKILASP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 162 bits (411), Expect = 1e-46
Identities = 93/260 (35%), Positives = 137/260 (52%), Gaps = 11/260 (4%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVK 80
+++G G+F KV R +G+ A+K + K IL+ E I+S R HP + +
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
LY T +++FVMEF GG+L I K R F E +R Y ++ SA+ + H +G+ +R
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD K++DFG+ KE I T CGTP Y+APEIL + Y G V
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGM--CKEGIFNGKTTSTFCGTPDYIAPEILQEMLY-GPSV 177
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W+ GV+L+ + G+ PF N ++ I E P W S D + + +P
Sbjct: 178 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237
Query: 260 RITV------DEILRDPWFK 273
R+ + ILR P+FK
Sbjct: 238 RLGSLTLGGEEAILRHPFFK 257
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-46
Identities = 94/255 (36%), Positives = 133/255 (52%), Gaps = 7/255 (2%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+F KV R T + A+K + K I+ H E ++++++ P IV L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 84 VLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+ K+Y V+ F GGELF + + GRF +R Y +L+ A+E H V +RDLK
Sbjct: 61 SFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLK 120
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMW 202
EN+LLD + + DFGL K ++ D +T CGTP Y+APE+L GY A VD W
Sbjct: 121 PENILLDYQGHIALCDFGL--CKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKA-VDWW 177
Query: 203 SCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRIT 262
+ GV+L+ + G PF D N+ MYRKI + R P D K + LL DP R+
Sbjct: 178 TLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237
Query: 263 V---DEILRDPWFKK 274
EI P+F +
Sbjct: 238 YNGAQEIKNHPFFSQ 252
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (405), Expect = 2e-46
Identities = 91/261 (34%), Positives = 127/261 (48%), Gaps = 16/261 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISI-MSRLRHPNIVK 80
K I GAF VY + TG AIK + K ++ +VK E +I M + P + K
Sbjct: 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
LY +K +Y VME+ GG+ + I G E +++Y +++ VE H RG+ HR
Sbjct: 62 LYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHR 121
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
D+K ENLL+D+ LK++DFGLS GTP Y+APE + G D
Sbjct: 122 DIKPENLLIDQTGHLKLTDFGLSRNGL-ENKK-----FVGTPDYLAPETILGVGDDKM-S 174
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTSPDLKWFIGRLLDT 255
D WS G V+F GY PF+ A++ I P+ + SP+ I RLL
Sbjct: 175 DWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234
Query: 256 DPATRI---TVDEILRDPWFK 273
DPA R+ EI P+FK
Sbjct: 235 DPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 158 bits (402), Expect = 1e-45
Identities = 93/285 (32%), Positives = 156/285 (54%), Gaps = 23/285 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTA-HVKREISIMSRL 73
+E+ +++G GA+ KV+ R V G+ A+K + K I++ TA H + E ++ +
Sbjct: 2 FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61
Query: 74 RH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYC 131
R P +V L+ T K++ ++++ GGELF + + F+E R Y +++ A+++
Sbjct: 62 RRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHL 121
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTLCGTPAYVAPEILA 190
H G+ +RD+KLEN+LLD + ++DFGLS KE + + ++ CGT Y+APE++
Sbjct: 122 HQLGIIYRDIKLENILLDSEGHVVLTDFGLS--KEFLAEEEERAYSFCGTIEYMAPEVIR 179
Query: 191 KK--GYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMA-MYRKIYKGEYRCPKWTSPD 244
G+D A VD WS GV+ F L G PF + N + + R+I K + PK S +
Sbjct: 180 GGSGGHDKA-VDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAE 238
Query: 245 LKWFIGRLLDTDPATRI---TVDEILRDPWFKK----DYKERKFP 282
+ FI +LL+ DP R+ DEI P+F+ D ++ P
Sbjct: 239 ARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIP 283
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 158 bits (401), Expect = 5e-45
Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 37/288 (12%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G +V+ R TG+ A+K + K+++++ V E I++ L HP + L
Sbjct: 7 KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66
Query: 82 YEVLATKAKIYFVMEFAKGGELFA---KISKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
Y T+ + VM++ GGELF + SE+++R Y +++ A+EY H G+ +
Sbjct: 67 YASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVY 126
Query: 139 RDLKLENLLLDENWDLKISDFGLS-------AVKEQIRPDGML----------------- 174
RDLK EN+LL E+ + +SDF LS + G
Sbjct: 127 RDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPS 186
Query: 175 ---HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY 231
++ GT Y+APE+++ G+ A VD W+ G++L+ + G PF N + I
Sbjct: 187 FRSNSFVGTEEYIAPEVISGDGHGSA-VDWWTLGILLYEMLYGTTPFKGSNRDETFSNIL 245
Query: 232 KGEYRCPK--WTSPDLKWFIGRLLDTDPATRI----TVDEILRDPWFK 273
K E P S + I +LL DP+ R+ EI + P+F+
Sbjct: 246 KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFR 293
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 157 bits (399), Expect = 7e-45
Identities = 91/256 (35%), Positives = 144/256 (56%), Gaps = 8/256 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT--AHVKREISIMSRLRHPNIV 79
K++G G+F KV T + AIKA+ K +L V+R + ++ HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA-WEHPFLT 59
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
L+ TK ++FVME+ GG+L I S GRF E +R Y ++I +++ H +G+ +
Sbjct: 60 HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLKL+N+LLD++ +KI+DFG+ KE + +G T CGTP Y+APEIL + Y+
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMC--KENMNGEGKASTFCGTPDYIAPEILKGQKYN-ES 176
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPA 258
VD WS GV+L+ + G PF+ + ++ I P+W S + K + +L + DP
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPT 236
Query: 259 TRITVDEILRD-PWFK 273
R+ VD +R P+F+
Sbjct: 237 KRLGVDGDIRQHPFFR 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 85/259 (32%), Positives = 133/259 (51%), Gaps = 11/259 (4%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV---KREISIMSRLRHPNIV 79
++G G F KV +TG+ AIKA+ K I+ + KR + RHP +V
Sbjct: 6 VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T+ + FVME+A GG+L I FSE + Y ++ ++Y H + +R
Sbjct: 66 NLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYR 125
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+NLLLD +KI+DFGL KE + T CGTP ++APE+L + Y A V
Sbjct: 126 DLKLDNLLLDTEGFVKIADFGL--CKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRA-V 182
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W GV+++ + G PF + ++ I E R P++ S + + RLL +P
Sbjct: 183 DWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLRRNPER 242
Query: 260 RI-----TVDEILRDPWFK 273
R+ +++ + P+F+
Sbjct: 243 RLGSGEKDAEDVKKQPFFR 261
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 85/289 (29%), Positives = 122/289 (42%), Gaps = 40/289 (13%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
Y+ IG G + VY R+ TG+ VAIK + K + G+ REI ++ L HPN
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKI-KLRFESEGIPKTALREIKLLKELNHPN 59
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHSR 134
I+KL +V K +Y V EF K+ K R E L + Y QL+ + +CHS
Sbjct: 60 IIKLLDVFRHKGDLYLVFEFMD--TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH 117
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT-LCGTPAYVAPEILAKKG 193
G+ HRDLK ENLL++ LK++DFGL+ +T T Y APE+L
Sbjct: 118 GILHRDLKPENLLINTEGVLKLADFGLARS---FGSPVRPYTHYVVTRWYRAPELLLGDK 174
Query: 194 YDGAKVDMWSCGVVL--FVLNAGYLP--------------FNDPN---LMAMYRKIYKGE 234
VD+WS G + + P P+ +
Sbjct: 175 GYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK 234
Query: 235 YRCPKW-----------TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
+ PK SP + ++L DP RIT ++ L P+F
Sbjct: 235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 154 bits (391), Expect = 7e-44
Identities = 87/297 (29%), Positives = 139/297 (46%), Gaps = 52/297 (17%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-LTAHVKREISIMSRLRHP 76
YE IG G + +VY RN +TG+ VA+K + + G +TA REI ++ +LRHP
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITA--IREIKLLQKLRHP 58
Query: 77 NIVKLYEVLATKAK--IYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
NIV+L E++ +K K IY V E+ G + +F+E + Y +QL+ ++Y
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTG---LLDSPEVKFTESQIKCYMKQLLEGLQY 115
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL- 189
HS G+ HRD+K N+L++ + LK++DFGL+ + + + T Y PE+L
Sbjct: 116 LHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWYRPPELLL 174
Query: 190 -AKKGYDGAKVDMWSCGVVLFVLNAGYLPF----------------------NDPNLMAM 226
A + Y VDMWS G +L L G F N P + +
Sbjct: 175 GATR-YGPE-VDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232
Query: 227 -----------YRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
Y++ + ++ P + +LL DP RI+ D+ L+ +F
Sbjct: 233 PWFENLKPKKPYKRRLREFFK--HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-43
Identities = 80/265 (30%), Positives = 131/265 (49%), Gaps = 13/265 (4%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLRHPN 77
G+ +G GAF+ Y R+V+TG +A+K V+ + + +++EI +M+RL HP+
Sbjct: 5 GQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPH 64
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
I+++ + +E+ GG + +SK G F E + Y +QL+ + Y H +
Sbjct: 65 IIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124
Query: 137 FHRDLKLENLLLDEN-WDLKISDFGLSA-VKEQIRPDGMLH-TLCGTPAYVAPEILAKKG 193
HRD+K NLL+D L+I+DFG +A + + G L GT A++APE+L +
Sbjct: 125 IHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ 184
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-----GEYRCPKWTSPDLKWF 248
Y G D+WS G V+ + P+N I+K P+ SP L+
Sbjct: 185 Y-GRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDV 243
Query: 249 IGRLLDTDPATRITVDEILRDPWFK 273
R L+ P R E+L+ P F+
Sbjct: 244 TLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 4e-43
Identities = 93/260 (35%), Positives = 151/260 (58%), Gaps = 13/260 (5%)
Query: 22 KIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
K++G G+F KV+ R + GQ A+K V K+ L+ K E I++ + HP I
Sbjct: 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFI 60
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVF 137
VKL+ T+ K+Y +++F +GG+LF ++SK F+E+ + Y +L A+++ HS G+
Sbjct: 61 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 120
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLK EN+LLDE +K++DFGLS KE I + ++ CGT Y+APE++ ++G+ +
Sbjct: 121 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 178
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
D WS GV++F + G LPF + I K + P++ SP+ + + L +P
Sbjct: 179 -ADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237
Query: 258 ATRI-----TVDEILRDPWF 272
A R+ V+EI R P+F
Sbjct: 238 ANRLGAGPDGVEEIKRHPFF 257
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 2e-42
Identities = 82/219 (37%), Positives = 123/219 (56%), Gaps = 5/219 (2%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
K+IG G+F KV + G A+K + K+ IL+ H+ E +++ + L+HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T K+YFV+++ GGELF + + R F E +R Y ++ SA+ Y HS + +R
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLK EN+LLD + ++DFGL KE + P+ T CGTP Y+APE+L K+ YD V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL--CKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRT-V 177
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
D W G VL+ + G PF ++ MY I + P
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP 216
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 5e-42
Identities = 89/264 (33%), Positives = 137/264 (51%), Gaps = 16/264 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLRHPNI 78
K++G G+F KV T + AIK + K IL+ T KR +++ ++ HP +
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFL 58
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVF 137
L+ TK +++FVME+ GG+L +I + R F E SR Y ++ A+ + H GV
Sbjct: 59 TALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVI 118
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLKL+N+LLD K++DFG+ KE I T CGTP Y+APEIL + Y G
Sbjct: 119 YRDLKLDNILLDAEGHCKLADFGM--CKEGILNGVTTTTFCGTPDYIAPEILQELEY-GP 175
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
VD W+ GV+++ + AG PF N ++ I + P W S + + + +P
Sbjct: 176 SVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNP 235
Query: 258 ATRI-------TVDEILRDPWFKK 274
R+ D I + P+FK+
Sbjct: 236 NKRLGCVASQGGEDAIKQHPFFKE 259
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 148 bits (376), Expect = 5e-42
Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 22/268 (8%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH---VKREISIMSRLRH 75
E K++G G+ VY R+ TG+ A+K KI G + RE+ +
Sbjct: 4 ERVKVLGQGSSGVVYKVRHKPTGKIYALK-----KIHVDGDEEFRKQLLRELKTLRSCES 58
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
P +VK Y + +I V+E+ GG L K E + +Q++ ++Y H+
Sbjct: 59 PYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGK-IPEPVLAYIARQILKGLDYLHT 117
Query: 134 -RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE-ILAK 191
R + HRD+K NLL++ ++KI+DFG+S V E +T GT Y++PE I +
Sbjct: 118 KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQCNTFVGTVTYMSPERIQGE 175
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGE-YRCP-KWTSPDLK 246
D+WS G+ L G PF P + + I G P + SP+ +
Sbjct: 176 --SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFR 233
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKK 274
FI L DP R + E+L+ P+ KK
Sbjct: 234 DFISACLQKDPKKRPSAAELLQHPFIKK 261
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 150 bits (382), Expect = 8e-42
Identities = 93/300 (31%), Positives = 140/300 (46%), Gaps = 46/300 (15%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E K+IG GAF +V + TG A+K + K ++L AHV+ E I++ +P
Sbjct: 3 FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAK-ISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+VKLY + +Y +ME+ GG++ + K F+E+ +R Y + I A++ H G
Sbjct: 63 VVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSA------------VKEQIRPDGMLHTLC------ 178
HRD+K +NLLLD +K+SDFGL + P L +
Sbjct: 123 IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSK 182
Query: 179 ------------------GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND 220
GTP Y+APE+ + GY + D WS GV+++ + GY PF
Sbjct: 183 RKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGY-NKECDWWSLGVIMYEMLVGYPPFCS 241
Query: 221 PNLMAMYRKI--YKGEYRCPKWT--SPDLKWFIGRLLDTDPATRI---TVDEILRDPWFK 273
N YRKI +K + P SP+ K I RL + R+ V+EI P+FK
Sbjct: 242 DNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLC-CEAERRLGNNGVNEIKSHPFFK 300
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 8e-42
Identities = 92/305 (30%), Positives = 132/305 (43%), Gaps = 51/305 (16%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ K IG GAF +V R V T A+K + K +L AHVK E I++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+VKLY K +YFVM++ GG++ + I G F E L+R Y +L A+E H G
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSA------------VKEQIRPDGM----------- 173
HRD+K +N+L+D + +K++DFGL + R D M
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182
Query: 174 ------------------LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215
H+L GTP Y+APE+L + GY D WS GV+L+ + G
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQL-CDWWSVGVILYEMLVGQ 241
Query: 216 LPFNDPNLMAMYRKI--YKGEYRCPKWT--SPDLKWFIGRLLDTDPATRI---TVDEILR 268
PF K+ ++ P S + I RL R+ DEI
Sbjct: 242 PPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300
Query: 269 DPWFK 273
P+FK
Sbjct: 301 HPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 2e-41
Identities = 90/261 (34%), Positives = 135/261 (51%), Gaps = 14/261 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
K+IG G+F KV R+ + A+K + K+ IL+ H+ E +++ + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T K+YFV+++ GGELF + + R F E +R Y ++ SA+ Y HS + +R
Sbjct: 61 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLK EN+LLD + ++DFGL KE I +G T CGTP Y+APE+L K+ YD V
Sbjct: 121 DLKPENILLDSQGHIVLTDFGL--CKENIEHNGTTSTFCGTPEYLAPEVLHKQPYD-RTV 177
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W G VL+ + G PF N MY I + + + + LL D
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237
Query: 260 RITVDEILRDPWFKKDYKERK 280
R+ K D+ E K
Sbjct: 238 RLG---------AKDDFMEIK 249
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-41
Identities = 84/259 (32%), Positives = 136/259 (52%), Gaps = 10/259 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KYE +++G GAF V+ R + V IK + +++ + A + E ++ L HP
Sbjct: 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLA-AQNECQVLKLLSHP 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHS 133
NI++ YE + VME+A GG L I K E +F Q++ A+ + H+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHT 119
Query: 134 RGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ + HRDLK +N+LLD++ +KI DFG+S + + +T+ GTP Y++PE+ K
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKI---LSSKSKAYTVVGTPCYISPELCEGK 176
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGR 251
Y+ K D+W+ G VL+ L + F NL A+ KI G + SPDL+ I
Sbjct: 177 PYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235
Query: 252 LLDTDPATRITVDEILRDP 270
+L+ DP+ R + +I+ P
Sbjct: 236 MLNLDPSKRPQLSQIMAQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 147 bits (374), Expect = 2e-41
Identities = 87/290 (30%), Positives = 131/290 (45%), Gaps = 39/290 (13%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+Y++ IG GA V+ ++ TG++VA+K V+ + L GG+ REI + +HP
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVA-LRRLEGGIPNQALREIKALQACQHP 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR--FSEQLSRRYFQQLISAVEYCHSR 134
+VKL +V + VME+ +L + E + Y + L+ V Y H+
Sbjct: 60 YVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL-AKKG 193
G+ HRDLK NLL+ + LKI+DFGL+ + + P H T Y APE+L +
Sbjct: 119 GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPELLYGARK 177
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPF----ND-------------PNL--------MAMYR 228
YD VD+W+ G + L G P ND PN + Y
Sbjct: 178 YDPG-VDLWAVGCIFAELLNG-SPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN 235
Query: 229 KIYKGEYRCPKW------TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
KI E + SP+ + LL DP+ R++ E LR P+F
Sbjct: 236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 147 bits (372), Expect = 2e-41
Identities = 81/268 (30%), Positives = 129/268 (48%), Gaps = 16/268 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YE+ ++IG GA A VY + + VAIK + +K +++E+ MS+ HPN
Sbjct: 3 YELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK--CQTSVDELRKEVQAMSQCNHPN 60
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELF----AKISKGRFSEQLSRRYFQQLISAVEYCHS 133
+VK Y +++ VM + GG L + +G E + ++++ +EY HS
Sbjct: 61 VVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHS 120
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ--IRPDGMLHTLCGTPAYVAPEILA- 190
G HRD+K N+LL E+ +KI+DFG+SA R + T GTP ++APE++
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------EYRCPKWTSPD 244
GYD K D+WS G+ L G P++ M + + K S
Sbjct: 181 VHGYD-FKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWF 272
+ I L DP+ R T +E+L+ +F
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 3e-41
Identities = 85/255 (33%), Positives = 140/255 (54%), Gaps = 11/255 (4%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+ V + TG+ VA+K + +K R L + E+ IM +HPNIV++Y
Sbjct: 27 IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRREL---LFNEVVIMRDYQHPNIVEMYS 83
Query: 84 VLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKL 143
+++ VMEF +GG L ++ R +E+ ++ A+ + H++GV HRD+K
Sbjct: 84 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKS 143
Query: 144 ENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWS 203
+++LL + +K+SDFG A + P +L GTP ++APE++++ Y G +VD+WS
Sbjct: 144 DSILLTSDGRVKLSDFGFCAQVSKEVPR--RKSLVGTPYWMAPEVISRLPY-GTEVDIWS 200
Query: 204 CGVVLFVLNAGYLP-FNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGRLLDTDPAT 259
G+++ + G P FN+P L AM ++I + SP L+ F+ R+L DPA
Sbjct: 201 LGIMVIEMVDGEPPYFNEPPLQAM-KRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQ 259
Query: 260 RITVDEILRDPWFKK 274
R T E+L P+ K
Sbjct: 260 RATAAELLNHPFLAK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 147 bits (371), Expect = 4e-41
Identities = 100/287 (34%), Positives = 158/287 (55%), Gaps = 25/287 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTA-HVKREISIMSRL 73
+E+ K++G GA+ KV+ R V +G+ A+K + K I++ T H + E ++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61
Query: 74 RH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYC 131
R P +V L+ T K++ ++++ GGELF +S + RF EQ + Y +++ A+E+
Sbjct: 62 RQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHL 121
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTLCGTPAYVAPEILA 190
H G+ +RD+KLEN+LLD N + ++DFGLS KE + ++ CGT Y+AP+I+
Sbjct: 122 HKLGIIYRDIKLENILLDSNGHVVLTDFGLS--KEFHEDEVERAYSFCGTIEYMAPDIVR 179
Query: 191 --KKGYDGAKVDMWSCGVVLFVLNAGYLPFN---DPNLMA-MYRKIYKGEYRCPKWTSPD 244
G+D A VD WS GV+++ L G PF + N A + R+I K E P+ S
Sbjct: 180 GGDGGHDKA-VDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSAL 238
Query: 245 LKWFIGRLLDTDPATRI-----TVDEILRDPWFKK----DYKERKFP 282
K I RLL DP R+ DEI + P+F+K D +K P
Sbjct: 239 AKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINWDDLAAKKVP 285
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (369), Expect = 4e-41
Identities = 79/259 (30%), Positives = 132/259 (50%), Gaps = 9/259 (3%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR---EISIMSRLRHPN 77
GK++G GAF +VY +V TG+ +A+K V V EI ++ L+H
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDP-DSPETKKEVNALECEIQLLKNLQHER 65
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV+ Y L + ME+ GG + ++ G +E ++R+Y +Q++ VEY HS +
Sbjct: 66 IVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCGTPAYVAPEILAKKGYD 195
HRD+K N+L D ++K+ DFG S + I G + ++ GTP +++PE+++ +GY
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGY- 184
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GEYRCPKWTSPDLKWFIGRLL 253
G K D+WS G + + P+ + MA KI + P SPD + F+ R
Sbjct: 185 GRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFLRRTF 244
Query: 254 DTDPATRITVDEILRDPWF 272
+ R + +E+LR +
Sbjct: 245 VENAKKRPSAEELLRHFFV 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 6e-40
Identities = 86/272 (31%), Positives = 134/272 (49%), Gaps = 26/272 (9%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV----SKQKILRGGLTAHVKREIS 68
LF E IG G+F +VY + RT Q VAIK + ++ +I +++EI
Sbjct: 1 ELFTLLEC---IGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI------EDIQQEIQ 51
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
+S+ R P I K Y +K++ +ME+ GG + G+ E ++++ +
Sbjct: 52 FLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGKLDETYIAFILREVLLGL 111
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML--HTLCGTPAYVAP 186
EY H G HRD+K N+LL E D+K++DFG+S Q+ M +T GTP ++AP
Sbjct: 112 EYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSG---QLT-STMSKRNTFVGTPFWMAP 167
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT----S 242
E++ + GYD K D+WS G+ L G P +D + M + I K P S
Sbjct: 168 EVIKQSGYDE-KADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--PPSLEGNKFS 224
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
K F+ L+ DP R + E+L+ + KK
Sbjct: 225 KPFKDFVSLCLNKDPKERPSAKELLKHKFIKK 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 7e-40
Identities = 91/271 (33%), Positives = 139/271 (51%), Gaps = 13/271 (4%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
K+IG G+F KV + G+ A+K + K+ +L H+ E +++ + ++HP +V
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T K+YFV++F GGELF + + R F E +R Y ++ SA+ Y HS + +R
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLK EN+LLD + ++DFGL KE I T CGTP Y+APE++ K+ YD V
Sbjct: 121 DLKPENILLDSQGHVVLTDFGL--CKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNT-V 177
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W G VL+ + G PF ++ MY I S + LL+ D
Sbjct: 178 DWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237
Query: 260 RI----TVDEILRDPWFKK----DYKERKFP 282
R+ EI P+F+ D +++K P
Sbjct: 238 RLGAKEDFLEIQEHPFFESLSWTDLEQKKIP 268
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 9e-40
Identities = 79/264 (29%), Positives = 132/264 (50%), Gaps = 21/264 (7%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+++ + +G G++ VY + TGQ VAIK V + L + +EISI+ + P
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP----VEEDLQE-IIKEISILKQCDSPY 59
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
IVK Y ++ VME+ G + KI+ +E+ Q + +EY HS
Sbjct: 60 IVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
HRD+K N+LL+E K++DFG+S + +T+ GTP ++APE++ + GY+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG--QLTDTMAKRNTVIGTPFWMAPEVIQEIGYN 177
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-------KWTSPDLKWF 248
K D+WS G+ + G P++D + M R I+ + P KW SP+ F
Sbjct: 178 -NKADIWSLGITAIEMAEGKPPYSDIHPM---RAIFMIPNKPPPTLSDPEKW-SPEFNDF 232
Query: 249 IGRLLDTDPATRITVDEILRDPWF 272
+ + L DP R + ++L+ P+
Sbjct: 233 VKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 1e-39
Identities = 83/272 (30%), Positives = 144/272 (52%), Gaps = 26/272 (9%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL------TAHVKREI 67
L+ + E +IG GA+ VY G++V TG+ VA+K ++ L + ++RE+
Sbjct: 2 LYQRLE---LIGRGAYGAVYRGKHVPTGRVVALKIIN--------LDTPDDDVSDIQREV 50
Query: 68 SIMSRLRH---PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQL 124
+++S+LR PNI K Y +++ +ME+A+GG + + G +E+ +++
Sbjct: 51 ALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISVIIREV 110
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
+ A++Y H GV HRD+K N+L+ ++K+ DFG++A+ Q T GTP ++
Sbjct: 111 LVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SKRSTFVGTPYWM 168
Query: 185 APE-ILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP-KWT 241
APE I K YD K D+WS G+ ++ + G P++D + AM R
Sbjct: 169 APEVITEGKYYD-TKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY 227
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
S L+ F+ LD +P R++ +E+L+ W K
Sbjct: 228 SKLLREFVAACLDEEPKERLSAEELLKSKWIK 259
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 143 bits (361), Expect = 2e-39
Identities = 89/258 (34%), Positives = 141/258 (54%), Gaps = 10/258 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLRHPNI 78
K++G G+F KV+ T Q AIKA+ K +L T KR +S+ HP +
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA--WEHPFL 58
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
LY TK ++FVME+ GG+L I S +F + Y ++I +++ HS+G+
Sbjct: 59 THLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIV 118
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLKL+N+LLD + +KI+DFG+ KE + D T CGTP Y+APEIL + Y
Sbjct: 119 YRDLKLDNILLDTDGHIKIADFGM--CKENMLGDAKTCTFCGTPDYIAPEILLGQKY-NT 175
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
VD WS GV+L+ + G PF+ + +++ I P+W + + K + +L +P
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREP 235
Query: 258 ATRITVD-EILRDPWFKK 274
R+ V +I + P+F++
Sbjct: 236 ERRLGVKGDIRQHPFFRE 253
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 93/285 (32%), Positives = 155/285 (54%), Gaps = 22/285 (7%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTA-HVKREISIMSRL 73
+E+ K++G GA+ KV+ R V TG+ A+K + K +++ T H + E +++ +
Sbjct: 2 FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61
Query: 74 RH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYC 131
R P +V L+ T+AK++ ++++ GGE+F + + FSE R Y ++I A+E+
Sbjct: 62 RQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHL 121
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTLCGTPAYVAPEILA 190
H G+ +RD+KLEN+LLD + ++DFGLS KE + + ++ CGT Y+APEI+
Sbjct: 122 HKLGIVYRDIKLENILLDSEGHVVLTDFGLS--KEFLSEEKERTYSFCGTIEYMAPEIIR 179
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFN---DPNLMA-MYRKIYKGEYRCPKWTSPDLK 246
KG G VD WS G+++F L G PF + N + + R+I K + P + P+ +
Sbjct: 180 GKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239
Query: 247 WFIGRLLDTDPATRI-----TVDEILRDPWFK----KDYKERKFP 282
+ +LL DP R+ EI P+FK + RK
Sbjct: 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKVN 284
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 3e-39
Identities = 75/258 (29%), Positives = 128/258 (49%), Gaps = 10/258 (3%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ IG G+F V+ + A+K + K+ R + E ++++L
Sbjct: 2 FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSSY 60
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHSR 134
I++ YE K K+ VME+A+ G+L + R E R+F Q++ + + HS+
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK 120
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML-HTLCGTPAYVAPEILAKKG 193
+ HRD+K NL LD ++KI D G++ + + + +T+ GTP Y++PE+ K
Sbjct: 121 KILHRDIKSLNLFLDAYDNVKIGDLGVAKL---LSDNTNFANTIVGTPYYLSPELCEDKP 177
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252
Y+ K D+W+ GVVL+ G PF+ N A+ KI +G + + S L I +
Sbjct: 178 YN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236
Query: 253 LDTDPATRITVDEILRDP 270
L D R ++LR+P
Sbjct: 237 LTKDYRQRPDTFQLLRNP 254
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 3e-39
Identities = 86/292 (29%), Positives = 130/292 (44%), Gaps = 41/292 (14%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKA--VSKQKILRGGLTAHVKREISIMSRLR 74
+YE GK +G G +A VY R+ TG+ VAIK + ++K + G+ REI ++ L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGG-ELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
HPNI+ L +V K+ I V EF + E K + + Y + +EY HS
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHS 120
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL--AK 191
+ HRDLK NLL+ + LK++DFGL+ + P+ + T Y APE+L A+
Sbjct: 121 NWILHRDLKPNNLLIASDGVLKLADFGLA--RSFGSPNRKMTHQVVTRWYRAPELLFGAR 178
Query: 192 KGYDGAKVDMWSCGVVL--FVLNAGYLP-----------------FNDPNLMAMYRKIYK 232
Y VDMWS G + +L +LP + N +
Sbjct: 179 H-YGVG-VDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDY 236
Query: 233 GEYRCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPWFK 273
E++ + LK + RLL +P RIT + L P+F
Sbjct: 237 VEFK--PFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFS 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (354), Expect = 7e-39
Identities = 90/266 (33%), Positives = 137/266 (51%), Gaps = 20/266 (7%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
YE+ + IG G + VY R++ TG+ VAIK + K+ G +++EIS++ RHP
Sbjct: 4 DYELIQRIGSGTYGDVYKARDIATGELVAIKVI---KLEPGDDFEIIQQEISMLKECRHP 60
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
NIV + + K++ VME+ GG L ++++G SE ++ + + Y H
Sbjct: 61 NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI-RPDGMLHTLCGTPAYVAPEILA--- 190
G HRD+K N+LL E+ D+K++DFG+SA Q+ + GTP ++APE+ A
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSA---QLTATIAKRKSFIGTPYWMAPEVAAVER 177
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP------KWTSPD 244
K GYDG K D+W+ G+ L P D + M I K + P KW SP
Sbjct: 178 KGGYDG-KCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKW-SPV 235
Query: 245 LKWFIGRLLDTDPATRITVDEILRDP 270
FI + L DP R T ++L+ P
Sbjct: 236 FHDFIKKCLTKDPKKRPTATKLLQHP 261
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 141 bits (357), Expect = 8e-39
Identities = 88/257 (34%), Positives = 139/257 (54%), Gaps = 10/257 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLRHPNI 78
K++G G+F KV G+ A+KA+ K +L T KR +++ +P +
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWE--NPFL 58
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
LY TK ++FVMEF GG+L I KGRF + Y +++ +++ HS+G+
Sbjct: 59 THLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGII 118
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLKL+N++LD + +KI+DFG+ KE + D T CGTP Y+APEIL Y +
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGM--CKENVFGDNRASTFCGTPDYIAPEILQGLKYTFS 176
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
VD WS GV+L+ + G PF+ + ++ I P+W + + K + +L + DP
Sbjct: 177 -VDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDP 235
Query: 258 ATRITVDEILRD-PWFK 273
R+ V +R P+FK
Sbjct: 236 TRRLGVVGNIRGHPFFK 252
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 78/264 (29%), Positives = 131/264 (49%), Gaps = 23/264 (8%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G + +V+ + TG+ VA+K + K + + HV E I++ + +VKL
Sbjct: 9 VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68
Query: 84 VLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+Y ME+ GG+ ++ G SE +R Y ++ AV+ H G HRDLK
Sbjct: 69 AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGML---HTLCGTPAYVAPEILAKKGYDGAKV 199
EN L+D + +K++DFGLS G++ +++ G+P Y+APE+L KGYD V
Sbjct: 129 PENFLIDASGHIKLTDFGLSK--------GIVTYANSVVGSPDYMAPEVLRGKGYD-FTV 179
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY--KGEYRCPKWTSPDLKW------FIGR 251
D WS G +L+ G+ PF+ + + K + P + P I +
Sbjct: 180 DYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITK 239
Query: 252 LLDTDPATRI-TVDEILRDPWFKK 274
L+ DP+ R ++++I P+FK+
Sbjct: 240 LI-NDPSRRFGSLEDIKNHPFFKE 262
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-38
Identities = 81/262 (30%), Positives = 138/262 (52%), Gaps = 11/262 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+YE+ K IG G+F K+Y + + IK + K+ A K+E+ ++++++HP
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEAS-KKEVILLAKMKHP 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHS 133
NIV + +++ VME+ GG+L +I++ R FSE +F Q+ +++ H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHD 119
Query: 134 RGVFHRDLKLENLLLDENWDL-KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
R + HRD+K +N+ L +N + K+ DFG++ + +T GTP Y++PEI +
Sbjct: 120 RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME--LAYTCVGTPYYLSPEICQNR 177
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWFIG 250
Y+ K D+WS G VL+ L PF NL + KI +G + P + S DL+ I
Sbjct: 178 PYNN-KTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNF-SRDLRSLIS 235
Query: 251 RLLDTDPATRITVDEILRDPWF 272
+L P R ++ IL+ P+
Sbjct: 236 QLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 138 bits (349), Expect = 4e-38
Identities = 83/267 (31%), Positives = 136/267 (50%), Gaps = 17/267 (6%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVS-------KQKILRGGLTAHVKREISIMSRL 73
G++IG G + +VY NV TG+ +A+K V + + + ++ EI + L
Sbjct: 6 GELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDL 65
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCH 132
H NIV+ T+ + +E+ GG + + + GRF EQL R + +Q++ + Y H
Sbjct: 66 DHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH 125
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI--LA 190
S+G+ HRDLK +NLL+D + KISDFG+S + I + ++ G+ ++APE+
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP------KWTSPD 244
+GY AKVD+WS G V+ + AG P++D +A K+ P SP
Sbjct: 186 SQGYS-AKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPV 244
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPW 271
F+ +P R T E+L+ P+
Sbjct: 245 ALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 7e-38
Identities = 82/267 (30%), Positives = 122/267 (45%), Gaps = 27/267 (10%)
Query: 19 EVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIM 70
E+GK +G GAF +VY G T VA+K L+ G + + E SIM
Sbjct: 2 ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVK------TLKEGASEEEREEFLEEASIM 55
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAV 128
+L HPNIV+L V +Y V E+ GG+L F + + + + + Q+ +
Sbjct: 56 KKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGM 115
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVA 185
EY S+ HRDL N L+ EN +KISDFGLS I D G ++A
Sbjct: 116 EYLESKNFVHRDLAARNCLVTENLVVKISDFGLS---RDIYEDDYYRKRGGGKLPIKWMA 172
Query: 186 PEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTS 242
PE L + +K D+WS GV+L+ + G P+ + + + G YR P+
Sbjct: 173 PESLKDGKFT-SKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDG-YRLPRPENCP 230
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRD 269
+L + + DP R T E++ D
Sbjct: 231 DELYELMLQCWAYDPEDRPTFSELVED 257
|
Length = 258 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 137 bits (348), Expect = 8e-38
Identities = 89/261 (34%), Positives = 134/261 (51%), Gaps = 20/261 (7%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G GAF KVY ++ TG A K + + L + EI I+S +HPNIV LYE
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQIES--EEELEDFMV-EIDILSECKHPNIVGLYE 69
Query: 84 VLATKAKIYFVMEFAKGGELFA---KISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
+ K++ ++EF GG L + ++ +G +E R +Q++ A+ + HS V HRD
Sbjct: 70 AYFYENKLWILIEFCDGGALDSIMLELERG-LTEPQIRYVCRQMLEALNFLHSHKVIHRD 128
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA-----KKGYD 195
LK N+LL + D+K++DFG+SA + T GTP ++APE++A YD
Sbjct: 129 LKAGNILLTLDGDVKLADFGVSA--KNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYD 186
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----YRCPKWTSPDLKWFIGR 251
K D+WS G+ L L P ++ N M + KI K E + KW+S F+
Sbjct: 187 -YKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSS-SFNDFLKS 244
Query: 252 LLDTDPATRITVDEILRDPWF 272
L DP R T E+L+ P+
Sbjct: 245 CLVKDPDDRPTAAELLKHPFV 265
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 137 bits (346), Expect = 8e-38
Identities = 85/261 (32%), Positives = 127/261 (48%), Gaps = 16/261 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSRL 73
Y +++G GAF + R V K V+ + L+ +R EI I+S L
Sbjct: 2 YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTR-----LSEKERRDALNEIVILSLL 56
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEY 130
+HPNI+ Y + ME+A GG L+ KI + + F E++ Y Q++SAV Y
Sbjct: 57 QHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSY 116
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
H G+ HRD+K N+ L + +K+ DFG+S K M T+ GTP Y++PE+
Sbjct: 117 IHKAGILHRDIKTLNIFLTKAGLIKLGDFGIS--KILGSEYSMAETVVGTPYYMSPELCQ 174
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFI 249
Y+ K D+W+ G VL+ L F+ N + + KI +G Y S +L +
Sbjct: 175 GVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLV 233
Query: 250 GRLLDTDPATRITVDEILRDP 270
LL DP R T DE+L P
Sbjct: 234 HSLLQQDPEKRPTADEVLDQP 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-37
Identities = 95/294 (32%), Positives = 131/294 (44%), Gaps = 43/294 (14%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMS 71
KYEV ++G GA+ V RN TG+ VAIK K K VK RE+ ++
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIK---KFKESED--DEDVKKTALREVKVLR 55
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSRRYFQQLISAVEY 130
+LRH NIV L E K ++Y V E+ + L + S G R Y QL+ A+ Y
Sbjct: 56 QLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY 115
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
CHS + HRD+K EN+L+ E+ LK+ DFG A + RP L T Y APE+L
Sbjct: 116 CHSHNIIHRDIKPENILVSESGVLKLCDFGF-ARALRARPASPLTDYVATRWYRAPELLV 174
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAG-------------YLPFN-----DPNLMAMYRK--I 230
G VD+W+ G ++ L G YL P+ ++
Sbjct: 175 GDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234
Query: 231 YKG------------EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
+ G E R P S F+ L DP R+T DE+L+ P+F
Sbjct: 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 3e-37
Identities = 77/258 (29%), Positives = 133/258 (51%), Gaps = 8/258 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY K IG G+F K ++ G+ IK ++ K + ++E++++S ++HP
Sbjct: 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLSNMKHP 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHS 133
NIV+ E +Y VM++ +GG+L+ KI+ R F E +F Q+ A+++ H
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
R + HRD+K +N+ L ++ +K+ DFG++ V + T GTP Y++PEI +
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE--LARTCIGTPYYLSPEICENRP 177
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRL 252
Y+ K D+W+ G VL+ + F N+ + KI +G Y S DL+ + +L
Sbjct: 178 YNN-KSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236
Query: 253 LDTDPATRITVDEILRDP 270
+P R +V+ IL
Sbjct: 237 FKRNPRDRPSVNSILEKN 254
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 3e-37
Identities = 81/251 (32%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVK 80
++IG G++AKV +T + A+K + K+ + V+ E + HP +V
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T+++++FV+EF GG+L + + R E+ +R Y ++ A+ + H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD +K++D+G+ KE IRP T CGTP Y+APEIL + Y G V
Sbjct: 121 DLKLDNVLLDAEGHIKLTDYGM--CKEGIRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 200 DMWSCGVVLFVLNAGYLPF------NDPNLMA---MYRKIYKGEYRCPKWTSPDLKWFIG 250
D W+ GV++F + AG PF ++P+ +++ I + + R P+ S +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237
Query: 251 RLLDTDPATRI 261
L+ DP R+
Sbjct: 238 GFLNKDPKERL 248
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (344), Expect = 4e-37
Identities = 95/298 (31%), Positives = 132/298 (44%), Gaps = 58/298 (19%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--------LRGGLTAHVKREISI 69
Y+V K +G G F VY RN TG+ VAIK + K+K LR VK S+
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLR-----EVK---SL 51
Query: 70 MSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLISA 127
HPNIVKL EV ++YFV E+ +G +L FSE + R Q++
Sbjct: 52 RKLNEHPNIVKLKEVFRENDELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
+ + H G FHRDLK ENLL+ +KI+DFGL+ +E IR T Y APE
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLA--RE-IRSRPPYTDYVSTRWYRAPE 168
Query: 188 ILAKKGYDGAKVDMWSCGVVLFVLNAGYL--P-FNDPNLMAMYRKIY------------- 231
IL + + VD+W+ G ++ L Y P F + + KI
Sbjct: 169 ILLRSTSYSSPVDIWALGCIMAEL---YTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPE 225
Query: 232 ------KGEYRCPKWT-----------SPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
K +R P++ SP+ I +L DP R T + L+ P+F
Sbjct: 226 GYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 136 bits (343), Expect = 4e-37
Identities = 88/261 (33%), Positives = 140/261 (53%), Gaps = 11/261 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG GA VY +V TGQ VAIK ++ Q+ + L + EI +M +HP
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKHP 76
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
NIV + +++ VME+ GG L +++ E ++ + A+E+ HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 136
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYD 195
HRD+K +N+LL + +K++DFG A QI P+ T+ GTP ++APE++ +K Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 196 GAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRL 252
G KVD+WS G++ + G P+ N+ L A+Y G E + P+ S + F+ R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 252
Query: 253 LDTDPATRITVDEILRDPWFK 273
L+ D R + E+L+ P+ K
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 135 bits (340), Expect = 1e-36
Identities = 88/261 (33%), Positives = 142/261 (54%), Gaps = 11/261 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG GA V+ +V TGQ VAIK ++ QK + L + EI +M L++P
Sbjct: 20 KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKEL---IINEILVMKELKNP 76
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
NIV + +++ VME+ GG L +++ E ++ + A+E+ H+ V
Sbjct: 77 NIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQV 136
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYD 195
HRD+K +N+LL + +K++DFG A QI P+ T+ GTP ++APE++ +K Y
Sbjct: 137 IHRDIKSDNVLLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 196 GAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRL 252
G KVD+WS G++ + G P+ N+ L A+Y G E + P+ SP + F+ R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDFLNRC 252
Query: 253 LDTDPATRITVDEILRDPWFK 273
L+ D R + E+L+ P+ K
Sbjct: 253 LEMDVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-36
Identities = 100/340 (29%), Positives = 170/340 (50%), Gaps = 32/340 (9%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVK 80
++IG G++AKV R +T + A+K V K+ + V+ E + + HP +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T+++++FV+E+ GG+L + + R E+ +R Y ++ A+ Y H RG+ +R
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD +K++D+G+ KE +RP T CGTP Y+APEIL + Y G V
Sbjct: 121 DLKLDNVLLDSEGHIKLTDYGM--CKEGLRPGDTTSTFCGTPNYIAPEILRGEDY-GFSV 177
Query: 200 DMWSCGVVLFVLNAGYLPF------NDPNLMA---MYRKIYKGEYRCPKWTSPDLKWFIG 250
D W+ GV++F + AG PF ++P+ +++ I + + R P+ S +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237
Query: 251 RLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDIISL 310
L+ DP R+ F F + D+DL + ++ + F
Sbjct: 238 SFLNKDPKERLGC---HPQTGFADIQGHPFFRNVDWDLME-------QKQVVPPFKP--- 284
Query: 311 SSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEE 350
N+SG F +N DA F NE + I+ K+++
Sbjct: 285 ----NISGEF-GLDNFDAQFTNEPVQLTPDDDDIVRKIDQ 319
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-36
Identities = 81/244 (33%), Positives = 130/244 (53%), Gaps = 9/244 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLRHPNI 78
++G G+F KV T + AIK + K I++ T KR +++ + P +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK--PPFL 63
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+L+ T ++YFVME+ GG+L I + G+F E + Y ++ + + HS+G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLKL+N++LD +KI+DFG+ KE I T CGTP Y+APEI+A + Y G
Sbjct: 124 YRDLKLDNVMLDAEGHIKIADFGM--CKENIFGGKTTRTFCGTPDYIAPEIIAYQPY-GK 180
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
VD W+ GV+L+ + AG PF+ + +++ I + PK S + LL P
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLTKHP 240
Query: 258 ATRI 261
A R+
Sbjct: 241 AKRL 244
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 3e-36
Identities = 79/262 (30%), Positives = 133/262 (50%), Gaps = 14/262 (5%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
G +++ K IG G F+ VY + G+ VA+K V +++ +EI ++ +L H
Sbjct: 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDH 61
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI----SKGR-FSEQLSRRYFQQLISAVEY 130
PN++K ++ V+E A G+L I + R E+ +YF QL SA+E+
Sbjct: 62 PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCGTPAYVAPEIL 189
HS+ + HRD+K N+ + +K+ D GL H+L GTP Y++PE +
Sbjct: 122 MHSKRIMHRDIKPANVFITATGVVKLGDLGLG---RFFSSKTTAAHSLVGTPYYMSPERI 178
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPF--NDPNLMAMYRKIYKGEYR-CPK-WTSPDL 245
+ GY+ K D+WS G +L+ + A PF + NL ++ +KI K +Y P S +L
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEEL 237
Query: 246 KWFIGRLLDTDPATRITVDEIL 267
+ + R ++ DP R + +L
Sbjct: 238 RDLVSRCINPDPEKRPDISYVL 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 135 bits (342), Expect = 4e-36
Identities = 93/270 (34%), Positives = 144/270 (53%), Gaps = 16/270 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++V K+IG GAF +V R+ + Q A+K +SK ++++ +A E IM+
Sbjct: 45 FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
IV+L+ +Y VME+ GG+L +S E+ +R Y +++ A++ HS G
Sbjct: 105 IVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH--TLCGTPAYVAPEILAKKGYD 195
HRD+K +N+LLD++ LK++DFG + +K + +GM+ T GTP Y++PE+L +G D
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFG-TCMK--MDANGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 196 ---GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPK--WTSPDLKWF 248
G + D WS GV L+ + G PF +L+ Y KI +K P S K
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQAKDL 281
Query: 249 IGRLLDTDPATRI---TVDEILRDPWFKKD 275
I L TD R+ VDEI P+FK D
Sbjct: 282 ICAFL-TDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 1e-35
Identities = 84/259 (32%), Positives = 129/259 (49%), Gaps = 15/259 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV 79
+ +G G+F +V + VAIK K KI++ HV E I++ + HP V
Sbjct: 36 RTLGTGSFGRVILAT-YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCV 94
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVFH 138
LY ++ +Y V+EF GGE F + + RF + Y Q++ EY S + +
Sbjct: 95 NLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVY 154
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLK ENLLLD++ +K++DFG + V + +TLCGTP Y+APEIL G+ G
Sbjct: 155 RDLKPENLLLDKDGFIKMTDFGFAKVVDT-----RTYTLCGTPEYIAPEILLNVGH-GKA 208
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPA 258
D W+ G+ ++ + G PF + +Y+KI +G PK+ + K + +LL D
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLMKKLLSHDLT 268
Query: 259 TRI-----TVDEILRDPWF 272
R + PWF
Sbjct: 269 KRYGNLKKGAQNVKEHPWF 287
|
Length = 340 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 3e-35
Identities = 93/270 (34%), Positives = 144/270 (53%), Gaps = 16/270 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YEV K+IG GAF +V R+ T + A+K +SK ++++ +A E IM+ P
Sbjct: 45 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+V+L+ +Y VME+ GG+L +S E+ +R Y +++ A++ HS G
Sbjct: 105 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 164
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH--TLCGTPAYVAPEILAKK--- 192
HRD+K +N+LLD++ LK++DFG ++ +GM+ T GTP Y++PE+L +
Sbjct: 165 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPKWT--SPDLKWF 248
GY G + D WS GV L+ + G PF +L+ Y KI +K P S + K
Sbjct: 222 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 281
Query: 249 IGRLLDTDPATRI---TVDEILRDPWFKKD 275
I L TD R+ V+EI R +FK D
Sbjct: 282 ICAFL-TDREVRLGRNGVEEIKRHLFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 4e-35
Identities = 78/261 (29%), Positives = 134/261 (51%), Gaps = 18/261 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E K+I GA+ VY R+ T Q A+K ++KQ ++ V E I++ +P
Sbjct: 3 FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+V ++ TK + VME+ +GG+ + + G ++R YF + + A+EY H+ G+
Sbjct: 63 VVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAV----------KEQIRPDG---MLHTLCGTPAY 183
HRDLK +NLL+ +K++DFGLS + + I D + +CGTP Y
Sbjct: 123 VHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEY 182
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT-- 241
+APE++ ++GY G VD W+ G++L+ G +PF ++ ++ + P+
Sbjct: 183 IAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGDEA 241
Query: 242 -SPDLKWFIGRLLDTDPATRI 261
D + I RLL +P R+
Sbjct: 242 LPADAQDLISRLLRQNPLERL 262
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 131 bits (331), Expect = 5e-35
Identities = 78/249 (31%), Positives = 137/249 (55%), Gaps = 12/249 (4%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVK 80
++IG G++AKV R + Q A+K V K+ + V+ E + + +P +V
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T ++++ V+E+ GG+L + + R E+ +R Y ++ A+ + H RG+ +R
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYR 120
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD + +K++D+G+ KE + P T CGTP Y+APEIL + Y G V
Sbjct: 121 DLKLDNVLLDADGHIKLTDYGM--CKEGLGPGDTTSTFCGTPNYIAPEILRGEEY-GFSV 177
Query: 200 DMWSCGVVLFVLNAGYLPF----NDPNLMA---MYRKIYKGEYRCPKWTSPDLKWFIGRL 252
D W+ GV++F + AG PF ++P++ +++ I + R P++ S +
Sbjct: 178 DWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237
Query: 253 LDTDPATRI 261
L+ DP R+
Sbjct: 238 LNKDPKERL 246
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 9e-35
Identities = 76/255 (29%), Positives = 130/255 (50%), Gaps = 9/255 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+Y V +++G G+F + ++V + Q A+K + K ++E ++++++HP
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSA--VEDSRKEAVLLAKMKHP 58
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGR-FSEQLSRRYFQQLISAVEYCHS 133
NIV E +Y VME+ GG+L KI +G+ F E ++F Q+ V++ H
Sbjct: 59 NIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
+ V HRD+K +N+ L +N +K+ DFG + + P T GTP YV PEI
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFG--SARLLTSPGAYACTYVGTPYYVPPEIWENMP 176
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252
Y+ K D+WS G +L+ L PF + + K+ +G Y+ P S +L+ I ++
Sbjct: 177 YNN-KSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235
Query: 253 LDTDPATRITVDEIL 267
+P +R + IL
Sbjct: 236 FKRNPRSRPSATTIL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (325), Expect = 2e-34
Identities = 91/301 (30%), Positives = 129/301 (42%), Gaps = 76/301 (25%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRG---GLTAHVKREISIMSRLRHPNIV 79
IG G + VY R+ TG+ VA+K KI L G+ + REIS++ L HPNIV
Sbjct: 7 IGEGTYGVVYKARDKLTGEIVALK-----KIRLETEDEGVPSTAIREISLLKELNHPNIV 61
Query: 80 KLYEVLATKAKIYFVMEF-----AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
+L +V+ ++ K+Y V EF K + L + Y QL+ + YCHS
Sbjct: 62 RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDP---PLIKSYLYQLLQGIAYCHSH 118
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
V HRDLK +NLL+D LK++DFGL+ A +R H + T Y APEIL
Sbjct: 119 RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVV-TLWYRAPEILLGSR 175
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---------YRC------- 237
VD+WS G + F + M R ++ G+ +R
Sbjct: 176 QYSTPVDIWSIGCI----------FAE---MVNRRPLFPGDSEIDQLFRIFRTLGTPDED 222
Query: 238 ---------------PKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPW 271
PKW DL + ++L DPA RI+ L+ P+
Sbjct: 223 VWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282
Query: 272 F 272
F
Sbjct: 283 F 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 78/270 (28%), Positives = 133/270 (49%), Gaps = 17/270 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++V ++G G F +V R TG A+K + K +L + + E I+S P
Sbjct: 3 FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
I +L K +Y VME+ GG+L + +++ +F E +++ Y +L+ A+ H G
Sbjct: 63 IPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL--CGTPAYVAPEILA--- 190
HRD+K EN+L+D +K++DFG +A ++ + M+++ GTP Y+APE+L
Sbjct: 123 YVHRDIKPENVLIDRTGHIKLADFGSAA---RLTANKMVNSKLPVGTPDYIAPEVLTTMN 179
Query: 191 --KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPK--WTSPD 244
KG G + D WS GV+ + + G PF++ Y I ++ + P+ S D
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK 274
I LL R+ + + P+F K
Sbjct: 240 FLDLIQSLL-CGQKERLGYEGLCCHPFFSK 268
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 129 bits (327), Expect = 3e-34
Identities = 71/214 (33%), Positives = 104/214 (48%), Gaps = 39/214 (18%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--------QKILRGGLTAHVKREIS 68
+YE+ K IG GA+ V + RTG+ VAIK +S ++ILR EI
Sbjct: 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILR---------EIK 51
Query: 69 IMSRLRHPNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQ 122
++ LRH NI+ L ++L + +Y V E +L I S ++ + +
Sbjct: 52 LLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELM-ETDLHKVIKSPQPLTDDHIQYFLY 110
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTP 181
Q++ ++Y HS V HRDLK N+L++ N DLKI DFGL+ V G L T
Sbjct: 111 QILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFL-----TE 165
Query: 182 AYV------APEI-LAKKGYDGAKVDMWSCGVVL 208
YV APE+ L+ Y A +D+WS G +
Sbjct: 166 -YVVTRWYRAPELLLSSSRYTKA-IDIWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 3e-34
Identities = 72/233 (30%), Positives = 113/233 (48%), Gaps = 26/233 (11%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
GK +G GAF +VY G+ + VA+K L+ + RE IM +
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKT------LKEDASEQQIEEFLREARIMRK 57
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEY 130
L HPN+VKL V + +Y VME+ +GG+L + + ++ + S + Q+ +EY
Sbjct: 58 LDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEY 117
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLS---AVKEQIRPDGMLHTLCGTPAYVAPE 187
S+ HRDL N L+ EN +KISDFGLS + R G + ++APE
Sbjct: 118 LESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPI----RWMAPE 173
Query: 188 ILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
L + + +K D+WS GV+L+ + G P+ + + + G YR P+
Sbjct: 174 SLKEGKF-TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNG-YRLPQ 224
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 130 bits (327), Expect = 5e-34
Identities = 91/270 (33%), Positives = 145/270 (53%), Gaps = 16/270 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
Y+V K+IG GAF +V R+ + + A+K +SK ++++ +A E IM+ P
Sbjct: 45 YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+V+L+ +Y VME+ GG+L +S E+ ++ Y +++ A++ HS G+
Sbjct: 105 VVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLI 164
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH--TLCGTPAYVAPEILAKK--- 192
HRD+K +N+LLD++ LK++DFG ++ GM+ T GTP Y++PE+L +
Sbjct: 165 HRDVKPDNMLLDKHGHLKLADFGTCMKMDET---GMVRCDTAVGTPDYISPEVLKSQGGD 221
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPK--WTSPDLKWF 248
GY G + D WS GV LF + G PF +L+ Y KI +K P+ S K
Sbjct: 222 GYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKHAKNL 281
Query: 249 IGRLLDTDPATRI---TVDEILRDPWFKKD 275
I L TD R+ V+EI + P+FK D
Sbjct: 282 ICAFL-TDREVRLGRNGVEEIKQHPFFKND 310
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 5e-34
Identities = 87/283 (30%), Positives = 126/283 (44%), Gaps = 40/283 (14%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G + VY RN TG+ VA+K + + G+ + REIS++ L HPNIVKL +
Sbjct: 8 IGEGTYGVVYKARNKLTGEVVALKKI-RLDTETEGVPSTAIREISLLKELNHPNIVKLLD 66
Query: 84 VLATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL 141
V+ T+ K+Y V EF + L + Y QL+ + +CHS V HRDL
Sbjct: 67 VIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDL 126
Query: 142 KLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
K +NLL++ +K++DFGL+ A +R H + T Y APEIL Y VD
Sbjct: 127 KPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVV-TLWYRAPEILLGCKYYSTAVD 183
Query: 201 MWSCGVVL--FVLNAGYLPFNDP--NLMAMYRKI----------------YKGEYRCPKW 240
+WS G + V P + L ++R + YK + PKW
Sbjct: 184 IWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF--PKW 241
Query: 241 TSPDLKWFI-----------GRLLDTDPATRITVDEILRDPWF 272
D + ++L DP RI+ L P+F
Sbjct: 242 ARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 5e-34
Identities = 85/261 (32%), Positives = 140/261 (53%), Gaps = 11/261 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG GA VY ++ TGQ VAIK ++ Q+ + L + EI +M ++P
Sbjct: 20 KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKEL---IINEILVMRENKNP 76
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
NIV + +++ VME+ GG L +++ E ++ + A+++ HS V
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQV 136
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYD 195
HRD+K +N+LL + +K++DFG A QI P+ T+ GTP ++APE++ +K Y
Sbjct: 137 IHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 192
Query: 196 GAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRL 252
G KVD+WS G++ + G P+ N+ L A+Y G E + P+ S + F+ R
Sbjct: 193 GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFRDFLNRC 252
Query: 253 LDTDPATRITVDEILRDPWFK 273
L+ D R + E+L+ P+ K
Sbjct: 253 LEMDVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 8e-34
Identities = 66/205 (32%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR--- 74
YE IG GA+ VY R++ TG+ VA+K V + G+ REI+++ +L
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVP-LSEEGIPLSTLREIALLKQLESFE 59
Query: 75 HPNIVKLYEVLATKA-----KIYFVMEFAKG--GELFAKISKGRFSEQLSRRYFQQLISA 127
HPNIV+L +V K+ V E +K K + + +QL+
Sbjct: 60 HPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRG 119
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC-GTPAYVAP 186
V++ HS + HRDLK +N+L+ + +KI+DFGL+ + M T T Y AP
Sbjct: 120 VDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS----FEMALTSVVVTLWYRAP 175
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVL 211
E+L + Y VDMWS G + L
Sbjct: 176 EVLLQSSY-ATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 9e-34
Identities = 85/280 (30%), Positives = 135/280 (48%), Gaps = 35/280 (12%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-R 74
G +E+ ++IG G + KVY R+ +TGQ VAIK + + +K E +I+ +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD----IIEDEEEEIKEEYNILRKYSN 61
Query: 75 HPNIVKLYEVLATKA------KIYFVMEFAKGG---ELFAKI--SKGRFSEQLSRRYFQQ 123
HPNI Y K +++ VME GG +L + R E+ ++
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRE 121
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
+ + Y H V HRD+K +N+LL +N ++K+ DFG+SA + G +T GTP +
Sbjct: 122 TLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--QLDSTLGRRNTFIGTPYW 179
Query: 184 VAPEILAKK-----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRC 237
+APE++A YD A+ D+WS G+ L G P D + M A++ KI +
Sbjct: 180 MAPEVIACDEQPDASYD-ARSDVWSLGITAIELADGKPPLCDMHPMRALF-KIPRNP--P 235
Query: 238 PKWTSPDLKW------FIGRLLDTDPATRITVDEILRDPW 271
P SP+ W FI L + R ++E+L P+
Sbjct: 236 PTLKSPE-NWSKKFNDFISECLIKNYEQRPFMEELLEHPF 274
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 1e-33
Identities = 80/264 (30%), Positives = 122/264 (46%), Gaps = 27/264 (10%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
GK +G GAF +VY G VA+K + ++ RE IM +L
Sbjct: 4 GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVK-----TLKEDASEQQIEEFLREARIMRKL 58
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRF---SEQLSRRYFQQLISAV 128
HPNIVKL V + + VME+ GG+L + + ++ + S+ LS + Q+ +
Sbjct: 59 DHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLS--FALQIARGM 116
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT-P-AYVAP 186
EY S+ HRDL N L+ EN +KISDFGLS + D G P ++AP
Sbjct: 117 EYLESKNFIHRDLAARNCLVGENLVVKISDFGLS---RDLYDDDYYKVKGGKLPIRWMAP 173
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPD 244
E L + + +K D+WS GV+L+ + G P+ + + + KG P P+
Sbjct: 174 ESLKEGKF-TSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKPPNCPPE 232
Query: 245 LKWFIGRLLDTDPATRITVDEILR 268
L + + DP R T E++
Sbjct: 233 LYKLMLQCWAEDPEDRPTFSELVE 256
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-33
Identities = 80/238 (33%), Positives = 132/238 (55%), Gaps = 9/238 (3%)
Query: 40 TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99
+G+ VA+K + +K R L + E+ IM +H N+V++Y +++ VMEF +
Sbjct: 44 SGKLVAVKKMDLRKQQRREL---LFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLE 100
Query: 100 GGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159
GG L ++ R +E+ ++ A+ H++GV HRD+K +++LL + +K+SDF
Sbjct: 101 GGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDF 160
Query: 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLP-F 218
G A + P +L GTP ++APE++++ Y G +VD+WS G+++ + G P F
Sbjct: 161 GFCAQVSKEVP--RRKSLVGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYF 217
Query: 219 NDPNL--MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
N+P L M M R + + SP LK F+ RLL DPA R T E+L+ P+ K
Sbjct: 218 NEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 126 bits (317), Expect = 1e-33
Identities = 78/263 (29%), Positives = 133/263 (50%), Gaps = 12/263 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLR 74
+Y + + +G G+F VY ++ + +K + + + L T +E ++S+L
Sbjct: 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD 60
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLISAVE 129
HP IVK + + + E+ +G +L K+ + + SE +F QL+ V
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVH 120
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
Y H R + HRDLK +N+ L N LKI DFG+S + + + T GTP Y++PE L
Sbjct: 121 YMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLATTFTGTPYYMSPEAL 177
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248
+GYD +K D+WS G +L+ + F N +++ +I +G P+ S L
Sbjct: 178 KHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236
Query: 249 IGRLLDTDPATRITVDEILRDPW 271
+ +L+ DP+ R + EILR+P+
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPF 259
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 82/253 (32%), Positives = 139/253 (54%), Gaps = 11/253 (4%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+ V R +G+ VA+K + +K R L + E+ IM +H N+V++Y+
Sbjct: 29 IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHQNVVEMYK 85
Query: 84 VLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKL 143
+++ +MEF +GG L +S+ R +E+ + ++ A+ Y HS+GV HRD+K
Sbjct: 86 SYLVGEELWVLMEFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKS 145
Query: 144 ENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMW 202
+++LL + +K+SDFG A QI D +L GTP ++APE++++ Y G +VD+W
Sbjct: 146 DSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRTPY-GTEVDIW 201
Query: 203 SCGVVLFVLNAGYLP-FNDPNLMAM--YRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
S G+++ + G P F+D + AM R + + SP L+ F+ R+L +P
Sbjct: 202 SLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERMLTREPQE 261
Query: 260 RITVDEILRDPWF 272
R T E+L P+
Sbjct: 262 RATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-33
Identities = 86/297 (28%), Positives = 132/297 (44%), Gaps = 62/297 (20%)
Query: 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNI 78
+GKI G G F++V ++ +TG+ AIK + K + + REI + RL HPNI
Sbjct: 4 LGKI-GEGTFSEVLKAQSRKTGKYYAIKCMKKH--FKSLEQVNNLREIQALRRLSPHPNI 60
Query: 79 VKLYEVL--ATKAKIYFVMEFAKGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHS 133
++L EVL ++ V E L+ I KGR E+ + Y QL+ ++++ H
Sbjct: 61 LRLIEVLFDRKTGRLALVFELMDM-NLYELI-KGRKRPLPEKRVKSYMYQLLKSLDHMHR 118
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV--------- 184
G+FHRD+K EN+L+ ++ LK++DFG R + P Y
Sbjct: 119 NGIFHRDIKPENILIKDD-ILKLADFG------SCR------GIYSKPPYTEYISTRWYR 165
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN------------------DPNLMAM 226
APE L GY G K+D+W+ G V F + + + F D ++
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKK 225
Query: 227 YRKIYKGEYRCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPWF 272
+RK Y P L+ + +LL DP RIT + LR P+F
Sbjct: 226 FRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-33
Identities = 91/291 (31%), Positives = 128/291 (43%), Gaps = 40/291 (13%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E IG G + VY R+ +G+ VA+K V R G+ REI+++ LRHPN
Sbjct: 9 FEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPN 67
Query: 78 IVKLYEVLATKA--KIYFVMEFAKG--GELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
IV+L EV+ K I+ VME+ + L + FSE + QL+ ++Y H
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT-PFSESQVKCLMLQLLRGLQYLHE 126
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL-AKK 192
+ HRDLK+ NLLL + LKI+DFGL+ P + T Y APE+L
Sbjct: 127 NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGL--PAKPMTPKVVTLWYRAPELLLGCT 184
Query: 193 GYDGAKVDMWSCGVVL--FVLNAGYLPFND--------------PN--------LMAMYR 228
Y A +DMW+ G +L + + LP PN + +
Sbjct: 185 TYTTA-IDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243
Query: 229 KIY--KGEYRCPKWTSPDLKWFIGRLLDT----DPATRITVDEILRDPWFK 273
K K Y K P L RLL+ DP R T +E L +FK
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-33
Identities = 79/265 (29%), Positives = 132/265 (49%), Gaps = 17/265 (6%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAV------SKQKILRGGLTAHVKREISIMSRLR 74
G +IG G+F VY G N +G+ +A+K V + K + + + REI+++ L+
Sbjct: 5 GALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ 64
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS 133
H NIV+ + +E+ GG + A ++ G F E L R + +Q++ + Y H+
Sbjct: 65 HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHN 124
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT----LCGTPAYVAPEIL 189
RG+ HRD+K N+L+D +KISDFG+S E + L G+ ++APE++
Sbjct: 125 RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVV 184
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW---TSPDLK 246
+ Y K D+WS G ++ + G PF D + KI GE P+ S +
Sbjct: 185 KQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI--GENASPEIPSNISSEAI 241
Query: 247 WFIGRLLDTDPATRITVDEILRDPW 271
F+ + + D R T E+L+ P+
Sbjct: 242 DFLEKTFEIDHNKRPTAAELLKHPF 266
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 3e-33
Identities = 81/286 (28%), Positives = 135/286 (47%), Gaps = 46/286 (16%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G +A VY GRN TG+ VA+K + G + REIS+M L+H NIV+L++
Sbjct: 8 LGEGTYATVYKGRNRTTGEIVALKEIHLDA--EEGTPSTAIREISLMKELKHENIVRLHD 65
Query: 84 VLATKAKIYFVMEFAKGGELFAKI----SKGRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
V+ T+ K+ V E+ +L + +G + + QL+ + +CH V HR
Sbjct: 66 VIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHR 124
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCG---TPAYVAPEILAKKGYD 195
DLK +NLL+++ +LK++DFGL+ R G+ ++T T Y AP++L
Sbjct: 125 DLKPQNLLINKRGELKLADFGLA------RAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY 178
Query: 196 GAKVDMWSCGVVLFVLNAGYLPF----NDPNLMAMYR-------KIYKGEYRCPKW---- 240
+D+WS G ++ + G F N+ L+ ++R + G + P++
Sbjct: 179 STSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF 238
Query: 241 --------------TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
P + RLL +P RI+ + L+ PWF
Sbjct: 239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-33
Identities = 89/293 (30%), Positives = 127/293 (43%), Gaps = 62/293 (21%)
Query: 27 GAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-GLTAHVKREISIMSRLRHPNIVKLYEVL 85
G + VY R+ +TG+ VA+K + +K G +T+ REI+I+ +L+HPNIV + EV+
Sbjct: 16 GTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITS--LREINILLKLQHPNIVTVKEVV 73
Query: 86 --ATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
+ KIY VME+ K + K F + + QL+S V + H + HR
Sbjct: 74 VGSNLDKIYMVMEYVEHDLKSL---METMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHR 130
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLK NLLL+ LKI DFGL+ +E P L T Y APE+L +
Sbjct: 131 DLKTSNLLLNNRGILKICDFGLA--REYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAI 188
Query: 200 DMWSCGVVL--FVLNAGYLP-----------FND---PNLMAMYRKIYKGEYRCP----- 238
DMWS G + + P F P KI+ G P
Sbjct: 189 DMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPT-----EKIWPGFSELPGAKKK 243
Query: 239 KWTSP-------------------DLKWFIGRLLDTDPATRITVDEILRDPWF 272
+T DL + RLL DPA RI+ ++ L+ P+F
Sbjct: 244 TFTKYPYNQLRKKFPALSLSDNGFDL---LNRLLTYDPAKRISAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|213380 cd12195, CIPK_C, C-terminal regulatory domain of Calcineurin B-Like (CBL)-interacting protein kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 4e-33
Identities = 52/121 (42%), Positives = 68/121 (56%), Gaps = 15/121 (12%)
Query: 303 NAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLA 362
NAFD+ISLSSG +LSGLF++ + RF S + E+I+EK+EE A+ +
Sbjct: 1 NAFDLISLSSGLDLSGLFEEEDEVKRE---TRFTSRKPAEEIIEKLEEAAKKL----GFR 53
Query: 363 VTKK-EWGAKLEGQN----GNFTMVIGIDRLTDDLVVVEIKKSMRRGEEN---WKDKLRP 414
V KK E G KLEGQ G + + + +T LVVVE+KKS E WKD LRP
Sbjct: 54 VRKKKEGGVKLEGQKGGRKGRLAVSVEVFEVTPSLVVVEVKKSAGDTLEYHKFWKDLLRP 113
Query: 415 A 415
Sbjct: 114 L 114
|
CIPKs are serine/threonine protein kinases (STKs), catalyzing the transfer of the gamma-phosphoryl group from ATP to S/T residues on protein substrates. They comprise a unique family in higher plants of proteins that interact with the calcineurin B-like (CBL) calcium sensors to form a signaling network that decode specific calcium signals triggered by a variety of environmental stimuli including salinity, drought, cold, light, and mechanical perturbation, among others. The specificity of the response relies on differences in expression and localization of both CBLs and CIPKs, as well as on the interaction specificity of CBL-CIPK combinations. There are 25, 30, and 43 CIPK genes identified in the Arabidopsis thaliana, Oryza sativa, and Zea mays genomes, respectively. The founding member of the CIPK family is Arabidopsis thaliana CIPK24, also called SOS2 (Salt Overlay Sensitive 2). CIPKs contain an N-terminal catalytic kinase domain and a C-terminal regulatory domain that contains the FISL (also called NAF for Asn-Ala-Phe) and PPI-binding motifs, which are involved in the interaction with CBLs and PP2C-type protein phosphatases, respectively. Studies using SOS2, SOS3, and ABI2 phosphatase show that the binding of CBL and PP2C-type protein phosphatase to CIPK is mutually exclusive. The binding of CBL to CIPK is inhibitory to kinase activity. Length = 116 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 4e-33
Identities = 85/261 (32%), Positives = 139/261 (53%), Gaps = 11/261 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG GA VY +V TGQ VAI+ ++ Q+ + L + EI +M ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
NIV + +++ VME+ GG L +++ E ++ + A+E+ HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT-LCGTPAYVAPEILAKKGYD 195
HRD+K +N+LL + +K++DFG A QI P+ + + GTP ++APE++ +K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAY- 193
Query: 196 GAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRL 252
G KVD+WS G++ + G P+ N+ L A+Y G E + P+ S + F+ R
Sbjct: 194 GPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 253 LDTDPATRITVDEILRDPWFK 273
LD D R + E+L+ + K
Sbjct: 254 LDMDVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 127 bits (321), Expect = 4e-33
Identities = 80/246 (32%), Positives = 113/246 (45%), Gaps = 47/246 (19%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K +G GAF +V V T A+K + K+ +L AHVK E I++ + +VKL
Sbjct: 7 KTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKL 66
Query: 82 YEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
Y K +YFVM++ GG++ + I F E L+R Y +L A+E H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRD 126
Query: 141 LKLENLLLDENWDLKISDFGLSA------------VKEQIRPDGM--------------- 173
+K +N+L+D + +K++DFGL IR D M
Sbjct: 127 IKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCG 186
Query: 174 ------------------LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215
H+L GTP Y+APE+L +KGY D WS GV+LF + G
Sbjct: 187 DRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILFEMLVGQ 245
Query: 216 LPFNDP 221
PF P
Sbjct: 246 PPFLAP 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 6e-33
Identities = 83/264 (31%), Positives = 136/264 (51%), Gaps = 14/264 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLRHPNI 78
++G G+F KV T + AIK + K +++ T KR +++ + P +
Sbjct: 6 MVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGK--PPFL 63
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+L+ T ++YFVME+ GG+L +I + GRF E + Y ++ + + HS+G+
Sbjct: 64 TQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGII 123
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLKL+N++LD +KI+DFG+ KE + T CGTP Y+APEI+A + Y G
Sbjct: 124 YRDLKLDNVMLDSEGHIKIADFGM--CKENMWDGVTTKTFCGTPDYIAPEIIAYQPY-GK 180
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
VD W+ GV+L+ + AG PF + +++ I + PK S + L+ P
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHP 240
Query: 258 ATRITVDEILRDPWFKKDYKERKF 281
R+ P ++D KE F
Sbjct: 241 GKRLGC-----GPEGERDIKEHAF 259
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 7e-33
Identities = 81/266 (30%), Positives = 127/266 (47%), Gaps = 22/266 (8%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLT-AHVKREISIMSRLRHPNIVKL 81
+G G F +V + TG+ A K + K+++ R G A +++I + ++ IV L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKI--LEKVSSRFIVSL 58
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKIS---KGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
TK + VM GG+L I + F E + Y Q+I +E+ H R + +
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVY 118
Query: 139 RDLKLENLLLDENWDLKISDFGLSA-VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
RDLK EN+LLD++ +++ISD GL+ +K + G GTP Y+APE+L + YD
Sbjct: 119 RDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRA----GTPGYMAPEVLQGEVYD-F 173
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
VD ++ G L+ + AG PF + R+ + P SP+ K LL
Sbjct: 174 SVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALL 233
Query: 254 DTDPATRI-----TVDEILRDPWFKK 274
DP R+ + DE+ P FK
Sbjct: 234 QKDPEKRLGCRGGSADEVREHPLFKD 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 8e-33
Identities = 84/260 (32%), Positives = 134/260 (51%), Gaps = 21/260 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQS-VAIKAVS-------KQKILRGGLTAHVKREISI 69
Y V + +G GAF VY R GQ+ +A+K ++ K K R + E++I
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 70 M-SRLRHPNIVKLYEVLATKAKIYFVMEFAKG---GELFA--KISKGRFSEQLSRRYFQQ 123
+ +LRHPNIV+ Y+ ++Y VM+ +G GE F K K RF+E+ F Q
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQ 121
Query: 124 LISAVEYCH-SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
++ A+ Y H + + HRDL N++L E+ + I+DFGL+ +Q +P+ L ++ GT
Sbjct: 122 MVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLA---KQKQPESKLTSVVGTIL 178
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWT 241
Y PEI+ + Y G K D+W+ G +L+ + PF N++++ KI + Y P+
Sbjct: 179 YSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGM 237
Query: 242 -SPDLKWFIGRLLDTDPATR 260
S D+ I L D R
Sbjct: 238 YSEDVTDVITSCLTPDAEAR 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 8e-33
Identities = 89/283 (31%), Positives = 142/283 (50%), Gaps = 39/283 (13%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G + VY GRN +TGQ VA+K + + + G+ + REIS++ L+HPNIV L +
Sbjct: 8 IGEGTYGVVYKGRNKKTGQIVAMKKI-RLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66
Query: 84 VLATKAKIYFVMEFAKGG--ELFAKISKGRFSE-QLSRRYFQQLISAVEYCHSRGVFHRD 140
VL ++++Y + EF + + KG++ + +L + Y Q++ + +CHSR V HRD
Sbjct: 67 VLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRD 126
Query: 141 LKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
LK +NLL+D +K++DFGL+ A +R H + T Y APE+L V
Sbjct: 127 LKPQNLLIDNKGVIKLADFGLARAFGIPVRV--YTHEVV-TLWYRAPEVLLGSPRYSTPV 183
Query: 200 DMWSCGVVLFVLNAGYLPF--NDPNLMAMYR----------KIYKG-----EYRC--PKW 240
D+WS G + F A P D + ++R ++ G +Y+ PKW
Sbjct: 184 DIWSIGTI-FAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKW 242
Query: 241 TSPDLKWF-----------IGRLLDTDPATRITVDEILRDPWF 272
L+ + ++L DPA RI+ + L P+F
Sbjct: 243 KKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 124 bits (311), Expect = 1e-32
Identities = 86/284 (30%), Positives = 141/284 (49%), Gaps = 27/284 (9%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
LF K E IG G+F +V+ G + RT Q VAIK + ++ +++EI+++S+
Sbjct: 5 LFTKLER---IGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQC 59
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
P + K Y K++ +ME+ GG + G F E ++++ ++Y HS
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHS 119
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSA--VKEQIRPDGMLHTLCGTPAYVAPEILAK 191
HRD+K N+LL E D+K++DFG++ QI+ + T GTP ++APE++ +
Sbjct: 120 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIQQ 175
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL------ 245
YD +K D+WS G+ L G P +D + M + + PK P L
Sbjct: 176 SAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVL-------FLIPKNNPPTLTGEFSK 227
Query: 246 --KWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFD 287
K FI L+ DP+ R T E+L+ + K+ K+ + E D
Sbjct: 228 PFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 1e-32
Identities = 87/280 (31%), Positives = 141/280 (50%), Gaps = 22/280 (7%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI 67
+ R+++ +E+ +G GAF KVY +N TG A K + + L ++ EI
Sbjct: 4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYMV-EI 60
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFA---KISKGRFSEQLSRRYFQQL 124
I++ HP IVKL K++ ++EF GG + A ++ +G Q+ + +Q+
Sbjct: 61 EILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQI-QVICRQM 119
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA--VKEQIRPDGMLHTLCGTPA 182
+ A++Y HS + HRDLK N+LL + D+K++DFG+SA VK R D + GTP
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFI----GTPY 175
Query: 183 YVAPEI-----LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--- 234
++APE+ + YD K D+WS G+ L + P ++ N M + KI K E
Sbjct: 176 WMAPEVVMCETMKDTPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT 234
Query: 235 YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
P S + + F+ LD P TR + ++L P+
Sbjct: 235 LSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 93/319 (29%), Positives = 141/319 (44%), Gaps = 58/319 (18%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K +G GAF +V R V T A+K + K+ +L AHVK E I++ + +V+L
Sbjct: 7 KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66
Query: 82 YEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
Y K +YFVM++ GG++ + I G F E L+R Y +L AVE H G HRD
Sbjct: 67 YYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126
Query: 141 LKLENLLLDENWDLKISDFGLSA------------VKEQIRPDGM--------------- 173
+K +N+L+D + +K++DFGL + +R D M
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCG 186
Query: 174 ------------------LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215
H+L GTP Y+APE+L + GY D WS GV+L+ + G
Sbjct: 187 DRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLVGQ 245
Query: 216 LPFNDPNLMAMYRKI--YKGEYRCPKWT--SPDLKWFIGRLL--DTDPATRITVDEILRD 269
PF + K+ ++ P SP+ I +L D + DEI
Sbjct: 246 PPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEIKAH 305
Query: 270 PWFK-----KDYKERKFPH 283
P+FK D +++ P+
Sbjct: 306 PFFKTIDFSSDLRQQSAPY 324
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 3e-32
Identities = 91/305 (29%), Positives = 139/305 (45%), Gaps = 55/305 (18%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K+IG GAF +V + TG+ A+K + K ++ + AHVK E +++ P +V L
Sbjct: 7 KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
Y +Y +MEF GG+L + K FSE ++R Y + + A+E H G HRD
Sbjct: 67 YYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRD 126
Query: 141 LKLENLLLDENWDLKISDFGLS-------------------------------------- 162
+K +N+L+D +K+SDFGLS
Sbjct: 127 IKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINL 186
Query: 163 --AVKEQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215
+ K+QI M ++ GTP Y+APEI ++GY G + D WS G ++F G+
Sbjct: 187 TMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGY-GQECDWWSLGAIMFECLIGW 245
Query: 216 LPFNDPNLMAMYRKI--YKGEYRCPK--WTSPDLKWFIGRLLDTDPATRI---TVDEILR 268
PF N YRKI ++ P S + + I RL+ T+ R+ EI
Sbjct: 246 PPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLI-TNAENRLGRGGAHEIKS 304
Query: 269 DPWFK 273
P+F+
Sbjct: 305 HPFFR 309
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 123 bits (309), Expect = 3e-32
Identities = 87/264 (32%), Positives = 134/264 (50%), Gaps = 18/264 (6%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLTAHVKREI--SIMSRLRHPNIV 79
IIG G F +VY R TG+ A+K + K++I ++ G T + I S++S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
+ T K+ F+++ GG+L +S+ G FSE R Y ++I +E+ H+R V +
Sbjct: 61 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVY 120
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDGA 197
RDLK N+LLDE+ ++ISD GL+ + +P H GT Y+APE+L K YD +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGVAYD-S 175
Query: 198 KVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254
D +S G +LF L G+ PF + + R P SP+L+ + LL
Sbjct: 176 SADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQ 235
Query: 255 TDPATRI-----TVDEILRDPWFK 273
D R+ E+ P+F+
Sbjct: 236 RDVNRRLGCLGRGAQEVKEHPFFR 259
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-32
Identities = 83/318 (26%), Positives = 136/318 (42%), Gaps = 54/318 (16%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG----GLTAHVKREISIMSR 72
+Y+ + IG GA+ V + R+G+ VAIK KI L RE+ I+
Sbjct: 6 RYKPIENIGSGAYGVVCSAIDTRSGKKVAIK-----KIPHAFDVPTLAKRTLRELKILRH 60
Query: 73 LRHPNIVKLYEVLATKAK----IYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISA 127
+H NI+ + ++L +Y VM+ +L I S +E+ R + QL+
Sbjct: 61 FKHDNIIAIRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRG 119
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL--SAVKEQIRPDGMLHTLCGTPAYVA 185
++Y HS V HRDLK NLL++E+ +L+I DFG+ + T Y A
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179
Query: 186 PEIL-AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDPN-----LMAM----------- 226
PE+L + Y A +DMWS G + + P + ++++
Sbjct: 180 PELLLSLPEYTTA-IDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238
Query: 227 ------YRKIYKGEYRCPK-WT------SPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
+ I + P W+ SP+ + ++L DP RITV++ L+ P+
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298
Query: 274 K----DYKERKFPHEDFD 287
+ D + P DFD
Sbjct: 299 QYHDPDDEPTCPPPFDFD 316
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 1e-31
Identities = 79/255 (30%), Positives = 135/255 (52%), Gaps = 9/255 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G++ +V R+ G+ IK ++ + R A ++E ++S+L+HPNIV
Sbjct: 6 RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKA-AEQEAQLLSQLKHPNIVAY 64
Query: 82 YEVL-ATKAKIYFVMEFAKGGELFAKI--SKGRF-SEQLSRRYFQQLISAVEYCHSRGVF 137
E +Y VM F +GG+L+ K+ KG+ E +F Q+ A++Y H + +
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHIL 124
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
HRDLK +N+ L +K+ D G++ V E M TL GTP Y++PE+ + K Y+
Sbjct: 125 HRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCDMASTLIGTPYYMSPELFSNKPYN-Y 181
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTD 256
K D+W+ G ++ + FN ++ ++ +I +G+ PK SP+L I +L
Sbjct: 182 KSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIATMLSKR 241
Query: 257 PATRITVDEILRDPW 271
P R +V ILR P+
Sbjct: 242 PEKRPSVKSILRQPY 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 96/330 (29%), Positives = 139/330 (42%), Gaps = 73/330 (22%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK-------QKILRGGLTAHVKREISIM 70
Y+ IG GA+ V + TG VAIK +S Q+ LR EI I+
Sbjct: 7 YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLR---------EIKIL 57
Query: 71 SRLRHPNIVKLYEVL-----ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR---RYF- 121
R +H NI+ + +++ + +Y V E + +L+ I ++ LS +YF
Sbjct: 58 RRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIK----TQHLSNDHIQYFL 112
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK-EQIRPDGMLHTLCGT 180
Q++ ++Y HS V HRDLK NLLL+ N DLKI DFGL+ + + G L T
Sbjct: 113 YQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVAT 172
Query: 181 PAYVAPEI-LAKKGYDGAKVDMWSCGVVLF--VLNAGYLPFND--------------PNL 223
Y APEI L KGY A +D+WS G +L + N P D P+
Sbjct: 173 RWYRAPEIMLNSKGYTKA-IDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS- 230
Query: 224 MAMYRKIYKGEYR--------CPK--WTS------PDLKWFIGRLLDTDPATRITVDEIL 267
I R PK W P + ++L +P RITV+E L
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290
Query: 268 RDPWFKKDY-------KERKFPHEDFDLKD 290
P+ ++ + E FP + D
Sbjct: 291 AHPYLEQYHDPSDEPVAEEPFPFDFELFDD 320
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 75/241 (31%), Positives = 127/241 (52%), Gaps = 5/241 (2%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKL 81
++G G+F KV T + AIK + K +++ E +++ + P + +L
Sbjct: 7 VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
+ T ++YFVME+ GG+L I + G+F E + Y ++ + + H RG+ +RD
Sbjct: 67 HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
LKL+N++LD +KI+DFG+ KE + T CGTP Y+APEI+A + Y G VD
Sbjct: 127 LKLDNVMLDSEGHIKIADFGM--CKEHMVDGVTTRTFCGTPDYIAPEIIAYQPY-GKSVD 183
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
W+ GV+L+ + AG PF+ + +++ I + PK S + L+ P+ R
Sbjct: 184 WWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMTKHPSKR 243
Query: 261 I 261
+
Sbjct: 244 L 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (302), Expect = 2e-31
Identities = 75/273 (27%), Positives = 119/273 (43%), Gaps = 40/273 (14%)
Query: 22 KIIGCGAFAKVYHGR---NVRTGQSVAIKAVS-------KQKILRGGLTAHVKREISIMS 71
K +G GAF +VY G+ VA+K + ++ L+ E +M
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLK---------EARVMK 51
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL----------FAKISKGRFSEQLSRRYF 121
+L HPN+V+L V + +Y V+E+ +GG+L F K S + +
Sbjct: 52 KLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFA 111
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
Q+ +EY S+ HRDL N L+ E+ +KISDFGLS + D G
Sbjct: 112 IQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLS---RDVYDDDYYRKKTGGK 168
Query: 182 AYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR- 236
+ APE L + +K D+WS GV+L+ + G P+ + + + KG YR
Sbjct: 169 LPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG-YRL 226
Query: 237 -CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
P++ +L + DP R T E++
Sbjct: 227 PKPEYCPDELYELMLSCWQLDPEDRPTFSELVE 259
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 5e-31
Identities = 81/254 (31%), Positives = 135/254 (53%), Gaps = 11/254 (4%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+ V TG+ VA+K + +K R L + E+ IM H N+V +Y
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRREL---LFNEVVIMRDYHHENVVDMYN 86
Query: 84 VLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKL 143
+++ VMEF +GG L ++ R +E+ ++ A+ Y H++GV HRD+K
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKS 146
Query: 144 ENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWS 203
+++LL + +K+SDFG A + P +L GTP ++APE++++ Y G +VD+WS
Sbjct: 147 DSILLTSDGRIKLSDFGFCAQVSKEVPK--RKSLVGTPYWMAPEVISRLPY-GTEVDIWS 203
Query: 204 CGVVLFVLNAGYLP-FNDPNLMAMYRKIYKG---EYRCPKWTSPDLKWFIGRLLDTDPAT 259
G+++ + G P FN+P L AM R+I + S L+ F+ +L +P+
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQAM-RRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQ 262
Query: 260 RITVDEILRDPWFK 273
R T E+L+ P+ K
Sbjct: 263 RATAQELLQHPFLK 276
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 78/254 (30%), Positives = 126/254 (49%), Gaps = 17/254 (6%)
Query: 35 GRNVRTGQSVAIK-AVSKQKILRGGL-------TAHVKREISIMSRLRHPNIVKLYEVLA 86
GRN T VA + + K+K++ + A+ + E+ ++ H IVK ++
Sbjct: 76 GRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK 135
Query: 87 TKAKIYFVMEFAKGGELFAKISKGRFSEQLSRR------YFQQLISAVEYCHSRGVFHRD 140
+ K+ +ME+ GG+L +I K R E L + F Q++ A++ HSR + HRD
Sbjct: 136 SDDKLLLIMEYGSGGDLNKQI-KQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRD 194
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
LK N+ L +K+ DFG S + + CGTP Y+APE+ +K Y K D
Sbjct: 195 LKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS-KKAD 253
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRLLDTDPAT 259
MWS GV+L+ L + PF P+ + +++ G+Y P S +K + LL +PA
Sbjct: 254 MWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGMKALLDPLLSKNPAL 313
Query: 260 RITVDEILRDPWFK 273
R T ++L + K
Sbjct: 314 RPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (296), Expect = 1e-30
Identities = 78/265 (29%), Positives = 128/265 (48%), Gaps = 19/265 (7%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAV---SKQKILRGGLTAHVKREISIMSRLRHPN 77
G+++G GA+ VY G GQ +A+K V + + ++ E+ ++ L+H N
Sbjct: 5 GEVLGKGAYGTVYCGL-TNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVN 63
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV+ I MEF GG + + +++ G E + +Y +Q++ V Y H+ V
Sbjct: 64 IVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCV 123
Query: 137 FHRDLKLENLLLDENWDLKISDFG----LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
HRD+K N++L N +K+ DFG L+ V ML ++ GTP ++APE++ +
Sbjct: 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES 183
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKGEYRCPKWTSPD-----LK 246
GY G K D+WS G +F + G P + L AM+ Y G +R PD
Sbjct: 184 GY-GRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF---YIGAHRGLMPRLPDSFSAAAI 239
Query: 247 WFIGRLLDTDPATRITVDEILRDPW 271
F+ L D R + ++LR +
Sbjct: 240 DFVTSCLTRDQHERPSALQLLRHDF 264
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 117 bits (296), Expect = 2e-30
Identities = 86/292 (29%), Positives = 136/292 (46%), Gaps = 44/292 (15%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KYE + IG G + V+ +N T + VA+K V G + + REI ++ L+H
Sbjct: 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHK 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGG-ELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIV+LY+VL + K+ V E+ + + G ++ + + QL+ + +CHS
Sbjct: 60 NIVRLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN 119
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM----LHTLCGTPAYVAPEIL-A 190
V HRDLK +NLL+++N +LK++DFGL+ R G+ T Y P++L
Sbjct: 120 VLHRDLKPQNLLINKNGELKLADFGLA------RAFGIPVRCYSAEVVTLWYRPPDVLFG 173
Query: 191 KKGYDGAKVDMWSCGVVLFVL-NAGYLPFNDPNLMAMYRKIYK--GEYRCPKWTS----P 243
K Y +DMWS G + L NAG F ++ ++I++ G W P
Sbjct: 174 AKLYS-TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232
Query: 244 DLKWF------------------IGR-----LLDTDPATRITVDEILRDPWF 272
D K + GR LL +P RI+ +E L+ P+F
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 4e-30
Identities = 87/275 (31%), Positives = 135/275 (49%), Gaps = 18/275 (6%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
D+SR N +E+ + IG G + VY RNV TG+ AIK + K+ G A V++E
Sbjct: 1 DLSRR-NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVI---KLEPGEDFAVVQQE 56
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLI 125
I +M +H NIV + + K++ MEF GG L G SE ++ +
Sbjct: 57 IIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL 116
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAYV 184
+ Y HS+G HRD+K N+LL +N +K++DFG+SA QI + GTP ++
Sbjct: 117 QGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSA---QITATIAKRKSFIGTPYWM 173
Query: 185 APEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTS 242
APE+ A +KG D+W+ G+ L P D + M + K ++ PK
Sbjct: 174 APEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKD 233
Query: 243 PDLKW------FIGRLLDTDPATRITVDEILRDPW 271
+KW F+ L +P R T +++L+ P+
Sbjct: 234 -KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 4e-30
Identities = 82/288 (28%), Positives = 131/288 (45%), Gaps = 39/288 (13%)
Query: 4 NTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIK--------AVSKQKIL 55
+G + E IG GA VY + TG+ A+K V +Q
Sbjct: 62 ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQ--- 118
Query: 56 RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL-FAKISKGRFSE 114
+ REI I+ + HPN+VK +++ +I ++EF GG L I+ +F
Sbjct: 119 -------ICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLA 171
Query: 115 QLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ-IRPDGM 173
++R Q++S + Y H R + HRD+K NLL++ ++KI+DFG+S + Q + P
Sbjct: 172 DVAR----QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDP--- 224
Query: 174 LHTLCGTPAYVAPEI----LAKKGYDGAKVDMWSCGVVLFVLNAGYLPF------NDPNL 223
++ GT AY++PE L YDG D+WS GV + G PF + +L
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASL 284
Query: 224 MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271
M P S + + FI L +PA R + ++L+ P+
Sbjct: 285 MCAI--CMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPF 330
|
Length = 353 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 6e-30
Identities = 71/225 (31%), Positives = 118/225 (52%), Gaps = 10/225 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+++ K IG G F++VY + + VA+K V +++ +EI ++ +L HPN
Sbjct: 4 FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL-----FAKISKGRFSEQLSRRYFQQLISAVEYCH 132
++K + ++ V+E A G+L + K K E+ +YF QL SAVE+ H
Sbjct: 64 VIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMH 123
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
SR V HRD+K N+ + +K+ D GL H+L GTP Y++PE + +
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIHEN 181
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPF--NDPNLMAMYRKIYKGEY 235
GY+ K D+WS G +L+ + A PF + NL ++ +KI + +Y
Sbjct: 182 GYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDY 225
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 7e-30
Identities = 83/246 (33%), Positives = 127/246 (51%), Gaps = 11/246 (4%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLTAHVKREI--SIMSRLRHPNIV 79
IIG G F +VY R TG+ A+K + K++I ++ G T + I S++S P IV
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
+ T K+ F+++ GG+L +S+ G FSE+ R Y ++I +E+ H+R V +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLK N+LLDE+ ++ISD GL+ + +P H GT Y+APE+L K +
Sbjct: 121 RDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGTAYDSS 176
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMAMY---RKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
D +S G +LF L G+ PF + R P SP+LK + LL
Sbjct: 177 ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236
Query: 256 DPATRI 261
D + R+
Sbjct: 237 DVSKRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-30
Identities = 79/267 (29%), Positives = 132/267 (49%), Gaps = 22/267 (8%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+F +VY G + RT + VAIK + ++ +++EI+++S+ P I + Y
Sbjct: 12 IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYG 69
Query: 84 VLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKL 143
K++ +ME+ GG + G E ++++ ++Y HS HRD+K
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKA 129
Query: 144 ENLLLDENWDLKISDFGLSA--VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDM 201
N+LL E D+K++DFG++ QI+ + T GTP ++APE++ + YD K D+
Sbjct: 130 ANVLLSEQGDVKLADFGVAGQLTDTQIKRN----TFVGTPFWMAPEVIKQSAYD-FKADI 184
Query: 202 WSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------GEYRCPKWTSPDLKWFIGRLLD 254
WS G+ L G P +D + M + I K G+Y P K F+ L+
Sbjct: 185 WSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKP------FKEFVEACLN 238
Query: 255 TDPATRITVDEILRDPWFKKDYKERKF 281
DP R T E+L+ + + K+ F
Sbjct: 239 KDPRFRPTAKELLKHKFITRYTKKTSF 265
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-29
Identities = 90/303 (29%), Positives = 134/303 (44%), Gaps = 51/303 (16%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G GAF V R+ TGQ+VAIK + K L RE+ ++ LRH NI+ L +
Sbjct: 18 VGMGAFGLVCSARDQLTGQNVAIKKIMK-PFSTPVLAKRTYRELKLLKHLRHENIISLSD 76
Query: 84 V-LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+ ++ IYFV E G +L ++ +Q + + Q++ ++Y HS GV HRDLK
Sbjct: 77 IFISPLEDIYFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLK 135
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG---TPAYVAPEI-LAKKGYDGAK 198
N+L++EN DLKI DFGL+ +++ + G T Y APEI L + YD +
Sbjct: 136 PSNILINENCDLKICDFGLARIQD--------PQMTGYVSTRYYRAPEIMLTWQKYD-VE 186
Query: 199 VDMWSCGVVLFVLNAG--YLPFNDP-------------------------NLMAMYRKIY 231
VD+WS G + + G P D N + + +
Sbjct: 187 VDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP 246
Query: 232 KGEYRCP-----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK--KDYKERKFPHE 284
K E P K P + ++L DP RI+ E L P+ D + E
Sbjct: 247 KRE-PVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDEPVAEE 305
Query: 285 DFD 287
FD
Sbjct: 306 KFD 308
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 79/257 (30%), Positives = 127/257 (49%), Gaps = 16/257 (6%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
+ + K IG G F++VY + G VA+K V ++ A +EI ++ +L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN 60
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-----SKGRFSEQLSRRYFQQLISAVE 129
HPN++K Y ++ V+E A G+L I K E+ +YF QL SA+E
Sbjct: 61 HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE 120
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
+ HSR V HRD+K N+ + +K+ D GL H+L GTP Y++PE +
Sbjct: 121 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERI 178
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPF--NDPNLMAMYRKIYKGEYRCPKWT----SP 243
+ GY+ K D+WS G +L+ + A PF + NL ++ +KI + +Y P S
Sbjct: 179 HENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDY--PPLPSDHYSE 235
Query: 244 DLKWFIGRLLDTDPATR 260
+L+ + ++ DP R
Sbjct: 236 ELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 2e-29
Identities = 94/319 (29%), Positives = 138/319 (43%), Gaps = 57/319 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI---LRGGLTAH-VKREISIMSR 72
KYE+ + +G GA+ V+ + RT + VA+K KI R A REI +
Sbjct: 8 KYEILQKLGKGAYGIVWKAIDRRTKEVVALK-----KIFDAFRNATDAQRTFREIMFLQE 62
Query: 73 LR-HPNIVKLYEVLATKAK----IYFVMEFAKGGELFAKISKGRFSEQLSRRY-FQQLIS 126
L HPNIVKL V+ KA+ IY V E+ + +L A I E + +RY QL+
Sbjct: 63 LGDHPNIVKLLNVI--KAENDKDIYLVFEYME-TDLHAVIRANIL-EDVHKRYIMYQLLK 118
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS---AVKEQIRPDGMLHTLCGTPAY 183
A++Y HS V HRDLK N+LL+ + +K++DFGL+ + E+ + +L T Y
Sbjct: 119 ALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWY 178
Query: 184 VAPEIL-AKKGYDGAKVDMWSCGVVLFVLNAGYLPF------------------------ 218
APEIL Y VDMWS G +L + G F
Sbjct: 179 RAPEILLGSTRYTKG-VDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDI 237
Query: 219 ---NDPNLMAMYRKIYKGEYR-----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDP 270
P M + + PK S D + +LL +P R+T +E L P
Sbjct: 238 ESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAEEALEHP 296
Query: 271 WFKKDYKERKFPHEDFDLK 289
+ + + P + +
Sbjct: 297 YVAQFHNPSDEPVLPYPIT 315
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 2e-29
Identities = 87/274 (31%), Positives = 132/274 (48%), Gaps = 28/274 (10%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-----SKQKILRGGLTAHVKREISIMS 71
KY + +++G GA V + V G+ A+K V S+ R + E+ +
Sbjct: 33 KYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRA------QAEVCCLL 86
Query: 72 RLRHPNIVKLYEVLATK--------AKIYFVMEFAKGGELFAKISKGR------FSEQLS 117
+IVK +E A K I V+++A G+L +I K R F E +
Sbjct: 87 NCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEI-KSRAKTNRTFREHEA 145
Query: 118 RRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177
F Q++ AV + HS+ + HRD+K N+LL N +K+ DFG S + D + T
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR- 236
CGTP YVAPEI +K Y K DM+S GV+L+ L PF+ N+ + K G Y
Sbjct: 206 CGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP 264
Query: 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDP 270
P SP+++ + LL +DP R + ++L P
Sbjct: 265 LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298
|
Length = 496 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 85/271 (31%), Positives = 143/271 (52%), Gaps = 20/271 (7%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ K+IG GAF +V + TGQ A+K ++K ++L+ TA + E ++
Sbjct: 3 FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
I L+ + +Y VM++ GG+L +SK R E ++R Y +++ A++ H G
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL--CGTPAYVAPEILAK-- 191
HRD+K +N+LLD+N ++++DFG S ++ + DG + + GTP Y++PEIL
Sbjct: 123 YVHRDIKPDNVLLDKNGHIRLADFG-SCLR--LLADGTVQSNVAVGTPDYISPEILQAME 179
Query: 192 --KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPKWT---SPD 244
KG G + D WS GV ++ + G PF +L+ Y KI +K ++ P S +
Sbjct: 180 DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239
Query: 245 LKWFIGRLLDTDPATRI---TVDEILRDPWF 272
K I RL+ P TR+ + + P+F
Sbjct: 240 AKDLIRRLI-CSPETRLGRNGLQDFKDHPFF 269
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 3e-29
Identities = 80/283 (28%), Positives = 141/283 (49%), Gaps = 25/283 (8%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
LF K E IG G+F +V+ G + RT + VAIK + ++ +++EI+++S+
Sbjct: 5 LFTKLEK---IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQC 59
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
P + K Y K++ +ME+ GG + G E ++++ ++Y HS
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHS 119
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSA--VKEQIRPDGMLHTLCGTPAYVAPEILAK 191
HRD+K N+LL E+ ++K++DFG++ QI+ + + GTP ++APE++ +
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV----GTPFWMAPEVIKQ 175
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------GEYRCPKWTSPD 244
YD +K D+WS G+ L G P ++ + M + I K G Y P
Sbjct: 176 SAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKP------ 228
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFD 287
LK F+ L+ +P+ R T E+L+ + + K+ + E D
Sbjct: 229 LKEFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELID 271
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 82/309 (26%), Positives = 130/309 (42%), Gaps = 54/309 (17%)
Query: 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG----GLTAHVKREI 67
+ KYE IG G F +V+ R+ +T Q VA+K K+L G REI
Sbjct: 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALK-----KVLMENEKEGFPITALREI 62
Query: 68 SIMSRLRHPNIVKLYEVLATKAK--------IYFVMEFAKGGELFAKIS--KGRFSEQLS 117
I+ L+H N+V L E+ TKA Y V EF + +L +S +F+
Sbjct: 63 KILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEI 121
Query: 118 RRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHT 176
++ + L++ + Y H + HRD+K N+L+ ++ LK++DFGL+ A +T
Sbjct: 122 KKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYT 181
Query: 177 -LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVL------FVLNAGYLPFNDPNL------ 223
T Y PE+L + G +DMW G ++ + G + L
Sbjct: 182 NRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCG 241
Query: 224 ------------MAMYRKIY--KGEYR------CPKWTSPDLKWFIGRLLDTDPATRITV 263
+ +++K+ +G+ R P P I +LL DPA RI
Sbjct: 242 SITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA 301
Query: 264 DEILRDPWF 272
D L +F
Sbjct: 302 DTALNHDFF 310
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 7e-29
Identities = 88/303 (29%), Positives = 133/303 (43%), Gaps = 57/303 (18%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
K+++ IG G + +VY R+ TG+ VA+K V + G REI I+ +L H
Sbjct: 8 KFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN-EKEGFPITAIREIKILRQLNHR 66
Query: 77 NIVKLYEVLATK----------AKIYFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQL 124
NIV L E++ K Y V E+ +L + G FSE + + +QL
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQL 125
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV--KEQIRP-DGMLHTLCGTP 181
+ + YCH + HRD+K N+LL+ +K++DFGL+ + E+ RP + TL
Sbjct: 126 LEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW--- 182
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVL---------FVLNA------------GY----- 215
Y PE+L + G +D+WSCG +L F N G
Sbjct: 183 -YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV 241
Query: 216 ------LP-FNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
LP FN YR+ + E+ + DL + +L DP+ R T +E L
Sbjct: 242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDL---LDHMLTLDPSKRCTAEEALN 298
Query: 269 DPW 271
PW
Sbjct: 299 SPW 301
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 8e-29
Identities = 76/259 (29%), Positives = 137/259 (52%), Gaps = 10/259 (3%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVS--KQKILRGGLTAHVKREISIMSRLRHPNI 78
GK++G GAF +VY +V TG+ +A K V + + ++ EI ++ L+H I
Sbjct: 7 GKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERI 66
Query: 79 VKLYEVLATKAK--IYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
V+ Y L +A+ + ME+ GG + ++ + G +E ++R+Y +Q++ + Y HS
Sbjct: 67 VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCGTPAYVAPEILAKKGY 194
+ HRD+K N+L D ++K+ DFG S + I G + ++ GTP +++PE+++ +GY
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186
Query: 195 DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKWTSPDLKWFIGRL 252
G K D+WS G + + P+ + MA KI + P S + F+G +
Sbjct: 187 -GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDFLGCI 245
Query: 253 LDTDPATRITVDEILRDPW 271
+ R + +E+LR P+
Sbjct: 246 F-VEARHRPSAEELLRHPF 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 2e-28
Identities = 85/295 (28%), Positives = 139/295 (47%), Gaps = 47/295 (15%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+YE + IG G + VY R+ T +++A+K + ++ G+ + REIS++ ++H
Sbjct: 3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQ-EDEGVPSTAIREISLLKEMQHG 61
Query: 77 NIVKLYEVLATKAKIYFVMEF-----AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
NIV+L +V+ ++ ++Y V E+ K + +K + +L + Y Q++ + YC
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAK---NPRLIKTYLYQILRGIAYC 118
Query: 132 HSRGVFHRDLKLENLLLDENWD-LKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEIL 189
HS V HRDLK +NLL+D + LK++DFGL+ A +R H + T Y APEIL
Sbjct: 119 HSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--FTHEVV-TLWYRAPEIL 175
Query: 190 AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDP--NLMAMYRKI--------------- 230
+ VD+WS G + V P + L ++R +
Sbjct: 176 LGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLP 235
Query: 231 -YKGEYRCPKWTSPDLKWFI-----------GRLLDTDPATRITVDEILRDPWFK 273
YK + PKW DL + ++L DP+ RIT L +FK
Sbjct: 236 DYKSAF--PKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 73/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRLRHPNIVK 80
+G G V + TG+ +A+K I A K RE+ I+ + P IV
Sbjct: 9 LGAGNSGVVSKVLHRPTGKIMAVK-----TIRLEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 81 LYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHS-RGVF 137
Y I ME+ GG L K +GR E++ + ++ + Y H +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKII 123
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
HRD+K N+L++ +K+ DFG+S + + + + T GT +Y+APE + Y
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVS--GQLV--NSLAKTFVGTSSYMAPERIQGNDY-SV 178
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAM-----YRKIYKGEYRCPKWT----SPDLKWF 248
K D+WS G+ L L G P+ N + I P+ SPD + F
Sbjct: 179 KSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEP--PPRLPSGKFSPDFQDF 236
Query: 249 IGRLLDTDPATRITVDEILRDPWFKK 274
+ L DP R + E+L P+ KK
Sbjct: 237 VNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 5e-28
Identities = 82/260 (31%), Positives = 131/260 (50%), Gaps = 18/260 (6%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82
++G G + VY R++ T +AIK + ++ R H EI++ S L+H NIV+
Sbjct: 15 VLGKGTYGIVYAARDLSTQVRIAIKEI-PERDSRYVQPLH--EEIALHSYLKHRNIVQYL 71
Query: 83 EVLATKAKIYFVMEFAKGGELFA----KISKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
+ ME GG L A K + +EQ Y +Q++ ++Y H + H
Sbjct: 72 GSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131
Query: 139 RDLKLENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK--KGYD 195
RD+K +N+L++ + +KISDFG S I P T GT Y+APE++ K +GY
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQYMAPEVIDKGPRGY- 188
Query: 196 GAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYR-KIYKGEYRCPKWTSPDLKWFIGR 251
GA D+WS G + + G PF +P AM++ ++K P+ S + K FI R
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIELGEPQ-AAMFKVGMFKIHPEIPESLSAEAKNFILR 247
Query: 252 LLDTDPATRITVDEILRDPW 271
+ DP R + ++L+DP+
Sbjct: 248 CFEPDPDKRASAHDLLQDPF 267
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 84/295 (28%), Positives = 132/295 (44%), Gaps = 49/295 (16%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
KYE ++G G++ V ++ TGQ VAIK K L VK REI ++ +
Sbjct: 2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIK-----KFLESEDDKMVKKIAMREIRMLKQ 56
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEY 130
LRH N+V L EV K ++Y V EF L K G E R+Y Q++ +E+
Sbjct: 57 LRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG-LDESRVRKYLFQILRGIEF 115
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT-LCGTPAYVAPEIL 189
CHS + HRD+K EN+L+ ++ +K+ DFG + + G ++T T Y APE+L
Sbjct: 116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFA---RTLAAPGEVYTDYVATRWYRAPELL 172
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAG--YLPFNDP------------NLMAMYRKIYKG-- 233
G VD+W+ G ++ + G P + NL+ +++I++
Sbjct: 173 VGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232
Query: 234 ----------------EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
E R PK S + + L DP R + ++L +F
Sbjct: 233 LFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 87/297 (29%), Positives = 136/297 (45%), Gaps = 43/297 (14%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E K+IG GAF +V + TG A+K + K +L AH++ E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+VK++ K +Y +MEF GG++ + K SE+ ++ Y + + A++ H G
Sbjct: 63 VVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGF 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGL-SAVKEQIRPD------------------------ 171
HRD+K +NLLLD +K+SDFGL + +K+ R +
Sbjct: 123 IHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKA 182
Query: 172 --------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL 223
+ ++ GTP Y+APE+ + GY+ D WS GV+++ + GY PF
Sbjct: 183 ETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 224 MAMYRKI--YKGEYRCPKWT--SPDLKWFIGRLLDTDPATRI---TVDEILRDPWFK 273
YRK+ +K P S K I R TD RI V+EI P+F+
Sbjct: 242 QETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFE 297
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-27
Identities = 83/298 (27%), Positives = 125/298 (41%), Gaps = 47/298 (15%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH- 75
YE + IG G + KVY R+ TG+ VA+K ++ ++ G+ REIS++ L
Sbjct: 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKK-TRLEMDEEGIPPTALREISLLQMLSES 60
Query: 76 PNIVKLYEVLAT-----KAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLI 125
IV+L +V K +Y V E+ S GR + + + QL+
Sbjct: 61 IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLL 120
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
V +CH GV HRDLK +NLL+D+ LKI+D GL I H + T Y
Sbjct: 121 KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF-SIPVKSYTHEIV-TLWYR 178
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------------ 232
APE+L + VD+WS G + ++ F + + I+K
Sbjct: 179 APEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPG 238
Query: 233 -------GEYRCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPWF 272
E+ P+W DL + ++L DPA RI+ L P+F
Sbjct: 239 VSKLRDWHEF--PQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYF 294
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 76/259 (29%), Positives = 131/259 (50%), Gaps = 10/259 (3%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV--SKQKILRGGLTAHVKREISIMSRLRH 75
+ +GK++G GAF +VY + TG+ +A+K V + ++ EI ++ L H
Sbjct: 4 WRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLH 63
Query: 76 PNIVKLYEVL--ATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCH 132
IV+ Y L + + ME GG + ++ S G +E ++R+Y +Q++ V Y H
Sbjct: 64 ERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLH 123
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCGTPAYVAPEILAK 191
S + HRD+K N+L D ++K+ DFG S + I G + ++ GTP +++PE+++
Sbjct: 124 SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISG 183
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKWTSPDLKWFI 249
+GY G K D+WS G + + P+ + MA KI P S + F+
Sbjct: 184 EGY-GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRDFL 242
Query: 250 GRLLDTDPATRITVDEILR 268
R+ + R + DE+LR
Sbjct: 243 KRIF-VEAKLRPSADELLR 260
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-27
Identities = 91/297 (30%), Positives = 134/297 (45%), Gaps = 53/297 (17%)
Query: 17 KYE-VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMS 71
KYE + KI G G++ V+ RN TGQ VAIK K + +K REI ++
Sbjct: 2 KYEKLSKI-GEGSYGVVFKCRNRETGQIVAIK-----KFVESEDDPVIKKIALREIRMLK 55
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+L+HPN+V L EV K K++ V E+ L K +G E L ++ Q + AV
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRG-VPEHLIKKIIWQTLQAVN 114
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
+CH HRD+K EN+L+ + +K+ DFG + + P T Y APE+L
Sbjct: 115 FCHKHNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYRAPELL 172
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAG-------------YL---PFNDPNLMAMYRKI--- 230
G VD+W+ G V L G YL D L+ +++I
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGD--LIPRHQQIFST 230
Query: 231 ---YKG------------EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
+KG E + P +SP L F+ L DP R++ +E+L P+F
Sbjct: 231 NQFFKGLSIPEPETREPLESKFPNISSPALS-FLKGCLQMDPTERLSCEELLEHPYF 286
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 81/313 (25%), Positives = 126/313 (40%), Gaps = 69/313 (22%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL----RGGLTAHVKREISIMSRL 73
YE+ +G G F +VY R ++TG+ VA+K KIL + G REI I+ +L
Sbjct: 10 YEILGKLGEGTFGEVYKARQIKTGRVVALK-----KILMHNEKDGFPITALREIKILKKL 64
Query: 74 RHPNIVKLYEVLATKAK--------IYFV---MEFAKGGELFAKISKGRFSEQLSRRYFQ 122
+HPN+V L ++ + +Y V M+ G L + + +E + Y
Sbjct: 65 KHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL--ENPSVKLTESQIKCYML 122
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
QL+ + Y H + HRD+K N+L+D LKI+DFGL+ + P+ GT
Sbjct: 123 QLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRK 182
Query: 183 YV---------APE-ILAKKGYDGAKVDMWSCGVVL----------------------FV 210
Y PE +L ++ Y A VD+W G V F
Sbjct: 183 YTNLVVTRWYRPPELLLGERRYTTA-VDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241
Query: 211 L----------NAGYLP-FNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
L LP + Y + + + P+ + +LL DP
Sbjct: 242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGK---LGPEGLDLLSKLLSLDPYK 298
Query: 260 RITVDEILRDPWF 272
R+T + L P+F
Sbjct: 299 RLTASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 6e-27
Identities = 81/274 (29%), Positives = 138/274 (50%), Gaps = 26/274 (9%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-R 74
G +E+ +++G G + +VY GR+V+TGQ AIK + + G +K+EI+++ +
Sbjct: 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 61
Query: 75 HPNIVKLYEVLATKA------KIYFVMEFAKGGEL--FAKISKGR-FSEQLSRRYFQQLI 125
H NI Y K +++ VMEF G + K +KG E+ ++++
Sbjct: 62 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREIL 121
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+ + H V HRD+K +N+LL EN ++K+ DFG+SA + R G +T GTP ++A
Sbjct: 122 RGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 179
Query: 186 PEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRC 237
PE++A YD K D+WS G+ + G P D + M I + +
Sbjct: 180 PEVIACDENPDATYD-FKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKS 238
Query: 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271
KW S + FI L + + R T +++++ P+
Sbjct: 239 KKW-SKKFQSFIESCLVKNHSQRPTTEQLMKHPF 271
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 8e-27
Identities = 77/268 (28%), Positives = 136/268 (50%), Gaps = 24/268 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV---------SKQKILRGGLTAHVKREIS 68
+ +GK++G GAF +VY + TG+ +A+K V SK+ ++ EI
Sbjct: 4 WRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKE-------VNALECEIQ 56
Query: 69 IMSRLRHPNIVKLYEVL--ATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
++ LRH IV+ Y L + K+ +E+ GG + ++ + G +E ++RRY +Q++
Sbjct: 57 LLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQIL 116
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCGTPAYV 184
V Y HS + HRD+K N+L D ++K+ DFG S + I G + ++ GTP ++
Sbjct: 117 QGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWM 176
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPKWTS 242
+PE+++ +GY G K D+WS + + P+ + MA KI + P S
Sbjct: 177 SPEVISGEGY-GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVS 235
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRDP 270
+ F+ ++ + R T + +LR P
Sbjct: 236 DACRDFLKQIF-VEEKRRPTAEFLLRHP 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 9e-27
Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 18/265 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ +G GAF KVY +N TG A K + + L ++ EI I++ HPN
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS--EEELEDYMV-EIDILASCDHPN 63
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR--FSEQLSRRYFQQLISAVEYCHSRG 135
IVKL + + ++ ++EF GG + A + + +E R +Q + A+ Y H
Sbjct: 64 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK 123
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL-----A 190
+ HRDLK N+L + D+K++DFG+SA + R + GTP ++APE++
Sbjct: 124 IIHRDLKAGNILFTLDGDIKLADFGVSA--KNTRTIQRRDSFIGTPYWMAPEVVMCETSK 181
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----YRCPKWTSPDLK 246
+ YD K D+WS G+ L + P ++ N M + KI K E + +W S + K
Sbjct: 182 DRPYD-YKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRW-SSEFK 239
Query: 247 WFIGRLLDTDPATRITVDEILRDPW 271
F+ + L+ + R T ++L+ P+
Sbjct: 240 DFLKKCLEKNVDARWTTTQLLQHPF 264
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 71/247 (28%), Positives = 117/247 (47%), Gaps = 35/247 (14%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E K+IG GAF +V + TG A+K + K +L H++ E I+
Sbjct: 3 FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+VK++ K +Y +MEF GG++ + K +E+ ++ Y + + A++ H G
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 137 FHRDLKLENLLLDENWDLKISDFGL-SAVKEQIRPD---GMLHTL--------------- 177
HRD+K +NLLLD +K+SDFGL + +K+ R + + H+L
Sbjct: 123 IHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKA 182
Query: 178 --------------CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL 223
GTP Y+APE+ + GY+ D WS GV+++ + GY PF
Sbjct: 183 ETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKL-CDWWSLGVIMYEMLIGYPPFCSETP 241
Query: 224 MAMYRKI 230
Y+K+
Sbjct: 242 QETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-26
Identities = 70/227 (30%), Positives = 121/227 (53%), Gaps = 11/227 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ K+IG GAF +V + + A+K ++K ++L+ TA + E ++ +
Sbjct: 3 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
I L+ + +Y VM++ GG+L +SK R E ++R Y +++ A++ H
Sbjct: 63 ITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT--LCGTPAYVAPEILAK-- 191
HRD+K +N+L+D N ++++DFG S +K + DG + + GTP Y++PEIL
Sbjct: 123 YVHRDIKPDNILMDMNGHIRLADFG-SCLK--LMEDGTVQSSVAVGTPDYISPEILQAME 179
Query: 192 --KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR 236
KG G + D WS GV ++ + G PF +L+ Y KI + R
Sbjct: 180 DGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 226
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-26
Identities = 72/227 (31%), Positives = 120/227 (52%), Gaps = 11/227 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ K+IG GAF +V + T + A+K ++K ++L+ TA + E +++
Sbjct: 3 FEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQW 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
I L+ + +Y VM++ GG+L +SK R E ++R Y +++ A+ H
Sbjct: 63 ITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT--LCGTPAYVAPEILAK-- 191
HRD+K +N+LLD N ++++DFG S +K + DG + + GTP Y++PEIL
Sbjct: 123 YVHRDIKPDNVLLDMNGHIRLADFG-SCLK--MNQDGTVQSSVAVGTPDYISPEILQAME 179
Query: 192 --KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR 236
G G + D WS GV ++ + G PF +L+ Y KI E R
Sbjct: 180 DGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER 226
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 4e-26
Identities = 77/274 (28%), Positives = 138/274 (50%), Gaps = 26/274 (9%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-R 74
G +E+ +++G G + +VY GR+V+TGQ AIK + + +K EI+++ +
Sbjct: 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSH 71
Query: 75 HPNIVKLYEVLATKA------KIYFVMEFAKGGEL--FAKISKGR-FSEQLSRRYFQQLI 125
H NI Y K+ +++ VMEF G + K +KG E ++++
Sbjct: 72 HRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREIL 131
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+ + H+ V HRD+K +N+LL EN ++K+ DFG+SA + R G +T GTP ++A
Sbjct: 132 RGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD--RTVGRRNTFIGTPYWMA 189
Query: 186 PEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRC 237
PE++A YD + D+WS G+ + G P D + M I + + +
Sbjct: 190 PEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKS 248
Query: 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271
KW+ + + G L+ +R + +++L+ P+
Sbjct: 249 KKWSKKFIDFIEGCLVKNYL-SRPSTEQLLKHPF 281
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 5e-26
Identities = 76/299 (25%), Positives = 129/299 (43%), Gaps = 52/299 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA-HVK---REISIMSR 72
+Y+ +G GA+ +V + +TG+ VAIK K+ R +A H K RE+ ++
Sbjct: 16 RYQNLSPVGSGAYGQVCSAFDTKTGRKVAIK-----KLSRPFQSAIHAKRTYRELRLLKH 70
Query: 73 LRHPNIVKLYEV------LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126
+ H N++ L +V L +Y V G +L + + S+ + Q++
Sbjct: 71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILR 129
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
++Y HS G+ HRDLK N+ ++E+ +LKI DFGL+ + D M T Y AP
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTD----DEMT-GYVATRWYRAP 184
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAG--YLPFNDP----------------------- 221
EI+ + VD+WS G ++ L G P +D
Sbjct: 185 EIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS 244
Query: 222 -----NLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
N + ++ K +++ +P + ++L DP RIT E L P+ +
Sbjct: 245 SESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAE 303
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-25
Identities = 81/311 (26%), Positives = 134/311 (43%), Gaps = 58/311 (18%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVS---KQKILRGGLTAHVKREISI 69
+L +Y + +GCG+ V+ + + VA+K + Q + H REI I
Sbjct: 2 DLGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSV------KHALREIKI 55
Query: 70 MSRLRHPNIVKLYEVLATK--------------AKIYFVMEFAKGGELFAKISKGRFSEQ 115
+ RL H NIVK+YEVL +Y V E+ + +L + +G SE+
Sbjct: 56 IRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMET-DLANVLEQGPLSEE 114
Query: 116 LSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQ-IRPDGM 173
+R + QL+ ++Y HS V HRDLK N+ ++ E+ LKI DFGL+ + + G
Sbjct: 115 HARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGY 174
Query: 174 LHTLCGTPAYVAPEI-LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---------- 222
L T Y +P + L+ Y A +DMW+ G + + G F +
Sbjct: 175 LSEGLVTKWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILE 233
Query: 223 ---------------LMAMYRKIYKGEYRCP-KWTSPDLKW----FIGRLLDTDPATRIT 262
++ + + GE R P + P + F+ ++L +P R+T
Sbjct: 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLT 293
Query: 263 VDEILRDPWFK 273
+E L P+
Sbjct: 294 AEEALMHPYMS 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-25
Identities = 75/260 (28%), Positives = 126/260 (48%), Gaps = 17/260 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YE+ + +G G + VY RN+ TG+ A+K + K+ G + +++EI ++ +H N
Sbjct: 11 YELIQRVGSGTYGDVYKARNLHTGELAAVKII---KLEPGDDFSLIQQEIFMVKECKHCN 67
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV + ++ K++ ME+ GG L G SE ++ + + Y HS+G
Sbjct: 68 IVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGK 127
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSA-VKEQIRPDGMLHTLCGTPAYVAPEILA--KKG 193
HRD+K N+LL +N D+K++DFG++A + I + GTP ++APE+ A K G
Sbjct: 128 MHRDIKGANILLTDNGDVKLADFGVAAKITATI---AKRKSFIGTPYWMAPEVAAVEKNG 184
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP------KWTSPDLKW 247
D+W+ G+ L P D + M + K ++ P KW S
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKW-SSTFHN 243
Query: 248 FIGRLLDTDPATRITVDEIL 267
F+ L +P R T + +L
Sbjct: 244 FVKISLTKNPKKRPTAERLL 263
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 4e-25
Identities = 79/274 (28%), Positives = 122/274 (44%), Gaps = 45/274 (16%)
Query: 27 GAFAKVYHGRNVRTGQSVAIKAVS-------KQKILRGGLTAHVKREISIMSRLRHPNIV 79
G+ K TG A+K ++ +++ILR E+ I + P IV
Sbjct: 15 GSVTKCRLKN---TGMIFALKTITTDPNPDLQKQILR---------ELEINKSCKSPYIV 62
Query: 80 KLYEVLATKAK--IYFVMEFAKGGEL---FAKISK--GRFSEQLSRRYFQQLISAVEYCH 132
K Y ++ I ME+ +GG L + K+ K GR E++ + + ++ + Y H
Sbjct: 63 KYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH 122
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
SR + HRD+K N+LL +K+ DFG+S E + + + T GT Y+APE + K
Sbjct: 123 SRKIIHRDIKPSNILLTRKGQVKLCDFGVSG--ELV--NSLAGTFTGTSFYMAPERIQGK 178
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCP----------K 239
Y D+WS G+ L + PF +P L + Y P K
Sbjct: 179 PYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIK 237
Query: 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
W S + K FI + L+ DP R T ++L PW K
Sbjct: 238 W-SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIK 270
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 6e-25
Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 43/286 (15%)
Query: 14 LFGKYEVGKI------IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--- 64
LF K + K+ IG G+F VY R+VRT + VAIK K+ G ++ K
Sbjct: 7 LFSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIK-----KMSYSGKQSNEKWQD 61
Query: 65 --REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSRRYF 121
+E+ + +LRHPN ++ + + VME+ G ++ K E
Sbjct: 62 IIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHKKPLQEVEIAAIC 121
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
+ + Y HS HRD+K N+LL E +K++DFG +++ ++ GTP
Sbjct: 122 HGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTP 175
Query: 182 AYVAPE-ILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
++APE ILA + YDG KVD+WS G+ L P + N M+ I + +
Sbjct: 176 YWMAPEVILAMDEGQYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND---- 230
Query: 239 KWTSPDLK---W------FIGRLLDTDPATRITVDEILRDPWFKKD 275
SP L W F+ L P R + +E+L+ + ++
Sbjct: 231 ---SPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 70/231 (30%), Positives = 111/231 (48%), Gaps = 24/231 (10%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVK----REISIMSRLR 74
K+IG G F +V GR G+ VAIK L+ G + + E SIM +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKT------LKAGSSDKQRLDFLTEASIMGQFD 63
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCH 132
HPNI++L V+ + + E+ + G L F + + G+F+ + + S ++Y
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLS 123
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG-TPA-YVAPEILA 190
HRDL N+L++ N K+SDFGLS E + T G P + APE +A
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLED--SEATYTTKGGKIPIRWTAPEAIA 181
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFND-PNLMAMYRKIYKGEYRCPK 239
+ + A D+WS G+V++ V++ G P+ D N + + + G YR P
Sbjct: 182 YRKFTSAS-DVWSFGIVMWEVMSYGERPYWDMSNQDVI-KAVEDG-YRLPP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 88/278 (31%), Positives = 133/278 (47%), Gaps = 39/278 (14%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+YEV K IG G F +V+ ++ RT + KA+S + L+ + + E+++M L+H
Sbjct: 14 EYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRG-LKEREKSQLVIEVNVMRELKHK 72
Query: 77 NIVKLYEVLATKA--KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVE 129
NIV+ + KA K+Y +MEF G+L I K G+ E +QL+ A+
Sbjct: 73 NIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALA 132
Query: 130 YCHS-------RGVFHRDLKLENLLLD-------------ENWD----LKISDFGLSAVK 165
YCH+ V HRDLK +N+ L N + KI DFGLS
Sbjct: 133 YCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLS--- 189
Query: 166 EQIRPDGMLHTLCGTPAYVAPEIL--AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-N 222
+ I + M H+ GTP Y +PE+L K YD K DMW+ G +++ L +G PF+ N
Sbjct: 190 KNIGIESMAHSCVGTPYYWSPELLLHETKSYDD-KSDMWALGCIIYELCSGKTPFHKANN 248
Query: 223 LMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
+ ++ +G K S +L I LL+ R
Sbjct: 249 FSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKER 286
|
Length = 1021 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 5e-24
Identities = 53/166 (31%), Positives = 89/166 (53%), Gaps = 3/166 (1%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K I GAF KVY GR + A+K V K ++ + V+ E ++ + P IV L
Sbjct: 10 KPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL 69
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
Y L + +Y VME+ GG++ + + G F E+++ +Y ++ A++Y H G+ HRD
Sbjct: 70 YYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
LK +N+L+ +K++DFGLS V + + + + TP+ P
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKVT--LNRELNMMDILTTPSMAKP 173
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 99.3 bits (247), Expect = 1e-23
Identities = 67/205 (32%), Positives = 106/205 (51%), Gaps = 21/205 (10%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-- 74
+YE IG GA+ VY R+ +G VA+K+V Q GL RE++++ RL
Sbjct: 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAF 59
Query: 75 -HPNIVKLYEVLAT-----KAKIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQL 124
HPNIV+L +V AT + K+ V E +L + K G +E + + +Q
Sbjct: 60 DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETI-KDLMRQF 117
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE-QIRPDGMLHTLCGTPAY 183
+ +++ H+ + HRDLK EN+L+ +K++DFGL+ + Q+ ++ TL Y
Sbjct: 118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW----Y 173
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVL 208
APE+L + Y VDMWS G +
Sbjct: 174 RAPEVLLQSTY-ATPVDMWSVGCIF 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 2e-23
Identities = 68/200 (34%), Positives = 101/200 (50%), Gaps = 6/200 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
K+EV ++G GA+ V R+ T + VAIK K + RE+ ++ L+
Sbjct: 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKF-KDSEENEEVKETTLRELKMLRTLKQE 60
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
NIV+L E + K+Y V E+ + EL ++ G E++ R Y QLI A+ +CH
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKV-RSYIYQLIKAIHWCHKN 119
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY 194
+ HRD+K ENLL+ N LK+ DFG + + + T Y +PE+L Y
Sbjct: 120 DIVHRDIKPENLLISHNDVLKLCDFGFARNLSE-GSNANYTEYVATRWYRSPELLLGAPY 178
Query: 195 DGAKVDMWSCGVVLFVLNAG 214
G VDMWS G +L L+ G
Sbjct: 179 -GKAVDMWSVGCILGELSDG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 3e-23
Identities = 60/202 (29%), Positives = 95/202 (47%), Gaps = 18/202 (8%)
Query: 22 KIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
K +G G F KV R TG+ VA+K++ + +REI I+ L H N
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSL--NHSGEEQHRSDFEREIEILRTLDHEN 67
Query: 78 IVKLYEVLATKAK---IYFVMEFAKGGELFAKISKGRFSEQLSR----RYFQQLISAVEY 130
IVK Y+ + K + +ME+ G L + R +Q++ + Q+ ++Y
Sbjct: 68 IVK-YKGVCEKPGGRSLRLIMEYLPSGSL--RDYLQRHRDQINLKRLLLFSSQICKGMDY 124
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA-YVAPEIL 189
S+ HRDL N+L++ +KISDFGL+ V + + + +P + APE L
Sbjct: 125 LGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECL 184
Query: 190 AKKGYDGAKVDMWSCGVVLFVL 211
+ A D+WS GV L+ L
Sbjct: 185 RTSKFSSAS-DVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 4e-23
Identities = 74/298 (24%), Positives = 128/298 (42%), Gaps = 57/298 (19%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+Y++ ++IG G +VY + + VA+K + + L RE I + L H
Sbjct: 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIH 61
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR------------RYFQQ 123
P IV +Y + + +Y+ M + +G L + + E LS+ F +
Sbjct: 62 PGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHK 121
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ---------IRPDGML 174
+ + +EY HS+GV HRDLK +N+LL ++ I D+G + K+ + +
Sbjct: 122 ICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC 181
Query: 175 HT-------LCGTPAYVAPEILAKKGYDGA-KVDMWSCGVVLFVLNAGYLPFN------- 219
++ + GTP Y+APE L G + D+++ GV+L+ + P+
Sbjct: 182 YSSMTIPGKIVGTPDYMAPERL--LGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 220 -------DPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRI-TVDEILRD 269
P +A YR+I P L + L DPA R +V E+ +D
Sbjct: 240 SYRDVILSPIEVAPYREI-----------PPFLSQIAMKALAVDPAERYSSVQELKQD 286
|
Length = 932 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 8e-23
Identities = 79/284 (27%), Positives = 130/284 (45%), Gaps = 40/284 (14%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-R 74
+E+ + IG G + KVY N + G A+K + + ++ E +I+ L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPN 77
Query: 75 HPNIVKLYEVL-----ATKAKIYFVMEFAKGGELFAKISKG------RFSEQLSRRYFQQ 123
HPN+VK Y + +++ V+E GG + ++ KG R E +
Sbjct: 78 HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSV-TELVKGLLICGQRLDEAMISYILYG 136
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
+ +++ H+ + HRD+K N+LL +K+ DFG+SA R +T GTP +
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFW 194
Query: 184 VAPEILA-KKGYD---GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+APE++A ++ YD A+ D+WS G+ L G DP L M+ K ++ P+
Sbjct: 195 MAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG-----DPPLFDMHP--VKTLFKIPR 247
Query: 240 WTSPDL----KW------FIGRLLDTDPATRITVDEILRDPWFK 273
P L KW FI + L D R +V +L P+ K
Sbjct: 248 NPPPTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 8e-23
Identities = 82/261 (31%), Positives = 117/261 (44%), Gaps = 34/261 (13%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSRLRHPNIV 79
IG G F VY G ++ VA+K R L +KR E I+ + HPNIV
Sbjct: 3 IGKGNFGDVYKGV-LKGNTEVAVKTC------RSTLPPDLKRKFLQEAEILKQYDHPNIV 55
Query: 80 KLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISA---VEYCHSR 134
KL V K IY VME GG L F + K R + ++ Q + A +EY S+
Sbjct: 56 KLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLT---VKKLLQMSLDAAAGMEYLESK 112
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP----AYVAPEILA 190
HRDL N L+ EN LKISDFG+S +E G+ G + APE L
Sbjct: 113 NCIHRDLAARNCLVGENNVLKISDFGMSREEE----GGIYTVSDGLKQIPIKWTAPEALN 168
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLM-AMYRKIYKGEYR--CPKWTSPDLK 246
Y ++ D+WS G++L+ + G P+ P + R+ + YR P+ ++
Sbjct: 169 YGRYT-SESDVWSYGILLWETFSLGDTPY--PGMSNQQTRERIESGYRMPAPQLCPEEIY 225
Query: 247 WFIGRLLDTDPATRITVDEIL 267
+ + DP R + EI
Sbjct: 226 RLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 97.4 bits (242), Expect = 1e-22
Identities = 62/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 15 FGKYEVG---KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
FGK E + +G G +A V+ GR+ T VA+K + + G RE+S++
Sbjct: 2 FGKMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLK 59
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFA-KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
L+H NIV L++++ T + V E+ K + + S + + Q++ + Y
Sbjct: 60 DLKHANIVTLHDIVHTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY 119
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
CH R V HRDLK +NLL++E +LK++DFGL+ K P T Y P++L
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDVLL 177
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAG 214
++DMW G + F + +G
Sbjct: 178 GSSEYSTQIDMWGVGCIFFEMASG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 1e-22
Identities = 72/252 (28%), Positives = 119/252 (47%), Gaps = 15/252 (5%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+F VY R+VRT + VAIK +S + +E+ + R++HPN ++
Sbjct: 33 IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKG 92
Query: 84 VLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+ + VME+ G ++ K E + + Y HS + HRD+K
Sbjct: 93 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 152
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI---LAKKGYDGAKV 199
N+LL E +K++DFG +++ P ++ GTP ++APE+ + + YDG KV
Sbjct: 153 AGNILLTEPGQVKLADFGSASI---ASP---ANSFVGTPYWMAPEVILAMDEGQYDG-KV 205
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGRLLDTD 256
D+WS G+ L P + N M+ I + E + +W S + F+ L
Sbjct: 206 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW-SDYFRNFVDSCLQKI 264
Query: 257 PATRITVDEILR 268
P R T +E+L+
Sbjct: 265 PQDRPTSEELLK 276
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.5 bits (238), Expect = 2e-22
Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 35/264 (13%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-----SKQKILRGGLTAHVKREISIMSRL 73
++G IG G F V G GQ VA+K + + Q L E S+M+ L
Sbjct: 9 KLGATIGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLA---------EASVMTTL 57
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGR----FSEQLSRRYFQQLISAV 128
RHPN+V+L V+ +Y V E+ G L + S+GR ++QL + +
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFAL--DVCEGM 115
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA-YVAPE 187
EY + HRDL N+L+ E+ K+SDFGL+ Q + G L P + APE
Sbjct: 116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL------PVKWTAPE 169
Query: 188 ILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPD 244
L +K + K D+WS G++L+ + + G +P+ L + + KG YR P+ P+
Sbjct: 170 ALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG-YRMEAPEGCPPE 227
Query: 245 LKWFIGRLLDTDPATRITVDEILR 268
+ + + DPA R T ++
Sbjct: 228 VYKVMKDCWELDPAKRPTFKQLRE 251
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-22
Identities = 85/302 (28%), Positives = 134/302 (44%), Gaps = 53/302 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH-VKREISIMSRLRH 75
+Y++ ++IG G++ V + TG+ VAIK + + A + REI ++ LRH
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKI--NDVFEHVSDATRILREIKLLRLLRH 58
Query: 76 PNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ----QLIS 126
P+IV++ ++ ++ IY V E +L I + ++ L+ + Q QL+
Sbjct: 59 PDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVI---KANDDLTPEHHQFFLYQLLR 114
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT-LCGTPAYVA 185
A++Y H+ VFHRDLK +N+L + + LKI DFGL+ V P + T T Y A
Sbjct: 115 ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRA 174
Query: 186 PEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--------------------- 222
PE+ Y A +D+WS G + + G F N
Sbjct: 175 PELCGSFFSKYTPA-IDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233
Query: 223 ----------LMAMYRKI-YKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271
L +M +K + P L+ + RLL DP R T +E L DP+
Sbjct: 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALR-LLERLLAFDPKDRPTAEEALADPY 292
Query: 272 FK 273
FK
Sbjct: 293 FK 294
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 3e-22
Identities = 63/205 (30%), Positives = 101/205 (49%), Gaps = 10/205 (4%)
Query: 15 FGKYE----VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
FGK E + K+ G G +A V+ GR+ T VA+K + + G RE+S++
Sbjct: 1 FGKLETYVKLDKL-GEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLL 57
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ-QLISAVE 129
L+H NIV L++++ T+ + V E+ + G + + F QL+ +
Sbjct: 58 KNLKHANIVTLHDIIHTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS 117
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
YCH R + HRDLK +NLL++E +LK++DFGL+ K P T Y P++L
Sbjct: 118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTKTYSNEVVTLWYRPPDVL 175
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAG 214
+DMW G +L+ + G
Sbjct: 176 LGSTEYSTPIDMWGVGCILYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.5 bits (237), Expect = 4e-22
Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 15/259 (5%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+F VY R+VR + VAIK +S + +E+ + +LRHPN ++
Sbjct: 23 IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG 82
Query: 84 VLATKAKIYFVMEFAKG-GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+ + VME+ G ++ K E + + Y HS + HRD+K
Sbjct: 83 CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVK 142
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI---LAKKGYDGAKV 199
N+LL E +K+ DFG +++ + P + GTP ++APE+ + + YDG KV
Sbjct: 143 AGNILLSEPGLVKLGDFGSASI---MAP---ANXFVGTPYWMAPEVILAMDEGQYDG-KV 195
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGRLLDTD 256
D+WS G+ L P + N M+ I + E + W S + F+ L
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW-SEYFRNFVDSCLQKI 254
Query: 257 PATRITVDEILRDPWFKKD 275
P R T + +L+ + ++
Sbjct: 255 PQDRPTSEVLLKHRFVLRE 273
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 5e-22
Identities = 69/205 (33%), Positives = 103/205 (50%), Gaps = 10/205 (4%)
Query: 15 FGK---YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
FGK Y+ +G G++A VY GR+ TGQ VA+K + + TA RE S++
Sbjct: 1 FGKLETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTA--IREASLLK 58
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVE 129
L+H NIV L++++ TK + V E+ +L + G S R + QL+ +
Sbjct: 59 DLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLA 117
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
YCH R V HRDLK +NLL+ E +LK++DFGL+ K P T Y P++L
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSV--PSKTYSNEVVTLWYRPPDVL 175
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAG 214
+DMW G + + + G
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATG 200
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 5e-22
Identities = 77/287 (26%), Positives = 123/287 (42%), Gaps = 43/287 (14%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLRHPNIVKL 81
IG GAF V+ + R G+ VA+K + Q ++ V RE+ ++ +H N++
Sbjct: 8 IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVS---CKRVFRELKMLCFFKHDNVLSA 64
Query: 82 YEVLATK-----AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
++L +IY V E + +S S + + Q++ ++Y HS G+
Sbjct: 65 LDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGI 124
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
HRD+K NLL++ N LKI DFGL+ V+E M + T Y APEIL +
Sbjct: 125 LHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQYYRAPEILMGSRHYT 183
Query: 197 AKVDMWSCGVVLFVLNAGYLPFN----------------DPNLMAMY-------RKIYKG 233
+ VD+WS G + L + F P+L AM I +G
Sbjct: 184 SAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRG 243
Query: 234 EYRCP------KWTSPDLK---WFIGRLLDTDPATRITVDEILRDPW 271
++ P +S + R+L DP RI+ + L P+
Sbjct: 244 PHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPY 290
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 6e-22
Identities = 83/268 (30%), Positives = 129/268 (48%), Gaps = 25/268 (9%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLRHPNIVKL 81
+G G F +V + TG+ A K ++K+++ +G A V++ I ++++ IV L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRI--LAKVHSRFIVSL 58
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKI-----SKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
TK + VM GG+L I F E + Y Q+IS +E+ H R +
Sbjct: 59 AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRI 118
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT--LCGTPAYVAPEILAKKGY 194
+RDLK EN+LLD + +++ISD GL AV+ + DG T GTP ++APE+L + Y
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGL-AVELK---DGQSKTKGYAGTPGFMAPELLQGEEY 174
Query: 195 DGAKVDMWSCGVVLFVLNAGYLPF----NDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250
D + VD ++ GV L+ + A PF + ++I P SP K F
Sbjct: 175 DFS-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCE 233
Query: 251 RLLDTDPATRI-----TVDEILRDPWFK 273
LL DP R+ D + P F+
Sbjct: 234 ALLAKDPEKRLGFRDGNCDGLRTHPLFR 261
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-22
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 8/204 (3%)
Query: 15 FGKYEVG---KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
FGK E +G G +A VY GR+ T VA+K + + G RE+S++
Sbjct: 2 FGKLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLK 59
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFA-KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
L+H NIV L++++ T+ + V E+ K + + + + + QL+ + Y
Sbjct: 60 DLKHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY 119
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
CH R V HRDLK +NLL++E +LK++DFGL+ K P T Y P+IL
Sbjct: 120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTKTYSNEVVTLWYRPPDILL 177
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAG 214
++DMW G + + ++ G
Sbjct: 178 GSTDYSTQIDMWGVGCIFYEMSTG 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 1e-21
Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 28/271 (10%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HP 76
+E+ + IG G + KV+ N + G A+K + + ++ E +I+ L HP
Sbjct: 20 WEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHP 75
Query: 77 NIVKLYEVLATKA-----KIYFVMEFAKGGELFAKISKG------RFSEQLSRRYFQQLI 125
N+VK Y + K +++ V+E GG + + KG R E + + +
Sbjct: 76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSV-TDLVKGFLKRGERMEEPIIAYILHEAL 134
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+++ H HRD+K N+LL +K+ DFG+SA R +T GTP ++A
Sbjct: 135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTSVGTPFWMA 192
Query: 186 PEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRC 237
PE++A YD A+ D+WS G+ L G P D + M KI +
Sbjct: 193 PEVIACEQQLDSTYD-ARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQ 251
Query: 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
P+ S + FI + L D R TV ++L+
Sbjct: 252 PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQ 282
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 1e-21
Identities = 75/229 (32%), Positives = 114/229 (49%), Gaps = 21/229 (9%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKR----EISIMSRLR 74
K+IG G F +V GR G+ VAIK L+ G T +R E SIM +
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKT------LKAGYTEKQRRDFLSEASIMGQFD 63
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCH 132
HPNI+ L V+ + V E+ + G L F + G+F+ + + S ++Y
Sbjct: 64 HPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLS 123
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT-PA-YVAPEILA 190
G HRDL N+L++ N K+SDFGLS V E P+ T G P + APE +A
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTAPEAIA 182
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
+ + A D+WS G+V++ V++ G P+ + + + + I +G YR P
Sbjct: 183 YRKFTSAS-DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEG-YRLP 229
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 94.1 bits (234), Expect = 2e-21
Identities = 77/309 (24%), Positives = 116/309 (37%), Gaps = 55/309 (17%)
Query: 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-----------SKQKILRGGLTAHVKREIS 68
G +G G + KV + TG+ VAIK V +Q + G+ RE+
Sbjct: 13 KGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELK 72
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLIS 126
IM+ ++H NI+ L +V I VM+ K+ K R +E + Q+++
Sbjct: 73 IMNEIKHENIMGLVDVYVEGDFINLVMDIMASD--LKKVVDRKIRLTESQVKCILLQILN 130
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-------AVKEQIRPDGMLHTLCG 179
+ H HRDL N+ ++ KI+DFGL+ + + M
Sbjct: 131 GLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEM 190
Query: 180 TPA-----YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-- 232
T Y APE+L VDMWS G + L G F N + +I++
Sbjct: 191 TSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELL 250
Query: 233 GEYRCPKW--------------TSP-DLKW-----------FIGRLLDTDPATRITVDEI 266
G W P DLK + LL +P RI+ E
Sbjct: 251 GTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEA 310
Query: 267 LRDPWFKKD 275
L+ +FK D
Sbjct: 311 LKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 2e-21
Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 15/245 (6%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G F +V+ GR VA+K S ++ L L A +E I+ + HPNIV+L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVK--SCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 84 VLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL 141
V K IY VME +GG+ F + R + + + + +EY S+ HRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 142 KLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP----AYVAPEILAKKGYDGA 197
N L+ E LKISDFG+S +E DG+ + G + APE L Y +
Sbjct: 121 AARNCLVTEKNVLKISDFGMSREEE----DGVYASTGGMKQIPVKWTAPEALNYGRYS-S 175
Query: 198 KVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDT 255
+ D+WS G++L+ + G +P+ + + I +G CP+ + + R +
Sbjct: 176 ESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEY 235
Query: 256 DPATR 260
DP R
Sbjct: 236 DPGQR 240
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 3e-21
Identities = 66/203 (32%), Positives = 96/203 (47%), Gaps = 20/203 (9%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
KY K IG GA+ V +N T + VAIK ++ + T REI ++ L
Sbjct: 6 KYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTL---REIKLLRHLD 62
Query: 75 HPNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKISKGRFSEQLSR---RYF-QQLI 125
H N++ + +++ + +Y V E +L I R S+ LS +YF QL+
Sbjct: 63 HENVIAIKDIMPPPHREAFNDVYIVYELMDT-DLHQII---RSSQTLSDDHCQYFLYQLL 118
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
++Y HS V HRDLK NLLL+ N DLKI DFGL+ + + T Y A
Sbjct: 119 RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE--KGDFMTEYVVTRWYRA 176
Query: 186 PEILAKKGYDGAKVDMWSCGVVL 208
PE+L +D+WS G +
Sbjct: 177 PELLLNCSEYTTAIDVWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 3e-21
Identities = 79/265 (29%), Positives = 128/265 (48%), Gaps = 32/265 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV-KREISIMSRLRH 75
K +G+IIG G F V G TGQ VA+K ++ +TA E ++M++L H
Sbjct: 7 KLTLGEIIGEGEFGAVLQGE--YTGQKVAVK------NIKCDVTAQAFLEETAVMTKLHH 58
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSR--RYFQQLISAVEYCH 132
N+V+L V+ +Y VME G L + ++GR + + ++ + +EY
Sbjct: 59 KNLVRLLGVILHNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
S+ + HRDL N+L+ E+ K+SDFGL+ V G+ ++ + APE L K
Sbjct: 118 SKKLVHRDLAARNILVSEDGVAKVSDFGLARVG----SMGVDNSKLPV-KWTAPEALKHK 172
Query: 193 GYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLKWFI 249
+ +K D+WS GV+L+ V + G P+ +L + + KG YR P+ D+ +
Sbjct: 173 KFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKG-YRMEPPEGCPADVYVLM 230
Query: 250 GRLLDTDPATRITVDEILRDPWFKK 274
+T+P R P F K
Sbjct: 231 TSCWETEPKKR---------PSFHK 246
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.7 bits (231), Expect = 4e-21
Identities = 87/325 (26%), Positives = 135/325 (41%), Gaps = 78/325 (24%)
Query: 17 KYEVGKIIGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
KYE+ IG G + +VY + N + G+ AIK K G++ REI+++ L+
Sbjct: 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK 60
Query: 75 HPNIVKLYEVLATKA--KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ---------Q 123
H N+V L EV A +Y + ++A+ +L+ I +F Q R Q
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQII---KFHRQAKRVSIPPSMVKSLLWQ 116
Query: 124 LISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGL-----SAVKEQIRPDGML 174
+++ V Y HS V HRDLK N+L+ E +KI D GL + +K D ++
Sbjct: 117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVV 176
Query: 175 HTLCGTPAYVAPEI-LAKKGYDGAKVDMWSCGVVLFVL-------------NAGYLPFND 220
T+ Y APE+ L + Y A +D+W+ G + L PF
Sbjct: 177 VTIW----YRAPELLLGARHYTKA-IDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQR 231
Query: 221 PNLMAMYR-------KIYKG-----EY-------RCPKWTSPDL-KWF------------ 248
L ++ K + EY + + S L KW
Sbjct: 232 DQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFD 291
Query: 249 -IGRLLDTDPATRITVDEILRDPWF 272
+ +LL+ DP RIT +E L P+F
Sbjct: 292 LLRKLLEYDPTKRITAEEALEHPYF 316
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 6e-21
Identities = 69/263 (26%), Positives = 117/263 (44%), Gaps = 15/263 (5%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
IG G+F VY N T + VA+K +S + +E+ + +L+HPN ++
Sbjct: 29 IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88
Query: 84 VLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+ + VME+ G ++ K E + + Y HS + HRD+K
Sbjct: 89 CYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIK 148
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI---LAKKGYDGAKV 199
N+LL E +K++DFG ++ ++ GTP ++APE+ + + YDG KV
Sbjct: 149 AGNILLTEPGQVKLADFGSASKSSPA------NSFVGTPYWMAPEVILAMDEGQYDG-KV 201
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGRLLDTD 256
D+WS G+ L P + N M+ I + + + +WT + F+ L
Sbjct: 202 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTD-SFRGFVDYCLQKI 260
Query: 257 PATRITVDEILRDPWFKKDYKER 279
P R E+LR + ++D R
Sbjct: 261 PQERPASAELLRHDFVRRDRPAR 283
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 92.5 bits (230), Expect = 7e-21
Identities = 84/303 (27%), Positives = 129/303 (42%), Gaps = 59/303 (19%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRT--GQSVAIKAVSK--QKILRGGLTAHVKREISIMSRL 73
YE+ K +G GA+ V RN T ++VAIK ++ K + L RE+ ++
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKI---LAKRALRELKLLRHF 58
Query: 74 R-HPNIVKLYEV-LATKAK---IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ----QL 124
R H NI LY++ + +Y E + +L I R + L+ +FQ Q+
Sbjct: 59 RGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQII---RSGQPLTDAHFQSFIYQI 114
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL----SAVKEQIRPDGMLHTLCGT 180
+ ++Y HS V HRDLK NLL++ + +LKI DFGL S + G + T
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGEN--AGFMTEYVAT 172
Query: 181 PAYVAPEI-LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------- 232
Y APEI L+ + Y A +D+WS G +L L F + + +I +
Sbjct: 173 RWYRAPEIMLSFQSYTKA-IDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDE 231
Query: 233 ---GEYRCPK-WT--------------------SPDLKWFIGRLLDTDPATRITVDEILR 268
PK +P + +LL DP RI+V+E L
Sbjct: 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291
Query: 269 DPW 271
P+
Sbjct: 292 HPY 294
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 91.7 bits (227), Expect = 8e-21
Identities = 64/209 (30%), Positives = 103/209 (49%), Gaps = 10/209 (4%)
Query: 15 FGK---YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
FGK YE + +G G++A VY G++ G+ VA+K + Q+ G RE S++
Sbjct: 1 FGKADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQE--EEGTPFTAIREASLLK 58
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVE 129
L+H NIV L++++ TK + V E+ +L + K G + + + QL+ +
Sbjct: 59 GLKHANIVLLHDIIHTKETLTLVFEYVHT-DLCQYMDKHPGGLHPENVKLFLFQLLRGLS 117
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
Y H R + HRDLK +NLL+ + +LK++DFGL+ K P T Y P++L
Sbjct: 118 YIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSHTYSNEVVTLWYRPPDVL 175
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218
+DMW G + + G F
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 20/215 (9%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVKR----EISIMS 71
++ ++IG G F +V GR G+ VAIK L+ G T +R E SIM
Sbjct: 7 KIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKT------LKSGYTEKQRRDFLSEASIMG 60
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+ HPNI+ L V+ + + EF + G L F + + G+F+ + + + ++
Sbjct: 61 QFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA---YVAP 186
Y HRDL N+L++ N K+SDFGLS E D + G + AP
Sbjct: 121 YLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAP 180
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFND 220
E +A + + A D+WS G+V++ V++ G P+ D
Sbjct: 181 EAIAYRKFTSAS-DVWSYGIVMWEVMSYGERPYWD 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 3e-20
Identities = 72/257 (28%), Positives = 118/257 (45%), Gaps = 19/257 (7%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V+ G ++ VA+K + L L E I+ + HPNIVKL
Sbjct: 1 ELLGKGNFGEVFKG-TLKDKTPVAVKTCKED--LPQELKIKFLSEARILKQYDHPNIVKL 57
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR--RYFQQLISAVEYCHSRGVFHR 139
V + IY VME GG+ + + K + + + ++ + + Y S+ HR
Sbjct: 58 IGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP----AYVAPEILAKKGYD 195
DL N L+ EN LKISDFG+S + D +++ G + APE L Y
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR-----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYS 172
Query: 196 GAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWFIGRL 252
++ D+WS G++L+ + G P+ ++ KG YR CP+ D+ + R
Sbjct: 173 -SESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKG-YRMSCPQKCPDDVYKVMQRC 230
Query: 253 LDTDPATRITVDEILRD 269
D P R E+ ++
Sbjct: 231 WDYKPENRPKFSELQKE 247
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 6e-20
Identities = 56/200 (28%), Positives = 99/200 (49%), Gaps = 7/200 (3%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G F +V + TG+ A K + K+++ + E I+ ++ P IV L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60
Query: 84 VLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSR--RYFQQLISAVEYCHSRGVFHRD 140
+K + VM GG+L + + G ++ R Y Q+ + + HS + +RD
Sbjct: 61 AFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRD 120
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
+K EN+LLD+ + ++SD GL+ +++ + GT Y+APEIL ++ Y VD
Sbjct: 121 MKPENVLLDDQGNCRLSDLGLAV---ELKDGKTITQRAGTNGYMAPEILKEEPYS-YPVD 176
Query: 201 MWSCGVVLFVLNAGYLPFND 220
++ G ++ + AG PF D
Sbjct: 177 WFAMGCSIYEMVAGRTPFKD 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 90.9 bits (225), Expect = 1e-19
Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK-----QKILRGG--LTAHVKREISIMSRL 73
GKI C A R G + + K K ++ G ++ EI + RL
Sbjct: 162 GKIFICALRASTEEAEARR-GVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRL 220
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLS------RRYFQQLISA 127
H NI+K+ E+L ++A Y + + +L++ + F + R +QL+ A
Sbjct: 221 NHENILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCA 279
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
VEY H + + HRD+KLEN+ L+ + + + DFG + E+ R + + GT A +PE
Sbjct: 280 VEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPE 338
Query: 188 ILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFND 220
ILA GY D+WSCG++L +L+ + P D
Sbjct: 339 ILAGDGY-CEITDIWSCGLILLDMLSHDFCPIGD 371
|
Length = 501 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-19
Identities = 62/210 (29%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 21 GKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
K +G G F V+ G R VAIK +R G + E +M +L HP
Sbjct: 9 LKELGSGQFGVVHLGKWRGKI---DVAIKM------IREGAMSEDDFIEEAKVMMKLSHP 59
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
N+V+LY V + I+ V E+ G L + + KG+ + + A+EY S
Sbjct: 60 NLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESN 119
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLS--AVKEQIRPDGMLHTLCGTP---AYVAPEIL 189
G HRDL N L+ E+ +K+SDFGL+ + +Q GT + PE+
Sbjct: 120 GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ------GTKFPVKWAPPEVF 173
Query: 190 AKKGYDGAKVDMWSCGVVLF-VLNAGYLPF 218
+ +K D+WS GV+++ V + G +P+
Sbjct: 174 DYSRFS-SKSDVWSFGVLMWEVFSEGKMPY 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 3e-19
Identities = 60/226 (26%), Positives = 109/226 (48%), Gaps = 14/226 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ + + +G G F +V+ G + VAIK + +L+ ++E+ + RLRH +
Sbjct: 8 FTLERKLGSGYFGEVWEGL-WKNRVRVAIKILKSDDLLKQQ---DFQKEVQALKRLRHKH 63
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQ-QLISAVEYCHSR 134
++ L+ V + +Y + E + G L F + +G+ S Q+ + Y +
Sbjct: 64 LISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ 123
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP-AYVAPEILAKKG 193
HRDL N+L+ E+ K++DFGL+ + I+ D L + P + APE +
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL---IKEDVYLSSDKKIPYKWTAPEAASHGT 180
Query: 194 YDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
+ K D+WS G++L+ + G +P+ N +Y +I G YR P
Sbjct: 181 FS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAG-YRMP 224
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 4e-19
Identities = 64/265 (24%), Positives = 117/265 (44%), Gaps = 16/265 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V + TG+ A K + K++I + A E I+ ++ +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 65
Query: 82 YEVLATKAKIYFVMEFAKGGEL---FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
TK + V+ GG+L + F E+ + Y ++ +E H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLK EN+LLD+ ++ISD GL+ +I + GT Y+APE++ + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAV---EIPEGETIRGRVGTVGYMAPEVVKNERY-TFS 181
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254
D W G +++ + G PF + R++ + + + S + +LL
Sbjct: 182 PDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQLLT 241
Query: 255 TDPATRI-----TVDEILRDPWFKK 274
DP R+ +E+ P+F+
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHPFFRT 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 4e-19
Identities = 56/187 (29%), Positives = 94/187 (50%), Gaps = 7/187 (3%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G++A VY G + GQ VA+K +S + G+ RE S++ L+H NIV L++
Sbjct: 13 LGEGSYATVYKGISRINGQLVALKVISMKT--EEGVPFTAIREASLLKGLKHANIVLLHD 70
Query: 84 VLATKAKIYFVMEFAKG--GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL 141
++ TK + FV E+ + + G + R + QL+ + Y H + + HRDL
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNV-RLFMFQLLRGLAYIHGQHILHRDL 129
Query: 142 KLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDM 201
K +NLL+ +LK++DFGL+ K P + T Y P++L + +D+
Sbjct: 130 KPQNLLISYLGELKLADFGLARAKSI--PSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 202 WSCGVVL 208
W G +
Sbjct: 188 WGAGCIF 194
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 4e-19
Identities = 74/295 (25%), Positives = 127/295 (43%), Gaps = 48/295 (16%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
+Y+ +G GA+ V + R Q VA+K +S+ Q ++ T RE+ ++ ++
Sbjct: 16 RYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTY---RELRLLKHMK 72
Query: 75 HPNIVKLYEVLATKA------KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
H N++ L +V ++Y V G +L + + S++ + QL+ +
Sbjct: 73 HENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGL 131
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
+Y HS G+ HRDLK N+ ++E+ +L+I DFGL+ + D + T Y APEI
Sbjct: 132 KYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEI 186
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAG--YLPFND----------------PNLMAMYRKI 230
+ + VD+WS G ++ L G P ND P ++
Sbjct: 187 MLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE 246
Query: 231 YKGEY--RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPWF 272
+ +Y P DLK + ++L D RI+ E L P+F
Sbjct: 247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 86.5 bits (214), Expect = 9e-19
Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 20/225 (8%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK---QKILRGGLTAHVKREISIMSRL 73
+Y K +G GA+ V + RTG+ VAIK +S+ +I RE++++ +
Sbjct: 16 RYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIF----AKRAYRELTLLKHM 71
Query: 74 RHPNIVKLYEVLATKA------KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISA 127
+H N++ L +V + Y VM + + KI SE + Q++
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD--LQKIMGHPLSEDKVQYLVYQMLCG 129
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
++Y HS G+ HRDLK NL ++E+ +LKI DFGL+ D + T Y APE
Sbjct: 130 LKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAPE 184
Query: 188 ILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK 232
++ + VD+WS G ++ + G F + + +I K
Sbjct: 185 VILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 229
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 84.9 bits (210), Expect = 1e-18
Identities = 71/255 (27%), Positives = 114/255 (44%), Gaps = 19/255 (7%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K +G G F V+ G+ R VAIKA+++ + K +M +L HP +V+L
Sbjct: 10 KELGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAK----VMMKLSHPKLVQL 64
Query: 82 YEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
Y V + +Y V EF + G L + + +G+ S+ + Q + +EY HR
Sbjct: 65 YGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHR 124
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKKGYDG 196
DL N L+ +K+SDFG++ + D + G + PE+ Y
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMT----RYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS- 179
Query: 197 AKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE--YRCPKWTSPDLKWFIGRLL 253
+K D+WS GV+++ V G +PF + + I +G YR PK S + +
Sbjct: 180 SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR-PKLASMTVYEVMYSCW 238
Query: 254 DTDPATRITVDEILR 268
P R T E+LR
Sbjct: 239 HEKPEGRPTFAELLR 253
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 68/265 (25%), Positives = 119/265 (44%), Gaps = 16/265 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V + TG+ A K + K++I + + E I+ ++ +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSL 65
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKI---SKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
TK + V+ GG+L I + F E + Y ++ +E H + +
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLK EN+LLD++ ++ISD GL+ + + GT Y+APE++ + Y +
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAV---HVPEGQTIKGRVGTVGYMAPEVVKNERYTFSP 182
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLM----AMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254
D W+ G +L+ + AG PF + R + + + + SPD + LL
Sbjct: 183 -DWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLC 241
Query: 255 TDPATRI-----TVDEILRDPWFKK 274
DP R+ E+ P FK+
Sbjct: 242 KDPKERLGCQGGGAREVKEHPLFKQ 266
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 2e-18
Identities = 67/226 (29%), Positives = 110/226 (48%), Gaps = 15/226 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSRLRHPN 77
K+IG G F +V+ G G+ A+ K L+ G T ++ E SIM + H N
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAI---KTLKPGYTEKQRQDFLSEASIMGQFSHHN 67
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
I++L V+ + E+ + G L + + G FS + + + ++Y
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN 127
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA--YVAPEILAKKG 193
HRDL N+L++ N + K+SDFGLS V E P+G T G + APE +A +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLED-DPEGTYTTSGGKIPIRWTAPEAIAYRK 186
Query: 194 YDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
+ A D+WS G+V++ V++ G P+ D + + + I G +R P
Sbjct: 187 FTSAS-DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDG-FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 90/321 (28%), Positives = 127/321 (39%), Gaps = 74/321 (23%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKR---EISIMS 71
+Y+ K IG GA V + TGQ+VAIK +S+ Q H KR E+ +M
Sbjct: 17 RYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQN------VTHAKRAYRELVLMK 70
Query: 72 RLRHPNIVKLYEV------LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYF-QQL 124
+ H NI+ L V L +Y VME L I E++S Y Q+
Sbjct: 71 LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQMDLDHERMS--YLLYQM 127
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
+ +++ HS G+ HRDLK N+++ + LKI DFGL+ M+ T Y
Sbjct: 128 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVTRYYR 184
Query: 185 APEILAKKGYDGAKVDMWSCGVVL------FVLNAGY------------LPFNDPNLM-- 224
APE++ GY VD+WS G ++ VL G L M
Sbjct: 185 APEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSR 243
Query: 225 -----AMY---RKIYKG---EYRCPKWTSP---------------DLKWFIGRLLDTDPA 258
Y R Y G E P P DL + ++L DP
Sbjct: 244 LQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL---LSKMLVIDPE 300
Query: 259 TRITVDEILRDPWFKKDYKER 279
RI+VD+ L+ P+ Y
Sbjct: 301 KRISVDDALQHPYINVWYDPS 321
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 3e-18
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 31/215 (14%)
Query: 17 KYEVGKIIGCGAFAKVYHG--RNVRTGQS---VAIKAVSKQKILRGGLTAHVKREISIMS 71
K + + +G G+F VY G + V G+ VAIK V++ +R + E S+M
Sbjct: 7 KITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI--EFLNEASVMK 64
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR--------RYFQ- 122
++V+L V++T VME G+L + + R + + ++ Q
Sbjct: 65 EFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQM 124
Query: 123 --QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA-VKEQ--IRPDG--MLH 175
++ + Y ++ HRDL N ++ E+ +KI DFG++ + E R G +L
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLL- 183
Query: 176 TLCGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF 209
P ++APE L K G K D+WS GVVL+
Sbjct: 184 -----PVRWMAPESL-KDGVFTTKSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 4e-18
Identities = 71/255 (27%), Positives = 112/255 (43%), Gaps = 14/255 (5%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
K +G G+F V G +G VA+K + K+ + +E +IM L H N+
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENL 58
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRR---YFQQLISAVEYCHSRG 135
++LY V+ T + V E A G L ++ K L Y Q+ + + Y S+
Sbjct: 59 IRLYGVVLTH-PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR 117
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY 194
HRDL N+LL + +KI DFGL A+ + M L A+ APE L + +
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177
Query: 195 DGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLKWFIGR 251
A D+W GV L+ + G P+ + + +KI K R P+ D+ + +
Sbjct: 178 SHAS-DVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236
Query: 252 LLDTDPATRITVDEI 266
+PA R T +
Sbjct: 237 CWAHNPADRPTFAAL 251
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 4e-18
Identities = 61/205 (29%), Positives = 99/205 (48%), Gaps = 20/205 (9%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH--VKREISIMSRLRHPNIVKL 81
IG G F V+ G + VAIK + R G + E +M +L HP +V+L
Sbjct: 12 IGSGQFGLVWLG-YWLEKRKVAIKTI------REGAMSEEDFIEEAQVMMKLSHPKLVQL 64
Query: 82 YEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
Y V ++ I V EF + G L + + +G+FS++ + + Y S V HR
Sbjct: 65 YGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKKGYDG 196
DL N L+ EN +K+SDFG++ + D + GT + +PE+ + Y
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMT----RFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYS- 179
Query: 197 AKVDMWSCGVVLF-VLNAGYLPFND 220
+K D+WS GV+++ V + G P+ +
Sbjct: 180 SKSDVWSFGVLMWEVFSEGKTPYEN 204
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-18
Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 19/211 (9%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
+Y+ +G GA+ V + +TG VA+K +S+ Q I+ T RE+ ++ ++
Sbjct: 18 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY---RELRLLKHMK 74
Query: 75 HPNIVKLYEVLATKAK-------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISA 127
H N++ L +V T A+ +Y V G +L + + ++ + Q++
Sbjct: 75 HENVIGLLDVF-TPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRG 132
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
++Y HS + HRDLK NL ++E+ +LKI DFGL+ D + T Y APE
Sbjct: 133 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPE 187
Query: 188 ILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218
I+ + VD+WS G ++ L G F
Sbjct: 188 IMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 218
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 5e-18
Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 17/200 (8%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
+Y K +G GA+ V + RTG VAIK + + Q L RE+ ++ ++
Sbjct: 16 RYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMK 72
Query: 75 HPNIVKLYEVLATKAKI------YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
H N++ L +V + Y VM F G +L + + SE + Q++ +
Sbjct: 73 HENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGL 131
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
+Y H+ G+ HRDLK NL ++E+ +LKI DFGL+ + D + T Y APE+
Sbjct: 132 KYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRWYRAPEV 186
Query: 189 LAKKGYDGAKVDMWSCGVVL 208
+ + VD+WS G ++
Sbjct: 187 ILNWMHYTQTVDIWSVGCIM 206
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 7e-18
Identities = 73/259 (28%), Positives = 116/259 (44%), Gaps = 20/259 (7%)
Query: 19 EVGKIIGCGAFAKVYHG-----RNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
+G+ IG G F VY G N + +VA+K + +E IM +
Sbjct: 9 TLGRCIGEGQFGDVYQGVYMSPENEKI--AVAVKTCKNC--TSPSVREKFLQEAYIMRQF 64
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR--RYFQQLISAVEYC 131
HP+IVKL V+ T+ ++ VME A GEL + + ++S L+ Y QL +A+ Y
Sbjct: 65 DHPHIVKLIGVI-TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYL 123
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT-P-AYVAPEIL 189
S+ HRD+ N+L+ +K+ DFGLS + + G P ++APE +
Sbjct: 124 ESKRFVHRDIAARNVLVSSPDCVKLGDFGLS---RYLEDESYYKASKGKLPIKWMAPESI 180
Query: 190 AKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247
+ + A D+W GV ++ +L G PF + +I GE P P L
Sbjct: 181 NFRRFTSAS-DVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239
Query: 248 FIGRLLDTDPATRITVDEI 266
+ + DP+ R E+
Sbjct: 240 LMTKCWAYDPSKRPRFTEL 258
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 59/203 (29%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHVKREISIMSRLR- 74
+YE IG GA+ KV+ R+++ G + VA+K V Q G+ RE++++ L
Sbjct: 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLET 60
Query: 75 --HPNIVKLYEVLAT-----KAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLI 125
HPN+V+L++V + K+ V E K+ + + + QL+
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 120
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+++ HS V HRDLK +N+L+ + +K++DFGL+ + L ++ T Y A
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRA 177
Query: 186 PEILAKKGYDGAKVDMWSCGVVL 208
PE+L + Y VD+WS G +
Sbjct: 178 PEVLLQSSY-ATPVDLWSVGCIF 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 1e-17
Identities = 70/254 (27%), Positives = 116/254 (45%), Gaps = 23/254 (9%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRLRHPNIVK 80
+G G + +VY G + +VA+K + + T V+ +E ++M ++HPN+V+
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKED-------TMEVEEFLKEAAVMKEIKHPNLVQ 66
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ---QLISAVEYCHSRGVF 137
L V + Y + EF G L + + E + Q+ SA+EY +
Sbjct: 67 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFI 126
Query: 138 HRDLKLENLLLDENWDLKISDFGLSA-VKEQIRPDGMLHTLCGTP-AYVAPEILAKKGYD 195
HRDL N L+ EN +K++DFGLS + H P + APE LA +
Sbjct: 127 HRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFS 183
Query: 196 GAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLKWFIGRL 252
K D+W+ GV+L+ + G P+ +L +Y + KG YR P+ P + +
Sbjct: 184 -IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKG-YRMERPEGCPPKVYELMRAC 241
Query: 253 LDTDPATRITVDEI 266
+P+ R + EI
Sbjct: 242 WQWNPSDRPSFAEI 255
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (203), Expect = 1e-17
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 16/208 (7%)
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHS 133
+PN +KLY + T +M++ K G+LF + +G+ SE ++ +QL+ A+ H
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127
Query: 134 RGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ H D+KLEN+L D D + + D+GL + G GT Y +PE +
Sbjct: 128 HNIIHNDIKLENVLYDRAKDRIYLCDYGLC------KIIGTPSCYDGTLDYFSPEKIKGH 181
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPF-NDP----NLMAMYRKIYKGEYRCPKWTSPDLKW 247
YD D W+ GV+ + L G PF D +L ++ ++ K + K S +
Sbjct: 182 NYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQK-KLPFIKNVSKNAND 239
Query: 248 FIGRLLDTDPATR-ITVDEILRDPWFKK 274
F+ +L + R +EI++ P+ K
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHPFLKI 267
|
Length = 267 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-17
Identities = 73/265 (27%), Positives = 121/265 (45%), Gaps = 18/265 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V + TG+ A K + K++I + + E I+ ++ +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNL 65
Query: 82 YEVLATKAKIYFVMEFAKGGEL-FAKISKGR--FSEQLSRRYFQQLISAVEYCHSRGVFH 138
TK + V+ GG+L F + G F E+ + Y +++ +E H +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTLCGTPAYVAPEILAKKGYDGA 197
RDLK EN+LLD+ ++ISD GL AVK P+G + GT Y+APE+L + Y
Sbjct: 126 RDLKPENILLDDYGHIRISDLGL-AVK---IPEGESIRGRVGTVGYMAPEVLNNQRY-TL 180
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
D W G +++ + G PF + R++ + E S + K LL
Sbjct: 181 SPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL 240
Query: 254 DTDPATRITVD-----EILRDPWFK 273
DP R+ E+ R P+F+
Sbjct: 241 TKDPKQRLGCQEEGAGEVKRHPFFR 265
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 2e-17
Identities = 88/322 (27%), Positives = 135/322 (41%), Gaps = 68/322 (21%)
Query: 2 GDNTGDISREVNLFGK--YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL 59
D I ++N Y++G IIG G+F VY + T + VAIK V +
Sbjct: 50 EDEEKMIDNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------ 103
Query: 60 TAHVKREISIMSRLRHPNIVKLYEVLATKA------KIYF--VMEFA-----KGGELFAK 106
+ RE+ IM L H NI+ L + T+ I+ VMEF K + +A+
Sbjct: 104 -QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYAR 162
Query: 107 ISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVK 165
+ L + Y QL A+ Y HS+ + HRDLK +NLL+D N LK+ DFG + K
Sbjct: 163 NNHA-LPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG--SAK 219
Query: 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN------ 219
+ + +C + Y APE++ +D+WS G ++ + GY F+
Sbjct: 220 NLLAGQRSVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD 278
Query: 220 --------------------DPNLMAM---------YRKIYKGEYRCPKWTSPDLKWFIG 250
+PN + +K++ PK T D FI
Sbjct: 279 QLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVF------PKGTPDDAINFIS 332
Query: 251 RLLDTDPATRITVDEILRDPWF 272
+ L +P R+ E L DP+F
Sbjct: 333 QFLKYEPLKRLNPIEALADPFF 354
|
Length = 440 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 4e-17
Identities = 79/269 (29%), Positives = 121/269 (44%), Gaps = 37/269 (13%)
Query: 24 IGCGAFAKVYHGR-NVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRLRHPNIV 79
+G G F +V+ G N T VA+K L+ G T K E IM +LRHP ++
Sbjct: 14 LGAGQFGEVWEGLWNNTT--PVAVKT------LKPG-TMDPKDFLAEAQIMKKLRHPKLI 64
Query: 80 KLYEVLATKAKIYFVMEFAKGGEL--FAKISKGR---FSEQLSRRYFQQLISAVEYCHSR 134
+LY V + IY V E K G L + + GR + + Q+ S + Y ++
Sbjct: 65 QLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMA--AQVASGMAYLEAQ 122
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAV-KEQI---RPDGMLHTLCGTPAYVAPEILA 190
HRDL N+L+ EN K++DFGL+ V KE I R + APE
Sbjct: 123 NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPI-----KWTAPEAAL 177
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKW 247
+ K D+WS G++L ++ G +P+ + +++ +G YR CP +L
Sbjct: 178 YNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQG-YRMPCPPGCPKELYD 235
Query: 248 FIGRLLDTDPATRITVDEILRDPWFKKDY 276
+ DP R T E L+ W +D+
Sbjct: 236 IMLDCWKEDPDDRPTF-ETLQ--WKLEDF 261
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 60/303 (19%)
Query: 17 KYEVGKIIGCGAFAKVY----HGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+Y + + G+ +V+ HG R V +KAV+ K REI I+
Sbjct: 93 QYNILSSLTPGSEGEVFVCTKHGDEQRK--KVIVKAVTGGKTP--------GREIDILKT 142
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYC 131
+ H I+ L K+ + VM K +LF + G + + ++L+ A+ Y
Sbjct: 143 ISHRAIINLIHAYRWKSTVCMVMPKYKC-DLFTYVDRSGPLPLEQAITIQRRLLEALAYL 201
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTLCGTPAYVAPEILA 190
H RG+ HRD+K EN+ LDE + + DFG +A K PD + GT +PE+LA
Sbjct: 202 HGRGIIHRDVKTENIFLDEPENAVLGDFG-AACKLDAHPDTPQCYGWSGTLETNSPELLA 260
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPF-----------------------------NDP 221
Y AK D+WS G+VLF ++ +
Sbjct: 261 LDPY-CAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGST 319
Query: 222 NLMAMYRKIYKGEYRCPKWTSP----------DLKWFIGRLLDTDPATRITVDEILRDPW 271
NL +++ Y R P +T P D+++ I ++L D R + +IL P
Sbjct: 320 NLCKHFKQ-YAIVLRPP-YTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPL 377
Query: 272 FKK 274
F K
Sbjct: 378 FTK 380
|
Length = 392 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 5e-17
Identities = 68/224 (30%), Positives = 109/224 (48%), Gaps = 30/224 (13%)
Query: 24 IGCGAFAKV----YHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV 79
+G G F KV Y TG+ VA+K++ + G A +K+EI I+ L H NIV
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIV 69
Query: 80 KLYEVLATK---AKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
K Y+ + T+ I +MEF G L + +K + + + +Y Q+ ++Y SR
Sbjct: 70 K-YKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSR 128
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL---CGTPAY-VAPEILA 190
HRDL N+L++ +KI DFGL+ + I D +T+ +P + APE L
Sbjct: 129 QYVHRDLAARNVLVESEHQVKIGDFGLT---KAIETDKEYYTVKDDLDSPVFWYAPECLI 185
Query: 191 KKGYDGAKVDMWSCGVVLFVL----NAGYLPFNDPNLMAMYRKI 230
+ + A D+WS GV L+ L ++ P M ++ K+
Sbjct: 186 QSKFYIAS-DVWSFGVTLYELLTYCDSESSP------MTLFLKM 222
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|217748 pfam03822, NAF, NAF domain | Back alignment and domain information |
|---|
Score = 74.5 bits (184), Expect = 5e-17
Identities = 24/52 (46%), Positives = 35/52 (67%), Gaps = 2/52 (3%)
Query: 302 LNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVAR 353
LNAFD+ISLSSG +LSGLF++ + RF S + +I+ K+EE+A+
Sbjct: 1 LNAFDLISLSSGLDLSGLFEE--EKKSKKKETRFTSRKPASEIISKLEEIAK 50
|
Length = 58 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 6e-17
Identities = 47/160 (29%), Positives = 74/160 (46%), Gaps = 10/160 (6%)
Query: 40 TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF-VMEFA 98
TG VAIK + A +RE ++ +RL HPNIV L + + F V E+
Sbjct: 2 TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYV 61
Query: 99 KGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDL 154
G L + + G + R Q++ A+ H++G+ HRDLK +N+++
Sbjct: 62 PGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 155 KISDFGLSAVKEQIRPDGML-----HTLCGTPAYVAPEIL 189
K+ DFG+ + +R + + GTP Y APE L
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQL 161
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 65/266 (24%), Positives = 114/266 (42%), Gaps = 20/266 (7%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G + VY + TG ++A+K + + L + E+ I+ + P IV Y
Sbjct: 9 LGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVSPYIVDFYG 66
Query: 84 VLATKAKIYFVMEFAKGGEL----FAKISKGRFSEQLSRRYFQQLISAVEYCHSR-GVFH 138
+ +Y ME+ G L ++ E + RR ++ +++ + H
Sbjct: 67 AFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA- 197
RD+K N+L++ N +K+ DFG+S + T G +Y+APE + G +
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVA----SLAKTNIGCQSYMAPERIKSGGPNQNP 182
Query: 198 ----KVDMWSCGVVLFVLNAG---YLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249
+ D+WS G+ + + G Y P N+ A I G+ P S D + F+
Sbjct: 183 TYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDAQDFV 242
Query: 250 GRLLDTDPATRITVDEILRDPWFKKD 275
+ L+ P R T ++L PW K
Sbjct: 243 AKCLNKIPNRRPTYAQLLEHPWLVKY 268
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.1 bits (200), Expect = 1e-16
Identities = 66/267 (24%), Positives = 108/267 (40%), Gaps = 52/267 (19%)
Query: 54 ILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFS 113
+++ G A E ++ RL HP ++ L +V V+ + +L+ + G
Sbjct: 198 VVKAGWYASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS-DLYTYL--GARL 254
Query: 114 EQLSRRYF----QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169
L +QL+SA++Y H G+ HRD+K EN+L++ D+ + DFG +
Sbjct: 255 RPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314
Query: 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF---VLNAG------------ 214
+ + GT APE+LA Y VD+WS G+V+F V A
Sbjct: 315 STPFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRP 373
Query: 215 ------------------YLPFNDPNLMAMYRKIYKGEYRCPKWTSP----------DLK 246
+ L++ YR R P +T P D++
Sbjct: 374 YDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRR-PAYTRPAWTRYYKLDLDVE 432
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFK 273
+ + R L D A R + E+LR P F+
Sbjct: 433 YLVCRALTFDGARRPSAAELLRLPLFQ 459
|
Length = 461 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 76/269 (28%), Positives = 119/269 (44%), Gaps = 33/269 (12%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR-----EISIMSRLRH--P 76
IG G +VY R +TG +A+K ++ R G KR ++ + S H P
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVK-----QMRRTGNKEENKRILMDLDVVLKS---HDCP 74
Query: 77 NIVKLYEVLATKAKIYFVME-FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR- 134
IVK Y T + ++ ME + + K +G E + + ++ A+ Y +
Sbjct: 75 YIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR-PDGMLHT-LCGTPAYVAPEIL--- 189
GV HRD+K N+LLD + ++K+ DFG+S R D T G AY+APE +
Sbjct: 135 GVIHRDVKPSNILLDASGNVKLCDFGISG-----RLVDSKAKTRSAGCAAYMAPERIDPP 189
Query: 190 -AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYRCP---KWTSPD 244
YD + D+WS G+ L L G P+ + + KI + E + SPD
Sbjct: 190 DPNPKYD-IRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPD 248
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFK 273
F+ L D R E+L+ P+ +
Sbjct: 249 FCSFVDLCLTKDHRKRPKYRELLQHPFIR 277
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 3e-16
Identities = 72/274 (26%), Positives = 117/274 (42%), Gaps = 33/274 (12%)
Query: 27 GAFAKVYHGRNVRTGQSVAIKAV---SKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
G+ +KV H + TG +A K V +K + + + RE+ IM R P IV Y
Sbjct: 19 GSVSKVKH---IPTGTVMAKKVVHIGAKSSVRK-----QILRELQIMHECRSPYIVSFYG 70
Query: 84 VLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRD 140
+ I MEF G L +I K G ++ + ++ + Y ++ + HRD
Sbjct: 71 AFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
+K N+L++ +K+ DFG+S E I + + T GT Y++PE + Y K D
Sbjct: 130 IKPSNILVNSRGQIKLCDFGVSG--ELI--NSIADTFVGTSTYMSPERIQGGKYT-VKSD 184
Query: 201 MWSCGVVLFVLNAGYLPFNDPN------------LMAMYRKIYKGEYRCPKWT-SPDLKW 247
+WS G+ + L G PF N L + + + + R P DL+
Sbjct: 185 VWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSDFPEDLRD 244
Query: 248 FIGRLLDTDPATRITVDEILRDPWFKKDYKERKF 281
F+ L DP R T ++ P F + +
Sbjct: 245 FVDACLLKDPTERPTPQQLCAMPPFIQALRASNV 278
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 81/308 (26%), Positives = 127/308 (41%), Gaps = 65/308 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKR---EISIMS 71
+Y+ K IG GA V + G +VA+K +S+ Q H KR E+ ++
Sbjct: 22 RYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQN------QTHAKRAYRELVLLK 75
Query: 72 RLRHPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI 125
+ H NI+ L V + +Y VME L I E++S +Q ++
Sbjct: 76 CVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQ-ML 133
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+++ HS G+ HRDLK N+++ + LKI DFGL+ + M+ T Y A
Sbjct: 134 CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT---NFMMTPYVVTRYYRA 190
Query: 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--------------- 230
PE++ GY VD+WS G ++ L G + F + + + K+
Sbjct: 191 PEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL 249
Query: 231 -------------YKG---EYRCPKWTSPD-----------LKWFIGRLLDTDPATRITV 263
Y G E P W P + + ++L DP RI+V
Sbjct: 250 QPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISV 309
Query: 264 DEILRDPW 271
DE LR P+
Sbjct: 310 DEALRHPY 317
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 65/203 (32%), Positives = 101/203 (49%), Gaps = 22/203 (10%)
Query: 22 KIIGCGAFAKV----YHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+++G G F KV Y N TG+ VA+K + ++ T+ K+EI+I+ L H N
Sbjct: 10 RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHEN 67
Query: 78 IVKLYEVLATKAK--IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
IVK + + + +ME+ G L + K + + + QQ+ + Y HS+
Sbjct: 68 IVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQH 127
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLS-AVKE-----QIRPDGMLHTLCGTPAY-VAPEI 188
HRDL N+LLD + +KI DFGL+ AV E ++R DG +P + A E
Sbjct: 128 YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDG------DSPVFWYAVEC 181
Query: 189 LAKKGYDGAKVDMWSCGVVLFVL 211
L + + A D+WS GV L+ L
Sbjct: 182 LKENKFSYAS-DVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 70/245 (28%), Positives = 113/245 (46%), Gaps = 19/245 (7%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+ IG G F V G G VA+K + + L E S+M++LRH N+V+L
Sbjct: 12 QTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLA-----EASVMTQLRHSNLVQL 64
Query: 82 YEVLAT-KAKIYFVMEFAKGGELFAKI-SKGR--FSEQLSRRYFQQLISAVEYCHSRGVF 137
V+ K +Y V E+ G L + S+GR ++ + A+EY +
Sbjct: 65 LGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFV 124
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
HRDL N+L+ E+ K+SDFGL+ + G L + APE L +K +
Sbjct: 125 HRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-----KWTAPEALREKKFS-T 178
Query: 198 KVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDT 255
K D+WS G++L+ + + G +P+ L + ++ KG + P P + + +
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDVMKQCWHL 238
Query: 256 DPATR 260
D ATR
Sbjct: 239 DAATR 243
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 2e-15
Identities = 66/247 (26%), Positives = 111/247 (44%), Gaps = 11/247 (4%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V + TG+ A K + K++I + A E I+ ++ +V L
Sbjct: 6 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSL 65
Query: 82 YEVLATKAKIYFVMEFAKGGEL-FAKISKGR--FSEQLSRRYFQQLISAVEYCHSRGVFH 138
TK + V+ GG+L F + G F EQ + Y +L +E + +
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLK EN+LLD+ ++ISD GL+ QI + GT Y+APE++ + Y +
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAV---QIPEGETVRGRVGTVGYMAPEVINNEKYTFSP 182
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMAMY----RKIYKGEYRCPKWTSPDLKWFIGRLLD 254
D W G +++ + G PF R++ + + + S D K LL
Sbjct: 183 -DWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLT 241
Query: 255 TDPATRI 261
+P R+
Sbjct: 242 KNPKERL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-15
Identities = 44/160 (27%), Positives = 68/160 (42%), Gaps = 24/160 (15%)
Query: 24 IGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRLRHPN 77
+G GAF KV+ G ++ + AV K L+ + + RE +++ +H N
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAV---KTLKETASNDARKDFEREAELLTNFQHEN 69
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELF---------AKISKGRFSE--QLSRRYF----Q 122
IVK Y V V E+ + G+L A K S +L+
Sbjct: 70 IVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAV 129
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162
Q+ S + Y S+ HRDL N L+ + +KI DFG+S
Sbjct: 130 QIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMS 169
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 3e-15
Identities = 69/248 (27%), Positives = 103/248 (41%), Gaps = 37/248 (14%)
Query: 24 IGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
+G GAF KVY G + SVAIK + + + ++E +MS L+HPNI
Sbjct: 13 LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNI 70
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELF-------------AKISKGRFSEQLSRRYF---- 121
V L V + + E+ G+L A+ L F
Sbjct: 71 VCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIA 130
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD--GMLHTLCG 179
Q+ + +EY S HRDL N L+ E +KISDFGLS ++ D +
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLS--RDIYSADYYRVQSKSLL 188
Query: 180 TPAYVAPE-ILAKKGYDGAKVDMWSCGVVLF-VLNAGYLP---FNDPNLMAMYRK--IYK 232
++ PE IL G + D+WS GVVL+ + + G P F++ ++ M R +
Sbjct: 189 PVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP 246
Query: 233 GEYRCPKW 240
CP
Sbjct: 247 CPEDCPAR 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 3e-15
Identities = 63/258 (24%), Positives = 110/258 (42%), Gaps = 19/258 (7%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82
I+G G VY ++ T + +A+K + + L + E+ I+ + P I+ Y
Sbjct: 8 ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE--LQKQIMSELEILYKCDSPYIIGFY 65
Query: 83 EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142
+ +I EF GG L + E + R ++ + Y S + HRD+K
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVK 122
Query: 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMW 202
N+L++ +K+ DFG+S Q+ + + T GT AY+APE ++ + Y G D+W
Sbjct: 123 PSNMLVNTRGQVKLCDFGVST---QL-VNSIAKTYVGTNAYMAPERISGEQY-GIHSDVW 177
Query: 203 SCGVVLFVLNAGYLPF-----NDPNLMAMYRKIYKGEYRCPKWT----SPDLKWFIGRLL 253
S G+ L G P+ N +LM + + P S FI + +
Sbjct: 178 SLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCM 237
Query: 254 DTDPATRITVDEILRDPW 271
P R + ++ P+
Sbjct: 238 RKQPKERPAPENLMDHPF 255
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 4e-15
Identities = 67/232 (28%), Positives = 103/232 (44%), Gaps = 36/232 (15%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIK-----AVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
+G G F +V+ G T + VA+K +S + L+ E IM +LRH +
Sbjct: 14 LGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQ---------EAQIMKKLRHDKL 63
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI-------SAVEYC 131
V+LY V + + IY V E+ G L + G + QL+ + Y
Sbjct: 64 VQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR----LPQLVDMAAQIAEGMAYL 119
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEI 188
SR HRDL N+L+ EN KI+DFGL+ + E D G + APE
Sbjct: 120 ESRNYIHRDLAARNILVGENLVCKIADFGLARLIE----DDEYTAREGAKFPIKWTAPEA 175
Query: 189 LAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
A G K D+WS G++L ++ G +P+ + ++ +G YR P+
Sbjct: 176 -ANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 1e-14
Identities = 61/219 (27%), Positives = 101/219 (46%), Gaps = 18/219 (8%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA-HVKREISIMSRLRHPNIVK 80
K +G G F V +G+ R VAIK + + G ++ E +M +L H +V+
Sbjct: 10 KELGTGQFGVVKYGK-WRGQYDVAIKMIKE-----GSMSEDEFIEEAKVMMKLSHEKLVQ 63
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR--RYFQQLISAVEYCHSRGVFH 138
LY V + IY V E+ G L + + Q S+ + + + Y S+ H
Sbjct: 64 LYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIH 123
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---APEILAKKGYD 195
RDL N L+D+ +K+SDFGLS + D + G+ V PE+L +
Sbjct: 124 RDLAARNCLVDDQGCVKVSDFGLS----RYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFS 179
Query: 196 GAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG 233
+K D+W+ GV+++ V + G +P+ N K+ +G
Sbjct: 180 -SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQG 217
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-14
Identities = 63/259 (24%), Positives = 119/259 (45%), Gaps = 38/259 (14%)
Query: 27 GAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE-ISIMSRLRHPNIVKLYEVL 85
G KV + RT Q+ +K + K ++ RE ++I+ PN+V L++ +
Sbjct: 4 GVIDKVLLVMDTRTQQTFILKGLRK--------SSEYSRERLTIIPHCV-PNMVCLHKYI 54
Query: 86 ATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLE 144
++ ++ V++ A+GG+L++ ISK E+ +R+ +++ A++ H G+ RDL
Sbjct: 55 VSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPN 114
Query: 145 NLLLDENWDLKISDFG-LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWS 203
N+LLD+ ++++ F S V++ + + + C APE+ A D WS
Sbjct: 115 NILLDDRGHIQLTYFSRWSEVEDSCDGEAVENMYC------APEVGGISEETEA-CDWWS 167
Query: 204 CGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-----EYRCPKWTSPDLKWFIGRLLDTDPA 258
G +LF L G + G P+W S + + + +LL +P
Sbjct: 168 LGAILFELLTG---------KTLVECHPSGINTHTTLNIPEWVSEEARSLLQQLLQFNPT 218
Query: 259 TRI-----TVDEILRDPWF 272
R+ V++I P+F
Sbjct: 219 ERLGAGVAGVEDIKSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (182), Expect = 1e-14
Identities = 82/323 (25%), Positives = 130/323 (40%), Gaps = 69/323 (21%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT 60
+GD+T + +Y+ K IG GA V + ++VAIK +S+
Sbjct: 8 VGDST------FTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHA 60
Query: 61 AHVKREISIMSRLRHPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSE 114
RE+ +M + H NI+ L V + +Y VME ++ +
Sbjct: 61 KRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQMELDH 118
Query: 115 QLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-- 172
+ Q++ +++ HS G+ HRDLK N+++ + LKI DFGL+ R G
Sbjct: 119 ERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTS 172
Query: 173 -MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVL--FVLNAGYLPFND--------- 220
M+ T Y APE++ GY VD+WS G ++ V + P D
Sbjct: 173 FMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 221 -------PNLMAMYRKIYKG--EYRCPKW---TSPDL--------------------KWF 248
P M + + E R PK+ T P L +
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290
Query: 249 IGRLLDTDPATRITVDEILRDPW 271
+ ++L DPA RI+VDE L+ P+
Sbjct: 291 LSKMLVIDPAKRISVDEALQHPY 313
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.8 bits (181), Expect = 2e-14
Identities = 47/194 (24%), Positives = 91/194 (46%), Gaps = 16/194 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
Y V K + G+ +V+ V +K K L + ++ + HP+
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGTTLIEAM---------LLQNVNHPS 118
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
++++ + L + A V+ +L+ ++K + +Q++ + Y H++
Sbjct: 119 VIRMKDTLVSGAITCMVLPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR 177
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
+ HRD+K EN+ +++ + I D G +A + P + L GT APE+LA+ Y+
Sbjct: 178 IIHRDVKTENIFINDVDQVCIGDLG-AAQFPVVAPAFL--GLAGTVETNAPEVLARDKYN 234
Query: 196 GAKVDMWSCGVVLF 209
+K D+WS G+VLF
Sbjct: 235 -SKADIWSAGIVLF 247
|
Length = 357 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 2e-14
Identities = 63/181 (34%), Positives = 91/181 (50%), Gaps = 17/181 (9%)
Query: 40 TGQSVAIKAV--SKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL--ATKAKIYFVM 95
TG+ VA+K + S + LR +REI I+ L+H NIVK V A + + VM
Sbjct: 32 TGEVVAVKKLQHSTAEHLR-----DFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVM 86
Query: 96 EFAKGGELFAKISKGRFSEQLSRR----YFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151
E+ G L + K R E+L R Y Q+ +EY S+ HRDL N+L++
Sbjct: 87 EYLPYGSLRDYLQKHR--ERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESE 144
Query: 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY-VAPEILAKKGYDGAKVDMWSCGVVLFV 210
+KI DFGL+ V Q + + +P + APE L + + A D+WS GVVL+
Sbjct: 145 NRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVAS-DVWSFGVVLYE 203
Query: 211 L 211
L
Sbjct: 204 L 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 2e-14
Identities = 78/320 (24%), Positives = 137/320 (42%), Gaps = 69/320 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+YE G +G G + VY + + G+ K + ++I G++ REI+++ L+HP
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKR-KDGKDE--KEYALKQIEGTGISMSACREIALLRELKHP 58
Query: 77 NIVKLYEVLATKA--KIYFVMEFAKGGELFAKISKGRFSE------QLSRRYFQ----QL 124
N++ L +V + + K++ + ++A+ +L+ I R S+ QL R + Q+
Sbjct: 59 NVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQI 117
Query: 125 ISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLSAV-KEQIRPDGMLHTLCG 179
+ + Y H+ V HRDLK N+L+ E +KI+D G + + ++P L +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYL-------------PFND------ 220
T Y APE+L + +D+W+ G + L PF+
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRI 237
Query: 221 ---------------------PNLMAMYRKIYKGEYRCPKW-----TSPDLKWF--IGRL 252
P L +R+ K+ PD K F + +L
Sbjct: 238 FSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKL 297
Query: 253 LDTDPATRITVDEILRDPWF 272
L DP RIT ++ L+DP+F
Sbjct: 298 LTMDPTKRITSEQALQDPYF 317
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 73.2 bits (179), Expect = 3e-14
Identities = 76/291 (26%), Positives = 131/291 (45%), Gaps = 32/291 (10%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G V ++ +G +A K + + ++ + + RE+ ++ P IV Y
Sbjct: 13 LGAGNGGVVTKVQHKPSGLIMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYG 70
Query: 84 VLATKAKIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSR-GVFHRDL 141
+ +I ME GG L + + R E++ + ++ + Y + + HRD+
Sbjct: 71 AFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDV 130
Query: 142 KLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDM 201
K N+L++ ++K+ DFG+S Q+ D M ++ GT +Y++PE L Y + D+
Sbjct: 131 KPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVGTRSYMSPERLQGTHYS-VQSDI 185
Query: 202 WSCGVVLFVLNAGYLPFNDPN---LMAMY-RKIYKGEYRCPKWTSPDL----KWFIGRLL 253
WS G+ L L G P P+ L A++ R + GE P SP + G +
Sbjct: 186 WSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGM 245
Query: 254 DTDPATRI--TVDEILRDP-------WFKKDYKER------KFPHEDFDLK 289
D+ PA I +D I+ +P F D++E K P E DLK
Sbjct: 246 DSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLK 296
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 3e-14
Identities = 48/163 (29%), Positives = 80/163 (49%), Gaps = 7/163 (4%)
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRY 120
+ RE+ ++ P IV Y + +I ME GG L + K GR EQ+ +
Sbjct: 49 QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKV 108
Query: 121 FQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
+I + Y + + HRD+K N+L++ ++K+ DFG+S Q+ D M ++ G
Sbjct: 109 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG---QL-IDSMANSFVG 164
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN 222
T +Y++PE L Y + D+WS G+ L + G P P+
Sbjct: 165 TRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPD 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 71.6 bits (176), Expect = 6e-14
Identities = 50/234 (21%), Positives = 93/234 (39%), Gaps = 42/234 (17%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+GK V+ ++ T VA+K ++ + L +++EI +L+HPN
Sbjct: 4 TLIGKCFEDLMI--VHLAKHKPTNTLVAVKKINLDSCSKEDLKL-LQQEIITSRQLQHPN 60
Query: 78 IVKLYEVLATKAKIYFVMEFAKGG---ELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
I+ +++Y V G +L E + +++A++Y HS+
Sbjct: 61 ILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSK 120
Query: 135 GVFHRDLKLENLLLDEN-------------------WDLKISDFGLSAVKEQIRPDGMLH 175
G HR +K ++LL + + DF S+VK
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL-------- 172
Query: 176 TLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY 227
+++PE+L + +GY+ K D++S G+ L G++PF D M
Sbjct: 173 ------PWLSPEVLQQNLQGYN-EKSDIYSVGITACELANGHVPFKDMPATQML 219
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 7e-14
Identities = 62/217 (28%), Positives = 94/217 (43%), Gaps = 23/217 (10%)
Query: 24 IGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVK 80
+G G F V G + VA+K + ++ I G RE S+M++L HP IV+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAG--KKEFLREASVMAQLDHPCIVR 60
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L V + + VME A G L + K R + Q+ + Y S+ HR
Sbjct: 61 LIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHR 119
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA------YVAPEILAKKG 193
DL N+LL KISDFG+S + + T A + APE +
Sbjct: 120 DLAARNVLLVNRHQAKISDFGMS---RALGAGSDYYR--ATTAGRWPLKWYAPECINYGK 174
Query: 194 YDGAKVDMWSCGVVLF-VLNAGYLPFND---PNLMAM 226
+ +K D+WS GV L+ + G P+ + ++AM
Sbjct: 175 FS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAM 210
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.9 bits (174), Expect = 9e-14
Identities = 73/269 (27%), Positives = 125/269 (46%), Gaps = 29/269 (10%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR---EISIMSRLRH-PNIV 79
+G GA+ V R+V TG +A+K +I + KR ++ I R P V
Sbjct: 9 LGRGAYGVVDKMRHVPTGTIMAVK-----RIRATVNSQEQKRLLMDLDISMRSVDCPYTV 63
Query: 80 KLYEVLATKAKIYFVMEFAKGG--ELFAKI-SKGRFSEQ--LSRRYFQQLISAVEYCHSR 134
Y L + ++ ME + + K+ KG + L + ++ A+EY HS+
Sbjct: 64 TFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVS-IVKALEYLHSK 122
Query: 135 -GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL-CGTPAYVAPE----I 188
V HRD+K N+L++ N +K+ DFG+S + D + T+ G Y+APE
Sbjct: 123 LSVIHRDVKPSNVLINRNGQVKLCDFGISG---YL-VDSVAKTIDAGCKPYMAPERINPE 178
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKGEY-RCPKWT-SPDL 245
L +KGYD K D+WS G+ + L G P+ + +++ + + P SP+
Sbjct: 179 LNQKGYD-VKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKFSPEF 237
Query: 246 KWFIGRLLDTDPATRITVDEILRDPWFKK 274
+ F+ + L + R E+L+ P+F+
Sbjct: 238 QDFVNKCLKKNYKERPNYPELLQHPFFEL 266
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 1e-13
Identities = 65/244 (26%), Positives = 108/244 (44%), Gaps = 35/244 (14%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGG 58
+GD+T + +Y+ K IG GA V + ++VAIK +S+ Q
Sbjct: 15 IGDST------FTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQN----- 63
Query: 59 LTAHVKR---EISIMSRLRHPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISK 109
H KR E+ +M + H NI+ L V + +Y VME ++ +
Sbjct: 64 -QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQ 120
Query: 110 GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169
+ Q++ +++ HS G+ HRDLK N+++ + LKI DFGL+ R
Sbjct: 121 MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------R 174
Query: 170 PDG---MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM 226
G M+ T Y APE++ GY VD+WS G ++ + G + F + +
Sbjct: 175 TAGTSFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQ 233
Query: 227 YRKI 230
+ K+
Sbjct: 234 WNKV 237
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 2e-13
Identities = 77/321 (23%), Positives = 140/321 (43%), Gaps = 71/321 (22%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+YE G +G G + VY + + G+ + + ++I G++ REI+++ L+HP
Sbjct: 3 EYE-GCKVGRGTYGHVYKAKR-KDGKD--DRDYALKQIEGTGISMSACREIALLRELKHP 58
Query: 77 NIVKLYEVLATKA--KIYFVMEFAKGGELFAKISKGRFSE------QLSR----RYFQQL 124
N++ L +V + A K++ + ++A+ +L+ I R S+ QL R Q+
Sbjct: 59 NVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQI 117
Query: 125 ISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLSAV-KEQIRPDGMLHTLCG 179
+ + Y H+ V HRDLK N+L+ E +KI+D G + + ++P L +
Sbjct: 118 LDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 177
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLF-----------------------------V 210
T Y APE+L + +D+W+ G + +
Sbjct: 178 TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRI 237
Query: 211 LNAGYLP----FNDPNLMAMYRKIYKGEYRCPKWTS-------------PDLKWF--IGR 251
N P + D M + + K ++R +T+ PD K F + +
Sbjct: 238 FNVMGFPADKDWEDIKKMPEHSTLMK-DFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQK 296
Query: 252 LLDTDPATRITVDEILRDPWF 272
LL DP RIT ++ ++DP+F
Sbjct: 297 LLTMDPIKRITSEQAMQDPYF 317
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 66/272 (24%), Positives = 108/272 (39%), Gaps = 34/272 (12%)
Query: 20 VGKIIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+GKI+G G F V G+ + + VA+K + + + E + M HP
Sbjct: 3 LGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFL-SEAACMKDFDHP 61
Query: 77 NIVKLYEV------LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI----- 125
N++KL V L K ++ F K G+L + + R + Q L+
Sbjct: 62 NVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121
Query: 126 --SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS------AVKEQIRPDGMLHTL 177
+EY +R HRDL N +L E+ + ++DFGLS Q R M
Sbjct: 122 IALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKM---- 177
Query: 178 CGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY 235
P ++A E LA + Y +K D+W+ GV ++ + G P+ +Y + G
Sbjct: 178 ---PVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNR 233
Query: 236 RCPKWTSPDLKWFI-GRLLDTDPATRITVDEI 266
D + + DP R T ++
Sbjct: 234 LKQPEDCLDELYDLMYSCWRADPKDRPTFTKL 265
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 68.8 bits (168), Expect = 4e-13
Identities = 64/237 (27%), Positives = 105/237 (44%), Gaps = 25/237 (10%)
Query: 18 YEVGKIIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
+ +G+++G G F V + + Q VA+K + K I RE + M
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 75 HPNIVKLYEV-LATKAK-----IYFVMEFAKGGELFAKISKGRFSE-------QLSRRYF 121
HPN++KL V L ++AK ++ F K G+L + R E Q R+
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
+ S +EY S+ HRDL N +L+EN + ++DFGLS ++I C +
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS---KKIYSGDYYRQGCASK 176
Query: 182 ---AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE 234
++A E LA Y D+W+ GV ++ ++ G P+ +Y + KG
Sbjct: 177 LPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN 232
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 4e-13
Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 30/267 (11%)
Query: 22 KIIGCGAFAKVYHGR-NVRTGQSVAIKAVSKQKILRGGLTAHV-KREISIMSRLRHPNIV 79
K +G G F +V+ G N T VA+K + G ++ E IM +LRH +V
Sbjct: 12 KKLGNGQFGEVWMGTWNGNT--KVAVKTLKP-----GTMSPESFLEEAQIMKKLRHDKLV 64
Query: 80 KLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSE--QLSRRYFQQLISAVEYCHSRG 135
+LY V+ ++ IY V E+ G L F K +GR + L Q+ + + Y
Sbjct: 65 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMA-AQVAAGMAYIERMN 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKK 192
HRDL+ N+L+ + KI+DFGL+ + E D G + APE A
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALY 177
Query: 193 GYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWFI 249
G K D+WS G++L ++ G +P+ N + ++ +G YR CP+ L +
Sbjct: 178 GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERG-YRMPCPQDCPISLHELM 236
Query: 250 GRLLDTDPATRITVDEILRDPWFKKDY 276
+ DP R T E L+ F +DY
Sbjct: 237 LQCWKKDPEERPTF-EYLQS--FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 67/268 (25%), Positives = 116/268 (43%), Gaps = 33/268 (12%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
++IG G F VYHG + + A+K++++ I +E IM HPN+
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNV 58
Query: 79 VKLYEV-LATKAKIYFVMEFAKGGELFAKISKGR----------FSEQLSRRYFQQLISA 127
+ L + L ++ V+ + K G+L I F Q+++
Sbjct: 59 LSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAK--------G 110
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA---VKEQIRPDGMLHTLCGTPA-Y 183
+EY S+ HRDL N +LDE++ +K++DFGL+ KE HT P +
Sbjct: 111 MEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN--HTGAKLPVKW 168
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWT 241
+A E L + + K D+WS GV+L+ ++ G P+ D + + + +G P++
Sbjct: 169 MALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYC 227
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRD 269
L + P R T E++
Sbjct: 228 PDPLYEVMLSCWHPKPEMRPTFSELVSR 255
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.8 bits (165), Expect = 9e-13
Identities = 62/204 (30%), Positives = 94/204 (46%), Gaps = 22/204 (10%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV-KREISIMSRLRHPNIVKLY 82
+G G F +V+ G T + VAIK + G ++ +E +M +LRH +V+LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTR-VAIKTLKP-----GTMSPEAFLQEAQVMKKLRHEKLVQLY 67
Query: 83 EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSR----RYFQQLISAVEYCHSRGVFH 138
V+ ++ IY V E+ G L KG + L Q+ S + Y H
Sbjct: 68 AVV-SEEPIYIVTEYMSKGSLL-DFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVH 125
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKKGYD 195
RDL+ N+L+ EN K++DFGL+ + E D G + APE A G
Sbjct: 126 RDLRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRF 180
Query: 196 GAKVDMWSCGVVLFVLNA-GYLPF 218
K D+WS G++L L G +P+
Sbjct: 181 TIKSDVWSFGILLTELTTKGRVPY 204
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 9e-13
Identities = 49/180 (27%), Positives = 86/180 (47%), Gaps = 17/180 (9%)
Query: 39 RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98
+T + V IKA + G T E I+ + HP+I++L ++
Sbjct: 115 KTCEHVVIKAGQRG----GTAT-----EAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165
Query: 99 KGGELFAKISKGR---FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155
K +L+ ++ R + L+ + ++ A++Y H + HRD+K EN+ ++ D+
Sbjct: 166 KT-DLYCYLAAKRNIAICDILAIE--RSVLRAIQYLHENRIIHRDIKAENIFINHPGDVC 222
Query: 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215
+ DFG + I + + GT A APE+LA+ Y G VD+WS G+VLF + +
Sbjct: 223 LGDFGAACFPVDINAN-KYYGWAGTIATNAPELLARDPY-GPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 68/268 (25%), Positives = 113/268 (42%), Gaps = 41/268 (15%)
Query: 24 IGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV 79
+G AF K+Y G + Q VAIK + + I ++E S+M+ L HPNIV
Sbjct: 13 LGECAFGKIYKGHLYLPGMDHAQLVAIKTL--KDINNPQQWGEFQQEASLMAELHHPNIV 70
Query: 80 KLYEVLATKAKIYFVMEFAKGGELF--------------AKISKGRFSEQLSRRYFQ--- 122
L V+ + + + E+ G+L + G L F
Sbjct: 71 CLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130
Query: 123 -QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL-----SAVKEQIRPDGMLHT 176
Q+ + +EY S H+DL N+L+ E +KISD GL SA +++P +L
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLP---FNDPNLMAMYRKIYK 232
++ PE + + + D+WS GVVL+ + + G P F++ ++ M RK +
Sbjct: 191 -----RWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRK--R 242
Query: 233 GEYRCPKWTSPDLKWFIGRLLDTDPATR 260
C + P + + P+ R
Sbjct: 243 QLLPCSEDCPPRMYSLMTECWQEGPSRR 270
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 30/242 (12%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQS----VAIK-------AVSKQKILRG 57
R + + E K++G GAF VY G + G+ VAIK + ++IL
Sbjct: 1 LRILKE-TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILD- 58
Query: 58 GLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQ 115
E +M+ + HP++V+L + + ++ + + G L + + K Q
Sbjct: 59 --------EAYVMASVDHPHVVRLLGICLSS-QVQLITQLMPLGCLLDYVRNHKDNIGSQ 109
Query: 116 LSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175
+ Q+ + Y + + HRDL N+L+ +KI+DFGL+ + + + H
Sbjct: 110 YLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD--VDEKEYH 167
Query: 176 TLCG-TP-AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYK 232
G P ++A E + + Y K D+WS GV ++ ++ G P+ + + + K
Sbjct: 168 AEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226
Query: 233 GE 234
GE
Sbjct: 227 GE 228
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 1e-12
Identities = 58/207 (28%), Positives = 100/207 (48%), Gaps = 24/207 (11%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K +G G F +V+ G VAIK++ + + A E ++M +L+HP +V+L
Sbjct: 12 KKLGAGQFGEVWMGY-YNGHTKVAIKSLKQGSMSPEAFLA----EANLMKQLQHPRLVRL 66
Query: 82 YEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYF----QQLISAVEYCHSRG 135
Y V+ T+ IY + E+ + G L F K +G +L+ Q+ + + +
Sbjct: 67 YAVV-TQEPIYIITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKN 122
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAV---KEQIRPDGMLHTLCGTPAYVAPEILAKK 192
HRDL+ N+L+ E KI+DFGL+ + E +G + + APE +
Sbjct: 123 YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPI----KWTAPEAI-NY 177
Query: 193 GYDGAKVDMWSCGVVLF-VLNAGYLPF 218
G K D+WS G++L ++ G +P+
Sbjct: 178 GTFTIKSDVWSFGILLTEIVTYGRIPY 204
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 79/280 (28%), Positives = 119/280 (42%), Gaps = 39/280 (13%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVS------KQKILRGGLTAHVKREISIMSRLRHPN 77
IG GAF V + +G +A+K + +QK L L +M P
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDV-------VMRSSDCPY 64
Query: 78 IVKLYEVLATKAKIYFVMEFAKGG-ELFAKI----SKGRFSEQLSRRYFQQLISAVEYCH 132
IVK Y L + + ME + F K K E++ + + A+ Y
Sbjct: 65 IVKFYGALFREGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLK 124
Query: 133 SR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL-CGTPAYVAPEILA 190
+ HRD+K N+LLD N ++K+ DFG+S D + T G Y+APE +
Sbjct: 125 EELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLV----DSIAKTRDAGCRPYMAPERID 180
Query: 191 ---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGEYRCPKWT----- 241
+ GYD + D+WS G+ L+ + G P+ N + ++ KG+ P +
Sbjct: 181 PSARDGYD-VRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGD--PPILSNSEER 237
Query: 242 --SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279
SP FI L D + R E+L P F KDY+ER
Sbjct: 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHP-FIKDYEER 276
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 66.6 bits (162), Expect = 2e-12
Identities = 61/226 (26%), Positives = 104/226 (46%), Gaps = 20/226 (8%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV-KREISIMSRLRHPNIVK 80
K +G G F +V+ G VA+K + G ++ E ++M L+H +V+
Sbjct: 12 KKLGAGQFGEVWMGY-YNNSTKVAVKTLKP-----GTMSVQAFLEEANLMKTLQHDKLVR 65
Query: 81 LYEVLATKAKIYFVMEFAKGGEL--FAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVF 137
LY V+ + IY + E+ G L F K +G + + Q+ + Y +
Sbjct: 66 LYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYI 125
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKKGY 194
HRDL+ N+L+ E+ KI+DFGL+ V E D G + APE + G
Sbjct: 126 HRDLRAANVLVSESLMCKIADFGLARVIE----DNEYTAREGAKFPIKWTAPEAI-NFGS 180
Query: 195 DGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
K D+WS G++L+ ++ G +P+ + + + +G YR P+
Sbjct: 181 FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRG-YRMPR 225
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 2e-12
Identities = 63/274 (22%), Positives = 110/274 (40%), Gaps = 54/274 (19%)
Query: 46 IKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFA 105
IK + +I+R E+ ++ P IV Y + +I ME GG L
Sbjct: 38 IKPAIRNQIIR---------ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQ 88
Query: 106 KISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSA 163
+ K GR E + + ++ + Y + HRD+K N+L++ ++K+ DFG+S
Sbjct: 89 VLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG 148
Query: 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL 223
+ I D M ++ GT +Y++PE L Y + D+WS G+ L + G P P+
Sbjct: 149 --QLI--DSMANSFVGTRSYMSPERLQGTHY-TVQSDIWSLGLSLVEMAIGRYPIPPPDA 203
Query: 224 ---------------------------------MAMYRKI-YKGEYRCPKWT----SPDL 245
MA++ + Y PK S +
Sbjct: 204 KELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF 263
Query: 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279
+ F+ + L +P R + E+ + P+ K+ E
Sbjct: 264 QDFVDKCLKKNPKERADLKELTKHPFIKRAELEE 297
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 2e-12
Identities = 49/168 (29%), Positives = 74/168 (44%), Gaps = 32/168 (19%)
Query: 24 IGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRLRHPN 77
IG GAF +V+ R + + + AV K+L+ +A ++ RE ++M+ HPN
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAALMAEFDHPN 69
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYF-------------- 121
IVKL V A + + E+ G+L F + R LS
Sbjct: 70 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129
Query: 122 -------QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162
+Q+ + + Y R HRDL N L+ EN +KI+DFGLS
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 177
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 2e-12
Identities = 75/282 (26%), Positives = 112/282 (39%), Gaps = 56/282 (19%)
Query: 22 KIIGCGAFAKVYHGR-----NVRTG-QSVAIKAVSKQKILRGGLTAHVK----REISIMS 71
+G GAF +VY G +G VA+K LR G T K +E +MS
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKT------LRKGATDQEKKEFLKEAHLMS 54
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVE-- 129
HPNIVKL V Y +ME +GG+L + + R R+ L++ E
Sbjct: 55 NFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDAR-----VERFGPPLLTLKELL 109
Query: 130 -----------YCHSRGVFHRDLKLENLLLDENWD-----LKISDFGL-----SAVKEQI 168
Y HRDL N L+ E +KI DFGL + +
Sbjct: 110 DICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRK 169
Query: 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPF---NDPNLM 224
+G+L ++APE L G + D+WS GV+++ +L G P+ N+ ++
Sbjct: 170 EGEGLLPV-----RWMAPESLL-DGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVL 223
Query: 225 AMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEI 266
G + P+ + + DP+ R T D I
Sbjct: 224 QHVTA--GGRLQKPENCPDKIYQLMTNCWAQDPSERPTFDRI 263
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 77/263 (29%), Positives = 118/263 (44%), Gaps = 26/263 (9%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83
+G G F +V+ G T + VAIK + ++ +E IM +LRH +V LY
Sbjct: 14 LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFL----QEAQIMKKLRHDKLVPLYA 68
Query: 84 VLATKAKIYFVMEFAKGGEL--FAKISKGRFSE--QLSRRYFQQLISAVEYCHSRGVFHR 139
V+ ++ IY V EF G L F K G++ + QL Q+ + Y HR
Sbjct: 69 VV-SEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMA-AQIADGMAYIERMNYIHR 126
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKKGYDG 196
DL+ N+L+ +N KI+DFGL+ + E D G + APE A G
Sbjct: 127 DLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIKWTAPEA-ALYGRFT 181
Query: 197 AKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWFIGRLL 253
K D+WS G++L ++ G +P+ + ++ +G YR CP+ L +
Sbjct: 182 IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERG-YRMPCPQGCPESLHELMKLCW 240
Query: 254 DTDPATRITVDEILRDPWFKKDY 276
DP R T + I F +DY
Sbjct: 241 KKDPDERPTFEYIQS---FLEDY 260
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 36/127 (28%), Positives = 62/127 (48%), Gaps = 17/127 (13%)
Query: 53 KILRGGLTAHVK----REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKIS 108
K+LR +T + +EI IMSRL++PNI++L V + + + E+ + G+L +S
Sbjct: 50 KMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS 109
Query: 109 KGRFSEQLSR-------------RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155
+ + Q+ S ++Y S HRDL N L+ ++ +K
Sbjct: 110 QREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIK 169
Query: 156 ISDFGLS 162
I+DFG+S
Sbjct: 170 IADFGMS 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 5e-12
Identities = 35/110 (31%), Positives = 55/110 (50%), Gaps = 12/110 (10%)
Query: 65 REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLS------- 117
+EI IMSRL+ PNI++L V T + + E+ + G+L +S+ E
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 118 -----RRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162
Q+ S ++Y S HRDL N L+ +N+ +KI+DFG+S
Sbjct: 128 SYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 64/226 (28%), Positives = 104/226 (46%), Gaps = 28/226 (12%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
N+ K E+G+ GAF KV+ N+ Q + AV K RE ++
Sbjct: 6 NIVLKRELGE----GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELL 61
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAK--------ISKGRFSEQLSRRY 120
+ L+H +IVK Y V + V E+ K G+L F + +++G +L++
Sbjct: 62 TNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQ 121
Query: 121 F----QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA---VKEQIRPDGM 173
QQ+ + + Y S+ HRDL N L+ EN +KI DFG+S + R G
Sbjct: 122 MLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGG- 180
Query: 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPF 218
HT+ ++ PE + + + + D+WS GVVL+ + G P+
Sbjct: 181 -HTMLPI-RWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPW 223
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 72/266 (27%), Positives = 114/266 (42%), Gaps = 27/266 (10%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---- 74
GK +G GAF KV +S A+ V+ K+L+ TAH ++MS L+
Sbjct: 38 SFGKTLGAGAFGKVVEATAYGLSKSDAVMKVA-VKMLKP--TAHSSEREALMSELKIMSH 94
Query: 75 ---HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLIS 126
H NIV L I + E+ G+L + + R + LS Y Q+
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY--QVAK 152
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT--PA-Y 183
+ + S+ HRDL N+LL +KI DFGL+ I D P +
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLA---RDIMNDSNYVVKGNARLPVKW 209
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKW 240
+APE + Y + D+WS G++L+ + + G P+ + + + K+ K YR P+
Sbjct: 210 MAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEI 266
++ + D DP R T +I
Sbjct: 269 APAEIYDIMKTCWDADPLKRPTFKQI 294
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 2e-11
Identities = 52/225 (23%), Positives = 95/225 (42%), Gaps = 33/225 (14%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
+GK +G G F KV R V+ + + ++ ++ E +++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFA------KISKGRFSEQLSRR-------- 119
HP+++KLY + + ++E+AK G L + K+ +R
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 120 -----------YFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168
+ Q+ ++Y + HRDL N+L+ E +KISDFGLS ++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLS--RDVY 178
Query: 169 RPDGMLHTLCG-TPA-YVAPEILAKKGYDGAKVDMWSCGVVLFVL 211
D + G P ++A E L Y + D+WS GV+L+ +
Sbjct: 179 EEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEI 222
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 2e-11
Identities = 59/226 (26%), Positives = 101/226 (44%), Gaps = 46/226 (20%)
Query: 17 KYEVGKIIGCGAFAKV----YHGRNVRTG-QSVAIKAVSKQKILRGGLTAH----VKREI 67
+ +GK +G GAF +V G + +VA+K +L+ T + E+
Sbjct: 13 RLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVK------MLKDDATEKDLSDLVSEM 66
Query: 68 SIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGG-------------ELFAKISKGRFS 113
+M + +H NI+ L V + +Y V+E+A G E +
Sbjct: 67 EMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPE 126
Query: 114 EQLSRR----YFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI- 168
E L+++ + Q+ +E+ S+ HRDL N+L+ E+ +KI+DFGL+ I
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186
Query: 169 ----RPDGMLHTLCGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF 209
+G L P ++APE L + Y + D+WS GV+L+
Sbjct: 187 YYRKTTNGRL------PVKWMAPEALFDRVYT-HQSDVWSFGVLLW 225
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 4e-11
Identities = 54/185 (29%), Positives = 91/185 (49%), Gaps = 16/185 (8%)
Query: 66 EISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSR--RYF 121
E ++M L+H +VKL+ V+ TK IY + EF G L F K +G + L + +
Sbjct: 51 EANVMKTLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLLDFLKSDEGS-KQPLPKLIDFS 108
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV---KEQIRPDGMLHTLC 178
Q+ + + R HRDL+ N+L+ + KI+DFGL+ V E +G +
Sbjct: 109 AQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPI- 167
Query: 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC 237
+ APE + G K D+WS G++L ++ G +P+ + + R + +G YR
Sbjct: 168 ---KWTAPEAI-NFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRM 222
Query: 238 PKWTS 242
P+ +
Sbjct: 223 PRPEN 227
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 63.1 bits (154), Expect = 4e-11
Identities = 42/173 (24%), Positives = 69/173 (39%), Gaps = 26/173 (15%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAVSKQ---------KILRGGLTAHVK- 64
+ +G G F +V+ S A + K+LR + + +
Sbjct: 5 QPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARE 64
Query: 65 ---REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRY- 120
+E+ I+SRL PNI +L V + +ME+ + G+L + K
Sbjct: 65 DFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS 124
Query: 121 ----FQQLI-------SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162
F L+ S + Y S HRDL N L+ +N+ +KI+DFG+S
Sbjct: 125 KSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMS 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 4e-11
Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 34/238 (14%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSRL-RHPN 77
+IG G F +V R + G ++ + K ++ + R E+ ++ +L HPN
Sbjct: 2 VIGEGNFGQVLKARIKKDG----LRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPN 57
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQ-------------LSRRYFQQL 124
I+ L + +Y +E+A G L + K R E LS +
Sbjct: 58 IINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117
Query: 125 IS----AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
+ ++Y + HRDL N+L+ EN+ KI+DFGLS +E + T+
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY----VKKTMGRL 173
Query: 181 PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR 236
P ++A E L Y D+WS GV+L+ +++ G P+ +Y K+ +G YR
Sbjct: 174 PVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG-YR 229
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 7e-11
Identities = 69/249 (27%), Positives = 102/249 (40%), Gaps = 39/249 (15%)
Query: 24 IGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
+G F KVY G T Q+VAIK + K K G L K E + SRL+HPNI
Sbjct: 13 LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTL-KDKA-EGPLREEFKHEAMMRSRLQHPNI 70
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFA-----------------KISKGRFSEQLSRRYF 121
V L V+ + + + + +L K K
Sbjct: 71 VCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
Q+ + +E+ S V H+DL N+L+ + ++KISD GL +E D + L G
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGL--FREVYAAD--YYKLMGNS 186
Query: 182 A----YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPF-----NDPNLMAMYRKIY 231
+++PE + G D+WS GVVL+ V + G P+ D M R++
Sbjct: 187 LLPIRWMSPEAIM-YGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVL 245
Query: 232 KGEYRCPKW 240
CP W
Sbjct: 246 PCPDDCPAW 254
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 61.8 bits (150), Expect = 7e-11
Identities = 69/274 (25%), Positives = 114/274 (41%), Gaps = 40/274 (14%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR------LRHPN 77
IG G F KV G G S A + V K+ LR +A ++ + L HPN
Sbjct: 3 IGNGWFGKVLLGE-AHRGMSKA-RVVVKE--LRA--SATPDEQLLFLQEVQPYRELNHPN 56
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSE------QLSRRYFQQLISAVEYC 131
+++ V+EF G+L + R + +R ++ S + +
Sbjct: 57 VLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC-GTP-AYVAPEIL 189
H H DL L N L + +KI D+GL+ EQ D + C P ++APE++
Sbjct: 117 HQADFIHSDLALRNCQLTADLSVKIGDYGLAL--EQYPEDYYITKDCHAVPLRWLAPELV 174
Query: 190 AKKGYDGAKVD------MWSCGVVLFVL-NAGYLPFND-PNLMAMYRKIYKGEYRCPKWT 241
+G D D +WS GV ++ L A P+ D + + + + + + + PK
Sbjct: 175 EIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPK-- 232
Query: 242 SPDL------KWF-IGRLLDTDPATRITVDEILR 268
P L +W+ + + DP TR T +E+
Sbjct: 233 -PQLDLKYSDRWYEVMQFCWLDPETRPTAEEVHE 265
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 9e-11
Identities = 58/268 (21%), Positives = 112/268 (41%), Gaps = 30/268 (11%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQS-----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+G G F +V+ + + V +KA+ K K L + +RE+ + +L H
Sbjct: 11 TTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHK 68
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
N+V+L + Y ++E+ G+L F + +K + + + A+ +
Sbjct: 69 NVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIAL 128
Query: 135 GV--------FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA-YVA 185
G+ HRDL N L+ ++K+S LS K+ + P ++A
Sbjct: 129 GMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLS--KDVYNSEYYKLRNALIPLRWLA 186
Query: 186 PEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPD 244
PE + + + K D+WS GV+++ V G LPF + + ++ G+ + P+
Sbjct: 187 PEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKL---ELPVPE 242
Query: 245 -----LKWFIGRLLDTDPATRITVDEIL 267
L + R +P R + E++
Sbjct: 243 GCPSRLYKLMTRCWAVNPKDRPSFSELV 270
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 63/236 (26%), Positives = 103/236 (43%), Gaps = 42/236 (17%)
Query: 66 EISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQ--------- 115
E+ ++ +L HPNI+ L + +Y +E+A G L + K R E
Sbjct: 57 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 116
Query: 116 -LSRRYFQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167
S QQL+ ++Y + HRDL N+L+ EN+ KI+DFGLS +E
Sbjct: 117 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEV 176
Query: 168 IRPDGMLHTLCGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA 225
+ T+ P ++A E L Y D+WS GV+L+ +++ G P+
Sbjct: 177 Y----VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 231
Query: 226 MYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKF 281
+Y K+ +G YR K + D + V +++R W +K Y+ F
Sbjct: 232 LYEKLPQG-YRLEKPLNCDDE----------------VYDLMRQCWREKPYERPSF 270
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 1e-10
Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 37/234 (15%)
Query: 19 EVGKIIGCGAFAKVYHG-----RNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
+ + +G GAF +VY G VA+K + + + E IMS+
Sbjct: 9 TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPE--SCSEQDESDFLMEALIMSKF 66
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLI------ 125
H NIV+L V + + ++E GG+L F + ++ R E+ S + L+
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPR-PERPSSLTMKDLLFCARDV 125
Query: 126 -SAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAVKEQIRPD-------GML 174
+Y HRD+ N LL KI+DFG++ ++ R ML
Sbjct: 126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMA--RDIYRASYYRKGGRAML 183
Query: 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPF-NDPNLMAM 226
++ PE G +K D+WS GV+L+ + + GY+P+ N M
Sbjct: 184 PI-----KWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVM 231
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.6 bits (149), Expect = 1e-10
Identities = 63/227 (27%), Positives = 105/227 (46%), Gaps = 16/227 (7%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHPNIV 79
K++G GAF VY G V G++V I K G A+V+ E IM+ + HP++V
Sbjct: 13 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+L V + I V + G L + K QL + Q+ + Y R +
Sbjct: 73 RLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKE----QIRPDGMLHTLCGTPAYVAPEILAKKG 193
HRDL N+L+ +KI+DFGL+ + E + DG + ++A E + +
Sbjct: 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPI----KWMALECIHYRK 187
Query: 194 YDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+ + D+WS GV ++ ++ G P++ + + KGE R P+
Sbjct: 188 FT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGE-RLPQ 232
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 60/218 (27%), Positives = 101/218 (46%), Gaps = 24/218 (11%)
Query: 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI---LRGGLTAHVKREISIMSRLRHP 76
+GK +G G F V G+ + S+ AV KI R + + E M HP
Sbjct: 3 LGKTLGEGEFGSVMEGQ-LNQDDSILKVAVKTMKIAICTRSEMEDFL-SEAVCMKEFDHP 60
Query: 77 NIVKLYEVL--ATKAKIY----FVMEFAKGGELFAKISKGRFSE-------QLSRRYFQQ 123
N+++L V +++ Y ++ F K G+L + + R + Q+ ++
Sbjct: 61 NVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTD 120
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH-TLCGTPA 182
+ S +EY S+ HRDL N +L+EN ++ ++DFGLS K+ D + P
Sbjct: 121 IASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS--KKIYNGDYYRQGRIAKMPV 178
Query: 183 -YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPF 218
++A E LA + Y K D+WS GV ++ + G P+
Sbjct: 179 KWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPY 215
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 57/194 (29%), Positives = 89/194 (45%), Gaps = 26/194 (13%)
Query: 66 EISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQ--------- 115
E+ ++ +L HPNI+ L + +Y +E+A G L + K R E
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111
Query: 116 ----LSRRYFQQLISAV----EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167
L+ + Q S V +Y + HRDL N+L+ EN KI+DFGLS +E
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171
Query: 168 IRPDGMLHTLCGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA 225
+ T+ P ++A E L Y K D+WS GV+L+ +++ G P+
Sbjct: 172 Y----VKKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAE 226
Query: 226 MYRKIYKGEYRCPK 239
+Y K+ +G YR K
Sbjct: 227 LYEKLPQG-YRMEK 239
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 60.1 bits (146), Expect = 3e-10
Identities = 63/239 (26%), Positives = 101/239 (42%), Gaps = 37/239 (15%)
Query: 27 GAFAKVYHG--RNVRTG--QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82
G F ++++G + + G + V +K V + +E ++ L H NI+ +
Sbjct: 17 GTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ--VTLLLQESCLLYGLSHQNILPIL 74
Query: 83 EVLATKAKIYFVME-FAKGGELFAKISKGRFSEQLSRRYFQ---------QLISAVEYCH 132
V + FV+ + G L + + R E + + Q+ + Y H
Sbjct: 75 HVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP----AYVAPEI 188
RGV H+D+ N ++DE +KI+D +A+ + P H L ++A E
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITD---NALSRDLFPMDY-HCLGDNENRPVKWMALES 190
Query: 189 LAKKGYDGAKVDMWSCGVVLFVL-NAGYLPFN--DPNLMAMYRKIYKGEYR------CP 238
L K Y A D+WS GV+L+ L G P+ DP MA Y K G YR CP
Sbjct: 191 LVNKEYSSAS-DVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLK--DG-YRLAQPINCP 245
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 5e-10
Identities = 52/214 (24%), Positives = 93/214 (43%), Gaps = 28/214 (13%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ------KILRGGLTAHVKR----EISIMS 71
+I+G G F ++ G +K SK+ LR G + +R E +
Sbjct: 11 RILGTGRFGELCRG---------CLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLG 61
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+ H NIV+L V+ + V E+ G L F + +G+ L S ++
Sbjct: 62 QFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMK 121
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG-TPA-YVAPE 187
Y G H+ L +L++ + KIS F ++ + + + T+ G +P + APE
Sbjct: 122 YLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRL---QEDKSEAIYTTMSGKSPVLWAAPE 178
Query: 188 ILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFND 220
+ + A D+WS G+V++ V++ G P+ D
Sbjct: 179 AIQYHHFSSAS-DVWSFGIVMWEVMSYGERPYWD 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 6e-10
Identities = 50/200 (25%), Positives = 91/200 (45%), Gaps = 18/200 (9%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI----SIMSRLRHPN 77
K++G GAF VY G + G+ V I K LR + +EI +M+ + +P+
Sbjct: 13 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIK--ELREATSPKANKEILDEAYVMASVDNPH 70
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+ +L + T + + + G L + + K Q + Q+ + Y R
Sbjct: 71 VCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR 129
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLS----AVKEQIRPDGMLHTLCGTPAYVAPEILAK 191
+ HRDL N+L+ +KI+DFGL+ A +++ +G + ++A E +
Sbjct: 130 LVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPI----KWMALESILH 185
Query: 192 KGYDGAKVDMWSCGVVLFVL 211
+ Y + D+WS GV ++ L
Sbjct: 186 RIYT-HQSDVWSYGVTVWEL 204
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 6e-10
Identities = 54/228 (23%), Positives = 96/228 (42%), Gaps = 20/228 (8%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
E+G+ G VY R+ TG V ++ + L A ++ E+ + RHPNI
Sbjct: 5 EIGR--GFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKA-LQNEVVLSHFFRHPNI 61
Query: 79 VKLYEVLATKAKIYFV---MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+ + V T + ++ + M + L SE L + + Y H G
Sbjct: 62 MTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG 121
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC--------GTPAYVAPE 187
HR++K ++L+ + + +S GLS + +R +G + +++PE
Sbjct: 122 YIHRNIKASHILISGDGLVSLS--GLSHLYSLVR-NGQKAKVVYDFPQFSTSVLPWLSPE 178
Query: 188 ILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG 233
+L + GY+ K D++S G+ L G +PF D M + KG
Sbjct: 179 LLRQDLYGYN-VKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKG 225
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 43/150 (28%), Positives = 70/150 (46%), Gaps = 28/150 (18%)
Query: 37 NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRLRHPNIVKLYEVLATKAKIY 92
NVR G+ + + AV KILR + + +E+ I+SRL+ PNI++L V + +
Sbjct: 40 NVRKGRPLLV-AV---KILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLC 95
Query: 93 FVMEFAKGGELFAKISKGRFSE-------------QLSRRYFQQLI-------SAVEYCH 132
+ E+ + G+L +S + L + L+ S ++Y
Sbjct: 96 MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS 155
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLS 162
S HRDL N L+ EN +KI+DFG+S
Sbjct: 156 SLNFVHRDLATRNCLVGENLTIKIADFGMS 185
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 58.4 bits (141), Expect = 1e-09
Identities = 65/234 (27%), Positives = 101/234 (43%), Gaps = 21/234 (8%)
Query: 24 IGCGAFAKVYHG-RNVRTGQ-SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+G G F V G +R Q VAIK + + + + RE IM +L +P IV++
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRM 60
Query: 82 YEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
V +A + VME A GG L F K + Q+ ++Y + HR
Sbjct: 61 IGVCEAEA-LMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHR 119
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAPEILAKKGYDG 196
DL N+LL KISDFGLS K D + APE + + +
Sbjct: 120 DLAARNVLLVNQHYAKISDFGLS--KALGADDSYYKARSAGKWPLKWYAPECINFRKFS- 176
Query: 197 AKVDMWSCGVVLF-VLNAGYLPFND---PNLMAMYRKIYKGE-YRCPKWTSPDL 245
++ D+WS G+ ++ + G P+ P +M+ I +G+ CP P++
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF---IEQGKRLDCPAECPPEM 227
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 1e-09
Identities = 63/228 (27%), Positives = 106/228 (46%), Gaps = 29/228 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVS-KQKILRGGLT----AHVKREISIMS 71
K +GK +G G F +V + + +AV+ K+L+ T + + E+ +M
Sbjct: 16 KLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMK 75
Query: 72 RL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSR-----RY 120
+ +H NI+ L +Y ++E+A G L + R +S ++R
Sbjct: 76 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMT 135
Query: 121 FQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173
F+ L+S +EY S+ HRDL N+L+ EN +KI+DFGL+ I D
Sbjct: 136 FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI--DYY 193
Query: 174 LHTLCGT-PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPF 218
T G P ++APE L + Y + D+WS GV+++ + G P+
Sbjct: 194 KKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPY 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 3e-09
Identities = 64/221 (28%), Positives = 100/221 (45%), Gaps = 40/221 (18%)
Query: 20 VGKIIGCGAFAKVY----HGRNVRTGQSVAIKAVSKQKILRGGLT----AHVKREISIMS 71
+GK +G G F +V +G + AV K+L+ T A + E+ +M
Sbjct: 16 LGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAV---KMLKDNATDKDLADLISEMELMK 72
Query: 72 RL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-------------FSEQLS 117
+ +H NI+ L V + +Y ++E+A G L + R EQLS
Sbjct: 73 LIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS 132
Query: 118 RRYFQQLISAV-------EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170
F+ L+S EY SR HRDL N+L+ E+ +KI+DFGL+ I
Sbjct: 133 ---FKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI-- 187
Query: 171 DGMLHTLCG-TPA-YVAPEILAKKGYDGAKVDMWSCGVVLF 209
D T G P ++APE L + Y + D+WS G++++
Sbjct: 188 DYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMW 227
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 4e-09
Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 22/207 (10%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA-HVKREISIMSRLRHPNIVK 80
K IG G F KV G V +G + A V + ++ E L+H N+++
Sbjct: 1 KEIGNGWFGKVILGE-VNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQ 59
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLS------RRYFQQLISAVEYCHSR 134
VMEF G+L + R +E ++ +R ++ + + H
Sbjct: 60 CLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN 119
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ----IRPDGMLHTLCGTPAYVAPEILA 190
H DL L N LL + +KI D+GLS K + + PD + L ++APE++
Sbjct: 120 NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL----RWIAPELVD 175
Query: 191 KKGYDGAKVD------MWSCGVVLFVL 211
+ + VD +WS GV ++ L
Sbjct: 176 EVHGNLLVVDQTKESNVWSLGVTIWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 8e-09
Identities = 56/208 (26%), Positives = 89/208 (42%), Gaps = 26/208 (12%)
Query: 24 IGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+G GAF KV+ N+ + + AV K +RE +++ L+H +IVK
Sbjct: 13 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 72
Query: 82 YEVLATKAKIYFVMEFAKGGEL--FAKI---------------SKGRFSEQLSRRYFQQL 124
Y V + V E+ K G+L F + +KG Q+
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA---VKEQIRPDGMLHTLCGTP 181
S + Y S+ HRDL N L+ N +KI DFG+S + R G HT+
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGG--HTMLPI- 189
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLF 209
++ PE + + + + D+WS GV+L+
Sbjct: 190 RWMPPESIMYRKFT-TESDVWSFGVILW 216
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 1e-08
Identities = 72/270 (26%), Positives = 117/270 (43%), Gaps = 65/270 (24%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHG--RNVRTGQS---VAIKAVSKQKILRGGLTA 61
++SRE K + + +G G+F VY G R++ G++ VA+K V++ LR +
Sbjct: 2 EVSRE-----KITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-- 54
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELF---------AKISKGRF 112
E S+M ++V+L V++ VME G+L A+ + GR
Sbjct: 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRP 114
Query: 113 SEQLSR--RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170
L + ++ + Y +++ HRDL N ++ ++ +KI DFG++ ++
Sbjct: 115 PPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMT--RDIYET 172
Query: 171 D-------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVL--------------- 208
D G+L ++APE L K G DMWS GVVL
Sbjct: 173 DYYRKGGKGLLPV-----RWMAPESL-KDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLS 226
Query: 209 ------FVLNAGYL--PFNDP----NLMAM 226
FV++ GYL P N P +LM M
Sbjct: 227 NEQVLKFVMDGGYLDQPDNCPERVTDLMRM 256
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 1e-08
Identities = 64/268 (23%), Positives = 98/268 (36%), Gaps = 35/268 (13%)
Query: 24 IGCGAFAKVYHG--RNVRT----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+G G F +Y G R G + V K + S+MS+L H +
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+VKLY V I V E+ K G L F K S +QL SA+ Y +
Sbjct: 63 LVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK 121
Query: 136 VFHRDLKLENLLL---DENW----DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
+ H ++ +N+L+ N +K+SD G+ ++APE
Sbjct: 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP------ITVLSREERVERIPWIAPEC 175
Query: 189 LAKKGYDGAKV------DMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT 241
+ D WS G L + + G P + + R Y+ ++R P
Sbjct: 176 -----IRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERF-YQDQHRLPMPD 229
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRD 269
+L I + DP R + ILRD
Sbjct: 230 CAELANLINQCWTYDPTKRPSFRAILRD 257
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 2e-08
Identities = 71/283 (25%), Positives = 126/283 (44%), Gaps = 36/283 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVS-KQKILRGGLT----AHVKREISIMS 71
+ +GK +G G F +V + + K V+ K+L+ T + + E+ +M
Sbjct: 13 RLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMK 72
Query: 72 RL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FS--------EQLS 117
+ +H NI+ L +Y ++E+A G L + R +S EQL+
Sbjct: 73 MIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLT 132
Query: 118 RRYFQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170
F+ L+S +EY S+ HRDL N+L+ E+ +KI+DFGL+ I
Sbjct: 133 ---FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI-- 187
Query: 171 DGMLHTLCGT-PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMY 227
D T G P ++APE L + Y + D+WS GV+L+ + G P+ + ++
Sbjct: 188 DYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246
Query: 228 RKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269
+ + +G P + +L + P+ R T +++ D
Sbjct: 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 2e-08
Identities = 49/194 (25%), Positives = 87/194 (44%), Gaps = 18/194 (9%)
Query: 40 TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99
TG+ V ++ ++ + +T ++ E+ + HPNIV +++ V F
Sbjct: 24 TGEYVTVRRINLEACTNEMVT-FLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMA 82
Query: 100 GGELFAKISKGRFSEQLSR----RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155
G I F + +S Q ++ A++Y H G HR +K ++L+ + D K
Sbjct: 83 YGSAKDLICT-HFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILI--SVDGK 139
Query: 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAY-------VAPEILAK--KGYDGAKVDMWSCGV 206
+ GL + I L + P Y ++PE+L + +GYD AK D++S G+
Sbjct: 140 VYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYD-AKSDIYSVGI 198
Query: 207 VLFVLNAGYLPFND 220
L G++PF D
Sbjct: 199 TACELANGHVPFKD 212
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 3e-08
Identities = 59/216 (27%), Positives = 93/216 (43%), Gaps = 33/216 (15%)
Query: 17 KYEVGKIIGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
K+E+G+ GAF KV+ N+ Q + AV K +RE +++ L+
Sbjct: 10 KWELGE----GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ 65
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELF---------AKI---SKGRFSEQLSRRYF- 121
H +IV+ Y V + V E+ + G+L AKI + QL+
Sbjct: 66 HQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQML 125
Query: 122 ---QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA---VKEQIRPDG--M 173
Q+ S + Y S HRDL N L+ + +KI DFG+S + R G M
Sbjct: 126 AIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTM 185
Query: 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209
L ++ PE + + + + D+WS GVVL+
Sbjct: 186 LPI-----RWMPPESILYRKFT-TESDIWSFGVVLW 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 3e-08
Identities = 60/231 (25%), Positives = 106/231 (45%), Gaps = 15/231 (6%)
Query: 24 IGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+G G F V G + ++ ++VA+K + K L + RE ++M +L +P IV++
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVK-ILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
+ ++ + VME A+ G L + K + +E+ Q+ ++Y HRD
Sbjct: 62 IGICEAESWM-LVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP----AYVAPEILAKKGYDG 196
L N+LL KISDFGLS + + D + + APE + +
Sbjct: 121 LAARNVLLVTQHYAKISDFGLS---KALGADENYYKAKTHGKWPVKWYAPECMNYYKFS- 176
Query: 197 AKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDL 245
+K D+WS GV+++ + G P+ + + I GE CP+ P++
Sbjct: 177 SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEM 227
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 5e-08
Identities = 46/152 (30%), Positives = 77/152 (50%), Gaps = 6/152 (3%)
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
Y Q+ +E+ SR HRDL N+LL EN +KI DFGL A PD +
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 242
Query: 180 TP-AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMY-RKIYKG-EY 235
P ++APE + + Y + D+WS GV+L+ + + G P+ + + R++ +G
Sbjct: 243 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM 301
Query: 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267
R P +T+P++ + +P+ R T E++
Sbjct: 302 RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELV 333
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 6e-08
Identities = 54/224 (24%), Positives = 98/224 (43%), Gaps = 17/224 (7%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
K++G G F V+ G + G S VAIK + + + R +++ S L H
Sbjct: 12 LKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTI-QDRSGRQTFQEITDHMLAMGS-LDHA 69
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYCHSR 134
IV+L + A + V + + G L + + Q + Q+ + Y
Sbjct: 70 YIVRLLG-ICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH 128
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG--MLHTLCGTP-AYVAPEILAK 191
+ HR+L N+LL + ++I+DFG V + + PD ++ TP ++A E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFG---VADLLYPDDKKYFYSEHKTPIKWMALESILF 185
Query: 192 KGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE 234
Y + D+WS GV ++ +++ G P+ + + KGE
Sbjct: 186 GRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGE 228
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 1e-07
Identities = 45/152 (29%), Positives = 71/152 (46%), Gaps = 6/152 (3%)
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
Y Q+ +E+ SR HRDL N+LL EN +KI DFGL A PD +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGSAR 237
Query: 180 TP-AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG--EY 235
P ++APE + K Y + D+WS GV+L+ + + G P+ + + + K
Sbjct: 238 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296
Query: 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267
R P+ +P++ + DP R T ++
Sbjct: 297 RAPENATPEIYRIMLACWQGDPKERPTFSALV 328
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-07
Identities = 34/97 (35%), Positives = 48/97 (49%), Gaps = 4/97 (4%)
Query: 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
GTP Y+APE+L K + A VD W+ GV LF G PFND +++ I + P
Sbjct: 542 GTPDYLAPELLLGKPHGPA-VDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWP 600
Query: 239 KWT---SPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
+ S + + I LL DP R + E+ + P F
Sbjct: 601 EGEEKLSVNAQNAIEILLTMDPTKRAGLKELKQHPLF 637
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 51.2 bits (122), Expect = 4e-07
Identities = 65/243 (26%), Positives = 108/243 (44%), Gaps = 35/243 (14%)
Query: 20 VGKIIGCGAFAKVYH----GRNVRTGQSVAIKAVSKQKILRGGLT----AHVKREISIMS 71
+GK +G G F +V G + V AV K+L+ T + + E+ +M
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAV---KMLKSDATEKDLSDLISEMEMMK 78
Query: 72 RL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRF-------------SEQLS 117
+ +H NI+ L +Y ++E+A G L + R EQLS
Sbjct: 79 MIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLS 138
Query: 118 RRYF----QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173
+ Q+ +EY S+ HRDL N+L+ E+ +KI+DFGL+ I D
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI--DYY 196
Query: 174 LHTLCGT-PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKI 230
T G P ++APE L + Y + D+WS GV+L+ + G P+ + +++ +
Sbjct: 197 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 255
Query: 231 YKG 233
+G
Sbjct: 256 KEG 258
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 5e-07
Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 9/147 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI----SIMSRLRHPN 77
K++G GAF VY G + G++V I K +LR + +EI +M+ + P
Sbjct: 13 KVLGSGAFGTVYKGIWIPDGENVKIPVAIK--VLRENTSPKANKEILDEAYVMAGVGSPY 70
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+ +L + T + + V + G L + + +K R Q + Q+ + Y
Sbjct: 71 VCRLLGICLT-STVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR 129
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLS 162
+ HRDL N+L+ +KI+DFGL+
Sbjct: 130 LVHRDLAARNVLVKSPNHVKITDFGLA 156
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.6 bits (118), Expect = 9e-07
Identities = 55/226 (24%), Positives = 102/226 (45%), Gaps = 38/226 (16%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHG--RNVRTGQ---SVAIKAVSKQKILRGGLTA 61
+++RE K + + +G G+F VY G + V + VAIK V++ +R +
Sbjct: 2 EVARE-----KITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-- 54
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLS---- 117
E S+M ++V+L V++ +ME G+L + + R + +
Sbjct: 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114
Query: 118 ----RRYFQ---QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170
++ Q ++ + Y ++ HRDL N ++ E++ +KI DFG++ ++
Sbjct: 115 PPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMT--RDIYET 172
Query: 171 D-------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209
D G+L +++PE L K G D+WS GVVL+
Sbjct: 173 DYYRKGGKGLLPV-----RWMSPESL-KDGVFTTYSDVWSFGVVLW 212
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 1e-06
Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 21/214 (9%)
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLI 125
S+MS++ H ++ ++ V ++ V EF + G L + KGR QQL
Sbjct: 68 SLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLA 127
Query: 126 SAVEYCHSRGVFHRDLKLENLLL-----DENWD--LKISDFGLS--AVKEQIRPDGMLHT 176
SA+ Y + + H ++ +N+LL E +K+SD G+S A+ + R + +
Sbjct: 128 SALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERI--- 184
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY 235
++APE + D WS G L + G +P + + + Y+ ++
Sbjct: 185 -----PWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE-RTPSEKERFYEKKH 238
Query: 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269
R P+ + +L I + L +P R + ILRD
Sbjct: 239 RLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 2e-06
Identities = 46/159 (28%), Positives = 75/159 (47%), Gaps = 15/159 (9%)
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
Y Q+ +E+ SR HRDL N+LL EN +KI DFGL A PD +
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGL-ARDIYKDPDYVRKGDAR 236
Query: 180 TP-AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMY-RKIYKG-EY 235
P ++APE + K Y + D+WS GV+L+ + + G P+ + + R++ +G
Sbjct: 237 LPLKWMAPESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295
Query: 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
R P++ +P++ + +P R P F +
Sbjct: 296 RAPEYATPEIYSIMLDCWHNNPEDR---------PTFSE 325
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 3e-06
Identities = 59/219 (26%), Positives = 96/219 (43%), Gaps = 30/219 (13%)
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLI 125
S+MS+L H ++V Y V + V E+ K G L + K +K + +QL
Sbjct: 51 SMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLA 110
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWD--------LKISDFGLSAVKEQIRPDGMLHTL 177
A+ + +G+ H ++ +N+LL D +K+SD G+S + P +L L
Sbjct: 111 WALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT---VLPKEIL--L 165
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFN--DPNLMAMYRKIYKGE 234
P +V PE + D WS G L+ + + G P + D +K+ E
Sbjct: 166 ERIP-WVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQ-----KKLQFYE 219
Query: 235 YR----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269
R PKWT +L I + +D +P R + I+RD
Sbjct: 220 DRHQLPAPKWT--ELANLINQCMDYEPDFRPSFRAIIRD 256
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 5e-06
Identities = 52/214 (24%), Positives = 90/214 (42%), Gaps = 21/214 (9%)
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLI 125
S+M ++ H +IV LY V + V EF + G +LF + + +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLA 115
Query: 126 SAVEYCHSRGVFHRDLKLENLLL-DENWD------LKISDFG--LSAVKEQIRPDGMLHT 176
SA+ Y + + H ++ +N+LL E D +K+SD G ++ + Q + +
Sbjct: 116 SALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQECVERI--- 172
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY 235
++APE + D WS G L+ + G +P D L R Y+G+
Sbjct: 173 -----PWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKER-FYEGQC 226
Query: 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269
+ +L + ++ DP R I+RD
Sbjct: 227 MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 1e-04
Identities = 42/170 (24%), Positives = 86/170 (50%), Gaps = 20/170 (11%)
Query: 12 VNLFGK-YEVGKIIGCGAFAKVYH----GRNVRTGQSVA-IKAVSKQKILRGGL---TAH 62
+++ GK +++ K+IGCG F VY + Q+VA I+ + + I+ L +
Sbjct: 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIY 66
Query: 63 VKREISIMSRLR---HPNIVKLYEVLATK-AKIYF---VME--FAKGGELFAKISKGRFS 113
+I++ + H I K Y + K ++Y+ ++E E+F +I +
Sbjct: 67 DIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKEIFKRIKC--KN 124
Query: 114 EQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163
++L + + +++ +EY H G+ H D+K EN+++D N I D+G+++
Sbjct: 125 KKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIAS 174
|
Length = 294 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 3e-04
Identities = 41/153 (26%), Positives = 71/153 (46%), Gaps = 12/153 (7%)
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP- 181
Q+ + + S+ HRDL N+LL KI DFGL+ IR D + + G
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLA---RDIRNDSN-YVVKGNAR 277
Query: 182 ---AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR- 236
++APE + Y + D+WS G++L+ + + G P+ + + + K+ K YR
Sbjct: 278 LPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM 336
Query: 237 -CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
P+ ++ + D DP R T +I++
Sbjct: 337 LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQ 369
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 42.1 bits (100), Expect = 4e-04
Identities = 13/47 (27%), Positives = 20/47 (42%), Gaps = 7/47 (14%)
Query: 248 FIGRLLDTDPATRITVDEILRDPWFKKDYKE-------RKFPHEDFD 287
+ ++L DP RIT DE L P+ + + F + FD
Sbjct: 268 LLEKMLVFDPKKRITADEALAHPYLAQLHDPEDEPVAKPPFDFDFFD 314
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-04
Identities = 47/205 (22%), Positives = 86/205 (41%), Gaps = 34/205 (16%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82
+I G Y G++++ G +K ++ + EI+ M +L+HPNIVKL
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMGKLQHPNIVKLI 749
Query: 83 EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH---SRGVFHR 139
+ ++ Y + E+ +G L +++ + S + R+ + A+ + H S V
Sbjct: 750 GLCRSEKGAYLIHEYIEGKNL-SEVLRN-LSWERRRKIAIGIAKALRFLHCRCSPAVVVG 807
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIR----PDGML---HTLCGTPAYVAPEILAKK 192
+L E +++D K++ G+L + AYVAPE K
Sbjct: 808 NLSPEKIIID--------------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETK 853
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLP 217
K D++ G++L L G P
Sbjct: 854 DIT-EKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 4e-04
Identities = 74/300 (24%), Positives = 119/300 (39%), Gaps = 61/300 (20%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
++++ ++G G F KV + + + A+K V T K EI M ++R
Sbjct: 129 QRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQ 184
Query: 76 PNIVKLYEVLATKAKIYFVMEFAK--------GGELFAKISK-GRFSEQLSRRYFQQLI- 125
+ + ++ K + YF E G L I K G FS R+ Q+I
Sbjct: 185 ADPADRFPLM--KIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSH----RHLAQIIF 238
Query: 126 ---SAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC--- 178
A++Y H+ + H DLK EN+L+ E D + + PD +C
Sbjct: 239 QTGVALDYFHTELHLMHTDLKPENILM-ETSDTVVD----PVTNRALPPDPCRVRICDLG 293
Query: 179 -------------GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF----NDP 221
T Y +PE++ G+ DMWS G +++ L G L + N
Sbjct: 294 GCCDERHSRTAIVSTRHYRSPEVVLGLGW-MYSTDMWSMGCIIYELYTGKLLYDTHDNLE 352
Query: 222 NLMAMYRKIYK--GEY--RCPKWTSPDLKWFIGRLLD-TDPA--TRI----TVDEILRDP 270
+L M + + + E+ RC + L G+L TDP RI V E++RD
Sbjct: 353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDD 412
|
Length = 467 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 5e-04
Identities = 39/124 (31%), Positives = 60/124 (48%), Gaps = 14/124 (11%)
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT-- 180
Q+ +E+ S+ HRDL N+LL + +KI DFGL+ I D + T
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLA---RDIMHDSNYVSKGSTFL 301
Query: 181 PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLM---AMYRKIYKGEY 235
P ++APE + Y D+WS G++L+ + + G P+ P ++ Y KI G Y
Sbjct: 302 PVKWMAPESIFDNLYTTLS-DVWSYGILLWEIFSLGGTPY--PGMIVDSTFYNKIKSG-Y 357
Query: 236 RCPK 239
R K
Sbjct: 358 RMAK 361
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.001
Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 28/163 (17%)
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS---------AVKEQIR 169
R+ Q+ +++ S+ HRD+ N+LL + KI DFGL+ VK R
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR 275
Query: 170 PDGMLHTLCGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA-- 225
P ++APE + Y + D+WS G++L+ + + G P+ P ++
Sbjct: 276 ----------LPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPY--PGILVNS 322
Query: 226 -MYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEI 266
Y+ + +G + P + P++ + + +P R T +I
Sbjct: 323 KFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQI 365
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 0.001
Identities = 40/153 (26%), Positives = 61/153 (39%), Gaps = 25/153 (16%)
Query: 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR------LRHPN 77
IG G F KV + T VA V + K A K + + + L+HPN
Sbjct: 3 IGNGWFGKVLLSE-IYTDTGVARVVVKELKA-----NASSKEQNEFLQQGDPYRILQHPN 56
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI---------SAV 128
I++ V E+ + G+L + +S EQ RR Q L+ + V
Sbjct: 57 ILQCLGQCVEAIPYLLVFEYCELGDLKSYLS----QEQWHRRNSQLLLLQRMACEIAAGV 112
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161
+ H H DL L N L + +K+ D+G+
Sbjct: 113 THMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 0.002
Identities = 52/242 (21%), Positives = 98/242 (40%), Gaps = 26/242 (10%)
Query: 41 GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY----EVLATKAKIYFVME 96
+ V I+ K L + EI + R+ NI+K+Y +++ ++ ++E
Sbjct: 43 NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILE 102
Query: 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC-------HSRGVFHRDLKLENLLLD 149
+ G L + K + LS + +L A++ C +++L + L+
Sbjct: 103 YCTRGYLREVLDKEK---DLS--FKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVT 157
Query: 150 ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVV 207
EN+ LKI GL + P ++ + Y + ++L Y K D++S GVV
Sbjct: 158 ENYKLKIICHGLEKIL-SSPPFKNVNFM----VYFSYKMLNDIFSEYT-IKDDIYSLGVV 211
Query: 208 LFVLNAGYLPFNDPNLMAMYRKIYK--GEYRCPKWTSPDLKWFIGRLLDTDPATRITVDE 265
L+ + G +PF + +Y I + P ++K + D R + E
Sbjct: 212 LWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRPNIKE 271
Query: 266 IL 267
IL
Sbjct: 272 IL 273
|
Length = 283 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.002
Identities = 35/121 (28%), Positives = 57/121 (47%), Gaps = 8/121 (6%)
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT-- 180
Q+ + +E+ S+ HRDL N+L+ E +KI DFGL+ I D + T
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLA---RDIMRDSNYISKGSTFL 303
Query: 181 P-AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
P ++APE + Y D+WS G++L+ + G P+ + + + K YR
Sbjct: 304 PLKWMAPESIFNNLYTTLS-DVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMA 362
Query: 239 K 239
K
Sbjct: 363 K 363
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 0.003
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 37/175 (21%)
Query: 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PN 77
+GK +G GAF VY V K V K+ T + EI + R+R PN
Sbjct: 136 LGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKA------TEYGAVEIWMNERVRRACPN 189
Query: 78 ----------------------IVKLYEVLATKAKIYFVMEFAKGGE--LFAKIS---KG 110
+V YE +T A + EF E L K+ KG
Sbjct: 190 SCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKG 249
Query: 111 -RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSA 163
++ + +Q++ A++ HS G+ HRD+K +N++ E + KI D G +A
Sbjct: 250 LERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAA 304
|
Length = 566 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 100.0 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.97 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.97 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.97 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.96 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.96 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.94 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.93 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.93 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.92 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.92 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.91 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.91 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.9 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.89 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.89 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.85 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.84 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.83 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.82 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.81 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.8 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.79 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.77 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.75 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.72 | |
| PF03822 | 63 | NAF: NAF domain; InterPro: IPR004041 The NAF domai | 99.66 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.6 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.59 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.56 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.56 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.49 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.41 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.39 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.32 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.29 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.22 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.19 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.12 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.07 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.02 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.97 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.93 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.82 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.66 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.61 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.55 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.53 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.42 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 98.41 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 98.34 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.33 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.31 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.28 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.24 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.15 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.08 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.74 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.73 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.67 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.64 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.59 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.45 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.45 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.36 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.36 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.35 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.21 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 97.14 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.84 | |
| PF02149 | 47 | KA1: Kinase associated domain 1; InterPro: IPR0017 | 96.84 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.81 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.8 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.8 | |
| PLN02236 | 344 | choline kinase | 96.58 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.52 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 96.49 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.21 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.89 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.88 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.39 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.38 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 94.82 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 94.58 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 93.53 |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-66 Score=515.33 Aligned_cols=322 Identities=49% Similarity=0.831 Sum_probs=276.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc--chHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG--GLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
....++|++++.||+|+||+|++|.+..+|..||+|+++++..... ....++.+|+.+|++++ ||||+++++++.+.
T Consensus 13 ~~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~ 92 (370)
T KOG0583|consen 13 QLSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATP 92 (370)
T ss_pred ccccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecC
Confidence 4678999999999999999999999999999999999888644322 45678889999999999 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~ 166 (417)
+.+|+|||||.||+|++++.. +++.|.+++.+|+||++|++|||++||+||||||||||++.+ +++||+|||+|....
T Consensus 93 ~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 93 TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 999999999999999999987 899999999999999999999999999999999999999999 999999999998764
Q ss_pred ccCCCCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCC-ChH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT-SPD 244 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~-s~~ 244 (417)
..+..+++.||||.|+|||++.+.+ |++.++|||||||+||.|++|+.||++.+...++.+|.++.+.+|.|+ |++
T Consensus 173 --~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~~~~S~~ 250 (370)
T KOG0583|consen 173 --GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPSYLLSPE 250 (370)
T ss_pred --CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCCCcCCHH
Confidence 3567899999999999999999998 999999999999999999999999999999999999999999999999 999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccc-ccccCC-CCC----C----CCC--c-ccccC--CCC-------C-CCCc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK-DYKERK-FPH----E----DFD--L-KDSVG--CNV-------G-SEKY 301 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~-~~~~~~-~~~----~----~~~--~-~~~~~--~~~-------~-~~~~ 301 (417)
+++|+++||.+||.+|+|+.+|+.||||+. ...... .+. . ... . ..... +.. . ....
T Consensus 251 ~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 330 (370)
T KOG0583|consen 251 ARSLIEKMLVPDPSTRITLLEILEHPWFQKENPLPSDELPSEVAPSAPSAPSAKDSVSPVETEDEKPLSPTSTPESLPLS 330 (370)
T ss_pred HHHHHHHHcCCCcccCCCHHHHhhChhhccCCCCCccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999999999999998 432210 000 0 000 0 00000 000 0 1347
Q ss_pred cCcchhhc-cCCCC--CCCCCCccCCCCCCCccccceeecC
Q 014849 302 LNAFDIIS-LSSGF--NLSGLFDDFNNNDAPFCNERFLSNE 339 (417)
Q Consensus 302 ~~~~~~is-~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~ 339 (417)
++++++++ ++++. +++++|+.... ....+|.+..
T Consensus 331 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~ 367 (370)
T KOG0583|consen 331 LNAYDLGSSLSTGINEALSGLFENEKE----KEEPRFASLT 367 (370)
T ss_pred cChhhhccccccccccccccccccccc----chhhhhhhcc
Confidence 88999887 78888 89998886653 1445555543
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-64 Score=506.06 Aligned_cols=264 Identities=38% Similarity=0.712 Sum_probs=252.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|+.++.||+|+|++||.+++..+|+.||+|++.+..+.+....+.+.+||+|.+.|+|||||+++++|++.+++|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 57999999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+|..++|..++++ +.++|.+|+.|++||+.||.|||+++|+|||||..||||+++.+|||+|||||+.... .+...
T Consensus 98 ELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~--~~Erk 175 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEY--DGERK 175 (592)
T ss_pred EecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecC--ccccc
Confidence 99999999999986 7899999999999999999999999999999999999999999999999999997653 34667
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
.|.||||+|+||||+.+.++. ..+||||+|||||.||.|++||...+..+.|.+|...++..|...|.++++||.+||+
T Consensus 176 ~TlCGTPNYIAPEVl~k~gHs-fEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~~ls~~A~dLI~~lL~ 254 (592)
T KOG0575|consen 176 KTLCGTPNYIAPEVLNKSGHS-FEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPSHLSAEAKDLIRKLLR 254 (592)
T ss_pred ceecCCCcccChhHhccCCCC-CchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCcccccccCHHHHHHHHHHhc
Confidence 899999999999999999985 9999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHhcCcccccccccCCCC
Q 014849 255 TDPATRITVDEILRDPWFKKDYKERKFP 282 (417)
Q Consensus 255 ~dP~~R~t~~eil~h~~f~~~~~~~~~~ 282 (417)
+||.+|||+++||.|+||++++.+...+
T Consensus 255 ~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 255 PNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 9999999999999999998888776654
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-65 Score=512.84 Aligned_cols=264 Identities=40% Similarity=0.770 Sum_probs=250.2
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.....|-|+++++||.|+-|.|.+|++..||+.+|||++.+..-........|.+||-||+.+.||||+++|++++++++
T Consensus 7 ~~~tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~ 86 (786)
T KOG0588|consen 7 HKNTIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQH 86 (786)
T ss_pred ccccccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCce
Confidence 34578999999999999999999999999999999999998754455556789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+|+||++||+||+++.. |+++|.+|+++|.||+.|+.|||..+||||||||+|+|||..+++||+|||+|.+-.
T Consensus 87 lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~--- 163 (786)
T KOG0588|consen 87 LYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEV--- 163 (786)
T ss_pred EEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeeccc---
Confidence 9999999999999998875 999999999999999999999999999999999999999999999999999998643
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
++.++.|.||+|.|.|||++.+.+|+|.++||||||||||.||+|++||++.|...++.++.+|.|..|..+|+++++||
T Consensus 164 ~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MPs~Is~eaQdLL 243 (786)
T KOG0588|consen 164 PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMPSNISSEAQDLL 243 (786)
T ss_pred CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCCCcCCHHHHHHH
Confidence 57799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++||+.||.+|+|.+||++|||++....
T Consensus 244 r~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 244 RRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred HHHhccCccccccHHHHhhCchhhcCCC
Confidence 9999999999999999999999986544
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-65 Score=490.18 Aligned_cols=264 Identities=41% Similarity=0.720 Sum_probs=237.0
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc----hHHHHHHHHHHHHhCCCCCcceEEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG----LTAHVKREISIMSRLRHPNIVKLYEVL 85 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----~~~~i~~Ei~il~~l~HpnIv~l~~~~ 85 (417)
....+.+.|.+.+.||+|+||.|.+|..+.||+.||||++++.+..... -...+.+|++||++|+|||||+++++|
T Consensus 166 ~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f 245 (475)
T KOG0615|consen 166 PPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF 245 (475)
T ss_pred ccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee
Confidence 3455889999999999999999999999999999999999988765422 234577999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCeEEeeeec
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---WDLKISDFGL 161 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---~~vkl~DFGl 161 (417)
..+...||||||+.||+|++++.. +.+.|+..+.+|+||+.|+.|||++||+||||||+|||+..+ ..+||+|||+
T Consensus 246 ~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 246 EVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred ecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccch
Confidence 999999999999999999999876 789999999999999999999999999999999999999876 7799999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~--~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p 238 (417)
|.+.. ......|.||||.|+||||+.++++. +.++||||+|||||.+|+|++||.+.... .+.++|.+|.+.+.
T Consensus 326 AK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~ 402 (475)
T KOG0615|consen 326 AKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG 402 (475)
T ss_pred hhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence 98765 46678999999999999999877643 45889999999999999999999886544 49999999998753
Q ss_pred --CC--CChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 239 --KW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 239 --~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.| +|.++++||.+||..||++|||++|+|+||||+...
T Consensus 403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAP 444 (475)
T ss_pred ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhccc
Confidence 34 589999999999999999999999999999998644
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-62 Score=465.09 Aligned_cols=261 Identities=41% Similarity=0.714 Sum_probs=244.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-.+.|++.++||+|+||+|+.++.++|++.+|+|++++.++.+....+++++|..||..++||.||+++..|++++++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 34578899999999999999999999999999999999999998888899999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|+||+.||+|+..|.+ |.++|+.|+.|+.+|+.||.|||++||+||||||+|||||.+|+++|+||||+...- ..
T Consensus 101 ylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~--~~ 178 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDL--KD 178 (357)
T ss_pred EEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcc--cC
Confidence 999999999999999985 899999999999999999999999999999999999999999999999999997432 23
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFI 249 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 249 (417)
+...++.|||+.|||||++.+.+|+ ..+|+|||||++|+|++|.+||.+.+...++++|.+++. ..|...|.++++|+
T Consensus 179 ~~~t~tfcGT~eYmAPEil~~~gy~-~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p~~ls~~ardll 257 (357)
T KOG0598|consen 179 GDATRTFCGTPEYMAPEILLGKGYD-KAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPPGYLSEEARDLL 257 (357)
T ss_pred CCccccccCCccccChHHHhcCCCC-cccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCCccCCHHHHHHH
Confidence 4566788999999999999999997 999999999999999999999999999999999999994 45555999999999
Q ss_pred HHhccCCCCCCC----CHHHHhcCcccccc
Q 014849 250 GRLLDTDPATRI----TVDEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~----t~~eil~h~~f~~~ 275 (417)
+++|+.||++|. ++.+|.+||||+..
T Consensus 258 ~~LL~rdp~~RLg~~~d~~~ik~HpfF~~i 287 (357)
T KOG0598|consen 258 KKLLKRDPRQRLGGPGDAEEIKRHPFFKGI 287 (357)
T ss_pred HHHhccCHHHhcCCCCChHHhhcCcccccC
Confidence 999999999996 79999999999864
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-61 Score=447.57 Aligned_cols=258 Identities=40% Similarity=0.718 Sum_probs=246.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.++|+..++||.|+||+|.+++++.+|..+|+|+++++.+.+....++..+|..+|+.+.||+++++++.+.+.+.+|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 34678999999999999999999999999999999999999988888999999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||||++||+|+.++.+ ++++|..|+.|+.||+.||+|||+++|++|||||||||||.+|++||+|||+|....
T Consensus 121 mvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~----- 195 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVS----- 195 (355)
T ss_pred EEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEec-----
Confidence 99999999999999987 899999999999999999999999999999999999999999999999999997543
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
+...|.||||.|+|||++..++|. .++|+|||||++|||++|++||.+.+...+|++|..++..+|..+++++++||++
T Consensus 196 ~rT~TlCGTPeYLAPEii~sk~yn-kavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP~~fs~~~kdLl~~ 274 (355)
T KOG0616|consen 196 GRTWTLCGTPEYLAPEIIQSKGYN-KAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFPSYFSSDAKDLLKK 274 (355)
T ss_pred CcEEEecCCccccChHHhhcCCCC-cchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCCcccCHHHHHHHHH
Confidence 457899999999999999999996 9999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCC-----CHHHHhcCccccccc
Q 014849 252 LLDTDPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 252 ~L~~dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
+|+.|-.+|. ...+|+.||||+.-.
T Consensus 275 LL~vD~t~R~gnlknG~~dIk~H~wF~~v~ 304 (355)
T KOG0616|consen 275 LLQVDLTKRFGNLKNGVEDIKNHPWFKGVD 304 (355)
T ss_pred HHhhhhHhhhcCcCCCccccccCccccccc
Confidence 9999999995 688999999998643
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-59 Score=461.16 Aligned_cols=263 Identities=35% Similarity=0.622 Sum_probs=244.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
..-..+|..++.||+|+|++|++|+++.+++.|||||+++..+.++...+-+.+|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 34567899999999999999999999999999999999999998888888899999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+|+||+++|+|.++|.+ |.|+|..++.|+.||++||+|||++|||||||||||||||.|+++||+|||.|.......
T Consensus 149 LYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred eEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 9999999999999999998 999999999999999999999999999999999999999999999999999987654321
Q ss_pred C-----------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 014849 170 P-----------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238 (417)
Q Consensus 170 ~-----------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 238 (417)
. .....+.+||-.|++||++..... +..+|||+||||||.|++|.+||.+.|.--.+++|..-++.+|
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~-~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp 307 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPA-GPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP 307 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCC-CcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC
Confidence 1 112256899999999999987665 5999999999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+++.+++||+++|..||.+|+|+++|++||||..-
T Consensus 308 ~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~V 344 (604)
T KOG0592|consen 308 EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGV 344 (604)
T ss_pred CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccC
Confidence 9999999999999999999999999999999999864
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-59 Score=445.86 Aligned_cols=262 Identities=43% Similarity=0.765 Sum_probs=248.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+..||++.++||+|+||+|.+|++...|+.||||.|.++++.+....-+|+|||+||+.|+||||+++|++|+.++++
T Consensus 49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKI 128 (668)
T KOG0611|consen 49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKI 128 (668)
T ss_pred cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceE
Confidence 46788999999999999999999999999999999999999998887888999999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
.+||||..||+|.+++.. +.|+|.+++.+|+||++|+.|||.++|+|||||.+|||||.|+++||+|||+|.++. .
T Consensus 129 vivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~---~ 205 (668)
T KOG0611|consen 129 VIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYA---D 205 (668)
T ss_pred EEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhc---c
Confidence 999999999999999987 899999999999999999999999999999999999999999999999999998765 4
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
...+.|.||+|.|.+||++++.+|.|+.+|-|||||+||.|..|..||++.+...+.++|.+|.+.-|.. +.++.-||+
T Consensus 206 ~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~~-PSdA~gLIR 284 (668)
T KOG0611|consen 206 KKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPET-PSDASGLIR 284 (668)
T ss_pred ccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCCC-CchHHHHHH
Confidence 5688999999999999999999999999999999999999999999999999999999999999988874 557899999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.||-.||.+|.|+++|-.|=|..=.+.
T Consensus 285 wmLmVNP~RRATieDiAsHWWvNwgy~ 311 (668)
T KOG0611|consen 285 WMLMVNPERRATIEDIASHWWVNWGYN 311 (668)
T ss_pred HHHhcCcccchhHHHHhhhheeecccc
Confidence 999999999999999999988764444
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-57 Score=437.16 Aligned_cols=261 Identities=38% Similarity=0.696 Sum_probs=240.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|+++.++..||||.+.+.+. .....+.+..||.+|+.++|||||+++++..+.+.+
T Consensus 6 ~~~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i 84 (429)
T KOG0595|consen 6 MRVVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFI 84 (429)
T ss_pred ccccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeE
Confidence 4568999999999999999999999999999999999998865 344577888999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC------CCeEEeeeeccee
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN------WDLKISDFGLSAV 164 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~------~~vkl~DFGls~~ 164 (417)
|+|||||+||+|.++|.+ ++++|..++.++.||+.||++||+++|+||||||+||||+.+ -.+||+|||+|+.
T Consensus 85 ~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~ 164 (429)
T KOG0595|consen 85 YLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARF 164 (429)
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhh
Confidence 999999999999999987 799999999999999999999999999999999999999865 4589999999987
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCC
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWT 241 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~ 241 (417)
.. +.....+.||+|.|||||++....|+ +|+|+||+|+|||++++|+.||+..+..+++..+.++.. ..|.+.
T Consensus 165 L~---~~~~a~tlcGSplYMAPEV~~~~~Yd-AKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~~~~~ 240 (429)
T KOG0595|consen 165 LQ---PGSMAETLCGSPLYMAPEVIMSQQYD-AKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVLPAEL 240 (429)
T ss_pred CC---chhHHHHhhCCccccCHHHHHhcccc-chhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCchhhhc
Confidence 65 56788999999999999999999998 999999999999999999999999999999998888764 345677
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++...+|+...|+.+|..|.+..+-+.|++......
T Consensus 241 s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~ 276 (429)
T KOG0595|consen 241 SNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQ 276 (429)
T ss_pred cCchhhhhhHHHhcCccccCchHHhhhhhhcccCcc
Confidence 888999999999999999999999999999986654
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-57 Score=447.39 Aligned_cols=262 Identities=35% Similarity=0.600 Sum_probs=237.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.+.|++++.||+|+||.||+|+.+.||+.+|+|++.++...+.+..++++.|-.+|....+|+||+||..|++...+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 36789999999999999999999999999999999999998888889999999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc-----
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ----- 167 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~----- 167 (417)
||||++||++..+|.+ +.|+|+.++.|+.+++.|++-+|+.|++||||||+|+|||..|++||+|||||.....
T Consensus 219 iMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~ 298 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIE 298 (550)
T ss_pred EEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhh
Confidence 9999999999999986 8999999999999999999999999999999999999999999999999999864211
Q ss_pred ---------------cCCCC-------------------------cccccccCccccccccccccCCCCChhhHHHHHHH
Q 014849 168 ---------------IRPDG-------------------------MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVV 207 (417)
Q Consensus 168 ---------------~~~~~-------------------------~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvi 207 (417)
...+. .....+|||.||||||+.+++|. ...|+||||||
T Consensus 299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~-~~cDwWSLG~I 377 (550)
T KOG0605|consen 299 SYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYG-KECDWWSLGCI 377 (550)
T ss_pred hhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCC-ccccHHHHHHH
Confidence 00000 11246899999999999999985 99999999999
Q ss_pred HHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCChHHHHHHHHhccCCCCCCC---CHHHHhcCcccccccc
Q 014849 208 LFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK--WTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKKDYK 277 (417)
Q Consensus 208 l~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~~~~ 277 (417)
+||||.|++||.+.++.+.+++|..-+ +..|. ..++++.+||.+||+ ||.+|. +++||++||||+.--.
T Consensus 378 myEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W 453 (550)
T KOG0605|consen 378 MYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDW 453 (550)
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCc
Confidence 999999999999999999999998765 45554 468999999999999 999999 5999999999997443
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-56 Score=426.58 Aligned_cols=257 Identities=29% Similarity=0.550 Sum_probs=234.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK-IY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~ 92 (417)
..+..+.+..||+|+.|+||+|+++.|++.+|+|++... .+.....|+.+|+++++.++||+||.+|+.|.++.. ++
T Consensus 77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~is 154 (364)
T KOG0581|consen 77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEIS 154 (364)
T ss_pred CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEE
Confidence 345788899999999999999999999999999999443 355567899999999999999999999999999995 99
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+||+|.+.+.. |+++|....+++.+++.||.|||. ++|+||||||.|||++..|.|||||||.|....
T Consensus 155 I~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv---- 230 (364)
T KOG0581|consen 155 ICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV---- 230 (364)
T ss_pred eehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh----
Confidence 99999999999999986 899999999999999999999995 999999999999999999999999999997653
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCC-CCCCCC-CCh
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKGE-YRCPKW-TSP 243 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~ 243 (417)
+....+.+||..|||||.+.+..|. .++||||||+.++|+..|+.||... +..+++..|..+. +..|.. +|+
T Consensus 231 nS~a~tfvGT~~YMsPERi~g~~Ys-~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ 309 (364)
T KOG0581|consen 231 NSIANTFVGTSAYMSPERISGESYS-VKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSP 309 (364)
T ss_pred hhhcccccccccccChhhhcCCcCC-cccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCH
Confidence 2367889999999999999999885 8899999999999999999999875 6778899998865 456776 999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++++||..||++||.+|||+.|+++|||+++...
T Consensus 310 ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~ 343 (364)
T KOG0581|consen 310 EFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFED 343 (364)
T ss_pred HHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccc
Confidence 9999999999999999999999999999987543
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-58 Score=413.44 Aligned_cols=260 Identities=38% Similarity=0.709 Sum_probs=237.3
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.+.+.+.|++.+.||+|.|+.||.+.+..||+.+|+|+++..+.... ..+.+.+|++|-+.|+|||||+|++.+.+...
T Consensus 6 ~~~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~ 84 (355)
T KOG0033|consen 6 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESF 84 (355)
T ss_pred ccccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccce
Confidence 35678899999999999999999999999999999999998876554 57889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~DFGls~~~~ 166 (417)
.|+|+|++.|++|+.-|.+ --++|..+..+.+||++||+|||.+||+|||+||+|+||.+ ...+||+|||++....
T Consensus 85 ~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~ 164 (355)
T KOG0033|consen 85 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN 164 (355)
T ss_pred eEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeC
Confidence 9999999999999877765 46899999999999999999999999999999999999954 3459999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--C--CC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK--W--TS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~--~s 242 (417)
.+.......|||.|||||++...+|. .++|||+||||||.||.|++||.+.+...+|++|..+.+..|. | ++
T Consensus 165 ---~g~~~~G~~GtP~fmaPEvvrkdpy~-kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is 240 (355)
T KOG0033|consen 165 ---DGEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVT 240 (355)
T ss_pred ---CccccccccCCCcccCHHHhhcCCCC-CcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCC
Confidence 44566778999999999999999885 8999999999999999999999999999999999999887654 3 58
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+++++|+++||..||.+|+|+.|.|+|||+++.
T Consensus 241 ~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 241 PEAKSLIRRMLTVNPKKRITADEALKHPWICNR 273 (355)
T ss_pred HHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence 999999999999999999999999999999864
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-55 Score=445.81 Aligned_cols=260 Identities=32% Similarity=0.592 Sum_probs=245.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.-...|.+.++||+|+||+|++|..+.+++.+|||+++|..+...+..+..+.|.+|+.... ||.+++++..|++++++
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34678999999999999999999999999999999999999999999999999999999886 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||+.||++...+..+.++|..|+.|+..++.||.|||++||||||||.+|||||.+|++||+|||++.- ....+
T Consensus 445 ~fvmey~~Ggdm~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe--~m~~g 522 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKE--GMGQG 522 (694)
T ss_pred EEEEEecCCCcEEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccc--cCCCC
Confidence 9999999999977666679999999999999999999999999999999999999999999999999999863 33355
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
....|.||||.|||||++.+..|. .++|+|||||+||+||.|..||.+.+.++++..|...+..+|.|+|.++.+++++
T Consensus 523 ~~TsTfCGTpey~aPEil~e~~Yt-~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ea~~il~~ 601 (694)
T KOG0694|consen 523 DRTSTFCGTPEFLAPEVLTEQSYT-RAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSKEAIAIMRR 601 (694)
T ss_pred CccccccCChhhcChhhhccCccc-chhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccHHHHHHHHH
Confidence 678899999999999999999995 9999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCcccccc
Q 014849 252 LLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 252 ~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
+|..||++|.. +++|+.||||+..
T Consensus 602 ll~k~p~kRLG~~e~d~~~i~~hpFFr~i 630 (694)
T KOG0694|consen 602 LLRKNPEKRLGSGERDAEDIKKHPFFRSI 630 (694)
T ss_pred HhccCcccccCCCCCCchhhhhCCccccC
Confidence 99999999994 6999999999964
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-56 Score=400.69 Aligned_cols=262 Identities=37% Similarity=0.677 Sum_probs=248.1
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
....--.++|++++.||+|-||.||+|+.+.++-.||+|++.++.+.+.+...+++||++|.+.|+||||+++|++|.+.
T Consensus 15 ~~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 15 ATKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS 94 (281)
T ss_pred cccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc
Confidence 34455678999999999999999999999999999999999999988888899999999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 AKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
..+|+++||.++|+|+..+.. .+++|..+..|..|++.|+.|||.++|+||||||+|+|++.+|.+||+|||.|...
T Consensus 95 ~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 95 KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 999999999999999999983 57999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHH
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
+.+...|.|||..|.|||...+.++| ..+|+|++|++.|+++.|.+||...+..+.|++|.+.++.+|..++.++
T Consensus 175 ----p~~kR~tlcgt~dyl~pEmv~~~~hd-~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p~~is~~a 249 (281)
T KOG0580|consen 175 ----PSNKRKTLCGTLDYLPPEMVEGRGHD-KFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFPSTISGGA 249 (281)
T ss_pred ----CCCCceeeecccccCCHhhcCCCCcc-chhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCCcccChhH
Confidence 35677899999999999999999998 9999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++||.+||..+|.+|.+..|++.|||+...
T Consensus 250 ~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~ 279 (281)
T KOG0580|consen 250 ADLISRLLVKNPIERLALTEVMDHPWIVAN 279 (281)
T ss_pred HHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence 999999999999999999999999998753
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=427.39 Aligned_cols=267 Identities=38% Similarity=0.622 Sum_probs=237.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----------chHHHHHHHHHHHHhCCCCCcce
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----------GLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
....++|++++.||+|.||+|.+|++..+++.||||++++....+. .-.+++++||.||++|.|||||+
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~ 172 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVK 172 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeE
Confidence 3457889999999999999999999999999999999987554321 12468999999999999999999
Q ss_pred EEEEEEeC--CEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 81 LYEVLATK--AKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 81 l~~~~~~~--~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
|+++..++ +++|||+|||..|.+...-..+. +++++|++|++.++.||.|||.+||+||||||.|+||+++|++||+
T Consensus 173 LiEvLDDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 173 LIEVLDDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EEEeecCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 99999765 58999999999999877665566 9999999999999999999999999999999999999999999999
Q ss_pred eeecceeeccc---CCCCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q 014849 158 DFGLSAVKEQI---RPDGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 158 DFGls~~~~~~---~~~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 231 (417)
|||.+..+... ..+..+....|||.|+|||.+.. ..|+|.+.||||+||+||.|+.|++||-+....+++.+|.
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 99999765322 12234455899999999999877 5688999999999999999999999999999999999999
Q ss_pred cCCCCCCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 232 KGEYRCPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 232 ~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.....+|.. ..+++++||.+||++||++|+++.+|..|||.......
T Consensus 333 n~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g~~ 381 (576)
T KOG0585|consen 333 NDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDGDS 381 (576)
T ss_pred cCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecceeccCCCC
Confidence 998888866 58999999999999999999999999999999876443
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-55 Score=431.88 Aligned_cols=263 Identities=38% Similarity=0.685 Sum_probs=247.5
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...+.|-|.+.++||+|-|+.|.+|++.-||..||||++++.+.. .....++..|++.|+.++|||||+||++..+.++
T Consensus 13 DgkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD-~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTK 91 (864)
T KOG4717|consen 13 DGKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLD-TLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTK 91 (864)
T ss_pred ccceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccc-hhhhhHHHHHHHHHHHhcCcCeeeeeehhcccce
Confidence 356889999999999999999999999999999999999998864 3457789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe-cCCCCeEEeeeecceeecc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL-DENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl-~~~~~vkl~DFGls~~~~~ 167 (417)
+|+|+|+-+||+|+++|.+ ..+.|+.+++||.||+.|+.|||+..||||||||+|+.+ ..-|-|||+|||++..+.
T Consensus 92 lyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~- 170 (864)
T KOG4717|consen 92 LYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ- 170 (864)
T ss_pred EEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC-
Confidence 9999999999999999986 689999999999999999999999999999999999876 567899999999997554
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (417)
++..+.+.||+..|-|||++.+..|+.+++||||||||||-|.+|++||...|..+.+..|+..+|..|...|.++++
T Consensus 171 --PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvPshvS~eCrd 248 (864)
T KOG4717|consen 171 --PGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVPSHVSKECRD 248 (864)
T ss_pred --CcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCchhhhHHHHH
Confidence 677899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||.+||..||++|.|.+||..++|++..-.
T Consensus 249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred HHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 999999999999999999999999986543
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-56 Score=407.44 Aligned_cols=255 Identities=33% Similarity=0.568 Sum_probs=227.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE-E-EeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV-L-ATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~-~-~~~~ 89 (417)
..-...|++.+.||+|+||.||++++..+|..+|.|.+..... +......+..|+.+|++|+|||||+++++ + +++.
T Consensus 15 ~~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~m-d~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 15 QKTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMM-DAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred cccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhc-cHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccch
Confidence 3445569999999999999999999999999999999986544 34456788899999999999999999983 3 4555
Q ss_pred EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH--cC--CeecCCCCCcEEecCCCCeEEeeee
Q 014849 90 KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHS--RG--VFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~--~g--ivHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.+++|||||.+|+|...|+. +.++|..++++|.||+.||.+||+ .. |.||||||.||+|+.+|.+||+|||
T Consensus 94 vlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfG 173 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFG 173 (375)
T ss_pred hhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccch
Confidence 59999999999999998853 579999999999999999999999 55 9999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CC-
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CP- 238 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p- 238 (417)
|++++.. .....++.+|||.||+||++...+|+ ++|||||+||++|||++-+.||.+.+..++.++|..++++ +|
T Consensus 174 L~r~l~s--~~tfA~S~VGTPyYMSPE~i~~~~Y~-~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~ 250 (375)
T KOG0591|consen 174 LGRFLSS--KTTFAHSLVGTPYYMSPERIHESGYN-FKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPD 250 (375)
T ss_pred hHhHhcc--hhHHHHhhcCCCcccCHHHHhcCCCC-cchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcH
Confidence 9998764 33466789999999999999999997 9999999999999999999999999999999999999986 77
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...|.++..||..|+.+||.+||+. +|++++.
T Consensus 251 ~~YS~~l~~li~~ci~vd~~~RP~t-----~~~v~di 282 (375)
T KOG0591|consen 251 EHYSTDLRELINMCIAVDPEQRPDT-----VPYVQDI 282 (375)
T ss_pred HHhhhHHHHHHHHHccCCcccCCCc-----chHHHHH
Confidence 6789999999999999999999987 5555543
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=430.46 Aligned_cols=258 Identities=35% Similarity=0.620 Sum_probs=240.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|-+.+.+|+|+||.||+|+.+.|.+.||||.+++.... ......+.+|++|++.++|||||.+++.|++..++|+|
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~-~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vV 79 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRN-EKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVV 79 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCc-hHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEE
Confidence 46899999999999999999999999999999999987643 23467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|||.| +|+.++.. +.++|+.++.++.|+++||.|||+++|.|||+||+|||++.+|.+|+||||+|+.... ....
T Consensus 80 te~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~--~t~v 156 (808)
T KOG0597|consen 80 TEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST--NTSV 156 (808)
T ss_pred ehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc--Ccee
Confidence 999988 99999986 8999999999999999999999999999999999999999999999999999986554 3446
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
+....|||.|||||++.+.+|+ ..+|.||+|||+||+++|++||......++.+.|.......|...|.++..|+..+|
T Consensus 157 ltsikGtPlYmAPElv~e~pyd-~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~~~S~~f~nfl~gLL 235 (808)
T KOG0597|consen 157 LTSIKGTPLYMAPELVEEQPYD-HTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPSTASSSFVNFLQGLL 235 (808)
T ss_pred eeeccCcccccCHHHHcCCCcc-chhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcccccHHHHHHHHHHh
Confidence 6778899999999999999997 999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+||.+|+|+.+++.|||++....
T Consensus 236 ~kdP~~RltW~~Ll~HpF~k~~~~ 259 (808)
T KOG0597|consen 236 IKDPAQRLTWTDLLGHPFWKGKIN 259 (808)
T ss_pred hcChhhcccHHHHhcChHHhhhhh
Confidence 999999999999999999986544
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-53 Score=416.04 Aligned_cols=257 Identities=37% Similarity=0.702 Sum_probs=235.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...+.|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 15 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 94 (329)
T PTZ00263 15 WKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVY 94 (329)
T ss_pred CCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEE
Confidence 34688999999999999999999999999999999998765544445677889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~---- 170 (329)
T PTZ00263 95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD---- 170 (329)
T ss_pred EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCC----
Confidence 99999999999998876 7899999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
...+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+.++..+....|.+.++.+++||++
T Consensus 171 -~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~ 248 (329)
T PTZ00263 171 -RTFTLCGTPEYLAPEVIQSKGHG-KAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKG 248 (329)
T ss_pred -CcceecCChhhcCHHHHcCCCCC-CcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCCCCCCHHHHHHHHH
Confidence 23456899999999999888875 8999999999999999999999999988999999999999999999999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCcccccc
Q 014849 252 LLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 252 ~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
||+.||.+||+ +++++.||||++.
T Consensus 249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~ 277 (329)
T PTZ00263 249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA 277 (329)
T ss_pred HhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence 99999999997 7999999999863
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-53 Score=420.52 Aligned_cols=262 Identities=40% Similarity=0.710 Sum_probs=240.0
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~ 89 (417)
...+...|++++.||+|.||.||.|+++.||+.+|+|++.+...........+.+|+++|+++. |||||++++++++..
T Consensus 30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~ 109 (382)
T KOG0032|consen 30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD 109 (382)
T ss_pred cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence 3556778999999999999999999999999999999999988765556788999999999998 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC----CCeEEeeeecceee
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN----WDLKISDFGLSAVK 165 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~----~~vkl~DFGls~~~ 165 (417)
.+|+|||+|.||+|++.|.+..++|..+..++.|++.++.|||+.||+||||||+|+|+... +.+|++|||+|...
T Consensus 110 ~~~lvmEL~~GGeLfd~i~~~~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~ 189 (382)
T KOG0032|consen 110 SVYLVMELCEGGELFDRIVKKHYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI 189 (382)
T ss_pred eEEEEEEecCCchHHHHHHHccCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence 99999999999999999987559999999999999999999999999999999999999543 47999999999875
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC--CC--C
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP--KW--T 241 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~--~ 241 (417)
.. ....++.||||.|+|||++...+|. ..+||||+||++|.|++|.+||.+.+......+|..+++.++ .| .
T Consensus 190 ~~---~~~~~~~~Gtp~y~APEvl~~~~y~-~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~i 265 (382)
T KOG0032|consen 190 KP---GERLHTIVGTPEYVAPEVLGGRPYG-DEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDI 265 (382)
T ss_pred cC---CceEeeecCCccccCchhhcCCCCC-cccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCcccc
Confidence 53 5678999999999999999988885 999999999999999999999999999999999999987553 34 4
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|..+++||++||..||.+|+|+.++|+|||++...
T Consensus 266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~ 300 (382)
T KOG0032|consen 266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG 300 (382)
T ss_pred CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence 89999999999999999999999999999998653
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=400.56 Aligned_cols=256 Identities=30% Similarity=0.463 Sum_probs=219.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|+..-.+|+|+||.||+|++++||+.||||.+.-+. .++....-..|||++|++++|||+|.++++|..+.++++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLV 79 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLV 79 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEE
Confidence 478999999999999999999999999999999985432 2333445567999999999999999999999999999999
Q ss_pred EeccCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|||+..-|.++-. ..+++++.+++|+.|++.|+.|||+++++|||||||||||+.+|.+||||||+|+.... ++..
T Consensus 80 FE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~--pgd~ 157 (396)
T KOG0593|consen 80 FEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA--PGDN 157 (396)
T ss_pred eeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--Ccch
Confidence 99998854444433 27899999999999999999999999999999999999999999999999999986653 4556
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------C-----
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--------------E----- 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------~----- 234 (417)
.+.++.|.+|+|||.+.+...+|.++||||+||++.||++|.+.|++.+..+..-.|.+. .
T Consensus 158 YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~G 237 (396)
T KOG0593|consen 158 YTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHG 237 (396)
T ss_pred hhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceee
Confidence 777899999999999999766689999999999999999999999998766655444321 0
Q ss_pred --CCCC----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 235 --YRCP----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 235 --~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
++-| +..+.-+.+|+++||..||.+|++.+|++.||||.
T Consensus 238 v~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd 288 (396)
T KOG0593|consen 238 VRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFD 288 (396)
T ss_pred eecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHH
Confidence 1111 12366788999999999999999999999999994
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-53 Score=408.60 Aligned_cols=260 Identities=33% Similarity=0.575 Sum_probs=224.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--EEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--KIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--~~~ 92 (417)
..+|..++.||+|+||.||++.+..+|...|||.+....... .+.+.+|+.+|+.++|||||++++...... .++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~ 92 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN 92 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence 567999999999999999999999999999999998763211 677899999999999999999999854444 699
Q ss_pred EEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecc-c
Q 014849 93 FVMEFAKGGELFAKISK-G-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQ-I 168 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~-~ 168 (417)
+.|||++||+|.+++.. + +|+|..++.|.+|+++||.|||++||+||||||+|||++. ++.+||+|||++..... .
T Consensus 93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~ 172 (313)
T KOG0198|consen 93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG 172 (313)
T ss_pred eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence 99999999999999987 4 7999999999999999999999999999999999999999 79999999999876553 1
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC--CCCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGE--YRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~--~~~p~~~s~~~ 245 (417)
..........|||.|||||++......+.++||||+||++.||+||+.||.. ....+..-.+.... +.+|.++|+++
T Consensus 173 ~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~~ls~~a 252 (313)
T KOG0198|consen 173 TKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPDSLSDEA 252 (313)
T ss_pred ccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCcccCHHH
Confidence 1223345678999999999998733333599999999999999999999988 44445444554443 57889999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++||.+||..||++|||++++|+|||.+....
T Consensus 253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred HHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 99999999999999999999999999987544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-53 Score=415.65 Aligned_cols=259 Identities=34% Similarity=0.534 Sum_probs=230.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AK 90 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~ 90 (417)
...+.|+.++.||+|+||.||+|++..||+.||+|.+..+.. +.++..-..|||.||++|+||||++|.+.+.++ ..
T Consensus 114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~-~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~s 192 (560)
T KOG0600|consen 114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNE-KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGS 192 (560)
T ss_pred cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccC-CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCce
Confidence 456789999999999999999999999999999999987753 456677778999999999999999999999877 78
Q ss_pred EEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
+|+|+|||+. +|.-++... +|++.+++.|++||+.||+|||++||.|||||..|||||.+|.+||+|||||++....
T Consensus 193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 9999999987 898888874 7999999999999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------CCCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----------YRCP 238 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------~~~p 238 (417)
. ...++..+-|.+|+|||.+.+..-+|.++|+||+||||.||++|++.|.+.+..+...+|.+-. ..+|
T Consensus 272 ~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP 350 (560)
T KOG0600|consen 272 G-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLP 350 (560)
T ss_pred C-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCC
Confidence 3 3346777889999999999998877899999999999999999999999999998888886421 1111
Q ss_pred -------------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 -------------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 -------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..+++.+.+|+..||..||.+|.|+.++|+|+||..
T Consensus 351 ~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 351 HATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT 405 (560)
T ss_pred cccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence 123788899999999999999999999999999954
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-52 Score=405.49 Aligned_cols=253 Identities=34% Similarity=0.621 Sum_probs=231.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47999999999999999999999999999999998754433334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++..... ..
T Consensus 81 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~-----~~ 155 (291)
T cd05612 81 EYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-----RT 155 (291)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccC-----Cc
Confidence 99999999999875 6899999999999999999999999999999999999999999999999999865432 22
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+..+..+...+|...++.+++||++||+
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 234 (291)
T cd05612 156 WTLCGTPEYLAPEVIQSKGHN-KAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFPRHLDLYAKDLIKKLLV 234 (291)
T ss_pred ccccCChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCCccCCHHHHHHHHHHcC
Confidence 356899999999999888775 8999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 014849 255 TDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.||.+||+ ++++++||||+.
T Consensus 235 ~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 235 VDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCHHHccCCccCCHHHHhcCccccC
Confidence 99999995 999999999975
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-54 Score=417.81 Aligned_cols=262 Identities=33% Similarity=0.511 Sum_probs=229.5
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
..+.++.||.+.+.||.|+||.||+|+..++|..||||.+.+....-+ ..--.||+..|++++ |||||+|.+++.++
T Consensus 4 ~~~~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~e--e~~nLREvksL~kln~hpniikL~Evi~d~ 81 (538)
T KOG0661|consen 4 TQVIFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWE--ECMNLREVKSLRKLNPHPNIIKLKEVIRDN 81 (538)
T ss_pred eehhHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHH--HHHHHHHHHHHHhcCCCCcchhhHHHhhcc
Confidence 346788999999999999999999999999999999999977653311 222358999999999 99999999999888
Q ss_pred C-EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 A-KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ~-~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
. .+|+|||||+. .|+.+++. ..|+|..++.|+.||+.||+|+|.+|+.|||+||||||+..+..+||+|||+|+-.
T Consensus 82 ~~~L~fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev 160 (538)
T KOG0661|consen 82 DRILYFVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREV 160 (538)
T ss_pred CceEeeeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEeccccccccc
Confidence 8 99999999976 89999976 57999999999999999999999999999999999999998889999999999865
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------ 233 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------ 233 (417)
. .....+.++.|.+|+|||++...++++.++|+|++|||++|+++-++.|.+.+..+.+-+|+.-
T Consensus 161 ~---SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg 237 (538)
T KOG0661|consen 161 R---SKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEG 237 (538)
T ss_pred c---cCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhH
Confidence 4 3456677889999999999999999999999999999999999999999999888877777531
Q ss_pred -------CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 -------EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 -------~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+.+| +..++++.+||.+||.+||.+|||+.|+|+||||+....
T Consensus 238 ~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~~ 299 (538)
T KOG0661|consen 238 YNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGRA 299 (538)
T ss_pred HHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccccc
Confidence 12222 125889999999999999999999999999999986443
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-54 Score=392.73 Aligned_cols=268 Identities=38% Similarity=0.687 Sum_probs=238.8
Q ss_pred CCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-----cchHHHHHHHHHHHHhC-CCCCcc
Q 014849 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-----GGLTAHVKREISIMSRL-RHPNIV 79 (417)
Q Consensus 6 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l-~HpnIv 79 (417)
+.......+..+|+-.+.||.|..+.|..|.++.||+.+|+|+++...-.. ..+.+.-.+|+.||+++ .||+|+
T Consensus 7 pd~~aa~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II 86 (411)
T KOG0599|consen 7 PDKDAAKGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYII 86 (411)
T ss_pred cchhhHhhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEE
Confidence 444555678899999999999999999999999999999999997532211 22445667899999998 599999
Q ss_pred eEEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 80 KLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 80 ~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+++++++++..+++|+|.|+.|+|+|++.. -.++|.+++++++||++|+.|||.++|+||||||+|||+++|-++||+|
T Consensus 87 ~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 87 DLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred EeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEec
Confidence 999999999999999999999999999987 5799999999999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccc------cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK------KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~------~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 232 (417)
||+|+... ++..+...||||.|.|||.+.. .|| +..+|+|+||||+|.||+|.+||.....+-|.+.|..
T Consensus 167 FGFa~~l~---~GekLrelCGTPgYLAPEtikC~m~e~~pGY-s~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 167 FGFACQLE---PGEKLRELCGTPGYLAPETIKCSMYENHPGY-SKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred cceeeccC---CchhHHHhcCCCcccChhheeeecccCCCCc-cchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 99998654 5678889999999999999853 355 4889999999999999999999999998999999999
Q ss_pred CCCC--CCCC--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 233 GEYR--CPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 233 ~~~~--~p~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|++. .|.| +|..+++||++||+.||.+|+|++|+|.||||.....
T Consensus 243 GkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~~~ 291 (411)
T KOG0599|consen 243 GKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQIAQ 291 (411)
T ss_pred cccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHHHH
Confidence 9875 4777 4788999999999999999999999999999975443
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-52 Score=407.86 Aligned_cols=251 Identities=38% Similarity=0.640 Sum_probs=227.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||+||+|++..+|+.||+|++.+..........++.+|+.+|+.++||||+++++++.+.+.+|+||||+.||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
+|.+.+.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~--~~~~~~~~~gt 158 (323)
T cd05571 81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCccccc--CCCcccceecC
Confidence 99998876 6899999999999999999999999999999999999999999999999999864221 22334567899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+.|+|||++.+..|+ .++||||+||++|+|++|..||...+.......+..+...+|...++++.+||++||+.||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05571 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred ccccChhhhcCCCCC-ccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHHc
Confidence 999999999888775 8999999999999999999999999988888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 014849 261 I-----TVDEILRDPWFKKD 275 (417)
Q Consensus 261 ~-----t~~eil~h~~f~~~ 275 (417)
| ++.++++||||+..
T Consensus 238 ~~~~~~~~~~ll~h~~f~~~ 257 (323)
T cd05571 238 LGGGPEDAKEIMEHRFFASI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-53 Score=422.81 Aligned_cols=265 Identities=45% Similarity=0.787 Sum_probs=249.8
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...+-++-|.+.++||+|.|++|.+|++..||..||||++++..... .....+.+|+++|+.++|||||++++++.++.
T Consensus 50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~-~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~ 128 (596)
T KOG0586|consen 50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNP-SKRQKLGREVDIMKSLNHPNIVKLFSVIETEA 128 (596)
T ss_pred cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccCh-HHHHHHHHHHHHHHhcCCcceeeeeeeeeecc
Confidence 34567899999999999999999999999999999999999876433 33456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+.+|++++++.+ ++..+..++.+|.|+++|++|||+++|+|||||++||||+.+-++||+|||+|.++.
T Consensus 129 ~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~-- 206 (596)
T KOG0586|consen 129 TLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFD-- 206 (596)
T ss_pred eeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeec--
Confidence 99999999999999999987 899999999999999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (417)
....+.+.||+|.|.|||++.+..|+|+.+|+||+|++||.|+.|.+||++.+..++......+.+.+|-..+.+..+|
T Consensus 207 -~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~ms~dce~l 285 (596)
T KOG0586|consen 207 -YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYMSCDCEDL 285 (596)
T ss_pred -ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccceeechhHHH
Confidence 5678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
|+++|.++|.+|++.++|+.|.|....+..
T Consensus 286 Lrk~lvl~Pskr~~~dqim~~~W~n~~~~~ 315 (596)
T KOG0586|consen 286 LRKFLVLNPSKRGPCDQIMKDRWRNDLLEA 315 (596)
T ss_pred HHHhhccCccccCCHHHhhhhcccchhhhh
Confidence 999999999999999999999999866554
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-52 Score=381.22 Aligned_cols=256 Identities=31% Similarity=0.524 Sum_probs=227.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.||...+.||+|+||.||+|++..||+.||||.+..... +.+......|||+.|+.++||||+.++++|...+.+.+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 589999999999999999999999999999999987653 4455667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++. +|...|+. ..++...++.|+.+++.||+|||++.|.||||||.|+|++++|.+||+|||+|+.+.. ++..
T Consensus 81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~--p~~~ 157 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGS--PNRI 157 (318)
T ss_pred Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCC--CCcc
Confidence 99976 89999986 5799999999999999999999999999999999999999999999999999998765 3344
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------- 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 234 (417)
....+-|.+|+|||.+.+...+|..+|+||.|||+.||+.|.+-|.+.+..+....|.+.-
T Consensus 158 ~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~ 237 (318)
T KOG0659|consen 158 QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVK 237 (318)
T ss_pred cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHH
Confidence 4555889999999999988777899999999999999999999999998888777776420
Q ss_pred ---CCCC------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ---YRCP------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ---~~~p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++.| ...++++.+|+.+||..||.+|+|+.|+++|+||+..
T Consensus 238 ~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~ 287 (318)
T KOG0659|consen 238 IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL 287 (318)
T ss_pred HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence 0111 1237888999999999999999999999999999874
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-51 Score=407.75 Aligned_cols=257 Identities=32% Similarity=0.590 Sum_probs=233.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..-.++|++.+.||+|+||.||+|.+..++ ..||+|++.+...........+.+|+.+++.++||||+++++++.+.+.
T Consensus 26 ~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~ 105 (340)
T PTZ00426 26 KMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESY 105 (340)
T ss_pred CCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCE
Confidence 344678999999999999999999976655 6899999987655445556778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
.|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 106 ~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~-- 183 (340)
T PTZ00426 106 LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT-- 183 (340)
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC--
Confidence 9999999999999999976 6899999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
...+.+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+....+.++..+...+|...+++++++|
T Consensus 184 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 259 (340)
T PTZ00426 184 ---RTYTLCGTPEYIAPEILLNVGHG-KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259 (340)
T ss_pred ---CcceecCChhhcCHHHHhCCCCC-ccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHH
Confidence 23467899999999999887774 89999999999999999999999999888999999998889999999999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCccccc
Q 014849 250 GRLLDTDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~-----t~~eil~h~~f~~ 274 (417)
++||+.||.+|+ |++++++||||++
T Consensus 260 ~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~ 289 (340)
T PTZ00426 260 KKLLSHDLTKRYGNLKKGAQNVKEHPWFGN 289 (340)
T ss_pred HHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999999999996 8999999999986
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=401.38 Aligned_cols=262 Identities=31% Similarity=0.488 Sum_probs=235.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|++.+.||+|.-|+||+|+.+.++..+|+|+++++......-..++..|-.||+.++||.++.||..+++....|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 56799999999999999999999999999999999999887766678888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc----
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ---- 167 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~---- 167 (417)
||||+||+|..+..+ +.++++.|+.|+.+++.||+|||..|||+||||||||||.++|++.|+||.||.....
T Consensus 156 meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~ 235 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTL 235 (459)
T ss_pred EecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCee
Confidence 999999999998875 5799999999999999999999999999999999999999999999999998753100
Q ss_pred -----------------------------c-C--------------------CCCcccccccCccccccccccccCCCCC
Q 014849 168 -----------------------------I-R--------------------PDGMLHTLCGTPAYVAPEILAKKGYDGA 197 (417)
Q Consensus 168 -----------------------------~-~--------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~ 197 (417)
. . .+......+||-.|+|||++.+.|+. .
T Consensus 236 ~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg-s 314 (459)
T KOG0610|consen 236 VKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG-S 314 (459)
T ss_pred eccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC-c
Confidence 0 0 00122346899999999999999985 9
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC--CChHHHHHHHHhccCCCCCCCC----HHHHhcCcc
Q 014849 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW--TSPDLKWFIGRLLDTDPATRIT----VDEILRDPW 271 (417)
Q Consensus 198 ~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~h~~ 271 (417)
++|+|+|||.+||||.|..||.+.+..+.+.+|......+|.. .+..+++||+++|.+||++|+. +.||++|||
T Consensus 315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpF 394 (459)
T KOG0610|consen 315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPF 394 (459)
T ss_pred hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCcc
Confidence 9999999999999999999999999999999999888877754 5789999999999999999998 999999999
Q ss_pred cccccc
Q 014849 272 FKKDYK 277 (417)
Q Consensus 272 f~~~~~ 277 (417)
|+.-..
T Consensus 395 F~gVnW 400 (459)
T KOG0610|consen 395 FEGVNW 400 (459)
T ss_pred ccCCCh
Confidence 986433
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-51 Score=397.42 Aligned_cols=261 Identities=31% Similarity=0.492 Sum_probs=231.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.+.|++...||.|.-+.||+|+.+.+++.||||+++.+++... .+.+++|++.|+.++||||++++..|.....+|
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LW 100 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELW 100 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEEecceeE
Confidence 346789999999999999999999999999999999999987554 788999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||.||.+|++.+.+.. ..++|..+..++++++.||.|||.+|-||||||+.||||+++|.|||+|||.+.......
T Consensus 101 vVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G 180 (516)
T KOG0582|consen 101 VVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSG 180 (516)
T ss_pred EeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccC
Confidence 99999999999999975 579999999999999999999999999999999999999999999999999987543322
Q ss_pred CC-C-cccccccCcccccccccc--ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC------
Q 014849 170 PD-G-MLHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK------ 239 (417)
Q Consensus 170 ~~-~-~~~~~~Gt~~y~APEvl~--~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~------ 239 (417)
.. . ...+..|||+|||||++. ..||+ .|+||||+|+...||.+|..||..-.++.+...-.++.++.+.
T Consensus 181 ~R~~~rf~tfvgtp~wmAPEvl~q~~~GYd-fKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~ 259 (516)
T KOG0582|consen 181 DRQVTRFNTFVGTPCWMAPEVLMQQLHGYD-FKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDK 259 (516)
T ss_pred ceeeEeeccccCcccccChHHhhhcccCcc-chhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCCh
Confidence 11 1 226789999999999954 45786 9999999999999999999999998888877766666665432
Q ss_pred ----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 240 ----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 240 ----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.++..++.+|..||+.||.+|||++++|+|+||++..
T Consensus 260 d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 260 DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAK 300 (516)
T ss_pred HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhcc
Confidence 3467889999999999999999999999999998643
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-51 Score=406.86 Aligned_cols=258 Identities=30% Similarity=0.511 Sum_probs=224.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP---- 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~---- 170 (417)
||++||+|.+++.+ +.+++.+++.++.|++.||.|||++||+||||||+|||++.++++||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~ 160 (363)
T cd05628 81 EFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFY 160 (363)
T ss_pred cCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCccccccccccccc
Confidence 99999999999875 7899999999999999999999999999999999999999999999999999864321100
Q ss_pred -----------------------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 171 -----------------------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 171 -----------------------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
.....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 161 RNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred ccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCC-CchhhhhhHHHHHHHHhCCCCCCCC
Confidence 0112356899999999999888886 8999999999999999999999999
Q ss_pred CHHHHHHHHhcC--CCCCCC--CCChHHHHHHHHhccCCCC---CCCCHHHHhcCcccccc
Q 014849 222 NLMAMYRKIYKG--EYRCPK--WTSPDLKWFIGRLLDTDPA---TRITVDEILRDPWFKKD 275 (417)
Q Consensus 222 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~---~R~t~~eil~h~~f~~~ 275 (417)
+..+.+.++... ...+|+ ..++++++||.+|+. +|. .||+++||++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence 988888888763 344454 368999999999875 444 46899999999999864
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-51 Score=400.10 Aligned_cols=249 Identities=37% Similarity=0.621 Sum_probs=226.1
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999999999999999999876544444466788999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~ 182 (417)
.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+||+.
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~ 158 (312)
T cd05585 81 FHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMK--DDDKTNTFCGTPE 158 (312)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCcc--CCCccccccCCcc
Confidence 999865 7899999999999999999999999999999999999999999999999999875322 1223456789999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCC-
Q 014849 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRI- 261 (417)
Q Consensus 183 y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~- 261 (417)
|+|||++.+..|+ .++||||+||++|+|++|..||.+.+....+..+......+|...++++++||.+||..||.+||
T Consensus 159 y~aPE~~~~~~~~-~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~~ 237 (312)
T cd05585 159 YLAPELLLGHGYT-KAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237 (312)
T ss_pred cCCHHHHcCCCCC-CccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHcCCCHHHcCC
Confidence 9999999888875 89999999999999999999999999999999999998899999999999999999999999997
Q ss_pred --CHHHHhcCcccccc
Q 014849 262 --TVDEILRDPWFKKD 275 (417)
Q Consensus 262 --t~~eil~h~~f~~~ 275 (417)
++.+++.||||.+.
T Consensus 238 ~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 238 YNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCCHHHHHcCCCcCCC
Confidence 58999999999864
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-50 Score=398.75 Aligned_cols=255 Identities=32% Similarity=0.573 Sum_probs=229.0
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH---HhCCCCCcceEEEEEEeCCEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM---SRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il---~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.++ +.++||||+++++++.+...+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 78999999999999999999999999999999876544444456777777665 456799999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|||+.|++|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 ~E~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG--FGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCC--CCCcc
Confidence 9999999999999888999999999999999999999999999999999999999999999999999864221 22334
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+..+....|...++++.++|.+||+
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~ 237 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYT-RAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSREAISIMRRLLR 237 (324)
T ss_pred cccccCccccCHhHhcCCCCC-cccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhh
Confidence 567899999999999887774 8999999999999999999999999988999999888888899999999999999999
Q ss_pred CCCCCCC-----CHHHHhcCcccccc
Q 014849 255 TDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 255 ~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
.||.+|| ++.++++||||++.
T Consensus 238 ~dP~~R~~~~~~~~~~l~~~~~f~~~ 263 (324)
T cd05589 238 RNPERRLGSGEKDAEDVKKQPFFRDI 263 (324)
T ss_pred cCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence 9999999 79999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-51 Score=400.55 Aligned_cols=250 Identities=37% Similarity=0.641 Sum_probs=226.5
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544445677889999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~gt 158 (328)
T cd05593 81 ELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGIT--DAATMKTFCGT 158 (328)
T ss_pred CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCC--cccccccccCC
Confidence 99988875 6799999999999999999999999999999999999999999999999999864221 12234457899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+......+|...++++.+||++||++||++|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (328)
T cd05593 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTLSADAKSLLSGLLIKDPNKR 237 (328)
T ss_pred cCccChhhhcCCCCC-ccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCCCHHHHHHHHHHcCCCHHHc
Confidence 999999999887774 8999999999999999999999998888888888888888999999999999999999999999
Q ss_pred C-----CHHHHhcCccccc
Q 014849 261 I-----TVDEILRDPWFKK 274 (417)
Q Consensus 261 ~-----t~~eil~h~~f~~ 274 (417)
+ ++.++++||||..
T Consensus 238 ~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 238 LGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHhcCCCcCC
Confidence 7 8999999999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=398.77 Aligned_cols=251 Identities=37% Similarity=0.652 Sum_probs=226.7
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+++.++||||+++++.+.+...+|+||||++||
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765444444667788999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+||
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~gt 158 (323)
T cd05595 81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGATMKTFCGT 158 (323)
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccC--CCCccccccCC
Confidence 99988875 6799999999999999999999999999999999999999999999999999864221 22233456899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|..+++++.+||.+||+.||.+|
T Consensus 159 ~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~L~~dP~~R 237 (323)
T cd05595 159 PEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 237 (323)
T ss_pred cCcCCcccccCCCCC-chhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHHHh
Confidence 999999999887775 8999999999999999999999999988888888888888899999999999999999999999
Q ss_pred C-----CHHHHhcCcccccc
Q 014849 261 I-----TVDEILRDPWFKKD 275 (417)
Q Consensus 261 ~-----t~~eil~h~~f~~~ 275 (417)
+ ++.++++||||.+.
T Consensus 238 ~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 238 LGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 8 89999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-50 Score=397.76 Aligned_cols=251 Identities=35% Similarity=0.625 Sum_probs=226.3
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566777888888876 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (320)
T cd05590 81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIF--NGKTTSTFCG 158 (320)
T ss_pred chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCc--CCCccccccc
Confidence 999998875 6899999999999999999999999999999999999999999999999999864321 2223455789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||...+..+++..+..+....|.+.++++.+||++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~L~~dP~~ 237 (320)
T cd05590 159 TPDYIAPEILQEMLYG-PSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLSQDAVDILKAFMTKNPTM 237 (320)
T ss_pred CccccCHHHHcCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 899999999999999999999999999999999999988999999999999999999999999
Q ss_pred CCCH------HHHhcCcccccc
Q 014849 260 RITV------DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~------~eil~h~~f~~~ 275 (417)
||++ +++++||||+..
T Consensus 238 R~~~~~~~~~~~~~~h~~f~~~ 259 (320)
T cd05590 238 RLGSLTLGGEEAILRHPFFKEL 259 (320)
T ss_pred CCCCCCCCCHHHHHcCCCcCCC
Confidence 9998 999999999763
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-50 Score=399.04 Aligned_cols=254 Identities=29% Similarity=0.518 Sum_probs=226.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 57999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 81 e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~ 155 (333)
T cd05600 81 EYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YA 155 (333)
T ss_pred eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----cc
Confidence 99999999999975 6899999999999999999999999999999999999999999999999999875432 34
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC------CCChHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK------WTSPDLK 246 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~------~~s~~~~ 246 (417)
.+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+.... ...|. ..++++.
T Consensus 156 ~~~~gt~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~ 234 (333)
T cd05600 156 NSVVGSPDYMAPEVLRGKGYD-FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234 (333)
T ss_pred CCcccCccccChhHhcCCCCC-CccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence 567899999999999888775 89999999999999999999999988888777765432 22233 3489999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+||.+||..+|.+|||++++++||||++.
T Consensus 235 ~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 235 DLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred HHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 99999999999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-50 Score=403.70 Aligned_cols=258 Identities=35% Similarity=0.601 Sum_probs=225.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.++..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC---
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD--- 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 171 (417)
||+.||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 81 E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (364)
T cd05599 81 EYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFY 160 (364)
T ss_pred CCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccccccc
Confidence 99999999999875 68999999999999999999999999999999999999999999999999998643211100
Q ss_pred ---------------------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC
Q 014849 172 ---------------------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218 (417)
Q Consensus 172 ---------------------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf 218 (417)
....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 161 RILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYN-KECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred ccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCC-CeeeeecchhHHHHhhcCCCCC
Confidence 011245799999999999888875 9999999999999999999999
Q ss_pred CCCCHHHHHHHHhcCC--CCCCC--CCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccc
Q 014849 219 NDPNLMAMYRKIYKGE--YRCPK--WTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKD 275 (417)
Q Consensus 219 ~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~f~~~ 275 (417)
.+.+..+.+.++.... +..|. ..++++++||.+||. +|.+|++ +.++++||||+..
T Consensus 240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 9988888887776543 33343 358999999999997 9999998 9999999999863
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-50 Score=395.59 Aligned_cols=256 Identities=30% Similarity=0.536 Sum_probs=230.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP-NIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~ 95 (417)
.|++.+.||+|+||.||+|++..+++.||+|++.+...........+..|+.+++.++|+ +|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 489999999999999999999999999999999876554444566788899999999765 5888999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~ 158 (324)
T cd05587 81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIF--GGKTT 158 (324)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCC--CCCce
Confidence 99999999998875 6899999999999999999999999999999999999999999999999999864221 22334
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+.+..+.......|...++++.+++++||.
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~ 237 (324)
T cd05587 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLLT 237 (324)
T ss_pred eeecCCccccChhhhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhh
Confidence 567899999999999888775 8999999999999999999999999989999999988888899999999999999999
Q ss_pred CCCCCCCCH-----HHHhcCcccccc
Q 014849 255 TDPATRITV-----DEILRDPWFKKD 275 (417)
Q Consensus 255 ~dP~~R~t~-----~eil~h~~f~~~ 275 (417)
+||.+|++. +++++||||+..
T Consensus 238 ~~P~~R~~~~~~~~~~~~~hp~~~~~ 263 (324)
T cd05587 238 KHPAKRLGCGPTGERDIREHAFFRRI 263 (324)
T ss_pred cCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999986 899999999863
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-52 Score=390.09 Aligned_cols=263 Identities=38% Similarity=0.656 Sum_probs=246.4
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+...-++.|+..++||+|+||+|-+|+.+.||+.+|||+++++-+......++-..|-++|+.++||.+..|...|++..
T Consensus 162 ~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~d 241 (516)
T KOG0690|consen 162 KNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQD 241 (516)
T ss_pred cceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCc
Confidence 33557889999999999999999999999999999999999998887777888889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+++||||+.||+|+..+.+ ..++|+.++.|-.+|++||.|||+++|++||||.+|+|||.+|++||+|||++. ...
T Consensus 242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCK--E~I 319 (516)
T KOG0690|consen 242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCK--EEI 319 (516)
T ss_pred eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccch--hcc
Confidence 99999999999999999987 789999999999999999999999999999999999999999999999999985 333
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~l 248 (417)
..+....+.||||.|.|||++....| |.++|+|.+||++|||++|++||...+...++.-|..++..+|..+|++++.|
T Consensus 320 ~~g~t~kTFCGTPEYLAPEVleDnDY-graVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFPr~ls~eAktL 398 (516)
T KOG0690|consen 320 KYGDTTKTFCGTPEYLAPEVLEDNDY-GRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFPRTLSPEAKTL 398 (516)
T ss_pred cccceeccccCChhhcCchhhccccc-cceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCCccCCHHHHHH
Confidence 45567789999999999999999988 59999999999999999999999999999999999999999999999999999
Q ss_pred HHHhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 249 IGRLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 249 i~~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
+..+|..||.+|. .+.||++|+||...
T Consensus 399 LsGLL~kdP~kRLGgGpdDakEi~~h~FF~~v 430 (516)
T KOG0690|consen 399 LSGLLKKDPKKRLGGGPDDAKEIMRHRFFASV 430 (516)
T ss_pred HHHHhhcChHhhcCCCchhHHHHHhhhhhccC
Confidence 9999999999998 58999999999864
|
|
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-50 Score=396.80 Aligned_cols=250 Identities=33% Similarity=0.586 Sum_probs=226.4
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+..|+.+++.+ +||||+++++++.++..+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 4699999999999999999999999999876554444556777899999866 799999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05591 81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGIL--NGVTTTTFCG 158 (321)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceeccc--CCcccccccc
Confidence 999988865 6899999999999999999999999999999999999999999999999999864322 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..|+ .++|||||||++|+|++|+.||...+....+..+..+....|.+.++++.+||++||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~~~L~~dp~~ 237 (321)
T cd05591 159 TPDYIAPEILQELEYG-PSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWLSKEAVSILKAFMTKNPNK 237 (321)
T ss_pred CccccCHHHHcCCCCC-CccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhccCHHH
Confidence 9999999999887775 899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CC-------CHHHHhcCccccc
Q 014849 260 RI-------TVDEILRDPWFKK 274 (417)
Q Consensus 260 R~-------t~~eil~h~~f~~ 274 (417)
|| +++++++||||..
T Consensus 238 R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 238 RLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred cCCCCCCCCCHHHHhcCCccCC
Confidence 99 9999999999975
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-50 Score=388.19 Aligned_cols=255 Identities=26% Similarity=0.396 Sum_probs=221.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||+||+|.+..+|+.||+|.+.+...........+.+|+.+|+.++||||+++++++.+.+.+++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 38899999999999999999999999999999987655443344567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GET 157 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCC---CCe
Confidence 9999999887753 3689999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
....+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||...+. ......+.......+...++++.+||
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li 236 (285)
T cd05631 158 VRGRVGTVGYMAPEVINNEKYT-FSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC 236 (285)
T ss_pred ecCCCCCCCccCHhhhcCCCCC-cccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence 3456799999999999888775 899999999999999999999987543 23334444455566777899999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
++||+.||.+||| ++++++||||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 9999999999997 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-50 Score=404.15 Aligned_cols=259 Identities=33% Similarity=0.553 Sum_probs=222.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 1 SMFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CCceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEE
Confidence 46999999999999999999999999999999998766555555678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 99999999999876 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 170 ----------------------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 170 ----------------------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
......+.+||+.|+|||++.+.+|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlG~il~ 239 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYT-QLCDWWSVGVILF 239 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCC-CccceeehhhHHH
Confidence 00012346899999999999888875 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhc--CCCCCCC--CCChHHHHHHHHhc--cCCCCCCCCHHHHhcCcccccc
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYK--GEYRCPK--WTSPDLKWFIGRLL--DTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~--~~s~~~~~li~~~L--~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+|++|..||...+..+...++.. .....|. ..++++.+||.+|+ ..+|..|+|+++++.||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~ 311 (381)
T cd05626 240 EMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV 311 (381)
T ss_pred HHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence 99999999998887766666653 2344444 46899999999965 4555569999999999999863
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-50 Score=386.27 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=214.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||.|+||.||+|++..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLV 81 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEE
Confidence 4689999999999999999999999999999999975432 22345677999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~--~~~ 158 (288)
T cd07871 82 FEYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSV--PTK 158 (288)
T ss_pred EeCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccC--CCc
Confidence 999976 89888864 4589999999999999999999999999999999999999999999999999875432 222
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------ 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 234 (417)
.....+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07871 159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR 238 (288)
T ss_pred cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence 33456789999999998765444589999999999999999999999877666554443210
Q ss_pred -CCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 -YRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 -~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+..| ...++++.+||++||++||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f 288 (288)
T cd07871 239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288 (288)
T ss_pred ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence 0111 2357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=407.21 Aligned_cols=257 Identities=33% Similarity=0.568 Sum_probs=231.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-..+|.....+|+|+.|.||.|....+++.||||.++.....+ .+-+.+|+.+|+..+|+|||++++.|.-.+.+
T Consensus 269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deL 345 (550)
T KOG0578|consen 269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDEL 345 (550)
T ss_pred CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhccccee
Confidence 445678999999999999999999999999999999999876544 56688999999999999999999999888999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++||+|.+.+....++|.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||+++......
T Consensus 346 WVVMEym~ggsLTDvVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~-- 423 (550)
T KOG0578|consen 346 WVVMEYMEGGSLTDVVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQ-- 423 (550)
T ss_pred EEEEeecCCCchhhhhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccccc--
Confidence 999999999999999999899999999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHhcCC--CCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA-MYRKIYKGE--YRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~-~~~~i~~~~--~~~p~~~s~~~~~l 248 (417)
....+.+|||+|||||++..+.| |+++||||||++++||.-|.+||-..++.. +|.--..|. +..|...|+.+++|
T Consensus 424 ~KR~TmVGTPYWMAPEVvtrk~Y-G~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~~~klS~~~kdF 502 (550)
T KOG0578|consen 424 SKRSTMVGTPYWMAPEVVTRKPY-GPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKNPEKLSPELKDF 502 (550)
T ss_pred CccccccCCCCccchhhhhhccc-CccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCCccccCHHHHHH
Confidence 36678899999999999999998 599999999999999999999998666554 444333443 45678899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+.+||+.||.+|+|+.|+|+||||+.
T Consensus 503 L~~cL~~dv~~RasA~eLL~HpFl~~ 528 (550)
T KOG0578|consen 503 LDRCLVVDVEQRASAKELLEHPFLKM 528 (550)
T ss_pred HHHHhhcchhcCCCHHHHhcChhhhh
Confidence 99999999999999999999999954
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-50 Score=404.28 Aligned_cols=258 Identities=34% Similarity=0.582 Sum_probs=223.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++++.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++.+.++..+|+||
T Consensus 1 ~~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 1 SMFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CCcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEE
Confidence 47999999999999999999999999999999998765544455678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
|||+||+|.+.+.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 99999999999876 679999999999999999999999999999999999999999999999999975321000
Q ss_pred ----------------------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 170 ----------------------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 170 ----------------------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
......+.+||+.|+|||++.+.+|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILY 239 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCC-CeeeEEechHHHH
Confidence 00112345899999999999988886 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccc
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYKG--EYRCP--KWTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKD 275 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~f~~~ 275 (417)
+|++|++||.+.+..+...++... ....| ...++++.+||.+|+ .+|.+|++ ++++++||||+..
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 240 EMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 999999999998877777666543 23334 346999999999986 59999997 9999999999864
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-50 Score=393.04 Aligned_cols=251 Identities=33% Similarity=0.608 Sum_probs=223.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+|+.||+|++.+..............|..++..+ +||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4799999999999999999999999999876543333455667788888754 899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05620 81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVF--GDNRASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeeccc--CCCceeccCC
Confidence 999998875 6899999999999999999999999999999999999999999999999999863221 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+...+...+.......|.+.+.++++||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (316)
T cd05620 159 TPDYIAPEILQGLKYT-FSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLFERDPTR 237 (316)
T ss_pred CcCccCHHHHcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999888775 899999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCH-HHHhcCcccccc
Q 014849 260 RITV-DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~-~eil~h~~f~~~ 275 (417)
||++ +++++||||+..
T Consensus 238 R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 238 RLGVVGNIRGHPFFKTI 254 (316)
T ss_pred cCCChHHHHcCCCcCCC
Confidence 9997 689999999764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=397.25 Aligned_cols=251 Identities=37% Similarity=0.647 Sum_probs=226.3
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+...+|+||||++||
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 47999999999999999999999999998765544444567788999999999999999999999999999999999999
Q ss_pred ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|...+.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~--~~~~~~~~~g 158 (325)
T cd05594 81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--DGATMKTFCG 158 (325)
T ss_pred cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCC--CCcccccccC
Confidence 99998875 679999999999999999999998 7999999999999999999999999999864321 1223345689
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|...++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~L~~dP~~ 237 (325)
T cd05594 159 TPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLSPEAKSLLSGLLKKDPKQ 237 (325)
T ss_pred CcccCCHHHHccCCCC-CccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhhcCHHH
Confidence 9999999999887775 899999999999999999999999988888888888888889999999999999999999999
Q ss_pred CC-----CHHHHhcCcccccc
Q 014849 260 RI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 260 R~-----t~~eil~h~~f~~~ 275 (417)
|+ ++.++++||||+..
T Consensus 238 R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 238 RLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred hCCCCCCCHHHHhcCCCcCCC
Confidence 97 99999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-50 Score=401.65 Aligned_cols=262 Identities=33% Similarity=0.500 Sum_probs=229.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~ 119 (370)
T cd05596 40 MKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLY 119 (370)
T ss_pred CCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEE
Confidence 34578999999999999999999999999999999998755444444566789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||++||+|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 120 lv~Ey~~gg~L~~~l~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~-~~ 198 (370)
T cd05596 120 MVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANG-MV 198 (370)
T ss_pred EEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCC-cc
Confidence 99999999999999988889999999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCChHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK--WTSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~ 245 (417)
...+.+||+.|+|||++.+.. +.+.++|||||||++|+|++|.+||.+.+....+.++.... ..+|. ..|.++
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~ 278 (370)
T cd05596 199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA 278 (370)
T ss_pred cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence 234568999999999987543 34589999999999999999999999999888888887643 44454 468999
Q ss_pred HHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
.+||++||+.+|.+ |+|++++++||||+..
T Consensus 279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~ 310 (370)
T cd05596 279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310 (370)
T ss_pred HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence 99999999999988 9999999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-50 Score=399.23 Aligned_cols=258 Identities=36% Similarity=0.621 Sum_probs=229.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47999999999999999999999999999999998765545455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 160 (350)
T cd05573 81 EYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160 (350)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCccccc
Confidence 99999999999876 689999999999999999999999999999999999999999999999999987543321
Q ss_pred ----------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 014849 170 ----------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY 227 (417)
Q Consensus 170 ----------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~ 227 (417)
........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYG-LECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred ccccccccccccccccccccccccccccccccCccccCHHHHcCCCCC-CceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 01123456799999999999888775 9999999999999999999999999888888
Q ss_pred HHHhc--CCCCCCCC--CChHHHHHHHHhccCCCCCCCC-HHHHhcCcccccc
Q 014849 228 RKIYK--GEYRCPKW--TSPDLKWFIGRLLDTDPATRIT-VDEILRDPWFKKD 275 (417)
Q Consensus 228 ~~i~~--~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t-~~eil~h~~f~~~ 275 (417)
.++.. .....|.. .++++.+||.+||. ||.+||+ ++++++||||+..
T Consensus 240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~ 291 (350)
T cd05573 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI 291 (350)
T ss_pred HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence 88876 44555544 49999999999997 9999999 9999999999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-50 Score=392.26 Aligned_cols=255 Identities=29% Similarity=0.535 Sum_probs=229.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.|++.+.||+|+||.||+|++..+++.||+|++.+..............|..++..+ +||+|+++++++.+.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 489999999999999999999999999999999876544444455677788888877 5899999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~--~~~~~ 158 (323)
T cd05616 81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMW--DGVTT 158 (323)
T ss_pred cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCC--CCCcc
Confidence 99999999998875 7899999999999999999999999999999999999999999999999999864321 12234
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+...++..+.......|...++++.+|+.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~l~ 237 (323)
T cd05616 159 KTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMT 237 (323)
T ss_pred ccCCCChhhcCHHHhcCCCCC-CccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcCCHHHHHHHHHHcc
Confidence 467899999999999988875 8999999999999999999999999999999999988888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCccccc
Q 014849 255 TDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.||.+|++ ..++++||||+.
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 238 KHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred cCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 99999998 489999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-50 Score=402.44 Aligned_cols=257 Identities=33% Similarity=0.566 Sum_probs=222.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||+||+|.+..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP---- 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~---- 170 (417)
||++||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~ 160 (377)
T cd05629 81 EFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYY 160 (377)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccc
Confidence 99999999999876 6799999999999999999999999999999999999999999999999999853211000
Q ss_pred ---------C--------------------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 171 ---------D--------------------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 171 ---------~--------------------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
. ......+||+.|+|||++.+..|+ .++|||||||++|
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ 239 (377)
T cd05629 161 QKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYG-QECDWWSLGAIMF 239 (377)
T ss_pred cccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCC-CceeeEecchhhh
Confidence 0 001135799999999999888875 8999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcC--CCCCCC--CCChHHHHHHHHhccCCCCCC---CCHHHHhcCccccc
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYKG--EYRCPK--WTSPDLKWFIGRLLDTDPATR---ITVDEILRDPWFKK 274 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R---~t~~eil~h~~f~~ 274 (417)
+|++|.+||.+.+..+.+.++... ....|. ..++++++||.+||. +|.+| +|+.|++.||||+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~ 310 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG 310 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence 999999999998888877777653 344454 368999999999998 77765 59999999999985
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-50 Score=394.15 Aligned_cols=250 Identities=31% Similarity=0.586 Sum_probs=220.5
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999999999999999999876554444566788999999988 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .......+.+|
T Consensus 81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~--~~~~~~~~~~g 158 (329)
T cd05588 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccc--cCCCccccccC
Confidence 999988865 789999999999999999999999999999999999999999999999999986321 12334456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------CHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---------NLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---------~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||... .....+..+.......|...++++.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~ 237 (329)
T cd05588 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIPRSLSVKASSVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 8999999999999999999999631 22235566777778889999999999999
Q ss_pred HhccCCCCCCCC------HHHHhcCccccc
Q 014849 251 RLLDTDPATRIT------VDEILRDPWFKK 274 (417)
Q Consensus 251 ~~L~~dP~~R~t------~~eil~h~~f~~ 274 (417)
+||+.||.+|+| ++++++||||+.
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999999999997 799999999975
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=401.36 Aligned_cols=263 Identities=33% Similarity=0.522 Sum_probs=228.5
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.++..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 34467899999999999999999999999999999999875544444456688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 119 ~lv~Ey~~gg~L~~~l~~~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~-~ 197 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG-M 197 (370)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC-c
Confidence 999999999999999988889999999999999999999999999999999999999999999999999987643211 1
Q ss_pred CcccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC--CCChH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK--WTSPD 244 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~ 244 (417)
....+.+||+.|+|||++.+.+ +.+.++||||+||++|+|++|..||...+....+.++.... +..|. ..++.
T Consensus 198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~ 277 (370)
T cd05621 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISKH 277 (370)
T ss_pred eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCHH
Confidence 1234678999999999997653 34589999999999999999999999998888888887643 44454 45899
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
+++++.+||+.+|.+ |+|++|+++||||+..
T Consensus 278 ~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 278 AKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999865544 8999999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-49 Score=383.06 Aligned_cols=254 Identities=30% Similarity=0.447 Sum_probs=214.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++...+.+|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 79 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVF 79 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEE
Confidence 479999999999999999999999999999999976532 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.+...... +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~~ 158 (287)
T cd07848 80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS-NANY 158 (287)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCcccccccc-cccc
Confidence 99999877665543 579999999999999999999999999999999999999999999999999987643211 1223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 235 (417)
...+||+.|+|||++.+..++ .++||||+||++|+|++|++||.+.+..+....+.... .
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07848 159 TEYVATRWYRSPELLLGAPYG-KAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL 237 (287)
T ss_pred cccccccccCCcHHHcCCCCC-CchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence 356799999999999887775 89999999999999999999998876544333222110 0
Q ss_pred CCC-------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 RCP-------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~~p-------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..| ...|+++.+||++||++||++|||++|+++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f 287 (287)
T cd07848 238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF 287 (287)
T ss_pred ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 011 1257789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=386.32 Aligned_cols=256 Identities=28% Similarity=0.460 Sum_probs=211.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 4789999999999999999999999999999999976532 22244677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 158 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSV--PSH 158 (303)
T ss_pred EECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccC--CCc
Confidence 99996 577777754 5799999999999999999999999999999999999999999999999999865332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhc--CCC---------C----
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYK--GEY---------R---- 236 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~--~~~---------~---- 236 (417)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+... ......+.. +.. .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (303)
T cd07869 159 TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHF 238 (303)
T ss_pred cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcccc
Confidence 334567899999999987655445899999999999999999999987532 222222211 000 0
Q ss_pred --------CCC---------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 --------CPK---------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 --------~p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.|. ..++++.+|+++||+.||++|||+.|+++||||++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~ 294 (303)
T cd07869 239 KPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL 294 (303)
T ss_pred ccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence 010 134678999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-50 Score=384.31 Aligned_cols=264 Identities=28% Similarity=0.459 Sum_probs=224.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----- 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----- 87 (417)
.+..+|...+.||+|+||.|+.|.++.||+.||||.+.... ...-...+..||+.+|+.++|+||+.+.+++..
T Consensus 19 ~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~ 97 (359)
T KOG0660|consen 19 EIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDK 97 (359)
T ss_pred eccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccc
Confidence 34567777899999999999999999999999999987432 344457888999999999999999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
-+.+|+|+|+| +.+|...|+.++ |+++.++.++.||+.||.|+|+.||+||||||.|+|++.++.+||+|||+|+...
T Consensus 98 f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~ 176 (359)
T KOG0660|consen 98 FNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLD 176 (359)
T ss_pred cceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceeecc
Confidence 35799999999 569999999876 9999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 232 (417)
.....+..+.++.|.+|+|||++....-++.++||||+|||+.||++|++.|.+.+....+..|..
T Consensus 177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~ 256 (359)
T KOG0660|consen 177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR 256 (359)
T ss_pred ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence 443455667788999999999987654446999999999999999999999988766555444421
Q ss_pred ---------CCCCCC--------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 233 ---------GEYRCP--------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 233 ---------~~~~~p--------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.....| +..++.+.+|+.+||..||.+|+|++|+|+|||+.....+
T Consensus 257 s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp 319 (359)
T KOG0660|consen 257 SEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDP 319 (359)
T ss_pred cHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCC
Confidence 011111 2468999999999999999999999999999999876544
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-50 Score=402.06 Aligned_cols=257 Identities=35% Similarity=0.566 Sum_probs=222.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998765444445677889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++||+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~ 160 (376)
T cd05598 81 DYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (376)
T ss_pred eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccccc
Confidence 99999999999876 678999999999999999999999999999999999999999999999999974221000
Q ss_pred ------------------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc
Q 014849 170 ------------------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 170 ------------------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~ 213 (417)
......+.+||+.|+|||++.+.+++ .++|||||||++|+|++
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyell~ 239 (376)
T cd05598 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYT-QLCDWWSVGVILYEMLV 239 (376)
T ss_pred ccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCC-cceeeeeccceeeehhh
Confidence 00011245899999999999888875 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChHHHHHHHHhccCCCCCCC---CHHHHhcCccccc
Q 014849 214 GYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKK 274 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~ 274 (417)
|+.||.+.+..+....+.... ...| ...++++.+||.+|+ .+|.+|+ |+.++++||||+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 999999988777766665432 2333 346899999999977 5999999 9999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=390.46 Aligned_cols=251 Identities=34% Similarity=0.656 Sum_probs=222.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+..............|..++.. .+||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 479999999999999999999999999987654444445556677777765 4899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~--~~~~~~~~~g 158 (316)
T cd05592 81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMN--GEGKASTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCC--CCCccccccC
Confidence 999998875 7899999999999999999999999999999999999999999999999999875322 1234456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+++..+.......|.+.++++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ll~~~l~~~P~~ 237 (316)
T cd05592 159 TPDYIAPEILKGQKYN-ESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWISKEAKDCLSKLFERDPTK 237 (316)
T ss_pred CccccCHHHHcCCCCC-CcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccCCHHH
Confidence 9999999999887775 899999999999999999999999998888888888888889999999999999999999999
Q ss_pred CCCH-HHHhcCcccccc
Q 014849 260 RITV-DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~-~eil~h~~f~~~ 275 (417)
||++ .++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 238 RLGVDGDIRQHPFFRGI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 9986 589999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=390.23 Aligned_cols=251 Identities=33% Similarity=0.636 Sum_probs=226.5
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.+++.+ +||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999999999999999999876544444566778899999888 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (318)
T cd05570 81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGIL--GGVTTSTFCG 158 (318)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCc--CCCcccceec
Confidence 999998876 5899999999999999999999999999999999999999999999999999864221 2223445689
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|+.||...+....+..+.......|...++++.+||++||+.||.+
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 237 (318)
T cd05570 159 TPDYIAPEILSYQPYG-PAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWLSKEAKSILKSFLTKNPEK 237 (318)
T ss_pred CccccCHHHhcCCCCC-cchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcCCHHHHHHHHHHccCCHHH
Confidence 9999999999888875 899999999999999999999999998889899988888889899999999999999999999
Q ss_pred CCCH-----HHHhcCcccccc
Q 014849 260 RITV-----DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~-----~eil~h~~f~~~ 275 (417)
|||+ .++++||||+..
T Consensus 238 R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 238 RLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred cCCCCCCCHHHHhcCCCcCCC
Confidence 9999 999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-49 Score=388.93 Aligned_cols=251 Identities=33% Similarity=0.611 Sum_probs=223.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+..............|..+++. ++||||+++++++.+...+|+||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 479999999999999999999999999987654333334566678888876 4899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (316)
T cd05619 81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENML--GDAKTCTFCG 158 (316)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCC--CCCceeeecC
Confidence 999999976 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+..+.+..+.......|.+.+.++.+||.+||+.||++
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~P~~ 237 (316)
T cd05619 159 TPDYIAPEILLGQKYN-TSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWLTREAKDILVKLFVREPER 237 (316)
T ss_pred CccccCHHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHhccCHhh
Confidence 9999999999887775 899999999999999999999999998888888887777888899999999999999999999
Q ss_pred CCCHH-HHhcCcccccc
Q 014849 260 RITVD-EILRDPWFKKD 275 (417)
Q Consensus 260 R~t~~-eil~h~~f~~~ 275 (417)
||++. ++++||||+..
T Consensus 238 R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 238 RLGVKGDIRQHPFFREI 254 (316)
T ss_pred cCCChHHHHcCcccCCC
Confidence 99996 99999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=390.91 Aligned_cols=252 Identities=36% Similarity=0.645 Sum_probs=224.9
Q ss_pred eeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 21 GKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.+.||+|+||.||+|++. .+++.||+|++.+..... ......+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e 80 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILE 80 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEe
Confidence 368999999999999864 578999999998754322 2334567899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|++|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~ 158 (323)
T cd05584 81 YLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH--EGTVTH 158 (323)
T ss_pred CCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc--CCCccc
Confidence 9999999999875 6789999999999999999999999999999999999999999999999999864321 223345
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
..+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+.......+..+....|...++++.+||.+||+.
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 237 (323)
T cd05584 159 TFCGTIEYMAPEILMRSGHG-KAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPPYLTPEARDLLKKLLKR 237 (323)
T ss_pred ccCCCccccChhhccCCCCC-CcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHccc
Confidence 57899999999999887775 89999999999999999999999999888889999999999999999999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 014849 256 DPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~-----t~~eil~h~~f~~~ 275 (417)
||++|| +++++++||||+..
T Consensus 238 ~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 238 NPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 999999 89999999999863
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=397.77 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=225.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.++..++||||+++++.+.+.+.+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46999999999999999999999999999999998765444555678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++||+|.+++.+ +.+++..++.++.|++.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus 81 E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~ 160 (360)
T cd05627 81 EFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFY 160 (360)
T ss_pred eCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccc
Confidence 99999999999875 789999999999999999999999999999999999999999999999999986432110
Q ss_pred ----------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 170 ----------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 170 ----------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 161 RNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYN-KLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred cccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCC-CcceeccccceeeecccCCCCCCCC
Confidence 00112346899999999999988886 8999999999999999999999999
Q ss_pred CHHHHHHHHhcC--CCCCCC--CCChHHHHHHHHhccCCCCCCC---CHHHHhcCcccccc
Q 014849 222 NLMAMYRKIYKG--EYRCPK--WTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKKD 275 (417)
Q Consensus 222 ~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~~ 275 (417)
+....+.++... ...+|. ..++++++||.+|+ .||.+|+ +++++++||||+..
T Consensus 240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcCCCCCCC
Confidence 888888887753 234444 36899999999987 4999998 58999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-49 Score=390.85 Aligned_cols=251 Identities=34% Similarity=0.575 Sum_probs=222.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
++||+|+||+||+|++..+|+.||+|++.+..........++.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765443333455556655 46789999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (323)
T cd05575 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIE--HSKTTSTFCG 158 (323)
T ss_pred CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCccccc--CCCccccccC
Confidence 999998875 6899999999999999999999999999999999999999999999999999864221 2233445689
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++.++.......+...++++.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (323)
T cd05575 159 TPEYLAPEVLRKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNISVSARHLLEGLLQKDRTK 237 (323)
T ss_pred ChhhcChhhhcCCCCC-ccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCHHh
Confidence 9999999999888775 899999999999999999999999999999999988888888888999999999999999999
Q ss_pred CCCH----HHHhcCcccccc
Q 014849 260 RITV----DEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~----~eil~h~~f~~~ 275 (417)
||++ .++++||||...
T Consensus 238 R~~~~~~~~~il~~~~~~~~ 257 (323)
T cd05575 238 RLGAKDDFLEIKNHVFFSSI 257 (323)
T ss_pred CCCCCCCHHHHHcCCCcCCC
Confidence 9987 699999999763
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-49 Score=388.08 Aligned_cols=256 Identities=29% Similarity=0.529 Sum_probs=228.8
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.|+..+.||+|+||.||+|.+..+|+.||+|++.+...........+..|+.+++.+. ||+|+++++++.+...+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 4789999999999999999999999999999998765444444567778999998886 577889999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .....
T Consensus 81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~--~~~~~ 158 (323)
T cd05615 81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMV--DGVTT 158 (323)
T ss_pred cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCC--CCccc
Confidence 99999999999876 7899999999999999999999999999999999999999999999999999864321 12233
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+....+..+.......|...++++.+++.+||+
T Consensus 159 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~ 237 (323)
T cd05615 159 RTFCGTPDYIAPEIIAYQPYG-KSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYPKSLSKEAVSICKGLMT 237 (323)
T ss_pred cCccCCccccCHHHHcCCCCC-CccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHHHcc
Confidence 456799999999999887775 8999999999999999999999999988899999988888899999999999999999
Q ss_pred CCCCCCCC-----HHHHhcCcccccc
Q 014849 255 TDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 255 ~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
.||.+|++ .+++++||||+..
T Consensus 238 ~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 238 KHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred cCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 99999997 5799999999863
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-49 Score=390.65 Aligned_cols=251 Identities=31% Similarity=0.588 Sum_probs=219.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|++..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 5799999999999999999999999999876554444566788899998776 799999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (329)
T cd05618 81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--PGDTTSTFCG 158 (329)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccC--CCCccccccC
Confidence 999988865 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---------PNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||.. .........+.......|...+..+.+||+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~ll~ 237 (329)
T cd05618 159 TPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 237 (329)
T ss_pred CccccCHHHHcCCCCC-CccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 9999999999888775 899999999999999999999952 122345566777778889999999999999
Q ss_pred HhccCCCCCCCC------HHHHhcCcccccc
Q 014849 251 RLLDTDPATRIT------VDEILRDPWFKKD 275 (417)
Q Consensus 251 ~~L~~dP~~R~t------~~eil~h~~f~~~ 275 (417)
+||+.||.+||| ++++++||||+..
T Consensus 238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 268 (329)
T cd05618 238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV 268 (329)
T ss_pred HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence 999999999998 5899999999763
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-49 Score=388.06 Aligned_cols=258 Identities=34% Similarity=0.589 Sum_probs=222.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.|++++.||+|+||.||+|++. .+|+.||+|++.+.... .......+.+|+.+++.++ ||||+++++++.+...+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4899999999999999999874 58899999999865432 2233567889999999995 89999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~-~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSE-E 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCcccccc-C
Confidence 999999999999998865 67999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHhcCCCCCCCCCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND----PNLMAMYRKIYKGEYRCPKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~----~~~~~~~~~i~~~~~~~p~~~s~~~~ 246 (417)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||.. .........+.......|...++.+.
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQ 239 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHH
Confidence 22334568999999999998765456899999999999999999999964 23445566677777778888999999
Q ss_pred HHHHHhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
+||.+||+.||++|| +++++++||||+..
T Consensus 240 ~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 240 DLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred HHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999999999999999 88999999999863
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-49 Score=394.50 Aligned_cols=263 Identities=33% Similarity=0.508 Sum_probs=227.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-.++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+...+
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYL 118 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 33458999999999999999999999999999999999875544444456678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++||+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++...... ..
T Consensus 119 ~lv~Ey~~gg~L~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~-~~ 197 (371)
T cd05622 119 YMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GM 197 (371)
T ss_pred EEEEcCCCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC-Cc
Confidence 99999999999999998888999999999999999999999999999999999999999999999999998754321 11
Q ss_pred CcccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPD 244 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 244 (417)
....+.+||+.|+|||++...+ +.+.++|||||||++|+|++|.+||.+.+....+.++.... ..+| ...++.
T Consensus 198 ~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 277 (371)
T cd05622 198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKE 277 (371)
T ss_pred ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHH
Confidence 1234678999999999987543 34589999999999999999999999999888888887643 3334 357999
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
+++||.+||..+|.+ |++++++++||||++.
T Consensus 278 ~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 278 AKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999844443 7899999999999864
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-49 Score=389.90 Aligned_cols=258 Identities=30% Similarity=0.503 Sum_probs=224.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46999999999999999999999999999999998765444445667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-~~~ 159 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK-MVN 159 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999987543221 112
Q ss_pred ccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChH
Q 014849 174 LHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~ 244 (417)
....+||+.|+|||++.. ....+.++|||||||++|+|++|..||...+....+.++.... ...| ...+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 239 (330)
T cd05601 160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD 239 (330)
T ss_pred eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence 234579999999999863 2223589999999999999999999999988888888776543 2233 357899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+||.+||+ ||.+|||+++++.||||+..
T Consensus 240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~ 269 (330)
T cd05601 240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269 (330)
T ss_pred HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCC
Confidence 9999999998 99999999999999999863
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-49 Score=387.76 Aligned_cols=250 Identities=34% Similarity=0.572 Sum_probs=221.0
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|.+..+|+.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765433334455566655 46779999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~--~~~~~~~~~g 158 (325)
T cd05604 81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIA--QSDTTTTFCG 158 (325)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCC--CCCCcccccC
Confidence 999988875 6899999999999999999999999999999999999999999999999999864221 2223456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+++.++.......++..+..+.++|++||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~ll~~~p~~ 237 (325)
T cd05604 159 TPEYLAPEVIRKQPYD-NTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQR 237 (325)
T ss_pred ChhhCCHHHHcCCCCC-CcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCCCHHHHHHHHHHhccCHHh
Confidence 9999999999888875 899999999999999999999999998899999988887777788999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014849 260 RITV----DEILRDPWFKK 274 (417)
Q Consensus 260 R~t~----~eil~h~~f~~ 274 (417)
||++ .++++||||..
T Consensus 238 R~~~~~~~~~i~~h~~f~~ 256 (325)
T cd05604 238 RLGAKEDFLEIQEHPFFES 256 (325)
T ss_pred cCCCCCCHHHHhcCCCcCC
Confidence 9976 59999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-48 Score=385.58 Aligned_cols=251 Identities=30% Similarity=0.568 Sum_probs=220.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||+||+|.+..+++.||+|++.+...........+.+|+.++..+ +||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 5799999999999999999999999999887654445567788999999888 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (327)
T cd05617 81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLG--PGDTTSTFCG 158 (327)
T ss_pred CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccC--CCCceecccC
Confidence 999988875 7899999999999999999999999999999999999999999999999999864221 2234456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-------CCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-------PNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
|+.|+|||++.+..|+ .++|||||||++|+|++|..||.. ......+..+.......|...++.+.++|++|
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~li~~~ 237 (327)
T cd05617 159 TPNYIAPEILRGEEYG-FSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIPRFLSVKASHVLKGF 237 (327)
T ss_pred CcccCCHHHHCCCCCC-chheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 9999999999888775 899999999999999999999953 22334566666677788888999999999999
Q ss_pred ccCCCCCCCC------HHHHhcCcccccc
Q 014849 253 LDTDPATRIT------VDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~t------~~eil~h~~f~~~ 275 (417)
|+.||.+|++ ++++++||||+..
T Consensus 238 L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 238 LNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred hccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 9999999997 5799999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-49 Score=385.37 Aligned_cols=250 Identities=34% Similarity=0.582 Sum_probs=221.4
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+|+.||+|++.+...........+.+|+. +++.++||||+++++++.+.+.+|+||||++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999999999999999998765444333445555654 67889999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ........+|
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~g 158 (321)
T cd05603 81 GELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVE--PEETTSTFCG 158 (321)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCC--CCCccccccC
Confidence 999988875 6799999999999999999999999999999999999999999999999999864221 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|..||...+...++..+.......|...+.++.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (321)
T cd05603 159 TPEYLAPEVLRKEPYD-RTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAACDLLVGLLHKDQRR 237 (321)
T ss_pred CcccCCHHHhcCCCCC-CcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHccCCHhh
Confidence 9999999999887775 889999999999999999999999998899999988888888889999999999999999999
Q ss_pred CCCH----HHHhcCccccc
Q 014849 260 RITV----DEILRDPWFKK 274 (417)
Q Consensus 260 R~t~----~eil~h~~f~~ 274 (417)
||++ .++++|+||..
T Consensus 238 R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 238 RLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred cCCCCCCHHHHhCCCCcCC
Confidence 9975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-49 Score=373.59 Aligned_cols=260 Identities=30% Similarity=0.423 Sum_probs=225.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKI 91 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 91 (417)
-.+.|+.+..|++|+||.||+|+++.|++.||+|.++.++ .+.++.-.-.|||.+|.+++|||||.+-++.. +-+.+
T Consensus 74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~i 152 (419)
T KOG0663|consen 74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKI 152 (419)
T ss_pred cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccccee
Confidence 3567999999999999999999999999999999998776 45566666779999999999999999999975 44579
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|||||+. +|..++.. .++...+++.+..|+++|++|||.+.|+||||||.|+|++..|.+||+|||+|+....
T Consensus 153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs-- 229 (419)
T KOG0663|consen 153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS-- 229 (419)
T ss_pred eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcC--
Confidence 999999977 89999976 5899999999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------------- 233 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 233 (417)
+-...+..+-|.+|+|||.+.+..-++.++|+||+|||+.||+++++.|.+....+...+|.+-
T Consensus 230 p~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp 309 (419)
T KOG0663|consen 230 PLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELP 309 (419)
T ss_pred CcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccc
Confidence 3344566788999999999998776679999999999999999999999998888777777531
Q ss_pred ---CCCCCC-----------C--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---EYRCPK-----------W--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---~~~~p~-----------~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
...+++ + .|....+|+..+|..||.+|.|++|.|+|+||.+...
T Consensus 310 ~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~ 369 (419)
T KOG0663|consen 310 AVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPL 369 (419)
T ss_pred hhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCC
Confidence 011111 1 3588899999999999999999999999999997544
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=390.53 Aligned_cols=250 Identities=36% Similarity=0.595 Sum_probs=219.3
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
||+|+||+||+|++..+|+.||+|++.+..........+..+|..++..+ +||||+++++++.+...+|+||||+.|
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999999999999999999876544333345556677777665 699999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~g 158 (330)
T cd05586 81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLT--DNKTTNTFCG 158 (330)
T ss_pred ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCC--CCCCccCccC
Confidence 999988875 7899999999999999999999999999999999999999999999999999864321 2233456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC-CChHHHHHHHHhccCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW-TSPDLKWFIGRLLDTDPA 258 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~-~s~~~~~li~~~L~~dP~ 258 (417)
|+.|+|||++.+....+.++|||||||++|+|++|+.||...+..+++.++..+....|.. .++++.+||++||++||.
T Consensus 159 t~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~~L~~~P~ 238 (330)
T cd05586 159 TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNVLSDEGRQFVKGLLNRNPQ 238 (330)
T ss_pred CccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHH
Confidence 9999999998765544589999999999999999999999999999999998888777754 689999999999999999
Q ss_pred CCC----CHHHHhcCcccccc
Q 014849 259 TRI----TVDEILRDPWFKKD 275 (417)
Q Consensus 259 ~R~----t~~eil~h~~f~~~ 275 (417)
+|| ++.++++||||+..
T Consensus 239 ~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 239 HRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred HCCCCCCCHHHHhcCccccCC
Confidence 998 79999999999853
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=383.90 Aligned_cols=256 Identities=30% Similarity=0.491 Sum_probs=209.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----CEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK-----AKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-----~~~ 91 (417)
||++.+.||+|+||.||+|++..+|+.||||.+..... ......++.+|+.+|+.++||||+++++++... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 69999999999999999999999999999999875322 222345688999999999999999999987543 358
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+. ++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 99999995 689888875 6799999999999999999999999999999999999999999999999999875322111
Q ss_pred -CCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------
Q 014849 171 -DGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--------------- 232 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 232 (417)
.......+||+.|+|||++.+ ..+ +.++|||||||++|+|++|++||.+.+.......+..
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKY-TPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhcccccc-CchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 122245689999999999865 445 5899999999999999999999987664432221110
Q ss_pred -----------CCCCC-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 233 -----------GEYRC-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 233 -----------~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...+. .+..++++.++|.+||+.||++|||++|+++||||+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~~ 296 (338)
T cd07859 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGL 296 (338)
T ss_pred hhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhhc
Confidence 00000 02357788999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=376.00 Aligned_cols=259 Identities=32% Similarity=0.511 Sum_probs=223.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCC----
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKA---- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~---- 89 (417)
+..|+..+.||+|+||+||+|+++.+|+.||+|.+..+... ++......||+.+|+.++|+| ||++++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 56688888999999999999999999999999999877532 455667789999999999999 999999998887
Q ss_pred --EEEEEEeccCCCChHHHHhc-C----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 90 --KIYFVMEFAKGGELFAKISK-G----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 90 --~~~lV~E~~~gg~L~~~i~~-~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.+|+|+||++- +|..++.. + .++...++.+++||+.||+|||++||+||||||+|||++++|.+||+|||+|
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA 167 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA 167 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence 89999999965 89998875 2 5888899999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--------- 233 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------- 233 (417)
+...- +.....+.++|.+|+|||++.+..+++..+||||+|||++||++++..|.+....+....|.+-
T Consensus 168 ra~~i--p~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W 245 (323)
T KOG0594|consen 168 RAFSI--PMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW 245 (323)
T ss_pred HHhcC--CcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence 85432 3344677889999999999998866679999999999999999999999998877776666431
Q ss_pred ---------CCCCCCCC------------ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---------EYRCPKWT------------SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---------~~~~p~~~------------s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
...+|.|. +++..+++.+||+.+|.+|+|+..++.||||+....
T Consensus 246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~ 310 (323)
T KOG0594|consen 246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE 310 (323)
T ss_pred CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence 11223332 358899999999999999999999999999987543
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-49 Score=386.29 Aligned_cols=250 Identities=35% Similarity=0.623 Sum_probs=223.4
Q ss_pred eEEeeeCceEEEEEEE---ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRN---VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|+||+||++++ ..+|+.||+|++.+.... .....++.+|+.+|+.++||||+++++++.+...+|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 6799999999999986 368899999999875432 222456778999999999999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
.||+|.+++.+ ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ........
T Consensus 81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~--~~~~~~~~ 158 (318)
T cd05582 81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HEKKAYSF 158 (318)
T ss_pred CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCC--CCCceecc
Confidence 99999999875 6799999999999999999999999999999999999999999999999999865332 22334567
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
+||+.|+|||++.+.+++ .++|||||||++|+|++|+.||...+.......+.......|...++++.+||++||+.||
T Consensus 159 ~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~~l~~~P 237 (318)
T cd05582 159 CGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRALFKRNP 237 (318)
T ss_pred cCChhhcCHHHHcCCCCC-CccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhhcCH
Confidence 899999999999887774 8999999999999999999999999988888889888888899999999999999999999
Q ss_pred CCCCC-----HHHHhcCcccccc
Q 014849 258 ATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 258 ~~R~t-----~~eil~h~~f~~~ 275 (417)
.+||| +++++.||||+..
T Consensus 238 ~~R~~a~~~~~~~~~~~~~~~~~ 260 (318)
T cd05582 238 ANRLGAGPDGVEEIKRHPFFSTI 260 (318)
T ss_pred hHcCCCCCCCHHHHhCCCCcCCC
Confidence 99999 7889999999863
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=384.68 Aligned_cols=250 Identities=34% Similarity=0.584 Sum_probs=220.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|++..+++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+.+|+||||+.|
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999999999999999998765433333344555544 56789999999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......+.+|
T Consensus 81 ~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~--~~~~~~~~~g 158 (325)
T cd05602 81 GELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE--HNGTTSTFCG 158 (325)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCccccc--CCCCcccccC
Confidence 999999876 6799999999999999999999999999999999999999999999999999864321 2334456789
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~ 259 (417)
|+.|+|||++.+..++ .++|||||||++|+|++|.+||.+.+..+++..+.......++..++.+.++|.+||+.||.+
T Consensus 159 t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 237 (325)
T cd05602 159 TPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 237 (325)
T ss_pred CccccCHHHHcCCCCC-CccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCCCHHHHHHHHHHcccCHHH
Confidence 9999999999887775 899999999999999999999999998899999888877778888999999999999999999
Q ss_pred CCCHH----HHhcCccccc
Q 014849 260 RITVD----EILRDPWFKK 274 (417)
Q Consensus 260 R~t~~----eil~h~~f~~ 274 (417)
|+++. ++++|+||..
T Consensus 238 R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 238 RLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCCCCCHHHHhcCcccCC
Confidence 99865 8999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-48 Score=375.21 Aligned_cols=248 Identities=31% Similarity=0.456 Sum_probs=214.8
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||+||+|.+..+|+.||+|.+.+...........+..|+.+|+.++||||+++++++.++..+|+||||++||+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999999999999999999876544333346678899999999999999999999999999999999999999
Q ss_pred HHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 104 FAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 104 ~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
.+.+. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... ........
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~ 158 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG--QSKTKGYA 158 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCC--CccccccC
Confidence 88773 246999999999999999999999999999999999999999999999999998654321 12234567
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
||+.|+|||++.+..++ .++||||+||++|+|++|+.||..... ......+.......|...++++.+++.+||+
T Consensus 159 g~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~ 237 (280)
T cd05608 159 GTPGFMAPELLQGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALLA 237 (280)
T ss_pred CCcCccCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHhc
Confidence 99999999999988775 899999999999999999999976532 3344455555566677789999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccc
Q 014849 255 TDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~-----t~~eil~h~~f~~ 274 (417)
.||++|| |++++++||||+.
T Consensus 238 ~~P~~R~~~~~~~~~~~l~h~~~~~ 262 (280)
T cd05608 238 KDPEKRLGFRDGNCDGLRTHPLFRD 262 (280)
T ss_pred CCHHHhcCCCCCCHHHHhcChhhhc
Confidence 9999999 8899999999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=374.76 Aligned_cols=254 Identities=25% Similarity=0.419 Sum_probs=220.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||+||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 48999999999999999999999999999999987654433334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.||+|.+.+.. ..+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GET 157 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCC---CCc
Confidence 9999999888753 4699999999999999999999999999999999999999999999999999875432 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+... ....+.......|...++.+.+||
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05605 158 IRGRVGTVGYMAPEVVKNERYT-FSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSIC 236 (285)
T ss_pred cccccCCCCccCcHHhcCCCCC-ccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHH
Confidence 3456899999999999877765 88999999999999999999998765533 233344444556677899999999
Q ss_pred HHhccCCCCCCC-----CHHHHhcCccccc
Q 014849 250 GRLLDTDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~-----t~~eil~h~~f~~ 274 (417)
.+||+.||.+|| +++++++||||.+
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 237 RQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred HHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 999999999999 8999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-48 Score=379.57 Aligned_cols=255 Identities=23% Similarity=0.413 Sum_probs=218.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|++..+|..+|+|++.... ......++.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 478999999999999999999999999999999997642 233456789999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~----~ 157 (331)
T cd06649 82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (331)
T ss_pred eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc----c
Confidence 999999999999976 6799999999999999999999986 699999999999999999999999999865422 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..++...+...
T Consensus 158 ~~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (331)
T cd06649 158 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP 236 (331)
T ss_pred ccccCCCCcCcCCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence 33456799999999999887775 8999999999999999999999876655443322110
Q ss_pred ---------------------------C-CCC-CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 ---------------------------E-YRC-PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ---------------------------~-~~~-p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
. ... ....++++++||.+||+.||++|||+.++++||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 0 000 113578899999999999999999999999999998643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-48 Score=380.19 Aligned_cols=259 Identities=31% Similarity=0.509 Sum_probs=221.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+++.||+|++.+....+......+.+|+.+++.++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 47999999999999999999999999999999998755444445667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.||+|.+++.+ +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~~~ 159 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG-TVQ 159 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC-Ccc
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986543211 112
Q ss_pred ccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC---CCCChH
Q 014849 174 LHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP---KWTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 244 (417)
....+||+.|+|||++.. .+..+.++||||+||++|+|++|+.||.+.+..+.+.++.... +..| ...+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 239 (331)
T cd05597 160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSEE 239 (331)
T ss_pred ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCHH
Confidence 233579999999999873 2334589999999999999999999999988888887776533 3333 346899
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
+++||++||..++++ |++++++++||||...
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~ 272 (331)
T cd05597 240 AKDLIRRLICSPETRLGRNGLQDFKDHPFFEGI 272 (331)
T ss_pred HHHHHHHHccCcccccCCCCHHHHhcCCCCCCC
Confidence 999999999664444 8899999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=391.02 Aligned_cols=261 Identities=29% Similarity=0.499 Sum_probs=231.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...-...|...+.||+|+||.||+|.+..|++.||||+++.+... ...+.+.+|+.+|..+++|||.++|+.+.....
T Consensus 8 ~~~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~ 85 (467)
T KOG0201|consen 8 KIDPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK 85 (467)
T ss_pred cCCcccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeeccc
Confidence 344456788889999999999999999999999999999987643 347789999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISKGRF-SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l-~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|++||||.||++.+.++.+.+ +|.++..++++++.|+.|+|+++.+|||||+.|||+..+|.+|++|||.+......
T Consensus 86 LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~- 164 (467)
T KOG0201|consen 86 LWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT- 164 (467)
T ss_pred HHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech-
Confidence 9999999999999999998665 99999999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 248 (417)
.....+.+|||.||||||+...+|+ .++||||||++.+||++|.+|+.+..++...--|-+..+ ..-..+|+.+++|
T Consensus 165 -~~rr~tfvGTPfwMAPEVI~~~~Y~-~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~~~~S~~~kEF 242 (467)
T KOG0201|consen 165 -VKRRKTFVGTPFWMAPEVIKQSGYD-TKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLDGDFSPPFKEF 242 (467)
T ss_pred -hhccccccccccccchhhhcccccc-chhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccccccCHHHHHH
Confidence 2334899999999999999988997 999999999999999999999999887655544444333 2334679999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|..||+.||+.|||+.++|+|+|++...
T Consensus 243 V~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 243 VEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred HHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 9999999999999999999999998633
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-48 Score=396.07 Aligned_cols=251 Identities=31% Similarity=0.435 Sum_probs=207.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK------ 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------ 88 (417)
.++|++++.||+|+||.||+|.+..+++.||||.+.... ....+|+.+|+.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 468999999999999999999999999999999885432 2335799999999999999999887432
Q ss_pred --CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeee
Q 014849 89 --AKIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFG 160 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFG 160 (417)
..+++||||+++ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccc
Confidence 257799999976 6766553 25799999999999999999999999999999999999999765 69999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------- 233 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 233 (417)
+|..... .....+.+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+.+.++...
T Consensus 217 la~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~ 293 (440)
T PTZ00036 217 SAKNLLA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTED 293 (440)
T ss_pred cchhccC---CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHH
Confidence 9975432 223345678999999999876544459999999999999999999999987766555444321
Q ss_pred ----------CC------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 ----------EY------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ----------~~------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.. .+|...++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 294 ~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 294 QLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLR 358 (440)
T ss_pred HHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhh
Confidence 00 12345678999999999999999999999999999998643
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-49 Score=382.90 Aligned_cols=329 Identities=28% Similarity=0.376 Sum_probs=260.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-...|+..|+||+|+||.||.|+-+.||+.+|+|.+++.++.+..-..-..+|-.||++++.|.||.+-..|++++.++
T Consensus 182 vt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LC 261 (591)
T KOG0986|consen 182 VTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALC 261 (591)
T ss_pred ccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceE
Confidence 34567899999999999999999999999999999999988877666677789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||..|+||+|..+|.+ | .++|+.++.|+.+|+.||.+||+++||+||+||+|||||+.|+++|+|.|||.-..
T Consensus 262 lVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~--- 338 (591)
T KOG0986|consen 262 LVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIP--- 338 (591)
T ss_pred EEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecC---
Confidence 99999999999888865 4 89999999999999999999999999999999999999999999999999997654
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCCCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
........+||..|||||++.+..|+ .++|+|||||+||+|+.|+-||.... .+++-+.+......+|..+|+++
T Consensus 339 ~g~~~~~rvGT~GYMAPEvl~ne~Y~-~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~~kFS~ea 417 (591)
T KOG0986|consen 339 EGKPIRGRVGTVGYMAPEVLQNEVYD-FSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYSDKFSEEA 417 (591)
T ss_pred CCCccccccCcccccCHHHHcCCccc-CCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcccccCHHH
Confidence 23344555999999999999999986 89999999999999999999997643 23555566666777889999999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCcccccccccC-CCCCCCCCcccccCCCCCCCCccCcchhhccC--CCCCCC
Q 014849 246 KWFIGRLLDTDPATRI-----TVDEILRDPWFKKDYKER-KFPHEDFDLKDSVGCNVGSEKYLNAFDIISLS--SGFNLS 317 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-----t~~eil~h~~f~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~is~~--~~~~~~ 317 (417)
++|.+.+|+.||.+|. +++++.+||||++.-... .......++-.. ......-.++||-+|| .|..|.
T Consensus 418 kslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rleagml~PPfiPd----p~aVyakDv~DIeqFs~VKGV~ld 493 (591)
T KOG0986|consen 418 KSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPD----PGAVYAKDVLDIEQFSTVKGVKLD 493 (591)
T ss_pred HHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHHhccCCCCCCCCC----ccccchhhhhhhhhcccccceecc
Confidence 9999999999999998 688999999999732221 111111111100 0111123456666665 366665
Q ss_pred CCCccCCCCCCCccccceeecCCHHH-HHHHHH
Q 014849 318 GLFDDFNNNDAPFCNERFLSNETPEK-ILEKVE 349 (417)
Q Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~-i~~~~~ 349 (417)
.-.+++..+.+..+-+.-|+++-+++ +.+.++
T Consensus 494 ~~D~~fy~~F~tg~vsipWQnE~~ET~~f~eln 526 (591)
T KOG0986|consen 494 DTDTDFYKNFATGSVSIPWQNEMIETECFEELN 526 (591)
T ss_pred cccHHHHHhccCCcccchHHHHHHHhhhHHHhh
Confidence 55555544332223344445555555 555554
|
|
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=373.06 Aligned_cols=257 Identities=26% Similarity=0.483 Sum_probs=215.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||.||+|++..+++.||+|.+..... ........+|+.+++.++||||+++++++.+++..|+|
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 82 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLV 82 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEE
Confidence 4789999999999999999999999999999999976542 22244677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|...+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 83 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~~ 159 (309)
T cd07872 83 FEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSV--PTK 159 (309)
T ss_pred EeCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCC--Ccc
Confidence 999976 78777754 4589999999999999999999999999999999999999999999999999865332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
.....++|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+....+.+.
T Consensus 160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (309)
T cd07872 160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK 239 (309)
T ss_pred ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence 2334578999999999876554468999999999999999999999887765544443221
Q ss_pred CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
....| ...++++++||.+||+.||.+|||+.|+++||||+...
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~ 293 (309)
T cd07872 240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG 293 (309)
T ss_pred hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence 01111 23578899999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-47 Score=398.16 Aligned_cols=261 Identities=32% Similarity=0.490 Sum_probs=228.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
...++|++.+.||+|+||+||+|++..+|+.||||++...... ......+.+|+.+|..++|+||+++++.+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 4568999999999999999999999999999999999876432 233566789999999999999999998775432
Q ss_pred -----EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 90 -----KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 90 -----~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
.+++||||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 47899999999999998853 46899999999999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCP 238 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p 238 (417)
|++.............+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+.. +.|
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s-~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~ 266 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYS-KKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP 266 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC
Confidence 999765433333344567899999999999888775 999999999999999999999999998888888776654 467
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...++++.+++.+||+.||.+|||+.++++|||++..
T Consensus 267 ~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 267 PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 7789999999999999999999999999999998753
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=368.72 Aligned_cols=251 Identities=29% Similarity=0.450 Sum_probs=209.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEE-----
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLA----- 86 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~----- 86 (417)
.+|++.+.||+|+||+||+|++.. +|+.||+|++..... .........+|+.+++.+ +||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccC-CCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 479999999999999999999865 468899999876542 222344566788887766 6999999999875
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
....+++||||+. ++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 80 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~ 158 (290)
T cd07862 80 RETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 158 (290)
T ss_pred CCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceE
Confidence 3457999999997 588888864 458999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-C------
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-R------ 236 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~------ 236 (417)
.... .......+||+.|+|||++.+..++ .++||||+||++|+|++|.+||.+.+..+.+.++..... +
T Consensus 159 ~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~ 234 (290)
T cd07862 159 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 234 (290)
T ss_pred eccC---CcccccccccccccChHHHhCCCCC-CccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence 5432 2334566799999999999877775 899999999999999999999999887777666643210 0
Q ss_pred --------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 --------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 --------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+..++.+++|+.+||+.||++|||+.|+++||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f 290 (290)
T cd07862 235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 290 (290)
T ss_pred hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence 012357788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-47 Score=393.95 Aligned_cols=258 Identities=28% Similarity=0.461 Sum_probs=226.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC-CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....|.+.+.||+|+||.||.|.+..+ ++.||+|.+.... ......+++|+.+|+.++|||||++++++.+.+.+
T Consensus 64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~ 140 (478)
T PTZ00267 64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL 140 (478)
T ss_pred CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence 3455699999999999999999998877 7889999775432 23345678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 92 YFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
|+||||++||+|.+.+.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~ 220 (478)
T PTZ00267 141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYS 220 (478)
T ss_pred EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecC
Confidence 999999999999887642 468999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDL 245 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~ 245 (417)
.........+.+||+.|+|||++.+..++ .++|||||||++|+|++|+.||...+..+...++..+... .|...++++
T Consensus 221 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~s~~~ 299 (478)
T PTZ00267 221 DSVSLDVASSFCGTPYYLAPELWERKRYS-KKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCPVSSGM 299 (478)
T ss_pred CccccccccccCCCccccCHhHhCCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccCCHHH
Confidence 33222334567899999999999887775 8999999999999999999999998888888888776653 566789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+++|.+||..||++|||+++++.|||++.
T Consensus 300 ~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 300 KALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 99999999999999999999999999874
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-47 Score=380.38 Aligned_cols=249 Identities=33% Similarity=0.554 Sum_probs=215.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE-EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS-VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-KIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~ 92 (417)
.....+.+.||+|+||+||+|..+ |+. ||+|++......... ...+.+|+.+|++++|||||++++++.++. ...
T Consensus 40 ~~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~ 116 (362)
T KOG0192|consen 40 PDELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLC 116 (362)
T ss_pred hHHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceE
Confidence 445667777999999999999994 445 999999876544333 678999999999999999999999999887 799
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecCCC-CeEEeeeecceeecc
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRG-VFHRDLKLENLLLDENW-DLKISDFGLSAVKEQ 167 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~g-ivHrDlkp~NILl~~~~-~vkl~DFGls~~~~~ 167 (417)
+||||+++|+|.+++.. +.++...+..++.||+.||+|||+++ ||||||||+|||++.++ ++||+|||+++....
T Consensus 117 iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~ 196 (362)
T KOG0192|consen 117 IVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI 196 (362)
T ss_pred EEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence 99999999999999954 78999999999999999999999999 99999999999999998 999999999987543
Q ss_pred cCCCCcccccccCcccccccccc--ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cC-CCCCCCCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY-KG-EYRCPKWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~--~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~ 243 (417)
.. .......||+.|||||++. ...|+ .++||||+|++||||+||..||.+.........+. .+ ....|...++
T Consensus 197 ~~--~~~~~~~GT~~wMAPEv~~~~~~~~~-~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~~~~~ 273 (362)
T KOG0192|consen 197 SK--TSMTSVAGTYRWMAPEVLRGEKSPYT-EKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPKECPP 273 (362)
T ss_pred cc--ccccCCCCCccccChhhhcCCCCcCC-ccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 21 2233368999999999999 55776 99999999999999999999999988766555554 33 3455777899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..|+.+||..||.+||++.+|+.-
T Consensus 274 ~l~~l~~~CW~~dp~~RP~f~ei~~~ 299 (362)
T KOG0192|consen 274 HLSSLMERCWLVDPSRRPSFLEIVSR 299 (362)
T ss_pred HHHHHHHHhCCCCCCcCCCHHHHHHH
Confidence 99999999999999999999999754
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-47 Score=380.54 Aligned_cols=258 Identities=28% Similarity=0.477 Sum_probs=212.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++....
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 96 (359)
T cd07876 18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLE 96 (359)
T ss_pred hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcc
Confidence 578999999999999999999999999999999999976532 2233567789999999999999999999986543
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+|+||||+.+ +|...+. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 97 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~ 174 (359)
T cd07876 97 EFQDVYLVMELMDA-NLCQVIH-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC 174 (359)
T ss_pred ccceeEEEEeCCCc-CHHHHHh-ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCccccc
Confidence 57999999976 5666553 458999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 232 (417)
.........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+....+.++..
T Consensus 175 ---~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (359)
T cd07876 175 ---TNFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQ 250 (359)
T ss_pred ---cCccCCCCcccCCCCCchhccCCCCC-cchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHH
Confidence 22233456789999999999888875 889999999999999999999987765433322211
Q ss_pred --------CCCC---------CCC-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 233 --------GEYR---------CPK-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 233 --------~~~~---------~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.... .|. ..++++++||.+||+.||++|||+.|+++||||+..+.
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 323 (359)
T cd07876 251 PTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYD 323 (359)
T ss_pred HHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhhcC
Confidence 0000 111 13577899999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-47 Score=366.61 Aligned_cols=255 Identities=42% Similarity=0.724 Sum_probs=232.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||.|.+..+++.||+|++.............+.+|+.+|++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 47999999999999999999999999999999998765544455678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||+|.|||++.++.+||+|||++...... .
T Consensus 81 e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~ 155 (290)
T cd05580 81 EYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----T 155 (290)
T ss_pred ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----C
Confidence 99999999999876 77999999999999999999999999999999999999999999999999998754321 3
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhcc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...+|++.|+|||.+.+..++ .++||||||+++|+|++|..||...+......++..+....|...++.++++|.+||+
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 234 (290)
T cd05580 156 YTLCGTPEYLAPEIILSKGYG-KAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSFFSPDAKDLIRNLLQ 234 (290)
T ss_pred CCCCCCccccChhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCCccCCHHHHHHHHHHcc
Confidence 456799999999998877664 8899999999999999999999988888888888888888898899999999999999
Q ss_pred CCCCCCC-----CHHHHhcCccccccc
Q 014849 255 TDPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 255 ~dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
.||.+|+ +++|+++||||+...
T Consensus 235 ~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 235 VDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCHHHccCcccCCHHHHHcCcccccCC
Confidence 9999999 999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=380.87 Aligned_cols=257 Identities=29% Similarity=0.477 Sum_probs=215.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...+.|+.++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...+.+|
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34678999999999999999999999999999999996543 2334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||+.+|+|... ...++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus 149 lv~e~~~~~~L~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT---HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT--MD 223 (353)
T ss_pred EEEecCCCCccccc---ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccc--cc
Confidence 99999999998653 34678888999999999999999999999999999999999999999999998764321 12
Q ss_pred cccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhc-CCCCCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL---MAMYRKIYK-GEYRCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~-~~~~~p~~~s~~ 244 (417)
.....+||+.|+|||++.. ..+.+.++|||||||++|+|++|+.||..... ......+.. .....+...+++
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASRE 303 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHH
Confidence 2345679999999999753 34556799999999999999999999974332 222222322 233456677899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+++||.+||..||++|||+.|+++||||.+..
T Consensus 304 l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 304 FRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999999999999999999999998753
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-47 Score=376.03 Aligned_cols=258 Identities=29% Similarity=0.492 Sum_probs=221.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||++++..+++.+|+|++.+...........+.+|+.++..++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47999999999999999999999999999999997654444444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.||+|.+++.+ +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~-~~~~ 159 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GTVQ 159 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccC-Ccce
Confidence 99999999999975 67999999999999999999999999999999999999999999999999998643211 1112
Q ss_pred ccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC---CCCChH
Q 014849 174 LHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP---KWTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p---~~~s~~ 244 (417)
....+||+.|+|||++.. ....+.++|||||||++|+|++|+.||...+..+.+.++.... +..| ...+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~ 239 (332)
T cd05623 160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED 239 (332)
T ss_pred ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence 234689999999999862 2333589999999999999999999999998888888887653 2333 246899
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~ 274 (417)
+++||++||..+|.+ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999765554 789999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=379.24 Aligned_cols=258 Identities=25% Similarity=0.413 Sum_probs=216.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--- 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--- 88 (417)
..+.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .......+.+|+.+|+.++||||+++++++...
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07878 11 WEVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSI 89 (343)
T ss_pred hhhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccc
Confidence 3567899999999999999999999999999999999976432 122345677899999999999999999987543
Q ss_pred ---CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 ---AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ---~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
...|++++++ |++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 90 ~~~~~~~~~~~~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 168 (343)
T cd07878 90 ENFNEVYLVTNLM-GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA 168 (343)
T ss_pred cccCcEEEEeecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence 4579999998 779998888788999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC----------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---------- 235 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---------- 235 (417)
.. ...+.+||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....
T Consensus 169 ~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd07878 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKI 243 (343)
T ss_pred CC-----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence 32 234567999999999998755456899999999999999999999988766554444322100
Q ss_pred -------------CC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 -------------RC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 -------------~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.. ....++.+.+||.+||+.||.+|||+.|+++||||....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~ 305 (343)
T cd07878 244 SSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYH 305 (343)
T ss_pred chhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccC
Confidence 00 113466789999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-47 Score=383.81 Aligned_cols=250 Identities=23% Similarity=0.337 Sum_probs=206.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+++.||+|.... ..+.+|+.+|+.++||||+++++++..+...++|
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv 161 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLI 161 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEE
Confidence 4689999999999999999999999999999996532 3457899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|++. ++|..++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus 162 ~e~~~-~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~-~~~~ 239 (391)
T PHA03212 162 LPRYK-TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANK 239 (391)
T ss_pred EecCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccc-cccc
Confidence 99995 588888765 67999999999999999999999999999999999999999999999999998643221 1223
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-------HHHHHHHHh---------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-------LMAMYRKIY--------------- 231 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-------~~~~~~~i~--------------- 231 (417)
....+||+.|+|||++.+..|+ .++||||+||++|+|++|..||.... .......+.
T Consensus 240 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~ 318 (391)
T PHA03212 240 YYGWAGTIATNAPELLARDPYG-PAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQ 318 (391)
T ss_pred cccccCccCCCChhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchh
Confidence 4456899999999999887774 99999999999999999998874321 111111111
Q ss_pred -----------cCCCC----CCC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 232 -----------KGEYR----CPK-----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 232 -----------~~~~~----~p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..... .|. ..+.++.+||.+||+.||.+|||++|+|+||||+...
T Consensus 319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~ 383 (391)
T PHA03212 319 ANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIP 383 (391)
T ss_pred HHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCC
Confidence 11011 111 1356789999999999999999999999999998743
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-47 Score=361.85 Aligned_cols=252 Identities=37% Similarity=0.669 Sum_probs=214.9
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++++.||+|+||+||+|.+..+++.||+|++......... .....+|+.+++.++||||+++++++.+....++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 89999999999999999999999999999999887543322 23345699999999999999999999999999999999
Q ss_pred cCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccc
Q 014849 98 AKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT 176 (417)
Q Consensus 98 ~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 176 (417)
+.+++|.+++. .+.+++.++..++.||+.||.+||++||+||||||+||+++.++.++|+|||++... .........
T Consensus 80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~--~~~~~~~~~ 157 (260)
T PF00069_consen 80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKL--SENNENFNP 157 (260)
T ss_dssp ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEES--TSTTSEBSS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--ccccccccc
Confidence 99999999998 589999999999999999999999999999999999999999999999999998753 123345556
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCC----CChHHHHHH
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKW----TSPDLKWFI 249 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~----~s~~~~~li 249 (417)
.++|+.|+|||++......+.++||||||+++|+|++|..||...+ ......+........+.. .++.+.++|
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 237 (260)
T PF00069_consen 158 FVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLI 237 (260)
T ss_dssp SSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHH
Confidence 7899999999998833344699999999999999999999999873 333333333322221111 237999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+||+.||++|||+.++++||||
T Consensus 238 ~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 238 KKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp HHHSSSSGGGSTTHHHHHTSGGG
T ss_pred HHHccCChhHCcCHHHHhcCCCC
Confidence 99999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-47 Score=376.18 Aligned_cols=258 Identities=29% Similarity=0.476 Sum_probs=221.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 47999999999999999999999999999999998754444444566888999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.||+|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 159 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG-TVQ 159 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC-cee
Confidence 99999999999975 579999999999999999999999999999999999999999999999999986543211 112
Q ss_pred ccccccCcccccccccccc----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC---CCChH
Q 014849 174 LHTLCGTPAYVAPEILAKK----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK---WTSPD 244 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~----~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~---~~s~~ 244 (417)
....+||+.|+|||++.+. +..+.++||||+||++|+|++|+.||...+..+.+.++.... ++.|. ..+++
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~ 239 (331)
T cd05624 160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE 239 (331)
T ss_pred eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence 2346799999999998752 223589999999999999999999999988888888877643 33343 35889
Q ss_pred HHHHHHHhccCCCCC--CCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPAT--RITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~--R~t~~eil~h~~f~~ 274 (417)
+++||.+||..+|++ |++++++++||||+.
T Consensus 240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred HHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 999999999876655 569999999999985
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-48 Score=385.36 Aligned_cols=258 Identities=30% Similarity=0.537 Sum_probs=238.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-EEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK-IYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-~~l 93 (417)
++.|++++.+|+|+||.+++++++..++.+++|.+...+..... .....+|+.++++++|||||.+.+.|..++. ++|
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~I 81 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCI 81 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEE
Confidence 57899999999999999999999999999999999887754433 4467899999999999999999999988888 999
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+||+||+|.+.|.. .-++|+.+..||.|++.|+.|||+++|+|||||+.||+++.++.|||+|||+|..... .
T Consensus 82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~--~ 159 (426)
T KOG0589|consen 82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNP--E 159 (426)
T ss_pred EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCC--c
Confidence 9999999999999975 3589999999999999999999999999999999999999999999999999987654 3
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
.....+..|||.||+||++.+.+|. .++|||||||++|||++-+++|...+...+..+|.++. .+.|...+.+++.||
T Consensus 160 ~~~a~tvvGTp~YmcPEil~d~pYn-~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~~ys~el~~lv 238 (426)
T KOG0589|consen 160 DSLASTVVGTPYYMCPEILSDIPYN-EKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPLPSMYSSELRSLV 238 (426)
T ss_pred hhhhheecCCCcccCHHHhCCCCCC-ccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCCCccccHHHHHHH
Confidence 3477889999999999999999996 99999999999999999999999999999999999988 678899999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.||..+|..||++.++|.+|..+...
T Consensus 239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~ 265 (426)
T KOG0589|consen 239 KSMLRKNPEHRPSALELLRRPHLLRYL 265 (426)
T ss_pred HHHhhcCCccCCCHHHHhhChhhhhHH
Confidence 999999999999999999999887443
|
|
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=357.08 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=220.8
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+.|++++.||+|+||.||.|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++.+...+|+
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46999999999999999999999999999999987543221 1124578899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC-
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD- 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~- 171 (417)
|+||++|++|.+.+.. +.+++..++.++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++.........
T Consensus 82 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~ 161 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161 (263)
T ss_pred EEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccccc
Confidence 9999999999998875 67999999999999999999999999999999999999999999999999998754322111
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li 249 (417)
......+|++.|+|||++.+..++ .++||||+||++|+|++|+.||...+......++... ....|...++.+.++|
T Consensus 162 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 240 (263)
T cd06625 162 TGMKSVTGTPYWMSPEVISGEGYG-RKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSHVSPDARNFL 240 (263)
T ss_pred ccccCCCcCccccCcceeccCCCC-chhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCCCccCCHHHHHHH
Confidence 111345788999999999887764 9999999999999999999999887666655555443 3456677899999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+||..+|.+|||+.++++||||
T Consensus 241 ~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 241 RRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred HHHhhcCcccCCCHHHHhhCCCC
Confidence 99999999999999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=414.29 Aligned_cols=261 Identities=32% Similarity=0.490 Sum_probs=237.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|+++++||+|+||.|.+++++.|++.||+|++++-...+....+.++.|-.+|.-.+.+.|++++..|.++.++|+|
T Consensus 74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlV 153 (1317)
T KOG0612|consen 74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLV 153 (1317)
T ss_pred HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEE
Confidence 46899999999999999999999999999999999997777777788999999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||++||+|..++.+ +++||+-|+.|+..|+.||+-+|+.|+|||||||+|||||.+|++||+|||.+..... +..-.
T Consensus 154 MdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~-dG~V~ 232 (1317)
T KOG0612|consen 154 MDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA-DGTVR 232 (1317)
T ss_pred EecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC-CCcEE
Confidence 999999999999988 6899999999999999999999999999999999999999999999999997754432 12234
Q ss_pred ccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCC--CCCChHH
Q 014849 174 LHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCP--KWTSPDL 245 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p--~~~s~~~ 245 (417)
..+.+|||.|++||++.. ++.+|...|+||+||++|||+.|..||...+..+.|.+|..- .+.+| ...|+++
T Consensus 233 s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~~~VSeea 312 (1317)
T KOG0612|consen 233 SSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFPDETDVSEEA 312 (1317)
T ss_pred eccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcccccCHHH
Confidence 567899999999999863 355689999999999999999999999999999999999876 56777 5679999
Q ss_pred HHHHHHhccCCCCCCCC---HHHHhcCcccccccc
Q 014849 246 KWFIGRLLDTDPATRIT---VDEILRDPWFKKDYK 277 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t---~~eil~h~~f~~~~~ 277 (417)
++||.++|. +|..|.. ++++..||||....+
T Consensus 313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W 346 (1317)
T KOG0612|consen 313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDW 346 (1317)
T ss_pred HHHHHHHhc-ChhhhcccccHHHHHhCccccCCCh
Confidence 999999996 8889998 999999999987544
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-48 Score=374.57 Aligned_cols=263 Identities=31% Similarity=0.537 Sum_probs=242.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
......|..+.+||+|+||+|.+|..+.|.+.+|||++.++-+.+....+.-..|-++|... +-|.+++++..|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 34567899999999999999999999999999999999999887777777777888888877 46899999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||+.||+|...|.+ |++.|..|..|+.+|+-||-|||++||++||||.+|||||.+|++||+|||++. +..-
T Consensus 425 LyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcK--Eni~ 502 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIF 502 (683)
T ss_pred eeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccc--cccc
Confidence 9999999999999999988 999999999999999999999999999999999999999999999999999985 2333
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
.+....|.||||.|+|||++..++| |.++|+||+||+|||||+|++||++.+..++++.|......+|+.+|.++.++.
T Consensus 503 ~~~TTkTFCGTPdYiAPEIi~YqPY-gksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyPKslSkEAv~ic 581 (683)
T KOG0696|consen 503 DGVTTKTFCGTPDYIAPEIIAYQPY-GKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYPKSLSKEAVAIC 581 (683)
T ss_pred CCcceeeecCCCcccccceEEeccc-ccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCcccccHHHHHHH
Confidence 4556788999999999999999998 599999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~~~~ 277 (417)
+..|...|.+|.. -.+|..||||+..-.
T Consensus 582 kg~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW 614 (683)
T KOG0696|consen 582 KGLLTKHPGKRLGCGPEGERDIREHPFFRRIDW 614 (683)
T ss_pred HHHhhcCCccccCCCCccccchhhCcchhhccH
Confidence 9999999999984 478999999986433
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=377.19 Aligned_cols=258 Identities=27% Similarity=0.442 Sum_probs=214.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||.|.+..+++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~ 99 (364)
T cd07875 21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 99 (364)
T ss_pred chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeeccccccc
Confidence 467899999999999999999999999999999999976432 223356678899999999999999999987543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+||||+.+ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~ 177 (364)
T cd07875 100 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 177 (364)
T ss_pred ccCeEEEEEeCCCC-CHHHHHH-hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccC
Confidence 468999999976 6766664 358899999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+.++...-.
T Consensus 178 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 253 (364)
T cd07875 178 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 253 (364)
T ss_pred C---CCcccCCcccCCcCCHHHHhCCCCC-chhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence 2 2233456799999999999888875 899999999999999999999998776665555432100
Q ss_pred -----------C--------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 -----------R--------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 -----------~--------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .+...++++++||.+||+.||.+|||+.|+++||||...+.
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 326 (364)
T cd07875 254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 326 (364)
T ss_pred HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccccC
Confidence 0 00112467899999999999999999999999999986544
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-47 Score=364.17 Aligned_cols=250 Identities=30% Similarity=0.470 Sum_probs=207.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEe-----C
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLAT-----K 88 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~-----~ 88 (417)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++.+ .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTN-EDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcC-CCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 69999999999999999999999999999999976432 222334566777777766 69999999998764 3
Q ss_pred CEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 89 AKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
..+++|+||+.+ +|.+++.. ..+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~ 158 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence 568999999975 88888764 35899999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----------- 234 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 234 (417)
.. ........||+.|+|||++.+..++ .++||||+||++|+|++|.+||...+......++....
T Consensus 159 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07863 159 SC---QMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD 234 (288)
T ss_pred cC---cccCCCccccccccCchHhhCCCCC-CcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCccc
Confidence 32 2223446789999999999887775 89999999999999999999998877665555543210
Q ss_pred C----------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 Y----------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~----------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+.+..+..+.+||.+||++||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f 288 (288)
T cd07863 235 VTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288 (288)
T ss_pred ccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0 0112346778999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-47 Score=376.36 Aligned_cols=258 Identities=28% Similarity=0.458 Sum_probs=212.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+++.||+|.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 92 (355)
T cd07874 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLE 92 (355)
T ss_pred hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccc
Confidence 567899999999999999999999999999999999976432 223356777899999999999999999998543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+||||+++ +|...+. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~e~~~~-~l~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~ 170 (355)
T cd07874 93 EFQDVYLVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 170 (355)
T ss_pred ccceeEEEhhhhcc-cHHHHHh-hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCC
Confidence 357999999976 5666654 358999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus 171 ~---~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (355)
T cd07874 171 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246 (355)
T ss_pred C---ccccCCccccCCccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence 2 2233456899999999999888875 8999999999999999999999887655443322110
Q ss_pred ---------C-----CC---------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---------E-----YR---------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---------~-----~~---------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .. .+...+.++++||.+||+.||++|||+.|+++||||+..+.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~~~ 319 (355)
T cd07874 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVWYD 319 (355)
T ss_pred HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcccC
Confidence 0 00 01123567899999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-47 Score=373.29 Aligned_cols=255 Identities=24% Similarity=0.434 Sum_probs=216.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+|..+|+|++.... ......++.+|+++|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence 478999999999999999999999999999999987642 233456788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.||+|.+++.. +.+++..+..++.|++.||.|||++ +|+||||||+|||++.++.+||+|||++..... .
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~----~ 157 (333)
T cd06650 82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----S 157 (333)
T ss_pred EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhh----h
Confidence 999999999999876 6799999999999999999999985 799999999999999999999999999864422 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH----------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI---------------------- 230 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---------------------- 230 (417)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|+.||.......+...+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGR 236 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccc
Confidence 23445799999999999877764 8999999999999999999999866543332111
Q ss_pred ----------------------hcCC-CCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 231 ----------------------YKGE-YRCP-KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 231 ----------------------~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.... ...+ ...++++++||.+||+.||++|||+.|++.||||+...
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 306 (333)
T cd06650 237 PLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE 306 (333)
T ss_pred hhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence 0100 0111 13578899999999999999999999999999998654
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-48 Score=367.82 Aligned_cols=252 Identities=31% Similarity=0.466 Sum_probs=213.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----- 89 (417)
.=+|+..+++|+|+||.||.|...++++.||||....++-.+ -+|+.+|+.++|||||++.-+|.+..
T Consensus 23 ~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-------nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~ 95 (364)
T KOG0658|consen 23 EISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-------NRELQIMRKLDHPNIVRLLYFFSSSTESDEV 95 (364)
T ss_pred EEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcC-------cHHHHHHHhcCCcCeeeEEEEEEecCCCchh
Confidence 346999999999999999999999999999999887654322 27999999999999999998885432
Q ss_pred EEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecce
Q 014849 90 KIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSA 163 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~ 163 (417)
...+||||++. +|...+. +.+++.-.++-|..||++||.|||+.|||||||||+|||+|.+ |.+||||||.|.
T Consensus 96 ~lnlVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK 174 (364)
T KOG0658|consen 96 YLNLVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAK 174 (364)
T ss_pred HHHHHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcce
Confidence 34579999976 8988887 3689999999999999999999999999999999999999977 899999999998
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------- 233 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------- 233 (417)
..... ....++..|..|+|||.+.+...++.+.||||+||++.||+.|++-|.+.+..+....|.+-
T Consensus 175 ~L~~~---epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 175 VLVKG---EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eeccC---CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHh
Confidence 76543 33355666999999999998776679999999999999999999999998877766665431
Q ss_pred -------CCC------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 -------EYR------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.. .....++++.+|+.++|..+|.+|.|+.|++.||||.....
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~ 314 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRD 314 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhC
Confidence 111 12234899999999999999999999999999999986544
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-47 Score=364.93 Aligned_cols=254 Identities=26% Similarity=0.420 Sum_probs=216.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+.+++.+.+...+|+|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987654444445567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.|++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~---~~~ 157 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQT 157 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCC---Ccc
Confidence 9999999988853 3699999999999999999999999999999999999999999999999999865432 122
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH-hcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---AMYRKI-YKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i-~~~~~~~p~~~s~~~~~li 249 (417)
....+||+.|+|||++.+..++ .++||||+||++|+|++|.+||...... .....+ .......+...++++.+|+
T Consensus 158 ~~~~~g~~~y~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05630 158 IKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC 236 (285)
T ss_pred ccCCCCCccccChHHHcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence 2345799999999999887775 8999999999999999999999864321 112221 1222345566889999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.+||+.||.+||| ++|+++||||+.
T Consensus 237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred HHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9999999999999 999999999975
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-47 Score=380.10 Aligned_cols=257 Identities=28% Similarity=0.433 Sum_probs=215.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-----KI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 91 (417)
.|++++.||+|+||.||+|.+..+|+.||||.+.... .......++.+|+.+|+.++||||+++++++.+.. .+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 4789999999999999999999999999999986532 12223567889999999999999999999998876 89
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|+||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~- 157 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDE- 157 (372)
T ss_pred EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCc-
Confidence 99999996 478777765 679999999999999999999999999999999999999999999999999987543221
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc------------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------------------ 232 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------ 232 (417)
........+|+.|+|||++.+....+.++||||+||++|+|++|++||.+.+.......+..
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~ 237 (372)
T cd07853 158 SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237 (372)
T ss_pred cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHH
Confidence 12233457899999999998765446899999999999999999999988776655544422
Q ss_pred -----CCC---------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 233 -----GEY---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 233 -----~~~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
... ......++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~ 295 (372)
T cd07853 238 AHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR 295 (372)
T ss_pred HHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence 111 12234578899999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=364.82 Aligned_cols=258 Identities=28% Similarity=0.493 Sum_probs=216.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~l 81 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTL 81 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEE
Confidence 35789999999999999999999999999999999875532 2234567789999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+.+ +|...+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 82 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~--~~ 158 (301)
T cd07873 82 VFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PT 158 (301)
T ss_pred EEecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCC--CC
Confidence 9999975 88887764 5689999999999999999999999999999999999999999999999999865332 12
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------ 233 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 233 (417)
.......+++.|+|||++.+....+.++|||||||++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (301)
T cd07873 159 KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEF 238 (301)
T ss_pred CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccc
Confidence 22334567999999999876655568999999999999999999999887765544433221
Q ss_pred -CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 -EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 -~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+..| ...++++++||.+||+.||.+|||++|+++||||+...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~ 293 (301)
T cd07873 239 KSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG 293 (301)
T ss_pred cccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 01111 23578899999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-46 Score=362.21 Aligned_cols=247 Identities=26% Similarity=0.406 Sum_probs=209.8
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||.||+|++..+|+.||+|.+.............+..|+.+|+.++||||+++++++.++..+|+||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999999999999999999765543333345566799999999999999999999999999999999999999
Q ss_pred HHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 104 FAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 104 ~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..... ........||
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGT 157 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCC---CceeeccCCC
Confidence 888753 3589999999999999999999999999999999999999999999999999875432 1223446799
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCC-CCCChHHHHHHHHhccC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCP-KWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p-~~~s~~~~~li~~~L~~ 255 (417)
+.|+|||++.+..++ .++||||+||++|+|++|..||.+.. .......+.......+ ..+++++++||++||+.
T Consensus 158 ~~y~aPE~~~~~~~~-~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 236 (277)
T cd05607 158 NGYMAPEILKEEPYS-YPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLAK 236 (277)
T ss_pred CCccCHHHHccCCCC-CchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhcc
Confidence 999999999887764 89999999999999999999997643 2334444444443332 35789999999999999
Q ss_pred CCCCCCCH----HHHhcCccccc
Q 014849 256 DPATRITV----DEILRDPWFKK 274 (417)
Q Consensus 256 dP~~R~t~----~eil~h~~f~~ 274 (417)
||++|||+ ++++.||||+.
T Consensus 237 ~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 237 KPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CHhhCCCCccchhhhhcChhhcC
Confidence 99999999 77889999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=361.32 Aligned_cols=255 Identities=26% Similarity=0.419 Sum_probs=221.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|+..+.||+|+||+||+|.+..+|+.||+|.+.............+.+|+.+|+.++|+||+.+++.+.+++.+|+|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 48899999999999999999999999999999987655444445567889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~---~~~ 157 (285)
T cd05632 81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GES 157 (285)
T ss_pred eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCC---CCc
Confidence 9999999888753 3699999999999999999999999999999999999999999999999999865432 122
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHhcCCCCCCCCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM----YRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~~~~~p~~~s~~~~~li 249 (417)
....+|++.|+|||++.+..++ .++|+||+||++|+|++|..||........ ...+.......+...++++.+|+
T Consensus 158 ~~~~~g~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (285)
T cd05632 158 IRGRVGTVGYMAPEVLNNQRYT-LSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC 236 (285)
T ss_pred ccCCCCCcCccChHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence 3455799999999999887775 899999999999999999999987655433 33334444556667889999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
.+||+.||++||| +.+++.|+||+..
T Consensus 237 ~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 237 KMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred HHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 9999999999999 8999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-48 Score=361.77 Aligned_cols=254 Identities=37% Similarity=0.669 Sum_probs=221.7
Q ss_pred ccccccCCeEE-eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE-
Q 014849 10 REVNLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA- 86 (417)
Q Consensus 10 ~~~~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~- 86 (417)
++..+.+.|.+ -++||-|-.|+|..|.++.||+.+|+|++.- ....+||++..-+. .|||||+++++++
T Consensus 55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D--------s~KARrEVeLHw~~s~h~~iV~IidVyeN 126 (400)
T KOG0604|consen 55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD--------SPKARREVELHWMASGHPHIVSIIDVYEN 126 (400)
T ss_pred hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc--------CHHHHhHhhhhhhhcCCCceEEeehhhhh
Confidence 44567888988 5679999999999999999999999998743 34566888876555 5999999999974
Q ss_pred ---eCCEEEEEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEe
Q 014849 87 ---TKAKIYFVMEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKIS 157 (417)
Q Consensus 87 ---~~~~~~lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~ 157 (417)
....+.+|||.++||+|+..|.. | .++|.+|..|.+||..|+.|||+.+|.||||||||+|... |..+||+
T Consensus 127 s~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLt 206 (400)
T KOG0604|consen 127 SYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLT 206 (400)
T ss_pred hccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEec
Confidence 45679999999999999999986 3 5999999999999999999999999999999999999964 4569999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcC
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKG 233 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~ 233 (417)
|||+|.... ..+.+.+.|-||.|+|||++....|+ ...|+||+|||+|.||+|++||.... ...|..+|..|
T Consensus 207 DfGFAK~t~---~~~~L~TPc~TPyYvaPevlg~eKyd-kscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~g 282 (400)
T KOG0604|consen 207 DFGFAKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTG 282 (400)
T ss_pred ccccccccC---CCccccCCcccccccCHHHhCchhcC-CCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhcc
Confidence 999997543 35678899999999999999999987 88999999999999999999997642 34688899999
Q ss_pred CCCCC--CC--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 234 EYRCP--KW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 234 ~~~~p--~~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+.+| .| .|.+++++|+++|..+|.+|.|+++++.|||+...
T Consensus 283 qy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~ 328 (400)
T KOG0604|consen 283 QYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY 328 (400)
T ss_pred CccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence 87776 45 48999999999999999999999999999999753
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-46 Score=387.93 Aligned_cols=252 Identities=25% Similarity=0.379 Sum_probs=204.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC------CCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH------PNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H------pnIv~l~~~~~~~ 88 (417)
.++|++.+.||+|+||+||+|.+..+++.||||++.... ........|+.+++.++| ++++++++++...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 478999999999999999999999999999999996432 123445677888777765 4588899988764
Q ss_pred -CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCC-------------
Q 014849 89 -AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENW------------- 152 (417)
Q Consensus 89 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~------------- 152 (417)
..+|+|||++ |++|.+++.+ +.+++..++.++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~ 282 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPP 282 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCC
Confidence 5789999998 6788888765 789999999999999999999998 5999999999999998765
Q ss_pred ---CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 014849 153 ---DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK 229 (417)
Q Consensus 153 ---~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 229 (417)
.+||+|||++.... ......+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+....
T Consensus 283 ~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~-~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~ 356 (467)
T PTZ00284 283 DPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWM-YSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL 356 (467)
T ss_pred CCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 49999999875322 223457899999999999988885 899999999999999999999988776544433
Q ss_pred HhcCCCCCC----------------------------C--------------CCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 230 IYKGEYRCP----------------------------K--------------WTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 230 i~~~~~~~p----------------------------~--------------~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
+.......| . ..++.+.+||.+||+.||.+|||++|+|
T Consensus 357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L 436 (467)
T PTZ00284 357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT 436 (467)
T ss_pred HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence 321100000 0 0145577999999999999999999999
Q ss_pred cCcccccccc
Q 014849 268 RDPWFKKDYK 277 (417)
Q Consensus 268 ~h~~f~~~~~ 277 (417)
+||||++.+.
T Consensus 437 ~Hp~~~~~~~ 446 (467)
T PTZ00284 437 THPYVLKYYP 446 (467)
T ss_pred cCccccccCC
Confidence 9999987544
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-46 Score=349.77 Aligned_cols=252 Identities=30% Similarity=0.555 Sum_probs=220.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV~ 95 (417)
.|++.+.||.|++|.||.|.+..+++.||+|.+...... ......+.+|+.+++.++|||++++++.+.. ...+|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNAS-RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 599999999999999999999999999999999765432 2235568899999999999999999998764 45789999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||+++++|.+.+.. ..+++.++..++.|++.|+.|||++|++||||||+||+++.++.++|+|||++..... ...
T Consensus 80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~--~~~ 157 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN--QCD 157 (257)
T ss_pred cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecc--cCC
Confidence 99999999998864 3589999999999999999999999999999999999999999999999999876533 223
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
...+..|++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+..+.. ..+...++.+.+++.+
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd08223 158 MASTLIGTPYYMSPELFSNKPYN-YKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPPMPKDYSPELGELIAT 236 (257)
T ss_pred ccccccCCcCccChhHhcCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 34556789999999999887765 889999999999999999999998887777666666554 4556788999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||++||++|||+.++++||||
T Consensus 237 ~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 237 MLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred HhccCcccCCCHHHHhcCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-46 Score=371.87 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=205.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|+.+ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP 83 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence 368999999999999999999853 456789999987542 222356788999999999 899999999988654
Q ss_pred -CEEEEEEeccCCCChHHHHhc----------------------------------------------------------
Q 014849 89 -AKIYFVMEFAKGGELFAKISK---------------------------------------------------------- 109 (417)
Q Consensus 89 -~~~~lV~E~~~gg~L~~~i~~---------------------------------------------------------- 109 (417)
..+|+||||++||+|.+++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (338)
T cd05102 84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET 163 (338)
T ss_pred CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence 468999999999999988863
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccc
Q 014849 110 -----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184 (417)
Q Consensus 110 -----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~ 184 (417)
..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+..+|+.|+
T Consensus 164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 243 (338)
T cd05102 164 DDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWM 243 (338)
T ss_pred cccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcccc
Confidence 137778889999999999999999999999999999999999999999999987543211111223345678899
Q ss_pred ccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH-HHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCC
Q 014849 185 APEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA-MYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRI 261 (417)
Q Consensus 185 APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~-~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~ 261 (417)
|||++.+..|+ .++|||||||++|+|++ |..||.+....+ ....+..+. ...|...++++.+++.+||+.||.+||
T Consensus 244 aPE~~~~~~~~-~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP 322 (338)
T cd05102 244 APESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKERP 322 (338)
T ss_pred CcHHhhcCCCC-cccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc
Confidence 99999887775 89999999999999996 999998765433 333343332 345667789999999999999999999
Q ss_pred CHHHHhc
Q 014849 262 TVDEILR 268 (417)
Q Consensus 262 t~~eil~ 268 (417)
|+.|+++
T Consensus 323 s~~el~~ 329 (338)
T cd05102 323 TFSALVE 329 (338)
T ss_pred CHHHHHH
Confidence 9999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-48 Score=360.25 Aligned_cols=268 Identities=31% Similarity=0.595 Sum_probs=229.7
Q ss_pred cccCCeEE-eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE
Q 014849 13 NLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAK 90 (417)
Q Consensus 13 ~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~ 90 (417)
.+.+-|++ .++||+|++|.|--|.+..||..+|||+++++ ......++.||++++.+++ |+||++|+++|++.++
T Consensus 74 ~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~ 150 (463)
T KOG0607|consen 74 KFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTR 150 (463)
T ss_pred hHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccce
Confidence 45566766 67899999999999999999999999999987 3345788999999999995 9999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~~~ 166 (417)
+|+|||-+.||.|...|.+ ..++|.+|.++.++|++||+|||.+||.||||||+|||..... .+|||||.+..-..
T Consensus 151 FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k 230 (463)
T KOG0607|consen 151 FYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIK 230 (463)
T ss_pred EEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccc
Confidence 9999999999999999876 6799999999999999999999999999999999999996654 48999999875322
Q ss_pred c-----cCCCCcccccccCcccccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------------C
Q 014849 167 Q-----IRPDGMLHTLCGTPAYVAPEILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---------------N 222 (417)
Q Consensus 167 ~-----~~~~~~~~~~~Gt~~y~APEvl~----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---------------~ 222 (417)
. ......+.++||+-.|||||+.. ...++..+.|.||||||||.||+|++||.+. -
T Consensus 231 ~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~C 310 (463)
T KOG0607|consen 231 LNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVC 310 (463)
T ss_pred cCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHH
Confidence 1 11234567889999999999963 2233348999999999999999999999542 1
Q ss_pred HHHHHHHHhcCCCCCCC--C--CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccCCCCC
Q 014849 223 LMAMYRKIYKGEYRCPK--W--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPH 283 (417)
Q Consensus 223 ~~~~~~~i~~~~~~~p~--~--~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~~~ 283 (417)
...++..|..|.+.+|. | +|.++++||+.+|..||.+|.++.++++|||++....+..++.
T Consensus 311 Q~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~~~ekalpt 375 (463)
T KOG0607|consen 311 QNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRCAPEKALPT 375 (463)
T ss_pred HHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCccccccchhccCCC
Confidence 34578889999999985 3 6999999999999999999999999999999998766655443
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=359.61 Aligned_cols=261 Identities=30% Similarity=0.455 Sum_probs=224.4
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..-.....+|++.+.||+|+||.||+|.+..+++.||+|.+...... ....+.+|+.+++.++||||+++++.+...
T Consensus 13 ~~~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~ 89 (296)
T cd06654 13 VSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVG 89 (296)
T ss_pred cccCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeC
Confidence 33455678999999999999999999999999999999999765432 246788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
...|+||||++|++|.+++..+.+++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 90 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~ 169 (296)
T cd06654 90 DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (296)
T ss_pred CEEEEeecccCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccc
Confidence 99999999999999999998888999999999999999999999999999999999999999999999999998653321
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~ 245 (417)
........|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.... ...|...++.+
T Consensus 170 --~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 246 (296)
T cd06654 170 --QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIF 246 (296)
T ss_pred --ccccCcccCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCCCCccccCHHH
Confidence 1223345789999999999877664 89999999999999999999998877644333333222 23455678899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+||.+||..||++|||+.+++.||||...
T Consensus 247 ~~li~~~l~~~p~~Rpt~~eil~~~~~~~~ 276 (296)
T cd06654 247 RDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276 (296)
T ss_pred HHHHHHHCcCCcccCcCHHHHhhChhhhcc
Confidence 999999999999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-47 Score=382.63 Aligned_cols=253 Identities=31% Similarity=0.476 Sum_probs=217.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-C-----CCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-H-----PNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-H-----pnIv~l~~~~ 85 (417)
..+..||++.++||+|+||.|-+|.+..|++.||||+++... ....+...|+.+|..|+ | -|+|+++++|
T Consensus 182 d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k----~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F 257 (586)
T KOG0667|consen 182 DHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK----RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF 257 (586)
T ss_pred ceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh----HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc
Confidence 345669999999999999999999999999999999998754 34678889999999997 4 3899999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CeEEeeee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW--DLKISDFG 160 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~--~vkl~DFG 160 (417)
..++++|||+|... .+|.++++. .+++...++.+++||+.||.+||+.||||.|||||||||...+ .|||+|||
T Consensus 258 ~fr~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFG 336 (586)
T KOG0667|consen 258 YFRNHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFG 336 (586)
T ss_pred ccccceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecc
Confidence 99999999999995 499999986 5689999999999999999999999999999999999996543 69999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------- 232 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------- 232 (417)
.|+... ....+++-+..|+||||+.+.+|+ .+.||||||||++||++|.+.|.+.+..+.+..|..
T Consensus 337 SSc~~~-----q~vytYiQSRfYRAPEVILGlpY~-~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~ 410 (586)
T KOG0667|consen 337 SSCFES-----QRVYTYIQSRFYRAPEVILGLPYD-TAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPK 410 (586)
T ss_pred cccccC-----CcceeeeeccccccchhhccCCCC-CccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHH
Confidence 998754 234488899999999999999997 889999999999999999999999887776665531
Q ss_pred --------------------------------------------CCCCCCC-----------CCChHHHHHHHHhccCCC
Q 014849 233 --------------------------------------------GEYRCPK-----------WTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 233 --------------------------------------------~~~~~p~-----------~~s~~~~~li~~~L~~dP 257 (417)
.+...|. .....+.+||++||.+||
T Consensus 411 mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP 490 (586)
T KOG0667|consen 411 MLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDP 490 (586)
T ss_pred HHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCc
Confidence 0001120 012456889999999999
Q ss_pred CCCCCHHHHhcCcccccc
Q 014849 258 ATRITVDEILRDPWFKKD 275 (417)
Q Consensus 258 ~~R~t~~eil~h~~f~~~ 275 (417)
.+|+|+.++|+||||...
T Consensus 491 ~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 491 AERITPAQALNHPFLTGT 508 (586)
T ss_pred hhcCCHHHHhcCcccccc
Confidence 999999999999999853
|
|
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=354.76 Aligned_cols=252 Identities=32% Similarity=0.526 Sum_probs=209.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 58999999999999999999999999999999876432 23335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|+. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI--PVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCC--Ccc
Confidence 997 578887753 4689999999999999999999999999999999999999999999999999865432 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
......+++.|+|||++.+....+.++|||||||++|+|++|++||.+.+.......+...
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (285)
T cd07861 157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK 236 (285)
T ss_pred cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence 2334567899999999876554458999999999999999999999876543322221110
Q ss_pred -CC---------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 -EY---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 -~~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.. ......++++.++|++||+.||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~ 285 (285)
T cd07861 237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285 (285)
T ss_pred hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence 00 0122358899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-46 Score=364.30 Aligned_cols=246 Identities=25% Similarity=0.465 Sum_probs=195.0
Q ss_pred eeEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEEEEe
Q 014849 21 GKIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIYFVME 96 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~lV~E 96 (417)
++.||+|+||.||+|++. .+++.||+|.+.... ....+.+|+.+|+.++||||+++++++.+ ...+|+|+|
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG-----ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC-----CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 578999999999999975 477899999986543 23457789999999999999999999854 467899999
Q ss_pred ccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCeEEeeeecc
Q 014849 97 FAKGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLS 162 (417)
Q Consensus 97 ~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~~vkl~DFGls 162 (417)
|+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9965 78777642 258999999999999999999999999999999999999 45678999999999
Q ss_pred eeecccC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHhc
Q 014849 163 AVKEQIR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------AMYRKIYK 232 (417)
Q Consensus 163 ~~~~~~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~~ 232 (417)
....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.. .....+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~ 239 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFN 239 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHH
Confidence 7654321 1223445789999999999987655568999999999999999999999643210 11111110
Q ss_pred ----------------------------CCCC----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 233 ----------------------------GEYR----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 233 ----------------------------~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.... .....++++.+||.+||++||.+|||++|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 240 VMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0000 001125678999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=357.75 Aligned_cols=259 Identities=31% Similarity=0.494 Sum_probs=224.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....+|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++.+.....+
T Consensus 15 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (296)
T cd06655 15 GDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ---PKKELIINEILVMKELKNPNIVNFLDSFLVGDEL 91 (296)
T ss_pred CCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC---chHHHHHHHHHHHHhcCCCceeeeeeeEecCceE
Confidence 3455789999999999999999999999999999999976432 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+|+||++|++|..++..+.+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~--~ 169 (296)
T cd06655 92 FVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--Q 169 (296)
T ss_pred EEEEEecCCCcHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccc--c
Confidence 99999999999999998888999999999999999999999999999999999999999999999999988654321 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 248 (417)
......+|++.|+|||.+.+..++ .++|||||||++|+|++|+.||...+.......+.... ...|...++.+.+|
T Consensus 170 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 248 (296)
T cd06655 170 SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSPIFRDF 248 (296)
T ss_pred ccCCCcCCCccccCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcccCCcccCCHHHHHH
Confidence 123345789999999999877764 89999999999999999999999887665544444332 23455678899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|.+||..||++|||+.+++.||||+...
T Consensus 249 i~~~l~~dp~~Rpt~~~il~~~~~~~~~ 276 (296)
T cd06655 249 LNRCLEMDVEKRGSAKELLQHPFLKLAK 276 (296)
T ss_pred HHHHhhcChhhCCCHHHHhhChHhhhcc
Confidence 9999999999999999999999998543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=351.01 Aligned_cols=255 Identities=31% Similarity=0.554 Sum_probs=219.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc------cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR------GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~------~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
+|.+++.||+|+||.||.|.+..+++.+|+|.+....... ....+.+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 6889999999999999999999999999999987543321 1234678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
.++|+||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANS 160 (267)
T ss_pred cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCccccccc
Confidence 9999999999999999976 679999999999999999999999999999999999999999999999999987553211
Q ss_pred C----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-CCCCCCCCChH
Q 014849 170 P----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPD 244 (417)
Q Consensus 170 ~----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 244 (417)
. ........|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||...+......++... ....|...+..
T Consensus 161 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd06628 161 LSTKTNGARPSLQGSVFWMAPEVVKQTSYT-RKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPSNISSE 239 (267)
T ss_pred ccCCccccccccCCCcCccChhHhccCCCC-chhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCcCCcccCHH
Confidence 1 1112345689999999999877765 8899999999999999999999887665555554443 33556677899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+.++|++||++||.+||++.++++||||
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 240 AIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 9999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-45 Score=360.36 Aligned_cols=259 Identities=32% Similarity=0.549 Sum_probs=226.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+..+++.||+|.+.+...........+.+|+.+++.++||||+++++.+.+....|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 37999999999999999999999999999999998765544345667889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC--
Q 014849 96 EFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP-- 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~-- 170 (417)
||+.|++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 99999999999875 4699999999999999999999999999999999999999999999999999764322110
Q ss_pred -------------------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 014849 171 -------------------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA 225 (417)
Q Consensus 171 -------------------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~ 225 (417)
........||..|+|||++.+..+ +.++|||||||++|+|++|..||...+...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~l~~g~~pf~~~~~~~ 239 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH-GSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCC-CchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence 011123468999999999987776 489999999999999999999999888887
Q ss_pred HHHHHhcCCCCCCCC--CChHHHHHHHHhccCCCCCCCC----HHHHhcCcccccc
Q 014849 226 MYRKIYKGEYRCPKW--TSPDLKWFIGRLLDTDPATRIT----VDEILRDPWFKKD 275 (417)
Q Consensus 226 ~~~~i~~~~~~~p~~--~s~~~~~li~~~L~~dP~~R~t----~~eil~h~~f~~~ 275 (417)
.+.++.......|.. .++.+.++|.+||..||++||| +++++.||||+..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 240 TFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred HHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence 777777666655554 5899999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-45 Score=360.21 Aligned_cols=253 Identities=24% Similarity=0.441 Sum_probs=215.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|..+|+|.+.... ......++.+|+++++.++||||+++++++.+.+.+|+||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICM 78 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEe
Confidence 36999999999999999999999999999999987542 2334567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++|++|.+++.. +.+++..+..++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.... ...
T Consensus 79 ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~----~~~ 154 (308)
T cd06615 79 EHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSM 154 (308)
T ss_pred eccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccc----ccc
Confidence 99999999999976 789999999999999999999997 599999999999999999999999999986432 223
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------- 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------- 234 (417)
..+.+|++.|+|||++.+..++ .++||||+||++|+|++|..||...+.......+....
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~-~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (308)
T cd06615 155 ANSFVGTRSYMSPERLQGTHYT-VQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS 233 (308)
T ss_pred cccCCCCcCccChhHhcCCCCC-ccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence 3456899999999998776664 89999999999999999999997665444333222110
Q ss_pred ------------------CCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ------------------YRCP-KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ------------------~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...| ...++++++|+.+||..||++|||+.++++||||++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~ 293 (308)
T cd06615 234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA 293 (308)
T ss_pred cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence 0111 1257789999999999999999999999999999864
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=355.74 Aligned_cols=263 Identities=30% Similarity=0.469 Sum_probs=224.7
Q ss_pred CccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 7 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.+++.....+.|++.+.||+|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++.+.
T Consensus 3 ~~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~ 79 (292)
T cd06644 3 HVRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFY 79 (292)
T ss_pred hhhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEE
Confidence 45566677789999999999999999999999999999999987542 233567888999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..+.+|+||||++|++|...+.+ +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 80 ~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~ 159 (292)
T cd06644 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAK 159 (292)
T ss_pred eCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCcccee
Confidence 99999999999999999887753 5789999999999999999999999999999999999999999999999998864
Q ss_pred ecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---C
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---R 236 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~ 236 (417)
... .........|++.|+|||++.+ ..+ +.++|||||||++|+|++|.+||...+....+.++..... .
T Consensus 160 ~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T cd06644 160 NVK--TLQRRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLS 236 (292)
T ss_pred ccc--cccccceecCCccccCceeeccccccCCCC-CchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCccCC
Confidence 322 1122344568999999999853 233 4789999999999999999999988776666666654432 3
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.|...+.++.++|++||..||++||+++++++||||...
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~ 275 (292)
T cd06644 237 QPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV 275 (292)
T ss_pred CCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence 355678899999999999999999999999999999754
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-48 Score=385.45 Aligned_cols=259 Identities=30% Similarity=0.458 Sum_probs=232.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...+-|+|+-.||.|+||+||+|.+++++-..|.|+|.... .+..+...-||.||..|.||+||+|++.|.-.+++|
T Consensus 29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLw 105 (1187)
T KOG0579|consen 29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLW 105 (1187)
T ss_pred CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceE
Confidence 34566889999999999999999999999999999997653 445678889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|..|||.||-....+-. ..|+|.+++-+++|++.||.|||+++|||||||..|||++-+|.++|+|||.|+.... .
T Consensus 106 iliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~--t 183 (1187)
T KOG0579|consen 106 ILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS--T 183 (1187)
T ss_pred EEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh--H
Confidence 99999999999887764 6799999999999999999999999999999999999999999999999999875332 3
Q ss_pred CCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---CCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---CPKWTS 242 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s 242 (417)
-....+..|||+||||||+. ..+|+ .++||||||+.|.+|..+.+|-..-+++..+-+|.+.+++ -|..++
T Consensus 184 ~qkRDsFIGTPYWMAPEVvmCET~KD~PYD-ykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLlqPS~Ws 262 (1187)
T KOG0579|consen 184 RQKRDSFIGTPYWMAPEVVMCETFKDQPYD-YKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQPSHWS 262 (1187)
T ss_pred HhhhccccCCcccccchheeeccccCCCch-hhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCcccCcchhh
Confidence 34556789999999999974 46776 9999999999999999999999999999999999988765 477889
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..+.+|+++||..||..||+++++++||||++...
T Consensus 263 ~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~S 297 (1187)
T KOG0579|consen 263 RSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPS 297 (1187)
T ss_pred hHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCc
Confidence 99999999999999999999999999999995443
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=358.41 Aligned_cols=262 Identities=29% Similarity=0.466 Sum_probs=224.1
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
......++|++.+.||+|+||.||+|.+..+|+.||+|.+...... ..+.+.+|+.+++.++||||+++++++....
T Consensus 13 ~~~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~ 89 (297)
T cd06656 13 SVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGD 89 (297)
T ss_pred ccCChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 3456679999999999999999999999999999999999764322 2466789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
..|+||||++|++|.+++.+..+++.++..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++......
T Consensus 90 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~- 168 (297)
T cd06656 90 ELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE- 168 (297)
T ss_pred EEEEeecccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC-
Confidence 9999999999999999998888999999999999999999999999999999999999999999999999998654321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~ 246 (417)
........|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+... ....|...++.+.
T Consensus 169 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (297)
T cd06656 169 -QSKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPERLSAVFR 246 (297)
T ss_pred -ccCcCcccCCccccCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCCCCCccccCHHHH
Confidence 1223445789999999999887764 8999999999999999999999876654332222222 1224556788899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+|+.+||..||++|||++++++||||+....
T Consensus 247 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 277 (297)
T cd06656 247 DFLNRCLEMDVDRRGSAKELLQHPFLKLAKP 277 (297)
T ss_pred HHHHHHccCChhhCcCHHHHhcCchhccccc
Confidence 9999999999999999999999999986443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-45 Score=373.33 Aligned_cols=254 Identities=28% Similarity=0.432 Sum_probs=208.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+..+|++++.||+|+||.||+|... .++..||+|.+.... ...+|+.+|+.++||||+++++++....
T Consensus 88 ~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~~ 159 (392)
T PHA03207 88 SVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWKS 159 (392)
T ss_pred hhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeCC
Confidence 345678999999999999999999764 456789999886532 3458999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+|||++. ++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 160 ~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 160 TVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred EEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9999999996 588888864 78999999999999999999999999999999999999999999999999998755433
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhc-------------
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL---MAMYRKIYK------------- 232 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~------------- 232 (417)
.........+||+.|+|||++....|+ .++|||||||++|+|++|..||.+.+. ...+..+.+
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~ 317 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYC-AKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG 317 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence 222233456799999999999888875 899999999999999999999976432 111111111
Q ss_pred ----------------CCCCCCC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 233 ----------------GEYRCPK-----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 233 ----------------~~~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+..|. ..+.++.+||++||..||++|||+.|++.||||++.
T Consensus 318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~ 381 (392)
T PHA03207 318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKE 381 (392)
T ss_pred chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhcc
Confidence 0111111 235678899999999999999999999999999864
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=352.08 Aligned_cols=257 Identities=31% Similarity=0.532 Sum_probs=224.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||.|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIM 78 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEE
Confidence 479999999999999999999999999999999976532 233567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
||+++++|.+++..+++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~--~~~~ 156 (274)
T cd06609 79 EYCGGGSCLDLLKPGKLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM--SKRN 156 (274)
T ss_pred EeeCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc--cccc
Confidence 99999999999988899999999999999999999999999999999999999999999999999987654321 2234
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCC-CChHHHHHHHHhc
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKW-TSPDLKWFIGRLL 253 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~-~s~~~~~li~~~L 253 (417)
...|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+.......+..... ..+.. .++++.+++.+||
T Consensus 157 ~~~~~~~y~~PE~~~~~~~~-~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 235 (274)
T cd06609 157 TFVGTPFWMAPEVIKQSGYD-EKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNKFSKPFKDFVSLCL 235 (274)
T ss_pred cccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCcccccCHHHHHHHHHHh
Confidence 45789999999999887765 999999999999999999999988776666555555433 23334 6889999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..||++|||++++++||||++...
T Consensus 236 ~~~p~~Rpt~~~il~~~~~~~~~~ 259 (274)
T cd06609 236 NKDPKERPSAKELLKHKFIKKAKK 259 (274)
T ss_pred hCChhhCcCHHHHhhChhhcCCCc
Confidence 999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=356.76 Aligned_cols=252 Identities=30% Similarity=0.526 Sum_probs=209.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|++..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+...+|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 69999999999999999999999999999999976532 23334567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..... .....
T Consensus 80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~--~~~~~ 156 (284)
T cd07839 80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGI--PVRCY 156 (284)
T ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCC--CCCCc
Confidence 9975 77776653 6799999999999999999999999999999999999999999999999999865432 11223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcCC-------------------
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKGE------------------- 234 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~------------------- 234 (417)
....+++.|+|||++.+....+.++||||+||++|+|++|..|| .+.+..+.+..+.+..
T Consensus 157 ~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07839 157 SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKP 236 (284)
T ss_pred CCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccc
Confidence 34567899999999877654468999999999999999998885 4454444444332110
Q ss_pred C----------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 Y----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+ ...+..++++++||.+||+.||.+|||+++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f 284 (284)
T cd07839 237 YPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF 284 (284)
T ss_pred cCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence 0 0112357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-46 Score=355.18 Aligned_cols=256 Identities=34% Similarity=0.498 Sum_probs=222.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||.|+||.||+|.+..+++.+|+|++.... ......+.+|+.+++.++||||+++++++.++...|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIES---EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCC---HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 467999999999999999999999899999999986542 22356788899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~--~~ 158 (280)
T cd06611 81 IEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST--LQ 158 (280)
T ss_pred eeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc--cc
Confidence 999999999999875 56999999999999999999999999999999999999999999999999987654321 22
Q ss_pred cccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~ 244 (417)
......||+.|+|||++.. ..+ +.++|+||+||++|+|++|.+||...+......++..+.. ..|..++.+
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~-~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (280)
T cd06611 159 KRDTFIGTPYWMAPEVVACETFKDNPY-DYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSKWSSS 237 (280)
T ss_pred ccceeecchhhcCHHHHhhcccCCCCC-CccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCcCCcccCCHH
Confidence 2345678999999999853 233 4789999999999999999999998887777777766543 345667899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.++|.+||+.+|.+|||++++++||||.+..
T Consensus 238 ~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 269 (280)
T cd06611 238 FNDFLKSCLVKDPDDRPTAAELLKHPFVSDQS 269 (280)
T ss_pred HHHHHHHHhccChhhCcCHHHHhcChhhcccc
Confidence 99999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-45 Score=350.63 Aligned_cols=252 Identities=28% Similarity=0.476 Sum_probs=212.8
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++..+..+|+
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~i 83 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWI 83 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEE
Confidence 4568999999999999999999999999999999997542 1224567899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..... ...
T Consensus 84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~--~~~ 161 (267)
T cd06646 84 CMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITA--TIA 161 (267)
T ss_pred EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecc--ccc
Confidence 9999999999998865 6899999999999999999999999999999999999999999999999999875432 112
Q ss_pred cccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-----KWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~ 244 (417)
.....+|++.|+|||.+.. ..+ +.++|+||+||++|+|++|..||...+.......+....+..| ..++..
T Consensus 162 ~~~~~~~~~~y~~PE~~~~~~~~~~-~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (267)
T cd06646 162 KRKSFIGTPYWMAPEVAAVEKNGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSST 240 (267)
T ss_pred ccCccccCccccCHhHcccccCCCC-cchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHH
Confidence 2344578999999999853 234 4789999999999999999999976554443333333333222 235789
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
+.+||++||+.||++|||+++|++|+|
T Consensus 241 ~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 241 FHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred HHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-45 Score=356.09 Aligned_cols=259 Identities=30% Similarity=0.561 Sum_probs=223.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++.+.||+|+||.||+|.+..+++.||+|.+.............+.+|+.+++.++||||+++++.+.+++.+|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 36999999999999999999999999999999998765433344567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR----- 169 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~----- 169 (417)
||++|++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (305)
T cd05609 81 EYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLY 160 (305)
T ss_pred ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcccccc
Confidence 99999999999976 779999999999999999999999999999999999999999999999999875311000
Q ss_pred --------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--
Q 014849 170 --------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK-- 239 (417)
Q Consensus 170 --------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~-- 239 (417)
.........|++.|+|||.+.+..+ +.++|||||||++|+|++|..||.+.+..+....+..+....|.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 239 (305)
T cd05609 161 EGHIEKDTREFLDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239 (305)
T ss_pred ccccccchhhccccCCccCccccCchhccCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 0001123468889999999887776 49999999999999999999999988888888887766544433
Q ss_pred -CCChHHHHHHHHhccCCCCCCCC---HHHHhcCcccccc
Q 014849 240 -WTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKD 275 (417)
Q Consensus 240 -~~s~~~~~li~~~L~~dP~~R~t---~~eil~h~~f~~~ 275 (417)
..++++.++|.+||++||++||| +.++++||||...
T Consensus 240 ~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~ 279 (305)
T cd05609 240 EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGL 279 (305)
T ss_pred ccCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCC
Confidence 46888999999999999999997 7999999999763
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=344.00 Aligned_cols=252 Identities=29% Similarity=0.488 Sum_probs=222.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|+||.||+|.+..+|+.|++|.+...... ......+.+|+.+++.++||||+++++++.+....|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 488999999999999999999999999999999765433 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++...... ...
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~--~~~ 157 (256)
T cd08529 80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDN--TNF 157 (256)
T ss_pred eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCc--cch
Confidence 9999999998865 46899999999999999999999999999999999999999999999999998754432 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 252 (417)
....+|++.|+|||++.+..++ .++|+|||||++++|++|..||...+......++..+..+ .+...+.++.+++.+|
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08529 158 ANTIVGTPYYLSPELCEDKPYN-EKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQMYSQQLAQLIDQC 236 (256)
T ss_pred hhccccCccccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999999887765 8999999999999999999999988877777777766543 3446788999999999
Q ss_pred ccCCCCCCCCHHHHhcCccc
Q 014849 253 LDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f 272 (417)
|+.+|++||++.++++|||+
T Consensus 237 l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 237 LTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred ccCCcccCcCHHHHhhCCCC
Confidence 99999999999999999995
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-46 Score=350.82 Aligned_cols=252 Identities=32% Similarity=0.554 Sum_probs=223.9
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|+||.||+|.+..+++.||+|++.+.........+.+.+|+.++++++||||+++++.+.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 59999999999999999999999999999999987665454557789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|+.|++|.+.+.. +.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~---~~~~~ 157 (258)
T cd05578 81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTP---DTLTT 157 (258)
T ss_pred CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCC---Ccccc
Confidence 9999999999976 4899999999999999999999999999999999999999999999999999875432 22334
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...|+..|+|||++.+..+ +.++|+||+|+++|+|++|..||...+ ...............|...++++.++|.+|
T Consensus 158 ~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (258)
T cd05578 158 STSGTPGYMAPEVLCRQGY-SVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLYPATWSTEAIDAINKL 236 (258)
T ss_pred ccCCChhhcCHHHHcccCC-CCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccCcccCcHHHHHHHHHH
Confidence 5678999999999987776 489999999999999999999998776 344444443356677778899999999999
Q ss_pred ccCCCCCCCCH--HHHhcCccc
Q 014849 253 LDTDPATRITV--DEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~--~eil~h~~f 272 (417)
|..||.+||++ .|+++||||
T Consensus 237 l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 237 LERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred ccCChhHcCCccHHHHhcCCCC
Confidence 99999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-45 Score=376.64 Aligned_cols=250 Identities=26% Similarity=0.413 Sum_probs=206.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
....|.+.+.||+|+||.||+|.+..+++.||||... .....+|+.+|++++|||||++++++...+..++
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence 4568999999999999999999999999999999532 2235689999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 238 v~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~ 316 (461)
T PHA03211 238 VLPKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST 316 (461)
T ss_pred EEEccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence 999995 588888764 56999999999999999999999999999999999999999999999999999765432222
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC--------CCHHHHHHHHhcCCC--------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND--------PNLMAMYRKIYKGEY-------- 235 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~--------~~~~~~~~~i~~~~~-------- 235 (417)
......+||+.|+|||++.+..++ .++|||||||+||+|++|..|+.. .....+.+.+.....
T Consensus 317 ~~~~~~~GT~~Y~APE~~~~~~~~-~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~ 395 (461)
T PHA03211 317 PFHYGIAGTVDTNAPEVLAGDPYT-PSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQH 395 (461)
T ss_pred ccccccCCCcCCcCHHHHcCCCCC-chHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCC
Confidence 233356799999999999888875 899999999999999998765432 112223333222211
Q ss_pred ---------------------CCCCC-----CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 236 ---------------------RCPKW-----TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 236 ---------------------~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..+.| .++++.+||.+||+.||.+|||+.|+|+||||+.
T Consensus 396 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 396 AGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred cchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence 01111 3568999999999999999999999999999974
|
|
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=350.78 Aligned_cols=254 Identities=30% Similarity=0.491 Sum_probs=215.9
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 699999999999999999999999999999999765432 3345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+ |++|.+.+.. +.+++.+++.++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus 80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~~~ 157 (286)
T cd07832 80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEE-PRLY 157 (286)
T ss_pred cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCC-CCcc
Confidence 99 9999998864 579999999999999999999999999999999999999999999999999987654321 1223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 235 (417)
....|++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+....+..+...- .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07832 158 SHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKI 237 (286)
T ss_pred ccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcc
Confidence 456789999999998766555689999999999999999999998776655544433210 0
Q ss_pred C-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 236 R-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 236 ~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
. ..+..+..+.+||.+||+.||++|||+++++.||||.
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~ 286 (286)
T cd07832 238 TFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT 286 (286)
T ss_pred cCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence 0 0123468889999999999999999999999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=349.89 Aligned_cols=254 Identities=30% Similarity=0.464 Sum_probs=212.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 579999999999999999999999999999999875432 2223456788999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.|...+.. +.+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 157 (286)
T cd07847 80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG--DDY 157 (286)
T ss_pred eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc--ccc
Confidence 99999888887765 679999999999999999999999999999999999999999999999999987654321 122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------C----C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------------E----Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------~----~ 235 (417)
....++..|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+... . .
T Consensus 158 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07847 158 TDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGL 237 (286)
T ss_pred cCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccc
Confidence 34567899999999876554458999999999999999999999876654433222110 0 0
Q ss_pred CCC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 RCP------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..| ...+..+.+||.+||++||++|||+.|++.||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f 286 (286)
T cd07847 238 SIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF 286 (286)
T ss_pred cCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence 001 1347789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-45 Score=353.43 Aligned_cols=261 Identities=31% Similarity=0.455 Sum_probs=219.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+|++.+.||+|+||.||+|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+...+|+|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 699999999999999999999999999999999766533 123455677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+ +++|.+++... .+++..+..++.||++||.|||++||+||||+|+||+++.++.++|+|||++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~--~~ 157 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP--NR 157 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC--Cc
Confidence 9999 88999999763 6999999999999999999999999999999999999999999999999998765432 12
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------------- 235 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 235 (417)
......+++.|+|||.+.+....+.++||||+||++|+|++|.+||.+.+..+.+.++.....
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T cd07841 158 KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYV 237 (298)
T ss_pred cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccc
Confidence 223345688999999986654446899999999999999999999988776655555432100
Q ss_pred ------C-----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccCC
Q 014849 236 ------R-----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280 (417)
Q Consensus 236 ------~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~ 280 (417)
. .....+..+.++|.+||.+||++|||+.|++.||||++...+..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~ 293 (298)
T cd07841 238 EFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTP 293 (298)
T ss_pred cccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCC
Confidence 0 01223678899999999999999999999999999998776543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-45 Score=344.84 Aligned_cols=252 Identities=30% Similarity=0.561 Sum_probs=222.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||+||.+.+..+|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+.+..|+|+|
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 699999999999999999999999999999999765432 2235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+.+++|.+.+.. ..+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++....... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~--~~ 157 (256)
T cd08218 80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTV--EL 157 (256)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcch--hh
Confidence 9999999998864 358999999999999999999999999999999999999999999999999987543211 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 252 (417)
.....|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+..+...++..+... .|...+.++.++|.+|
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 236 (256)
T cd08218 158 ARTCIGTPYYLSPEICENRPYN-NKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLRNLVSQL 236 (256)
T ss_pred hhhccCCccccCHHHhCCCCCC-CccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCCcccCCHHHHHHHHHH
Confidence 2345689999999998877664 8999999999999999999999988888888777766653 5666789999999999
Q ss_pred ccCCCCCCCCHHHHhcCccc
Q 014849 253 LDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f 272 (417)
|+.+|.+||++.++++||||
T Consensus 237 l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 237 FKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred hhCChhhCcCHHHHhhCcCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-45 Score=345.90 Aligned_cols=255 Identities=30% Similarity=0.521 Sum_probs=219.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++++.||.|+||.||+|.+..++..+|+|++....... ....+.+|+.+|+.++||||+++++.+......|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 47999999999999999999998999999999997654322 4678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 96 EFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||++++++.++|+|||++.........
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~ 158 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158 (267)
T ss_pred eccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence 99999999999864 46899999999999999999999999999999999999999999999999998754432221
Q ss_pred --CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CC-----CCCCh
Q 014849 172 --GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CP-----KWTSP 243 (417)
Q Consensus 172 --~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-----~~~s~ 243 (417)
......+|++.|+|||++......+.++|+|||||++|+|++|+.||...+....+.++...... .+ ..+++
T Consensus 159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd06610 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSK 238 (267)
T ss_pred cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccH
Confidence 13345578999999999877633458999999999999999999999887776666665554322 11 24578
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+.+++.+||..||++|||+.+++.||||
T Consensus 239 ~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 239 SFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 89999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=350.47 Aligned_cols=251 Identities=31% Similarity=0.495 Sum_probs=212.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||.|++..+++.||+|++..... .....+.+|+.+++.++||||+++++.+......|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPG---EDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCch---hHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 3589999999999999999999999999999999875431 2245678899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++..... ....
T Consensus 85 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~--~~~~ 162 (267)
T cd06645 85 MEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA--TIAK 162 (267)
T ss_pred EeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccC--cccc
Confidence 999999999998865 7899999999999999999999999999999999999999999999999999865432 1122
Q ss_pred ccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC-----CCCChHH
Q 014849 174 LHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-----KWTSPDL 245 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-----~~~s~~~ 245 (417)
.....|++.|+|||++. ...+ +.++|+||+||++|+|++|..||................+..+ ..++..+
T Consensus 163 ~~~~~~~~~y~aPE~~~~~~~~~~-~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (267)
T cd06645 163 RKSFIGTPYWMAPEVAAVERKGGY-NQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSF 241 (267)
T ss_pred cccccCcccccChhhhccccCCCC-CchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHH
Confidence 34457999999999974 3334 4899999999999999999999976554443333333333222 2356789
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
.++|.+||..||++|||++++++|||
T Consensus 242 ~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 242 HHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred HHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=361.56 Aligned_cols=255 Identities=22% Similarity=0.382 Sum_probs=207.7
Q ss_pred EEeeEEeee--CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 19 EVGKIIGCG--AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 19 ~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
++.++||+| +|++||++.++.+|+.||+|.++.+.. .......+.+|+.+++.++||||+++++++.+++..|+|||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 79 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTS 79 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEe
Confidence 356789999 789999999999999999999976543 23345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC---
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--- 170 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~--- 170 (417)
|+++|+|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.++++||+.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~ 159 (327)
T cd08227 80 FMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR 159 (327)
T ss_pred ccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence 9999999999864 4589999999999999999999999999999999999999999999999986532211000
Q ss_pred --CCcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 014849 171 --DGMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---------- 236 (417)
Q Consensus 171 --~~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 236 (417)
.......+++..|+|||++.+. +| +.++||||+||++|+|++|+.||..............+..+
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (327)
T cd08227 160 VVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPA 238 (327)
T ss_pred ccccccccccceecccChHHhhcccCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhh
Confidence 0111234578889999998763 45 48999999999999999999999876544433332222111
Q ss_pred ------------------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 ------------------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.....++.+.+||.+||+.||++|||++|+++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~ 313 (327)
T cd08227 239 EELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI 313 (327)
T ss_pred hhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence 011236789999999999999999999999999999763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=348.58 Aligned_cols=252 Identities=29% Similarity=0.506 Sum_probs=213.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT----- 87 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~----- 87 (417)
..++|++.+.||+|+||.||+|.+..+++.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG 79 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence 4578999999999999999999999999999999987543 2245788999999998 69999999999865
Q ss_pred -CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 88 -KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 88 -~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
...+|+||||+.+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.
T Consensus 80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~ 159 (272)
T cd06637 80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA 159 (272)
T ss_pred CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence 3578999999999999998875 368999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--C
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--R 236 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~ 236 (417)
.... ......+.+|++.|+|||++.. ..| +.++||||+||++|+|++|..||...........+..... .
T Consensus 160 ~~~~--~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 236 (272)
T cd06637 160 QLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL 236 (272)
T ss_pred eccc--ccccCCcccccccccCHhHhccccCcCCCC-CchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCCCCCC
Confidence 5432 1223455679999999999863 344 4789999999999999999999987665554444433322 1
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+...+.++.+|+.+||..||.+|||+.+++.||||
T Consensus 237 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 237 KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 233467899999999999999999999999999998
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-45 Score=351.37 Aligned_cols=254 Identities=30% Similarity=0.490 Sum_probs=218.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
-|++.+.||+|+||.||+|.+..++..+++|.+.... ......+.+|+.+++.++||||+++++++......|+|+|
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e 82 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 82 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCC---HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEE
Confidence 3788999999999999999999999999999986543 2235677889999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|+++++|...+.. +.+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..... .....
T Consensus 83 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~--~~~~~ 160 (282)
T cd06643 83 FCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR--TIQRR 160 (282)
T ss_pred ecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccc--ccccc
Confidence 9999999888754 6799999999999999999999999999999999999999999999999999865322 11223
Q ss_pred cccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHH
Q 014849 175 HTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLK 246 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~ 246 (417)
....||+.|+|||++. +..+ +.++||||+||++|+|++|.+||...+..+...++.... ...|..++.++.
T Consensus 161 ~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (282)
T cd06643 161 DSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLAQPSRWSSEFK 239 (282)
T ss_pred ccccccccccCHhhccccCCCCCCC-CccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCCCCCccccCHHHH
Confidence 4457899999999984 2334 478999999999999999999999887776666665443 234556788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+||.+||+.||.+|||++++++||||+...
T Consensus 240 ~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 269 (282)
T cd06643 240 DFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269 (282)
T ss_pred HHHHHHccCChhhCcCHHHHhcCCCEeccC
Confidence 999999999999999999999999998653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-47 Score=374.62 Aligned_cols=257 Identities=33% Similarity=0.566 Sum_probs=240.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-....+++.+||-|+||.|-++........+|+|++++..+.+....+++..|-.||..++.|.||++|..|.+...+|+
T Consensus 418 ~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYm 497 (732)
T KOG0614|consen 418 KLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYM 497 (732)
T ss_pred chhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhh
Confidence 45667889999999999999998766655799999999988888888999999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
.||-|-||+|+..+.. |.+++..++.|+.-+++|++|||++|||+|||||+|++|+.+|-+||.|||+|.... .+.
T Consensus 498 LmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~---~g~ 574 (732)
T KOG0614|consen 498 LMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIG---SGR 574 (732)
T ss_pred hHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhc---cCC
Confidence 9999999999999986 899999999999999999999999999999999999999999999999999997654 567
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~ 250 (417)
...|.||||.|+|||++.+++++ .++|.||||+++||||+|.+||.+.+++..|..|.+|- +.+|..++..+.+||+
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD-~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~Pr~I~k~a~~Lik 653 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHD-RAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFPRRITKTATDLIK 653 (732)
T ss_pred ceeeecCCcccccchhhhccCcc-hhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcccccchhHHHHHH
Confidence 78999999999999999999998 99999999999999999999999999999999999874 6789999999999999
Q ss_pred HhccCCCCCCCC-----HHHHhcCccccc
Q 014849 251 RLLDTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 251 ~~L~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
++...+|.+|.. +.+|.+|.||..
T Consensus 654 ~LCr~~P~ERLG~~~~gI~DIkkH~Wf~g 682 (732)
T KOG0614|consen 654 KLCRDNPTERLGYQKGGINDIKKHRWFEG 682 (732)
T ss_pred HHHhcCcHhhhccccCChHHHHhhhhhhc
Confidence 999999999995 999999999975
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-45 Score=346.84 Aligned_cols=254 Identities=28% Similarity=0.479 Sum_probs=216.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc---ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+|++++.||+|+||.||+|.+ .+|+.+|+|.+...... ......++.+|+.+++.++||||+++++++.+....|+
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISI 79 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEE
Confidence 589999999999999999987 58899999998754321 12234678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc----
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI---- 168 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~---- 168 (417)
|+||++|++|.+++.+ +.+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++......
T Consensus 80 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 80 FMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 9999999999999976 78999999999999999999999999999999999999999999999999988643211
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~ 245 (417)
..........|++.|+|||++.+..++ .++|+|||||++|+|++|..||...+.......+... ....|...+.++
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYG-RKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMPRLPDSFSAAA 238 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCc-chhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCCCCCCCCCHHH
Confidence 111223445789999999999887775 8999999999999999999999876655444444332 234566678999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.++|++||.++|++|||+.+++.||||
T Consensus 239 ~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 239 IDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=349.63 Aligned_cols=250 Identities=23% Similarity=0.415 Sum_probs=211.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+..+++.||+|++.... .......+.+|+.++++++||||+++++.+.+....++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 78 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT 78 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEE
Confidence 36889999999999999999999999999999997643 2223567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
||+++++|..+ +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++..... ....
T Consensus 79 e~~~~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~----~~~~ 151 (279)
T cd06619 79 EFMDGGSLDVY---RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN----SIAK 151 (279)
T ss_pred ecCCCCChHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccc----cccc
Confidence 99999998654 4578999999999999999999999999999999999999999999999999865432 2334
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-------HHHHHHHhcCCC-CC-CCCCChHHH
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-------MAMYRKIYKGEY-RC-PKWTSPDLK 246 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-------~~~~~~i~~~~~-~~-p~~~s~~~~ 246 (417)
..+||+.|+|||++.+..++ .++|+||+||++|+|++|..||..... ......+..... .. ....+++++
T Consensus 152 ~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (279)
T cd06619 152 TYVGTNAYMAPERISGEQYG-IHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFV 230 (279)
T ss_pred CCCCChhhcCceeecCCCCC-CcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHHH
Confidence 56899999999999887774 899999999999999999999965221 122222222221 11 234678999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++|.+||+.||.+||+++++++||||+..
T Consensus 231 ~li~~~l~~~P~~Rp~~~eil~~~~~~~~ 259 (279)
T cd06619 231 HFITQCMRKQPKERPAPENLMDHPFIVQY 259 (279)
T ss_pred HHHHHHhhCChhhCCCHHHHhcCcccccc
Confidence 99999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=346.80 Aligned_cols=247 Identities=38% Similarity=0.687 Sum_probs=219.9
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||.|+||.||+|++..+++.||+|++.+...........+.+|+.+++.++||||+++++.+.++...|+|+||++|++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 68999999999999999999999999876654445567899999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~ 182 (417)
.+++.+ ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....+|++.
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~ 157 (262)
T cd05572 81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPE 157 (262)
T ss_pred HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcC
Confidence 999976 578999999999999999999999999999999999999999999999999987553321 2334578999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHh--cCCCCCCCCCChHHHHHHHHhccCCCC
Q 014849 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--LMAMYRKIY--KGEYRCPKWTSPDLKWFIGRLLDTDPA 258 (417)
Q Consensus 183 y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~--~~~~~~p~~~s~~~~~li~~~L~~dP~ 258 (417)
|+|||.+....++ .++|+||+|+++|+|++|..||.... ....+.++. ......|...++++.++|.+||..||+
T Consensus 158 ~~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~ 236 (262)
T cd05572 158 YVAPEIILNKGYD-FSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPNYIDKAAKDLIKQLLRRNPE 236 (262)
T ss_pred ccChhHhcCCCCC-ChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHccCChh
Confidence 9999998877775 89999999999999999999998776 667777776 345566777789999999999999999
Q ss_pred CCCC-----HHHHhcCccccc
Q 014849 259 TRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 259 ~R~t-----~~eil~h~~f~~ 274 (417)
+||| +.|+++||||++
T Consensus 237 ~R~~~~~~~~~~l~~~~~~~~ 257 (262)
T cd05572 237 ERLGNLKGGIKDIKKHKWFNG 257 (262)
T ss_pred hCcCCcccCHHHHhcChhhhC
Confidence 9999 999999999985
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=346.94 Aligned_cols=256 Identities=32% Similarity=0.530 Sum_probs=215.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-------cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-------GGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+|.+.+.||+|+||+||+|.+..+|+.||+|.+....... ....+.+.+|+.+++.++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 6999999999999999999999999999999986432211 112456788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+++||||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 161 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDI 161 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeecccccccccc
Confidence 99999999999999999876 78999999999999999999999999999999999999999999999999998754332
Q ss_pred CCCCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC----CC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK----WT 241 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~----~~ 241 (417)
..........|+..|+|||++.... ..+.++|+||||+++|+|++|..||...+......++.... ...+. .+
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (272)
T cd06629 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNL 241 (272)
T ss_pred ccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCccccccC
Confidence 2222234567899999999987654 23589999999999999999999998766554444433222 22222 34
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+.++.++|.+||.++|++|||++++++||||
T Consensus 242 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 242 SPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 7899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-45 Score=350.62 Aligned_cols=249 Identities=33% Similarity=0.461 Sum_probs=205.2
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHH---hCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS---RLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~---~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
.||+|+||.||+|.+..+|+.+|+|.+.+.............+|..+++ ..+||||+.+++++.+.+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999998765433322333344544443 3479999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 100 GGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 100 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++..... ......+
T Consensus 81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~----~~~~~~~ 156 (279)
T cd05633 81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (279)
T ss_pred CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccc----cCccCcC
Confidence 9999998875 7899999999999999999999999999999999999999999999999999864432 1223457
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
||+.|+|||.+.+....+.++||||+||++|+|++|..||.... ...............|...++++.++|.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 236 (279)
T cd05633 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVELPDSFSPELKSLLEGLLQR 236 (279)
T ss_pred CCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcCCccccCHHHHHHHHHHhcC
Confidence 99999999998643333489999999999999999999997532 222222233334556777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCcccccc
Q 014849 256 DPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~-----t~~eil~h~~f~~~ 275 (417)
||++|| |+.++++||||+..
T Consensus 237 ~p~~R~~~~~~~~~~~~~h~~~~~~ 261 (279)
T cd05633 237 DVSKRLGCLGRGAQEVKEHVFFKGI 261 (279)
T ss_pred CHHHhcCCCCCCHHHHHhCccccCC
Confidence 999999 69999999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=353.58 Aligned_cols=260 Identities=32% Similarity=0.467 Sum_probs=216.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKI 91 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 91 (417)
-.++|++.+.||+|+||.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++... +.+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSI 83 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeE
Confidence 46789999999999999999999999999999999976542 222334566899999999999999999998654 579
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.+ +|.+.+.. ..+++.++..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~ 162 (309)
T cd07845 84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA 162 (309)
T ss_pred EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence 999999975 78887764 679999999999999999999999999999999999999999999999999987654321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------------
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------------- 233 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------------- 233 (417)
.......+++.|+|||++.+....+.++|||||||++|+|++|.+||...+..+.+..+...
T Consensus 163 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (309)
T cd07845 163 --KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP 240 (309)
T ss_pred --CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence 22233446888999999876544458999999999999999999999988877766655431
Q ss_pred ---CCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---EYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+..+ .+.++++.+||.+||++||++|||+++++.||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~ 298 (309)
T cd07845 241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPL 298 (309)
T ss_pred ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCC
Confidence 11111 235888999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-45 Score=351.10 Aligned_cols=254 Identities=28% Similarity=0.419 Sum_probs=214.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++.+.... ......+.+|+.+++.++||||+++++++.++...|+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 4799999999999999999999999999999998764332 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.|...... +.+++.++..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~--~~~~ 157 (286)
T cd07846 80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GEVY 157 (286)
T ss_pred ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCC--cccc
Confidence 99999998887765 57999999999999999999999999999999999999999999999999998754332 1223
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------C
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------Y 235 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~ 235 (417)
....|++.|+|||++.+....+.++||||+||++|+|++|.+||......+....+.... .
T Consensus 158 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (286)
T cd07846 158 TDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGM 237 (286)
T ss_pred CcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcc
Confidence 445689999999998765555689999999999999999999998766544433332100 0
Q ss_pred C------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 R------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .++..+..+.+|+.+||+.+|++|||+.++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 286 (286)
T cd07846 238 RLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF 286 (286)
T ss_pred ccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence 0 123457889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-45 Score=351.53 Aligned_cols=240 Identities=21% Similarity=0.283 Sum_probs=209.1
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEec
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----KAKIYFVMEF 97 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~ 97 (417)
..+|+|+++.||+|.. +|+.||||++.+.........+.+.+|+.+|++++||||+++++++.+ ...+++||||
T Consensus 26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 6799999999999988 789999999987654444445778899999999999999999999876 4578999999
Q ss_pred cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
++||+|.+++.. +.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++..... ...
T Consensus 104 ~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~-----~~~ 178 (283)
T PHA02988 104 CTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSS-----PPF 178 (283)
T ss_pred CCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcc-----ccc
Confidence 999999999976 6799999999999999999999984 999999999999999999999999999875432 123
Q ss_pred ccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHH
Q 014849 176 TLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 251 (417)
...||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+..+++..+... .+..|...++.+.+|+.+
T Consensus 179 ~~~~~~~y~aPE~~~~~~~~~-~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~ 257 (283)
T PHA02988 179 KNVNFMVYFSYKMLNDIFSEY-TIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIVEA 257 (283)
T ss_pred cccCcccccCHHHhhhccccc-cchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCCcCcHHHHHHHHH
Confidence 4578999999999976 455 49999999999999999999999998888888877544 345555678999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||+.||++|||+.|+++.
T Consensus 258 cl~~dp~~Rps~~ell~~ 275 (283)
T PHA02988 258 CTSHDSIKRPNIKEILYN 275 (283)
T ss_pred HhcCCcccCcCHHHHHHH
Confidence 999999999999999864
|
|
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-45 Score=393.78 Aligned_cols=265 Identities=31% Similarity=0.472 Sum_probs=219.1
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
......+.++|++++.||+|+||+||+|.+..+++.||+|++...... ......+.+|+.+|+.++|||||++++++.+
T Consensus 5 ~~~ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~d 83 (1021)
T PTZ00266 5 YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLN 83 (1021)
T ss_pred ccCCccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEe
Confidence 344567789999999999999999999999999999999999765432 2335678899999999999999999998854
Q ss_pred --CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-------CCeecCCCCCcEEecC---
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR-------GVFHRDLKLENLLLDE--- 150 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~-------givHrDlkp~NILl~~--- 150 (417)
...+|+||||+.+|+|.++|.. +.+++..++.|+.||+.||.|||+. +|+||||||+||||+.
T Consensus 84 e~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~ 163 (1021)
T PTZ00266 84 KANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIR 163 (1021)
T ss_pred cCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcc
Confidence 4679999999999999998864 5799999999999999999999995 4999999999999964
Q ss_pred --------------CCCeEEeeeecceeecccCCCCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCC
Q 014849 151 --------------NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGY 215 (417)
Q Consensus 151 --------------~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~ 215 (417)
.+.+||+|||++..... .......+||+.|+|||++.+. ...+.++||||||||||+|++|.
T Consensus 164 ~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~---~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk 240 (1021)
T PTZ00266 164 HIGKITAQANNLNGRPIAKIGDFGLSKNIGI---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240 (1021)
T ss_pred ccccccccccccCCCCceEEccCCccccccc---cccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCC
Confidence 23489999999875432 2234556899999999998643 22358999999999999999999
Q ss_pred CCCCCCCHH-HHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 216 LPFNDPNLM-AMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 216 ~Pf~~~~~~-~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.||...+.. .+...+...........++++.+||.+||+.+|.+|||+.|+|.|||++...
T Consensus 241 ~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~ 302 (1021)
T PTZ00266 241 TPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG 302 (1021)
T ss_pred CCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence 999865544 4444444333222245689999999999999999999999999999998543
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=358.25 Aligned_cols=261 Identities=29% Similarity=0.469 Sum_probs=213.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 80 (336)
T cd07849 3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESF 80 (336)
T ss_pred cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeeccccccc
Confidence 5689999999999999999999999999999999986422 223456678899999999999999999987544
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
..+|+|+||+.+ +|...+..+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~lv~e~~~~-~l~~~~~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 81 NDVYIVQELMET-DLYKLIKTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred ceEEEEehhccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 368999999965 8888888889999999999999999999999999999999999999999999999999998754322
Q ss_pred CC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc---------------
Q 014849 169 RP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--------------- 232 (417)
Q Consensus 169 ~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--------------- 232 (417)
.. .......+||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS 239 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence 11 11223467899999999976544446899999999999999999999987654433222211
Q ss_pred CC-------C----C-----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 233 GE-------Y----R-----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 233 ~~-------~----~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.. . . ..+..++++.++|.+||+.||.+|||+.|+++||||+....
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~~~ 300 (336)
T cd07849 240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQYHD 300 (336)
T ss_pred hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCccccccCC
Confidence 00 0 0 01235788999999999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-45 Score=349.41 Aligned_cols=256 Identities=38% Similarity=0.676 Sum_probs=228.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 94 (417)
.+|.+.+.||+|+||.||+|.+..+|+.||+|++.+...........+.+|+.+++.++ ||||+++++++.+.+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 47999999999999999999999999999999998765544444577889999999998 99999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC---
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--- 170 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~--- 170 (417)
|||+.+++|.+.+.+ +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++++|||++........
T Consensus 81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~ 160 (280)
T cd05581 81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES 160 (280)
T ss_pred EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence 999999999999977 5899999999999999999999999999999999999999999999999999875443221
Q ss_pred ---------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Q 014849 171 ---------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235 (417)
Q Consensus 171 ---------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 235 (417)
........|++.|+|||++....+ +.++|||||||+++++++|..||...+....+..+.....
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~ 239 (280)
T cd05581 161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPA-GKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEY 239 (280)
T ss_pred CCCCCccccccccccccccccccCCccccCHHHhCCCCC-ChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCC
Confidence 122334568899999999877665 4899999999999999999999998887777777777788
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCH----HHHhcCccc
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITV----DEILRDPWF 272 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~----~eil~h~~f 272 (417)
..|...++.+.++|.+||+.||++|||+ +++++||||
T Consensus 240 ~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~ 280 (280)
T cd05581 240 SFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280 (280)
T ss_pred CCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence 8888889999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-45 Score=347.03 Aligned_cols=256 Identities=30% Similarity=0.527 Sum_probs=215.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc---cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR---GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+|+.++.||+|+||.||.|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++.+.+.+++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4889999999999999999999999999999997543211 2235678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCC-
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRP- 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~- 170 (417)
|+||+.|++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++ .+||+|||++........
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 160 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160 (268)
T ss_pred EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccccccccccccccc
Confidence 9999999999999876 7899999999999999999999999999999999999998876 599999999865433211
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---h--cCCCCCCCCCChH
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI---Y--KGEYRCPKWTSPD 244 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~--~~~~~~p~~~s~~ 244 (417)
.......+||..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+ . ......|...+++
T Consensus 161 ~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (268)
T cd06630 161 AGEFQGQLLGTIAFMAPEVLRGEQYG-RSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG 239 (268)
T ss_pred CCccccccccccceeCHhHhccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence 1112345689999999999877765 8999999999999999999999765433222222 1 1234456667899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
+.+++.+||..+|++|||+.++++||||+
T Consensus 240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 240 LRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 99999999999999999999999999995
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=351.22 Aligned_cols=256 Identities=25% Similarity=0.451 Sum_probs=217.8
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.... .......+.+|+.++++++||||+++++.+...+.+|+||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCM 78 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEE
Confidence 47999999999999999999999999999999986542 2223467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 96 EFAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||++|++|..++..+ .+++..+..++.||+.||.|||+ .||+||||||+||+++.++.+||+|||++....
T Consensus 79 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~---- 154 (286)
T cd06622 79 EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV---- 154 (286)
T ss_pred eecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCccccc----
Confidence 999999999888764 79999999999999999999997 599999999999999999999999999986432
Q ss_pred CCcccccccCccccccccccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---HhcCC-CCCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGY-----DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK---IYKGE-YRCPKWT 241 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y-----~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~---i~~~~-~~~p~~~ 241 (417)
.....+.+|++.|+|||.+.+... .+.++||||+||++|+|++|..||...+....... +..+. ...|...
T Consensus 155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (286)
T cd06622 155 ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234 (286)
T ss_pred CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCccc
Confidence 223345678999999999865432 25789999999999999999999977654443333 33333 3456668
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++++.+||.+||+.+|++||++++++.||||.....
T Consensus 235 ~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~ 270 (286)
T cd06622 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKN 270 (286)
T ss_pred CHHHHHHHHHHcccCcccCCCHHHHhcChhhhhccC
Confidence 999999999999999999999999999999986543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-44 Score=348.44 Aligned_cols=253 Identities=30% Similarity=0.516 Sum_probs=207.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLV 81 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEE
Confidence 5789999999999999999999999999999999976432 12234567899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...... ..
T Consensus 82 ~e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--~~ 158 (291)
T cd07844 82 FEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP--SK 158 (291)
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCC--Cc
Confidence 999985 89888864 57899999999999999999999999999999999999999999999999998643221 11
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcC------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKG------------------ 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~------------------ 233 (417)
......+++.|+|||++.+....+.++||||+||++|+|++|+.||.+.+ ..+....+.+.
T Consensus 159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07844 159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEF 238 (291)
T ss_pred cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhcccc
Confidence 22234578899999998764434589999999999999999999997665 22322222110
Q ss_pred -C--CCC---------CCCCC--hHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 -E--YRC---------PKWTS--PDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 -~--~~~---------p~~~s--~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. ... ....+ .++.+++.+||++||.+|||+.++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f 291 (291)
T cd07844 239 KPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291 (291)
T ss_pred ccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 000 01223 788899999999999999999999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=341.06 Aligned_cols=248 Identities=30% Similarity=0.558 Sum_probs=218.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||++.+..+++.+|+|.+..... ....+.+.+|+.+++.++||||+++++.+.+...+|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKS--SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcc--hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 58999999999999999999999999999999875432 2345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+++++|.+++.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.++++|||++...... ...
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~--~~~ 156 (255)
T cd08219 79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP--GAY 156 (255)
T ss_pred eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccc--ccc
Confidence 9999999998864 45899999999999999999999999999999999999999999999999998755331 222
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~ 252 (417)
.....|++.|+|||++.+..++ .++|+||+|+++|+|++|..||...+.......+..+... .|...+..+.+||.+|
T Consensus 157 ~~~~~~~~~~~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 235 (255)
T cd08219 157 ACTYVGTPYYVPPEIWENMPYN-NKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPLPSHYSYELRSLIKQM 235 (255)
T ss_pred cccccCCccccCHHHHccCCcC-chhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCCCcccCHHHHHHHHHH
Confidence 2345789999999999877764 8999999999999999999999998887777777666543 5666789999999999
Q ss_pred ccCCCCCCCCHHHHhcC
Q 014849 253 LDTDPATRITVDEILRD 269 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h 269 (417)
|+.||++|||+.+++.-
T Consensus 236 l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 236 FKRNPRSRPSATTILSR 252 (255)
T ss_pred HhCCcccCCCHHHHhhc
Confidence 99999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=344.53 Aligned_cols=255 Identities=28% Similarity=0.509 Sum_probs=214.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--GGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIY 92 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 92 (417)
.|++++.||+|+||.||+|.+..+|+.||+|.+....... ......+.+|+.+++.++||||+++++++.+ ...++
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 6899999999999999999999999999999987543211 1234578899999999999999999998865 46789
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-C
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR-P 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~-~ 170 (417)
+++||+++++|.+.+.. +.+++.....++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... .
T Consensus 83 l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~ 162 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS 162 (266)
T ss_pred EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc
Confidence 99999999999999876 679999999999999999999999999999999999999999999999999987543211 1
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~l 248 (417)
........|+..|+|||.+.+..++ .++||||+||++|+|++|+.||..........++... ....|...++.++++
T Consensus 163 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 241 (266)
T cd06651 163 GTGIRSVTGTPYWMSPEVISGEGYG-RKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSHISEHARDF 241 (266)
T ss_pred CCccccCCccccccCHHHhCCCCCC-chhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCchhcCHHHHHH
Confidence 1222345689999999999877764 8999999999999999999999877655544444322 234566778899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
+ +||..+|++|||++|+++||||+
T Consensus 242 i-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 242 L-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred H-HHhcCChhhCcCHHHHhcCcccc
Confidence 9 67778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=339.27 Aligned_cols=252 Identities=33% Similarity=0.533 Sum_probs=223.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|+||.||.+++..+++.+++|.+...... .....++.+|+.++++++||||+++++++.+...++++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 699999999999999999999999999999998765432 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|++|++|.+.+.. ..+++..+..++.|++.||.|||+.|++||||+|+||+++.++.+||+|||++....... ..
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~--~~ 157 (256)
T cd08221 80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEY--SM 157 (256)
T ss_pred ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccc--cc
Confidence 9999999999875 368999999999999999999999999999999999999999999999999987543322 13
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCChHHHHHHHHh
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-PKWTSPDLKWFIGRL 252 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~li~~~ 252 (417)
.....|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+..+....+..+.+.. +...+.++.+++.+|
T Consensus 158 ~~~~~~~~~y~ape~~~~~~~~-~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 236 (256)
T cd08221 158 AETVVGTPYYMSPELCQGVKYN-FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPVVSVYSSELISLVHSL 236 (256)
T ss_pred ccccCCCccccCHhhcCCCCCC-CcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccCHHHHHHHHHH
Confidence 3456789999999998877664 88999999999999999999999988888888877766543 455789999999999
Q ss_pred ccCCCCCCCCHHHHhcCccc
Q 014849 253 LDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f 272 (417)
|.++|.+|||+.++++|||+
T Consensus 237 l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 237 LQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred cccCcccCCCHHHHhhCcCC
Confidence 99999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-45 Score=366.94 Aligned_cols=251 Identities=24% Similarity=0.366 Sum_probs=207.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|++..+| ..||+|++..... ......+.+|+.+|+.+ +||||+++++.+.+.
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~ 114 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAH--TDEREALMSELKILSHLGQHKNIVNLLGACTHG 114 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCC--HHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence 457999999999999999999975444 5799999976532 22356788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISK----------------------------------------------------------- 109 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (417)
...|+||||+++|+|.+++..
T Consensus 115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (374)
T cd05106 115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS 194 (374)
T ss_pred CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence 999999999999999988742
Q ss_pred ------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 110 ------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 110 ------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
.++++..+++++.||+.||.|||++||+||||||+|||++.++.+||+|||++.............+.
T Consensus 195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 14788889999999999999999999999999999999999999999999998754322111112233
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHHhcc
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~ 254 (417)
.+++.|+|||++.+..|+ .++||||+||++|+|++ |..||........+.+.... ....|...++++.+++.+||+
T Consensus 275 ~~~~~y~aPE~~~~~~~~-~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 353 (374)
T cd05106 275 RLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWN 353 (374)
T ss_pred CCccceeCHHHhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHHcC
Confidence 456789999999877775 89999999999999997 99999876544433333333 345667789999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 014849 255 TDPATRITVDEILR 268 (417)
Q Consensus 255 ~dP~~R~t~~eil~ 268 (417)
.||++|||+.++++
T Consensus 354 ~dp~~RPs~~~l~~ 367 (374)
T cd05106 354 LEPTERPTFSQISQ 367 (374)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-45 Score=363.43 Aligned_cols=246 Identities=25% Similarity=0.391 Sum_probs=199.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..+|++.+.||+|+||.||+|.+..+++.||+|+..+. ....|+.+++.++||||+++++++.+....|+|
T Consensus 65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 45799999999999999999999999999999975432 234689999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||++. ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 136 ~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~---~~ 211 (357)
T PHA03209 136 LPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV---AP 211 (357)
T ss_pred EEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc---Cc
Confidence 99996 478887754 5799999999999999999999999999999999999999999999999999864321 12
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCH----------HHHHHHHhcC---CCCCC
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY-LPFNDPNL----------MAMYRKIYKG---EYRCP 238 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~-~Pf~~~~~----------~~~~~~i~~~---~~~~p 238 (417)
......||+.|+|||++.+..|+ .++||||+||++|+|+++. .+|..... ..+...+... ...+|
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 290 (357)
T PHA03209 212 AFLGLAGTVETNAPEVLARDKYN-SKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFP 290 (357)
T ss_pred ccccccccccccCCeecCCCCCC-chhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcC
Confidence 23456799999999999888775 8999999999999999854 44443211 0111111100 00011
Q ss_pred ------------------------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 ------------------------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 ------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...+.++.+||.+||+.||.+|||+.|+++||||++
T Consensus 291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 291 RDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence 123567788999999999999999999999999985
|
|
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=359.58 Aligned_cols=260 Identities=28% Similarity=0.463 Sum_probs=215.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 467899999999999999999999999999999999875432 223345677899999999999999999988644
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+||||+.+ +|.+.+... +++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~-l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~ 169 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 169 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhhc-CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCC
Confidence 357999999965 788877654 9999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------ 234 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 234 (417)
. ........||+.|+|||.+.+..++ .++|||||||++|+|++|+.||...+....+.++...-
T Consensus 170 ~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (353)
T cd07850 170 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ 245 (353)
T ss_pred C---CCCCCCCcccccccCHHHHhCCCCC-CchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 2223445789999999999888875 89999999999999999999998776554444332100
Q ss_pred ----------C-----C---------C-------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccC
Q 014849 235 ----------Y-----R---------C-------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279 (417)
Q Consensus 235 ----------~-----~---------~-------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 279 (417)
. . . +...++.++++|.+||+.||++|||+.|++.||||+.++.+.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~~~~~ 321 (353)
T cd07850 246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVWYDPS 321 (353)
T ss_pred hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhccCCc
Confidence 0 0 0 112355689999999999999999999999999999777643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=342.30 Aligned_cols=256 Identities=29% Similarity=0.505 Sum_probs=214.8
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~ 91 (417)
..|++++.||+|+||.||.|.+..+|+.||+|.+...... .......+.+|+.+++.++||||+++++++.+ ...+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 4799999999999999999999999999999998643211 12235678899999999999999999998866 3578
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR- 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~- 169 (417)
|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+|+||||+||+++.++.++|+|||++.......
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~ 161 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL 161 (265)
T ss_pred EEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc
Confidence 999999999999999876 678999999999999999999999999999999999999999999999999987543211
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 247 (417)
........+|+..|+|||++.+..++ .++|||||||++|+|++|+.||..........++... ....|...+..+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (265)
T cd06652 162 SGTGMKSVTGTPYWMSPEVISGEGYG-RKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPHVSDHCRD 240 (265)
T ss_pred cccccccCCCCccccChhhhcCCCCC-cchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCCCchhhCHHHHH
Confidence 11123445789999999999877764 8999999999999999999999876655544444432 23345667888999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
+|++||. +|++|||++++++|||+.
T Consensus 241 ~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 241 FLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred HHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 9999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=340.22 Aligned_cols=251 Identities=33% Similarity=0.523 Sum_probs=217.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||.|+||.||+|.+..+++.+|+|++..... .....+.+|+.+++.++||||+++++++.+...+|++
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPG---DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCch---hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEE
Confidence 3689999999999999999999999999999999976532 2467888999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++...... ..
T Consensus 79 ~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~--~~ 156 (262)
T cd06613 79 MEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--IA 156 (262)
T ss_pred EeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhh--hh
Confidence 999999999998865 58999999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccccCcccccccccccc---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-----CCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAKK---GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-----PKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~---~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-----p~~~s~~ 244 (417)
.....+|+..|+|||.+.+. .++ .++|+|||||++|+|++|.+||...+.......+....+.. +...+.+
T Consensus 157 ~~~~~~~~~~y~~Pe~~~~~~~~~~~-~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (262)
T cd06613 157 KRKSFIGTPYWMAPEVAAVERKGGYD-GKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV 235 (262)
T ss_pred ccccccCCccccCchhhcccccCCcC-chhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence 23445789999999998766 565 89999999999999999999998877665555554443322 2234678
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
+.+++.+||..+|..|||+.+++.|+|
T Consensus 236 ~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 236 FHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred HHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=348.10 Aligned_cols=250 Identities=33% Similarity=0.470 Sum_probs=209.2
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE---ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~E---i~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+||+|+||.||+|.+..+++.||+|++.+..............| +..++...||||+++++++.+...+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 48999999999999999999999999987644322222223333 344555689999999999999999999999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 100 GGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 100 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
|++|.+++.. +.+++..++.++.|++.||.|||+++|+||||||+||+++.++.+||+|||++..... ......+
T Consensus 81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~----~~~~~~~ 156 (278)
T cd05606 81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK----KKPHASV 156 (278)
T ss_pred CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc----cCCcCcC
Confidence 9999988865 6799999999999999999999999999999999999999999999999999864432 1234568
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
|++.|+|||++.+....+.++||||+||++|+|++|+.||... ........+.......|...++++.+++.+||..
T Consensus 157 ~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~ 236 (278)
T cd05606 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQR 236 (278)
T ss_pred CCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCCCCcCCHHHHHHHHHHhhc
Confidence 9999999999875433358899999999999999999999876 4444444455555667777899999999999999
Q ss_pred CCCCCC-----CHHHHhcCccccccc
Q 014849 256 DPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 256 dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
+|.+|| ++.++++||||+...
T Consensus 237 ~p~~R~~~~~~~~~~ll~~~~~~~~~ 262 (278)
T cd05606 237 DVNRRLGCLGRGAQEVKEHPFFRSLD 262 (278)
T ss_pred CHHhccCCCCCCHHHHHhCccccCCC
Confidence 999999 999999999998743
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-45 Score=348.46 Aligned_cols=252 Identities=25% Similarity=0.362 Sum_probs=216.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 457999999999999999999986655 689999986543 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..|++|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999998864 3578889999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFT-TESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCc-hhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222233445678899999998877765 89999999999999998 999999988888888776
Q ss_pred cCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.. ..|...++++.+|+.+||+.||.+|||+.||+++
T Consensus 241 ~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 241 SRQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 6543 4566789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=351.54 Aligned_cols=251 Identities=22% Similarity=0.260 Sum_probs=205.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEcc----------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVR----------------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn 77 (417)
..++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+|+.++|||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCC
Confidence 35789999999999999999998532 34579999987543 2223567889999999999999
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHHHhcC--------------------CCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 014849 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKG--------------------RFSEQLSRRYFQQLISAVEYCHSRGVF 137 (417)
Q Consensus 78 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~--------------------~l~e~~~~~i~~ql~~aL~ylH~~giv 137 (417)
|+++++++.+.+..|+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 999999999999999999999999999988542 356778899999999999999999999
Q ss_pred ecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CC
Q 014849 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GY 215 (417)
Q Consensus 138 HrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~ 215 (417)
||||||+|||++.++.+||+|||++................+++.|+|||++....++ .++|||||||++|+|++ +.
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~~~~ 239 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFT-TASDVWAFGVTLWEILMLCKE 239 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCC-chhhhHHHHHHHHHHHHccCC
Confidence 9999999999999999999999998754322211222344568899999998877764 89999999999999986 67
Q ss_pred CCCCCCCHHHHHHHHhc---C-----CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 216 LPFNDPNLMAMYRKIYK---G-----EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 216 ~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
.||...+..+....+.. . ....|...++.+.+|+.+||+.||.+|||+++|.
T Consensus 240 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~ 299 (304)
T cd05096 240 QPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIH 299 (304)
T ss_pred CCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence 88887666555443321 1 1223456788999999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=345.32 Aligned_cols=255 Identities=27% Similarity=0.455 Sum_probs=214.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK--- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~--- 88 (417)
...++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +|||++++++++...
T Consensus 19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~ 94 (291)
T cd06639 19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKL 94 (291)
T ss_pred CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEecccc
Confidence 45789999999999999999999999999999999986532 2246678899999998 799999999998653
Q ss_pred --CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 89 --AKIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
...|+||||++|++|.+++. ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 95 ~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~ 174 (291)
T cd06639 95 VGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGV 174 (291)
T ss_pred CCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeeccc
Confidence 46899999999999998875 25789999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY----DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-- 235 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y----~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 235 (417)
+....... ......+|++.|+|||++..... .+.++||||+||++|+|++|++||...+.......+.+...
T Consensus 175 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 252 (291)
T cd06639 175 SAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPT 252 (291)
T ss_pred chhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCC
Confidence 87543211 12234578999999999864321 25899999999999999999999988766555555544422
Q ss_pred -CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 236 -RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 236 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
..|...+..+.+||.+||+.||++|||+.|+++||||+
T Consensus 253 ~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 253 LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 23445678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=352.96 Aligned_cols=247 Identities=25% Similarity=0.459 Sum_probs=193.9
Q ss_pred EeeEEeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKIYFVM 95 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV~ 95 (417)
.++.||+|+||.||+|++.. ++..||+|.+.... ....+.+|+.+|+.++||||+++++++. +...+|+|+
T Consensus 5 ~g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG-----ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred eceEeccCCCeeEEEEEecCCCccceEEEEEecCCC-----CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 35789999999999999754 66899999986543 2345778999999999999999999884 456899999
Q ss_pred eccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCeEEeeeec
Q 014849 96 EFAKGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGL 161 (417)
Q Consensus 96 E~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~~vkl~DFGl 161 (417)
||+.+ +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~ 158 (317)
T cd07867 80 DYAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGF 158 (317)
T ss_pred eeeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccc
Confidence 99965 77776631 248899999999999999999999999999999999999 5667899999999
Q ss_pred ceeecccC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HHHHHHh
Q 014849 162 SAVKEQIR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------AMYRKIY 231 (417)
Q Consensus 162 s~~~~~~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------~~~~~i~ 231 (417)
+....... ........+||+.|+|||++.+....+.++||||+||++|+|++|.+||...... ....++.
T Consensus 159 a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~ 238 (317)
T cd07867 159 ARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIF 238 (317)
T ss_pred eeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHH
Confidence 97653321 1122345678999999999987655569999999999999999999999653211 0000000
Q ss_pred c----------------------------CCCC----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 232 K----------------------------GEYR----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 232 ~----------------------------~~~~----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .... .....+..+.+||.+||+.||.+|||++|+++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 239 SVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred HhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0 0000 011235668899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=338.56 Aligned_cols=251 Identities=33% Similarity=0.547 Sum_probs=220.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++.+......++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 699999999999999999999999999999999875432 2346778899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~~~ 172 (417)
|++|++|.+++.. ..+++..+..++.|++.||.|||++|++||||+|+||+++.++ .+||+|||++...... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~---~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSK---S 156 (256)
T ss_pred cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCC---c
Confidence 9999999999975 2489999999999999999999999999999999999998655 5799999998755322 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
......|++.|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+..+.. ..|...++++.+++.+
T Consensus 157 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 235 (256)
T cd08220 157 KAYTVVGTPCYISPELCEGKPYN-QKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYSPDLRQLILS 235 (256)
T ss_pred cccccccCCcccCchhccCCCCC-cccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCCCCCcCHHHHHHHHH
Confidence 23345789999999999877664 899999999999999999999998887777777765543 4566789999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||.+||++|||+.|+++||||
T Consensus 236 ~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 236 MLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred HccCChhhCCCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-44 Score=345.50 Aligned_cols=257 Identities=31% Similarity=0.594 Sum_probs=219.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 93 (417)
.|++.+.||+|+||.||+|.+..+++.||+|++.... ......++.+|+.+++.++ |||++++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5888999999999999999999999999999987543 2233567889999999997 9999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 94 VMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||++|++|.+++..+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ..
T Consensus 80 v~e~~~~~~L~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~--~~ 157 (277)
T cd06917 80 IMEYAEGGSVRTLMKAGPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS--SK 157 (277)
T ss_pred EEecCCCCcHHHHHHccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc--cc
Confidence 9999999999999988889999999999999999999999999999999999999999999999999987654322 22
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCC-CCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPK-WTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~-~~s~~~~~li~~ 251 (417)
.....|++.|+|||.+.+....+.++|+|||||++|+|++|..||...+.......+..... .++. ..+.++.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 237 (277)
T cd06917 158 RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGYSKLLREFVAA 237 (277)
T ss_pred cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCCCcccCCHHHHHHHHH
Confidence 34457899999999987544445899999999999999999999988776555444433322 2222 267899999999
Q ss_pred hccCCCCCCCCHHHHhcCcccccccc
Q 014849 252 LLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||+.||++|||+.+++.||||++...
T Consensus 238 ~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 238 CLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HcCCCcccCcCHHHHhhChHhhcccc
Confidence 99999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=347.70 Aligned_cols=248 Identities=31% Similarity=0.476 Sum_probs=212.9
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||+||+|.+..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++...+..|+||||++|++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999999999999999999875543333455667899999999999999999999999999999999999999
Q ss_pred HHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccC
Q 014849 104 FAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 104 ~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
.+++.. + .+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++..... ........|+
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~ 157 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGT 157 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhcc---CCccccccCC
Confidence 998865 3 699999999999999999999999999999999999999999999999999865432 2223345678
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCCCCCCCCCChHHHHHHHHhccCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~d 256 (417)
..|+|||++.+..++ .++||||+||++|+|++|+.||..... ..+...+.......|...++++.++|.+||+.|
T Consensus 158 ~~y~~PE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 236 (277)
T cd05577 158 PGYMAPEVLQGEVYD-FSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKD 236 (277)
T ss_pred CCcCCHHHhcCCCCC-chhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCC
Confidence 899999998877764 899999999999999999999977543 333344444455566778999999999999999
Q ss_pred CCCCC-----CHHHHhcCcccccc
Q 014849 257 PATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 257 P~~R~-----t~~eil~h~~f~~~ 275 (417)
|.+|| ++.+++.||||++.
T Consensus 237 p~~R~~~~~~~~~~ll~h~~~~~~ 260 (277)
T cd05577 237 PEKRLGCRGGSADEVREHPLFKDL 260 (277)
T ss_pred hhHccCCCcccHHHHHhChhhhcC
Confidence 99999 88889999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=345.80 Aligned_cols=255 Identities=33% Similarity=0.520 Sum_probs=215.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++||||+++++++.+.+..|+||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 79 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVF 79 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEE
Confidence 589999999999999999999999999999999876432 3334578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||++++.+.....+ ..+++.++..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++........ ...
T Consensus 80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~-~~~ 158 (288)
T cd07833 80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-SPL 158 (288)
T ss_pred ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc-ccc
Confidence 99998777766654 5799999999999999999999999999999999999999999999999999876543221 133
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------------------
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--------------------- 233 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--------------------- 233 (417)
....+++.|+|||++......+.++||||+|+++|+|++|.+||.+.+..+....+...
T Consensus 159 ~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (288)
T cd07833 159 TDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238 (288)
T ss_pred cCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcccccc
Confidence 45678999999999987734459999999999999999999999877655443332210
Q ss_pred CC-----------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 EY-----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 ~~-----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+ ..|...++++.+||++||..+|++|||++++++||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f 288 (288)
T cd07833 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288 (288)
T ss_pred ccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence 00 1233458889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-45 Score=343.03 Aligned_cols=250 Identities=35% Similarity=0.637 Sum_probs=221.5
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||.|+||.||+|.+..+|+.+|+|++.............+.+|+.+++.++||||+++++.+.+....|+++||+.|++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 68999999999999999999999999776544444567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC------CCcccc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP------DGMLHT 176 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~------~~~~~~ 176 (417)
.+++.+ +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++........ ......
T Consensus 81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ 160 (265)
T cd05579 81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKR 160 (265)
T ss_pred HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccC
Confidence 999976 7899999999999999999999999999999999999999999999999999865332211 112344
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCC--ChHHHHHHHHhcc
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT--SPDLKWFIGRLLD 254 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~--s~~~~~li~~~L~ 254 (417)
.++++.|+|||.+....+ +.++|+||||+++|+|++|..||........+..+..+....|... ++.+.+++.+||+
T Consensus 161 ~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 239 (265)
T cd05579 161 IVGTPDYIAPEVILGQGH-SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLISKLLV 239 (265)
T ss_pred cccCccccCHHHhcCCCC-CcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCccccCCHHHHHHHHHHhc
Confidence 578899999999887765 4899999999999999999999999988888888887777766665 8999999999999
Q ss_pred CCCCCCCCH---HHHhcCccccc
Q 014849 255 TDPATRITV---DEILRDPWFKK 274 (417)
Q Consensus 255 ~dP~~R~t~---~eil~h~~f~~ 274 (417)
.+|.+|||+ .++++||||++
T Consensus 240 ~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 240 PDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred CCHhhcCCCccHHHHhcCccccC
Confidence 999999999 99999999974
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=349.24 Aligned_cols=259 Identities=29% Similarity=0.452 Sum_probs=209.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-- 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-- 89 (417)
....++|++.+.||+|+||.||+|.+..+++.||||.+..... .......+.+|+.++++++||||+++++++.+..
T Consensus 8 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 86 (310)
T cd07865 8 CDEVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKATP 86 (310)
T ss_pred cchhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHHhCCCCCccceEEEEeccccc
Confidence 3457789999999999999999999999999999999875432 2223445678999999999999999999986543
Q ss_pred ------EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 90 ------KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 90 ------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
..|+||||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 87 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 87 YNRYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ccCCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 56999999965 78777765 3799999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CC---
Q 014849 162 SAVKEQIRPD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GE--- 234 (417)
Q Consensus 162 s~~~~~~~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~--- 234 (417)
+......... .......++..|+|||.+.+....+.++||||+||++|+|++|+.||.+.+.......+.. +.
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 8754332211 1223456789999999987654345899999999999999999999988765543332221 10
Q ss_pred --------------CCC-------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 --------------YRC-------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 --------------~~~-------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
... +...++.+.+||.+||..||.+|||++|+++||||
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence 001 11235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=346.69 Aligned_cols=258 Identities=30% Similarity=0.492 Sum_probs=222.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|+..+.||.|+||.||.|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 4578899999999999999999999999999999875432 22356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|||++|++|.+++..+++++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~e~~~~~~L~~~i~~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~ 158 (277)
T cd06640 81 MEYLGGGSALDLLRAGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ--IKR 158 (277)
T ss_pred EecCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc--ccc
Confidence 999999999999988899999999999999999999999999999999999999999999999999986543221 122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L 253 (417)
....++..|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..+. ...+...+.++.+++.+||
T Consensus 159 ~~~~~~~~y~apE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06640 159 NTFVGTPFWMAPEVIQQSAYD-SKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEFSKPFKEFIDACL 237 (277)
T ss_pred ccccCcccccCHhHhccCCCc-cHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCCCCCchhhhHHHHHHHHHHc
Confidence 335688899999999877664 89999999999999999999998877665555443332 2334456788999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.+|++|||+.+++.||||.+...
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~~~ 261 (277)
T cd06640 238 NKDPSFRPTAKELLKHKFIVKNAK 261 (277)
T ss_pred ccCcccCcCHHHHHhChHhhhcch
Confidence 999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=368.26 Aligned_cols=257 Identities=33% Similarity=0.667 Sum_probs=226.2
Q ss_pred ccccCCeEE--eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEV--GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i--~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+..-|.| .++||+|.||+||-|.++.+|+.||||+|++.++.... ..++++|+.||+.+.||.||.+--.+++++
T Consensus 558 vd~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~e 636 (888)
T KOG4236|consen 558 VDISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPE 636 (888)
T ss_pred hhHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCc
Confidence 344455655 68999999999999999999999999999998875543 589999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~ 164 (417)
++++|||.+.|.-|.-.+. +|+|+|...+.+..||+.||.|||-++|+|.|||||||||.+.. .+||||||+|++
T Consensus 637 rvFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi 716 (888)
T KOG4236|consen 637 RVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI 716 (888)
T ss_pred eEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence 9999999997744444443 38999999999999999999999999999999999999997654 599999999998
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC--C--
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK--W-- 240 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~-- 240 (417)
... .....+.+|||.|.|||++.+++|. ...|+||.|||+|.-|.|..||... +++-.+|..+.+.+|+ |
T Consensus 717 IgE---ksFRrsVVGTPAYLaPEVLrnkGyN-rSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~e 790 (888)
T KOG4236|consen 717 IGE---KSFRRSVVGTPAYLAPEVLRNKGYN-RSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSE 790 (888)
T ss_pred cch---hhhhhhhcCCccccCHHHHhhcccc-ccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhh
Confidence 763 3456778999999999999999998 8899999999999999999999765 4566778888877764 3
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+++++.+||..+|+..-.+|.|++..+.|||+++.
T Consensus 791 is~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~y 825 (888)
T KOG4236|consen 791 ISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDY 825 (888)
T ss_pred cCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcc
Confidence 58999999999999999999999999999999864
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-44 Score=342.75 Aligned_cols=253 Identities=31% Similarity=0.512 Sum_probs=213.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC---
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~--- 89 (417)
..++|++.+.||+|+||.||+|.+..+++.+++|++..... ...++.+|+.+++.+ .||||+++++++.+..
T Consensus 4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 79 (275)
T cd06608 4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG 79 (275)
T ss_pred chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence 45899999999999999999999999999999999876532 246788999999999 6999999999986644
Q ss_pred ---EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
.+|+||||+++++|.+++.. +.+++..++.++.|++.||.|||++|++||||+|+||+++.++.+||+|||+
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 58999999999999988753 5799999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG----YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-- 235 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~----y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 235 (417)
+...... ........|++.|+|||++.... ..+.++|||||||++|+|++|+.||...+......++.....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~ 237 (275)
T cd06608 160 SAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPT 237 (275)
T ss_pred ceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCC
Confidence 8754321 22334567899999999975422 224789999999999999999999987766665555554432
Q ss_pred -CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+...+.++++||.+||..||++|||+.++++|||+
T Consensus 238 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 238 LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 2233367889999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-44 Score=346.57 Aligned_cols=252 Identities=31% Similarity=0.489 Sum_probs=210.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||.|+||.||+|++..+|+.||||.+..+.. .......+.+|++++++++||||+++++++.+....|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 48999999999999999999999999999999876532 22334678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+. ++|..++.. +.+++..+..++.|++.||+|||++|++||||+|+||+++.++.+||+|||++...... ...
T Consensus 80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~--~~~ 156 (284)
T cd07860 80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP--VRT 156 (284)
T ss_pred ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccC--ccc
Confidence 996 578887753 57899999999999999999999999999999999999999999999999998654321 122
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------C
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------Y 235 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------~ 235 (417)
.....+++.|+|||++.+....+.++|||||||++|+|++|+.||...+......++.... .
T Consensus 157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T cd07860 157 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236 (284)
T ss_pred cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh
Confidence 3344678999999998776655689999999999999999999998766544333322100 0
Q ss_pred CC-----------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 RC-----------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 ~~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+ .+..+++++++|.+||+.||.+|||++++++||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f 284 (284)
T cd07860 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284 (284)
T ss_pred hcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence 01 12357889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=340.25 Aligned_cols=249 Identities=29% Similarity=0.502 Sum_probs=216.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.+++|.+..... ..++.+|+.+++.++||||+++++.+.+....|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 679999999999999999999998999999999875532 578899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++++|.+++.. ..+++..++.++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++....... ..
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~--~~ 155 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM--AK 155 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc--cc
Confidence 99999999999864 578999999999999999999999999999999999999999999999999987544321 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~ 250 (417)
.....|++.|+|||++.+..++ .++||||+||++|+|++|+.||...........+... ....+...+.++.++|.
T Consensus 156 ~~~~~~~~~y~~PE~~~~~~~~-~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 234 (256)
T cd06612 156 RNTVIGTPFWMAPEVIQEIGYN-NKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPTLSDPEKWSPEFNDFVK 234 (256)
T ss_pred cccccCCccccCHHHHhcCCCC-chhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCCCCchhhcCHHHHHHHH
Confidence 3345588999999999888775 8999999999999999999999877655444333322 22334456789999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||+.||++|||+.|+++||||
T Consensus 235 ~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 235 KCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred HHHhcChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-44 Score=337.98 Aligned_cols=253 Identities=32% Similarity=0.559 Sum_probs=217.9
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
||+..+.||+|+||+||+|.+..+++.|++|.+...... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 688999999999999999999889999999998764321 122356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+||++|++|.+++.. +.+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||++....... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~ 157 (258)
T cd06632 81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---F 157 (258)
T ss_pred EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc---c
Confidence 999999999999876 569999999999999999999999999999999999999999999999999987643221 2
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCCCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~ 251 (417)
.....|++.|+|||.+......+.++|+||+||++|+|++|..||..........++.. .....|...++++.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (258)
T cd06632 158 AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILK 237 (258)
T ss_pred ccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCcCCCcCHHHHHHHHH
Confidence 34567899999999987665235899999999999999999999987765554444443 2234566778999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||+.+|++|||+.+++.|||+
T Consensus 238 ~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 238 CLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred HhhcCcccCcCHHHHhcCCCC
Confidence 999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-45 Score=352.69 Aligned_cols=260 Identities=27% Similarity=0.458 Sum_probs=222.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.....|.....||+|+||.||++.+..+++.||||.+.... ......+.+|+.+++.++||||+++++.+...+..|
T Consensus 19 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~ 95 (292)
T cd06658 19 DPREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRK---QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELW 95 (292)
T ss_pred chHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecch---HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEE
Confidence 44566777888999999999999999999999999986543 223567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||+++++|.+++..+++++.++..++.||+.||.|||++||+||||||+||+++.++.++|+|||++..... ...
T Consensus 96 lv~e~~~~~~L~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~--~~~ 173 (292)
T cd06658 96 VVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK--EVP 173 (292)
T ss_pred EEEeCCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccc--ccc
Confidence 999999999999999888899999999999999999999999999999999999999999999999999864332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFI 249 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li 249 (417)
.....+|++.|+|||.+.+..++ .++||||+||++|+|++|+.||...+.......+.... ...+...+..+.+++
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 252 (292)
T cd06658 174 KRKSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFL 252 (292)
T ss_pred cCceeecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCccccccccCHHHHHHH
Confidence 23456789999999999877765 89999999999999999999998877666555544322 222234688899999
Q ss_pred HHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.+||..||++|||++++++||||+....+
T Consensus 253 ~~~l~~~P~~Rpt~~~il~~~~~~~~~~~ 281 (292)
T cd06658 253 DLMLVREPSQRATAQELLQHPFLKLAGPP 281 (292)
T ss_pred HHHccCChhHCcCHHHHhhChhhhccCCc
Confidence 99999999999999999999999865543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=342.90 Aligned_cols=250 Identities=19% Similarity=0.273 Sum_probs=211.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+|++.+.||+|+||.||+|.+. ..+..||+|.+..... ......+.+|+.+|+.++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 357999999999999999999865 4567899999976532 22345788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+|||++.++.+|++|||.+.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~ 161 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA 161 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc
Confidence 999999999999998875 579999999999999999999999999999999999999999999999999875432111
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
........+++.|+|||++.+..++ .++||||+||++|++++ |..||.+.+..+....+..+. .+.|...+..+.+
T Consensus 162 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (266)
T cd05064 162 -IYTTMSGKSPVLWAAPEAIQYHHFS-SASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLHQ 239 (266)
T ss_pred -hhcccCCCCceeecCHHHHhhCCcc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHH
Confidence 1111123456789999999887775 89999999999999775 999999888877777776553 3556667899999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 014849 248 FIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~ 268 (417)
++.+||+.+|.+|||+++|++
T Consensus 240 li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 240 LMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred HHHHHcCCCchhCCCHHHHHH
Confidence 999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=343.73 Aligned_cols=248 Identities=33% Similarity=0.509 Sum_probs=206.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK--AKIYFV 94 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~--~~~~lV 94 (417)
|++.+.||+|+||.||+|.+..+++.||+|.+.+.... .......+|+.+++++. ||||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKS--LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCC--chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 78999999999999999999999999999998754321 11233457888998885 99999999999887 899999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++|++||||+|+||+++. +.+||+|||++...... .
T Consensus 79 ~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~---~ 153 (282)
T cd07831 79 FELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK---P 153 (282)
T ss_pred EecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC---C
Confidence 999975 78777764 56899999999999999999999999999999999999999 99999999998754321 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------C
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------E 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~ 234 (417)
......+++.|+|||++...++.+.++||||+||++|+|++|.+||.+.+..+....+... .
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (282)
T cd07831 154 PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMN 233 (282)
T ss_pred CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccccc
Confidence 2234568999999998766566668999999999999999999999987766555444321 1
Q ss_pred CCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 YRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+..| ...+.++.++|.+||++||++|||++++++||||
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~ 282 (282)
T cd07831 234 YNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF 282 (282)
T ss_pred ccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence 1111 2357899999999999999999999999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=338.15 Aligned_cols=252 Identities=34% Similarity=0.594 Sum_probs=220.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~~lV 94 (417)
+|++.+.||.|+||.||+|.+..+|+.||+|++...... .....++.+|+.+++.++||||+++++++. .....|++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMT-EKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 589999999999999999999999999999999765432 233567889999999999999999999775 34678999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH-----HcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCH-----SRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH-----~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
|||+++++|.+++.. +++++..++.++.||+.||.||| +.+++||||+|+||+++.++.+||+|||++..
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~ 159 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI 159 (265)
T ss_pred ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence 999999999988853 57899999999999999999999 99999999999999999999999999999876
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCCh
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSP 243 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 243 (417)
..... ....+..|++.|+|||++.+..++ .++|+||||+++|+|++|..||...+...+...+..+.+ ..|...++
T Consensus 160 ~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (265)
T cd08217 160 LGHDS--SFAKTYVGTPYYMSPEQLNHMSYD-EKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSS 236 (265)
T ss_pred ccCCc--ccccccccCCCccChhhhcCCCCC-chhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCccccCH
Confidence 54321 113455789999999999877764 899999999999999999999999887788777777665 35667789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
++.+++.+||..+|++|||+.+|++|||+
T Consensus 237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 99999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-44 Score=345.72 Aligned_cols=253 Identities=29% Similarity=0.498 Sum_probs=212.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE-----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA----- 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~----- 86 (417)
...++|++.+.||.|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 13 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~ 88 (282)
T cd06636 13 DPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE----DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPP 88 (282)
T ss_pred ChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh----HHHHHHHHHHHHHHHhcCCCcEEEEeeehhccccc
Confidence 45689999999999999999999999999999999986643 2245678899999998 6999999999984
Q ss_pred -eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 87 -TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 87 -~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
....+|++|||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~ 168 (282)
T cd06636 89 GHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVS 168 (282)
T ss_pred CCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcch
Confidence 34689999999999999998864 45899999999999999999999999999999999999999999999999998
Q ss_pred eeecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR- 236 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 236 (417)
..... ........+|++.|+|||++.. ..++ .++|+|||||++|+|++|..||...........+......
T Consensus 169 ~~~~~--~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~-~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~ 245 (282)
T cd06636 169 AQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATYD-YRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 245 (282)
T ss_pred hhhhc--cccCCCcccccccccCHhhcCcccCcCcCCC-cccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCCCC
Confidence 64432 1123345679999999999863 3453 7899999999999999999999876655444444333221
Q ss_pred -CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 -CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 -~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+...+.++.+||.+||..||.+|||+.||++||||
T Consensus 246 ~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 246 LKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred CcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 123468899999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-44 Score=344.16 Aligned_cols=253 Identities=29% Similarity=0.493 Sum_probs=205.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv 81 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFV 81 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEE
Confidence 3679999999999999999999999999999999976532 22344667899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||+. ++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 82 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~--~~~ 158 (291)
T cd07870 82 FEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSI--PSQ 158 (291)
T ss_pred Eeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCC--CCC
Confidence 99996 567666543 5688999999999999999999999999999999999999999999999999865332 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhc--C--------------C-
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYK--G--------------E- 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~--~--------------~- 234 (417)
......+++.|+|||++.+....+.++|||||||++|+|++|..||...+.. +...++.. + .
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (291)
T cd07870 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNY 238 (291)
T ss_pred CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccc
Confidence 2344567999999999876543358899999999999999999999765432 22222110 0 0
Q ss_pred ----C-CC-CC---------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 ----Y-RC-PK---------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ----~-~~-p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+ +. ..++++.+++.+||+.||.+|||+.|++.||||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~ 291 (291)
T cd07870 239 KPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF 291 (291)
T ss_pred cchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence 0 00 00 125688999999999999999999999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=363.91 Aligned_cols=252 Identities=23% Similarity=0.341 Sum_probs=207.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||+||+|.+ ..++..||+|++..... ....+.+.+|+.+|+.+ +||||+++++++.+.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~ 111 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHINIVNLLGACTVG 111 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC--cHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC
Confidence 45899999999999999999974 35677899999965432 22356788999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISKG---------------------------------------------------------- 110 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 110 (417)
...|+||||++||+|.+++...
T Consensus 112 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (375)
T cd05104 112 GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRS 191 (375)
T ss_pred CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccc
Confidence 9999999999999999887531
Q ss_pred ------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 111 ------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 111 ------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 192 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 192 GSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred ceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 36788899999999999999999999999999999999999999999999987543222111
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
......+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .....+..+. ...|...+.++.+|+
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~-~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 350 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYDIM 350 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCC-CCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHHHH
Confidence 22233456789999999887775 89999999999999997 99999876544 3333343332 334566788999999
Q ss_pred HHhccCCCCCCCCHHHHhcC
Q 014849 250 GRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h 269 (417)
.+||++||++|||+.|+++.
T Consensus 351 ~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 351 KSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred HHHccCChhHCcCHHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-44 Score=337.19 Aligned_cols=255 Identities=33% Similarity=0.581 Sum_probs=216.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
||.+.+.||+|+||.||.|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++...+.+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 799999999999999999999999999999999766432 3356789999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-c-
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-M- 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~- 173 (417)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++.......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 9999999999976 468999999999999999999999999999999999999999999999999987653322111 1
Q ss_pred ccccccCccccccccccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcC-CCCCCCCC--ChHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKG--YDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKG-EYRCPKWT--SPDLKW 247 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~--y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~-~~~~p~~~--s~~~~~ 247 (417)
....++++.|+|||++.... ..+.++||||+||++|+|++|+.||.... .......+..+ ....|.+. ++.+.+
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIPDSLQLSPEGKD 239 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCCcccccCHHHHH
Confidence 23467899999999987654 12489999999999999999999997653 22332223322 33455555 899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+|.+||+.+|++|||+++++.|||+
T Consensus 240 li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 240 FLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHHHccCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-44 Score=342.68 Aligned_cols=256 Identities=28% Similarity=0.487 Sum_probs=222.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
-|++.+.||+|+||.||+|.+..+++.||+|++..... ......+.+|+.+++.++||||+++++.+......|+|||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 82 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIME 82 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEE
Confidence 47888999999999999999999999999999865432 2235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccc
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT 176 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 176 (417)
|+++++|.+++..+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 83 ~~~~~~l~~~i~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~--~~~~~ 160 (277)
T cd06641 83 YLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ--IKRNT 160 (277)
T ss_pred eCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccch--hhhcc
Confidence 9999999999988889999999999999999999999999999999999999999999999999986543211 12234
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhccC
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~ 255 (417)
..|+..|+|||.+.+..++ .++|+||+||++|+|++|..||...+.......+..... ..+...+.++.+++.+||..
T Consensus 161 ~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 239 (277)
T cd06641 161 FVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNK 239 (277)
T ss_pred ccCCccccChhhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCCCCcccCHHHHHHHHHHccC
Confidence 5689999999998876664 899999999999999999999988776666655544432 34566789999999999999
Q ss_pred CCCCCCCHHHHhcCcccccccc
Q 014849 256 DPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 256 dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+|.+||++.++++||||.+...
T Consensus 240 ~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 240 EPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred ChhhCcCHHHHHhCHHHhhhhh
Confidence 9999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=344.41 Aligned_cols=254 Identities=31% Similarity=0.455 Sum_probs=208.9
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCE----
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAK---- 90 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~---- 90 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999876532 2233467788999999995 6999999999877665
Q ss_pred -EEEEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecc
Q 014849 91 -IYFVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLS 162 (417)
Q Consensus 91 -~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls 162 (417)
+|+||||+++ +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 80 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~ 158 (295)
T cd07837 80 SLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLG 158 (295)
T ss_pred eEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccc
Confidence 8999999986 78887753 24799999999999999999999999999999999999998 889999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------- 235 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------- 235 (417)
..... .........+++.|+|||++.+....+.++||||+||++|+|++|..||.+.+......++.....
T Consensus 159 ~~~~~--~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 159 RAFSI--PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW 236 (295)
T ss_pred eecCC--CccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhC
Confidence 64422 112223346789999999987644445899999999999999999999988766554444332100
Q ss_pred ----------CCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 236 ----------RCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 236 ----------~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
..| +..++++.+||.+||.+||.+|||+.|++.||||+
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~ 295 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD 295 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence 001 23678899999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-44 Score=343.30 Aligned_cols=256 Identities=27% Similarity=0.458 Sum_probs=213.6
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE--
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA-- 86 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~-- 86 (417)
.-....++|++.+.||+|+||.||+|.+..+++.+|+|++.... .....+.+|+.+++.+ +||||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 87 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKK 87 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence 33567889999999999999999999999999999999886432 1245678899999999 6999999999873
Q ss_pred ---eCCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 87 ---TKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 87 ---~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+...+|+||||++|++|.+.+.. +.+++..+..++.|++.||.|||+++|+||||||+||+++.++.+||+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence 45679999999999999987642 5689999999999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~ 233 (417)
||++...... ........|++.|+|||++.. ..+ +.++||||+||++|+|++|..||...+......++...
T Consensus 168 fg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~ 244 (286)
T cd06638 168 FGVSAQLTST--RLRRNTSVGTPFWMAPEVIACEQQLDSTY-DARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN 244 (286)
T ss_pred CCceeecccC--CCccccccCCCcccChhhhchhhhccccc-cchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc
Confidence 9998754321 122344579999999999853 234 48999999999999999999999887655544444332
Q ss_pred C---CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 234 E---YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 234 ~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. ...|...+..+.+||.+||+.||++|||+.|+++|+||
T Consensus 245 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 245 PPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred CCCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 2 22345567889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-45 Score=362.88 Aligned_cols=243 Identities=27% Similarity=0.423 Sum_probs=211.7
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
+.+++.||+|.||.||+|... ....||+|.+..... ..+.+.+|+++|++|+|+|||++++++..+..+||||||
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~-~~~~vavk~ik~~~m----~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~ 282 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWN-GSTKVAVKTIKEGSM----SPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEY 282 (468)
T ss_pred HHHHHHhcCCccceEEEEEEc-CCCcccceEEecccc----ChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEe
Confidence 455788999999999999994 335899999876432 246777999999999999999999999998899999999
Q ss_pred cCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 98 AKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 98 ~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
++.|+|.+++.. +.+...+...++.||++||+||+++++|||||.+.||||+++..+||+|||||+..... .....
T Consensus 283 m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~-~Y~~~ 361 (468)
T KOG0197|consen 283 MPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDD-EYTAS 361 (468)
T ss_pred cccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCC-ceeec
Confidence 999999999985 57899999999999999999999999999999999999999999999999999843321 11111
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHh
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~ 252 (417)
...--+..|.|||.+....++ .+|||||+||+|+||+| |+.||.+.+..+....+.+|. .+.|..+++++.+++..|
T Consensus 362 ~~~kfPIkWtAPEa~~~~~FS-~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~CP~~vY~lM~~C 440 (468)
T KOG0197|consen 362 EGGKFPIKWTAPEALNYGKFS-SKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGCPDEVYELMKSC 440 (468)
T ss_pred CCCCCCceecCHHHHhhCCcc-cccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCCCHHHHHHHHHH
Confidence 122224569999999988885 99999999999999987 999999999999999998874 788999999999999999
Q ss_pred ccCCCCCCCCHHHHh
Q 014849 253 LDTDPATRITVDEIL 267 (417)
Q Consensus 253 L~~dP~~R~t~~eil 267 (417)
|..+|++|||++.+.
T Consensus 441 W~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 441 WHEDPEDRPTFETLR 455 (468)
T ss_pred hhCCcccCCCHHHHH
Confidence 999999999998664
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-44 Score=347.23 Aligned_cols=254 Identities=33% Similarity=0.469 Sum_probs=214.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 92 (417)
.+.|++.+.||+|+||.||+|.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++... ...|
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIY 82 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEE
Confidence 45799999999999999999999999999999999765432 33345677899999999999999999998877 8999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|+||+.+ +|.+.+.. ..+++.+++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 83 lv~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~-- 159 (293)
T cd07843 83 MVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSP-- 159 (293)
T ss_pred EEehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCC--
Confidence 99999975 89888865 45899999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---------------- 234 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 234 (417)
........+++.|+|||.+.+....+.++||||+||++|+|++|.+||...+..+...++....
T Consensus 160 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (293)
T cd07843 160 LKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG 239 (293)
T ss_pred ccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence 1223445678999999998766545689999999999999999999999877666555543210
Q ss_pred ---------------CCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 ---------------YRCPKW-TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ---------------~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+|.. .++.+.++|++||+.||++|||+.|+++||||
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f 293 (293)
T cd07843 240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293 (293)
T ss_pred hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence 012222 47889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=353.30 Aligned_cols=258 Identities=27% Similarity=0.423 Sum_probs=217.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+.. ........+.+|+.+|+.++||||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 36889999999999999999999999999999999986542 22233557889999999999999999999987654
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+++||||+ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~ 169 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTD 169 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccccccc
Confidence 469999999 7799998888889999999999999999999999999999999999999999999999999986532
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---------- 236 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---------- 236 (417)
. ......+++.|+|||++.+....+.++|+|||||++|+|++|..||.+.+....+.++......
T Consensus 170 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (343)
T cd07880 170 S-----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ 244 (343)
T ss_pred c-----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence 2 2234567999999999876444468999999999999999999999887765555444321111
Q ss_pred ---------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ---------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ---------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.....++.+.++|.+||+.||++|||+.+++.||||+....
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~ 306 (343)
T cd07880 245 SEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHD 306 (343)
T ss_pred chhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcC
Confidence 11346788999999999999999999999999999986533
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-44 Score=338.54 Aligned_cols=252 Identities=29% Similarity=0.511 Sum_probs=214.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|++..+++.||||.+.............+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred CcceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEE
Confidence 36899999999999999999999999999999998765444444556788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~- 159 (267)
T cd08228 81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK- 159 (267)
T ss_pred EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccch-
Confidence 999999999988742 45899999999999999999999999999999999999999999999999998765422
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHHHhcCCCC-C-CCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--LMAMYRKIYKGEYR-C-PKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~i~~~~~~-~-p~~~s~~~ 245 (417)
........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||.... .......+....++ . +...+..+
T Consensus 160 -~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (267)
T cd08228 160 -TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKL 237 (267)
T ss_pred -hHHHhcCCCCccccChhhhccCCCC-chhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 1223345789999999999887775 89999999999999999999996543 34445554443322 2 23567889
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+++.+||+.+|++|||+.++++.
T Consensus 238 ~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 238 RELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred HHHHHHHCCCCcccCcCHHHHHHH
Confidence 999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-44 Score=347.73 Aligned_cols=260 Identities=30% Similarity=0.473 Sum_probs=221.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||++.+..+++.||+|.+.... ....+.+.+|+.+++.++||||+++++++......
T Consensus 15 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~ 91 (293)
T cd06647 15 GDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKHPNIVNYLDSYLVGDEL 91 (293)
T ss_pred cCchhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcE
Confidence 445689999999999999999999999999999999986542 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+|+||+++++|.+++.+..+++.++..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .
T Consensus 92 ~lv~e~~~~~~L~~~~~~~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~--~ 169 (293)
T cd06647 92 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--Q 169 (293)
T ss_pred EEEEecCCCCcHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc--c
Confidence 99999999999999998888999999999999999999999999999999999999999999999999988654321 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~l 248 (417)
.......|++.|+|||.+.+..++ .++|+||+||++|++++|+.||...+.......+.... +..+...+..++++
T Consensus 170 ~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 248 (293)
T cd06647 170 SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 248 (293)
T ss_pred cccccccCChhhcCchhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCCCccccCHHHHHH
Confidence 223345789999999998877664 89999999999999999999998776544433332221 22233457889999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|.+||+.+|++||++.+++.||||+....
T Consensus 249 i~~~l~~~p~~Rp~~~~il~h~~~~~~~~ 277 (293)
T cd06647 249 LNRCLEMDVEKRGSAKELLQHPFLKIAKP 277 (293)
T ss_pred HHHHccCChhhCcCHHHHhcCHHHhcCcc
Confidence 99999999999999999999999986553
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-47 Score=354.86 Aligned_cols=254 Identities=26% Similarity=0.422 Sum_probs=225.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..-|.++..||+|+||.||+|.++++|+.+|||.+..+. ....+.+||+||++++.|+||++|+.+-..+.+|+|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 345788999999999999999999999999999887654 267788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||..|+..+.+.. ..|+|+++..+++.-+.||.|||...-+|||||..||||+.+|+.||+|||.+..... .-.
T Consensus 107 MEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTD--TMA 184 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTD--TMA 184 (502)
T ss_pred hhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhh--hHH
Confidence 999999999999874 6799999999999999999999999999999999999999999999999999865432 334
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFI 249 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li 249 (417)
..++..|||.||||||+..-+|+ .++||||||+...||..|++||.+-.++...--|-... +.-|..+|+++.+|+
T Consensus 185 KRNTVIGTPFWMAPEVI~EIGY~-~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~KPE~WS~~F~DFi 263 (502)
T KOG0574|consen 185 KRNTVIGTPFWMAPEVIEEIGYD-TKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFKKPEEWSSEFNDFI 263 (502)
T ss_pred hhCccccCcccccHHHHHHhccc-hhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCCChHhhhhHHHHHH
Confidence 56788999999999999999998 89999999999999999999999887765443333322 334666799999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++||..+|++|.|+-++++|||.++..
T Consensus 264 ~~CLiK~PE~R~TA~~L~~H~FiknA~ 290 (502)
T KOG0574|consen 264 RSCLIKKPEERKTALRLCEHTFIKNAP 290 (502)
T ss_pred HHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence 999999999999999999999998643
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=354.47 Aligned_cols=258 Identities=29% Similarity=0.469 Sum_probs=212.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.++|++.+.||.|+||.||+|.+..+|+.||+|.+..... .....+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 79 (342)
T cd07854 3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLT 79 (342)
T ss_pred cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccc
Confidence 56899999999999999999999999999999999876543 3356788999999999999999999876544
Q ss_pred ---------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEee
Q 014849 89 ---------AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISD 158 (417)
Q Consensus 89 ---------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~D 158 (417)
...|+|+||+. ++|.+.+..+.+++..++.++.||++||.|||++||+||||||+||+++. ++.+|++|
T Consensus 80 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 80 EDVGSLTELNSVYIVQEYME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccccceEEEEeeccc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 35899999997 48999888888999999999999999999999999999999999999974 55789999
Q ss_pred eecceeecccCC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---
Q 014849 159 FGLSAVKEQIRP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--- 234 (417)
Q Consensus 159 FGls~~~~~~~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--- 234 (417)
||++........ .+......|++.|+|||++......+.++|||||||++|+|++|..||...+..+....+....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVV 238 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 999875432111 1122334688999999987654444589999999999999999999998776655544433211
Q ss_pred ----------------------C-----CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ----------------------Y-----RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ----------------------~-----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
. ...+..+.++.+||.+||++||.+|||+++++.||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 239 REEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred ChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence 0 0112467889999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=342.34 Aligned_cols=251 Identities=30% Similarity=0.504 Sum_probs=211.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|++|.||+|++..+|+.||||++..... ......+.+|+.+++.++||||+++++.+.+.+..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 58999999999999999999999999999999976532 2234567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|+.+ +|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...... ..
T Consensus 79 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~--~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VN 155 (284)
T ss_pred cCCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCC--cc
Confidence 9986 88887754 35899999999999999999999999999999999999999999999999998654321 12
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------------ 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------------ 234 (417)
......+++.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+...++....
T Consensus 156 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (284)
T cd07836 156 TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235 (284)
T ss_pred ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc
Confidence 22345678999999998765545689999999999999999999999877665555443210
Q ss_pred CC-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 YR-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.. ..+..++.+.++|.+||+.||.+|||+.++++||||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f 284 (284)
T cd07836 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF 284 (284)
T ss_pred ccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 00 112347788999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-45 Score=348.60 Aligned_cols=256 Identities=29% Similarity=0.481 Sum_probs=219.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|+..+.||+|+||.||+|.+..+++.||+|.+..... ......+.+|+.+++.++||||+++++.+......|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccc--hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 3467788899999999999999999999999999875432 22356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+||+++++|.+.+..+.+++..++.++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~--~~~~ 158 (277)
T cd06642 81 MEYLGGGSALDLLKPGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT--QIKR 158 (277)
T ss_pred EEccCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc--chhh
Confidence 99999999999998888999999999999999999999999999999999999999999999999998654321 1122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhc
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L 253 (417)
....|+..|+|||++.+..++ .++|+||+||++|+|++|..||...........+..+.. ..+...+.++.++|.+||
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l 237 (277)
T cd06642 159 NTFVGTPFWMAPEVIKQSAYD-FKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSKPFKEFVEACL 237 (277)
T ss_pred hcccCcccccCHHHhCcCCCc-hhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCCCCcccCHHHHHHHHHHc
Confidence 334688999999999887765 899999999999999999999987665554444433322 233456788999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+|++|||+.++++||||++.
T Consensus 238 ~~~p~~Rp~~~~il~~~~~~~~ 259 (277)
T cd06642 238 NKDPRFRPTAKELLKHKFITRY 259 (277)
T ss_pred cCCcccCcCHHHHHHhHHHHHH
Confidence 9999999999999999999754
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=342.72 Aligned_cols=257 Identities=29% Similarity=0.483 Sum_probs=221.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|...+.||+|++|.||+|.+..+++.+++|.+..... .....+.+|+.+++.++||||+++++++......|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v 94 (285)
T cd06648 18 RSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVV 94 (285)
T ss_pred hHhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccch---hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEE
Confidence 3456677899999999999999999999999999864322 2245688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+||+.|++|.+.+..+++++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 95 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~--~~~~ 172 (285)
T cd06648 95 MEFLEGGALTDIVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE--VPRR 172 (285)
T ss_pred EeccCCCCHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccC--Cccc
Confidence 99999999999998888999999999999999999999999999999999999999999999999987643321 1122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC---CCCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC---PKWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---p~~~s~~~~~li~~ 251 (417)
....|++.|+|||.+.+..++ .++||||+||++|+|++|..||...+......++....... +...++.+.+++.+
T Consensus 173 ~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 251 (285)
T cd06648 173 KSLVGTPYWMAPEVISRLPYG-TEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDR 251 (285)
T ss_pred ccccCCccccCHHHhcCCCCC-CcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCCcccccCCHHHHHHHHH
Confidence 345689999999999877765 89999999999999999999998888777777766553322 22367899999999
Q ss_pred hccCCCCCCCCHHHHhcCcccccccc
Q 014849 252 LLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||+.+|++|||+.++++||||++...
T Consensus 252 ~l~~~p~~Rpt~~~il~~~~~~~~~~ 277 (285)
T cd06648 252 MLVRDPAQRATAAELLNHPFLAKAGP 277 (285)
T ss_pred HcccChhhCcCHHHHccCcccccCCC
Confidence 99999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=336.24 Aligned_cols=252 Identities=31% Similarity=0.578 Sum_probs=218.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||+|.+..+|..+|+|.+...... ....+.+.+|+.+++.++||||+++++.+.+....|+|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMP-VKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhcc-chhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 699999999999999999999999999999999775432 2235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-eEEeeeecceeecccCCCC
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~-vkl~DFGls~~~~~~~~~~ 172 (417)
|+++++|.+.+.. ..+++..+..++.|++.||.|||+++++|+||||+||++++++. +||+|||.+..... ...
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~--~~~ 157 (257)
T cd08225 80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND--SME 157 (257)
T ss_pred cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccC--Ccc
Confidence 9999999998865 25899999999999999999999999999999999999998865 69999998875432 112
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
......|++.|+|||++.+..++ .++|+||+||++++|++|..||...+.......+..+.. ..++..+.++.++|.+
T Consensus 158 ~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 236 (257)
T cd08225 158 LAYTCVGTPYYLSPEICQNRPYN-NKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPISPNFSRDLRSLISQ 236 (257)
T ss_pred cccccCCCccccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCCCCCCCCHHHHHHHHH
Confidence 22345689999999998877765 899999999999999999999998887777776665543 2345568899999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||..+|++|||+.+++.||||
T Consensus 237 ~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 237 LFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred HhccChhhCcCHHHHhhCCCC
Confidence 999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-44 Score=344.45 Aligned_cols=257 Identities=26% Similarity=0.435 Sum_probs=218.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+++.++||||+++++.+.....+|+||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM 82 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence 57999999999999999999999999999999987543 2334678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++++|.+++.. +.+++..++.++.|++.||.|||+ +|++||||||+||+++.++.++|+|||++..... ..
T Consensus 83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~----~~ 158 (284)
T cd06620 83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN----SI 158 (284)
T ss_pred ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh----hc
Confidence 99999999998876 679999999999999999999997 6999999999999999999999999999864322 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-----------HHHHHHhcCC-CCCCCC-
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-----------AMYRKIYKGE-YRCPKW- 240 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-----------~~~~~i~~~~-~~~p~~- 240 (417)
....+|+..|+|||++.+..++ .++||||+||++|+|++|..||...+.. .....+.... ...+..
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~-~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYT-VKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPSSD 237 (284)
T ss_pred cCccccCcccCCHHHHccCCCC-ccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCchh
Confidence 2346799999999998877664 8999999999999999999999865431 2333333322 222322
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccccC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 279 (417)
.+.++.+|+.+||++||++|||+.|+++|+||.+...+.
T Consensus 238 ~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~~ 276 (284)
T cd06620 238 FPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRAS 276 (284)
T ss_pred cCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccccc
Confidence 678899999999999999999999999999998765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-44 Score=337.93 Aligned_cols=247 Identities=36% Similarity=0.593 Sum_probs=210.3
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
+.||+|+||.||+|.+..+|+.||+|++.+...........+..|..++ ...+|||++++++++.+.+.+|+|+||++|
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5799999999999999999999999999765432222233444555444 455899999999999999999999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
++|.+++.. +.+++..+..++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++..... .....|
T Consensus 82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~ 155 (260)
T cd05611 82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVG 155 (260)
T ss_pred CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCC
Confidence 999999976 6799999999999999999999999999999999999999999999999998864322 234568
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----CCCCChHHHHHHHHhccC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC----PKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~s~~~~~li~~~L~~ 255 (417)
++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+....+..+..+.... +...++++.++|.+||+.
T Consensus 156 ~~~y~~pe~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 234 (260)
T cd05611 156 TPDYLAPETILGVGD-DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCM 234 (260)
T ss_pred CcCccChhhhcCCCC-cchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccC
Confidence 899999999987775 589999999999999999999999988888877776654432 234689999999999999
Q ss_pred CCCCCC---CHHHHhcCcccccc
Q 014849 256 DPATRI---TVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~---t~~eil~h~~f~~~ 275 (417)
||++|| +++|++.||||++.
T Consensus 235 ~p~~R~~~~~~~~~l~~~~~~~~ 257 (260)
T cd05611 235 DPAKRLGANGYQEIKSHPFFKSI 257 (260)
T ss_pred CHHHccCCCcHHHHHcChHhhcC
Confidence 999999 55899999999753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=342.34 Aligned_cols=257 Identities=22% Similarity=0.303 Sum_probs=214.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|.++. .+..||+|.+..... ......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (288)
T cd05061 5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESAS--LRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ 82 (288)
T ss_pred HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence 4689999999999999999997652 355899998865432 222446778999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
..|+||||+++|+|.+++.. ..++...++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D 162 (288)
T cd05061 83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD 162 (288)
T ss_pred CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence 99999999999999999863 1245678889999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YR 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~ 236 (417)
||+++...............++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ..
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~ 241 (288)
T cd05061 163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLD 241 (288)
T ss_pred CCccccccccccccccCCCcccccccCHHHhccCCCC-hHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 9998754322111112223457789999998877764 89999999999999998 899999888888777776554 34
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhc------Cccccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILR------DPWFKK 274 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~------h~~f~~ 274 (417)
.|...++.+.+++.+||+.||++|||+.++++ ||||+.
T Consensus 242 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 242 QPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 56667899999999999999999999999987 888864
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-44 Score=342.19 Aligned_cols=251 Identities=24% Similarity=0.344 Sum_probs=215.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||.||+|.+.. +++.||+|.+..... ......+.+|+++|+.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 4579999999999999999998753 468899999875432 223578899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCe
Q 014849 90 KIYFVMEFAKGGELFAKISK---------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~v 154 (417)
..|+||||++|++|.+++.. ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999863 247889999999999999999999999999999999999999999
Q ss_pred EEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 014849 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 155 kl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 233 (417)
||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~ 240 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQG 240 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcc-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC
Confidence 99999998654322111222344567899999999887775 89999999999999998 99999988888888888776
Q ss_pred CCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 234 EYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 234 ~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
... .|...+..+.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 241 RLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred CcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 654 35567899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=347.47 Aligned_cols=256 Identities=28% Similarity=0.483 Sum_probs=220.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.-|+....||+|+||.||+|.+..+++.||+|++..... .....+.+|+.+++.++||||+++++.+......|+|+
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEE
Confidence 346667789999999999999999999999999865432 23566889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
||+++++|...+....+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... .....
T Consensus 98 e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~--~~~~~ 175 (297)
T cd06659 98 EFLQGGALTDIVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRK 175 (297)
T ss_pred ecCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccc--ccccc
Confidence 9999999999888788999999999999999999999999999999999999999999999999998643321 12234
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChHHHHHHHHh
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~~ 252 (417)
..+|++.|+|||++.+..++ .++||||+||++|+|++|+.||...+.......+..... ..+...++.+.++|.+|
T Consensus 176 ~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~ 254 (297)
T cd06659 176 SLVGTPYWMAPEVISRTPYG-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHKISPVLRDFLERM 254 (297)
T ss_pred ceecCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCccccCCCCHHHHHHHHHH
Confidence 56799999999999877764 899999999999999999999988776666655544322 22345678899999999
Q ss_pred ccCCCCCCCCHHHHhcCcccccccc
Q 014849 253 LDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|+.+|++|||++++++||||.+...
T Consensus 255 l~~~P~~Rps~~~ll~~~~~~~~~~ 279 (297)
T cd06659 255 LTREPQERATAQELLDHPFLLQTGL 279 (297)
T ss_pred hcCCcccCcCHHHHhhChhhccCCC
Confidence 9999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-44 Score=340.20 Aligned_cols=253 Identities=28% Similarity=0.487 Sum_probs=217.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+++.+|+|.+..... .....++.+|+.+++.++||||+++++.+.+....|+++
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 78 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN--EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICM 78 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC--hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEE
Confidence 468899999999999999999999999999999976532 234567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||+.|++|.+++.. ..+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.+......
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~---- 154 (265)
T cd06605 79 EYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNS---- 154 (265)
T ss_pred EecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHH----
Confidence 99999999999875 679999999999999999999999 99999999999999999999999999998654321
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCC-CCCCCC-CChHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKGE-YRCPKW-TSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~-~~~p~~-~s~~~ 245 (417)
......|++.|+|||.+.+..++ .++||||+||++|+|++|..||... ...+....+.... ...|.. .++++
T Consensus 155 ~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (265)
T cd06605 155 LAKTFVGTSSYMAPERIQGNDYS-VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF 233 (265)
T ss_pred HhhcccCChhccCHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence 11226789999999999887775 8999999999999999999999764 3334444444332 233443 78899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++|.+||..||.+|||+.+++.||||+..
T Consensus 234 ~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~ 263 (265)
T cd06605 234 QDFVNLCLIKDPRERPSYKELLEHPFIKKY 263 (265)
T ss_pred HHHHHHHcCCCchhCcCHHHHhhCchhhcc
Confidence 999999999999999999999999999753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=330.84 Aligned_cols=252 Identities=38% Similarity=0.649 Sum_probs=223.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||.|+||.||+|.+..+++.||+|++..... .......+.+|+++++.++|||++++++.+......++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 69999999999999999999999999999999976543 22345678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|++|++|.+.+.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc--
Confidence 9999999998864 569999999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIG 250 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 250 (417)
......+|++.|+|||.+....++ .++|+||+|+++++|++|..||...+.......+..... ..|...+..+.+++.
T Consensus 158 ~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 236 (258)
T cd08215 158 DLAKTVVGTPYYLSPELCQNKPYN-YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPSQYSSELRNLVS 236 (258)
T ss_pred ceecceeeeecccChhHhccCCCC-ccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHH
Confidence 234556899999999998877765 889999999999999999999998887777777666543 455677899999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||..+|++|||+.++++||||
T Consensus 237 ~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 237 SLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HHcCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.21 Aligned_cols=255 Identities=28% Similarity=0.443 Sum_probs=207.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIY 92 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~ 92 (417)
+|++.+.||+|+||.||+|.+.. +++.||+|.+.............+.+|+.+++.++||||+++++++.+. ..+|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 69999999999999999999988 8999999999875433344456778999999999999999999999888 8899
Q ss_pred EEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC----CCCeEEeeeecc
Q 014849 93 FVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE----NWDLKISDFGLS 162 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~----~~~vkl~DFGls 162 (417)
+||||+.+ +|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 67665531 36899999999999999999999999999999999999999 899999999998
Q ss_pred eeecccCC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------HHHHHh-
Q 014849 163 AVKEQIRP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA---------MYRKIY- 231 (417)
Q Consensus 163 ~~~~~~~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~---------~~~~i~- 231 (417)
........ .......++|+.|+|||++.+....+.++|||||||++|+|++|++||.+.+... ....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 76533221 1123345789999999998765444589999999999999999999997544221 000000
Q ss_pred -------------------------cCCCCCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 232 -------------------------KGEYRCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 232 -------------------------~~~~~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
......+ ...+.++.+++.+||++||++|||+.|+++||||
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 0001111 1456789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=339.89 Aligned_cols=253 Identities=21% Similarity=0.284 Sum_probs=211.3
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..++|++.+.||+|+||.||.|.+. .++..||+|.+..... .....++.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4568999999999999999999864 2456899999864321 12245678999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 89 AKIYFVMEFAKGGELFAKISKG-----------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~-----------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
+..++||||+++++|.+++... .++...+..++.|++.||.|||++|++||||||+|||+++++.+||+
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 9999999999999999988641 25677889999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y 235 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 235 (417)
|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLL 240 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence 99998643321111112234567889999999877764 89999999999999998 799999888877777666554 3
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..|...++.+.+++.+||+.||++|||+.|++++
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 241 DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5566778899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=341.70 Aligned_cols=250 Identities=24% Similarity=0.359 Sum_probs=212.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...|.+.+.||+|+||+||++.+. .++..+|+|.+.... ......+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcC---HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 357999999999999999999852 355679999886542 233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-C-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 90 KIYFVMEFAKGGELFAKISK-G-------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~-------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
..|+||||+++++|.+++.. + .+++..+..++.||+.||+|||++|++||||||+|||++.++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999998863 2 489999999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+..+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~ 239 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 239 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999998754322111122334467889999999877765 89999999999999998 999999888888888887766
Q ss_pred C-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 235 Y-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 235 ~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
. ..+...++++.+|+.+||++||.+|||+.+++.
T Consensus 240 ~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 240 VLQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 4 445567899999999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-44 Score=352.97 Aligned_cols=259 Identities=26% Similarity=0.422 Sum_probs=218.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK- 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~- 90 (417)
..+.++|++.+.||+|+||.||+|++..+++.||+|++..... .......+.+|+.+++.++||||+++++++.....
T Consensus 11 ~~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (343)
T cd07851 11 WEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSL 89 (343)
T ss_pred ecccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccc
Confidence 3578899999999999999999999999999999999875432 22234667889999999999999999988766554
Q ss_pred -----EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 91 -----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 91 -----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
.|+|+||+ |++|.+++..+++++..+..++.|++.||.|||+.||+||||||+||+++.++.+||+|||++...
T Consensus 90 ~~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~ 168 (343)
T cd07851 90 EDFQDVYLVTHLM-GADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT 168 (343)
T ss_pred cccccEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence 99999999 669999998888999999999999999999999999999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---------
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--------- 236 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--------- 236 (417)
.. ......+|+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+....+..+......
T Consensus 169 ~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 243 (343)
T cd07851 169 DD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI 243 (343)
T ss_pred cc-----cccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence 32 2344578999999999876544468999999999999999999999887766655554331100
Q ss_pred ----------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ----------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ----------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.....++.+.+||.+||++||++|||+.++++||||++...
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~ 306 (343)
T cd07851 244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHD 306 (343)
T ss_pred cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCC
Confidence 01235888999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-44 Score=351.46 Aligned_cols=263 Identities=27% Similarity=0.441 Sum_probs=214.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE----eCC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA----TKA 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~----~~~ 89 (417)
+.++|++.+.||+|+||.||.|.+..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++. ...
T Consensus 3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 81 (334)
T cd07855 3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK 81 (334)
T ss_pred hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCc
Confidence 34789999999999999999999999999999999976432 2234567788999999999999999998875 345
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 160 (334)
T cd07855 82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS 160 (334)
T ss_pred eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence 7999999996 589888865 67999999999999999999999999999999999999999999999999998654321
Q ss_pred C--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--------------
Q 014849 169 R--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232 (417)
Q Consensus 169 ~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~-------------- 232 (417)
. ......+.+|+..|+|||++.+....+.++||||+||++|+|++|+.||.+.+.......+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~ 240 (334)
T cd07855 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG 240 (334)
T ss_pred CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence 1 112223557899999999987644446899999999999999999999987765433322111
Q ss_pred -----------C-CCCC-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 233 -----------G-EYRC-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 233 -----------~-~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
. .... .+..++++.++|++||+.+|++|||+++++.||||++...+
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~~~~ 303 (334)
T cd07855 241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDP 303 (334)
T ss_pred hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhccCC
Confidence 0 0000 12357889999999999999999999999999999865443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-45 Score=341.54 Aligned_cols=258 Identities=31% Similarity=0.591 Sum_probs=234.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~l 93 (417)
.+.|++.++||+|+|++|.+++.+.|.+.+|+|+++++.+...+..+-+..|-.+..+. +||.+|-++..|.+++.+++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 56799999999999999999999999999999999999887777778888888888776 69999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|.||++||+|.-.+.+ ++|+|+.|+.|..+|+.||.|||++||++||||..|+|||..|++||+|+|+.. ....+..
T Consensus 329 vieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmck--e~l~~gd 406 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCK--EGLGPGD 406 (593)
T ss_pred EEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhh--cCCCCCc
Confidence 9999999999777765 789999999999999999999999999999999999999999999999999875 3455677
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-------CCHH-HHHHHHhcCCCCCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-------PNLM-AMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-------~~~~-~~~~~i~~~~~~~p~~~s~~ 244 (417)
...|.||||+|+|||++.+..| |.++|+|+|||++|||++|+-||+- .|.+ -+++-|......+|...|-.
T Consensus 407 ~tstfcgtpnyiapeilrgeey-gfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvk 485 (593)
T KOG0695|consen 407 TTSTFCGTPNYIAPEILRGEEY-GFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVK 485 (593)
T ss_pred ccccccCCCcccchhhhccccc-CceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehh
Confidence 8889999999999999999988 6999999999999999999999952 2333 35677778889999999999
Q ss_pred HHHHHHHhccCCCCCCC------CHHHHhcCcccccc
Q 014849 245 LKWFIGRLLDTDPATRI------TVDEILRDPWFKKD 275 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~------t~~eil~h~~f~~~ 275 (417)
+...++.-|++||.+|. .+.++..|+||+..
T Consensus 486 as~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i 522 (593)
T KOG0695|consen 486 ASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI 522 (593)
T ss_pred hHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC
Confidence 99999999999999997 58999999999853
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=343.72 Aligned_cols=258 Identities=26% Similarity=0.406 Sum_probs=217.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....+|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+....
T Consensus 11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~ 90 (307)
T cd06607 11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTA 90 (307)
T ss_pred CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeE
Confidence 34557799999999999999999999999999999999765433334456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|+||+.| +|.+.+. .+.+++..+..++.||+.||.|||+.||+||||+|.||+++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~-- 167 (307)
T cd06607 91 WLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP-- 167 (307)
T ss_pred EEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCC--
Confidence 999999975 6766664 36799999999999999999999999999999999999999999999999999865432
Q ss_pred CCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CC-CCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RC-PKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~-p~~~s~~~ 245 (417)
.....|++.|+|||++.. .+..+.++||||+||++|+|++|+.||...+.......+..... .. +..++..+
T Consensus 168 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (307)
T cd06607 168 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDWSDYF 243 (307)
T ss_pred ----CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCCchhhCHHH
Confidence 234568899999999742 22235899999999999999999999998876665555544332 22 23457889
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.++|.+||..||++|||+.+++.||||....
T Consensus 244 ~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 244 RNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred HHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 9999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=333.17 Aligned_cols=254 Identities=30% Similarity=0.540 Sum_probs=221.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|++.+.||+|++|.||+|.+..+|+.||+|++...... .....+.+|+.+++.++||||+++++++......|+|+
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVL 78 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEE
Confidence 3689999999999999999999999999999998765421 34678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++++|.+++.. +.+++..+..++.|++.|+.|||+ .|++||||+|+||+++.++.++|+|||++....... ..
T Consensus 79 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~--~~ 156 (264)
T cd06623 79 EYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL--DQ 156 (264)
T ss_pred EecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC--Cc
Confidence 99999999999976 789999999999999999999999 999999999999999999999999999987654321 22
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCC-CCCCCC-CChHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGE-YRCPKW-TSPDLKWF 248 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~-~~~p~~-~s~~~~~l 248 (417)
.....++..|+|||.+.+..+ +.++|+||||+++|+|++|..||... ...+....+.... ...+.. .+..+.++
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (264)
T cd06623 157 CNTFVGTVTYMSPERIQGESY-SYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF 235 (264)
T ss_pred ccceeecccccCHhhhCCCCC-CchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence 235678999999999887765 48999999999999999999999876 4555566655433 334444 78899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
|.+||.++|++|||+.++++||||+.
T Consensus 236 i~~~l~~~p~~R~~~~~ll~~~~~~~ 261 (264)
T cd06623 236 ISACLQKDPKKRPSAAELLQHPFIKK 261 (264)
T ss_pred HHHHccCChhhCCCHHHHHhCHHHHh
Confidence 99999999999999999999999974
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=333.88 Aligned_cols=244 Identities=28% Similarity=0.448 Sum_probs=204.7
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||+|++..+|+.||+|.+.... .......+.+|+.+++.++||||+++++++......|+||||+.++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 46999999999999999999999999886432 2334567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................+
T Consensus 79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 158 (252)
T cd05084 79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI 158 (252)
T ss_pred cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCC
Confidence 99999864 4689999999999999999999999999999999999999999999999999864321111000111123
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHHHhccCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
+..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+.......+... ....|...+..+.+|+.+||++||
T Consensus 159 ~~~y~aPE~~~~~~~~-~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 237 (252)
T cd05084 159 PVKWTAPEALNYGRYS-SESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPCPELCPDAVYRLMERCWEYDP 237 (252)
T ss_pred ceeecCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCcccCCHHHHHHHHHHcCCCh
Confidence 4569999999877764 89999999999999997 99999877766655555443 345566678999999999999999
Q ss_pred CCCCCHHHHhc
Q 014849 258 ATRITVDEILR 268 (417)
Q Consensus 258 ~~R~t~~eil~ 268 (417)
++|||+.++++
T Consensus 238 ~~Rps~~~~~~ 248 (252)
T cd05084 238 GQRPSFSTVHQ 248 (252)
T ss_pred hhCcCHHHHHH
Confidence 99999999975
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=328.90 Aligned_cols=254 Identities=31% Similarity=0.566 Sum_probs=220.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV 94 (417)
+|.+.+.||+|++|.||.|.+..+++.|++|++...... ......+.+|+.++++++||||+++++.+.+. ...++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 589999999999999999999999999999999766432 33467888999999999999999999999988 899999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+||+++++|.+++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999876 5899999999999999999999999999999999999999999999999999876654322112
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhc--CCCCCCCCCChHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYK--GEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~li~ 250 (417)
.....++..|+|||.+....+ +.++||||+|+++|+|++|..||.... .......+.. .....|...+..+.++|.
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~ 238 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEY-GRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEPPEIPEHLSEEAKDFLR 238 (260)
T ss_pred ccCCCCCccccCHhhhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccccCCCcCCCcccCHHHHHHHH
Confidence 345678999999999887765 489999999999999999999998765 3333333332 334556677899999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||..||++|||+.+++.||||
T Consensus 239 ~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 239 KCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred HhCcCChhhCCCHHHHhhCCCC
Confidence 9999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.74 Aligned_cols=252 Identities=23% Similarity=0.349 Sum_probs=212.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...|++.+.||+|+||+||+|.+. .++..||+|.+.... .......+.+|+.+++.++||||+++++++.....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 81 (283)
T cd05090 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN--NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQP 81 (283)
T ss_pred hhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCc
Confidence 357999999999999999999853 456789999986532 22234678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 91 IYFVMEFAKGGELFAKISK------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
.|+||||+++++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++
T Consensus 82 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~ 161 (283)
T cd05090 82 VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQL 161 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCC
Confidence 9999999999999998842 2378889999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++................++..|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+.......+.
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~ 240 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFS-SDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR 240 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222223445567789999999877664 89999999999999998 999998877766666655
Q ss_pred cCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
... ...|...++.+.+++.+||+.||.+||++.+|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 241 KRQLLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 443 45667789999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=329.17 Aligned_cols=252 Identities=35% Similarity=0.629 Sum_probs=221.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|++|.||.|.+..+++.||+|.+...... ......+.+|+++++.++|||++++++++.+....|+++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 699999999999999999999999999999999876432 2346788999999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|+++++|.+.+.. +.+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++........ ...
T Consensus 80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~ 157 (254)
T cd06627 80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK--DDA 157 (254)
T ss_pred cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc--ccc
Confidence 9999999999876 7899999999999999999999999999999999999999999999999999876543222 234
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCCCCCCCCChHHHHHHHHhcc
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY-KGEYRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~~~~~p~~~s~~~~~li~~~L~ 254 (417)
...|++.|+|||.+.+..+ +.++||||+|+++|+|++|..||...+......++. ......|...++.+.+++.+||.
T Consensus 158 ~~~~~~~y~~pe~~~~~~~-~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~ 236 (254)
T cd06627 158 SVVGTPYWMAPEVIEMSGA-STASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHPPLPEGISPELKDFLMQCFQ 236 (254)
T ss_pred ccccchhhcCHhhhcCCCC-CcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHHh
Confidence 4578999999999877765 489999999999999999999998766554444433 33445666778999999999999
Q ss_pred CCCCCCCCHHHHhcCccc
Q 014849 255 TDPATRITVDEILRDPWF 272 (417)
Q Consensus 255 ~dP~~R~t~~eil~h~~f 272 (417)
.+|++|||+.+++.||||
T Consensus 237 ~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 237 KDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CChhhCcCHHHHhcCCCC
Confidence 999999999999999998
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=350.39 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=213.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
...++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~ 92 (345)
T cd07877 14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 92 (345)
T ss_pred hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccc
Confidence 456899999999999999999999999999999999976432 222345678899999999999999999988543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|++++++ |++|.+.+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus 93 ~~~~~~lv~~~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~ 171 (345)
T cd07877 93 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD 171 (345)
T ss_pred ccccEEEEehhc-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEeccccccccc
Confidence 3578888887 7799988887889999999999999999999999999999999999999999999999999986532
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
.......||+.|+|||++.+....+.++||||+||++|+|++|..||...+.......+.....
T Consensus 172 -----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (345)
T cd07877 172 -----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 246 (345)
T ss_pred -----ccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcc
Confidence 2234457899999999987644345899999999999999999999987665554443322110
Q ss_pred ------------CC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 ------------RC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 ------------~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.. ....++++.++|.+||++||.+|||+.+++.||||++...
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~ 308 (345)
T cd07877 247 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 308 (345)
T ss_pred cHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCC
Confidence 00 1124788999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=339.27 Aligned_cols=251 Identities=31% Similarity=0.503 Sum_probs=209.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++.+.||.|++|.||+|.+..+|+.||+|++..+.. .......+.+|+.+++.++|||++++++++.+....|+++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 7889999999999999999999999999999976542 223345678899999999999999999999999999999999
Q ss_pred cCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 98 AKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 98 ~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+. ++|.+++.. . .+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~--~~~~ 156 (283)
T cd07835 80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP--VRTY 156 (283)
T ss_pred cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCC--cccc
Confidence 95 589988865 3 5899999999999999999999999999999999999999999999999998654321 1122
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------------------
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------- 234 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------- 234 (417)
....+++.|+|||++.+....+.++||||+||++|+|++|++||...+......++.+..
T Consensus 157 ~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd07835 157 THEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT 236 (283)
T ss_pred CccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh
Confidence 334578999999998765444589999999999999999999998776544433332210
Q ss_pred ---C------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 ---Y------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ---~------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. ......++.+.++|.+||++||.+|||++|++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~ 283 (283)
T cd07835 237 FPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283 (283)
T ss_pred cccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence 0 1123456889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=339.96 Aligned_cols=249 Identities=27% Similarity=0.424 Sum_probs=207.6
Q ss_pred cccccCCeEEeeEE--eeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 014849 11 EVNLFGKYEVGKII--GCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~L--G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~ 87 (417)
.....++|++.+.+ |+|+||.||++++..++..+|+|++....... .|+.....+ +||||+++++.+..
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~ 80 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTT 80 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEec
Confidence 34556788888777 99999999999999999999999987653211 122222222 79999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~ 165 (417)
.+..|+||||++|++|.+++.. +.+++.+++.++.|++.||.|||+.|++||||||+||+++.++ .++|+|||++...
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 81 LKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred CCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999999999976 5899999999999999999999999999999999999999998 9999999998654
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----HHHHHhcCCCCCCCCC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWT 241 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~----~~~~i~~~~~~~p~~~ 241 (417)
.. .....|++.|+|||++.+..++ .++||||+||++|+|++|..||....... ............++..
T Consensus 161 ~~------~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (267)
T PHA03390 161 GT------PSCYDGTLDYFSPEKIKGHNYD-VSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233 (267)
T ss_pred CC------CccCCCCCcccChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhcccCCccccc
Confidence 32 1234689999999999888875 89999999999999999999998654322 1222223444556678
Q ss_pred ChHHHHHHHHhccCCCCCCCC-HHHHhcCccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRIT-VDEILRDPWFKK 274 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t-~~eil~h~~f~~ 274 (417)
++.+.+||.+||++||.+||+ ++++++||||++
T Consensus 234 ~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 234 SKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred CHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 999999999999999999996 699999999973
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=334.94 Aligned_cols=251 Identities=25% Similarity=0.370 Sum_probs=213.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
++|++.+.||+|+||.||+|.+..+ ...||+|.+.... .......+.+|+.+++.++||||+++++.+.+....|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 81 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVM 81 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceE
Confidence 5799999999999999999998654 4579999986543 2333567888999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 82 iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (266)
T cd05033 82 IITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA 161 (266)
T ss_pred EEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence 99999999999999865 5799999999999999999999999999999999999999999999999999876542111
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+ ..+.|...++.+.++
T Consensus 162 ~~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 240 (266)
T cd05033 162 TYTTKGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPPPMDCPSALYQL 240 (266)
T ss_pred ceeccCCCCCccccChhhhccCCCc-cccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223456789999999877775 89999999999999997 99999887777777777654 334566678999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
+.+||+.+|++|||+.+++++
T Consensus 241 i~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 241 MLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred HHHHcCCCcccCcCHHHHHHH
Confidence 999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=346.23 Aligned_cols=251 Identities=22% Similarity=0.352 Sum_probs=210.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..+|++.+.||+|+||+||+|.+..+|+. ||+|++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 35799999999999999999998776664 8999986432 223456788999999999999999999998765 5
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++|+||+.+|+|.+.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~ 162 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAD 162 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCC
Confidence 7899999999999999875 46899999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 246 (417)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+....+....+..+ ..+.|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (316)
T cd05108 163 EKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY 241 (316)
T ss_pred CcceeccCCccceeecChHHhccCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 211111223456789999999887775 89999999999999997 99999987766655444433 2355677889999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..||.+|||+.+++.+
T Consensus 242 ~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 242 MIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred HHHHHHccCChhhCcCHHHHHHH
Confidence 99999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.76 Aligned_cols=265 Identities=27% Similarity=0.362 Sum_probs=217.2
Q ss_pred cccCCeEE-eeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----------chHHHHHHHHHHHHhCCCCCcce
Q 014849 13 NLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----------GLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 13 ~~~~~y~i-~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
.+.+||.. .+.||+|+||.||+|.+..+++.||+|++........ .....+.+|+.+++.++||||++
T Consensus 5 ~~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 84 (335)
T PTZ00024 5 SISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMG 84 (335)
T ss_pred ccccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceee
Confidence 46788975 6889999999999999999999999999875432211 01225778999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 81 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
+++++......|+||||+. |+|.+.+.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+||
T Consensus 85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df 163 (335)
T PTZ00024 85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF 163 (335)
T ss_pred eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence 9999999999999999997 589888865 67999999999999999999999999999999999999999999999999
Q ss_pred ecceeeccc------------CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 014849 160 GLSAVKEQI------------RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY 227 (417)
Q Consensus 160 Gls~~~~~~------------~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~ 227 (417)
|++...... ..........+++.|+|||.+.+....+.++|||||||++|+|++|.+||.+.+..+.+
T Consensus 164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~ 243 (335)
T PTZ00024 164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL 243 (335)
T ss_pred cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 998754310 01112234467889999999876554568999999999999999999999988766655
Q ss_pred HHHhcCC--C--------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 228 RKIYKGE--Y--------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 228 ~~i~~~~--~--------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..+.... . ......+.++.++|.+||+++|++|||++|++.||||+.....
T Consensus 244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~ 322 (335)
T PTZ00024 244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLP 322 (335)
T ss_pred HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence 5443210 0 0012347889999999999999999999999999999876543
|
|
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=314.17 Aligned_cols=256 Identities=30% Similarity=0.531 Sum_probs=220.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|.-.+.||+|++|+|++|++++|++.||+|.+..+. .+++......|||.+|+.++|.|||+++++..+..++-+|+
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvf 80 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeH
Confidence 46778889999999999999999999999999998765 34556678889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||.. +|..+... |.++.+.++.++.|++.||.|||++++.|||+||+|+|++.||.+|++|||+++.+.- +-.-
T Consensus 81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgi--pvrc 157 (292)
T KOG0662|consen 81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGI--PVRC 157 (292)
T ss_pred HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCC--ceEe
Confidence 99965 88887765 8899999999999999999999999999999999999999999999999999986543 2233
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcC-------CCC---------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKG-------EYR--------- 236 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~-------~~~--------- 236 (417)
....+-|.+|++|.++.+...++.+.|+||.|||+.|+. +|.+.|.+.+..+...+|.+- .++
T Consensus 158 ysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk 237 (292)
T KOG0662|consen 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYK 237 (292)
T ss_pred eeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCc
Confidence 445567999999999988776679999999999999997 589999999888888777541 110
Q ss_pred ----CCC---------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 ----CPK---------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ----~p~---------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+|. ..+..-++|++++|.-+|.+|+++++.++||||.+.
T Consensus 238 ~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~ 289 (292)
T KOG0662|consen 238 PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF 289 (292)
T ss_pred ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence 111 123456899999999999999999999999999753
|
|
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=337.87 Aligned_cols=255 Identities=26% Similarity=0.440 Sum_probs=206.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISI-MSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+.|++.+.||+|+||.||+|++..+|+.||+|.+....... ...++..|+.+ ++.++||||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 46999999999999999999999999999999987653221 23445556664 6777999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
|||++ |+|.+.+.. ..+++..+..++.|++.||.|||++ +++||||||+|||++.++.+||+|||++......
T Consensus 79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 79 MEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99997 477666542 4689999999999999999999998 9999999999999999999999999998754321
Q ss_pred CCCCcccccccCccccccccccc----cCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC-CCCCC-CCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAK----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKG-EYRCP-KWT 241 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~-~~~~p-~~~ 241 (417)
.......|+..|+|||++.+ .++ +.++|+||+||++|+|++|..||... +..+....+..+ ....| ..+
T Consensus 158 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (283)
T cd06617 158 ---VAKTIDAGCKPYMAPERINPELNQKGY-DVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLPAEKF 233 (283)
T ss_pred ---cccccccCCccccChhhcCCccccccc-CccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCCcccc
Confidence 11233568899999998864 334 48899999999999999999999753 222223333322 23333 346
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.++.++|.+||..+|++|||+.++++||||++...
T Consensus 234 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 269 (283)
T cd06617 234 SPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLS 269 (283)
T ss_pred CHHHHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence 889999999999999999999999999999997643
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-43 Score=339.18 Aligned_cols=257 Identities=29% Similarity=0.463 Sum_probs=211.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|++|.||+|.+..+|+.||+|.+..... .......+.+|+.+++.++||||+++++++.+....|+|
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLV 79 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEE
Confidence 3689999999999999999999999999999999866532 223346778999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCC
Q 014849 95 MEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~ 170 (417)
|||+++ +|.+.+.. . .+++..+..++.||+.||.|||++|++||||+|+||+++. ++.+||+|||++......
T Consensus 80 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-- 156 (294)
T PLN00009 80 FEYLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-- 156 (294)
T ss_pred Eecccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC--
Confidence 999964 78777754 2 3688889999999999999999999999999999999985 456999999998654321
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC----------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---------------- 234 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---------------- 234 (417)
........|++.|+|||++.+....+.++||||+||++|+|++|.+||...+..+...++....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (294)
T PLN00009 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236 (294)
T ss_pred ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence 1122345678999999998765444589999999999999999999998776655554432110
Q ss_pred -------CC------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 -------YR------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 -------~~------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+. ..+..++++.+++.+||+.||++||++.++++||||++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~ 290 (294)
T PLN00009 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL 290 (294)
T ss_pred hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence 00 112357889999999999999999999999999999864
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=331.72 Aligned_cols=250 Identities=31% Similarity=0.556 Sum_probs=214.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|.+..+|+.||+|.+.............+.+|+.+++.++||||+++++.+.+....++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 68999999999999999999999999999999997654444444678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 96 EFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||+|+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~-- 159 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCC--
Confidence 99999999988853 45899999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCC-CCCC-CCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKGEY-RCPK-WTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~-~~p~-~~s~~~~ 246 (417)
........|++.|+|||.+.+..++ .++|+|||||++|+|++|+.||... +.......+..+.+ +.|. ..+..+.
T Consensus 160 ~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08224 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELR 238 (267)
T ss_pred CcccceecCCccccCHHHhccCCCC-chhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCCChhhcCHHHH
Confidence 2223445789999999999887775 8999999999999999999999654 33445555554443 2343 5788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
++|.+||.++|++|||+.+|++
T Consensus 239 ~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 239 DLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHHHHHcCCCcccCCCHHHHHH
Confidence 9999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=348.61 Aligned_cols=258 Identities=29% Similarity=0.427 Sum_probs=212.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+..+|++.+.||+|+||.||.|++..+|+.||||.+..... .......+.+|+.+++.++||||+++++++...
T Consensus 3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~ 81 (337)
T cd07858 3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAF 81 (337)
T ss_pred cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheeccccccc
Confidence 45789999999999999999999999999999999876432 222345677899999999999999999987644
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..+|+|+||+. ++|.+.+.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 160 (337)
T cd07858 82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE 160 (337)
T ss_pred CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence 35899999996 588888865 7899999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-------------- 233 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 233 (417)
. .....+..|+..|+|||++......+.++||||+||++|+|++|++||.+.+.......+...
T Consensus 161 ~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (337)
T cd07858 161 K--GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN 238 (337)
T ss_pred C--cccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence 1 123345678999999999876443468999999999999999999999876543332222110
Q ss_pred --------------CC---CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 234 --------------EY---RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 234 --------------~~---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.. ...+..++++.+||++||++||++|||++++++||||+..
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~ 297 (337)
T cd07858 239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL 297 (337)
T ss_pred hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence 00 0123468889999999999999999999999999999764
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-43 Score=330.89 Aligned_cols=246 Identities=43% Similarity=0.736 Sum_probs=222.4
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|+||.||.|.+..+++.+|+|++.+...........+.+|+.+++.++||||+++++++.++..+|+||||+.+++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 68999999999999989999999999887655555567889999999999999999999999999999999999999999
Q ss_pred HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcc
Q 014849 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182 (417)
Q Consensus 104 ~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~ 182 (417)
.+++.. +.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .......|+..
T Consensus 81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~ 158 (250)
T cd05123 81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPE 158 (250)
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCcc
Confidence 999976 579999999999999999999999999999999999999999999999999987653321 23345678999
Q ss_pred ccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCC
Q 014849 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 183 y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t 262 (417)
|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+....+..|...+..+.+++++||..||++|||
T Consensus 159 ~~~Pe~~~~~~~-~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~R~~ 237 (250)
T cd05123 159 YLAPEVLLGKGY-GKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSPEARDLISGLLQKDPTKRLG 237 (250)
T ss_pred ccChHHhCCCCC-CchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCHHHHHHHHHHhcCCHhhCCC
Confidence 999999887665 4899999999999999999999998887888888888888888888999999999999999999999
Q ss_pred H---HHHhcCccc
Q 014849 263 V---DEILRDPWF 272 (417)
Q Consensus 263 ~---~eil~h~~f 272 (417)
+ +++++||||
T Consensus 238 ~~~~~~l~~~~~f 250 (250)
T cd05123 238 SGGAEEIKAHPFF 250 (250)
T ss_pred cccHHHHHhCCCC
Confidence 9 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=330.95 Aligned_cols=245 Identities=28% Similarity=0.418 Sum_probs=214.8
Q ss_pred eEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|+||.||+|.+... +..||+|++....... ....+.+|+.+++.++||||+++++++.+...+++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 4799999999999999866 8999999997654322 4678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 99 KGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 99 ~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 99999999875 56899999999999999999999999999999999999999999999999998765432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........+++.|+|||.+....++ .++|||||||++|+|++ |..||...........+..+. ...|...++++.
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFT-SKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY 237 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcc-hhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCccCChHHH
Confidence 222233455678999999998877664 89999999999999998 699999988888888877543 456778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||+.||++|||+.+++++
T Consensus 238 ~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 238 ELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHccCCcccCcCHHHHHHh
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=333.76 Aligned_cols=247 Identities=31% Similarity=0.500 Sum_probs=206.2
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
...||+|+||.||+|.+..++..||+|.+..... .....+.+|+.+++.++||||+++++++.+...+|+|+||+++
T Consensus 13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 89 (268)
T cd06624 13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPG 89 (268)
T ss_pred eEEEecCCceEEEEeEecCCCcEEEEEEecCCCH---HHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCC
Confidence 4589999999999999999999999998865432 2356788999999999999999999999999999999999999
Q ss_pred CChHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCCCCccc
Q 014849 101 GELFAKISK--GRF--SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 101 g~L~~~i~~--~~l--~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
++|.+.+.. +.+ ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++...... .....
T Consensus 90 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~ 167 (268)
T cd06624 90 GSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI--NPCTE 167 (268)
T ss_pred CCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccC--CCccc
Confidence 999999875 455 88899999999999999999999999999999999976 678999999998654321 12233
Q ss_pred ccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHH-HhcCCCCCCCCCChHHHHHHHH
Q 014849 176 TLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM--AMYRK-IYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~-i~~~~~~~p~~~s~~~~~li~~ 251 (417)
...|++.|+|||++.+.. ..+.++|+||+||++|+|++|..||...... ..... ........|...++++.+|+++
T Consensus 168 ~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 247 (268)
T cd06624 168 TFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEIPESLSAEAKNFILR 247 (268)
T ss_pred cCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhccCCCCCcccCHHHHHHHHH
Confidence 346899999999986543 2358999999999999999999999754322 22221 1223345677788999999999
Q ss_pred hccCCCCCCCCHHHHhcCccc
Q 014849 252 LLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f 272 (417)
||+.+|++|||+.|++.||||
T Consensus 248 ~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 248 CFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HcCCCchhCCCHHHHHhCCCC
Confidence 999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-43 Score=334.85 Aligned_cols=250 Identities=24% Similarity=0.348 Sum_probs=209.6
Q ss_pred eEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE----
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK---- 90 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~---- 90 (417)
|.+++.||+|+||.||.|.... ++..||+|.+..+... ......+.+|+.+++.++||||+++++++.+...
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHT-YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCC-HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 6789999999999999998765 4478999998765332 2235678899999999999999999998765443
Q ss_pred --EEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 91 --IYFVMEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 91 --~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
.++++||+++|+|...+.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 8999999999999888732 3589999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 239 (417)
+................++..|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+..+.+..+..+. ...|.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPE 238 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCC-cccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 8754332221122233456789999998777664 89999999999999998 999999888777777766553 45677
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++++.+++.+||+.||++|||+.|++++
T Consensus 239 ~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 239 DCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 789999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=340.60 Aligned_cols=252 Identities=23% Similarity=0.346 Sum_probs=214.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+|++.+.||+|+||+||+|.+..+ ++.||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~ 81 (283)
T cd05091 4 LSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ 81 (283)
T ss_pred HHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC
Confidence 34688999999999999999987543 5789999997543 2234567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||+++++
T Consensus 82 ~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~ 161 (283)
T cd05091 82 PLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKL 161 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCC
Confidence 99999999999999998742 2478888999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++................+++.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 162 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 162 NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred ceEecccccccccccchheeeccCccCCccccCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999998754322222223344567899999998776664 89999999999999998 899999988888888887
Q ss_pred cCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.. ..|...+..+.+|+.+||+.+|.+|||+.+|+..
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 241 NRQVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 7654 4567788999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-43 Score=335.41 Aligned_cols=250 Identities=30% Similarity=0.539 Sum_probs=212.9
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||+|++..+|+.+|||.+............++.+|+.+++.++||||+++++++.+....+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 67999999999999999999999999999999887654434444567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 96 EFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 96 E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+.|++|.+++.. +.+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~-- 159 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK-- 159 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccC--
Confidence 99999999998752 46899999999999999999999999999999999999999999999999998654321
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHhcCCCC--CCCCCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL--MAMYRKIYKGEYR--CPKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~~~~~~--~p~~~s~~~~ 246 (417)
.......+|++.|+|||.+.+..++ .++|+||||+++|+|++|..||.+... ......+....++ .+...++.+.
T Consensus 160 ~~~~~~~~~~~~~~ape~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (267)
T cd08229 160 TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 238 (267)
T ss_pred CcccccccCCcCccCHHHhcCCCcc-chhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCCCCcccccHHHH
Confidence 1223456799999999999887765 899999999999999999999976432 3444444443332 2245788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||+.||++|||+.+|++
T Consensus 239 ~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 239 QLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HHHHHhcCCCcccCCCHHHHHH
Confidence 9999999999999999998864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=335.91 Aligned_cols=256 Identities=30% Similarity=0.457 Sum_probs=212.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIYF 93 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~l 93 (417)
++|+..+.||.|++|.||+|.+..+++.+|+|.+..... .....++.+|+++++.++||||+++++++.+ ...+|+
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 78 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGI 78 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEE
Confidence 579999999999999999999999999999999976432 2345678899999999999999999998854 457999
Q ss_pred EEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 94 VMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
||||++|++|.+++.. +.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus 79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~- 157 (287)
T cd06621 79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN- 157 (287)
T ss_pred EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccc-
Confidence 9999999999887642 5689999999999999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcCCC-CCC----
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKGEY-RCP---- 238 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~~~-~~p---- 238 (417)
.......++..|+|||.+.+..++ .++|||||||++|+|++|.+||... ...+....+..... ..+
T Consensus 158 ---~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (287)
T cd06621 158 ---SLAGTFTGTSFYMAPERIQGKPYS-ITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG 233 (287)
T ss_pred ---cccccccCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence 112245678899999999887775 8999999999999999999999865 22344444433211 111
Q ss_pred --CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 239 --KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 239 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
...++.+.++|.+||.+||++|||+.|++.||||++...+
T Consensus 234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 1235789999999999999999999999999999765543
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=347.48 Aligned_cols=264 Identities=31% Similarity=0.445 Sum_probs=216.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe--C
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT--K 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~--~ 88 (417)
..+.++|++.+.||+|+||.||+|.+..+|+.+|+|.+..... .......+.+|+.+++++ +||||+++++++.. .
T Consensus 3 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~ 81 (337)
T cd07852 3 KHILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAEND 81 (337)
T ss_pred chhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCC
Confidence 4577899999999999999999999999999999999865322 122245577899999999 99999999998864 3
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
...|+||||+.+ +|...+..+.+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 82 ~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~ 160 (337)
T cd07852 82 KDIYLVFEYMET-DLHAVIRANILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSEL 160 (337)
T ss_pred ceEEEEeccccc-CHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence 478999999975 9999988778899999999999999999999999999999999999999999999999998754332
Q ss_pred CC---CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-----------
Q 014849 169 RP---DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE----------- 234 (417)
Q Consensus 169 ~~---~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~----------- 234 (417)
.. ........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+........++....
T Consensus 161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd07852 161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240 (337)
T ss_pred cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence 21 1233456789999999998765555689999999999999999999998766554433322110
Q ss_pred ----------------C----CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 235 ----------------Y----RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 235 ----------------~----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. ...+..+.++.++|.+||+.||++|||+.++++||||++...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~~~ 303 (337)
T cd07852 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQFHN 303 (337)
T ss_pred HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhhcc
Confidence 0 011225788999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=335.17 Aligned_cols=253 Identities=23% Similarity=0.300 Sum_probs=214.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..++|++.+.||+|+||.||+|.+...+ ..||+|.+.... .......+.+|+.+|+.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 3568999999999999999999986544 789999986442 122345678999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 89 AKIYFVMEFAKGGELFAKISK-----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
...|+||||+++|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 999999999999999998853 236788999999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y 235 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 235 (417)
|||++................+|..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. .
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~ 240 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFT-TKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL 240 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCC-cccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence 99998754332222223445678899999998776664 89999999999999998 999999888777777766543 4
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..|...+.++.+++.+||+.+|++|||+.++++.
T Consensus 241 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~ 274 (277)
T cd05032 241 DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSS 274 (277)
T ss_pred CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 5577778999999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=334.84 Aligned_cols=250 Identities=23% Similarity=0.355 Sum_probs=207.7
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe------CC
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT------KA 89 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~~ 89 (417)
|.+++.||+|+||.||+|.+..+++ .+|+|.+..... .......+.+|+.+|+.++||||+++++++.. ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 4578999999999999999987776 699998876432 22335678899999999999999999997632 23
Q ss_pred EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
..+++|||+.+|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 57899999999999887731 34889999999999999999999999999999999999999999999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 240 (417)
................+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+......+..+..+.. ..+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 238 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYT-TKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQPPD 238 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcC-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 764322211112233567789999999877764 89999999999999998 8999998887787777776543 45566
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+.++|.+||++||++|||+.+++++
T Consensus 239 ~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 239 CLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred CCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 78899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=335.01 Aligned_cols=252 Identities=33% Similarity=0.548 Sum_probs=212.5
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKIYFVM 95 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~~lV~ 95 (417)
|++.+.||+|+||.||+|.+..+|+.+|+|++.... ........+.+|+.+++.++|||++++++++.+. ...|+|+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 789999999999999999999999999999998764 2334456788999999999999999999999888 8999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+++ +|.+.+.. ..+++..++.++.||+.||.|||++|++|+||+|+||++++++.+||+|||++........ ..
T Consensus 80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (287)
T cd07840 80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS-AD 157 (287)
T ss_pred ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc-cc
Confidence 99975 88888865 4799999999999999999999999999999999999999999999999999876543221 12
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------------------ 235 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------------ 235 (417)
.....++..|+|||.+.+....+.++||||+||++|+|++|+.||...+......++.....
T Consensus 158 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (287)
T cd07840 158 YTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFEN 237 (287)
T ss_pred ccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhh
Confidence 33446788999999877654446899999999999999999999998876665555443110
Q ss_pred -----C-------CCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -----R-------CPKW-TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -----~-------~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .... .++.+.+++++||+.||.+|||++++++||||
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~ 287 (287)
T cd07840 238 LKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287 (287)
T ss_pred ccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence 0 0011 27889999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=336.74 Aligned_cols=252 Identities=22% Similarity=0.308 Sum_probs=211.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 3679999999999999999999987 78899999886443 2223456888999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEee
Q 014849 90 KIYFVMEFAKGGELFAKISKG--------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISD 158 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~D 158 (417)
..|+||||+.|++|.+++... .+++..+..++.||+.||.|||++|++||||||+|||++.++ .+||+|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 999999999999999998642 488999999999999999999999999999999999998765 599999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYR 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~ 236 (417)
||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ...
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 241 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFT-SKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLD 241 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC
Confidence 9998754221111111223345679999999877775 99999999999999996 99999988777766665543 345
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.|...+..+.+++.+||+.||++|||+.++++|
T Consensus 242 ~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 242 PPKGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 567788999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-43 Score=330.71 Aligned_cols=246 Identities=26% Similarity=0.406 Sum_probs=210.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|++.+.||+|+||.||+|... .+..+|+|.+..... ...++.+|+.+|+.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~ 78 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVT 78 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEE
Confidence 46899999999999999999884 456899998864432 2457889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++||+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ...
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~-~~~ 157 (256)
T cd05114 79 EFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDE-YTS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCc-eec
Confidence 99999999998864 568999999999999999999999999999999999999999999999999886432111 111
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||++....+. .++||||+||++|+|++ |+.||...+..+....+..+.. ..|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYS-SKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVYEVMYS 236 (256)
T ss_pred cCCCCCchhhCChhhcccCccc-hhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHH
Confidence 1122345679999999877775 89999999999999999 9999999888888888776543 3466678899999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 014849 252 LLDTDPATRITVDEILR 268 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~ 268 (417)
||+.||++|||++++++
T Consensus 237 c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 237 CWHEKPEGRPTFAELLR 253 (256)
T ss_pred HccCCcccCcCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-43 Score=332.16 Aligned_cols=248 Identities=25% Similarity=0.414 Sum_probs=213.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|++.+.||+|+||.||+|.+..+++.||+|++..+. .....+.+|+.+++.++||||+++++++.....+++||
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 81 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEE
Confidence 46999999999999999999999999999999986542 12467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||+++++|.+++.. ..+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++........ .
T Consensus 82 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~-~ 160 (263)
T cd05052 82 EFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-T 160 (263)
T ss_pred EeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee-e
Confidence 99999999999864 3589999999999999999999999999999999999999999999999999875432111 1
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 250 (417)
......+++.|+|||.+.+..++ .++|||||||++|+|++ |..||.+.+..+.+..+..+ ....|...++++.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (263)
T cd05052 161 AHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRMERPEGCPPKVYELMR 239 (263)
T ss_pred ccCCCCCccccCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHH
Confidence 11122346679999998877775 88999999999999998 99999988888877777654 34566778899999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 014849 251 RLLDTDPATRITVDEILRD 269 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h 269 (417)
+||+.||++|||+.++++.
T Consensus 240 ~cl~~~p~~Rp~~~~l~~~ 258 (263)
T cd05052 240 ACWQWNPSDRPSFAEIHQA 258 (263)
T ss_pred HHccCCcccCCCHHHHHHH
Confidence 9999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-43 Score=343.15 Aligned_cols=250 Identities=25% Similarity=0.397 Sum_probs=209.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcE--EEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQS--VAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
-.+.|++.+.||+|+||.||+|.+..+|.. +|+|.+... ........+.+|+.++.++ +||||+++++++.+.+.
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 5 EWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred chhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 356899999999999999999999888865 466665432 2233456788999999999 89999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 91 IYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
+|+||||+++++|.+++.. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 9999999999999998863 14789999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 232 (417)
+||+|||++...... .......+++.|+|||++....+ +.++|||||||++|+|++ |.+||...+..+....+..
T Consensus 163 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~-~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~ 238 (303)
T cd05088 163 AKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVY-TTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 238 (303)
T ss_pred EEeCccccCcccchh---hhcccCCCcccccCHHHHhccCC-cccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc
Confidence 999999998532211 01111234667999999877766 489999999999999998 9999998887777776654
Q ss_pred CC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 233 GE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 233 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+. ...|...++++.+|+.+||+.+|++|||+++++++
T Consensus 239 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 239 GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 42 33455578999999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=330.44 Aligned_cols=255 Identities=29% Similarity=0.498 Sum_probs=216.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc--cccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 91 (417)
..|++++.||+|+||.||+|.+..+|+.||+|.+..... ........+.+|+.+++.++||||+++++.+.+. ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 479999999999999999999999999999999864321 1223456788999999999999999999998664 568
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
++++||++|++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~ 161 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICM 161 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccccccc
Confidence 999999999999999875 6799999999999999999999999999999999999999999999999999875432111
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHH
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKW 247 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~ 247 (417)
........|++.|+|||.+.+..++ .++|+|||||++|+|++|..||..........++... ....|...++.+.+
T Consensus 162 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~ 240 (264)
T cd06653 162 SGTGIKSVTGTPYWMSPEVISGEGYG-RKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDGVSDACRD 240 (264)
T ss_pred cCccccccCCcccccCHhhhcCCCCC-ccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCCCcccCHHHHH
Confidence 1122345689999999999887764 8999999999999999999999887666555555433 23457778999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+|.+||+ +|..|||+.+++.|||.
T Consensus 241 ~i~~~l~-~~~~r~~~~~~~~~~~~ 264 (264)
T cd06653 241 FLKQIFV-EEKRRPTAEFLLRHPFV 264 (264)
T ss_pred HHHHHhc-CcccCccHHHHhcCCCC
Confidence 9999999 57999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-43 Score=340.97 Aligned_cols=255 Identities=23% Similarity=0.357 Sum_probs=213.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYE 83 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~ 83 (417)
....++|.+++.||+|+||.||+|.+.. ++..+|+|.+..+. .......+.+|+.+++.+ +||||+++++
T Consensus 14 ~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~ 91 (307)
T cd05098 14 EVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 91 (307)
T ss_pred eeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 3446899999999999999999998753 33579999997643 222346788899999999 7999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 84 VLATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 84 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
++.....+|+||||+++|+|.+++... .++..+++.++.|++.||+|||++|++||||||+||
T Consensus 92 ~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Ni 171 (307)
T cd05098 92 ACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 171 (307)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHhe
Confidence 999999999999999999999998642 478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
|++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 172 ll~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~~~g~~p~~~~~~~~ 250 (307)
T cd05098 172 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 250 (307)
T ss_pred EEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC-cHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence 9999999999999998654321111111222345789999999877764 89999999999999998 999999888877
Q ss_pred HHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 226 MYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 226 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+...+..+. ...|...+.++.+|+.+||..+|++|||+.+++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 251 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 777776554 35566778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=363.27 Aligned_cols=245 Identities=35% Similarity=0.523 Sum_probs=217.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.+...|++...+|.|+|+.|..+.+..+++..++|++.+.. .+..+|+.++... +||||+++++++.+...+
T Consensus 319 ~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~ 391 (612)
T KOG0603|consen 319 PFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEI 391 (612)
T ss_pred CcchhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCcee
Confidence 46788999999999999999999999999999999998762 2334677666555 699999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe-cCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL-DENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl-~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|||++.|+.|.+.+...+....++..|+.||+.|+.|||++||+||||||+|||+ ++.|+++|+|||.+.....
T Consensus 392 ~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~--- 468 (612)
T KOG0603|consen 392 YLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELER--- 468 (612)
T ss_pred eeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCch---
Confidence 999999999999999987665558899999999999999999999999999999999 6899999999999865432
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
...+.|-|..|+|||++...+|+ +++||||||++||+||+|+.||..... .++...+..+.+. .+.|..+++||
T Consensus 469 --~~~tp~~t~~y~APEvl~~~~yt-~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s--~~vS~~AKdLl 543 (612)
T KOG0603|consen 469 --SCDTPALTLQYVAPEVLAIQEYT-EACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS--ECVSDEAKDLL 543 (612)
T ss_pred --hhcccchhhcccChhhhccCCCC-cchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc--cccCHHHHHHH
Confidence 25677889999999999999997 999999999999999999999976544 4777777666655 88999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f 272 (417)
++||++||.+|+++.+++.||||
T Consensus 544 ~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 544 QQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred HHhccCChhhCcChhhhccCcch
Confidence 99999999999999999999999
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-43 Score=350.48 Aligned_cols=251 Identities=25% Similarity=0.398 Sum_probs=205.1
Q ss_pred CCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-C
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT-K 88 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~-~ 88 (417)
++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+++++ +||||+++++++.. .
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~ 84 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKPG 84 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence 58999999999999999999754 3567899999875432 22245677899999999 89999999998754 4
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISK----------------------------------------------------------- 109 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (417)
..+|++|||+++++|.+.+..
T Consensus 85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (337)
T cd05054 85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE 164 (337)
T ss_pred CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence 678999999999999988742
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccc
Q 014849 110 ---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186 (417)
Q Consensus 110 ---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~AP 186 (417)
..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++................++..|+||
T Consensus 165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP 244 (337)
T cd05054 165 LYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAP 244 (337)
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCc
Confidence 25788999999999999999999999999999999999999999999999998754322211122334567789999
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-HHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCH
Q 014849 187 EILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY-RKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITV 263 (417)
Q Consensus 187 Evl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~-~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~ 263 (417)
|++.+..++ .++|||||||++|+|++ |..||.+....+.. ..+..+. ...|...++++.+++.+||+.+|++|||+
T Consensus 245 E~~~~~~~~-~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~ 323 (337)
T cd05054 245 ESIFDKVYT-TQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRPTF 323 (337)
T ss_pred HHhcCCCCC-ccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCcCH
Confidence 999888876 89999999999999997 99999875543333 3333322 34456678999999999999999999999
Q ss_pred HHHhcC
Q 014849 264 DEILRD 269 (417)
Q Consensus 264 ~eil~h 269 (417)
.|+++|
T Consensus 324 ~ell~~ 329 (337)
T cd05054 324 SELVEI 329 (337)
T ss_pred HHHHHH
Confidence 999876
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-43 Score=340.11 Aligned_cols=256 Identities=28% Similarity=0.497 Sum_probs=208.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC------
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK------ 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~------ 88 (417)
.++|++.+.||+|+||.||+|.+..+++.+|+|++..... .........+|+.+++.++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNE-KDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccC-CCCcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 6899999999999999999999999999999999876542 222234567899999999999999999887433
Q ss_pred --CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 89 --AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..+|+|+||+.+ +|...+.. ..+++..++.++.||++||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 164 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP 164 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence 357999999975 67666653 5799999999999999999999999999999999999999999999999999875
Q ss_pred ecccCCC---------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Q 014849 165 KEQIRPD---------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235 (417)
Q Consensus 165 ~~~~~~~---------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 235 (417)
....... .......|++.|+|||.+.+....+.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~ 244 (311)
T cd07866 165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG 244 (311)
T ss_pred ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 4322111 1123346789999999987654445899999999999999999999998877665555432110
Q ss_pred -----------------------CCC-------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -----------------------RCP-------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -----------------------~~p-------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
..+ ...++.+.++|.+||..||.+|||+.|++.||||
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence 000 1234678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-43 Score=338.67 Aligned_cols=257 Identities=29% Similarity=0.508 Sum_probs=212.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
...++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 457889999999999999999999999999999999976532 2233456778999999999999999999987654
Q ss_pred -------EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 90 -------KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 90 -------~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.+|+|+||+++ +|...+.. ..+++..++.++.|++.||.|||+.||+||||||+||++++++.+||+|||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg 161 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCccc
Confidence 89999999987 67666654 479999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--C---
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--Y--- 235 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~--- 235 (417)
++........ .......+++.|+|||.+.+....+.++|||||||++|+|++|++||...+..+....+.... .
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (302)
T cd07864 162 LARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA 240 (302)
T ss_pred ccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence 9876533211 122233568889999998765444689999999999999999999998877665554443310 0
Q ss_pred -------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 236 -------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 236 -------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
......++.+.+++.+||+.||++|||+.+++.||||
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 241 VWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL 302 (302)
T ss_pred hcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence 0011357889999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=335.72 Aligned_cols=259 Identities=35% Similarity=0.576 Sum_probs=219.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.|++.+.||.|+||.||.|.+. .+|+.||+|++....... .....++.+|+.+++.+ +||||+++++.+......
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4899999999999999999985 488999999997654322 23356788999999999 589999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|+||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||+|+|||++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~- 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE- 159 (290)
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc-
Confidence 999999999999999875 679999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCCCCCCCCChHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
.......+|+..|+|||.+... ...+.++||||+||++|+|++|..||... ....+...+.....+.|...++.+
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA 239 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCCccCCHHH
Confidence 1223456789999999998653 23358899999999999999999999743 234455555556666777789999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRI-----TVDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-----t~~eil~h~~f~~~~ 276 (417)
.+++.+||+.||++|| ++++++.||||++..
T Consensus 240 ~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 240 KDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred HHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999999999999997 899999999998653
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=338.46 Aligned_cols=252 Identities=24% Similarity=0.398 Sum_probs=213.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC-----cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG-----QSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g-----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++.+.||+|+||.||+|.+...+ ..+|+|.+..... ......+.+|+.+++++ +||||+++++++...
T Consensus 11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 468999999999999999999986543 7899999876432 22345688999999999 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 89 AKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
..+|++|||+.+|+|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.+
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~ 168 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTED 168 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCC
Confidence 999999999999999998842 458899999999999999999999999999999999999999
Q ss_pred CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 014849 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKI 230 (417)
Q Consensus 152 ~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 230 (417)
+.+||+|||++................++..|+|||++.+..++ .++||||+||++|+|++ |..||...+..+.+..+
T Consensus 169 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~ 247 (293)
T cd05053 169 HVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL 247 (293)
T ss_pred CeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC-cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 99999999998764432211112223356789999998877775 89999999999999997 99999998888877777
Q ss_pred hcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+. ...|...+.++.+|+.+||..||++|||+.+++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 248 KEGYRMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred HcCCcCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 6554 34566678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-44 Score=371.44 Aligned_cols=246 Identities=30% Similarity=0.486 Sum_probs=206.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEE-EE---e---
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEV-LA---T--- 87 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~-~~---~--- 87 (417)
.+++|.+.|.+|+|+.||+|++...|..||+|.+-.. ++.....+++||.+|++|+ |||||.+++. .. .
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~ 113 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNG 113 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCc
Confidence 4678899999999999999999988899999988654 4556788999999999997 9999999993 21 1
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.-.++|.||||.||.|-+++.+ .+|+|.++.+||.|+++||.+||... |||||||-|||||+.+|+.||||||.+
T Consensus 114 ~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa 193 (738)
T KOG1989|consen 114 VWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA 193 (738)
T ss_pred eeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence 1358899999999999999974 57999999999999999999999997 999999999999999999999999988
Q ss_pred eeecccC--CCCc--c---cccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc
Q 014849 163 AVKEQIR--PDGM--L---HTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 163 ~~~~~~~--~~~~--~---~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~ 232 (417)
+-.-... ..+. + -...-||.|+|||.+. +.+ .+.|+|||+|||+||-|+....||++... -.|..
T Consensus 194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~p-I~eKsDIWALGclLYkLCy~t~PFe~sg~----laIln 268 (738)
T KOG1989|consen 194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLP-IGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILN 268 (738)
T ss_pred ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCC-CcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEe
Confidence 6321111 0000 0 0123599999999864 444 46999999999999999999999998743 24678
Q ss_pred CCCCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 233 GEYRCPK--WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 233 ~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.|.+|+ .++..+++||+.||++||.+||+|.+++.+
T Consensus 269 g~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~ 307 (738)
T KOG1989|consen 269 GNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEE 307 (738)
T ss_pred ccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHH
Confidence 8888776 579999999999999999999999999854
|
|
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=339.08 Aligned_cols=255 Identities=29% Similarity=0.482 Sum_probs=217.3
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|+-...||+|+||.||.|.+..+|+.||+|.+.... ......+.+|+.+++.++||||+++++.+...+..|+||||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 98 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEF 98 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEec
Confidence 344578999999999999999999999999885432 22356788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 98 AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 98 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
+++++|.+.+..+++++..++.++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ......
T Consensus 99 ~~~~~L~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~--~~~~~~ 176 (292)
T cd06657 99 LEGGALTDIVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV--PRRKSL 176 (292)
T ss_pred CCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc--cccccc
Confidence 999999998888889999999999999999999999999999999999999999999999999876443211 122345
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHHHHhcc
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~~L~ 254 (417)
+|++.|+|||.+.+..+ +.++|+||+||++|+|++|.+||...........+.... .......++++.+++.+||+
T Consensus 177 ~~~~~y~~pE~~~~~~~-~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~ 255 (292)
T cd06657 177 VGTPYWMAPELISRLPY-GPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLV 255 (292)
T ss_pred ccCccccCHHHhcCCCC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcccCCcccCCHHHHHHHHHHHh
Confidence 78999999999877666 489999999999999999999998877665555443322 22334468899999999999
Q ss_pred CCCCCCCCHHHHhcCccccccccc
Q 014849 255 TDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 255 ~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.||.+||++.+++.||||.+...+
T Consensus 256 ~~P~~R~~~~~ll~~~~~~~~~~~ 279 (292)
T cd06657 256 RDPAQRATAAELLKHPFLAKAGPP 279 (292)
T ss_pred CCcccCcCHHHHhcChHHhccCCC
Confidence 999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-43 Score=355.11 Aligned_cols=251 Identities=25% Similarity=0.364 Sum_probs=206.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|.+... +..||||++.... .....+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 56788999999999999999987543 3479999996542 2233567889999999996 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISK----------------------------------------------------------- 109 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~----------------------------------------------------------- 109 (417)
..+|+|||||++|+|.+++..
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 999999999999999887743
Q ss_pred --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 110 --------------------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 110 --------------------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
..+++..+..++.|++.||.|||++||+||||||+|||++.+
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 136778889999999999999999999999999999999999
Q ss_pred CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHH
Q 014849 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRK 229 (417)
Q Consensus 152 ~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~ 229 (417)
+.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...... ..+..
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT-TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHH
Confidence 99999999998754332222222344577889999999887775 89999999999999996 99999876443 33444
Q ss_pred HhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 230 IYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 230 i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+..+ ....|...++++.+++.+||+.||++|||+.++.+
T Consensus 353 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 353 IKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred HhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 4433 23445667889999999999999999999998865
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=337.92 Aligned_cols=257 Identities=23% Similarity=0.363 Sum_probs=216.0
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEc-------cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNV-------RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKL 81 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l 81 (417)
.-....++|++++.||+|+||.||.|++. .++..||+|.+.... .......+.+|+.+++.+ +||||+++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~ 86 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINL 86 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchhe
Confidence 33456789999999999999999999753 234579999987542 222356788999999999 89999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLE 144 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~ 144 (417)
++++......|+||||+.+|+|.+++... .++...+..++.||+.||.|||++||+||||||+
T Consensus 87 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 166 (304)
T cd05101 87 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAAR 166 (304)
T ss_pred eEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccc
Confidence 99999999999999999999999988642 3677888999999999999999999999999999
Q ss_pred cEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 014849 145 NLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNL 223 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~ 223 (417)
|||++.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.
T Consensus 167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999998755432222223334567889999999887775 88999999999999998 8999999888
Q ss_pred HHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 224 MAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 224 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++...+..+. ...|...+..+.+|+.+||.++|++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 246 EELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 88887776543 34456678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=344.05 Aligned_cols=259 Identities=31% Similarity=0.445 Sum_probs=218.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-----KI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 91 (417)
||++.+.||+|+||.||+|++..+|+.||+|.+.... ........+.+|+.+++.++||||+++++++.+.. .+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 6999999999999999999999999999999987643 12334567889999999999999999999987775 89
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++........
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEEecchhh-hHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 999999974 88888876 5899999999999999999999999999999999999999999999999999886543221
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-------------
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR------------- 236 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------- 236 (417)
........+|+.|+|||++.+....+.++|+||+||++|+|++|.+||.+.+..+.+..+......
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 238 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK 238 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence 112344568999999999987733458999999999999999999999988877766665432110
Q ss_pred ------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.....++++.++|.+||+++|.+|||+++++.||||+....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~ 297 (330)
T cd07834 239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHD 297 (330)
T ss_pred hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhcc
Confidence 01225788999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=337.56 Aligned_cols=248 Identities=24% Similarity=0.385 Sum_probs=209.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc--EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~ 92 (417)
++|++.+.||+|+||.||+|.+..++. .+++|.+.... .......+.+|+.+++++ +||||+++++++.+...+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA--SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC--CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 689999999999999999999987775 46888776322 222356788999999999 7999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 93 FVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
+|+||+++++|.+++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 99999999999999864 2488899999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++....... .......+..|+|||++....++ .++|||||||++|+|++ |.+||.+.+..+...++..+.
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~ 235 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYT-TKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY 235 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence 99999985322110 01112235579999999877775 89999999999999997 999999988888877776553
Q ss_pred -CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 235 -YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 235 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
...|...++++.+|+.+||+.||.+|||++++++.
T Consensus 236 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 236 RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 34566688999999999999999999999999765
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-43 Score=332.75 Aligned_cols=247 Identities=22% Similarity=0.399 Sum_probs=213.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|++++.||.|+||.||+|.+.. ++.+|+|++..... .....+.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 4569999999999999999999977 89999999876532 2255788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++...... .
T Consensus 81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~--~ 158 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED--V 158 (261)
T ss_pred EeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc--c
Confidence 999999999999975 46899999999999999999999999999999999999999999999999998654221 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
.......+++.|+|||++.+..+. .++|||||||++|+|++ |.+||...+..+.+..+..+ ..+.|...++.+.+++
T Consensus 159 ~~~~~~~~~~~~~~PE~~~~~~~~-~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 237 (261)
T cd05148 159 YLSSDKKIPYKWTAPEAASHGTFS-TKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEIYKIM 237 (261)
T ss_pred ccccCCCCceEecCHHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCCCCCCCHHHHHHH
Confidence 112233457789999999877765 88999999999999998 89999988877777777654 3455667889999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||+.||++|||+.++++
T Consensus 238 ~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 238 LECWAAEPEDRPSFKALRE 256 (261)
T ss_pred HHHcCCCchhCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-44 Score=354.23 Aligned_cols=256 Identities=28% Similarity=0.427 Sum_probs=211.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~l 93 (417)
...|++.+.||+|+.++||++...+. +.+|+|.+.... .+......+.+||..|.+|+ |.+||+|++|-.+++.+||
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 45799999999999999999998544 456666554332 34556788999999999995 9999999999999999999
Q ss_pred EEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||-+- +|...+.++ -.+....+.|.+|++.|+.++|.+||||-||||.|+|+- .|.+||+|||+|.........
T Consensus 438 vmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTs 515 (677)
T KOG0596|consen 438 VMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTS 515 (677)
T ss_pred Eeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccccc
Confidence 9998754 999999873 345458999999999999999999999999999999984 468999999999876554445
Q ss_pred CcccccccCccccccccccccCCC----------CChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCC--CCCC
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYD----------GAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGE--YRCP 238 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~----------~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~--~~~p 238 (417)
-...+.|||+.|||||.+....++ +.++||||||||||+|+.|++||..-. ...-+..|.... ..+|
T Consensus 516 I~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp 595 (677)
T KOG0596|consen 516 IVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFP 595 (677)
T ss_pred eeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCcccccc
Confidence 566788999999999998654443 678999999999999999999997643 444445555543 3566
Q ss_pred CCCChH-HHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 KWTSPD-LKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 ~~~s~~-~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...+.. +.++++.||..||++|||+.++|+|||.+-
T Consensus 596 ~~~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 596 DIPENDELIDVMKCCLARDPKKRWSIPELLQHPFLQI 632 (677)
T ss_pred CCCCchHHHHHHHHHHhcCcccCCCcHHHhcCccccc
Confidence 555544 999999999999999999999999999974
|
|
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-44 Score=360.55 Aligned_cols=255 Identities=27% Similarity=0.413 Sum_probs=222.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..|.=.+.||+|+||.||.|++..+.+.||||.++.+.-...+-...|.+|++.|++++|||+|.+-++|......|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 35667889999999999999999999999999998877666566778999999999999999999999999999999999
Q ss_pred eccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||-| +-.|++. +.++.|.++..|+.+.+.||+|||+++.||||||..||||++.|.|||+|||.+.+.. +
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~------P 178 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA------P 178 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC------c
Confidence 99966 6677765 4689999999999999999999999999999999999999999999999999987653 3
Q ss_pred ccccccCcccccccccc--ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CC-CCCChHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CP-KWTSPDLKWFI 249 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~--~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p-~~~s~~~~~li 249 (417)
..+.+|||+||||||+. ..|.++-++||||||+...+|...++|+-..|.+...--|...+.+ ++ ..+|..++.|+
T Consensus 179 AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eWS~~F~~Fv 258 (948)
T KOG0577|consen 179 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRNFV 258 (948)
T ss_pred hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchhHHHHHHHH
Confidence 46789999999999986 3343448899999999999999999999888888666666555433 22 33588899999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..||++-|..|||.++++.|+|......
T Consensus 259 d~CLqKipqeRptse~ll~H~fv~R~Rp 286 (948)
T KOG0577|consen 259 DSCLQKIPQERPTSEELLKHRFVLRERP 286 (948)
T ss_pred HHHHhhCcccCCcHHHHhhcchhccCCC
Confidence 9999999999999999999999875443
|
|
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=336.63 Aligned_cols=251 Identities=24% Similarity=0.353 Sum_probs=212.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||.||+|.+. .++..+++|.+..... .....+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 457999999999999999999864 3456799998865432 22456889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..++||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999854 2378999999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.++|+|||++................|++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+.
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~ 239 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECIT 239 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHh
Confidence 9999999998654322111222345578899999999887765 89999999999999998 999998888877777776
Q ss_pred cCCCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+... .+...+..+.+++.+||+.||++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~ 278 (291)
T cd05094 240 QGRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKI 278 (291)
T ss_pred CCCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 66543 455568899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-43 Score=336.90 Aligned_cols=251 Identities=22% Similarity=0.250 Sum_probs=210.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC----------------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG----------------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g----------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI 78 (417)
.++|++++.||+|+||.||+|.+..++ ..||+|.+..... ......+.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDAS--DNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccC--HHHHHHHHHHHHHHHhcCCCCE
Confidence 468999999999999999999876544 5689999876532 2346778899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhc-C-----------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-G-----------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~-----------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
+++++++......++||||+.+++|.+++.. . .+++..++.++.|++.||.|||++||+||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999999865 2 589999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GYLPFNDPNLM 224 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~~Pf~~~~~~ 224 (417)
+++.++.++|+|||++................+|+.|+|||.+....+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKF-TTKSDVWAFGVTLWEILTLCREQPYEHLTDQ 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCC-CccchhhhhHHHHHHHHhcCCCCCCCCcChH
Confidence 999999999999999875433222222334556789999999887666 499999999999999987 78899887766
Q ss_pred HHHHHHhcC--------CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 AMYRKIYKG--------EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ~~~~~i~~~--------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..+..+... ....|...+.++.+++.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 241 QVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred HHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 666555432 12334556789999999999999999999999964
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=340.31 Aligned_cols=259 Identities=31% Similarity=0.490 Sum_probs=214.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~ 91 (417)
.+.++|++.+.||.|+||.||+|.+..+|+.||+|.+.+... .......+.+|+.+++.++||||+++++++.. ....
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 357899999999999999999999999999999999875432 22335678899999999999999999999865 5679
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+|+||+ +++|...+..+.+++..+..++.|+++||.|||++||+||||+|.|||++.++.+||+|||++....
T Consensus 86 ~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~----- 159 (328)
T cd07856 86 YFVTELL-GTDLHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD----- 159 (328)
T ss_pred EEEeehh-ccCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC-----
Confidence 9999999 5689988888889999999999999999999999999999999999999999999999999986432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc-------------------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------------------- 232 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~------------------- 232 (417)
....+..+++.|+|||++.+....+.++||||+||++|+|++|+.||...+.......+..
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (328)
T cd07856 160 PQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTL 239 (328)
T ss_pred CCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhH
Confidence 2223456789999999986633335899999999999999999999987654332211110
Q ss_pred -------CCCCC-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 233 -------GEYRC-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 233 -------~~~~~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..... .+..++.+.++|++||+.+|++|||+++++.||||+....+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~ 297 (328)
T cd07856 240 RFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDP 297 (328)
T ss_pred HHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCC
Confidence 00011 12357889999999999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=374.13 Aligned_cols=252 Identities=25% Similarity=0.387 Sum_probs=206.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||.||+|++..+|+.||+|++..+.........++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLV 80 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYT 80 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEE
Confidence 58999999999999999999999999999999999765433344566788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 95 MEFAKGGELFAKISK------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
|||++||+|.+.+.. ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++
T Consensus 81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA 160 (932)
T PRK13184 81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA 160 (932)
T ss_pred EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence 999999999998753 23456678899999999999999999999999999999999999999999999
Q ss_pred eeecccCC----------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 014849 163 AVKEQIRP----------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM 226 (417)
Q Consensus 163 ~~~~~~~~----------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~ 226 (417)
........ .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||........
T Consensus 161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S-~kSDIWSLGVILyELLTG~~PF~~~~~~ki 239 (932)
T PRK13184 161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPAS-ESTDIYALGVILYQMLTLSFPYRRKKGRKI 239 (932)
T ss_pred eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCC-cHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence 76521100 0111235799999999999887774 899999999999999999999987654433
Q ss_pred HHHH-hcCCCC--CCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 227 YRKI-YKGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 227 ~~~i-~~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
.... ...... .....++.+.+++.+||..||++||+..+.+
T Consensus 240 ~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeL 283 (932)
T PRK13184 240 SYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQEL 283 (932)
T ss_pred hhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHH
Confidence 2221 111111 1234678899999999999999998755544
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=365.43 Aligned_cols=262 Identities=28% Similarity=0.429 Sum_probs=198.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccC-CcEEEEEEe--------------ecccccccchHHHHHHHHHHHHhCCCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAV--------------SKQKILRGGLTAHVKREISIMSRLRHP 76 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i--------------~~~~~~~~~~~~~i~~Ei~il~~l~Hp 76 (417)
..+.++|++++.||+|+||+||+|..+.. +...+.|.+ .+..........++.+|+.+|+.++||
T Consensus 144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp 223 (501)
T PHA03210 144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE 223 (501)
T ss_pred hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence 34568999999999999999999976543 222332211 111111122345688999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKG------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE 150 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~ 150 (417)
||+++++++.+....|+|+|++. ++|.+++..+ ......++.++.||+.||.|||++||+||||||+|||++.
T Consensus 224 nIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~ 302 (501)
T PHA03210 224 NILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC 302 (501)
T ss_pred CcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECC
Confidence 99999999999999999999995 4777776432 2346778899999999999999999999999999999999
Q ss_pred CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCC-CCCCC--CHHHHH
Q 014849 151 NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYL-PFNDP--NLMAMY 227 (417)
Q Consensus 151 ~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~-Pf~~~--~~~~~~ 227 (417)
++.+||+|||++....... .......+||+.|+|||++.+.+|+ .++|||||||++|+|++|.. ||... +....+
T Consensus 303 ~~~vkL~DFGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 303 DGKIVLGDFGTAMPFEKER-EAFDYGWVGTVATNSPEILAGDGYC-EITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCEEEEeCCCceecCccc-ccccccccCCcCCCCchhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999997654321 1223356899999999999988875 89999999999999999875 44332 222222
Q ss_pred HHHhcC------CCC---------------------CC-----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 228 RKIYKG------EYR---------------------CP-----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 228 ~~i~~~------~~~---------------------~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++... +++ .+ ...+.++.++|.+||+.||.+|||+.|+|.||||...
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~ 460 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE 460 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence 221110 000 00 1235677888999999999999999999999999764
Q ss_pred c
Q 014849 276 Y 276 (417)
Q Consensus 276 ~ 276 (417)
.
T Consensus 461 ~ 461 (501)
T PHA03210 461 E 461 (501)
T ss_pred C
Confidence 3
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-44 Score=357.51 Aligned_cols=258 Identities=33% Similarity=0.551 Sum_probs=223.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|..++.||-|+||+|.+++..+|...+|+|.+.+..+.......+++.|-.||.....+.||+||..|.++..+|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 45688999999999999999999999999999999999888888889999999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc-----
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI----- 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~----- 168 (417)
|+|++||++..++-+ |-|+|+.|+.|+.+|..|+++.|..|+|||||||+|||||.+|++||+||||++-+...
T Consensus 708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY 787 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 787 (1034)
T ss_pred EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence 999999999988765 89999999999999999999999999999999999999999999999999998743110
Q ss_pred -------CCC----------------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc
Q 014849 169 -------RPD----------------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 169 -------~~~----------------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~ 213 (417)
+.+ -..+..+||++|+||||+...+|. ...|+||.|||||+|+.
T Consensus 788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~-q~cdwws~gvil~em~~ 866 (1034)
T KOG0608|consen 788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT-QLCDWWSVGVILYEMLV 866 (1034)
T ss_pred ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc-ccchhhHhhHHHHHHhh
Confidence 000 012456899999999999999996 89999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhc--C--CCCCCCCCChHHHHHHHHhccCCCCCCC---CHHHHhcCccccc
Q 014849 214 GYLPFNDPNLMAMYRKIYK--G--EYRCPKWTSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKK 274 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~--~--~~~~p~~~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~ 274 (417)
|++||.+.+..+...++.. . .+..-..+|+++.+||.++.+ +++.|. ..+++..||||+.
T Consensus 867 g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 867 GQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred CCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 9999988766554444332 1 122334579999999998764 788898 4778999999985
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=338.20 Aligned_cols=258 Identities=24% Similarity=0.386 Sum_probs=216.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....+.|...+.||+|+||+||+|.+..+|+.||+|++.............+.+|+.+++.++|||++++++++.+....
T Consensus 17 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 96 (313)
T cd06633 17 DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTA 96 (313)
T ss_pred CCHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 34455688888999999999999999999999999999865443444456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.| +|.+.+.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|||++....
T Consensus 97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--- 172 (313)
T cd06633 97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--- 172 (313)
T ss_pred EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence 999999965 77776653 578999999999999999999999999999999999999999999999999875321
Q ss_pred CCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~ 245 (417)
......|+..|+|||++.. .+..+.++|||||||++|+|++|..||...+......++.....+. ...++..+
T Consensus 173 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (313)
T cd06633 173 ---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEWTDSF 249 (313)
T ss_pred ---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCHHH
Confidence 2234678999999999852 2323588999999999999999999998877666555554443321 22356789
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++|+.+||+.+|.+|||+.+++.||||+...
T Consensus 250 ~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 250 RGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred HHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999998644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=322.18 Aligned_cols=248 Identities=33% Similarity=0.578 Sum_probs=214.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|++.+.||+|++|.||+|.+..+++.+++|++..... .....+.+|+.+++.++||||+++++++......++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 48999999999999999999998999999999976543 235788899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 97 FAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 97 ~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
|++|++|.+.+.. +.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||.+........ .
T Consensus 78 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~ 154 (253)
T cd05122 78 FCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---R 154 (253)
T ss_pred cCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc---c
Confidence 9999999999876 4799999999999999999999999999999999999999999999999999876543221 3
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCCC--CCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-YRCP--KWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-~~~p--~~~s~~~~~li~~ 251 (417)
....|+..|+|||.+....+ +.++|+||+|+++|+|++|..||...+............ ...+ ...+..+.++|.+
T Consensus 155 ~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 233 (253)
T cd05122 155 NTMVGTPYWMAPEVINGKPY-DYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEKWSDEFKDFLKK 233 (253)
T ss_pred cceecCCcccCHHHHcCCCC-CccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcCcccccCHHHHHHHHH
Confidence 45678999999999887665 489999999999999999999998875444433333222 2222 2237889999999
Q ss_pred hccCCCCCCCCHHHHhcCcc
Q 014849 252 LLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~ 271 (417)
||+.||++|||+.++++|||
T Consensus 234 ~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 234 CLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred HccCChhhCCCHHHHhcCCC
Confidence 99999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-42 Score=326.99 Aligned_cols=247 Identities=25% Similarity=0.380 Sum_probs=209.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+. +++.||+|.+..... ...++.+|+.+++.++||||+++++++...+..|+|
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred hhheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 357999999999999999999974 557899999865432 245688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 80 TELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred eecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 999999999999875 25899999999999999999999999999999999999999999999999998765421111
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
......++..|+|||++.+..++ .++|||||||++|+|++ |++||.+.+.......+... ....+...++.+.+++
T Consensus 160 -~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05068 160 -AREGAKFPIKWTAPEAALYNRFS-IKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPCPPGCPKELYDIM 237 (261)
T ss_pred -ccCCCcCceeccCccccccCCCC-chhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHHH
Confidence 11112234579999998877764 89999999999999999 99999988877777776554 2345566789999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||+.+|++||++.++++
T Consensus 238 ~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 238 LDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred HHHhhcCcccCCCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-45 Score=391.23 Aligned_cols=262 Identities=31% Similarity=0.541 Sum_probs=228.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.-||.-+..+|.|.||+||-|.+..||...|+|.+..+... ......+.+|..++..++|||+|++|++-.+.+..
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence 34566888999999999999999999999999999999776544 44567889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc--
Q 014849 92 YFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI-- 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~-- 168 (417)
||.||||.||+|.+.+..| -.+|...+.|..|++.|+.|||++|||||||||+||+|+.+|.+|++|||.|......
T Consensus 1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999999999985 5788889999999999999999999999999999999999999999999988654332
Q ss_pred CCCCcccccccCccccccccccccC--CCCChhhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCCCCCCCCCChH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG--YDGAKVDMWSCGVVLFVLNAGYLPFND--PNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~--y~~~~sDIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
.-.+.+....|||.|||||++.+.. -.+.++|||||||+..||.||+.||.. .+-.-||+--....+++|...|++
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~~ls~~ 1469 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIPERLSSE 1469 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCchhhhHh
Confidence 1234667789999999999997543 235789999999999999999999974 334455655555567889999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.++||.+||..||.+|+++.||++|-|-+.
T Consensus 1470 g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1470 GRDFLEHCLEQDPKMRWTASQLLEHAFGKS 1499 (1509)
T ss_pred HHHHHHHHHhcCchhhhHHHHHHHhhcccc
Confidence 999999999999999999999999987654
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=334.15 Aligned_cols=258 Identities=31% Similarity=0.528 Sum_probs=223.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
......|++.+.||+|+||.||.|.+..+++.||+|++..... ....+.+|+.+++.++||||+++++.+......
T Consensus 15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 90 (286)
T cd06614 15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL 90 (286)
T ss_pred CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence 4567789999999999999999999988999999999976532 356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|+||++|++|.+++... .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~- 169 (286)
T cd06614 91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE- 169 (286)
T ss_pred EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc-
Confidence 9999999999999999874 7999999999999999999999999999999999999999999999999987643321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-C--CCCCCChHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-R--CPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~--~p~~~s~~~~ 246 (417)
........+++.|+|||++.+..++ .++|+||+||++|+|++|..||...+.......+..... . .+..++.++.
T Consensus 170 -~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 247 (286)
T cd06614 170 -KSKRNSVVGTPYWMAPEVIKRKDYG-PKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK 247 (286)
T ss_pred -hhhhccccCCcccCCHhHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCcchhhCCHHHH
Confidence 1122345688999999999877765 899999999999999999999998776655555543332 2 2233678899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++|.+||+.+|.+|||+.+++.|+||++..
T Consensus 248 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 277 (286)
T cd06614 248 DFLNKCLVKDPEKRPSAEELLQHPFLKKAC 277 (286)
T ss_pred HHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence 999999999999999999999999999843
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=331.48 Aligned_cols=251 Identities=22% Similarity=0.338 Sum_probs=210.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..+|++.+.||+|+||.||+|.+..+|+ .||+|++.... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~ 82 (279)
T cd05109 6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-T 82 (279)
T ss_pred hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-C
Confidence 4579999999999999999999887777 48999986543 223356788999999999999999999998754 4
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++++||+++|+|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~ 162 (279)
T cd05109 83 VQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID 162 (279)
T ss_pred cEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence 7899999999999999865 57999999999999999999999999999999999999999999999999998765422
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........+++.|+|||.+.+..++ .++|||||||++|+|++ |..||...........+..+. .+.+...++++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05109 163 ETEYHADGGKVPIKWMALESILHRRFT-HQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred cceeecCCCccchhhCCHHHhccCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCccCCHHHH
Confidence 111111222346789999999887775 89999999999999998 999998877766666555543 344566789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..||++|||+.++++.
T Consensus 242 ~li~~~l~~dp~~Rp~~~~l~~~ 264 (279)
T cd05109 242 MIMVKCWMIDSECRPRFRELVDE 264 (279)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=343.49 Aligned_cols=255 Identities=28% Similarity=0.455 Sum_probs=210.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||+|++.+... .......+.+|+.+++.++||||+++++++...
T Consensus 12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~ 90 (342)
T cd07879 12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGD 90 (342)
T ss_pred ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCC
Confidence 457899999999999999999999999999999999876432 233355678999999999999999999998654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+|+||+.. +|...+ ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~ 168 (342)
T cd07879 91 EFQDFYLVMPYMQT-DLQKIM-GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHAD 168 (342)
T ss_pred CCceEEEEeccccc-CHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCC
Confidence 357999999964 676655 3478999999999999999999999999999999999999999999999999986432
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------ 234 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 234 (417)
. ......||+.|+|||++.+....+.++||||+||++|+|++|+.||.+.+....+..+....
T Consensus 169 ~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (342)
T cd07879 169 A-----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE 243 (342)
T ss_pred C-----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence 1 22345688999999998764434589999999999999999999999877655544433210
Q ss_pred -----------CCC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 -----------YRC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 -----------~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
... .+..++++.+||.+||+.||.+|||+++++.||||+..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 000 12356789999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=338.41 Aligned_cols=252 Identities=23% Similarity=0.373 Sum_probs=211.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
.++|.+++.||+|+||.||+|++.. ....+|+|.+.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 88 (314)
T cd05099 11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT 88 (314)
T ss_pred HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence 4689999999999999999998643 34579999987542 222356788999999999 6999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD 149 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~ 149 (417)
+...+|+||||+++|+|.+++.. ..++...+..++.||+.||.|||++|++||||||+|||++
T Consensus 89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~ 168 (314)
T cd05099 89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVT 168 (314)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEc
Confidence 99999999999999999998854 2478889999999999999999999999999999999999
Q ss_pred CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 014849 150 ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYR 228 (417)
Q Consensus 150 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 228 (417)
.++.+||+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~ 247 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT-HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFK 247 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC-ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999998754322221222223345789999999877764 89999999999999998 999999888888777
Q ss_pred HHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+. ...|...+.++.+++.+||..||++|||+.++++.
T Consensus 248 ~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~ 289 (314)
T cd05099 248 LLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEA 289 (314)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 776654 34566678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=328.48 Aligned_cols=247 Identities=24% Similarity=0.400 Sum_probs=209.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+. ++..+|+|++..... ....+.+|+.+++.++||||+++++++......|+||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVT 78 (256)
T ss_pred HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEE
Confidence 35899999999999999999885 567899999865432 2356778999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~-~~ 157 (256)
T cd05059 79 EYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY-TS 157 (256)
T ss_pred ecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc-cc
Confidence 99999999999864 5689999999999999999999999999999999999999999999999999865432111 01
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+..+ ....|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFS-SKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTEVYTIMYS 236 (256)
T ss_pred cCCCCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHH
Confidence 1111234579999999887775 89999999999999998 89999887777777776654 345566679999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||..+|++|||+.++++.
T Consensus 237 cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 237 CWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred HhcCChhhCcCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=334.89 Aligned_cols=249 Identities=23% Similarity=0.352 Sum_probs=209.5
Q ss_pred CeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
+|++.+.||+|+||.||+|.+.. ....+|+|.+..... .....++.+|+.+++.++||||+++++.+...+..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENAS--SSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCC--HHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 58899999999999999998754 335799998865432 12246788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 92 YFVMEFAKGGELFAKISK-------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
|+|+||+.+++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 999999999999998753 2478889999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
|+++++.+||+|||++...............+++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.....
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~ 237 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIAPER 237 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcc-hHhHHHHHHHHHHHHHhcCCCCCCCCCHHH
Confidence 9999999999999998754322211122334567889999998877765 89999999999999998 999999888777
Q ss_pred HHHHHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 226 MYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 226 ~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....+..+ ....|...+.++.+++.+||++||++|||+.++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~ 281 (290)
T cd05045 238 LFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISK 281 (290)
T ss_pred HHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 76665543 34456678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=336.97 Aligned_cols=253 Identities=24% Similarity=0.335 Sum_probs=209.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
...++|++.+.||+|+||.||+|.+ ..++..||+|++.... .....+.+.+|+.+++++ +||||+++++.+.
T Consensus 32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 109 (302)
T cd05055 32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACT 109 (302)
T ss_pred ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEe
Confidence 3456899999999999999999975 3456689999987543 223356788999999999 7999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.....|+||||+.+|+|.+++.. ..+++.++..++.|++.||.|||++||+||||||+|||++.++.+|++|||++.
T Consensus 110 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 110 IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred cCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999999999865 238999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC--CCCCCC
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE--YRCPKW 240 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~ 240 (417)
...............+++.|+|||.+....++ .++||||+||++|+|++ |..||.+.+..+.+.+..... ...|..
T Consensus 190 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 268 (302)
T cd05055 190 DIMNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEH 268 (302)
T ss_pred cccCCCceeecCCCCcccccCCHhhhccCCCC-cHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcCCCCCC
Confidence 54322111112233467889999999877765 89999999999999998 999998877655444443332 234566
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++.+.+++.+||.++|++|||+.|+++
T Consensus 269 ~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 269 APAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred CCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 7899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=344.25 Aligned_cols=256 Identities=21% Similarity=0.330 Sum_probs=205.3
Q ss_pred eEEeee--CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCG--AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
..||+| +||+||+|.+..+|+.||+|++...... ....+.+.+|+.+++.++||||+++++++..+...|+|+||+.
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 345555 9999999999999999999999765432 2335788999999999999999999999999999999999999
Q ss_pred CCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC----
Q 014849 100 GGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG---- 172 (417)
Q Consensus 100 gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~---- 172 (417)
+++|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.++++||+.+..........
T Consensus 83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (328)
T cd08226 83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY 162 (328)
T ss_pred CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence 9999998875 358999999999999999999999999999999999999999999999998653221110000
Q ss_pred -cccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--------------
Q 014849 173 -MLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-------------- 236 (417)
Q Consensus 173 -~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-------------- 236 (417)
......++..|+|||++.+.. ..+.++||||+||++|+|++|.+||..................
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (328)
T cd08226 163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR 242 (328)
T ss_pred cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence 011223567799999987642 1258999999999999999999999876655444333222110
Q ss_pred ---------------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 237 ---------------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 237 ---------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.+...++.+.+||++||+.||++|||+.|+++||||+.....
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~ 317 (328)
T cd08226 243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQ 317 (328)
T ss_pred hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence 112246778999999999999999999999999999876553
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-42 Score=337.19 Aligned_cols=257 Identities=26% Similarity=0.415 Sum_probs=218.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
....|+..+.||+|+||.||+|.+..+|+.||+|++............++.+|+.+++.++|||++++++++.+....|+
T Consensus 23 ~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 102 (317)
T cd06635 23 PEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWL 102 (317)
T ss_pred chhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEE
Confidence 34558899999999999999999999999999999986544444456688899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+.| +|.+.+. .+.+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++....
T Consensus 103 v~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~----- 176 (317)
T cd06635 103 VMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIAS----- 176 (317)
T ss_pred EEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccC-----
Confidence 9999975 7777664 3679999999999999999999999999999999999999999999999999876432
Q ss_pred CcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLKW 247 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~ 247 (417)
......|++.|+|||++.. .+..+.++||||+||++|+|++|..||...+.......+....... +...++.+++
T Consensus 177 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 255 (317)
T cd06635 177 -PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEWSDYFRN 255 (317)
T ss_pred -CcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCCCCccccHHHHH
Confidence 1234578999999999742 2233589999999999999999999998877666666665544322 2346788999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++.+||+.+|.+|||+.++++|+|+.....
T Consensus 256 li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 256 FVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred HHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 999999999999999999999999976543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=332.83 Aligned_cols=250 Identities=23% Similarity=0.348 Sum_probs=211.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+|.+.+.||+|+||.||+|... .++..+|+|.+.... ......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCC---HHHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 457889999999999999999743 456789999886542 234567899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
..|++|||+++++|.+++.. ..+++..+..++.||+.||.|||++|++||||||+|||+++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 99999999999999998864 24789999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 232 (417)
+||+|||++................+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+..
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 239 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQ 239 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHc
Confidence 999999998654321111122234457889999999887775 89999999999999998 9999988877777766665
Q ss_pred CC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 233 GE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 233 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+. ...|...++.+.++|.+||+.||++||+++++++
T Consensus 240 ~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 240 GRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred CccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 53 4556678899999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=370.15 Aligned_cols=149 Identities=33% Similarity=0.615 Sum_probs=139.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||+||+|.+..+++.||||++............++.+|+.+++.++||||++++.++.+...+|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 57899999999999999999999999999999999876555555567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
|||+.|++|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 83 mEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999875 678999999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-44 Score=358.80 Aligned_cols=247 Identities=31% Similarity=0.552 Sum_probs=216.0
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGE 102 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~ 102 (417)
+||+|+||+||.|+|..|...+|||.+.... ......+..||.+.+.|+|.|||++++.+..++.+-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekd---sr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKD---SREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeeccccc---chhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 6999999999999999999999999996542 2336678899999999999999999999999999999999999999
Q ss_pred hHHHHhc--CCC--CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCeEEeeeecceeecccCCCCccccc
Q 014849 103 LFAKISK--GRF--SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 103 L~~~i~~--~~l--~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
|.+++.. |++ .|...-.|-+||++||.|||++.|||||||-+|+|++ -.|.+||+|||-+..... -+....|.
T Consensus 659 LSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~TETF 736 (1226)
T KOG4279|consen 659 LSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCTETF 736 (1226)
T ss_pred HHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhcc--CCcccccc
Confidence 9999986 888 8889999999999999999999999999999999995 578999999998875544 34456788
Q ss_pred ccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHHH-HhcCCCCCCCCCChHHHHHHHHh
Q 014849 178 CGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN--LMAMYRK-IYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 178 ~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~--~~~~~~~-i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
.||..|||||++.. .|| |.++|||||||.+.||.||++||..-. ...|++. ..+--++.|...|.+++.||.+|
T Consensus 737 TGTLQYMAPEvIDqG~RGY-G~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iPeelsaeak~Filrc 815 (1226)
T KOG4279|consen 737 TGTLQYMAPEVIDQGPRGY-GKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIPEELSAEAKNFILRC 815 (1226)
T ss_pred ccchhhhChHhhccCCcCC-CchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCcHHHHHHHHHHHHHH
Confidence 89999999999864 355 799999999999999999999997533 2344432 23445677888899999999999
Q ss_pred ccCCCCCCCCHHHHhcCcccccc
Q 014849 253 LDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+.+||..||++.++|++||++.+
T Consensus 816 Fepd~~~R~sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 816 FEPDPCDRPSAKDLLQDPFLQHN 838 (1226)
T ss_pred cCCCcccCccHHHhccCcccccC
Confidence 99999999999999999999876
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=327.46 Aligned_cols=247 Identities=24% Similarity=0.356 Sum_probs=209.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++.+.||+|+||.||.|.+. .+..+|+|.+..... ..+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred HHeEEeeEecCcccceEEEEEec-CCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 46999999999999999999874 345699998865432 2456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.+|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~ 157 (256)
T cd05113 79 EYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce-ee
Confidence 99999999999875 4689999999999999999999999999999999999999999999999999865422111 01
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||.+.+..++ .++|||||||++|+|++ |..||...+.......+..+.. ..|...++.+.+++.+
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFS-SKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVYAIMYS 236 (256)
T ss_pred cCCCccChhhCCHHHHhcCccc-chhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHH
Confidence 1112345679999999877765 89999999999999998 9999998887777777766543 3455678999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||.+||.+|||+.+++.+
T Consensus 237 cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 237 CWHEKAEERPTFQQLLSS 254 (256)
T ss_pred HcCCCcccCCCHHHHHHh
Confidence 999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=327.41 Aligned_cols=247 Identities=23% Similarity=0.371 Sum_probs=209.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+ .+++.||+|.+..... ..+.+.+|+.+++.++||||+++++.+.+....|++
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYII 79 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEE
Confidence 46899999999999999999997 4667899998865432 256788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+.+++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 158 (261)
T cd05072 80 TEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY- 158 (261)
T ss_pred EecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce-
Confidence 999999999998864 5688999999999999999999999999999999999999999999999999876432111
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
.......++..|+|||.+....++ .++|||||||++|+|++ |..||...+.......+..+. .+.+...+.++.+++
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 237 (261)
T cd05072 159 TAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRMENCPDELYDIM 237 (261)
T ss_pred eccCCCccceecCCHHHhccCCCC-hhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHH
Confidence 111223456789999998877664 89999999999999998 999999887777777666542 233445688999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||..+|++|||++++.+
T Consensus 238 ~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 238 KTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=325.52 Aligned_cols=250 Identities=34% Similarity=0.514 Sum_probs=220.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|++.+.||+|+||.||++.+..+++.+|+|.+...... ......+.+|+.+++.++||||+++++++.+....|+|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 599999999999999999999999999999999765432 2235567789999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||+|.||+++.++.+||+|||++......
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~--- 156 (256)
T cd08530 80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN--- 156 (256)
T ss_pred hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence 9999999998865 56899999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIG 250 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~ 250 (417)
......|++.|+|||.+.+..++ .++|+||+|+++|+|++|+.||...+..+....+..+.++ .+...+.++++++.
T Consensus 157 -~~~~~~~~~~~~~Pe~~~~~~~~-~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 234 (256)
T cd08530 157 -MAKTQIGTPHYMAPEVWKGRPYS-YKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPIPPIYSQDLQNFIR 234 (256)
T ss_pred -CcccccCCccccCHHHHCCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCchhhCHHHHHHHH
Confidence 33446789999999999887765 8999999999999999999999998887777777666543 45567899999999
Q ss_pred HhccCCCCCCCCHHHHhcCccc
Q 014849 251 RLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f 272 (417)
+||..+|++|||+.++++||+.
T Consensus 235 ~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 235 SMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred HHcCCCcccCCCHHHHhcCCCC
Confidence 9999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=327.92 Aligned_cols=244 Identities=24% Similarity=0.339 Sum_probs=205.3
Q ss_pred EEeeeCceEEEEEEE--ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 23 IIGCGAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
.||+|+||.||+|.+ ..+++.+|+|++.... ......+.+.+|+.+++.++||||+++++++. ....++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 5678999999987543 23334677889999999999999999999875 4567999999999
Q ss_pred CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC-Ccccccc
Q 014849 101 GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLC 178 (417)
Q Consensus 101 g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~~~~~~ 178 (417)
|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||.||+++.++.+||+|||++......... .......
T Consensus 80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 999999865 67999999999999999999999999999999999999999999999999998754322110 0112234
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTD 256 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~d 256 (417)
+++.|+|||.+....++ .++|||||||++|+|++ |..||.+.+.......+..+. .+.|...++++.++|.+||++|
T Consensus 160 ~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~~~~~ 238 (257)
T cd05116 160 WPVKWYAPECMNYYKFS-SKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMECPQRCPPEMYDLMKLCWTYG 238 (257)
T ss_pred CCccccCHhHhccCCcC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHhccC
Confidence 46789999998776664 89999999999999997 999999888777777776654 4567778999999999999999
Q ss_pred CCCCCCHHHHhcC
Q 014849 257 PATRITVDEILRD 269 (417)
Q Consensus 257 P~~R~t~~eil~h 269 (417)
|++|||+++|.+.
T Consensus 239 p~~Rp~~~~i~~~ 251 (257)
T cd05116 239 VDERPGFAVVELR 251 (257)
T ss_pred chhCcCHHHHHHH
Confidence 9999999999653
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=328.85 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=211.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.+.|++.+.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 3 VSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred hHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3569999999999999999999987765 59999987542 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++||||+++++|.+++.. +.+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 999999999999998864 568999999999999999999999999999999999999999999999999986543222
Q ss_pred CCCcccccc---cCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChH
Q 014849 170 PDGMLHTLC---GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPD 244 (417)
Q Consensus 170 ~~~~~~~~~---Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 244 (417)
......... ++..|+|||.+....++ .++||||+||++|+|++ |..||...+..+....+... ..+.|...++.
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 239 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTA 239 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCccc-chhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCcccCCHH
Confidence 111111112 24579999999887775 89999999999999886 99999988877777776543 23445567889
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+++.+||..+|++||++++++..
T Consensus 240 ~~~li~~~l~~~p~~Rp~~~~i~~~ 264 (269)
T cd05065 240 LHQLMLDCWQKDRNARPKFGQIVST 264 (269)
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=333.06 Aligned_cols=251 Identities=26% Similarity=0.363 Sum_probs=212.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|.+. .++..||+|++.... .......+.+|+.+++.++||||+++++++.+..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 467999999999999999999874 367899999987543 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
..|+|+||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||.||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 99999999999999998863 1367888999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
+++.++.++|+|||++................+++.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999998654322111122233456779999999887775 89999999999999997 889998888888
Q ss_pred HHHHHhcCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 226 MYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 226 ~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....+..+.. ..|...++++.+|+.+||+.||++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~ 284 (288)
T cd05050 241 VIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284 (288)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 7777776654 456677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=345.14 Aligned_cols=252 Identities=25% Similarity=0.389 Sum_probs=204.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT- 87 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~- 87 (417)
.++|++++.||+|+||.||+|.+ ..+++.||||++..... ......+.+|+.+|..+ +||||+++++++..
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 35899999999999999999985 35678999999975432 22356788999999999 68999999998754
Q ss_pred CCEEEEEEeccCCCChHHHHhc----------------------------------------------------------
Q 014849 88 KAKIYFVMEFAKGGELFAKISK---------------------------------------------------------- 109 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~---------------------------------------------------------- 109 (417)
...+++||||+++|+|.+++..
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4578999999999999988753
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 110 ----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 110 ----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
..++...+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.............+..+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 1357778889999999999999999999999999999999999999999999875432211112223345
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcC-CCCCCCCCChHHHHHHHHhccCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTD 256 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~d 256 (417)
++.|+|||++.+..++ .++|||||||++|+|++ |..||...... .....+..+ ....|.+.++++.+++.+||+.|
T Consensus 244 ~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~~ 322 (343)
T cd05103 244 PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE 322 (343)
T ss_pred CcceECcHHhcCCCCC-chhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccCC
Confidence 6789999999887775 89999999999999996 99999875433 233333333 34556778899999999999999
Q ss_pred CCCCCCHHHHhcC
Q 014849 257 PATRITVDEILRD 269 (417)
Q Consensus 257 P~~R~t~~eil~h 269 (417)
|++|||+.+|++|
T Consensus 323 p~~Rps~~eil~~ 335 (343)
T cd05103 323 PSQRPTFSELVEH 335 (343)
T ss_pred hhhCcCHHHHHHH
Confidence 9999999999987
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=327.08 Aligned_cols=247 Identities=25% Similarity=0.375 Sum_probs=208.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+..+ ..||+|++..... ...++.+|+.+++.++||||+++++.+.. ...|+
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~l 77 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 77 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEE
Confidence 357899999999999999999998655 4699999976432 24578899999999999999999998754 56899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+........
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~ 157 (262)
T cd05071 78 VTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 157 (262)
T ss_pred EEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence 9999999999999875 3589999999999999999999999999999999999999999999999999875432211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
.......++..|+|||++.+..++ .++||||+||++|+|++ |.+||.+.........+..+. ...+...+..+.++
T Consensus 158 -~~~~~~~~~~~y~~PE~~~~~~~~-~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 235 (262)
T cd05071 158 -TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 235 (262)
T ss_pred -ccccCCcccceecCHhHhccCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCCccccCHHHHHH
Confidence 112234467789999998877774 89999999999999999 899999887777777665542 34556678999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||++||++|||+.++++
T Consensus 236 i~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 236 MCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred HHHHccCCcccCCCHHHHHH
Confidence 99999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=328.16 Aligned_cols=251 Identities=27% Similarity=0.402 Sum_probs=210.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++++.||+|+||.||+|.+..++. .+|+|.+..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 3689999999999999999999875544 799999865432 22356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||++|++|.+++.. +.+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 160 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccc
Confidence 999999999999999875 568999999999999999999999999999999999999999999999999987543221
Q ss_pred CCC-cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 170 PDG-MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~-~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
... ......+++.|+|||.+.+..++ .++|+|||||++|++++ |..||.+....+....+..+. .+.+...++.+.
T Consensus 161 ~~~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (267)
T cd05066 161 EAAYTTRGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH 239 (267)
T ss_pred ceeeecCCCccceeecCHhHhccCccC-chhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCCCCCCCHHHH
Confidence 111 11112235689999999877764 89999999999999886 999998887777776666542 334445688999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||+.+|.+|||+.++++
T Consensus 240 ~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 240 QLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred HHHHHHcccCchhCCCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=330.46 Aligned_cols=251 Identities=22% Similarity=0.316 Sum_probs=207.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.++|++.+.||+|+||+||+|.+..+|+. +++|.+.... .......+..|+.+++.++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-AS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-Cc
Confidence 46899999999999999999999888875 6666664321 12234567788889999999999999998754 45
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++++||+++|+|.+++.. +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPD 162 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCC
Confidence 7899999999999999964 57899999999999999999999999999999999999999999999999999754322
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~ 246 (417)
..........|+..|+|||++.+..++ .++||||+||++|+|++ |..||.+.........+..+.. ..|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~pE~~~~~~~~-~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05111 163 DKKYFYSEHKTPIKWMALESILFGRYT-HQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVY 241 (279)
T ss_pred CcccccCCCCCcccccCHHHhccCCcC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCCCCCCCHHHH
Confidence 222222345577889999999877775 99999999999999998 9999998776665555554443 34555678899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..||++|||+.|+++.
T Consensus 242 ~li~~c~~~~p~~Rps~~el~~~ 264 (279)
T cd05111 242 MVMVKCWMIDENVRPTFKELANE 264 (279)
T ss_pred HHHHHHcCCCcccCcCHHHHHHH
Confidence 99999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=339.79 Aligned_cols=253 Identities=23% Similarity=0.366 Sum_probs=212.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRT-------GQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVL 85 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~ 85 (417)
...+|++++.||+|+||.||.|++... +..||+|++.... .......+.+|+.+++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA--TDKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 345899999999999999999987532 2369999887542 223356788999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL 148 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl 148 (417)
.....+|+++||+++|+|.+++... .++...+..++.|++.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 9999999999999999999988641 36778889999999999999999999999999999999
Q ss_pred cCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 014849 149 DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY 227 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 227 (417)
+.++.+||+|||+++...............++..|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+..
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~ 246 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF 246 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999998754332211122223345679999999887775 88999999999999998 89999998888888
Q ss_pred HHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 228 RKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 228 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+..+. ...|...+.++.+++.+||+.+|.+|||+.|++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 247 KLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 7776653 34566678899999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=334.49 Aligned_cols=255 Identities=25% Similarity=0.354 Sum_probs=206.7
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV 94 (417)
..|+..+.||+|+||.||++.+..+|+.||+|.+...... .....+.+|+.++.++. ||||+++++++..+...|++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3567788999999999999999999999999998765422 33567889999999996 99999999999999999999
Q ss_pred EeccCCCChHHH---Hh---cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 95 MEFAKGGELFAK---IS---KGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 95 ~E~~~gg~L~~~---i~---~~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|||+.+ +|.++ +. .+.+++..+..++.|++.||+|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999865 44432 21 26799999999999999999999975 999999999999999999999999999864322
Q ss_pred cCCCCcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCC-CC----CC
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEY-RC----PK 239 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~----p~ 239 (417)
........|++.|+|||++.+. ...+.++||||+||++|+|++|++||...+. .....++..+.. .. +.
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (288)
T cd06616 161 ---SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEER 237 (288)
T ss_pred ---CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCC
Confidence 1222344689999999998766 2335899999999999999999999976542 223333333222 11 22
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..++++.+||.+||++||++|||+++++.||||+...
T Consensus 238 ~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 238 EFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred ccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 3688999999999999999999999999999998643
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=334.59 Aligned_cols=251 Identities=22% Similarity=0.259 Sum_probs=205.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC--------------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcce
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG--------------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g--------------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
..+|++.+.||+|+||.||+|++..++ ..||+|.+.... .......+.+|+++|+.++||||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~ 81 (295)
T cd05097 4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR 81 (295)
T ss_pred hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence 358999999999999999999875432 359999987542 2234567889999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 014849 81 LYEVLATKAKIYFVMEFAKGGELFAKISKG-------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLL 147 (417)
Q Consensus 81 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~-------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NIL 147 (417)
+++++......|+||||+.+++|.+++... .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus 82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil 161 (295)
T cd05097 82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL 161 (295)
T ss_pred EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEE
Confidence 999999999999999999999999988542 3678889999999999999999999999999999999
Q ss_pred ecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 014849 148 LDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GYLPFNDPNLMA 225 (417)
Q Consensus 148 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~~Pf~~~~~~~ 225 (417)
++.++.+||+|||++................+++.|+|||++....+ +.++|||||||++|+|++ |..||...+..+
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKF-TTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCc-CchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 99999999999999865432211112233445778999999887776 499999999999999987 778998877665
Q ss_pred HHHHHhc-----C---CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 226 MYRKIYK-----G---EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 226 ~~~~i~~-----~---~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....+.. + ....+...++.+.+|+.+||+.||++|||+++|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 241 VIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 5544321 1 12234556889999999999999999999999965
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=331.06 Aligned_cols=247 Identities=32% Similarity=0.477 Sum_probs=205.6
Q ss_pred EEeeEEeeeCceEEEEEEEc----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 19 EVGKIIGCGAFAKVYHGRNV----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
++.+.||.|+||.||.|... ..+..|+||++.... .......+.+|+.+++.++||||+++++++...+..++|
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv 79 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSS--SEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLV 79 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTS--SHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEecccc--ccccceeeeeccccccccccccccccccccccccccccc
Confidence 57899999999999999987 456789999995432 223367889999999999999999999999988889999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||+++|+|.+++... .+++.....++.||+.||.|||+++++|+||+|.|||++.++.+||+|||++.........
T Consensus 80 ~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~ 159 (259)
T PF07714_consen 80 MEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY 159 (259)
T ss_dssp EE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999999764 7999999999999999999999999999999999999999999999999998765222122
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li 249 (417)
.......+...|+|||.+....++ .++||||||+++|+|++ |+.||.+.+..+...++..+.. ..|...+..+.++|
T Consensus 160 ~~~~~~~~~~~~~aPE~~~~~~~~-~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 238 (259)
T PF07714_consen 160 KNDSSQQLPLRYLAPEVLKDGEYT-KKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPIPDNCPKDIYSLI 238 (259)
T ss_dssp EESTTSESGGGGS-HHHHHHSEES-HHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTSBTTSBHHHHHHH
T ss_pred cccccccccccccccccccccccc-ccccccccccccccccccccccccccccccccccccccccceeccchhHHHHHHH
Confidence 223345577889999999887764 99999999999999999 7899999888888888866553 45667899999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||..||++|||+.+|++
T Consensus 239 ~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 239 QQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HHHT-SSGGGS--HHHHHH
T ss_pred HHHcCCChhhCcCHHHHHh
Confidence 9999999999999999975
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-42 Score=331.28 Aligned_cols=259 Identities=32% Similarity=0.566 Sum_probs=217.5
Q ss_pred CeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.|++.+.||+|+||.||+|++. .+++.||+|++.+.... ......++.+|+.+++.+ +||||+++++.+.+...+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4899999999999999999864 46789999999765432 223356778999999999 599999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.||+|.+.+.. +.+++..++.++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++...... .
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAE-E 159 (288)
T ss_pred EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccc-c
Confidence 999999999999998875 67999999999999999999999999999999999999999999999999998654322 1
Q ss_pred CCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCCCCCCCCChHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
.......+|++.|+|||.+.+.. ..+.++||||+|+++|+|++|..||... ...+....+.......|..+++++
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 239 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEA 239 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCHHH
Confidence 11223457899999999986543 2358999999999999999999999643 233445555666677788889999
Q ss_pred HHHHHHhccCCCCCCCC---HHHHhcCccccccc
Q 014849 246 KWFIGRLLDTDPATRIT---VDEILRDPWFKKDY 276 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t---~~eil~h~~f~~~~ 276 (417)
.++|.+||+.||++||| +.++++||||+...
T Consensus 240 ~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~ 273 (288)
T cd05583 240 RDFIQKLLEKDPKKRLGANGADEIKNHPFFQGID 273 (288)
T ss_pred HHHHHHHhcCCHhhccCcchHHHHhcCcccccCC
Confidence 99999999999999998 57889999998643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=328.45 Aligned_cols=252 Identities=30% Similarity=0.543 Sum_probs=215.5
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
||.+.+.||+|+||.||+|.+..++..+++|++...... ......++.+|+.+++.++||||+++++.+.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 799999999999999999999888888888887653321 222345677899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 95 MEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||+++++|.+.+.. +.+++..++.++.|++.||.|||++|++|+||+|+||+++. +.+||+|||++.....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~-- 157 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMG-- 157 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCC--
Confidence 999999999987742 56999999999999999999999999999999999999975 5699999999875432
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 248 (417)
.........|++.|+|||.+.+..++ .++|+||+|+++|+|++|..||...+......++..+.. ..|...+.++.++
T Consensus 158 ~~~~~~~~~~~~~~~~pe~~~~~~~~-~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 236 (260)
T cd08222 158 SCDLATTFTGTPYYMSPEALKHQGYD-SKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPETYSRQLNSI 236 (260)
T ss_pred CcccccCCCCCcCccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCCcchhcHHHHHH
Confidence 12233455689999999998877775 889999999999999999999998877777777665543 3455678899999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f 272 (417)
|.+||..||++||++.++++||||
T Consensus 237 i~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 237 MQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred HHHHhcCChhhCcCHHHHhhCCCC
Confidence 999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=325.94 Aligned_cols=247 Identities=25% Similarity=0.381 Sum_probs=208.8
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+. .+..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~l 77 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTM----SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYI 77 (260)
T ss_pred chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCC----CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEE
Confidence 3568999999999999999999874 667899999876432 2456889999999999999999999875 456899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05070 78 VTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc-
Confidence 9999999999999864 458999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........++..|+|||.+.+..++ .++|||||||++|+|++ |.+||.+.+..+....+..+ ..+.|...+..+.+|
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPISLHEL 235 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCc-chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHHH
Confidence 1111222356679999998776664 89999999999999999 99999988877777777654 445667788999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||.+||++|||+.++.+
T Consensus 236 i~~~l~~~p~~Rpt~~~l~~ 255 (260)
T cd05070 236 MLQCWKKDPEERPTFEYLQS 255 (260)
T ss_pred HHHHcccCcccCcCHHHHHH
Confidence 99999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-42 Score=336.44 Aligned_cols=259 Identities=28% Similarity=0.422 Sum_probs=208.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccC--CcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe----CC
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRT--GQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT----KA 89 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~----~~ 89 (417)
+|++.+.||+|+||.||+|++..+ ++.||+|.+.... ........+.+|+.+++.+ +||||+++++.... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 599999999999999999999888 9999999987532 2223355678899999999 59999999987532 24
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+++||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 6889999986 589888865 68999999999999999999999999999999999999999999999999998754322
Q ss_pred CC--CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 169 RP--DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 169 ~~--~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
.. ........||+.|+|||++.+....+.++||||+||++|+|++|.+||...+.......+...
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhh
Confidence 11 112344679999999998765332358999999999999999999999876644433322210
Q ss_pred ------------C---CC---CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ------------E---YR---CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ------------~---~~---~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .. .....+..+.+++.+||+.||++|||+.+++.||||++...
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~~ 300 (332)
T cd07857 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWHD 300 (332)
T ss_pred hhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhcC
Confidence 0 00 01124788999999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-42 Score=328.10 Aligned_cols=250 Identities=23% Similarity=0.374 Sum_probs=212.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.++|++.+.||+|+||.||+|.+..+|+ .+|+|.+..... ......+.+|+.+|+.++||||+++++++.+ ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 4689999999999999999999877765 589998876532 2335678899999999999999999999887 78
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++|+||+.+|+|.+++.. +.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~ 162 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVD 162 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCc
Confidence 9999999999999999875 46999999999999999999999999999999999999999999999999998764422
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........++..|+|||.+....++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (279)
T cd05057 163 EKEYHAEGGKVPIKWMALESILHRIYT-HKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQPPICTIDVY 241 (279)
T ss_pred ccceecCCCcccccccCHHHhhcCCcC-chhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCCCCCCCHHHH
Confidence 111111222345789999998777765 89999999999999998 999999988888777776654 455667789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||..||+.|||+.++++
T Consensus 242 ~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 242 MVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred HHHHHHcCCChhhCCCHHHHHH
Confidence 9999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-42 Score=330.57 Aligned_cols=251 Identities=33% Similarity=0.531 Sum_probs=212.1
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++.+.||+|++|.||+|.+..+|+.+|+|.+..... .......+.+|+.+|+.++||||+++++++.++...|+|+||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 6788999999999999999999999999999876543 223456788999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
+.+ +|.+.+.. +.+++..+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||.+....... ....
T Consensus 80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~--~~~~ 156 (283)
T cd05118 80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV--RPYT 156 (283)
T ss_pred cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--cccc
Confidence 976 88877765 589999999999999999999999999999999999999999999999999987654321 1233
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------------CC
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------------YR 236 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------------~~ 236 (417)
...++..|+|||.+.+....+.++|+||+||++|+|++|+.||...+..+.+.++...- ..
T Consensus 157 ~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (283)
T cd05118 157 HYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFS 236 (283)
T ss_pred CccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhh
Confidence 35678899999998776334589999999999999999999998877666555443210 00
Q ss_pred C-----------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 C-----------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 ~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+..+.++.++|.+||++||.+||++.+++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~ 283 (283)
T cd05118 237 FPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283 (283)
T ss_pred hccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence 0 11257789999999999999999999999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=328.47 Aligned_cols=249 Identities=31% Similarity=0.465 Sum_probs=207.7
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEeCCE----
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLATKAK---- 90 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~~~~---- 90 (417)
|++.+.||+|+||.||+|.+..+++.||+|++..... .......+.+|+.+++++ +||||+++++++.+...
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 7899999999999999999988999999999975432 222344566788877766 59999999999988776
Q ss_pred -EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 91 -IYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 -~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
+|++|||+.+ +|.+++.. ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++....
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~ 158 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceecc
Confidence 9999999975 78888764 358999999999999999999999999999999999999999999999999987653
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----C-----
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-----R----- 236 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-----~----- 236 (417)
.. .......+++.|+|||++.+..+. .++|+||+||++|+|++|.+||.+.+..+.+.++..... .
T Consensus 159 ~~---~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07838 159 FE---MALTSVVVTLWYRAPEVLLQSSYA-TPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNV 234 (287)
T ss_pred CC---cccccccccccccChHHhccCCCC-CcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCc
Confidence 22 223344688999999999877764 899999999999999999999998887776666543110 0
Q ss_pred ------C-----------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 237 ------C-----------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 237 ------~-----------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
. .+..++.+.++|.+||+.||++||++++++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~ 287 (287)
T cd07838 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287 (287)
T ss_pred ccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence 0 01235778899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-42 Score=329.54 Aligned_cols=251 Identities=26% Similarity=0.355 Sum_probs=202.4
Q ss_pred cCCe-EEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--
Q 014849 15 FGKY-EVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-- 87 (417)
Q Consensus 15 ~~~y-~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-- 87 (417)
.+|| ++.+.||+|+||+||++. ...+++.||+|++..... ......+.+|+.+|+.++||||+++++++..
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 79 (283)
T cd05080 2 HKRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQG 79 (283)
T ss_pred ChhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 4677 999999999999998764 345788999999875431 2235667899999999999999999998765
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
...+|+||||+.+++|.+++....+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 80 ~~~~~lv~e~~~~~~l~~~~~~~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 159 (283)
T cd05080 80 GKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 159 (283)
T ss_pred CceEEEEecCCCCCCHHHHHHHcCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCC
Confidence 34689999999999999999888899999999999999999999999999999999999999999999999999875432
Q ss_pred cCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HHH-------------HHHh
Q 014849 168 IRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM--AMY-------------RKIY 231 (417)
Q Consensus 168 ~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~--~~~-------------~~i~ 231 (417)
.... .......++..|+|||.+.+..++ .++|||||||++|+|++|..||...... ++. ..+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T cd05080 160 GHEYYRVREDGDSPVFWYAVECLKENKFS-YASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLE 238 (283)
T ss_pred cchhhccCCCCCCCceeeCHhHhcccCCC-cccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhh
Confidence 1111 111223456779999998876664 8999999999999999999998653211 111 1111
Q ss_pred cC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 232 KG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 232 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.+ ..+.|...+..+.+++.+||++||++|||++++++
T Consensus 239 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 239 RGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred cCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 11 12345567889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=332.43 Aligned_cols=251 Identities=22% Similarity=0.268 Sum_probs=204.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc----------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR----------------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~----------------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI 78 (417)
.++|++.+.||+|+||.||+|.+.. ++..+|+|++.... ......++.+|+.+|+.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCc
Confidence 3579999999999999999986532 34579999987542 22335678899999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKG------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
+++++++.+....|+||||+++++|.+++... .+++..+..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 99999999999999999999999999988652 366778999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA--GYLPFNDPNLM 224 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~--G~~Pf~~~~~~ 224 (417)
|++.++.++|+|||++................+++.|+|||+.....+ +.++|||||||++|+|++ |..||...+..
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~-~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~ 240 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKF-TTASDVWAFGVTLWEILTLCKEQPYSQLSDE 240 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCc-cchhhhhHHHHHHHHHHHhCCCCCccccChH
Confidence 999999999999999875432211112223445678999998877666 489999999999999998 78999877665
Q ss_pred HHHHHHh--------cCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 AMYRKIY--------KGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ~~~~~i~--------~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+...... ....+.|...++.+.+|+.+||+.||.+|||+.+|++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 241 QVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 5444321 1123345567899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=323.95 Aligned_cols=247 Identities=23% Similarity=0.375 Sum_probs=208.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.. .+++.||+|.+..... ...++.+|+.+|+.++||||+++++++. ....|+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred chHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 456899999999999999999986 4678899999875432 2457889999999999999999999874 456899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||+.+++|.+++.. ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~- 156 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE- 156 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC-
Confidence 9999999999998864 468999999999999999999999999999999999999999999999999986543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
........++..|+|||++....+. .++||||+||++|+|++ |++||.+.+..+....+..+. ...|...+.++.++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 235 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPRPDNCPEELYEL 235 (260)
T ss_pred cccccCCcccccccCHHHhccCCcC-cccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1111223456789999998877664 89999999999999998 999999888777777665542 34556678899999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||+.+|++|||+++++.
T Consensus 236 i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 236 MRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred HHHHccCChhhCCCHHHHHH
Confidence 99999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=321.88 Aligned_cols=248 Identities=25% Similarity=0.378 Sum_probs=211.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+. .++.||+|.+..... ....+.+|+.+++.++||||+++++++.+....|+
T Consensus 4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 3568999999999999999999975 568899999875432 24678899999999999999999999999899999
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........
T Consensus 79 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY 158 (261)
T ss_pred EEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh
Confidence 9999999999999865 3689999999999999999999999999999999999999999999999999875432111
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
.......++..|+|||.+.+..+ +.++||||+||++|+|++ |+.||.+.+......++..+ ....|...+.++.++
T Consensus 159 -~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (261)
T cd05034 159 -TAREGAKFPIKWTAPEAANYGRF-TIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELYDL 236 (261)
T ss_pred -hhhhccCCCccccCHHHhccCCc-CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 11112234568999999987666 489999999999999998 99999988877777777654 334566678899999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||+.+|++|||++++.+
T Consensus 237 i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 237 MLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred HHHHcccCcccCCCHHHHHH
Confidence 99999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=328.76 Aligned_cols=251 Identities=32% Similarity=0.531 Sum_probs=212.0
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++.+.||+|+||.||.|.+..+++.||+|++.... ........+.+|+.+++.++||||+++++++.+....|+|+||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 678899999999999999999999999999998754 2333456778899999999999999999999999999999999
Q ss_pred cCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
+.+ +|.+.+... .+++..+..++.|++.||.|||++||+||||+|+||+++.++.+||+|||++...... .....
T Consensus 80 ~~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~--~~~~~ 156 (282)
T cd07829 80 CDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIP--LRTYT 156 (282)
T ss_pred cCc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCC--ccccC
Confidence 975 899999764 7999999999999999999999999999999999999999999999999998754321 11233
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------CCCC
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------EYRC 237 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------~~~~ 237 (417)
...++..|+|||.+......+.++|+||+||++|+|++|.+||...+....+.++... ....
T Consensus 157 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (282)
T cd07829 157 HEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTF 236 (282)
T ss_pred ccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccc
Confidence 4456888999999877634458999999999999999999999887766555444321 0001
Q ss_pred C-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 238 P-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 238 p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
+ +..+.++.++|.+||..||++||++++++.||||
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~ 282 (282)
T cd07829 237 PKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282 (282)
T ss_pred cccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence 1 1236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=322.17 Aligned_cols=243 Identities=26% Similarity=0.349 Sum_probs=204.2
Q ss_pred eEEeeeCceEEEEEEEccCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVRTG---QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|+||.||+|....++ ..+|+|.+...... .....+.+|+.+++.+.||||+++++++.. ...++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence 47999999999999876655 78999999766532 345678899999999999999999998764 4689999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-cccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHT 176 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~ 176 (417)
.+|+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... ....
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999976 569999999999999999999999999999999999999999999999999987553221110 0111
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhcc
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 254 (417)
..++..|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+.... ...|...++.+.++|.+||.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~ 236 (257)
T cd05060 158 GRWPLKWYAPECINYGKFS-SKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYSIMLSCWK 236 (257)
T ss_pred ccccccccCHHHhcCCCCC-ccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHhc
Confidence 1234679999999877764 89999999999999998 999999888777777766554 35667788999999999999
Q ss_pred CCCCCCCCHHHHhc
Q 014849 255 TDPATRITVDEILR 268 (417)
Q Consensus 255 ~dP~~R~t~~eil~ 268 (417)
+||++|||+.++++
T Consensus 237 ~~p~~Rp~~~~l~~ 250 (257)
T cd05060 237 YRPEDRPTFSELES 250 (257)
T ss_pred CChhhCcCHHHHHH
Confidence 99999999999975
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=323.34 Aligned_cols=251 Identities=25% Similarity=0.367 Sum_probs=210.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.+.|+..+.||+|+||.||+|.+..+++ .+|+|.+.... .......+.+|+.+++.++||||+++++++.+....
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 3578999999999999999999876665 79999886542 222356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++++|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~ 161 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDP 161 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceeccccc
Confidence 999999999999999864 579999999999999999999999999999999999999999999999999987543221
Q ss_pred CCCcc-cccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 170 PDGML-HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~-~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..... .....++.|+|||++....++ .++|||||||++|+|++ |..||...+.......+..+. .+.+...++++.
T Consensus 162 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 240 (268)
T cd05063 162 EGTYTTSGGKIPIRWTAPEAIAYRKFT-SASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY 240 (268)
T ss_pred ccceeccCCCcCceecCHHHhhcCCcC-hHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 11111 112234579999999877764 89999999999999987 999998887777777776542 233445688999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.+||+.+|++||++.++++
T Consensus 241 ~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 241 QLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HHHHHHcCCCcccCcCHHHHHH
Confidence 9999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-42 Score=347.48 Aligned_cols=252 Identities=23% Similarity=0.351 Sum_probs=207.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
.++|.+++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.+|.++. ||||+++++++.+.
T Consensus 36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 457889999999999999999964 355689999997543 2223457889999999997 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC----------------------------------------------------------
Q 014849 89 AKIYFVMEFAKGGELFAKISKG---------------------------------------------------------- 110 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~---------------------------------------------------------- 110 (417)
+.+|+||||+.+|+|.+++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 9999999999999999988531
Q ss_pred -----------------------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 014849 111 -----------------------------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD 149 (417)
Q Consensus 111 -----------------------------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~ 149 (417)
.++...++.++.||+.||.|||++||+||||||+|||++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~ 273 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLIC 273 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEe
Confidence 256667888999999999999999999999999999999
Q ss_pred CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH-
Q 014849 150 ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY- 227 (417)
Q Consensus 150 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~- 227 (417)
.++.+||+|||++.............+.++++.|+|||.+.+..+. .++|||||||++|+|++ |..||......+..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~ 352 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYT-TLSDVWSFGILLWEIFTLGGTPYPELPMNEQFY 352 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCC-cHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHH
Confidence 9999999999998754322111122344678899999999877764 89999999999999998 89999875544443
Q ss_pred HHHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 228 RKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 228 ~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+..+ ....|...+.++.+|+.+||..+|.+||++.+|++.
T Consensus 353 ~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~ 395 (401)
T cd05107 353 NAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL 395 (401)
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 333333 234566789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=322.16 Aligned_cols=246 Identities=26% Similarity=0.397 Sum_probs=206.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+ ..+|+|.+..... ..+.+.+|+.+++.++|||++++++++. ....|+|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v 78 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIV 78 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEE
Confidence 46899999999999999999998555 4699998865432 2456788999999999999999999875 4568999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||++....... .
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~-~ 157 (260)
T cd05069 79 TEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE-Y 157 (260)
T ss_pred EEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc-c
Confidence 999999999999864 348899999999999999999999999999999999999999999999999987543221 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
.......++..|+|||.+.+..++ .++||||+||++|+|++ |.+||.+.+..+....+... ....|...+..+.+++
T Consensus 158 ~~~~~~~~~~~y~~Pe~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 236 (260)
T cd05069 158 TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGCPESLHELM 236 (260)
T ss_pred cccCCCccchhhCCHHHhccCCcC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHH
Confidence 111223456789999998776664 89999999999999999 99999988877777776654 2345666789999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
++||.+||++|||++++++
T Consensus 237 ~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 237 KLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred HHHccCCcccCcCHHHHHH
Confidence 9999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=321.98 Aligned_cols=241 Identities=27% Similarity=0.432 Sum_probs=206.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE-EeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL-ATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~~~~l 93 (417)
..+|++.+.||+|+||.||+|.. .|+.||+|.+.... ....+.+|+.++++++|||++++++++ .+.+..|+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~l 77 (256)
T cd05082 5 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 77 (256)
T ss_pred HHhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCc-----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEE
Confidence 35799999999999999999976 48899999986432 245688999999999999999999875 55678999
Q ss_pred EEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~--- 154 (256)
T cd05082 78 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS--- 154 (256)
T ss_pred EEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccc---
Confidence 99999999999998752 488999999999999999999999999999999999999999999999999864322
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
......++..|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+..+. ...+...++.+.++
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 231 (256)
T cd05082 155 --TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVYDV 231 (256)
T ss_pred --cCCCCccceeecCHHHHccCCCC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHH
Confidence 11234456789999999877765 88999999999999997 999999888877777776543 34456678999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||+.+|++|||+.++++
T Consensus 232 i~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 232 MKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred HHHHhcCChhhCcCHHHHHH
Confidence 99999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=335.23 Aligned_cols=254 Identities=22% Similarity=0.339 Sum_probs=201.7
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+++.+|.| +.||.+++..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+....|++|||+
T Consensus 5 ~i~~~~~~~--~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~ 81 (314)
T cd08216 5 LIGKCFEDL--MIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLM 81 (314)
T ss_pred hhhHhhcCC--ceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEecc
Confidence 344444444 5566666667999999999986532 2334678999999999999999999999999999999999999
Q ss_pred CCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC-----C
Q 014849 99 KGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR-----P 170 (417)
Q Consensus 99 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~-----~ 170 (417)
++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||.+....... .
T Consensus 82 ~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 82 AYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 99999999874 468999999999999999999999999999999999999999999999999876432111 1
Q ss_pred CCcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------------- 235 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------- 235 (417)
........++..|+|||++... +| +.++|+||+||++|+|++|..||.+............+..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~-~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGY-NEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhc
Confidence 1122344578889999998763 45 4889999999999999999999987654443322111110
Q ss_pred ---------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 ---------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+..+++++.+|+.+||+.||++|||++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 00112246788999999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=333.18 Aligned_cols=256 Identities=26% Similarity=0.408 Sum_probs=214.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
....+|...+.||+|+||.||+|++..+++.+|+|.+............++.+|+.+++.++|||++++++++......|
T Consensus 12 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 91 (308)
T cd06634 12 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAW 91 (308)
T ss_pred CcHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeE
Confidence 34456888999999999999999999999999999987643333334567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|+||+.| +|.+.+. ...+++..+..++.|++.||.|||++|++||||+|+||+++.++.+||+|||++.....
T Consensus 92 lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--- 167 (308)
T cd06634 92 LVMEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--- 167 (308)
T ss_pred EEEEccCC-CHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC---
Confidence 99999974 7777664 35689999999999999999999999999999999999999999999999999865432
Q ss_pred CCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~ 246 (417)
.....|++.|+|||++.+ .+..+.++|||||||++|+|++|..||...+.......+..+..+. +...+..+.
T Consensus 168 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (308)
T cd06634 168 ---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 244 (308)
T ss_pred ---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCcCcccccHHHH
Confidence 234568999999999752 2223578999999999999999999998776555544444443322 335678899
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+||++||+.+|.+|||+++++.|||+...
T Consensus 245 ~li~~cl~~~P~~Rp~~~~ll~~~~~~~~ 273 (308)
T cd06634 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (308)
T ss_pred HHHHHHhhCCcccCCCHHHHhhCcccccc
Confidence 99999999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=320.80 Aligned_cols=242 Identities=28% Similarity=0.469 Sum_probs=210.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|++.+.||+|+||.||+|.. .|+.||+|.+..... ...++.+|+.+++.++||||+++++++.+....|+|
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v 78 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIV 78 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEE
Confidence 45799999999999999999987 489999999976532 356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+++++|.+++.. . .+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 79 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~--- 155 (256)
T cd05039 79 TEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG--- 155 (256)
T ss_pred EEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccc---
Confidence 999999999999875 2 6999999999999999999999999999999999999999999999999998754221
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
.....++..|+|||.+....+ +.++|||||||++|+|++ |..||...+...+...+..+ ....|...++.+.++|
T Consensus 156 --~~~~~~~~~~~ape~~~~~~~-~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 232 (256)
T cd05039 156 --QDSGKLPVKWTAPEALREKKF-STKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRMEAPEGCPPEVYKVM 232 (256)
T ss_pred --cccCCCcccccCchhhcCCcC-CcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCCccCCCHHHHHHH
Confidence 112334667999999877666 489999999999999997 99999988877776666544 3345666789999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||..+|++|||+.++++
T Consensus 233 ~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 233 KDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred HHHhccChhhCcCHHHHHH
Confidence 9999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-44 Score=331.76 Aligned_cols=265 Identities=28% Similarity=0.477 Sum_probs=214.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
+.-...|++...||+|+||+||+|....++. .+|||.+..++- ..+......||+.+++.++||||+.|..++.+
T Consensus 20 ve~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~ 98 (438)
T KOG0666|consen 20 VEDLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLS 98 (438)
T ss_pred HHHHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhc
Confidence 3456789999999999999999997665544 689999977643 33445667799999999999999999999877
Q ss_pred -CCEEEEEEeccCCCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC----CCeEE
Q 014849 88 -KAKIYFVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN----WDLKI 156 (417)
Q Consensus 88 -~~~~~lV~E~~~gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~----~~vkl 156 (417)
...+|+++||++. +|...|.- ..++...++.++.||++|+.|||++-|+||||||.|||+..+ |.|||
T Consensus 99 ~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKI 177 (438)
T KOG0666|consen 99 HDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKI 177 (438)
T ss_pred cCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEe
Confidence 8899999999987 89888752 468999999999999999999999999999999999999887 89999
Q ss_pred eeeecceeeccc-CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------HH
Q 014849 157 SDFGLSAVKEQI-RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------AM 226 (417)
Q Consensus 157 ~DFGls~~~~~~-~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------~~ 226 (417)
+|||+++++... .+-......+-|.+|+|||.+.+...++.+.|+|+.|||+.||++-.+.|.+.... +.
T Consensus 178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ 257 (438)
T KOG0666|consen 178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ 257 (438)
T ss_pred ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence 999999976532 22224456678999999999999887789999999999999999998888542111 11
Q ss_pred HHHHhc--C-----CC----CCCCC--------------------------CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 227 YRKIYK--G-----EY----RCPKW--------------------------TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 227 ~~~i~~--~-----~~----~~p~~--------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+|.. | .+ ..|.+ .++.+.+|+.+||+.||.+|+|+++.|+|
T Consensus 258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 122211 0 00 01111 25668999999999999999999999999
Q ss_pred ccccccccc
Q 014849 270 PWFKKDYKE 278 (417)
Q Consensus 270 ~~f~~~~~~ 278 (417)
+||.++..+
T Consensus 338 ~yF~~d~lp 346 (438)
T KOG0666|consen 338 PYFTEDPLP 346 (438)
T ss_pred cccccCCCC
Confidence 999987544
|
|
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=322.52 Aligned_cols=243 Identities=24% Similarity=0.346 Sum_probs=202.8
Q ss_pred EEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCC
Q 014849 23 IIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKG 100 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~g 100 (417)
.||+|+||.||+|.+. .++..||+|++.... .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence 3899999999999875 455679999986543 23345678899999999999999999998764 568999999999
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-ccccc
Q 014849 101 GELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG-MLHTL 177 (417)
Q Consensus 101 g~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~-~~~~~ 177 (417)
++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......... .....
T Consensus 79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 158 (257)
T cd05115 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAG 158 (257)
T ss_pred CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCC
Confidence 999998863 579999999999999999999999999999999999999999999999999987543211111 11112
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 255 (417)
.+++.|+|||++....++ .++|||||||++|+|++ |..||.+....+....+..+. ..+|...++++.++|.+||..
T Consensus 159 ~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c~~~ 237 (257)
T cd05115 159 KWPLKWYAPECINFRKFS-SRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYALMKDCWIY 237 (257)
T ss_pred CCCcccCCHHHHccCCCC-chhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCC
Confidence 335789999998877764 89999999999999996 999999888777777776644 456777899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 014849 256 DPATRITVDEILRD 269 (417)
Q Consensus 256 dP~~R~t~~eil~h 269 (417)
||++||++.+|++.
T Consensus 238 ~~~~Rp~~~~i~~~ 251 (257)
T cd05115 238 KWEDRPNFAKVEER 251 (257)
T ss_pred ChhhCcCHHHHHHH
Confidence 99999999999653
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-42 Score=327.18 Aligned_cols=249 Identities=34% Similarity=0.493 Sum_probs=207.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEe
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E 96 (417)
|++.+.||+|+||.||+|.+..+++.||||.+...... .......+|+..++.++ ||||+++++++.++...|+|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 78999999999999999999999999999998654321 11234457999999999 9999999999999999999999
Q ss_pred ccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 97 FAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 97 ~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|+ +|+|.+.+.. ..+++..+..++.|++.+|.|||++|++|+||+|.||+++.++.++|+|||++...... ..
T Consensus 79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~---~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSR---PP 154 (283)
T ss_pred cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCC---CC
Confidence 99 7789888865 26899999999999999999999999999999999999999999999999998754321 22
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------C
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-------------------E 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------------~ 234 (417)
.....|+..|+|||++......+.++|+||+|+++++|++|++||...+..+.+.++... .
T Consensus 155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (283)
T cd07830 155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG 234 (283)
T ss_pred cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence 334568999999999865443458999999999999999999999887665554443210 0
Q ss_pred CC-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 235 YR-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 235 ~~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.. .....++++.++|++||+.||++|||+.|++.||||
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~ 283 (283)
T cd07830 235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF 283 (283)
T ss_pred ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence 00 011236789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=319.09 Aligned_cols=247 Identities=25% Similarity=0.405 Sum_probs=211.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.+|++.+.||+|+||.||+|.+. .++.+|+|.+..... ....+.+|+.+++.++||||+++++++......|+|+
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAM----SEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCC----CHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 47999999999999999999884 577899998865432 2456889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.+++|.+++.. +.+++..+..++.|++.|+.|||++|++||||||+||+++.++.+||+|||++........ ..
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~~ 157 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY-TS 157 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc-cc
Confidence 99999999998864 5689999999999999999999999999999999999999999999999999875432111 11
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 251 (417)
.....++..|+|||.+.+..+. .++|||||||++|+|++ |+.||.......+...+..+. ...|...+..+.+|+.+
T Consensus 158 ~~~~~~~~~~~aPe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 236 (256)
T cd05112 158 STGTKFPVKWSSPEVFSFSKYS-SKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSVYELMQH 236 (256)
T ss_pred cCCCccchhhcCHhHhccCCcC-hHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCCCCCCHHHHHHHHH
Confidence 1223356789999999877765 89999999999999998 999999888888887776653 33456678999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||+.+|++|||+.++++.
T Consensus 237 ~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 237 CWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred HcccChhhCCCHHHHHHh
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=319.45 Aligned_cols=247 Identities=30% Similarity=0.428 Sum_probs=211.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTG----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+++.+.||+|+||.||.|.+..++ ..||+|++..... ......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDAD--EQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCC--hHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 357899999999999999998776 8999999965532 1146788899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-C-C-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK-G-R-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~-~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||+++++|.+.+.. . . +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........
T Consensus 79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 158 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY 158 (258)
T ss_pred EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceecccccc
Confidence 9999999999999875 2 2 99999999999999999999999999999999999999999999999999876543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~l 248 (417)
... ....+++.|+|||.+....+ +.++|||||||++|+|++ |.+||...+.......+..+.. ..+...+.++.++
T Consensus 159 ~~~-~~~~~~~~y~~Pe~~~~~~~-~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (258)
T smart00219 159 YKK-KGGKLPIRWMAPESLKDGKF-TSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPKPENCPPEIYKL 236 (258)
T ss_pred ccc-ccCCCcccccChHHhccCCC-CcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHH
Confidence 111 11236789999999866666 489999999999999998 8999998888888777766543 4566678999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
+.+||..||++|||+.++++
T Consensus 237 i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 237 MLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred HHHHCcCChhhCcCHHHHHh
Confidence 99999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=325.18 Aligned_cols=242 Identities=26% Similarity=0.411 Sum_probs=202.3
Q ss_pred eEEeeeCceEEEEEEEccCCc--EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
++||+|+||.||+|++..+|. .+|+|.+.... .......+.+|+.+++++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC--CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 468999999999999988876 46888876432 223356788999999999 7999999999999999999999999
Q ss_pred CCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 99 KGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 99 ~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
++|+|.+++... .+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999998642 378899999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 239 (417)
+...... ......+.++.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+.+..+..+. ...+.
T Consensus 159 ~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 234 (270)
T cd05047 159 SRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL 234 (270)
T ss_pred ccccchh---hhccCCCCccccCChHHHccCCCC-chhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCCC
Confidence 8532211 111122346679999999877764 89999999999999997 999999888777777765542 34455
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.++.+++.+||..||.+|||+.+++..
T Consensus 235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (270)
T cd05047 235 NCDDEVYDLMRQCWREKPYERPSFAQILVS 264 (270)
T ss_pred cCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=320.06 Aligned_cols=244 Identities=30% Similarity=0.407 Sum_probs=206.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+.||+|+||.||.|.+.. ++.||+|.+...... .....+.+|+.+++.++||||+++++++.+....|+||||+.|+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~ 77 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGG 77 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCC
Confidence 479999999999999977 999999998765432 34567889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++................+
T Consensus 78 ~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~ 157 (251)
T cd05041 78 SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQI 157 (251)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcc
Confidence 99999864 5689999999999999999999999999999999999999999999999999865432111111122334
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHHHhccCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
+..|+|||.+.+..+ +.++|||||||++|+|++ |..||...+.......+... ....|...+..+.+++.+||..+|
T Consensus 158 ~~~y~~PE~~~~~~~-~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 236 (251)
T cd05041 158 PIKWTAPEALNYGRY-TSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQLCPEEIYRLMLQCWAYDP 236 (251)
T ss_pred eeccCChHhhccCCC-CcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHhccCh
Confidence 667999999887666 489999999999999998 89999888777666666544 344566778999999999999999
Q ss_pred CCCCCHHHHhcC
Q 014849 258 ATRITVDEILRD 269 (417)
Q Consensus 258 ~~R~t~~eil~h 269 (417)
++|||+.|+++.
T Consensus 237 ~~Rp~~~ell~~ 248 (251)
T cd05041 237 ENRPSFSEIYNE 248 (251)
T ss_pred hhCcCHHHHHHH
Confidence 999999999863
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-41 Score=325.32 Aligned_cols=251 Identities=21% Similarity=0.320 Sum_probs=209.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~ 89 (417)
..+|++.+.||+|+||.||+|.+.. ++..||+|.+.... .......+.+|+.+|+.++||||+++++++.. +.
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~ 82 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHA--SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGE 82 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence 4689999999999999999999876 36889999886432 23345678899999999999999999998655 57
Q ss_pred EEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 90 KIYFVMEFAKGGELFAKISK---------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
..++++||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||
T Consensus 83 ~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g 162 (280)
T cd05043 83 PPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNA 162 (280)
T ss_pred CCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCC
Confidence 88999999999999998864 348899999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCP 238 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p 238 (417)
+++...............++..|+|||++.+..++ .++|||||||++|++++ |.+||...+..+....+..+. +..+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 241 (280)
T cd05043 163 LSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYS-SASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP 241 (280)
T ss_pred CcccccCCceEEeCCCCCcchhccCHHHHhcCCCC-chhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC
Confidence 98643221111111223456789999999877775 89999999999999998 999999888777776665542 2344
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
...++++.+++.+||..||++|||+.++++
T Consensus 242 ~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 242 INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 556889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=326.86 Aligned_cols=238 Identities=24% Similarity=0.355 Sum_probs=198.8
Q ss_pred eEEeeeCceEEEEEEEccCCcE-------EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQS-------VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~-------vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+.||+|+||.||+|.+..++.. +|+|.+.... ....+.+.+|+.+|+.++||||+++++++......++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 4689999999999998766544 8888886543 23356778899999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--------eEEeeeeccee
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--------LKISDFGLSAV 164 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--------vkl~DFGls~~ 164 (417)
|||+++|+|..++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++. ++++|||++..
T Consensus 78 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~ 157 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISIT 157 (258)
T ss_pred EecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccc
Confidence 999999999999975 35899999999999999999999999999999999999987765 69999998754
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCCCCCCCCCCh
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
.. ......+++.|+|||++.+....+.++|||||||++|+|++| .+||...+..... .........|...+.
T Consensus 158 ~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~ 230 (258)
T cd05078 158 VL------PKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKL-QFYEDRHQLPAPKWT 230 (258)
T ss_pred cC------CchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHH-HHHHccccCCCCCcH
Confidence 32 123456889999999998754445899999999999999998 5777665544433 334445566766788
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
++.+|+.+||+.||++|||+++|++.
T Consensus 231 ~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 231 ELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHHHHHHHHhccChhhCCCHHHHHHh
Confidence 99999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=351.75 Aligned_cols=258 Identities=28% Similarity=0.565 Sum_probs=225.8
Q ss_pred cccccCCe-EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 11 EVNLFGKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 11 ~~~~~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
++.-.||| +...+||+|+|-+||+|.|..+|-.||.-.+....+.+ ....+++..|+.+|+.|+|||||++|..+.+.
T Consensus 34 e~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~ 113 (632)
T KOG0584|consen 34 EKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT 113 (632)
T ss_pred ccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence 35556777 56788999999999999999999999987776555433 34468899999999999999999999999776
Q ss_pred CE--EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEecCC-CCeEEeeeecc
Q 014849 89 AK--IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR--GVFHRDLKLENLLLDEN-WDLKISDFGLS 162 (417)
Q Consensus 89 ~~--~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~--givHrDlkp~NILl~~~-~~vkl~DFGls 162 (417)
.+ +.+|+|++..|+|+.++.+ ++++...++.|++||+.||.|||++ .|+|||||-+||+|+.+ |.|||+|.|||
T Consensus 114 ~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLA 193 (632)
T KOG0584|consen 114 DNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLA 193 (632)
T ss_pred CCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHH
Confidence 65 9999999999999999987 8999999999999999999999998 49999999999999765 89999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCC--CCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYR--CPK 239 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~--~p~ 239 (417)
++..... ....+|||.|||||.+. ..|+ ..+||||||+.+.||.|+..||.. .+..++|+++..|..+ +.+
T Consensus 194 tl~r~s~----aksvIGTPEFMAPEmYE-E~Yn-E~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl~k 267 (632)
T KOG0584|consen 194 TLLRKSH----AKSVIGTPEFMAPEMYE-ENYN-ELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAALSK 267 (632)
T ss_pred HHhhccc----cceeccCccccChHHHh-hhcc-hhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHhhc
Confidence 9865422 23478999999999987 6787 999999999999999999999975 6788999999988654 233
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
--.|++++||.+||.. .+.|+|+.|+|.||||..+
T Consensus 268 V~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d 302 (632)
T KOG0584|consen 268 VKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED 302 (632)
T ss_pred cCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence 4489999999999999 9999999999999999875
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=323.75 Aligned_cols=250 Identities=22% Similarity=0.354 Sum_probs=212.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.+|++.+.||+|+||+||+|+... +.+.||+|.+.... .......+.+|+.+++.++||||+++++++.+...
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 82 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP 82 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence 679999999999999999999754 35679999886543 22245678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-C---------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 91 IYFVMEFAKGGELFAKISK-G---------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~---------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.|+||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++.++++|||
T Consensus 83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~ 162 (275)
T cd05046 83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLS 162 (275)
T ss_pred ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccc
Confidence 9999999999999999875 3 58999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC--CC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY--RC 237 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~ 237 (417)
++...... .........+++.|+|||.+.+..+. .++|||||||++|+|++ |..||.+.........+..+.. ..
T Consensus 163 ~~~~~~~~-~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~ 240 (275)
T cd05046 163 LSKDVYNS-EYYKLRNALIPLRWLAPEAVQEDDFS-TKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV 240 (275)
T ss_pred cccccCcc-cccccCCceeEEeecChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC
Confidence 97643211 11122344567889999998776664 88999999999999998 8999988777777777765543 34
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+...+..+.+++.+||+.||++|||+.+++..
T Consensus 241 ~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 241 PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 55678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=317.02 Aligned_cols=243 Identities=28% Similarity=0.450 Sum_probs=204.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
++||+|+||.||+|.. .+++.+|+|.+.... .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus 1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 77 (250)
T cd05085 1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGG 77 (250)
T ss_pred CccCCCCCceEEEEEe-cCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCC
Confidence 4789999999999986 478899999987543 2223456889999999999999999999999999999999999999
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G 179 (417)
+|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ........+
T Consensus 78 ~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~ 156 (250)
T cd05085 78 DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGI-YSSSGLKQI 156 (250)
T ss_pred cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccc-cccCCCCCC
Confidence 99998864 468999999999999999999999999999999999999999999999999986432211 111112244
Q ss_pred CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCC
Q 014849 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 180 t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP 257 (417)
++.|+|||++....+ +.++||||+||++|++++ |..||.+.+.......+..+. ...|...+..+.+++.+||..+|
T Consensus 157 ~~~y~aPE~~~~~~~-~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p 235 (250)
T cd05085 157 PIKWTAPEALNYGRY-SSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKP 235 (250)
T ss_pred cccccCHHHhccCCC-CchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccCc
Confidence 677999999877666 489999999999999998 999999887777666665543 34566788999999999999999
Q ss_pred CCCCCHHHHhcC
Q 014849 258 ATRITVDEILRD 269 (417)
Q Consensus 258 ~~R~t~~eil~h 269 (417)
++|||+.++++.
T Consensus 236 ~~Rp~~~~l~~~ 247 (250)
T cd05085 236 ENRPKFSELQKE 247 (250)
T ss_pred ccCCCHHHHHHH
Confidence 999999999753
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=319.72 Aligned_cols=243 Identities=29% Similarity=0.427 Sum_probs=205.8
Q ss_pred eEEeeeCceEEEEEEEcc-CCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 22 KIIGCGAFAKVYHGRNVR-TGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
+.||+|++|.||+|.+.. .++ .||+|.+...... .....+.+|+.++++++||||+++++++.+ ...++|+||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999999865 333 6999999876543 456788999999999999999999999988 8999999999
Q ss_pred CCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC-Ccc
Q 014849 99 KGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GML 174 (417)
Q Consensus 99 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~-~~~ 174 (417)
++++|.+.+.. +.+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......... ...
T Consensus 78 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 157 (257)
T cd05040 78 PLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVME 157 (257)
T ss_pred CCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceecc
Confidence 99999999876 35899999999999999999999999999999999999999999999999998765331111 111
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~ 251 (417)
....++..|+|||.+....++ .++|||||||++|+|++ |..||...+..+....+... ....|...+..+.+++.+
T Consensus 158 ~~~~~~~~y~~pE~~~~~~~~-~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 236 (257)
T cd05040 158 EHLKVPFAWCAPESLRTRTFS-HASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEACPQDIYNVMLQ 236 (257)
T ss_pred cCCCCCceecCHHHhcccCcC-chhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCCCCccCCHHHHHHHHH
Confidence 234577889999999887775 88999999999999998 99999888877777666542 233455668899999999
Q ss_pred hccCCCCCCCCHHHHhc
Q 014849 252 LLDTDPATRITVDEILR 268 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~ 268 (417)
||+.+|++|||+.++++
T Consensus 237 ~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 237 CWAHNPADRPTFAALRE 253 (257)
T ss_pred HCCCCcccCCCHHHHHH
Confidence 99999999999999975
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=327.57 Aligned_cols=258 Identities=26% Similarity=0.426 Sum_probs=209.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.-.+.|++.+.||+|+||.||+|.+..+++.||+|.+.+... ......+.+|+.++..+. ||||+++++++.+....
T Consensus 12 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~ 89 (296)
T cd06618 12 ADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDV 89 (296)
T ss_pred CCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeE
Confidence 345789999999999999999999998999999999976432 122445667777776665 99999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
|+||||+.+ .|.+.+.. +.+++..+..++.|++.||.|||+ .||+||||+|+||+++.++.+||+|||++......
T Consensus 90 ~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~ 168 (296)
T cd06618 90 FICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDS 168 (296)
T ss_pred EEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence 999999854 67776654 679999999999999999999997 59999999999999999999999999998654321
Q ss_pred CCCCcccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCC-CCC--CCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEY-RCP--KWT 241 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~-~~p--~~~ 241 (417)
.......|++.|+|||.+.+.. ..+.++|||||||++|+|++|+.||..... .+.+..+..... ..+ ...
T Consensus 169 ---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (296)
T cd06618 169 ---KAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGF 245 (296)
T ss_pred ---CcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCCCCCCC
Confidence 1123345788999999987543 224889999999999999999999976432 344445444432 222 235
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.++.+|+.+||..||++|||+++++.||||+...
T Consensus 246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 280 (296)
T cd06618 246 SPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYE 280 (296)
T ss_pred CHHHHHHHHHHccCChhhCCCHHHHhcChhhhccc
Confidence 78999999999999999999999999999998644
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=322.29 Aligned_cols=238 Identities=22% Similarity=0.335 Sum_probs=195.1
Q ss_pred eEEeeeCceEEEEEEEcc------------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 22 KIIGCGAFAKVYHGRNVR------------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~------------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+.||+|+||.||+|.... ....||+|++.... ......+.+|+.+++.++||||+++++++.++.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSH---RDISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhh---hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998532 23358999876542 233556788999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-------eEEeeee
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD-------LKISDFG 160 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~-------vkl~DFG 160 (417)
..++||||+++|+|..++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++. +|++|||
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g 157 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPG 157 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCC
Confidence 99999999999999888864 56999999999999999999999999999999999999987664 8999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKGEYRCPK 239 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 239 (417)
++..... .....|+..|+|||++......+.++||||+||++|+|+ .|..||......+.. +..........
T Consensus 158 ~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~~~~~~~ 230 (262)
T cd05077 158 IPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEGQCMLVT 230 (262)
T ss_pred CCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhcCccCCC
Confidence 8854321 123467889999999875444458999999999999997 699999876654432 33334444444
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++++.+||.+||+.||.+||++.+|+++
T Consensus 231 ~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 231 PSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred CChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 456889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=320.74 Aligned_cols=228 Identities=25% Similarity=0.415 Sum_probs=193.6
Q ss_pred eCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHH
Q 014849 27 GAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAK 106 (417)
Q Consensus 27 G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~ 106 (417)
|.||+||+|++..+|+.||+|.+.+... ..+|...+....||||+++++++.+....|+||||++||+|.+.
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 8999999999999999999999976531 22444555566799999999999999999999999999999998
Q ss_pred Hhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccc
Q 014849 107 ISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185 (417)
Q Consensus 107 i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~A 185 (417)
+.+ +.+++..+..++.|+++||.|||++||+||||||+||+++.++.++++|||.+..... ......+++.|+|
T Consensus 76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~-----~~~~~~~~~~y~a 150 (237)
T cd05576 76 ISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVED-----SCDGEAVENMYCA 150 (237)
T ss_pred HHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccc-----ccccCCcCccccC
Confidence 865 6799999999999999999999999999999999999999999999999998754332 1233456788999
Q ss_pred cccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCH--
Q 014849 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITV-- 263 (417)
Q Consensus 186 PEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~-- 263 (417)
||.+....++ .++|+||+||++|+|++|+.||........ .......|.+.++.++++|.+||+.||++|||+
T Consensus 151 PE~~~~~~~~-~~~DvwslG~il~el~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~ 225 (237)
T cd05576 151 PEVGGISEET-EACDWWSLGAILFELLTGKTLVECHPSGIN----THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGV 225 (237)
T ss_pred CcccCCCCCC-chhhHHHHHHHHHHHHHCcchhhcCchhcc----cccccCCcccCCHHHHHHHHHHccCCHHHhcCCCc
Confidence 9998777764 899999999999999999998865432110 112345788899999999999999999999985
Q ss_pred ---HHHhcCccc
Q 014849 264 ---DEILRDPWF 272 (417)
Q Consensus 264 ---~eil~h~~f 272 (417)
++++.||||
T Consensus 226 ~~~~~~~~h~~~ 237 (237)
T cd05576 226 AGVEDIKSHPFF 237 (237)
T ss_pred cchHHHHcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-41 Score=320.49 Aligned_cols=250 Identities=26% Similarity=0.375 Sum_probs=208.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+|.+.+.||+|+||.||+|.+..+ ...||||.+..... ....+.+.+|+.+++.++||||+++++++.+. ..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITEN-PV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcCC-Cc
Confidence 35699999999999999999987554 35699998865431 23356788999999999999999999988764 57
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~ 161 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccccc
Confidence 899999999999999975 358999999999999999999999999999999999999999999999999986543221
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
.. ......+++.|+|||.+....++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...++.+.+
T Consensus 162 ~~-~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (270)
T cd05056 162 YY-KASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 239 (270)
T ss_pred ce-ecCCCCccccccChhhhccCCCC-chhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHH
Confidence 11 11122345679999998877764 89999999999999885 999999888777766666554 4556778899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcC
Q 014849 248 FIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h 269 (417)
+|.+||.++|++|||+.+++..
T Consensus 240 li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 240 LMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=348.63 Aligned_cols=250 Identities=24% Similarity=0.405 Sum_probs=216.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
+..+...++..||+|.||+||+|++.. .||||+++.+.... +..+.+++|+.+++.-+|.||+-+.+++..+.. .
T Consensus 389 Ip~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 389 IPPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred cCHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 456677899999999999999999854 59999998876543 367889999999999999999999999988876 9
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+.+|.|.+|..++.- -+|.....+.|++|++.||.|||.++|||||||..||+|++++.|||+||||+........
T Consensus 464 IiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g 543 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSG 543 (678)
T ss_pred eeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeecc
Confidence 99999999999998864 5799999999999999999999999999999999999999999999999999987766556
Q ss_pred CCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----CCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-----CPKWTS 242 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~s 242 (417)
...+...-|...|||||++.. .+| +..+||||+||++|||++|.+||...+...++-.+.+|... .-...+
T Consensus 544 ~~q~~qp~gsilwmAPEvIRmqd~nPf-S~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~p 622 (678)
T KOG0193|consen 544 EQQLEQPHGSLLWMAPEVIRMQDDNPF-SFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCP 622 (678)
T ss_pred ccccCCCccchhhhcHHHHhhcccCCC-CcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCH
Confidence 666777789999999999863 345 59999999999999999999999977776666555565322 112345
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++++|+..||..+|++||++.+||.
T Consensus 623 k~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 623 KAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHHHHHHHhcCcccCccHHHHHH
Confidence 68999999999999999999999987
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=324.10 Aligned_cols=237 Identities=24% Similarity=0.337 Sum_probs=194.4
Q ss_pred EEeeeCceEEEEEEEccC------------------------CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc
Q 014849 23 IIGCGAFAKVYHGRNVRT------------------------GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~------------------------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI 78 (417)
.||+|+||.||+|....+ ...||+|++.... ......+.+|+.+++.++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHhcCCCCCe
Confidence 699999999999975322 2358999886543 2234567789999999999999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---- 152 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---- 152 (417)
+++++++.+....|+||||+++|+|..++.. +++++..+..++.||+.||.|||++||+||||||+|||++..+
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~ 158 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEG 158 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccC
Confidence 9999999999999999999999999988864 6799999999999999999999999999999999999997654
Q ss_pred ---CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHH-HcCCCCCCCCCHHHHHH
Q 014849 153 ---DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVL-NAGYLPFNDPNLMAMYR 228 (417)
Q Consensus 153 ---~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~l-l~G~~Pf~~~~~~~~~~ 228 (417)
.+|++|||++..... .....+++.|+|||.+.+....+.++|||||||++|+| ++|..||......+...
T Consensus 159 ~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~ 232 (274)
T cd05076 159 TSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKER 232 (274)
T ss_pred ccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHH
Confidence 389999998753221 12345788899999987644446999999999999998 57999998776554433
Q ss_pred HHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
........|...++++.++|.+||+.+|++|||+.+++++
T Consensus 233 -~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 233 -FYEKKHRLPEPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred -HHHhccCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 2333445555567889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=317.03 Aligned_cols=248 Identities=23% Similarity=0.347 Sum_probs=207.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|.+. .+..+|+|.+.... ...+.+.+|+.+++.++||||+++++++.+ ...|
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEec-CCccEEEEecCCCh----hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 35689999999999999999999864 56679999886532 124678899999999999999999999887 7789
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++|||+++++|.+++.+ ..++...+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 99999999999999865 357888999999999999999999999999999999999999999999999986543211
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
. .......++..|+|||++....+ +.++|+|||||++|++++ |.+||...+.......+..+. .+.+...+.++.+
T Consensus 157 ~-~~~~~~~~~~~y~~PE~~~~~~~-~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (260)
T cd05073 157 Y-TAREGAKFPIKWTAPEAINFGSF-TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYN 234 (260)
T ss_pred c-ccccCCcccccccCHhHhccCCc-CccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCcccCCHHHHH
Confidence 1 11122335677999999987666 489999999999999998 999999887777776665542 2345667889999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 014849 248 FIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~ 268 (417)
++.+||++||++||++.++++
T Consensus 235 ~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 235 IMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred HHHHHcccCcccCcCHHHHHH
Confidence 999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=327.11 Aligned_cols=251 Identities=25% Similarity=0.357 Sum_probs=207.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.++|++.+.||+|+||.||+|.+..+|. .||+|.+..... ......+.+|+.+++.++||||+++++++... .
T Consensus 6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~ 82 (303)
T cd05110 6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTG--PKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T 82 (303)
T ss_pred hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence 4578999999999999999999988886 468888765432 22344678999999999999999999998765 4
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++++||+++|+|.+.+.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~ 162 (303)
T cd05110 83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGD 162 (303)
T ss_pred ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCc
Confidence 6799999999999999875 36899999999999999999999999999999999999999999999999999754432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
..........++..|+|||.+.+..++ .++|||||||++|+|++ |..||.+.........+..+. ++.+...+.++.
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~-~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (303)
T cd05110 163 EKEYNADGGKMPIKWMALECIHYRKFT-HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQPPICTIDVY 241 (303)
T ss_pred ccccccCCCccccccCCHHHhccCCCC-hHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCCCCCCCHHHH
Confidence 221122234567789999999877764 89999999999999997 999998876655555444433 344556788999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||..+|++||++.++++.
T Consensus 242 ~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 242 MVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred HHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=320.76 Aligned_cols=245 Identities=21% Similarity=0.279 Sum_probs=192.8
Q ss_pred eEEeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||.||+|.... ....+|+|.+.... .......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999996532 44578888775432 22234567889999999999999999999999999999999999
Q ss_pred CCChHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 100 GGELFAKISKG------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 100 gg~L~~~i~~~------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999998652 246788899999999999999999999999999999999999999999999864322111111
Q ss_pred ccccccCcccccccccccc------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc-CCCC-----CCCC
Q 014849 174 LHTLCGTPAYVAPEILAKK------GYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK-GEYR-----CPKW 240 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~------~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~-~~~~-----~p~~ 240 (417)
.....+++.|+|||++... ...+.++|||||||++|+|++ |.+||......+...++.. .... .+..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLK 238 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccccc
Confidence 2234467789999997532 223589999999999999998 8999988766655554433 2222 2334
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++.+..++..|+ .||++|||++++++-
T Consensus 239 ~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~ 266 (269)
T cd05042 239 YSDRWYEVMQFCW-LDPETRPTAEEVHEL 266 (269)
T ss_pred CCHHHHHHHHHHh-cCcccccCHHHHHHH
Confidence 6788899999998 599999999999753
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=321.32 Aligned_cols=244 Identities=25% Similarity=0.374 Sum_probs=203.9
Q ss_pred eEEeeeCceEEEEEEEccCC------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTG------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.||+|+||.||+|.+.... +.+|+|.+.+... ......+.+|+.+++.++||||+++++++.+....|+||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 46899999999999986544 7899998865421 223567889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CeEEeeeecc
Q 014849 96 EFAKGGELFAKISK--------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-----DLKISDFGLS 162 (417)
Q Consensus 96 E~~~gg~L~~~i~~--------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-----~vkl~DFGls 162 (417)
||++|++|.+++.. ..+++..+..++.|++.||.|||+++++|+||||+||+++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 99999999998853 2378899999999999999999999999999999999999887 8999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~ 240 (417)
................++..|+|||++.+..+ +.++|||||||++|+|++ |..||...+..+....+..+ .+..+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKF-TTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPEN 237 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCc-ccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCccc
Confidence 64432211112223345788999999987776 599999999999999998 99999988777776666543 3455667
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++.+.++|.+||.++|++|||+.++++
T Consensus 238 ~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 238 CPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred chHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 7899999999999999999999999975
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-41 Score=317.00 Aligned_cols=245 Identities=24% Similarity=0.353 Sum_probs=200.1
Q ss_pred eEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEEEEec
Q 014849 22 KIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA-TKAKIYFVMEF 97 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~lV~E~ 97 (417)
+.||+|+||.||+|.+.. .+..||+|.+.... .......+.+|+.+++.++||||+++++++. .+...|+||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT--DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC--CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 468999999999998754 34579999885432 2233567889999999999999999999764 45678999999
Q ss_pred cCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC--CCc
Q 014849 98 AKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--DGM 173 (417)
Q Consensus 98 ~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~--~~~ 173 (417)
+.+|+|.+++.. ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++........ ...
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 158 (262)
T cd05058 79 MKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHN 158 (262)
T ss_pred CCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecc
Confidence 999999999875 4567888899999999999999999999999999999999999999999999864322110 011
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~ 251 (417)
.....+++.|+|||.+.+..++ .++|||||||++|+|++ |.+||...+..+....+..+.. ..|...++.+.+++.+
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 237 (262)
T cd05058 159 HTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLYEVMLS 237 (262)
T ss_pred cccCcCCccccChhHhccCccc-hHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCcCCHHHHHHHHH
Confidence 1233457789999998877764 89999999999999999 5778888777777776665543 3455678899999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||.++|++||++.++++.
T Consensus 238 cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 238 CWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HcCCChhhCCCHHHHHHH
Confidence 999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-41 Score=319.89 Aligned_cols=244 Identities=22% Similarity=0.235 Sum_probs=193.7
Q ss_pred eEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||.||+|... .++..+|+|.+..... ......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS--VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999864 3567899998865532 2224578889999999999999999999999999999999999
Q ss_pred CCChHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 100 GGELFAKISK------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 100 gg~L~~~i~~------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|+|.+++.. ..+++..++.++.|++.||.|||++|++||||||+||+++.++++||+|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999998864 2456778889999999999999999999999999999999999999999999864322111112
Q ss_pred ccccccCccccccccccccC------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CC--CCC---CC
Q 014849 174 LHTLCGTPAYVAPEILAKKG------YDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EY--RCP---KW 240 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~------y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~--~~p---~~ 240 (417)
....+|++.|+|||++.+.. ..+.++||||+||++|+|++ |..||......+........ .. ..| ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLP 238 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCC
Confidence 23456788999999986432 12578999999999999996 99999877655544332222 22 112 23
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++.+.+++.+|+ .+|++|||++||..
T Consensus 239 ~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 239 LSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred CChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 5778899999999 68999999999974
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=344.04 Aligned_cols=249 Identities=30% Similarity=0.451 Sum_probs=214.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc---E-EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ---S-VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~-vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
++-.+.+.||+|+||.||+|..+..+. . ||+|....+..........+.+|+++|+.++|||||++||+...+..+
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 445667999999999999998765433 3 899998764444555677889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|||+|+||+|.+++.+. .++..+...++.+.+.||+|||+++++||||-..|+|++.++.+||+|||+|+.-..
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~-- 314 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ-- 314 (474)
T ss_pred EEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCcc--
Confidence 9999999999999999873 499999999999999999999999999999999999999999999999999875331
Q ss_pred CCCccccc-ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCChHH
Q 014849 170 PDGMLHTL-CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY--RCPKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~-~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 245 (417)
....... --+..|+|||.+....|+ .++||||+||++||+++ |..||.+.+..+...+|....+ +.|...+.++
T Consensus 315 -~~~~~~~~klPirWLAPEtl~~~~~s-~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~~~p~~~ 392 (474)
T KOG0194|consen 315 -YVMKKFLKKLPIRWLAPETLNTGIFS-FKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPSKTPKEL 392 (474)
T ss_pred -eeeccccccCcceecChhhhccCccc-cccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCCCCHHHH
Confidence 1111112 246779999999988775 99999999999999998 8999999999999999966554 4566678889
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 014849 246 KWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..++.+||..||++|||+.++.+
T Consensus 393 ~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 393 AKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred HHHHHHhccCChhhccCHHHHHH
Confidence 99999999999999999999964
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=366.29 Aligned_cols=256 Identities=32% Similarity=0.558 Sum_probs=213.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT---- 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~---- 87 (417)
.+....|+..++||+|+||.||+++++-+|+.||||.|.... .......+.+|+..|.+|+|||||++|..+..
T Consensus 475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~ 552 (1351)
T KOG1035|consen 475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAE 552 (1351)
T ss_pred hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCc
Confidence 356777899999999999999999999999999999998765 34456789999999999999999998743210
Q ss_pred --------------------------------------------------------------------------------
Q 014849 88 -------------------------------------------------------------------------------- 87 (417)
Q Consensus 88 -------------------------------------------------------------------------------- 87 (417)
T Consensus 553 ~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~ 632 (1351)
T KOG1035|consen 553 LTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSN 632 (1351)
T ss_pred cccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccc
Confidence
Q ss_pred ---------------------------C--------CEEEEEEeccCCCChHHHHhcCCCC--HHHHHHHHHHHHHHHHH
Q 014849 88 ---------------------------K--------AKIYFVMEFAKGGELFAKISKGRFS--EQLSRRYFQQLISAVEY 130 (417)
Q Consensus 88 ---------------------------~--------~~~~lV~E~~~gg~L~~~i~~~~l~--e~~~~~i~~ql~~aL~y 130 (417)
+ ..+||-||||+...|.+.+..+.+. .+.++++|+||++||.|
T Consensus 633 tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaY 712 (1351)
T KOG1035|consen 633 TSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAY 712 (1351)
T ss_pred ccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHH
Confidence 0 2489999999998888898887764 88999999999999999
Q ss_pred HHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec----------------ccCCCCcccccccCccccccccccccC-
Q 014849 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE----------------QIRPDGMLHTLCGTPAYVAPEILAKKG- 193 (417)
Q Consensus 131 lH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~----------------~~~~~~~~~~~~Gt~~y~APEvl~~~~- 193 (417)
+|+.|||||||||.||+|+++++|||+|||+++... .....+..+..+||-.|+|||++.+..
T Consensus 713 IH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~ 792 (1351)
T KOG1035|consen 713 IHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS 792 (1351)
T ss_pred HHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence 999999999999999999999999999999997611 011222456679999999999998766
Q ss_pred --CCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCCCCCCC----ChHHHHHHHHhccCCCCCCCCHHHH
Q 014849 194 --YDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYRCPKWT----SPDLKWFIGRLLDTDPATRITVDEI 266 (417)
Q Consensus 194 --y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~~----s~~~~~li~~~L~~dP~~R~t~~ei 266 (417)
|+ .|+|+||||||||||+ .||.. ........++.++.++.|..+ -+....+|++||++||++|||+.|+
T Consensus 793 ~~Yn-~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eL 868 (1351)
T KOG1035|consen 793 NKYN-SKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATEL 868 (1351)
T ss_pred cccc-chhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHH
Confidence 65 9999999999999998 45643 234456667777777766322 3556889999999999999999999
Q ss_pred hcCcccc
Q 014849 267 LRDPWFK 273 (417)
Q Consensus 267 l~h~~f~ 273 (417)
|++.||.
T Consensus 869 L~s~llp 875 (1351)
T KOG1035|consen 869 LNSELLP 875 (1351)
T ss_pred hhccCCC
Confidence 9999996
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=315.39 Aligned_cols=241 Identities=29% Similarity=0.459 Sum_probs=205.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||.+.. +++.||+|.+.... ....+.+|+.+++.++||||+++++++... ..|+|
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v 76 (254)
T cd05083 5 LQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIV 76 (254)
T ss_pred HHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEE
Confidence 36799999999999999999864 78899999986532 245788999999999999999999998665 47999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+.+++|.+++.. ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus 77 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--- 153 (254)
T cd05083 77 MELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--- 153 (254)
T ss_pred EECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc---
Confidence 999999999999864 35899999999999999999999999999999999999999999999999998653211
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
......+..|+|||.+.+..++ .++|+|||||++|+|++ |.+||...+..+....+.++. ...+...++.+.+++
T Consensus 154 --~~~~~~~~~y~~pe~~~~~~~~-~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 230 (254)
T cd05083 154 --VDNSKLPVKWTAPEALKHKKFS-SKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLM 230 (254)
T ss_pred --CCCCCCCceecCHHHhccCCcC-chhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCCCCCcCCHHHHHHH
Confidence 1223346779999998876664 89999999999999997 999999888877777766553 234455788999999
Q ss_pred HHhccCCCCCCCCHHHHhcC
Q 014849 250 GRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h 269 (417)
++||+.+|+.|||+.++++.
T Consensus 231 ~~~l~~~p~~Rp~~~~l~~~ 250 (254)
T cd05083 231 TSCWETEPKKRPSFHKLREK 250 (254)
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=314.45 Aligned_cols=252 Identities=24% Similarity=0.353 Sum_probs=205.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE-----eCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA-----TKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-----~~~ 89 (417)
..||++.+.||+|+|+.||++.+..+++.+|+|.+..... +..+...+||...++++||||++++++.. ...
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 4699999999999999999999999999999999987652 34678899999999999999999988753 334
Q ss_pred EEEEEEeccCCCChHHHHhc----C-CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK----G-RFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~----~-~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
..|++++|...|+|.+.+.. | -++|.++.+||.+|++||.+||+.. ++||||||.|||+++.+.+++.|||.+
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~ 176 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSA 176 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCc
Confidence 59999999999999998864 3 6999999999999999999999998 999999999999999999999999988
Q ss_pred eeecccCCCC-------cccccccCccccccccccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHh
Q 014849 163 AVKEQIRPDG-------MLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNL--MAMYRKIY 231 (417)
Q Consensus 163 ~~~~~~~~~~-------~~~~~~Gt~~y~APEvl~~~~y~--~~~sDIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~ 231 (417)
+...-.-.+. .......|..|+|||.+.-+.+. +.++|||||||+||+|+.|.-||+..-. ..+.-.+.
T Consensus 177 ~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~ 256 (302)
T KOG2345|consen 177 TQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQ 256 (302)
T ss_pred cccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeee
Confidence 7532111111 11122348889999998755443 6899999999999999999999963210 01111233
Q ss_pred cCCCCCCC--CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEYRCPK--WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~~~p~--~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.+.+|. .+|..+.++|+.||++||.+||++.+++.+
T Consensus 257 n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~ 296 (302)
T KOG2345|consen 257 NAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSK 296 (302)
T ss_pred ccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 44554443 378999999999999999999999999865
|
|
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=322.28 Aligned_cols=249 Identities=27% Similarity=0.408 Sum_probs=201.3
Q ss_pred eEEeeEEeeeCceEEEEEEE----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--CEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRN----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--AKI 91 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~~~ 91 (417)
|++.+.||+|+||.||.|.. ..++..||+|.+.... .......+.+|+.+++.++||||+++++++.+. ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 6 LKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 68999999999999999974 4678899999986543 223356788999999999999999999998775 678
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~ 163 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK 163 (284)
T ss_pred EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence 999999999999999865 358999999999999999999999999999999999999999999999999987543221
Q ss_pred CC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---------------HHHHHHHHhcC
Q 014849 170 PD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---------------LMAMYRKIYKG 233 (417)
Q Consensus 170 ~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---------------~~~~~~~i~~~ 233 (417)
.. .......|+..|+|||++.+..++ .++||||+||++|+|+++..|+.... .......+..+
T Consensus 164 ~~~~~~~~~~~~~~y~apE~~~~~~~~-~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 242 (284)
T cd05079 164 EYYTVKDDLDSPVFWYAPECLIQSKFY-IASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEG 242 (284)
T ss_pred cceeecCCCCCCccccCHHHhccCCCC-ccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcC
Confidence 11 122345677889999998877764 89999999999999999877653321 11111112222
Q ss_pred -CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 234 -EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 234 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.+...++.+.+|+.+||+.||++|||+.+++++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 243 KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 223455678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=319.63 Aligned_cols=250 Identities=24% Similarity=0.352 Sum_probs=206.7
Q ss_pred eEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 014849 18 YEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----- 89 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----- 89 (417)
|++.++||+|+||.||+|.+. .+++.||||++..+.. .....+++.+|+.+|+.++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 678999999999999999864 3678999999976532 2233567889999999999999999999875432
Q ss_pred -EEEEEEeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 90 -KIYFVMEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
..++++||+.+|+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 35789999999999887632 2478999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~ 239 (417)
+................+++.|++||.+....++ .++|||||||++|+|++ |.+||.+.+..+.+..+..+. ...+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~-~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 238 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYT-THSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPP 238 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccc-hhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCCC
Confidence 8754322111122234456789999999877775 89999999999999998 999999888777777666543 34556
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++.+.+++.+||+.+|+.|||+.+++..
T Consensus 239 ~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 239 DCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=319.49 Aligned_cols=250 Identities=26% Similarity=0.348 Sum_probs=199.6
Q ss_pred CCeEEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 014849 16 GKYEVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KA 89 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~ 89 (417)
.+|++.+.||+|+||.||.|. +..+++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 479999999999999999997 45678999999986543 2235678899999999999999999998643 45
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
.+|+|+||+++++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999865 4689999999999999999999999999999999999999999999999999876432
Q ss_pred cCCCCc-ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH----------------HHHHH
Q 014849 168 IRPDGM-LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----------------MYRKI 230 (417)
Q Consensus 168 ~~~~~~-~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~----------------~~~~i 230 (417)
...... .....++..|+|||++.+..++ .++|||||||++|+|++|..|+....... +...+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELL 239 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcC-hHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHH
Confidence 211111 1112234569999999877764 89999999999999999987765432110 11111
Q ss_pred hcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
... .++.+...+.++.+|+.+||.++|++|||+.++++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~ 279 (284)
T cd05081 240 KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQ 279 (284)
T ss_pred hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 111 223455678899999999999999999999999763
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-42 Score=354.81 Aligned_cols=249 Identities=26% Similarity=0.386 Sum_probs=219.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...-+..+.||+|+||+||+|+.. ...+.||||.++... ...+..+++||+.+|..++|||||+|++++..++
T Consensus 485 r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a--~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 485 RSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA--ENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred hhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc--cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 345677899999999999999753 344679999997654 3335788999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCe
Q 014849 90 KIYFVMEFAKGGELFAKISK---------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~v 154 (417)
.+|+|+|||..|||.+++.. +.|+..+-..++.||+.||.||-++.+|||||-..|+||.++..|
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV 642 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence 99999999999999998842 127888999999999999999999999999999999999999999
Q ss_pred EEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC
Q 014849 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 155 kl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~ 233 (417)
||+|||+++-....+.........-..+|||||.|....|+ .+|||||+||+|||+++ |..||.+-...+.+.-|..+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFT-teSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g 721 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFT-TESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG 721 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCccc-chhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence 99999999876655544444344457889999999988885 89999999999999986 99999999999999999887
Q ss_pred C-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHH
Q 014849 234 E-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEI 266 (417)
Q Consensus 234 ~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~ei 266 (417)
. +.+|...+.++.+|+..||+.+|++||++.||
T Consensus 722 ~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI 755 (774)
T KOG1026|consen 722 QLLSCPENCPTEVYSLMLECWNENPKRRPSFKEI 755 (774)
T ss_pred CcccCCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence 6 58899999999999999999999999999998
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=312.26 Aligned_cols=252 Identities=25% Similarity=0.438 Sum_probs=212.3
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..+.+..||.|+.|.|++++.+.+|...|||.+.+.. +.+...+|.+.+.++.... .|.||+.+++|.++..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~--Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG--NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC--CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 3455678999999999999999999999999998765 3344678888888887765 899999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|.|.. .+..++.. ++++|..+-++...+++||.||.. +||+|||+||.|||+|..|++|+||||+|...-.. .
T Consensus 171 elMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS---k 246 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS---K 246 (391)
T ss_pred HHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc---c
Confidence 99843 44444443 789999999999999999999985 68999999999999999999999999999754321 1
Q ss_pred cccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHHHHhcCCCCC-C--CCCChHH
Q 014849 173 MLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGEYRC-P--KWTSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-~~~~~~~i~~~~~~~-p--~~~s~~~ 245 (417)
......|.+.|||||.+.. ..|+ .++||||||+.|+||.||..||.+.+ ..++..++...++++ | ..+|+++
T Consensus 247 AhtrsAGC~~YMaPERidp~~~~kYD-iRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F 325 (391)
T KOG0983|consen 247 AHTRSAGCAAYMAPERIDPPDKPKYD-IRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDF 325 (391)
T ss_pred ccccccCCccccCccccCCCCCCccc-hhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHH
Confidence 2234578999999999863 3565 89999999999999999999999854 447778888766543 2 3489999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+|+..||+.|+.+||...++|+|||++..
T Consensus 326 ~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 326 QSFVKDCLTKDHRKRPKYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHhhcCcccCcchHHHhcCcceeec
Confidence 999999999999999999999999999753
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=314.82 Aligned_cols=249 Identities=30% Similarity=0.530 Sum_probs=211.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccc-------cccchHHHHHHHHHHHHh-CCCCCcceEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKI-------LRGGLTAHVKREISIMSR-LRHPNIVKLYEVLAT 87 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~-------~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~ 87 (417)
.|++.+.||+|+||.||+|.+.. +++.+|+|.+..... ........+.+|+.+++. ++||||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 38899999999999999999987 788999999864321 122234566788888865 799999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
....|+||||+.|++|.+.+.. ..+++..++.++.|++.||.|||+ .|++||||+|+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999887732 469999999999999999999996 7899999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-C-C
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-P-K 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p-~ 239 (417)
+...... .......|+..|+|||.+.+..+ +.++|+||||+++|+|++|..||...+.......+..+.+.. + .
T Consensus 161 ~~~~~~~---~~~~~~~~~~~~~~Pe~~~~~~~-~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 236 (269)
T cd08528 161 AKQKQPE---SKLTSVVGTILYSCPEIVKNEPY-GEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEG 236 (269)
T ss_pred eeecccc---cccccccCcccCcChhhhcCCCC-chHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcCCcc
Confidence 8764432 13455678999999999987666 589999999999999999999999888777777776655432 2 2
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++++.++|.+||+.||++|||+.|+..+
T Consensus 237 ~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 237 MYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred cCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 568999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=313.61 Aligned_cols=236 Identities=25% Similarity=0.312 Sum_probs=194.2
Q ss_pred eEEeeeCceEEEEEEEccCC----------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTG----------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g----------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
+.||+|+||.||+|.+..++ ..+++|++..... ....+.+|+.+|+.++||||+++++++.. ...
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHR----DSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchh----hHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 47999999999999998777 3588887754431 15678899999999999999999999887 778
Q ss_pred EEEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-------CeEEeeeecc
Q 014849 92 YFVMEFAKGGELFAKISK-G-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-------DLKISDFGLS 162 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-------~vkl~DFGls 162 (417)
++||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a 155 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCcc
Confidence 999999999999999875 3 689999999999999999999999999999999999999887 7999999998
Q ss_pred eeecccCCCCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 240 (417)
..... .....++..|+|||++... ...+.++|||||||++|+|++ |..||...+......... .....|..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~-~~~~~~~~ 228 (259)
T cd05037 156 ITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ-DQHRLPMP 228 (259)
T ss_pred ccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh-cCCCCCCC
Confidence 75432 2234577889999998776 234589999999999999998 688887765433333322 22223333
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+.++|.+||..+|.+|||+.++++.
T Consensus 229 ~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 257 (259)
T cd05037 229 DCAELANLINQCWTYDPTKRPSFRAILRD 257 (259)
T ss_pred CchHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 35889999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=319.31 Aligned_cols=254 Identities=17% Similarity=0.192 Sum_probs=194.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccch--------HHHHHHHHHHHHhCCCCCcce
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGL--------TAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~--------~~~i~~Ei~il~~l~HpnIv~ 80 (417)
....++|++.+.||+|+||+||+|.+..+ +..+|+|+........... ......++..++.+.|+||++
T Consensus 8 ~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~ 87 (294)
T PHA02882 8 DITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPK 87 (294)
T ss_pred ccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCc
Confidence 34567999999999999999999999877 6778888754332110000 011223444566778999999
Q ss_pred EEEEEEeCC----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 81 LYEVLATKA----KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 81 l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
+++...... ..|+++|++.. ++.+.+.. ...++..++.++.|++.||.|||++||+||||||+|||++.++.++
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~ 166 (294)
T PHA02882 88 YYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGY 166 (294)
T ss_pred EEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEE
Confidence 998765443 45788888744 66666655 4578899999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-H-----
Q 014849 156 ISDFGLSAVKEQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-M----- 224 (417)
Q Consensus 156 l~DFGls~~~~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~----- 224 (417)
|+|||+|+....... ........||+.|+|||++.+..|+ .++||||+||++|+|++|.+||.+.+. .
T Consensus 167 l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~-~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~ 245 (294)
T PHA02882 167 IIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVT-RRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA 245 (294)
T ss_pred EEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence 999999976532111 1122335799999999999888774 999999999999999999999986521 1
Q ss_pred ---HHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 ---AMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ---~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+...++..+....+ ..++.+.+++..||..+|++||++++|++
T Consensus 246 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 246 AKCDFIKRLHEGKIKIK-NANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hHHHHHHHhhhhhhccC-CCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 22344444444333 35788999999999999999999999975
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-42 Score=339.43 Aligned_cols=235 Identities=27% Similarity=0.467 Sum_probs=204.0
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.-++-||.|+.|.||+|+. .++.||||.++-- -..+|+-|+.|+||||+.|.+++...-.++||||||
T Consensus 127 sELeWlGSGaQGAVF~Grl--~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfC 194 (904)
T KOG4721|consen 127 SELEWLGSGAQGAVFLGRL--HNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFC 194 (904)
T ss_pred hhhhhhccCcccceeeeec--cCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeecc
Confidence 3456799999999999997 6789999966322 125788899999999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
..|-|...++. +.+.......|..+|+.||.|||.+.|||||||.-||||+.+..|||+|||-+...... ...-..
T Consensus 195 a~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSF 271 (904)
T KOG4721|consen 195 AQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK---STKMSF 271 (904)
T ss_pred ccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh---hhhhhh
Confidence 99999999987 57888889999999999999999999999999999999999999999999988654322 334568
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCChHHHHHHHHhccC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~ 255 (417)
|||..|||||++.+.+.. .|+||||+||+|||||||..||.+-+...++--+... .++.|...++.++-||++||+-
T Consensus 272 aGTVaWMAPEvIrnePcs-EKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~s 350 (904)
T KOG4721|consen 272 AGTVAWMAPEVIRNEPCS-EKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNS 350 (904)
T ss_pred hhhHhhhCHHHhhcCCcc-cccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCcccCchHHHHHHHHHHhc
Confidence 999999999999999986 9999999999999999999999887655443222222 3567888899999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 014849 256 DPATRITVDEILRD 269 (417)
Q Consensus 256 dP~~R~t~~eil~h 269 (417)
.|..||++.+|+.|
T Consensus 351 KpRNRPSFrqil~H 364 (904)
T KOG4721|consen 351 KPRNRPSFRQILLH 364 (904)
T ss_pred CCCCCccHHHHHHH
Confidence 99999999999988
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-43 Score=316.93 Aligned_cols=266 Identities=28% Similarity=0.437 Sum_probs=221.0
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--- 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--- 87 (417)
.....+.|+-...+|+|.||.|++|+...+|+.||+|++--+. .+.++.....+|+.+|..++|+|++.+++++.+
T Consensus 12 ~~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~~lkHenv~nliEic~tk~T 90 (376)
T KOG0669|consen 12 FCDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQLLKHENVVNLIEICRTKAT 90 (376)
T ss_pred ceecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccC
Confidence 3567889999999999999999999999999999998765432 245566677899999999999999999988743
Q ss_pred -----CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 88 -----KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 88 -----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
...+|+|+.+|.. +|+-++.. -+++..++.++++++++||.|+|+..|+|||+||+|+||+.+|.+||+|||
T Consensus 91 p~~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 91 PTNRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred CcccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 3469999999976 89999876 479999999999999999999999999999999999999999999999999
Q ss_pred cceeecccC--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhc--CCC-
Q 014849 161 LSAVKEQIR--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--GEY- 235 (417)
Q Consensus 161 ls~~~~~~~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~--~~~- 235 (417)
+++.+.... ........+-|.+|++||.+.+..-+|++.|||..|||+.+|+++.+-|.+.+......-|.. |.+
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 997553321 222345567799999999999887778999999999999999999999988765554443321 110
Q ss_pred -------------------CCCC-------------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 236 -------------------RCPK-------------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 236 -------------------~~p~-------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+.|+ ..++++.+|+.+||..||.+|+++.+++.|.||.++..+
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~p 324 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMP 324 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcc
Confidence 0111 125688999999999999999999999999999987665
|
|
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-40 Score=312.68 Aligned_cols=244 Identities=20% Similarity=0.264 Sum_probs=193.0
Q ss_pred eEEeeeCceEEEEEEEccC--CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNVRT--GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~--g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||+||+|..... ...+++|.+..... ......+.+|+.+++.++||||+++++.+.+....|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999976433 23466776654322 2235678899999999999999999999999999999999999
Q ss_pred CCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 100 GGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 100 gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
+|+|.+++.+ ..+++..+..++.||+.||.|||+++++||||||+|||++.++.+||+|||++............
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 79 LGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred CCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999998864 23567788899999999999999999999999999999999999999999987532211111122
Q ss_pred cccccCccccccccccccC------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C-----CCCCCC
Q 014849 175 HTLCGTPAYVAPEILAKKG------YDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y-----RCPKWT 241 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~------y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~-----~~p~~~ 241 (417)
...+|++.|+|||++.... ..+.++|||||||++|+|++ |..||...+..+.+..+..+. . ..+...
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPY 238 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCC
Confidence 3467899999999975321 12478999999999999986 688998877776666654432 1 223346
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
++.+.+++.+|| .+|++|||++++++
T Consensus 239 ~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 239 SERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred cHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 888999999999 68999999999965
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-40 Score=314.39 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=203.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEc----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CC
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNV----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KA 89 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~ 89 (417)
..|++.+.||+|+||.||+|... .+++.+|+|++...... .....+.+|+++++.++||||+++++++.. ..
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 46888999999999999999864 35889999999765432 246788999999999999999999999877 66
Q ss_pred EEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..++||||+++++|.+++... .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 899999999999999999763 599999999999999999999999999999999999999999999999999876542
Q ss_pred cCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHh
Q 014849 168 IRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA---------------MYRKIY 231 (417)
Q Consensus 168 ~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~---------------~~~~i~ 231 (417)
.... .......++..|+|||.+....+. .++|||||||++|+|++|..||....... +...+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~-~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFS-SASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLK 240 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCC-cccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHH
Confidence 1111 111123445679999998877664 88999999999999999999987543211 122222
Q ss_pred cC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 232 KG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 232 ~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.. ..+.|...+.++.+++.+||+++|++|||+.|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 241 EGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred cCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 21 23344556789999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-41 Score=340.13 Aligned_cols=242 Identities=34% Similarity=0.530 Sum_probs=200.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----- 89 (417)
.+-|+..+.||+|+||.||++++++||+.||||.+.+....+ ..+..-+|+++|++++|||||+++++-++..
T Consensus 12 ~y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r--~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~ 89 (732)
T KOG4250|consen 12 NYLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLR--PRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVT 89 (732)
T ss_pred CcceeehhhhcCCccceeeeecccccccchhHHhhhhhcccc--hHHHHHHHHHHHHHcCchhhhhhcccCCccccCccc
Confidence 477899999999999999999999999999999998865333 3677889999999999999999999865544
Q ss_pred -EEEEEEeccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCC--CeEEeeee
Q 014849 90 -KIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD--ENW--DLKISDFG 160 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~--~~~--~vkl~DFG 160 (417)
.-.+|||||.||+|+..+.+ .+|+|.+.+.++..+..||.|||++||+||||||.||++- .+| ..||+|||
T Consensus 90 ~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 90 RLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 46789999999999999975 5799999999999999999999999999999999999983 334 37999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHHHHhcC--
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-----NLMAMYRKIYKG-- 233 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-----~~~~~~~~i~~~-- 233 (417)
.|+-.+ .+....+.+||+.|.+||.+..+.+++..+|.||+||++|+..||.+||... +..-++..+.+.
T Consensus 170 ~Arel~---d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELD---DNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCC---CCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 998655 4557889999999999999987666679999999999999999999999542 222334333221
Q ss_pred ------------------CCCCCCCCChHH----HHHHHHhccCCCCCCC
Q 014849 234 ------------------EYRCPKWTSPDL----KWFIGRLLDTDPATRI 261 (417)
Q Consensus 234 ------------------~~~~p~~~s~~~----~~li~~~L~~dP~~R~ 261 (417)
.++.|...++.+ ..++..+|..+|.+|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~ 296 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG 296 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence 123344444443 3467789999999998
|
|
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=351.32 Aligned_cols=250 Identities=24% Similarity=0.384 Sum_probs=214.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ-----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..-++.+.||+|+||.||.|.-..... .||||.+.+.. +......+.+|..+|+.++|||||++++++-+...
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~--~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~ 769 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS--SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP 769 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC
Confidence 456889999999999999998765332 38888886643 45567889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKISKG--------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.++++|||.||+|..+|.+. .++......++.||+.|+.||+++++|||||...|+||+....|||+|||+|
T Consensus 770 ~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 770 PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchh
Confidence 99999999999999999753 4888899999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH-HHhcCCCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYR-KIYKGEYRCPKW 240 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~-~i~~~~~~~p~~ 240 (417)
+..........-....-...|||||.+....+ +.++|||||||+|||+++ |..||.+.+..+... -...+..+.|..
T Consensus 850 rDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iF-tskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~ 928 (1025)
T KOG1095|consen 850 RDIYDKDYYRKHGEAMLPVKWMPPESLKDGIF-TSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSY 928 (1025)
T ss_pred HhhhhchheeccCccccceecCCHHHHhhccc-ccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCC
Confidence 84332222211111122467999999998777 499999999999999987 999999998888777 445567888999
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
++..+.++|..||+.+|++||++..|++
T Consensus 929 CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 929 CPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred CChHHHHHHHHHccCChhhCccHHHHHh
Confidence 9999999999999999999999999987
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-41 Score=321.32 Aligned_cols=253 Identities=28% Similarity=0.439 Sum_probs=208.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CC----cceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PN----IVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pn----Iv~l~~~~ 85 (417)
-.+.+||++..+||+|+||+|-.+.+.+++..||+|+++.-.. ..+..+-|+.+|.++.+ |+ +|++.++|
T Consensus 85 D~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF 160 (415)
T KOG0671|consen 85 DILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQMRDWF 160 (415)
T ss_pred cccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence 3568899999999999999999999999999999999965321 23445568999999842 33 77888889
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-------------
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD------------- 149 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~------------- 149 (417)
.-.+++++|+|.+ |.++++++.. .+++-..++.+..||+.+++|||+.+++|-||||||||+.
T Consensus 161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~ 239 (415)
T KOG0671|consen 161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK 239 (415)
T ss_pred hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence 9999999999999 7799999987 3689999999999999999999999999999999999983
Q ss_pred -------CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 014849 150 -------ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN 222 (417)
Q Consensus 150 -------~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~ 222 (417)
.+..++|+|||.|+...+. -.+.+.|..|+||||+.+-|++ .+.||||+||||+||.+|...|....
T Consensus 240 ~~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS-~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 240 VCFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWS-QPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred cceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcC-CccCceeeeeEEEEeeccceecccCC
Confidence 1346899999998864432 2567789999999999999996 89999999999999999999998765
Q ss_pred HHH---HHHHHhcC------------------CCCCCCC-------------------------CChHHHHHHHHhccCC
Q 014849 223 LMA---MYRKIYKG------------------EYRCPKW-------------------------TSPDLKWFIGRLLDTD 256 (417)
Q Consensus 223 ~~~---~~~~i~~~------------------~~~~p~~-------------------------~s~~~~~li~~~L~~d 256 (417)
..+ |.+.|... ....|.. ...++.+||++||..|
T Consensus 314 n~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fD 393 (415)
T KOG0671|consen 314 NLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFD 393 (415)
T ss_pred cHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccC
Confidence 443 44444321 1111110 0234678999999999
Q ss_pred CCCCCCHHHHhcCcccccc
Q 014849 257 PATRITVDEILRDPWFKKD 275 (417)
Q Consensus 257 P~~R~t~~eil~h~~f~~~ 275 (417)
|.+|+|+.|+|.||||...
T Consensus 394 P~~RiTl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 394 PARRITLREALSHPFFARL 412 (415)
T ss_pred ccccccHHHHhcCHHhhcC
Confidence 9999999999999999864
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=321.89 Aligned_cols=248 Identities=29% Similarity=0.451 Sum_probs=196.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-KIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~l 93 (417)
.+.|.-...||+|+||.||+|... .|+.||||.+....... ..++.+|+.+|.+++|||+|+|+++|.+.+ ..++
T Consensus 74 T~~Fs~~~~ig~Ggfg~VYkG~l~-~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 74 TNNFSESNLIGEGGFGTVYKGVLS-DGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HhCCchhcceecCCCeEEEEEEEC-CCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 467788899999999999999984 44899999876654321 345999999999999999999999999988 5999
Q ss_pred EEeccCCCChHHHHhc--C-CCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 94 VMEFAKGGELFAKISK--G-RFSEQLSRRYFQQLISAVEYCHSRG---VFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~-~l~e~~~~~i~~ql~~aL~ylH~~g---ivHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|+||++.|+|.+.+.. + .+++..+.+|+.+++.||+|||... |+||||||.|||||++.+.||+|||+|.....
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999875 3 7899999999999999999999854 99999999999999999999999999954332
Q ss_pred cCCCCccccc-ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC------HHHHHH-HHhcCC---CC
Q 014849 168 IRPDGMLHTL-CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN------LMAMYR-KIYKGE---YR 236 (417)
Q Consensus 168 ~~~~~~~~~~-~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~------~~~~~~-~i~~~~---~~ 236 (417)
. .....+. .||..|+|||.+..... +.++||||+||+|.||++|+.|.+... ..+... .+..+. +-
T Consensus 230 ~--~~~~~~~~~gt~gY~~PEy~~~g~l-t~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eii 306 (361)
T KOG1187|consen 230 G--DTSVSTTVMGTFGYLAPEYASTGKL-TEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIV 306 (361)
T ss_pred c--ccceeeecCCCCccCChhhhccCCc-CcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhhee
Confidence 0 2222222 89999999999877444 599999999999999999998887532 222211 222221 11
Q ss_pred CCC----CCC--hH---HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 237 CPK----WTS--PD---LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 237 ~p~----~~s--~~---~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.|. ..+ .. +..+..+|++.+|..||++.|+.+.
T Consensus 307 D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~ 348 (361)
T KOG1187|consen 307 DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKE 348 (361)
T ss_pred CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHH
Confidence 111 122 23 3456789999999999999997543
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=335.21 Aligned_cols=257 Identities=30% Similarity=0.528 Sum_probs=225.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe---
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT--- 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~--- 87 (417)
....+.|++.+++|.|.+|+||+++++.+|+..|+|+.+... ...+.+.-|..||+.. .|||++.+|+++.-
T Consensus 15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~ 90 (953)
T KOG0587|consen 15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP 90 (953)
T ss_pred CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecC
Confidence 345678999999999999999999999999999999987653 2356777889999887 59999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.+.+|||||||.||+.-|+++. +++.|..+..|++.++.|+.+||.+.++|||||-.||||+.+|.||++|||+|
T Consensus 91 ~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 91 GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 4689999999999999999875 68999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCcccccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKK-----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR- 236 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-----~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~- 236 (417)
+..+. .-+...|..|||.||||||+... .|+ ..+|+||||++..||-.|.+|+-+..++..+-+|-+...+
T Consensus 171 aQlds--T~grRnT~iGtP~WMAPEViac~e~~d~tyd-~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPPk 247 (953)
T KOG0587|consen 171 AQLDS--TVGRRNTFIGTPYWMAPEVIACDESPDATYD-YRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPK 247 (953)
T ss_pred eeeec--ccccccCcCCCcccccceeeecccCCCCCcc-cccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCcc
Confidence 87765 44667889999999999998643 344 8899999999999999999999999888777676655432
Q ss_pred --CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 --CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 --~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
-|..++.++.++|..||..|-.+||+..++++|||.+..
T Consensus 248 Lkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~e~ 288 (953)
T KOG0587|consen 248 LKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFITEQ 288 (953)
T ss_pred ccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccccc
Confidence 355678999999999999999999999999999999843
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=339.34 Aligned_cols=253 Identities=19% Similarity=0.303 Sum_probs=179.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccC----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRT----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV----- 84 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~----- 84 (417)
-.++|++.+.||+|+||.||+|++..+ +..||+|.+..... .+...+| .++...+.++..+...
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~ 202 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV 202 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence 467899999999999999999999988 99999998754321 1111111 1122222233222211
Q ss_pred -EEeCCEEEEEEeccCCCChHHHHhcCCC---------------------CHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 014849 85 -LATKAKIYFVMEFAKGGELFAKISKGRF---------------------SEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142 (417)
Q Consensus 85 -~~~~~~~~lV~E~~~gg~L~~~i~~~~l---------------------~e~~~~~i~~ql~~aL~ylH~~givHrDlk 142 (417)
......+++|+||+.+++|.+++....+ .+..+..++.||+.||.|||++||+|||||
T Consensus 203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLK 282 (566)
T PLN03225 203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVK 282 (566)
T ss_pred ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCC
Confidence 2456689999999999999998865321 234567899999999999999999999999
Q ss_pred CCcEEecC-CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCC---------------------CChhh
Q 014849 143 LENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD---------------------GAKVD 200 (417)
Q Consensus 143 p~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~---------------------~~~sD 200 (417)
|+|||++. ++.+||+|||+|+..... ......+.+||+.|+|||.+....+. +.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~-~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVG-INYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccccc-cccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999986 579999999999754321 12234567899999999976432221 24569
Q ss_pred HHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-------C--------------CCCChHHHHHHHHhccCCCCC
Q 014849 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-------P--------------KWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 201 IwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-------p--------------~~~s~~~~~li~~~L~~dP~~ 259 (417)
|||+||+||+|+++..|++.. .......+....... + ...+....+||.+||+.||++
T Consensus 362 VwSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~k 440 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQ 440 (566)
T ss_pred cHHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCccc
Confidence 999999999999988776542 222222222211111 0 111233458999999999999
Q ss_pred CCCHHHHhcCcccccc
Q 014849 260 RITVDEILRDPWFKKD 275 (417)
Q Consensus 260 R~t~~eil~h~~f~~~ 275 (417)
|||+.|+|+||||+..
T Consensus 441 R~ta~e~L~Hpff~~~ 456 (566)
T PLN03225 441 RISAKAALAHPYFDRE 456 (566)
T ss_pred CCCHHHHhCCcCcCCC
Confidence 9999999999999864
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=292.03 Aligned_cols=239 Identities=46% Similarity=0.809 Sum_probs=208.2
Q ss_pred CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHH
Q 014849 28 AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI 107 (417)
Q Consensus 28 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i 107 (417)
+||.||+|.+..+|+.+|+|++........ ...+.+|+..+++++||||+++++.+......++++||+.+++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 589999999999999999999976543221 578889999999999999999999999999999999999999999998
Q ss_pred hcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccc
Q 014849 108 SKG-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186 (417)
Q Consensus 108 ~~~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~AP 186 (417)
... .+++..+..++.|++.++.|||+.|++|+||+|.||+++.++.++|+|||.+...... .......|++.|+||
T Consensus 79 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~---~~~~~~~~~~~~~~p 155 (244)
T smart00220 79 KKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPG---GLLTTFVGTPEYMAP 155 (244)
T ss_pred HhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccc---cccccccCCcCCCCH
Confidence 764 4899999999999999999999999999999999999999999999999998765432 134456789999999
Q ss_pred ccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCCCCCC---CChHHHHHHHHhccCCCCCCCC
Q 014849 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYRCPKW---TSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 187 Evl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~~~~~li~~~L~~dP~~R~t 262 (417)
|.+....++ .++||||+|+++++|++|..||.. .+.......+.......+.. .+.++.+++.+||..+|++||+
T Consensus 156 E~~~~~~~~-~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 234 (244)
T smart00220 156 EVLLGKGYG-KAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT 234 (244)
T ss_pred HHHccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence 999877775 799999999999999999999988 56666666665555443322 7789999999999999999999
Q ss_pred HHHHhcCccc
Q 014849 263 VDEILRDPWF 272 (417)
Q Consensus 263 ~~eil~h~~f 272 (417)
+.++++||||
T Consensus 235 ~~~~~~~~~~ 244 (244)
T smart00220 235 AEEALQHPFF 244 (244)
T ss_pred HHHHhhCCCC
Confidence 9999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=301.70 Aligned_cols=258 Identities=29% Similarity=0.474 Sum_probs=216.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
....||.-.+.+|.|+- .|..|.|..++++||+|.+..... ......+..+|...|..++|+||++++++|.-.
T Consensus 14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~-n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~ 91 (369)
T KOG0665|consen 14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQ-NQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLE 91 (369)
T ss_pred eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccc-cCccchhhhhhhhhhhhhcccceeeeeeccCccccHH
Confidence 34568999999999999 899999999999999999987733 334467888999999999999999999998543
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+|||+++. +|...+. -.++-.....++.|++.|+.|+|+.||+||||||+||++..++.+||.|||+|+..+
T Consensus 92 ~~~e~y~v~e~m~~-nl~~vi~-~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~ 169 (369)
T KOG0665|consen 92 EFQEVYLVMELMDA-NLCQVIL-MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTED 169 (369)
T ss_pred HHHhHHHHHHhhhh-HHHHHHH-HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccC
Confidence 368999999965 7877765 467788899999999999999999999999999999999999999999999997543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
.+-..+.++.|..|.|||++.+.+|. +.+||||+|||+.||++|+..|.+.+..+.+.++...
T Consensus 170 ---~~~~mtpyVvtRyyrapevil~~~~k-e~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~ 245 (369)
T KOG0665|consen 170 ---TDFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ 245 (369)
T ss_pred ---cccccCchhheeeccCchheeccCCc-ccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence 33456678899999999999999975 9999999999999999999999987766666655320
Q ss_pred -----------C---CC----CCC-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 234 -----------E---YR----CPK-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 234 -----------~---~~----~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+ +. +|. .-+..+++|+.+||..||++|.|++++|.||||+-++.+
T Consensus 246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~vw~~~ 319 (369)
T KOG0665|consen 246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIKVWYDP 319 (369)
T ss_pred HHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeeeeeccc
Confidence 0 00 111 124568999999999999999999999999999955443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=289.81 Aligned_cols=251 Identities=27% Similarity=0.481 Sum_probs=207.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC--EE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA--KI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~--~~ 91 (417)
.+.|++.+.+|+|-++.|+.|.+..+++.++||++..-+ ...|+||+.||+.|+ ||||++++++..++. ..
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 568999999999999999999999999999999997654 578999999999997 999999999987653 57
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~~~~~ 170 (417)
.+|+||+...+...+-. .|+...++.|+.||+.||+||||.||.|||+||+|+++|.. ..++|+|+|+|.+.. +
T Consensus 111 aLiFE~v~n~Dfk~ly~--tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH---p 185 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP--TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH---P 185 (338)
T ss_pred hhHhhhhccccHHHHhh--hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcC---C
Confidence 79999998876554433 58888999999999999999999999999999999999865 469999999997654 4
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHHHHhc-------------CCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN-DPNLMAMYRKIYK-------------GEYR 236 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~-~~~~~~~~~~i~~-------------~~~~ 236 (417)
....+-.+.+..|--||.+..-.+...+.|+||+||+|..|...+-||- +.+..+..-+|.+ -...
T Consensus 186 ~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~ 265 (338)
T KOG0668|consen 186 GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQID 265 (338)
T ss_pred CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccC
Confidence 4455666778889999999876655699999999999999999988873 4443343333321 0011
Q ss_pred CC-------------C-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 237 CP-------------K-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 237 ~p-------------~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+ . ..++++.+|+.++|..|.++|+|+.|+|.||||....
T Consensus 266 Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~~~ 329 (338)
T KOG0668|consen 266 LDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAPVR 329 (338)
T ss_pred CChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHHHH
Confidence 11 1 1379999999999999999999999999999998544
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=311.02 Aligned_cols=265 Identities=29% Similarity=0.435 Sum_probs=219.5
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc----ccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL----RGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~----~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
-..+..||-++.+||+|+|+.||+|.+....+.||+|+-...+.. +.+...+..||..|.+.|.||.||++|++|.
T Consensus 458 HptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfs 537 (775)
T KOG1151|consen 458 HPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFS 537 (775)
T ss_pred CcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeee
Confidence 356788999999999999999999999999999999987554432 2334567889999999999999999999985
Q ss_pred -eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc--CCeecCCCCCcEEec---CCCCeEEeee
Q 014849 87 -TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR--GVFHRDLKLENLLLD---ENWDLKISDF 159 (417)
Q Consensus 87 -~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~--givHrDlkp~NILl~---~~~~vkl~DF 159 (417)
+...++-|+|||+|.+|.-+++. ..++|.+|+.|+.||+.||.||... .|+|-||||.||||- .-|.+||+||
T Consensus 538 lDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF 617 (775)
T KOG1151|consen 538 LDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF 617 (775)
T ss_pred eccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence 55678999999999999999987 5689999999999999999999976 699999999999994 3478999999
Q ss_pred ecceeecccCCC-----CcccccccCcccccccccc-c--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH---HHH
Q 014849 160 GLSAVKEQIRPD-----GMLHTLCGTPAYVAPEILA-K--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA---MYR 228 (417)
Q Consensus 160 Gls~~~~~~~~~-----~~~~~~~Gt~~y~APEvl~-~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~---~~~ 228 (417)
|||.+.+....+ .+.....||-+|++||.+. + .+-.+.++||||.|||+|..+.|+-||....... .+.
T Consensus 618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeN 697 (775)
T KOG1151|consen 618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQEN 697 (775)
T ss_pred chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhh
Confidence 999987654332 2334567999999999864 2 2344789999999999999999999997653322 122
Q ss_pred HHhcC-C--CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 229 KIYKG-E--YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 229 ~i~~~-~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.|.++ + ++..+-.++++++||++||+..-+.|+.+.++-.||+|.-.
T Consensus 698 TIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh 747 (775)
T KOG1151|consen 698 TILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPH 747 (775)
T ss_pred chhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccch
Confidence 33333 2 34445679999999999999999999999999999999753
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=315.65 Aligned_cols=253 Identities=28% Similarity=0.454 Sum_probs=213.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC------CCCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR------HPNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~------HpnIv~l~~~~ 85 (417)
..+-+||++.-..|+|-|++|..|.+..-|+.||||+|....+ |...=.+|++||+.|+ --|+++|+.+|
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F 503 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHCLRLFRHF 503 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh
Confidence 3567899999999999999999999999999999999987543 3344468999999996 35899999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-G---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFG 160 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFG 160 (417)
...+++|||+|... ..|.+.+.+ | +|....++.|++||+.||..|-..||+|.||||.|||+++.. .+||||||
T Consensus 504 ~hknHLClVFE~Ls-lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfG 582 (752)
T KOG0670|consen 504 KHKNHLCLVFEPLS-LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFG 582 (752)
T ss_pred hhcceeEEEehhhh-chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCc
Confidence 99999999999884 489999986 3 588899999999999999999999999999999999998765 48999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 240 (417)
.|.... ......+.-+..|.|||++.+.+|+ ...|+||.||.||||.||+..|++.+...|++-.+...-++|..
T Consensus 583 SA~~~~----eneitPYLVSRFYRaPEIiLG~~yd-~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~K 657 (752)
T KOG0670|consen 583 SASFAS----ENEITPYLVSRFYRAPEIILGLPYD-YPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNK 657 (752)
T ss_pred cccccc----cccccHHHHHHhccCcceeecCccc-CCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHH
Confidence 987654 3445556667789999999999998 89999999999999999999999988887775543221111110
Q ss_pred -----------------------------------------------------C-------ChHHHHHHHHhccCCCCCC
Q 014849 241 -----------------------------------------------------T-------SPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 241 -----------------------------------------------------~-------s~~~~~li~~~L~~dP~~R 260 (417)
+ -..+++|+.+||..||++|
T Consensus 658 mlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KR 737 (752)
T KOG0670|consen 658 MLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKR 737 (752)
T ss_pred HhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhc
Confidence 0 1346789999999999999
Q ss_pred CCHHHHhcCccccc
Q 014849 261 ITVDEILRDPWFKK 274 (417)
Q Consensus 261 ~t~~eil~h~~f~~ 274 (417)
+|+.++|.||||+.
T Consensus 738 it~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 738 ITVNQALKHPFITE 751 (752)
T ss_pred CCHHHHhcCCcccC
Confidence 99999999999974
|
|
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=314.49 Aligned_cols=245 Identities=27% Similarity=0.416 Sum_probs=206.8
Q ss_pred eEEeeEEeeeCceEEEEEEEcc--CC--cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVR--TG--QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~--~g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..+.+.||.|.||.||.|.... .| -.||||.++.+. ..+..+.+..|..+|+.++|||||++++++.+. .+|+
T Consensus 391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi 467 (974)
T KOG4257|consen 391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI 467 (974)
T ss_pred ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence 3456789999999999998643 23 359999998754 333478899999999999999999999998755 6899
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||+++-|+|..++.. ..|+......|+.||+.||.|||+..+|||||...|||+.+.--|||+|||+|+..+.....
T Consensus 468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY 547 (974)
T KOG4257|consen 468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY 547 (974)
T ss_pred EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence 9999999999999986 57888889999999999999999999999999999999999999999999999876532221
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
... ...-+.-|||||.++-..++ .+||||.|||.+||++ .|.-||.+-...+.+..|-+|+ .++|+.+++.+..|+
T Consensus 548 kaS-~~kLPIKWmaPESINfRrFT-tASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCPp~LYslm 625 (974)
T KOG4257|consen 548 KAS-RGKLPIKWMAPESINFRRFT-TASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCPPALYSLM 625 (974)
T ss_pred hcc-ccccceeecCccccchhccc-chhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCCCCCCChHHHHHH
Confidence 111 11224559999999877775 8899999999999976 5999999987777777777765 789999999999999
Q ss_pred HHhccCCCCCCCCHHHHh
Q 014849 250 GRLLDTDPATRITVDEIL 267 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil 267 (417)
.+||..+|.+||.+.+|.
T Consensus 626 skcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 626 SKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHHhccCcccCCcHHHHH
Confidence 999999999999887764
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=318.50 Aligned_cols=257 Identities=27% Similarity=0.398 Sum_probs=220.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC-Cc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT-GQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+-.++.+++++||+|+||.|+.|.+... |+ .||||.+....... ....+.+|+.+|..|+|||+|+||++..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 3456778899999999999999998653 33 58999997765432 47889999999999999999999999988 6
Q ss_pred EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 KIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+.+|+|++++|+|.+.+.+ +.|.......|+.||+.||.||.+++.|||||-..||||-....|||+||||.+...
T Consensus 184 p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg 263 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALG 263 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccC
Confidence 78999999999999999975 568888999999999999999999999999999999999999899999999998665
Q ss_pred ccCCCC-cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCh
Q 014849 167 QIRPDG-MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSP 243 (417)
Q Consensus 167 ~~~~~~-~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 243 (417)
..+... +.....-...|+|||.+....+. .++|+|++||.+|||++ |..||.+.+...++++|-.++ ++-|+.++.
T Consensus 264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFS-haSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRPk~cse 342 (1039)
T KOG0199|consen 264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFS-HASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRPKYCSE 342 (1039)
T ss_pred CCCcceEecCCCcCcccccCHhHhcccccc-ccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCCCCCChH
Confidence 432211 11112234569999999998885 99999999999999997 799999999999999988654 567889999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
++.++++.||..+|++|||+..|.++-+.+
T Consensus 343 dIY~imk~cWah~paDRptFsair~~~~l~ 372 (1039)
T KOG0199|consen 343 DIYQIMKNCWAHNPADRPTFSAIREDLVLA 372 (1039)
T ss_pred HHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence 999999999999999999999998665544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=312.62 Aligned_cols=260 Identities=19% Similarity=0.277 Sum_probs=189.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc----------------cCCcEEEEEEeecccccc-----------cchHHHHHHH
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV----------------RTGQSVAIKAVSKQKILR-----------GGLTAHVKRE 66 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~----------------~~g~~vAiK~i~~~~~~~-----------~~~~~~i~~E 66 (417)
-.++|++.+.||+|+||.||+|... ..++.||||.+....... ....+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 4678999999999999999999753 345679999986532110 0111223357
Q ss_pred HHHHHhCCCCCc-----ceEEEEEEe--------CCEEEEEEeccCCCChHHHHhc--C---------------------
Q 014849 67 ISIMSRLRHPNI-----VKLYEVLAT--------KAKIYFVMEFAKGGELFAKISK--G--------------------- 110 (417)
Q Consensus 67 i~il~~l~HpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~i~~--~--------------------- 110 (417)
+.++.+++|.++ +++++++.. +...|+|+||+.+++|.+++.. +
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777776654 566666542 4568999999999999887753 1
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccc
Q 014849 111 --RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188 (417)
Q Consensus 111 --~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEv 188 (417)
.++...++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++....... ........+||.|+|||+
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeChhh
Confidence 23556788999999999999999999999999999999999999999999986533211 111112334899999999
Q ss_pred ccccC--------------------CC-CChhhHHHHHHHHHHHHcCCC-CCCCCC-----------HHHHHHHHhcCCC
Q 014849 189 LAKKG--------------------YD-GAKVDMWSCGVVLFVLNAGYL-PFNDPN-----------LMAMYRKIYKGEY 235 (417)
Q Consensus 189 l~~~~--------------------y~-~~~sDIwSlGvil~~ll~G~~-Pf~~~~-----------~~~~~~~i~~~~~ 235 (417)
+.... |. ..+.||||+|||+|+|++|.+ ||.+.. ....++.+....+
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~ 461 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY 461 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence 75432 11 124799999999999999986 775421 1111222233333
Q ss_pred CCC--CCCChHHHHHHHHhccCCC---CCCCCHHHHhcCccccc
Q 014849 236 RCP--KWTSPDLKWFIGRLLDTDP---ATRITVDEILRDPWFKK 274 (417)
Q Consensus 236 ~~p--~~~s~~~~~li~~~L~~dP---~~R~t~~eil~h~~f~~ 274 (417)
.++ ...++.+.+|+.+||..+| .+|+|++|+|+||||..
T Consensus 462 ~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 462 DFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred CcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 333 3468899999999999766 68999999999999964
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=290.69 Aligned_cols=256 Identities=27% Similarity=0.447 Sum_probs=210.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-----EE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-----KI 91 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-----~~ 91 (417)
..+-.|.||.|+||.||.+.|..+|+.||+|.+..-. .+-....++-+|+++|...+|.|++..+++..... .+
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvf-q~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi 132 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVF-QNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL 132 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHH-HHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence 3456789999999999999999999999999886532 23334678889999999999999999999876654 47
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+++|++.. +|...|.. ..++.+.++-+++||+.||.|||+.||.||||||.|+|+++|+.+||||||+++..+....
T Consensus 133 YV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 133 YVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 889999854 88887765 7899999999999999999999999999999999999999999999999999987654332
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-------------------
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY------------------- 231 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~------------------- 231 (417)
..+ ...+-|.+|+|||++.+...++.++||||.|||+.|||..+..|...++.+...-|.
T Consensus 212 ~hM-TqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk 290 (449)
T KOG0664|consen 212 LNM-THEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK 290 (449)
T ss_pred hhh-HHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence 222 334669999999999988777799999999999999999999998776665444432
Q ss_pred ----cCCCCCCC-----------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 232 ----KGEYRCPK-----------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 232 ----~~~~~~p~-----------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++....|. ....+...++.++|.+||++|++.++.+.|++..+.
T Consensus 291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~e~ 349 (449)
T KOG0664|consen 291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLEEG 349 (449)
T ss_pred HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccccc
Confidence 22222221 223567789999999999999999999999988654
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=287.37 Aligned_cols=251 Identities=26% Similarity=0.402 Sum_probs=205.3
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
-...||.|+||+|++-.++.+|+..|||.|..... +....++..|.... +.-+.||||++|+..-.++.-|+.||+|
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM 145 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM 145 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH
Confidence 34578999999999999999999999999987654 23356777777654 4456899999999999999999999999
Q ss_pred CCCChHHHH------hcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 99 KGGELFAKI------SKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 99 ~gg~L~~~i------~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+- +|..+- .+.+++|+..-.+.--.+.||+||-. ..|+|||+||.||||+..|.+||||||++..... .
T Consensus 146 d~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~---S 221 (361)
T KOG1006|consen 146 DI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD---S 221 (361)
T ss_pred hh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH---H
Confidence 54 554322 23689999999999999999999985 5899999999999999999999999999864321 1
Q ss_pred CcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCCC---CC---CCC
Q 014849 172 GMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYRC---PK---WTS 242 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~~---p~---~~s 242 (417)
-..+.-.|...|||||.+.. .||+ .+||+||||+.|||+.||..||.. .+..+...++..+.++. +. ..|
T Consensus 222 iAkT~daGCrpYmAPERi~p~~~gyD-iRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s 300 (361)
T KOG1006|consen 222 IAKTVDAGCRPYMAPERIDPSDKGYD-IRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYS 300 (361)
T ss_pred HHhhhccCCccccChhccCCccCCcc-hhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccC
Confidence 12233468889999999864 4677 999999999999999999999975 44556666777776643 22 268
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..+.++|.-||.+|-+.||+..+++++||++....
T Consensus 301 ~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 301 FSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred HHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 89999999999999999999999999999986443
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=303.11 Aligned_cols=240 Identities=27% Similarity=0.467 Sum_probs=210.7
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+...||.|.||.||.+.++.-.-.||||.++-+.. ..+.+..|..+|+.++|||+|+|+++|..+-.+|||+|||
T Consensus 270 tMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM 345 (1157)
T KOG4278|consen 270 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFM 345 (1157)
T ss_pred eeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecc
Confidence 345679999999999999999888999999865542 3678899999999999999999999999999999999999
Q ss_pred CCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 99 KGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 99 ~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
..|+|.+++.. ..++.-....++.||.+||.||..+++|||||...|+|+.++..|||+||||+++... ....
T Consensus 346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtg----DTYT 421 (1157)
T KOG4278|consen 346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTG----DTYT 421 (1157)
T ss_pred cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcC----Ccee
Confidence 99999999975 3577778889999999999999999999999999999999999999999999998642 1122
Q ss_pred cccc---CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHH
Q 014849 176 TLCG---TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 176 ~~~G---t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 250 (417)
...| ..-|.|||.+.-..+. .++|||+|||+|||+.| |--||.+-+..+.|.-+-++ ...-|..+++.+.+|++
T Consensus 422 AHAGAKFPIKWTAPEsLAyNtFS-iKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGCPpkVYeLMr 500 (1157)
T KOG4278|consen 422 AHAGAKFPIKWTAPESLAYNTFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGCPPKVYELMR 500 (1157)
T ss_pred cccCccCcccccCcccccccccc-cchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCCCHHHHHHHH
Confidence 2223 4569999999877775 89999999999999976 89999999999888877665 35678999999999999
Q ss_pred HhccCCCCCCCCHHHHh
Q 014849 251 RLLDTDPATRITVDEIL 267 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil 267 (417)
.||+++|.+||++.||-
T Consensus 501 aCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 501 ACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHhcCCcccCccHHHHH
Confidence 99999999999999983
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=301.97 Aligned_cols=249 Identities=22% Similarity=0.287 Sum_probs=209.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
-++..+++.||+|-||.|.+|.- ..+..||+|.++.... ......+.+||++|.+|+|||||++++++...+.+++|
T Consensus 537 Rs~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~--~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI 613 (807)
T KOG1094|consen 537 RSRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDAT--KNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMI 613 (807)
T ss_pred hhheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccc--hhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHH
Confidence 35678899999999999999987 4478999999987653 33467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISKGRF---SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l---~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||++.|+|..++.+... ......+++.||++||+||.+.+++||||.|.|+|++.++++||+|||+|+-.......
T Consensus 614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence 999999999999987432 44556679999999999999999999999999999999999999999999855433333
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHH--HcCCCCCCCCCHHHHHHHHhc---C-----CCCCCCCC
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVL--NAGYLPFNDPNLMAMYRKIYK---G-----EYRCPKWT 241 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~l--l~G~~Pf~~~~~~~~~~~i~~---~-----~~~~p~~~ 241 (417)
......+-+.+|||||.+....++ .++|+|++|+.+||+ ++...||...+.++..++... . -+.-|.-+
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFt-taSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~c 772 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFT-TASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPAC 772 (807)
T ss_pred eeecceeeeeeehhHHHHHhcccc-chhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcC
Confidence 333334456889999999887775 899999999999986 568899998877776665432 1 13457778
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
+..+..||.+||..+-.+|||++++-
T Consensus 773 p~~lyelml~Cw~~es~~RPsFe~lh 798 (807)
T KOG1094|consen 773 PQGLYELMLRCWRRESEQRPSFEQLH 798 (807)
T ss_pred cHHHHHHHHHHhchhhhcCCCHHHHH
Confidence 89999999999999999999999993
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=314.35 Aligned_cols=250 Identities=27% Similarity=0.425 Sum_probs=218.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
....|.++||.|.||.||.|+.+..|+ .||||.++.-.. +.....+..|+.||-+..||||++|-++......+.
T Consensus 629 s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gyt--ekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvM 706 (996)
T KOG0196|consen 629 SCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVM 706 (996)
T ss_pred hheEEEEEEecccccceecccccCCCCcceeEEEeeeccCcc--HHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeE
Confidence 345789999999999999999987774 699999975432 233567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||+|||+.|+|..++.. |+++..+..-+++-|++||.||.+.|+|||||...|||++.|-..|++|||+|++.+...
T Consensus 707 IiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~- 785 (996)
T KOG0196|consen 707 IITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP- 785 (996)
T ss_pred EEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC-
Confidence 99999999999999975 889999999999999999999999999999999999999999999999999999775432
Q ss_pred CCccccccc--CccccccccccccCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHH
Q 014849 171 DGMLHTLCG--TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLK 246 (417)
Q Consensus 171 ~~~~~~~~G--t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 246 (417)
.....+..| ..+|.|||.+....++ .+|||||+||++||.+ .|..||.+....+.++.|..+ .++.|..++..+.
T Consensus 786 ~~~ytt~GGKIPiRWTAPEAIa~RKFT-sASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~aL~ 864 (996)
T KOG0196|consen 786 EAAYTTLGGKIPIRWTAPEAIAYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPAALY 864 (996)
T ss_pred CccccccCCccceeecChhHhhhcccC-chhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcHHHH
Confidence 333333333 4679999999988885 8999999999999755 699999999989999888766 4566778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcC
Q 014849 247 WFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h 269 (417)
.|+..||++|-..||++.||..+
T Consensus 865 qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 865 QLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred HHHHHHHHHHhhcCCCHHHHHHH
Confidence 99999999999999999999875
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-36 Score=337.30 Aligned_cols=238 Identities=22% Similarity=0.346 Sum_probs=189.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...|...+.||+|+||.||+|++..+|..||+|.+..... ...+|+.+|++++|||||++++++.+....|+|
T Consensus 689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv 761 (968)
T PLN00113 689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLI 761 (968)
T ss_pred HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEE
Confidence 3456777899999999999999999999999998864321 113568899999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---HcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH---SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH---~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||++||+|.+++. .+++..+..++.|++.||+||| +.+|+||||||+||+++.++..++. ||.+.....
T Consensus 762 ~Ey~~~g~L~~~l~--~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---- 834 (968)
T PLN00113 762 HEYIEGKNLSEVLR--NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---- 834 (968)
T ss_pred EeCCCCCcHHHHHh--cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc----
Confidence 99999999999996 4889999999999999999999 6699999999999999999888876 665533211
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-----HHHHHHHHhc---------CCC--
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-----LMAMYRKIYK---------GEY-- 235 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~-----~~~~~~~i~~---------~~~-- 235 (417)
..+..||+.|+|||++.+..|+ .++||||+||++|||++|+.||+... ..+....... ...
T Consensus 835 --~~~~~~t~~y~aPE~~~~~~~~-~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 911 (968)
T PLN00113 835 --DTKCFISSAYVAPETRETKDIT-EKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRG 911 (968)
T ss_pred --CCCccccccccCcccccCCCCC-cccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccC
Confidence 1234689999999999887775 89999999999999999999996421 1111111110 000
Q ss_pred --CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 --RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 --~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.....++.+++.+||+.||++|||+.|+++.
T Consensus 912 ~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 912 DVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred CCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 0011112346789999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=317.02 Aligned_cols=247 Identities=28% Similarity=0.423 Sum_probs=199.7
Q ss_pred EeeEEeeeCceE-EEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEEec
Q 014849 20 VGKIIGCGAFAK-VYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 20 i~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
--+++|.|+-|+ ||+|.. .|+.||||.+-.+. .+-+.|||..|+.. .|||||++|..-.+++.+||++|.
T Consensus 513 ~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL 584 (903)
T KOG1027|consen 513 PKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL 584 (903)
T ss_pred cHHHcccCCCCcEEEEEee--CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence 346789999986 799987 78899999875443 45678999999988 599999999999999999999999
Q ss_pred cCCCChHHHHhcC-C----CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CC--CeEEeeeecceeecc
Q 014849 98 AKGGELFAKISKG-R----FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NW--DLKISDFGLSAVKEQ 167 (417)
Q Consensus 98 ~~gg~L~~~i~~~-~----l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~--~vkl~DFGls~~~~~ 167 (417)
|.. +|.++++.. . ......+..+.|+++||++||+.+|+||||||+||||+. ++ .++|+|||++.....
T Consensus 585 C~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~ 663 (903)
T KOG1027|consen 585 CAC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAG 663 (903)
T ss_pred hhh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCC
Confidence 976 899999862 1 111345789999999999999999999999999999976 34 589999999976543
Q ss_pred cC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCCCCCCCC---CC
Q 014849 168 IR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGEYRCPKW---TS 242 (417)
Q Consensus 168 ~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~~~p~~---~s 242 (417)
.. .-....+..||-.|+|||++...... .++||||+||++|..++| ..||.+.- +...+|..+.+..-.. ..
T Consensus 664 ~~sS~~r~s~~sGt~GW~APE~L~~~~~~-~avDiFslGCvfyYvltgG~HpFGd~~--~R~~NIl~~~~~L~~L~~~~d 740 (903)
T KOG1027|consen 664 GKSSFSRLSGGSGTSGWQAPEQLREDRKT-QAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQANILTGNYTLVHLEPLPD 740 (903)
T ss_pred CcchhhcccCCCCcccccCHHHHhccccC-cccchhhcCceEEEEecCCccCCCchH--HhhhhhhcCccceeeeccCch
Confidence 22 22245677899999999999876654 789999999999987775 99998764 3334677776543221 12
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
.++.+||.+||.++|..||++.++|.||+|+...+.
T Consensus 741 ~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr 776 (903)
T KOG1027|consen 741 CEAKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR 776 (903)
T ss_pred HHHHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence 289999999999999999999999999999876554
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=302.82 Aligned_cols=206 Identities=31% Similarity=0.526 Sum_probs=186.8
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHH-----HHHHHHHHHHhCC---CCCcceE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA-----HVKREISIMSRLR---HPNIVKL 81 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~-----~i~~Ei~il~~l~---HpnIv~l 81 (417)
+...-+..|...+.||.|+||+|++|.+++....|+||.|.++++.-..+.+ .+-.||+||..++ |+||+++
T Consensus 555 ~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKl 634 (772)
T KOG1152|consen 555 KEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKL 634 (772)
T ss_pred eeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhh
Confidence 3344566799999999999999999999999999999999999886554433 2457999999998 9999999
Q ss_pred EEEEEeCCEEEEEEec-cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 82 YEVLATKAKIYFVMEF-AKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
+++|++++.+|++||- -+|.+||++|+. .+++|.++..+|+|++.|+++||+.||+|||||-+|+.++.+|-+||+||
T Consensus 635 LdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 635 LDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred hheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 9999999999999996 467899999986 78999999999999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN 219 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~ 219 (417)
|.|+.. ..++..+.+||..|.|||++.+..|-|..-|||+||++||.+.....||.
T Consensus 715 gsaa~~----ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYT----KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhh----cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 998764 45778899999999999999999999999999999999999988888875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-37 Score=309.72 Aligned_cols=266 Identities=30% Similarity=0.500 Sum_probs=229.9
Q ss_pred CCCCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEE
Q 014849 3 DNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82 (417)
Q Consensus 3 ~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~ 82 (417)
.-++.++++ .-.++|++.+.+|.|++|.||+|+++.+++..|+|+++.+-- ....-+..||-+++.++|||||.++
T Consensus 3 ~~~~disrr-nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~---dd~~~iqqei~~~~dc~h~nivay~ 78 (829)
T KOG0576|consen 3 SPKSDISRR-NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPG---DDFSGIQQEIGMLRDCRHPNIVAYF 78 (829)
T ss_pred Cccchhhhc-CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCC---ccccccccceeeeecCCCcChHHHH
Confidence 345566666 778899999999999999999999999999999999987642 2356678899999999999999999
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 83 EVLATKAKIYFVMEFAKGGELFAKIS-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 83 ~~~~~~~~~~lV~E~~~gg~L~~~i~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
+-+.....+|++||||.||+|.+.-. .|.++|.++...++..+.|++|||+.|-+|||||-.|||+++.|.+|++|||.
T Consensus 79 gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgv 158 (829)
T KOG0576|consen 79 GSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGV 158 (829)
T ss_pred hhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCc
Confidence 99999999999999999999988665 49999999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 238 (417)
++.... .-.......|||.|||||+-. ..+|. ..+|||++|+...++-.-++|..+...+....-..+..+..|
T Consensus 159 saqita--ti~KrksfiGtpywmapEvaaverkggyn-qlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 159 SAQITA--TIAKRKSFIGTPYWMAPEVAAVERKGGYN-QLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hhhhhh--hhhhhhcccCCccccchhHHHHHhccccc-ccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 875432 223445678999999999952 44564 999999999999999888888877777766666666666554
Q ss_pred -----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 -----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 -----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+++-+.+|++.+|..+|++|||++.+|.|||....
T Consensus 236 ~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 236 TLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred cccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 3458889999999999999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=288.17 Aligned_cols=132 Identities=26% Similarity=0.466 Sum_probs=114.9
Q ss_pred ccc-CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----C---CCcceEEE
Q 014849 13 NLF-GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----H---PNIVKLYE 83 (417)
Q Consensus 13 ~~~-~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----H---pnIv~l~~ 83 (417)
.+. +||-+.+.||.|-|++||+|.|..+.+.||+|+.+... ...+....||.+|++++ | .+||+|++
T Consensus 74 ~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD 149 (590)
T KOG1290|consen 74 VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLD 149 (590)
T ss_pred cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeec
Confidence 455 89999999999999999999999999999999987543 23556678999999984 3 36999999
Q ss_pred EEEe----CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEec
Q 014849 84 VLAT----KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLD 149 (417)
Q Consensus 84 ~~~~----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~ 149 (417)
.|.. ..+++||+|+. |-.|..+|.. +.++...++.|++||+.||+|||.+ ||||-||||+||||.
T Consensus 150 ~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 150 HFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC 222 (590)
T ss_pred cceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence 9854 46899999999 6688888875 6799999999999999999999965 999999999999983
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=299.89 Aligned_cols=246 Identities=26% Similarity=0.433 Sum_probs=207.4
Q ss_pred EEeeEEeeeCceEEEEEEEc---c----CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 19 EVGKIIGCGAFAKVYHGRNV---R----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~---~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
.+.+.||+|+||+|++|.-. . ....||||.+...... .....+..|+.+|+.+ +||||+.+++.+..++.
T Consensus 299 ~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~ 376 (609)
T KOG0200|consen 299 KLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP 376 (609)
T ss_pred cccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence 56779999999999999743 1 1457999998765432 4467889999999998 59999999999999999
Q ss_pred EEEEEeccCCCChHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 91 IYFVMEFAKGGELFAKISKGR-----------------FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
+++|+||+..|+|.+++...+ ++..+...++.||+.|++||++..++||||-..|||+..+..
T Consensus 377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~ 456 (609)
T KOG0200|consen 377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV 456 (609)
T ss_pred eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence 999999999999999998766 899999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCccccccc--CccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC-HHHHHHH
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCG--TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPN-LMAMYRK 229 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~G--t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~-~~~~~~~ 229 (417)
+||+|||+|+.......... ....| ...|||||.+....|+ .++||||+||+|||+++ |..||.+-. ..++++.
T Consensus 457 ~kIaDFGlar~~~~~~~y~~-~~~~~~LP~kWmApEsl~~~~ft-~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~ 534 (609)
T KOG0200|consen 457 IKIADFGLARDHYNKDYYRT-KSSAGTLPVKWMAPESLFDRVFT-SKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEF 534 (609)
T ss_pred EEEccccceeccCCCCceEe-cCCCCccceeecCHHHhccCccc-ccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHH
Confidence 99999999985432221111 11122 3349999999997775 99999999999999987 899998854 5667777
Q ss_pred HhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 230 IYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 230 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+..|. ...|...++++.++++.||+.+|++||++.++.+
T Consensus 535 l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~ 574 (609)
T KOG0200|consen 535 LKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVE 574 (609)
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence 77765 4778999999999999999999999999999965
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=248.82 Aligned_cols=212 Identities=44% Similarity=0.772 Sum_probs=187.0
Q ss_pred EeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 24 IGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 24 LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
||+|++|.||++.+..+|+.+++|++....... ....+.+|+..++.++|++|+++++++......++++|++.|++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999998889999999997664321 356789999999999999999999999999999999999999999
Q ss_pred HHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCCCCcccccccC
Q 014849 104 FAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180 (417)
Q Consensus 104 ~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt 180 (417)
.+++... .++...+..++.+++.++.+||++|++|+||+|.||+++. ++.++|+|||.+........ ......+.
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~ 156 (215)
T cd00180 79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGT 156 (215)
T ss_pred HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCC
Confidence 9999864 7999999999999999999999999999999999999999 89999999999876543211 23345678
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
..|++||.+......+.++|+|++|+++++| ..+.+++.+|++.||++|
T Consensus 157 ~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------~~~~~~l~~~l~~~p~~R 205 (215)
T cd00180 157 PAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------PELKDLIRKMLQKDPEKR 205 (215)
T ss_pred CCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------HHHHHHHHHHhhCCcccC
Confidence 8999999987762345899999999999999 678999999999999999
Q ss_pred CCHHHHhcCc
Q 014849 261 ITVDEILRDP 270 (417)
Q Consensus 261 ~t~~eil~h~ 270 (417)
|++.++++++
T Consensus 206 ~~~~~l~~~~ 215 (215)
T cd00180 206 PSAKEILEHL 215 (215)
T ss_pred cCHHHHhhCC
Confidence 9999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=272.75 Aligned_cols=248 Identities=25% Similarity=0.445 Sum_probs=199.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCcceEEEEEEeC--
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR--LRHPNIVKLYEVLATK-- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~HpnIv~l~~~~~~~-- 88 (417)
.+..+..+.+.+|+|.||.||+|.+ -|+.||||++.... .....||.+|.+. |+|+||+.+++.-...
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~g 279 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNG 279 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc--cCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCC
Confidence 3466789999999999999999999 58899999996542 4566778877765 5999999999874322
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCeEEee
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR--------GVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~--------givHrDlkp~NILl~~~~~vkl~D 158 (417)
+.+|+|++|-+.|+|+|++....++.+...+++..+++||++||.. .|+|||||..|||+..||..-|+|
T Consensus 280 s~TQLwLvTdYHe~GSL~DyL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IAD 359 (513)
T KOG2052|consen 280 SWTQLWLVTDYHEHGSLYDYLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 359 (513)
T ss_pred ceEEEEEeeecccCCcHHHHHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEee
Confidence 4799999999999999999999999999999999999999999954 599999999999999999999999
Q ss_pred eecceeeccc--CCCCcccccccCcccccccccccc----CCC-CChhhHHHHHHHHHHHHc----------CCCCCC--
Q 014849 159 FGLSAVKEQI--RPDGMLHTLCGTPAYVAPEILAKK----GYD-GAKVDMWSCGVVLFVLNA----------GYLPFN-- 219 (417)
Q Consensus 159 FGls~~~~~~--~~~~~~~~~~Gt~~y~APEvl~~~----~y~-~~~sDIwSlGvil~~ll~----------G~~Pf~-- 219 (417)
+|||-...+. .-+-..+..+||.+|||||++... -++ -..+||||+|.|+||+.. -++||.
T Consensus 360 LGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~ 439 (513)
T KOG2052|consen 360 LGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDV 439 (513)
T ss_pred ceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccC
Confidence 9999765443 123355778999999999998542 111 146899999999999864 258885
Q ss_pred ---CCCHHHHHHHHhcCCC--CCC-CCCChH----HHHHHHHhccCCCCCCCCHHHHhc
Q 014849 220 ---DPNLMAMYRKIYKGEY--RCP-KWTSPD----LKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 220 ---~~~~~~~~~~i~~~~~--~~p-~~~s~~----~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+++.++|.+-+.-.++ ..| .|.|.+ +..+++.||..||.-|.|+--|.+
T Consensus 440 Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKK 498 (513)
T KOG2052|consen 440 VPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKK 498 (513)
T ss_pred CCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHH
Confidence 4677777666554433 334 455544 356889999999999999877754
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-33 Score=277.13 Aligned_cols=244 Identities=26% Similarity=0.382 Sum_probs=200.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC---
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR--LRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~HpnIv~l~~~~~~~~--- 89 (417)
.....+.+++|+|.||.||+|.. +++.||||++.... .+.+.+|-.|.+. ++|+||+++++.-...+
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~------kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~ 280 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQE------KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADR 280 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc--cCceeEEEecCHHH------HHHHHhHHHHHhccCccchhHHHhhchhccCCccc
Confidence 44567889999999999999997 66999999997654 4566677777665 57999999998865444
Q ss_pred -EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEecCCCCeEEeee
Q 014849 90 -KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR---------GVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~---------givHrDlkp~NILl~~~~~vkl~DF 159 (417)
.+++|+||-+.|+|.+++....++.....+++..++.||+|||+. +|+|||||..||||.+|++.-|+||
T Consensus 281 ~eywLVt~fh~kGsL~dyL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 281 MEYWLVTEFHPKGSLCDYLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred cceeEEeeeccCCcHHHHHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 899999999999999999999999999999999999999999964 6999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCC-----CChhhHHHHHHHHHHHHcCC------------CCCC---
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD-----GAKVDMWSCGVVLFVLNAGY------------LPFN--- 219 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~-----~~~sDIwSlGvil~~ll~G~------------~Pf~--- 219 (417)
|+|..+....+.+..+..+||.+|||||++.+.--- -.+.||||+|.+||||++.. +||.
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~ev 440 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEV 440 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHh
Confidence 999988877777888889999999999999754221 13689999999999997642 4453
Q ss_pred --CCCHHHHHHHHhcC--CCCCCCCC-----ChHHHHHHHHhccCCCCCCCCHHHH
Q 014849 220 --DPNLMAMYRKIYKG--EYRCPKWT-----SPDLKWFIGRLLDTDPATRITVDEI 266 (417)
Q Consensus 220 --~~~~~~~~~~i~~~--~~~~p~~~-----s~~~~~li~~~L~~dP~~R~t~~ei 266 (417)
.+...+|.....+. ++.+|..+ -..+.+.+..||+.||+-|.|+.=+
T Consensus 441 G~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv 496 (534)
T KOG3653|consen 441 GNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCV 496 (534)
T ss_pred cCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence 35666666655543 34444322 3456788999999999999997544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=265.88 Aligned_cols=257 Identities=27% Similarity=0.437 Sum_probs=205.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEE-EEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEV-LATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~-~~~~~ 89 (417)
..+.+.|.|.+.||+|.||++.+|+++.+.+.+++|.+.+.... ...+.+|..-=-.| .|.||+.-|++ |++.+
T Consensus 20 v~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d 95 (378)
T KOG1345|consen 20 VDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSD 95 (378)
T ss_pred cchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence 56789999999999999999999999999999999999876532 45667776543334 48999999987 68888
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CC-CCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-EN-WDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~-~~vkl~DFGls~~~~~ 167 (417)
.+++++||++-|+|.+-+...++-|....+++.||++|+.|+|++++||||||.+||||- .| -.+||||||+++..+
T Consensus 96 ~YvF~qE~aP~gdL~snv~~~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g- 174 (378)
T KOG1345|consen 96 AYVFVQEFAPRGDLRSNVEAAGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVG- 174 (378)
T ss_pred eEEEeeccCccchhhhhcCcccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccC-
Confidence 999999999999999999998999999999999999999999999999999999999993 22 369999999987533
Q ss_pred cCCCCcccccccCcccccccccccc---CC-CCChhhHHHHHHHHHHHHcCCCCCCCCCH----HHHHHHHhcCC-CCCC
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKK---GY-DGAKVDMWSCGVVLFVLNAGYLPFNDPNL----MAMYRKIYKGE-YRCP 238 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~---~y-~~~~sDIwSlGvil~~ll~G~~Pf~~~~~----~~~~~~i~~~~-~~~p 238 (417)
...+..--+..|.|||++... .+ ..+.+|||.+|+|+|..|+|.+||..... -..+.+...+. ...|
T Consensus 175 ----~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P 250 (378)
T KOG1345|consen 175 ----TTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPALP 250 (378)
T ss_pred ----ceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCccCc
Confidence 222333346779999986432 11 14778999999999999999999974322 22333444333 3344
Q ss_pred ---CCCChHHHHHHHHhccCCCCCC---CCHHHHhcCcccccccc
Q 014849 239 ---KWTSPDLKWFIGRLLDTDPATR---ITVDEILRDPWFKKDYK 277 (417)
Q Consensus 239 ---~~~s~~~~~li~~~L~~dP~~R---~t~~eil~h~~f~~~~~ 277 (417)
..+|+.+.++.++-|.++|++| .++...+...|......
T Consensus 251 ~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~~i~ 295 (378)
T KOG1345|consen 251 KKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEKLIK 295 (378)
T ss_pred hhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHhhhc
Confidence 3469999999999999999999 56667777777765444
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=289.95 Aligned_cols=247 Identities=24% Similarity=0.350 Sum_probs=210.6
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
.+.+++||+|+||+||+|.+...|+ +||||++..... ......+.+|+-+|.+|+|||+++|++++.... +-|
T Consensus 698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~ql 774 (1177)
T KOG1025|consen 698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQL 774 (1177)
T ss_pred hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHH
Confidence 4557899999999999999876665 588888876543 334678899999999999999999999998776 889
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|++|+++|.|.+++.. +.+--+....|..||++||.|||.++++||||-..|+|+..-.++||+|||++.+.......
T Consensus 775 vtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 775 VTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred HHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 9999999999999874 67888899999999999999999999999999999999999999999999999876543222
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
-......-.+.|||=|.+....|. .++||||+||.+||++| |.-|+.+....++-.-+..++ ...|+..+-++..++
T Consensus 855 y~~~~gK~pikwmale~i~~~~~t-hqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsqPpiCtiDVy~~m 933 (1177)
T KOG1025|consen 855 YSAPGGKVPIKWMALESIRIRKYT-HQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQPPICTIDVYMVM 933 (1177)
T ss_pred ccccccccCcHHHHHHHhhccCCC-chhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCCCCCccHHHHHHH
Confidence 111222235669999999988885 99999999999999987 999999988887777666654 678999999999999
Q ss_pred HHhccCCCCCCCCHHHHhc
Q 014849 250 GRLLDTDPATRITVDEILR 268 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~ 268 (417)
.+||-.|+..||+++++..
T Consensus 934 vkCwmid~~~rp~fkel~~ 952 (1177)
T KOG1025|consen 934 VKCWMIDADSRPTFKELAE 952 (1177)
T ss_pred HHHhccCcccCccHHHHHH
Confidence 9999999999999988754
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=250.94 Aligned_cols=219 Identities=43% Similarity=0.702 Sum_probs=187.9
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
|++++.||.|++|.||+|.+..+++.+|+|.+...... .....+.+|+..++.++|+|++++++.+......++++|+
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 67899999999999999999989999999999875432 2467888999999999999999999999999999999999
Q ss_pred cCCCChHHHHhc-CC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 98 AKGGELFAKISK-GR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 98 ~~gg~L~~~i~~-~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
+++++|.+.+.. .. +++..+..++.|++.++.+||++|++|+||+|.||+++.++.++|+|||++........ ....
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~-~~~~ 157 (225)
T smart00221 79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLA-ALLK 157 (225)
T ss_pred cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccc-cccc
Confidence 999999999976 34 89999999999999999999999999999999999999999999999999876543221 1334
Q ss_pred ccccCccccccccc-cccCCCCChhhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHHHhcCCCCCCCC
Q 014849 176 TLCGTPAYVAPEIL-AKKGYDGAKVDMWSCGVVLFVLNAGYLPFND--PNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 176 ~~~Gt~~y~APEvl-~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~i~~~~~~~p~~ 240 (417)
..+++..|++||.+ ....+. .++|+||||+++++|++|+.||.. .+...+.+.+..+.....+|
T Consensus 158 ~~~~~~~~~~pe~~~~~~~~~-~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 224 (225)
T smart00221 158 TVKGTPFYLAPEVLLGGKGYG-EAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWEW 224 (225)
T ss_pred ceeccCCcCCHhHhcCCCCCC-chhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCcccccc
Confidence 56788999999998 455554 699999999999999999999987 44447778887776554443
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=273.96 Aligned_cols=255 Identities=26% Similarity=0.467 Sum_probs=203.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~ 88 (417)
.+...|.+...+|+|+|+.||+|.+.. ..+.||+|.+.... ...++.+|+++|..+. +.||+.+.+.+..+
T Consensus 33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn 107 (418)
T KOG1167|consen 33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNN 107 (418)
T ss_pred hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccC
Confidence 456789999999999999999999887 78899999987653 2567899999999995 99999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~~ 167 (417)
+...+|+||++.-+-.++... ++-.+++.|++.++.||.++|.+||+||||||.|+|.+.. +.-.|.|||+|...+.
T Consensus 108 d~v~ivlp~~~H~~f~~l~~~--l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~ 185 (418)
T KOG1167|consen 108 DQVAIVLPYFEHDRFRDLYRS--LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDG 185 (418)
T ss_pred CeeEEEecccCccCHHHHHhc--CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHh
Confidence 999999999999888887764 6788899999999999999999999999999999999754 5689999999862110
Q ss_pred cC--------------C-----------------CC-----------cccccccCccccccccccccCCCCChhhHHHHH
Q 014849 168 IR--------------P-----------------DG-----------MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCG 205 (417)
Q Consensus 168 ~~--------------~-----------------~~-----------~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlG 205 (417)
.. + .+ ......|||+|+|||++...+-.++++||||.|
T Consensus 186 ~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~G 265 (418)
T KOG1167|consen 186 YQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAG 265 (418)
T ss_pred hhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecc
Confidence 00 0 00 001246999999999999888888999999999
Q ss_pred HHHHHHHcCCCCCCCC-CHHHHHHHHh--------------cCC---------------------------CCCC-----
Q 014849 206 VVLFVLNAGYLPFNDP-NLMAMYRKIY--------------KGE---------------------------YRCP----- 238 (417)
Q Consensus 206 vil~~ll~G~~Pf~~~-~~~~~~~~i~--------------~~~---------------------------~~~p----- 238 (417)
||+.-++++..||-.. +.......|. -|. .++.
T Consensus 266 VI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~ 345 (418)
T KOG1167|consen 266 VILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTE 345 (418)
T ss_pred ceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccccccee
Confidence 9999999999999321 0000000000 000 0000
Q ss_pred -----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 -----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 -----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..++..+.+|+.+||..||.+|+|+++.|+||||..
T Consensus 346 ~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~ 386 (418)
T KOG1167|consen 346 REIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDE 386 (418)
T ss_pred eccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence 112457899999999999999999999999999983
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=246.99 Aligned_cols=210 Identities=25% Similarity=0.450 Sum_probs=173.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 94 (417)
+...-+..||+|++|.|-+-++..+|+..|+|.+...- .....+++.+|+.+..+. .+|.+|.+|+.+.....+|+.
T Consensus 46 d~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIc 123 (282)
T KOG0984|consen 46 DDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWIC 123 (282)
T ss_pred hhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEe
Confidence 34455778999999999999999999999999997543 233456777888876654 689999999999999999999
Q ss_pred EeccCCCChHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 95 MEFAKGGELFAKI----SK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i----~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
||.|+. +|..+- .+ +..+|...-+++..++.||.|||++ .|+|||+||.|||++.+|++|+||||+|....
T Consensus 124 ME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~-- 200 (282)
T KOG0984|consen 124 MELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLV-- 200 (282)
T ss_pred HHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeeh--
Confidence 999964 675543 33 6799999999999999999999987 79999999999999999999999999997543
Q ss_pred CCCCcccc-cccCcccccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcC
Q 014849 169 RPDGMLHT-LCGTPAYVAPEILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKG 233 (417)
Q Consensus 169 ~~~~~~~~-~~Gt~~y~APEvl~----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~ 233 (417)
+....+ -.|...|||||.+. .++|+ .+|||||||+.++||.+++.||+. .++.+.++++...
T Consensus 201 --dSiAkt~daGCkpYmaPEri~~e~n~~gY~-vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVee 268 (282)
T KOG0984|consen 201 --DSIAKTMDAGCKPYMAPERINPELNQKGYS-VKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEE 268 (282)
T ss_pred --hhhHHHHhcCCCccCChhhcCcccCcccce-eehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcC
Confidence 222233 56888999999975 34776 999999999999999999999974 5666777776654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=299.41 Aligned_cols=200 Identities=17% Similarity=0.187 Sum_probs=148.7
Q ss_pred hCCC-CCcceEEEEE-------EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 014849 72 RLRH-PNIVKLYEVL-------ATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL 141 (417)
Q Consensus 72 ~l~H-pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDl 141 (417)
.++| +||+++++.+ .....+++++|++ +++|.+++.. +.+++.+++.++.||+.||+|||++||+||||
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDl 106 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNV 106 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 3455 5777788776 2334678889987 5699999975 46999999999999999999999999999999
Q ss_pred CCCcEEecC-------------------CCCeEEeeeecceeecccCC--------------CCcccccccCcccccccc
Q 014849 142 KLENLLLDE-------------------NWDLKISDFGLSAVKEQIRP--------------DGMLHTLCGTPAYVAPEI 188 (417)
Q Consensus 142 kp~NILl~~-------------------~~~vkl~DFGls~~~~~~~~--------------~~~~~~~~Gt~~y~APEv 188 (417)
||+||||+. ++.+|++|||+++....... .......+||+.|||||+
T Consensus 107 KP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~ 186 (793)
T PLN00181 107 RPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEE 186 (793)
T ss_pred CchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhh
Confidence 999999965 34566666666643211000 000112468999999999
Q ss_pred ccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 189 l~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
+.+..| +.++|||||||+||||++|.+|+.... .....+.....+ .+....+....++.+||++||.+|||+.|++
T Consensus 187 ~~~~~~-~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~~P~~Rps~~eil 263 (793)
T PLN00181 187 DNGSSS-NCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWLLHPEPSCRPSMSELL 263 (793)
T ss_pred hccCCC-CchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHhCCCChhhCcChHHHh
Confidence 998888 499999999999999999999976432 122222211111 1112356678999999999999999999999
Q ss_pred cCcccccc
Q 014849 268 RDPWFKKD 275 (417)
Q Consensus 268 ~h~~f~~~ 275 (417)
+||||.+.
T Consensus 264 ~h~~~~~~ 271 (793)
T PLN00181 264 QSEFINEP 271 (793)
T ss_pred hchhhhhh
Confidence 99999753
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-33 Score=293.65 Aligned_cols=263 Identities=31% Similarity=0.518 Sum_probs=211.4
Q ss_pred ccCCe-EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecc---cccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 14 LFGKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ---KILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 14 ~~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~---~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
+..+| .-.+++|.|++|.|+.+.........+.|..... ..........+..|..+-..++|||++.....+....
T Consensus 315 ~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~ 394 (601)
T KOG0590|consen 315 FSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEID 394 (601)
T ss_pred cccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcc
Confidence 34556 5688999999999999988877777777765421 1111122233667888888899999988777776666
Q ss_pred EEEEEEeccCCCChHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~-~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.++.+||||++ +|+.++... .++..++..+|+||+.||+|+|+.||.|||+||+|+++..+|.+||+|||.+..+...
T Consensus 395 ~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~ 473 (601)
T KOG0590|consen 395 GILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYP 473 (601)
T ss_pred cchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccC
Confidence 66777999999 999999884 9999999999999999999999999999999999999999999999999999876554
Q ss_pred CCC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH-H--------HHhcCCCCC
Q 014849 169 RPD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY-R--------KIYKGEYRC 237 (417)
Q Consensus 169 ~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~-~--------~i~~~~~~~ 237 (417)
... ......||+..|+|||++.+..|+...+||||+|+|++.|.+|+.||.-....+.. . ++..+..+.
T Consensus 474 ~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~ 553 (601)
T KOG0590|consen 474 WEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRL 553 (601)
T ss_pred cchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHH
Confidence 444 46677899999999999999999999999999999999999999999754433211 1 111111222
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
-..++...+.+|.+||++||.+|+|+++|++++||+....
T Consensus 554 ~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~ 593 (601)
T KOG0590|consen 554 LSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC 593 (601)
T ss_pred HHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence 2334677889999999999999999999999999997544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-28 Score=234.70 Aligned_cols=255 Identities=33% Similarity=0.533 Sum_probs=214.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC-CcceEEEEEEeCCEEEEEEe
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP-NIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp-nIv~l~~~~~~~~~~~lV~E 96 (417)
|++.+.||.|+|+.||.+.+. ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 78 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVME 78 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEe
Confidence 889999999999999999997 88999999887654444577889999999999988 79999999988888999999
Q ss_pred ccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~~ 171 (417)
++.++++.+.+... .+++..+..++.|++.++.|+|+.|++|||+||+||+++..+ .++++|||++.........
T Consensus 79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~ 158 (384)
T COG0515 79 YVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158 (384)
T ss_pred cCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence 99999999777763 699999999999999999999999999999999999999998 6999999998754332221
Q ss_pred ----CcccccccCcccccccccccc--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCC-CCCC
Q 014849 172 ----GMLHTLCGTPAYVAPEILAKK--GYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYR-CPKW 240 (417)
Q Consensus 172 ----~~~~~~~Gt~~y~APEvl~~~--~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~-~p~~ 240 (417)
......+||+.|+|||.+... .+.....|+||+|++++++++|..||.... .......+.....+ ....
T Consensus 159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (384)
T COG0515 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP 238 (384)
T ss_pred ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence 135778999999999999874 455689999999999999999999998776 34555555554433 2222
Q ss_pred CC--------hHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TS--------PDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s--------~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.. ..+.+++.+++..+|..|.+..+...++|....
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~~ 281 (384)
T COG0515 239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHL 281 (384)
T ss_pred cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhhCc
Confidence 22 468999999999999999999999988766543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-31 Score=268.73 Aligned_cols=240 Identities=34% Similarity=0.564 Sum_probs=211.3
Q ss_pred EEeeeCceEEEEEE---EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEecc
Q 014849 23 IIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~---~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
++|+|+||+|++++ ..+.|+.+|+|+..+......... +-..|-.++..++ ||.+|+++..++++++.|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 47999999998764 446888999999988765443323 5566888888887 999999999999999999999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTL 177 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~ 177 (417)
.||+|+..+.. ..+.+...+.+...++.+++++|+.||+|||+|++||+++.+|++++.|||++...-.. ...
T Consensus 80 rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~------~~~ 153 (612)
T KOG0603|consen 80 RGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKE------KIA 153 (612)
T ss_pred ccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhh------hhc
Confidence 99999999887 67888899999999999999999999999999999999999999999999998754221 122
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP 257 (417)
|||..|||||+++ ++. ..+|.||+|+++|+|++|..||.. +....|.+.++..|...+..+++++..++..+|
T Consensus 154 cgt~eymApEI~~--gh~-~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~~l~~~a~~~~~~l~~r~p 226 (612)
T KOG0603|consen 154 CGTYEYRAPEIIN--GHL-SAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPRELSAEARSLFRQLFKRNP 226 (612)
T ss_pred ccchhhhhhHhhh--ccC-CcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCchhhhHHHHHHHHHHHhhCH
Confidence 9999999999998 554 889999999999999999999988 777888999999999999999999999999999
Q ss_pred CCCCC-----HHHHhcCccccccc
Q 014849 258 ATRIT-----VDEILRDPWFKKDY 276 (417)
Q Consensus 258 ~~R~t-----~~eil~h~~f~~~~ 276 (417)
..|.- +.||++|+||+...
T Consensus 227 ~nrLg~~~~~~~eik~h~f~~~i~ 250 (612)
T KOG0603|consen 227 ENRLGAGPDGVDEIKQHEFFQSID 250 (612)
T ss_pred HHHhccCcchhHHHhccchheeee
Confidence 99984 68999999998643
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=226.55 Aligned_cols=158 Identities=22% Similarity=0.206 Sum_probs=129.1
Q ss_pred CChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 101 GELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 101 g~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
|+|.+++.. +.+++.+++.++.|++.||.|||+++ ||+|||++.++.+|+ ||++...... ..+
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~-------~~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE-------QSR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc-------cCC
Confidence 689999974 46999999999999999999999999 999999999999999 9998765431 236
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCCC-------CCCCCh--HHHHH
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYRC-------PKWTSP--DLKWF 248 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~l 248 (417)
||+.|+|||++.+..|+ .++||||+||++|+|++|..||..... ......+....... +...+. ++.++
T Consensus 66 g~~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (176)
T smart00750 66 VDPYFMAPEVIQGQSYT-EKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADF 144 (176)
T ss_pred CcccccChHHhcCCCCc-chhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHH
Confidence 89999999999988885 899999999999999999999976543 23333333222111 122233 68999
Q ss_pred HHHhccCCCCCCCCHHHHhcCccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
|.+||..||.+|||+.|+++|+|+..
T Consensus 145 i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 145 MRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred HHHHHhcccccccCHHHHHHHHHHHH
Confidence 99999999999999999999999863
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=238.29 Aligned_cols=251 Identities=20% Similarity=0.258 Sum_probs=206.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE-EeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ-----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL-ATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~ 88 (417)
..|+++.-++-+|+||.||.|.+++... .|-+|.+.... .+-....+..|--.+..+.|||+.+..++. ++.
T Consensus 283 r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~ 360 (563)
T KOG1024|consen 283 RCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY 360 (563)
T ss_pred hhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc
Confidence 4578888899999999999998765433 35555443221 112245566788888888999999999986 556
Q ss_pred CEEEEEEeccCCCChHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 89 AKIYFVMEFAKGGELFAKISK---------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~---------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
...++++.+..-|+|..++.. +.++..+...++.|++.|++|||++||+|.||...|.+||+.-.+||+|=
T Consensus 361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs 440 (563)
T KOG1024|consen 361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS 440 (563)
T ss_pred CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence 678888999999999888862 24677788899999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRC 237 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~ 237 (417)
.+|+..-..+..-.-...-.+..||+||.+.+..|. .++|+|||||+||||++ |+.|+-+-++.+++.-+.+|. ..-
T Consensus 441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~ys-sasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ 519 (563)
T KOG1024|consen 441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYS-SASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ 519 (563)
T ss_pred hhccccCcccccccCCCCCCcccccCHHHHhhhhhc-chhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence 999865443333333334456779999999999986 88999999999999986 999999999999999988874 566
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
|-.+++++...+.-||..+|++||+++|+..
T Consensus 520 P~NCPDeLf~vMacCWallpeeRPsf~Qlv~ 550 (563)
T KOG1024|consen 520 PFNCPDELFTVMACCWALLPEERPSFSQLVI 550 (563)
T ss_pred CCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence 8888999999999999999999999999854
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=244.93 Aligned_cols=172 Identities=20% Similarity=0.231 Sum_probs=137.8
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccc--cccchHHHHHHHHHHHHhCCCCCcce-EEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLRHPNIVK-LYEVL 85 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~--~~~~~~~~i~~Ei~il~~l~HpnIv~-l~~~~ 85 (417)
....+.++|++++.||+|+||+||+|++.. +++.||||++..... ........+.+|+.+|+.++|+|++. +++.
T Consensus 12 ~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~- 90 (365)
T PRK09188 12 QIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT- 90 (365)
T ss_pred ccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc-
Confidence 446789999999999999999999999876 788889998753311 12234567899999999999999985 5442
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCeEEeeeeccee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL-KLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDl-kp~NILl~~~~~vkl~DFGls~~ 164 (417)
+..|+||||++|++|... .. .. ...++.|++.||.|||++||+|||| ||+|||++.++.+||+|||+|+.
T Consensus 91 ---~~~~LVmE~~~G~~L~~~-~~--~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~ 161 (365)
T PRK09188 91 ---GKDGLVRGWTEGVPLHLA-RP--HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASV 161 (365)
T ss_pred ---CCcEEEEEccCCCCHHHh-Cc--cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcccee
Confidence 458999999999999732 21 11 2578899999999999999999999 99999999999999999999986
Q ss_pred ecccCCCC------cccccccCccccccccccc
Q 014849 165 KEQIRPDG------MLHTLCGTPAYVAPEILAK 191 (417)
Q Consensus 165 ~~~~~~~~------~~~~~~Gt~~y~APEvl~~ 191 (417)
........ ...+.++++.|+|||.+..
T Consensus 162 ~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 162 FRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 54332222 2357789999999999864
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.9e-26 Score=223.22 Aligned_cols=248 Identities=23% Similarity=0.296 Sum_probs=194.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCC----CCcceEEEEE-EeCCE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH----PNIVKLYEVL-ATKAK 90 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H----pnIv~l~~~~-~~~~~ 90 (417)
+|.+.+.||+|+||.||+|.+..++ ..+|+|+........ ...+..|+.+|..+.. +++.++++.. .+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~---~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSK---PSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCC---CccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999997775 689999887653222 1267789999998873 6899999999 58888
Q ss_pred EEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----CCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-----WDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-----~~vkl~DFGls 162 (417)
-|+||+.+ |.+|.++... ++++...+..++.|++.+|.++|+.|++||||||.|+++... ..+.|.|||++
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGla 174 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLA 174 (322)
T ss_pred eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCC
Confidence 99999999 7799997743 689999999999999999999999999999999999999765 35999999999
Q ss_pred eeecccCC-------CCc-ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHHh
Q 014849 163 AVKEQIRP-------DGM-LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---AMYRKIY 231 (417)
Q Consensus 163 ~~~~~~~~-------~~~-~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---~~~~~i~ 231 (417)
+....... ... .....||..|+++.+..+... +.+.|+||++.++.+|+.|.+||...... ..+.+..
T Consensus 175 r~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~-~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~ 253 (322)
T KOG1164|consen 175 RRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQ-GRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDP 253 (322)
T ss_pred ccccccCCCCcccccCCCCccCCCCccccccHHHhCCCcc-CCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHh
Confidence 83221111 111 233459999999999887776 59999999999999999999999765432 2222222
Q ss_pred cCCCC--CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..... .....+..+..+...+-..+...+|....+...
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 254 RKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 22221 223345677777777777899999988877655
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.5e-27 Score=246.35 Aligned_cols=226 Identities=31% Similarity=0.574 Sum_probs=184.1
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
+........|+.+|++..|++|.||+.+++.|.+.+|+| ++++... .|- ++.....|.+|
T Consensus 76 s~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li--------lRn--ilt~a~npfvv--------- 135 (1205)
T KOG0606|consen 76 SRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI--------LRN--ILTFAGNPFVV--------- 135 (1205)
T ss_pred cccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh--------hhc--cccccCCccee---------
Confidence 366777889999999999999999999999999999994 5544321 111 44445566555
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|+-...++. |.++.+. +.+++|+|+.||+|||+||+|+||..=|++|++|||++..--.
T Consensus 136 ------------gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLm 195 (1205)
T KOG0606|consen 136 ------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLM 195 (1205)
T ss_pred ------------chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhh
Confidence 566666655 6677655 7899999999999999999999999999999999999864211
Q ss_pred cCCC----C---------cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Q 014849 168 IRPD----G---------MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 168 ~~~~----~---------~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
.... + .-...||||.|+||||+..+|| |..+|+|++|+|+|+++-|..||.+.+.++++.+.....
T Consensus 196 s~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgy-gkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~ 274 (1205)
T KOG0606|consen 196 SLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGY-GKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD 274 (1205)
T ss_pred hccchhhhcchHHHHHHhhhccccCCccccChhhhhhhcc-CCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh
Confidence 1110 0 1123599999999999999999 699999999999999999999999999999999998877
Q ss_pred CCCCCC---CChHHHHHHHHhccCCCCCCC---CHHHHhcCcccccc
Q 014849 235 YRCPKW---TSPDLKWFIGRLLDTDPATRI---TVDEILRDPWFKKD 275 (417)
Q Consensus 235 ~~~p~~---~s~~~~~li~~~L~~dP~~R~---t~~eil~h~~f~~~ 275 (417)
...|.. ..++++++|.++|+.+|..|. .+-++++|+||+..
T Consensus 275 i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 275 IEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred ccccccCcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 666543 578999999999999999998 58899999999863
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-26 Score=245.74 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=194.1
Q ss_pred CCCCCCCcccc-------ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-cccchHHHHHHHHHHHHh
Q 014849 1 MGDNTGDISRE-------VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLTAHVKREISIMSR 72 (417)
Q Consensus 1 ~~~~~~~~~~~-------~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~ 72 (417)
||+|...-+.. ..+...|...+.||.+.|=+|.+|++. .|. |+||++-+... ..-....+..+|++ ...
T Consensus 1 MGnqls~~sQi~~~e~yfsd~~~e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l 77 (1431)
T KOG1240|consen 1 MGNQLSLPSQISPVEVYFSDLSVECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FAL 77 (1431)
T ss_pred CCcccccccccchHHHHhhcCccceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHh
Confidence 78876642221 234457899999999999999999994 444 99999977652 12222344455666 677
Q ss_pred CCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 73 l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~-l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
++|||.+.+.-+..+...-|+|-+|+.. +|+|.+..++ +..-+.+.|+.||+.||..||..||+|||||.|||||+.-
T Consensus 78 ~~~pn~lPfqk~~~t~kAAylvRqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSW 156 (1431)
T KOG1240|consen 78 MKAPNCLPFQKVLVTDKAAYLVRQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSW 156 (1431)
T ss_pred hcCCcccchHHHHHhhHHHHHHHHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeee
Confidence 8999999999888888899999999976 8999999865 6777889999999999999999999999999999999999
Q ss_pred CCeEEeeeecceee--cccCCCC---cccccccCccccccccccccC-C---------CCChhhHHHHHHHHHHHHc-CC
Q 014849 152 WDLKISDFGLSAVK--EQIRPDG---MLHTLCGTPAYVAPEILAKKG-Y---------DGAKVDMWSCGVVLFVLNA-GY 215 (417)
Q Consensus 152 ~~vkl~DFGls~~~--~~~~~~~---~~~~~~Gt~~y~APEvl~~~~-y---------~~~~sDIwSlGvil~~ll~-G~ 215 (417)
..+.|+||..-... ...++.. ...|..--.+|.|||.+...+ + -+++.||||+||+++||++ |+
T Consensus 157 NW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~ 236 (1431)
T KOG1240|consen 157 NWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGR 236 (1431)
T ss_pred chhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCC
Confidence 99999999743211 1111111 223444456799999986532 1 1467899999999999976 79
Q ss_pred CCCCCCC-----------HHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 216 LPFNDPN-----------LMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 216 ~Pf~~~~-----------~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+||.-.. .....++| .+..++.||..|++.||++|.++++.|+.
T Consensus 237 PlF~LSQL~aYr~~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~ 291 (1431)
T KOG1240|consen 237 PLFTLSQLLAYRSGNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQK 291 (1431)
T ss_pred CcccHHHHHhHhccCccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHh
Confidence 9995322 22222222 35679999999999999999999999986
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.2e-25 Score=199.56 Aligned_cols=244 Identities=26% Similarity=0.355 Sum_probs=193.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-PNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~ 90 (417)
-...++|++++.||+|+||.+|+|....+|..||||+-+... --.++..|..+.+.|++ ..|..+..+..++..
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a-----~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~y 85 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA-----KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDY 85 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC-----CCcchhHHHHHHHHhccCCCCchhhhhcccccc
Confidence 356789999999999999999999999999999999865432 14577789999999986 778888888888889
Q ss_pred EEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~~ 165 (417)
-.+||++. |.+|.++.. .++++...+.-++-|++.-++|+|.++++||||||+|+|+.-+- .+.++|||+|...
T Consensus 86 nvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky 164 (341)
T KOG1163|consen 86 NVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY 164 (341)
T ss_pred ceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhh
Confidence 99999999 779998875 47899999999999999999999999999999999999986443 5899999999765
Q ss_pred cccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCC
Q 014849 166 EQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRC 237 (417)
Q Consensus 166 ~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~ 237 (417)
..... ...-....||..|.+--...+... +..-|+-|+|.+|..+..|.+||.+-. ..+-+++|...+...
T Consensus 165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eq-SRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~ 243 (341)
T KOG1163|consen 165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQ-SRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMST 243 (341)
T ss_pred ccccccccCccccCCccceeeeehhhhhhhhhhh-hhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCC
Confidence 43322 223344679999998766555444 478899999999999999999998743 345566776655544
Q ss_pred C-----CCCChHHHHHHHHhccCCCCCCCC
Q 014849 238 P-----KWTSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 238 p-----~~~s~~~~~li~~~L~~dP~~R~t 262 (417)
| ..++.++.-.+.-|=..--.+-|.
T Consensus 244 ~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pd 273 (341)
T KOG1163|consen 244 PIEVLCKGFPAEFAMYLNYCRGLGFEEKPD 273 (341)
T ss_pred CHHHHhCCCcHHHHHHHHHHhhcCCCCCCc
Confidence 3 345777777776665544455554
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.3e-25 Score=206.02 Aligned_cols=174 Identities=17% Similarity=0.161 Sum_probs=137.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHH------HHHHHHHHHhCCCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH------VKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~------i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.+.++|++.++||.|+||.||++.+ ++..+|+|++..+....+..... +.+|+..+.++.||+|..+..++.
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~ 105 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYL 105 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeee
Confidence 4689999999999999999999765 57789999997665444333333 579999999999999999998865
Q ss_pred eC--------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 87 TK--------AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 87 ~~--------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
.. +..++||||++|.+|.+... +++ ....+++.+|..||++|++|||+||.||+++.+| ++|+|
T Consensus 106 ~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 106 LAERKTLRYAHTYIMLIEYIEGVELNDMPE---ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ecccccccccCCeEEEEEEECCccHHHhhh---ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 43 35899999999999987732 333 2456999999999999999999999999999998 99999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHH
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVL 211 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~l 211 (417)
||.+....... ....++....|+ .++||||||+.+..+
T Consensus 178 fg~~~~~~e~~--------------a~d~~vler~y~-~~~di~~lg~~~~~~ 215 (232)
T PRK10359 178 LSGKRCTAQRK--------------AKDRIDLERHYG-IKNEIKDLGYYLLIY 215 (232)
T ss_pred CCCcccccchh--------------hHHHHHHHhHhc-ccccccceeEeehHH
Confidence 99875332110 011134555676 789999999988755
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.9e-24 Score=200.47 Aligned_cols=241 Identities=22% Similarity=0.326 Sum_probs=192.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
..-.|++++.||+|+||..+.|.+.-++++||||.-.... ...+++.|....+.|. .++|...|.+.....+-.
T Consensus 26 VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~Ni 100 (449)
T KOG1165|consen 26 VGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNI 100 (449)
T ss_pred ecccceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhh
Confidence 3448999999999999999999999999999999765432 2678999999999986 699999998888888888
Q ss_pred EEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-----CeEEeeeecceee
Q 014849 93 FVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-----DLKISDFGLSAVK 165 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-----~vkl~DFGls~~~ 165 (417)
+|+|+. |.+|.|+.. .++|+...+..++.|++.-++|+|++.+|+|||||+|+||...+ .+.++|||+|...
T Consensus 101 LVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 101 LVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred hhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 999999 779988875 47899999999999999999999999999999999999997544 4899999999754
Q ss_pred cccC-----CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCCC
Q 014849 166 EQIR-----PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---PNLMAMYRKIYKGEYRC 237 (417)
Q Consensus 166 ~~~~-----~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~ 237 (417)
.... +........||-.||+--...+...+ .+-|+-|||-+++.+|.|.+||.+ .+..+-|++|...+...
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQS-RRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T 258 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRST 258 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhh-hhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccC
Confidence 3322 23344456799999998877777664 889999999999999999999976 56778888886554433
Q ss_pred C-----CCCChHHHHHHHHhccCCCCCCC
Q 014849 238 P-----KWTSPDLKWFIGRLLDTDPATRI 261 (417)
Q Consensus 238 p-----~~~s~~~~~li~~~L~~dP~~R~ 261 (417)
| ..++.++...++-.=..+-.+-|
T Consensus 259 ~i~~Lc~g~P~efa~Yl~yvR~L~F~E~P 287 (449)
T KOG1165|consen 259 PIEVLCEGFPEEFATYLRYVRRLDFFETP 287 (449)
T ss_pred CHHHHHhcCHHHHHHHHHHHHhcCcccCC
Confidence 3 23444554444333333333334
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.2e-25 Score=199.51 Aligned_cols=141 Identities=25% Similarity=0.299 Sum_probs=112.9
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----------------------hHHHHHHHHHHHHhCCCCC
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----------------------LTAHVKREISIMSRLRHPN 77 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~Hpn 77 (417)
...||+|+||.||+|.+. +|+.||+|++......... ......+|+.+|..+.+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~ 80 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG 80 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence 468999999999999996 9999999999765321111 0123346999999998888
Q ss_pred cceEEEEEEeCCEEEEEEeccCCCChHHH-HhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEecCCCCeE
Q 014849 78 IVKLYEVLATKAKIYFVMEFAKGGELFAK-ISKGRFSEQLSRRYFQQLISAVEYC-HSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 78 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~-i~~~~l~e~~~~~i~~ql~~aL~yl-H~~givHrDlkp~NILl~~~~~vk 155 (417)
+.....+.... .++||||++|+++... +..+.+++..+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 81 v~~p~~~~~~~--~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 81 IPCPEPILLKS--HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCCcEEEecC--CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 75444332222 3899999999887655 4457899999999999999999999 799999999999999998 47899
Q ss_pred Eeeeecceee
Q 014849 156 ISDFGLSAVK 165 (417)
Q Consensus 156 l~DFGls~~~ 165 (417)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.1e-24 Score=206.37 Aligned_cols=232 Identities=24% Similarity=0.348 Sum_probs=152.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC----------CCcceEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH----------PNIVKLYEVLA 86 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H----------pnIv~l~~~~~ 86 (417)
.+..++.||.|+|+.||.+++.+||+.+|+|++...........+++++|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46778999999999999999999999999999976653334456777777755555432 12232233321
Q ss_pred e------------CC-----EEEEEEeccCCCChHHHHhc----CCC----CHHHHHHHHHHHHHHHHHHHHcCCeecCC
Q 014849 87 T------------KA-----KIYFVMEFAKGGELFAKISK----GRF----SEQLSRRYFQQLISAVEYCHSRGVFHRDL 141 (417)
Q Consensus 87 ~------------~~-----~~~lV~E~~~gg~L~~~i~~----~~l----~e~~~~~i~~ql~~aL~ylH~~givHrDl 141 (417)
- .+ +.+++|+-+. ++|.+.+.. ... .......+..|++..+++||+.|++|+||
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi 171 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI 171 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence 1 11 2356777774 488777542 222 22233445599999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccccccc--------CCCCChhhHHHHHHHHHHHHc
Q 014849 142 KLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK--------GYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 142 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~--------~y~~~~sDIwSlGvil~~ll~ 213 (417)
+|+|++++.+|.++|+||+.....+. .......+..|.|||..... .+ +.+.|.|+||+++|.|+|
T Consensus 172 ~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~-t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 172 KPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPY-TFATDAWQLGITLYSLWC 245 (288)
T ss_dssp SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE--HHHHHHHHHHHHHHHHH
T ss_pred ceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCccccee-eeccCHHHHHHHHHHHHH
Confidence 99999999999999999987654322 11113346779999987543 23 588999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhccCCCCCC
Q 014849 214 GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
|.+||........... .+ .|. ..+..++.||+++|++||.+|
T Consensus 246 ~~lPf~~~~~~~~~~~----~f~~C~-~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADPEW----DFSRCR-DMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTSGG----GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccccc----cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence 9999987643322111 22 344 678899999999999999988
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-26 Score=241.53 Aligned_cols=259 Identities=32% Similarity=0.522 Sum_probs=221.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
...|++.+.||+|+|+.|-.+.+.. +...+|.|.+.... .......++..|..+-+.+. |+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 6789999999999999999988743 44567888776553 33445677888999988887 999999999999999999
Q ss_pred EEEeccCCCChHHHH-hc-C-CCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCC-CeEEeeeecceeecc
Q 014849 93 FVMEFAKGGELFAKI-SK-G-RFSEQLSRRYFQQLISAVEYCH-SRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQ 167 (417)
Q Consensus 93 lV~E~~~gg~L~~~i-~~-~-~l~e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~ 167 (417)
++++|..|+++++.+ .. . ..+...+..++.|+..++.|+| ..++.|||+||+|.+++.++ +++++|||+|.....
T Consensus 98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~ 177 (601)
T KOG0590|consen 98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRN 177 (601)
T ss_pred cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccc
Confidence 999999999999999 55 3 6788889999999999999999 99999999999999999999 999999999987766
Q ss_pred -cCCCCccccccc-CccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHhcC--C--CCCCCC
Q 014849 168 -IRPDGMLHTLCG-TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM-YRKIYKG--E--YRCPKW 240 (417)
Q Consensus 168 -~~~~~~~~~~~G-t~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~-~~~i~~~--~--~~~p~~ 240 (417)
......+...|| ++.|+|||...+..|.+...|+||+|+++..+++|..|+........ +...... . ......
T Consensus 178 ~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (601)
T KOG0590|consen 178 KNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNS 257 (601)
T ss_pred cCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCcccc
Confidence 556677888999 99999999999988999999999999999999999999976544321 1222221 1 233345
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.+..+.+++.++|..+|..|.+++++..+||+..
T Consensus 258 ~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 258 ISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred CChhhhhcccccccCCchhccccccccccccccc
Confidence 6888999999999999999999999999999987
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=1e-23 Score=192.24 Aligned_cols=143 Identities=22% Similarity=0.287 Sum_probs=115.8
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----------------------hHHHHHHHHHHHHhCCCC
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----------------------LTAHVKREISIMSRLRHP 76 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----------------------~~~~i~~Ei~il~~l~Hp 76 (417)
+.+.||+|+||.||+|.+. +|+.||||++......... ......+|+..+.++.|+
T Consensus 1 ~~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~ 79 (190)
T cd05145 1 INGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEA 79 (190)
T ss_pred CCceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhC
Confidence 3578999999999999986 9999999999875321000 022346899999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCe
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~v 154 (417)
++.....+.... .|+||||++|+++.. .+..+++++..+..++.|++.++.++|+ +||+||||||+|||++ ++.+
T Consensus 80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~ 156 (190)
T cd05145 80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP 156 (190)
T ss_pred CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence 886555443333 489999999886543 4556788999999999999999999999 9999999999999999 7899
Q ss_pred EEeeeecceeec
Q 014849 155 KISDFGLSAVKE 166 (417)
Q Consensus 155 kl~DFGls~~~~ 166 (417)
+|+|||++....
T Consensus 157 ~liDFG~a~~~~ 168 (190)
T cd05145 157 YIIDVSQAVELD 168 (190)
T ss_pred EEEEcccceecC
Confidence 999999987543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.9e-24 Score=205.55 Aligned_cols=188 Identities=28% Similarity=0.418 Sum_probs=146.0
Q ss_pred CCCCcceEEEEEEe---------------------------CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHH
Q 014849 74 RHPNIVKLYEVLAT---------------------------KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126 (417)
Q Consensus 74 ~HpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~ 126 (417)
+|||||++...|.+ +..+|+||.-.+. +|..++..+..+...++-++.|+++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~~s~r~~~~~laQlLE 352 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRHRSYRTGRVILAQLLE 352 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCCCchHHHHHHHHHHHH
Confidence 59999999877643 3479999998866 8999999888999999999999999
Q ss_pred HHHHHHHcCCeecCCCCCcEEe--cCCC--CeEEeeeecceeecccC-----CCCcccccccCccccccccccccCC---
Q 014849 127 AVEYCHSRGVFHRDLKLENLLL--DENW--DLKISDFGLSAVKEQIR-----PDGMLHTLCGTPAYVAPEILAKKGY--- 194 (417)
Q Consensus 127 aL~ylH~~givHrDlkp~NILl--~~~~--~vkl~DFGls~~~~~~~-----~~~~~~~~~Gt~~y~APEvl~~~~y--- 194 (417)
|+.|||++||.|||+|.+|||+ |+++ .+.|+|||.+- .+... ...-.....|.-.-||||+....+-
T Consensus 353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL-Ad~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCL-ADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceee-eccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999998 3443 48999999653 22211 1111123457888999999764321
Q ss_pred --CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh-cC-CCCCCCCCChHHHHHHHHhccCCCCCCCCH
Q 014849 195 --DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY-KG-EYRCPKWTSPDLKWFIGRLLDTDPATRITV 263 (417)
Q Consensus 195 --~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~-~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~ 263 (417)
+-.++|.|++|.+.||++....||.+...+.+-..-. .. -+..|...++.+++|+..+|+.||++|++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp 504 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSP 504 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCc
Confidence 1368999999999999999999998855443222111 12 245678889999999999999999999984
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=187.13 Aligned_cols=135 Identities=21% Similarity=0.294 Sum_probs=110.1
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-----CCCCcceEEEEEEeCC---EE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-----RHPNIVKLYEVLATKA---KI 91 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-----~HpnIv~l~~~~~~~~---~~ 91 (417)
-.+.||+|+||.||. +..++.. +||++..... ...+.+.+|+.+++.+ .||||+++++++.++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 7777666 6999876432 2356789999999999 5799999999998874 44
Q ss_pred E-EEEec--cCCCChHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHHcCCeecCCCCCcEEecC----CCCeEEeeeecc
Q 014849 92 Y-FVMEF--AKGGELFAKISKGRFSEQLSRRYFQQLISAV-EYCHSRGVFHRDLKLENLLLDE----NWDLKISDFGLS 162 (417)
Q Consensus 92 ~-lV~E~--~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL-~ylH~~givHrDlkp~NILl~~----~~~vkl~DFGls 162 (417)
+ +|+|| +.+++|.+++.++.+++. ..++.|++.++ +|||+++|+||||||+|||++. ++.++|+||+.+
T Consensus 80 ~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 80 YDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred EEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 4 78999 558999999988777777 35677888777 9999999999999999999974 347999995543
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.4e-22 Score=183.60 Aligned_cols=192 Identities=17% Similarity=0.182 Sum_probs=143.0
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-hHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-LTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~ 95 (417)
..+...|++|+||+||.+.. .+..++.+.+......... ....+.+|+++|++|. |++|++++++ +..|++|
T Consensus 4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvm 77 (218)
T PRK12274 4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDR 77 (218)
T ss_pred cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEE
Confidence 34678999999999998776 7778887777554321111 1225789999999995 5889999886 3479999
Q ss_pred eccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCC-CCCcEEecCCCCeEEeeeecceeecccCCC---
Q 014849 96 EFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDL-KLENLLLDENWDLKISDFGLSAVKEQIRPD--- 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDl-kp~NILl~~~~~vkl~DFGls~~~~~~~~~--- 171 (417)
||+.|.+|...+..+ ...++.|++.+|.+||++||+|||| ||+|||++.+|.++|+|||+|.........
T Consensus 78 eyI~G~~L~~~~~~~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~ 151 (218)
T PRK12274 78 SYLAGAAMYQRPPRG------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL 151 (218)
T ss_pred eeecCccHHhhhhhh------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence 999999987654321 2357899999999999999999999 799999999999999999999754321110
Q ss_pred ---C-----cccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 172 ---G-----MLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 172 ---~-----~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
. ..+-...++.|++|+.-.-- ..+-...+.++.|+-+|.+.|+.+|+-+.
T Consensus 152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 0 01122368888988864322 11125679999999999999999987554
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=181.32 Aligned_cols=143 Identities=22% Similarity=0.246 Sum_probs=114.8
Q ss_pred CeEEeeEEeeeCceEEEEEE-EccCCcEEEEEEeecccccc---------------------cchHHHHHHHHHHHHhCC
Q 014849 17 KYEVGKIIGCGAFAKVYHGR-NVRTGQSVAIKAVSKQKILR---------------------GGLTAHVKREISIMSRLR 74 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~-~~~~g~~vAiK~i~~~~~~~---------------------~~~~~~i~~Ei~il~~l~ 74 (417)
-|++.+.||+|+||.||+|. +..+|+.||+|++....... ......+.+|+.+++++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 37899999999999999999 66899999999997643110 001234678999999997
Q ss_pred CCC--cceEEEEEEeCCEEEEEEeccCCCChHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHcC-CeecCCCCCcEEecC
Q 014849 75 HPN--IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG-VFHRDLKLENLLLDE 150 (417)
Q Consensus 75 Hpn--Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i-~~~~l~e~~~~~i~~ql~~aL~ylH~~g-ivHrDlkp~NILl~~ 150 (417)
+.+ +.+.++. . ..|+||||+.|++|.... ....+.+..+..++.|++.++.+||++| |+||||||+||+++
T Consensus 109 ~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~- 183 (237)
T smart00090 109 EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH- 183 (237)
T ss_pred hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-
Confidence 633 3444432 2 358999999998887655 3456777778899999999999999999 99999999999999
Q ss_pred CCCeEEeeeeccee
Q 014849 151 NWDLKISDFGLSAV 164 (417)
Q Consensus 151 ~~~vkl~DFGls~~ 164 (417)
++.++|+|||.+..
T Consensus 184 ~~~i~LiDFg~a~~ 197 (237)
T smart00090 184 DGKVVIIDVSQSVE 197 (237)
T ss_pred CCCEEEEEChhhhc
Confidence 88999999998864
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=172.55 Aligned_cols=137 Identities=26% Similarity=0.330 Sum_probs=116.0
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----GLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+.||+|++|.||+|.+ .|..+++|+......... ....++.+|+.++..+.|++|.....++.+.+..++|||
T Consensus 2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e 79 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVME 79 (211)
T ss_pred cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEE
Confidence 6799999999999987 778899998654332111 113467789999999999999887777777788999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
|++|++|.+.+..... ....++.+++.+|.++|+.|++|||++|.|||++ ++.++|+|||.+..
T Consensus 80 ~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 80 YIEGEPLKDLINSNGM---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred EeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999999875322 7889999999999999999999999999999999 78999999998864
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.5e-21 Score=176.56 Aligned_cols=241 Identities=20% Similarity=0.334 Sum_probs=193.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
++...+...|.+.-.|..|++++ .|..++.|++...... ......+..|.-.|+...||||+.+++.+.++.++.++
T Consensus 189 ~~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~i 265 (448)
T KOG0195|consen 189 VSSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVII 265 (448)
T ss_pred hhhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEe
Confidence 44556777888999999999999 4556777887654432 22234566788889999999999999999999999999
Q ss_pred EeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEe--eeecceeecc
Q 014849 95 MEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKIS--DFGLSAVKEQ 167 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~--DFGls~~~~~ 167 (417)
..|++.|+|+..+..+ ..+..++.+++.+++.|+.|||+.. |----|....+++|++-+.+|+ |--+|..
T Consensus 266 sq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq--- 342 (448)
T KOG0195|consen 266 SQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--- 342 (448)
T ss_pred eeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee---
Confidence 9999999999999763 3678899999999999999999874 4444588899999999877664 3333211
Q ss_pred cCCCCcccccccCccccccccccccCCC--CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~--~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~ 243 (417)
. ....-+|.||+||.+..++-+ -.++|+||+.++++||.|...||.+-.+++.--+|.-. ...+|+.+++
T Consensus 343 --e----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ippgis~ 416 (448)
T KOG0195|consen 343 --E----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIPPGISR 416 (448)
T ss_pred --c----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCCCCccH
Confidence 1 112347899999999887665 35799999999999999999999998888776666543 4568999999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHh
Q 014849 244 DLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil 267 (417)
.+..|+.-|++.||.+||.+..|.
T Consensus 417 hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 417 HMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHHHHHHhcCCCCcCCCcceeh
Confidence 999999999999999999987663
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.6e-19 Score=165.09 Aligned_cols=133 Identities=24% Similarity=0.307 Sum_probs=108.7
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEec
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----GLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~ 97 (417)
+||+|+||.||+|.. +|..+++|+......... ....++.+|+.+++.++|+++....-+.......++||||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 78 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEY 78 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEE
Confidence 489999999999985 678999998654322111 1235677899999999998766555555566678999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 98 AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 98 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
++|++|.+.+..... .++.|++.+|.+||+.|++|||++|.||+++ ++.++++|||++..
T Consensus 79 ~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 79 IEGKPLKDVIEEGND------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY 138 (199)
T ss_pred ECCccHHHHHhhcHH------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence 999999988765321 7899999999999999999999999999999 78999999999865
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.5e-20 Score=197.01 Aligned_cols=234 Identities=22% Similarity=0.304 Sum_probs=175.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~ 91 (417)
..+|.|-+.+|+|+||+||.|.+.. |+.||+|+=.......--...+++ .+|+ -+.|..++..+.-.+.-
T Consensus 697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~------~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVM------ERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHH------HhhchhhhcchHHHHHHHccCCcc
Confidence 4589999999999999999999976 999999987665443332333333 3333 23455555444445566
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-------CCCCeEEeeeecce
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-------ENWDLKISDFGLSA 163 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-------~~~~vkl~DFGls~ 163 (417)
++|+||.+.|+|.+++.. +.+++..+..+..|++..|+.||..+|||+||||+|+||. .+--++|+|||-|.
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~si 849 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSI 849 (974)
T ss_pred eeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccce
Confidence 899999999999999986 6799999999999999999999999999999999999993 23359999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----CC
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-----CP 238 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p 238 (417)
...-..........++|..+-.+|...++++. ..+|.|.+..+++.||.|+.- +...|... ++
T Consensus 850 Dm~lfp~~~~F~~~~~td~f~C~EM~~grpWt-Yq~DyfGlAa~~h~mLFG~y~-----------q~~~g~~~~~~~~~~ 917 (974)
T KOG1166|consen 850 DMKLFPDGTKFKAVWHTDLFDCIEMREGRPWT-YQIDYFGLAATVHVMLFGKYM-----------EVKNGSSWMVKTNFP 917 (974)
T ss_pred eeeEcCCCcEEeeeeccccchhHHHhcCCCCc-hhhhhHHHHHHHHHHHHHHHH-----------HhcCCcceeccccch
Confidence 55433344577788999999999999999996 999999999999999999632 12222211 22
Q ss_pred CCC-ChHHHHHHHHhccCCCCCCCCHHHHh
Q 014849 239 KWT-SPDLKWFIGRLLDTDPATRITVDEIL 267 (417)
Q Consensus 239 ~~~-s~~~~~li~~~L~~dP~~R~t~~eil 267 (417)
..+ -+-..+++..+|++|-..=|.+.+|.
T Consensus 918 Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr 947 (974)
T KOG1166|consen 918 RYWKRDMWNKFFDLLLNPDCDTLPNLQELR 947 (974)
T ss_pred hhhhHHHHHHHHHHHhCcCcccchhHHHHH
Confidence 222 23346678888885555545555543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.6e-19 Score=165.40 Aligned_cols=138 Identities=20% Similarity=0.273 Sum_probs=109.9
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-------------------chHHHHHHHHHHHHhCCCCC-
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-------------------GLTAHVKREISIMSRLRHPN- 77 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-------------------~~~~~i~~Ei~il~~l~Hpn- 77 (417)
|.+.+.||+|+||.||+|.+ .+|+.||||++......-. .......+|+.++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 88899999999999999988 4899999999865431000 01123568999999998874
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEE
Q 014849 78 -IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 78 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl 156 (417)
++..+. ....++||||++|++|...... ..+..++.+++.++.++|+.||+||||||+||+++.++.++|
T Consensus 96 ~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~l 166 (198)
T cd05144 96 PVPKPID----WNRHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYI 166 (198)
T ss_pred CCCceee----cCCceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEE
Confidence 444443 2456899999999998765431 345678899999999999999999999999999999999999
Q ss_pred eeeecceee
Q 014849 157 SDFGLSAVK 165 (417)
Q Consensus 157 ~DFGls~~~ 165 (417)
+|||++...
T Consensus 167 iDfg~~~~~ 175 (198)
T cd05144 167 IDWPQMVST 175 (198)
T ss_pred EECCccccC
Confidence 999998543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.4e-20 Score=186.49 Aligned_cols=250 Identities=22% Similarity=0.303 Sum_probs=169.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEE------
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE------ 83 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~------ 83 (417)
...+.+.+.+..+..+++.+...+-... ..-+.-+..+.+ +........+++-.+....|-+..-+.+
T Consensus 241 ~~~~s~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d---~~~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~ 317 (516)
T KOG1033|consen 241 EESGSSSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVD---SLCACKYTFRQLGVLVDSSHSNRSILEDLRPSLF 317 (516)
T ss_pred cccccccccccccccccCCchhhhhcccchhhhhccchhhhcc---chhhhhhhhhhhhheeccccCCcccccCCCCchh
Confidence 3344556666666666666655443222 222333322221 1122334455665555554433332222
Q ss_pred -EE-----EeCCEEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 84 -VL-----ATKAKIYFVMEFAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 84 -~~-----~~~~~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
.+ .....+||.|++|.-.+|.++|..+ ..+......++.|+..|++| +|.+|||+||.||+...++.
T Consensus 318 ~~~~~~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q 394 (516)
T KOG1033|consen 318 ESSKRNKVGKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQ 394 (516)
T ss_pred hhccccccccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchh
Confidence 11 1133689999999999999999742 46677889999999999999 99999999999999999999
Q ss_pred eEEeeeecceeecccC----CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHH
Q 014849 154 LKISDFGLSAVKEQIR----PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYR 228 (417)
Q Consensus 154 vkl~DFGls~~~~~~~----~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~ 228 (417)
+||.|||+.+...... .........||++||+||.+.+..|. .++||||||+|||||+.- ..+|.. .....
T Consensus 395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~-~kvdIyaLGlil~EL~~~f~T~~er---~~t~~ 470 (516)
T KOG1033|consen 395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYS-EKVDIYALGLILAELLIQFSTQFER---IATLT 470 (516)
T ss_pred hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhh-hhcchhhHHHHHHHHHHHhccHHHH---HHhhh
Confidence 9999999987554332 12244567899999999999999985 999999999999999862 222221 22333
Q ss_pred HHhcCCCCCCCC-CChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 229 KIYKGEYRCPKW-TSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 229 ~i~~~~~~~p~~-~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
.+..+.++.-.+ -.|.-..|+.+||.+.|.+||++.+.--|+|.
T Consensus 471 d~r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 471 DIRDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hhhcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 344444441122 24566799999999999999988777777664
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.79 E-value=6.8e-19 Score=184.99 Aligned_cols=140 Identities=21% Similarity=0.267 Sum_probs=113.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-----cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-----GGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...|...+.||+|+||+||+|... +..+++|+........ .....++.+|+.+|+.++|++++....+..+..
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~ 409 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE 409 (535)
T ss_pred ccccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC
Confidence 345567899999999999999874 3445555433221111 112356789999999999999998887777777
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..++||||++|++|.+.+. ....++.|++.+|.+||++|++||||||+|||+ .++.++|+|||++..
T Consensus 410 ~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 410 EKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 8899999999999998875 357899999999999999999999999999999 677899999999865
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.3e-18 Score=176.67 Aligned_cols=200 Identities=22% Similarity=0.399 Sum_probs=157.5
Q ss_pred HHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCC-eecCCCCCcE
Q 014849 70 MSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGV-FHRDLKLENL 146 (417)
Q Consensus 70 l~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~gi-vHrDlkp~NI 146 (417)
|+.+.|.|+.++++...+...++.|.+||.-|+|.|.+.. -+++..-...+.++|+.||.|+|...| +|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 4678999999999999999999999999999999999987 467777788889999999999998877 9999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCC------CCChhhHHHHHHHHHHHHcCCCCCCC
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY------DGAKVDMWSCGVVLFVLNAGYLPFND 220 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y------~~~~sDIwSlGvil~~ll~G~~Pf~~ 220 (417)
+++....+||+|||+..+..........+...-...|.|||.+..... -+.+.||||+|+|++|+++...||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 999999999999999876542111111122223456999999876422 24679999999999999999999976
Q ss_pred C----CHHHHHHHHhc-CCCCC-CC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 221 P----NLMAMYRKIYK-GEYRC-PK-----WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 221 ~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
. ...+....+.+ +...+ |. ...+++..++.+||..+|..||+++++...
T Consensus 161 ~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~ 220 (484)
T KOG1023|consen 161 RNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSK 220 (484)
T ss_pred ccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhh
Confidence 3 22345555555 22111 21 234568899999999999999999998543
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.5e-18 Score=156.93 Aligned_cols=139 Identities=24% Similarity=0.319 Sum_probs=101.4
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHH---------------------HHHHHHHHHHhCCCCC-
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA---------------------HVKREISIMSRLRHPN- 77 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~---------------------~i~~Ei~il~~l~Hpn- 77 (417)
+++.||+|+||.||.|.+. +|+.||||++............ ....|...+..+.+.+
T Consensus 1 ~~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~ 79 (187)
T cd05119 1 VGGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGV 79 (187)
T ss_pred CCcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCC
Confidence 3578999999999999986 8999999998764321111111 1135666666665443
Q ss_pred -cceEEEEEEeCCEEEEEEeccCCCChHH-HHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCe
Q 014849 78 -IVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 78 -Iv~l~~~~~~~~~~~lV~E~~~gg~L~~-~i~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~v 154 (417)
+.+.+.. ...++||||++|+.+.. .+...... .+++.++.|++.++.++|+ +||+||||||+||+++ ++.+
T Consensus 80 ~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 80 PVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CCCceEec----CCCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 4455543 23589999999954422 12211111 6788999999999999999 9999999999999999 8899
Q ss_pred EEeeeecceee
Q 014849 155 KISDFGLSAVK 165 (417)
Q Consensus 155 kl~DFGls~~~ 165 (417)
+++|||.+...
T Consensus 154 ~liDfg~a~~~ 164 (187)
T cd05119 154 YIIDVPQAVEI 164 (187)
T ss_pred EEEECcccccc
Confidence 99999998643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.1e-17 Score=157.92 Aligned_cols=138 Identities=17% Similarity=0.337 Sum_probs=107.6
Q ss_pred eeEEe-eeCceEEEEEEEccCCcEEEEEEeecccc----cc------cchHHHHHHHHHHHHhCCCCCc--ceEEEEEEe
Q 014849 21 GKIIG-CGAFAKVYHGRNVRTGQSVAIKAVSKQKI----LR------GGLTAHVKREISIMSRLRHPNI--VKLYEVLAT 87 (417)
Q Consensus 21 ~~~LG-~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~----~~------~~~~~~i~~Ei~il~~l~HpnI--v~l~~~~~~ 87 (417)
+..|| .|+.|+||.+.. .+..+++|.+..... .. .....++.+|+.++..++|++| ++.+++...
T Consensus 36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV 113 (239)
T ss_pred CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence 45676 777777887776 378899998865322 11 1224567899999999998875 677766433
Q ss_pred C-C---EEEEEEeccCC-CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 K-A---KIYFVMEFAKG-GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 ~-~---~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
. . ..++|||+++| .+|.+++..+.+++.. +.||+.+|.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 114 RHGLFYRADILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred ecCcceeeeEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 2 23599999997 6899888877777654 578999999999999999999999999999999999999987
Q ss_pred ee
Q 014849 163 AV 164 (417)
Q Consensus 163 ~~ 164 (417)
..
T Consensus 190 ~~ 191 (239)
T PRK01723 190 EL 191 (239)
T ss_pred cc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=1.3e-18 Score=185.06 Aligned_cols=262 Identities=26% Similarity=0.413 Sum_probs=213.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.+.+.+-+-+|+|+.+..+.-..+|...++|+..+...........++++-.++-..++|-+++..-.+.-....+++
T Consensus 803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~ 882 (1205)
T KOG0606|consen 803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLV 882 (1205)
T ss_pred CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchh
Confidence 45678888899999999999999999988888877554333332344444554444445667777666555667789999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc-----
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI----- 168 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~----- 168 (417)
++|..|++|...+.. +..+++-++.+...+..+.+|||+..+.|||++|.|+|...+|+.+++|||........
T Consensus 883 ~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~ 962 (1205)
T KOG0606|consen 883 GHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTD 962 (1205)
T ss_pred hHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcCC
Confidence 999999999999987 77899999999999999999999999999999999999999999999999832211100
Q ss_pred ----------------------CCC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 014849 169 ----------------------RPD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM 224 (417)
Q Consensus 169 ----------------------~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~ 224 (417)
..+ ...+...||+.|.|||.+.+... +..+|+|+.|+++++.++|.+||......
T Consensus 963 ~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~h-gs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 963 LSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRH-GSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred cccccccCccccccccccccccccchhhccccccCCCcccCCcccccccC-CCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence 000 12345679999999999988776 58899999999999999999999999999
Q ss_pred HHHHHHhcCCCCCC---CCCChHHHHHHHHhccCCCCCCCCHH---HHhcCcccccccc
Q 014849 225 AMYRKIYKGEYRCP---KWTSPDLKWFIGRLLDTDPATRITVD---EILRDPWFKKDYK 277 (417)
Q Consensus 225 ~~~~~i~~~~~~~p---~~~s~~~~~li~~~L~~dP~~R~t~~---eil~h~~f~~~~~ 277 (417)
..+++|..+..+.| ...++++++++.++|..+|.+|..+. +...|+||+..-.
T Consensus 1042 ~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~ 1100 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDW 1100 (1205)
T ss_pred hhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCc
Confidence 99999998877654 45689999999999999999999887 9999999986544
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.72 E-value=2e-17 Score=142.22 Aligned_cols=132 Identities=23% Similarity=0.263 Sum_probs=113.3
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 97 (417)
+.+.||+|.++.||++... +..+++|....... ...+.+|+.+++.++| +++++++.+....+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEec--CCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 4678999999999999984 37899999865432 4578899999999987 5899999988888899999999
Q ss_pred cCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 98 AKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR---GVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 98 ~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~---givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
+.|+.+... +......++.+++.++.++|.. +++|+|++|+||+++.++.++++|||.+..
T Consensus 75 ~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 75 IEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred cCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 999877654 5566778899999999999984 799999999999999989999999998753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PF03822 NAF: NAF domain; InterPro: IPR004041 The NAF domain is a 24 amino acid domain that is found in a plant-specific subgroup of serine-threonine protein kinases (CIPKs), that interact with calcineurin B-like calcium sensor proteins (CBLs) | Back alignment and domain information |
|---|
Probab=99.66 E-value=8.2e-17 Score=117.56 Aligned_cols=62 Identities=50% Similarity=0.741 Sum_probs=48.5
Q ss_pred CCccCcchhhccCCCCCCCCCCccCCCCCCCccccceeecCCHHHHHHHHHHHHHhhcCCCceEEEE
Q 014849 299 EKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTK 365 (417)
Q Consensus 299 ~~~~~~~~~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 365 (417)
|..+|||||||+|+|||||+||+..... ...+++||+|++||++|+++||++|+.+ ||+|+|
T Consensus 2 p~~lNAFdiIS~S~G~DLSgLFe~~~~~-~~~~~~RF~S~~~~~~Ii~klEe~a~~~----~~~V~K 63 (63)
T PF03822_consen 2 PKSLNAFDIISLSSGFDLSGLFEEKDKS-SVKRETRFTSKEPASEIIEKLEEIAKKL----GFRVKK 63 (63)
T ss_dssp -EE--HHHHHCTSTTTSCGGGGGCG-S--SS---EEEEESS-HHHHHHHHHHHHHHT----TEEEEE
T ss_pred CccccHHHHHHhccCCChHHhcCccccc-cccccceEecCCCHHHHHHHHHHHHHhc----CceeeC
Confidence 5679999999999999999999876541 1126899999999999999999999999 999975
|
Whereas the N-terminal part of CIPKs comprises a conserved catalytic domain typical of Ser-Thr kinases, the much less conserved C-terminal domain appears to be unique to this subgroup of kinases. The only exception is the NAF domain that forms an 'island of conservation' in this otherwise variable region. The NAF domain has been named after the prominent conserved amino acids Asn-Ala-Phe. It represents a minimum protein interaction module that is both necessary and sufficient to mediate the interaction with the CBL calcium sensor proteins []. The secondary structure of the NAF domain is currently not known, but secondary structure computation of the C-terminal region of Arabidopsis thaliana CBL-interacting protein kinase 1 revealed a long helical structure [].; GO: 0007165 signal transduction; PDB: 2ZFD_B 2EHB_D. |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=6.8e-16 Score=160.28 Aligned_cols=146 Identities=21% Similarity=0.335 Sum_probs=102.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--------------------------c-----cchHH
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--------------------------R-----GGLTA 61 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--------------------------~-----~~~~~ 61 (417)
.++..|+. +.||+|++|.||.|+.+.+|+.||||+..+.-.. + .+...
T Consensus 117 ~~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~ 195 (537)
T PRK04750 117 EWFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEK 195 (537)
T ss_pred HHHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHH
Confidence 34667887 8999999999999999888999999999754200 0 01222
Q ss_pred HHHHH------HHHHHhCC----CCCcceEEEEEEe-CCEEEEEEeccCCCChHHH--Hhc-C----CCCHHHHHHHHHH
Q 014849 62 HVKRE------ISIMSRLR----HPNIVKLYEVLAT-KAKIYFVMEFAKGGELFAK--ISK-G----RFSEQLSRRYFQQ 123 (417)
Q Consensus 62 ~i~~E------i~il~~l~----HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~--i~~-~----~l~e~~~~~i~~q 123 (417)
.+.+| +..+.+++ +.+.+.+-.++.+ .+..++||||+.|+.+.+. +.. + .+.+..+..++.|
T Consensus 196 ~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q 275 (537)
T PRK04750 196 TLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ 275 (537)
T ss_pred HHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 33333 33333332 3333443344432 4456899999999999764 333 3 3556666667777
Q ss_pred HHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeecceeec
Q 014849 124 LISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGLSAVKE 166 (417)
Q Consensus 124 l~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGls~~~~ 166 (417)
++ ..|++|+|+||.||+++.+| .+++.|||++...+
T Consensus 276 if-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 276 VF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 65 59999999999999999988 89999999987553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.59 E-value=5.4e-15 Score=151.31 Aligned_cols=140 Identities=21% Similarity=0.281 Sum_probs=96.9
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-------------------------------cchHH------HHH
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-------------------------------GGLTA------HVK 64 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------------------------------~~~~~------~i~ 64 (417)
+.||.|++|.||+|+. .+|+.||||+....-... .+... .+.
T Consensus 123 ~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 6799999999999997 589999999985431000 00001 233
Q ss_pred HHHHHHHhCC-----CCCcceEEEEE-EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHH-HHHHHHHcC
Q 014849 65 REISIMSRLR-----HPNIVKLYEVL-ATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLIS-AVEYCHSRG 135 (417)
Q Consensus 65 ~Ei~il~~l~-----HpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~-aL~ylH~~g 135 (417)
+|...+.+++ +|+|. +-.++ .-.+..++||||++|++|.+.... ...+ ...++.+++. .+..+|..|
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~-vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 202 REAANASELGENFKNDPGVY-VPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEE-eCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCC
Confidence 4555555542 34332 22222 223456899999999999887643 2222 3445666665 478899999
Q ss_pred CeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 136 ivHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
++|+|+||.||+++.+|.++++|||++....
T Consensus 278 ~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 278 FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 9999999999999999999999999987654
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.56 E-value=2e-15 Score=153.77 Aligned_cols=255 Identities=19% Similarity=0.192 Sum_probs=189.7
Q ss_pred cCCeEEeeEEee--eCceEEEEEEE--ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGC--GAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~--G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~ 89 (417)
..++-+...+|. |.+|.||.+.. ..+++.+|+|.=..... ......+=.+|+...+.++ |+|.++.+..+++.+
T Consensus 113 ~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s-~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~ 191 (524)
T KOG0601|consen 113 DQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFS-PPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG 191 (524)
T ss_pred hhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCC-CccccccccchhhcccccCccccccccCcccccCC
Confidence 446677888999 99999999998 99999999997322111 0111122235666666664 999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-C-CCCHHHHHHHHHHHHH----HHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK-G-RFSEQLSRRYFQQLIS----AVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~-~l~e~~~~~i~~ql~~----aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls 162 (417)
..|+-+|+|. .+|..+... . -+++..++.++.+... ||.++|+.+++|-|+||.||++..+ ...+++|||+.
T Consensus 192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v 270 (524)
T KOG0601|consen 192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV 270 (524)
T ss_pred cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence 9999999995 678777765 3 4899999999999999 9999999999999999999999999 88999999998
Q ss_pred eeecccCCCC---cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCC
Q 014849 163 AVKEQIRPDG---MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKGEYRC 237 (417)
Q Consensus 163 ~~~~~~~~~~---~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~ 237 (417)
.......-.. .....-|...|++||+..+- .+...||+++|.+..+-.+|..+.... +.....+++. ....+
T Consensus 271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l--~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~-ip~e~ 347 (524)
T KOG0601|consen 271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGL--ATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY-IPLEF 347 (524)
T ss_pred EEccCCccccceeeeecCCCCceEeChhhhccc--cchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc-Cchhh
Confidence 7654322111 11122567789999997653 368999999999988877776554332 1111111111 01111
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
-...+.++...+..|++.+|-.|++.+.++.|++...
T Consensus 348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s 384 (524)
T KOG0601|consen 348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHS 384 (524)
T ss_pred hcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccc
Confidence 2233667777999999999999999999999999874
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.56 E-value=6.8e-14 Score=144.08 Aligned_cols=171 Identities=18% Similarity=0.317 Sum_probs=135.7
Q ss_pred EEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCC
Q 014849 34 HGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFS 113 (417)
Q Consensus 34 ~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~ 113 (417)
.|..+.++.+|.|.+.+...- .....+.+-++.|+.++||||+++++.+++.+.+|+|+|-+.- |..+++. +.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~P--l~~~lk~--l~ 102 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRP--LETVLKE--LG 102 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecccc--HHHHHHH--hH
Confidence 467778999999999977642 4567788999999999999999999999999999999999863 6666664 33
Q ss_pred HHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccccccc
Q 014849 114 EQLSRRYFQQLISAVEYCH-SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192 (417)
Q Consensus 114 e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~ 192 (417)
+.....-+.||+.||.||| +.+++|++|.-..|+++..|..||++|-++........ +.+...--..|..|+.+...
T Consensus 103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s 180 (690)
T KOG1243|consen 103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPS 180 (690)
T ss_pred HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCcc
Confidence 6677788899999999997 67899999999999999999999999998865443222 12222223346777765433
Q ss_pred CCCCChhhHHHHHHHHHHHHcCCC
Q 014849 193 GYDGAKVDMWSCGVVLFVLNAGYL 216 (417)
Q Consensus 193 ~y~~~~sDIwSlGvil~~ll~G~~ 216 (417)
. -..|.|.|||++++++.|.+
T Consensus 181 ~---~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 181 E---WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred c---cchhhhhHHHHHHHHhCccc
Confidence 3 34799999999999999943
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.49 E-value=4e-13 Score=122.44 Aligned_cols=140 Identities=16% Similarity=0.201 Sum_probs=104.4
Q ss_pred eEEeeeCceEEEEEEEcc------CCcEEEEEEeeccccc-------------------ccchHHHHH----HHHHHHHh
Q 014849 22 KIIGCGAFAKVYHGRNVR------TGQSVAIKAVSKQKIL-------------------RGGLTAHVK----REISIMSR 72 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~-------------------~~~~~~~i~----~Ei~il~~ 72 (417)
-.||.|--+.||.|.... .+..+|||+....... +......+. +|+..|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 468999999999998643 3579999998542210 011122333 89999999
Q ss_pred CCC--CCcceEEEEEEeCCEEEEEEeccCCCChH-HHHhcCCCCHHHHHHHHHHHHHHHHHH-HHcCCeecCCCCCcEEe
Q 014849 73 LRH--PNIVKLYEVLATKAKIYFVMEFAKGGELF-AKISKGRFSEQLSRRYFQQLISAVEYC-HSRGVFHRDLKLENLLL 148 (417)
Q Consensus 73 l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~L~-~~i~~~~l~e~~~~~i~~ql~~aL~yl-H~~givHrDlkp~NILl 148 (417)
+.. -++.+++.+ ..-++||||+.+..+. ..+....+++.++..++.|++.+|..+ |+.||+|+||+|.|||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~ 158 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW 158 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 864 456666654 4568999999876553 234444566777888899999999999 89999999999999999
Q ss_pred cCCCCeEEeeeecceeec
Q 014849 149 DENWDLKISDFGLSAVKE 166 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~ 166 (417)
+ ++.+.|+|||.+...+
T Consensus 159 ~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 159 H-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred E-CCcEEEEECCCceeCC
Confidence 7 4689999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.9e-13 Score=121.24 Aligned_cols=127 Identities=20% Similarity=0.230 Sum_probs=97.4
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccC
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~ 99 (417)
.+.|+.|.++.||.++. .|+.|++|+...... ......+|+.+++.+.+.++ .+++.... +..++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTE----LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEE--CCeEEEEEeCCCCcc----cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 46789999999999987 478999998755421 12345789999998876554 45555433 33589999999
Q ss_pred CCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCC-----eecCCCCCcEEecCCCCeEEeeeecce
Q 014849 100 GGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV-----FHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 100 gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~gi-----vHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
|.++... ......++.+++.+|..||+.++ +|+|++|.||+++ ++.++++|||.+.
T Consensus 75 G~~l~~~-------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~ 135 (170)
T cd05151 75 GSELLTE-------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG 135 (170)
T ss_pred CCccccc-------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence 9887643 11124567899999999999985 9999999999999 6689999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.41 E-value=9.8e-14 Score=141.49 Aligned_cols=254 Identities=18% Similarity=0.152 Sum_probs=189.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEc-cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNV-RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.....++|-.+..||.|.|+.|+...-+ .++..+++|...+......... .-..|+.+...+ .|.++++.+..+...
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~ 338 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQL 338 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccc
Confidence 3456788999999999999999988755 7888999998865543221111 112455555555 499999999888888
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~ 166 (417)
...|+-.|||.|+++...+.- ..+.+...+++..|++.++.++|+..++|+|+||.||++..+ +..+++|||..+...
T Consensus 339 r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~ 418 (524)
T KOG0601|consen 339 RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLA 418 (524)
T ss_pred ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccccc
Confidence 889999999999988766643 578899999999999999999999999999999999999886 788999999875321
Q ss_pred ccCCCCcccccccCcccc-ccccccccCCCCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHhcCCCCCCCCCChH
Q 014849 167 QIRPDGMLHTLCGTPAYV-APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~-APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
. .. ....+.-++. .+|++........++|++|||.-+.+..+|... .... ....|..+..+........
T Consensus 419 ~--~~---~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~----~~~~i~~~~~p~~~~~~~~ 489 (524)
T KOG0601|consen 419 F--SS---GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV----QSLTIRSGDTPNLPGLKLQ 489 (524)
T ss_pred e--ec---ccccccccccccchhhccccccccccccccccccccccccCcccCcccc----cceeeecccccCCCchHHh
Confidence 1 00 1111233444 355555444446999999999999999888643 2222 2334555656555555588
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+..+.+.++.+++..|+.+.++..|.=|-.
T Consensus 490 ~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~ 519 (524)
T KOG0601|consen 490 LQVLLKVMINPDRKRRPSAVELSLHSEFYR 519 (524)
T ss_pred hhhhhhhhcCCccccchhhhhhcccchhhh
Confidence 899999999999999999999988865543
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.3e-13 Score=127.61 Aligned_cols=201 Identities=17% Similarity=0.271 Sum_probs=143.1
Q ss_pred HHhCCCCCcceEEEEEEeC-----CEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc--CCe
Q 014849 70 MSRLRHPNIVKLYEVLATK-----AKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR--GVF 137 (417)
Q Consensus 70 l~~l~HpnIv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~--giv 137 (417)
|-.+-|.|||++|.++.+. ....+++||+..|+|..++++ ..+......+|+-||++||.|||+. .|+
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 4445699999999998654 458899999999999998864 3588888999999999999999987 499
Q ss_pred ecCCCCCcEEecCCCCeEEeeeecceeecccCCCC--cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCC
Q 014849 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG--MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215 (417)
Q Consensus 138 HrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~--~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~ 215 (417)
|+.+...-|++..+|-+|+.---............ ......|-+.|.|||.=....- +.++|||++|....+|..|.
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~-~~a~dIy~fgmcAlemailE 279 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNT-TGASDIYKFGMCALEMAILE 279 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCccccc-ccchhhhhhhHHHHHHHHhe
Confidence 99999999999999988886433222211111111 1112346788999997443333 46799999999999998775
Q ss_pred CC-CCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 216 LP-FNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 216 ~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.- -.+.........+.+.-+-. ..+--+.++++||+..|+.||++.+++.||-.-+
T Consensus 280 iq~tnseS~~~~ee~ia~~i~~l---en~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 280 IQSTNSESKVEVEENIANVIIGL---ENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred eccCCCcceeehhhhhhhheeec---cCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 43 23322222222222211111 1233467899999999999999999999987643
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.32 E-value=1.7e-11 Score=109.08 Aligned_cols=135 Identities=21% Similarity=0.300 Sum_probs=105.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccch-----HHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL-----TAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~-----~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
..+++|+-+.+|.+.. -|..+.+|.=.++....+.. ..+..+|..+|..++--.|....-+..++....|+||
T Consensus 2 ~~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me 79 (204)
T COG3642 2 DLIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVME 79 (204)
T ss_pred chhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEE
Confidence 3578999999999966 34457777654433333332 3455679999999987677666666677788889999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
|+.|-.|.+.+... ...++..+=.-+.-||..||+|+||.+.||++...+ +.++||||+.+.
T Consensus 80 ~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 80 YIEGELLKDALEEA------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred EeCChhHHHHHHhc------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 99998888888765 256777788888899999999999999999998775 999999998653
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.29 E-value=2.2e-11 Score=112.34 Aligned_cols=139 Identities=19% Similarity=0.295 Sum_probs=108.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeC---CEEEEEEe
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATK---AKIYFVME 96 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~---~~~~lV~E 96 (417)
+.||.|.++.||++... .|+.+++|+....... .....+.+|..+++.+.+ .++.+++.+.... +..|+|||
T Consensus 4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEec-CCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 67899999999999874 3689999997654321 134567899999999976 4467777776554 26789999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-------------------------------------------
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS------------------------------------------- 133 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~------------------------------------------- 133 (417)
|++|.++.+.+..+.+++.....++.+++.+|..||+
T Consensus 81 ~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 81 RVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred EeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 9999988776543567777777888888888888873
Q ss_pred -------------cCCeecCCCCCcEEecC--CCCeEEeeeecce
Q 014849 134 -------------RGVFHRDLKLENLLLDE--NWDLKISDFGLSA 163 (417)
Q Consensus 134 -------------~givHrDlkp~NILl~~--~~~vkl~DFGls~ 163 (417)
..++|+|++|.||+++. ++.+.|+||+.+.
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 23699999999999998 5668999999875
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.6e-10 Score=102.54 Aligned_cols=143 Identities=22% Similarity=0.252 Sum_probs=109.6
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----LTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
...++-||+-+.|+.+.. .|+...||.=.......+. ...+.++|+++|.+++--.|.-..-++.+...-.++
T Consensus 11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ 88 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIY 88 (229)
T ss_pred cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEE
Confidence 677899999999999987 7888888865444333322 245677899999998766666555566677777899
Q ss_pred EeccCC-CChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEeeeeccee
Q 014849 95 MEFAKG-GELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAV 164 (417)
Q Consensus 95 ~E~~~g-g~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~DFGls~~ 164 (417)
|||++| .++.+++.. ....+.....++++|=+.+.-||..+|+|+||..+||+|..+|+ +.++|||++..
T Consensus 89 ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 89 MEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 999988 466666653 22333333789999999999999999999999999999976653 58999999864
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.19 E-value=6.4e-10 Score=111.99 Aligned_cols=210 Identities=20% Similarity=0.268 Sum_probs=155.9
Q ss_pred ceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCEEEEEEeccCC-CCh
Q 014849 29 FAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----KAKIYFVMEFAKG-GEL 103 (417)
Q Consensus 29 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~~~lV~E~~~g-g~L 103 (417)
-.+.|+|....+|..|++|.+...+.... .....-+++.+++.|+|||.+.+++.+ ...+.+|++|.++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 35789999999999999999955443322 223345678899999999999999874 3479999999875 567
Q ss_pred HHHHh----------------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 104 FAKIS----------------KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 104 ~~~i~----------------~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
.++.- ..+.+|...+.|+.||..||.++|+.|+.-+-|.|.+||++.+-.++|+..|+..+...
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 66431 13578999999999999999999999999999999999999998999998887765442
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC-CCCHHHH-HHHHhcCCCCCCCCCChHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN-DPNLMAM-YRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~-~~~~~~~-~~~i~~~~~~~p~~~s~~~ 245 (417)
.. + |-+... .+-|.=.||.+++.|.+|..--. ....... ...| ....|.++
T Consensus 446 d~---------~-------~~le~~----Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS~D~ 498 (655)
T KOG3741|consen 446 DP---------T-------EPLESQ----QQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYSTDL 498 (655)
T ss_pred CC---------C-------cchhHH----hhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhhHHH
Confidence 11 0 112211 45688899999999999964411 1111111 1222 23468899
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++|.-+...+++. -++.+++.+
T Consensus 499 rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 499 RNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999999887 678888765
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.12 E-value=6.1e-10 Score=101.07 Aligned_cols=127 Identities=25% Similarity=0.409 Sum_probs=85.6
Q ss_pred EEEEEEEccCCcEEEEEEeecccc-----------------------cccchHHHHHHHHHHHHhCCCC--CcceEEEEE
Q 014849 31 KVYHGRNVRTGQSVAIKAVSKQKI-----------------------LRGGLTAHVKREISIMSRLRHP--NIVKLYEVL 85 (417)
Q Consensus 31 ~Vy~a~~~~~g~~vAiK~i~~~~~-----------------------~~~~~~~~i~~Ei~il~~l~Hp--nIv~l~~~~ 85 (417)
.||.|.. ..|..+|+|+...... ..........+|.+.|+++..- ++.+++.+
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~- 78 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY- 78 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-
Confidence 4899998 6788999999854210 0011134567899999999876 46677654
Q ss_pred EeCCEEEEEEeccC--CCChHHHHhcCCCCHHHHHHHHHHHHHHHHH-HHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 86 ATKAKIYFVMEFAK--GGELFAKISKGRFSEQLSRRYFQQLISAVEY-CHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 86 ~~~~~~~lV~E~~~--gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~y-lH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
++ -.+||||++ |..+.. +....++......++.+++..+.. +|+.||+|+||.+.|||++++ .+.|+|||.+
T Consensus 79 -~~--~~ivME~I~~~G~~~~~-l~~~~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qa 153 (188)
T PF01163_consen 79 -NR--NVIVMEYIGEDGVPLPR-LKDVDLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQA 153 (188)
T ss_dssp -ET--TEEEEE--EETTEEGGC-HHHCGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTE
T ss_pred -eC--CEEEEEecCCCccchhh-HHhccccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcc
Confidence 33 369999998 655543 333333355677888899986665 579999999999999999988 8999999987
Q ss_pred ee
Q 014849 163 AV 164 (417)
Q Consensus 163 ~~ 164 (417)
..
T Consensus 154 v~ 155 (188)
T PF01163_consen 154 VD 155 (188)
T ss_dssp EE
T ss_pred ee
Confidence 64
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.07 E-value=3e-09 Score=101.97 Aligned_cols=140 Identities=15% Similarity=0.133 Sum_probs=97.2
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccc---ccc-----chHHHHHHHHHHHHhCCCCCc--ceEEEEEEe-----
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI---LRG-----GLTAHVKREISIMSRLRHPNI--VKLYEVLAT----- 87 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~---~~~-----~~~~~i~~Ei~il~~l~HpnI--v~l~~~~~~----- 87 (417)
.+-......|..... .|+.+.||....... .+. .-.....+|...+..|..-+| +.++.+.+.
T Consensus 29 ~v~~~~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 29 VFRELEGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred EEecCCCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 333333344555443 677899996643221 000 011246789888888853333 233444432
Q ss_pred CCEEEEEEeccCCC-ChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-------CCCeEE
Q 014849 88 KAKIYFVMEFAKGG-ELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-------NWDLKI 156 (417)
Q Consensus 88 ~~~~~lV~E~~~gg-~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-------~~~vkl 156 (417)
...-++|||+++|. +|.+++.. ...++.....++.+++..+.-||..||+|+|++|.|||++. ++.+.+
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L 186 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV 186 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence 23578999999886 78888753 45677788899999999999999999999999999999975 467999
Q ss_pred eeeeccee
Q 014849 157 SDFGLSAV 164 (417)
Q Consensus 157 ~DFGls~~ 164 (417)
+||+.+..
T Consensus 187 IDl~r~~~ 194 (268)
T PRK15123 187 IDLHRAQI 194 (268)
T ss_pred EECCcccc
Confidence 99998753
|
|
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.02 E-value=9.4e-11 Score=121.60 Aligned_cols=155 Identities=21% Similarity=0.322 Sum_probs=114.3
Q ss_pred HHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccC------CCCcc-cccccCccccccccccccC
Q 014849 122 QQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR------PDGML-HTLCGTPAYVAPEILAKKG 193 (417)
Q Consensus 122 ~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~------~~~~~-~~~~Gt~~y~APEvl~~~~ 193 (417)
.+.+.|+.|+|.. ++||+.|.|++|.++.+|.+||+.|+++.-..... .+... .-..-...|.|||++....
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 3444999999965 89999999999999999999999999875433211 01111 1122356799999998844
Q ss_pred CCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHHHHHHh----cCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 194 YDGAKVDMWSCGVVLFVLN-AGYLPFNDPNLMAMYRKIY----KGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 194 y~~~~sDIwSlGvil~~ll-~G~~Pf~~~~~~~~~~~i~----~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++++|++|+||++|.+. .|+.-+...+....+..-. .+.+..+..+++++++=+.++|..++..||++.+++.
T Consensus 186 -~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~ 264 (700)
T KOG2137|consen 186 -NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLS 264 (700)
T ss_pred -ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhc
Confidence 469999999999999998 5666565543333222211 1223345677899999999999999999999999999
Q ss_pred Ccccccccc
Q 014849 269 DPWFKKDYK 277 (417)
Q Consensus 269 h~~f~~~~~ 277 (417)
.|||.+...
T Consensus 265 ~~ff~D~~~ 273 (700)
T KOG2137|consen 265 IPFFSDPGL 273 (700)
T ss_pred ccccCCchh
Confidence 999987543
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.97 E-value=1.3e-08 Score=100.53 Aligned_cols=233 Identities=18% Similarity=0.227 Sum_probs=152.8
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEE------EEeCC-E
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEV------LATKA-K 90 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~------~~~~~-~ 90 (417)
..++.||+|+-+.+|-.-.. +. .+-|++.+... ..+. .....|... .||-+-.-+.+ ..+.+ .
T Consensus 14 ~~gr~LgqGgea~ly~l~e~--~d-~VAKIYh~Ppp-----a~~a-qk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~ 84 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEV--RD-QVAKIYHAPPP-----AAQA-QKVAELAATPDAPLLNYRVAWPQATLHGGRRGKV 84 (637)
T ss_pred CCCccccCCccceeeecchh--hc-hhheeecCCCc-----hHHH-HHHHHhccCCCCcchhhhhcccHHHhhCCCccce
Confidence 45788999999999965432 22 34477765432 1111 122233333 46644331111 12233 3
Q ss_pred EEEEEeccCCCChHHHH-hc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKI-SK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i-~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
+-+.|..++|..--..+ .. .....+-+.+..+.|+.+.+.||..|.+-+|+.++|+|+++++.|.|.|=..-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf 164 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF 164 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence 88999999886443322 21 13567788899999999999999999999999999999999999999885543
Q ss_pred eeecccCCCCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcC-CCCCCCC-------CHHHHHHH
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDP-------NLMAMYRK 229 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~-------~~~~~~~~ 229 (417)
.+. ..+......+|.+.|.+||... +.+- ++..|.|.|||++|+||.| +.||.+- +..+ ..
T Consensus 165 qi~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r-~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E--~~ 238 (637)
T COG4248 165 QIN---ANGTLHLCPVGVSEFTPPELQTLPSFVGFER-TANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLE--TD 238 (637)
T ss_pred eec---cCCceEecccCccccCCHHHhccccccccCC-CccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcch--hh
Confidence 222 2333445678999999999864 2233 4789999999999998876 9999652 2111 12
Q ss_pred HhcCCC-----------CCC---CC--CChHHHHHHHHhccC--CCCCCCCHHHH
Q 014849 230 IYKGEY-----------RCP---KW--TSPDLKWFIGRLLDT--DPATRITVDEI 266 (417)
Q Consensus 230 i~~~~~-----------~~p---~~--~s~~~~~li~~~L~~--dP~~R~t~~ei 266 (417)
|..+.+ +.| +| .++++..|..+|+.. +|.-|||++.-
T Consensus 239 Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW 293 (637)
T COG4248 239 IAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAW 293 (637)
T ss_pred hhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHH
Confidence 322211 122 11 478899999999853 36789987543
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=6.3e-09 Score=97.90 Aligned_cols=137 Identities=25% Similarity=0.327 Sum_probs=105.2
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecc-------cccc------------cchHHHHHHHHHHHHhCCCC--
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ-------KILR------------GGLTAHVKREISIMSRLRHP-- 76 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-------~~~~------------~~~~~~i~~Ei~il~~l~Hp-- 76 (417)
+.++..||-|--+.||.|.+ ..|..+|||.=..- +..+ .-......+|..+|.+|...
T Consensus 93 e~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 46789999999999999999 48899999963210 0000 01123467899999999765
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEE
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl 156 (417)
.|.+.+++ +...+||||++|-.|...- ++...+..++..|+.-+.-+-..||+|+|+++-||+++++|.+.+
T Consensus 172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~v 243 (304)
T COG0478 172 KVPKPIAW----NRHAVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVV 243 (304)
T ss_pred CCCCcccc----ccceeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEE
Confidence 67777664 4568999999997775442 245556677788888888788999999999999999999999999
Q ss_pred eeeecce
Q 014849 157 SDFGLSA 163 (417)
Q Consensus 157 ~DFGls~ 163 (417)
+||-.+.
T Consensus 244 IDwPQ~v 250 (304)
T COG0478 244 IDWPQAV 250 (304)
T ss_pred EeCcccc
Confidence 9997654
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.5e-08 Score=89.77 Aligned_cols=105 Identities=20% Similarity=0.326 Sum_probs=83.8
Q ss_pred HHHHHHHHHHHHhCCCCC--cceEEEEEEeC----CEEEEEEeccCCC-ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 014849 60 TAHVKREISIMSRLRHPN--IVKLYEVLATK----AKIYFVMEFAKGG-ELFAKISK-GRFSEQLSRRYFQQLISAVEYC 131 (417)
Q Consensus 60 ~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~ql~~aL~yl 131 (417)
.....+|...+..|..-+ +.+.+.+.... ..-++|+|+++|. +|.+++.. ..++......++.++...+.-|
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKL 134 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHH
Confidence 446778888888775332 34455554442 2468999999884 78888876 4577788899999999999999
Q ss_pred HHcCCeecCCCCCcEEecCCC---CeEEeeeeccee
Q 014849 132 HSRGVFHRDLKLENLLLDENW---DLKISDFGLSAV 164 (417)
Q Consensus 132 H~~givHrDlkp~NILl~~~~---~vkl~DFGls~~ 164 (417)
|.+||+|+|++|.|||++.++ .+.++||+-+..
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 999999999999999999887 799999997754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.77 E-value=1.8e-07 Score=86.34 Aligned_cols=140 Identities=19% Similarity=0.209 Sum_probs=94.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchH------HHHHHHHHHHHhCC---CCCcceEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT------AHVKREISIMSRLR---HPNIVKLYE 83 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~------~~i~~Ei~il~~l~---HpnIv~l~~ 83 (417)
.+.+.|++.+++-......|.+..- .|+.+++|............. ....+++..+..++ -.....++-
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 4578899999999988888877664 778999998865432111100 11223444444443 223333222
Q ss_pred EEE-----eCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 84 VLA-----TKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 84 ~~~-----~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+.+ -....+++|||++|.+|.+... +++ .+...+.+++.-+|+.|++|+|..|.|++++.++ +++.|
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 221 1234568999999988876543 333 3446778889999999999999999999999665 99999
Q ss_pred eecc
Q 014849 159 FGLS 162 (417)
Q Consensus 159 FGls 162 (417)
|+-.
T Consensus 178 ~~~k 181 (229)
T PF06176_consen 178 TQGK 181 (229)
T ss_pred Cccc
Confidence 9854
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.6e-07 Score=83.27 Aligned_cols=137 Identities=14% Similarity=0.148 Sum_probs=98.8
Q ss_pred eeeCceEEEEEEEccCCcEEEEEEeecccc--cc-cchHHHHHHHHHHHHhCCCCC--cceEEEEEEe----CCEEEEEE
Q 014849 25 GCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LR-GGLTAHVKREISIMSRLRHPN--IVKLYEVLAT----KAKIYFVM 95 (417)
Q Consensus 25 G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--~~-~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~----~~~~~lV~ 95 (417)
|+|+-+.|+.... .|+.+-+|.-..... .. +.-...+.+|+..|+.|..-+ +.+....-.. .-.-+||+
T Consensus 27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 4588888888664 444677776541111 11 223567889999999886322 4444422111 12478999
Q ss_pred eccCC-CChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--eEEeeeecce
Q 014849 96 EFAKG-GELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--LKISDFGLSA 163 (417)
Q Consensus 96 E~~~g-g~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--vkl~DFGls~ 163 (417)
|-+.| .+|.+.+..+ +.++.....++.++...+.-||+.|+.|+|+.+.|||++.+|. ++++||--++
T Consensus 105 e~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r 178 (216)
T PRK09902 105 EDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR 178 (216)
T ss_pred EeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence 97754 5888888663 4578888899999999999999999999999999999987777 9999998664
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.61 E-value=4.7e-07 Score=84.53 Aligned_cols=148 Identities=18% Similarity=0.256 Sum_probs=103.5
Q ss_pred cccCCeEEeeEEee---eCceEEEEEEEccCCcEEEEEEeecccccccch---------------------HHHHHHHHH
Q 014849 13 NLFGKYEVGKIIGC---GAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL---------------------TAHVKREIS 68 (417)
Q Consensus 13 ~~~~~y~i~~~LG~---G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~---------------------~~~i~~Ei~ 68 (417)
.+..+..+....|. |--++||+|.. .++..+|+|++......-... ..-..+|..
T Consensus 42 ~L~~rg~i~~~~g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~ 120 (268)
T COG1718 42 RLLSRGVITELVGCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFR 120 (268)
T ss_pred HHhcCCceeeeEeeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHH
Confidence 45666666666665 55557999987 678999999996543321110 112346888
Q ss_pred HHHhCCC--CCcceEEEEEEeCCEEEEEEeccCCCC-hHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCC
Q 014849 69 IMSRLRH--PNIVKLYEVLATKAKIYFVMEFAKGGE-LFAKISKGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLE 144 (417)
Q Consensus 69 il~~l~H--pnIv~l~~~~~~~~~~~lV~E~~~gg~-L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~ 144 (417)
-|+++.. =.+.+.+.+.. -.+||||+.... -.-.+..-++...++..++.+++..+.-|-. .|+||+||+.=
T Consensus 121 NL~R~~eAGVrvP~Pi~~~~----nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEy 196 (268)
T COG1718 121 NLKRAYEAGVRVPEPIAFRN----NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEY 196 (268)
T ss_pred HHHHHHHcCCCCCCceeecC----CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhh
Confidence 8887753 34555555432 468999996531 1223333344455899999999999999988 89999999999
Q ss_pred cEEecCCCCeEEeeeecceeec
Q 014849 145 NLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~ 166 (417)
|||+. ++.+.|+|||.|....
T Consensus 197 NiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 197 NILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred heEEE-CCeEEEEECccccccC
Confidence 99999 7789999999886544
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.60 E-value=1.9e-09 Score=110.96 Aligned_cols=239 Identities=20% Similarity=0.188 Sum_probs=167.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAKIYFV 94 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV 94 (417)
..|+...-+++|+.+++++++...+...+ .+.+... ..++-++++|.+++||| .+..++-+..+...+++
T Consensus 242 kws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 242 KWSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred cchHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHHHccCCCCcccccccCCcccccchh
Confidence 34556667889999999999987665444 5554332 34456888999999999 77777777778889999
Q ss_pred EeccCCC-ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGG-ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg-~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
++++.++ +-...+.. -.+.+.+.....+.-..+++++|+.-=+||| ||+..+ +..|..||+....... .
T Consensus 313 ~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~---~ 384 (829)
T KOG0576|consen 313 MRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTR---T 384 (829)
T ss_pred hhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCc---c
Confidence 9999887 22222111 2244444555666778899999998778999 888766 5799999998764432 2
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCC---CCCCChHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRC---PKWTSPDLK 246 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~---p~~~s~~~~ 246 (417)
....+..+|+.++|||+.....++ ...|.|++|+-..++--|-+|-..+- .....+..+. +.. ..|....-+
T Consensus 385 ~~~~t~~~~~~~~~pev~~~~~~~-~~p~~~~~~~~~~~~ap~~pPr~~P~--~~~~~~g~~p~s~~L~~~~aw~~~~~~ 461 (829)
T KOG0576|consen 385 MKPRTAIGTPEPLAPEVIQENTID-GCPDSGSLAVSAIQMAPGLPPRSSPP--AVLPMIGNGPNSPMLTDKSAWSPVFHR 461 (829)
T ss_pred cccccCCCCCCCCCchhhcccccc-cCCCccCCCcchhhcCCCCCCCCCCc--cccCCCCCCCCccccchhhhcCccccc
Confidence 245677899999999999988887 88999999987777878877754421 1000011010 000 112222223
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
++...|+..-|..|+...+.+.|.+|..
T Consensus 462 ~~~~~~~~g~P~~pkv~mgacfsKvfng 489 (829)
T KOG0576|consen 462 DFPAPCLNGLPPTPKVHMGACFSKVFNG 489 (829)
T ss_pred CCcccccCCCCCCCcchhhHHHHHHhcc
Confidence 4778899999999999999999988864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.1e-06 Score=82.31 Aligned_cols=132 Identities=13% Similarity=0.152 Sum_probs=84.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~~~lV~E~~~ 99 (417)
..+|+|..+.||+. .|..+++|...... ....+.+|.++|+.+..-+ +.+.+.+....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTH----KTGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEe----cCCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 56899999999973 25567888875422 2456789999999986433 4677888778888899999999
Q ss_pred CCC-hHH--------------HH-------hc---CCCCHH-HHHHHHHHH----------HH-HHHHHH----HcCCee
Q 014849 100 GGE-LFA--------------KI-------SK---GRFSEQ-LSRRYFQQL----------IS-AVEYCH----SRGVFH 138 (417)
Q Consensus 100 gg~-L~~--------------~i-------~~---~~l~e~-~~~~i~~ql----------~~-aL~ylH----~~givH 138 (417)
|.. +.. .+ .. ...+.. ....+..++ .. ...+|. ...++|
T Consensus 78 G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~H 157 (226)
T TIGR02172 78 GKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLH 157 (226)
T ss_pred CccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEe
Confidence 963 111 11 10 001100 001111111 11 112222 124789
Q ss_pred cCCCCCcEEecCCCCeEEeeeecce
Q 014849 139 RDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 139 rDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
+|+.|.||++++++ +.|+||+.+.
T Consensus 158 gD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 158 GDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred cCCCCCcEEEcCCC-cEEEechhcC
Confidence 99999999999988 9999999774
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.53 E-value=4.1e-07 Score=94.48 Aligned_cols=142 Identities=18% Similarity=0.240 Sum_probs=91.2
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccc---------------------------c----chHH------HHH
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR---------------------------G----GLTA------HVK 64 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---------------------------~----~~~~------~i~ 64 (417)
+-++.++-|.||.|+.. +|+.||||+....-... . +... .+.
T Consensus 131 ~PiAsASIaQVH~A~L~-sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLK-SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEec-CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 56889999999999984 59999999975421000 0 0011 233
Q ss_pred HHHHHHHhCC-----CCCcceEEEEEEeCCEEEEEEeccCCCChHHH--HhcCCCCHHHHHHHHHHHHHHHHHHHHcCCe
Q 014849 65 REISIMSRLR-----HPNIVKLYEVLATKAKIYFVMEFAKGGELFAK--ISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137 (417)
Q Consensus 65 ~Ei~il~~l~-----HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~--i~~~~l~e~~~~~i~~ql~~aL~ylH~~giv 137 (417)
+|...+.+++ .|++.=..-+++-.+.-.++|||++|-.+.+. +.....+.......+.++. +..+-..|++
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff 287 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF 287 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence 4555555542 24333222233334556899999999998877 4445555333322222221 2223348999
Q ss_pred ecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 138 HRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 138 HrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
|.|.+|.||+++.+|.+-+.|||+....+
T Consensus 288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 288 HADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred ccCCCccceEEecCCcEEEEcCcceecCC
Confidence 99999999999999999999999986543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.42 E-value=3.7e-06 Score=77.66 Aligned_cols=136 Identities=18% Similarity=0.252 Sum_probs=83.8
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC--CcceEEEEE---EeCCEEEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP--NIVKLYEVL---ATKAKIYFVM 95 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp--nIv~l~~~~---~~~~~~~lV~ 95 (417)
++.|+.|..+.||...... ..+++|+.... .....+.+|..+++.+... .+.+++... ......+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT--SEEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC--cEEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999999844 59999987554 2356788899998888533 355666643 3344689999
Q ss_pred eccCCCChHH----------------HHhc---C-----CCCHHH------HHH---------------HHHHHHH-HHH
Q 014849 96 EFAKGGELFA----------------KISK---G-----RFSEQL------SRR---------------YFQQLIS-AVE 129 (417)
Q Consensus 96 E~~~gg~L~~----------------~i~~---~-----~l~e~~------~~~---------------i~~ql~~-aL~ 129 (417)
++++|..+.. .+.. - .+.... ... ....+.. .+.
T Consensus 75 ~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (239)
T PF01636_consen 75 EYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQ 154 (239)
T ss_dssp EEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred EEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHH
Confidence 9999987776 1110 0 001000 000 0112222 334
Q ss_pred HHHH-------cCCeecCCCCCcEEec-CCCCeEEeeeecce
Q 014849 130 YCHS-------RGVFHRDLKLENLLLD-ENWDLKISDFGLSA 163 (417)
Q Consensus 130 ylH~-------~givHrDlkp~NILl~-~~~~vkl~DFGls~ 163 (417)
.+++ ..++|+|+.|.|||++ +++.+-|.||+.+.
T Consensus 155 ~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~ 196 (239)
T PF01636_consen 155 ELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAG 196 (239)
T ss_dssp HHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred HHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccce
Confidence 4442 4599999999999999 66667899999765
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.41 E-value=2.8e-06 Score=93.33 Aligned_cols=202 Identities=20% Similarity=0.221 Sum_probs=142.8
Q ss_pred HHHHHHHHhCCCCCcceEEEEEEeCC----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 014849 64 KREISIMSRLRHPNIVKLYEVLATKA----KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFH 138 (417)
Q Consensus 64 ~~Ei~il~~l~HpnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givH 138 (417)
.-|+..+....|+|+++++.+-.... .+.+..|+|++-++...+.. +..+....+.+..++++|+.|+|+....|
T Consensus 230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~ 309 (1351)
T KOG1035|consen 230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEH 309 (1351)
T ss_pred HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccce
Confidence 34666777789999999998864433 23345678999999998887 88999999999999999999999996666
Q ss_pred cCCCCC---cEEecCCCCeEEe--eeecceeecccCCCCcccccccCccccccccccccCCC-CChhhHHHHHHHHHHHH
Q 014849 139 RDLKLE---NLLLDENWDLKIS--DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLN 212 (417)
Q Consensus 139 rDlkp~---NILl~~~~~vkl~--DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~-~~~sDIwSlGvil~~ll 212 (417)
.-+... +-..+..+.+.++ ||+.+........ .....-+..+.|||......+. +...|+|.+|..+..+.
T Consensus 310 v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~ 386 (1351)
T KOG1035|consen 310 VVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS 386 (1351)
T ss_pred eEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence 655554 4444566677777 8887765443221 1222335668888887766654 22369999999999988
Q ss_pred cCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 213 AGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 213 ~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.|..+-.-. .....+. +........+++.+|+..++++|+++.+++.|+|.+....
T Consensus 387 ~~~~i~~~~---~~~~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~ 442 (1351)
T KOG1035|consen 387 QGEDISEKS---AVPVSLL------DVLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTD 442 (1351)
T ss_pred hcCcccccc---cchhhhh------ccccchhhhhhhhhhcchhhhhccchhhhhhchhcccccc
Confidence 875442111 1111111 1112226788999999999999999999999999875443
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=98.34 E-value=3.6e-08 Score=109.61 Aligned_cols=207 Identities=16% Similarity=0.089 Sum_probs=153.5
Q ss_pred HHHHHHHhCCCCCcceEEEEE--EeCCEEEEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcC--
Q 014849 65 REISIMSRLRHPNIVKLYEVL--ATKAKIYFVMEFAKGGELFAKISKG-----RFSEQLSRRYFQQLISAVEYCHSRG-- 135 (417)
Q Consensus 65 ~Ei~il~~l~HpnIv~l~~~~--~~~~~~~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~aL~ylH~~g-- 135 (417)
.|..-++...|+++...+.-. .+....|.+++|+.+|.+++.|.+| .+.+.-+....++.+.+..-+|+..
T Consensus 1278 ~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnl 1357 (2724)
T KOG1826|consen 1278 SERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNL 1357 (2724)
T ss_pred hhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccC
Confidence 344455667899888766544 3345688999999999999999763 2444445455556588888888652
Q ss_pred ---CeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHH
Q 014849 136 ---VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLN 212 (417)
Q Consensus 136 ---ivHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll 212 (417)
.+|+++|+-|-+|..+-++|++++|+.+...+ .........++|.|++|++.+.-.+. .++|+|+.|+-+|++.
T Consensus 1358 g~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp--~~sf~Gl~l~sp~~v~qli~N~ik~t-~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1358 GNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP--VLSFFGLELCSPIYVLQLIKNEIKFT-KRSDILRRSLSLYLRS 1434 (2724)
T ss_pred CccchhhhhhhhccceecCCcccccccccccccCc--hHhhhhhhhCCHHHHHHHHHHHHhhh-hHHHHHHHHHHHHHHh
Confidence 79999999999999999999999999874322 22344567789999999999888875 6699999999999999
Q ss_pred cCCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 213 AGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 213 ~G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.|..||.......+...+..+. +..+...+.++-.....+|-+.-..||.-..++.-+.|.-
T Consensus 1435 ~~n~~fi~flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1435 DGNAYFIFFLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred cccHHHHHHHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 9998875544444444444333 2344555666667777777788889999999988877753
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.33 E-value=4.7e-06 Score=78.57 Aligned_cols=130 Identities=15% Similarity=0.129 Sum_probs=81.7
Q ss_pred eeCc-eEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCCCh
Q 014849 26 CGAF-AKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVMEFAKGGEL 103 (417)
Q Consensus 26 ~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg~L 103 (417)
.|.. +.||.... .+..+.+|+..... ...+.+|+.+++.+. +--+.+++.+....+..++|||+++|..|
T Consensus 8 ~g~~~~~v~~~~~--~~~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 8 EGQSGATVYRLDG--KNPGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred CCCCcCeEEEEcC--CCCcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3444 78999875 34688888875432 345678999988884 34466777777776778999999999776
Q ss_pred HHHH----------------hc-CCC-------CHH------HHHHHHH----------------HHHHHHHHHH-----
Q 014849 104 FAKI----------------SK-GRF-------SEQ------LSRRYFQ----------------QLISAVEYCH----- 132 (417)
Q Consensus 104 ~~~i----------------~~-~~l-------~e~------~~~~i~~----------------ql~~aL~ylH----- 132 (417)
.... .. ..+ ... .....+. ++...+..|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 5321 00 001 100 0000000 0111122221
Q ss_pred --HcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 133 --SRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 133 --~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~ 192 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG 192 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence 2348999999999999998778899999774
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.31 E-value=1.4e-05 Score=73.24 Aligned_cols=131 Identities=19% Similarity=0.271 Sum_probs=96.8
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-------------cccchHHHHHHHHHHHHhCC------CCCcceE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-------------LRGGLTAHVKREISIMSRLR------HPNIVKL 81 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-------------~~~~~~~~i~~Ei~il~~l~------HpnIv~l 81 (417)
...||+|+.-.||. + .......||+...... .......+..+|+.-...+. +.+|.++
T Consensus 6 ~~~i~~G~~R~cy~--H-P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--H-PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEE--C-CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 35789999999996 3 3445688999977650 01122456667777666665 7889999
Q ss_pred EEEEEeCCEEEEEEeccCC------CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---
Q 014849 82 YEVLATKAKIYFVMEFAKG------GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW--- 152 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~g------g~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~--- 152 (417)
+++.+|+.-.-+|+|.+.. -+|.+++..+.+++ . +...|-+-..||-+++|+.+|++|.||++..+.
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~~~~-~---~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGGLTE-E---LRQALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCCccH-H---HHHHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 9999999999999998743 36788888788877 3 334555666788999999999999999996442
Q ss_pred -CeEEee
Q 014849 153 -DLKISD 158 (417)
Q Consensus 153 -~vkl~D 158 (417)
.+.|+|
T Consensus 159 ~~lvlID 165 (199)
T PF10707_consen 159 FRLVLID 165 (199)
T ss_pred eEEEEEe
Confidence 366665
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.4e-06 Score=86.79 Aligned_cols=138 Identities=22% Similarity=0.271 Sum_probs=89.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-----------------------------cchHHHHH------HH
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-----------------------------GGLTAHVK------RE 66 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-----------------------------~~~~~~i~------~E 66 (417)
+.||.-+.|.||.|+.+. |+.||||+=...- .+ .+....+. +|
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l-~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~E 244 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGL-EKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKE 244 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcCh-HHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHH
Confidence 578999999999999965 9999999853311 00 01111222 22
Q ss_pred HHHH----HhCCCCC------cceEEEEEEeCCEEEEEEeccCCCChHH--HHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Q 014849 67 ISIM----SRLRHPN------IVKLYEVLATKAKIYFVMEFAKGGELFA--KISKGRFSEQLSRRYFQQLISAVEYCHSR 134 (417)
Q Consensus 67 i~il----~~l~Hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~--~i~~~~l~e~~~~~i~~ql~~aL~ylH~~ 134 (417)
.+-. +.+.|-+ |.++|-.+ .+...++||||+|..+.| .|.+.+++...+...+.+...-+ +-..
T Consensus 245 A~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~q--If~~ 320 (538)
T KOG1235|consen 245 AKNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQ--IFKT 320 (538)
T ss_pred HHhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHH--HHhc
Confidence 2222 2233544 33433322 345689999999987755 45566677765555444444333 3356
Q ss_pred CCeecCCCCCcEEecC----CCCeEEeeeecceee
Q 014849 135 GVFHRDLKLENLLLDE----NWDLKISDFGLSAVK 165 (417)
Q Consensus 135 givHrDlkp~NILl~~----~~~vkl~DFGls~~~ 165 (417)
|++|.|=+|.||++.. ++.+.+-|||+....
T Consensus 321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~i 355 (538)
T KOG1235|consen 321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVI 355 (538)
T ss_pred CCccCCCCCCcEEEecCCCCCccEEEEcccccccc
Confidence 7999999999999984 667999999997644
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.24 E-value=1.4e-05 Score=88.56 Aligned_cols=81 Identities=19% Similarity=0.329 Sum_probs=58.0
Q ss_pred EeeEEeeeCceEEEEEEEccCC--cEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCc--ceEEEEEEeC---CEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTG--QSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNI--VKLYEVLATK---AKI 91 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnI--v~l~~~~~~~---~~~ 91 (417)
-.+.++.|.+..+|+......+ ..+++|........ .....+.+|+.+|+.+. |+++ .+.+.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~--~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL--QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC--ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998764332 46777765443221 12457889999999996 6665 7778777664 467
Q ss_pred EEEEeccCCCC
Q 014849 92 YFVMEFAKGGE 102 (417)
Q Consensus 92 ~lV~E~~~gg~ 102 (417)
|+||||++|..
T Consensus 120 flVME~v~G~~ 130 (822)
T PLN02876 120 FYIMEYLEGRI 130 (822)
T ss_pred eEEEEecCCcc
Confidence 99999999864
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.15 E-value=1.5e-05 Score=70.86 Aligned_cols=138 Identities=23% Similarity=0.283 Sum_probs=96.7
Q ss_pred cccccCCe--EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcc-eEEEEEEe
Q 014849 11 EVNLFGKY--EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV-KLYEVLAT 87 (417)
Q Consensus 11 ~~~~~~~y--~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv-~l~~~~~~ 87 (417)
-....+.| ++.+.||+|.+|.||++.+ .|..+|+|+=..+. ....+..|.++|..+.-.++- ++|.+.
T Consensus 15 ~~~~~~~~~~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds-----~r~~l~kEakiLeil~g~~~~p~vy~yg-- 85 (201)
T COG2112 15 LNVEEGKYELRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDS-----PRRNLEKEAKILEILAGEGVTPEVYFYG-- 85 (201)
T ss_pred eeeeccchhhhhhhhhhcccccEEEEeec--cCceEEEEEecCCc-----chhhHHHHHHHHHHhhhcCCCceEEEec--
Confidence 33444555 4578899999999999998 56699999876554 256788999999998865554 444443
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC-CCcEEecCCCCeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK-LENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlk-p~NILl~~~~~vkl~DFGls~~~ 165 (417)
..++.|||+.|-.|.+.-..+ + ++-...++++---|-..||-|..|. |...+|-.++.+.|+||..|++.
T Consensus 86 --~~~i~me~i~G~~L~~~~~~~--~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 86 --EDFIRMEYIDGRPLGKLEIGG--D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred --hhhhhhhhhcCcchhhhhhcc--c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 234569999998887664432 1 2333455566555667899999997 44444445558999999988743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.08 E-value=7.2e-05 Score=68.39 Aligned_cols=130 Identities=21% Similarity=0.232 Sum_probs=91.9
Q ss_pred ccCCeEEeeEEeeeCc-eEEEEEEEccCCcEEEEEEeec---c-------ccccc--------chHHHHHHHHHHHHhC-
Q 014849 14 LFGKYEVGKIIGCGAF-AKVYHGRNVRTGQSVAIKAVSK---Q-------KILRG--------GLTAHVKREISIMSRL- 73 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~---~-------~~~~~--------~~~~~i~~Ei~il~~l- 73 (417)
....++..+.||.|+- |.||+++- .|+.+|+|++.. . ..... .....+..|.++..+|
T Consensus 35 h~~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLk 112 (207)
T PF13095_consen 35 HGDDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLK 112 (207)
T ss_pred CCCcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHH
Confidence 3478999999999999 99999987 788999999321 1 01000 1123455676666555
Q ss_pred --CCCCc--ceEEEEEEeC------------------CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 014849 74 --RHPNI--VKLYEVLATK------------------AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131 (417)
Q Consensus 74 --~HpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~yl 131 (417)
.+.++ |+.|+++.-. ...-||.||++... .+. ..=+.++.+-|..+
T Consensus 113 e~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~--------~~~----~~~~~~~~~dl~~~ 180 (207)
T PF13095_consen 113 EAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP--------PLQ----IRDIPQMLRDLKIL 180 (207)
T ss_pred hccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc--------ccc----hhHHHHHHHHHHHH
Confidence 45666 9999987221 13457888776643 222 33456778888899
Q ss_pred HHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 132 H~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
|..||+-+|+++.|.. .=||+|||.+
T Consensus 181 ~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 181 HKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHCCeeeccCcccccc-----CCEEEecccC
Confidence 9999999999999987 4589999854
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.99 E-value=3e-05 Score=72.79 Aligned_cols=73 Identities=11% Similarity=0.140 Sum_probs=46.0
Q ss_pred eEEeeeCce-EEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC---CcceEEEEEEeC---CEEEEE
Q 014849 22 KIIGCGAFA-KVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP---NIVKLYEVLATK---AKIYFV 94 (417)
Q Consensus 22 ~~LG~G~fg-~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp---nIv~l~~~~~~~---~~~~lV 94 (417)
+.++.|+.. .||... ..+.+|+..... ....+.+|..+|+.+... .+.+.+...... ...|++
T Consensus 3 ~~~~~gG~~n~vy~~~-----~~~VlR~~~~~~-----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l 72 (235)
T cd05155 3 EPVDSGGTDNATFRLG-----DDMSVRLPSAAG-----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSV 72 (235)
T ss_pred eeccCCCcccceEEcC-----CceEEEcCCccc-----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEE
Confidence 456766666 588752 357778654321 245788999999888532 344555443332 235889
Q ss_pred EeccCCCChH
Q 014849 95 MEFAKGGELF 104 (417)
Q Consensus 95 ~E~~~gg~L~ 104 (417)
|++++|.++.
T Consensus 73 ~~~i~G~~l~ 82 (235)
T cd05155 73 YRWLEGETAT 82 (235)
T ss_pred EEeecCCCCC
Confidence 9999997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00011 Score=66.85 Aligned_cols=97 Identities=19% Similarity=0.238 Sum_probs=80.0
Q ss_pred HHHHHHHhCCC-CCcceEEEEEEeCCEEEEEEeccCCCChHHH---Hhc-CCCCHHHHHHHHHHHHHHHHHHHH---cCC
Q 014849 65 REISIMSRLRH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAK---ISK-GRFSEQLSRRYFQQLISAVEYCHS---RGV 136 (417)
Q Consensus 65 ~Ei~il~~l~H-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---i~~-~~l~e~~~~~i~~ql~~aL~ylH~---~gi 136 (417)
.|.-+|+.+++ +++++++|.+- .++|.||...+++... +.. ...++..+.+++.++++.+.+++. ..+
T Consensus 8 ~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~ 83 (188)
T PF12260_consen 8 NEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF 83 (188)
T ss_pred cHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence 58888999986 69999999884 2678999987766532 111 346888999999999999999997 458
Q ss_pred eecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 137 FHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 137 vHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
...|++|+|+-++++|++|+.|.......
T Consensus 84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEeecchHHeEEeCCCcEEEEechhcchh
Confidence 99999999999999999999999976543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00056 Score=69.28 Aligned_cols=80 Identities=18% Similarity=0.150 Sum_probs=56.2
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-c-c--cchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-L-R--GGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~-~--~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~l 93 (417)
.+.||.|.+..||.+.+...++.++||.-..... . . ....++...|...|+.+. ..++++++.+ +....++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 4689999999999999854446899998542111 0 1 123567778888888863 3467777776 4456789
Q ss_pred EEeccCCCC
Q 014849 94 VMEFAKGGE 102 (417)
Q Consensus 94 V~E~~~gg~ 102 (417)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998744
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.73 E-value=0.00038 Score=64.99 Aligned_cols=75 Identities=23% Similarity=0.267 Sum_probs=48.9
Q ss_pred eeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEEEEEecc
Q 014849 21 GKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+.|..|-...+|++.... .++.|++|+...... ......+|+.+++.+...+ .++++.... + .++|||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~----~~~d~~~E~~~~~~l~~~gl~P~v~~~~~--~--~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE----LIIDRERELRIHKLLSKHGLAPKLYATFQ--N--GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc----ceecHHHHHHHHHHHHhCCCCCeEEEEeC--C--cEEEEee
Confidence 4667888888999987643 367899997754321 1123457888998885433 344444332 2 4799999
Q ss_pred CCCCh
Q 014849 99 KGGEL 103 (417)
Q Consensus 99 ~gg~L 103 (417)
+|..+
T Consensus 75 ~G~~l 79 (235)
T cd05157 75 PGRTL 79 (235)
T ss_pred CCCcC
Confidence 98765
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00036 Score=67.66 Aligned_cols=135 Identities=18% Similarity=0.192 Sum_probs=83.8
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEV------LATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 92 (417)
.+.+..|....+|+... .+..+++|+.... ....+..|+.++..+.+.+ +.+++.. ....+..+
T Consensus 19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~------~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~ 90 (296)
T cd05153 19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKV------SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPA 90 (296)
T ss_pred eecccCccccceEEEEe--CCCcEEEEEcCCC------ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceE
Confidence 56677888889998865 3457888987541 2456778888888875332 4444431 23345678
Q ss_pred EEEeccCCCChHH-----------HHh---c--CCCCH------------HHHH--------HHHHHHHHHHHHHHH---
Q 014849 93 FVMEFAKGGELFA-----------KIS---K--GRFSE------------QLSR--------RYFQQLISAVEYCHS--- 133 (417)
Q Consensus 93 lV~E~~~gg~L~~-----------~i~---~--~~l~e------------~~~~--------~i~~ql~~aL~ylH~--- 133 (417)
+|+++++|..+.. .+. . ..+.. .... .....+..++.++.+
T Consensus 91 ~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~ 170 (296)
T cd05153 91 ALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDP 170 (296)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhh
Confidence 9999999876521 010 0 00000 0000 011122334444443
Q ss_pred ----cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 ----RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 ----~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.|.|||+++++.+.|.||+.+.
T Consensus 171 ~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 171 SDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred hcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 479999999999999998777899999764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.64 E-value=0.00092 Score=65.25 Aligned_cols=79 Identities=11% Similarity=0.093 Sum_probs=55.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC---CCcceEEEEEEe---CCEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH---PNIVKLYEVLAT---KAKI 91 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H---pnIv~l~~~~~~---~~~~ 91 (417)
-.-.+.||.|..+.||.... ++..+.+|... .. .....+.+|...|+.|.. -.+.+.++++.. .+.-
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~--~~~~~~~k~~~-~~----~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~ 88 (297)
T PRK10593 16 LSRVECISEQPYAALWALYD--SQGNPMPLMAR-SF----STPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPD 88 (297)
T ss_pred hheeeecCCccceeEEEEEc--CCCCEEEEEec-cc----ccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCe
Confidence 34467899999999999865 22357777742 21 013467789999988853 357788877654 3668
Q ss_pred EEEEeccCCCCh
Q 014849 92 YFVMEFAKGGEL 103 (417)
Q Consensus 92 ~lV~E~~~gg~L 103 (417)
++|||+++|+.+
T Consensus 89 ~LVmE~i~G~~~ 100 (297)
T PRK10593 89 VLLLERLRGVSV 100 (297)
T ss_pred EEEEeccCCEec
Confidence 999999998754
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.59 E-value=0.00032 Score=66.71 Aligned_cols=132 Identities=18% Similarity=0.214 Sum_probs=78.1
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEeccCCC
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~~gg 101 (417)
.+..|-...+|+.. .+|+.+++|+...... ...-...+|..+++.+....+ .+++... . -++|+||++|.
T Consensus 3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~--~~~v~e~i~G~ 73 (256)
T TIGR02721 3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCK---ALGVDRQREYQILQALSALGLAPKPILVN--E--HWLLVEWLEGE 73 (256)
T ss_pred cCCCcCcCCeEEEE--eCCccEEEeeCCcccc---cccCcHHHHHHHHHHHHhcCCCCceEEEe--C--CEEEEEeccCc
Confidence 34567778899887 3567888887644321 111134678899998864333 3444432 2 26899999987
Q ss_pred ChHH--------------HHh---cC-----CCC-HHHHHHHHHHHH---------HHHHHHHH--------cCCeecCC
Q 014849 102 ELFA--------------KIS---KG-----RFS-EQLSRRYFQQLI---------SAVEYCHS--------RGVFHRDL 141 (417)
Q Consensus 102 ~L~~--------------~i~---~~-----~l~-e~~~~~i~~ql~---------~aL~ylH~--------~givHrDl 141 (417)
.+.. .+. .- +++ ......+..++. ..+..+-. ..++|+|+
T Consensus 74 ~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl 153 (256)
T TIGR02721 74 VITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDV 153 (256)
T ss_pred ccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCC
Confidence 6531 111 10 111 122223332221 11222222 24899999
Q ss_pred CCCcEEecCCCCeEEeeeeccee
Q 014849 142 KLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 142 kp~NILl~~~~~vkl~DFGls~~ 164 (417)
.|.||++++++ +.|.||..+..
T Consensus 154 ~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 154 HAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CcCcEEEeCCC-CEEEeccccCc
Confidence 99999999887 89999998753
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.0011 Score=65.43 Aligned_cols=139 Identities=27% Similarity=0.336 Sum_probs=96.8
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccc--------ccc--------------chH-HHHHHHHHHHHhCCCCCcc
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--------LRG--------------GLT-AHVKREISIMSRLRHPNIV 79 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~--------------~~~-~~i~~Ei~il~~l~HpnIv 79 (417)
.|..|--+.||+|.. .+|..+|||++..+-. ... .+. --...|++-|++|+...|.
T Consensus 151 CiSTGKEANVYHat~-~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 151 CISTGKEANVYHATE-EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred ccccCccceeEeeec-CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 456688888999988 6788899999854321 110 011 1234678888888765544
Q ss_pred eEEEEEEeCCEEEEEEeccCC-CChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCcEEecCCCCeEEe
Q 014849 80 KLYEVLATKAKIYFVMEFAKG-GELFAKISKGRFSEQLSRRYFQQLISAVEYCH-SRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 80 ~l~~~~~~~~~~~lV~E~~~g-g~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
-.--+.. + ...|||+++.+ |--.-.+..-.++...++.+.+|++.-|.-|- ..++||.||.-=|+|+.+ |.+.|+
T Consensus 230 ~PePIlL-k-~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyhd-G~lyiI 306 (520)
T KOG2270|consen 230 CPEPILL-K-NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYHD-GKLYII 306 (520)
T ss_pred CCCceee-e-cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEEC-CEEEEE
Confidence 2222211 2 24689999953 22334555567888999999999999998885 679999999999999965 479999
Q ss_pred eeecceee
Q 014849 158 DFGLSAVK 165 (417)
Q Consensus 158 DFGls~~~ 165 (417)
|.+.|.-.
T Consensus 307 DVSQSVE~ 314 (520)
T KOG2270|consen 307 DVSQSVEH 314 (520)
T ss_pred EccccccC
Confidence 99877543
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00096 Score=65.25 Aligned_cols=136 Identities=19% Similarity=0.205 Sum_probs=81.1
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEE------EEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEV------LATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~------~~~~~~~~ 92 (417)
.+.++.|.-..+|.+.. .+| .+++|+..... ..+.+..|+.++..|...+ +.+++.. ....+..+
T Consensus 27 i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~-----~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~ 99 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV-----KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPA 99 (307)
T ss_pred ccccCCccccceEEEEe-CCC-cEEEEEecCCC-----CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEE
Confidence 56677787789998864 344 67788765421 1345566777777774322 3343331 12245678
Q ss_pred EEEeccCCCChH-----------HHH---hc--CCCC--------HHH-----HH----------HHHHHHHHHHHHHHH
Q 014849 93 FVMEFAKGGELF-----------AKI---SK--GRFS--------EQL-----SR----------RYFQQLISAVEYCHS 133 (417)
Q Consensus 93 lV~E~~~gg~L~-----------~~i---~~--~~l~--------e~~-----~~----------~i~~ql~~aL~ylH~ 133 (417)
++++|++|.++. ..+ .. ..++ ... .. .....+...++++..
T Consensus 100 ~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~ 179 (307)
T TIGR00938 100 CLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDK 179 (307)
T ss_pred EEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHh
Confidence 999999986531 011 00 1110 000 00 011123334555542
Q ss_pred -------cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 -------RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 -------~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.+.||+++.++.+.|.||+.+.
T Consensus 180 ~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 180 FWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred hhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 689999999999999998877899999764
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0021 Score=63.06 Aligned_cols=135 Identities=16% Similarity=0.195 Sum_probs=75.1
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEE------EEEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYE------VLATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~------~~~~~~~~~ 92 (417)
.+.++.|....+|.... .+| .+++|++... ....+..|+.+++.|...+ +.+.+. +....+..+
T Consensus 27 ~~~l~~G~~n~~y~v~t-~~g-~~vLK~~~~~------~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~ 98 (319)
T PRK05231 27 LKGIAEGIENSNFFLTT-TQG-EYVLTLFERL------TAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPA 98 (319)
T ss_pred cchhccccccceEEEEe-CCC-cEEEEEeccC------ChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEE
Confidence 34566777788999875 233 6888987511 1234445666666653211 333332 123356789
Q ss_pred EEEeccCCCChH-----------HHHhc-----CCCC----------H--HHHH-----------HHHHH-HHHHHHHHH
Q 014849 93 FVMEFAKGGELF-----------AKISK-----GRFS----------E--QLSR-----------RYFQQ-LISAVEYCH 132 (417)
Q Consensus 93 lV~E~~~gg~L~-----------~~i~~-----~~l~----------e--~~~~-----------~i~~q-l~~aL~ylH 132 (417)
++++|++|..+. ..+.+ ..++ . .... ..+.+ +-..++.+.
T Consensus 99 ~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (319)
T PRK05231 99 AIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLA 178 (319)
T ss_pred EEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhh
Confidence 999999997531 11110 0010 0 0000 11111 111122222
Q ss_pred -------HcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 133 -------SRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 133 -------~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
..|+||+|+.|.|||++.+...-|.||+.+.
T Consensus 179 ~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~ 216 (319)
T PRK05231 179 SAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC 216 (319)
T ss_pred ccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence 2489999999999999976556899999874
|
|
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00015 Score=70.37 Aligned_cols=136 Identities=18% Similarity=0.278 Sum_probs=99.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc------------c---ccch----HHHHHHHHHHHHhCCCC-
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI------------L---RGGL----TAHVKREISIMSRLRHP- 76 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~------------~---~~~~----~~~i~~Ei~il~~l~Hp- 76 (417)
=|.+|..||-|--+.||.+-+ ..|++.++|.=..-+. . ...+ .-...+|...|+.|...
T Consensus 93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g 171 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG 171 (465)
T ss_pred hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence 367899999999999999998 6788999985321100 0 0001 11344788888888531
Q ss_pred -CcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 77 -NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 77 -nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
-|.+.++ .+..++|||++.|-.|...-. ...+..++..++.-+--|..+|+||+|+.-=||++++++.++
T Consensus 172 fpVPkpiD----~~RH~Vvmelv~g~Pl~~v~~-----v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~ 242 (465)
T KOG2268|consen 172 FPVPKPID----HNRHCVVMELVDGYPLRQVRH-----VEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIV 242 (465)
T ss_pred CCCCCccc----ccceeeHHHhhcccceeeeee-----cCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEE
Confidence 2444443 356789999999987754431 123557778888888999999999999999999999999999
Q ss_pred Eeeeecc
Q 014849 156 ISDFGLS 162 (417)
Q Consensus 156 l~DFGls 162 (417)
++||--.
T Consensus 243 vIDFPQm 249 (465)
T KOG2268|consen 243 VIDFPQM 249 (465)
T ss_pred EeechHh
Confidence 9999743
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.35 E-value=0.0017 Score=63.21 Aligned_cols=76 Identities=22% Similarity=0.281 Sum_probs=49.0
Q ss_pred eeEEeeeCceEEEEEEEcc------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYF 93 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~l 93 (417)
++.|..|-...+|++.... +++.+++|+..... .......+|..+++.+...++ .+++..+. . .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~----~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~-~---~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV----ELLIDRERELVVFARLSERNLGPKLYGIFP-N---GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC----cceechHHHHHHHHHHHhCCCCCceEEEeC-C---Cc
Confidence 3556667777899887533 36889999965432 112456788888888864333 34555443 2 35
Q ss_pred EEeccCCCChH
Q 014849 94 VMEFAKGGELF 104 (417)
Q Consensus 94 V~E~~~gg~L~ 104 (417)
|+||++|..+.
T Consensus 75 v~e~i~G~~l~ 85 (302)
T cd05156 75 IEEFIPSRTLT 85 (302)
T ss_pred hhheeCCCcCC
Confidence 89999887653
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.21 E-value=0.0013 Score=67.56 Aligned_cols=164 Identities=20% Similarity=0.277 Sum_probs=105.0
Q ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCee
Q 014849 60 TAHVKREISIMSRLRHPNIVKLYEVLATK-AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138 (417)
Q Consensus 60 ~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givH 138 (417)
..++.-...+++.+.|+|..+.+.+.... ....+|+|++ +.+|.+.+..+.+-... +. .+|+.|
T Consensus 26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~l~~~s---~~-----------~~~~~~ 90 (725)
T KOG1093|consen 26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGNLKDES---LL-----------AHGVLH 90 (725)
T ss_pred HHHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcccchhh---hc-----------ccccce
Confidence 34566778899999999999999886543 3577899999 55899988765432111 11 222222
Q ss_pred cCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC
Q 014849 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218 (417)
Q Consensus 139 rDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf 218 (417)
.|+ ++.+| -+. . . | |- ..++++||||+|.|+.++.-|...+
T Consensus 91 -----~~~-------~~~td-~~~---t----~-----------~--~~------~~~pKsdVwsl~~i~~el~L~~~l~ 131 (725)
T KOG1093|consen 91 -----LNI-------IYITD-HFL---T----K-----------Y--PS------PIGPKSDVWSLGFIILELYLGISLE 131 (725)
T ss_pred -----ehh-------hhccc-ccc---c----c-----------C--CC------CCCcchhhhhHHHHHHHHHHhhHHH
Confidence 222 33333 010 0 0 0 11 1135999999999999999998777
Q ss_pred CCCCHHHHHHHHhcCCCCCC------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 219 NDPNLMAMYRKIYKGEYRCP------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 219 ~~~~~~~~~~~i~~~~~~~p------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
......+....+.+-....- ...+.....+..+|+-..|..||...++++++-|...+.
T Consensus 132 ~~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev~~ 202 (725)
T KOG1093|consen 132 AELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEVYK 202 (725)
T ss_pred HHHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHHHh
Confidence 66554444444432211100 112445667889999999999999999999999876543
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0038 Score=62.22 Aligned_cols=85 Identities=14% Similarity=0.112 Sum_probs=54.5
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccc-cc---cchHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEEE
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LR---GGLTAHVKREISIMSRLR--HP-NIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~---~~~~~~i~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV~ 95 (417)
.+|.|...-||++.+...++.|+||.-..--. .. +-...+...|..+|+... -| .++++|.+ ++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 57899999999999854447899997542211 11 223566778888887764 24 46666554 555567999
Q ss_pred eccCCCC-hHHHHhc
Q 014849 96 EFAKGGE-LFAKISK 109 (417)
Q Consensus 96 E~~~gg~-L~~~i~~ 109 (417)
|+++... |...+.+
T Consensus 80 EdL~~~~ilR~~Li~ 94 (370)
T TIGR01767 80 EDLSHHKIARKGLIE 94 (370)
T ss_pred hhCccchHHHHHHHc
Confidence 9985533 3344433
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0094 Score=58.54 Aligned_cols=141 Identities=14% Similarity=0.244 Sum_probs=82.2
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCC--EEEEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKA--KIYFVM 95 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~--~~~lV~ 95 (417)
+++....|.--.+|...+. ++.+++. ... ............+|..+|+.+.- --+..-+.++.+.. ..|.||
T Consensus 29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~ 104 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVM 104 (321)
T ss_pred eeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEE
Confidence 3444433444445665553 7788887 332 12223346677889999888753 22334455555544 779999
Q ss_pred eccCCCChHHHHhcCCCC---------------------------------HHHHHHHHHH--------------HHHHH
Q 014849 96 EFAKGGELFAKISKGRFS---------------------------------EQLSRRYFQQ--------------LISAV 128 (417)
Q Consensus 96 E~~~gg~L~~~i~~~~l~---------------------------------e~~~~~i~~q--------------l~~aL 128 (417)
+|+.|..+.+.......+ ..+...+..+ ...-.
T Consensus 105 ~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~ 184 (321)
T COG3173 105 EWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLI 184 (321)
T ss_pred EEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHH
Confidence 999984332221111111 0111111111 12233
Q ss_pred HHHHHc--------CCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 129 EYCHSR--------GVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 129 ~ylH~~--------givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
.|++.+ .++|+|+.+.||+++.++.+-|.||+++.+
T Consensus 185 ~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 185 KWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 444433 489999999999999999999999999875
|
|
| >PF02149 KA1: Kinase associated domain 1; InterPro: IPR001772 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0016 Score=45.12 Aligned_cols=34 Identities=15% Similarity=0.076 Sum_probs=29.4
Q ss_pred cceEEEEEEEEec-CceEEEEEEecCCc---hhhhhcc
Q 014849 377 GNFTMVIGIDRLT-DDLVVVEIKKSMRR---GEENWKD 410 (417)
Q Consensus 377 ~~~~~~~~~~~~~-~~~~~v~~~~~~g~---~~~~~~~ 410 (417)
-.+.+.+||+.+. ++++.|.|+|.+|| |+++|.+
T Consensus 3 ~~v~fEieV~kl~~~~l~Gv~~kRi~Gd~~~yk~lc~~ 40 (47)
T PF02149_consen 3 EVVKFEIEVCKLPRLGLYGVDFKRISGDSWQYKDLCSK 40 (47)
T ss_dssp C-EEEEEEEEEECCCTCEEEEEEEEES-HHHHHHHHHH
T ss_pred cceEEEEEEEEecCCCeeEEEEEEeeCCHHHHHHHHHH
Confidence 4578999999998 89999999999999 9999983
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. Members of the KIN2/PAR-1/MARK kinase subfamily are conserved from yeast to human and share the same domain organisation: an N-terminal kinase domain (IPR000719 from INTERPRO) and a C-terminal kinase associated domain 1 (KA1). Some members of the KIN1/PAR-1/MARK family also contain an UBA domain (IPR000449 from INTERPRO). Members of this kinase subfamily are involved in various biological processes such as cell polarity, cell cycle control, intracellular signalling, microtubule stability and protein stability []. The function of the KA1 domain is not yet known. Some proteins known to contain a KA1 domain are listed below: Mammalian MAP/microtubule affinity-regulating kinases (MARK 1,2,3). They regulate polarity in neuronal cell models and appear to function redundantly in phosphorylating MT-associated proteins and in regulating MT stability []. Mammalian maternal embryonic leucine zipper kinase (MELK). It phosphorylates ZNF622 and may contribute to its redirection to the nucleus. It may be involved in the inhibition of spliceosome assembly during mitosis. Caenorhabditis elegans and drosophila PAR-1 protein. It is required for establishing polarity in embryos where it is asymmetrically distributed []. Fungal Kin1 and Kin2 protein kinases involved in regulation of exocytosis. They localise to the cytoplasmic face of the plasma membrane []. Plant KIN10 and KIN11 proteins, catalytic subunits of the putative trimeric SNF1-related protein kinase (SnRK) complex. This entry represents the KA1 domain.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3OSE_A 1V5S_A 1UL7_A. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.014 Score=56.90 Aligned_cols=29 Identities=31% Similarity=0.612 Sum_probs=25.5
Q ss_pred cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 ~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.+.||+++. +.+.|.||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 47899999999999988 678999999653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.0095 Score=57.52 Aligned_cols=30 Identities=27% Similarity=0.382 Sum_probs=25.1
Q ss_pred CCeecCCCCCcEEecCCCC-eEEeeeeccee
Q 014849 135 GVFHRDLKLENLLLDENWD-LKISDFGLSAV 164 (417)
Q Consensus 135 givHrDlkp~NILl~~~~~-vkl~DFGls~~ 164 (417)
.++|+|++|.|||++.++. .-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998753
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.80 E-value=0.02 Score=58.11 Aligned_cols=77 Identities=16% Similarity=0.091 Sum_probs=53.6
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-ccc---chHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRG---GLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~---~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~ 92 (417)
..+.+|.|....||+..+ .++.++||.-..... ... ....+...|...|+.+. ..++.+++.+..+ .-+
T Consensus 36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCE
Confidence 477889999999999887 355799997652221 111 13456667788887764 2478888887664 357
Q ss_pred EEEeccCC
Q 014849 93 FVMEFAKG 100 (417)
Q Consensus 93 lV~E~~~g 100 (417)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999977
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.023 Score=56.58 Aligned_cols=135 Identities=16% Similarity=0.188 Sum_probs=79.2
Q ss_pred eeEEeeeCceEEEEEEEcc----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcc-eEEEEEEeCCEEEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV-KLYEVLATKAKIYFVM 95 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv-~l~~~~~~~~~~~lV~ 95 (417)
.+.|-.|-.-.+|++.... +++.|.+|+..... ....+ ..+|..+++.+..-++- ++++.+.. . .|.
T Consensus 41 i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-g---~v~ 112 (344)
T PLN02236 41 VIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-G---RVE 112 (344)
T ss_pred EEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECC-c---eEE
Confidence 3445557788899986432 34789999876542 22233 26788998888643333 45555532 2 589
Q ss_pred eccCCCChHHH--------------Hh---cCC------C-CHHHHHHHHHHH-----------------HHHHHHH---
Q 014849 96 EFAKGGELFAK--------------IS---KGR------F-SEQLSRRYFQQL-----------------ISAVEYC--- 131 (417)
Q Consensus 96 E~~~gg~L~~~--------------i~---~~~------l-~e~~~~~i~~ql-----------------~~aL~yl--- 131 (417)
+|++|.+|... +. +.. . .......++.++ ...+..|
T Consensus 113 efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~ 192 (344)
T PLN02236 113 EFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKE 192 (344)
T ss_pred EeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHH
Confidence 99987665311 11 100 1 112232333222 1111122
Q ss_pred -H----HcCCeecCCCCCcEEecC-CCCeEEeeeecce
Q 014849 132 -H----SRGVFHRDLKLENLLLDE-NWDLKISDFGLSA 163 (417)
Q Consensus 132 -H----~~givHrDlkp~NILl~~-~~~vkl~DFGls~ 163 (417)
. ...++|+|+++.|||+++ ++.+.++||..+.
T Consensus 193 ~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~ 230 (344)
T PLN02236 193 LSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS 230 (344)
T ss_pred hcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence 1 235899999999999986 4679999999875
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.016 Score=58.61 Aligned_cols=78 Identities=21% Similarity=0.199 Sum_probs=54.0
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc---cchHHHHHHHHHHHHhCC--CC-CcceEEEEEEeCCEEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR---GGLTAHVKREISIMSRLR--HP-NIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~---~~~~~~i~~Ei~il~~l~--Hp-nIv~l~~~~~~~~~~~lV 94 (417)
.+.||.|.-.-||++.+...++.|+||.-..--... +-..++..-|..+|+... -| +++++|.+ ++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678899999999999984346789998653221111 223567788999998774 34 56666654 55556789
Q ss_pred EeccCC
Q 014849 95 MEFAKG 100 (417)
Q Consensus 95 ~E~~~g 100 (417)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999854
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.49 E-value=0.0084 Score=60.20 Aligned_cols=124 Identities=21% Similarity=0.238 Sum_probs=83.3
Q ss_pred eEEeeeCceEEEEEEE---------------ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEE
Q 014849 22 KIIGCGAFAKVYHGRN---------------VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVL 85 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~---------------~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~ 85 (417)
..+|.|+-+.||.|.- +...+.+|||+.++. ...++++...||.-.. -+|+|.-..+.
T Consensus 195 ~PIGsG~IAQVY~atl~~a~lekd~~~~~~~~~~tq~~AiKv~Hp~------V~~~ir~Dl~Il~f~Akl~~~vP~l~wL 268 (565)
T KOG1236|consen 195 EPIGSGCIAQVYRATLKTAYLEKDSGKEYVQKLGTQSCAIKVLHPN------VEKQIRLDLGILGFGAKLINNVPDLSWL 268 (565)
T ss_pred cccccchhhhhhhhhhhHHHhhcccchhhhcCCccceeeeeccCcc------HHHHHHHHHHHHhhhhhhhhhcCccccc
Confidence 4589999999999852 234567999998654 2455666666654432 22222111110
Q ss_pred ----------------------------------------------EeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHH
Q 014849 86 ----------------------------------------------ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRR 119 (417)
Q Consensus 86 ----------------------------------------------~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~ 119 (417)
.--+...++-+|..|-++..+++....+|...++
T Consensus 269 ~l~~~vkqF~v~ln~QvdL~~EA~hL~rF~~NF~~s~~V~fP~P~~~~~~~~vl~E~~~~Gl~v~~~v~~~~~pe~l~kk 348 (565)
T KOG1236|consen 269 SLPLEVKQFSVGLNAQVDLRQEALHLPRFTNNFSGSKKVLFPKPIAPLHTDLVLVETYERGLSVLRFVKWKSQPEALVKK 348 (565)
T ss_pred cCcchHHHHHHHHHhhcchhhhhhhhHHHHHhcccceeecCCcccccccccceeeeeccccccHHhhhhcccChHHHHHH
Confidence 0113456777899999999999877778877777
Q ss_pred HHHHHHHHHHHHH-HcCCeecCCCCCcEEecCC
Q 014849 120 YFQQLISAVEYCH-SRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 120 i~~ql~~aL~ylH-~~givHrDlkp~NILl~~~ 151 (417)
++.--+.|+.-+- -.+++|.|+.|.||++-.+
T Consensus 349 va~lg~~AllkMl~vDNFvHaDlHPGNVlirf~ 381 (565)
T KOG1236|consen 349 VAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN 381 (565)
T ss_pred HHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence 7776677665544 5689999999999999544
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.21 E-value=0.042 Score=54.41 Aligned_cols=134 Identities=18% Similarity=0.185 Sum_probs=77.0
Q ss_pred eEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEec
Q 014849 22 KIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~ 97 (417)
+.|..|---.+|+...... +..|.+++...... . .-.-.+|..+++.+..-++ .+++.++. .+ +|.+|
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~---~-~IdR~~E~~il~~l~~~gl~P~~l~~~~-~G---~i~~f 91 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD---Y-VIDRERELQAIKYLSAAGFGAKLLGVFG-NG---MIQSF 91 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC---e-EechHHHHHHHHHHHhcCCCCceeEEeC-Cc---Eeehh
Confidence 4444477778898865432 34789998754321 1 1223578888888865444 35555543 22 58999
Q ss_pred cCCCChHH----------HH----h---cCC------C-CHHHHHHHHHHH----------------------HHHHHHH
Q 014849 98 AKGGELFA----------KI----S---KGR------F-SEQLSRRYFQQL----------------------ISAVEYC 131 (417)
Q Consensus 98 ~~gg~L~~----------~i----~---~~~------l-~e~~~~~i~~ql----------------------~~aL~yl 131 (417)
++|..|.. .+ . ... . ....+..++.++ ..-+..+
T Consensus 92 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l 171 (330)
T PLN02421 92 INARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVEL 171 (330)
T ss_pred hcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHH
Confidence 98765521 11 1 111 1 112233333332 1112222
Q ss_pred H----HcC----CeecCCCCCcEEecC-CCCeEEeeeecce
Q 014849 132 H----SRG----VFHRDLKLENLLLDE-NWDLKISDFGLSA 163 (417)
Q Consensus 132 H----~~g----ivHrDlkp~NILl~~-~~~vkl~DFGls~ 163 (417)
. +.+ .||.|+.|.|||+++ ++.++++||..|.
T Consensus 172 ~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag 212 (330)
T PLN02421 172 KEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS 212 (330)
T ss_pred HHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence 1 122 799999999999975 4689999999875
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.054 Score=52.97 Aligned_cols=29 Identities=24% Similarity=0.325 Sum_probs=27.0
Q ss_pred CCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 135 GVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 135 givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
++||+|+.+.|+|++.++.+.++||..+.
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~ 225 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKAS 225 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence 79999999999999999999999999764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.024 Score=52.08 Aligned_cols=30 Identities=27% Similarity=0.488 Sum_probs=21.6
Q ss_pred CCeecCCCCCcEEe-cCCCCeEEeeeeccee
Q 014849 135 GVFHRDLKLENLLL-DENWDLKISDFGLSAV 164 (417)
Q Consensus 135 givHrDlkp~NILl-~~~~~vkl~DFGls~~ 164 (417)
.++|.|+.|.|||+ +.++.++++||..|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 58999999999999 8889999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.88 E-value=0.063 Score=52.13 Aligned_cols=76 Identities=16% Similarity=0.169 Sum_probs=47.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV 94 (417)
-+-.+.++.|....+|... .+++.+.+|+-.... ...+..|..-|+.|. --.+++.+.+....+.-|+|
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~------~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG------RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG------CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh------HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3456778999999999977 688899999876322 234556777777773 44577888888777777999
Q ss_pred EeccCCC
Q 014849 95 MEFAKGG 101 (417)
Q Consensus 95 ~E~~~gg 101 (417)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999776
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.39 E-value=0.12 Score=52.29 Aligned_cols=76 Identities=21% Similarity=0.246 Sum_probs=45.0
Q ss_pred EeeEEeeeCceEEEEEEEccC-CcE-----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRT-GQS-----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIY 92 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~-g~~-----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~ 92 (417)
..+.|..|-...+|++..... +.. |.+.+... .....-.-.+|+.+++.+...++ .++++.+. -+
T Consensus 54 ~i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~----~g 125 (383)
T PTZ00384 54 EIKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG----DF 125 (383)
T ss_pred EEEEeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecC----CE
Confidence 344555588889999875332 222 44433211 11112233578999999875444 45666554 26
Q ss_pred EEEeccCCCCh
Q 014849 93 FVMEFAKGGEL 103 (417)
Q Consensus 93 lV~E~~~gg~L 103 (417)
++.||++|..|
T Consensus 126 ~l~efIeGr~l 136 (383)
T PTZ00384 126 TIQEWVEGNTM 136 (383)
T ss_pred EEEEEeccccC
Confidence 89999998766
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.38 E-value=0.19 Score=49.73 Aligned_cols=129 Identities=19% Similarity=0.277 Sum_probs=79.0
Q ss_pred CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC------cce----EEEEEEeCCEEEEEEec
Q 014849 28 AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN------IVK----LYEVLATKAKIYFVMEF 97 (417)
Q Consensus 28 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn------Iv~----l~~~~~~~~~~~lV~E~ 97 (417)
.--.||+... ..|+. ++|+.... ....++.-|+..|..|.-.. +.. .+.....+.+.+-+.+|
T Consensus 37 ~eN~~f~~~~-~~g~~-iLki~~~~-----~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~ 109 (331)
T COG2334 37 EENSNFRVQT-EDGRY-ILKIYRPG-----WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEY 109 (331)
T ss_pred ccCceEEEEe-cCCCe-EEEEecCC-----CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEe
Confidence 4456888877 34444 89988764 12567778888888874221 221 12222333488889999
Q ss_pred cCCCChHH------------H---Hh--cCCC-----------CHH----H---------HHHHHHHHHHHHHHHHHc--
Q 014849 98 AKGGELFA------------K---IS--KGRF-----------SEQ----L---------SRRYFQQLISAVEYCHSR-- 134 (417)
Q Consensus 98 ~~gg~L~~------------~---i~--~~~l-----------~e~----~---------~~~i~~ql~~aL~ylH~~-- 134 (417)
++|..+.. . +. ...+ ... . ......++...++.+.+.
T Consensus 110 l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~ 189 (331)
T COG2334 110 LPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLP 189 (331)
T ss_pred cCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhch
Confidence 99987762 0 00 0011 111 0 011334445555555543
Q ss_pred ------C--CeecCCCCCcEEecCCCC-eEEeeeecce
Q 014849 135 ------G--VFHRDLKLENLLLDENWD-LKISDFGLSA 163 (417)
Q Consensus 135 ------g--ivHrDlkp~NILl~~~~~-vkl~DFGls~ 163 (417)
+ +||+|+.|.||+++.+.. .-+.||+.+.
T Consensus 190 ~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 190 AHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred hhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence 3 999999999999999885 8999999763
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.74 Score=45.42 Aligned_cols=70 Identities=14% Similarity=0.142 Sum_probs=43.2
Q ss_pred CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEE---E--EEEeCCEEEEEEeccCC
Q 014849 28 AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLY---E--VLATKAKIYFVMEFAKG 100 (417)
Q Consensus 28 ~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~---~--~~~~~~~~~lV~E~~~g 100 (417)
.-..||.... .+|..+++|+..... ....++..|+..+..|.... ++... + +..-++..+.++++++|
T Consensus 37 ~eN~vy~v~~-~~~~~~vlKv~r~~~----~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G 111 (325)
T PRK11768 37 YENRVYQFGD-EDGRRVVAKFYRPER----WSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGG 111 (325)
T ss_pred ccceEEEEec-CCCCEEEEEEcCccc----CCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCC
Confidence 4456888775 566789999875432 12566777888887664211 22211 1 12335678889999988
Q ss_pred CC
Q 014849 101 GE 102 (417)
Q Consensus 101 g~ 102 (417)
..
T Consensus 112 ~~ 113 (325)
T PRK11768 112 RA 113 (325)
T ss_pred CC
Confidence 64
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.58 E-value=0.63 Score=53.10 Aligned_cols=135 Identities=13% Similarity=0.222 Sum_probs=76.6
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-------CCCcceE-----EEEEEe-C
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-------HPNIVKL-----YEVLAT-K 88 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-------HpnIv~l-----~~~~~~-~ 88 (417)
+.|+. ..-.+|+... .+|+.+++|+.+... ....+..|...|..|. -|.+++. +..... .
T Consensus 31 ~~L~s-~~d~nf~v~~-~~g~~yVLKi~~~~~-----~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~ 103 (1013)
T PRK06148 31 TPLDG-ERDLNFRLTT-DDGADYILKIVNPSE-----PRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPD 103 (1013)
T ss_pred eecCC-cCCceEEEEe-CCCCeEEEEEcCCcc-----chhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCC
Confidence 56643 4567888765 567789999987642 1233445555665442 2333321 112221 2
Q ss_pred C--EEEEEEeccCCCChHHH-----------------H----hc-------CCCC-----------------HHHHHHHH
Q 014849 89 A--KIYFVMEFAKGGELFAK-----------------I----SK-------GRFS-----------------EQLSRRYF 121 (417)
Q Consensus 89 ~--~~~lV~E~~~gg~L~~~-----------------i----~~-------~~l~-----------------e~~~~~i~ 121 (417)
+ ..+.+++|++|..|.+. + .. ..+. ....+.++
T Consensus 104 G~~~~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l 183 (1013)
T PRK06148 104 GEPRLLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALV 183 (1013)
T ss_pred CceEEEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHH
Confidence 2 56778999999776541 0 00 0000 01122333
Q ss_pred HHHHHHHHH-----HH--HcCCeecCCCCCcEEecCCC--CeE-Eeeeecce
Q 014849 122 QQLISAVEY-----CH--SRGVFHRDLKLENLLLDENW--DLK-ISDFGLSA 163 (417)
Q Consensus 122 ~ql~~aL~y-----lH--~~givHrDlkp~NILl~~~~--~vk-l~DFGls~ 163 (417)
.+++....- +. .+++||+|+.+.|||++.++ .+. |+|||.+.
T Consensus 184 ~~~~~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 184 ERFLARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred HHHHHHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 333333221 11 25799999999999999875 555 99999875
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=93.53 E-value=0.31 Score=48.63 Aligned_cols=87 Identities=22% Similarity=0.301 Sum_probs=59.4
Q ss_pred CCCCcceEEEEEEe-CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCC
Q 014849 74 RHPNIVKLYEVLAT-KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDEN 151 (417)
Q Consensus 74 ~HpnIv~l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~ 151 (417)
.-++..+++-+-.+ ....|++|++- |+.| ..+.. -..+++..+|.+.+..++-+..+ ..=|||+.-.||||+ +
T Consensus 283 g~~~~e~~~vv~~de~~y~yl~~kdh-gt~i-s~ik~--~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~ 357 (488)
T COG5072 283 GSVFLETLKVVSLDETLYLYLHFKDH-GTPI-SIIKA--DRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E 357 (488)
T ss_pred cchhhhcceEEecCCceEEEEEEecC-Ccee-eeeec--ccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence 34555555544422 33456666654 3333 33322 23456778888888877777655 689999999999999 9
Q ss_pred CCeEEeeeecceee
Q 014849 152 WDLKISDFGLSAVK 165 (417)
Q Consensus 152 ~~vkl~DFGls~~~ 165 (417)
|+|-|+||-++++.
T Consensus 358 GnvtLIDfklsRl~ 371 (488)
T COG5072 358 GNVTLIDFKLSRLS 371 (488)
T ss_pred CceEEEEeeeeecc
Confidence 99999999999853
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 417 | ||||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 5e-58 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 6e-58 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-57 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-57 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 2e-55 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-55 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 2e-55 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 6e-55 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-54 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-54 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-54 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 2e-53 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-53 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 5e-53 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-52 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-52 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-52 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 2e-51 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-50 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-46 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 5e-46 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-46 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-46 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-45 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-45 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 4e-45 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 4e-45 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-45 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 2e-43 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 9e-42 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-41 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 7e-41 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 2e-40 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 2e-40 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 2e-40 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 5e-40 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 7e-40 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 2e-39 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-39 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 3e-39 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 4e-39 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 6e-39 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 6e-39 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-39 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 8e-39 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 9e-39 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-38 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-38 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-38 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-38 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 2e-38 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-38 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 2e-38 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-38 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-38 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-38 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-38 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-38 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 4e-38 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 4e-38 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 4e-38 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 4e-38 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 4e-38 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-38 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 6e-38 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 6e-38 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 6e-38 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 7e-38 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 7e-38 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-37 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 1e-37 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 1e-37 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-37 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 2e-37 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-37 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 2e-37 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-37 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-37 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 2e-37 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 3e-37 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-37 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-37 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 4e-37 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-37 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 6e-37 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 6e-37 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 7e-37 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-37 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-37 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 7e-37 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-37 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-37 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-37 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-37 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 9e-37 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-36 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-36 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-36 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-36 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-36 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-36 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-36 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-36 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-36 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-36 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-36 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-36 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-36 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 2e-36 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-36 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-36 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-36 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-36 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-36 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-36 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-36 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-36 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-36 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-36 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-36 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-36 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-36 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-36 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-36 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-36 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-36 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-36 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-36 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-36 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-36 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-36 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-36 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-36 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 5e-36 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 5e-36 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 6e-36 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 6e-36 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-36 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-36 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-36 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 7e-36 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 7e-36 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-36 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 7e-36 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 7e-36 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-36 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-36 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-36 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 8e-36 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 8e-36 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 9e-36 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 9e-36 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 9e-36 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-36 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 9e-36 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 1e-35 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-35 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 2e-35 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 2e-35 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 2e-35 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-35 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 2e-35 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 2e-35 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 3e-35 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 3e-35 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 3e-35 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 4e-35 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-35 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-35 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-35 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-35 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 4e-35 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 5e-35 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 7e-35 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 7e-35 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 8e-35 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 8e-35 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-34 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 1e-34 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-34 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 2e-34 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 2e-34 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-34 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 2e-34 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-34 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-34 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-34 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-34 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 7e-34 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-33 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-33 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-33 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-33 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-33 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 7e-33 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 8e-33 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 9e-33 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-32 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-32 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-32 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-32 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-32 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-32 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-32 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-32 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-32 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 1e-32 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-32 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-32 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-32 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-32 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-32 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-32 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 2e-32 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 3e-32 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-32 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-32 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 8e-32 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 8e-32 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 9e-32 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 1e-31 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-31 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 2e-31 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-31 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-31 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-31 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 2e-31 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-31 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-31 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 8e-31 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 1e-30 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-30 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 3e-30 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 4e-30 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 4e-30 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-30 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-30 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 5e-30 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 5e-30 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-30 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-30 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 5e-30 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-29 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 2e-29 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 2e-29 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 3e-29 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 3e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 8e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 9e-29 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-28 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-28 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 3e-28 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-28 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-28 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 7e-28 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 8e-28 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 8e-28 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-27 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-27 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-27 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 2e-27 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 4e-27 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 6e-27 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 7e-27 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 7e-27 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 7e-27 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 8e-27 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 8e-27 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 9e-27 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 9e-27 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-27 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 9e-27 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-26 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 1e-26 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 1e-26 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-26 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 2e-26 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 2e-26 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 2e-26 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 2e-26 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 3e-26 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 4e-26 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 5e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 5e-26 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 6e-26 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 6e-26 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 6e-26 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 7e-26 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 8e-26 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-25 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 1e-25 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 1e-25 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-25 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-25 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-25 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-25 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-25 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 4e-25 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 6e-25 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 7e-25 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 8e-25 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 8e-25 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-24 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-24 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-24 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 6e-24 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 6e-24 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 1e-23 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-23 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-23 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-23 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-22 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-22 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-22 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-22 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 8e-22 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 9e-22 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-21 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 3e-21 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-21 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-21 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 3e-21 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 3e-21 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 3e-21 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 4e-21 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 5e-21 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 8e-21 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-20 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-20 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-20 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-20 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-20 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-20 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-20 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-20 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-20 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-20 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 2e-20 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 2e-20 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-20 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-20 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 3e-20 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-20 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-20 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-20 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-20 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 3e-20 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 3e-20 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-20 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-20 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 3e-20 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-20 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 3e-20 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 3e-20 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 3e-20 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-20 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 3e-20 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 3e-20 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 3e-20 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-20 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 3e-20 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 3e-20 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 3e-20 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 4e-20 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 5e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 8e-20 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-19 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 1e-19 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 1e-19 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-19 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 2e-19 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-19 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-19 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 2e-19 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 2e-19 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 2e-19 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 2e-19 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-19 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-19 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-19 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-19 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 3e-19 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-19 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-19 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-19 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 4e-19 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 4e-19 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 4e-19 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 4e-19 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 4e-19 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 5e-19 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 5e-19 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 6e-19 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 7e-19 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-19 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 8e-19 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 8e-19 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 9e-19 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 9e-19 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 9e-19 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 1e-18 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-18 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 1e-18 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 1e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-18 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-18 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-18 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-18 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 7e-18 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 1e-17 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-17 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 5e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 6e-17 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 1e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 3e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 3e-16 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 3e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-16 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-16 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-16 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 7e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-15 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-15 | ||
| 2zfd_B | 123 | The Crystal Structure Of Plant Specific Calcium Bin | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-15 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-15 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-15 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-15 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-15 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-15 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-15 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-15 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-15 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 9e-15 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-15 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-14 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-14 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-14 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-14 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-14 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-14 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-14 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-14 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 3e-14 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-14 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 3e-14 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-14 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-14 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 4e-14 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-14 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-14 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-14 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-14 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 6e-14 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-14 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-14 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-14 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 6e-14 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 6e-14 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-14 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 7e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 7e-14 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 7e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 9e-14 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-13 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-13 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-13 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 1e-13 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 2e-13 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 2e-13 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-13 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 2e-13 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-13 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 3e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 3e-13 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-13 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 3e-13 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 4e-13 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-13 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-13 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 5e-13 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 8e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-13 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 1e-12 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-12 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-12 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-12 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 2e-12 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 2e-12 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-12 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 2e-12 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 2e-12 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-12 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 3e-12 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-12 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-12 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 3e-12 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-12 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-12 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-12 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 3e-12 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-12 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 3e-12 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 3e-12 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 3e-12 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 3e-12 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 4e-12 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-12 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-12 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 4e-12 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-12 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-12 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-12 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 4e-12 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 4e-12 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 4e-12 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-12 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-12 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-12 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 4e-12 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-12 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-12 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-12 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 4e-12 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 5e-12 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-12 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 5e-12 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-12 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 5e-12 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-12 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 5e-12 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 5e-12 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 5e-12 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 5e-12 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 5e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 5e-12 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 5e-12 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-12 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-12 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-12 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-12 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 6e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-12 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 6e-12 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 6e-12 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-12 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-12 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 6e-12 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-12 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-12 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-12 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-12 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-12 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-12 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-12 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 6e-12 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 6e-12 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 7e-12 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 7e-12 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-12 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 7e-12 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 7e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-12 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-12 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 7e-12 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-12 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-12 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 7e-12 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-12 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 8e-12 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-12 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 8e-12 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 8e-12 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 8e-12 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 8e-12 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 8e-12 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 8e-12 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 8e-12 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-12 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 8e-12 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 8e-12 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 8e-12 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 8e-12 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 8e-12 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 9e-12 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 9e-12 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 9e-12 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 9e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 9e-12 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 9e-12 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 9e-12 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 9e-12 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 9e-12 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 9e-12 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 1e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-11 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-11 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-11 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-11 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-11 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-11 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-11 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-11 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-11 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 3e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-11 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 3e-11 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 4e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 4e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-11 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 4e-11 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 4e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-11 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-11 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-11 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 5e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 5e-11 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-11 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 5e-11 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 5e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 5e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 5e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 5e-11 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-11 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 6e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 6e-11 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 6e-11 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 7e-11 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 7e-11 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 7e-11 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 7e-11 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-11 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 8e-11 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 8e-11 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 8e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 8e-11 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 8e-11 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 9e-11 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 9e-11 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-10 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-10 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-10 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-10 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 1e-10 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-10 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 2e-10 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 2e-10 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 2e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 2e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 2e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 2e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 2e-10 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-10 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-10 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 2e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 2e-10 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-10 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-10 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 2e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 3e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 3e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 3e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-10 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 4e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 4e-10 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 5e-10 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 5e-10 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-10 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-10 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 5e-10 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-10 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 6e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-10 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 6e-10 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 6e-10 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 6e-10 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-10 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 7e-10 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 7e-10 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 7e-10 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 7e-10 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 8e-10 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 1e-09 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 1e-09 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-09 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-09 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 2e-09 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-09 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-09 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-09 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 3e-09 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 3e-09 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 4e-09 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-09 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 4e-09 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-09 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-09 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-09 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-08 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 1e-08 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 1e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-08 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-08 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 2e-08 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-08 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-08 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-08 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-08 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 4e-08 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 4e-08 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 4e-08 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-08 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-08 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 6e-08 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 8e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-07 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 1e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-07 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-07 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-07 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-07 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-07 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 2e-07 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-07 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 3e-07 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-07 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-07 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 4e-07 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 4e-07 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 4e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 4e-07 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 4e-07 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 5e-07 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-07 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 5e-07 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 5e-07 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 5e-07 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 5e-07 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 5e-07 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 5e-07 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 5e-07 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 6e-07 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-07 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 6e-07 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 6e-07 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-07 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 7e-07 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-07 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 7e-07 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-07 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 7e-07 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-07 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-07 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-07 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-07 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 8e-07 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 9e-07 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 1e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 1e-06 | ||
| 4hni_A | 296 | Crystal Structure Of Ck1e In Complex With Pf4800567 | 1e-06 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-06 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-06 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 1e-06 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 1e-06 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-06 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 1e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-06 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-06 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-06 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-06 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-06 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-06 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 1e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-06 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 1e-06 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-06 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-06 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-06 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 2e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 2e-06 | ||
| 2pzi_A | 681 | Crystal Structure Of Protein Kinase Pkng From Mycob | 2e-06 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-06 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-06 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-06 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 2e-06 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 2e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-06 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-06 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 2e-06 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-06 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-06 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-06 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 3e-06 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 3e-06 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-06 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 3e-06 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-06 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-06 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 3e-06 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-06 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 3e-06 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-06 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-06 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 3e-06 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-06 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-06 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-06 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-06 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-06 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 4e-06 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-06 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 4e-06 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 4e-06 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-06 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 4e-06 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-06 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 5e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 5e-06 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 5e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-06 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 5e-06 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 5e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-06 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 5e-06 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 6e-06 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 6e-06 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 6e-06 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-06 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 6e-06 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 6e-06 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 6e-06 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-06 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 6e-06 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 7e-06 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-06 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 7e-06 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 8e-06 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 8e-06 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-06 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 8e-06 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 9e-06 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 9e-06 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 9e-06 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 9e-06 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-05 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-05 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 1e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 1e-05 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 1e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 2e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 2e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 2e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-05 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 2e-05 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-05 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 3e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 3e-05 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-05 | ||
| 4f99_A | 361 | Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti | 3e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-05 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 4e-05 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 5e-05 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 5e-05 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 5e-05 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-05 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-05 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 6e-05 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 7e-05 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 7e-05 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 7e-05 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 7e-05 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 8e-05 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-05 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-04 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-04 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-04 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-04 | ||
| 3sv0_A | 483 | Crystal Structure Of Casein Kinase-1 Like Protein I | 2e-04 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-04 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-04 |
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2ZFD|B Chain B, The Crystal Structure Of Plant Specific Calcium Binding Protein Atcbl2 In Complex With The Regulatory Domain Of Atcipk14 Length = 123 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 464 bits (1196), Expect = e-165
Identities = 113/278 (40%), Positives = 165/278 (59%), Gaps = 4/278 (1%)
Query: 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR 65
G G Y +G +G G F KV G + TG VA+K +++QKI + +KR
Sbjct: 1 GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60
Query: 66 EISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQL 124
EI + RHP+I+KLY+V++T + VME+ GGELF I GR E +RR FQQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
+SAV+YCH V HRDLK EN+LLD + + KI+DFGLS + + L T CG+P Y
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYA 177
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPD 244
APE+++ + Y G +VD+WSCGV+L+ L G LPF+D ++ +++KI G + P++ +
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRS 237
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
+ + +L DP R T+ +I WFK+D FP
Sbjct: 238 VATLLMHMLQVDPLKRATIKDIREHEWFKQDLPSYLFP 275
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 462 bits (1192), Expect = e-164
Identities = 97/275 (35%), Positives = 148/275 (53%), Gaps = 6/275 (2%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSR 72
L GKY +G ++G G++ KV + T A+K + K+K+ R A+VK+EI ++ R
Sbjct: 3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRR 62
Query: 73 LRHPNIVKLYEVL--ATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLISAV 128
LRH N+++L +VL K K+Y VME+ G E+ + + RF + YF QLI +
Sbjct: 63 LRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
EY HS+G+ H+D+K NLLL LKIS G++ D T G+PA+ PEI
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI 182
Query: 189 LA-KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247
+ G KVD+WS GV L+ + G PF N+ ++ I KG Y P P L
Sbjct: 183 ANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPLSD 242
Query: 248 FIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
+ +L+ +PA R ++ +I + WF+K + + P
Sbjct: 243 LLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAP 277
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 463 bits (1193), Expect = e-164
Identities = 97/306 (31%), Positives = 157/306 (51%), Gaps = 6/306 (1%)
Query: 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
V +++ + +G GA+ +V N T ++VA+K V ++ + ++K+EI I
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICIN 59
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVE 129
L H N+VK Y Y +E+ GGELF +I E ++R+F QL++ V
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
Y H G+ HRD+K ENLLLDE +LKISDFGL+ V + +L+ +CGT YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGEYRCPKWT--SPDLK 246
++ + VD+WSCG+VL + AG LP++ P + Y + + W
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFD 306
+ ++L +P+ RIT+ +I +D W+ K K+ S + S+ + D
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLD 299
Query: 307 IISLSS 312
++S
Sbjct: 300 FSPVNS 305
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 461 bits (1188), Expect = e-164
Identities = 93/276 (33%), Positives = 148/276 (53%), Gaps = 6/276 (2%)
Query: 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
V +++ + +G GA+ +V N T ++VA+K V ++ + ++K+EI I
Sbjct: 2 AVPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICIN 59
Query: 71 SRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVE 129
L H N+VK Y Y +E+ GGELF +I E ++R+F QL++ V
Sbjct: 60 KMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
Y H G+ HRD+K ENLLLDE +LKISDFGL+ V + +L+ +CGT YVAPE+L
Sbjct: 120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGEYRCPKWT--SPDLK 246
++ + VD+WSCG+VL + AG LP++ P + Y + + W
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL 239
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
+ ++L +P+ RIT+ +I +D W+ K K+
Sbjct: 240 ALLHKILVENPSARITIPDIKKDRWYNKPLKKGAKR 275
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 460 bits (1185), Expect = e-161
Identities = 112/278 (40%), Positives = 169/278 (60%), Gaps = 4/278 (1%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
G Y +G +G G F KV G++ TG VA+K +++QKI + ++REI
Sbjct: 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQ 68
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISA 127
+ RHP+I+KLY+V++T + I+ VME+ GGELF I GR E+ SRR FQQ++S
Sbjct: 69 NLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSG 128
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
V+YCH V HRDLK EN+LLD + + KI+DFGLS + + L T CG+P Y APE
Sbjct: 129 VDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRTSCGSPNYAAPE 185
Query: 188 ILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247
+++ + Y G +VD+WS GV+L+ L G LPF+D ++ +++KI G + P++ +P +
Sbjct: 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245
Query: 248 FIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
+ +L DP R T+ +I WFK+D + FP +
Sbjct: 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDP 283
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 452 bits (1166), Expect = e-160
Identities = 119/284 (41%), Positives = 174/284 (61%), Gaps = 5/284 (1%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI 67
++ G Y + + +G G+F KV + +T Q VA+K +S+Q + + + V+REI
Sbjct: 1 MAISKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREI 60
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLIS 126
S + LRHP+I+KLY+V+ T I V+E+A GGELF I K R +E RR+FQQ+I
Sbjct: 61 SYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIIC 119
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
A+EYCH + HRDLK ENLLLD+N ++KI+DFGLS + + L T CG+P Y AP
Sbjct: 120 AIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNI---MTDGNFLKTSCGSPNYAAP 176
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLK 246
E++ K Y G +VD+WSCG+VL+V+ G LPF+D + +++K+ Y P + SP +
Sbjct: 177 EVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQ 236
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKD 290
I R++ DP RIT+ EI RDPWF + + P E+
Sbjct: 237 SLIRRMIVADPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSY 280
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 449 bits (1157), Expect = e-158
Identities = 121/341 (35%), Positives = 169/341 (49%), Gaps = 30/341 (8%)
Query: 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISI 69
++ +Y+ K IG G F R+ T + VA+K + + + +V+REI
Sbjct: 14 PIMHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDE----NVQREIIN 69
Query: 70 MSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAV 128
LRHPNIV+ EV+ T + +ME+A GGEL+ +I + GRFSE +R +FQQL+S V
Sbjct: 70 HRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGV 129
Query: 129 EYCHSRGVFHRDLKLENLLLDENW--DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
YCHS + HRDLKLEN LLD + LKI DFG S + GTPAY+AP
Sbjct: 130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKS---SVLHSQPKSTVGTPAYIAP 186
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK----IYKGEYRCPK--W 240
E+L ++ YDG D+WSCGV L+V+ G PF DP YRK I +Y P
Sbjct: 187 EVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR 246
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY--------------KERKFPHEDF 286
SP+ I R+ DPATRI++ EI WF K+ +E + P +
Sbjct: 247 ISPECCHLISRIFVADPATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSL 306
Query: 287 DLKDSVGCNVGSEKYLNAFDIISLSSGFNLSGLFDDFNNND 327
D + N ++ +L DDF++
Sbjct: 307 DTIMQIISEATIPAVRNRCLDDFMTDNLDLDDDMDDFDSES 347
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-158
Identities = 93/292 (31%), Positives = 143/292 (48%), Gaps = 10/292 (3%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ + +Y G+ +G G FAK + + T + A K V K +L+ + E
Sbjct: 6 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 65
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
ISI L H ++V + ++ V+E + L + +E +R Y +Q++
Sbjct: 66 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 125
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+Y H V HRDLKL NL L+E+ ++KI DFGL+ E LCGTP Y+A
Sbjct: 126 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIA 183
Query: 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL 245
PE+L+KKG+ +VD+WS G +++ L G PF L Y +I K EY PK +P
Sbjct: 184 PEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 242
Query: 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHE------DFDLKDS 291
I ++L TDP R T++E+L D +F Y + P F + S
Sbjct: 243 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLPITCLTIPPRFSIAPS 294
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 446 bits (1149), Expect = e-157
Identities = 91/277 (32%), Positives = 140/277 (50%), Gaps = 4/277 (1%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ + +Y G+ +G G FAK + + T + A K V K +L+ + E
Sbjct: 32 EVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSME 91
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
ISI L H ++V + ++ V+E + L + +E +R Y +Q++
Sbjct: 92 ISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIV 151
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+Y H V HRDLKL NL L+E+ ++KI DFGL+ E LCGTP Y+A
Sbjct: 152 LGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGERKKVLCGTPNYIA 209
Query: 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL 245
PE+L+KKG+ +VD+WS G +++ L G PF L Y +I K EY PK +P
Sbjct: 210 PEVLSKKGHSF-EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA 268
Query: 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
I ++L TDP R T++E+L D +F Y + P
Sbjct: 269 ASLIQKMLQTDPTARPTINELLNDEFFTSGYIPARLP 305
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 437 bits (1126), Expect = e-154
Identities = 89/269 (33%), Positives = 148/269 (55%), Gaps = 5/269 (1%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
++VG ++G G+FA VY ++ TG VAIK + K+ + + G+ V+ E+ I +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS 133
P+I++LY +Y V+E GE+ + FSE +R + Q+I+ + Y HS
Sbjct: 71 PSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHS 130
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
G+ HRDL L NLLL N ++KI+DFGL+ + P +TLCGTP Y++PEI +
Sbjct: 131 HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISPEIATRSA 188
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
+ G + D+WS G + + L G PF+ + K+ +Y P + S + K I +LL
Sbjct: 189 H-GLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIHQLL 247
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFP 282
+PA R+++ +L P+ ++ +
Sbjct: 248 RRNPADRLSLSSVLDHPFMSRNSSTKSKD 276
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 433 bits (1117), Expect = e-153
Identities = 94/269 (34%), Positives = 150/269 (55%), Gaps = 6/269 (2%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
+++G+ +G G F VY R + +A+K + K ++ + G+ ++REI I S LR
Sbjct: 13 IDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR 72
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS 133
HPNI+++Y + +IY ++EFA GEL+ ++ K GRF EQ S + ++L A+ YCH
Sbjct: 73 HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHE 132
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
R V HRD+K ENLL+ +LKI+DFG S +R T+CGT Y+ PE++ K
Sbjct: 133 RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPEMIEGKT 188
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
+D KVD+W GV+ + G PF+ P+ +R+I + + P + S K I +LL
Sbjct: 189 HD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDGSKDLISKLL 247
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFP 282
P R+ + ++ PW K + + P
Sbjct: 248 RYHPPQRLPLKGVMEHPWVKANSRRVLPP 276
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 434 bits (1117), Expect = e-153
Identities = 98/298 (32%), Positives = 145/298 (48%), Gaps = 31/298 (10%)
Query: 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--------- 56
S + +Y + IG G++ V N A+K +SK+K++R
Sbjct: 3 SGSSGDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 57 --------------GGLTAHVKREISIMSRLRHPNIVKLYEVL--ATKAKIYFVMEFAKG 100
G V +EI+I+ +L HPN+VKL EVL + +Y V E
Sbjct: 63 PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQ 122
Query: 101 GELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160
G + + SE +R YFQ LI +EY H + + HRD+K NLL+ E+ +KI+DFG
Sbjct: 123 GPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFG 182
Query: 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPF 218
+S E D +L GTPA++APE L+ +K + G +D+W+ GV L+ G PF
Sbjct: 183 VSN--EFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF 240
Query: 219 NDPNLMAMYRKIYKGEYRCPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
D +M ++ KI P + DLK I R+LD +P +RI V EI PW +
Sbjct: 241 MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 421 bits (1085), Expect = e-148
Identities = 89/272 (32%), Positives = 146/272 (53%), Gaps = 6/272 (2%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
+E+G+ +G G F VY R ++ +A+K + K ++ + G+ ++RE+ I S LR
Sbjct: 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR 67
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS 133
HPNI++LY ++Y ++E+A G ++ ++ K +F EQ + Y +L +A+ YCHS
Sbjct: 68 HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 127
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
+ V HRD+K ENLLL +LKI+DFG S P LCGT Y+ PE++ +
Sbjct: 128 KRVIHRDIKPENLLLGSAGELKIADFGWSVH----APSSRRTDLCGTLDYLPPEMIEGRM 183
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
+D KVD+WS GV+ + G PF Y++I + E+ P + + + I RLL
Sbjct: 184 HD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 242
Query: 254 DTDPATRITVDEILRDPWFKKDYKERKFPHED 285
+P+ R + E+L PW + +
Sbjct: 243 KHNPSQRPMLREVLEHPWITANSSKPSNCQNK 274
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 423 bits (1089), Expect = e-148
Identities = 115/283 (40%), Positives = 173/283 (61%), Gaps = 5/283 (1%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
G++ + E G Y + K IG G FAKV R++ TG+ VAIK + K ++ L
Sbjct: 1 GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSL-Q 59
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRY 120
+ RE+ IM L HPNIVKL+EV+ T+ +Y +ME+A GGE+F + + GR E+ +R
Sbjct: 60 KLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSK 119
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
F+Q++SAV+YCH + + HRDLK ENLLLD + ++KI+DFG S + G L CG
Sbjct: 120 FRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSN---EFTVGGKLDAFCGA 176
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240
P Y APE+ K YDG +VD+WS GV+L+ L +G LPF+ NL + ++ +G+YR P +
Sbjct: 177 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPH 283
S D + + R L +P R T+++I++D W ++E +
Sbjct: 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEEDELKP 279
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 415 bits (1069), Expect = e-145
Identities = 85/284 (29%), Positives = 138/284 (48%), Gaps = 16/284 (5%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT-----AHV 63
+ E KY +G GAF V+ + + V +K + K+K+L V
Sbjct: 17 ACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 64 KREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA-KGGELFAKI-SKGRFSEQLSRRYF 121
EI+I+SR+ H NI+K+ ++ + VME G +LFA I R E L+ F
Sbjct: 77 TLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIF 136
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
+QL+SAV Y + + HRD+K EN+++ E++ +K+ DFG +A + + +T CGT
Sbjct: 137 RQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY---LERGKLFYTFCGTI 193
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT 241
Y APE+L Y G +++MWS GV L+ L PF + + + P
Sbjct: 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYLV 247
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
S +L + LL P R T+++++ DPW + + E+
Sbjct: 248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEE 291
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 407 bits (1047), Expect = e-142
Identities = 80/287 (27%), Positives = 135/287 (47%), Gaps = 20/287 (6%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT---AHVKR 65
+Y +G ++G G F V+ G + VAIK + + ++L
Sbjct: 24 KDREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL 83
Query: 66 EISIMSRLR----HPNIVKLYEVLATKAKIYFVMEFA-KGGELFAKI-SKGRFSEQLSRR 119
E++++ ++ HP +++L + T+ V+E +LF I KG E SR
Sbjct: 84 EVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRC 143
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLC 178
+F Q+++A+++CHSRGV HRD+K EN+L+D K+ DFG A + D
Sbjct: 144 FFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGA----LLHDEPYTDFD 199
Query: 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
GT Y PE +++ Y +WS G++L+ + G +PF ++I + E P
Sbjct: 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFER------DQEILEAELHFP 253
Query: 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
SPD I R L P++R +++EIL DPW + ++
Sbjct: 254 AHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVPLNPSK 300
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 398 bits (1025), Expect = e-139
Identities = 80/285 (28%), Positives = 133/285 (46%), Gaps = 18/285 (6%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH---VKR 65
+ L +Y+VG ++G G F VY G V VAIK V K +I G + V
Sbjct: 36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM 95
Query: 66 EISIMSRLRH--PNIVKLYEVLATKAKIYFVMEFAKG-GELFAKI-SKGRFSEQLSRRYF 121
E+ ++ ++ +++L + ++E + +LF I +G E+L+R +F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
Q++ AV +CH+ GV HRD+K EN+L+D N +LK+ DFG A + D + GT
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA----LLKDTVYTDFDGT 211
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240
Y PE + Y G +WS G++L+ + G +PF +I +G+ +
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR 265
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
S + + I L P+ R T +EI PW + ++
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIH 310
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 379 bits (975), Expect = e-131
Identities = 61/321 (19%), Positives = 125/321 (38%), Gaps = 51/321 (15%)
Query: 4 NTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG------ 57
+ + Y + + + G F K+ + A+K K + +
Sbjct: 19 LNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKS 76
Query: 58 --------GLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK 109
K E+ I++ +++ + ++ ++Y + E+ + +
Sbjct: 77 NNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY 136
Query: 110 ---------GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDF 159
Q+ + + ++++ Y H+ + + HRD+K N+L+D+N +K+SDF
Sbjct: 137 FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDF 196
Query: 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILA-KKGYDGAKVDMWSCGVVLFVLNAGYLPF 218
G S D + GT ++ PE + + Y+GAKVD+WS G+ L+V+ +PF
Sbjct: 197 GESE----YMVDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF 252
Query: 219 ND-PNLMAMYRKIYKGEYRCP-------------------KWTSPDLKWFIGRLLDTDPA 258
+ +L+ ++ I P + S + F+ L +PA
Sbjct: 253 SLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPA 312
Query: 259 TRITVDEILRDPWFKKDYKER 279
RIT ++ L+ W E
Sbjct: 313 ERITSEDALKHEWLADTNIED 333
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 338 bits (869), Expect = e-115
Identities = 71/296 (23%), Positives = 123/296 (41%), Gaps = 37/296 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+E ++G GAF +V RN + AIK + + + + E+ +++ L H
Sbjct: 7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLNHQ 62
Query: 77 NIVKLYEV-------------LATKAKIYFVMEFAKGGELFAKISKGR--FSEQLSRRYF 121
+V+ Y + K+ ++ ME+ + G L+ I R F
Sbjct: 63 YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ------------IR 169
+Q++ A+ Y HS+G+ HRDLK N+ +DE+ ++KI DFGL+ +
Sbjct: 123 RQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182
Query: 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK 229
L + GT YVA E+L G+ K+DM+S G++ F + Y + + +K
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNILKK 240
Query: 230 IYKGEYRCPKW----TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKF 281
+ P K I L+D DP R +L W +++
Sbjct: 241 LRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVI 296
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 326 bits (838), Expect = e-110
Identities = 104/287 (36%), Positives = 153/287 (53%), Gaps = 22/287 (7%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH-----VKREI 67
L +Y + K +G GA +V +T + VAIK +SK+K G V+ EI
Sbjct: 7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLIS 126
I+ +L HP I+K+ + Y V+E +GGELF K+ R E + YF Q++
Sbjct: 67 EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 127 AVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
AV+Y H G+ HRDLK EN+LL +E+ +KI+DFG S + + ++ TLCGTP Y
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 182
Query: 184 VAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYR--C 237
+APE+L GY VD WS GV+LF+ +GY PF++ +++ +I G+Y
Sbjct: 183 LAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 241
Query: 238 PKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
W S + +LL DP R T +E LR PW + + +RKF
Sbjct: 242 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQ 288
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-107
Identities = 99/286 (34%), Positives = 155/286 (54%), Gaps = 17/286 (5%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y+V + +G GAF+ V + TG A K ++ +K L ++RE I +L+HP
Sbjct: 7 NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRKLQHP 65
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIV+L++ + ++ Y V + GGELF I ++ +SE + QQ++ ++ YCHS G
Sbjct: 66 NIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG 125
Query: 136 VFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ HR+LK ENLLL + +K++DFGL+ + H GTP Y++PE+L K
Sbjct: 126 IVHRNLKPENLLLASKAKGAAVKLADFGLAIE---VNDSEAWHGFAGTPGYLSPEVLKKD 182
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW--TSPDLKWF 248
Y VD+W+CGV+L++L GY PF D + +Y +I G Y P+W +P+ K
Sbjct: 183 PY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGC 294
I +L +P RIT D+ L+ PW + H +D+V C
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWICNRERVASAIH----RQDTVDC 283
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 320 bits (822), Expect = e-107
Identities = 103/286 (36%), Positives = 153/286 (53%), Gaps = 22/286 (7%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH-----VKREI 67
L +Y + K +G GA +V +T + VAI+ +SK+K G V+ EI
Sbjct: 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEI 191
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLIS 126
I+ +L HP I+K+ + Y V+E +GGELF K+ R E + YF Q++
Sbjct: 192 EILKKLNHPCIIKIKNFFDAE-DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 127 AVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
AV+Y H G+ HRDLK EN+LL +E+ +KI+DFG S + + ++ TLCGTP Y
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGETSLMRTLCGTPTY 307
Query: 184 VAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEY--RC 237
+APE+L GY VD WS GV+LF+ +GY PF++ +++ +I G+Y
Sbjct: 308 LAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIP 366
Query: 238 PKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKF 281
W S + +LL DP R T +E LR PW + + +RKF
Sbjct: 367 EVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKF 412
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 317 bits (814), Expect = e-106
Identities = 95/279 (34%), Positives = 147/279 (52%), Gaps = 21/279 (7%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH-----VKREI 67
+ KY+ +IG G + V + TG A+K + +RE
Sbjct: 91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRET 150
Query: 68 SIMSRLR-HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
I+ ++ HP+I+ L + + + ++ V + + GELF + K SE+ +R + L+
Sbjct: 151 HILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLL 210
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
AV + H+ + HRDLK EN+LLD+N +++SDFG S + P L LCGTP Y+A
Sbjct: 211 EAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC---HLEPGEKLRELCGTPGYLA 267
Query: 186 PEIL------AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--C 237
PEIL GY G +VD+W+CGV+LF L AG PF + M R I +G+Y+
Sbjct: 268 PEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSS 326
Query: 238 PKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
P+W S +K I RLL DP R+T ++ L+ P+F++
Sbjct: 327 PEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 316 bits (812), Expect = e-106
Identities = 98/293 (33%), Positives = 155/293 (52%), Gaps = 19/293 (6%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT 60
M + + S Y+V + +G GAF+ V + TG A K ++ +K L
Sbjct: 20 MMNASTKFSD------NYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDF 72
Query: 61 AHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRR 119
++RE I +L+HPNIV+L++ + ++ Y V + GGELF I ++ +SE +
Sbjct: 73 QKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASH 132
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHT 176
QQ++ ++ YCHS G+ HR+LK ENLLL + +K++DFGL+ ++ H
Sbjct: 133 CIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI---EVNDSEAWHG 189
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR 236
GTP Y++PE+L K Y VD+W+CGV+L++L GY PF D + +Y +I G Y
Sbjct: 190 FAGTPGYLSPEVLKKDPY-SKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYD 248
Query: 237 --CPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
P+W +P+ K I +L +P RIT D+ L+ PW + H
Sbjct: 249 YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVASAIHRQ 301
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 104/282 (36%), Positives = 141/282 (50%), Gaps = 22/282 (7%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
G GDI++ Y + IG G++ +V T A K + K +
Sbjct: 1 GSTKGDINQ------YYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYF-VED--VD 51
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRY 120
K+EI IM L HPNI++LYE IY VME GGELF ++ K F E + R
Sbjct: 52 RFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARI 111
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTL 177
+ ++SAV YCH V HRDLK EN L + LK+ DFGL+A +P M+ T
Sbjct: 112 MKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR---FKPGKMMRTK 168
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR- 236
GTP YV+P++L + Y G + D WS GV+++VL GY PF+ P + KI +G +
Sbjct: 169 VGTPYYVSPQVL-EGLY-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTF 226
Query: 237 -CPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
W SP + I RLL P RIT + L WF+K
Sbjct: 227 PEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 312 bits (801), Expect = e-105
Identities = 93/285 (32%), Positives = 142/285 (49%), Gaps = 23/285 (8%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR------GGLTAHVKREISIM 70
YE +I+G G + V + T + A+K + L +E+ I+
Sbjct: 18 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 71 SRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAV 128
++ HPNI++L + T + V + K GELF + K SE+ +R+ + L+ +
Sbjct: 78 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
H + HRDLK EN+LLD++ ++K++DFG S Q+ P L +CGTP+Y+APEI
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAPEI 194
Query: 189 LA------KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW 240
+ GY G +VDMWS GV+++ L AG PF M M R I G Y+ P+W
Sbjct: 195 IECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW 253
Query: 241 T--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPH 283
S +K + R L P R T +E L P+F + Y + H
Sbjct: 254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF-QQYVVEEVRH 297
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 311 bits (798), Expect = e-105
Identities = 95/280 (33%), Positives = 154/280 (55%), Gaps = 14/280 (5%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ + +Y + ++G G+F +V ++ T Q A+K ++K + T+ + RE
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILRE 71
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
+ ++ +L HPNI+KL+E+L + Y V E GGELF +I + RFSE + R +Q+
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 126 SAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
S + Y H + HRDLK EN+LL +++ D+KI DFGLS + + + GT
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC---FQQNTKMKDRIGTAY 188
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW 240
Y+APE+L + Y K D+WS GV+L++L +G PF N + +++ G+Y P+W
Sbjct: 189 YIAPEVL-RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 241 T--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
S D K I ++L P+ RIT + L PW +K E
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSE 286
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 311 bits (800), Expect = e-105
Identities = 99/267 (37%), Positives = 155/267 (58%), Gaps = 16/267 (5%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+ +++G GAF++V+ + TG+ A+K + K R + ++ EI+++ +++H
Sbjct: 10 TFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFR---DSSLENEIAVLKKIKHE 66
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIV L ++ + Y VM+ GGELF +I +G ++E+ + QQ++SAV+Y H G
Sbjct: 67 NIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG 126
Query: 136 VFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ HRDLK ENLL +EN + I+DFGLS +++ +G++ T CGTP YVAPE+LA+K
Sbjct: 127 IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGYVAPEVLAQK 182
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKW--TSPDLKWF 248
Y VD WS GV+ ++L GY PF + ++ KI +G Y P W S K F
Sbjct: 183 PY-SKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDF 241
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKD 275
I LL+ DP R T ++ L PW +
Sbjct: 242 ICHLLEKDPNERYTCEKALSHPWIDGN 268
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-104
Identities = 81/279 (29%), Positives = 134/279 (48%), Gaps = 18/279 (6%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ + + + + +G GAF V+ +G IK ++K + ++ E
Sbjct: 13 NLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVP--MEQIEAE 70
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-----SKGRFSEQLSRRYF 121
I ++ L HPNI+K++EV +Y VME +GGEL +I SE
Sbjct: 71 IEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELM 130
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLC 178
+Q+++A+ Y HS+ V H+DLK EN+L + +KI DFGL+ + + D
Sbjct: 131 KQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL---FKSDEHSTNAA 187
Query: 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--- 235
GT Y+APE+ K+ K D+WS GVV++ L G LPF +L + +K E
Sbjct: 188 GTALYMAPEVF-KRDV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYA 245
Query: 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
+ +P + ++L DP R + ++L WFK+
Sbjct: 246 VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 308 bits (791), Expect = e-103
Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 51/306 (16%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ + I+G GA A V+ GR+ +TG AIK + LR RE ++ +L H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 78 IVKLYEVL--ATKAKIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYC 131
IVKL+ + T +MEF G L+ + + E + ++ + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 132 HSRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
G+ HR++K N++ D K++DFG + ++ D +L GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 188 ILAKKGYD-------GAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEY- 235
+ + GA VD+WS GV + G LPF + KI G+
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 236 ------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271
+ L + +L+ D D+ +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 272 FKKDYK 277
Sbjct: 306 DILHRG 311
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 308 bits (790), Expect = e-103
Identities = 71/278 (25%), Positives = 120/278 (43%), Gaps = 20/278 (7%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y + K IG G +KV+ N Q AIK V+ ++ L + EI+ +++L+
Sbjct: 29 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQH 86
Query: 77 N--IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHS 133
+ I++LY+ T IY VME +L + + K + Y++ ++ AV H
Sbjct: 87 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 145
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
G+ H DLK N L+ + LK+ DFG++ + + + GT Y+ PE +
Sbjct: 146 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 204
Query: 194 YD----------GAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKG-EYRCPKW 240
K D+WS G +L+ + G PF + ++ I E P
Sbjct: 205 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 264
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
DL+ + L DP RI++ E+L P+ +
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 302
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 308 bits (792), Expect = e-102
Identities = 96/277 (34%), Positives = 149/277 (53%), Gaps = 12/277 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+Y++ + +G GAF+ V V GQ A ++ +K L ++RE I L+HP
Sbjct: 12 EYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRLLKHP 70
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIV+L++ ++ + Y + + GGELF I ++ +SE + QQ++ AV +CH G
Sbjct: 71 NIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG 130
Query: 136 VFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
V HR+LK ENLLL + +K++DFGL+ E GTP Y++PE+L K
Sbjct: 131 VVHRNLKPENLLLASKLKGAAVKLADFGLA--IEVEGEQQAWFGFAGTPGYLSPEVLRKD 188
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWT--SPDLKWF 248
Y G VD+W+CGV+L++L GY PF D + +Y++I G Y P+W +P+ K
Sbjct: 189 PY-GKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 247
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
I ++L +P+ RIT E L+ PW H
Sbjct: 248 INKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQ 284
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 312 bits (800), Expect = e-100
Identities = 74/315 (23%), Positives = 114/315 (36%), Gaps = 47/315 (14%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
S G +E+ + +G G F V + TG+ VAIK ++ + EI
Sbjct: 7 SLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPK--NRERWCLEIQ 64
Query: 69 IMSRLRHPNIVKLYEVLATKAKI------YFVMEFAKGGELFAKISK----GRFSEQLSR 118
IM +L HPN+V EV K+ ME+ +GG+L +++ E R
Sbjct: 65 IMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIR 124
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAVKEQIRPDGMLH 175
+ SA+ Y H + HRDLK EN++L KI D G + ++ +
Sbjct: 125 TLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK---ELDQGELCT 181
Query: 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235
GT Y+APE+L +K Y VD WS G + F G+ PF + + +
Sbjct: 182 EFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKS 240
Query: 236 RCPKWTSPDL-------------------------KWFIGRLLDTDPATRITVDEILRDP 270
DL +W + +L R T +
Sbjct: 241 NEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERW-LQCMLMWHQRQRGTDPQNPNVG 299
Query: 271 WFK--KDYKERKFPH 283
F+ K
Sbjct: 300 CFQALDSILSLKLLS 314
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 306 bits (785), Expect = e-100
Identities = 95/282 (33%), Positives = 154/282 (54%), Gaps = 14/282 (4%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ + +Y + ++G G+F +V ++ T Q A+K ++K + T+ + RE
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKAS-AKNKDTSTILRE 71
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
+ ++ +L HPNI+KL+E+L + Y V E GGELF +I + RFSE + R +Q+
Sbjct: 72 VELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVF 131
Query: 126 SAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
S + Y H + HRDLK EN+LL +++ D+KI DFGLS + + + GT
Sbjct: 132 SGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLS---TCFQQNTKMKDRIGTAY 188
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW 240
Y+APE+L + Y K D+WS GV+L++L +G PF N + +++ G+Y P+W
Sbjct: 189 YIAPEVL-RGTY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW 246
Query: 241 T--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280
S D K I ++L P+ RIT + L PW +K E
Sbjct: 247 RTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSSETP 288
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = e-100
Identities = 66/306 (21%), Positives = 112/306 (36%), Gaps = 51/306 (16%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ + I+G GA A V+ GR+ +TG AIK + LR RE ++ +L H N
Sbjct: 11 WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKN 68
Query: 78 IVKLYEVL--ATKAKIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYC 131
IVKL+ + T +MEF G L+ + + E + ++ + +
Sbjct: 69 IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHL 128
Query: 132 HSRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
G+ HR++K N++ D K++DFG + ++ D +L GT Y+ P+
Sbjct: 129 RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR---ELEDDEQFVSLYGTEEYLHPD 185
Query: 188 ILAKKGYD-------GAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEY- 235
+ + GA VD+WS GV + G LPF + KI G+
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPS 245
Query: 236 ------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271
+ L + +L+ D D+ +
Sbjct: 246 GAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETS 305
Query: 272 FKKDYK 277
Sbjct: 306 DILHRM 311
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 300 bits (771), Expect = e-100
Identities = 70/278 (25%), Positives = 119/278 (42%), Gaps = 20/278 (7%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y + K IG G +KV+ N Q AIK V+ ++ + EI+ +++L+
Sbjct: 10 IYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQH 67
Query: 77 N--IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHS 133
+ I++LY+ T IY VME +L + + K + Y++ ++ AV H
Sbjct: 68 SDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQ 126
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
G+ H DLK N L+ + LK+ DFG++ + + + GT Y+ PE +
Sbjct: 127 HGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMS 185
Query: 194 YD----------GAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKG-EYRCPKW 240
K D+WS G +L+ + G PF + ++ I E P
Sbjct: 186 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 245
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
DL+ + L DP RI++ E+L P+ +
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 283
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 87/322 (27%), Positives = 137/322 (42%), Gaps = 54/322 (16%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LRGGLTAHVK 64
+ L KY + IG G++ V +T AIK ++K KI + +K
Sbjct: 17 QGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK 76
Query: 65 REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--------------- 109
E+ +M +L HPNI +LYEV + I VME GG L K++
Sbjct: 77 TEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVK 136
Query: 110 --------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKL 143
E+L +Q+ SA+ Y H++G+ HRD+K
Sbjct: 137 TQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKP 196
Query: 144 ENLLL--DENWDLKISDFGLSAVKEQIRP--DGMLHTLCGTPAYVAPEIL--AKKGYDGA 197
EN L ++++++K+ DFGLS ++ + T GTP +VAPE+L + Y G
Sbjct: 197 ENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESY-GP 255
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWT--SPDLKWFIGRLL 253
K D WS GV+L +L G +PF N ++ + P + SP + + LL
Sbjct: 256 KCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLL 315
Query: 254 DTDPATRITVDEILRDPWFKKD 275
+ + R L+ PW +
Sbjct: 316 NRNVDERFDAMRALQHPWISQF 337
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 97/288 (33%), Positives = 150/288 (52%), Gaps = 18/288 (6%)
Query: 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREI 67
+V YE+ ++IG G F+ V N TGQ A+K V K G T +KRE
Sbjct: 18 DDVLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREA 77
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-----SKGRFSEQLSRRYFQ 122
SI L+HP+IV+L E ++ +Y V EF G +L +I + +SE ++ Y +
Sbjct: 78 SICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
Q++ A+ YCH + HRD+K +LL + + +K+ FG++ + + G
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVA--IQLGESGLVAGGRVG 195
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--C 237
TP ++APE++ ++ Y G VD+W CGV+LF+L +G LPF ++ I KG+Y+
Sbjct: 196 TPHFMAPEVVKREPY-GKPVDVWGCGVILFILLSGCLPFYGTKER-LFEGIIKGKYKMNP 253
Query: 238 PKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPH 283
+W S K + R+L DPA RITV E L PW K+ + H
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIH 301
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = e-100
Identities = 104/283 (36%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
G N +S +EV +G GA + VY + T + A+K + K
Sbjct: 45 GSNRDALSD------FFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKK 93
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRY 120
V+ EI ++ RL HPNI+KL E+ T +I V+E GGELF +I KG +SE+ +
Sbjct: 94 IVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADA 153
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTL 177
+Q++ AV Y H G+ HRDLK ENLL + LKI+DFGLS + + ++ T+
Sbjct: 154 VKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI---VEHQVLMKTV 210
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGEY- 235
CGTP Y APEIL Y G +VDMWS G++ ++L G+ PF D M+R+I EY
Sbjct: 211 CGTPGYCAPEILRGCAY-GPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYY 269
Query: 236 -RCPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
P W S + K + +L+ DP R+T + L+ PW
Sbjct: 270 FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK 312
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 301 bits (773), Expect = e-100
Identities = 70/279 (25%), Positives = 119/279 (42%), Gaps = 20/279 (7%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
Y + K IG G +KV+ N Q AIK V+ ++ L + EI+ +++L+
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTL-DSYRNEIAYLNKLQQ 113
Query: 76 PN--IVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCH 132
+ I++LY+ T IY VME +L + + K + Y++ ++ AV H
Sbjct: 114 HSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
G+ H DLK N L+ + LK+ DFG++ + + + G Y+ PE +
Sbjct: 173 QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231
Query: 193 GYD----------GAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKG-EYRCPK 239
K D+WS G +L+ + G PF + ++ I E P
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291
Query: 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
DL+ + L DP RI++ E+L P+ +
Sbjct: 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP 330
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 302 bits (776), Expect = 6e-99
Identities = 97/283 (34%), Positives = 151/283 (53%), Gaps = 13/283 (4%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+Y+ +++G G+F +V ++ TGQ A+K +SK+++ + + RE+ ++ +
Sbjct: 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQ 82
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYC 131
L HPNI+KLYE K Y V E GGELF +I S+ RFSE + R +Q++S + Y
Sbjct: 83 LDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYM 142
Query: 132 HSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
H + HRDLK ENLLL ++ +++I DFGLS + GT Y+APE+
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH---FEASKKMKDKIGTAYYIAPEV 199
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW--TSPD 244
L Y K D+WS GV+L++L +G PFN N + +K+ KG+Y P+W S
Sbjct: 200 L-HGTY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSES 257
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFD 287
K I ++L P+ RI+ + L W + KE+
Sbjct: 258 AKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISVDVPSL 300
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 295 bits (758), Expect = 6e-99
Identities = 88/271 (32%), Positives = 138/271 (50%), Gaps = 16/271 (5%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAHVKREISIMSRL 73
YE+G+ +G G FA V R TG+ A K + K+++ RG ++RE++I+ +
Sbjct: 6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREI 65
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCH 132
RHPNI+ L+++ K + ++E GGELF + K +E + ++ +Q++ V Y H
Sbjct: 66 RHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLH 125
Query: 133 SRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
S+ + H DLK EN++L N +K+ DFG++ I + GTP +VAPEI
Sbjct: 126 SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK---IEAGNEFKNIFGTPEFVAPEI 182
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW--TSPD 244
+ + G + DMWS GV+ ++L +G PF I Y + TS
Sbjct: 183 VNYEPL-GLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
K FI RLL DP R+T+ + L W K
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 302 bits (774), Expect = 2e-98
Identities = 95/293 (32%), Positives = 142/293 (48%), Gaps = 23/293 (7%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH---------- 62
+ Y + +G GA+ +V + AIK + K + +G +
Sbjct: 33 KIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEE 92
Query: 63 VKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYF 121
+ EIS++ L HPNI+KL++V K Y V EF +GGELF +I ++ +F E +
Sbjct: 93 IYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIM 152
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLC 178
+Q++S + Y H + HRD+K EN+LL + ++KI DFGLS D L
Sbjct: 153 KQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLS---SFFSKDYKLRDRL 209
Query: 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--R 236
GT Y+APE+L KK Y K D+WSCGV++++L GY PF N + +K+ KG+Y
Sbjct: 210 GTAYYIAPEVL-KKKY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFD 267
Query: 237 CPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFD 287
W S + K I +L D R T +E L W KK +
Sbjct: 268 FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTL 320
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 299 bits (768), Expect = 1e-97
Identities = 102/280 (36%), Positives = 152/280 (54%), Gaps = 14/280 (5%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
S++ +L Y+ K +G GA+ +V R+ T AIK + K + + + E++
Sbjct: 30 SKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTS-VSTSSNSKLLEEVA 88
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISA 127
++ L HPNI+KLY+ K Y VME KGGELF +I + +F+E + +Q++S
Sbjct: 89 VLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSG 148
Query: 128 VEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
V Y H + HRDLK ENLLL +++ +KI DFGLSAV + GT Y+
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAV---FENQKKMKERLGTAYYI 205
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKWT- 241
APE+L +K Y K D+WS GV+LF+L AGY PF + RK+ KG+Y P+W
Sbjct: 206 APEVL-RKKY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKN 263
Query: 242 -SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280
S K I ++L D RI+ + L PW K+ +++
Sbjct: 264 VSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKE 303
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 293 bits (751), Expect = 3e-97
Identities = 92/282 (32%), Positives = 142/282 (50%), Gaps = 16/282 (5%)
Query: 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAH 62
G + R+ N+ Y+ G+ +G G FA V R TG A K + K++ RG
Sbjct: 1 GTVFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRED 60
Query: 63 VKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYF 121
++RE+SI+ ++HPN++ L+EV K + ++E GGELF + K +E+ + +
Sbjct: 61 IEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFL 120
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTL 177
+Q+++ V Y HS + H DLK EN++L +KI DFGL+ I +
Sbjct: 121 KQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK---IDFGNEFKNI 177
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-- 235
GTP +VAPEI+ + G + DMWS GV+ ++L +G PF + Y
Sbjct: 178 FGTPEFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEF 236
Query: 236 RCPKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
+ TS K FI RLL DP R+T+ + L+ PW K
Sbjct: 237 EDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 292 bits (749), Expect = 5e-97
Identities = 84/288 (29%), Positives = 141/288 (48%), Gaps = 16/288 (5%)
Query: 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAHVKRE 66
++ + Y++G+ +G G FA V R TG A K + K++ RG ++RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
+SI+ ++ H N++ L++V + + ++E GGELF + K SE+ + + +Q++
Sbjct: 66 VSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 126 SAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
V Y H++ + H DLK EN++L +K+ DFGL+ +I + GTP
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIEDGVEFKNIFGTP 182
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPK 239
+VAPEI+ + G + DMWS GV+ ++L +G PF I Y
Sbjct: 183 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEF 241
Query: 240 W--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
+ TS K FI +LL + R+T+ E LR PW ++ +
Sbjct: 242 FSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRE 289
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 293 bits (752), Expect = 5e-97
Identities = 86/288 (29%), Positives = 141/288 (48%), Gaps = 16/288 (5%)
Query: 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAHVKRE 66
++ + Y++G+ +G G FA V R TG A K + K++ RG ++RE
Sbjct: 6 KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLI 125
+SI+ ++ HPNI+ L++V + + ++E GGELF + K SE+ + + +Q++
Sbjct: 66 VSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQIL 125
Query: 126 SAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
V Y H++ + H DLK EN++L +K+ DFGL+ I + GTP
Sbjct: 126 DGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHE---IEDGVEFKNIFGTP 182
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPK 239
+VAPEI+ + G + DMWS GV+ ++L +G PF I Y
Sbjct: 183 EFVAPEIVNYEPL-GLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEF 241
Query: 240 W--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
+ TS K FI +LL + R+T+ E LR PW ++ +
Sbjct: 242 FSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRE 289
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 291 bits (748), Expect = 2e-96
Identities = 92/293 (31%), Positives = 136/293 (46%), Gaps = 23/293 (7%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
YEV + IG G+++ + T A+K + K K EI I+ R
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLR 71
Query: 73 L-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEY 130
+HPNI+ L +V +Y V E KGGEL KI + FSE+ + + VEY
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEY 131
Query: 131 CHSRGVFHRDLKLENLLL----DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
H++GV HRDLK N+L ++I DFG + +G+L T C T +VAP
Sbjct: 132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLR--AENGLLMTPCYTANFVAP 189
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYR--CPKWT 241
E+L ++GYD A D+WS GV+L+ + GY PF D + +I G++ W
Sbjct: 190 EVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWN 248
Query: 242 --SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSV 292
S K + ++L DP R+T +LR PW + ++ D V
Sbjct: 249 SVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 289 bits (742), Expect = 7e-96
Identities = 99/307 (32%), Positives = 155/307 (50%), Gaps = 30/307 (9%)
Query: 10 REVNLFGKYEVG---KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ + Y++ K +G G+F+ + ++ Q+ A+K +SK+ A+ ++E
Sbjct: 2 KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRME------ANTQKE 55
Query: 67 ISIMSRLR-HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQL 124
I+ + HPNIVKL+EV + + VME GGELF +I K FSE + ++L
Sbjct: 56 ITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKL 115
Query: 125 ISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDG-MLHTLCGT 180
+SAV + H GV HRDLK ENLL ++N ++KI DFG + PD L T C T
Sbjct: 116 VSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR---LKPPDNQPLKTPCFT 172
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN-------LMAMYRKIYKG 233
Y APE+L + GYD D+WS GV+L+ + +G +PF + + + +KI KG
Sbjct: 173 LHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKG 231
Query: 234 EYR--CPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLK 289
++ W S + K I LL DP R+ + + + W + + P D+
Sbjct: 232 DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDIL 291
Query: 290 DSVGCNV 296
S G V
Sbjct: 292 GSSGAAV 298
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 285 bits (731), Expect = 3e-94
Identities = 79/279 (28%), Positives = 123/279 (44%), Gaps = 17/279 (6%)
Query: 8 ISREVNLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
N Y + K +G G FA V + TGQ A K + K++ A + E
Sbjct: 20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRR-RGQDCRAEILHE 78
Query: 67 ISIMSRLRH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI---SKGRFSEQLSRRYFQ 122
I+++ + P ++ L+EV ++I ++E+A GGE+F+ SE R +
Sbjct: 79 IAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK 138
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
Q++ V Y H + H DLK +N+LL D+KI DFG+S +I L + G
Sbjct: 139 QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR---KIGHACELREIMG 195
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--C 237
TP Y+APEIL DMW+ G++ ++L PF + Y I +
Sbjct: 196 TPEYLAPEILNYDPI-TTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE 254
Query: 238 PKW--TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
+ S FI LL +P R T + L W ++
Sbjct: 255 ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQ 293
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 282 bits (723), Expect = 4e-93
Identities = 74/273 (27%), Positives = 128/273 (46%), Gaps = 16/273 (5%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
L+ KY + + +G G F V+ + ++ K V + + VK+EISI++
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNI 57
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEY 130
RH NI+ L+E + ++ + EF G ++F +I S +E+ Y Q+ A+++
Sbjct: 58 ARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQF 117
Query: 131 CHSRGVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
HS + H D++ EN++ + +KI +FG + Q++P L P Y APE+
Sbjct: 118 LHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGDNFRLLFTAPEYYAPEV 174
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKW--TSPD 244
DMWS G +++VL +G PF + I EY + S +
Sbjct: 175 HQHDVV-STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
F+ RLL + +R+T E L+ PW K+ +
Sbjct: 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 283 bits (725), Expect = 1e-92
Identities = 80/282 (28%), Positives = 142/282 (50%), Gaps = 15/282 (5%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
++ +++ Y++ + +G GAF V+ TG+ K ++ L VK EIS
Sbjct: 44 VKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEIS 100
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLIS 126
IM++L HP ++ L++ K ++ ++EF GGELF +I+ + SE Y +Q
Sbjct: 101 IMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE 160
Query: 127 AVEYCHSRGVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
+++ H + H D+K EN++ + +KI DFGL+ ++ PD ++ T +
Sbjct: 161 GLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT---KLNPDEIVKVTTATAEFA 217
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKW-- 240
APEI+ ++ G DMW+ GV+ +VL +G PF + + + + + ++ +
Sbjct: 218 APEIVDREPV-GFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSS 276
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
SP+ K FI LL +P R+TV + L PW K D+
Sbjct: 277 VSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 318
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 283 bits (726), Expect = 1e-92
Identities = 95/299 (31%), Positives = 151/299 (50%), Gaps = 32/299 (10%)
Query: 10 REVNLFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
++ + Y+V +++G G KV N RT + A+K + R RE+
Sbjct: 55 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVE 106
Query: 69 IMSRL-RHPNIVKLYEV----LATKAKIYFVMEFAKGGELFAKI-SKG--RFSEQLSRRY 120
+ R + P+IV++ +V A + + VME GGELF++I +G F+E+ +
Sbjct: 107 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEI 166
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTL 177
+ + A++Y HS + HRD+K ENLL N LK++DFG + + L T
Sbjct: 167 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK---ETTSHNSLTTP 223
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKG 233
C TP YVAPE+L + YD DMWS GV++++L GY PF + +A M +I G
Sbjct: 224 CYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 282
Query: 234 EYR--CPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDL 288
+Y P+W+ S ++K I LL T+P R+T+ E + PW + K + P +
Sbjct: 283 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 341
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 280 bits (719), Expect = 3e-92
Identities = 88/287 (30%), Positives = 144/287 (50%), Gaps = 33/287 (11%)
Query: 9 SREVNLFGKYEVGK-IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI 67
++ + Y++ K ++G G KV + RTGQ A+K + ++E+
Sbjct: 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK--------ARQEV 72
Query: 68 SIMSRL-RHPNIVKLYEV----LATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRR 119
+ P+IV + +V K + +ME +GGELF++I + F+E+ +
Sbjct: 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAE 132
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHT 176
+ + +A+++ HS + HRD+K ENLL +++ LK++DFG + Q L T
Sbjct: 133 IMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ----NALQT 188
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYK 232
C TP YVAPE+L + YD DMWS GV++++L G+ PF M R+I
Sbjct: 189 PCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRL 247
Query: 233 GEYR--CPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
G+Y P+W+ S D K I LL TDP R+T+ + + PW +
Sbjct: 248 GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQS 294
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 1e-91
Identities = 93/264 (35%), Positives = 145/264 (54%), Gaps = 8/264 (3%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++ GKI+G G+F+ V R + T + AIK + K+ I++ +V RE +MSRL HP
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
VKLY K+YF + +AK GEL I K G F E +R Y +++SA+EY H +G+
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGI 151
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
HRDLK EN+LL+E+ ++I+DFG + V ++ GT YV+PE+L +K
Sbjct: 152 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 211
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
+ D+W+ G +++ L AG PF N +++KI K EY P+ P + + +LL D
Sbjct: 212 S-SDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLD 270
Query: 257 PATRIT------VDEILRDPWFKK 274
R+ + P+F+
Sbjct: 271 ATKRLGCEEMEGYGPLKAHPFFES 294
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 278 bits (713), Expect = 7e-91
Identities = 82/277 (29%), Positives = 134/277 (48%), Gaps = 17/277 (6%)
Query: 9 SREVNLFGKYEVGK--IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
+++ + Y V K I+G G F +V+ TG +A K + + + VK E
Sbjct: 80 AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKD---KEEVKNE 136
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQL 124
IS+M++L H N+++LY+ +K I VME+ GGELF +I +E + + +Q+
Sbjct: 137 ISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQI 196
Query: 125 ISAVEYCHSRGVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
+ + H + H DLK EN+L + +KI DFGL+ + +P L GTP
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR---RYKPREKLKVNFGTPE 253
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKW 240
++APE++ DMWS GV+ ++L +G PF N I + ++
Sbjct: 254 FLAPEVVNYDFV-SFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF 312
Query: 241 --TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
S + K FI +LL + + RI+ E L+ PW
Sbjct: 313 QDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 275 bits (705), Expect = 2e-90
Identities = 83/305 (27%), Positives = 143/305 (46%), Gaps = 39/305 (12%)
Query: 13 NLFGKYEVGK-IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
Y++ + ++G GA A+V N+ T Q A+K + KQ + V RE+ ++
Sbjct: 9 RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHI---RSRVFREVEMLY 65
Query: 72 RLR-HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVE 129
+ + H N+++L E + + Y V E +GG + + I + F+E + Q + SA++
Sbjct: 66 QCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALD 125
Query: 130 YCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRP-----DGMLHTLCGTP 181
+ H++G+ HRDLK EN+L ++ +KI DF L + + L T CG+
Sbjct: 126 FLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSA 185
Query: 182 AYVAPEIL-----AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL------------- 223
Y+APE++ YD + D+WS GV+L++L +GY PF
Sbjct: 186 EYMAPEVVEAFSEEASIYD-KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPA 244
Query: 224 --MAMYRKIYKGEYR--CPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
++ I +G+Y W S K I +LL D R++ ++L+ PW +
Sbjct: 245 CQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCAP 304
Query: 278 ERKFP 282
E P
Sbjct: 305 ENTLP 309
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 3e-90
Identities = 83/285 (29%), Positives = 130/285 (45%), Gaps = 15/285 (5%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
+ ++ Y++ + +G GAF V+ TG + A K V V++EI
Sbjct: 150 IKHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQ 206
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLIS 126
MS LRHP +V L++ ++ + EF GGELF K+ + SE + Y +Q+
Sbjct: 207 TMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCK 266
Query: 127 AVEYCHSRGVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
+ + H H DLK EN++ + +LK+ DFGL+A + P + GT +
Sbjct: 267 GLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFA 323
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKW-- 240
APE+ K G DMWS GV+ ++L +G PF N R + ++ +
Sbjct: 324 APEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSG 382
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED 285
S D K FI +LL DP TR+T+ + L PW +
Sbjct: 383 ISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIP 427
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 273 bits (699), Expect = 4e-89
Identities = 73/262 (27%), Positives = 132/262 (50%), Gaps = 8/262 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG G+F K ++ G+ IK ++ ++ +RE+++++ ++HP
Sbjct: 25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKER-EESRREVAVLANMKHP 83
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHS 133
NIV+ E +Y VM++ +GG+LF +I+ F E +F Q+ A+++ H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHD 143
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
R + HRD+K +N+ L ++ +++ DFG++ V + GTP Y++PEI K
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS--TVELARACIGTPYYLSPEICENKP 201
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRL 252
Y+ K D+W+ G VL+ L F ++ + KI G + S DL+ + +L
Sbjct: 202 YN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQL 260
Query: 253 LDTDPATRITVDEILRDPWFKK 274
+P R +V+ IL + K
Sbjct: 261 FKRNPRDRPSVNSILEKGFIAK 282
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 267 bits (685), Expect = 5e-88
Identities = 84/271 (30%), Positives = 135/271 (49%), Gaps = 17/271 (6%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
YEV IG G++ + R G+ + K + + + E++++ L+HP
Sbjct: 7 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQM-LVSEVNLLRELKHP 65
Query: 77 NIVKLYE--VLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLISAVE 129
NIV+ Y+ + T +Y VME+ +GG+L + I+KG E+ R QL A++
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 130 YCHSRG-----VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
CH R V HRDLK N+ LD ++K+ DFGL+ + T GTP Y+
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH--DTSFAKTFVGTPYYM 183
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSP 243
+PE + + Y+ K D+WS G +L+ L A PF + + KI +G++ R P S
Sbjct: 184 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 242
Query: 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
+L I R+L+ R +V+EIL +P +
Sbjct: 243 ELNEIITRMLNLKDYHRPSVEEILENPLILE 273
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 269 bits (688), Expect = 3e-87
Identities = 38/302 (12%), Positives = 89/302 (29%), Gaps = 54/302 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-- 74
G ++G + TG+S + + +K E+ + LR
Sbjct: 74 TLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGI 133
Query: 75 -----------------------HPNIVKLYEVLATK--AKIYFVMEFAK------GGEL 103
++++ +F+ + G L
Sbjct: 134 KNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVL 193
Query: 104 FAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162
+ S + Q+I + H G+ H L+ +++LD+ + ++ F
Sbjct: 194 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHL 253
Query: 163 AVKEQIRPDGMLHTLCGTPAYVAPEILA----------KKGYDGAKVDMWSCGVVLFVLN 212
DG + + PE+ A ++ D W+ G+V++ +
Sbjct: 254 ------VRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIW 307
Query: 213 AGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
LP + I++ P ++ + L R+ + + P +
Sbjct: 308 CADLPITKDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEY 363
Query: 273 KK 274
++
Sbjct: 364 EQ 365
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 262 bits (672), Expect = 5e-86
Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 36/286 (12%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++ ++IG G F +V+ ++ G++ IK V +RE+ +++L H N
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVN 65
Query: 78 IVKLYE----------------VLATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSR 118
IV + ++ MEF G L I K + + L+
Sbjct: 66 IVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLAL 125
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178
F+Q+ V+Y HS+ + +RDLK N+ L + +KI DFGL ++ DG
Sbjct: 126 ELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTS---LKNDGKRTRSK 182
Query: 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC 237
GT Y++PE ++ + Y +VD+++ G++L +L+ F + + G
Sbjct: 183 GTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFETSKF---FTDLRDGII-- 236
Query: 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPH 283
K + +LL P R EILR K E+ H
Sbjct: 237 SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEKNERH 282
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 5e-84
Identities = 71/283 (25%), Positives = 119/283 (42%), Gaps = 35/283 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-H 75
+ V +++ G FA VY ++V +G+ A+K + + + + +E+ M +L H
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEK---NRAIIQEVCFMKKLSGH 85
Query: 76 PNIVKLY-------EVLATKAKIYFVMEFAKGGELFAKI----SKGRFSEQLSRRYFQQL 124
PNIV+ E T + ++ G+L + S+G S + F Q
Sbjct: 86 PNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQT 145
Query: 125 ISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLSAV----------KEQIRPDG 172
AV++ H + + HRDLK+ENLLL +K+ DFG + ++
Sbjct: 146 CRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVE 205
Query: 173 MLHTLCGTPAYVAPEI--LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI 230
T TP Y PEI L G K D+W+ G +L++L PF D + I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----I 261
Query: 231 YKGEYRCPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPW 271
G+Y P I +L +P R+++ E++
Sbjct: 262 VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 8e-84
Identities = 88/262 (33%), Positives = 156/262 (59%), Gaps = 12/262 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+++ + +G G+F +V+ R+ G+ A+K + K+ ++R H E ++S + HP
Sbjct: 8 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
I++++ +I+ +M++ +GGELF+ + K RF +++ Y ++ A+EY HS+ +
Sbjct: 68 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 127
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK EN+LLD+N +KI+DFG + K + +TLCGTP Y+APE+++ K Y+
Sbjct: 128 IYRDLKPENILLDKNGHIKITDFGFA--KYV---PDVTYTLCGTPDYIAPEVVSTKPYNK 182
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
+ +D WS G++++ + AGY PF D N M Y KI E R P + + D+K + RL+ D
Sbjct: 183 S-IDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 241
Query: 257 PATRI-----TVDEILRDPWFK 273
+ R+ +++ PWFK
Sbjct: 242 LSQRLGNLQNGTEDVKNHPWFK 263
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 259 bits (664), Expect = 8e-84
Identities = 94/262 (35%), Positives = 143/262 (54%), Gaps = 12/262 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++ K +G G+F +V ++ +G A+K + KQK+++ H E I+ + P
Sbjct: 43 FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
+VKL + +Y VME+ GGE+F+ + + GRFSE +R Y Q++ EY HS +
Sbjct: 103 LVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK ENLL+D+ ++++DFG + K G TLCGTP +APEI+ KGY+
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFA--KR---VKGRTWTLCGTPEALAPEIILSKGYNK 217
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
A VD W+ GV+++ + AGY PF + +Y KI G+ R P S DLK + LL D
Sbjct: 218 A-VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 257 PATRI-----TVDEILRDPWFK 273
R V++I WF
Sbjct: 277 LTKRFGNLKNGVNDIKNHKWFA 298
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 258 bits (660), Expect = 9e-84
Identities = 80/281 (28%), Positives = 130/281 (46%), Gaps = 12/281 (4%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+ + K IG G F++VY + G VA+K V ++ A +EI ++ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----FSEQLSRRYFQQLISAVEY 130
PN++K Y ++ V+E A G+L I + E+ +YF QL SA+E+
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
HSR V HRD+K N+ + +K+ D GL H+L GTP Y++PE +
Sbjct: 152 MHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS--KTTAAHSLVGTPYYMSPERIH 209
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPF--NDPNLMAMYRKIYKGEY-RCPKWT-SPDLK 246
+ GY+ K D+WS G +L+ + A PF + NL ++ +KI + +Y P S +L+
Sbjct: 210 ENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELR 268
Query: 247 WFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFD 287
+ ++ DP R V + H
Sbjct: 269 QLVNMCINPDPEKRPDVTYVYDVAKRMHACTASSLEHHHHH 309
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 256 bits (657), Expect = 3e-83
Identities = 58/294 (19%), Positives = 105/294 (35%), Gaps = 25/294 (8%)
Query: 3 DNTGDISREVNLFG-KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
+N V + Y + +G G F+ V + G A+K + +
Sbjct: 15 ENLYFQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQD---RE 71
Query: 62 HVKREISIMSRLRHPNIVKLYEV----LATKAKIYFVMEFAKGGELFAKI-----SKGRF 112
+RE + HPNI++L K + + ++ F K G L+ +I
Sbjct: 72 EAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL 131
Query: 113 SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV-------K 165
+E + +E H++G HRDLK N+LL + + D G
Sbjct: 132 TEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYD--GAKVDMWSCGVVLFVLNAGYLPFNDPNL 223
Q T +Y APE+ + + + + D+WS G VL+ + G P++
Sbjct: 192 RQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQ 251
Query: 224 -MAMYRKIYKGEYRCPKWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
+ + P+ S L + ++ DP R + +L +
Sbjct: 252 KGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQ 305
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 254 bits (651), Expect = 2e-82
Identities = 57/262 (21%), Positives = 105/262 (40%), Gaps = 13/262 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RH 75
++ +G G++ +V+ R+ G+ A+K A E+ ++ +H
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQH 116
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS 133
P V+L + +Y E G L E Y + + A+ + HS
Sbjct: 117 PCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHS 175
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
+G+ H D+K N+ L K+ DFGL ++ G G P Y+APE+L +
Sbjct: 176 QGLVHLDVKPANIFLGPRGRCKLGDFGLLV---ELGTAGAGEVQEGDPRYMAPELL-QGS 231
Query: 194 YDGAKVDMWSCGVVLFVLNAGY-LPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252
Y D++S G+ + + LP + + E+ S +L+ + +
Sbjct: 232 YG-TAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF--TAGLSSELRSVLVMM 288
Query: 253 LDTDPATRITVDEILRDPWFKK 274
L+ DP R T + +L P ++
Sbjct: 289 LEPDPKLRATAEALLALPVLRQ 310
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 249 bits (637), Expect = 7e-79
Identities = 78/316 (24%), Positives = 125/316 (39%), Gaps = 50/316 (15%)
Query: 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
E +L KI+G G+ V + G+ VA+K + EI ++
Sbjct: 10 EQSLKNLVVSEKILGYGSSGTVVF-QGSFQGRPVAVKRMLIDFC------DIALMEIKLL 62
Query: 71 SRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLS-------RRYF 121
+ HPN+++ Y T +Y +E L + SK E L
Sbjct: 63 TESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLD-------------ENWDLKISDFGLSA--VKE 166
+Q+ S V + HS + HRDLK +N+L+ EN + ISDFGL
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181
Query: 167 QIRPDGMLHTLCGTPAYVAPEIL-------AKKGYDGAKVDMWSCGVVLF-VLNAGYLPF 218
Q L+ GT + APE+L K+ +D++S G V + +L+ G PF
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRL-TRSIDIFSMGCVFYYILSKGKHPF 240
Query: 219 NDPNLMAMYRKIYKGEYRCPKWTSPDLKW-------FIGRLLDTDPATRITVDEILRDPW 271
D + I +G + + + I +++D DP R T ++LR P
Sbjct: 241 GDKY--SRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPL 298
Query: 272 FKKDYKERKFPHEDFD 287
F K+ +F + D
Sbjct: 299 FWPKSKKLEFLLKVSD 314
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 244 bits (624), Expect = 2e-78
Identities = 84/290 (28%), Positives = 133/290 (45%), Gaps = 52/290 (17%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHP 76
+++G G KV N RT + A+K + R RE+ + R + P
Sbjct: 20 KVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWRASQCP 71
Query: 77 NIVKLYEV----LATKAKIYFVMEFAKGGELFAKI-SKG--RFSEQLSRRYFQQLISAVE 129
+IV++ +V A + + VME GGELF++I +G F+E+ + + + A++
Sbjct: 72 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 130 YCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
Y HS + HRD+K ENLL N LK++DFG A
Sbjct: 132 YLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF-----------------------AK 168
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYR--CPKW 240
E + YD DMWS GV++++L GY PF + +A M +I G+Y P+W
Sbjct: 169 ETT-GEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW 226
Query: 241 T--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDL 288
+ S ++K I LL T+P R+T+ E + PW + K + P +
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 276
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 242 bits (619), Expect = 7e-78
Identities = 63/294 (21%), Positives = 108/294 (36%), Gaps = 34/294 (11%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+E + +G G F V+ +N + AIK + V RE+ +++L HP
Sbjct: 6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELA--REKVMREVKALAKLEHP 63
Query: 77 NIVKLYEV------------LATKAKIYFVMEFAKGGELFAKISKGR----FSEQLSRRY 120
IV+ + + K +Y M+ + L ++ +
Sbjct: 64 GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV----------KEQIRP 170
F Q+ AVE+ HS+G+ HRDLK N+ + +K+ DFGL +
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183
Query: 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM-YRK 229
GT Y++PE + Y KVD++S G++LF L PF+
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFEL---LYPFSTQMERVRTLTD 239
Query: 230 IYKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
+ ++ P + +L P R I+ + F+ K
Sbjct: 240 VRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDFPGKTV 293
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 245 bits (628), Expect = 2e-77
Identities = 60/281 (21%), Positives = 108/281 (38%), Gaps = 25/281 (8%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RH 75
+ ++G GA + + R + + VA+K + + + RE+ ++ H
Sbjct: 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEH 77
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS 133
PN+++ + + Y +E L + + QQ S + + HS
Sbjct: 78 PNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS 136
Query: 134 RGVFHRDLKLENLLLDENWD-----LKISDFGLSAVKEQIRP-DGMLHTLCGTPAYVAPE 187
+ HRDLK N+L+ ISDFGL R + GT ++APE
Sbjct: 137 LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196
Query: 188 IL---AKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW--- 240
+L K+ VD++S G V + V++ G PF + C
Sbjct: 197 MLSEDCKENPT-YTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255
Query: 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKF 281
+ I +++ DP R + +L+ P+F K+ +F
Sbjct: 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSLEKQLQF 296
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 5e-77
Identities = 72/275 (26%), Positives = 138/275 (50%), Gaps = 13/275 (4%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
D + +VN +E+ + IG G+F KV + T + A+K ++KQK + +V +E
Sbjct: 7 DENEDVNFD-HFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKE 65
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLI 125
+ IM L HP +V L+ + ++ V++ GG+L + + F E+ + + +L+
Sbjct: 66 LQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV 125
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
A++Y ++ + HRD+K +N+LLDE+ + I+DF ++ + + + T+ GT Y+A
Sbjct: 126 MALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA--AM-LPRETQITTMAGTKPYMA 182
Query: 186 PEILAKK---GYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCPK 239
PE+ + + GY A VD WS GV + L G P+ + + + P
Sbjct: 183 PEMFSSRKGAGYSFA-VDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS 241
Query: 240 WTSPDLKWFIGRLLDTDPATRI-TVDEILRDPWFK 273
S ++ + +LL+ +P R + ++ P+
Sbjct: 242 AWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 240 bits (615), Expect = 8e-77
Identities = 85/263 (32%), Positives = 141/263 (53%), Gaps = 13/263 (4%)
Query: 22 KIIGCGAFAKVY---HGRNVRTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRLRHPN 77
+++G G + KV+ TG+ A+K + K I+ TAH K E +I+ ++HP
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV L T K+Y ++E+ GGELF ++ + G F E + Y ++ A+ + H +G+
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK EN++L+ +K++DFGL KE I + HT CGT Y+APEIL + G++
Sbjct: 143 IYRDLKPENIMLNHQGHVKLTDFGLC--KESIHDGTVTHTFCGTIEYMAPEILMRSGHNR 200
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
A VD WS G +++ + G PF N KI K + P + + + + + +LL +
Sbjct: 201 A-VDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEARDLLKKLLKRN 259
Query: 257 PATRI-----TVDEILRDPWFKK 274
A+R+ E+ P+F+
Sbjct: 260 AASRLGAGPGDAGEVQAHPFFRH 282
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 239 bits (611), Expect = 4e-76
Identities = 98/258 (37%), Positives = 144/258 (55%), Gaps = 9/258 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G F KV R TG+ A+K + K+ I+ AH E ++ RHP + L
Sbjct: 11 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140
T ++ FVME+A GGELF +S+ F+E+ +R Y +++SA+EY HSR V +RD
Sbjct: 71 KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130
Query: 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVD 200
+KLENL+LD++ +KI+DFGL KE I + T CGTP Y+APE+L Y A VD
Sbjct: 131 IKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA-VD 187
Query: 201 MWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATR 260
W GVV++ + G LPF + + ++ I E R P+ SP+ K + LL DP R
Sbjct: 188 WWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKKDPKQR 247
Query: 261 I-----TVDEILRDPWFK 273
+ E++ +F
Sbjct: 248 LGGGPSDAKEVMEHRFFL 265
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 240 bits (614), Expect = 4e-76
Identities = 87/258 (33%), Positives = 131/258 (50%), Gaps = 9/258 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
K+IG G+F KV R+ A+K + K+ IL+ H+ E +++ + ++HP +V
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T K+YFV+++ GGELF + + F E +R Y ++ SA+ Y HS + +R
Sbjct: 104 LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 163
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLK EN+LLD + ++DFGL KE I + T CGTP Y+APE+L K+ YD V
Sbjct: 164 DLKPENILLDSQGHIVLTDFGLC--KENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRT-V 220
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W G VL+ + G PF N MY I + + + + LL D
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTK 280
Query: 260 RI----TVDEILRDPWFK 273
R+ EI +F
Sbjct: 281 RLGAKDDFMEIKSHVFFS 298
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 239 bits (610), Expect = 1e-75
Identities = 42/301 (13%), Positives = 83/301 (27%), Gaps = 48/301 (15%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
K ++ + + G + V+ R+V + A+K + + +RL
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGE 122
Query: 77 NIVKLYEVL--------------------------ATKAKIYFVMEFAKG-----GELFA 105
+ + + A +M A
Sbjct: 123 SPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD 182
Query: 106 KI--SKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163
+ +G QLI S+G+ H +NL + + L + D
Sbjct: 183 FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW 242
Query: 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLPF--ND 220
+ Y E L ++ W G+ ++ + +LPF
Sbjct: 243 -----KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 221 PNLMAMYRKIYKGEYRCPKWT-------SPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
P + +++ +K IGR L+ D R+ E + P F
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFL 357
Query: 274 K 274
+
Sbjct: 358 Q 358
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 237 bits (606), Expect = 2e-75
Identities = 88/262 (33%), Positives = 144/262 (54%), Gaps = 13/262 (4%)
Query: 22 KIIGCGAFAKVY---HGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
K++G G+F KV+ Q A+K + K + K E I+ + HP I
Sbjct: 30 KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFI 88
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVF 137
VKL+ T+ K+Y +++F +GG+LF ++SK F+E+ + Y +L A+++ HS G+
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGII 148
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
+RDLK EN+LLDE +K++DFGLS KE I + ++ CGT Y+APE++ ++G+ +
Sbjct: 149 YRDLKPENILLDEEGHIKLTDFGLS--KESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQS 206
Query: 198 KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
D WS GV++F + G LPF + I K + P++ SP+ + + L +P
Sbjct: 207 -ADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNP 265
Query: 258 ATRI-----TVDEILRDPWFKK 274
A R+ V+EI R +F
Sbjct: 266 ANRLGAGPDGVEEIKRHSFFST 287
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 3e-75
Identities = 45/289 (15%), Positives = 95/289 (32%), Gaps = 35/289 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
V ++G GAFA+VY + + Q +K + + +
Sbjct: 66 LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERLK 122
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK------GRFSEQLSRRYFQQLI 125
+K Y + V E G L I+ + L + +++
Sbjct: 123 PSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRML 182
Query: 126 SAVEYCHSRGVFHRDLKLENLLL-----------DENWDLKISDFGLSAVKEQIRPDGML 174
+E H + H D+K +N +L D + L + D G S + +
Sbjct: 183 YMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIF 242
Query: 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKG 233
C T + E+L+ K ++ ++D + ++ + G Y+ + +++
Sbjct: 243 TAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGLFRR 301
Query: 234 EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR---DPWFKKDYKER 279
W F +L+ + ++LR F++ Y +
Sbjct: 302 LPHLDMWNE-----FFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNK 345
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 4e-75
Identities = 83/255 (32%), Positives = 138/255 (54%), Gaps = 6/255 (2%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
K++G G+F KV+ +T Q AIKA+ K +L E ++S HP +
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 82
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
++ TK ++FVME+ GG+L I +F + Y ++I +++ HS+G+ +R
Sbjct: 83 MFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYR 142
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD++ +KI+DFG+ KE + D +T CGTP Y+APEIL + Y+ + V
Sbjct: 143 DLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS-V 199
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D WS GV+L+ + G PF+ + ++ I P+W + K + +L +P
Sbjct: 200 DWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEK 259
Query: 260 RI-TVDEILRDPWFK 273
R+ +I + P F+
Sbjct: 260 RLGVRGDIRQHPLFR 274
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 238 bits (608), Expect = 8e-75
Identities = 92/268 (34%), Positives = 143/268 (53%), Gaps = 16/268 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
YEV K+IG GAF +V R+ T + A+K +SK ++++ +A E IM+ P
Sbjct: 71 YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+V+L+ +Y VME+ GG+L +S E+ +R Y +++ A++ HS G
Sbjct: 131 VVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFI 190
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML--HTLCGTPAYVAPEILAKKGYD 195
HRD+K +N+LLD++ LK++DFG ++ +GM+ T GTP Y++PE+L +G D
Sbjct: 191 HRDVKPDNMLLDKSGHLKLADFGTCM---KMNKEGMVRCDTAVGTPDYISPEVLKSQGGD 247
Query: 196 ---GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPK--WTSPDLKWF 248
G + D WS GV L+ + G PF +L+ Y KI +K P S + K
Sbjct: 248 GYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNL 307
Query: 249 IGRLLDTDPATRIT---VDEILRDPWFK 273
I L TD R+ V+EI R +FK
Sbjct: 308 ICAFL-TDREVRLGRNGVEEIKRHLFFK 334
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 7e-74
Identities = 76/259 (29%), Positives = 130/259 (50%), Gaps = 10/259 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
++G G+F KV T + A+K + K +++ E +++ + P + +
Sbjct: 26 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 85
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T ++YFVME+ GG+L I + GRF E + Y ++ + + S+G+ +R
Sbjct: 86 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 145
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N++LD +KI+DFG+ KE I T CGTP Y+APEI+A + Y + V
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 202
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W+ GV+L+ + AG PF + +++ I + PK S + L+ P
Sbjct: 203 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 262
Query: 260 RI-----TVDEILRDPWFK 273
R+ +I +F+
Sbjct: 263 RLGCGPEGERDIKEHAFFR 281
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-73
Identities = 92/260 (35%), Positives = 134/260 (51%), Gaps = 11/260 (4%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
+++G G+F KV R TG A+K + K IL+ E I+S HP + +
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T +++FVMEF GG+L I K RF E +R Y ++ISA+ + H +G+ +R
Sbjct: 89 LFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYR 148
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD K++DFG+ KE I T CGTP Y+APEIL + Y A V
Sbjct: 149 DLKLDNVLLDHEGHCKLADFGMC--KEGICNGVTTATFCGTPDYIAPEILQEMLYGPA-V 205
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W+ GV+L+ + G+ PF N ++ I E P W D + + +P
Sbjct: 206 DWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTM 265
Query: 260 RI------TVDEILRDPWFK 273
R+ ILR P+FK
Sbjct: 266 RLGSLTQGGEHAILRHPFFK 285
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 6e-73
Identities = 82/269 (30%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
++IG G++AKV R +T + A+K V K+ + V+ E + + HP +V
Sbjct: 15 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T+++++FV+E+ GG+L + + + E+ +R Y ++ A+ Y H RG+ +R
Sbjct: 75 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 134
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD +K++D+G+ KE +RP T CGTP Y+APEIL + Y + V
Sbjct: 135 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 191
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMA---------MYRKIYKGEYRCPKWTSPDLKWFIG 250
D W+ GV++F + AG PF+ +++ I + + R P+ S +
Sbjct: 192 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 251
Query: 251 RLLDTDPATRI------TVDEILRDPWFK 273
L+ DP R+ +I P+F+
Sbjct: 252 SFLNKDPKERLGCHPQTGFADIQGHPFFR 280
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 7e-73
Identities = 97/259 (37%), Positives = 144/259 (55%), Gaps = 10/259 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
K++G G F KV + TG+ A+K + K+ I+ AH E ++ RHP + L
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTAL 213
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHR 139
T ++ FVME+A GGELF +S+ FSE +R Y +++SA++Y HS + V +R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKLENL+LD++ +KI+DFGL KE I+ + T CGTP Y+APE+L Y A V
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLC--KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRA-V 330
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W GVV++ + G LPF + + ++ I E R P+ P+ K + LL DP
Sbjct: 331 DWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLKKDPKQ 390
Query: 260 RI-----TVDEILRDPWFK 273
R+ EI++ +F
Sbjct: 391 RLGGGSEDAKEIMQHRFFA 409
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-72
Identities = 81/269 (30%), Positives = 142/269 (52%), Gaps = 20/269 (7%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
++IG G++AKV R +T + A++ V K+ + V+ E + + HP +V
Sbjct: 58 RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T+++++FV+E+ GG+L + + + E+ +R Y ++ A+ Y H RG+ +R
Sbjct: 118 LHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYR 177
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N+LLD +K++D+G+ KE +RP T CGTP Y+APEIL + Y + V
Sbjct: 178 DLKLDNVLLDSEGHIKLTDYGMC--KEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS-V 234
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMA---------MYRKIYKGEYRCPKWTSPDLKWFIG 250
D W+ GV++F + AG PF+ +++ I + + R P+ S +
Sbjct: 235 DWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLK 294
Query: 251 RLLDTDPATRI------TVDEILRDPWFK 273
L+ DP R+ +I P+F+
Sbjct: 295 SFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 231 bits (589), Expect = 4e-72
Identities = 40/295 (13%), Positives = 89/295 (30%), Gaps = 43/295 (14%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR--- 74
G ++G + TG+S + + +K E+ + LR
Sbjct: 80 LVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIK 139
Query: 75 -------------------HPNIVKLYEVLATKAKIYFVMEF-----------AKGGELF 104
P K+ V + ++ + F G L
Sbjct: 140 NQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL 199
Query: 105 AKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163
+ S + Q+I + H G+ H L+ +++LD+ + ++ F
Sbjct: 200 SHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH-L 258
Query: 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK----VDMWSCGVVLFVLNAGYLPFN 219
V++ + P A +L + D W+ G+ ++ + LP
Sbjct: 259 VRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNT 318
Query: 220 DPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
D + I++ P ++ + L R+ + + P +++
Sbjct: 319 DDAALGGSEWIFRSCKNIP----QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ 369
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 230 bits (587), Expect = 2e-71
Identities = 77/273 (28%), Positives = 136/273 (49%), Gaps = 22/273 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ K+IG GAF +V + + A+K ++K ++L+ TA + E ++
Sbjct: 76 FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
I L+ +Y VM++ GG+L +SK R E+++R Y +++ A++ H
Sbjct: 136 ITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH 195
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML--HTLCGTPAYVAPEIL---- 189
HRD+K +N+L+D N ++++DFG + + DG + GTP Y++PEIL
Sbjct: 196 YVHRDIKPDNILMDMNGHIRLADFGSC--LKLM-EDGTVQSSVAVGTPDYISPEILQAME 252
Query: 190 -AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI--YKGEYRCPKWT---SP 243
K Y G + D WS GV ++ + G PF +L+ Y KI +K ++ P S
Sbjct: 253 GGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSE 311
Query: 244 DLKWFIGRLLDTDPATRIT---VDEILRDPWFK 273
+ K I RL+ R+ +++ + P+F
Sbjct: 312 NAKDLIRRLI-CSREHRLGQNGIEDFKKHPFFS 343
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 228 bits (582), Expect = 6e-71
Identities = 78/274 (28%), Positives = 133/274 (48%), Gaps = 22/274 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+E+ K+IG GAF++V + +TGQ A+K ++K +L+ G + + E ++
Sbjct: 63 FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG 135
I +L+ + +Y VME+ GG+L +SK R +++R Y +++ A++ H G
Sbjct: 123 ITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG 182
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML--HTLCGTPAYVAPEILAKKG 193
HRD+K +N+LLD ++++DFG ++R DG + GTP Y++PEIL G
Sbjct: 183 YVHRDIKPDNILLDRCGHIRLADFGSCL---KLRADGTVRSLVAVGTPDYLSPEILQAVG 239
Query: 194 YD------GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-----CPKWTS 242
G + D W+ GV + + G PF + Y KI + +
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299
Query: 243 PDLKWFIGRLLDTDPATRIT---VDEILRDPWFK 273
+ + FI RLL P TR+ + P+F
Sbjct: 300 EEARDFIQRLL-CPPETRLGRGGAGDFRTHPFFF 332
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 7e-71
Identities = 91/271 (33%), Positives = 146/271 (53%), Gaps = 21/271 (7%)
Query: 22 KIIGCGAFAKVY---HGRNVRTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRLRH-P 76
K++G GA+ KV+ TG+ A+K + K I+ + T H + E ++ +R P
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG 135
+V L+ T+ K++ ++++ GGELF +S+ RF+E + Y +++ A+E+ H G
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG 179
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML-HTLCGTPAYVAPEIL--AKK 192
+ +RD+KLEN+LLD N + ++DFGLS KE + + + CGT Y+AP+I+
Sbjct: 180 IIYRDIKLENILLDSNGHVVLTDFGLS--KEFVADETERAYDFCGTIEYMAPDIVRGGDS 237
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPF----NDPNLMAMYRKIYKGEYRCPKWTSPDLKWF 248
G+D A VD WS GV+++ L G PF + + R+I K E P+ S K
Sbjct: 238 GHDKA-VDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDL 296
Query: 249 IGRLLDTDPATRI-----TVDEILRDPWFKK 274
I RLL DP R+ DEI +F+K
Sbjct: 297 IQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 327
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 3e-70
Identities = 76/259 (29%), Positives = 130/259 (50%), Gaps = 10/259 (3%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVK 80
++G G+F KV T + A+K + K +++ E +++ + P + +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQ 406
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHR 139
L+ T ++YFVME+ GG+L I + GRF E + Y ++ + + S+G+ +R
Sbjct: 407 LHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYR 466
Query: 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKV 199
DLKL+N++LD +KI+DFG+ KE I T CGTP Y+APEI+A + Y + V
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMC--KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKS-V 523
Query: 200 DMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPAT 259
D W+ GV+L+ + AG PF + +++ I + PK S + L+ P
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGK 583
Query: 260 RI-----TVDEILRDPWFK 273
R+ +I +F+
Sbjct: 584 RLGCGPEGERDIKEHAFFR 602
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 4e-69
Identities = 74/266 (27%), Positives = 126/266 (47%), Gaps = 17/266 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V+ + TG+ A K ++K+++ + E I++++ IV L
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSL 250
Query: 82 YEVLATKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGV 136
TK + VM GG++ I F E + Y Q++S +E+ H R +
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNI 310
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK EN+LLD++ +++ISD GL+ E GTP ++APE+L + YD
Sbjct: 311 IYRDLKPENVLLDDDGNVRISDLGLA--VELKAGQTKTKGYAGTPGFMAPELLLGEEYDF 368
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFIGRL 252
+ VD ++ GV L+ + A PF + +++ + P SP K F L
Sbjct: 369 S-VDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCEAL 427
Query: 253 LDTDPATRI-----TVDEILRDPWFK 273
L DP R+ + D + P F+
Sbjct: 428 LQKDPEKRLGFRDGSCDGLRTHPLFR 453
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 2e-65
Identities = 68/264 (25%), Positives = 119/264 (45%), Gaps = 16/264 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81
+++G G F +V + TG+ A K + K++I + A E I+ ++ +V L
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSL 249
Query: 82 YEVLATKAKIYFVMEFAKGGELF---AKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
TK + V+ GG+L + + F E + Y ++ +E H + +
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309
Query: 139 RDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAK 198
RDLK EN+LLD++ ++ISD GL+ + + GT Y+APE++ + Y +
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLA--VH-VPEGQTIKGRVGTVGYMAPEVVKNERYTFS- 365
Query: 199 VDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYRCPKWTSPDLKWFIGRLLD 254
D W+ G +L+ + AG PF + R + + + SP + +LL
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQLLC 425
Query: 255 TDPATRI-----TVDEILRDPWFK 273
DPA R+ + E+ P FK
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLFK 449
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 1e-64
Identities = 83/266 (31%), Positives = 128/266 (48%), Gaps = 18/266 (6%)
Query: 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNI 78
+IIG G F +VY R TG+ A+K + K++I E ++S + P I
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 254
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVF 137
V + T K+ F+++ GG+L +S+ G FSE R Y ++I +E+ H+R V
Sbjct: 255 VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVV 314
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDG 196
+RDLK N+LLDE+ ++ISD GL+ + H GT Y+APE+L K YD
Sbjct: 315 YRDLKPANILLDEHGHVRISDLGLA--CDF--SKKKPHASVGTHGYMAPEVLQKGVAYDS 370
Query: 197 AKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253
+ D +S G +LF L G+ PF + + R P SP+L+ + LL
Sbjct: 371 S-ADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLL 429
Query: 254 DTDPATRI-----TVDEILRDPWFKK 274
D R+ E+ P+F+
Sbjct: 430 QRDVNRRLGCLGRGAQEVKESPFFRS 455
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 2e-63
Identities = 65/264 (24%), Positives = 107/264 (40%), Gaps = 17/264 (6%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+G G+F +V+ ++ +TG A+K V + E+ + L P
Sbjct: 60 MTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPR 111
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGV 136
IV LY + + ME +GG L I + G E + Y Q + +EY H+R +
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRI 171
Query: 137 FHRDLKLENLLLDEN-WDLKISDFGLSAVKEQIRPDGML---HTLCGTPAYVAPEILAKK 192
H D+K +N+LL + + DFG + + L + GT ++APE++ K
Sbjct: 172 LHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGK 231
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFI 249
D AKVD+WS ++ + G P+ + KI P +P I
Sbjct: 232 PCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTAQAI 290
Query: 250 GRLLDTDPATRITVDEILRDPWFK 273
L +P R + E+ R
Sbjct: 291 QEGLRKEPVHRASAMELRRKVGKA 314
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 3e-63
Identities = 83/290 (28%), Positives = 136/290 (46%), Gaps = 18/290 (6%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA 61
GD D+ + + ++G G + VY GR++ +AIK + ++ +
Sbjct: 8 GDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDS---RYSQ 64
Query: 62 HVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFA--KISKGRF--SEQLS 117
+ EI++ L+H NIV+ + I ME GG L A + G +EQ
Sbjct: 65 PLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI 124
Query: 118 RRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHT 176
Y +Q++ ++Y H + HRD+K +N+L++ + LKISDFG S I P T
Sbjct: 125 GFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTET 182
Query: 177 LCGTPAYVAPEIL--AKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLM-AMYRKIYK 232
GT Y+APEI+ +GY G D+WS G + + G PF + AM+ K+
Sbjct: 183 FTGTLQYMAPEIIDKGPRGY-GKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGM 240
Query: 233 GEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280
+ P+ S + K FI + + DP R +++L D + K K++K
Sbjct: 241 FKVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKKKK 290
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-62
Identities = 67/272 (24%), Positives = 128/272 (47%), Gaps = 20/272 (7%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
F K+ IG G+F VY G + T VA + +K+ + K E ++ L+
Sbjct: 27 FLKF--DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQ 83
Query: 75 HPNIVKLY----EVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVE 129
HPNIV+ Y + K I V E G L + + ++ R + +Q++ ++
Sbjct: 84 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 143
Query: 130 YCHSRG--VFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+ H+R + HRDLK +N+ + +KI D GL+ +K + GTP ++AP
Sbjct: 144 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA----SFAKAVIGTPEFMAP 199
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGE--YRCPKWTSP 243
E+ ++ YD VD+++ G+ + + P+++ N +YR++ G K P
Sbjct: 200 EMY-EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257
Query: 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
++K I + + R ++ ++L +F+++
Sbjct: 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 4e-62
Identities = 54/285 (18%), Positives = 97/285 (34%), Gaps = 38/285 (13%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RH 75
++ + IG G F V+ G AIK K + RE+ + L +H
Sbjct: 12 EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNAL-REVYAHAVLGQH 70
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEY 130
++V+ + A + E+ GG L IS+ F E + Q+ + Y
Sbjct: 71 SHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130
Query: 131 CHSRGVFHRDLKLENLLLDEN-------------------WDLKISDFGLSAVKEQIRPD 171
HS + H D+K N+ + KI D G
Sbjct: 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRI------ 184
Query: 172 GMLHTLCGTPAYVAPEILA-KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI 230
G ++A E+L + K D+++ + + AG P P + +I
Sbjct: 185 SSPQVEEGDSRFLANEVLQENYTHLP-KADIFALALTVVCA-AGAEPL--PRNGDQWHEI 240
Query: 231 YKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
+G R P+ S + + ++ DP R + +++
Sbjct: 241 RQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLS 285
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 9e-59
Identities = 74/260 (28%), Positives = 119/260 (45%), Gaps = 18/260 (6%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
+ + IG G+F V+ G VA+K + +Q RE++IM RLRHPNI
Sbjct: 40 NIKEKIGAGSFGTVHRAE--WHGSDVAVKILMEQD-FHAERVNEFLREVAIMKRLRHPNI 96
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV------EYCH 132
V + + V E+ G L+ + K EQL R ++L A Y H
Sbjct: 97 VLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER--RRLSMAYDVAKGMNYLH 154
Query: 133 SRG--VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
+R + HR+LK NLL+D+ + +K+ DFGLS +K + GTP ++APE+L
Sbjct: 155 NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK--SAAGTPEWMAPEVLR 212
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWF 248
+ + K D++S GV+L+ L P+ + N + + R P+ +P +
Sbjct: 213 DEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAI 271
Query: 249 IGRLLDTDPATRITVDEILR 268
I +P R + I+
Sbjct: 272 IEGCWTNEPWKRPSFATIMD 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-56
Identities = 64/260 (24%), Positives = 118/260 (45%), Gaps = 15/260 (5%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
VG+ IG G+F VY G+ VA+K ++ L A K E+ ++ + RH NI
Sbjct: 27 TVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNI 82
Query: 79 VKLYEVLATKAKIYFVMEFAKGGELFA--KISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
+ +T ++ V ++ +G L+ S+ +F + +Q ++Y H++ +
Sbjct: 83 LLFMGY-STAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD- 195
HRDLK N+ L E+ +KI DFGL+ K + L G+ ++APE++ + +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNP 201
Query: 196 -GAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYR-----CPKWTSPDLKWF 248
+ D+++ G+VL+ L G LP+++ N + + +G +K
Sbjct: 202 YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRL 261
Query: 249 IGRLLDTDPATRITVDEILR 268
+ L R + IL
Sbjct: 262 MAECLKKKRDERPSFPRILA 281
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 1e-55
Identities = 53/284 (18%), Positives = 96/284 (33%), Gaps = 20/284 (7%)
Query: 8 ISREVNLFGKYEVGKIIGC--GAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR 65
+ REV K E I+ + + +
Sbjct: 51 VMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSV 110
Query: 66 EISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR----FSEQLSRRYF 121
+I M N V + + K +Y M+ + L +++ + F
Sbjct: 111 KIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF 170
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV----------KEQIRPD 171
Q+ AVE+ HS+G+ HRDLK N+ + +K+ DFGL +
Sbjct: 171 IQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 230
Query: 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY 231
GT Y++PE + Y KVD++S G++LF L + + + +
Sbjct: 231 ATHTGQVGTKLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQM--ERVRIITDVR 287
Query: 232 KGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
++ P + +L P R +I+ + F+
Sbjct: 288 NLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 181 bits (461), Expect = 4e-54
Identities = 72/269 (26%), Positives = 120/269 (44%), Gaps = 34/269 (12%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
+ + EV +++G GAF V + + VAIK + + + E+ +SR+
Sbjct: 7 YKEIEVEEVVGRGAFGVVCKAK--WRAKDVAIKQIESESERK-----AFIVELRQLSRVN 59
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS-------A 127
HPNIVKLY A + VME+A+GG L+ + + +S
Sbjct: 60 HPNIVKLYG--ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAA---HAMSWCLQCSQG 114
Query: 128 VEYCHSR---GVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
V Y HS + HRDLK NLLL LKI DFG + + + G+ A+
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT-----HMTNNKGSAAW 169
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND--PNLMAMYRKIYKGEYR--CPK 239
+APE+ Y K D++S G++L+ + PF++ + ++ G R K
Sbjct: 170 MAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGT-RPPLIK 227
Query: 240 WTSPDLKWFIGRLLDTDPATRITVDEILR 268
++ + R DP+ R +++EI++
Sbjct: 228 NLPKPIESLMTRCWSKDPSQRPSMEEIVK 256
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 1e-53
Identities = 73/265 (27%), Positives = 112/265 (42%), Gaps = 23/265 (8%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLTAHVKREISIMSRLRHPN 77
+ +IIG G F KVY G VA+KA +V++E + + L+HPN
Sbjct: 10 TLEEIIGIGGFGKVYRAF--WIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPN 67
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG-- 135
I+ L V + + VMEFA+GG L +S R + + Q+ + Y H
Sbjct: 68 IIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIV 127
Query: 136 -VFHRDLKLENLLLDE--------NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+ HRDLK N+L+ + N LKI+DFGL+ + + G A++AP
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR----TTKMSAAGAYAWMAP 183
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYR--CPKWTSP 243
E++ + D+WS GV+L+ L G +PF L Y P
Sbjct: 184 EVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK-LALPIPSTCPE 241
Query: 244 DLKWFIGRLLDTDPATRITVDEILR 268
+ + DP +R + IL
Sbjct: 242 PFAKLMEDCWNPDPHSRPSFTNILD 266
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-53
Identities = 83/314 (26%), Positives = 128/314 (40%), Gaps = 63/314 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
KYE ++G G++ V RN TG+ VAIK K L VK REI ++ +
Sbjct: 26 KYENLGLVGEGSYGMVMKCRNKDTGRIVAIK-----KFLESDDDKMVKKIAMREIKLLKQ 80
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAV 128
LRH N+V L EV K + Y V EF ++ Q+ ++Y Q+I+ +
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFVDHTILD---DLELFPNGLDYQVVQKYLFQIINGI 137
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYV 184
+CHS + HRD+K EN+L+ ++ +K+ DFG + + T Y
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV--YDDEVATR----WYR 191
Query: 185 APEIL--AKKGYDGAKVDMWSCGVVLFVLNAG-------------YLPFN-----DPNLM 224
APE+L K Y A VD+W+ G ++ + G Y P
Sbjct: 192 APELLVGDVK-YGKA-VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQ 249
Query: 225 AMYRKI--YKGEYRCPKWT------------SPDLKWFIGRLLDTDPATRITVDEILRDP 270
++ K + G R P+ S + + L DP R E+L
Sbjct: 250 ELFNKNPVFAG-VRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHD 308
Query: 271 WFKKDYKERKFPHE 284
+F+ D +F E
Sbjct: 309 FFQMDGFAERFSQE 322
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 3e-53
Identities = 81/262 (30%), Positives = 140/262 (53%), Gaps = 11/262 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+ IG G+ V R +G+ VA+K + +K R L + E+ IM +H
Sbjct: 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRREL---LFNEVVIMRDYQHF 102
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
N+V++Y+ +++ +MEF +GG L +S+ R +E+ + ++ A+ Y H++GV
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGV 162
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM-LHTLCGTPAYVAPEILAKKGYD 195
HRD+K +++LL + +K+SDFG A QI D +L GTP ++APE++++ Y
Sbjct: 163 IHRDIKSDSILLTLDGRVKLSDFGFCA---QISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 196 GAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRL 252
+VD+WS G+++ + G P F+D + AM R + + SP L+ F+ R+
Sbjct: 220 -TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERM 278
Query: 253 LDTDPATRITVDEILRDPWFKK 274
L DP R T E+L P+ +
Sbjct: 279 LVRDPQERATAQELLDHPFLLQ 300
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 5e-53
Identities = 78/317 (24%), Positives = 120/317 (37%), Gaps = 69/317 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
KYE IG G++ V+ RN TGQ VAIK K L +K REI ++ +
Sbjct: 4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIK-----KFLESEDDPVIKKIALREIRMLKQ 58
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAV 128
L+HPN+V L EV K +++ V E+ + E L + Q + AV
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLH---ELDRYQRGVPEHLVKSITWQTLQAV 115
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYV 184
+CH HRD+K EN+L+ ++ +K+ DFG + + T Y
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRW----YR 169
Query: 185 APEIL-AKKGYDGAKVDMWSCGVVL----------------------------------- 208
+PE+L Y G VD+W+ G V
Sbjct: 170 SPELLVGDTQY-GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQ 228
Query: 209 -FVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEIL 267
F N + P+ + E + P S + L DP R+T +++L
Sbjct: 229 VFSTNQYFSGVKIPD----PEDMEPLELKFPNI-SYPALGLLKGCLHMDPTERLTCEQLL 283
Query: 268 RDPWFKKDYKERKFPHE 284
P+F+ + E
Sbjct: 284 HHPYFENIREIEDLAKE 300
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 5e-53
Identities = 51/265 (19%), Positives = 98/265 (36%), Gaps = 29/265 (10%)
Query: 19 EVGKIIGCGAFAKVYHGR-NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ +++ GR G + +K + + + E + HPN
Sbjct: 13 NFLTKLNENHSGELWKGRWQ---GNDIVVKVLKVRD-WSTRKSRDFNEECPRLRIFSHPN 68
Query: 78 IVKLYEVLAT--KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV------E 129
++ + + + + G L+ + +G + + + Q + A+
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGT-NFVVDQS--QAVKFALDMARGMA 125
Query: 130 YCHSRG--VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
+ H+ + L ++++DE+ +IS + + PA+VAPE
Sbjct: 126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-------PGRMYAPAWVAPE 178
Query: 188 ILAKKGYDGA--KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSP 243
L KK D DMWS V+L+ L +PF D + M + K+ R P SP
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISP 238
Query: 244 DLKWFIGRLLDTDPATRITVDEILR 268
+ + ++ DPA R D I+
Sbjct: 239 HVSKLMKICMNEDPAKRPKFDMIVP 263
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 9e-53
Identities = 62/267 (23%), Positives = 120/267 (44%), Gaps = 24/267 (8%)
Query: 19 EVGKIIGCGAFAKVYHGR-NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
E+G++IG G F +VYHGR + VAI+ + ++ L A KRE+ + RH N
Sbjct: 36 EIGELIGKGRFGQVYHGRWH----GEVAIRLIDIERDNEDQLKA-FKREVMAYRQTRHEN 90
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFA--KISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+V + + + KG L++ + +K +R+ Q+++ + Y H++G
Sbjct: 91 VVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQI---RPDGMLHTLCGTPAYVAPEILAKK 192
+ H+DLK +N+ D N + I+DFGL ++ + R + L G ++APEI+ +
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209
Query: 193 GYDGA--------KVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---CPKWT 241
D D+++ G + + L+A PF A+ ++ G +
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG-MKPNLSQIGM 268
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILR 268
++ + + R T +++
Sbjct: 269 GKEISDILLFCWAFEQEERPTFTKLMD 295
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-52
Identities = 65/270 (24%), Positives = 113/270 (41%), Gaps = 27/270 (10%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRLRH 75
G+++G G F + + TG+ + +K L + +E+ +M L H
Sbjct: 13 IHGEVLGKGCFGQAIKVTHRETGEVMVMK------ELIRFDEETQRTFLKEVKVMRCLEH 66
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYCHS 133
PN++K VL ++ F+ E+ KGG L I ++ + + + S + Y HS
Sbjct: 67 PNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ------------IRPDGMLHTLCGTP 181
+ HRDL N L+ EN ++ ++DFGL+ + +T+ G P
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNP 186
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYR--CP 238
++APE++ + YD KVD++S G+VL + D + +G CP
Sbjct: 187 YWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRYCP 245
Query: 239 KWTSPDLKWFIGRLLDTDPATRITVDEILR 268
P R D DP R + ++
Sbjct: 246 PNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 176 bits (449), Expect = 2e-52
Identities = 84/262 (32%), Positives = 137/262 (52%), Gaps = 11/262 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG GA VY +V TGQ VAI+ ++ Q+ + L + EI +M ++P
Sbjct: 21 KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKEL---IINEILVMRENKNP 77
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
NIV + +++ VME+ GG L +++ E ++ + A+E+ HS V
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQV 137
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYD 195
HRD+K +N+LL + +K++DFG A QI P+ T+ GTP ++APE++ +K Y
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCA---QITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 196 GAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKG--EYRCPKWTSPDLKWFIGRL 252
KVD+WS G++ + G P N+ L A+Y G E + P+ S + F+ R
Sbjct: 195 P-KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 253 LDTDPATRITVDEILRDPWFKK 274
L+ D R + E+L+ + K
Sbjct: 254 LEMDVEKRGSAKELLQHQFLKI 275
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-52
Identities = 77/288 (26%), Positives = 118/288 (40%), Gaps = 28/288 (9%)
Query: 1 MGDNTGDISREVNL-FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL 59
MG + SR L + E K IG G F V+ GR V+ VAIK++
Sbjct: 3 MGGSEFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETE 62
Query: 60 TAHV----KREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFS 113
+RE+ IMS L HPNIVKLY VMEF G+L+ ++
Sbjct: 63 MIEKFQEFQREVFIMSNLNHPNIVKLYG--LMHNPPRMVMEFVPCGDLYHRLLDKAHPIK 120
Query: 114 EQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWD-----LKISDFGLSAVKE 166
+ R + +EY ++ + HRDL+ N+ L + K++DFGLS
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180
Query: 167 QIRPDGMLHTLCGTPAYVAPEILAKKG--YDGAKVDMWSCGVVLFVLNAGYLPFND--PN 222
+ L G ++APE + + Y K D +S ++L+ + G PF++
Sbjct: 181 H-----SVSGLLGNFQWMAPETIGAEEESYT-EKADTYSFAMILYTILTGEGPFDEYSYG 234
Query: 223 LMAMYRKIYKGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
+ I + R P+ P L+ I DP R I++
Sbjct: 235 KIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 2e-51
Identities = 74/272 (27%), Positives = 140/272 (51%), Gaps = 20/272 (7%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ + IG G+F +V+ G + RT + VAIK + ++ +++EI+++S+ P
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPY 81
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVF 137
+ K Y K++ +ME+ GG + G E ++++ ++Y HS
Sbjct: 82 VTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKI 141
Query: 138 HRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML--HTLCGTPAYVAPEILAKKGYD 195
HRD+K N+LL E+ ++K++DFG++ Q+ D + +T GTP ++APE++ + YD
Sbjct: 142 HRDIKAANVLLSEHGEVKLADFGVAG---QLT-DTQIKRNTFVGTPFWMAPEVIKQSAYD 197
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP-----KWTSPDLKWFI 249
+K D+WS G+ L G P ++ + M ++ I K P + S LK F+
Sbjct: 198 -SKADIWSLGITAIELARGEPPHSELHPMKVLF-LIPKNN---PPTLEGNY-SKPLKEFV 251
Query: 250 GRLLDTDPATRITVDEILRDPWFKKDYKERKF 281
L+ +P+ R T E+L+ + ++ K+ +
Sbjct: 252 EACLNKEPSFRPTAKELLKHKFILRNAKKTSY 283
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 7e-51
Identities = 90/311 (28%), Positives = 131/311 (42%), Gaps = 62/311 (19%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV--SKQKILRGGL--TAH 62
D+ +YE +G G FA VY R+ T Q VAIK + + + G+ TA
Sbjct: 4 DVKSRAK---RYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTA- 59
Query: 63 VKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSR 118
REI ++ L HPNI+ L + K+ I V +F + K + + +
Sbjct: 60 -LREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIK 115
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH-- 175
Y + +EY H + HRDLK NLLLDEN LK++DFGL+ + R H
Sbjct: 116 AYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQV 173
Query: 176 -TLCGTPAYVAPEIL--AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDPNLMAMYRKI 230
T Y APE+L A+ Y VDMW+ G +L +L +LP + + +I
Sbjct: 174 VTRW----YRAPELLFGARM-YGVG-VDMWAVGCILAELLLRVPFLPGDSD--LDQLTRI 225
Query: 231 YK--G---EYRCPKWTS-PDLKWF----------------------IGRLLDTDPATRIT 262
++ G E + P S PD F I L +P RIT
Sbjct: 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285
Query: 263 VDEILRDPWFK 273
+ L+ +F
Sbjct: 286 ATQALKMKYFS 296
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 170 bits (434), Expect = 2e-50
Identities = 87/302 (28%), Positives = 141/302 (46%), Gaps = 62/302 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRLR 74
KYE + IG G + V+ +N T + VA+K V + G+ +A REI ++ L+
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRV-RLDDDDEGVPSSA--LREICLLKELK 59
Query: 75 HPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
H NIV+L++VL + K+ V EF K + G ++ + + QL+ + +
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGF 116
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYVAP 186
CHSR V HRDLK +NLL++ N +LK+++FGL+ A +R TL Y P
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLW----YRPP 170
Query: 187 EIL--AKKGYDGAKVDMWSCGVV---LFVLNAGYLPFNDPN--LMAMYR-------KIYK 232
++L AK Y + +DMWS G + L P ND + L ++R + +
Sbjct: 171 DVLFGAKL-YSTS-IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWP 228
Query: 233 G-----EYRC-PKWTSP---------------DLKWFIGRLLDTDPATRITVDEILRDPW 271
+Y+ P + + DL + LL +P RI+ +E L+ P+
Sbjct: 229 SMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDL---LQNLLKCNPVQRISAEEALQHPY 285
Query: 272 FK 273
F
Sbjct: 286 FS 287
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 5e-50
Identities = 87/302 (28%), Positives = 137/302 (45%), Gaps = 60/302 (19%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRLR 74
KY + IG G + VY +N G++ A+K + + + G+ T REISI+ L+
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKI-RLEKEDEGIPSTT--IREISILKELK 58
Query: 75 HPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
H NIVKLY+V+ TK ++ V E K + +G ++ + QL++ + Y
Sbjct: 59 HSNIVKLYDVIHTKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYVAP 186
CH R V HRDLK +NLL++ +LKI+DFGL+ A +R H TL Y AP
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK--YTHEIVTLW----YRAP 169
Query: 187 EIL--AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDPN--LMAMYRKI---------- 230
++L +KK Y +D+WS G + V P LM ++R +
Sbjct: 170 DVLMGSKK-YSTT-IDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227
Query: 231 ------YKGEYRCPKWTSPDLKWF-----------IGRLLDTDPATRITVDEILRDPWFK 273
Y + + + F + ++L DP RIT + L +FK
Sbjct: 228 VTELPKYDPNF--TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK 285
Query: 274 KD 275
++
Sbjct: 286 EN 287
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 168 bits (429), Expect = 3e-49
Identities = 84/323 (26%), Positives = 133/323 (41%), Gaps = 70/323 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRLR 74
+++ + +G G +A VY G N TG VA+K V G TA REIS+M L+
Sbjct: 6 QFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTA--IREISLMKELK 61
Query: 75 HPNIVKLYEVLATKAKIYFVMEFA----KG--GELFAKISKGRFSEQLSRRYFQQLISAV 128
H NIV+LY+V+ T+ K+ V EF K + L + + QL+ +
Sbjct: 62 HENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGL 121
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYV 184
+CH + HRDLK +NLL+++ LK+ DFGL+ A + TL Y
Sbjct: 122 AFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNT--FSSEVVTLW----YR 175
Query: 185 APEIL--AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDPN--LMAMYRKI-------- 230
AP++L ++ Y + +D+WSCG +L + P + L ++ +
Sbjct: 176 APDVLMGSRT-YSTS-IDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLW 233
Query: 231 --------YKGEYRCPKWTSPDLKWFIG----------------RLLDTDPATRITVDEI 266
Y + DL+ + LL +P R++ +
Sbjct: 234 PSVTKLPKYNPNI--QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291
Query: 267 LRDPWFKKDYK------ERKFPH 283
L PWF + Y R H
Sbjct: 292 LHHPWFAEYYHHASMGGSRSHHH 314
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 3e-49
Identities = 78/300 (26%), Positives = 130/300 (43%), Gaps = 59/300 (19%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRLR 74
KY+ + +G G + VY ++ G+ VA+K + + G+ TA REIS++ L
Sbjct: 22 KYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRI-RLDAEDEGIPSTA--IREISLLKELH 77
Query: 75 HPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
HPNIV L +V+ ++ + V EF K +K + + Y QL+ V +
Sbjct: 78 HPNIVSLIDVIHSERCLTLVFEFMEKDLKK---VLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYVAP 186
CH + HRDLK +NLL++ + LK++DFGL+ A +R H TL Y AP
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS--YTHEVVTLW----YRAP 188
Query: 187 EIL--AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDPN--LMAMYRKI---------- 230
++L +KK Y + VD+WS G + + P + L ++ +
Sbjct: 189 DVLMGSKK-YSTS-VDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQ 246
Query: 231 ------YKGEYRCPKWTSPDLKWF-----------IGRLLDTDPATRITVDEILRDPWFK 273
+K + + + +L DP RI+ + + P+FK
Sbjct: 247 VQELPLWK-QRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFK 305
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 4e-49
Identities = 76/280 (27%), Positives = 130/280 (46%), Gaps = 20/280 (7%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
+ R+++ +E+ +G GAF KVY +N TG A K + + E
Sbjct: 10 HVRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVE 66
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQL 124
I I++ HP IVKL K++ ++EF GG + +E + +Q+
Sbjct: 67 IEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQM 126
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD-GMLHTLCGTPAY 183
+ A+ + HS+ + HRDLK N+L+ D++++DFG+SA + + GTP +
Sbjct: 127 LEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSA---KNLKTLQKRDSFIGTPYW 183
Query: 184 VAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGE--- 234
+APE++ YD K D+WS G+ L + P ++ N M + KI K +
Sbjct: 184 MAPEVVMCETMKDTPYDY-KADIWSLGITLIEMAQIEPPHHELNPMRVLL-KIAKSDPPT 241
Query: 235 YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
P S + + F+ LD +P TR + ++L P+
Sbjct: 242 LLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSS 281
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 4e-49
Identities = 72/266 (27%), Positives = 120/266 (45%), Gaps = 17/266 (6%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+ + IG G+F VY R+VR + VAIK +S + +E+ + +LRHP
Sbjct: 55 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHP 114
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
N ++ + + VME+ G ++ K E + + Y HS
Sbjct: 115 NTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 174
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA---KK 192
+ HRD+K N+LL E +K+ DFG ++ + P ++ GTP ++APE++ +
Sbjct: 175 MIHRDVKAGNILLSEPGLVKLGDFGSAS---IMAPA---NSFVGTPYWMAPEVILAMDEG 228
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKG---EYRCPKWTSPDLKWF 248
YDG KVD+WS G+ L P + N M A+Y I + + W S + F
Sbjct: 229 QYDG-KVDVWSLGITCIELAERKPPLFNMNAMSALY-HIAQNESPALQSGHW-SEYFRNF 285
Query: 249 IGRLLDTDPATRITVDEILRDPWFKK 274
+ L P R T + +L+ + +
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFVLR 311
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 167 bits (426), Expect = 6e-49
Identities = 75/266 (28%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
++V + +G G++ VY + TGQ VAIK V + L+ + +EISIM + P
Sbjct: 30 VFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQ-----EIIKEISIMQQCDSP 84
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
++VK Y ++ VME+ G + ++ +E Q + +EY H
Sbjct: 85 HVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML--HTLCGTPAYVAPEILAKK 192
HRD+K N+LL+ K++DFG++ Q+ D M +T+ GTP ++APE++ +
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAG---QLT-DTMAKRNTVIGTPFWMAPEVIQEI 200
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKG---EYRCPKWTSPDLKWF 248
GY+ D+WS G+ + G P+ D + M A++ I +R P+ S + F
Sbjct: 201 GYNC-VADIWSLGITAIEMAEGKPPYADIHPMRAIF-MIPTNPPPTFRKPELWSDNFTDF 258
Query: 249 IGRLLDTDPATRITVDEILRDPWFKK 274
+ + L P R T ++L+ P+ +
Sbjct: 259 VKQCLVKSPEQRATATQLLQHPFVRS 284
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 2e-48
Identities = 73/298 (24%), Positives = 126/298 (42%), Gaps = 55/298 (18%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRLR 74
Y +G G +A VY G++ T VA+K + + G TA RE+S++ L+
Sbjct: 3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEH--EEGAPCTA--IREVSLLKDLK 58
Query: 75 HPNIVKLYEVLATKAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
H NIV L++++ T+ + V E+ K + + + + QL+ + Y
Sbjct: 59 HANIVTLHDIIHTEKSLTLVFEYLDKDLKQ---YLDDCGNIINMHNVKLFLFQLLRGLAY 115
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYVAP 186
CH + V HRDLK +NLL++E +LK++DFGL+ A + + TL Y P
Sbjct: 116 CHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKT--YDNEVVTLW----YRPP 169
Query: 187 EIL-AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------------- 232
+IL Y +DMW G + + + G F + I++
Sbjct: 170 DILLGSTDYSTQ-IDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGI 228
Query: 233 ------GEYRCPKWTSPDLKWF-----------IGRLLDTDPATRITVDEILRDPWFK 273
Y PK+ + L + +LL + RI+ ++ ++ P+F
Sbjct: 229 LSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFL 286
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 5e-48
Identities = 84/302 (27%), Positives = 135/302 (44%), Gaps = 58/302 (19%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRLR 74
+Y +G G + +VY + T ++VAIK + + + G+ TA RE+S++ L+
Sbjct: 35 RYRRITKLGEGTYGEVYKAIDTVTNETVAIKRI-RLEHEEEGVPGTA--IREVSLLKELQ 91
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHS 133
H NI++L V+ +++ + E+A+ +L + S ++ + + QLI+ V +CHS
Sbjct: 92 HRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHS 150
Query: 134 RGVFHRDLKLENLLLDENWD-----LKISDFGLS-AVKEQIRPDGMLH---TLCGTPAYV 184
R HRDLK +NLLL + LKI DFGL+ A IR H TL Y
Sbjct: 151 RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQ--FTHEIITLW----YR 204
Query: 185 APEIL-AKKGYDGAKVDMWSCGVVL--FVLNAGYLPFNDPN--LMAMYRKI--------- 230
PEIL + Y + VD+WS + ++ P + L ++ +
Sbjct: 205 PPEILLGSRHYSTS-VDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 231 -------YKGEYRCPKWTSPDLKWFIGRLLDT------------DPATRITVDEILRDPW 271
+K + PK+ LK +G LLD DP RI+ L P+
Sbjct: 264 GVTALPDWKQSF--PKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPY 321
Query: 272 FK 273
F
Sbjct: 322 FS 323
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 3e-47
Identities = 81/305 (26%), Positives = 132/305 (43%), Gaps = 43/305 (14%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV----SKQKILR 56
M +++ + +N YE+ ++IG GA A V + VAIK + + +
Sbjct: 1 MSEDSSALPWSINR-DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSM-- 57
Query: 57 GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELF---------AKI 107
+ +EI MS+ HPNIV Y K +++ VM+ GG + +
Sbjct: 58 ----DELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEH 113
Query: 108 SKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167
G E ++++ +EY H G HRD+K N+LL E+ ++I+DFG+SA
Sbjct: 114 KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSA---F 170
Query: 168 IRPDGML------HTLCGTPAYVAPE-ILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND 220
+ G + T GTP ++APE + +GYD K D+WS G+ L G P++
Sbjct: 171 LATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYD-FKADIWSFGITAIELATGAAPYHK 229
Query: 221 PNLM-AMY----------RKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269
M + + + K+ + I L DP R T E+LR
Sbjct: 230 YPPMKVLMLTLQNDPPSLETGVQDKEMLKKY-GKSFRKMISLCLQKDPEKRPTAAELLRH 288
Query: 270 PWFKK 274
+F+K
Sbjct: 289 KFFQK 293
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 6e-47
Identities = 75/309 (24%), Positives = 121/309 (39%), Gaps = 65/309 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG----LTAHVKREISIMSR 72
+YE IG GA+ VY R+ +G VA+K+V GG ++ RE++++ R
Sbjct: 10 RYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPIST--VREVALLRR 67
Query: 73 LR---HPNIVKLYEVLATK-----AKIYFVMEFA----KGGELFAKISKGRFSEQLSRRY 120
L HPN+V+L +V AT K+ V E + K + +
Sbjct: 68 LEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRT--YLDKAPPPGLPAETIKDL 125
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
+Q + +++ H+ + HRDLK EN+L+ +K++DFGL+ R L T
Sbjct: 126 MRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLA------RIYSYQMAL--T 177
Query: 181 PA-----YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--- 232
P Y APE+L + Y VDMWS G + + F + KI+
Sbjct: 178 PVVVTLWYRAPEVLLQSTYATP-VDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 233 --------GEYRCPKWTSPDLKW------------------FIGRLLDTDPATRITVDEI 266
+ P+ P + +L +P RI+
Sbjct: 237 LPPEDDWPRDVSLPRGAFP--PRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRA 294
Query: 267 LRDPWFKKD 275
L+ + KD
Sbjct: 295 LQHSYLHKD 303
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 78/311 (25%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
Y K+IG G+F VY + +G+ VAIK K+L+ + RE+ IM +L
Sbjct: 55 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIK-----KVLQ-----DKRFKNRELQIMRKL 104
Query: 74 RHPNIVKLYEVLATKA------KIYFVMEF-----AKGGELFAKISKGRFSEQLSRRYFQ 122
H NIV+L + + V+++ + +++ +K + Y
Sbjct: 105 DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR-AKQTLPVIYVKLYMY 163
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDGMLHTLCGTP 181
QL ++ Y HS G+ HRD+K +NLLLD + LK+ DFG + K+ +R + + +C +
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA--KQLVRGEPNVSYIC-SR 220
Query: 182 AYVAPE-ILAKKGYDGAKVDMWSCGVV---------LF--------------VL---NAG 214
Y APE I Y + +D+WS G V +F VL
Sbjct: 221 YYRAPELIFGATDYTSS-IDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 279
Query: 215 YLPFNDPNLMAMYRKIYKGEYRCPKW------------TSPDLKWFIGRLLDTDPATRIT 262
+ +PN E++ P+ T P+ RLL+ P R+T
Sbjct: 280 QIREMNPNYT---------EFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLT 330
Query: 263 VDEILRDPWFK 273
E +F
Sbjct: 331 PLEACAHSFFD 341
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 3e-46
Identities = 85/318 (26%), Positives = 131/318 (41%), Gaps = 76/318 (23%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL----RGGL--TAHVKREISIM 70
KYE IG G F +V+ R+ +TGQ VA+K K+L + G TA REI I+
Sbjct: 18 KYEKLAKIGQGTFGEVFKARHRKTGQKVALK-----KVLMENEKEGFPITA--LREIKIL 70
Query: 71 SRLRHPNIVKLYEVLATKA--------KIYFVMEFA----KGGELFAKISKGRFSEQLSR 118
L+H N+V L E+ TKA IY V +F G +F+ +
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIK 127
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS---AVKEQIRPDGMLH 175
R Q L++ + Y H + HRD+K N+L+ + LK++DFGL+ ++ + +P+ +
Sbjct: 128 RVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187
Query: 176 ---TLCGTPAYVAPEIL--AKKGYDGAKVDMWSCGVVL---------------------- 208
TL Y PE+L + Y G +D+W G ++
Sbjct: 188 RVVTLW----YRPPELLLGERD-Y-GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241
Query: 209 FVL----------NAGYLP-FNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDP 257
L N + L+ ++ K + L I +LL DP
Sbjct: 242 SQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALD-LIDKLLVLDP 300
Query: 258 ATRITVDEILRDPWFKKD 275
A RI D+ L +F D
Sbjct: 301 AQRIDSDDALNHDFFWSD 318
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 5e-46
Identities = 85/304 (27%), Positives = 148/304 (48%), Gaps = 30/304 (9%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
D+S + G +E+ +++G G + +VY GR+V+TGQ AIK + + G +K+E
Sbjct: 15 DLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQE 70
Query: 67 ISIMSRL-RHPNIVKLYE------VLATKAKIYFVMEFAKGG---ELFAKISKGRFSEQL 116
I+++ + H NI Y +++ VMEF G +L E+
Sbjct: 71 INMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW 130
Query: 117 SRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI-RPDGMLH 175
++++ + + H V HRD+K +N+LL EN ++K+ DFG+SA Q+ R G +
Sbjct: 131 IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA---QLDRTVGRRN 187
Query: 176 TLCGTPAYVAPEILAKK-----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRK 229
T GTP ++APE++A YD K D+WS G+ + G P D + M A++
Sbjct: 188 TFIGTPYWMAPEVIACDENPDATYDF-KSDLWSLGITAIEMAEGAPPLCDMHPMRALF-L 245
Query: 230 IYKGE---YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDF 286
I + + KW S + FI L + + R +++++ P+ + ER+ +
Sbjct: 246 IPRNPAPRLKSKKW-SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPNERQVRIQLK 304
Query: 287 DLKD 290
D D
Sbjct: 305 DHID 308
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 158 bits (403), Expect = 2e-45
Identities = 71/304 (23%), Positives = 124/304 (40%), Gaps = 61/304 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGL--TAHVKREISIMSRL 73
+YE IG GA+ KV+ R+++ G+ VA+K V + + G+ + RE++++ L
Sbjct: 12 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRV-RVQTGEEGMPLST--IREVAVLRHL 68
Query: 74 R---HPNIVKLYEVLAT-----KAKIYFVMEFA----KGGELFAKISKGRFSEQLSRRYF 121
HPN+V+L++V + K+ V E K+ + + +
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT--YLDKVPEPGVPTETIKDMM 126
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
QL+ +++ HS V HRDLK +N+L+ + +K++DFGL+ R L T
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA------RIYSFQMAL--TS 178
Query: 182 A-----YVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK---- 232
Y APE+L + Y VD+WS G + + F + + KI
Sbjct: 179 VVVTLWYRAPEVLLQSSYATP-VDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGL 237
Query: 233 -------GEYRCPKWTSPDLKW----------------FIGRLLDTDPATRITVDEILRD 269
+ P+ + + L +PA RI+ L
Sbjct: 238 PGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 297
Query: 270 PWFK 273
P+F+
Sbjct: 298 PYFQ 301
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 2e-45
Identities = 87/305 (28%), Positives = 131/305 (42%), Gaps = 67/305 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y K+IG G+F V+ + V + + VAIK V + K + RE+ IM ++HP
Sbjct: 41 AYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKN-------RELQIMRIVKHP 92
Query: 77 NIVKLYEVLATKA------KIYFVMEF-----AKGGELFAKISKGRFSEQLSRRYFQQLI 125
N+V L + + V+E+ + +AK K L + Y QL+
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAK-LKQTMPMLLIKLYMYQLL 151
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWD-LKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
++ Y HS G+ HRD+K +NLLLD LK+ DFG + K I + + +C + Y
Sbjct: 152 RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSA--KILIAGEPNVSYIC-SRYYR 208
Query: 185 APE-ILAKKGYDGAKVDMWSCGVV---------LF--------------VL--------- 211
APE I Y +D+WS G V LF VL
Sbjct: 209 APELIFGATNYT-TNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIK 267
Query: 212 --NAGYLPFNDPNLMAM-YRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
N Y+ P + + K+++ P+ T PD I RLL+ P+ R+T E L
Sbjct: 268 TMNPNYMEHKFPQIRPHPFSKVFR-----PR-TPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 269 DPWFK 273
P+F
Sbjct: 322 HPFFD 326
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 9e-45
Identities = 63/302 (20%), Positives = 122/302 (40%), Gaps = 53/302 (17%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI 67
++R++ L + +G G + +V+ G G++VA+K S + + + E+
Sbjct: 6 VARDITL------LECVGKGRYGEVWRGS--WQGENVAVKIFSSRDEK----SWFRETEL 53
Query: 68 SIMSRLRHPNIVKLY----EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQ 123
LRH NI+ + +++ + + + G L+ + R
Sbjct: 54 YNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLS 113
Query: 124 LISAVEYCHSR--------GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--DGM 173
+ S + + H + HRDLK +N+L+ +N I+D GL+ + Q D
Sbjct: 114 IASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVG 173
Query: 174 LHTLCGTPAYVAPEILAKKGYDGA-----KVDMWSCGVVL----------FVLNAGYLPF 218
+ GT Y+APE+L + +VD+W+ G+VL ++ PF
Sbjct: 174 NNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPF 233
Query: 219 -----NDPNLMAMYRKIYKGEYR---CPKWTSPDLKWFIGRLL----DTDPATRITVDEI 266
NDP+ M + + + R +W S + +L+ +P+ R+T I
Sbjct: 234 YDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRI 293
Query: 267 LR 268
+
Sbjct: 294 KK 295
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 157 bits (398), Expect = 1e-44
Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 61/303 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIK---AVSKQKILRGGLTAHVKREISIMSRL 73
Y++ + +G G +++V+ N+ + V +K V K+KI R EI I+ L
Sbjct: 37 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKR---------EIKILENL 87
Query: 74 R-HPNIVKLYEVL--ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
R PNI+ L +++ V E + ++ R Y +++ A++Y
Sbjct: 88 RGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT--LTDYDIRFYMYEILKALDY 145
Query: 131 CHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
CHS G+ HRD+K N+++D E+ L++ D+GL+ E P + + + PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELL 202
Query: 190 -AKKGYDGAKVDMWSCGVVLFVLNAGYLPF---ND--------------PNLMAMYRKIY 231
+ YD + +DMWS G +L + PF +D +L K
Sbjct: 203 VDYQMYDYS-LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 261
Query: 232 KGEYR-----CPKWTSPDLKWFI----------------GRLLDTDPATRITVDEILRDP 270
+ + + F+ +LL D +R+T E + P
Sbjct: 262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 321
Query: 271 WFK 273
+F
Sbjct: 322 YFY 324
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 6e-43
Identities = 61/317 (19%), Positives = 113/317 (35%), Gaps = 60/317 (18%)
Query: 16 GKYEVGKIIGCGA--FAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
G YE+ +IG G V R TG+ V ++ ++ + +T ++ E+ +
Sbjct: 25 GCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVT-FLQGELHVSKLF 83
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGG---ELFAKISKGRFSEQLSRRYFQQLISAVEY 130
HPNIV +++ V F G +L +E Q ++ A++Y
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDY 143
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSA--VKEQIRPDGMLHTLC---GTPAYVA 185
H G HR +K ++L+ + + +S + + R + +++
Sbjct: 144 IHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLS 203
Query: 186 PEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------- 233
PE+L +GYD AK D++S G+ L G++PF D M + G
Sbjct: 204 PEVLQQNLQGYD-AKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262
Query: 234 ------------------------------------EYRCPKWTSPDLKWFIGRLLDTDP 257
+ + SP F+ + L +P
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322
Query: 258 ATRITVDEILRDPWFKK 274
R + +L +FK+
Sbjct: 323 DARPSASTLLNHSFFKQ 339
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 2e-42
Identities = 77/333 (23%), Positives = 125/333 (37%), Gaps = 78/333 (23%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM---SRL 73
+++V ++ G G F V G+ TG SVAIK K+++ RE+ IM + L
Sbjct: 24 RFQVERMAGQGTFGTVQLGKEKSTGMSVAIK-----KVIQDPRFR--NRELQIMQDLAVL 76
Query: 74 RHPNIVKLYEVLATKAK-------IYFVMEFAKGGELFAKISKGRFSEQ-LSRRYFQ--- 122
HPNIV+L T + + VME+ L + +
Sbjct: 77 HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPPPILIKVFL 135
Query: 123 -QLISAVEYCH--SRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLC 178
QLI ++ H S V HRD+K N+L++ + LK+ DFG + P + +C
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP--NVAYIC 193
Query: 179 GTPAYVAPE-ILAKKGYDGAKVDMWSCGVV---------LF--------------VL--- 211
+ Y APE I + Y A VD+WS G + +F VL
Sbjct: 194 -SRYYRAPELIFGNQHYTTA-VDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 212 --------NAGYLPFNDPNLMAM-YRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRIT 262
N + + N + + ++ K + + + LL P R+
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSD--HSLK-DAKEAYDLLSALLQYLPEERMK 308
Query: 263 VDEILRDPWFKKDYKE--------RKFPHEDFD 287
E L P+F + + + P + F
Sbjct: 309 PYEALCHPYF-DELHDPATKLPNNKDLPEDLFR 340
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-41
Identities = 69/327 (21%), Positives = 130/327 (39%), Gaps = 75/327 (22%)
Query: 17 KYEV-GKIIGCGAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
+E G +G G + VY + + + A+K +I G++ REI+++ L
Sbjct: 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALK-----QIEGTGISMSACREIALLREL 75
Query: 74 RHPNIVKLYEVLATKA--KIYFVMEFA---------KGGELFAKISKGRFSEQLSRRYFQ 122
+HPN++ L +V + A K++ + ++A A + + +
Sbjct: 76 KHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLY 135
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWD----LKISDFGLS-AVKEQIRPDGMLHTL 177
Q++ + Y H+ V HRDLK N+L+ +KI+D G + ++P L +
Sbjct: 136 QILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPV 195
Query: 178 CGTPAYVAPEIL--AKKGYDGAKVDMWSCGVV---------LF-----VLNAGYLPFND- 220
T Y APE+L A+ Y A +D+W+ G + +F + +D
Sbjct: 196 VVTFWYRAPELLLGARH-YTKA-IDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQ 253
Query: 221 ----------------PNLMAM--YRKIYKGEYRCPKWTSPDLKWF-------------- 248
++ M + + K R +K+
Sbjct: 254 LDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHL 313
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKD 275
+ +LL DP RIT ++ ++DP+F +D
Sbjct: 314 LQKLLTMDPIKRITSEQAMQDPYFLED 340
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 149 bits (377), Expect = 1e-41
Identities = 62/291 (21%), Positives = 123/291 (42%), Gaps = 47/291 (16%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
+ + IG G F +V+ G+ G+ VA+K S ++ + + EI LRH NI
Sbjct: 45 VLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENI 98
Query: 79 VKLY----EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
+ + T +++ V ++ + G LF +++ + + + S + + H
Sbjct: 99 LGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHME 158
Query: 135 GVF--------HRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--DGMLHTLCGTPAYV 184
V HRDLK +N+L+ +N I+D GL+ + D + GT Y+
Sbjct: 159 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 185 APEILAKKGYDGA-----KVDMWSCGVVL---------FVLNAGY-LPF-----NDPNLM 224
APE+L + D+++ G+V ++ Y LP+ +DP++
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 225 AMYRKIYKGEYR---CPKWTSPDLKWFIGRLL----DTDPATRITVDEILR 268
M + + + + R +W S + + +++ + A R+T I +
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 329
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (372), Expect = 7e-41
Identities = 60/291 (20%), Positives = 121/291 (41%), Gaps = 47/291 (16%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI 78
++ K IG G + +V+ G+ G+ VA+K + + + EI +RH NI
Sbjct: 40 QMVKQIGKGRYGEVWMGK--WRGEKVAVKVFFTTEEA----SWFRETEIYQTVLMRHENI 93
Query: 79 VKLY----EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
+ + + ++Y + ++ + G L+ + + + +S + + H+
Sbjct: 94 LGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTE 153
Query: 135 --------GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR--PDGMLHTLCGTPAYV 184
+ HRDLK +N+L+ +N I+D GL+ D +T GT Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213
Query: 185 APEILAKKGYDGA-----KVDMWSCGVVL----------FVLNAGYLPF-----NDPNLM 224
PE+L + DM+S G++L ++ LP+ +DP+
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273
Query: 225 AMYRKIYKGEYR---CPKWTSPDLKWFIGRLL----DTDPATRITVDEILR 268
M + + R +W+S + +G+L+ +PA+R+T + +
Sbjct: 274 DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (371), Expect = 1e-40
Identities = 65/323 (20%), Positives = 119/323 (36%), Gaps = 66/323 (20%)
Query: 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV---SKQKILRGG 58
G++ + +E +G G V+ + +G +A K + K I
Sbjct: 24 KQKVGELKDDD-----FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRN-- 76
Query: 59 LTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQL 116
+ RE+ ++ P IV Y + +I ME GG L ++ K GR EQ+
Sbjct: 77 ---QIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQI 132
Query: 117 SRRYFQQLISAVEYCHSRG-VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175
+ +I + Y + + HRD+K N+L++ ++K+ DFG+S D M +
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI----DSMAN 188
Query: 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235
+ GT +Y++PE L Y + D+WS G+ L + G P P+ +
Sbjct: 189 SFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVE 247
Query: 236 RCPKWT--------------------------------------------SPDLKWFIGR 251
T S + + F+ +
Sbjct: 248 GDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNK 307
Query: 252 LLDTDPATRITVDEILRDPWFKK 274
L +PA R + +++ + K+
Sbjct: 308 CLIKNPAERADLKQLMVHAFIKR 330
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-40
Identities = 74/272 (27%), Positives = 118/272 (43%), Gaps = 27/272 (9%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV------KREI 67
+ +Y++ +G G + VY + VAIK + +RE+
Sbjct: 9 INERYKIVDKLGGGGMSTVYLAEDTILNIKVAIK------AIFIPPREKEETLKRFEREV 62
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLIS 126
S+L H NIV + +V Y VME+ +G L I S G S + + Q++
Sbjct: 63 HNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHT--LCGTPAY 183
+++ H + HRD+K +N+L+D N LKI DFG++ A+ E + T + GT Y
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET----SLTQTNHVLGTVQY 178
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA-MYRKIYKGEYRCPKWTS 242
+PE AK D++S G+VL+ + G PFN ++ + I
Sbjct: 179 FSPE-QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVR 237
Query: 243 PD----LKWFIGRLLDTDPATR-ITVDEILRD 269
D L I R + D A R T+ E+ D
Sbjct: 238 KDIPQSLSNVILRATEKDKANRYKTIQEMKDD 269
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-40
Identities = 74/330 (22%), Positives = 125/330 (37%), Gaps = 86/330 (26%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY +GK +G G+F V ++ +G+ A+K K+L+ RE+ IM L H
Sbjct: 8 KYSLGKTLGTGSFGIVCEVFDIESGKRFALK-----KVLQDPRYK--NRELDIMKVLDHV 60
Query: 77 NIVKLYEVLATKAK--------------------------------------IYFVMEFA 98
NI+KL + T + +ME+
Sbjct: 61 NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120
Query: 99 KGGELFAKISKGRFSEQ-LSRRYFQ----QLISAVEYCHSRGVFHRDLKLENLLLD-ENW 152
L + S + + QL AV + HS G+ HRD+K +NLL++ ++
Sbjct: 121 -PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDN 179
Query: 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE-ILAKKGYDGAKVDMWSCGVV---- 207
LK+ DFG + K+ I + + +C + Y APE +L Y + +D+WS G V
Sbjct: 180 TLKLCDFGSA--KKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPS-IDLWSIGCVFGEL 235
Query: 208 -----LF--------------VL---NAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTS 242
LF ++ + +P+ + K P+ T
Sbjct: 236 ILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTP 295
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRDPWF 272
+ ++L +P RI E + P+F
Sbjct: 296 SLAIDLLEQILRYEPDLRINPYEAMAHPFF 325
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 5e-40
Identities = 76/325 (23%), Positives = 124/325 (38%), Gaps = 64/325 (19%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
+Y+ K IG GA V + ++VAIK +S+ Q RE+ +M +
Sbjct: 63 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQT---HAKRAYRELVLMKCVN 119
Query: 75 HPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ-QLISA 127
H NI+ L V + +Y VME L I E++ Y Q++
Sbjct: 120 HKNIISLLNVFTPQKTLEEFQDVYLVMELM-DANLCQVIQMELDHERM--SYLLYQMLCG 176
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
+++ HS G+ HRDLK N+++ + LKI DFGL+ M+ T Y APE
Sbjct: 177 IKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA---RTAGTSFMMTPYVVTRYYRAPE 233
Query: 188 ILAKKGYDGAKVDMWSCGV---------VLF-------------------------VLNA 213
++ GY VD+WS G +LF L
Sbjct: 234 VILGMGYKEN-VDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 292
Query: 214 GY------LPFNDP-NLMAMYRK-IYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDE 265
P ++ ++ + K + + + ++L DPA RI+VD+
Sbjct: 293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDD 352
Query: 266 ILRDPWFKKDYKERKFP---HEDFD 287
L+ P+ Y + + +D
Sbjct: 353 ALQHPYINVWYDPAEVEAPPPQIYD 377
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 6e-40
Identities = 77/305 (25%), Positives = 120/305 (39%), Gaps = 52/305 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+Y K +GCG V+ + + VAIK + H REI I+ RL H
Sbjct: 12 RYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQ---SVKHALREIKIIRRLDHD 68
Query: 77 NIVKLYEVLATKAK--------------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ 122
NIVK++E+L +Y V E+ +L + +G E+ +R +
Sbjct: 69 NIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-ETDLANVLEQGPLLEEHARLFMY 127
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLS-AVKEQIRPDGMLHTLCGT 180
QL+ ++Y HS V HRDLK NL ++ E+ LKI DFGL+ + G L T
Sbjct: 128 QLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 181 PAYVAPEI-LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK------- 232
Y +P + L+ Y A +DMW+ G + + G F + + + I +
Sbjct: 188 KWYRSPRLLLSPNNYTKA-IDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHE 246
Query: 233 ----------GEY--RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRD 269
Y L F+ ++L P R+T +E L
Sbjct: 247 EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH 306
Query: 270 PWFKK 274
P+
Sbjct: 307 PYMSI 311
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 7e-40
Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 24/272 (8%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV---SKQKILRGGLTAHVKREISI-MSRL 73
E +G G +V+ R +TG +A+K + ++ + + ++ + +
Sbjct: 27 LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-----RILMDLDVVLKSH 81
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGG-ELFAKISKGRFSEQLSRRYFQQLISAVEYCH 132
P IV+ + T ++ ME E K +G E++ + ++ A+ Y
Sbjct: 82 DCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 133 S-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL-- 189
GV HRD+K N+LLDE +K+ DFG+S ++ D G AY+APE +
Sbjct: 142 EKHGVIHRDVKPSNILLDERGQIKLCDFGISG---RLVDDKAKDRSAGCAAYMAPERIDP 198
Query: 190 ---AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGE---YRCPKWTS 242
K YD + D+WS G+ L L G P+ + + K+ + E S
Sbjct: 199 PDPTKPDYD-IRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMGFS 257
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
D + F+ L D R +++L + K+
Sbjct: 258 GDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR 289
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 3e-39
Identities = 76/329 (23%), Positives = 124/329 (37%), Gaps = 69/329 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-GLTAHVK---REISIMSR 72
+Y+ K IG GA V + ++VAIK K+ R H K RE+ +M
Sbjct: 26 RYQNLKPIGSGAQGIVCAAYDAILERNVAIK-----KLSRPFQNQTHAKRAYRELVLMKC 80
Query: 73 LRHPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126
+ H NI+ L V + +Y VME L ++ + + Q++
Sbjct: 81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-DANL-CQVIQMELDHERMSYLLYQMLC 138
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG---TPAY 183
+++ HS G+ HRDLK N+++ + LKI DFGL+ R G + T Y
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA------RTAGTSFMMTPYVVTRYY 192
Query: 184 VAPEILAKKGYDGAKVDMWSCGV---------VLF------------------------- 209
APE++ GY VD+WS G VLF
Sbjct: 193 RAPEVILGMGYKEN-VDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMK 251
Query: 210 VLNAGY------LPFNDP-NLMAMYRK-IYKGEYRCPKWTSPDLKWFIGRLLDTDPATRI 261
L P + ++ ++ + K + + + ++L D + RI
Sbjct: 252 KLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI 311
Query: 262 TVDEILRDPWFKKDYKERKFPHEDFDLKD 290
+VDE L+ P+ Y + + D
Sbjct: 312 SVDEALQHPYINVWYDPSEAEAPPPKIPD 340
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 4e-39
Identities = 82/312 (26%), Positives = 127/312 (40%), Gaps = 66/312 (21%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIK-------AVSKQKILRGGLTAHVKREISI 69
+++ ++G GA+ V + TG+ VAIK + + LR EI I
Sbjct: 12 DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLR---------EIKI 62
Query: 70 MSRLRHPNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ-Q 123
+ +H NI+ ++ + + +Y + E +L IS S+ +YF Q
Sbjct: 63 LKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-QTDLHRVISTQMLSDD-HIQYFIYQ 120
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP-- 181
+ AV+ H V HRDLK NLL++ N DLK+ DFGL+ + ++ D T +
Sbjct: 121 TLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180
Query: 182 AYV------APEI-LAKKGYDGAKVDMWSCGVVLFVLNAG--YLPFND------------ 220
+V APE+ L Y A +D+WSCG +L L P D
Sbjct: 181 EFVATRWYRAPEVMLTSAKYSRA-MDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGII 239
Query: 221 --PNLMAMYRKIYKGEYR-----CPKWTSPDLKW-----------FIGRLLDTDPATRIT 262
P+ R I R P + + L+ + R+L DPA RIT
Sbjct: 240 GTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRIT 299
Query: 263 VDEILRDPWFKK 274
E L P+ +
Sbjct: 300 AKEALEHPYLQT 311
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 1e-38
Identities = 56/293 (19%), Positives = 105/293 (35%), Gaps = 47/293 (16%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
++ ++ G F V+ + + VA+K Q + + E+ + ++H
Sbjct: 25 PLQLLEVKARGRFGCVWKAQ--LLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHE 78
Query: 77 NIVKLY----EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH 132
NI++ + ++ + F + G L + S + + + Y H
Sbjct: 79 NILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLH 138
Query: 133 SR----------GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
+ HRD+K +N+LL N I+DFGL+ E + G H GT
Sbjct: 139 EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRR 198
Query: 183 YVAPEILAKKGYDGA----KVDMWSCGVVL-----------FVLNAGYLPF-----NDPN 222
Y+APE+L ++DM++ G+VL ++ LPF P+
Sbjct: 199 YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS 258
Query: 223 LMAMYRKIYKGEYRCP---KWTSPDLKWFIGRLL----DTDPATRITVDEILR 268
L M + + R W + + D D R++ +
Sbjct: 259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 58/238 (24%), Positives = 107/238 (44%), Gaps = 22/238 (9%)
Query: 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT 60
D T + SRE FG Y + +++G G VY + + VA+K ++ L+
Sbjct: 20 HMDGTAE-SREGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALK------LMSETLS 72
Query: 61 AHV------KREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFS 113
+ +RE RL+ P++V +++ ++Y M G +L A + + G +
Sbjct: 73 SDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLA 132
Query: 114 EQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL-SAVKEQIRPDG 172
+ +Q+ SA++ H+ G HRD+K EN+L+ + + DFG+ SA ++
Sbjct: 133 PPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE----K 188
Query: 173 MLHT--LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYR 228
+ GT Y+APE + + + D+++ VL+ G P+ L M
Sbjct: 189 LTQLGNTVGTLYYMAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGA 245
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 2e-38
Identities = 69/273 (25%), Positives = 124/273 (45%), Gaps = 24/273 (8%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV------KREI 67
L +YE+G+I+G G ++V+ R++R + VA+K +LR L +RE
Sbjct: 10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVK------VLRADLARDPSFYLRFRREA 63
Query: 68 SIMSRLRHPNIVKLY---EVLATKAKIYF-VMEFAKGGELFAKISK-GRFSEQLSRRYFQ 122
+ L HP IV +Y E + + VME+ G L + G + + +
Sbjct: 64 QNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIA 123
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTP 181
A+ + H G+ HRD+K N+++ +K+ DFG++ A+ + + GT
Sbjct: 124 DACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK-- 239
Y++PE A+ A+ D++S G VL+ + G PF + +++ + + + P
Sbjct: 184 QYLSPE-QARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242
Query: 240 --WTSPDLKWFIGRLLDTDPATR-ITVDEILRD 269
S DL + + L +P R T E+ D
Sbjct: 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 275
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 3e-38
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 43/225 (19%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR----GGLTAHVKREISIMSR 72
+YE+ +IG G++ V + + VAIK KILR + REI+I++R
Sbjct: 54 RYEIRHLIGTGSYGHVCEAYDKLEKRVVAIK-----KILRVFEDLIDCKRILREIAILNR 108
Query: 73 LRHPNIVKLYEVLATKA-----KIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLIS 126
L H ++VK+ +++ K ++Y V+E A + + +E + L+
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLV 167
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA---- 182
V+Y HS G+ HRDLK N L++++ +K+ DFGL+ + +
Sbjct: 168 GVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNL 227
Query: 183 ---------------YV------APEI-LAKKGYDGAKVDMWSCG 205
+V APE+ L ++ Y A +D+WS G
Sbjct: 228 VTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA-IDVWSIG 271
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 7e-38
Identities = 67/287 (23%), Positives = 124/287 (43%), Gaps = 38/287 (13%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV---SKQKILRGGLTAHVKREISI-MSRL 73
+ IG GA+ V + +GQ +A+K + +K + + ++ + M
Sbjct: 24 LKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQK-----QLLMDLDVVMRSS 78
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGG-----ELFAKISKGRFSEQLSRRYFQQLISAV 128
P IV+ Y L + + ME + + E++ + + A+
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKAL 138
Query: 129 EYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC-GTPAYVAP 186
+ + HRD+K N+LLD + ++K+ DFG+S Q+ D + T G Y+AP
Sbjct: 139 NHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISG---QLV-DSIAKTRDAGCRPYMAP 194
Query: 187 EILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYR---KIYKGE----- 234
E + ++GYD + D+WS G+ L+ L G P+ P +++ ++ KG+
Sbjct: 195 ERIDPSASRQGYD-VRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLS 251
Query: 235 -YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280
++ SP F+ L D + R E+L+ P+ Y+ER
Sbjct: 252 NSEEREF-SPSFINFVNLCLTKDESKRPKYKELLKHPFILM-YEERA 296
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-37
Identities = 75/299 (25%), Positives = 114/299 (38%), Gaps = 48/299 (16%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
+Y IG GA+ V + VAIK KI + + REI I+ R
Sbjct: 28 RYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-----KISPFEHQTYCQRTLREIKILLRF 82
Query: 74 RHPNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
RH NI+ + +++ +Y V + +L+ + S + Q++ +
Sbjct: 83 RHENIIGINDIIRAPTIEQMKDVYIVQDLM-ETDLYKLLKTQHLSNDHICYFLYQILRGL 141
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPE 187
+Y HS V HRDLK NLLL+ DLKI DFGL+ G L T Y APE
Sbjct: 142 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 188 I-LAKKGYDGAKVDMWSC---------GVVLF----VLN-----AGYLPFNDPNLMAMYR 228
I L KGY + +D+WS +F L+ G L +
Sbjct: 202 IMLNSKGYTKS-IDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260
Query: 229 KIYKGEY--RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPWFKK 274
+ Y P + ++L +P RI V++ L P+ ++
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQ 319
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 143 bits (363), Expect = 1e-37
Identities = 60/257 (23%), Positives = 96/257 (37%), Gaps = 32/257 (12%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHV----KREIS 68
+ G+YEV I G +Y + G+ V +K L A E
Sbjct: 78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLK------GLVHSGDAEAQAMAMAERQ 131
Query: 69 IMSRLRHPNIVKLYEV-----LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQ 123
++ + HP+IV+++ Y VME+ G L + + + Y +
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL-KRSKGQKLPVAEAIAYLLE 190
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
++ A+ Y HS G+ + DLK EN++L E LK+ D G L GTP +
Sbjct: 191 ILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAV------SRINSFGYLYGTPGF 243
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSP 243
APEI+ + D+++ G L L N + + E T
Sbjct: 244 QAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYD 295
Query: 244 DLKWFIGRLLDTDPATR 260
+ R +D DP R
Sbjct: 296 SYGRLLRRAIDPDPRQR 312
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-37
Identities = 77/304 (25%), Positives = 127/304 (41%), Gaps = 63/304 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
Y +G GA+ V + R+G+ VAIK +S+ Q + RE+ ++ ++
Sbjct: 25 TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEI---FAKRAYRELLLLKHMQ 81
Query: 75 HPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
H N++ L +V + Y VM F +L KI +FSE+ + Q++ +
Sbjct: 82 HENVIGLLDVFTPASSLRNFYDFYLVMPFM-QTDL-QKIMGLKFSEEKIQYLVYQMLKGL 139
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---- 184
+Y HS GV HRDLK NL ++E+ +LKI DFGL+ + YV
Sbjct: 140 KYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTG-----------YVVTRW 188
Query: 185 --APEI-LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--G------ 233
APE+ L+ Y+ VD+WS G ++ + G F + + +I K G
Sbjct: 189 YRAPEVILSWMHYNQT-VDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247
Query: 234 ----------EY--RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDP 270
Y P+ D + ++L+ D R+T + L P
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHP 307
Query: 271 WFKK 274
+F+
Sbjct: 308 FFEP 311
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 3e-37
Identities = 77/304 (25%), Positives = 120/304 (39%), Gaps = 62/304 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
Y + +G GA+ V + RTG VAIK + + Q L RE+ ++ +R
Sbjct: 26 VYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSEL---FAKRAYRELRLLKHMR 82
Query: 75 HPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
H N++ L +V Y VM F G +L + + E + Q++ +
Sbjct: 83 HENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGL 141
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---- 184
Y H+ G+ HRDLK NL ++E+ +LKI DFGL+ R T YV
Sbjct: 142 RYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA------RQADSEMT-----GYVVTRW 190
Query: 185 --APEI-LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--G------ 233
APE+ L Y VD+WS G ++ + G F + + ++I K G
Sbjct: 191 YRAPEVILNWMRYTQT-VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 249
Query: 234 ----------EY--RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDP 270
Y P+ D + ++L D R+T E L P
Sbjct: 250 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHP 309
Query: 271 WFKK 274
+F+
Sbjct: 310 YFES 313
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 7e-37
Identities = 69/299 (23%), Positives = 121/299 (40%), Gaps = 52/299 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--QKILRGGLTAHVKREISIMSRLR 74
+Y+ +G GA+ V + +TG VA+K +S+ Q I+ RE+ ++ ++
Sbjct: 30 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSII---HAKRTYRELRLLKHMK 86
Query: 75 HPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128
H N++ L +V +Y V G +L + + ++ + Q++ +
Sbjct: 87 HENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGL 145
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP-DGMLHTLCGTPAYVAPE 187
+Y HS + HRDLK NL ++E+ +LKI DFGL+ R + T Y APE
Sbjct: 146 KYIHSADIIHRDLKPSNLAVNEDCELKILDFGLA------RHTADEMTGYVATRWYRAPE 199
Query: 188 I-LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK--G----------- 233
I L Y+ VD+WS G ++ L G F + + + I + G
Sbjct: 200 IMLNWMHYNQT-VDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258
Query: 234 -----EY--RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEILRDPWFKK 274
Y + + + ++L D RIT + L +F +
Sbjct: 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQ 317
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-36
Identities = 64/277 (23%), Positives = 118/277 (42%), Gaps = 33/277 (11%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV----SKQKILRGGLTAHVKREISI-MSR 72
E +G GA+ V R+V +GQ +A+K + + Q+ R + ++ I M
Sbjct: 9 LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKR------LLMDLDISMRT 62
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGG--ELFAKISK--GRFSEQLSRRYFQQLISAV 128
+ P V Y L + ++ ME + + ++ E + + ++ A+
Sbjct: 63 VDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 129 EYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
E+ HS V HRD+K N+L++ +K+ DFG+S + D G Y+APE
Sbjct: 123 EHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---YLVDDVAKDIDAGCKPYMAPE 179
Query: 188 ILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGEYRCP---- 238
+ +KGY K D+WS G+ + L P++ +++ + P
Sbjct: 180 RINPELNQKGYS-VKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP--SPQLPA 236
Query: 239 -KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
K+ S + F + L + R T E+++ P+F
Sbjct: 237 DKF-SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL 272
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 5e-36
Identities = 85/373 (22%), Positives = 135/373 (36%), Gaps = 103/373 (27%)
Query: 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--------QKILRG 57
G + R V KYE+ K +G GA+ V+ + RTG+ VA+K + Q+ R
Sbjct: 1 GRVDRHVL--RKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFR- 57
Query: 58 GLTAHVKREISIMSRLR-HPNIVKLYEVLATKAK--IYFVMEFAKGGELFAKISKGRFSE 114
EI I++ L H NIV L VL +Y V ++ +L A I +
Sbjct: 58 --------EIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-ETDLHAVIR----AN 104
Query: 115 QLSRRYFQ----QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170
L + Q QLI ++Y HS G+ HRD+K N+LL+ +K++DFGLS IR
Sbjct: 105 ILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164
Query: 171 DGMLHTLCGTPA-------------YV------APEI-LAKKGYDGAKVDMWSCGVVL-- 208
L YV APEI L Y +DMWS G +L
Sbjct: 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKG-IDMWSLGCILGE 223
Query: 209 ------------------------------------------FVLNAGY---LPFNDPNL 223
+ + + ++
Sbjct: 224 ILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRD 283
Query: 224 MAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP- 282
+ K + + + + +LL +P RI+ ++ L+ P+ + + P
Sbjct: 284 IFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPN 343
Query: 283 ---HEDFDLKDSV 292
+ D+V
Sbjct: 344 CDHIITIPINDNV 356
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-35
Identities = 73/324 (22%), Positives = 116/324 (35%), Gaps = 61/324 (18%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTA-----HVK---REIS 68
Y V + I G++ V G + G VAIK V + K REI
Sbjct: 23 PYTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIR 81
Query: 69 IMSRLRHPNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ- 122
+++ HPNI+ L ++ + +Y V E +L I R +S ++ Q
Sbjct: 82 LLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-RTDLAQVIHDQR--IVISPQHIQY 138
Query: 123 ---QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
++ + H GV HRDL N+LL +N D+ I DF L+ + D
Sbjct: 139 FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLA---REDTADANKTHYVT 195
Query: 180 TPAYVAPEI-LAKKGYDGAKVDMWSC---------GVVLF----VLN-----AGYLPFND 220
Y APE+ + KG+ VDMWS LF N +
Sbjct: 196 HRWYRAPELVMQFKGFTKL-VDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK 254
Query: 221 PNLMAMYRKIYKGEY---RCPKWTSPDLKW-----------FIGRLLDTDPATRITVDEI 266
+ M+ +Y + I ++L+ +P RI+ ++
Sbjct: 255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQA 314
Query: 267 LRDPWFKKDYKERKFPH---EDFD 287
LR P+F+ + E F
Sbjct: 315 LRHPYFESLFDPLDLTEGLSERFH 338
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 2e-35
Identities = 56/224 (25%), Positives = 101/224 (45%), Gaps = 46/224 (20%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSK--------QKILRGGLTAHVKREIS 68
Y + +IG G++ VY + T ++VAIK V++ ++ILR EI+
Sbjct: 27 NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILR---------EIT 77
Query: 69 IMSRLRHPNIVKLYEVLATKAK-----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ- 122
I++RL+ I++LY+++ +Y V+E A +L F + +
Sbjct: 78 ILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA-DSDLKKLFKTPIFLTEEHIKTILY 136
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
L+ + H G+ HRDLK N LL+++ +K+ DFGL+ + +++ L
Sbjct: 137 NLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 183 --------------YV------APEI-LAKKGYDGAKVDMWSCG 205
+V APE+ L ++ Y + +D+WS G
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKS-IDIWSTG 239
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-35
Identities = 50/219 (22%), Positives = 84/219 (38%), Gaps = 38/219 (17%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIK---AVSKQKILRGGLTAHVKREISIMSRLRH 75
++ ++IG G + VY G + VA+K ++Q + ++ I + + H
Sbjct: 16 KLLELIGRGRYGAVYKGS--LDERPVAVKVFSFANRQNFIN-------EKNIYRVPLMEH 66
Query: 76 PNIVKLY-----EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
NI + + + VME+ G L +S S R + + Y
Sbjct: 67 DNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAY 126
Query: 131 CHS---------RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR------PDGMLH 175
H+ + HRDL N+L+ + ISDFGLS R D
Sbjct: 127 LHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAI 186
Query: 176 TLCGTPAYVAPEIL------AKKGYDGAKVDMWSCGVVL 208
+ GT Y+APE+L +VDM++ G++
Sbjct: 187 SEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 6e-34
Identities = 39/254 (15%), Positives = 80/254 (31%), Gaps = 38/254 (14%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
G+Y + G + + + + VA+ V Q +L + +SR+
Sbjct: 29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRI 88
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
P + ++ +V+ T+A V E+ +GG L +++ S + R Q L +A + H
Sbjct: 89 DKPGVARVLDVVHTRAGGLVVAEWIRGGSL-QEVADTSPSPVGAIRAMQSLAAAADAAHR 147
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
GV + + + D+ + PA +
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVL----------------------AYPATMPDA------ 179
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-------KWTSPDLK 246
+ D+ G L+ L P + + + + P + +
Sbjct: 180 --NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS 237
Query: 247 WFIGRLLDTDPATR 260
R + D R
Sbjct: 238 AVAARSVQGDGGIR 251
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 3e-33
Identities = 74/263 (28%), Positives = 114/263 (43%), Gaps = 25/263 (9%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRLR 74
+G+ IG G F +V+ GR VA+K R L +K +E I+ +
Sbjct: 117 VLGEQIGRGNFGEVFSGRLRADNTLVAVK------SCRETLPPDLKAKFLQEARILKQYS 170
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCH 132
HPNIV+L V K IY VME +GG+ F + R + + + +EY
Sbjct: 171 HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE 230
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY----VAPEI 188
S+ HRDL N L+ E LKISDFG+S + DG+ G APE
Sbjct: 231 SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEA----DGVYAASGGLRQVPVKWTAPEA 286
Query: 189 LAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDL 245
L Y ++ D+WS G++L+ + G P+ + + + KG R CP+ +
Sbjct: 287 LNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKG-GRLPCPELCPDAV 344
Query: 246 KWFIGRLLDTDPATRITVDEILR 268
+ + +P R + I +
Sbjct: 345 FRLMEQCWAYEPGQRPSFSTIYQ 367
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-31
Identities = 62/276 (22%), Positives = 114/276 (41%), Gaps = 41/276 (14%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIK-AVSKQKILRGGLTAHVK----REISIMSRLRH 75
K++G GAF VY G + G+ V I A+ K LR + E +M+ + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASVDN 76
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
P++ +L + + + + + G L + + K Q + Q+ + Y
Sbjct: 77 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT--P-AYVAPEILA 190
R + HRDL N+L+ +KI+DFGL+ + + + + G P ++A E +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLK- 246
+ Y + D+WS GV ++ ++ G P++ + + KG R P + D+
Sbjct: 193 HRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQPPICTIDVYM 250
Query: 247 -----WFIGRLLDTDPATR-------ITVDEILRDP 270
W D +R I ++ RDP
Sbjct: 251 IMRKCW------MIDADSRPKFRELIIEFSKMARDP 280
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 66/272 (24%), Positives = 113/272 (41%), Gaps = 43/272 (15%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIK-----AVSKQKILRGGLTAHVKREISIMSRL 73
+ +G G + +VY G + +VA+K + ++ L+ E ++M +
Sbjct: 223 TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---------EAAVMKEI 273
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGR---FSEQLSRRYFQQLISAV 128
+HPN+V+L V + Y + EF G L + + + L Q+ SA+
Sbjct: 274 KHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY--MATQISSAM 331
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY--VAP 186
EY + HR+L N L+ EN +K++DFGLS + D AP
Sbjct: 332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG---DTYTAHAGAKFPIKWTAP 388
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSP 243
E LA + K D+W+ GV+L+ + G P+ +L +Y + K YR P+
Sbjct: 389 ESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMERPEGCPE 446
Query: 244 DLK------WFIGRLLDTDPATRITVDEILRD 269
+ W +P+ R + EI +
Sbjct: 447 KVYELMRACW------QWNPSDRPSFAEIHQA 472
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 8e-30
Identities = 65/241 (26%), Positives = 106/241 (43%), Gaps = 32/241 (13%)
Query: 16 GKYEV-------GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--RE 66
GK+ + + IG G F V+ G VAIK +R G + E
Sbjct: 1 GKWVIDPSELTFVQEIGSGQFGLVHLGY-WLNKDKVAIK------TIREGAMSEEDFIEE 53
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQL 124
+M +L HP +V+LY V +A I V EF + G L + + +G F+ + +
Sbjct: 54 AEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDV 113
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGT 180
+ Y V HRDL N L+ EN +K+SDFG++ V +
Sbjct: 114 CEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKF------ 167
Query: 181 PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
P + +PE+ + Y +K D+WS GV+++ V + G +P+ + + + I G +R
Sbjct: 168 PVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTG-FRLY 225
Query: 239 K 239
K
Sbjct: 226 K 226
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-29
Identities = 54/230 (23%), Positives = 102/230 (44%), Gaps = 20/230 (8%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIK-AVSKQKILRGGLTAHVK----REISIMSRLRH 75
K++G GAF VY G + G+ V I A+ K LR + E +M+ + +
Sbjct: 20 IKVLGSGAFGTVYKGLWIPEGEKVKIPVAI---KELREATSPKANKEILDEAYVMASVDN 76
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
P++ +L + + + + + G L + + K Q + Q+ + Y
Sbjct: 77 PHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 135
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT--P-AYVAPEILA 190
R + HRDL N+L+ +KI+DFGL+ + + + + G P ++A E +
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+ Y + D+WS GV ++ ++ G P++ + + KG R P+
Sbjct: 193 HRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG-ERLPQ 240
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 2e-29
Identities = 65/242 (26%), Positives = 100/242 (41%), Gaps = 27/242 (11%)
Query: 21 GKIIGCGAFAKVYHGR-NVRTGQS--VAIKAVSKQKILRGGLTAHVK------REISIMS 71
+ +G G+F V G + +G++ VA+K L+ + + + RE++ M
Sbjct: 23 LEKLGDGSFGVVRRGEWDAPSGKTVSVAVK------CLKPDVLSQPEAMDDFIREVNAMH 76
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
L H N+++LY V + V E A G L + +G F RY Q+ +
Sbjct: 77 SLDHRNLIRLYGV-VLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 135
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTP---AYVAP 186
Y S+ HRDL NLLL +KI DFGL + + D A+ AP
Sbjct: 136 YLESKRFIHRDLAARNLLLATRDLVKIGDFGLM--RALPQNDDHYVMQEHRKVPFAWCAP 193
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSP 243
E L + + D W GV L+ + G P+ N + KI K R P+
Sbjct: 194 ESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQ 252
Query: 244 DL 245
D+
Sbjct: 253 DI 254
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 3e-29
Identities = 69/266 (25%), Positives = 108/266 (40%), Gaps = 37/266 (13%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
+ +G G F +V+ G VAIK L+ G + +E +M +LRH
Sbjct: 270 RLEVKLGQGCFGEVWMGT-WNGTTRVAIK------TLKPGTMSPEAFLQEAQVMKKLRHE 322
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRF--SEQLSRRYFQQLISAVEYCH 132
+V+LY V ++ IY V E+ G L F K G++ QL Q+ S + Y
Sbjct: 323 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-MAAQIASGMAYVE 380
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY--VAPEILA 190
HRDL+ N+L+ EN K++DFGL+ I + APE
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAAL 437
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLK- 246
+ K D+WS G++L + G +P+ + ++ +G YR CP L
Sbjct: 438 YGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD 495
Query: 247 -----WFIGRLLDTDPATRITVDEIL 267
W +P R T + +
Sbjct: 496 LMCQCW------RKEPEERPTFEYLQ 515
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 6e-29
Identities = 69/268 (25%), Positives = 108/268 (40%), Gaps = 37/268 (13%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
+ +G G F +V+ G VAIK L+ G + +E +M +LRH
Sbjct: 187 RLEVKLGQGCFGEVWMGT-WNGTTRVAIK------TLKPGTMSPEAFLQEAQVMKKLRHE 239
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRF--SEQLSRRYFQQLISAVEYCH 132
+V+LY V ++ IY V E+ G L F K G++ QL Q+ S + Y
Sbjct: 240 KLVQLYAV-VSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVD-MAAQIASGMAYVE 297
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY--VAPEILA 190
HRDL+ N+L+ EN K++DFGL+ I + APE
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLA---RLIEDNEYTARQGAKFPIKWTAPEAAL 354
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLK- 246
+ K D+WS G++L + G +P+ + ++ +G YR CP L
Sbjct: 355 YGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERG-YRMPCPPECPESLHD 412
Query: 247 -----WFIGRLLDTDPATRITVDEILRD 269
W +P R T + +
Sbjct: 413 LMCQCW------RKEPEERPTFEYLQAF 434
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 7e-29
Identities = 66/361 (18%), Positives = 120/361 (33%), Gaps = 98/361 (27%)
Query: 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
E +Y + + +G G F+ V+ +++ VA+K V K+ + EI ++
Sbjct: 14 EPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE----AAEDEIKLL 69
Query: 71 SRLR-----------HPNIVKLYEVLATKAKIYFVMEFAKGG--------------ELFA 105
R+ +I+KL + +F + G L
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLD--------HFNHKGPNGVHVVMVFEVLGENLLALIK 121
Query: 106 KISKGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDE------NWDLKISD 158
K ++ +QL+ ++Y H R G+ H D+K EN+L++ +KI+D
Sbjct: 122 KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIAD 181
Query: 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF 218
G +A D T Y +PE+L + D+WS ++F L G F
Sbjct: 182 LG-NACWY----DEHYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLF 235
Query: 219 ---------NDPNLMAMY---------------------------------------RKI 230
D + +A +
Sbjct: 236 EPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 295
Query: 231 YKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKD 290
+Y+ K + ++ F+ +L DP R ++ PW K + D +L
Sbjct: 296 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDRELYG 355
Query: 291 S 291
S
Sbjct: 356 S 356
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-29
Identities = 56/241 (23%), Positives = 102/241 (42%), Gaps = 32/241 (13%)
Query: 16 GKYEV-------GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--RE 66
G E+ K +G G F V G+ + VA+K +++ G + + +E
Sbjct: 1 GHMELKREEITLLKELGSGQFGVVKLGK-WKGQYDVAVK------MIKEGSMSEDEFFQE 53
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQL 124
M +L HP +VK Y V + + IY V E+ G L + + +
Sbjct: 54 AQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDV 113
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGT 180
+ + S HRDL N L+D + +K+SDFG++ V +
Sbjct: 114 CEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKF------ 167
Query: 181 PA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238
P + APE+ Y +K D+W+ G++++ V + G +P++ + K+ +G +R
Sbjct: 168 PVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQG-HRLY 225
Query: 239 K 239
+
Sbjct: 226 R 226
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 70/235 (29%), Positives = 109/235 (46%), Gaps = 25/235 (10%)
Query: 19 EVGKIIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMS 71
+ KIIG G +V +GR + VAIKA L+ G T + E SIM
Sbjct: 52 HIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKA------LKAGYTERQRRDFLSEASIMG 105
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+ HPNI++L V+ V E+ + G L F + G+F+ + + + +
Sbjct: 106 QFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMR 165
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYV---A 185
Y G HRDL N+L+D N K+SDFGLS +++ +T G + A
Sbjct: 166 YLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA---YTTTGGKIPIRWTA 222
Query: 186 PEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
PE +A + + + D+WS GVV++ VL G P+ + + + +G YR P
Sbjct: 223 PEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEG-YRLPA 275
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-28
Identities = 64/234 (27%), Positives = 108/234 (46%), Gaps = 24/234 (10%)
Query: 20 VGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMS 71
K+IG G F +VY G + + VAIK L+ G T + E IM
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT------LKAGYTEKQRVDFLGEAGIMG 101
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+ H NI++L V++ + + E+ + G L F + G FS + + + ++
Sbjct: 102 QFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMK 161
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---AP 186
Y + HRDL N+L++ N K+SDFGLS V E +T G + AP
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD--PEATYTTSGGKIPIRWTAP 219
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
E ++ + + + D+WS G+V++ V+ G P+ + + + + I G +R P
Sbjct: 220 EAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDG-FRLPT 271
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 68/233 (29%), Positives = 112/233 (48%), Gaps = 23/233 (9%)
Query: 20 VGKIIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSR 72
+ K++G G F +V GR + SVAIK L+ G T +R E SIM +
Sbjct: 49 IDKVVGAGEFGEVCSGRLKLPSKKEISVAIKT------LKVGYTEKQRRDFLGEASIMGQ 102
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEY 130
HPNI++L V+ + V E+ + G L F + +F+ + + S ++Y
Sbjct: 103 FDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---APE 187
G HRDL N+L++ N K+SDFGL V E +T G + +PE
Sbjct: 163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD--PEAAYTTRGGKIPIRWTSPE 220
Query: 188 ILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+A + + + D+WS G+VL+ V++ G P+ + + + + + +G YR P
Sbjct: 221 AIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEG-YRLPP 271
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-28
Identities = 50/230 (21%), Positives = 97/230 (42%), Gaps = 20/230 (8%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQSVAIK-AVSKQKILRGGLTAHVK----REISIMSRLRH 75
K++G G F V+ G + G+S+ I + K++ + + L H
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCI---KVIEDKSGRQSFQAVTDHMLAIGSLDH 74
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
+IV+L + + + V ++ G L + +G QL + Q+ + Y
Sbjct: 75 AHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEE 133
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT--P-AYVAPEILA 190
G+ HR+L N+LL ++++DFG++ + + PD P ++A E +
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADL---LPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
Y + D+WS GV ++ ++ G P+ L + + KG R +
Sbjct: 191 FGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKG-ERLAQ 238
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 3e-28
Identities = 73/252 (28%), Positives = 103/252 (40%), Gaps = 29/252 (11%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGR-NVRTGQ-SVAIKAVSKQKILRGGLTAHVK- 64
+ R+ L E +GCG F V G +R Q VAIK +L+ G
Sbjct: 6 LKRDNLLIADIE----LGCGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTE 55
Query: 65 ---REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRR 119
RE IM +L +P IV+L V + VME A GG L F +
Sbjct: 56 EMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAE 114
Query: 120 YFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG 179
Q+ ++Y + HRDL N+LL KISDFGLS K D
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSA 172
Query: 180 T--P-AYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY 235
P + APE + + + ++ D+WS GV ++ L+ G P+ + I +G
Sbjct: 173 GKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-K 230
Query: 236 R--CPKWTSPDL 245
R CP P+L
Sbjct: 231 RMECPPECPPEL 242
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 58/207 (28%), Positives = 89/207 (42%), Gaps = 32/207 (15%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
+ +G G F KV R TG+ VA+K+ L+ + +EI I+
Sbjct: 26 IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKS------LKPESGGNHIADLKKEIEILRN 79
Query: 73 LRHPNIVKLYEVLATKAK--IYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAV 128
L H NIVK + I +MEF G L + +K + + + +Y Q+ +
Sbjct: 80 LYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGM 139
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ------IRPDGMLHTLCGTP- 181
+Y SR HRDL N+L++ +KI DFGL+ E ++ D P
Sbjct: 140 DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS------PV 193
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVL 208
+ APE L + + D+WS GV L
Sbjct: 194 FWYAPECLMQSKFY-IASDVWSFGVTL 219
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
+ +G G F V R TG+ VA+K L+ H++ REI I+ L
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILKSL 68
Query: 74 RHPNIVKLYEVLATKAK--IYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+H NIVK V + + + +ME+ G L + + K R +Y Q+ +E
Sbjct: 69 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 128
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ------IRPDGMLHTLCGTP-A 182
Y ++ HRDL N+L++ +KI DFGL+ V Q ++ G P
Sbjct: 129 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES------PIF 182
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVL 208
+ APE L + + D+WS GVVL
Sbjct: 183 WYAPESLTESKFS-VASDVWSFGVVL 207
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 5e-28
Identities = 60/206 (29%), Positives = 92/206 (44%), Gaps = 31/206 (15%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
+ +G G F V R TG+ VA+K L+ H++ REI I+ L
Sbjct: 46 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK------LQHSTEEHLRDFEREIEILKSL 99
Query: 74 RHPNIVKLYEVLATKAK--IYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+H NIVK V + + + +ME+ G L + + K R +Y Q+ +E
Sbjct: 100 QHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGME 159
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ------IRPDGMLHTLCGTP-A 182
Y ++ HRDL N+L++ +KI DFGL+ V Q ++ G P
Sbjct: 160 YLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES------PIF 213
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVL 208
+ APE L + + D+WS GVVL
Sbjct: 214 WYAPESLTESKFS-VASDVWSFGVVL 238
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 63/295 (21%), Positives = 102/295 (34%), Gaps = 57/295 (19%)
Query: 20 VGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK-----REISIMSR 72
K +G G F V G + + ++VA+K IL+ E ++M +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVK------ILKNEANDPALKDELLAEANVMQQ 74
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYC 131
L +P IV++ + VME A+ G L + + R ++ Q+ ++Y
Sbjct: 75 LDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYL 133
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV------- 184
HRDL N+LL KISDFGLS Y
Sbjct: 134 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRA-----------DENYYKAQTHGKW 182
Query: 185 -----APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR-- 236
APE + + +K D+WS GV+++ + G P+ + + KG R
Sbjct: 183 PVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG-ERMG 240
Query: 237 CPKWTSPDLK------WFIGRLLDTDPATRITVDEILR--DPWFKKDYKERKFPH 283
CP ++ W D R + ++ E H
Sbjct: 241 CPAGCPREMYDLMNLCW------TYDVENRPGFAAVELRLRNYYYDVVNEGHHHH 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (286), Expect = 2e-27
Identities = 65/234 (27%), Positives = 105/234 (44%), Gaps = 30/234 (12%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVK----REISIMSRL 73
G+ IG G F V+ G + +VAIK + + V+ +E M +
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIK------TCKNCTSDSVREKFLQEALTMRQF 448
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYC 131
HP+IVKL V+ T+ ++ +ME GEL F ++ K Y QL +A+ Y
Sbjct: 449 DHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYL 507
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGTPA-YVAP 186
S+ HRD+ N+L+ N +K+ DFGLS +++ G L P ++AP
Sbjct: 508 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWMAP 561
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
E + + + + D+W GV ++ +L G PF + +I G R P
Sbjct: 562 ESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 613
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 2e-27
Identities = 62/232 (26%), Positives = 103/232 (44%), Gaps = 25/232 (10%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
+ +G G + +VY G + +VA+K L+ + +E ++M ++HP
Sbjct: 16 TMKHKLGGGQYGEVYEGVWKKYSLTVAVK------TLKEDTMEVEEFLKEAAVMKEIKHP 69
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGR---FSEQLSRRYFQQLISAVEYC 131
N+V+L V + Y + EF G L + + + L Q+ SA+EY
Sbjct: 70 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLY--MATQISSAMEYL 127
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT--PA-YVAPEI 188
+ HRDL N L+ EN +K++DFGLS + G P + APE
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIKWTAPES 183
Query: 189 LAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
LA + K D+W+ GV+L+ + G P+ +L +Y + K YR +
Sbjct: 184 LAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKD-YRMER 233
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 2e-27
Identities = 59/231 (25%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
K +G G F V +G+ R VAIK +++ G + + E +M L H
Sbjct: 27 TFLKELGTGQFGVVKYGK-WRGQYDVAIK------MIKEGSMSEDEFIEEAKVMMNLSHE 79
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
+V+LY V + I+ + E+ G L + + + RF Q + + A+EY S+
Sbjct: 80 KLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESK 139
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGTPA-YVAPEIL 189
HRDL N L+++ +K+SDFGLS V + P + PE+L
Sbjct: 140 QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKF------PVRWSPPEVL 193
Query: 190 AKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+ +K D+W+ GV+++ + + G +P+ I +G R +
Sbjct: 194 MYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQG-LRLYR 242
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} Length = 123 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-27
Identities = 53/119 (44%), Positives = 73/119 (61%), Gaps = 9/119 (7%)
Query: 300 KYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGD 359
+ +NAFDIIS S GFNLSGLF D D ERF+S T E+++E++EE+ +
Sbjct: 4 RRMNAFDIISGSPGFNLSGLFGDARKYDR---VERFVSAWTAERVVERLEEIVS---AEN 57
Query: 360 RLAVTKKEWGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEEN---WKDKLRPA 415
K+ WG K+EGQ GNF MV+ I++LTD+LV++E++K R W D LRP
Sbjct: 58 LTVAKKETWGMKIEGQKGNFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPF 116
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 2e-27
Identities = 59/206 (28%), Positives = 84/206 (40%), Gaps = 31/206 (15%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
+G G F V R TG VA+K L+ + REI I+ L
Sbjct: 28 ISQLGKGNFGSVELCRYDPLGDNTGALVAVKQ------LQHSGPDQQRDFQREIQILKAL 81
Query: 74 RHPNIVKLYEV-LATKAK-IYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
IVK V + + VME+ G L F + + R Y Q+ +E
Sbjct: 82 HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGME 141
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ------IRPDGMLHTLCGTP-A 182
Y SR HRDL N+L++ +KI+DFGL+ + +R G P
Sbjct: 142 YLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS------PIF 195
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVL 208
+ APE L+ + + D+WS GVVL
Sbjct: 196 WYAPESLSDNIFS-RQSDVWSFGVVL 220
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 66/232 (28%), Positives = 105/232 (45%), Gaps = 31/232 (13%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV-KREISIMSRLRHPN 77
++ + IG G F V G G VA+K ++ TA E S+M++LRH N
Sbjct: 24 KLLQTIGKGEFGDVMLG--DYRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHSN 75
Query: 78 IVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGR---FSEQLSRRYFQQLISAVEYC 131
+V+L V + K +Y V E+ G L + + L + + A+EY
Sbjct: 76 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK--FSLDVCEAMEYL 133
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---APEI 188
HRDL N+L+ E+ K+SDFGL+ + G L P V APE
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------P--VKWTAPEA 185
Query: 189 LAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
L +K + K D+WS G++L+ + + G +P+ L + ++ KG Y+
Sbjct: 186 LREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDA 235
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 61/236 (25%), Positives = 102/236 (43%), Gaps = 30/236 (12%)
Query: 19 EVGKIIGCGAFAKVYHGR-NVRTGQS--VAIKAVSKQKILRGGLTAHVK----REISIMS 71
+ +I+G G F +VY G G+ VA+K + T K E IM
Sbjct: 15 VLNRILGEGFFGEVYEGVYTNHKGEKINVAVK------TCKKDCTLDNKEKFMSEAVIMK 68
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
L HP+IVKL ++ + + +ME GEL + + +K Y Q+ A+
Sbjct: 69 NLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGTP-AYV 184
Y S HRD+ + N+L+ +K+ DFGLS ++++ L P ++
Sbjct: 128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRL------PIKWM 181
Query: 185 APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+PE + + + D+W V ++ +L+ G PF + + KG R PK
Sbjct: 182 SPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG-DRLPK 235
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 64/280 (22%), Positives = 108/280 (38%), Gaps = 51/280 (18%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVK----REISIMS 71
++IG G F VYHG + A+K+ L E IM
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS------LNRITDIGEVSQFLTEGIIMK 81
Query: 72 RLRHPNIVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAV 128
HPN++ L + L ++ V+ + K G+L F + + + + Q+ +
Sbjct: 82 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 141
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV-------KEQIRPDGMLHTLCGTP 181
+Y S+ HRDL N +LDE + +K++DFGL+ + L P
Sbjct: 142 KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL------P 195
Query: 182 AYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR- 236
V A E L + + K D+WS GV+L+ ++ G P+ D N + + +G R
Sbjct: 196 --VKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRL 251
Query: 237 -CPKWTSPDLK------WFIGRLLDTDPATRITVDEILRD 269
P++ L W R + E++
Sbjct: 252 LQPEYCPDPLYEVMLKCW------HPKAEMRPSFSELVSR 285
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-27
Identities = 59/205 (28%), Positives = 88/205 (42%), Gaps = 30/205 (14%)
Query: 21 GKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
+ +G G F KV N TG+ VA+K L+ + +EI I+
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVK------ALKADAGPQHRSGWKQEIDILRT 89
Query: 73 LRHPNIVKLYEVLATKAK--IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEY 130
L H +I+K + VME+ G L + + + QQ+ + Y
Sbjct: 90 LYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAY 149
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKE-----QIRPDGMLHTLCGTP-AY 183
H++ HRDL N+LLD + +KI DFGL+ AV E ++R DG P +
Sbjct: 150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDS------PVFW 203
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVL 208
APE L + + D+WS GV L
Sbjct: 204 YAPECLKEYKFY-YASDVWSFGVTL 227
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 6e-27
Identities = 66/236 (27%), Positives = 107/236 (45%), Gaps = 30/236 (12%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVK----REISIMS 71
E+G+ IG G F V+ G + +VAIK + + V+ +E M
Sbjct: 18 ELGRCIGEGQFGDVHQGIYMSPENPALAVAIK------TCKNCTSDSVREKFLQEALTMR 71
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVE 129
+ HP+IVKL V+ T+ ++ +ME GEL F ++ K Y QL +A+
Sbjct: 72 QFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALA 130
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGTPA-YV 184
Y S+ HRD+ N+L+ N +K+ DFGLS +++ G L P ++
Sbjct: 131 YLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKL------PIKWM 184
Query: 185 APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
APE + + + + D+W GV ++ +L G PF + +I G R P
Sbjct: 185 APESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENG-ERLPM 238
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 6e-27
Identities = 77/346 (22%), Positives = 125/346 (36%), Gaps = 96/346 (27%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-SKQKILRGGLTAHVKREISIMSR 72
+YE+ +IG G+F +V + + VAIK + +K+ L E+ ++
Sbjct: 52 WMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQI-----EVRLLEL 106
Query: 73 LRHP------NIVKLYEVLATKAKIYFVME------FAKGGELFAKISKGRFSEQLSRRY 120
+ IV L + + V E + +L + S L+R++
Sbjct: 107 MNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSYNLY----DLLRNTNFRGVSLNLTRKF 162
Query: 121 FQQLISAVEYCHSR--GVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQIRPDGMLHT 176
QQ+ +A+ + + + H DLK EN+LL + +KI DFG S+ + ++
Sbjct: 163 AQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQL----GQRIYQ 217
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAM------- 226
+ Y +PE+L YD A +DMWS G +L ++ G F N+ + M
Sbjct: 218 YIQSRFYRSPEVLLGMPYDLA-IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276
Query: 227 ---------------------------YRKIYKGEYRCPKWTSPD--------------- 244
K K EY+ P
Sbjct: 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRA 336
Query: 245 ------------LKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
K I R+LD DP TRI L+ +FKK E
Sbjct: 337 GESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTADE 382
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 9e-27
Identities = 73/264 (27%), Positives = 115/264 (43%), Gaps = 37/264 (14%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV-KREISIMSRLRHPN 77
++ + IG G F V G G VA+K ++ TA E S+M++LRH N
Sbjct: 196 KLLQTIGKGEFGDVMLG--DYRGNKVAVK------CIKNDATAQAFLAEASVMTQLRHSN 247
Query: 78 IVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYF-QQLISAVEYCHS 133
+V+L V + K +Y V E+ G L + + F + A+EY
Sbjct: 248 LVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEG 307
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA-YVAPEILAKK 192
HRDL N+L+ E+ K+SDFGL+ + G L P + APE L +K
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL------PVKWTAPEALREK 361
Query: 193 GYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLK--- 246
+ K D+WS G++L+ + + G +P+ L + ++ KG Y+ P P +
Sbjct: 362 KFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-YKMDAPDGCPPAVYDVM 419
Query: 247 ---WFIGRLLDTDPATRITVDEIL 267
W D ATR T ++
Sbjct: 420 KNCW------HLDAATRPTFLQLR 437
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 69/240 (28%), Positives = 98/240 (40%), Gaps = 25/240 (10%)
Query: 20 VGKIIGCGAFAKVYHGR-NVRTGQ-SVAIKAVSKQKILRGGLTAHVK----REISIMSRL 73
+GCG F V G +R Q VAIK +L+ G RE IM +L
Sbjct: 340 ADIELGCGNFGSVRQGVYRMRKKQIDVAIK------VLKQGTEKADTEEMMREAQIMHQL 393
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYC 131
+P IV+L V + VME A GG L F + Q+ ++Y
Sbjct: 394 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 452
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT--P-AYVAPEI 188
+ HR+L N+LL KISDFGLS K D P + APE
Sbjct: 453 EEKNFVHRNLAARNVLLVNRHYAKISDFGLS--KALGADDSYYTARSAGKWPLKWYAPEC 510
Query: 189 LAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDL 245
+ + + ++ D+WS GV ++ L+ G P+ + I +G R CP P+L
Sbjct: 511 INFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQG-KRMECPPECPPEL 568
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 63/299 (21%), Positives = 113/299 (37%), Gaps = 47/299 (15%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVK----REISIMS 71
++IG G F VYHG + A+K+ L E IM
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKS------LNRITDIGEVSQFLTEGIIMK 145
Query: 72 RLRHPNIVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAV 128
HPN++ L + L ++ V+ + K G+L F + + + + Q+ +
Sbjct: 146 DFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGM 205
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---- 184
++ S+ HRDL N +LDE + +K++DFGL+ + T A +
Sbjct: 206 KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLA---RDMYDKEFDSVHNKTGAKLPVKW 262
Query: 185 -APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKW 240
A E L + + K D+WS GV+L+ ++ G P+ D N + + +G R P++
Sbjct: 263 MALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG-RRLLQPEY 320
Query: 241 TSPDLK------WFIGRLLDTDPATRITVDEI------LRDPWFKKDYKERKFPHEDFD 287
L W R + E+ + + + Y + +
Sbjct: 321 CPDPLYEVMLKCW------HPKAEMRPSFSELVSRISAIFSTFIGEHYVHVNATYVNVK 373
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 2e-26
Identities = 58/234 (24%), Positives = 106/234 (45%), Gaps = 31/234 (13%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
++ + +G G F +V+ G VA+K L+ G + E ++M +L+H
Sbjct: 16 KLVERLGAGQFGEVWMGY-YNGHTKVAVK------SLKQGSMSPDAFLAEANLMKQLQHQ 68
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGR---FSEQLSRRYFQQLISAVEYC 131
+V+LY V T+ IY + E+ + G L F K G ++ L Q+ + +
Sbjct: 69 RLVRLYAV-VTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLD--MAAQIAEGMAFI 125
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQI---RPDGMLHTLCGTPA-YVAP 186
R HRDL+ N+L+ + KI+DFGL+ +++ R P + AP
Sbjct: 126 EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKF------PIKWTAP 179
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
E + + K D+WS G++L ++ G +P+ + + + +G YR +
Sbjct: 180 EAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERG-YRMVR 231
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 66/344 (19%), Positives = 120/344 (34%), Gaps = 98/344 (28%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-SKQKILRGGLTAHVKREISIMS 71
L + V + +G G F +V +++ + A+K V + +K R E I+
Sbjct: 32 LLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKI-----EADILK 86
Query: 72 RLRH-----PNIVKLYEVLATKAKIYFVME------FAKGGELFAKISKGRFSEQLSRRY 120
++++ NIVK + + + E + E+ + + F + + Y
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMCLIFEPLGPSLY----EIITRNNYNGFHIEDIKLY 142
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENW-------------------------DLK 155
+++ A+ Y + H DLK EN+LLD+ + +K
Sbjct: 143 CIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202
Query: 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY 215
+ DFG A + ++ T Y APE++ G+D + DMWS G VL L G
Sbjct: 203 LIDFG-CATFKSDY----HGSIINTRQYRAPEVILNLGWDVS-SDMWSFGCVLAELYTGS 256
Query: 216 LPF---NDPNLMAM-------------------------YRKIYKGEYRCPKWTSPDLKW 247
L F +AM + K + + +K
Sbjct: 257 LLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKH 316
Query: 248 ------------------FIGRLLDTDPATRITVDEILRDPWFK 273
F+ +L DP R + E+L+ + +
Sbjct: 317 VKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-26
Identities = 61/230 (26%), Positives = 103/230 (44%), Gaps = 23/230 (10%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVK--REISIMSRLRHP 76
++ K +G G F +V+ VA+K ++ G + E ++M L+H
Sbjct: 191 KLEKKLGAGQFGEVWMAT-YNKHTKVAVK------TMKPGSMSVEAFLAEANVMKTLQHD 243
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYF-QQLISAVEYCHS 133
+VKL+ V TK IY + EF G L F K +G F Q+ + +
Sbjct: 244 KLVKLHAV-VTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 302
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV---APEILA 190
R HRDL+ N+L+ + KI+DFGL+ ++ D G + APE +
Sbjct: 303 RNYIHRDLRAANILVSASLVCKIADFGLA----RVIEDNEYTAREGAKFPIKWTAPEAIN 358
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239
+ K D+WS G++L ++ G +P+ + + R + +G YR P+
Sbjct: 359 FGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERG-YRMPR 406
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-25
Identities = 64/242 (26%), Positives = 97/242 (40%), Gaps = 29/242 (11%)
Query: 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS 68
S E+ + +Y +G+ IG G+F +Y G ++ G+ VAIK + + E
Sbjct: 2 SMELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESK 56
Query: 69 IMSRLRH-PNIVKLYEVLATKAKIYFVMEFAKG---GELFAKISKGRFSEQLSRRYFQQL 124
I ++ I + A VME G +LF +FS + Q+
Sbjct: 57 IYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLF-NFCSRKFSLKTVLLLADQM 114
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAVKEQIRPDGMLH------ 175
IS +EY HS+ HRD+K +N L+ + I DFGL+ K+ H
Sbjct: 115 ISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLA--KKYRDARTHQHIPYREN 172
Query: 176 -TLCGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLP---FNDPNLMAMYRKI 230
L GT Y + I G + + D+ S G VL N G LP Y +I
Sbjct: 173 KNLTGTARYAS--INTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERI 230
Query: 231 YK 232
+
Sbjct: 231 SE 232
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 62/228 (27%), Positives = 104/228 (45%), Gaps = 27/228 (11%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-SKQKILRGGLTAHVKREISIMSR 72
+ +YEV K+IG G+F +V + + Q VA+K V ++++ R EI I+
Sbjct: 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAE-----EIRILEH 149
Query: 73 LRH------PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRF---SEQLSRRYFQQ 123
LR N++ + E + I E L+ I K +F S L R++
Sbjct: 150 LRKQDKDNTMNVIHMLENFTFRNHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHS 208
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENW--DLKISDFGLSAVKEQIRPDGMLHTLCGTP 181
++ ++ H + H DLK EN+LL + +K+ DFG S + Q ++T +
Sbjct: 209 ILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-----RVYTYIQSR 263
Query: 182 AYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAM 226
Y APE++ Y +DMWS G +L L GY ++ + +A
Sbjct: 264 FYRAPEVILGARYGMP-IDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 68/346 (19%), Positives = 115/346 (33%), Gaps = 86/346 (24%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGR-NVRTGQSVAIKAV-SKQKILRGGLTAHVKREISIM 70
L +YE+ +G G F KV + R VA+K + + K EI+++
Sbjct: 16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARL-----EINVL 70
Query: 71 SRLRHP------NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRF---SEQLSRRYF 121
+++ V + + + E G F + + F R
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMA 129
Query: 122 QQLISAVEYCHSRGVFHRDLKLENLLLDENW-------------------DLKISDFGLS 162
QL A+ + H + H DLK EN+L + ++++DFG S
Sbjct: 130 YQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-S 188
Query: 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---N 219
A + T+ T Y PE++ + G+ D+WS G +LF G+ F
Sbjct: 189 ATFDHEH----HTTIVATRHYRPPEVILELGWAQP-CDVWSIGCILFEYYRGFTLFQTHE 243
Query: 220 DPNLMAM----------------------------YRKIYKGEYRCPKWTSP-------- 243
+ + M + + + P
Sbjct: 244 NREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQD 303
Query: 244 -----DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHE 284
L + R+L+ DPA RIT+ E L P+F E + H
Sbjct: 304 SLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLTPEERSFHT 349
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 60/235 (25%), Positives = 95/235 (40%), Gaps = 29/235 (12%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR- 74
K+ +G+ IG G+F ++Y G N++T + VAIK + + + E I L+
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQG 61
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKG---GELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
I + VM+ G +LF S+ + S + Q+I+ VE+
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR-KLSLKTVLMLADQMINRVEFV 119
Query: 132 HSRGVFHRDLKLENLLLDENWD---LKISDFGLSAVKEQIRPDGMLH-------TLCGTP 181
HS+ HRD+K +N L+ + I DFGL+ K+ H L GT
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLA--KKYRDTSTHQHIPYRENKNLTGTA 177
Query: 182 AYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLP---FNDPNLMAMYRKIYK 232
Y + + G + + D+ S G VL G LP Y KI +
Sbjct: 178 RYAS--VNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISE 230
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 7e-25
Identities = 62/254 (24%), Positives = 97/254 (38%), Gaps = 38/254 (14%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+G+++G G F V + + S VA+K + K I+ RE + M H
Sbjct: 26 TLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKML-KADIIASSDIEEFLREAACMKEFDH 84
Query: 76 PNIVKLYEV------LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI---- 125
P++ KL V ++ F K G+L A + R E Q L+
Sbjct: 85 PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 126 ---SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRPDGMLHTL 177
+EY SR HRDL N +L E+ + ++DFGLS + L
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL--- 201
Query: 178 CGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG 233
P V A E LA Y D+W+ GV ++ ++ G P+ +Y + G
Sbjct: 202 ---P--VKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG 255
Query: 234 EYR--CPKWTSPDL 245
R P ++
Sbjct: 256 -NRLKQPPECMEEV 268
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 8e-25
Identities = 64/239 (26%), Positives = 98/239 (41%), Gaps = 35/239 (14%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+ VGK IGCG F ++ G+N+ T + VAIK + + E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAP-----QLHLEYRFYKQLGS 63
Query: 76 -PNIVKLYEVLATKAKIYFVMEFAKGG----ELFAKISKGRFSEQLSRRYFQQLISAVEY 130
I ++Y V+E G +LF + FS + QLIS +EY
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL--GPSLEDLF-DLCDRTFSLKTVLMIAIQLISRMEY 120
Query: 131 CHSRGVFHRDLKLENLLL------DENWDLKISDFGLSAVKEQIRPDGMLH-------TL 177
HS+ + +RD+K EN L+ + + I DF L+ KE I P+ H +L
Sbjct: 121 VHSKNLIYRDVKPENFLIGRPGNKTQQV-IHIIDFALA--KEYIDPETKKHIPYREHKSL 177
Query: 178 CGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLP---FNDPNLMAMYRKIYK 232
GT Y++ I G + + D+ + G + G LP L Y+KI
Sbjct: 178 TGTARYMS--INTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGD 234
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 61/242 (25%), Positives = 102/242 (42%), Gaps = 37/242 (15%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQS---VAIKAVSKQKILRGGLTAHVK----REISIMS 71
++IG G F VYHG + Q+ AIK+ L RE +M
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKS------LSRITEMQQVEAFLREGLLMR 77
Query: 72 RLRHPNIVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAV 128
L HPN++ L + L + + ++ + G+L F + + + + + Q+ +
Sbjct: 78 GLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGM 137
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV-------KEQIRPDGMLHTLCGTP 181
EY + HRDL N +LDE++ +K++DFGL+ Q L P
Sbjct: 138 EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL------P 191
Query: 182 AYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYRC 237
V A E L + K D+WS GV+L+ +L G P+ + + + +G R
Sbjct: 192 --VKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG-RRL 247
Query: 238 PK 239
P+
Sbjct: 248 PQ 249
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 3e-24
Identities = 52/252 (20%), Positives = 91/252 (36%), Gaps = 50/252 (19%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQS-------VAIKAVSKQKILRGGLTAHVK---REIS 68
+ +G G F K++ G G V +K +L + + S
Sbjct: 11 IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLK------VLDKAHRNYSESFFEAAS 64
Query: 69 IMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLIS 126
+MS+L H ++V Y V + V EF K G L + K +K + +QL +
Sbjct: 65 MMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAA 124
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDL--------KISDFGLSAV-------KEQIRPD 171
A+ + + H ++ +N+LL D K+SD G+S +E+I
Sbjct: 125 AMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQERIP-- 182
Query: 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKI 230
+V PE + D WS G L+ + + G P + + +
Sbjct: 183 -----------WVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 231 YKGEYR--CPKW 240
++ PK
Sbjct: 232 EDR-HQLPAPKA 242
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 51/237 (21%), Positives = 89/237 (37%), Gaps = 31/237 (13%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
Y+VG+ IG G+F ++ G N+ Q VAIK ++ ++ E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAP-----QLRDEYRTYKLLAG 64
Query: 76 -PNIVKLYEVLATKAKIYFVMEFAKG---GELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
I +Y V++ G +L + +FS + +Q+++ V+
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLL-DLCGRKFSVKTVAMAAKQMLARVQSI 122
Query: 132 HSRGVFHRDLKLENLLLDENWDLK-----ISDFGLSAVKEQIRPDGMLH-------TLCG 179
H + + +RD+K +N L+ + DFG+ K P H L G
Sbjct: 123 HEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV--KFYRDPVTKQHIPYREKKNLSG 180
Query: 180 TPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLP---FNDPNLMAMYRKIYK 232
T Y++ I G + + D+ + G V G LP Y +I +
Sbjct: 181 TARYMS--INTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGE 235
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 4e-24
Identities = 60/303 (19%), Positives = 115/303 (37%), Gaps = 55/303 (18%)
Query: 19 EVGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
+ + +G G+F VY G + V + A+ K + + + E S+M
Sbjct: 28 TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAI---KTVNEAASMRERIEFLNEASVMKE 84
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQ--LSRRYFQQLI--- 125
++V+L V++ +ME G+L + + + + L+ ++I
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 126 ----SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRPDGMLHT 176
+ Y ++ HRDL N ++ E++ +KI DFG++ + E G+L
Sbjct: 145 GEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLL-- 202
Query: 177 LCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYK 232
P V +PE L + D+WS GVVL+ + P+ + + R + +
Sbjct: 203 ----P--VRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255
Query: 233 GEYR--CPKWTSPDLK------WFIGRLLDTDPATRITVDEILR--DPWFKKDYKERKFP 282
G P L W +P R + EI+ + ++E F
Sbjct: 256 G-GLLDKPDNCPDMLFELMRMCW------QYNPKMRPSFLEIISSIKEEMEPGFREVSFY 308
Query: 283 HED 285
+ +
Sbjct: 309 YSE 311
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 5e-24
Identities = 76/342 (22%), Positives = 120/342 (35%), Gaps = 92/342 (26%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAV-SKQKILRGGLTAHVKREISIM 70
L +YE+ +G GAF KV + + G + VA+K V + + + EI ++
Sbjct: 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARS-----EIQVL 65
Query: 71 SRLRHP------NIVKLYEVLATKAKIYFVME------FAKGGELFAKISKGRFSEQLSR 118
L V++ E I V E + + + F R
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELLGLSTY----DFIKENGFLPFRLDHIR 121
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-------------------DLKISDF 159
+ Q+ +V + HS + H DLK EN+L ++ D+K+ DF
Sbjct: 122 KMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181
Query: 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF- 218
G SA + TL T Y APE++ G+ D+WS G +L G+ F
Sbjct: 182 G-SATYDDEH----HSTLVSTRHYRAPEVILALGWSQP-CDVWSIGCILIEYYLGFTVFP 235
Query: 219 --NDPNLMAM----------------YRKIY-------------KGEYRCPKWTS----- 242
+ +AM ++ Y G Y
Sbjct: 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFM 295
Query: 243 -------PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
L I ++L+ DPA RIT+ E L+ P+F K
Sbjct: 296 LSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKK 337
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 6e-23
Identities = 59/210 (28%), Positives = 90/210 (42%), Gaps = 46/210 (21%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLY 82
+IG G F KVY G +R G VA+K + +G + EI +S RHP++V L
Sbjct: 46 LIGHGVFGKVYKGV-LRDGAKVALK-RRTPESSQG--IEEFETEIETLSFCRHPHLVSLI 101
Query: 83 EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI------------SA--V 128
+ ++ + ++ + G L + +A +
Sbjct: 102 GFCDERNEMILIYKY---------MENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGL 152
Query: 129 EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG---------MLHTLCG 179
Y H+R + HRD+K N+LLDEN+ KI+DFG+S + + G
Sbjct: 153 HYLHTRAIIHRDVKSINILLDENFVPKITDFGIS----KKGTELDQTHLSTVVK-----G 203
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209
T Y+ PE KG K D++S GVVLF
Sbjct: 204 TLGYIDPE-YFIKGRLTEKSDVYSFGVVLF 232
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 97.4 bits (243), Expect = 6e-23
Identities = 62/253 (24%), Positives = 97/253 (38%), Gaps = 37/253 (14%)
Query: 19 EVGKIIGCGAFAKVYHGR---NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+GKI+G G F V G T VA+K + K E + M H
Sbjct: 37 ILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTM-KLDNSSQREIEEFLSEAACMKDFSH 95
Query: 76 PNIVKLYEV-----LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLI----- 125
PN+++L V K ++ F K G+L + R Q L+
Sbjct: 96 PNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVD 155
Query: 126 --SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRPDGMLHTLC 178
+EY +R HRDL N +L ++ + ++DFGLS + +
Sbjct: 156 IALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM---- 211
Query: 179 GTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE 234
P V A E LA + Y +K D+W+ GV ++ + G P+ MY + G
Sbjct: 212 --P--VKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHG- 265
Query: 235 YR--CPKWTSPDL 245
+R P+ +L
Sbjct: 266 HRLKQPEDCLDEL 278
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 3e-22
Identities = 66/249 (26%), Positives = 105/249 (42%), Gaps = 46/249 (18%)
Query: 21 GKIIGCGAFAKVYHGRNVRTGQS--VAIKAVSKQKILRGGLTAHVK----REISIMSRL- 73
+IG G F +V R + G AIK ++ + E+ ++ +L
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIK------RMKEYASKDDHRDFAGELEVLCKLG 83
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRY--------FQQ 123
HPNI+ L + +Y +E+A G L F + S+ ++ QQ
Sbjct: 84 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 124 LI-------SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE--QIRPDGML 174
L+ ++Y + HRDL N+L+ EN+ KI+DFGLS +E + G L
Sbjct: 144 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL 203
Query: 175 HTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKI 230
P V A E L Y D+WS GV+L+ +++ G P+ +Y K+
Sbjct: 204 ------P--VRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 254
Query: 231 YKGEYRCPK 239
+G YR K
Sbjct: 255 PQG-YRLEK 262
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 3e-22
Identities = 50/221 (22%), Positives = 82/221 (37%), Gaps = 43/221 (19%)
Query: 19 EVGKIIGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
+ +G F KVY G G+ A+ K L+ ++ E + +R
Sbjct: 12 RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAI---KTLKDKAEGPLREEFRHEAMLRAR 68
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL----------FAKISKGRFSEQLSRRYFQ 122
L+HPN+V L V+ + + + G+L S S
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 123 QLI-------SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ-----IRP 170
+ + +EY S V H+DL N+L+ + ++KISD GL +
Sbjct: 129 DFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG 188
Query: 171 DGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVL 208
+ +L P + APE + + D+WS GVVL
Sbjct: 189 NSLL------P--IRWMAPEAIMYGKFS-IDSDIWSYGVVL 220
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} Length = 143 | Back alignment and structure |
|---|
Score = 88.9 bits (220), Expect = 2e-21
Identities = 34/125 (27%), Positives = 54/125 (43%), Gaps = 12/125 (9%)
Query: 297 GSEKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVA 356
+NAF++I+LS G NLS LFD + RF+S P +I+ +E VA
Sbjct: 2 EGPLMMNAFEMITLSQGLNLSALFDRRQDFVKRQ--TRFVSRREPSEIIANIEAVAN--- 56
Query: 357 DGDRLAVTKKEWGAKLE----GQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEENWK--D 410
+ + +LE + G +VI I + L +V+++K+ E K
Sbjct: 57 -SMGFKSHTRNFKTRLEGLSSIKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK 115
Query: 411 KLRPA 415
KL
Sbjct: 116 KLCSK 120
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 92.7 bits (231), Expect = 3e-21
Identities = 71/303 (23%), Positives = 118/303 (38%), Gaps = 65/303 (21%)
Query: 21 GKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRL- 73
GK +G GAF KV + +V AV K+L+ A K E+ IMS L
Sbjct: 51 GKTLGAGAFGKVVEATAFGLGKEDAVLKVAV---KMLKSTAHADEKEALMSELKIMSHLG 107
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--------FAKISKGRFSEQLSRRYFQQLI 125
+H NIV L + + E+ G+L + F+ S + L+
Sbjct: 108 QHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLL 167
Query: 126 S-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRPDGM 173
+ + S+ HRD+ N+LL KI DFGL+ + ++ +
Sbjct: 168 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 227
Query: 174 LHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA---M 226
L P V APE + Y + D+WS G++L+ + + G P+ P ++
Sbjct: 228 L------P--VKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPY--PGILVNSKF 276
Query: 227 YRKIYKGEYR--CPKWTSPDLK------WFIGRLLDTDPATRITVDEILR--DPWFKKDY 276
Y+ + G Y+ P + ++ W +P R T +I ++D
Sbjct: 277 YKLVKDG-YQMAQPAFAPKNIYSIMQACW------ALEPTHRPTFQQICSFLQEQAQEDR 329
Query: 277 KER 279
+ER
Sbjct: 330 RER 332
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 7e-21
Identities = 53/219 (24%), Positives = 87/219 (39%), Gaps = 41/219 (18%)
Query: 19 EVGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRL 73
+ +G GAF KV+ N+ Q + AV K L+ + + RE +++ L
Sbjct: 44 VLKWELGEGAFGKVFLAECHNLLPEQDKMLVAV---KALKEASESARQDFQREAELLTML 100
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGEL---------FAKISKGRFSEQLSRRYFQQL 124
+H +IV+ + V + V E+ + G+L AK+ G QL
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 125 ISAV-------EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRPDG 172
++ Y HRDL N L+ + +KI DFG+S + +
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRT 220
Query: 173 MLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVL 208
ML P + PE + + + + D+WS GVVL
Sbjct: 221 ML------P--IRWMPPESILYRKFT-TESDVWSFGVVL 250
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 9e-21
Identities = 55/229 (24%), Positives = 87/229 (37%), Gaps = 51/229 (22%)
Query: 19 EVGKIIGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
E + IG GAF +V+ R + + + AV K+L+ +A ++ RE ++M+
Sbjct: 50 EYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAV---KMLKEEASADMQADFQREAALMAE 106
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL------------------FAKISKGRFSE 114
+PNIVKL V A + + E+ G+L S
Sbjct: 107 FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP 166
Query: 115 QLSRRYFQQLISAV-------EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKE 166
+ + Y R HRDL N L+ EN +KI+DFGLS +
Sbjct: 167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYS 226
Query: 167 Q----IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVL 208
+ + P + PE + Y + D+W+ GVVL
Sbjct: 227 ADYYKADGNDAI------P--IRWMPPESIFYNRYT-TESDVWAYGVVL 266
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 9e-21
Identities = 62/267 (23%), Positives = 102/267 (38%), Gaps = 55/267 (20%)
Query: 19 EVGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
GK +G GAF KV + + AV K+L+ + E+ ++S
Sbjct: 26 SFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAV---KMLKPSAHLTEREALMSELKVLSY 82
Query: 73 L-RHPNIVKLYEVLATKAKIYFVMEFAKGGEL------------FAKISKGRFSEQLSRR 119
L H NIV L + E+ G+L +K S +
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 120 YFQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ---- 167
+ L+S + + S+ HRDL N+LL KI DFGL+ +K
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202
Query: 168 IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNL 223
++ + L P V APE + Y + D+WS G+ L+ + + G P+ P +
Sbjct: 203 VKGNARL------P--VKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPY--PGM 251
Query: 224 MA---MYRKIYKGEYR--CPKWTSPDL 245
Y+ I +G +R P+ ++
Sbjct: 252 PVDSKFYKMIKEG-FRMLSPEHAPAEM 277
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 90.4 bits (225), Expect = 1e-20
Identities = 57/218 (26%), Positives = 90/218 (41%), Gaps = 42/218 (19%)
Query: 21 GKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK---REISIMSRLRH 75
+ +G GAF KV+ N+ + + AV K L+ A K RE +++ L+H
Sbjct: 20 KRELGEGAFGKVFLAECYNLSPTKDKMLVAV---KALKDPTLAARKDFQREAELLTNLQH 76
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGEL----------FAKISKGRFSEQLSRRYFQQLI 125
+IVK Y V + V E+ K G+L + G+ + Q++
Sbjct: 77 EHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQML 136
Query: 126 -------SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRPDGM 173
S + Y S+ HRDL N L+ N +KI DFG+S V + M
Sbjct: 137 HIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTM 196
Query: 174 LHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVL 208
L P + PE + + + + D+WS GV+L
Sbjct: 197 L------P--IRWMPPESIMYRKFT-TESDVWSFGVIL 225
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 2e-20
Identities = 56/202 (27%), Positives = 89/202 (44%), Gaps = 29/202 (14%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIK---AVSKQKILRGGLTAHVKREISIMSRLRHPNIV 79
I+G G F KVY GR + G VA+K Q G + E+ ++S H N++
Sbjct: 37 ILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQ-----GGELQFQTEVEMISMAVHRNLL 90
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQL----SRRYFQQLISAV------E 129
+L T + V + G + A + R Q +R L SA +
Sbjct: 91 RLRGFCMTPTERLLVYPYMANGSV-ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149
Query: 130 YCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH---TLCGTPAYVAP 186
+C + + HRD+K N+LLDE ++ + DFGL+ ++ H + GT ++AP
Sbjct: 150 HCDPK-IIHRDVKAANILLDEEFEAVVGDFGLA----KLMDYKDTHVTTAVRGTIGHIAP 204
Query: 187 EILAKKGYDGAKVDMWSCGVVL 208
E G K D++ GV+L
Sbjct: 205 E-YLSTGKSSEKTDVFGYGVML 225
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 3e-20
Identities = 58/228 (25%), Positives = 94/228 (41%), Gaps = 52/228 (22%)
Query: 19 EVGKIIGCGAFAKVYHGR-------NVRTGQSVAIKAVSKQKILRGGLTAHVK----REI 67
+GK +G GAF +V + +VA+K +L+ T E+
Sbjct: 38 TLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVK------MLKDDATEKDLSDLVSEM 91
Query: 68 SIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRY---- 120
+M + +H NI+ L +Y ++E+A G L + + + E
Sbjct: 92 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 151
Query: 121 ----FQQLISAV-------EYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ- 167
F+ L+S EY S+ HRDL N+L+ EN +KI+DFGL+ +
Sbjct: 152 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 211
Query: 168 ---IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF 209
+G L P V APE L + Y + D+WS GV+++
Sbjct: 212 YYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 250
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 57/228 (25%), Positives = 94/228 (41%), Gaps = 52/228 (22%)
Query: 19 EVGKIIGCGAFAKVYHGR-------NVRTGQSVAIKAVSKQKILRGGLTAHVK----REI 67
+GK +G G F +V + +VA+K +L+ T E+
Sbjct: 84 TLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVK------MLKDDATEKDLSDLVSEM 137
Query: 68 SIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRY---- 120
+M + +H NI+ L +Y ++E+A G L + + + E
Sbjct: 138 EMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPE 197
Query: 121 ----FQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ- 167
F+ L+S +EY S+ HRDL N+L+ EN +KI+DFGL+ +
Sbjct: 198 EQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNID 257
Query: 168 ---IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF 209
+G L P V APE L + Y + D+WS GV+++
Sbjct: 258 YYKKTTNGRL------P--VKWMAPEALFDRVYT-HQSDVWSFGVLMW 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 4e-20
Identities = 62/258 (24%), Positives = 99/258 (38%), Gaps = 47/258 (18%)
Query: 19 EVGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
+ + +G GAF +VY G + S AV K L + + E I+S+
Sbjct: 33 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV---KTLPEVCSEQDELDFLMEALIISK 89
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSE--QLSRRYFQQLI--- 125
H NIV+ V + +ME GG+L F + ++ R S+ L+ L+
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLA---MLDLLHVA 146
Query: 126 ----SAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLS-AVKEQ----IRPDGM 173
+Y HRD+ N LL KI DFG++ + M
Sbjct: 147 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAM 206
Query: 174 LHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRK 229
L P V PE + + +K D WS GV+L+ + + GY+P+ + +
Sbjct: 207 L------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 257
Query: 230 IYKGEYR--CPKWTSPDL 245
+ G R PK +
Sbjct: 258 VTSG-GRMDPPKNCPGPV 274
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 4e-20
Identities = 60/228 (26%), Positives = 94/228 (41%), Gaps = 51/228 (22%)
Query: 21 GKIIGCGAFAKVYHGR--NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRLR 74
GK +G G F KV +++ AV K+L+ + E +++ ++
Sbjct: 28 GKTLGEGEFGKVVKATAFHLKGRAGYTTVAV---KMLKENASPSELRDLLSEFNVLKQVN 84
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRY------------ 120
HP+++KLY + + ++E+AK G L F + S+ L
Sbjct: 85 HPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDE 144
Query: 121 ----FQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ- 167
LIS ++Y + HRDL N+L+ E +KISDFGLS V E+
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 168 ---IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF 209
R G + P V A E L Y + D+WS GV+L+
Sbjct: 205 SYVKRSQGRI------P--VKWMAIESLFDHIYT-TQSDVWSFGVLLW 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 5e-20
Identities = 66/264 (25%), Positives = 109/264 (41%), Gaps = 54/264 (20%)
Query: 21 GKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSRL- 73
GK +G GAF +V + + AV K+L+ G T E+ I+ +
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAV---KMLKEGATHSEHRALMSELKILIHIG 88
Query: 74 RHPNIVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRY--------FQ 122
H N+V L + ++EF K G L + + + F +
Sbjct: 89 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148
Query: 123 QLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ----IRP 170
LI +E+ SR HRDL N+LL E +KI DFGL+ + + +
Sbjct: 149 HLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 171 DGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA- 225
D L P + APE + + Y + D+WS GV+L+ + + G P+ P +
Sbjct: 209 DARL------P--LKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY--PGVKID 257
Query: 226 --MYRKIYKGEYR--CPKWTSPDL 245
R++ +G R P +T+P++
Sbjct: 258 EEFCRRLKEG-TRMRAPDYTTPEM 280
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 89.4 bits (222), Expect = 8e-20
Identities = 66/288 (22%), Positives = 104/288 (36%), Gaps = 59/288 (20%)
Query: 19 EVGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
+ + +G GAF +VY G + S AV K L + + E I+S+
Sbjct: 74 TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAV---KTLPEVCSEQDELDFLMEALIISK 130
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSE--QLSRRYFQQLI--- 125
H NIV+ V + ++E GG+L F + ++ R S+ L+ L+
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA---MLDLLHVA 187
Query: 126 ----SAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLS-AVKEQ----IRPDGM 173
+Y HRD+ N LL KI DFG++ + M
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAM 247
Query: 174 LHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRK 229
L P V PE + + +K D WS GV+L+ + + GY+P+ + +
Sbjct: 248 L------P--VKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF 298
Query: 230 IYKGEYR--CPKWTSPDLK------WFIGRLLDTDPATRITVDEILRD 269
+ G R PK + W P R IL
Sbjct: 299 VTSG-GRMDPPKNCPGPVYRIMTQCW------QHQPEDRPNFAIILER 339
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 88.4 bits (220), Expect = 9e-20
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 29/201 (14%)
Query: 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV--KREISIMSRLRHPNIVK 80
+G G F VY G +VA+K ++ +EI +M++ +H N+V+
Sbjct: 38 KMGEGGFGVVYKG--YVNNTTVAVKKLAAMVD-ITTEELKQQFDQEIKVMAKCQHENLVE 94
Query: 81 LYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLS--RRYFQQLISA--VEYCHSRGV 136
L + + V + G L ++S + LS R +A + + H
Sbjct: 95 LLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH 154
Query: 137 FHRDLKLENLLLDENWDLKISDFGL---------SAVKEQIRPDGMLHTLCGTPAYVAPE 187
HRD+K N+LLDE + KISDFGL + + +I GT AY+APE
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIV---------GTTAYMAPE 205
Query: 188 ILAKKGYDGAKVDMWSCGVVL 208
L +G K D++S GVVL
Sbjct: 206 AL--RGEITPKSDIYSFGVVL 224
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 9e-20
Identities = 42/233 (18%), Positives = 73/233 (31%), Gaps = 41/233 (17%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
++ +GK IG G F +Y + A V + G L E+ R+
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPL----FSELKFYQRVAK 92
Query: 76 PNIVKLYEVLATKAK------IYFVMEFAKGGE---------------LFAKISKGRFSE 114
+ +K + + KG + + G F +
Sbjct: 93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQ--NGTFKK 150
Query: 115 QLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI--SDFGLSAVKEQIRPDG 172
+ +++ +EY H H D+K NLLL ++ +D+GLS
Sbjct: 151 STVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLS--YRYCPNGN 208
Query: 173 MLH-------TLCGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLP 217
GT + + + A KG + D+ G + G LP
Sbjct: 209 HKQYQENPRKGHNGTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLP 259
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 71/384 (18%), Positives = 119/384 (30%), Gaps = 144/384 (37%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG--LTAHVKREISIM 70
G+Y V + +G G F+ V+ +++ + VA+ K+++ T EI ++
Sbjct: 34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAM------KVVKSAEHYTETALDEIRLL 87
Query: 71 SRLR-----HPN---IVKLYEVLATKAKIYF------------VMEFAKGGELFAKISK- 109
+R PN +V+L + F V E G L I K
Sbjct: 88 KSVRNSDPNDPNREMVVQLLD--------DFKISGVNGTHICMVFEVL-GHHLLKWIIKS 138
Query: 110 --GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLL------------------ 148
++ QQ++ ++Y H++ + H D+K EN+LL
Sbjct: 139 NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQ 198
Query: 149 -------------------------------DENWDLKISDFGLSAVKEQIRPDGMLHTL 177
E +KI+D G +
Sbjct: 199 RSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA-----CWVHKHFTED 253
Query: 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---------NDPNLMAM-- 226
T Y + E+L GY+ D+WS + F L G F D + +A+
Sbjct: 254 IQTRQYRSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALII 312
Query: 227 ---------------YRKIY---KGEYR----CPKWTSPD---------------LKWFI 249
Y K + KG+ + W + F+
Sbjct: 313 ELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFL 372
Query: 250 GRLLDTDPATRITVDEILRDPWFK 273
+L+ P R T E LR PW
Sbjct: 373 LPMLELIPEKRATAAECLRHPWLN 396
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 57/226 (25%), Positives = 90/226 (39%), Gaps = 52/226 (23%)
Query: 21 GKIIGCGAFAKVYHGR-------NVRTGQSVAIKAVSKQKILRGGLTAHVK----REISI 69
GK +G GAF +V VA+K +L+ T E+ +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVK------MLKSDATEKDLSDLISEMEM 127
Query: 70 MSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGEL----------FAKISKGRFSEQLSR 118
M + +H NI+ L +Y ++E+A G L + S +
Sbjct: 128 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 187
Query: 119 RYFQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQ--- 167
+ L+S +EY S+ HRDL N+L+ E+ +KI+DFGL+ +
Sbjct: 188 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 247
Query: 168 -IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF 209
+G L P V APE L + Y + D+WS GV+L+
Sbjct: 248 KKTTNGRL------P--VKWMAPEALFDRIYT-HQSDVWSFGVLLW 284
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 6e-19
Identities = 58/230 (25%), Positives = 93/230 (40%), Gaps = 51/230 (22%)
Query: 19 EVGKIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVK----REISIMSR 72
E GK++G GAF KV + + AV K+L+ + + E+ +M++
Sbjct: 48 EFGKVLGSGAFGKVMNATAYGISKTGVSIQVAV---KMLKEKADSSEREALMSELKMMTQ 104
Query: 73 L-RHPNIVKLYEVLATKAKIYFVMEFAKGGEL-----------------FAKISKGRFSE 114
L H NIV L IY + E+ G+L + + E
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 115 QLSRRYFQQLIS-------AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKE 166
L+ F+ L+ +E+ + HRDL N+L+ +KI DFGL+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224
Query: 167 Q----IRPDGMLHTLCGTPAYV---APEILAKKGYDGAKVDMWSCGVVLF 209
+R + L P V APE L + Y K D+WS G++L+
Sbjct: 225 DSNYVVRGNARL------P--VKWMAPESLFEGIYT-IKSDVWSYGILLW 265
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 44/254 (17%), Positives = 77/254 (30%), Gaps = 51/254 (20%)
Query: 16 GKYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
++VG IG G F +Y +V + +K G L E+
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDN---GPL----FTELKFY 87
Query: 71 SRLRHPNIVKLYEVLATKAKI------YFVMEFAKGGE---------------LFAKISK 109
R P ++ + + + G ++ +K
Sbjct: 88 QRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAK 147
Query: 110 GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI--SDFGLSAVKEQ 167
RFS + + +++ +EY H H D+K NLLL+ ++ D+GL+
Sbjct: 148 -RFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLA--YRY 204
Query: 168 IRPDGMLH-------TLCGTPAYVAPEILAKKGYD-GAKVDMWSCGVVLFVLNAGYLP-- 217
GT + + I A G + D+ G + G+LP
Sbjct: 205 CPEGVHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE 262
Query: 218 -FNDPNLMAMYRKI 230
KI
Sbjct: 263 DNLKDPKYVRDSKI 276
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 7e-17
Identities = 35/245 (14%), Positives = 76/245 (31%), Gaps = 33/245 (13%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTG--------QSVAIKAVSK-------QKILRGGLT 60
++++ +Y T Q ++K +K Q +
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAK 101
Query: 61 AHVKREISIMSRLRHPNIVKLYEVLATKAKIYF-VMEFAKG---GELFAKISKGRFSEQL 116
+ + I + K F V+ G K SE+
Sbjct: 102 PLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERS 160
Query: 117 SRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI--SDFGLSAV----KEQIR- 169
+ +L+ A+E+ H H ++ EN+ +D ++ + +G + + +
Sbjct: 161 VLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAY 220
Query: 170 PDGMLHTLCGTPAYVAPEILAKKGYDGA-KVDMWSCGVVLFVLNAGYLP---FNDPNLMA 225
+G G +++ + KG + + D+ S G + G+LP
Sbjct: 221 VEGSRSPHEGDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDI 278
Query: 226 MYRKI 230
M +K
Sbjct: 279 MKQKQ 283
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.8 bits (175), Expect = 4e-14
Identities = 33/191 (17%), Positives = 58/191 (30%), Gaps = 47/191 (24%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH-----VKREISIMS 71
K + + IG G F +V+ VAIK ++ + + + EI I
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISK 78
Query: 72 RL---------RHPNIVKLYEV------------------------------LATKAKIY 92
L R + L V +++
Sbjct: 79 ELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLF 138
Query: 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDEN 151
V+EF GG ++ S ++ QL +++ + HRDL N+LL +
Sbjct: 139 IVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 152 WDLKISDFGLS 162
K+
Sbjct: 199 SLKKLHYTLNG 209
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 5e-08
Identities = 36/186 (19%), Positives = 64/186 (34%), Gaps = 12/186 (6%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR----EISIMSRL- 73
++GK +G GAF +V ++ + V+ K+L+ G T R E+ I+ +
Sbjct: 25 KLGKPLGRGAFGQVIEADAFGIDKTATCRTVA-VKMLKEGATHSEHRALMSELKILIHIG 83
Query: 74 RHPNIVKLY-EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH 132
H N+V L + ++EF K G L + R + + +Y
Sbjct: 84 HHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVG 143
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ DLK + + S F K + ++ E L
Sbjct: 144 AI---PVDLKRRLDSITSSQSSASSGFVEE--KSLSDVEEEEAPEDLYKDFLTLEHLICY 198
Query: 193 GYDGAK 198
+ AK
Sbjct: 199 SFQVAK 204
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 6e-08
Identities = 38/127 (29%), Positives = 61/127 (48%), Gaps = 20/127 (15%)
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS--AVKEQI---RPDGMLHTL 177
Q+ +E+ SR HRDL N+LL E +KI DFGL+ K+ + D L
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL--- 257
Query: 178 CGTPA-YVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA---MYRKIYK 232
P ++APE + + Y + D+WS GV+L+ + + G P+ P + R++ +
Sbjct: 258 ---PLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPY--PGVKIDEEFCRRLKE 311
Query: 233 GEYRCPK 239
G R
Sbjct: 312 G-TRMRA 317
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 48.3 bits (114), Expect = 4e-06
Identities = 70/408 (17%), Positives = 132/408 (32%), Gaps = 121/408 (29%)
Query: 52 QKILRGGLTAHVKREISIMSRLRHP--NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK 109
Q + + L+ K EI + + ++L+ L +K + V +F + +I+
Sbjct: 39 QDMPKSILS---KEEIDHIIMSKDAVSGTLRLFWTLLSKQE-EMVQKFVEEVL---RINY 91
Query: 110 GRFSEQLSRRYFQQLISAVEYCHSRGVFHRD---------------LKLENLLLDENWDL 154
+ Q + Y R + D LKL LL
Sbjct: 92 KFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALL------ 145
Query: 155 KISDFGLSAVKEQIRP------DGMLHTLCG-TPAYVAPEILAKKGYDGAKV-DMWSCGV 206
++RP DG+L G T +A KV +
Sbjct: 146 ------------ELRPAKNVLIDGVLG--SGKT-------WVALDVCLSYKVQCKMDFKI 184
Query: 207 VLFVLNAGYLPFNDPN-LMAMYRKIYKGEYRC-PKWTSPDLKWFIGRLLDTDPATRITVD 264
F LN N P ++ M +K+ Y+ P WTS D ++ +
Sbjct: 185 --FWLNLKNC--NSPETVLEMLQKLL---YQIDPNWTS---------RSDHSSNIKLRIH 228
Query: 265 EILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDI---ISLSSGFNLSGLFD 321
I ++ K + + + L + V + K NAF++ I L++ F + D
Sbjct: 229 SI--QAELRRLLKSKPYENCLLVLLN-----VQNAKAWNAFNLSCKILLTTRF--KQVTD 279
Query: 322 DFNNNDA-PFCNERFLSNETPEKILE--------KVEEVARLVADGDRLAVT-----KKE 367
+ + TP+++ + +++ R V + ++ ++
Sbjct: 280 FLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRD 339
Query: 368 WGAKLEGQNGNFTMVIGIDRLTDDLVVVEIKKSMRRGEENWKDKLRPA 415
A + N+ V D+LT I+ S+ + L PA
Sbjct: 340 GLATWD----NWKHV-NCDKLTT-----IIESSL--------NVLEPA 369
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* Length = 282 | Back alignment and structure |
|---|
Score = 43.8 bits (103), Expect = 6e-05
Identities = 28/157 (17%), Positives = 54/157 (34%), Gaps = 25/157 (15%)
Query: 18 YEVGKIIGCGAFAKVYHGRN----------VRTGQSVAIKAVSKQKIL----RGGLTAHV 63
+GK++G G + V++ + + G + K K+
Sbjct: 92 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA 151
Query: 64 KREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQ 123
+ E + +L+ + K+Y +ME EL+ +
Sbjct: 152 RNEFRALQKLQGLAVPKVYAWEGN----AVLMELIDAKELYRV------RVENPDEVLDM 201
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160
++ V + RG+ H DL N+L+ E + I DF
Sbjct: 202 ILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP 237
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258 | Back alignment and structure |
|---|
Score = 40.8 bits (95), Expect = 4e-04
Identities = 32/168 (19%), Positives = 56/168 (33%), Gaps = 27/168 (16%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQ--SVAIK-------AVSKQKILRGGLTAHVKREIS 68
+G +I G A V++ V G+ ++A+K K G R IS
Sbjct: 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRIS 108
Query: 69 IMSRLR------HPNIVKLYEVLATKAKIYF------VMEFAKGGELFAKISK---GRFS 113
++ N+ + E + + Y +MEF EL A
Sbjct: 109 PKEKVFIWTEKEFRNLERAKEAGVSVPQPYTYMKNVLLMEFIGEDELPAPTLVELGRELK 168
Query: 114 EQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFG 160
E F ++ V+ + + H DL N++ + + D G
Sbjct: 169 ELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYIDK--VYFIDMG 214
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 2zfd_B | 123 | Putative uncharacterized protein T20L15_90; calciu | 99.97 | |
| 2ehb_D | 143 | CBL-interacting serine/threonine-protein kinase 2; | 99.96 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.96 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.8 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.48 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.35 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.23 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.16 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.89 | |
| 3ose_A | 120 | Serine/threonine-protein kinase MARK1; kinase asso | 98.87 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.71 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.62 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.48 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.39 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.37 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.32 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.19 | |
| 1v5s_A | 126 | MAP/microtubule affinity-regulating kinase 3; Ka1 | 98.12 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.81 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 97.77 | |
| 4eai_A | 106 | 5'-AMP-activated protein kinase catalytic subunit | 97.68 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.59 | |
| 2v8q_A | 157 | 5'-AMP-activated protein kinase catalytic subunit; | 97.58 | |
| 2y8l_A | 173 | 5'-AMP-activated protein kinase catalytic subunit; | 97.51 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.51 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.49 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.29 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.19 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.17 | |
| 4eag_A | 130 | EG:132E8.2 protein; AMPK, transferase; HET: ATP TA | 97.15 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.14 | |
| 2qrd_A | 137 | SNF1-like protein kinase SSP2; AMPK, ADP, ATP-bind | 97.13 | |
| 3t4n_A | 179 | Carbon catabolite-derepressing protein kinase; CBS | 96.97 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.96 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.73 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.09 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.7 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 93.08 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 91.52 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 90.63 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.61 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-70 Score=533.08 Aligned_cols=260 Identities=36% Similarity=0.628 Sum_probs=244.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++++.||+|+||+||+|+++.+|+.||||++++....+......+.+|+++|+.++|||||++++++.+++.+|+
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 34679999999999999999999999999999999998776666667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||||+||+|++++.+ +.++|.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|..........
T Consensus 110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~ 189 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 189 (311)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence 9999999999999976 899999999999999999999999999999999999999999999999999998765544555
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...+.||||.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.+|.++.+.+|..+|+++++||++|
T Consensus 190 ~~~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~l 268 (311)
T 4aw0_A 190 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPEKFFPKARDLVEKL 268 (311)
T ss_dssp CBCCCCSCGGGCCHHHHHHSCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTCCHHHHHHHHHH
T ss_pred cccCcccCcccCCHHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccCHHHHHHHHHH
Confidence 67789999999999999998885 99999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCHHH------HhcCccccc
Q 014849 253 LDTDPATRITVDE------ILRDPWFKK 274 (417)
Q Consensus 253 L~~dP~~R~t~~e------il~h~~f~~ 274 (417)
|+.||++|||++| |++||||+.
T Consensus 269 L~~dp~~R~t~~e~~~~~~i~~Hp~F~~ 296 (311)
T 4aw0_A 269 LVLDATKRLGCEEMEGYGPLKAHPFFES 296 (311)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence 9999999999988 589999986
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-70 Score=522.70 Aligned_cols=259 Identities=46% Similarity=0.850 Sum_probs=224.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..|+|++++.||+|+||+||+|+++.+|+.||||++++....+.....++.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 11 ~ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 11 HIGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp ---CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred EeeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 35899999999999999999999999999999999998776666667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||| +|+|.+++.+ +++++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 91 vmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---~~ 166 (275)
T 3hyh_A 91 VIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GN 166 (275)
T ss_dssp EEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred EEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCC---CC
Confidence 99999 6799998875 7899999999999999999999999999999999999999999999999999976432 33
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...+.||||.|||||++.+.+|++.++|||||||++|+|++|++||.+.+...++.++..+.+.+|.+.|+++++||.+|
T Consensus 167 ~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 246 (275)
T 3hyh_A 167 FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRM 246 (275)
T ss_dssp --------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHHHH
T ss_pred ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHH
Confidence 45678999999999999999998899999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCHHHHhcCccccccc
Q 014849 253 LDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|++||++|||++|+++||||+.+.
T Consensus 247 L~~dP~~R~s~~eil~hpw~k~~~ 270 (275)
T 3hyh_A 247 LIVNPLNRISIHEIMQDDWFKVDL 270 (275)
T ss_dssp SCSSGGGSCCHHHHHHCHHHHTTC
T ss_pred ccCChhHCcCHHHHHcCcccccCC
Confidence 999999999999999999998653
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-67 Score=518.99 Aligned_cols=257 Identities=29% Similarity=0.460 Sum_probs=234.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..+|++.+.||+|+||+||+|+++.||+.||||++++.... ..+.+.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876432 245678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||||+||+|.+++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 150 mEy~~gg~L~~~l~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 227 (346)
T 4fih_A 150 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 227 (346)
T ss_dssp ECCCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--SSCCB
T ss_pred EeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCC--CCCcc
Confidence 9999999999999989999999999999999999999999999999999999999999999999999986543 23456
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~ 251 (417)
.+.||||.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+..+.+..|..... ..+..+|+++++||.+
T Consensus 228 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 306 (346)
T 4fih_A 228 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 306 (346)
T ss_dssp CCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCSCGGGSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccccCCHHHHHHHHH
Confidence 678999999999999998885 999999999999999999999999999998888876543 2334579999999999
Q ss_pred hccCCCCCCCCHHHHhcCcccccccc
Q 014849 252 LLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||+.||++|||++|+|+||||++...
T Consensus 307 ~L~~dP~~R~ta~e~l~Hp~~~~~~~ 332 (346)
T 4fih_A 307 LLVRDPAQRATAAELLKHPFLAKAGP 332 (346)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred HcCCChhHCcCHHHHhcCHhhcCCCC
Confidence 99999999999999999999987543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-67 Score=520.59 Aligned_cols=259 Identities=28% Similarity=0.534 Sum_probs=230.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+++.+|+.+|+.++|||||++++++.+++.+|||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiV 101 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV 101 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 46999999999999999999999999999999999877543 33467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+||+|.++|.. ..++|.+++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|+..... .
T Consensus 102 mEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~--~ 179 (350)
T 4b9d_A 102 MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNST--V 179 (350)
T ss_dssp EECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHH--H
T ss_pred EeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCC--c
Confidence 999999999999964 35799999999999999999999999999999999999999999999999999765321 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIG 250 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 250 (417)
....+.|||+.|||||++.+.+|+ .++|||||||+||+|++|++||.+.+..+++.++..+.+ +.+..+|+++++||.
T Consensus 180 ~~~~~~~GT~~YmAPE~l~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~s~~~~~li~ 258 (350)
T 4b9d_A 180 ELARACIGTPYYLSPEICENKPYN-NKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVS 258 (350)
T ss_dssp HHHHHHHSCCTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccCCCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCCccCCHHHHHHHH
Confidence 234567999999999999999886 899999999999999999999999999999999998876 456778999999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+||+.||++|||++|+|+||||++...
T Consensus 259 ~~L~~dP~~R~s~~e~l~hp~~~~~~~ 285 (350)
T 4b9d_A 259 QLFKRNPRDRPSVNSILEKGFIAKRIE 285 (350)
T ss_dssp HHTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred HHccCChhHCcCHHHHhcCHHhhcCCC
Confidence 999999999999999999999987543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-67 Score=509.83 Aligned_cols=255 Identities=34% Similarity=0.614 Sum_probs=228.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
++|++++.||+|+||+||+|++. .+++.||||++++....... ..++.+|+.+|+.++|||||++++++.+++.+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~-~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ 102 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD-RVRTKMERDILVEVNHPFIVKLHYAFQTEGKLY 102 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEE-CC------CCCCCCCCTTEECEEEEEEETTEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHH-HHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEE
Confidence 67999999999999999999984 47889999999876543322 346789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+|||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++||+||||||+|||++.+|++||+|||+|+.... ..
T Consensus 103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~--~~ 180 (304)
T 3ubd_A 103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID--HE 180 (304)
T ss_dssp EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-------
T ss_pred EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC--CC
Confidence 99999999999999986 8899999999999999999999999999999999999999999999999999975432 23
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 251 (417)
....+.||||.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.+|.++.+.+|..+|+++++||++
T Consensus 181 ~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~ 259 (304)
T 3ubd_A 181 KKAYSFCGTVEYMAPEVVNRRGHT-QSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQFLSPEAQSLLRM 259 (304)
T ss_dssp CCCCSCCCCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHH
T ss_pred ccccccccCcccCCHHHhccCCCC-CCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 455678999999999999999886 8999999999999999999999999999999999999999999999999999999
Q ss_pred hccCCCCCCCC-----HHHHhcCccccc
Q 014849 252 LLDTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 252 ~L~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
||+.||++||| ++|+++||||+.
T Consensus 260 ~L~~dP~~R~ta~~~~~~eil~Hp~f~~ 287 (304)
T 3ubd_A 260 LFKRNPANRLGAGPDGVEEIKRHSFFST 287 (304)
T ss_dssp HTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred HcccCHHHCCCCCcCCHHHHHcCccccC
Confidence 99999999998 589999999986
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-65 Score=519.59 Aligned_cols=256 Identities=29% Similarity=0.467 Sum_probs=234.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..+|++.+.||+|+||+||+|+++.+|+.||||+++..... ..+.+.+|+.+|+.++|||||++++++.+.+.+|||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999876432 245688999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcc
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGML 174 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~ 174 (417)
||||+||+|.+++..+++++.+++.|+.||+.||+|||++||+||||||+||||+.+|++||+|||+|+.... .....
T Consensus 227 mEy~~gG~L~~~i~~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~--~~~~~ 304 (423)
T 4fie_A 227 MEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK--EVPRR 304 (423)
T ss_dssp EECCTTEEHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCS--SCCCB
T ss_pred EeCCCCCcHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCC--CCccc
Confidence 9999999999999989999999999999999999999999999999999999999999999999999986543 23456
Q ss_pred cccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHHHHHHH
Q 014849 175 HTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 175 ~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~~li~~ 251 (417)
.+.|||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+..+.+..|.... +..+..+|+++++||.+
T Consensus 305 ~~~~GTp~YmAPEvl~~~~y~-~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~dli~~ 383 (423)
T 4fie_A 305 KSLVGTPYWMAPELISRLPYG-PEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDR 383 (423)
T ss_dssp CCCEECTTTCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSSCHHHHHHHHH
T ss_pred cccccCcCcCCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCCcccccCCHHHHHHHHH
Confidence 788999999999999998885 99999999999999999999999999998888887653 33455689999999999
Q ss_pred hccCCCCCCCCHHHHhcCccccccc
Q 014849 252 LLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
||+.||++|||++|+|+||||++..
T Consensus 384 ~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 384 LLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp HSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred HcCCChhHCcCHHHHhcCHHhcCCC
Confidence 9999999999999999999998754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-64 Score=489.42 Aligned_cols=256 Identities=26% Similarity=0.525 Sum_probs=223.8
Q ss_pred cccCCe-EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 014849 13 NLFGKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT---- 87 (417)
Q Consensus 13 ~~~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~---- 87 (417)
...+|| ++.+.||+|+||+||+|.++.+++.||+|++...... .....++.+|+.+|+.++|||||++++++.+
T Consensus 22 ~~~gr~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~ 100 (290)
T 3fpq_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKG 100 (290)
T ss_dssp CTTSSEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETT
T ss_pred CCCCceEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCC
Confidence 345777 8889999999999999999999999999999876543 3346788999999999999999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecC-CCCeEEeeeecce
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDE-NWDLKISDFGLSA 163 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~-~~~vkl~DFGls~ 163 (417)
+..+|+|||||+||+|.+++.+ +.+++.+++.|+.||+.||+|||++| |+||||||+||||+. +|++||+|||+|+
T Consensus 101 ~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~ 180 (290)
T 3fpq_A 101 KKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred CcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCE
Confidence 4569999999999999999976 78999999999999999999999999 999999999999974 7999999999997
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCCCC--CCCC
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGEYR--CPKW 240 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~--~p~~ 240 (417)
... .....+.||||.|||||++.+ +|+ .++|||||||+||+|++|++||.+. +...++..+..+..+ .+..
T Consensus 181 ~~~----~~~~~~~~GTp~YmAPE~~~~-~y~-~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~ 254 (290)
T 3fpq_A 181 LKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKV 254 (290)
T ss_dssp GCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGC
T ss_pred eCC----CCccCCcccCccccCHHHcCC-CCC-cHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCCCCCcc
Confidence 532 345677899999999999865 575 9999999999999999999999764 556677777766433 4566
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++++++||.+||+.||++|||++|+++||||++.
T Consensus 255 ~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 255 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp CCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 78999999999999999999999999999999863
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-64 Score=493.63 Aligned_cols=254 Identities=26% Similarity=0.372 Sum_probs=224.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|++.+.||+|+||+||+|+++.+|+.||||+++++... .+|+.+|+.++|||||++++++.+++.+|||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~~l~HpnIV~l~~~~~~~~~~~iv 128 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACAGLSSPRIVPLYGAVREGPWVNIF 128 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHHhCCCCCCCcEEEEEEECCEEEEE
Confidence 46799999999999999999999999999999999875432 3699999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++||+||||||+||||+.+| ++||+|||+|+.........
T Consensus 129 mEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~ 208 (336)
T 4g3f_A 129 MELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGK 208 (336)
T ss_dssp ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-------
T ss_pred EeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCccc
Confidence 999999999999976 8899999999999999999999999999999999999999998 59999999998654322111
Q ss_pred ---cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChHHH
Q 014849 173 ---MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPDLK 246 (417)
Q Consensus 173 ---~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~~ 246 (417)
...+.||||.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.+|..... ..|+.+|+++.
T Consensus 209 ~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~s~~~~ 287 (336)
T 4g3f_A 209 SLLTGDYIPGTETHMAPEVVMGKPCD-AKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIREIPPSCAPLTA 287 (336)
T ss_dssp -----CCCCCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGGGSCTTSCHHHH
T ss_pred ceecCCccccCccccCHHHHCCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCchhcCccCCHHHH
Confidence 22346899999999999999886 899999999999999999999998887777888877664 35778999999
Q ss_pred HHHHHhccCCCCCCCCHHHH-------------hcCcccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEI-------------LRDPWFKKDYK 277 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~ei-------------l~h~~f~~~~~ 277 (417)
+||.+||+.||.+|||+.|+ ++|||+++...
T Consensus 288 ~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~ 331 (336)
T 4g3f_A 288 QAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE 331 (336)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred HHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence 99999999999999999998 57999876433
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-62 Score=494.02 Aligned_cols=261 Identities=28% Similarity=0.402 Sum_probs=226.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.++|++++.||+|+||+||+|+++.||+.||||++.+... ......++.+|+.+|+.++|||||++++++.+.
T Consensus 52 i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~ 130 (398)
T 4b99_A 52 VGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGE 130 (398)
T ss_dssp CCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTT
T ss_pred CCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeeccccccc
Confidence 45689999999999999999999999999999999976543 233456788999999999999999999997643
Q ss_pred -CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 -AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 -~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
+.+|+|||||. |+|.+++.+ +++++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+...
T Consensus 131 ~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~ 209 (398)
T 4b99_A 131 FKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC 209 (398)
T ss_dssp CCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred CCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence 67999999996 579999876 789999999999999999999999999999999999999999999999999997543
Q ss_pred cc--CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-------
Q 014849 167 QI--RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC------- 237 (417)
Q Consensus 167 ~~--~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~------- 237 (417)
.. .......+.|||+.|||||++.+..|++.++||||+|||+|+|++|++||.+.+..+.+..|.......
T Consensus 210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~ 289 (398)
T 4b99_A 210 TSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQA 289 (398)
T ss_dssp ------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-
T ss_pred cCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhh
Confidence 22 223455678999999999999888777799999999999999999999999999888888775432111
Q ss_pred ------------------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 238 ------------------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 238 ------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+..|+++.+||.+||+.||++|||++|+|+||||++..
T Consensus 290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~ 352 (398)
T 4b99_A 290 VGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH 352 (398)
T ss_dssp ----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred hhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence 123588999999999999999999999999999998654
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-60 Score=488.57 Aligned_cols=388 Identities=32% Similarity=0.594 Sum_probs=308.5
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..+....++|++++.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.
T Consensus 9 ~~~~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~ 88 (476)
T 2y94_A 9 HDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP 88 (476)
T ss_dssp CCSCCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cCCCceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC
Confidence 34456789999999999999999999999999999999999877654445567899999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
+.+|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++.....
T Consensus 89 ~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~ 168 (476)
T 2y94_A 89 SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 168 (476)
T ss_dssp SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCT
T ss_pred CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccc
Confidence 999999999999999999976 6899999999999999999999999999999999999999999999999999976542
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (417)
.....+.|||+.|+|||++.+..|.+.++|||||||++|+|++|..||.+.+...++.++..+.+..|...++++.+
T Consensus 169 ---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 245 (476)
T 2y94_A 169 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQYLNPSVIS 245 (476)
T ss_dssp ---TCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCCTTCCHHHHH
T ss_pred ---cccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCCccCCHHHHH
Confidence 34456789999999999999888877999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccccCCCCCCCC----------------Cccccc----CC--C-CCCCCc---
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDF----------------DLKDSV----GC--N-VGSEKY--- 301 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~~~~~~----------------~~~~~~----~~--~-~~~~~~--- 301 (417)
||++||+.||.+|||++|+++||||+........+.... ...... .+ + ......
T Consensus 246 Li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 325 (476)
T 2y94_A 246 LLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMIDDEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVA 325 (476)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTCHHHHTTCCTTTTTSSSCSSCSHHHHHHHHSCCCC------------------------
T ss_pred HHHHHcCCCchhCcCHHHHHhCHHhhhcCccccCCCCcccccccCCHHHHHHHHHHcCCCHHHHHHHHhCCCCCCHHHHH
Confidence 999999999999999999999999987543221111000 000000 00 0 000000
Q ss_pred -------------cCcch---------------------hhcc------CCCCCCCCCCccCCC---CCCCccccceeec
Q 014849 302 -------------LNAFD---------------------IISL------SSGFNLSGLFDDFNN---NDAPFCNERFLSN 338 (417)
Q Consensus 302 -------------~~~~~---------------------~is~------~~~~~~~~~~~~~~~---~~~~~~~~~~~~~ 338 (417)
...|- .+.. +....++.+...... .........+.|+
T Consensus 326 y~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~lgi~s~ 405 (476)
T 2y94_A 326 YHLIIDNRRIMNEAKDFYLATSPPDSFLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQ 405 (476)
T ss_dssp -------CCTTCCSSHHHHHHHHHHSCGGGTSCCCCSSCTTTTCSCCCCCCSTTCTTTSSSTTTCSCCCCCCEEESEEEC
T ss_pred HHHHHhchhhhhhhhccccccCCccccccccccccCCcccCCcccccCCcccccccccccccccccccccceeeecCccC
Confidence 00000 0000 000111111110000 0111234566799
Q ss_pred CCHHHHHHHHHHHHHhhcCCCceEEEE-eeeeEEEEee----ccceEEEEEEEEecCceEEEEEEecCCc
Q 014849 339 ETPEKILEKVEEVARLVADGDRLAVTK-KEWGAKLEGQ----NGNFTMVIGIDRLTDDLVVVEIKKSMRR 403 (417)
Q Consensus 339 ~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~v~~~~~~g~ 403 (417)
..|.+||..|..+.+.+ ||.|++ ..+.|++.-. ...+.|.+++|++.+..+||||++..|+
T Consensus 406 ~~p~~im~ev~~al~~l----g~~Wk~~~~~~i~~r~~~~~~~~~~k~~lqly~~~~~~~llDf~~~~~~ 471 (476)
T 2y94_A 406 SRPNDIMAEVCRAIKQL----DYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDE 471 (476)
T ss_dssp SCHHHHHHHHHHHHHTT----TCBCCEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred CCHHHHHHHHHHHHHHc----CCeeccCCCEEEEEEECCCCCCceEEEEEEEEEecCCcEEEEeeecCCC
Confidence 99999999999999999 999954 6788888622 2346799999999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-61 Score=509.40 Aligned_cols=257 Identities=33% Similarity=0.495 Sum_probs=230.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHH---HHHHHhCCCCCcceEEEEEEeCCE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE---ISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~E---i~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
-.++|+++++||+|+||+||+|+++.||+.||||++++..+........+.+| +.+++.++|||||++++++.+++.
T Consensus 187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ 266 (689)
T 3v5w_A 187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 266 (689)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCE
Confidence 46789999999999999999999999999999999998765444444444444 666777899999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|||||||+||+|+++|.+ +.++|..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||+|.....
T Consensus 267 lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~-- 344 (689)
T 3v5w_A 267 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK-- 344 (689)
T ss_dssp EEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS--
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC--
Confidence 9999999999999999976 8999999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccCccccccccccc-cCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCCCCCCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAK-KGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~-~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
....+.||||.|||||++.+ .+| +.++||||||||+|+|++|++||.+. +...+...+....+.+|..+|+++
T Consensus 345 --~~~~t~~GTp~YmAPEvl~~~~~y-~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p~~~S~~a 421 (689)
T 3v5w_A 345 --KKPHASVGTHGYMAPEVLQKGVAY-DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPEL 421 (689)
T ss_dssp --CCCCSCCSCGGGCCHHHHSTTCCC-CTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred --CCCCCccCCcCccCHHHHhCCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCCccCCHHH
Confidence 34567899999999999975 456 59999999999999999999999763 455677888888999999999999
Q ss_pred HHHHHHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
++||.+||+.||.+|++ ++||++||||+..
T Consensus 422 ~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i 456 (689)
T 3v5w_A 422 RSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 456 (689)
T ss_dssp HHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC
T ss_pred HHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC
Confidence 99999999999999998 7999999999863
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-60 Score=475.29 Aligned_cols=255 Identities=24% Similarity=0.426 Sum_probs=212.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.+.++|++++.||+|+||+||+|+++ .+++.||+|++.+.. ...++.+|+++|+.+ +|||||++++++.++
T Consensus 18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~ 92 (361)
T 4f9c_A 18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKN 92 (361)
T ss_dssp GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEET
T ss_pred CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEEC
Confidence 46789999999999999999999875 468899999986543 245788999999998 699999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~~~~ 167 (417)
+.+|+|||||+||+|.+++. ++++.+++.|+.||+.||+|||++||+||||||+|||++.+ +++||+|||+|+....
T Consensus 93 ~~~~lvmE~~~g~~L~~~~~--~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~ 170 (361)
T 4f9c_A 93 DHVVIAMPYLEHESFLDILN--SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHD 170 (361)
T ss_dssp TEEEEEEECCCCCCHHHHHT--TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTT
T ss_pred CEEEEEEeCCCcccHHHHHc--CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCC
Confidence 99999999999999999984 69999999999999999999999999999999999999877 7999999999975432
Q ss_pred cC--------------------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-
Q 014849 168 IR--------------------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND- 220 (417)
Q Consensus 168 ~~--------------------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~- 220 (417)
.. ......+.|||+.|+|||++.+..+++.++||||+|||+|+|++|++||..
T Consensus 171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~ 250 (361)
T 4f9c_A 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKA 250 (361)
T ss_dssp CSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCC
T ss_pred ccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCC
Confidence 11 112345679999999999998876667999999999999999999999954
Q ss_pred CCHHHHHHHHhc--------------------------------------CCC----------------CCCCCCChHHH
Q 014849 221 PNLMAMYRKIYK--------------------------------------GEY----------------RCPKWTSPDLK 246 (417)
Q Consensus 221 ~~~~~~~~~i~~--------------------------------------~~~----------------~~p~~~s~~~~ 246 (417)
.+..+....|.. ... ......|++++
T Consensus 251 ~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~ 330 (361)
T 4f9c_A 251 SDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAY 330 (361)
T ss_dssp SSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHH
T ss_pred CCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHH
Confidence 344343333321 000 01123689999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+||++||+.||++|||++|+|+||||++
T Consensus 331 DLl~~lL~~dP~~R~ta~eaL~Hp~f~~ 358 (361)
T 4f9c_A 331 DLLDKLLDLNPASRITAEEALLHPFFKD 358 (361)
T ss_dssp HHHHHHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred HHHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 9999999999999999999999999985
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-61 Score=468.21 Aligned_cols=256 Identities=25% Similarity=0.404 Sum_probs=204.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA---- 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~---- 89 (417)
+.+.|++++.||+|+||+||+|+++.+|+.||||++.... .....+++.+|+.+|+.++|||||++++++.+.+
T Consensus 3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----
T ss_pred cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccc
Confidence 3467999999999999999999999999999999997653 3334578899999999999999999999987554
Q ss_pred --------EEEEEEeccCCCChHHHHhc-CC---CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 90 --------KIYFVMEFAKGGELFAKISK-GR---FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 90 --------~~~lV~E~~~gg~L~~~i~~-~~---l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
.+|+|||||+||+|.+++.. +. .++..++.|+.||++||+|||++||+||||||+||||+.+|++||+
T Consensus 81 ~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~ 160 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVG 160 (299)
T ss_dssp ------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEEC
T ss_pred ccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEc
Confidence 47999999999999999976 33 4567789999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCC----------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHH
Q 014849 158 DFGLSAVKEQIRPD----------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAM 226 (417)
Q Consensus 158 DFGls~~~~~~~~~----------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~ 226 (417)
|||+|+........ ....+.||||.|||||++.+.+|+ .++|||||||++|+|++ ||..... ...
T Consensus 161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~-~~~DiwSlGvilyell~---Pf~~~~~~~~~ 236 (299)
T 4g31_A 161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYS-HKVDIFSLGLILFELLY---PFSTQMERVRT 236 (299)
T ss_dssp CCCCC--------------------------CCCTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHS---CCSSHHHHHHH
T ss_pred cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCC-CHHHHHHHHHHHHHHcc---CCCCccHHHHH
Confidence 99999865432211 123457999999999999998886 99999999999999996 8865432 233
Q ss_pred HHHHhcCCCC-CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 227 YRKIYKGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 227 ~~~i~~~~~~-~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...+....++ .+...++.+.+||.+||++||++|||+.|+++||||++.
T Consensus 237 ~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~ 286 (299)
T 4g31_A 237 LTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDL 286 (299)
T ss_dssp HHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC
T ss_pred HHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCC
Confidence 4444444332 112346778999999999999999999999999999853
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-60 Score=497.73 Aligned_cols=259 Identities=32% Similarity=0.530 Sum_probs=236.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.+.++|++++.||+|+||+||+|+++.+|+.||+|++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 154 ~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~---~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~ 230 (573)
T 3uto_A 154 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 230 (573)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccch---hhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 456899999999999999999999999999999999976542 23567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCeEEeeeecceeeccc
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN--WDLKISDFGLSAVKEQI 168 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~--~~vkl~DFGls~~~~~~ 168 (417)
+|||||+||+|++++.. +++++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 231 iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~-- 308 (573)
T 3uto_A 231 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 308 (573)
T ss_dssp EEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECC--
T ss_pred EEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEcc--
Confidence 99999999999999964 689999999999999999999999999999999999999854 899999999998654
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCChH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSPD 244 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 244 (417)
......+.|||+.|||||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+.+.+|..+.+.++ ..+|++
T Consensus 309 -~~~~~~~~~GT~~y~APEv~~~~~y~-~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 386 (573)
T 3uto_A 309 -PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 386 (573)
T ss_dssp -TTSEEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHH
T ss_pred -CCCceeeeEECccccCHHHhCCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 34556788999999999999999985 999999999999999999999999999999999998877654 457999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+++||++||+.||.+|||++|+|+||||+....+
T Consensus 387 ~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~ 420 (573)
T 3uto_A 387 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP 420 (573)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCC
Confidence 9999999999999999999999999999975543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-61 Score=464.62 Aligned_cols=255 Identities=23% Similarity=0.336 Sum_probs=224.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|.+.+.||+|+||+||+|++. .+|+.||||+++... ....+++.+|+++|++++|||||++++++.+++
T Consensus 12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 88 (299)
T 4asz_A 12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDAS---DNARKDFHREAELLTNLQHEHIVKFYGVCVEGD 88 (299)
T ss_dssp GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCC---hHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 467999999999999999999875 468899999997542 334678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeE
Q 014849 90 KIYFVMEFAKGGELFAKISK--------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLK 155 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vk 155 (417)
.+|+|||||+||+|.+++.. ..+++.++..++.||++||.|||+++|+||||||+||||+.++++|
T Consensus 89 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~K 168 (299)
T 4asz_A 89 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 168 (299)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEE
Confidence 99999999999999999864 3699999999999999999999999999999999999999999999
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||+|+..............+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+..+.
T Consensus 169 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~ 247 (299)
T 4asz_A 169 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFT-TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR 247 (299)
T ss_dssp ECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred ECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence 9999999765443333333456799999999999998886 99999999999999998 999999999999999998876
Q ss_pred -CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 -YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+.|..+++++.+||.+||+.||++|||++|| ++|+++.
T Consensus 248 ~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~~~ 287 (299)
T 4asz_A 248 VLQRPRTCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQNL 287 (299)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHHHH
T ss_pred CCCCCccchHHHHHHHHHHcCCChhHCcCHHHH--HHHHHHH
Confidence 46788899999999999999999999999999 5677653
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-58 Score=454.66 Aligned_cols=272 Identities=42% Similarity=0.771 Sum_probs=244.2
Q ss_pred CCCCCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceE
Q 014849 2 GDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKL 81 (417)
Q Consensus 2 ~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l 81 (417)
|+..++.+......++|++.+.||+|+||+||+|++..+|+.||||++.+... ......++.+|+.+|+.++||||+++
T Consensus 1 g~s~~s~~~~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l 79 (328)
T 3fe3_A 1 GNSIASCADEQPHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKL 79 (328)
T ss_dssp ----------CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCccccccccCCccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeE
Confidence 45566777778899999999999999999999999999999999999987653 33346778899999999999999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
++++.+.+.+|+||||++||+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||
T Consensus 80 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG 159 (328)
T 3fe3_A 80 FEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFG 159 (328)
T ss_dssp EEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTT
T ss_pred EEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeecc
Confidence 9999999999999999999999999865 889999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCC
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 240 (417)
++.... ......+.+||+.|+|||++.+..+++.++|||||||++|+|++|.+||.+.+...+..++..+.+..|..
T Consensus 160 ~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~ 236 (328)
T 3fe3_A 160 FSNEFT---VGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236 (328)
T ss_dssp CCGGGS---SSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTT
T ss_pred CceecC---CCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCC
Confidence 987543 33456778999999999999999888889999999999999999999999999999999999999999999
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.++++.+||++||+.||.+|||++|+++||||+....
T Consensus 237 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 273 (328)
T 3fe3_A 237 MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHE 273 (328)
T ss_dssp SCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCT
T ss_pred CCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCc
Confidence 9999999999999999999999999999999987543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-59 Score=459.96 Aligned_cols=251 Identities=21% Similarity=0.323 Sum_probs=214.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+|.+.+.||+|+||+||+|++. .+++.||||+++... ....+++.+|+.+|++++|||||++++++.+..
T Consensus 40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~---~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~ 116 (329)
T 4aoj_A 40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEAS---ESARQDFQREAELLTMLQHQHIVRFFGVCTEGR 116 (329)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCS---HHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 357899999999999999999865 468899999997542 334678999999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
.+|+|||||+||+|.+++.. +++++.++..|+.||+.||.|||+++|+||||||+||||+.+++
T Consensus 117 ~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~ 196 (329)
T 4aoj_A 117 PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLV 196 (329)
T ss_dssp SEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTE
T ss_pred EEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCc
Confidence 99999999999999998853 35899999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 232 (417)
+||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |+.||.+.+..++...+..
T Consensus 197 ~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~-~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~ 275 (329)
T 4aoj_A 197 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT-TESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275 (329)
T ss_dssp EEECCCC----------------CCCCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred EEEcccccceeccCCCcceecCcccccccccChhhhcCCCCC-ccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence 999999999865443333344567899999999999998885 99999999999999998 9999999998988888887
Q ss_pred CC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 233 GE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 233 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+. ++.|..+++++.+||.+||+.||++|||+.||+++
T Consensus 276 g~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 276 GRELERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp TCCCCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred CCCCCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 64 67788899999999999999999999999999865
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-59 Score=455.54 Aligned_cols=254 Identities=23% Similarity=0.349 Sum_probs=225.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
.-.+.+++.+.||+|+||+||+|+.. .+++.||||++.... .....+.+.+|+.+|++++|||||++++++.+
T Consensus 23 i~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~ 100 (308)
T 4gt4_A 23 ISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLLGVVTK 100 (308)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE
Confidence 34578999999999999999999853 477899999997543 33346789999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE 150 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~ 150 (417)
.+.+|+|||||++|+|.+++.. +.+++.++..++.||+.||.|||+++|+||||||+||||++
T Consensus 101 ~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 180 (308)
T 4gt4_A 101 DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYD 180 (308)
T ss_dssp SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECC
Confidence 9999999999999999999843 35899999999999999999999999999999999999999
Q ss_pred CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHH
Q 014849 151 NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRK 229 (417)
Q Consensus 151 ~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~ 229 (417)
++++||+|||+|+............+.+||+.|||||++.+..|+ .++||||+||+||||+| |..||.+.+..++...
T Consensus 181 ~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s-~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~ 259 (308)
T 4gt4_A 181 KLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFS-IDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEM 259 (308)
T ss_dssp GGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHH
T ss_pred CCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCC-ccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999866544444455678999999999999988885 99999999999999998 8999999999999988
Q ss_pred HhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 230 IYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 230 i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+..+. .+.|..+++++.+|+.+||+.||++|||+.||+++
T Consensus 260 i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 260 IRNRQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 88765 46788899999999999999999999999999875
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-59 Score=451.57 Aligned_cols=249 Identities=23% Similarity=0.398 Sum_probs=204.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+++++++.||+|+||+||+|+.. ..||||+++.... .....+.+.+|+.+|++++|||||++++++.. +.+|+|
T Consensus 35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iV 109 (307)
T 3omv_A 35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIV 109 (307)
T ss_dssp TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEE
Confidence 467889999999999999999864 3599999975432 23346789999999999999999999998754 568999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+||+|.+++.. +++++.++..|+.||+.||.|||++||+||||||+||||+.++++||+|||+|+.........
T Consensus 110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 189 (307)
T 3omv_A 110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ 189 (307)
T ss_dssp EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence 999999999999964 679999999999999999999999999999999999999999999999999998765444444
Q ss_pred cccccccCcccccccccccc---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH-HHhcCCC-----CCCCCCCh
Q 014849 173 MLHTLCGTPAYVAPEILAKK---GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYR-KIYKGEY-----RCPKWTSP 243 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~---~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~-~i~~~~~-----~~p~~~s~ 243 (417)
...+.+||+.|||||++.+. .| +.++|||||||+||||+||+.||.+.+...... .+..+.. ..|..+++
T Consensus 190 ~~~~~~GT~~ymAPE~l~~~~~~~y-~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~ 268 (307)
T 3omv_A 190 QVEQPTGSVLWMAPEVIRMQDNNPF-SFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPK 268 (307)
T ss_dssp ----CCCCTTSCCHHHHHCCSSCCC-CHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCH
T ss_pred eecccccCCCccCHHHhhccCCCCC-CcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchH
Confidence 56678999999999999643 35 489999999999999999999998866544443 3433321 23456789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
++.+||.+||+.||++|||+.||+++
T Consensus 269 ~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 269 AMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999999999999999999988655
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-57 Score=448.05 Aligned_cols=261 Identities=34% Similarity=0.595 Sum_probs=233.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
..-.++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.+ +||||+++++++.+.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 44578999999999999999999999999999999999887655555677888999999988 69999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||+.||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~-- 176 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC-- 176 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeeccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+++.++..+...+|.+.++++.+||
T Consensus 177 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li 255 (353)
T 3txo_A 177 NGVTTATFCGTPDYIAPEILQEMLYG-PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGIL 255 (353)
T ss_dssp ---------CCGGGCCHHHHHHHHCT-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCccccccCCCcCeEChhhcCCCCcC-CccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 23345678999999999999988885 99999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCH------HHHhcCcccccc
Q 014849 250 GRLLDTDPATRITV------DEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t~------~eil~h~~f~~~ 275 (417)
++||+.||.+||++ +|+++||||+..
T Consensus 256 ~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 256 KSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp HHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred HHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 99999999999998 899999999863
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-56 Score=439.23 Aligned_cols=258 Identities=36% Similarity=0.640 Sum_probs=238.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv 83 (337)
T 1o6l_A 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEE
Confidence 57899999999999999999999999999999999887554455577889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..... ....
T Consensus 84 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~~~ 161 (337)
T 1o6l_A 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCC
T ss_pred EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhccc--CCCc
Confidence 999999999999876 7899999999999999999999999999999999999999999999999999874321 2334
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
..+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+...++..+......+|...++++.+||.+||
T Consensus 162 ~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL 240 (337)
T 1o6l_A 162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccccChhhCChhhhcCCCCC-chhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 5678999999999999988885 999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCcccccc
Q 014849 254 DTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 254 ~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
+.||.+|| +++|+++||||+..
T Consensus 241 ~~dP~~R~g~~~~~~~ei~~h~~f~~~ 267 (337)
T 1o6l_A 241 KKDPKQRLGGGPSDAKEVMEHRFFLSI 267 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred hcCHHHhcCCCCCCHHHHHcCCCcCCC
Confidence 99999999 99999999999853
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-57 Score=449.88 Aligned_cols=252 Identities=25% Similarity=0.384 Sum_probs=217.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-----CcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCcceEEEEEEe-
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-----GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-PNIVKLYEVLAT- 87 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-pnIv~l~~~~~~- 87 (417)
.++|++++.||+|+||+||+|.+..+ ++.||||++..... ......+.+|+.+|+.++| ||||++++++.+
T Consensus 63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~--~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~ 140 (353)
T 4ase_A 63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 140 (353)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT
T ss_pred HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec
Confidence 46899999999999999999998654 46899999976532 2235678899999999976 999999999865
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE 150 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~ 150 (417)
.+.+|+|||||+||+|.++|.. ..+++.++..|+.||+.||.|||+++|+||||||+|||++.
T Consensus 141 ~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~ 220 (353)
T 4ase_A 141 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 220 (353)
T ss_dssp TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECG
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCC
Confidence 4679999999999999999853 24899999999999999999999999999999999999999
Q ss_pred CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH-HHHHH
Q 014849 151 NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNL-MAMYR 228 (417)
Q Consensus 151 ~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~-~~~~~ 228 (417)
++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||+||||+| |..||.+.+. ..+..
T Consensus 221 ~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~-~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~ 299 (353)
T 4ase_A 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299 (353)
T ss_dssp GGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHH
T ss_pred CCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCC-CcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999865433222344567899999999999998886 99999999999999998 9999988653 44555
Q ss_pred HHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+ .++.|...++++.+||.+||+.||++|||+.||++|
T Consensus 300 ~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~ 341 (353)
T 4ase_A 300 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 341 (353)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 55554 467788899999999999999999999999999988
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-57 Score=446.73 Aligned_cols=263 Identities=44% Similarity=0.818 Sum_probs=238.7
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.....++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+++.
T Consensus 4 ~~~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~ 83 (336)
T 3h4j_B 4 SKRHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTD 83 (336)
T ss_dssp CCSEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCE
Confidence 34678999999999999999999999999999999999987655545556788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||+ +|+|.+.+.. +++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 84 ~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~--- 159 (336)
T 3h4j_B 84 IVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMT--- 159 (336)
T ss_dssp EEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTT---
T ss_pred EEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceecc---
Confidence 99999999 6789888865 889999999999999999999999999999999999999999999999999997543
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
......+.|||+.|+|||++.+..|.+.++|||||||++|+|++|.+||.+.+....+.++..+.+..|...++++.+||
T Consensus 160 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 239 (336)
T 3h4j_B 160 DGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDFLSPGAQSLI 239 (336)
T ss_dssp TSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCcccCCHHHHHHH
Confidence 23345678999999999999988887799999999999999999999999887777777777777888999999999999
Q ss_pred HHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 250 GRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++||+.||.+|||++|+++||||+....
T Consensus 240 ~~~L~~dP~~Rpt~~eil~hp~~~~~~~ 267 (336)
T 3h4j_B 240 RRMIVADPMQRITIQEIRRDPWFNVNLP 267 (336)
T ss_dssp HTTSCSSGGGSCCHHHHTTCHHHHTTCC
T ss_pred HHHcCCChhHCcCHHHHHhChhhccCCc
Confidence 9999999999999999999999987543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-55 Score=431.89 Aligned_cols=256 Identities=34% Similarity=0.682 Sum_probs=238.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.++|++.+.||+|+||+||+|++..+|+.||+|++.+.........+.+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 4 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 83 (318)
T 1fot_A 4 SLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFM 83 (318)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEE
T ss_pred ChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEE
Confidence 35789999999999999999999999999999999988765444556788899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.... .
T Consensus 84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~-----~ 158 (318)
T 1fot_A 84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-----D 158 (318)
T ss_dssp EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECS-----S
T ss_pred EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecC-----C
Confidence 9999999999999976 789999999999999999999999999999999999999999999999999997643 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+....+.++..+...+|...++++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~~l 237 (318)
T 1fot_A 159 VTYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRL 237 (318)
T ss_dssp CBCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred ccccccCCccccCHhHhcCCCCC-cccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHHHHH
Confidence 34567999999999999988885 89999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC-----CHHHHhcCcccccc
Q 014849 253 LDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
|+.||.+|| +++++++||||+..
T Consensus 238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~ 265 (318)
T 1fot_A 238 ITRDLSQRLGNLQNGTEDVKNHPWFKEV 265 (318)
T ss_dssp TCSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hccCHHHcCCCcCCCHHHHhcCccccCC
Confidence 999999999 99999999999863
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-56 Score=438.93 Aligned_cols=261 Identities=31% Similarity=0.576 Sum_probs=238.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
....++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|..+|+.+ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 34578999999999999999999999999999999999887654445567788999999876 99999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 170 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML-- 170 (345)
T ss_dssp EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhccc--
Confidence 9999999999999999986 7899999999999999999999999999999999999999999999999999874321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
......+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+..+++.++..+....|.+.++++.+||
T Consensus 171 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (345)
T 1xjd_A 171 GDAKTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLL 249 (345)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCCcccCCCCCcccCChhhhcCCCCC-ChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccCHHHHHHH
Confidence 23345678999999999999988885 99999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCCHH-HHhcCcccccc
Q 014849 250 GRLLDTDPATRITVD-EILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~-eil~h~~f~~~ 275 (417)
.+||+.||.+|||+. +|++||||+..
T Consensus 250 ~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 250 VKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp HHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred HHHhcCCHhHcCCChHHHHcCccccCC
Confidence 999999999999998 99999999864
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-55 Score=434.95 Aligned_cols=260 Identities=32% Similarity=0.545 Sum_probs=235.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
...+.++|++++.||+|+||.||+|++..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 7 ~~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~ 86 (361)
T 2yab_A 7 QQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN 86 (361)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred CCChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe
Confidence 45678899999999999999999999999999999999987653221 235788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGLS 162 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGls 162 (417)
.+.+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a 166 (361)
T 2yab_A 87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA 166 (361)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence 9999999999999999999976 6899999999999999999999999999999999999998877 7999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP---- 238 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---- 238 (417)
..... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+..+..+.+.++
T Consensus 167 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 242 (361)
T 2yab_A 167 HEIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242 (361)
T ss_dssp EECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHH
T ss_pred eEcCC---CCccccCCCCccEECchHHcCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhc
Confidence 76542 2345667899999999999888875 999999999999999999999999999999999998887665
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...++++++||.+||.+||.+|||+.|+++||||+.
T Consensus 243 ~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred cCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 467999999999999999999999999999999985
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-55 Score=443.63 Aligned_cols=260 Identities=30% Similarity=0.571 Sum_probs=232.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.-.++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|..+|+++ +||||+++++++.+.+.+
T Consensus 49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~ 128 (396)
T 4dc2_A 49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 128 (396)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEE
T ss_pred CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEE
Confidence 3467899999999999999999999999999999999987665555566788999999876 899999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||++||+|..++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.... ..
T Consensus 129 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~--~~ 206 (396)
T 4dc2_A 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGL--RP 206 (396)
T ss_dssp EEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCC--CT
T ss_pred EEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecc--cC
Confidence 999999999999999876 789999999999999999999999999999999999999999999999999987422 23
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCCCCCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---------PNLMAMYRKIYKGEYRCPKWT 241 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~ 241 (417)
.....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.. .....++..+......+|...
T Consensus 207 ~~~~~~~~gt~~Y~aPE~l~~~~~~-~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 285 (396)
T 4dc2_A 207 GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 285 (396)
T ss_dssp TCCBCCCCBCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCCTTS
T ss_pred CCccccccCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCCCcC
Confidence 3456778999999999999998885 999999999999999999999963 234457788888999999999
Q ss_pred ChHHHHHHHHhccCCCCCCCCH------HHHhcCcccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITV------DEILRDPWFKKD 275 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~------~eil~h~~f~~~ 275 (417)
++++++||++||+.||.+||++ +||++||||+..
T Consensus 286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i 325 (396)
T 4dc2_A 286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 325 (396)
T ss_dssp CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTC
T ss_pred CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCC
Confidence 9999999999999999999984 899999999863
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-55 Score=434.29 Aligned_cols=258 Identities=35% Similarity=0.635 Sum_probs=240.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 116 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNL 116 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEE
Confidence 45678999999999999999999999999999999999887655555577889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 117 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~--- 193 (350)
T 1rdq_E 117 YMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG--- 193 (350)
T ss_dssp EEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS---
T ss_pred EEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccC---
Confidence 999999999999999986 7899999999999999999999999999999999999999999999999999976432
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
...+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+++.++..+...+|..+++++.+||.
T Consensus 194 --~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 270 (350)
T 1rdq_E 194 --RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLR 270 (350)
T ss_dssp --CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHH
T ss_pred --CcccccCCccccCHHHhcCCCCC-CcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 23567999999999999988885 999999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 251 RLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 251 ~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
+||+.||.+||+ +++|++||||+..
T Consensus 271 ~lL~~dp~~R~~~~~~~~~ei~~h~~f~~~ 300 (350)
T 1rdq_E 271 NLLQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp HHSCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred HHhhcCHHhccCCccCCHHHHHhCcCcCCC
Confidence 999999999998 9999999999853
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-55 Score=435.17 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=237.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
....++|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|..+|+.+ +||||+++++++.+.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 44578999999999999999999999999999999999887655555577888999999988 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||++||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~-- 173 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW-- 173 (353)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc--
Confidence 9999999999999999986 8899999999999999999999999999999999999999999999999999874321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
......+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+++.++......+|...++++.+||
T Consensus 174 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 252 (353)
T 2i0e_A 174 DGVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAIC 252 (353)
T ss_dssp TTCCBCCCCSCGGGCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHH
T ss_pred CCcccccccCCccccChhhhcCCCcC-CcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 23345678999999999999988885 99999999999999999999999999999999999999999999999999999
Q ss_pred HHhccCCCCCCCC-----HHHHhcCccccc
Q 014849 250 GRLLDTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
.+||+.||.+||+ +++|++||||+.
T Consensus 253 ~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 253 KGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp HHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred HHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999999994 699999999985
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=429.97 Aligned_cols=260 Identities=30% Similarity=0.567 Sum_probs=234.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.-.++|++++.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.+ +||||+++++++.+.+.+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 3467899999999999999999999999999999999987665555677888999999987 899999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~--~ 163 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR--P 163 (345)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCC--T
T ss_pred EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccC--C
Confidence 999999999999999876 7899999999999999999999999999999999999999999999999999874321 2
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---------CCHHHHHHHHhcCCCCCCCCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---------PNLMAMYRKIYKGEYRCPKWT 241 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---------~~~~~~~~~i~~~~~~~p~~~ 241 (417)
.....+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.. .+...++..+......+|...
T Consensus 164 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p~~~ 242 (345)
T 3a8x_A 164 GDTTSTFCGTPNYIAPEILRGEDYG-FSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSL 242 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCCTTS
T ss_pred CCcccccCCCccccCccccCCCCCC-hHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCCCCC
Confidence 3345678999999999999988885 999999999999999999999975 344567778888888999999
Q ss_pred ChHHHHHHHHhccCCCCCCCCH------HHHhcCcccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITV------DEILRDPWFKKD 275 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~------~eil~h~~f~~~ 275 (417)
++++.+||.+||+.||.+||++ +|+++||||+..
T Consensus 243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~ 282 (345)
T 3a8x_A 243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282 (345)
T ss_dssp CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCC
Confidence 9999999999999999999995 899999999853
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-54 Score=418.62 Aligned_cols=258 Identities=30% Similarity=0.471 Sum_probs=230.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||+||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 16 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 92 (297)
T 3fxz_A 16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL 92 (297)
T ss_dssp SCGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEE
Confidence 4567899999999999999999999999999999999976543 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||+.||+|.+++....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 93 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 170 (297)
T 3fxz_A 93 WVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQ 170 (297)
T ss_dssp EEEEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TT
T ss_pred EEEEECCCCCCHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCC--cc
Confidence 9999999999999999988999999999999999999999999999999999999999999999999999876543 22
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~l 248 (417)
....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.......+... ....|...++.+.+|
T Consensus 171 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 249 (297)
T 3fxz_A 171 SKRSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDF 249 (297)
T ss_dssp CCBCCCCSCGGGCCHHHHHCSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSCGGGSCHHHHHH
T ss_pred cccCCccCCcCccChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCccccCHHHHHH
Confidence 344567899999999999988885 9999999999999999999999988877665555433 334566789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|.+||+.||.+|||++|+++||||+..
T Consensus 250 i~~~l~~dp~~Rps~~ell~h~~~~~~ 276 (297)
T 3fxz_A 250 LNRCLEMDVEKRGSAKELLQHQFLKIA 276 (297)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred HHHHccCChhHCcCHHHHhhChhhccc
Confidence 999999999999999999999999864
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-54 Score=417.35 Aligned_cols=263 Identities=36% Similarity=0.614 Sum_probs=225.4
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----------------------chHHHHHHH
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----------------------GLTAHVKRE 66 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----------------------~~~~~i~~E 66 (417)
......++|++.+.||+|+||.||+|++..+|+.||||++.+...... ...+.+.+|
T Consensus 7 ~~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E 86 (298)
T 2zv2_A 7 GDCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQE 86 (298)
T ss_dssp ---CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHH
T ss_pred CCceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHH
Confidence 344567999999999999999999999999999999999977543211 123568899
Q ss_pred HHHHHhCCCCCcceEEEEEEe--CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 014849 67 ISIMSRLRHPNIVKLYEVLAT--KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLE 144 (417)
Q Consensus 67 i~il~~l~HpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~ 144 (417)
+.+|+.++||||+++++++.+ ...+|+||||+++++|.+++..+.+++.+++.++.||+.||.|||++||+||||||+
T Consensus 87 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~ 166 (298)
T 2zv2_A 87 IAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS 166 (298)
T ss_dssp HHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred HHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence 999999999999999999987 678999999999999999877788999999999999999999999999999999999
Q ss_pred cEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCC--CCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 014849 145 NLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY--DGAKVDMWSCGVVLFVLNAGYLPFNDPN 222 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y--~~~~sDIwSlGvil~~ll~G~~Pf~~~~ 222 (417)
|||++.++.+||+|||++..... ........+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.+
T Consensus 167 Nil~~~~~~~kl~Dfg~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 167 NLLVGEDGHIKIADFGVSNEFKG--SDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp GEEECTTSCEEECCCTTCEECSS--SSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HEEECCCCCEEEecCCCcccccc--ccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 99999999999999999976543 2233456789999999999976543 3688999999999999999999999998
Q ss_pred HHHHHHHHhcCCCCCC--CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 223 LMAMYRKIYKGEYRCP--KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 223 ~~~~~~~i~~~~~~~p--~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.......+.......| ...++++.+||.+||+.||++|||+.|+++||||++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 245 IMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp HHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred HHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 8888888877665554 467899999999999999999999999999999963
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-54 Score=422.17 Aligned_cols=257 Identities=28% Similarity=0.476 Sum_probs=233.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.+.++|++++.||+|+||.||+|.+..+|+.||+|++.... .....+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~----~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 77 (321)
T 1tki_A 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc----ccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEE
Confidence 46789999999999999999999999999999999987542 23456889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--CCCeEEeeeecceeeccc
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE--NWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~--~~~vkl~DFGls~~~~~~ 168 (417)
+||||++||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 78 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~-- 155 (321)
T 1tki_A 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECC--
Confidence 99999999999999976 46999999999999999999999999999999999999987 7899999999997654
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCChH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSPD 244 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 244 (417)
........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+..+.+..+ ...+++
T Consensus 156 -~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T 1tki_A 156 -PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -CCCccccccCChhhcCcHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHH
Confidence 23345667899999999999887664 999999999999999999999999999999999988887665 367999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.+||.+||..||.+|||+.|+++||||++...
T Consensus 234 ~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 266 (321)
T 1tki_A 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHHcCCChhHCcCHHHHhcChhhccCcc
Confidence 999999999999999999999999999987543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-54 Score=439.42 Aligned_cols=262 Identities=34% Similarity=0.514 Sum_probs=233.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+...+|
T Consensus 66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 145 (410)
T 3v8s_A 66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 145 (410)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 34678999999999999999999999999999999998765544444566889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
+||||++||+|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++....... ..
T Consensus 146 lV~E~~~gg~L~~~l~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~-~~ 224 (410)
T 3v8s_A 146 MVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG-MV 224 (410)
T ss_dssp EEECCCTTEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-EE
T ss_pred EEEeCCCCCcHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC-cc
Confidence 99999999999999988899999999999999999999999999999999999999999999999999997643211 11
Q ss_pred cccccccCccccccccccccC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC--CCCChHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKG---YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP--KWTSPDL 245 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~---y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~ 245 (417)
...+.|||+.|+|||++.+.+ +.+.++|||||||++|+|++|++||.+.+....+.+|..+. +.+| ..+|+++
T Consensus 225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~ 304 (410)
T 3v8s_A 225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA 304 (410)
T ss_dssp ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence 234779999999999998765 13589999999999999999999999999999999987653 3444 4689999
Q ss_pred HHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
++||++||+.+|.+ |++++||++||||+..
T Consensus 305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999998 9999999999999864
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-54 Score=431.79 Aligned_cols=261 Identities=32% Similarity=0.530 Sum_probs=228.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHH-HHhCCCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISI-MSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~i-l~~l~HpnIv~l~~~~~~~~~ 90 (417)
....++|++++.||+|+||+||+|++..+++.||||++.+..........++.+|..+ ++.++||||+++++++.+.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 3456899999999999999999999999999999999998776555556677788777 577899999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~-- 191 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE-- 191 (373)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC--
T ss_pred EEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc--
Confidence 9999999999999999976 7899999999999999999999999999999999999999999999999999874322
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFI 249 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li 249 (417)
......+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+.+..+++.++.......|..+++++++||
T Consensus 192 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~li 270 (373)
T 2r5t_A 192 HNSTTSTFCGTPEYLAPEVLHKQPYD-RTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLL 270 (373)
T ss_dssp CCCCCCSBSCCCCCCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCCSSSCHHHHHHH
T ss_pred CCCccccccCCccccCHHHhCCCCCC-chhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCCCCCCHHHHHHH
Confidence 23455678999999999999988885 99999999999999999999999999999999999999899999999999999
Q ss_pred HHhccCCCCCCCCH----HHHhcCcccccc
Q 014849 250 GRLLDTDPATRITV----DEILRDPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t~----~eil~h~~f~~~ 275 (417)
.+||+.||.+||++ .++++||||+..
T Consensus 271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~ 300 (373)
T 2r5t_A 271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLI 300 (373)
T ss_dssp HHHTCSSGGGSTTTTTTHHHHHTSGGGTTC
T ss_pred HHHcccCHHhCCCCCCCHHHHhCCccccCC
Confidence 99999999999986 699999999853
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-54 Score=422.42 Aligned_cols=264 Identities=35% Similarity=0.614 Sum_probs=227.5
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++++.||+|+||+||+|++..+++.||+|++...... ...+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 80 (323)
T 3tki_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (323)
T ss_dssp CTTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CcHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEccccc--chHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 45789999999999999999999999999999999999765432 2245688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999999999986 5799999999999999999999999999999999999999999999999999986554333
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCC--CCCChHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP--KWTSPDLKW 247 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~ 247 (417)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+.......+ ...++++.+
T Consensus 161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (323)
T 3tki_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (323)
T ss_dssp ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcccccCCccccCCHHHHH
Confidence 444567799999999999988887778999999999999999999999875543 33333333333333 457899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||.+||+.||.+|||++|+++||||++...
T Consensus 241 li~~~L~~dP~~R~t~~eil~h~~~~~~~~ 270 (323)
T 3tki_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLK 270 (323)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHccCChhhCcCHHHHhhChhhccccc
Confidence 999999999999999999999999987654
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-54 Score=430.80 Aligned_cols=261 Identities=27% Similarity=0.496 Sum_probs=236.6
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.....++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 34557899999999999999999999999999999999988765555567889999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+|+||||+.||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~--- 166 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLP--- 166 (384)
T ss_dssp EEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeecc---
Confidence 9999999999999999986 689999999999999999999999999999999999999999999999999997653
Q ss_pred CCCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCCCCCCCCh
Q 014849 170 PDGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFND---PNLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
......+.+||+.|+|||++.. .+| +.++|||||||++|+|++|..||.. .....+...+.......|..+++
T Consensus 167 ~~~~~~~~~gt~~Y~aPE~~~~~~~~~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p~~~s~ 245 (384)
T 4fr4_A 167 RETQITTMAGTKPYMAPEMFSSRKGAGY-SFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPSAWSQ 245 (384)
T ss_dssp TTCCBCCCCSCGGGCCGGGTCCCSSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCCTTSCH
T ss_pred CCCceeccCCCccccCCeeeccCCCCCC-CccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCCCcCCH
Confidence 2345567899999999999874 345 4899999999999999999999974 45667777888888889999999
Q ss_pred HHHHHHHHhccCCCCCCCC-HHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRIT-VDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t-~~eil~h~~f~~~ 275 (417)
++.+||.+||+.||.+||+ ++++++||||+..
T Consensus 246 ~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~ 278 (384)
T 4fr4_A 246 EMVSLLKKLLEPNPDQRFSQLSDVQNFPYMNDI 278 (384)
T ss_dssp HHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhcCCHhHhcccHHHHHcChhhhcC
Confidence 9999999999999999998 9999999999864
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-54 Score=439.19 Aligned_cols=260 Identities=35% Similarity=0.652 Sum_probs=232.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++.+.... ......+.+|+.+|+.++||||+++++++.+.+..
T Consensus 7 ~~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 85 (444)
T 3soa_A 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHH 85 (444)
T ss_dssp CHHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEE
T ss_pred ccccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEE
Confidence 46778999999999999999999999999999999999876542 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD---ENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~---~~~~vkl~DFGls~~~~~ 167 (417)
|+||||+.||+|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus 86 ~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~ 165 (444)
T 3soa_A 86 YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG 165 (444)
T ss_dssp EEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCT
T ss_pred EEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecC
Confidence 999999999999998875 7899999999999999999999999999999999999998 467899999999976543
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 243 (417)
........+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+..+..+.+..|. ..++
T Consensus 166 --~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 242 (444)
T 3soa_A 166 --EQQAWFGFAGTPGYLSPEVLRKDPYG-KPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTP 242 (444)
T ss_dssp --TCCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred --CCceeecccCCcccCCHHHhcCCCCC-CccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCH
Confidence 22334567899999999999888875 9999999999999999999999999999999999988776553 4689
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 243 ~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~ 274 (444)
T 3soa_A 243 EAKDLINKMLTINPSKRITAAEALKHPWISHR 274 (444)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred HHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence 99999999999999999999999999999864
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-54 Score=427.48 Aligned_cols=259 Identities=36% Similarity=0.677 Sum_probs=232.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++...... ......+.+|+.+|+.++||||+++++++.+.+..
T Consensus 25 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~ 103 (362)
T 2bdw_A 25 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 103 (362)
T ss_dssp CHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 45678999999999999999999999999999999999876542 23356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls~~~~~ 167 (417)
|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 104 ~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~ 183 (362)
T 2bdw_A 104 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 183 (362)
T ss_dssp EEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTT
T ss_pred EEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecC
Confidence 999999999999999876 6799999999999999999999999999999999999998654 599999999976542
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~ 243 (417)
.......+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+....+..+..+.+..|. ..++
T Consensus 184 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 259 (362)
T 2bdw_A 184 ---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259 (362)
T ss_dssp ---CCSCCCSCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCH
T ss_pred ---CcccccCCCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 2334567899999999999888775 8999999999999999999999999999999999888776553 3689
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 260 ~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 260 EAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999999999999999999999999999754
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-53 Score=419.24 Aligned_cols=262 Identities=33% Similarity=0.589 Sum_probs=225.5
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.....++|++.+.||+|+||.||+|++. .+|+.||+|++.+..... ......+.+|+.+|+.++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 3456789999999999999999999985 689999999998764322 223456789999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
+.+.+|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~ 171 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKES 171 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC---
T ss_pred cCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccc
Confidence 99999999999999999999976 78999999999999999999999999999999999999999999999999998643
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHH
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
.. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+......++.......|...++++
T Consensus 172 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p~~~~~~~ 248 (327)
T 3a62_A 172 IH--DGTVTHTFCGTIEYMAPEILMRSGHN-RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPYLTQEA 248 (327)
T ss_dssp ---------CTTSSCCTTSCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTSCHHH
T ss_pred cc--CCccccccCCCcCccCHhhCcCCCCC-CcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCHHH
Confidence 22 22334567899999999999887774 9999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 246 KWFIGRLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
.+||.+||..||.+|| +++|+++||||+..
T Consensus 249 ~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 249 RDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp HHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred HHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999999999999999 89999999999853
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=406.41 Aligned_cols=267 Identities=42% Similarity=0.782 Sum_probs=232.6
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..+....++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.
T Consensus 4 ~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 83 (276)
T 2h6d_A 4 HDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP 83 (276)
T ss_dssp ---CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred ccCcceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC
Confidence 34556789999999999999999999999999999999999876544445567889999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
+..|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 84 TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 999999999999999999975 7899999999999999999999999999999999999999999999999999875432
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (417)
.......+||+.|+|||++.+..+.+.++||||||+++|+|++|..||...+.......+..+....|...++++.+
T Consensus 164 ---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 240 (276)
T 2h6d_A 164 ---GEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEYLNRSVAT 240 (276)
T ss_dssp ----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHH
T ss_pred ---CcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCchhcCHHHHH
Confidence 22345668999999999998877766899999999999999999999999999999999988888889999999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+|.+||+.||.+|||++|+++||||++....
T Consensus 241 li~~~l~~~p~~Rps~~~~l~h~~~~~~~~~ 271 (276)
T 2h6d_A 241 LLMHMLQVDPLKRATIKDIREHEWFKQDLPS 271 (276)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHSHHHHTTCCG
T ss_pred HHHHHccCChhhCCCHHHHHhChhhccCchh
Confidence 9999999999999999999999999876543
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=417.51 Aligned_cols=261 Identities=33% Similarity=0.556 Sum_probs=233.6
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
...+.++|++++.||+|+||.||+|.+..+|+.||+|++.+...... ...+.+.+|+.+|+.++||||+++++++.+
T Consensus 6 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 85 (326)
T 2y0a_A 6 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN 85 (326)
T ss_dssp CSCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cCCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 34577899999999999999999999999999999999987643221 235778999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGLS 162 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGls 162 (417)
...+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a 165 (326)
T 2y0a_A 86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA 165 (326)
T ss_dssp SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence 9999999999999999999976 6899999999999999999999999999999999999999887 7999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP---- 238 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p---- 238 (417)
..... .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+....+....+..+
T Consensus 166 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 241 (326)
T 2y0a_A 166 HKIDF---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241 (326)
T ss_dssp EECCT---TSCCCCCCSCTTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred eECCC---CCccccccCCcCcCCceeecCCCCC-cHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCcccc
Confidence 76542 2334567899999999999887775 999999999999999999999999998888888877766554
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 242 ~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~ 278 (326)
T 2y0a_A 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 278 (326)
T ss_dssp TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred ccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence 4578999999999999999999999999999999854
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-54 Score=438.37 Aligned_cols=260 Identities=36% Similarity=0.626 Sum_probs=227.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|.+..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 145 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~ 224 (446)
T 4ejn_A 145 VTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLC 224 (446)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEE
T ss_pred CChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEE
Confidence 35688999999999999999999999999999999998765544445667889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||++||+|.+++.. +.+++..++.++.||+.||.|||+ +||+||||||+|||++.++.+||+|||++..... .
T Consensus 225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~--~ 302 (446)
T 4ejn_A 225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK--D 302 (446)
T ss_dssp EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC--C
Confidence 99999999999999876 789999999999999999999998 9999999999999999999999999999864321 2
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
.....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+...++..+......+|...++++.+||.
T Consensus 303 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~~~~~~~li~ 381 (446)
T 4ejn_A 303 GATMKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLS 381 (446)
T ss_dssp ----CCSSSCGGGCCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCccccCHhhcCCCCCC-CccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 3345668999999999999888875 999999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 251 RLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 251 ~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
+||+.||.+|| |++|+++||||+..
T Consensus 382 ~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 382 GLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp HHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred HHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 99999999999 99999999999864
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-54 Score=420.74 Aligned_cols=249 Identities=22% Similarity=0.297 Sum_probs=197.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----K 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 90 (417)
..+|.+.+.||+|+||+||+|++ +|+.||||+++.... ......+|+..+..++|||||++++++.+.+ .
T Consensus 2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~----~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~ 75 (303)
T 3hmm_A 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceE
Confidence 35799999999999999999987 689999999975431 1222345677777899999999999987653 6
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR--------GVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~--------givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
+|+|||||+||+|.+++...+++++.+.+++.|++.||.|||++ ||+||||||+||||+.++++||+|||+|
T Consensus 76 ~~lV~Ey~~~gsL~~~l~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla 155 (303)
T 3hmm_A 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEecCCCCCcHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence 89999999999999999988999999999999999999999987 9999999999999999999999999999
Q ss_pred eeecccCC--CCcccccccCccccccccccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCC---------------
Q 014849 163 AVKEQIRP--DGMLHTLCGTPAYVAPEILAKKGY-----DGAKVDMWSCGVVLFVLNAGYLPFND--------------- 220 (417)
Q Consensus 163 ~~~~~~~~--~~~~~~~~Gt~~y~APEvl~~~~y-----~~~~sDIwSlGvil~~ll~G~~Pf~~--------------- 220 (417)
+....... .....+.+||+.|||||++.+... .+.++|||||||+||||++|.+||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~ 235 (303)
T 3hmm_A 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence 87653221 122345689999999999976421 24789999999999999999776532
Q ss_pred CCHHHHHHHHhcCCC--CCCCCC-----ChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 221 PNLMAMYRKIYKGEY--RCPKWT-----SPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 221 ~~~~~~~~~i~~~~~--~~p~~~-----s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.....+...+..... ..|... ++.+.+|+.+||+.||++|||+.||++.
T Consensus 236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 233445544444433 233321 2457899999999999999999999864
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=422.69 Aligned_cols=260 Identities=36% Similarity=0.633 Sum_probs=227.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc--chHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG--GLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~--~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++........ ...+.+.+|+.+|+.++||||+++++++.+.+
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 99 (351)
T 3c0i_A 20 VLFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDG 99 (351)
T ss_dssp CCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred CccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 4567899999999999999999999999999999999976543221 23577899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEeeeec
Q 014849 90 KIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGL 161 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~DFGl 161 (417)
.+|+|||||+|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||+
T Consensus 100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~ 179 (351)
T 3c0i_A 100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV 179 (351)
T ss_dssp EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence 99999999999999887753 25899999999999999999999999999999999999987655 99999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC---
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP--- 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 238 (417)
+..... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+ ...+..+..+.+..+
T Consensus 180 a~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~ 255 (351)
T 3c0i_A 180 AIQLGE--SGLVAGGRVGTPHFMAPEVVKREPYG-KPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQ 255 (351)
T ss_dssp CEECCT--TSCBCCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHH
T ss_pred eeEecC--CCeeecCCcCCcCccCHHHHcCCCCC-chHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCccc
Confidence 976543 22234567899999999999888875 99999999999999999999998854 566777777776554
Q ss_pred -CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 -KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...++++.+||.+||+.||++|||+.|+++||||+..
T Consensus 256 ~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 256 WSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred cccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 4579999999999999999999999999999999864
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=407.05 Aligned_cols=258 Identities=29% Similarity=0.502 Sum_probs=219.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||+||+|++..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 79 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEE
Confidence 4689999999999999999999999999999999987653 334457788999999999999999999999999999999
Q ss_pred EeccCCCChHHHH-h-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKI-S-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i-~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.| +|.+.+ . .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 ~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 156 (292)
T 3o0g_A 80 FEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVR 156 (292)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCS--CCS
T ss_pred EecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCC--ccc
Confidence 999987 555544 3 37899999999999999999999999999999999999999999999999999976542 233
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHHHHhcCC-----------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKGE----------------- 234 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~P-f~~~~~~~~~~~i~~~~----------------- 234 (417)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..| |.+.+..+....+....
T Consensus 157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 236 (292)
T 3o0g_A 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY 236 (292)
T ss_dssp CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence 445678999999999998777556999999999999999988777 56666666666654310
Q ss_pred ------------CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 235 ------------YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 235 ------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
...++..++++++||.+||+.||++|||++|+++||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~ 290 (292)
T 3o0g_A 237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC 290 (292)
T ss_dssp CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence 011224688999999999999999999999999999998643
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-53 Score=405.80 Aligned_cols=261 Identities=34% Similarity=0.669 Sum_probs=235.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++++.||+|+||.||+|.+..+++.||+|++.+...........+.+|+.+++.++||||+++++++.+.+..
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 34578999999999999999999999999999999999876655555567899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+++++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 85 ~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~--- 161 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS--- 161 (279)
T ss_dssp EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred EEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCc---
Confidence 999999999999999876 7899999999999999999999999999999999999999999999999998854332
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|...++++.+||.
T Consensus 162 -~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 239 (279)
T 3fdn_A 162 -SRRTDLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS 239 (279)
T ss_dssp -------CCCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred -ccccccCCCCCccCHhHhccCCCC-ccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCCCcCCHHHHHHHH
Confidence 233456899999999999887764 899999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+||+.||.+|||+.|+++||||+....
T Consensus 240 ~~l~~~p~~Rps~~e~l~h~~~~~~~~ 266 (279)
T 3fdn_A 240 RLLKHNPSQRPMLREVLEHPWITANSS 266 (279)
T ss_dssp HHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred HHhccChhhCCCHHHHhhCccccCCcc
Confidence 999999999999999999999987654
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-53 Score=413.22 Aligned_cols=266 Identities=27% Similarity=0.410 Sum_probs=218.6
Q ss_pred CCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE
Q 014849 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV 84 (417)
Q Consensus 5 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~ 84 (417)
+.+......+.++|++.+.||+|+||.||+|++. +|+.||+|++..... .......+.+|+.+|+.++||||++++++
T Consensus 10 ~~~~~~~q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 87 (311)
T 3niz_A 10 GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDV 87 (311)
T ss_dssp -----CEECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred cccceeecchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeE
Confidence 3445566789999999999999999999999994 699999999976542 33445778899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 85 LATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 85 ~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
+.+...+|+||||+.| +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 88 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a 166 (311)
T 3niz_A 88 IHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLA 166 (311)
T ss_dssp ECCSSCEEEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred EccCCEEEEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCc
Confidence 9999999999999986 78777765 46999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCC----
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYR---- 236 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~---- 236 (417)
..... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+...++... ...
T Consensus 167 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 244 (311)
T 3niz_A 167 RAFGI--PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREW 244 (311)
T ss_dssp EETTS--CCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTS
T ss_pred eecCC--CcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHh
Confidence 76532 2233455689999999999987554569999999999999999999999876655555444321 000
Q ss_pred ------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 ------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++..++++.+||.+||++||++|||++|+++||||++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 307 (311)
T 3niz_A 245 PQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307 (311)
T ss_dssp GGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred hhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence 112357899999999999999999999999999999863
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-53 Score=422.10 Aligned_cols=259 Identities=42% Similarity=0.718 Sum_probs=218.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|++..+|+.||+|++..... ....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 91 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAA----IDENVQREIINHRSLRHPNIVRFKEVILTPTHL 91 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTT----SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcc----ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEE
Confidence 3456899999999999999999999999999999999976532 235678999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--eEEeeeecceeeccc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--LKISDFGLSAVKEQI 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--vkl~DFGls~~~~~~ 168 (417)
|+||||+.||+|.+++.. +++++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++....
T Consensus 92 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~-- 169 (361)
T 3uc3_A 92 AIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV-- 169 (361)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccc--
Confidence 999999999999999875 78999999999999999999999999999999999999987765 9999999986432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCCC--CCC
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCPK--WTS 242 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~--~~s 242 (417)
........+||+.|+|||++.+..+++.++|||||||++|+|++|..||.+.+ .......+....+..|. ..+
T Consensus 170 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s 248 (361)
T 3uc3_A 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRIS 248 (361)
T ss_dssp ------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCTTSCCC
T ss_pred -ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCCcCCCC
Confidence 22334567899999999999988887667999999999999999999998743 34556666666666665 469
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+++.+||.+||+.||.+|||+.|+++||||.+...
T Consensus 249 ~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~~~ 283 (361)
T 3uc3_A 249 PECCHLISRIFVADPATRISIPEIKTHSWFLKNLP 283 (361)
T ss_dssp HHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTTCC
T ss_pred HHHHHHHHHHccCChhHCcCHHHHHhCcchhcCCc
Confidence 99999999999999999999999999999987543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=402.70 Aligned_cols=272 Identities=33% Similarity=0.573 Sum_probs=245.4
Q ss_pred CCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE
Q 014849 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV 84 (417)
Q Consensus 5 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~ 84 (417)
.+.+.......++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||++++++
T Consensus 4 ~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~ 83 (294)
T 2rku_A 4 IPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGF 83 (294)
T ss_dssp CCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred CcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeee
Confidence 34444456678899999999999999999999999999999999987765555567788999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 85 LATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 85 ~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
+.+.+..|+||||+.|++|.+++.. +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 163 (294)
T 2rku_A 84 FEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLAT 163 (294)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred eccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCce
Confidence 9999999999999999999998876 789999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCh
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
.... ........+||+.|+|||++.+..++ .++||||+||++|+|++|..||...+..+.+..+.......|...++
T Consensus 164 ~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 2rku_A 164 KVEY--DGERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINP 240 (294)
T ss_dssp ECCS--TTCCBCCCCSCCSSCCHHHHTTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCH
T ss_pred eccc--CccccccccCCCCcCCcchhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCccccCH
Confidence 6542 12234456899999999999887774 89999999999999999999999999888888898888889999999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccccccC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~~ 279 (417)
.+.+||.+||+.||++|||++|+++||||+....+.
T Consensus 241 ~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~ 276 (294)
T 2rku_A 241 VAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA 276 (294)
T ss_dssp HHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred HHHHHHHHHcccChhhCcCHHHHhhChheecCCcCC
Confidence 999999999999999999999999999998776543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=435.60 Aligned_cols=260 Identities=28% Similarity=0.481 Sum_probs=229.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++++.||+|+||+||+|++..+++.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|+
T Consensus 72 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~l 151 (437)
T 4aw2_A 72 HREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYL 151 (437)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEE
T ss_pred ChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEE
Confidence 35789999999999999999999999999999999987655444445568899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+.||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|...... ..
T Consensus 152 V~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-~~ 230 (437)
T 4aw2_A 152 VMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED-GT 230 (437)
T ss_dssp EECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-SC
T ss_pred EEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC-CC
Confidence 9999999999999976 68999999999999999999999999999999999999999999999999999754321 11
Q ss_pred CcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCC---C
Q 014849 172 GMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKW---T 241 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~---~ 241 (417)
......|||+.|+|||++. ...| +.++|||||||++|+|++|++||.+.+..+.+.++... .+.+|.. .
T Consensus 231 ~~~~~~~GT~~Y~APE~l~~~~~~~~~~-~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~ 309 (437)
T 4aw2_A 231 VQSSVAVGTPDYISPEILQAMEGGKGRY-GPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDV 309 (437)
T ss_dssp EECCSCCSCGGGCCHHHHHHHHTSCCEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCCCS
T ss_pred cccccccCCcCeeChHHHhhcccCCCCC-CCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccccC
Confidence 1234478999999999987 3345 59999999999999999999999999999999888753 3455544 7
Q ss_pred ChHHHHHHHHhccCCCCC--CCCHHHHhcCcccccc
Q 014849 242 SPDLKWFIGRLLDTDPAT--RITVDEILRDPWFKKD 275 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~--R~t~~eil~h~~f~~~ 275 (417)
|+++++||++||+.+|++ |++++|+++||||+..
T Consensus 310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i 345 (437)
T 4aw2_A 310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI 345 (437)
T ss_dssp CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCC
Confidence 999999999999988888 9999999999999853
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-53 Score=403.98 Aligned_cols=267 Identities=34% Similarity=0.681 Sum_probs=239.5
Q ss_pred CCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE
Q 014849 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL 85 (417)
Q Consensus 6 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~ 85 (417)
+.+.+.....++|++++.||+|+||.||+|.+..+++.||+|++.............+.+|+.+++.++||||+++++++
T Consensus 4 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~ 83 (284)
T 2vgo_A 4 AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYF 83 (284)
T ss_dssp ------CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hhCCccchhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEE
Confidence 44556667789999999999999999999999999999999999876554444567889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
.+.+..|+||||+++++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus 84 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~ 163 (284)
T 2vgo_A 84 HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVH 163 (284)
T ss_dssp ECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEeccccccc
Confidence 999999999999999999999876 7899999999999999999999999999999999999999999999999999865
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChH
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.......|...+++
T Consensus 164 ~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (284)
T 2vgo_A 164 APS----LRRRTMCGTLDYLPPEMIEGKTHD-EKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPFLSDG 238 (284)
T ss_dssp CSS----SCBCCCCSCGGGCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHH
T ss_pred Ccc----cccccccCCCCcCCHHHhccCCCC-cccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCCCcCCHH
Confidence 432 223456899999999999887775 899999999999999999999999998888889988888899999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.+||.+||..||.+|||++++++||||+....
T Consensus 239 ~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~ 271 (284)
T 2vgo_A 239 SKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR 271 (284)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred HHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence 999999999999999999999999999986543
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=410.63 Aligned_cols=267 Identities=34% Similarity=0.587 Sum_probs=243.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++++.||+|+||.||+|.+..+++.||+|++.+.........+.+.+|+.+++.++||||+++++++.+.+.+
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 37 PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeE
Confidence 45578999999999999999999999999999999999877655555677889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.|++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .
T Consensus 117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~--~ 194 (335)
T 2owb_A 117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--D 194 (335)
T ss_dssp EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS--T
T ss_pred EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc--C
Confidence 999999999999998876 7899999999999999999999999999999999999999999999999999976542 1
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+.+..+....+..|...++.+.+||.
T Consensus 195 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 273 (335)
T 2owb_A 195 GERKKVLCGTPNYIAPEVLSKKGHS-FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQ 273 (335)
T ss_dssp TCCBCCCCSCCSSCCHHHHHTSCBC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCTTSCHHHHHHHH
T ss_pred cccccccCCCccccCHHHhccCCCC-chhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCCccCCHHHHHHHH
Confidence 2234557899999999999887774 999999999999999999999999998888888988888999999999999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccccccCCC
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDYKERKF 281 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~~~~~~ 281 (417)
+||+.||++|||++|+++||||+..+.+...
T Consensus 274 ~~l~~dp~~Rps~~ell~~~~~~~~~~~~~~ 304 (335)
T 2owb_A 274 KMLQTDPTARPTINELLNDEFFTSGYIPARL 304 (335)
T ss_dssp HHTCSSGGGSCCGGGGGGSHHHHTSCCCSCC
T ss_pred HHccCChhHCcCHHHHhcCccccCCCccccC
Confidence 9999999999999999999999987765443
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-53 Score=424.10 Aligned_cols=263 Identities=29% Similarity=0.431 Sum_probs=214.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCC-
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKA- 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~- 89 (417)
..+.++|++++.||+|+||.||+|.+..+|+.||||++.+.. .......++.+|+.+|+.+. ||||+++++++...+
T Consensus 5 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~ 83 (388)
T 3oz6_A 5 RHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADND 83 (388)
T ss_dssp HHHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTS
T ss_pred CcccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCC
Confidence 456789999999999999999999999999999999996543 23334567889999999997 999999999997554
Q ss_pred -EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 -KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+. ++|...+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 ~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 162 (388)
T 3oz6_A 84 RDVYLVFDYME-TDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI 162 (388)
T ss_dssp SCEEEEEECCS-EEHHHHHHHTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred CEEEEEecccC-cCHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence 7999999997 58999998889999999999999999999999999999999999999999999999999999764321
Q ss_pred -------------------CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 014849 169 -------------------RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK 229 (417)
Q Consensus 169 -------------------~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 229 (417)
.........+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+....+..
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~ 242 (388)
T 3oz6_A 163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242 (388)
T ss_dssp CCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 1122345679999999999998754446999999999999999999999999888777766
Q ss_pred HhcCCC-----------------------------------------------CCCCCCChHHHHHHHHhccCCCCCCCC
Q 014849 230 IYKGEY-----------------------------------------------RCPKWTSPDLKWFIGRLLDTDPATRIT 262 (417)
Q Consensus 230 i~~~~~-----------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t 262 (417)
+...-. ..+...++++.+||.+||+.||.+|||
T Consensus 243 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t 322 (388)
T 3oz6_A 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS 322 (388)
T ss_dssp HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence 642100 011256889999999999999999999
Q ss_pred HHHHhcCccccccc
Q 014849 263 VDEILRDPWFKKDY 276 (417)
Q Consensus 263 ~~eil~h~~f~~~~ 276 (417)
++|+++||||+...
T Consensus 323 ~~e~l~Hp~~~~~~ 336 (388)
T 3oz6_A 323 ANDALKHPFVSIFH 336 (388)
T ss_dssp HHHHTTSTTTTTTC
T ss_pred HHHHhCCHHHHHhc
Confidence 99999999998643
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-52 Score=397.67 Aligned_cols=261 Identities=36% Similarity=0.676 Sum_probs=233.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
+.+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..
T Consensus 2 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (284)
T 3kk8_A 2 TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFH 80 (284)
T ss_dssp CTTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEE
Confidence 4578999999999999999999999999999999999987654 233356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~DFGls~~~~~ 167 (417)
|+||||+.|++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++. +||+|||++.....
T Consensus 81 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~ 160 (284)
T 3kk8_A 81 YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND 160 (284)
T ss_dssp EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence 999999999999888875 78999999999999999999999999999999999999987665 99999999976542
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 243 (417)
.......+||+.|+|||++.+..++ .++||||+||++|+|++|..||.+.+.......+..+....| ...++
T Consensus 161 ---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (284)
T 3kk8_A 161 ---SEAWHGFAGTPGYLSPEVLKKDPYS-KPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 236 (284)
T ss_dssp ---SCBCCCSCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred ---CccccCCCCCcCCcCchhhcCCCCC-cccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCH
Confidence 2334557899999999999888775 999999999999999999999999999999888888776554 35689
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++.+||.+||++||++|||++|+++||||++...
T Consensus 237 ~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~ 270 (284)
T 3kk8_A 237 EAKSLIDSMLTVNPKKRITADQALKVPWICNRER 270 (284)
T ss_dssp HHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCC
T ss_pred HHHHHHHHHcccChhhCCCHHHHhcCccccCChh
Confidence 9999999999999999999999999999987543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-53 Score=404.56 Aligned_cols=256 Identities=30% Similarity=0.499 Sum_probs=215.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++.+.||+|+||.||+|++ .+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEE
Confidence 47899999999999999999999 7899999999976543 233356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.+ +|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 155 (288)
T 1ob3_A 79 FEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVR 155 (288)
T ss_dssp EECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred EEecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCc--ccc
Confidence 999986 89888875 6899999999999999999999999999999999999999999999999999875432 122
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CC---------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EY--------------- 235 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~--------------- 235 (417)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.+. ..
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 1ob3_A 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYD 235 (288)
T ss_dssp ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccc
Confidence 3445689999999999977554469999999999999999999999998877666655431 00
Q ss_pred ------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 236 ------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 236 ------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+...++++.+||.+||+.||++|||++|+++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 236 PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN 287 (288)
T ss_dssp TTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred cccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence 0123468899999999999999999999999999999863
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=428.43 Aligned_cols=260 Identities=29% Similarity=0.464 Sum_probs=228.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.+|..++||||+++++++.+.+.+|
T Consensus 58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~ 137 (412)
T 2vd5_A 58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY 137 (412)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 34678999999999999999999999999999999998765444444566889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||++||+|.+++.+ ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus 138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~- 216 (412)
T 2vd5_A 138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG- 216 (412)
T ss_dssp EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS-
T ss_pred EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC-
Confidence 99999999999999976 479999999999999999999999999999999999999999999999999997643211
Q ss_pred CCcccccccCccccccccccc-------cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCC---
Q 014849 171 DGMLHTLCGTPAYVAPEILAK-------KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCP--- 238 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~-------~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p--- 238 (417)
.....+.|||+.|+|||++.. ..| +.++|||||||++|+|++|+.||.+.+..+.+.+|.... ...|
T Consensus 217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~-~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~ 295 (412)
T 2vd5_A 217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSY-GPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVD 295 (412)
T ss_dssp CEECSSCCSCGGGCCHHHHHHHHTCTTCSEE-CTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC---
T ss_pred ccccceeccccCcCCHHHHhhcccCcCCCCC-ChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCccc
Confidence 112345699999999999973 345 599999999999999999999999999999988887632 3344
Q ss_pred CCCChHHHHHHHHhccCCCCCC---CCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATR---ITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R---~t~~eil~h~~f~~~ 275 (417)
..+|+++++||++||+ +|.+| ++++|+++||||+..
T Consensus 296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i 334 (412)
T 2vd5_A 296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGL 334 (412)
T ss_dssp -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTC
T ss_pred cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCC
Confidence 5789999999999999 99998 599999999999864
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-52 Score=419.56 Aligned_cols=266 Identities=22% Similarity=0.363 Sum_probs=221.9
Q ss_pred ccccccCCeEEeeEEeee--CceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 10 REVNLFGKYEVGKIIGCG--AFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G--~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
.-..-.++|++++.||+| +||.||+|++..+|+.||||++..... .......+.+|+.+|+.++|||||++++++.+
T Consensus 19 ~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~ 97 (389)
T 3gni_B 19 SFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIA 97 (389)
T ss_dssp CCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred cccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE
Confidence 334567899999999999 999999999999999999999987653 33456788899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 88 KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
.+.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~ 177 (389)
T 3gni_B 98 DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLS 177 (389)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEccccccee
Confidence 9999999999999999999865 6799999999999999999999999999999999999999999999999998864
Q ss_pred ecccC-----CCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--
Q 014849 165 KEQIR-----PDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-- 235 (417)
Q Consensus 165 ~~~~~-----~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-- 235 (417)
..... ........+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+.......+..+..
T Consensus 178 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 256 (389)
T 3gni_B 178 MISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGY-DAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPC 256 (389)
T ss_dssp CEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCB-CTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------
T ss_pred eccccccccccccccccccccccccCHHHHhccCCCC-CcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCc
Confidence 32111 1122344589999999999987 455 4899999999999999999999987654444433332211
Q ss_pred --------------------------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 236 --------------------------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 236 --------------------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
+.+...++++.+||.+||+.||++|||++|+++|||
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~ 336 (389)
T 3gni_B 257 LLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSF 336 (389)
T ss_dssp -------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGG
T ss_pred cccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHH
Confidence 134557899999999999999999999999999999
Q ss_pred cccccc
Q 014849 272 FKKDYK 277 (417)
Q Consensus 272 f~~~~~ 277 (417)
|+....
T Consensus 337 f~~~~~ 342 (389)
T 3gni_B 337 FKQIKR 342 (389)
T ss_dssp GGGC--
T ss_pred HHHHhh
Confidence 987543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-53 Score=436.07 Aligned_cols=261 Identities=36% Similarity=0.617 Sum_probs=235.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++.+.||+|+||.||+|++..+|+.||||++.+...........+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 101 (484)
T 3nyv_A 22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYF 101 (484)
T ss_dssp CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 46778999999999999999999999999999999999877655555578899999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vkl~DFGls~~~~~ 167 (417)
|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 102 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~- 180 (484)
T 3nyv_A 102 YLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE- 180 (484)
T ss_dssp EEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC-
T ss_pred EEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc-
Confidence 999999999999998875 789999999999999999999999999999999999999 567899999999987543
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 243 (417)
........+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+...++..+.+..+ ...|+
T Consensus 181 --~~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 256 (484)
T 3nyv_A 181 --ASKKMKDKIGTAYYIAPEVLHG-TY-DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSE 256 (484)
T ss_dssp --CCCSHHHHTTGGGTCCHHHHHT-CC-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCH
T ss_pred --cccccccCCCCccccCceeecC-CC-CCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCH
Confidence 2344567789999999999876 45 4999999999999999999999999999999999988876543 34789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++++||++||++||.+|||+.|+++||||+....
T Consensus 257 ~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~~ 290 (484)
T 3nyv_A 257 SAKDLIRKMLTYVPSMRISARDALDHEWIQTYTK 290 (484)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHTC
T ss_pred HHHHHHHHHCCCChhHCcCHHHHhhChhhccccc
Confidence 9999999999999999999999999999987544
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-52 Score=398.15 Aligned_cols=259 Identities=38% Similarity=0.643 Sum_probs=233.1
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...+.++|++.+.||+|+||.||+|.+..++..||+|++..... ...+.+.+|+.+++.++||||+++++++.+...
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 80 (277)
T 3f3z_A 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTD 80 (277)
T ss_dssp --CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCe
Confidence 44678899999999999999999999999999999999976543 235778899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vkl~DFGls~~~~ 166 (417)
.|+||||++|++|.+.+.. +.+++..++.++.|++.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~ 160 (277)
T 3f3z_A 81 IYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFK 160 (277)
T ss_dssp EEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred EEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceecc
Confidence 9999999999999998875 789999999999999999999999999999999999999 788999999999987654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s 242 (417)
. .......+||+.|+|||++.+. + +.++|||||||++|+|++|..||...+..+...++..+....|. ..+
T Consensus 161 ~---~~~~~~~~~t~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (277)
T 3f3z_A 161 P---GKMMRTKVGTPYYVSPQVLEGL-Y-GPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVS 235 (277)
T ss_dssp T---TSCBCCCCSCTTTCCHHHHTTC-B-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSC
T ss_pred C---ccchhccCCCCCccChHHhccc-C-CchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCC
Confidence 2 3344567899999999998654 4 58999999999999999999999999999999999888877764 579
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+.+.+||.+||++||.+|||+.++++||||++...
T Consensus 236 ~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~ 270 (277)
T 3f3z_A 236 PQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270 (277)
T ss_dssp HHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccc
Confidence 99999999999999999999999999999987544
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-53 Score=402.31 Aligned_cols=261 Identities=33% Similarity=0.669 Sum_probs=209.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++++.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..|
T Consensus 8 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SSGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEE
T ss_pred cccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEE
Confidence 35678999999999999999999999999999999998765544455678999999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||+++++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~-- 165 (278)
T 3cok_A 88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP-- 165 (278)
T ss_dssp EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC--
Confidence 99999999999999976 57999999999999999999999999999999999999999999999999998765421
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+......++....+..|...++++.+||.
T Consensus 166 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 244 (278)
T 3cok_A 166 HEKHYTLCGTPNYISPEIATRSAHG-LESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSFLSIEAKDLIH 244 (278)
T ss_dssp ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCCCTTSCHHHHHHHH
T ss_pred CCcceeccCCCCcCCcchhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCCccccCHHHHHHHH
Confidence 2233456899999999999877764 899999999999999999999998776677777777777888889999999999
Q ss_pred HhccCCCCCCCCHHHHhcCccccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+||+.||++|||++++++||||+...
T Consensus 245 ~~l~~dp~~Rps~~~~l~h~~~~~~~ 270 (278)
T 3cok_A 245 QLLRRNPADRLSLSSVLDHPFMSRNS 270 (278)
T ss_dssp HHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred HHcccCHhhCCCHHHHhcCccccCCC
Confidence 99999999999999999999998654
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-53 Score=413.86 Aligned_cols=256 Identities=36% Similarity=0.633 Sum_probs=208.0
Q ss_pred cccccCCeEEe---eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 014849 11 EVNLFGKYEVG---KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLA 86 (417)
Q Consensus 11 ~~~~~~~y~i~---~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~ 86 (417)
...+.++|++. +.||+|+||.||+|.+..+|+.||||++.+.. ...+.+|+.+++.+. ||||+++++++.
T Consensus 3 ~~~f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~l~~l~~h~niv~~~~~~~ 76 (325)
T 3kn6_A 3 DSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRM------EANTQKEITALKLCEGHPNIVKLHEVFH 76 (325)
T ss_dssp CCHHHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGG------HHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred CCcchhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhh------hhhHHHHHHHHHHhcCCCCeeEEEEEEE
Confidence 45677889996 89999999999999999999999999997542 467789999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecc
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLS 162 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls 162 (417)
+....|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 77 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a 156 (325)
T 3kn6_A 77 DQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFA 156 (325)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTC
T ss_pred cCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccc
Confidence 99999999999999999999976 6799999999999999999999999999999999999998766 7999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-------CHHHHHHHHhcCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-------NLMAMYRKIYKGEY 235 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-------~~~~~~~~i~~~~~ 235 (417)
..... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||... ...+...++..+.+
T Consensus 157 ~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~ 233 (325)
T 3kn6_A 157 RLKPP--DNQPLKTPCFTLHYAAPELLNQNGYD-ESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDF 233 (325)
T ss_dssp EECCC------------------------CCCC-HHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCC
T ss_pred eecCC--CCCcccccCCCcCccCHHHhcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCC
Confidence 76443 23345677899999999999888875 8999999999999999999999764 34567788888877
Q ss_pred CCCC----CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 236 RCPK----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 236 ~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+. ..++++.+||.+||++||.+|||++|+++||||+..
T Consensus 234 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~ 277 (325)
T 3kn6_A 234 SFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG 277 (325)
T ss_dssp CCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred CCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence 6653 479999999999999999999999999999999864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-53 Score=451.32 Aligned_cols=260 Identities=28% Similarity=0.508 Sum_probs=239.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.-.++|++++.||+|+||+||+|++..+++.||||++.+...........+.+|..+|..+ +||||+++++++.+.+.+
T Consensus 338 ~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~ 417 (674)
T 3pfq_A 338 MKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRL 417 (674)
T ss_dssp --CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEE
T ss_pred ccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEE
Confidence 3467899999999999999999999999999999999887655555567888999999987 799999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||++||+|.+++.. +.+++..++.|+.||+.||.|||++||+||||||+||||+.+|++||+|||++..... .
T Consensus 418 ~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~--~ 495 (674)
T 3pfq_A 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW--D 495 (674)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC--T
T ss_pred EEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc--C
Confidence 999999999999999986 8899999999999999999999999999999999999999999999999999975322 2
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 250 (417)
.....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+++.+|......+|..+++++.+||+
T Consensus 496 ~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~ 574 (674)
T 3pfq_A 496 GVTTKTFCGTPDYIAPEIIAYQPYG-KSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICK 574 (674)
T ss_dssp TCCBCCCCSCSSSCCHHHHTCCCBS-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCCTTSCHHHHHHHH
T ss_pred CcccccccCCCcccCHhhhcCCCCC-ccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 3345678999999999999988885 999999999999999999999999999999999999999999999999999999
Q ss_pred HhccCCCCCCCCH-----HHHhcCcccccc
Q 014849 251 RLLDTDPATRITV-----DEILRDPWFKKD 275 (417)
Q Consensus 251 ~~L~~dP~~R~t~-----~eil~h~~f~~~ 275 (417)
+||+.||.+||++ +||++||||+..
T Consensus 575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i 604 (674)
T 3pfq_A 575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYI 604 (674)
T ss_dssp HHSCSSSTTCTTCSTTHHHHHHSSGGGSSC
T ss_pred HHccCCHHHCCCCCCCcHHHHhcCccccCC
Confidence 9999999999997 999999999863
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-52 Score=418.99 Aligned_cols=260 Identities=30% Similarity=0.520 Sum_probs=231.8
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+|+.+|+.++||||+++++++.+...
T Consensus 46 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~---~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~ 122 (387)
T 1kob_A 46 QGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYP---LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYE 122 (387)
T ss_dssp CSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSE
T ss_pred CCccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccch---hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCE
Confidence 34567899999999999999999999999999999999976532 224578899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--CCCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE--NWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~--~~~vkl~DFGls~~~~ 166 (417)
+|+||||+.||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....
T Consensus 123 ~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~ 202 (387)
T 1kob_A 123 MVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN 202 (387)
T ss_dssp EEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC
T ss_pred EEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecC
Confidence 9999999999999999975 47999999999999999999999999999999999999974 4679999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 242 (417)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....+..+ ...+
T Consensus 203 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s 278 (387)
T 1kob_A 203 P---DEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVS 278 (387)
T ss_dssp T---TSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSC
T ss_pred C---CcceeeeccCCCccCchhccCCCCC-CcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCC
Confidence 2 3345567899999999999887775 899999999999999999999999998888888887765443 3578
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 279 ~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 279 PEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 313 (387)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcc
Confidence 99999999999999999999999999999987543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-52 Score=432.90 Aligned_cols=262 Identities=36% Similarity=0.613 Sum_probs=231.1
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc----------chHHHHHHHHHHHHhCCCCCcce
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG----------GLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~----------~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
...+.++|++++.||+|+||+||+|.+..+++.||+|++.+...... ...+.+.+|+.+|+.++||||++
T Consensus 31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~ 110 (504)
T 3q5i_A 31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIK 110 (504)
T ss_dssp CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCC
T ss_pred CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCe
Confidence 34678999999999999999999999999999999999987654321 34577899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEE
Q 014849 81 LYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKI 156 (417)
Q Consensus 81 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl 156 (417)
+++++.+...+|+|||||+||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 111 ~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl 190 (504)
T 3q5i_A 111 LFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKI 190 (504)
T ss_dssp EEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEE
T ss_pred EEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEE
Confidence 99999999999999999999999998875 7899999999999999999999999999999999999998876 6999
Q ss_pred eeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC
Q 014849 157 SDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR 236 (417)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 236 (417)
+|||++..... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+.
T Consensus 191 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~ 265 (504)
T 3q5i_A 191 VDFGLSSFFSK---DYKLRDRLGTAYYIAPEVLKK-KY-NEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYY 265 (504)
T ss_dssp CCCTTCEECCT---TSCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC
T ss_pred EECCCCEEcCC---CCccccccCCcCCCCHHHhcc-CC-CchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999976542 334566789999999999874 45 59999999999999999999999999999999999988876
Q ss_pred CC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 CP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+ ...|+++++||++||++||.+|||++|+++||||++...
T Consensus 266 ~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~ 310 (504)
T 3q5i_A 266 FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN 310 (504)
T ss_dssp CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence 65 567999999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=440.14 Aligned_cols=258 Identities=27% Similarity=0.419 Sum_probs=234.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||+||+|++..+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 45678999999999999999999999999999999998876555555678889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~-- 338 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPE-- 338 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT--
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceeccc--
Confidence 99999999999999875 2499999999999999999999999999999999999999999999999999976532
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCCCCCCCCChHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
.....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.+. ....+...+......+|..+++++
T Consensus 339 -~~~~~~~~GT~~Y~APEvl~~~~~~-~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p~~~s~~~ 416 (576)
T 2acx_A 339 -GQTIKGRVGTVGYMAPEVVKNERYT-FSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSPQA 416 (576)
T ss_dssp -TCCEECCCSCGGGCCHHHHTTCEES-SHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred -CccccccCCCccccCHHHHcCCCCC-ccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCCccCCHHH
Confidence 2344567999999999999988875 9999999999999999999999875 356677777777788888999999
Q ss_pred HHHHHHhccCCCCCCC-----CHHHHhcCccccc
Q 014849 246 KWFIGRLLDTDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-----t~~eil~h~~f~~ 274 (417)
++||.+||+.||.+|| +++|+++||||+.
T Consensus 417 ~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 417 RSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp HHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred HHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 9999999999999999 8999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-53 Score=418.03 Aligned_cols=254 Identities=35% Similarity=0.609 Sum_probs=224.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
..+.++|++++.||+|+||+||+|.+..+|+.||+|++.+... ...+|+.+|.++ +||||+++++++.+...
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~ 90 (342)
T 2qr7_A 18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKY 90 (342)
T ss_dssp -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSE
T ss_pred cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCE
Confidence 4678899999999999999999999999999999999977542 234688888887 79999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-C---CeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-W---DLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~---~vkl~DFGls~~~ 165 (417)
+|+||||+.||+|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||+..+ + .+||+|||++...
T Consensus 91 ~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 91 VYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp EEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999999999876 679999999999999999999999999999999999998443 3 4999999999765
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCCCCC----
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---PNLMAMYRKIYKGEYRCP---- 238 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~~~p---- 238 (417)
.. ......+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|..||.. .+..++...+..+.+..+
T Consensus 171 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~ 247 (342)
T 2qr7_A 171 RA--ENGLLMTPCYTANFVAPEVLERQGYD-AACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW 247 (342)
T ss_dssp BC--TTCCBCCSSCCSSCCCHHHHHHHHHH-HHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT
T ss_pred cC--CCCceeccCCCccccCHHHhcCCCCC-CccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc
Confidence 43 23455678999999999999887775 899999999999999999999985 466788888888877654
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...++++.+||++||..||++|||+.++++||||...
T Consensus 248 ~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~ 284 (342)
T 2qr7_A 248 NSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284 (342)
T ss_dssp TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred ccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCc
Confidence 4579999999999999999999999999999999764
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=433.83 Aligned_cols=267 Identities=35% Similarity=0.619 Sum_probs=232.8
Q ss_pred CCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE
Q 014849 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV 84 (417)
Q Consensus 5 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~ 84 (417)
++.......+.++|++++.||+|+||+||+|.+..+|+.||||++.+.... ......+.+|+.+|+.++||||++++++
T Consensus 11 ~~~~~~~g~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~ 89 (486)
T 3mwu_A 11 RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEI 89 (486)
T ss_dssp ---CTTCCHHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CccccccCChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence 344455567899999999999999999999999999999999999875432 2336788999999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCeEEeeee
Q 014849 85 LATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD---ENWDLKISDFG 160 (417)
Q Consensus 85 ~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~---~~~~vkl~DFG 160 (417)
+.+...+|+|||||.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg 169 (486)
T 3mwu_A 90 LEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFG 169 (486)
T ss_dssp EECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCS
T ss_pred EEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECC
Confidence 9999999999999999999998865 7899999999999999999999999999999999999995 45679999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC--
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-- 238 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p-- 238 (417)
++..... .......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..+....+..+.+..+
T Consensus 170 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 244 (486)
T 3mwu_A 170 LSTCFQQ---NTKMKDRIGTAYYIAPEVLRG-TY-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP 244 (486)
T ss_dssp CTTTBCC---C----CCTTGGGGCCGGGGGS-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG
T ss_pred cCeECCC---CCccCCCcCCCCCCCHHHhCC-CC-CchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 9975432 334556789999999999876 35 5899999999999999999999999999999999988776543
Q ss_pred --CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 239 --KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 239 --~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
...|+++++||.+||++||.+|||+.|+++||||++...
T Consensus 245 ~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 245 QWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 346899999999999999999999999999999987544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=409.36 Aligned_cols=259 Identities=31% Similarity=0.519 Sum_probs=208.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 81 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLV 81 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEE
Confidence 578999999999999999999999999999999997654 223356788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 95 MEFAKGGELFAKISK-------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
|||+.| +|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 160 (317)
T 2pmi_A 82 FEFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGI 160 (317)
T ss_dssp EECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTS
T ss_pred EEecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCC
Confidence 999984 89888753 3599999999999999999999999999999999999999999999999999976532
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--C----------
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--Y---------- 235 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~---------- 235 (417)
........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.... .
T Consensus 161 --~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 238 (317)
T 2pmi_A 161 --PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTK 238 (317)
T ss_dssp --CCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGG
T ss_pred --CcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhh
Confidence 22334566899999999999875444699999999999999999999999988877766664310 0
Q ss_pred ----------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 236 ----------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 236 ----------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..+...++++.+||.+||+.||++|||++|+++||||++.+.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 239 LPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp CTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC-
T ss_pred hhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccch
Confidence 0122467899999999999999999999999999999976543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-52 Score=436.20 Aligned_cols=260 Identities=28% Similarity=0.415 Sum_probs=234.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||+||+|+++.+|+.||+|++.+...........+.+|+.+|+.++||||+++++++.+.+.+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 44678999999999999999999999999999999998876655555678899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 93 FVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
+||||++||+|.+++.. ..+++..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||++.....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999998864 3699999999999999999999999999999999999999999999999999976542
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHHHHhcCCCCCCCCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
. .....+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+. +...+...+.......|..+++
T Consensus 342 ~--~~~~~~~~GT~~Y~APE~l~~~~~~-~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p~~~s~ 418 (543)
T 3c4z_A 342 G--QTKTKGYAGTPGFMAPELLLGEEYD-FSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSP 418 (543)
T ss_dssp T--CCCBCCCCSCTTTSCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred C--CcccccccCCccccChhhhcCCCCC-hHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCCcccCH
Confidence 1 2233456999999999999988885 9999999999999999999999875 4567888888888889999999
Q ss_pred HHHHHHHHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
++.+||.+||+.||.+||+ +++|++||||+..
T Consensus 419 ~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i 455 (543)
T 3c4z_A 419 ASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDI 455 (543)
T ss_dssp HHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred HHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence 9999999999999999996 5899999999863
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=397.85 Aligned_cols=264 Identities=30% Similarity=0.535 Sum_probs=225.6
Q ss_pred CCCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEE
Q 014849 4 NTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83 (417)
Q Consensus 4 ~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~ 83 (417)
..++......+.++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+|+.++||||+++++
T Consensus 10 ~~~~~~~~g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~ 87 (285)
T 3is5_A 10 GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRS--QVPMEQIEAEIEVLKSLDHPNIIKIFE 87 (285)
T ss_dssp ---CCEESSCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGC--CSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred ccccCCCCCChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeecccc--chhHHHHHHHHHHHHhCCCchHHhHHH
Confidence 345566677889999999999999999999999999999999999987642 233678899999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeE
Q 014849 84 VLATKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLK 155 (417)
Q Consensus 84 ~~~~~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vk 155 (417)
++.+....|+||||++||+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+|
T Consensus 88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~k 167 (285)
T 3is5_A 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIK 167 (285)
T ss_dssp EEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEE
T ss_pred heecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEE
Confidence 99999999999999999999998843 579999999999999999999999999999999999999 4567899
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY 235 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~ 235 (417)
|+|||++..... .......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.+.+.......+.....
T Consensus 168 l~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~ 242 (285)
T 3is5_A 168 IIDFGLAELFKS---DEHSTNAAGTALYMAPEVFKR-DV-TFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEP 242 (285)
T ss_dssp ECCCCCCCC-------------CTTGGGCCHHHHTT-CC-CHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred EEeeecceecCC---cccCcCcccccCcCChHHhcc-CC-CcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCc
Confidence 999999975442 233456789999999999864 44 5899999999999999999999999988888777766554
Q ss_pred CCC---CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 236 RCP---KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 236 ~~p---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..+ ...++++.+||.+||+.||++|||+.|+++||||++
T Consensus 243 ~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp CCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 433 336899999999999999999999999999999985
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-52 Score=402.32 Aligned_cols=260 Identities=29% Similarity=0.434 Sum_probs=216.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
+.++|++++.||+|+||.||+|.+..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|+
T Consensus 1 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 1 MMEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESED-DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp --CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CcccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEE
Confidence 46899999999999999999999999999999999876532 33345677899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+++++|.+++.. +.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 80 v~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~~ 157 (311)
T 4agu_A 80 VFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTG--PSD 157 (311)
T ss_dssp EEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccC--ccc
Confidence 9999999999998875 6799999999999999999999999999999999999999999999999999976542 223
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------- 233 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------- 233 (417)
.....+||+.|+|||++.+....+.++||||+||++|+|++|.+||.+.+..+....+...
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (311)
T 4agu_A 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFS 237 (311)
T ss_dssp --------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGT
T ss_pred ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccc
Confidence 3456789999999999987555569999999999999999999999998776655444321
Q ss_pred --CCCCC----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 --EYRCP----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 --~~~~p----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+.| +..++++.+||.+||++||.+|||++|+++||||++..
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 292 (311)
T 4agu_A 238 GVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR 292 (311)
T ss_dssp TCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence 01111 34688899999999999999999999999999998643
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-52 Score=404.49 Aligned_cols=260 Identities=31% Similarity=0.529 Sum_probs=233.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..+.++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+|+.++||||+++++++.+.
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 87 (321)
T 2a2a_A 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR 87 (321)
T ss_dssp SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS
T ss_pred hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 4577899999999999999999999999999999999987543221 1357789999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeecce
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGLSA 163 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGls~ 163 (417)
+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~ 167 (321)
T 2a2a_A 88 TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH 167 (321)
T ss_dssp SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence 999999999999999999976 6799999999999999999999999999999999999999888 79999999997
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----C
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----K 239 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~ 239 (417)
.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+....+..+ .
T Consensus 168 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 243 (321)
T 2a2a_A 168 EIED---GVEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFS 243 (321)
T ss_dssp ECCT---TCCCCCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHT
T ss_pred ecCc---cccccccCCCCCccCcccccCCCCC-CccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhc
Confidence 6543 2234556899999999999887774 999999999999999999999999998888888887776654 4
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 244 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 244 HTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp TCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred ccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 678999999999999999999999999999999753
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=411.94 Aligned_cols=267 Identities=27% Similarity=0.428 Sum_probs=212.6
Q ss_pred CCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE
Q 014849 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV 84 (417)
Q Consensus 5 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~ 84 (417)
+.+........++|++.+.||+|+||.||+|++..+|+.||||++..... .......+.+|+.+|+.++||||++++++
T Consensus 23 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (329)
T 3gbz_A 23 SVSAAPSATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSV 101 (329)
T ss_dssp ---------CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEE
T ss_pred eeccCCcccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEE
Confidence 34445567788999999999999999999999999999999999976542 23335567799999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-----CCCCeEEee
Q 014849 85 LATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-----ENWDLKISD 158 (417)
Q Consensus 85 ~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-----~~~~vkl~D 158 (417)
+.+...+|+||||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus 102 ~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~D 180 (329)
T 3gbz_A 102 IHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGD 180 (329)
T ss_dssp EEETTEEEEEEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred EecCCEEEEEEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECc
Confidence 9999999999999985 99998876 6799999999999999999999999999999999999995 444599999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YR 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~ 236 (417)
||++..... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+...++.... ..
T Consensus 181 fg~a~~~~~--~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~ 258 (329)
T 3gbz_A 181 FGLARAFGI--PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258 (329)
T ss_dssp TTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred CCCccccCC--cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCc
Confidence 999975432 22334556889999999999876655699999999999999999999999988777766664321 00
Q ss_pred ---------CCC-------------------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 237 ---------CPK-------------------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 237 ---------~p~-------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.+. ..++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 325 (329)
T 3gbz_A 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN 325 (329)
T ss_dssp TTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred hhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence 011 157899999999999999999999999999999864
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-52 Score=431.60 Aligned_cols=258 Identities=28% Similarity=0.459 Sum_probs=215.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+.. .......++.+|+.+|+.++||||+++++++...
T Consensus 59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 137 (464)
T 3ttj_A 59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLE 137 (464)
T ss_dssp EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTT
T ss_pred eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccc
Confidence 45789999999999999999999999999999999998653 2334467888999999999999999999999654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+||||+.+ +|.+.+.. .+++..++.++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 138 ~~~~~~lv~E~~~~-~l~~~~~~-~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 215 (464)
T 3ttj_A 138 EFQDVYLVMELMDA-NLCQVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 215 (464)
T ss_dssp TCCEEEEEEECCSE-EHHHHHTS-CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC----
T ss_pred cCCeEEEEEeCCCC-CHHHHHhh-cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecC
Confidence 478999999977 46666643 59999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
. .......+||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+.+.++.....
T Consensus 216 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~ 291 (464)
T 3ttj_A 216 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 291 (464)
T ss_dssp ----CCCC----CCCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred C---CcccCCCcccccccCHHHHcCCCCC-HHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence 2 3345678999999999999998886 899999999999999999999999988777766643110
Q ss_pred ----------------CCCCCC---------------ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 ----------------RCPKWT---------------SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 ----------------~~p~~~---------------s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+|..+ ++++.+||.+||+.||++|||++|+|+||||+....
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 364 (464)
T 3ttj_A 292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 364 (464)
T ss_dssp HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhccC
Confidence 000000 467899999999999999999999999999987554
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=395.35 Aligned_cols=264 Identities=35% Similarity=0.602 Sum_probs=229.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++++.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.+..
T Consensus 3 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (276)
T 2yex_A 3 VPFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQ 80 (276)
T ss_dssp HHHHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred CceecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEE
Confidence 3467899999999999999999999999999999999976543 23457889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~ 160 (276)
T 2yex_A 81 YLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (276)
T ss_dssp EEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred EEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc
Confidence 999999999999999976 5799999999999999999999999999999999999999999999999999976543333
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCC--CCCCChHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRC--PKWTSPDLKW 247 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~--p~~~s~~~~~ 247 (417)
.......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+.. ..+..+....... +...++.+.+
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (276)
T 2yex_A 161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLA 240 (276)
T ss_dssp ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTSTTGGGSCHHHHH
T ss_pred hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcccccCchhhcCHHHHH
Confidence 334556789999999999988777668999999999999999999999876533 3334444333222 3457899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||.+||+.||.+|||++|+++||||++...
T Consensus 241 li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 270 (276)
T 2yex_A 241 LLHKILVENPSARITIPDIKKDRWYNKPLK 270 (276)
T ss_dssp HHHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHHCCCCchhCCCHHHHhcCccccChhh
Confidence 999999999999999999999999987654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=430.12 Aligned_cols=259 Identities=39% Similarity=0.614 Sum_probs=226.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++++.||+|+||+||+|++..+++.||+|++.+..... .....+.+|+.+|+.++||||+++++++.+...+
T Consensus 33 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 111 (494)
T 3lij_A 33 GHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNY 111 (494)
T ss_dssp CCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred CchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEE
Confidence 456778999999999999999999999999999999998765332 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---WDLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---~~vkl~DFGls~~~~~ 167 (417)
|+|||||.||+|.+.+.. +++++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++.....
T Consensus 112 ~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~ 191 (494)
T 3lij_A 112 YLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191 (494)
T ss_dssp EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBT
T ss_pred EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCC
Confidence 999999999999998865 789999999999999999999999999999999999999764 4599999999986543
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 243 (417)
.......+||+.|+|||++.+ .| +.++|||||||++|+|++|.+||.+.+..++..++..+.+..+ ...++
T Consensus 192 ---~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 266 (494)
T 3lij_A 192 ---QKKMKERLGTAYYIAPEVLRK-KY-DEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSE 266 (494)
T ss_dssp ---TBCBCCCCSCTTTCCHHHHTT-CB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCH
T ss_pred ---CccccccCCCcCeeCHHHHcc-cC-CCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCH
Confidence 234456789999999999864 45 4899999999999999999999999999999999988876654 34789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++++||++||++||.+|||+.|+++||||++..
T Consensus 267 ~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~~ 299 (494)
T 3lij_A 267 GAKDLIKQMLQFDSQRRISAQQALEHPWIKEMC 299 (494)
T ss_dssp HHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHHH
T ss_pred HHHHHHHHHCCCChhhCccHHHHhcCcccccCc
Confidence 999999999999999999999999999998753
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-51 Score=401.90 Aligned_cols=254 Identities=28% Similarity=0.476 Sum_probs=226.6
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
.|+..+.||+|+||.||+|++..+|+.||||++..... ...+.+.+|+.+|+.++||||+++++++...+..|+|||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 122 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME 122 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 48999999999999999999999999999999976532 235678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccc
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT 176 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~ 176 (417)
|++|++|.+++...++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus 123 ~~~~~~L~~~l~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~~~~ 200 (321)
T 2c30_A 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKD--VPKRKS 200 (321)
T ss_dssp CCCSCBHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSS--SCCBCC
T ss_pred cCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccC--cccccc
Confidence 999999999998889999999999999999999999999999999999999999999999999998765432 223356
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---CCCCCChHHHHHHHHhc
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---CPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~~L 253 (417)
.+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.....+ .+...++.+.+||.+||
T Consensus 201 ~~gt~~y~aPE~~~~~~~~-~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l 279 (321)
T 2c30_A 201 LVGTPYWMAPEVISRSLYA-TEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERML 279 (321)
T ss_dssp CCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCCTTGGGSCHHHHHHHHHHS
T ss_pred ccCCccccCHhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCcCccccCCHHHHHHHHHHc
Confidence 7899999999999887775 8999999999999999999999998888877777655432 23456899999999999
Q ss_pred cCCCCCCCCHHHHhcCccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.||++|||+.|+++||||+...
T Consensus 280 ~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 280 VRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp CSSTTTSCCHHHHHTSGGGGGCC
T ss_pred cCChhhCcCHHHHhcChhhccCC
Confidence 99999999999999999998643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-52 Score=401.91 Aligned_cols=260 Identities=28% Similarity=0.425 Sum_probs=215.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCC---CCCcceEEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLR---HPNIVKLYEVLA 86 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~ 86 (417)
..+.++|++.+.||+|+||+||+|++..+|+.||+|++...... .......+.+|+.+++.++ ||||+++++++.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~ 84 (308)
T 3g33_A 5 SMATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCA 84 (308)
T ss_dssp -----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEE
T ss_pred cccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeee
Confidence 45678999999999999999999999999999999999765421 1222356678888887775 999999999998
Q ss_pred eCC-----EEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 87 TKA-----KIYFVMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 87 ~~~-----~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
+.. .+++||||+.| +|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D 163 (308)
T 3g33_A 85 TSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD 163 (308)
T ss_dssp ECCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred ccCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence 765 68999999974 999998763 399999999999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-- 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-- 236 (417)
||++.... ........+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+...++......
T Consensus 164 fg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~ 239 (308)
T 3g33_A 164 FGLARIYS---YQMALTPVVVTLWYRAPEVLLQSTYA-TPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 239 (308)
T ss_dssp CSCTTTST---TCCCSGGGGCCCSSCCHHHHHTSCCC-STHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred CccccccC---CCcccCCccccccccCchHHcCCCCC-chHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence 99997543 23345667899999999999888875 8999999999999999999999998888777766532100
Q ss_pred -------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 237 -------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 237 -------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+..++++.+||.+||++||++|||+.|+++||||++..
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~ 304 (308)
T 3g33_A 240 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304 (308)
T ss_dssp TTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred hhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence 0124678999999999999999999999999999998753
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-51 Score=401.37 Aligned_cols=262 Identities=31% Similarity=0.556 Sum_probs=219.8
Q ss_pred cccccCCeEEe-eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 11 EVNLFGKYEVG-KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 11 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
...+.++|++. +.||+|+||.||+|.+..+|+.||||++.... ......+.+|+.+|+++ +||||+++++++.+.
T Consensus 7 ~~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~ 83 (316)
T 2ac3_A 7 SGRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE 83 (316)
T ss_dssp CCCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET
T ss_pred CcccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC
Confidence 45678899995 88999999999999999999999999997653 23367788999999985 799999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEeeeeccee
Q 014849 89 AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLSAV 164 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~DFGls~~ 164 (417)
+.+|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++..
T Consensus 84 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~ 163 (316)
T 2ac3_A 84 DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSG 163 (316)
T ss_dssp TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-
T ss_pred CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccc
Confidence 999999999999999999976 78999999999999999999999999999999999999998876 99999999875
Q ss_pred ecccC-----CCCcccccccCccccccccccc-----cCCCCChhhHHHHHHHHHHHHcCCCCCCCCC------------
Q 014849 165 KEQIR-----PDGMLHTLCGTPAYVAPEILAK-----KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN------------ 222 (417)
Q Consensus 165 ~~~~~-----~~~~~~~~~Gt~~y~APEvl~~-----~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~------------ 222 (417)
..... ......+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~-~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~ 242 (316)
T 2ac3_A 164 IKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIY-DKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEAC 242 (316)
T ss_dssp ------------------CCSGGGCCHHHHHHTSHHHHHH-TTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CC
T ss_pred cccCCccccccccccccccCCcCccChHHhhcccccccCC-CcccccHhHHHHHHHHHHCCCCCcccccccccccccccc
Confidence 43211 1123345679999999999875 345 489999999999999999999998753
Q ss_pred ---HHHHHHHHhcCCCCCC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 223 ---LMAMYRKIYKGEYRCP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 223 ---~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
...++..+..+.+..| ...++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 243 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~ 303 (316)
T 2ac3_A 243 PACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA 303 (316)
T ss_dssp HHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred hhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence 3456677777777666 35789999999999999999999999999999998643
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=408.90 Aligned_cols=256 Identities=39% Similarity=0.640 Sum_probs=210.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++.+.||+|+||.||+|++..+++.||||++.... ..+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 123 (349)
T 2w4o_A 49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEI 123 (349)
T ss_dssp SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeE
Confidence 456788999999999999999999999999999999997643 245678899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~DFGls~~~~~ 167 (417)
|+||||+.||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||++.....
T Consensus 124 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~ 203 (349)
T 2w4o_A 124 SLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203 (349)
T ss_dssp EEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred EEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence 999999999999999876 67999999999999999999999999999999999999975 88999999999876432
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCC----CCCC
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP----KWTS 242 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p----~~~s 242 (417)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.. .++..+....+..+ ...+
T Consensus 204 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 279 (349)
T 2w4o_A 204 ---QVLMKTVCGTPGYCAPEILRGCAYG-PEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVS 279 (349)
T ss_dssp ------------CGGGSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSC
T ss_pred ---ccccccccCCCCccCHHHhcCCCCC-cccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCC
Confidence 2334567899999999999887774 9999999999999999999999775544 46777777665433 3468
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+++.+||.+||+.||++|||+.|+++||||+...
T Consensus 280 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 280 LNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313 (349)
T ss_dssp HHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTT
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 9999999999999999999999999999998643
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-52 Score=407.94 Aligned_cols=265 Identities=32% Similarity=0.508 Sum_probs=225.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc--ccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL--RGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~--~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..+.++|++++.||+|+||.||+|.+..+++.||+|++.+.... .......+.+|+.+|+.++||||+++++++.+.+
T Consensus 22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 101 (345)
T 3hko_A 22 LELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQ 101 (345)
T ss_dssp HHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSS
T ss_pred hhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCC
Confidence 45778999999999999999999999999999999999876432 2344678899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------------------------------------CCCCHHHHHHHHHHHHHHH
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------------------------------------GRFSEQLSRRYFQQLISAV 128 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------------------------------------~~l~e~~~~~i~~ql~~aL 128 (417)
..|+||||++||+|.+++.. ..+++..++.++.||+.||
T Consensus 102 ~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l 181 (345)
T 3hko_A 102 YICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSAL 181 (345)
T ss_dssp EEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHH
T ss_pred eEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHH
Confidence 99999999999999998851 1246788999999999999
Q ss_pred HHHHHcCCeecCCCCCcEEecCCC--CeEEeeeecceeecccCCCC--cccccccCcccccccccccc-CCCCChhhHHH
Q 014849 129 EYCHSRGVFHRDLKLENLLLDENW--DLKISDFGLSAVKEQIRPDG--MLHTLCGTPAYVAPEILAKK-GYDGAKVDMWS 203 (417)
Q Consensus 129 ~ylH~~givHrDlkp~NILl~~~~--~vkl~DFGls~~~~~~~~~~--~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwS 203 (417)
.|||++||+||||||+|||++.++ .+||+|||++.......... .....+||+.|+|||++.+. ...+.++||||
T Consensus 182 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 261 (345)
T 3hko_A 182 HYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261 (345)
T ss_dssp HHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred HHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence 999999999999999999998777 89999999998654322211 34567899999999998752 33358999999
Q ss_pred HHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 204 CGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 204 lGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|||++|+|++|..||.+.+..+....+.......+. ..++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence 999999999999999999988888888776654432 3689999999999999999999999999999998643
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-51 Score=406.58 Aligned_cols=265 Identities=29% Similarity=0.415 Sum_probs=223.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT---- 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~---- 87 (417)
....++|++++.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+|+.++||||+++++++.+
T Consensus 13 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 91 (351)
T 3mi9_A 13 CDEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASP 91 (351)
T ss_dssp SCBGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC---
T ss_pred cccccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccc
Confidence 3567999999999999999999999999999999999976543 23335677899999999999999999999977
Q ss_pred ----CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 88 ----KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 88 ----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
.+.+|+||||+.| +|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 92 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 92 YNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp -----CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred cccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchh
Confidence 4579999999986 77777765 6799999999999999999999999999999999999999999999999999
Q ss_pred ceeecccC--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 014849 162 SAVKEQIR--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239 (417)
Q Consensus 162 s~~~~~~~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 239 (417)
+....... ........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+.......+.......+.
T Consensus 171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~ 250 (351)
T 3mi9_A 171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250 (351)
T ss_dssp CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence 97654221 2234456789999999999987554569999999999999999999999998887777666543222111
Q ss_pred C--------------------------------CChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 240 W--------------------------------TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 240 ~--------------------------------~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
. .++.+.+||.+||+.||.+|||++|+++||||+....+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~ 321 (351)
T 3mi9_A 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMP 321 (351)
T ss_dssp TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCC
T ss_pred hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCc
Confidence 1 16779999999999999999999999999999875443
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-52 Score=412.18 Aligned_cols=256 Identities=33% Similarity=0.579 Sum_probs=226.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----GLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
..+.++|++.+.||+|+||.||+|++..+|+.||||++........ .....+.+|+.+|+.++||||+++++++.
T Consensus 20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~ 99 (335)
T 3dls_A 20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFE 99 (335)
T ss_dssp THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEE
T ss_pred cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 3567899999999999999999999999999999999987653222 12345678999999999999999999999
Q ss_pred eCCEEEEEEeccCCC-ChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 87 TKAKIYFVMEFAKGG-ELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg-~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
+.+.+|+||||+.+| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 100 ~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~ 179 (335)
T 3dls_A 100 NQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY 179 (335)
T ss_dssp CSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred eCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence 999999999999766 99999986 5899999999999999999999999999999999999999999999999999976
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChH
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
... .....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|..||.... .........|...+++
T Consensus 180 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~~~ 250 (335)
T 3dls_A 180 LER---GKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------ETVEAAIHPPYLVSKE 250 (335)
T ss_dssp CCT---TCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------GGTTTCCCCSSCCCHH
T ss_pred CCC---CCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------HHHhhccCCCcccCHH
Confidence 542 3345567899999999999988887789999999999999999999997632 2334455667778999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.+||.+||++||.+|||++++++||||++..
T Consensus 251 l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 251 LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred HHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 99999999999999999999999999998654
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-52 Score=399.25 Aligned_cols=264 Identities=36% Similarity=0.638 Sum_probs=230.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEE--EeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVL--ATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~--~~~~ 89 (417)
.+.++|++++.||+|+||.||+|.+..+++.||+|++....... ......+.+|+.+++.++||||+++++++ .+..
T Consensus 2 ~l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (305)
T 2wtk_C 2 KLIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQ 81 (305)
T ss_dssp ---CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---
T ss_pred ccccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCC
Confidence 46789999999999999999999999999999999998764322 23467889999999999999999999998 4556
Q ss_pred EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 KIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..|+||||+.++ |.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~ 160 (305)
T 2wtk_C 82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH 160 (305)
T ss_dssp CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence 899999999887 6666543 679999999999999999999999999999999999999999999999999998655
Q ss_pred ccCCCCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDL 245 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~ 245 (417)
............||+.|+|||++.+.. +.+.++|||||||++|+|++|..||.+.+.......+..+.+..|...++.+
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~l 240 (305)
T 2wtk_C 161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIPGDCGPPL 240 (305)
T ss_dssp TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCCSSSCHHH
T ss_pred ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCCCccCHHH
Confidence 433344455678999999999987643 3357999999999999999999999999999999999999989999999999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+||.+||+.||.+|||++|+++||||++...
T Consensus 241 ~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 241 SDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred HHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence 99999999999999999999999999987654
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=407.82 Aligned_cols=256 Identities=27% Similarity=0.404 Sum_probs=221.4
Q ss_pred CccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----CCCcceE
Q 014849 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----HPNIVKL 81 (417)
Q Consensus 7 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----HpnIv~l 81 (417)
++.....+.++|++.+.||+|+||+||+|++..+|+.||||++.... .......+|+.+++.++ ||||+++
T Consensus 26 ~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~h~~iv~~ 101 (360)
T 3llt_A 26 SWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIK----KYTRSAKIEADILKKIQNDDINNNNIVKY 101 (360)
T ss_dssp CCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCH----HHHHHHHHHHHHHHHTCCCSTTGGGBCCE
T ss_pred eeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccch----hhhhhhHHHHHHHHHhcccCCCCCCeecc
Confidence 34555678899999999999999999999999999999999997432 23456778999999997 9999999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--------
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-------- 150 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-------- 150 (417)
++++...+..|+||||+ |++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 102 ~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~ 180 (360)
T 3llt_A 102 HGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLI 180 (360)
T ss_dssp EEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEE
T ss_pred cceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccccccc
Confidence 99999999999999999 89999999763 5999999999999999999999999999999999999975
Q ss_pred -----------------CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc
Q 014849 151 -----------------NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA 213 (417)
Q Consensus 151 -----------------~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~ 213 (417)
++.+||+|||++..... .....+||+.|+|||++.+..|+ .++|||||||++|+|++
T Consensus 181 ~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~ 254 (360)
T 3llt_A 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLGWD-VSSDMWSFGCVLAELYT 254 (360)
T ss_dssp EEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHH
T ss_pred chhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCCCC-CccchHHHHHHHHHHHH
Confidence 78999999999975432 23456899999999999988875 99999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCC----------------------------------------------CCChHHHH
Q 014849 214 GYLPFNDPNLMAMYRKIYKGEYRCPK----------------------------------------------WTSPDLKW 247 (417)
Q Consensus 214 G~~Pf~~~~~~~~~~~i~~~~~~~p~----------------------------------------------~~s~~~~~ 247 (417)
|..||...+..+....+.....+.|. ..++.+.+
T Consensus 255 g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 334 (360)
T 3llt_A 255 GSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCD 334 (360)
T ss_dssp SSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHH
T ss_pred CCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHH
Confidence 99999998877766655443222221 12367789
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
||.+||++||.+|||++|+++||||+
T Consensus 335 li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 335 FLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp HHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred HHHHHhcCChhhCCCHHHHhcCcccC
Confidence 99999999999999999999999996
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-51 Score=416.00 Aligned_cols=269 Identities=26% Similarity=0.396 Sum_probs=215.1
Q ss_pred CccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 7 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
+..+...+.++|++++.||+|+||.||+|++..+|+.||||++.... .......++.+|+.+|+.++||||+++++++.
T Consensus 17 Q~~~~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~ 95 (432)
T 3n9x_A 17 QGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLII 95 (432)
T ss_dssp TCGGGCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECC
T ss_pred cCCCcceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEe
Confidence 33445678899999999999999999999999999999999997643 23334678899999999999999999999997
Q ss_pred eC-----CEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 87 TK-----AKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 87 ~~-----~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.. ..+|+||||+. ++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 96 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFG 174 (432)
T 3n9x_A 96 PDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFG 174 (432)
T ss_dssp CSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCT
T ss_pred cCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCC
Confidence 76 57999999996 499999987 579999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCC--------------------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC------
Q 014849 161 LSAVKEQIRPD--------------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG------ 214 (417)
Q Consensus 161 ls~~~~~~~~~--------------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G------ 214 (417)
++......... ....+.+||+.|+|||++......+.++||||||||+|+|++|
T Consensus 175 la~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 254 (432)
T 3n9x_A 175 LARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHIN 254 (432)
T ss_dssp TCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCS
T ss_pred CcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccc
Confidence 99865432211 2346789999999999975554446999999999999999984
Q ss_pred -----CCCCCCCC-----------------HHHHHHHH------------------------hcCCCCCC-------CCC
Q 014849 215 -----YLPFNDPN-----------------LMAMYRKI------------------------YKGEYRCP-------KWT 241 (417)
Q Consensus 215 -----~~Pf~~~~-----------------~~~~~~~i------------------------~~~~~~~p-------~~~ 241 (417)
.++|.+.+ .......+ .......+ +..
T Consensus 255 ~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 334 (432)
T 3n9x_A 255 DPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSI 334 (432)
T ss_dssp SGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTS
T ss_pred ccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCC
Confidence 44554432 01111111 11111111 347
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++++.+||.+||+.||.+|||++|+|+||||+....
T Consensus 335 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 370 (432)
T 3n9x_A 335 SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK 370 (432)
T ss_dssp CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence 899999999999999999999999999999987544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-52 Score=404.91 Aligned_cols=258 Identities=26% Similarity=0.449 Sum_probs=212.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
+++|++++.||+|+||.||+|.+..+|+.||+|++...... .....+.+|+.+|+.++||||+++++++.+.+..|+|
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 78 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLV 78 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEeccccc--ccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEE
Confidence 47899999999999999999999999999999999755321 1122345799999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.| +|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ...
T Consensus 79 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~--~~~ 155 (324)
T 3mtl_A 79 FEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSI--PTK 155 (324)
T ss_dssp EECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC-------
T ss_pred eccccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccC--Ccc
Confidence 999975 88888865 4699999999999999999999999999999999999999999999999999875432 223
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------------- 235 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 235 (417)
.....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.+...
T Consensus 156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 235 (324)
T 3mtl_A 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK 235 (324)
T ss_dssp -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence 345568999999999998755456999999999999999999999999888877766644110
Q ss_pred --C-----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 --R-----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 --~-----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
. .+...++++.+||.+||+.||.+|||++|+++||||.+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 290 (324)
T 3mtl_A 236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGE 290 (324)
T ss_dssp HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCS
T ss_pred ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhccc
Confidence 0 11235788999999999999999999999999999987544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-51 Score=411.84 Aligned_cols=257 Identities=27% Similarity=0.427 Sum_probs=217.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......++.+|+.+|+.++||||+++++++...
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~ 100 (367)
T 1cm8_A 22 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100 (367)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred eecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccc
Confidence 45789999999999999999999999999999999996643 2334467788999999999999999999999765
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+||||+ |++|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 179 (367)
T 1cm8_A 101 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 179 (367)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred cCceEEEEEecC-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence 3569999999 8899999988899999999999999999999999999999999999999999999999999997643
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
. .....+||+.|+|||++.+....+.++||||+||++|+|++|++||.+.+..+.+..+.....
T Consensus 180 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~ 254 (367)
T 1cm8_A 180 S-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254 (367)
T ss_dssp S-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred c-----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence 2 244568999999999998744345999999999999999999999999887776666543110
Q ss_pred --------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 --------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+...++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~ 315 (367)
T 1cm8_A 255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH 315 (367)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhc
Confidence 12234689999999999999999999999999999998643
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-51 Score=415.96 Aligned_cols=253 Identities=34% Similarity=0.621 Sum_probs=211.3
Q ss_pred ccccCCeEEe-eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCcceEEEEEEe--
Q 014849 12 VNLFGKYEVG-KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVKLYEVLAT-- 87 (417)
Q Consensus 12 ~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~HpnIv~l~~~~~~-- 87 (417)
..+.++|++. +.||+|+||+||+|.+..+|+.||||++... ..+.+|+.++ +..+||||+++++++..
T Consensus 57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~ 128 (400)
T 1nxk_A 57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLY 128 (400)
T ss_dssp SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEE
T ss_pred CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecc
Confidence 4567788887 7999999999999999999999999998632 3566888887 55689999999999876
Q ss_pred --CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEeee
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISDF 159 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~DF 159 (417)
...+|+|||||.||+|.+++.. ..+++.+++.++.||+.||.|||++||+||||||+|||++. ++.+||+||
T Consensus 129 ~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DF 208 (400)
T 1nxk_A 129 AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 208 (400)
T ss_dssp TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCC
T ss_pred cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEec
Confidence 6789999999999999999976 25999999999999999999999999999999999999997 788999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM----AMYRKIYKGEY 235 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~ 235 (417)
|++.... ......+.|||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+.. .+...+..+.+
T Consensus 209 G~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~ 284 (400)
T 1nxk_A 209 GFAKETT---SHNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 284 (400)
T ss_dssp TTCEECC--------------CTTCCGGGSCCCCSS-SHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCC
T ss_pred ccccccC---CCCccccCCCCCCccCHhhcCCCCCC-CcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcc
Confidence 9997543 23345678999999999999888885 9999999999999999999999765432 24555666665
Q ss_pred CCC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 RCP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 ~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..| ..+++++.+||++||+.||.+|||+.|+++||||+...
T Consensus 285 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 329 (400)
T 1nxk_A 285 EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 329 (400)
T ss_dssp CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTT
T ss_pred cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCC
Confidence 554 34799999999999999999999999999999998643
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-51 Score=396.42 Aligned_cols=258 Identities=38% Similarity=0.699 Sum_probs=227.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...+.++|++.+.||+|+||.||+|++..+|+.||+|++...... ....+.+|+.+++.++||||+++++++.+.+.
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (304)
T 2jam_A 4 TTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAF---RDSSLENEIAVLKKIKHENIVTLEDIYESTTH 80 (304)
T ss_dssp --CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred ccchhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccccc---chHHHHHHHHHHHhCCCCCeeehhhhcccCCE
Confidence 456788999999999999999999999999999999999865322 24568899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vkl~DFGls~~~~ 166 (417)
.|+||||++|++|.+.+.. +.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 81 YYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred EEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 9999999999999998875 789999999999999999999999999999999999999 788899999999986532
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 242 (417)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.+..+ ...+
T Consensus 161 ----~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 235 (304)
T 2jam_A 161 ----NGIMSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDIS 235 (304)
T ss_dssp ----CBTTHHHHSCCCBCCTTTBSSCSCC-HHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSC
T ss_pred ----CCccccccCCCCccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCC
Confidence 2234567899999999999887775 999999999999999999999999998888888887765443 4578
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+++.+||.+||..||.+|||++|+++||||+...
T Consensus 236 ~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 269 (304)
T 2jam_A 236 ESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT 269 (304)
T ss_dssp HHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred HHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence 9999999999999999999999999999998643
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=406.73 Aligned_cols=262 Identities=27% Similarity=0.432 Sum_probs=223.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.++|++.+.||+|+||.||+|.+..+++.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 102 (364)
T 3qyz_A 25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 102 (364)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCcccc
Confidence 4579999999999999999999999999999999997533 233457788999999999999999999999765
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
...|+||||+.| +|.+++..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 103 ~~~~iv~e~~~~-~L~~~l~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 103 KDVYIVQDLMET-DLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp CCEEEEEECCSE-EHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred ceEEEEEcccCc-CHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 479999999975 9999998889999999999999999999999999999999999999999999999999999865432
Q ss_pred CC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-------------
Q 014849 169 RP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------- 234 (417)
Q Consensus 169 ~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------- 234 (417)
.. .......+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 261 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 261 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCC
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhh
Confidence 22 2234567899999999997765544699999999999999999999999877666555543210
Q ss_pred ---------C---------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 235 ---------Y---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 235 ---------~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
. ..+...++++.+||.+||++||.+|||++|+++||||++.+.+
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~~~ 323 (364)
T 3qyz_A 262 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323 (364)
T ss_dssp HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhccCc
Confidence 0 0123468899999999999999999999999999999876543
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-51 Score=391.70 Aligned_cols=267 Identities=32% Similarity=0.564 Sum_probs=229.5
Q ss_pred CCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc------ccchHHHHHHHHHHHHhCC-CCCc
Q 014849 6 GDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL------RGGLTAHVKREISIMSRLR-HPNI 78 (417)
Q Consensus 6 ~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~------~~~~~~~i~~Ei~il~~l~-HpnI 78 (417)
++......+.++|++.+.||+|+||.||+|.+..+|+.||+|++...... .......+.+|+.+|+.+. ||||
T Consensus 7 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i 86 (298)
T 1phk_A 7 PGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86 (298)
T ss_dssp --------CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTB
T ss_pred ccccCCcchhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCE
Confidence 33444567899999999999999999999999999999999999765311 1223467789999999996 9999
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
+++++++.+....|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+
T Consensus 87 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~ 166 (298)
T 1phk_A 87 IQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLT 166 (298)
T ss_dssp CCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred eeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEe
Confidence 9999999999999999999999999999976 689999999999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCcccccccccc------ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA------KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~------~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 231 (417)
|||++..... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...+.......+.
T Consensus 167 dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 242 (298)
T 1phk_A 167 DFGFSCQLDP---GEKLREVCGTPSYLAPEIIECSMNDNHPGY-GKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM 242 (298)
T ss_dssp CCTTCEECCT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCB-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccchhhcCC---CcccccccCCccccCHHHhccccccccccC-CcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence 9999876542 33445678999999999985 2334 589999999999999999999999999888888888
Q ss_pred cCCCCCC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 232 KGEYRCP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 232 ~~~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+.+..+ ...++.+.+||.+||+.||.+|||+.|+++||||++..
T Consensus 243 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (298)
T 1phk_A 243 SGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYV 291 (298)
T ss_dssp HTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred cCCcccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhcc
Confidence 7766543 24688999999999999999999999999999998654
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-51 Score=411.94 Aligned_cols=255 Identities=31% Similarity=0.519 Sum_probs=221.6
Q ss_pred ccCCeEE--eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 14 LFGKYEV--GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 14 ~~~~y~i--~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
+.+.|++ .+.||+|+||.||+|.+..+|+.||+|++..... ...+.+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 161 (373)
T 2x4f_A 85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGM---KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDI 161 (373)
T ss_dssp GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEccccc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEE
Confidence 4456666 6789999999999999999999999999976542 2356788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe--cCCCCeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl--~~~~~vkl~DFGls~~~~~ 167 (417)
|+||||++|++|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++.....
T Consensus 162 ~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~ 241 (373)
T 2x4f_A 162 VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241 (373)
T ss_dssp EEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCT
T ss_pred EEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCC
Confidence 999999999999998864 469999999999999999999999999999999999999 5677899999999976542
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 243 (417)
.......+||+.|+|||++....++ .++|||||||++|+|++|..||.+.+..+.+.++....+..+ ...++
T Consensus 242 ---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 317 (373)
T 2x4f_A 242 ---REKLKVNFGTPEFLAPEVVNYDFVS-FPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISE 317 (373)
T ss_dssp ---TCBCCCCCSSCTTCCHHHHTTCBCC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCH
T ss_pred ---ccccccccCCCcEeChhhccCCCCC-cHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCH
Confidence 2344566899999999999877664 899999999999999999999999998888888887766554 45789
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 318 ~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 318 EAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 99999999999999999999999999999864
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-51 Score=405.84 Aligned_cols=259 Identities=36% Similarity=0.663 Sum_probs=228.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL-----RGGLTAHVKREISIMSRL-RHPNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~ 85 (417)
..+.++|++.+.||+|+||.||+|++..+|+.||||++...... .......+.+|+.+++.+ +||||+++++++
T Consensus 90 ~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 169 (365)
T 2y7j_A 90 KEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSY 169 (365)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred hhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEE
Confidence 34568899999999999999999999999999999999765311 122345778999999999 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
...+..|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..
T Consensus 170 ~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~ 249 (365)
T 2y7j_A 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCH 249 (365)
T ss_dssp EBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred eeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccc
Confidence 999999999999999999999976 6899999999999999999999999999999999999999999999999999876
Q ss_pred ecccCCCCcccccccCcccccccccccc------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKK------GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP 238 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~------~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p 238 (417)
... .......+||+.|+|||++.+. .| +.++|||||||++|+|++|..||...+.......+..+.+..+
T Consensus 250 ~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~-~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~ 325 (365)
T 2y7j_A 250 LEP---GEKLRELCGTPGYLAPEILKCSMDETHPGY-GKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFS 325 (365)
T ss_dssp CCT---TCCBCCCCSCGGGCCHHHHHHTTCTTSCCB-CTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred cCC---CcccccCCCCCCccChhhccccccccCcCC-CchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC
Confidence 542 3345567899999999998632 34 5899999999999999999999999988888888887776543
Q ss_pred ----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 239 ----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 239 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...++.+.+||.+||+.||.+|||++|+++||||++
T Consensus 326 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 326 SPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 357889999999999999999999999999999974
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-51 Score=420.45 Aligned_cols=263 Identities=26% Similarity=0.410 Sum_probs=200.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----- 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----- 87 (417)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+.. .......++.+|+.+|+.++||||+++++++..
T Consensus 50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~ 128 (458)
T 3rp9_A 50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128 (458)
T ss_dssp CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTT
T ss_pred ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCccc
Confidence 45689999999999999999999999999999999997643 233346788899999999999999999999843
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...+|+||||+ +++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||++....
T Consensus 129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~ 207 (458)
T 3rp9_A 129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207 (458)
T ss_dssp CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence 35799999998 5689998876 679999999999999999999999999999999999999999999999999997653
Q ss_pred ccCC-------------------------CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc--------
Q 014849 167 QIRP-------------------------DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-------- 213 (417)
Q Consensus 167 ~~~~-------------------------~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-------- 213 (417)
.... .......+||+.|+|||++......+.++||||||||+|+|++
T Consensus 208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~ 287 (458)
T 3rp9_A 208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY 287 (458)
T ss_dssp SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence 2111 1234567899999999987544434599999999999999998
Q ss_pred ---CCCCCCCCCH--------------------HHHHHHHhc--C--------------------CC---------CCCC
Q 014849 214 ---GYLPFNDPNL--------------------MAMYRKIYK--G--------------------EY---------RCPK 239 (417)
Q Consensus 214 ---G~~Pf~~~~~--------------------~~~~~~i~~--~--------------------~~---------~~p~ 239 (417)
|.+||.+.+. .+....|.. + .+ ...+
T Consensus 288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 367 (458)
T 3rp9_A 288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP 367 (458)
T ss_dssp GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence 7788866441 111111110 0 00 0113
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..++++.+||++||+.||.+|||++|+|+||||+....
T Consensus 368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~ 405 (458)
T 3rp9_A 368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI 405 (458)
T ss_dssp TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence 45899999999999999999999999999999987543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-51 Score=389.48 Aligned_cols=259 Identities=32% Similarity=0.564 Sum_probs=227.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
+.++|++++.||+|+||.||+|++..+|+.||+|++........ ...+.+.+|+.+|+.++||||+++++++.+...
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 82 (283)
T 3bhy_A 3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTD 82 (283)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCe
Confidence 45789999999999999999999999999999999987643321 236788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGls~~~ 165 (417)
.|+||||+++++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+||+++.++ .+||+|||++...
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 83 VVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 9999999999999999975 7899999999999999999999999999999999999998877 8999999998765
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWT 241 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 241 (417)
.. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+....+.......+ ...
T Consensus 163 ~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (283)
T 3bhy_A 163 EA---GNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNT 238 (283)
T ss_dssp C-----------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred cC---CCcccccCCCcCccCcceecCCCCC-cchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccC
Confidence 32 2233456799999999999877774 999999999999999999999999998888888877666544 467
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
++.+.+||.+||..||++|||+.|+++||||+...
T Consensus 239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 89999999999999999999999999999998654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=397.67 Aligned_cols=263 Identities=30% Similarity=0.427 Sum_probs=228.2
Q ss_pred ccccccCCeEEe-eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEe
Q 014849 10 REVNLFGKYEVG-KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLAT 87 (417)
Q Consensus 10 ~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~ 87 (417)
....+.++|.+. +.||+|+||.||+|++..+|+.||+|++...... ......+.+|+.+++.+. ||||+++++++.+
T Consensus 22 ~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~ 100 (327)
T 3lm5_A 22 SMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYEN 100 (327)
T ss_dssp CHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred HHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEe
Confidence 335788899998 9999999999999999999999999999876432 334677889999999995 6999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEeeeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISDFGL 161 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~DFGl 161 (417)
...+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~ 180 (327)
T 3lm5_A 101 TSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGM 180 (327)
T ss_dssp SSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGG
T ss_pred CCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcc
Confidence 9999999999999999999854 67999999999999999999999999999999999999988 78999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC---
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP--- 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 238 (417)
+..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus 181 a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 256 (327)
T 3lm5_A 181 SRKIGH---ACELREIMGTPEYLAPEILNYDPIT-TATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEET 256 (327)
T ss_dssp CEEC------------CCCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT
T ss_pred ccccCC---ccccccccCCcCccCCeeecCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchh
Confidence 976542 2234557899999999999888775 999999999999999999999999998888887776654433
Q ss_pred -CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 239 -KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 239 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
...++.+.+||.+||+.||.+|||++++++||||+....
T Consensus 257 ~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~ 296 (327)
T 3lm5_A 257 FSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296 (327)
T ss_dssp TTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred hcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence 357899999999999999999999999999999987543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-52 Score=404.02 Aligned_cols=267 Identities=23% Similarity=0.398 Sum_probs=225.2
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
+.....+.++|++++.||+|+||.||+|++..+|+.||+|++.............+.+|+.+++.++||||+++++++..
T Consensus 4 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 83 (311)
T 3ork_A 4 MTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEA 83 (311)
T ss_dssp CCCCSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEE
T ss_pred CCCcceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeec
Confidence 44556789999999999999999999999999999999999987655555556788999999999999999999999865
Q ss_pred CC----EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 88 KA----KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 88 ~~----~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
.. ..|+||||++|++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 84 ~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a 163 (311)
T 3ork_A 84 ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIA 163 (311)
T ss_dssp EETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC
T ss_pred cCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCc
Confidence 54 45999999999999999975 78999999999999999999999999999999999999999999999999999
Q ss_pred eeecccC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----
Q 014849 163 AVKEQIR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC---- 237 (417)
Q Consensus 163 ~~~~~~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~---- 237 (417)
....... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.......
T Consensus 164 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 242 (311)
T 3ork_A 164 RAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSAR 242 (311)
T ss_dssp ------------------CCTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHH
T ss_pred ccccccccccccccccCcCcccCCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccc
Confidence 7543321 11233456799999999999888775 89999999999999999999999988887776666555433
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+...++++.+||.+||+.||.+||+..+++.|+|++..
T Consensus 243 ~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~ 280 (311)
T 3ork_A 243 HEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH 280 (311)
T ss_dssp STTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred cCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence 24578999999999999999999999999999999853
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-51 Score=387.15 Aligned_cols=257 Identities=19% Similarity=0.285 Sum_probs=218.5
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT 87 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~ 87 (417)
.....+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.++..+ +||||+++++++.+
T Consensus 4 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~ 82 (289)
T 1x8b_A 4 GMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAG-SVDEQNALREVYAHAVLGQHSHVVRYFSAWAE 82 (289)
T ss_dssp -CCCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTT-SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE
T ss_pred cccccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec
Confidence 34456788999999999999999999999999999999999865432 22356788999999999 99999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-----------
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN----------- 151 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~----------- 151 (417)
.+..|+||||++|++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~ 162 (289)
T 1x8b_A 83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162 (289)
T ss_dssp TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC-------------
T ss_pred CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccc
Confidence 9999999999999999999864 569999999999999999999999999999999999999844
Q ss_pred --------CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 014849 152 --------WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL 223 (417)
Q Consensus 152 --------~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~ 223 (417)
..+||+|||++..... ....+||+.|+|||++.+....+.++|||||||++|+|++|.+|+.....
T Consensus 163 ~~~~~~~~~~~kl~Dfg~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~ 236 (289)
T 1x8b_A 163 EDDWASNKVMFKIGDLGHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ 236 (289)
T ss_dssp -------CCCEEECCCTTCEETTC------SCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH
T ss_pred cccccCCceEEEEcccccccccCC------ccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH
Confidence 4799999999876432 12346999999999998765555899999999999999999988766543
Q ss_pred HHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 224 MAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 224 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...+..+. ...|...++++.+||.+||+.||.+|||+.|+++||||++.
T Consensus 237 ---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 237 ---WHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA 286 (289)
T ss_dssp ---HHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred ---HHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence 33444444 35677889999999999999999999999999999999864
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-51 Score=392.40 Aligned_cols=264 Identities=26% Similarity=0.356 Sum_probs=222.7
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
...+..+.++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~g~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~ 82 (294)
T 4eqm_A 3 HMIGKIINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE 82 (294)
T ss_dssp -CCSSCEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC
T ss_pred cchhhHhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee
Confidence 34566788999999999999999999999999999999999977655555556788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+.+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 83 ~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 162 (294)
T 4eqm_A 83 DDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALS 162 (294)
T ss_dssp SSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-
T ss_pred CCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccc
Confidence 9999999999999999999976 789999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-----CCCCC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR-----CPKWT 241 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~-----~p~~~ 241 (417)
.. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+......+......+ .+...
T Consensus 163 ~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (294)
T 4eqm_A 163 ET-SLTQTNHVLGTVQYFSPEQAKGEATD-ECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDI 240 (294)
T ss_dssp -------------CCSSCCHHHHHTCCCC-TTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTS
T ss_pred cc-cccccCccccCccccCHhHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCC
Confidence 22 11233456899999999999887774 8999999999999999999999998877766555554432 34567
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
++.+.++|.+||.+||.+||+..+.+.+.|..
T Consensus 241 ~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~ 272 (294)
T 4eqm_A 241 PQSLSNVILRATEKDKANRYKTIQEMKDDLSS 272 (294)
T ss_dssp CHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHT
T ss_pred CHHHHHHHHHHhcCCHhHccccHHHHHHHHHH
Confidence 89999999999999999999655555555543
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-51 Score=404.03 Aligned_cols=261 Identities=30% Similarity=0.426 Sum_probs=215.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...++|++++.||+|+||.||+|.+..+|+.||+|++....... ......+.+|+.+++.++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 45689999999999999999999999999999999997643221 1223467899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.|+||||+.+ +|.+.+.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~- 164 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS- 164 (346)
T ss_dssp CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS-
T ss_pred eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccC-
Confidence 9999999986 88888875 4699999999999999999999999999999999999999999999999999975432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CC---------C
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YR---------C 237 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~---------~ 237 (417)
........+||+.|+|||++.+....+.++|||||||++|+|++|.+||.+.+..+.+.++.... .. .
T Consensus 165 -~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 243 (346)
T 1ua2_A 165 -PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243 (346)
T ss_dssp -CCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred -CcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccC
Confidence 23344567899999999999765544689999999999999999999999988887777665421 00 0
Q ss_pred -----------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 238 -----------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 238 -----------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
....++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 244 PDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 299 (346)
T ss_dssp TTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCC
Confidence 133468899999999999999999999999999998754
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-51 Score=400.28 Aligned_cols=258 Identities=24% Similarity=0.412 Sum_probs=212.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-- 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-- 89 (417)
.++.++|++.+.||+|+||.||+|++..+|+.||||++.... .....+.+.+|+.+|+.++||||+++++++.+..
T Consensus 2 s~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~ 79 (332)
T 3qd2_B 2 SRYLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPE 79 (332)
T ss_dssp CHHHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSC
T ss_pred chhhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccc
Confidence 356789999999999999999999999999999999997654 3334678899999999999999999999985543
Q ss_pred -------------------------------------------------------EEEEEEeccCCCChHHHHhcC----
Q 014849 90 -------------------------------------------------------KIYFVMEFAKGGELFAKISKG---- 110 (417)
Q Consensus 90 -------------------------------------------------------~~~lV~E~~~gg~L~~~i~~~---- 110 (417)
.+|+|||||+|++|.+++...
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~ 159 (332)
T 3qd2_B 80 KWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLE 159 (332)
T ss_dssp HHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGG
T ss_pred hhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCcc
Confidence 489999999999999999762
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC----------CCcccccccC
Q 014849 111 RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP----------DGMLHTLCGT 180 (417)
Q Consensus 111 ~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~----------~~~~~~~~Gt 180 (417)
..++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ .......+||
T Consensus 160 ~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt 239 (332)
T 3qd2_B 160 DREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGT 239 (332)
T ss_dssp GSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-C
T ss_pred chhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCC
Confidence 356677999999999999999999999999999999999999999999999986543211 1223456899
Q ss_pred ccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-CCCCChHHHHHHHHhccCCCCC
Q 014849 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC-PKWTSPDLKWFIGRLLDTDPAT 259 (417)
Q Consensus 181 ~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~-p~~~s~~~~~li~~~L~~dP~~ 259 (417)
+.|+|||++.+..++ .++|||||||++|+|++|..|+... ......+.....+. +...++++.+||.+||++||.+
T Consensus 240 ~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 316 (332)
T 3qd2_B 240 KLYMSPEQIHGNNYS-HKVDIFSLGLILFELLYSFSTQMER--VRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE 316 (332)
T ss_dssp GGGSCHHHHHCCCCC-THHHHHHHHHHHHHHHSCCCCHHHH--HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred cCccChHHhcCCCCc-chhhHHHHHHHHHHHHHcCCChhHH--HHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence 999999999888775 9999999999999999998775322 23333333333221 1234788899999999999999
Q ss_pred CCCHHHHhcCccccc
Q 014849 260 RITVDEILRDPWFKK 274 (417)
Q Consensus 260 R~t~~eil~h~~f~~ 274 (417)
|||++|+++||||++
T Consensus 317 Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 317 RPEATDIIENAIFEN 331 (332)
T ss_dssp SCCHHHHHHSTTCCC
T ss_pred CCCHHHHhhchhhhc
Confidence 999999999999975
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=400.62 Aligned_cols=260 Identities=28% Similarity=0.407 Sum_probs=218.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.+|+.+++.++||||+++++++.+.+..|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 100 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDD-DKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY 100 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCC-chHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEE
Confidence 357899999999999999999999999999999999976542 2334566789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ..
T Consensus 101 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~--~~ 178 (331)
T 4aaa_A 101 LVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAA--PG 178 (331)
T ss_dssp EEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred EEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecC--Cc
Confidence 99999999999888764 7899999999999999999999999999999999999999999999999999975432 22
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC------------------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------ 233 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------------ 233 (417)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+...
T Consensus 179 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 258 (331)
T 4aaa_A 179 EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVF 258 (331)
T ss_dssp -----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGG
T ss_pred cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhcccc
Confidence 33456789999999999987645569999999999999999999999988776655544321
Q ss_pred -CCCC------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 234 -EYRC------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 234 -~~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.... .+..++.+.+||.+||+.||.+|||+.|+++||||+..
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~ 313 (331)
T 4aaa_A 259 AGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD 313 (331)
T ss_dssp TTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred ccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence 0111 12468899999999999999999999999999999864
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-50 Score=400.61 Aligned_cols=255 Identities=26% Similarity=0.413 Sum_probs=223.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
...+|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+|+.++||||+++++++.+.+..|+
T Consensus 52 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~l 131 (348)
T 1u5q_A 52 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 131 (348)
T ss_dssp HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEE
Confidence 34679999999999999999999999999999999987644444445678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||+. |+|.+.+. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 132 v~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---- 206 (348)
T 1u5q_A 132 VMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---- 206 (348)
T ss_dssp EEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS----
T ss_pred EEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC----
Confidence 999997 47877775 36899999999999999999999999999999999999999999999999999875432
Q ss_pred CcccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC--CCCCCChHHH
Q 014849 172 GMLHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLK 246 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~--~p~~~s~~~~ 246 (417)
....+||+.|+|||++. ...| +.++|||||||++|+|++|..||...+.......+.....+ .+...++.+.
T Consensus 207 --~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 283 (348)
T 1u5q_A 207 --ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFR 283 (348)
T ss_dssp --BCCCCSCGGGCCHHHHHTTSSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCCTTSCHHHH
T ss_pred --CCcccCCcceeCHhhhccccCCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCCCCCCHHHH
Confidence 23568999999999985 3445 48999999999999999999999988877776666655433 2456789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+||.+||+.||++|||++++++||||....
T Consensus 284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred HHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999999999999999999999997643
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-51 Score=395.27 Aligned_cols=252 Identities=22% Similarity=0.344 Sum_probs=207.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh-CCCCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~-l~HpnIv~l~~~~~~~~~~ 91 (417)
.+.++|++.+.||+|+||+||+|++..+|+.||||++......... .....+|+..+.. .+||||+++++++.+.+.+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~-~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~ 132 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKD-RARKLAEVGSHEKVGQHPCCVRLEQAWEEGGIL 132 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHH-HHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHH-HHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEE
Confidence 3457899999999999999999999999999999998664332222 3344455555544 4999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 133 ~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~-- 209 (311)
T 3p1a_A 133 YLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT-- 209 (311)
T ss_dssp EEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred EEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc--
Confidence 9999999 6689888765 5699999999999999999999999999999999999999999999999999876542
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC--CCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY--RCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~~~ 247 (417)
.......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||..... ...+..+.. ..+...++++.+
T Consensus 210 -~~~~~~~~gt~~y~aPE~~~~-~~-~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~l~~ 283 (311)
T 3p1a_A 210 -AGAGEVQEGDPRYMAPELLQG-SY-GTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQGYLPPEFTAGLSSELRS 283 (311)
T ss_dssp ------CCCCCGGGCCGGGGGT-CC-STHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTTTCCCHHHHTTSCHHHHH
T ss_pred -CCCCcccCCCccccCHhHhcC-CC-CchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhccCCCcccccCCCHHHHH
Confidence 233455679999999999876 55 5899999999999999999776655332 333333332 234567899999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
||.+||++||++|||++|+++||||++
T Consensus 284 li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 284 VLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred HHHHHcCCChhhCcCHHHHHhCccccC
Confidence 999999999999999999999999985
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=411.92 Aligned_cols=259 Identities=38% Similarity=0.678 Sum_probs=212.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc-----chHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG-----GLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~-----~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
..+.++|++.+.||+|+||+||+|.+..+++.||+|++.+...... .....+.+|+.+|+.++||||+++++++.
T Consensus 131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~ 210 (419)
T 3i6u_A 131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 210 (419)
T ss_dssp HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 4567899999999999999999999999999999999987653211 12235789999999999999999999975
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEEeeeecc
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKISDFGLS 162 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl~DFGls 162 (417)
. ...|+||||+.||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus 211 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a 289 (419)
T 3i6u_A 211 A-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 289 (419)
T ss_dssp S-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTT
T ss_pred c-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeecccc
Confidence 4 568999999999999998876 7899999999999999999999999999999999999997654 5999999999
Q ss_pred eeecccCCCCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYRCP 238 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~~p 238 (417)
..... .....+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|.+||..... ..+...+..+.+..+
T Consensus 290 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~ 365 (419)
T 3i6u_A 290 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 365 (419)
T ss_dssp TSCC--------------CTTCCTTTTC----CTT-HHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCC
T ss_pred eecCC---CccccccCCCCCccCceeeecCCCCCC-CchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCC
Confidence 76542 334567789999999999864 344 4899999999999999999999986543 244555666655443
Q ss_pred ----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 ----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 366 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 366 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred chhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 3578999999999999999999999999999999864
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-51 Score=405.36 Aligned_cols=258 Identities=28% Similarity=0.441 Sum_probs=211.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
.+.++|++++.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+|+.++||||+++++++....
T Consensus 22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 100 (371)
T 2xrw_A 22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLE 100 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTT
T ss_pred chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccc
Confidence 467899999999999999999999999999999999976532 3334567889999999999999999999997665
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+|+||||+.| +|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 101 ~~~~~~lv~e~~~~-~l~~~~~-~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~ 178 (371)
T 2xrw_A 101 EFQDVYIVMELMDA-NLCQVIQ-MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG 178 (371)
T ss_dssp TCCEEEEEEECCSE-EHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC-----
T ss_pred cccceEEEEEcCCC-CHHHHHh-hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccccc
Confidence 89999999976 7888775 569999999999999999999999999999999999999999999999999997543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC---------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--------- 237 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--------- 237 (417)
. .......+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+....+.++.......
T Consensus 179 ~---~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 254 (371)
T 2xrw_A 179 T---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ 254 (371)
T ss_dssp --------------CTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred c---ccccCCceecCCccCHHHhcCCCCC-chHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 2234567899999999999988875 89999999999999999999999988877777665421100
Q ss_pred ----------CC-----------------C------CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 238 ----------PK-----------------W------TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 238 ----------p~-----------------~------~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|. . .++++++||++||+.||.+|||++|+++||||+....
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~~ 327 (371)
T 2xrw_A 255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVWYD 327 (371)
T ss_dssp HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhhcC
Confidence 00 0 1467899999999999999999999999999986543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-50 Score=387.45 Aligned_cols=261 Identities=27% Similarity=0.479 Sum_probs=232.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.....+|++++.||+|+||.||+|++..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+....
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 95 (303)
T 3a7i_A 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKL 95 (303)
T ss_dssp ECGGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEE
T ss_pred CChHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeE
Confidence 3456789999999999999999999999999999999986643 23467889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|+||||++|++|.+++..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus 96 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~--~ 173 (303)
T 3a7i_A 96 WIIMEYLGGGSALDLLEPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT--Q 173 (303)
T ss_dssp EEEEECCTTEEHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTT--B
T ss_pred EEEEEeCCCCcHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcc--c
Confidence 99999999999999999899999999999999999999999999999999999999999999999999999765432 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCCChHHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIG 250 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~ 250 (417)
......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..... ..+...++.+.+||.
T Consensus 174 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 252 (303)
T 3a7i_A 174 IKRNTFVGTPFWMAPEVIKQSAYD-SKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYSKPLKEFVE 252 (303)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCCSSCCHHHHHHHH
T ss_pred cccCccCCCcCccCHHHHhcCCCC-chhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCCCccccCHHHHHHHH
Confidence 233456899999999999887775 899999999999999999999999887777766655443 456678999999999
Q ss_pred HhccCCCCCCCCHHHHhcCcccccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+||+.||.+|||+.++++||||.+...
T Consensus 253 ~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 253 ACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp HHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred HHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 999999999999999999999986543
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-51 Score=406.26 Aligned_cols=258 Identities=24% Similarity=0.388 Sum_probs=204.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK---- 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~---- 88 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+|+.++||||+++++++...
T Consensus 26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 104 (367)
T 2fst_X 26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104 (367)
T ss_dssp EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccc
Confidence 45689999999999999999999999999999999997643 2233456788999999999999999999998654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+|+|++ +++|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 105 ~~~~~~lv~e~~-~~~L~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~ 183 (367)
T 2fst_X 105 EFNDVYLVTHLM-GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA 183 (367)
T ss_dssp GCCCCEEEEECC-CEECC-----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC--------
T ss_pred cCCeEEEEeccc-CCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccccc
Confidence 5689999999 7899999988899999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------------ 234 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------------ 234 (417)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+.+..
T Consensus 184 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~ 258 (367)
T 2fst_X 184 D-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS 258 (367)
T ss_dssp ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred c-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence 2 23456899999999999874444699999999999999999999999988777666554310
Q ss_pred -----------CCC--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 235 -----------YRC--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 235 -----------~~~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
... ....++++.+||.+||+.||.+|||++|+++||||+....
T Consensus 259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~ 320 (367)
T 2fst_X 259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320 (367)
T ss_dssp CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccC
Confidence 001 1235788999999999999999999999999999986543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-50 Score=398.33 Aligned_cols=259 Identities=27% Similarity=0.434 Sum_probs=214.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKAKI 91 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~ 91 (417)
..++|++.+.||+|+||.||+|.+ .+++.||||++..... .......+.+|+.+|+.++| |||+++++++.+...+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeecccc-chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 456799999999999999999998 5799999999986543 23345778899999999987 9999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||| +.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........
T Consensus 85 ~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~ 162 (343)
T 3dbq_A 85 YMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT 162 (343)
T ss_dssp EEEEC-CCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC-----
T ss_pred EEEEe-CCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc
Confidence 99999 557899999976 6899999999999999999999999999999999999997 57899999999976544333
Q ss_pred CCcccccccCccccccccccc-----------cCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcC--CCC
Q 014849 171 DGMLHTLCGTPAYVAPEILAK-----------KGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKG--EYR 236 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~-----------~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~--~~~ 236 (417)
.......+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||... +.......+... ...
T Consensus 163 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~ 241 (343)
T 3dbq_A 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI-SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE 241 (343)
T ss_dssp -------CCCCSSCCHHHHHHCC-----------C-CHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC
T ss_pred cccCCCCcCCcCcCCHHHHhhccccccccccccCC-CchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccC
Confidence 334456789999999999865 334 58999999999999999999999874 333444444433 345
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.|...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~ 282 (343)
T 3dbq_A 242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 282 (343)
T ss_dssp CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC
T ss_pred CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCC
Confidence 67778899999999999999999999999999999986543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=409.26 Aligned_cols=255 Identities=28% Similarity=0.440 Sum_probs=216.5
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC------CCCCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL------RHPNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l------~HpnIv~l~~~~ 85 (417)
..+.++|++++.||+|+||.||+|.+..+++.||||++.... ....++.+|+.+++.+ +||||+++++++
T Consensus 93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~ 168 (429)
T 3kvw_A 93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENF 168 (429)
T ss_dssp CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEE
T ss_pred CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeec
Confidence 456789999999999999999999999999999999997543 2345677888888877 577999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--eEEeeee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--LKISDFG 160 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--vkl~DFG 160 (417)
.....+|+||||+. ++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||
T Consensus 169 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG 247 (429)
T 3kvw_A 169 TFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247 (429)
T ss_dssp EETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred ccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecc
Confidence 99999999999996 589998875 34999999999999999999999999999999999999999987 9999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC----
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---- 236 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---- 236 (417)
+|.... ....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+....+......
T Consensus 248 ~a~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~ 321 (429)
T 3kvw_A 248 SSCYEH-----QRVYTYIQSRFYRAPEVILGARYG-MPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQK 321 (429)
T ss_dssp TCEETT-----CCCCSSCSCGGGCCHHHHHTBCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred cceecC-----CcccccCCCCCccChHHHhCCCCC-chHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHH
Confidence 986532 234567899999999999988875 9999999999999999999999998877666554321000
Q ss_pred -------------------------------------------------------CCCCCChHHHHHHHHhccCCCCCCC
Q 014849 237 -------------------------------------------------------CPKWTSPDLKWFIGRLLDTDPATRI 261 (417)
Q Consensus 237 -------------------------------------------------------~p~~~s~~~~~li~~~L~~dP~~R~ 261 (417)
.+...++++.+||.+||++||++||
T Consensus 322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rp 401 (429)
T 3kvw_A 322 LLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRM 401 (429)
T ss_dssp HHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSC
T ss_pred HHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCC
Confidence 0112367899999999999999999
Q ss_pred CHHHHhcCcccccccc
Q 014849 262 TVDEILRDPWFKKDYK 277 (417)
Q Consensus 262 t~~eil~h~~f~~~~~ 277 (417)
|++|+|+||||++...
T Consensus 402 ta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 402 TPGQALRHPWLRRRLP 417 (429)
T ss_dssp CHHHHHTSTTTC----
T ss_pred CHHHHhCChhhccCCC
Confidence 9999999999997543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-50 Score=383.39 Aligned_cols=254 Identities=25% Similarity=0.505 Sum_probs=219.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----CCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----KAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----~~~ 90 (417)
..+|++.+.||+|+||.||+|.+..++..||+|++...... ......+.+|+.+|+.++||||+++++++.. ...
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 103 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKC 103 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCce
Confidence 44689999999999999999999999999999999876542 3346778899999999999999999999865 467
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEec-CCCCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLD-ENWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~-~~~~vkl~DFGls~~~~ 166 (417)
+|+||||+++++|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++ .++.+||+|||++....
T Consensus 104 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~ 183 (290)
T 1t4h_A 104 IVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 183 (290)
T ss_dssp EEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccc
Confidence 9999999999999999987 78999999999999999999999999 99999999999997 78999999999986432
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCC--CCCCCCCh
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEY--RCPKWTSP 243 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~--~~p~~~s~ 243 (417)
.......+||+.|+|||++.+ .+ +.++|||||||++|+|++|..||.. .+....+..+..+.. ..+...++
T Consensus 184 ----~~~~~~~~~t~~y~aPE~~~~-~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (290)
T 1t4h_A 184 ----ASFAKAVIGTPEFMAPEMYEE-KY-DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 257 (290)
T ss_dssp ----TTSBEESCSSCCCCCGGGGGT-CC-CTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGGCCCH
T ss_pred ----ccccccccCCcCcCCHHHHhc-cC-CCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCccccCCCCCH
Confidence 234456789999999998864 34 5999999999999999999999987 445555555555432 23455688
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++.+||.+||+.||.+|||++|+++||||++.
T Consensus 258 ~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 258 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999999999999999999999999863
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-51 Score=400.04 Aligned_cols=259 Identities=23% Similarity=0.449 Sum_probs=229.2
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccch--------------HHHHHHHHHHHHhCCCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGL--------------TAHVKREISIMSRLRHP 76 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~--------------~~~i~~Ei~il~~l~Hp 76 (417)
.....++|++++.||+|+||.||+|.+ +|+.||+|++.......... ...+.+|+.+++.++||
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~ 103 (348)
T 2pml_X 26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNE 103 (348)
T ss_dssp SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCT
T ss_pred cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCC
Confidence 345679999999999999999999999 99999999998765433221 27889999999999999
Q ss_pred CcceEEEEEEeCCEEEEEEeccCCCChHHH------Hhc---CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcE
Q 014849 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAK------ISK---GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENL 146 (417)
Q Consensus 77 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------i~~---~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NI 146 (417)
||+++++++.+.+..|+||||++|++|.++ +.. +.+++..++.++.||+.||.|||+ +||+||||||+||
T Consensus 104 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Ni 183 (348)
T 2pml_X 104 YCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNI 183 (348)
T ss_dssp TBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGE
T ss_pred CcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhE
Confidence 999999999999999999999999999998 653 679999999999999999999999 9999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-H
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-M 224 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~ 224 (417)
|++.++.+||+|||++..... ......+||+.|+|||++.+. .+++.++|||||||++|+|++|..||...+. .
T Consensus 184 l~~~~~~~kl~dfg~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 259 (348)
T 2pml_X 184 LMDKNGRVKLSDFGESEYMVD----KKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV 259 (348)
T ss_dssp EECTTSCEEECCCTTCEECBT----TEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred EEcCCCcEEEecccccccccc----ccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence 999999999999999976532 244567899999999999877 5553499999999999999999999998776 7
Q ss_pred HHHHHHhcCCCCCC-------------------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 225 AMYRKIYKGEYRCP-------------------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 225 ~~~~~i~~~~~~~p-------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+....+..+....| ...++++.+||.+||+.||.+|||++|+++||||+..
T Consensus 260 ~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~ 329 (348)
T 2pml_X 260 ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADT 329 (348)
T ss_dssp HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTC
T ss_pred HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCC
Confidence 78888887777766 5679999999999999999999999999999999864
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-50 Score=391.41 Aligned_cols=252 Identities=25% Similarity=0.449 Sum_probs=213.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEe--CCE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLAT--KAK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~--~~~ 90 (417)
..++|++++.||+|+||.||+|++..+|+.||+|++.... ...+.+|+.+|+.++ ||||+++++++.+ ...
T Consensus 34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3678999999999999999999999999999999987532 467889999999997 9999999999988 678
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~ 169 (417)
.++||||+.+++|.+++. .+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus 108 ~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~-- 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ--TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG--GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT--
T ss_pred eEEEEeccCchhHHHHHH--hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC--
Confidence 999999999999999886 499999999999999999999999999999999999999777 799999999976542
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHH-------------hcCCC
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKI-------------YKGEY 235 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i-------------~~~~~ 235 (417)
.......+||+.|+|||++.+....+.++|||||||++|+|++|..||... +..+....+ .....
T Consensus 184 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 262 (330)
T 3nsz_A 184 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262 (330)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcc
Confidence 334456789999999999987554569999999999999999999999543 222222221 11111
Q ss_pred CC------------------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 RC------------------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 ~~------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.. +...++++.+||.+||++||.+|||++|+++||||+...
T Consensus 263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp CCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred ccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 11 122689999999999999999999999999999998654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-50 Score=404.87 Aligned_cols=257 Identities=27% Similarity=0.432 Sum_probs=215.6
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--CCCcceEEEEEEeCCEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR--HPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--HpnIv~l~~~~~~~~~~~l 93 (417)
.+|++++.||+|+||+||+|.+.. ++.||||++..... .......+.+|+.+|+.++ ||||+++++++.+.+.+|+
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~l 133 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYM 133 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEE
Confidence 469999999999999999999864 99999999987643 3334678899999999997 5999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||| +.+++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..........
T Consensus 134 v~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~ 211 (390)
T 2zmd_A 134 VME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSV 211 (390)
T ss_dssp EEE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-------
T ss_pred EEe-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccc
Confidence 999 568899999876 6899999999999999999999999999999999999995 5799999999998654332233
Q ss_pred cccccccCcccccccccccc----------CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCC--CCCCC
Q 014849 173 MLHTLCGTPAYVAPEILAKK----------GYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGE--YRCPK 239 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~----------~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~--~~~p~ 239 (417)
...+.+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... +.......+.... ...|.
T Consensus 212 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~ 291 (390)
T 2zmd_A 212 VKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPD 291 (390)
T ss_dssp --CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCCC
T ss_pred cCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCCc
Confidence 34567899999999998652 22358999999999999999999999875 3344555555443 45678
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.++++.+||.+||+.||.+|||+.|+++||||+...
T Consensus 292 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 328 (390)
T 2zmd_A 292 IPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328 (390)
T ss_dssp CSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred cchHHHHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence 8899999999999999999999999999999998644
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=403.63 Aligned_cols=252 Identities=28% Similarity=0.402 Sum_probs=213.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT------ 87 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------ 87 (417)
..++|++++.||+|+||.||+|++..+|+.||||++..+.. ...+|+.+|+.++||||+++++++.+
T Consensus 5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC-----
T ss_pred ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcccc
Confidence 45799999999999999999999999999999999865432 12379999999999999999999844
Q ss_pred --------------------------------CCEEEEEEeccCCCChHHHHh----c-CCCCHHHHHHHHHHHHHHHHH
Q 014849 88 --------------------------------KAKIYFVMEFAKGGELFAKIS----K-GRFSEQLSRRYFQQLISAVEY 130 (417)
Q Consensus 88 --------------------------------~~~~~lV~E~~~gg~L~~~i~----~-~~l~e~~~~~i~~ql~~aL~y 130 (417)
...+++||||++| +|.+.+. . +.+++..++.++.||+.||.|
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~ 156 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGF 156 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 3458999999985 7766654 2 679999999999999999999
Q ss_pred HHHcCCeecCCCCCcEEec-CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHH
Q 014849 131 CHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF 209 (417)
Q Consensus 131 lH~~givHrDlkp~NILl~-~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~ 209 (417)
||++||+||||||+|||++ .++.+||+|||++..... .......+||+.|+|||++.+....+.++||||+||++|
T Consensus 157 LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (383)
T 3eb0_A 157 IHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFG 233 (383)
T ss_dssp HHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCT---TSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCC---CCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHH
Confidence 9999999999999999998 688999999999976532 233456788999999999987664569999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHHHHhcC-----------------CCC------------CCCCCChHHHHHHHHhccCCCCCC
Q 014849 210 VLNAGYLPFNDPNLMAMYRKIYKG-----------------EYR------------CPKWTSPDLKWFIGRLLDTDPATR 260 (417)
Q Consensus 210 ~ll~G~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~~L~~dP~~R 260 (417)
+|++|.+||.+.+..+....+... ... +|...++++.+||.+||+.||.+|
T Consensus 234 ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R 313 (383)
T 3eb0_A 234 ELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLR 313 (383)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGS
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999998877766665431 011 345578899999999999999999
Q ss_pred CCHHHHhcCccccccc
Q 014849 261 ITVDEILRDPWFKKDY 276 (417)
Q Consensus 261 ~t~~eil~h~~f~~~~ 276 (417)
||+.|+++||||+...
T Consensus 314 ~t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 314 INPYEAMAHPFFDHLR 329 (383)
T ss_dssp CCHHHHHTSGGGHHHH
T ss_pred CCHHHHhcCHHHHHHH
Confidence 9999999999998643
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=399.99 Aligned_cols=260 Identities=33% Similarity=0.554 Sum_probs=225.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~ 89 (417)
.++|++.+.||+|+||.||+|++. .+|+.||||++.+.... .......+.+|+.+|+.+ +||||+++++++.+..
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 132 (355)
T 1vzo_A 53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 132 (355)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence 479999999999999999999985 58999999999765432 223345677899999999 6999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+.||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~ 212 (355)
T 1vzo_A 133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 212 (355)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence 99999999999999999976 78999999999999999999999999999999999999999999999999999754321
Q ss_pred CCCCcccccccCcccccccccccc-CCCCChhhHHHHHHHHHHHHcCCCCCCC----CCHHHHHHHHhcCCCCCCCCCCh
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKK-GYDGAKVDMWSCGVVLFVLNAGYLPFND----PNLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~-~y~~~~sDIwSlGvil~~ll~G~~Pf~~----~~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||.. .....+...+.......|...++
T Consensus 213 -~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 291 (355)
T 1vzo_A 213 -ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 291 (355)
T ss_dssp -GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCCcccCH
Confidence 12233456899999999999753 2235899999999999999999999964 34556667777777888888999
Q ss_pred HHHHHHHHhccCCCCCCC-----CHHHHhcCcccccc
Q 014849 244 DLKWFIGRLLDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
.+.+||.+||..||.+|| |++|+++||||++.
T Consensus 292 ~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 292 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999999999999999999 99999999999863
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-50 Score=394.95 Aligned_cols=263 Identities=27% Similarity=0.439 Sum_probs=220.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC---
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--- 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--- 88 (417)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 7 ~~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 84 (353)
T 2b9h_A 7 YNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFE 84 (353)
T ss_dssp CCSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS--SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCST
T ss_pred cccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc--cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccC
Confidence 357789999999999999999999999999999999996432 333456788999999999999999999987654
Q ss_pred --CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 --AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 --~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...|+||||+. ++|.+.+..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 85 ~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~ 163 (353)
T 2b9h_A 85 NFNEVYIIQELMQ-TDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID 163 (353)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEeccC-ccHHHHHhhcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence 67999999997 589999988899999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCC--------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--C--
Q 014849 167 QIRPD--------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--E-- 234 (417)
Q Consensus 167 ~~~~~--------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~-- 234 (417)
..... ......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+... .
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~ 243 (353)
T 2b9h_A 164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH 243 (353)
T ss_dssp ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence 22111 12234689999999999876444569999999999999999999999998866555443210 0
Q ss_pred --------------------CC--------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 235 --------------------YR--------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 235 --------------------~~--------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.. .+...++++.+||.+||+.||++|||+.|+++||||+....
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~ 314 (353)
T 2b9h_A 244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHD 314 (353)
T ss_dssp STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCC
Confidence 00 11357889999999999999999999999999999986543
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=387.89 Aligned_cols=263 Identities=29% Similarity=0.467 Sum_probs=223.2
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
+.......++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.+
T Consensus 11 ~~~~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 87 (302)
T 2j7t_A 11 VRRDLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYH 87 (302)
T ss_dssp CBSSSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred cccccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeee
Confidence 3445577899999999999999999999999999999999997653 2336778899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
.+..|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 88 ~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 167 (302)
T 2j7t_A 88 DGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKN 167 (302)
T ss_dssp C-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHH
T ss_pred CCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccc
Confidence 9999999999999999998864 67999999999999999999999999999999999999999999999999987532
Q ss_pred cccCCCCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC---C
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR---C 237 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~---~ 237 (417)
... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...+.......+.....+ .
T Consensus 168 ~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 244 (302)
T 2j7t_A 168 LKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPY-DYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLLT 244 (302)
T ss_dssp HHH--HHC-----CCGGGCCHHHHHHHHTTSTTT-TTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSS
T ss_pred ccc--ccccccccCChhhcCCeeeccccCCCCCC-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCcccCC
Confidence 211 11223457999999999984 3444 58999999999999999999999998888777777665432 3
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
|...++++.+||.+||+.||.+|||+.++++||||+...
T Consensus 245 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 283 (302)
T 2j7t_A 245 PSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSIT 283 (302)
T ss_dssp GGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCC
T ss_pred ccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhc
Confidence 556789999999999999999999999999999998643
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-50 Score=398.13 Aligned_cols=258 Identities=23% Similarity=0.409 Sum_probs=220.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.... .......+.+|+.+|+.++||||+++++++.+.+.+
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 345789999999999999999999999999999999997653 334467889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++......
T Consensus 107 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence 999999999999999976 7899999999999999999999996 9999999999999999999999999998654321
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-------------------
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI------------------- 230 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i------------------- 230 (417)
.....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+
T Consensus 186 ---~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 261 (360)
T 3eqc_A 186 ---MANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPG 261 (360)
T ss_dssp ---C----CCCCTTCCHHHHTTCCCS-HHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------
T ss_pred ---cccCCCCCCCeECHHHHcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCC
Confidence 23456899999999999887775 9999999999999999999999887655432221
Q ss_pred -----------------------hcCCC-CC-CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 231 -----------------------YKGEY-RC-PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 231 -----------------------~~~~~-~~-p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..... .. +...++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 262 RPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp ------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred CcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 11111 11 223688999999999999999999999999999998654
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=389.73 Aligned_cols=262 Identities=29% Similarity=0.444 Sum_probs=216.5
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE----
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA---- 86 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~---- 86 (417)
...+.++|++++.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++.
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 82 (320)
T 2i6l_A 6 GFDLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTD---PQSVKHALREIKIIRRLDHDNIVKVFEILGPSGS 82 (320)
T ss_dssp CEEETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCS---HHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSC
T ss_pred cCccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCC---hHHHHHHHHHHHHHHhcCCCCeeEEEEecccccc
Confidence 4567899999999999999999999999999999999987542 334677889999999999999999999873
Q ss_pred ----------eCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCeE
Q 014849 87 ----------TKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLK 155 (417)
Q Consensus 87 ----------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~~~vk 155 (417)
+....|+||||+. |+|.+++..+++++..++.++.||+.||.|||++||+||||||+|||++ .++.+|
T Consensus 83 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~k 161 (320)
T 2i6l_A 83 QLTDDVGSLTELNSVYIVQEYME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLK 161 (320)
T ss_dssp BCCC----CCSCSEEEEEEECCS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEE
T ss_pred ccccccccccccCceeEEeeccC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEE
Confidence 4478999999998 5999999989999999999999999999999999999999999999997 567899
Q ss_pred EeeeecceeecccC-CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIR-PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~-~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++....... .........||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~ 241 (320)
T 2i6l_A 162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241 (320)
T ss_dssp ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence 99999997653221 12234556789999999998764444699999999999999999999999988777666554321
Q ss_pred CC------------------------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 235 YR------------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 235 ~~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.. .+...++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 313 (320)
T 2i6l_A 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYS 313 (320)
T ss_dssp CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTC
T ss_pred CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCccccccc
Confidence 10 1245789999999999999999999999999999998643
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=383.95 Aligned_cols=259 Identities=36% Similarity=0.640 Sum_probs=228.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
...+.++|++.+.||+|+||.||+|.+..+++.||+|++...... ......+.+|+.+++.++||||+++++++.+...
T Consensus 17 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 95 (287)
T 2wei_A 17 QGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSS 95 (287)
T ss_dssp THHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred HHHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCe
Confidence 346778999999999999999999999999999999999876432 3346788999999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCeEEeeeecceeec
Q 014849 91 IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---WDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---~~vkl~DFGls~~~~ 166 (417)
.|+||||+.+++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~ 175 (287)
T 2wei_A 96 FYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQ 175 (287)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBC
T ss_pred EEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeec
Confidence 9999999999999988865 789999999999999999999999999999999999999764 469999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s 242 (417)
. .......+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+..+....+..+.+..+ ...+
T Consensus 176 ~---~~~~~~~~~~~~y~aPE~~~~~-~-~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 2wei_A 176 Q---NTKMKDRIGTAYYIAPEVLRGT-Y-DEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250 (287)
T ss_dssp C---CSSCSCHHHHHTTCCHHHHTTC-C-CTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSC
T ss_pred C---CCccccccCcccccChHHhcCC-C-CCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcC
Confidence 2 2233456799999999998764 4 5899999999999999999999999998888888887765443 4578
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+++.+||.+||++||.+|||+.|+++||||++.
T Consensus 251 ~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~ 283 (287)
T 2wei_A 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWIQKY 283 (287)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred HHHHHHHHHHcccChhhCcCHHHHhcCHHHhcc
Confidence 999999999999999999999999999999864
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=383.39 Aligned_cols=259 Identities=32% Similarity=0.563 Sum_probs=227.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eCCEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TKAKI 91 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~~~~ 91 (417)
..++|++.+.||+|+||.||+|.+..+|+.||+|++..... .....+.+.+|+.+++.++||||+++++++. +...+
T Consensus 4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 4 RAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEE
T ss_pred chhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceE
Confidence 46799999999999999999999999999999999987543 2334667889999999999999999999874 46789
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCeEEeeeec
Q 014849 92 YFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRG-----VFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~g-----ivHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
|+||||++|++|.+++.. ..+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~ 162 (279)
T 2w5a_A 83 YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 162 (279)
T ss_dssp EEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCH
T ss_pred EEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCch
Confidence 999999999999999864 24999999999999999999999999 99999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKW 240 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~ 240 (417)
+..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+..+.. ..|..
T Consensus 163 ~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~ 239 (279)
T 2w5a_A 163 ARILNH--DTSFAKTFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR 239 (279)
T ss_dssp HHHC-----CHHHHHHHSCCTTCCHHHHHCC-CC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCTT
T ss_pred heeecc--ccccccccCCCccccChHHhccCCCC-chhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCcc
Confidence 875432 11223456899999999999887775 999999999999999999999999988888888887765 56777
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.++++.++|.+||+.||.+|||+.|+++|+|+....
T Consensus 240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~ 275 (279)
T 2w5a_A 240 YSDELNEIITRMLNLKDYHRPSVEEILENPLILEHH 275 (279)
T ss_dssp SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred cCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence 899999999999999999999999999999998653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-52 Score=413.03 Aligned_cols=249 Identities=14% Similarity=0.202 Sum_probs=207.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH---HHHhCCCCCcceEE-------EE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS---IMSRLRHPNIVKLY-------EV 84 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~---il~~l~HpnIv~l~-------~~ 84 (417)
.++|++++.||+|+||.||+|++..+|+.||||++.+.........+.+.+|+. +|+.++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 578999999999999999999999999999999998765555556788999994 55555799999998 77
Q ss_pred EEeCCE-----------------EEEEEeccCCCChHHHHhc-CCCCH-------HHHHHHHHHHHHHHHHHHHcCCeec
Q 014849 85 LATKAK-----------------IYFVMEFAKGGELFAKISK-GRFSE-------QLSRRYFQQLISAVEYCHSRGVFHR 139 (417)
Q Consensus 85 ~~~~~~-----------------~~lV~E~~~gg~L~~~i~~-~~l~e-------~~~~~i~~ql~~aL~ylH~~givHr 139 (417)
+.+++. .|+||||+ +|+|.+++.. +.+++ ..+..++.||+.||.|||++||+||
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr 230 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT 230 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 776643 89999999 6799999975 44555 7888899999999999999999999
Q ss_pred CCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCcccccccccccc-----------CCCCChhhHHHHHHHH
Q 014849 140 DLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK-----------GYDGAKVDMWSCGVVL 208 (417)
Q Consensus 140 Dlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~-----------~y~~~~sDIwSlGvil 208 (417)
||||+|||++.++.+||+|||++... .....+.+| +.|+|||++.+. .| +.++|||||||++
T Consensus 231 Dikp~NIll~~~~~~kL~DFG~a~~~-----~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~-~~~~DvwSlG~il 303 (377)
T 3byv_A 231 YLRPVDIVLDQRGGVFLTGFEHLVRD-----GARVVSSVS-RGFEPPELEARRATISYHRDRRTLM-TFSFDAWALGLVI 303 (377)
T ss_dssp CCCGGGEEECTTCCEEECCGGGCEET-----TCEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC-CHHHHHHHHHHHH
T ss_pred CCCHHHEEEcCCCCEEEEechhheec-----CCcccCCCC-cCccChhhhcccccccccccccccC-ChhhhHHHHHHHH
Confidence 99999999999999999999999752 234556788 999999999887 66 4999999999999
Q ss_pred HHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 209 FVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 209 ~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|+|++|..||.+.+.......+. ..+...++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus 304 ~elltg~~Pf~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~ 366 (377)
T 3byv_A 304 YWIWCADLPITKDAALGGSEWIF----RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 366 (377)
T ss_dssp HHHHHSSCCC------CCSGGGG----SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHHH
T ss_pred HHHHHCCCCCcccccccchhhhh----hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHHH
Confidence 99999999998766544433332 3345678999999999999999999999999999999864
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-50 Score=391.53 Aligned_cols=260 Identities=38% Similarity=0.674 Sum_probs=216.2
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL-----RGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
..+.++|++.+.||+|+||.||+|.+..+|+.||||++...... .......+.+|+.+|+.++||||+++++++.
T Consensus 6 ~~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 85 (322)
T 2ycf_A 6 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD 85 (322)
T ss_dssp HHHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred hhhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEc
Confidence 45678999999999999999999999999999999999765431 1122345789999999999999999999997
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEeeeecc
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISDFGLS 162 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~DFGls 162 (417)
... .|+||||+.|++|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~ 164 (322)
T 2ycf_A 86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS 164 (322)
T ss_dssp SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence 766 8999999999999998876 68999999999999999999999999999999999999987665 999999999
Q ss_pred eeecccCCCCcccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP 238 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p 238 (417)
..... .......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||...... .....+..+.+..+
T Consensus 165 ~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 240 (322)
T 2ycf_A 165 KILGE---TSLMRTLCGTPTYLAPEVLVSVGTAGY-NRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFI 240 (322)
T ss_dssp EECCC---CHHHHHHHSCCTTCCHHHHHHTTTTTC-TTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCC
T ss_pred eeccc---ccccccccCCcCccCchhhccCCCCCC-CchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccC
Confidence 76532 22345678999999999974 3344 58999999999999999999999765332 34444555554432
Q ss_pred ----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 239 ----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 239 ----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
...++++.+||.+||+.||.+|||++++++||||+...
T Consensus 241 ~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~~ 282 (322)
T 2ycf_A 241 PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDED 282 (322)
T ss_dssp HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred chhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCHH
Confidence 45789999999999999999999999999999998643
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=396.93 Aligned_cols=256 Identities=28% Similarity=0.444 Sum_probs=216.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI- 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 91 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++..... .......+.+|+.+++.++||||+++++++...+..
T Consensus 39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~ 117 (371)
T 4exu_A 39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 117 (371)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSST
T ss_pred cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEeccccc-chhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcc
Confidence 467899999999999999999999999999999999976532 333467788999999999999999999999877654
Q ss_pred -----EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 92 -----YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 92 -----~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 118 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 195 (371)
T 4exu_A 118 NFYDFYLVMPFMQ-TDLQKIMG-MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 195 (371)
T ss_dssp TCCCCEEEEECCC-EEHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC----
T ss_pred cceeEEEEEcccc-ccHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccccc
Confidence 99999997 58887774 459999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.....
T Consensus 196 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 270 (371)
T 4exu_A 196 -----AEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 270 (371)
T ss_dssp ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred -----cCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence 2234568999999999998744446999999999999999999999999887776666543110
Q ss_pred --------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 236 --------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 236 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+...++++.+||.+||++||.+|||++|+++||||+...
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~ 331 (371)
T 4exu_A 271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 331 (371)
T ss_dssp CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCC
Confidence 01234689999999999999999999999999999998643
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-50 Score=402.22 Aligned_cols=255 Identities=31% Similarity=0.425 Sum_probs=211.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-- 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-- 89 (417)
.....+|++++.||+|+||.||+|++..+++ ||+|.+...... ..+|+.+|+.++||||+++++++....
T Consensus 36 ~~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~-------~~~E~~il~~l~h~niv~l~~~~~~~~~~ 107 (394)
T 4e7w_A 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRF-------KNRELQIMRIVKHPNVVDLKAFFYSNGDK 107 (394)
T ss_dssp CEEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTS-------CCHHHHHHHTCCCTTBCCEEEEEEEESSS
T ss_pred CcccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcch-------HHHHHHHHHhCCCCCcceEEEEEEecCCC
Confidence 4456789999999999999999999987766 888887654321 237999999999999999999985543
Q ss_pred ----EEEEEEeccCCCChHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCeEEeeee
Q 014849 90 ----KIYFVMEFAKGGELFAKIS----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFG 160 (417)
Q Consensus 90 ----~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~~~vkl~DFG 160 (417)
.+|+||||++++.+..... .+.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||
T Consensus 108 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG 187 (394)
T 4e7w_A 108 KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFG 187 (394)
T ss_dssp SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCT
T ss_pred CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCC
Confidence 4899999998754433322 36899999999999999999999999999999999999999 78999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------- 233 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------- 233 (417)
++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+....+.+.
T Consensus 188 ~a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~ 264 (394)
T 4e7w_A 188 SAKILIA---GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE 264 (394)
T ss_dssp TCEECCT---TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred CcccccC---CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence 9976532 233456788999999999987654569999999999999999999999998877666655431
Q ss_pred ----------CCC------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ----------EYR------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ----------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
... ++...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 330 (394)
T 4e7w_A 265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRT 330 (394)
T ss_dssp HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTS
T ss_pred HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhcc
Confidence 011 23347899999999999999999999999999999986543
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=390.83 Aligned_cols=267 Identities=29% Similarity=0.450 Sum_probs=198.1
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
.......++|++.+.||+|+||.||+|.+..+|+.||+|++..... ......+.+|+.+++.++||||+++++++.+.
T Consensus 8 ~p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 85 (303)
T 2vwi_A 8 LPWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK 85 (303)
T ss_dssp -----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESS
T ss_pred cccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeec
Confidence 3345567899999999999999999999999999999999976542 22356788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHh---------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 89 AKIYFVMEFAKGGELFAKIS---------KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~---------~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
+..|+||||++|++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 86 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df 165 (303)
T 2vwi_A 86 DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADF 165 (303)
T ss_dssp SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEec
Confidence 99999999999999999885 246999999999999999999999999999999999999999999999999
Q ss_pred ecceeecccC---CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC
Q 014849 160 GLSAVKEQIR---PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR 236 (417)
Q Consensus 160 Gls~~~~~~~---~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 236 (417)
|++....... ........+||+.|+|||++.+....+.++|||||||++|+|++|..||...+..............
T Consensus 166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~ 245 (303)
T 2vwi_A 166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPP 245 (303)
T ss_dssp HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCC
T ss_pred cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCC
Confidence 9986543211 1122345689999999999876333359999999999999999999999887655544444333221
Q ss_pred ----------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 237 ----------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 237 ----------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+...++++.+||.+||+.||.+|||+.++++||||++...
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 296 (303)
T 2vwi_A 246 SLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAKN 296 (303)
T ss_dssp CTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC-----
T ss_pred ccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCCC
Confidence 22456889999999999999999999999999999986543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-50 Score=392.12 Aligned_cols=254 Identities=27% Similarity=0.455 Sum_probs=212.7
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA- 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~- 89 (417)
...+.++|++++.||+|+||.||+|++..+|+.||||++....... ..+.+.+|+.+|+.++||||+++++++....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 81 (319)
T 4euu_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLR--PVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (319)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGS--CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred ccCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccc--hHHHHHHHHHHHHhcCCCCcceEEEEeecCCC
Confidence 4467789999999999999999999999999999999998654322 3567789999999999999999999998765
Q ss_pred -EEEEEEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCeEEeeee
Q 014849 90 -KIYFVMEFAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFG 160 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~~vkl~DFG 160 (417)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg 161 (319)
T 4euu_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (319)
T ss_dssp CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCC
Confidence 789999999999999999752 39999999999999999999999999999999999999 778889999999
Q ss_pred cceeecccCCCCcccccccCcccccccccc--------ccCCCCChhhHHHHHHHHHHHHcCCCCCCCC----CHHHHHH
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILA--------KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP----NLMAMYR 228 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~--------~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~----~~~~~~~ 228 (417)
++..... .....+.+||+.|+|||++. +..+ +.++|||||||++|+|++|..||... ...+...
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~ 237 (319)
T 4euu_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (319)
T ss_dssp TCEECCT---TCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCB-CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHH
T ss_pred CceecCC---CCceeecccCCCccCHHHhhhccccccccCCC-CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHH
Confidence 9976543 23445678999999999986 3444 58999999999999999999999642 2234444
Q ss_pred HHhcCCC---------------------CC----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCc
Q 014849 229 KIYKGEY---------------------RC----PKWTSPDLKWFIGRLLDTDPATRITVDEILRDP 270 (417)
Q Consensus 229 ~i~~~~~---------------------~~----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 270 (417)
++..+.. +. +...++.+.+||.+||+.||++|||++|+++||
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~ 304 (319)
T 4euu_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET 304 (319)
T ss_dssp HHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred HHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence 4443322 11 112245788999999999999999999999997
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=386.64 Aligned_cols=260 Identities=28% Similarity=0.492 Sum_probs=218.5
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT- 87 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~- 87 (417)
.-....++|++++.||+|+||.||+|++..+|+.||+|++.... .....+.+|+.+++.+ +||||+++++++..
T Consensus 18 ~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~ 93 (326)
T 2x7f_A 18 ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKK 93 (326)
T ss_dssp CCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEEC
T ss_pred hccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeec
Confidence 33567899999999999999999999999999999999997543 2246788999999998 79999999999977
Q ss_pred -----CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 88 -----KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 88 -----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
...+|+||||+.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Df 173 (326)
T 2x7f_A 94 NPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173 (326)
T ss_dssp C--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCC
T ss_pred cCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeC
Confidence 5689999999999999999875 57999999999999999999999999999999999999999999999999
Q ss_pred ecceeecccCCCCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|++..... ........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+.......+....
T Consensus 174 g~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 250 (326)
T 2x7f_A 174 GVSAQLDR--TVGRRNTFIGTPYWMAPEVIACDENPDATY-DFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP 250 (326)
T ss_dssp TTTC---------------CCGGGCCHHHHC--------C-CTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred cCceecCc--CccccccccCCccccChhhhccccccCcCC-CccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc
Confidence 99876432 122344568999999999986 3344 589999999999999999999999888777666665544
Q ss_pred CC--CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 235 YR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 235 ~~--~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.+ .+...++.+.+||.+||..||.+|||++++++||||++..
T Consensus 251 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~ 294 (326)
T 2x7f_A 251 APRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQP 294 (326)
T ss_dssp CCCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCT
T ss_pred cccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCc
Confidence 32 2455789999999999999999999999999999998654
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=384.81 Aligned_cols=257 Identities=28% Similarity=0.468 Sum_probs=219.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.... ....+.+|+.+++.++||||+++++++.+.+.+
T Consensus 25 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 25 KQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp -----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 456789999999999999999999999999999999997643 246788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.|++|.+++. .+.+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~- 178 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT- 178 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTT-
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhh-
Confidence 99999999999999986 368999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---CCCCCCCChHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE---YRCPKWTSPDLK 246 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~---~~~p~~~s~~~~ 246 (417)
.......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.......+.... +..|...++++.
T Consensus 179 -~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 256 (314)
T 3com_A 179 -MAKRNTVIGTPFWMAPEVIQEIGYN-CVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPELWSDNFT 256 (314)
T ss_dssp -BSCBCCCCSCGGGCCHHHHSSSCBC-TTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSSGGGSCHHHH
T ss_pred -ccccCccCCCCCccChhhcCCCCCC-ccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcccCCcccCCHHHH
Confidence 2233456799999999999888775 89999999999999999999999887766555554432 334556789999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+||.+||..||.+|||+.++++||||+...
T Consensus 257 ~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 257 DFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp HHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred HHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 999999999999999999999999998654
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-50 Score=382.61 Aligned_cols=258 Identities=23% Similarity=0.343 Sum_probs=203.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|++..+|+.||+|++..... .......+.++...++.++||||+++++++.+.+..|
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~ 82 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVN-SQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVW 82 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---C-HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccC-cHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEE
Confidence 346899999999999999999999999999999999976532 2222334455566688899999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 93 FVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
+||||++| +|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++....
T Consensus 83 lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 83 ICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp EEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred EEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999975 77766542 5799999999999999999999998 99999999999999999999999999987654
Q ss_pred ccCCCCcccccccCccccccccc----cccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHh-cCCCCC-CC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEIL----AKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIY-KGEYRC-PK 239 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl----~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~-~~~~~~-p~ 239 (417)
. .......+||+.|+|||++ .+..+ +.++||||+||++|+|++|..||.. ........... ...... +.
T Consensus 162 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (290)
T 3fme_A 162 D---DVAKDIDAGCKPYMAPERINPELNQKGY-SVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPAD 237 (290)
T ss_dssp -----------CCCCCCSCHHHHSCCTTC--C-CHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCTT
T ss_pred c---cccccccCCCccccChhhcChhhcCcCC-CcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcccc
Confidence 2 2233445799999999997 33344 5899999999999999999999986 33333333333 333333 34
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..++++.+||.+||+.||++|||+.|+++||||+...
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~ 274 (290)
T 3fme_A 238 KFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE 274 (290)
T ss_dssp TSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence 6799999999999999999999999999999998654
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=386.13 Aligned_cols=257 Identities=27% Similarity=0.450 Sum_probs=215.3
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|++ +|+.||+|++..... .......+.+|+.+|++++||||+++++++.+...+
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCce
Confidence 34578999999999999999999987 688999999976543 233456788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 92 YFVMEFAKGGELFAKISKGR----FSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~----l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
|+||||+.||+|.+++.... +++..+..++.||+.||.|||++| |+||||||+|||++.++.+||+|||++...
T Consensus 110 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~ 189 (309)
T 3p86_A 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189 (309)
T ss_dssp EEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-----
T ss_pred EEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccc
Confidence 99999999999999998632 999999999999999999999999 999999999999999999999999998754
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh--cCCCCCCCCCCh
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY--KGEYRCPKWTSP 243 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~--~~~~~~p~~~s~ 243 (417)
.. ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+..+....+. ......|...++
T Consensus 190 ~~--~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 266 (309)
T 3p86_A 190 AS--TFLSSKSAAGTPEWMAPEVLRDEPSN-EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNP 266 (309)
T ss_dssp --------------CCTTSCHHHHTTCCCC-TTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCCCTTSCH
T ss_pred cc--cccccccCCCCccccChhhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCCCccCCH
Confidence 32 12234567899999999999888774 89999999999999999999999988887776663 345667888999
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhc--Cccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILR--DPWFKK 274 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~--h~~f~~ 274 (417)
++.+||.+||+.||.+|||+.++++ +++++.
T Consensus 267 ~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 267 QVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999999999999999987 355543
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=402.45 Aligned_cols=253 Identities=29% Similarity=0.414 Sum_probs=210.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
...+|++.+.||+|+||.||+|++..+|+.||||++..... ...+|+.+|+.++||||+++++++...
T Consensus 52 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 52 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTT
T ss_pred ccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCCc
Confidence 34579999999999999999999999999999999875432 123799999999999999999998432
Q ss_pred -CEEEEEEeccCCCChHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeec
Q 014849 89 -AKIYFVMEFAKGGELFAKIS-----KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGL 161 (417)
Q Consensus 89 -~~~~lV~E~~~gg~L~~~i~-----~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGl 161 (417)
..+++||||+.+ +|.+.+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+
T Consensus 125 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~ 203 (420)
T 1j1b_A 125 EVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGS 203 (420)
T ss_dssp EEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred ceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchh
Confidence 247799999986 5655543 3679999999999999999999999999999999999999965 5689999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-------- 233 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------- 233 (417)
+..... .......+||+.|+|||++.+....+.++|||||||++|+|++|++||.+.+..+.+.++.+.
T Consensus 204 a~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~ 280 (420)
T 1j1b_A 204 AKQLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQ 280 (420)
T ss_dssp CEECCT---TCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred hhhccc---CCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence 976532 223345789999999999977644469999999999999999999999998876665555431
Q ss_pred ---------CCCC------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 ---------EYRC------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ---------~~~~------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.+.+ +...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 281 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~ 345 (420)
T 1j1b_A 281 IREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 345 (420)
T ss_dssp HHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred HHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence 1122 2346889999999999999999999999999999986543
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-49 Score=387.22 Aligned_cols=256 Identities=28% Similarity=0.426 Sum_probs=216.6
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEE-ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC------CcceE
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRN-VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP------NIVKL 81 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~-~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp------nIv~l 81 (417)
..+..+.++|++.+.||+|+||.||+|.+ ..+|+.||+|++.... .....+.+|+.+++.++|+ +++++
T Consensus 7 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~ 82 (339)
T 1z57_A 7 QSGDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD----RYCEAARSEIQVLEHLNTTDPNSTFRCVQM 82 (339)
T ss_dssp STTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHHCTTCTTCBCCE
T ss_pred ecCCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC----chhHHHHHHHHHHHHhhhcCCCCceeeEee
Confidence 34556789999999999999999999999 5688999999996532 2356788999999988765 49999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC--------
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-------- 150 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-------- 150 (417)
++++.+.+.+|+||||+ +++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 83 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~ 161 (339)
T 1z57_A 83 LEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYN 161 (339)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred ecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccC
Confidence 99999999999999999 88999988753 6899999999999999999999999999999999999987
Q ss_pred -----------CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 014849 151 -----------NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN 219 (417)
Q Consensus 151 -----------~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~ 219 (417)
++.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 162 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 235 (339)
T 1z57_A 162 PKIKRDERTLINPDIKVVDFGSATYDDE-----HHSTLVSTRHYRAPEVILALGWS-QPCDVWSIGCILIEYYLGFTVFP 235 (339)
T ss_dssp ----CEEEEESCCCEEECCCSSCEETTS-----CCCSSCSCGGGCCHHHHTTSCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred CccccccccccCCCceEeeCcccccCcc-----ccccccCCccccChHHhhCCCCC-cchhhHHHHHHHHHHHhCCCCCC
Confidence 67899999999875332 23456899999999999888875 99999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCC--------------------------------------------CCCChHHHHHHHHhccC
Q 014849 220 DPNLMAMYRKIYKGEYRCP--------------------------------------------KWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 220 ~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~ 255 (417)
..+..+....+.....+.| ...++++.+||.+||+.
T Consensus 236 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 315 (339)
T 1z57_A 236 THDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEY 315 (339)
T ss_dssp CSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCc
Confidence 8877665544432111111 11246788999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 014849 256 DPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~t~~eil~h~~f~~~ 275 (417)
||.+|||+.|+++||||+..
T Consensus 316 dP~~Rpt~~ell~hp~f~~~ 335 (339)
T 1z57_A 316 DPAKRITLREALKHPFFDLL 335 (339)
T ss_dssp STTTSCCHHHHTTSGGGGGG
T ss_pred CcccccCHHHHhcCHHHHHH
Confidence 99999999999999999864
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-50 Score=400.98 Aligned_cols=259 Identities=21% Similarity=0.276 Sum_probs=224.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEE-----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
...++|++++.||+|+||+||+|+ +..+++.||||++.... ......++.+|+.+|+.++||||+++++++.+
T Consensus 68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 145 (367)
T 3l9p_A 68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQ 145 (367)
T ss_dssp CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence 446789999999999999999999 55678899999996532 22335578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC---CeEE
Q 014849 88 KAKIYFVMEFAKGGELFAKISK--------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW---DLKI 156 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~--------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~---~vkl 156 (417)
....|+||||+.||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+| .+||
T Consensus 146 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL 225 (367)
T 3l9p_A 146 SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKI 225 (367)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEE
T ss_pred CCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEE
Confidence 9999999999999999999864 2499999999999999999999999999999999999999655 4999
Q ss_pred eeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-
Q 014849 157 SDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE- 234 (417)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~- 234 (417)
+|||++...............+||+.|+|||++.+..|+ .++|||||||++|+|++ |..||...+..+....+..+.
T Consensus 226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~ 304 (367)
T 3l9p_A 226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR 304 (367)
T ss_dssp CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred CCCccccccccccccccCCCcCCcccEECHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 999999755443333445567789999999999888775 99999999999999998 999999999888888887765
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 235 YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 235 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...|...++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 305 ~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 305 MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 4567778999999999999999999999999999988754
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=394.90 Aligned_cols=262 Identities=27% Similarity=0.402 Sum_probs=212.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--------cchHHHHHHHHHHHHhCCCCCcceEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--------GGLTAHVKREISIMSRLRHPNIVKLYE 83 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--------~~~~~~i~~Ei~il~~l~HpnIv~l~~ 83 (417)
..+.++|++++.||+|+||.||+|.+. +|+.||||++....... ......+.+|+.+|+.++||||+++++
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 96 (362)
T 3pg1_A 18 HAMQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRD 96 (362)
T ss_dssp HHTTCSCEEEEEEEEETTEEEEEEECT-TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSE
T ss_pred HHhccceEEeEEeccCCCEEEEEEECC-CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceee
Confidence 467899999999999999999999985 49999999996643221 223478899999999999999999999
Q ss_pred EEEe-----CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEE
Q 014849 84 VLAT-----KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 84 ~~~~-----~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl 156 (417)
++.. ...+|+||||+. |+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 97 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl 175 (362)
T 3pg1_A 97 IFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITI 175 (362)
T ss_dssp EEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEE
T ss_pred eEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEE
Confidence 9843 347999999998 588887765 47999999999999999999999999999999999999999999999
Q ss_pred eeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--
Q 014849 157 SDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-- 234 (417)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-- 234 (417)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+....
T Consensus 176 ~Dfg~~~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~ 252 (362)
T 3pg1_A 176 CDFNLAREDTA---DANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT 252 (362)
T ss_dssp CCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred EecCccccccc---ccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 99999874332 2334557899999999998874444699999999999999999999999988777666654210
Q ss_pred ----------------------C--------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 235 ----------------------Y--------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 235 ----------------------~--------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
. ..++..++.+.+||.+||++||.+|||+.|+++||||+..+.+
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 326 (362)
T 3pg1_A 253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326 (362)
T ss_dssp CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence 0 0123458889999999999999999999999999999876543
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-49 Score=389.95 Aligned_cols=256 Identities=28% Similarity=0.447 Sum_probs=215.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE--
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK-- 90 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~-- 90 (417)
.+.++|++.+.||+|+||.||+|.+..+|+.||||++.... ........+.+|+.+++.++||||+++++++.+...
T Consensus 21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 99 (353)
T 3coi_A 21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99 (353)
T ss_dssp EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGG
T ss_pred ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccc
Confidence 46789999999999999999999999999999999997643 233346778899999999999999999999987654
Q ss_pred ----EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 91 ----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 91 ----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
+|+||||+. ++|.+.+. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 100 ~~~~~~lv~e~~~-~~l~~~~~-~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 177 (353)
T 3coi_A 100 NFYDFYLVMPFMQ-TDLQKIMG-LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD 177 (353)
T ss_dssp GCCCCEEEEECCS-EEGGGTTT-SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC--
T ss_pred cceeEEEEecccc-CCHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCCC
Confidence 599999997 58887775 369999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC-------------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------- 233 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~------------- 233 (417)
. .....+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+..+....+.+.
T Consensus 178 ~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 252 (353)
T 3coi_A 178 A-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN 252 (353)
T ss_dssp -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred C-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence 2 2345689999999999887444469999999999999999999999998877665554321
Q ss_pred ---------------C---CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 ---------------E---YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ---------------~---~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
. ...+...++++.+||.+||+.||++|||++|+++||||+...
T Consensus 253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 313 (353)
T 3coi_A 253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFR 313 (353)
T ss_dssp CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTC
T ss_pred hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhcc
Confidence 0 112345689999999999999999999999999999998643
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=388.17 Aligned_cols=265 Identities=22% Similarity=0.321 Sum_probs=204.3
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
......++|++++.||+|+||.||+|.+..++. .||+|++...... ....+.+.+|+.+++.++||||+++++++.
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 95 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSL 95 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEE
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceee
Confidence 334557899999999999999999999887775 8999999765432 234678899999999999999999999998
Q ss_pred eCCEE------EEEEeccCCCChHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 87 TKAKI------YFVMEFAKGGELFAKISKG-------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 87 ~~~~~------~lV~E~~~gg~L~~~i~~~-------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
+.... |+||||+.+|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 96 ~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~ 175 (323)
T 3qup_A 96 RSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMT 175 (323)
T ss_dssp CC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSC
T ss_pred ccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCC
Confidence 77665 9999999999999988541 5999999999999999999999999999999999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhc
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYK 232 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~ 232 (417)
+||+|||++................+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..
T Consensus 176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~ 254 (323)
T 3qup_A 176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYT-VHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254 (323)
T ss_dssp EEECCCCC-----------------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHT
T ss_pred EEEeeccccccccccccccccccccCcccccCchhhcCCCCC-CccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhc
Confidence 999999999765433322333445678899999999888775 99999999999999999 9999999887777777766
Q ss_pred CC-CCCCCCCChHHHHHHHHhccCCCCCCCC-------HHHHhcCccccccc
Q 014849 233 GE-YRCPKWTSPDLKWFIGRLLDTDPATRIT-------VDEILRDPWFKKDY 276 (417)
Q Consensus 233 ~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t-------~~eil~h~~f~~~~ 276 (417)
+. ...|...++++.+||.+||+.||.+||| +++++.|||+....
T Consensus 255 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~ 306 (323)
T 3qup_A 255 GNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTS 306 (323)
T ss_dssp TCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-------
T ss_pred CCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCC
Confidence 54 5667788999999999999999999999 88899999997643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=395.91 Aligned_cols=253 Identities=24% Similarity=0.380 Sum_probs=221.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc-------cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV-------RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVL 85 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~ 85 (417)
..++|++++.||+|+||.||+|++. .++..||+|++.... .......+.+|+.+|+.+ +||||+++++++
T Consensus 79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~ 156 (370)
T 2psq_A 79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGAC 156 (370)
T ss_dssp CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE
T ss_pred cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3578999999999999999999975 355679999997653 233466789999999999 899999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL 148 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl 148 (417)
.+.+.+|+||||+.||+|.+++... .+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 157 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 236 (370)
T 2psq_A 157 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLV 236 (370)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE
T ss_pred ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEE
Confidence 9999999999999999999998752 47899999999999999999999999999999999999
Q ss_pred cCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 014849 149 DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY 227 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 227 (417)
+.++.+||+|||++................||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..++.
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DvwslG~il~ellt~g~~p~~~~~~~~~~ 315 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 315 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence 99999999999999865443333334455678999999999888775 99999999999999999 99999998887777
Q ss_pred HHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 228 RKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 228 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+..+. ...|...++++.+||.+||+.||.+|||+.|++++
T Consensus 316 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 316 KLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 7776654 45677889999999999999999999999999875
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-50 Score=405.73 Aligned_cols=261 Identities=25% Similarity=0.432 Sum_probs=199.2
Q ss_pred ccccCCeEE-eeEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-
Q 014849 12 VNLFGKYEV-GKIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT- 87 (417)
Q Consensus 12 ~~~~~~y~i-~~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~- 87 (417)
..+.+.|++ ++.||+|+||+||+|++. .+++.||||++..... ...+.+|+.+|+.++||||+++++++.+
T Consensus 16 ~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (405)
T 3rgf_A 16 ERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSH 90 (405)
T ss_dssp CCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHHHCCCTTBCCCCEEEEET
T ss_pred hhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHHhcCCCCeeeEeeEEecC
Confidence 456778988 779999999999999976 5789999999975432 3567899999999999999999999954
Q ss_pred -CCEEEEEEeccCCCChHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCC
Q 014849 88 -KAKIYFVMEFAKGGELFAKISK----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENW 152 (417)
Q Consensus 88 -~~~~~lV~E~~~gg~L~~~i~~----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~ 152 (417)
...+|+||||+.| +|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 91 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~ 169 (405)
T 3rgf_A 91 ADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERG 169 (405)
T ss_dssp TTTEEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTT
T ss_pred CCCeEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCC
Confidence 7799999999975 78777642 249999999999999999999999999999999999999 7788
Q ss_pred CeEEeeeecceeeccc-CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-------
Q 014849 153 DLKISDFGLSAVKEQI-RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM------- 224 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~-~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~------- 224 (417)
.+||+|||++...... .........+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+..
T Consensus 170 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~ 249 (405)
T 3rgf_A 170 RVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPY 249 (405)
T ss_dssp CEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCC
T ss_pred cEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccc
Confidence 9999999999765432 12234456789999999999988665569999999999999999999999765431
Q ss_pred --HHHHHHhc--CCCCC------------------------------------CCCCChHHHHHHHHhccCCCCCCCCHH
Q 014849 225 --AMYRKIYK--GEYRC------------------------------------PKWTSPDLKWFIGRLLDTDPATRITVD 264 (417)
Q Consensus 225 --~~~~~i~~--~~~~~------------------------------------p~~~s~~~~~li~~~L~~dP~~R~t~~ 264 (417)
+....+.. +.... ....++.+.+||.+||++||.+|||++
T Consensus 250 ~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~ 329 (405)
T 3rgf_A 250 HHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSE 329 (405)
T ss_dssp CHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHH
T ss_pred hHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHH
Confidence 22222221 00000 011267899999999999999999999
Q ss_pred HHhcCccccccccc
Q 014849 265 EILRDPWFKKDYKE 278 (417)
Q Consensus 265 eil~h~~f~~~~~~ 278 (417)
|+|+||||+....+
T Consensus 330 e~L~hp~f~~~~~~ 343 (405)
T 3rgf_A 330 QAMQDPYFLEDPLP 343 (405)
T ss_dssp HHHTSGGGTSSSCC
T ss_pred HHhcChhhccCCCC
Confidence 99999999876443
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-50 Score=398.55 Aligned_cols=255 Identities=26% Similarity=0.427 Sum_probs=209.7
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--------CCCcce
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR--------HPNIVK 80 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--------HpnIv~ 80 (417)
..+..+.++|++.+.||+|+||+||+|++..+|+.||||++.... .....+.+|+.+|+.++ ||||++
T Consensus 30 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~ 105 (397)
T 1wak_A 30 KIGDLFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAE----HYTETALDEIRLLKSVRNSDPNDPNREMVVQ 105 (397)
T ss_dssp CTTCEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHSCTTCGGGGGBCC
T ss_pred ehhhhcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCC----cchHHHHHHHHHHHHHhhcCCCCCCcceeee
Confidence 334567799999999999999999999999999999999997542 23567889999999986 788999
Q ss_pred EEEEEE----eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCC
Q 014849 81 LYEVLA----TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENW 152 (417)
Q Consensus 81 l~~~~~----~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~ 152 (417)
+++++. +...+|+||||+ +++|.+.+.. +.+++..++.++.||+.||.|||++ ||+||||||+|||++.++
T Consensus 106 ~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~ 184 (397)
T 1wak_A 106 LLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNE 184 (397)
T ss_dssp EEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCH
T ss_pred eecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccc
Confidence 999987 566899999999 5566666543 4699999999999999999999999 999999999999999776
Q ss_pred -------------------------------------------------CeEEeeeecceeecccCCCCcccccccCccc
Q 014849 153 -------------------------------------------------DLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183 (417)
Q Consensus 153 -------------------------------------------------~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y 183 (417)
.+||+|||++..... .....+||+.|
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~-----~~~~~~gt~~y 259 (397)
T 1wak_A 185 QYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK-----HFTEDIQTRQY 259 (397)
T ss_dssp HHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTB-----CSCSCCSCGGG
T ss_pred hhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccc-----cCccCCCCCcc
Confidence 799999999976532 23456899999
Q ss_pred cccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC------HHHHHHHHhc--CC---------------------
Q 014849 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN------LMAMYRKIYK--GE--------------------- 234 (417)
Q Consensus 184 ~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~------~~~~~~~i~~--~~--------------------- 234 (417)
+|||++.+..|+ .++|||||||++|+|++|..||...+ .......+.. +.
T Consensus 260 ~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~ 338 (397)
T 1wak_A 260 RSLEVLIGSGYN-TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGD 338 (397)
T ss_dssp CCHHHHHTSCCC-THHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSS
T ss_pred cCChhhcCCCCC-cHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccc
Confidence 999999988875 89999999999999999999997643 2222222211 00
Q ss_pred -------------------CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 235 -------------------YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 235 -------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+..+...++.+.+||.+||++||.+|||++|+++||||+.
T Consensus 339 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~ 397 (397)
T 1wak_A 339 LKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397 (397)
T ss_dssp BSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred cccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence 0111222466889999999999999999999999999973
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-49 Score=391.85 Aligned_cols=259 Identities=25% Similarity=0.334 Sum_probs=205.5
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE-
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK- 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~- 90 (417)
....++|++.+.||+|+||.||+|++..+|+.||||++...... .....+++..++.++||||+++++++.+...
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF----RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC----CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc----cHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 46688999999999999999999999999999999998654322 3345678888889999999999999865433
Q ss_pred ------EEEEEeccCCCChHHHH----hc-CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEecC-CCCeEE
Q 014849 91 ------IYFVMEFAKGGELFAKI----SK-GRFSEQLSRRYFQQLISAVEYCH--SRGVFHRDLKLENLLLDE-NWDLKI 156 (417)
Q Consensus 91 ------~~lV~E~~~gg~L~~~i----~~-~~l~e~~~~~i~~ql~~aL~ylH--~~givHrDlkp~NILl~~-~~~vkl 156 (417)
+|+||||+.++ |...+ .. ..+++..++.++.|++.||.||| ++||+||||||+|||++. ++.+||
T Consensus 95 ~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl 173 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKL 173 (360)
T ss_dssp CTTCEEEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEE
T ss_pred cccceeEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEE
Confidence 89999999875 43332 22 67999999999999999999999 999999999999999997 899999
Q ss_pred eeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-
Q 014849 157 SDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY- 235 (417)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~- 235 (417)
+|||++..... .......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+....+..+.+...
T Consensus 174 ~Dfg~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~ 250 (360)
T 3e3p_A 174 CDFGSAKKLSP---SEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGC 250 (360)
T ss_dssp CCCTTCBCCCT---TSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred eeCCCceecCC---CCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCC
Confidence 99999976543 23344568999999999997766556999999999999999999999999888777766653110
Q ss_pred -------------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 236 -------------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 236 -------------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..+...++++.+||.+||+.||.+|||+.|+++||||++...+
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~ 324 (360)
T 3e3p_A 251 PSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP 324 (360)
T ss_dssp CCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred CCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence 1112246789999999999999999999999999999976543
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=379.16 Aligned_cols=257 Identities=28% Similarity=0.477 Sum_probs=210.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-----
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT----- 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~----- 87 (417)
.+.++|++++.||+|+||.||+|++..+|+.||||++.... .....+.+|+.+++.++||||+++++++.+
T Consensus 3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 78 (303)
T 1zy4_A 3 RYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTE----EKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFV 78 (303)
T ss_dssp HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEH----HHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCC
T ss_pred cccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccH----HHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchh
Confidence 45689999999999999999999999999999999996532 235678899999999999999999998754
Q ss_pred --------CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 88 --------KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 88 --------~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
...+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 79 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 79 KPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp C------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEEC
T ss_pred hhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEe
Confidence 4679999999999999999975 358899999999999999999999999999999999999999999999
Q ss_pred eeecceeecccC------------CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHH
Q 014849 158 DFGLSAVKEQIR------------PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLM 224 (417)
Q Consensus 158 DFGls~~~~~~~------------~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~ 224 (417)
|||++....... ........+||+.|+|||++.+.+..+.++|||||||++|+|++ ||.. .+..
T Consensus 159 dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~ 235 (303)
T 1zy4_A 159 DFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERV 235 (303)
T ss_dssp CCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHH
T ss_pred eCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHH
Confidence 999987543211 11234566899999999999876545699999999999999998 5553 3344
Q ss_pred HHHHHHhcCCCCCCC----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 225 AMYRKIYKGEYRCPK----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 225 ~~~~~i~~~~~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
.....+.......|. ..++.+.+||.+||+.||.+|||+.++++||||+...
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (303)
T 1zy4_A 236 NILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH 291 (303)
T ss_dssp HHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred HHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence 556666655554443 3466799999999999999999999999999997643
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=384.94 Aligned_cols=254 Identities=28% Similarity=0.357 Sum_probs=219.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...++|++.+.||+|+||.||+|.+..+|+ .||||++.... .......+.+|+.+|+.++||||+++++++.+.+
T Consensus 46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 123 (325)
T 3kul_A 46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGR 123 (325)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGG
T ss_pred cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCC
Confidence 457899999999999999999999986665 49999997543 2334567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..|+||||++||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 124 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 124 LAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp CCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred ccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 99999999999999999964 6899999999999999999999999999999999999999999999999999986543
Q ss_pred cCCCC-cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChH
Q 014849 168 IRPDG-MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPD 244 (417)
Q Consensus 168 ~~~~~-~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 244 (417)
..... ......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|...+++
T Consensus 204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (325)
T 3kul_A 204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFS-SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHA 282 (325)
T ss_dssp ---CCEECC---CCGGGSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CccceeeccCCCCcccccCHhHhcCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCCCCCcCHH
Confidence 22111 22234568889999999887775 89999999999999999 99999999988888887765 45667788999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+||.+||..||.+|||+.++++.
T Consensus 283 l~~li~~~l~~dp~~Rps~~eil~~ 307 (325)
T 3kul_A 283 LHQLMLDCWHKDRAQRPRFSQIVSV 307 (325)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999864
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=387.74 Aligned_cols=254 Identities=26% Similarity=0.341 Sum_probs=222.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
...++|++++.||+|+||.||+|++. .+++.||+|++.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 44689999999999999999999997 456899999997653 23346788999999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCC
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLK 142 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlk 142 (417)
.+..|+||||++||+|.+++.. +.+++.+++.++.||+.||.|||++||+|||||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 201 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 201 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 9999999999999999999865 569999999999999999999999999999999
Q ss_pred CCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCC
Q 014849 143 LENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDP 221 (417)
Q Consensus 143 p~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~ 221 (417)
|+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.
T Consensus 202 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~ 280 (343)
T 1luf_A 202 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGM 280 (343)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred cceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcC-cccccHHHHHHHHHHHhcCCCcCCCC
Confidence 99999999999999999998765433222334456789999999999887775 99999999999999999 99999999
Q ss_pred CHHHHHHHHhcCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 222 NLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 222 ~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+..+....+..+.. ..|...++++.+||.+||+.||.+|||+.+++++
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~ 329 (343)
T 1luf_A 281 AHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI 329 (343)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence 88888888877664 5677889999999999999999999999999865
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=388.18 Aligned_cols=257 Identities=30% Similarity=0.561 Sum_probs=224.2
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCC--CCCcceEEEEE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLR--HPNIVKLYEVL 85 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~--HpnIv~l~~~~ 85 (417)
...+.++|++++.||+|+||.||+|.+..+|+.||||++........ .....+.+|+.+++.++ ||||+++++++
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~ 117 (320)
T 3a99_A 38 KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF 117 (320)
T ss_dssp --CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE
T ss_pred cCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEE
Confidence 35678999999999999999999999999999999999987654321 11245668999999996 59999999999
Q ss_pred EeCCEEEEEEeccCC-CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCeEEeeeecc
Q 014849 86 ATKAKIYFVMEFAKG-GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLS 162 (417)
Q Consensus 86 ~~~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~~~vkl~DFGls 162 (417)
.+.+..++|||++.+ ++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++
T Consensus 118 ~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~ 197 (320)
T 3a99_A 118 ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197 (320)
T ss_dssp ECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTC
T ss_pred ecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccc
Confidence 999999999999986 899999875 7899999999999999999999999999999999999999 7789999999998
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTS 242 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s 242 (417)
..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|..||...+ .+..+....+...+
T Consensus 198 ~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~~~~~ 267 (320)
T 3a99_A 198 ALLKD----TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVS 267 (320)
T ss_dssp EECCS----SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCC
T ss_pred ccccc----ccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcccccccccCC
Confidence 76542 234456799999999999888877789999999999999999999997642 34455666778889
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+++.+||.+||+.||.+|||++|+++||||++...
T Consensus 268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 302 (320)
T 3a99_A 268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL 302 (320)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccC
Confidence 99999999999999999999999999999987544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=400.10 Aligned_cols=254 Identities=17% Similarity=0.170 Sum_probs=196.5
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC--CCCCcceEE-------EEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL--RHPNIVKLY-------EVLA 86 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~HpnIv~l~-------~~~~ 86 (417)
..|++++.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.+ +||||++++ +++.
T Consensus 62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~ 141 (371)
T 3q60_A 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA 141 (371)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence 3599999999999999999999999999999999886554445567788885555544 699988755 5554
Q ss_pred eC-----------------CEEEEEEeccCCCChHHHHhc--CCCCHHHH------HHHHHHHHHHHHHHHHcCCeecCC
Q 014849 87 TK-----------------AKIYFVMEFAKGGELFAKISK--GRFSEQLS------RRYFQQLISAVEYCHSRGVFHRDL 141 (417)
Q Consensus 87 ~~-----------------~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~------~~i~~ql~~aL~ylH~~givHrDl 141 (417)
.+ ..+|+||||++ |+|.+++.. ..+++... ..++.||+.||.|||++||+||||
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDi 220 (371)
T 3q60_A 142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHF 220 (371)
T ss_dssp ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcC
Confidence 43 34899999998 799999975 34555544 577799999999999999999999
Q ss_pred CCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 014849 142 KLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFN 219 (417)
Q Consensus 142 kp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~ 219 (417)
||+|||++.+|.+||+|||+|.... .......||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.
T Consensus 221 kp~NIll~~~~~~kL~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~-~~~~DiwSlG~il~elltg~~Pf~ 294 (371)
T 3q60_A 221 TPDNLFIMPDGRLMLGDVSALWKVG-----TRGPASSVPVTYAPREFLNASTATF-THALNAWQLGLSIYRVWCLFLPFG 294 (371)
T ss_dssp SGGGEEECTTSCEEECCGGGEEETT-----CEEEGGGSCGGGCCHHHHTCSEEEC-CHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred CHHHEEECCCCCEEEEecceeeecC-----CCccCccCCcCCcChhhccCCCCCc-CccccHHHHHHHHHHHHhCCCCCC
Confidence 9999999999999999999997543 22225567799999999976 556 599999999999999999999998
Q ss_pred CCCHHH--HHHH-----HhcCCCCC--CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 220 DPNLMA--MYRK-----IYKGEYRC--PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 220 ~~~~~~--~~~~-----i~~~~~~~--p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+..... .+.. .....+.. +...++.+.+||.+||+.||++|||+.++++||||++..
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 295 LVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp BCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred CcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence 763221 0100 01112222 346799999999999999999999999999999998643
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=379.99 Aligned_cols=258 Identities=28% Similarity=0.433 Sum_probs=217.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEc-cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEE--
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNV-RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLA-- 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~-- 86 (417)
...++|++.+.||+|+||.||+|++. .+|+.||+|++...... ......+.+|+.+++.+ +||||+++++++.
T Consensus 8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~ 86 (326)
T 1blx_A 8 RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS 86 (326)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred CchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence 45689999999999999999999995 67899999999765432 22233556777777766 8999999999987
Q ss_pred ---eCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 87 ---TKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 87 ---~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
.....|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg 165 (326)
T 1blx_A 87 RTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG 165 (326)
T ss_dssp ECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred ccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence 5678999999998 599998875 359999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE------ 234 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~------ 234 (417)
++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+......++....
T Consensus 166 ~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~ 241 (326)
T 1blx_A 166 LARIYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE 241 (326)
T ss_dssp SCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred ccccccC---CCCccccccccceeCHHHHhcCCCC-cchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence 9875432 1234456899999999999887775 99999999999999999999999988777766664310
Q ss_pred -C--------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 235 -Y--------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 235 -~--------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+ ..+...++.+.+||.+||+.||.+|||+.|+++||||+...
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 304 (326)
T ss_dssp GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence 0 12245688999999999999999999999999999998643
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-49 Score=392.92 Aligned_cols=255 Identities=28% Similarity=0.410 Sum_probs=215.5
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CC-----CcceEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HP-----NIVKLYE 83 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-Hp-----nIv~l~~ 83 (417)
....+.++|++.+.||+|+||+||+|++..+|+.||||++.... ....++.+|+.+++.++ |+ +|+++++
T Consensus 48 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~ 123 (382)
T 2vx3_A 48 NGEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK----AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKR 123 (382)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH----HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEE
T ss_pred cCCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH----HHHHHHHHHHHHHHHHHhcccccceeEEEeee
Confidence 34567899999999999999999999999999999999997542 23567778999998885 55 4999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHH--HcCCeecCCCCCcEEec--CCCCeEE
Q 014849 84 VLATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCH--SRGVFHRDLKLENLLLD--ENWDLKI 156 (417)
Q Consensus 84 ~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH--~~givHrDlkp~NILl~--~~~~vkl 156 (417)
++...+.+|+||||+.| +|.+++.. +.+++..++.++.||+.||.||| +.||+||||||+|||++ .++.+||
T Consensus 124 ~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL 202 (382)
T 2vx3_A 124 HFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKI 202 (382)
T ss_dssp EEEETTEEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEE
T ss_pred eeccCCceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEE
Confidence 99999999999999965 99998875 46999999999999999999999 57999999999999994 5778999
Q ss_pred eeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC
Q 014849 157 SDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR 236 (417)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~ 236 (417)
+|||++.... ......+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+...++......
T Consensus 203 ~DFG~a~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~ 276 (382)
T 2vx3_A 203 VDFGSSCQLG-----QRIYQYIQSRFYRSPEVLLGMPYD-LAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGI 276 (382)
T ss_dssp CCCTTCEETT-----CCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCS
T ss_pred EeccCceecc-----cccccccCCccccChHHHcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence 9999997643 234567899999999999988875 9999999999999999999999998887777666432100
Q ss_pred C-------------------------------------CCCC---------------------------ChHHHHHHHHh
Q 014849 237 C-------------------------------------PKWT---------------------------SPDLKWFIGRL 252 (417)
Q Consensus 237 ~-------------------------------------p~~~---------------------------s~~~~~li~~~ 252 (417)
. |... ++++.+||.+|
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m 356 (382)
T 2vx3_A 277 PPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRM 356 (382)
T ss_dssp CCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHH
T ss_pred CCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHh
Confidence 0 0000 13789999999
Q ss_pred ccCCCCCCCCHHHHhcCcccccc
Q 014849 253 LDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|++||++|||++|+|+||||++.
T Consensus 357 L~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 357 LDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TCSCTTTSCCHHHHTTSGGGCC-
T ss_pred cCCChhhCCCHHHHhcCcccccC
Confidence 99999999999999999999864
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=375.01 Aligned_cols=256 Identities=30% Similarity=0.485 Sum_probs=211.7
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
+|.....||+|+||.||+|.+..+++.||+|++.... ......+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 99 (295)
T 2clq_A 23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME 99 (295)
T ss_dssp TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence 3334449999999999999999999999999997653 2335678899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-CCCeEEeeeecceeecccCCC
Q 014849 97 FAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-NWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 97 ~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-~~~vkl~DFGls~~~~~~~~~ 171 (417)
|++|++|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++...... .
T Consensus 100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~--~ 177 (295)
T 2clq_A 100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI--N 177 (295)
T ss_dssp CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC----
T ss_pred eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCC--C
Confidence 99999999998752 4679999999999999999999999999999999999987 899999999998765432 2
Q ss_pred CcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCH-H-HHHH-HHhcCCCCCCCCCChHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-M-AMYR-KIYKGEYRCPKWTSPDLKW 247 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~-~~~~-~i~~~~~~~p~~~s~~~~~ 247 (417)
......+||+.|+|||++.+.. ..+.++|||||||++|+|++|..||...+. . .... .........|...++++.+
T Consensus 178 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (295)
T 2clq_A 178 PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHPEIPESMSAEAKA 257 (295)
T ss_dssp ---CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCCCCCTTSCHHHHH
T ss_pred CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccccccccccccCCHHHHH
Confidence 2234567999999999987643 135899999999999999999999975432 2 2222 2233445667788999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 248 FIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
||.+||+.||++|||++++++||||+....
T Consensus 258 li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 287 (295)
T 2clq_A 258 FILKCFEPDPDKRACANDLLVDEFLKVSSK 287 (295)
T ss_dssp HHHHTTCSSTTTSCCHHHHHTSGGGCC---
T ss_pred HHHHHccCChhhCCCHHHHhcChhhhhccc
Confidence 999999999999999999999999986543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-49 Score=385.08 Aligned_cols=256 Identities=25% Similarity=0.386 Sum_probs=214.8
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCC-cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC------cceE
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTG-QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN------IVKL 81 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn------Iv~l 81 (417)
..+..+.++|++.+.||+|+||+||+|.+..++ +.||+|++.... .....+.+|+.+++.++|++ ++.+
T Consensus 12 ~~g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~ 87 (355)
T 2eu9_A 12 RIGDWLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVG----KYREAARLEINVLKKIKEKDKENKFLCVLM 87 (355)
T ss_dssp CTTCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHHCTTSCSCBCCE
T ss_pred ccCceecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccc----cchhHHHHHHHHHHHHhhcCCCCceeEEEe
Confidence 345667899999999999999999999998877 689999997532 23567788999999998765 9999
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----------
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---------- 148 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---------- 148 (417)
++++...+..|+||||+ +++|.+.+.. ..+++.+++.++.||+.||.|||++||+||||||+|||+
T Consensus 88 ~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~ 166 (355)
T 2eu9_A 88 SDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYN 166 (355)
T ss_dssp EEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEEC
T ss_pred eeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccc
Confidence 99999999999999999 5677776654 369999999999999999999999999999999999999
Q ss_pred ---------cCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 014849 149 ---------DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFN 219 (417)
Q Consensus 149 ---------~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~ 219 (417)
+.++.+||+|||++.... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.
T Consensus 167 ~~~~~~~~~~~~~~~kl~Dfg~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~ 240 (355)
T 2eu9_A 167 EHKSCEEKSVKNTSIRVADFGSATFDH-----EHHTTIVATRHYRPPEVILELGWA-QPCDVWSIGCILFEYYRGFTLFQ 240 (355)
T ss_dssp CC-CCCEEEESCCCEEECCCTTCEETT-----SCCCSSCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCC
T ss_pred ccccccccccCCCcEEEeecCcccccc-----ccccCCcCCCcccCCeeeecCCCC-CccchHHHHHHHHHHHhCCCCCC
Confidence 567899999999997533 223456899999999999888875 99999999999999999999999
Q ss_pred CCCHHHHHHHHhcCCCCCC--------------------------------------------CCCChHHHHHHHHhccC
Q 014849 220 DPNLMAMYRKIYKGEYRCP--------------------------------------------KWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 220 ~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~~~~~li~~~L~~ 255 (417)
..+..+....+.......| ...++++.+||.+||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~ 320 (355)
T 2eu9_A 241 THENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEF 320 (355)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCS
T ss_pred CCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcC
Confidence 8876655444332211111 11135788999999999
Q ss_pred CCCCCCCHHHHhcCcccccc
Q 014849 256 DPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 256 dP~~R~t~~eil~h~~f~~~ 275 (417)
||.+|||+.|+++||||+..
T Consensus 321 dP~~Rpt~~e~l~hp~f~~~ 340 (355)
T 2eu9_A 321 DPAQRITLAEALLHPFFAGL 340 (355)
T ss_dssp STTTSCCHHHHTTSGGGGGC
T ss_pred ChhhCcCHHHHhcChhhcCC
Confidence 99999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-49 Score=392.23 Aligned_cols=254 Identities=25% Similarity=0.390 Sum_probs=215.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEE-----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
...++|++++.||+|+||.||+|+ +..+++.||||++.... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~ 96 (359)
T 3vhe_A 19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 96 (359)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC--CHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence 446899999999999999999999 55677999999997643 223356789999999999 7899999999987
Q ss_pred eCC-EEEEEEeccCCCChHHHHhcCC------------------------------------------------------
Q 014849 87 TKA-KIYFVMEFAKGGELFAKISKGR------------------------------------------------------ 111 (417)
Q Consensus 87 ~~~-~~~lV~E~~~gg~L~~~i~~~~------------------------------------------------------ 111 (417)
+.+ .+|+||||+.||+|.+++....
T Consensus 97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 176 (359)
T 3vhe_A 97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV 176 (359)
T ss_dssp STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence 755 4999999999999999997521
Q ss_pred -------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 112 -------------FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 112 -------------l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++................
T Consensus 177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 256 (359)
T 3vhe_A 177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR 256 (359)
T ss_dssp -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CE
T ss_pred hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccC
Confidence 8999999999999999999999999999999999999999999999999997554322223445667
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HHHHHHhcC-CCCCCCCCChHHHHHHHHhccC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~ 255 (417)
||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+.. .....+..+ ....|...++++.++|.+||+.
T Consensus 257 ~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 257 LPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp ECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCceeEChhhhcCCCCC-chhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 89999999999888775 99999999999999998 99999886543 333333333 4567788999999999999999
Q ss_pred CCCCCCCHHHHhcC
Q 014849 256 DPATRITVDEILRD 269 (417)
Q Consensus 256 dP~~R~t~~eil~h 269 (417)
||.+|||+.|+++|
T Consensus 336 dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRPTFSELVEH 349 (359)
T ss_dssp SGGGSCCHHHHHHH
T ss_pred ChhhCCCHHHHHHH
Confidence 99999999999987
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=390.06 Aligned_cols=255 Identities=24% Similarity=0.367 Sum_probs=224.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCC-------cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTG-------QSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYE 83 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~ 83 (417)
....++|++++.||+|+||.||+|++..++ ..||+|++.... ......++.+|+.+++.+ +||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 345689999999999999999999986433 579999997653 233457788999999999 8999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 84 VLATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 84 ~~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
++.+.+..|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 222 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 222 (382)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceE
Confidence 999999999999999999999999753 499999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
|++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+
T Consensus 223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwslG~il~ellt~g~~p~~~~~~~~ 301 (382)
T 3tt0_A 223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301 (382)
T ss_dssp EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHH
T ss_pred EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCC-chhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999865543333344556788999999999887775 99999999999999999 999999999888
Q ss_pred HHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 226 MYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 226 ~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
....+..+. ...|...++++.+||.+||+.||++|||+.|++++
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 302 LFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp HHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 888877663 45677889999999999999999999999999987
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-48 Score=371.85 Aligned_cols=248 Identities=25% Similarity=0.395 Sum_probs=219.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+++.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (269)
T 4hcu_A 9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 83 (269)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred hhhceeeheecCCCccEEEEEEec-CCCeEEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEE
Confidence 468999999999999999999996 678899999976542 246788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus 84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~ 162 (269)
T 4hcu_A 84 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 162 (269)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred EEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc-cc
Confidence 999999999999965 569999999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 250 (417)
......||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ....|...++++.+++.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~ 241 (269)
T 4hcu_A 163 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 241 (269)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred cccCcccccccCCHHHhcCCCCC-chhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCCCCcCCHHHHHHHH
Confidence 22345578899999999887775 99999999999999999 99999999988888888776 44567778999999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 014849 251 RLLDTDPATRITVDEILRD 269 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h 269 (417)
+||+.||.+|||+.+++++
T Consensus 242 ~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 242 HCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCCcccCcCHHHHHHH
Confidence 9999999999999999976
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=384.23 Aligned_cols=258 Identities=30% Similarity=0.585 Sum_probs=212.7
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhC----CCCCcceEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRL----RHPNIVKLY 82 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l----~HpnIv~l~ 82 (417)
....+.++|++++.||+|+||.||+|++..+|+.||+|++........ .....+.+|+.+++.+ +||||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 345678899999999999999999999999999999999976543221 1123455799999998 899999999
Q ss_pred EEEEeCCEEEEEEec-cCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec-CCCCeEEeee
Q 014849 83 EVLATKAKIYFVMEF-AKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD-ENWDLKISDF 159 (417)
Q Consensus 83 ~~~~~~~~~~lV~E~-~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~-~~~~vkl~DF 159 (417)
+++.+.+..++|||+ +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+||
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 999999999999999 789999999976 7799999999999999999999999999999999999999 8899999999
Q ss_pred ecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC
Q 014849 160 GLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK 239 (417)
Q Consensus 160 Gls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 239 (417)
|++..... ......+||+.|+|||++.+..+.+.++|||||||++|+|++|+.||.... .+.......+.
T Consensus 185 g~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~~ 254 (312)
T 2iwi_A 185 GSGALLHD----EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA 254 (312)
T ss_dssp SSCEECCS----SCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCCT
T ss_pred chhhhccc----CcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCcc
Confidence 99876542 234566799999999999888777679999999999999999999997642 34456677788
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..++++.+||.+||+.||++|||++|+++||||+....
T Consensus 255 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~ 292 (312)
T 2iwi_A 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE 292 (312)
T ss_dssp TSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred cCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence 89999999999999999999999999999999987543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-49 Score=385.90 Aligned_cols=256 Identities=33% Similarity=0.580 Sum_probs=188.3
Q ss_pred cccccccCCeEEe-eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 9 SREVNLFGKYEVG-KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 9 ~~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
.+...+.++|++. +.||+|+||+||+|.+..+|+.||||++.... ....+....++.++||||+++++++..
T Consensus 21 ~~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~e~~~~~~~~~h~~i~~~~~~~~~ 93 (336)
T 3fhr_A 21 PKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP-------KARQEVDHHWQASGGPHIVCILDVYEN 93 (336)
T ss_dssp CBCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH-------HHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred CCCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH-------HHHHHHHHHHHhcCCCChHHHHHHHhh
Confidence 3446788999995 57999999999999999999999999986532 112223334677899999999999876
Q ss_pred ----CCEEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCeEEe
Q 014849 88 ----KAKIYFVMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---WDLKIS 157 (417)
Q Consensus 88 ----~~~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---~~vkl~ 157 (417)
...+|+||||+.||+|.+++... .+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+
T Consensus 94 ~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~ 173 (336)
T 3fhr_A 94 MHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLT 173 (336)
T ss_dssp EETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEEC
T ss_pred ccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEe
Confidence 55699999999999999999762 69999999999999999999999999999999999999864 459999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH----HHHHhcC
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM----YRKIYKG 233 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~----~~~i~~~ 233 (417)
|||++.... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+.... ...+..+
T Consensus 174 Dfg~~~~~~----~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (336)
T 3fhr_A 174 DFGFAKETT----QNALQTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG 248 (336)
T ss_dssp CCTTCEEC--------------------------CHHH-HHHHHHHHHHHHHHHHHSSCCC-------------------
T ss_pred ccccceecc----ccccccCCCCcCccChhhhCCCCCC-chhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc
Confidence 999997543 2334567899999999999877775 899999999999999999999977654433 2233333
Q ss_pred CCCCC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 234 EYRCP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 234 ~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
....| ...++++.+||.+||+.||.+|||++|+++||||+...
T Consensus 249 ~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 295 (336)
T 3fhr_A 249 QYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSM 295 (336)
T ss_dssp --CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGG
T ss_pred ccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccc
Confidence 33332 45799999999999999999999999999999998754
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=389.52 Aligned_cols=261 Identities=25% Similarity=0.447 Sum_probs=212.4
Q ss_pred CccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----------C
Q 014849 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----------H 75 (417)
Q Consensus 7 ~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------H 75 (417)
.........++|++++.||+|+||.||+|.+..+|+.||||++..... ....+.+|+.+++.++ |
T Consensus 10 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~~~~ 85 (373)
T 1q8y_A 10 AFKGEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGA 85 (373)
T ss_dssp CCTTCEETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred eecCCcccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCcc----chhhhhHHHHHHHHhhcccccchhcccc
Confidence 333444556899999999999999999999999999999999975432 3466788999998886 8
Q ss_pred CCcceEEEEEEeCC----EEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEE
Q 014849 76 PNIVKLYEVLATKA----KIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLL 147 (417)
Q Consensus 76 pnIv~l~~~~~~~~----~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NIL 147 (417)
|||+++++++...+ .+++||||+ |++|.+++.. +.+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIl 164 (373)
T 1q8y_A 86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164 (373)
T ss_dssp TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEE
T ss_pred chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeE
Confidence 99999999987654 899999999 8899999875 5699999999999999999999998 9999999999999
Q ss_pred ec------CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 148 LD------ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 148 l~------~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
++ ..+.+||+|||++..... .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||...
T Consensus 165 l~~~~~~~~~~~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~ 238 (373)
T 1q8y_A 165 MEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPD 238 (373)
T ss_dssp EEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---
T ss_pred EeccCCCcCcceEEEcccccccccCC-----CCCCCCCCccccCcHHHhCCCCC-chHhHHHHHHHHHHHHhCCCCCCCC
Confidence 94 344799999999976542 23456899999999999988775 9999999999999999999999865
Q ss_pred CH------HHHHHHHhc------------------------------------------CCCCCCCCCChHHHHHHHHhc
Q 014849 222 NL------MAMYRKIYK------------------------------------------GEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 222 ~~------~~~~~~i~~------------------------------------------~~~~~p~~~s~~~~~li~~~L 253 (417)
+. ......+.. ..+..|...++++.+||.+||
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L 318 (373)
T 1q8y_A 239 EGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML 318 (373)
T ss_dssp ------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred cccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence 41 122222211 112233344678899999999
Q ss_pred cCCCCCCCCHHHHhcCccccccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
+.||.+|||++|+++||||++....
T Consensus 319 ~~dP~~Rpt~~ell~hp~f~~~~~~ 343 (373)
T 1q8y_A 319 QLDPRKRADAGGLVNHPWLKDTLGM 343 (373)
T ss_dssp CSSTTTCBCHHHHHTCGGGTTCTTC
T ss_pred ccCccccCCHHHHhhChhhhcccCc
Confidence 9999999999999999999976543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-49 Score=381.06 Aligned_cols=251 Identities=25% Similarity=0.415 Sum_probs=212.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..-.++|++++.||+|+||+||+|.+..+|+.||+|++... .......+.+|+.+|+.++||||+++++++.+.+..
T Consensus 6 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 6 IFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 34468999999999999999999999999999999998543 234467889999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.||+|.+++.. +.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 999999999999999976 679999999999999999999999999999999999999999999999999997653322
Q ss_pred CC------------CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH-----HHHHHhc
Q 014849 170 PD------------GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA-----MYRKIYK 232 (417)
Q Consensus 170 ~~------------~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~-----~~~~i~~ 232 (417)
.. ....+.+||+.|+|||++.+..++ .++|||||||++|+|++|..||....... ......
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~- 240 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYD-EKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL- 240 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCC-THHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH-
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc-
Confidence 11 111256899999999999988775 99999999999999999999986532110 001111
Q ss_pred CCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 233 GEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 233 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
....|...++.+.++|.+||+.||++|||+.++++
T Consensus 241 -~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 241 -DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp -HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred -cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 12346678899999999999999999999999986
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-49 Score=380.48 Aligned_cols=253 Identities=23% Similarity=0.340 Sum_probs=220.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
..++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|+.++||||+++++++.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 98 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD 98 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC
Confidence 4679999999999999999999983 456899999997543 233457788999999999999999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC-------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCC
Q 014849 89 AKIYFVMEFAKGGELFAKISKG-------------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKL 143 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~-------------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp 143 (417)
+..|+||||+.|++|.+++... .+++.+++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp 178 (314)
T 2ivs_A 99 GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAA 178 (314)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccch
Confidence 9999999999999999998752 289999999999999999999999999999999
Q ss_pred CcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCC
Q 014849 144 ENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPN 222 (417)
Q Consensus 144 ~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~ 222 (417)
+|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+
T Consensus 179 ~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~ 257 (314)
T 2ivs_A 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT-TQSDVWSFGVLLWEIVTLGGNPYPGIP 257 (314)
T ss_dssp GGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred heEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcC-chhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999765432222223445678999999999887775 99999999999999999 999999988
Q ss_pred HHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 223 LMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 223 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.......+..+. ...|...++++.+||.+||+.||.+|||+.+++++
T Consensus 258 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~ 305 (314)
T 2ivs_A 258 PERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD 305 (314)
T ss_dssp GGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 777777776654 45677789999999999999999999999999876
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=368.37 Aligned_cols=249 Identities=29% Similarity=0.477 Sum_probs=207.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc-cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
-.++|++.+.||+|+||.||+|.+ +|+.||+|++....... ....+.+.+|+.+++.++||||+++++++.+.+..|
T Consensus 5 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 82 (271)
T 3dtc_A 5 DFAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLC 82 (271)
T ss_dssp CTTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CE
T ss_pred chhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceE
Confidence 357999999999999999999998 48999999997654322 233567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CeecCCCCCcEEecC--------CCCeEEeeeec
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG---VFHRDLKLENLLLDE--------NWDLKISDFGL 161 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~g---ivHrDlkp~NILl~~--------~~~vkl~DFGl 161 (417)
+||||++|++|.+++..+++++..++.++.|++.||.|||++| |+||||||+|||++. ++.+||+|||+
T Consensus 83 lv~e~~~~~~L~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~ 162 (271)
T 3dtc_A 83 LVMEFARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGL 162 (271)
T ss_dssp EEEECCTTEEHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC
T ss_pred EEEEcCCCCCHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCc
Confidence 9999999999999998889999999999999999999999999 999999999999986 77899999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--CCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--YRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--~~~p~ 239 (417)
+..... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+.......+.... ...|.
T Consensus 163 ~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 237 (271)
T 3dtc_A 163 AREWHR----TTKMSAAGAYAWMAPEVIRASMFS-KGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS 237 (271)
T ss_dssp -----------------CCGGGSCHHHHHHCCCS-HHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCCCT
T ss_pred cccccc----ccccCCCCccceeCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCCCc
Confidence 875432 222356799999999999887775 99999999999999999999999988777766666554 45567
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++.+.++|.+||+.||.+|||+.|++++
T Consensus 238 ~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 238 TCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 789999999999999999999999999875
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-49 Score=393.32 Aligned_cols=252 Identities=27% Similarity=0.421 Sum_probs=218.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.+.+.+|+|
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 190 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIV 190 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTS--CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccC--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEE
Confidence 468999999999999999999999999999999987542 223345678999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++||+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus 191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~ 270 (377)
T 3cbl_A 191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA 270 (377)
T ss_dssp EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence 999999999999875 469999999999999999999999999999999999999999999999999987533211111
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~ 250 (417)
......+|+.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|...++++.+||.
T Consensus 271 ~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~ 349 (377)
T 3cbl_A 271 SGGLRQVPVKWTAPEALNYGRYS-SESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLME 349 (377)
T ss_dssp CSSCCEEEGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHH
T ss_pred cCCCCCCCcCcCCHhHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHH
Confidence 11223457889999999877775 89999999999999998 99999998887777776655 35677888999999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 014849 251 RLLDTDPATRITVDEILRD 269 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h 269 (417)
+||+.||++|||++++++.
T Consensus 350 ~cl~~dP~~Rps~~~i~~~ 368 (377)
T 3cbl_A 350 QCWAYEPGQRPSFSTIYQE 368 (377)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHcCCCchhCcCHHHHHHH
Confidence 9999999999999999753
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-48 Score=375.37 Aligned_cols=258 Identities=23% Similarity=0.363 Sum_probs=211.3
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
......++|++.+.||+|+||.||+|++..+++.||+|++.............+.+|+.+++.++||||+++++++.+.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~ 107 (309)
T 2h34_A 28 REGTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDG 107 (309)
T ss_dssp ------CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETT
T ss_pred CCCcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCC
Confidence 45667899999999999999999999999999999999998765545555678899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
..|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 108 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 187 (309)
T 2h34_A 108 QLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDE 187 (309)
T ss_dssp EEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------
T ss_pred eEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccc
Confidence 99999999999999999976 78999999999999999999999999999999999999999999999999998754322
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CCCCCCChHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCPKWTSPDL 245 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~p~~~s~~~ 245 (417)
. .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||...+...+...+..... ..+...++++
T Consensus 188 ~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 265 (309)
T 2h34_A 188 K-LTQLGNTVGTLYYMAPERFSESHAT-YRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQAIPRPSTVRPGIPVAF 265 (309)
T ss_dssp ----------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSCCCCGGGTSTTCCTHH
T ss_pred c-cccccccCCCcCccCHHHHcCCCCC-chHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccCCCCccccCCCCCHHH
Confidence 1 1233456799999999999887764 899999999999999999999998877655555543322 2456689999
Q ss_pred HHHHHHhccCCCCCCC-CHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRI-TVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~-t~~eil~h 269 (417)
.++|.+||+.||.+|| |++++++.
T Consensus 266 ~~li~~~l~~dP~~Rp~s~~~l~~~ 290 (309)
T 2h34_A 266 DAVIARGMAKNPEDRYVTCGDLSAA 290 (309)
T ss_dssp HHHHHHHTCSSGGGSCSSHHHHHHH
T ss_pred HHHHHHhccCCHHHHHHhHHHHHHH
Confidence 9999999999999999 88888753
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-48 Score=382.58 Aligned_cols=254 Identities=22% Similarity=0.352 Sum_probs=210.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEE----EEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSV----AIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
....++|++.+.||+|+||+||+|++..+|+.+ |+|.+.... .......+.+|+.+|+.++||||+++++++.+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 345679999999999999999999998888765 666664332 22345788999999999999999999999987
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
.. .++|+||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++...
T Consensus 89 ~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 ST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp SS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred CC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 66 7899999999999999875 67999999999999999999999999999999999999999999999999999765
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCCh
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSP 243 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~ 243 (417)
.............||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+.......+..+. ...|...+.
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 246 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTI 246 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTBCH
T ss_pred cCCcccccccCCCccccccChHHhccCCCC-chhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCCCccCCH
Confidence 443333333445678899999999988775 99999999999999999 999999887777766666553 566778899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
++.+++.+||+.||.+|||+.+++++
T Consensus 247 ~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 247 DVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp HHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 99999999999999999999999987
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=367.00 Aligned_cols=249 Identities=22% Similarity=0.330 Sum_probs=218.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+. ++..||+|++..... ...++.+|+.+++.++||||+++++++.+....|+
T Consensus 6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (268)
T 3sxs_A 6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI 80 (268)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence 4578999999999999999999885 677899999976542 24678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||++|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++....... .
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-~ 159 (268)
T 3sxs_A 81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ-Y 159 (268)
T ss_dssp EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC-E
T ss_pred EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh-h
Confidence 9999999999999975 459999999999999999999999999999999999999999999999999987543221 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
.......||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+. ...|...++.+.++|
T Consensus 160 ~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li 238 (268)
T 3sxs_A 160 VSSVGTKFPVKWSAPEVFHYFKYS-SKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIM 238 (268)
T ss_dssp EECCSCCCCGGGCCHHHHHHSEEE-TTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred hcccCCCcCcccCCHHHHhccCCc-hhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCCCcChHHHHHHH
Confidence 122334567889999999887775 89999999999999999 999999998888887777665 345667799999999
Q ss_pred HHhccCCCCCCCCHHHHhcC
Q 014849 250 GRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~h 269 (417)
.+||+.||.+|||+.+++++
T Consensus 239 ~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 239 YSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp HHTTCSSGGGSCCHHHHHHH
T ss_pred HHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999987
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-48 Score=377.92 Aligned_cols=254 Identities=21% Similarity=0.285 Sum_probs=222.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
...++|++.+.||+|+||.||+|.+. .+++.||+|++..... ......+.+|+.+|+.++||||+++++++.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 99 (322)
T 1p4o_A 22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS--MRERIEFLNEASVMKEFNCHHVVRLLGVVSQ 99 (322)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSC--HHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccC--HHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence 44679999999999999999999986 4678999999975432 2235578899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEE
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl 156 (417)
.+..|+||||+.||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus 100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl 179 (322)
T 1p4o_A 100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKI 179 (322)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEE
T ss_pred CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEE
Confidence 9999999999999999998864 45799999999999999999999999999999999999999999999
Q ss_pred eeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC
Q 014849 157 SDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY 235 (417)
Q Consensus 157 ~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~ 235 (417)
+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+..
T Consensus 180 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~ 258 (322)
T 1p4o_A 180 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 258 (322)
T ss_dssp CCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCC
T ss_pred CcCccccccccccccccccCCCCCCCccChhhhccCCCC-chhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCc
Confidence 999998755433322333455779999999999887775 89999999999999999 8999999988888888776653
Q ss_pred -CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 -RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 -~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..|...++.+.+||.+||+.||.+|||+.|++++
T Consensus 259 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 259 LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 5677789999999999999999999999999987
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-48 Score=372.97 Aligned_cols=247 Identities=23% Similarity=0.332 Sum_probs=213.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCC-------cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTG-------QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL 85 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~ 85 (417)
...++|++.+.||+|+||.||+|.+..++ ..||+|++.... ....+.+.+|+.+|+.++||||+++++++
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~ 81 (289)
T 4fvq_A 5 IRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVC 81 (289)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEE
T ss_pred echhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence 34679999999999999999999998887 479999997643 33467889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC--------eE
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD--------LK 155 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~--------vk 155 (417)
.+.+..|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++. +|
T Consensus 82 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~k 161 (289)
T 4fvq_A 82 VCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIK 161 (289)
T ss_dssp CCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEE
T ss_pred EeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceee
Confidence 9999999999999999999999763 4999999999999999999999999999999999999998887 99
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++.... ......||+.|+|||++.+....+.++|||||||++|+|++| .+||...+.... .......
T Consensus 162 l~Dfg~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~-~~~~~~~ 234 (289)
T 4fvq_A 162 LSDPGISITVL------PKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK-LQFYEDR 234 (289)
T ss_dssp ECCCCSCTTTS------CHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHH-HHHHHTT
T ss_pred eccCccccccc------CccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHH-HHHhhcc
Confidence 99999985432 224567899999999998744446999999999999999995 556655554443 3444556
Q ss_pred CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 235 YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 235 ~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
...|...++++.+||.+||+.||.+|||+.+++++
T Consensus 235 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 235 HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 66777789999999999999999999999999987
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-49 Score=383.47 Aligned_cols=253 Identities=22% Similarity=0.339 Sum_probs=215.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcE----EEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~----vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
...++|++.+.||+|+||+||+|.+..+|+. ||+|++.... .......+.+|+.+++.++||||+++++++.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~- 86 (325)
T 3kex_A 10 FKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG- 86 (325)
T ss_dssp CCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHHTCCCTTBCCEEEEECB-
T ss_pred cCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-
Confidence 3457899999999999999999999988887 6666664332 11223456789999999999999999999864
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...++||||+.+|+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++++||+|||++....
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 558999999999999999875 579999999999999999999999999999999999999999999999999998765
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPD 244 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 244 (417)
............||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. ...|...+++
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYT-HQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQICTID 245 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCCTTBCTT
T ss_pred cccccccccCCCCcccccChHHhccCCCC-hhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCCCcCcHH
Confidence 43333444566788899999999887775 99999999999999999 999999888777777776653 5567778999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.++|.+||..||.+|||+.+++++
T Consensus 246 ~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 246 VYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-48 Score=383.03 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=214.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|+.+ +||||+++++++.+.
T Consensus 44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 44 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 578999999999999999999973 467789999997543 223357889999999999 899999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 014849 89 AKIYFVMEFAKGGELFAKISKG------------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLE 144 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~------------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~ 144 (417)
+..|+||||++||+|.+++... .+++..++.++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~ 201 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAAR 201 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGG
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence 9999999999999999999752 2789999999999999999999999999999999
Q ss_pred cEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 014849 145 NLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNL 223 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~ 223 (417)
|||++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.
T Consensus 202 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 202 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred hEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCC-hhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999999999999999999765443333334556789999999999887775 99999999999999998 9999988664
Q ss_pred HHHHHHHhcC--CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCc
Q 014849 224 MAMYRKIYKG--EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDP 270 (417)
Q Consensus 224 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~ 270 (417)
......+... ....|...++++.+||.+||+.||.+|||+.+++++.
T Consensus 281 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l 329 (344)
T 1rjb_A 281 DANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL 329 (344)
T ss_dssp SHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence 4444443333 3456777899999999999999999999999999874
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=377.24 Aligned_cols=255 Identities=23% Similarity=0.315 Sum_probs=217.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVL 85 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~ 85 (417)
....++|++++.||+|+||.||+|.+ ..+++.||+|++..... ....+.+.+|+.+|+.+ +||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchh--HHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 34467999999999999999999985 45788999999976532 22357788999999999 999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcE
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKG-------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENL 146 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NI 146 (417)
.+.+..|+||||+++|+|.+++... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni 176 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNI 176 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceE
Confidence 9999999999999999999998753 389999999999999999999999999999999999
Q ss_pred EecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 014849 147 LLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMA 225 (417)
Q Consensus 147 Ll~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~ 225 (417)
|++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+...
T Consensus 177 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~ 255 (313)
T 1t46_A 177 LLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDS 255 (313)
T ss_dssp EEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSH
T ss_pred EEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCCcccchh
Confidence 9999999999999999765443222233456688999999999887775 99999999999999998 999998765443
Q ss_pred HHHHHhcC--CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 226 MYRKIYKG--EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 226 ~~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
........ ....|...++++.+||.+||+.||.+|||+.|++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 301 (313)
T 1t46_A 256 KFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301 (313)
T ss_dssp HHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence 33333322 234466789999999999999999999999999875
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=370.34 Aligned_cols=252 Identities=19% Similarity=0.239 Sum_probs=215.3
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~ 89 (417)
...+.++|++++.||+|+||.||+|.+..+|+.||+|++..... ...+.+|+.+++.+ +|||++++++++.+..
T Consensus 5 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~ 79 (298)
T 1csn_A 5 NNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGL 79 (298)
T ss_dssp -CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETT
T ss_pred CcccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCc
Confidence 35577899999999999999999999999999999999865432 34577899999999 7999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-----eEEeeeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD-----LKISDFGLS 162 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~-----vkl~DFGls 162 (417)
..|+||||+ |++|.+++.. +++++..+..++.||+.||.|||++||+||||||+|||++.++. +||+|||++
T Consensus 80 ~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~ 158 (298)
T 1csn_A 80 HNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMV 158 (298)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTC
T ss_pred eeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccc
Confidence 999999999 9999999985 46999999999999999999999999999999999999988776 999999999
Q ss_pred eeecccCCC-----CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCC
Q 014849 163 AVKEQIRPD-----GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGE 234 (417)
Q Consensus 163 ~~~~~~~~~-----~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~ 234 (417)
......... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+. +....+..+....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~ 237 (298)
T 1csn_A 159 KFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKK 237 (298)
T ss_dssp EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHH
T ss_pred cccccccccccccccCccCCCCCcccCCchhhcCCCCC-hHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhc
Confidence 865432221 234567899999999999887774 9999999999999999999999873 4445555544332
Q ss_pred CC-----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 235 YR-----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 235 ~~-----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.. .+...++++.+||.+||+.||++|||+++|++.
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 238 QSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred cCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 21 234678999999999999999999999999765
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=382.82 Aligned_cols=250 Identities=24% Similarity=0.316 Sum_probs=214.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~ 90 (417)
..+.++|++++.||+|+||+||+|.+..+|+.||||++..... ...+.+|+.+++.+ +||||+++++++.+...
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~ 79 (330)
T 2izr_A 5 LMVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR-----APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKY 79 (330)
T ss_dssp CEETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS-----SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTE
T ss_pred EEEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc-----hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCc
Confidence 3466789999999999999999999999999999999876532 23577999999999 99999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-----eEEeeeecce
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD-----LKISDFGLSA 163 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~-----vkl~DFGls~ 163 (417)
.|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|||++.
T Consensus 80 ~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~ 158 (330)
T 2izr_A 80 NAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158 (330)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred cEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence 99999999 9999999974 68999999999999999999999999999999999999999887 9999999998
Q ss_pred eecccCCC-----CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHHHHhcCCC
Q 014849 164 VKEQIRPD-----GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND---PNLMAMYRKIYKGEY 235 (417)
Q Consensus 164 ~~~~~~~~-----~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~---~~~~~~~~~i~~~~~ 235 (417)
........ ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+ .+..+.+.++.....
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~ 237 (330)
T 2izr_A 159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS-RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237 (330)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHH
T ss_pred eeecCCCCccccccccCCcCCCccccChHHHcCCCCC-chhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhc
Confidence 65432221 123567899999999999988874 999999999999999999999987 455566666654443
Q ss_pred CCCC----CCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 236 RCPK----WTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 236 ~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..|. ...+++.++|.+||+.||.+||++++|++
T Consensus 238 ~~~~~~~~~~~p~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 238 ATPIEVLCENFPEMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HSCHHHHTTTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred cCCHHHHhccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 3331 11349999999999999999999999876
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-48 Score=371.62 Aligned_cols=253 Identities=26% Similarity=0.362 Sum_probs=208.0
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
....++|++++.||+|+||.||+|.+..+ +..||+|++.... .....+.+.+|+.+++.++||||+++++++. .
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S
T ss_pred EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEc-c
Confidence 45678999999999999999999998654 4579999986542 2334567889999999999999999999984 5
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
+..|+||||+.+++|.+++.. ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 88 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 88 NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC--------
T ss_pred CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccC
Confidence 568999999999999999975 369999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChH
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPD 244 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 244 (417)
... ........+|+.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+..+. .+.|...+++
T Consensus 168 ~~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 245 (281)
T 1mp8_A 168 DST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPT 245 (281)
T ss_dssp ------------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHH
T ss_pred ccc-ccccccCCCcccccChhhcccCCCC-CccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCCCCCCCHH
Confidence 321 1122345678899999999887775 89999999999999996 999999888777777776654 4567788999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.++|.+||+.||.+|||+.+++++
T Consensus 246 l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 246 LYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-48 Score=379.79 Aligned_cols=256 Identities=21% Similarity=0.350 Sum_probs=212.4
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEE----EEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSV----AIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL 85 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v----AiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~ 85 (417)
......++|++.+.||+|+||.||+|++..+++.+ |+|.+.... .......+.+|+.+|+.++||||+++++++
T Consensus 9 ~~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 86 (327)
T 3lzb_A 9 LRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGIC 86 (327)
T ss_dssp CEECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred hcccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence 34455789999999999999999999999998876 455443322 233467889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.+.. .++|+||+.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus 87 ~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~ 165 (327)
T 3lzb_A 87 LTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAK 165 (327)
T ss_dssp ESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC--
T ss_pred ecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCccee
Confidence 8776 7899999999999999875 679999999999999999999999999999999999999999999999999998
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCC
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWT 241 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~ 241 (417)
...............||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+.......+..+. .+.|...
T Consensus 166 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 244 (327)
T 3lzb_A 166 LLGAEEKEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPIC 244 (327)
T ss_dssp --------------CCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTB
T ss_pred EccCccccccccCCCccccccCHHHHcCCCCC-hHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccC
Confidence 65443333334455678899999999988875 99999999999999999 999999988777777666554 5667788
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
++++.+||.+||..||.+|||+.|+++.
T Consensus 245 ~~~l~~li~~~l~~dp~~Rps~~ell~~ 272 (327)
T 3lzb_A 245 TIDVYMIMRKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 9999999999999999999999999874
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-48 Score=373.61 Aligned_cols=262 Identities=27% Similarity=0.411 Sum_probs=212.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC--CCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR--HPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~--HpnIv~l~~~~~~~~ 89 (417)
....++|++.+.||+|+||.||+|.+. +|+.||+|++..... .......+.+|+.+++.++ ||||+++++++.+.+
T Consensus 24 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 101 (313)
T 3cek_A 24 SVKGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101 (313)
T ss_dssp EETTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSS
T ss_pred eeccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCC
Confidence 344668999999999999999999984 689999999976543 2334677899999999997 599999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
..|+||| +.+++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||+++ +.+||+|||++......
T Consensus 102 ~~~lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~ 179 (313)
T 3cek_A 102 YIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPD 179 (313)
T ss_dssp EEEEEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC----
T ss_pred EEEEEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeeccccccccCc
Confidence 9999999 567899999976 68999999999999999999999999999999999999965 78999999999765433
Q ss_pred CCCCcccccccCcccccccccccc----------CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCC--C
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKK----------GYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGE--Y 235 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~----------~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~--~ 235 (417)
.........+||+.|+|||++.+. ...+.++|||||||++|+|++|..||... +.......+.... .
T Consensus 180 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~ 259 (313)
T 3cek_A 180 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI 259 (313)
T ss_dssp ----------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC
T ss_pred cccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccccc
Confidence 333334566899999999998652 23358999999999999999999999865 3334444444433 4
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..|...++++.+||.+||+.||.+|||+.|+++||||+....
T Consensus 260 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 301 (313)
T 3cek_A 260 EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTH 301 (313)
T ss_dssp CCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred CCcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence 567777899999999999999999999999999999986543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-48 Score=368.37 Aligned_cols=250 Identities=24% Similarity=0.332 Sum_probs=217.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.-.++|++.+.||+|+||.||+|.+. ++..||+|++..... ...++.+|+.+++.++||||+++++++.+.+..|
T Consensus 21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 95 (283)
T 3gen_A 21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIF 95 (283)
T ss_dssp CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEE
T ss_pred CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeE
Confidence 44679999999999999999999885 778899999976542 2467889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 174 (283)
T 3gen_A 96 IITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE- 174 (283)
T ss_dssp EEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH-
T ss_pred EEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc-
Confidence 99999999999999976 689999999999999999999999999999999999999999999999999987543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
........||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+. ...|...++.+.+|
T Consensus 175 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 253 (283)
T 3gen_A 175 YTSSVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTI 253 (283)
T ss_dssp HHSTTSTTSCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCccCcccCCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCCCCcCCHHHHHH
Confidence 1112334578899999999887774 99999999999999998 999999998888888887764 45567789999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|.+||+.||.+|||+.++++|
T Consensus 254 i~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 254 MYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp HHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-48 Score=377.46 Aligned_cols=254 Identities=24% Similarity=0.377 Sum_probs=219.9
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEc-------cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNV-------RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEV 84 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~-------~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~ 84 (417)
...++|++++.||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+|+.+ +||||++++++
T Consensus 32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~ 109 (334)
T 2pvf_A 32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA 109 (334)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence 34689999999999999999999986 467889999997653 233456788999999999 89999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 014849 85 LATKAKIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLL 147 (417)
Q Consensus 85 ~~~~~~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NIL 147 (417)
+.+.+.+|+||||+.||+|.+++... .+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 110 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl 189 (334)
T 2pvf_A 110 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVL 189 (334)
T ss_dssp ECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEE
Confidence 99999999999999999999999753 3899999999999999999999999999999999999
Q ss_pred ecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 014849 148 LDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAM 226 (417)
Q Consensus 148 l~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~ 226 (417)
++.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+.
T Consensus 190 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~ 268 (334)
T 2pvf_A 190 VTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYT-HQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL 268 (334)
T ss_dssp ECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcC-hHHHHHHHHHHHHHHHhCCCCCcCcCCHHHH
Confidence 999999999999999765432222223345678999999999887775 99999999999999999 9999999988888
Q ss_pred HHHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 227 YRKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 227 ~~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
...+..+. ...|...++++.++|.+||+.||.+|||+.|++++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 269 FKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 87777654 45677789999999999999999999999999876
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-47 Score=366.09 Aligned_cols=254 Identities=28% Similarity=0.413 Sum_probs=212.9
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc----hHHHHHHHHHHHHhCCCCCcceEEE
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG----LTAHVKREISIMSRLRHPNIVKLYE 83 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~----~~~~i~~Ei~il~~l~HpnIv~l~~ 83 (417)
........++|++.+.||+|+||.||+|++..+++.||+|++......... ....+.+|+.+++.++||||+++++
T Consensus 11 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 90 (287)
T 4f0f_A 11 SRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG 90 (287)
T ss_dssp -CCCBCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred hhhhhhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhhe
Confidence 344456678999999999999999999999999999999999765432221 1267889999999999999999999
Q ss_pred EEEeCCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCC-----e
Q 014849 84 VLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWD-----L 154 (417)
Q Consensus 84 ~~~~~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~-----v 154 (417)
++.+.. ++||||++||+|.+.+.. +.+++..+..++.|++.||.|||++| |+||||||+|||++.++. +
T Consensus 91 ~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~ 168 (287)
T 4f0f_A 91 LMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCA 168 (287)
T ss_dssp EETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCE
T ss_pred eecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeE
Confidence 997776 699999999999998864 57999999999999999999999999 999999999999988876 9
Q ss_pred EEeeeecceeecccCCCCcccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--HHHHHH
Q 014849 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM--AMYRKI 230 (417)
Q Consensus 155 kl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~--~~~~~i 230 (417)
||+|||++.... ......+||+.|+|||++.. ..+ +.++|||||||++|+|++|..||...+.. .....+
T Consensus 169 kl~Dfg~~~~~~-----~~~~~~~g~~~y~aPE~~~~~~~~~-~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 242 (287)
T 4f0f_A 169 KVADFGLSQQSV-----HSVSGLLGNFQWMAPETIGAEEESY-TEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242 (287)
T ss_dssp EECCCTTCBCCS-----SCEECCCCCCTTSCGGGSSCSSCEE-CHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred EeCCCCcccccc-----ccccccCCCccccCchhhccCCCCc-CchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence 999999986432 23455789999999999843 333 58999999999999999999999865432 223333
Q ss_pred hcC--CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKG--EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
... ....|...++++.+||.+||+.||.+|||++++++.
T Consensus 243 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 283 (287)
T 4f0f_A 243 REEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKE 283 (287)
T ss_dssp HHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hccCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 333 345677889999999999999999999999999863
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-48 Score=370.08 Aligned_cols=259 Identities=24% Similarity=0.367 Sum_probs=226.6
Q ss_pred CCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE
Q 014849 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV 84 (417)
Q Consensus 5 ~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~ 84 (417)
+++...-....++|++.+.||+|+||.||+|.+..+++.||+|++.... ...+.+.+|+.+++.++||||++++++
T Consensus 2 ~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~ 77 (288)
T 3kfa_A 2 SPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGV 77 (288)
T ss_dssp CTTCCTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred CCchhcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence 3455556677889999999999999999999999999999999997543 235678899999999999999999999
Q ss_pred EEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 85 LATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 85 ~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
+.+....|+||||+.|++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||+
T Consensus 78 ~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~ 157 (288)
T 3kfa_A 78 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGL 157 (288)
T ss_dssp ECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCG
T ss_pred EccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCcc
Confidence 9999999999999999999999975 4599999999999999999999999999999999999999999999999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCC
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPK 239 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~ 239 (417)
+...... .........||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+... ....|.
T Consensus 158 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T 3kfa_A 158 SRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPE 235 (288)
T ss_dssp GGTSCSS-SSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT
T ss_pred ceeccCC-ccccccCCccccCcCChhhhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCCCC
Confidence 8764422 11233445678899999999888775 99999999999999999 99999988877777666655 355677
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..++.+.+||.+||..||.+|||+.++++.
T Consensus 236 ~~~~~l~~li~~~l~~dp~~Rps~~~~~~~ 265 (288)
T 3kfa_A 236 GCPEKVYELMRACWQWNPSDRPSFAEIHQA 265 (288)
T ss_dssp TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCHHHHHHHHHHhCCChhhCcCHHHHHHH
Confidence 889999999999999999999999999764
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-48 Score=379.12 Aligned_cols=260 Identities=21% Similarity=0.277 Sum_probs=218.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEE-----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~-----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
....++|++++.||+|+||.||+|+ +..+++.||+|++.... ......++.+|+.+++.++||||+++++++.
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (327)
T 2yfx_A 26 EVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSL 103 (327)
T ss_dssp BCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEc
Confidence 3457899999999999999999999 56788999999996442 2334567889999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhcC--------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC---CCeE
Q 014849 87 TKAKIYFVMEFAKGGELFAKISKG--------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---WDLK 155 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~~--------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---~~vk 155 (417)
+....|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.+ ..+|
T Consensus 104 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~k 183 (327)
T 2yfx_A 104 QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAK 183 (327)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEE
T ss_pred CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEE
Confidence 999999999999999999999752 38999999999999999999999999999999999999854 4599
Q ss_pred EeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC
Q 014849 156 ISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE 234 (417)
Q Consensus 156 l~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~ 234 (417)
|+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+.
T Consensus 184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~ 262 (327)
T 2yfx_A 184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFT-SKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262 (327)
T ss_dssp ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC
T ss_pred ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCC-chhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCC
Confidence 9999998754333222333456789999999999887775 99999999999999998 999999988888887777654
Q ss_pred -CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 235 -YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 235 -~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...|...++.+.+||.+||+.||.+|||+.+++++.|+..
T Consensus 263 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 263 RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 4566778999999999999999999999999999988754
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=371.22 Aligned_cols=257 Identities=25% Similarity=0.405 Sum_probs=200.7
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|.+..+|+.||||++...... ......+.++..+++.++||||+++++++.+.+.+|
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 100 (318)
T 2dyl_A 22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNK-EENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVF 100 (318)
T ss_dssp CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccc-hHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEE
Confidence 4568999999999999999999999999999999999765422 222334445556788899999999999999999999
Q ss_pred EEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||||+ ++.+..... .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus 101 lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (318)
T 2dyl_A 101 IAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD-- 177 (318)
T ss_dssp EEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred EEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccC--
Confidence 999999 555655554 37899999999999999999999995 999999999999999999999999999865432
Q ss_pred CCCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCCCC-CC--CC
Q 014849 170 PDGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEYR-CP--KW 240 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~~~-~p--~~ 240 (417)
.......+||+.|+|||++. ...+ +.++|||||||++|+|++|..||.. .+.......+..+... .| ..
T Consensus 178 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (318)
T 2dyl_A 178 -DKAKDRSAGCAAYMAPERIDPPDPTKPDY-DIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLPGHMG 255 (318)
T ss_dssp ----------CCTTCCHHHHC--------C-CTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCCSSSC
T ss_pred -CccccccCCCccccChhhcccccccccCC-ccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCCccCC
Confidence 22334567999999999985 3344 5899999999999999999999987 4555666666655432 23 34
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++++.+||.+||+.||.+|||++++++||||+..
T Consensus 256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRY 290 (318)
T ss_dssp CCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHH
T ss_pred CCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhc
Confidence 78999999999999999999999999999999864
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-48 Score=377.96 Aligned_cols=249 Identities=22% Similarity=0.303 Sum_probs=205.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----K 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 90 (417)
.++|++++.||+|+||+||+|++. ++.||||++..... ......+|+.+|+.++||||+++++++.+.. .
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~ 96 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDK----QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVD 96 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCch----HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCce
Confidence 568999999999999999999884 89999999975431 2345567999999999999999999997743 5
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc----------CCeecCCCCCcEEecCCCCeEEeeee
Q 014849 91 IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR----------GVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~----------givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
+|+||||+++|+|.+++..+.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||
T Consensus 97 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 97 LWLITAFHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EEEEEecCCCCCHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 89999999999999999988999999999999999999999999 99999999999999999999999999
Q ss_pred cceeecccCCCCcccccccCccccccccccccCC----CCChhhHHHHHHHHHHHHcCCCCCCCC---------------
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY----DGAKVDMWSCGVVLFVLNAGYLPFNDP--------------- 221 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y----~~~~sDIwSlGvil~~ll~G~~Pf~~~--------------- 221 (417)
++...............+||+.|+|||++.+... .+.++|||||||++|+|++|..||.+.
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~ 256 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQH 256 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSS
T ss_pred cccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccC
Confidence 9987655444444556789999999999976322 236889999999999999999999653
Q ss_pred -CHHHHHHHHhcCCCC--CCCC-----CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 222 -NLMAMYRKIYKGEYR--CPKW-----TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 222 -~~~~~~~~i~~~~~~--~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
....+...+...... .+.. .++++.+||.+||+.||++|||+.|+++.
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~ 312 (322)
T 3soc_A 257 PSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER 312 (322)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 233333333332221 1111 13458999999999999999999999864
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-47 Score=375.67 Aligned_cols=251 Identities=25% Similarity=0.394 Sum_probs=216.8
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEE--EEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSV--AIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~v--AiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~ 89 (417)
.-.++|++.+.||+|+||.||+|++..+|..+ |+|.+.... .......+.+|+.+|+.+ +||||+++++++.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 22 LDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp CCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc--chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 44689999999999999999999999999866 999887532 223356788999999999 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcC-----------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC
Q 014849 90 KIYFVMEFAKGGELFAKISKG-----------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~-----------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~ 152 (417)
..|+||||++|++|.+++... .+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 999999999999999998753 599999999999999999999999999999999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHh
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~ 231 (417)
.+||+|||++...... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+.
T Consensus 180 ~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~ 255 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP 255 (327)
T ss_dssp CEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred eEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCC-chhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhh
Confidence 9999999998643221 122345678999999999887775 99999999999999998 999999999888888887
Q ss_pred cCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 232 KGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 232 ~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+. ...|...++++.+||.+||+.||.+|||+++++++
T Consensus 256 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 256 QGYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp GTCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 663 45667789999999999999999999999999987
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=362.47 Aligned_cols=248 Identities=20% Similarity=0.292 Sum_probs=216.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC--C
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK--A 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~--~ 89 (417)
....++|++.+.||+|+||.||+|++ +|+.||+|++..... .......+.+|+.+++.++||||+++++++.+. .
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 82 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAP 82 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCC
Confidence 34567999999999999999999998 488999999987543 223356789999999999999999999999887 7
Q ss_pred EEEEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..|+||||++||+|.+++... .+++..+..++.||+.||.|||++| |+||||||+|||++.++.++|+|||++..
T Consensus 83 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~ 162 (271)
T 3kmu_A 83 HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFS 162 (271)
T ss_dssp SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCT
T ss_pred CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceee
Confidence 899999999999999999863 4899999999999999999999999 99999999999999999999999998643
Q ss_pred ecccCCCCcccccccCccccccccccccCCCC--ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--CCCCCCC
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG--AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG--EYRCPKW 240 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~--~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~--~~~~p~~ 240 (417)
. .....+||+.|+|||++.+..+.. .++|||||||++|+|++|..||.+.+.......+... ....|..
T Consensus 163 ~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3kmu_A 163 F-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG 235 (271)
T ss_dssp T-------SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCCTT
T ss_pred e-------cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCCCC
Confidence 2 223457899999999998766542 3899999999999999999999998888776666544 3456778
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++++.++|.+||+.||++|||++++++.
T Consensus 236 ~~~~~~~li~~~l~~~p~~Rps~~~il~~ 264 (271)
T 3kmu_A 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPI 264 (271)
T ss_dssp CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 89999999999999999999999999863
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=370.52 Aligned_cols=255 Identities=24% Similarity=0.326 Sum_probs=209.3
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.....++|++.+.||+|+||.||+|+ +..+|+.||+|++.... ......+.+|+.+|+.++||||+++++++.
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKGVCY 81 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34467899999999999999999998 66799999999997542 233567889999999999999999999985
Q ss_pred e--CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 87 T--KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 87 ~--~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
. ...+|+||||++||+|.+++.. .++++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus 82 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~ 161 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLT 161 (295)
T ss_dssp HHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred cCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccc
Confidence 4 4568999999999999999976 45999999999999999999999999999999999999999999999999999
Q ss_pred eeecccCC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----------------H
Q 014849 163 AVKEQIRP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM----------------A 225 (417)
Q Consensus 163 ~~~~~~~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~----------------~ 225 (417)
........ ........||+.|+|||++.+..++ .++|||||||++|+|++|..||...... .
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 240 (295)
T 3ugc_A 162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFH 240 (295)
T ss_dssp C-------------CTTCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHH
T ss_pred ccccCCcceeeeccCCCCccceeCcHHhcCCCCC-hHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHH
Confidence 76543221 1223345678889999999888875 9999999999999999999998754321 1
Q ss_pred HHHHHh-cCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 226 MYRKIY-KGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 226 ~~~~i~-~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
....+. ....+.|...++++.+||.+||+.||++|||+.|+++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~ 285 (295)
T 3ugc_A 241 LIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALR 285 (295)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 222222 23456677889999999999999999999999999763
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-48 Score=376.06 Aligned_cols=256 Identities=23% Similarity=0.364 Sum_probs=192.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHH-HHHhCCCCCcceEEEEEEeCCEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREIS-IMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~-il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
..++|++++.||+|+||.||+|.+..+|+.||||++..... .....++.+|+. +++.++||||+++++++.+.+..|
T Consensus 20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~ 97 (327)
T 3aln_A 20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD--EKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCW 97 (327)
T ss_dssp CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCC--HHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEE
T ss_pred CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccC--chHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceE
Confidence 46899999999999999999999999999999999976532 222345556665 777889999999999999999999
Q ss_pred EEEeccCCCChHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHc-CCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 93 FVMEFAKGGELFAKIS------KGRFSEQLSRRYFQQLISAVEYCHSR-GVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~------~~~l~e~~~~~i~~ql~~aL~ylH~~-givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
+||||+.| +|.+++. .+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++...
T Consensus 98 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~ 176 (327)
T 3aln_A 98 ICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176 (327)
T ss_dssp EEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-
T ss_pred EEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceec
Confidence 99999986 7777665 46799999999999999999999999 9999999999999999999999999998754
Q ss_pred cccCCCCcccccccCcccccccccc----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCC-C--
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILA----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYR-C-- 237 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~-~-- 237 (417)
.. .......+||+.|+|||++. +..+ +.++|||||||++|+|++|..||.+.+. .+....+..+... .
T Consensus 177 ~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~-~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 252 (327)
T 3aln_A 177 VD---SIAKTRDAGCRPYMAPERIDPSASRQGY-DVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSN 252 (327)
T ss_dssp --------------------------------C-CSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCC
T ss_pred cc---ccccccCCCCccccCceeeccccCcCCC-CchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCC
Confidence 32 12233457999999999983 4445 4899999999999999999999987542 2333333333221 1
Q ss_pred --CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 238 --PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 238 --p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+...++++.+||.+||+.||.+|||+.++++||||....
T Consensus 253 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 293 (327)
T 3aln_A 253 SEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYE 293 (327)
T ss_dssp CSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred cccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhH
Confidence 234789999999999999999999999999999998643
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-47 Score=362.14 Aligned_cols=248 Identities=25% Similarity=0.386 Sum_probs=218.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++.+.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+++.++||||+++++++.+.+..|+|
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (267)
T 3t9t_A 7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 81 (267)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEE
Confidence 468999999999999999999995 778999999976543 246788999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ..
T Consensus 82 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~-~~ 160 (267)
T 3t9t_A 82 TEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YT 160 (267)
T ss_dssp ECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH-HH
T ss_pred EeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc-cc
Confidence 999999999999975 569999999999999999999999999999999999999999999999999987543211 11
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHH
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIG 250 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~ 250 (417)
......||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+. ...|...++.+.+++.
T Consensus 161 ~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~ 239 (267)
T 3t9t_A 161 SSTGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMN 239 (267)
T ss_dssp STTSTTCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHHH
T ss_pred ccccccccccccChhhhcCCCcc-chhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCCCccCcHHHHHHHH
Confidence 22345678899999999887775 99999999999999999 999999998888888887763 4456778999999999
Q ss_pred HhccCCCCCCCCHHHHhcC
Q 014849 251 RLLDTDPATRITVDEILRD 269 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h 269 (417)
+||+.||.+|||+.+++++
T Consensus 240 ~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 240 HCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp HHTCSSGGGSCCHHHHHHH
T ss_pred HHccCChhhCcCHHHHHHH
Confidence 9999999999999999875
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=365.21 Aligned_cols=255 Identities=31% Similarity=0.534 Sum_probs=208.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|.+..+|+.||+|++.............+.+|+.+++.++||||+++++++.+.+..
T Consensus 28 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 28 YNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp TSSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred cccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcE
Confidence 45678999999999999999999999999999999999865544455567888999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 92 YFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
|+||||+.+++|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 108 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~ 187 (310)
T 2wqm_A 108 NIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFS 187 (310)
T ss_dssp EEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC-------
T ss_pred EEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeec
Confidence 999999999999998853 569999999999999999999999999999999999999999999999999987543
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcCCCCC--CCCCC
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKGEYRC--PKWTS 242 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~~~~~--p~~~s 242 (417)
.. ........||+.|+|||++.+..++ .++|||||||++|+|++|..||.+. +.......+....++. +...+
T Consensus 188 ~~--~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 264 (310)
T 2wqm_A 188 SK--TTAAHSLVGTPYYMSPERIHENGYN-FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYS 264 (310)
T ss_dssp -------------CCSSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCCCTTTSC
T ss_pred CC--CccccccCCCeeEeChHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCCcccccC
Confidence 31 2233456799999999999887775 8999999999999999999999754 4445666666555432 25578
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~l~~li~~~l~~dp~~Rps~~~il~~ 291 (310)
T 2wqm_A 265 EELRQLVNMCINPDPEKRPDVTYVYDV 291 (310)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999999999999999999999999864
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=376.03 Aligned_cols=254 Identities=23% Similarity=0.345 Sum_probs=216.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQ-----SVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
...++|++++.||+|+||.||+|.+..+++ .||+|++.... .......+.+|+.+|+.+ +||||+++++++.
T Consensus 43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~ 120 (333)
T 2i1m_A 43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT 120 (333)
T ss_dssp CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence 346789999999999999999999987765 79999997653 223456788999999999 8999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK---------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~---------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
+.+.+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~ 200 (333)
T 2i1m_A 121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNG 200 (333)
T ss_dssp SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGG
T ss_pred cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCC
Confidence 99999999999999999998853 357999999999999999999999999999999999999999
Q ss_pred CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHH
Q 014849 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKI 230 (417)
Q Consensus 152 ~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i 230 (417)
+.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.........+
T Consensus 201 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~ 279 (333)
T 2i1m_A 201 HVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYT-VQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKL 279 (333)
T ss_dssp GEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHH
T ss_pred CeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCC-hHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHH
Confidence 99999999999765433222233456678999999999887775 99999999999999998 99999876544444444
Q ss_pred hcC--CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKG--EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
... ....|...++.+.+||.+||+.||.+|||+.|++++
T Consensus 280 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 320 (333)
T 2i1m_A 280 VKDGYQMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSF 320 (333)
T ss_dssp HHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HhcCCCCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence 333 334567789999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-48 Score=373.97 Aligned_cols=254 Identities=25% Similarity=0.389 Sum_probs=215.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEE-----ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLA 86 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~-----~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~ 86 (417)
...++|++++.||+|+||.||+|.+ ..+++.||+|++.... .......+.+|+.+++.+ +||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 4467999999999999999999985 4577899999997653 223356788999999999 6999999999987
Q ss_pred eCC-EEEEEEeccCCCChHHHHhcCC-----------------CCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 014849 87 TKA-KIYFVMEFAKGGELFAKISKGR-----------------FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL 148 (417)
Q Consensus 87 ~~~-~~~lV~E~~~gg~L~~~i~~~~-----------------l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl 148 (417)
..+ .+|+||||++||+|.+++.... +++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~ 181 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 181 (316)
T ss_dssp CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEE
Confidence 654 5999999999999999997632 8999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH-HH
Q 014849 149 DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM-AM 226 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~-~~ 226 (417)
+.++.+||+|||++................||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.. ..
T Consensus 182 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 260 (316)
T 2xir_A 182 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 260 (316)
T ss_dssp CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHH
T ss_pred CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhcccccc-chhHHHHHHHHHHHHHhCCCCCCcccchhHHH
Confidence 99999999999999765432222234456789999999999887775 99999999999999998 99999876533 33
Q ss_pred HHHHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 227 YRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 227 ~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
...+..+ ....|...++++.++|.+||+.||.+|||+.|+++|
T Consensus 261 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 304 (316)
T 2xir_A 261 CRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 304 (316)
T ss_dssp HHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 4444443 356677889999999999999999999999999987
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=367.07 Aligned_cols=257 Identities=25% Similarity=0.380 Sum_probs=212.2
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV 84 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~ 84 (417)
........+|++++.||+|+||.||+|+ +..+|+.||+|++.... .......+.+|+.+|+.++||||++++++
T Consensus 14 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~ 91 (302)
T 4e5w_A 14 DPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGI 91 (302)
T ss_dssp CTTBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ChhhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeE
Confidence 3334446679999999999999999999 57799999999997654 23346788999999999999999999999
Q ss_pred EEeC--CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeee
Q 014849 85 LATK--AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFG 160 (417)
Q Consensus 85 ~~~~--~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFG 160 (417)
+.+. ..+|+||||++|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus 92 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg 171 (302)
T 4e5w_A 92 CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFG 171 (302)
T ss_dssp EEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCT
T ss_pred EecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccc
Confidence 9876 679999999999999999954 679999999999999999999999999999999999999999999999999
Q ss_pred cceeecccCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---------------CHH
Q 014849 161 LSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---------------NLM 224 (417)
Q Consensus 161 ls~~~~~~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---------------~~~ 224 (417)
++......... .......||+.|+|||++.+..++ .++|||||||++|+|++|..|+... ...
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 250 (302)
T 4e5w_A 172 LTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFY-IASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVT 250 (302)
T ss_dssp TCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHH
T ss_pred ccccccCCCcceeccCCCCCCccccCCeeecCCCCC-cchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHH
Confidence 99765432111 223456789999999999887775 8999999999999999999986432 112
Q ss_pred HHHHHHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 AMYRKIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 ~~~~~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.....+..+ ....|...++++.+||.+||+.||.+|||+.++++
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 251 RLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 223333332 34567788999999999999999999999999985
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-47 Score=365.54 Aligned_cols=253 Identities=25% Similarity=0.337 Sum_probs=217.1
Q ss_pred cCCeEEee-EEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGK-IIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|.+.+ .||+|+||.||+|.+. .+++.||+|++.... .......+.+|+.+++.++||||+++++++. .+..
T Consensus 8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~ 84 (287)
T 1u59_A 8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEAL 84 (287)
T ss_dssp GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSE
T ss_pred HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-CCCc
Confidence 46788876 9999999999999864 578889999997653 2334677899999999999999999999994 5568
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~ 164 (287)
T 1u59_A 85 MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 164 (287)
T ss_dssp EEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCc
Confidence 999999999999999964 569999999999999999999999999999999999999999999999999997653221
Q ss_pred C-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHH
Q 014849 170 P-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLK 246 (417)
Q Consensus 170 ~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~ 246 (417)
. ........||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+. ...|...++++.
T Consensus 165 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~ 243 (287)
T 1u59_A 165 SYYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELY 243 (287)
T ss_dssp CEECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHH
T ss_pred ceeeccccccccccccCHHHhccCCCC-chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCCCCCcCHHHH
Confidence 1 1122334578999999999877775 89999999999999998 999999988778777777664 456778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 247 WFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
++|.+||+.||.+|||+.+++++.+
T Consensus 244 ~li~~~l~~~p~~Rps~~~l~~~l~ 268 (287)
T 1u59_A 244 ALMSDCWIYKWEDRPDFLTVEQRMR 268 (287)
T ss_dssp HHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred HHHHHHcCCChhhCcCHHHHHHHHH
Confidence 9999999999999999999998743
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-47 Score=369.28 Aligned_cols=255 Identities=24% Similarity=0.333 Sum_probs=207.6
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.-.++|++++.||+|+||.||+|.+.. +++.||+|++..... .......+.+|+.+++.++||||+++++++.+..
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 109 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS 109 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence 346799999999999999999998765 566899999976543 2233567889999999999999999999987765
Q ss_pred E-----EEEEEeccCCCChHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 90 K-----IYFVMEFAKGGELFAKIS-------KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 90 ~-----~~lV~E~~~gg~L~~~i~-------~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
. .|+||||+.+++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~ 189 (313)
T 3brb_A 110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVA 189 (313)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEEC
T ss_pred ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEe
Confidence 3 599999999999999883 2569999999999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-C
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-Y 235 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~ 235 (417)
|||++................|++.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+. .
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~ 268 (313)
T 3brb_A 190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYT-SKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL 268 (313)
T ss_dssp SCSCC----------------CCGGGSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred ecCcceecccccccCcccccCCCccccCchhhcCCCcc-chhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence 99998765432222233445678999999999887775 99999999999999999 999999888777777776653 4
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..|...++++.+||.+||..||.+|||+.+++++
T Consensus 269 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 269 KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 5677789999999999999999999999999875
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=364.35 Aligned_cols=252 Identities=23% Similarity=0.302 Sum_probs=210.0
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE-EEeCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV-LATKA 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~-~~~~~ 89 (417)
...+.++|++++.||+|+||.||+|++..+|+.||+|++..... ..++.+|+.+++.++|++++..+.. .....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 3uzp_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp -CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSS-----CCHHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred cceeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcc-----hhHHHHHHHHHHHhhcCCCCCccccccCCCC
Confidence 34578899999999999999999999999999999999876532 3457899999999998876655554 47788
Q ss_pred EEEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vkl~DFGls~~ 164 (417)
..|+||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 157 (296)
T 3uzp_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccc
Confidence 999999999 899999997 3679999999999999999999999999999999999999 4888999999999986
Q ss_pred ecccCCC-----CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCC
Q 014849 165 KEQIRPD-----GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYR 236 (417)
Q Consensus 165 ~~~~~~~-----~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~ 236 (417)
....... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+ ....+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 3uzp_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCChhhhcCCCCC-cchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccC
Confidence 5433221 123566899999999999887774 99999999999999999999998632 22333333333332
Q ss_pred C-----CCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 237 C-----PKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 237 ~-----p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
. +...++++.+||.+||+.||.+|||++++++.
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred CchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 2 26678999999999999999999999999764
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-47 Score=366.50 Aligned_cols=255 Identities=25% Similarity=0.428 Sum_probs=200.0
Q ss_pred cccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 9 SREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 9 ~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
.......++|++++.||+|+||.||+|.+. ..||+|++..... .......+.+|+.+|+.++||||++++++. ..
T Consensus 17 ~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 17 DDWEIPDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp -CCBCCTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCccCccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 344566789999999999999999999864 3599999976542 233457789999999999999999999965 55
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
...++||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 568999999999999999964 679999999999999999999999999999999999999999999999999997654
Q ss_pred ccCCCCcccccccCcccccccccc---ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhcCCCC-----C
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILA---KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYKGEYR-----C 237 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~---~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~~~~~-----~ 237 (417)
...........+||+.|+|||++. +..+ +.++|||||||++|+|++|..||...+. ......+..+... .
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 250 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPY-SFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKV 250 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCS-CHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSS
T ss_pred cccccccccccCCCccccCchhhcccCCCCC-CcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhc
Confidence 433334455678999999999986 3444 4799999999999999999999987544 4444444444332 2
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+...++++.+||.+||+.||.+|||+.++++.
T Consensus 251 ~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 282 (289)
T 3og7_A 251 RSNCPKRMKRLMAECLKKKRDERPSFPRILAE 282 (289)
T ss_dssp CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cccCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 34568999999999999999999999999864
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=364.74 Aligned_cols=249 Identities=27% Similarity=0.428 Sum_probs=215.2
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--- 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--- 87 (417)
...+.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ..+.+|+.+++.++||||+++++++..
T Consensus 6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 78 (284)
T 2a19_B 6 DKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDY 78 (284)
T ss_dssp CHHHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEE
T ss_pred cchhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEecccc
Confidence 3457789999999999999999999999999999999997642 345689999999999999999999864
Q ss_pred -------------CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC
Q 014849 88 -------------KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN 151 (417)
Q Consensus 88 -------------~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~ 151 (417)
...+|+||||+++++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 ~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~ 158 (284)
T 2a19_B 79 DPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDT 158 (284)
T ss_dssp C---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEET
T ss_pred CcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCC
Confidence 4568999999999999999964 579999999999999999999999999999999999999999
Q ss_pred CCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHh
Q 014849 152 WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIY 231 (417)
Q Consensus 152 ~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~ 231 (417)
+.+||+|||++..... .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||... ......+.
T Consensus 159 ~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~--~~~~~~~~ 232 (284)
T 2a19_B 159 KQVKIGDFGLVTSLKN---DGKRTRSKGTLRYMSPEQISSQDYG-KEVDLYALGLILAELLHVCDTAFET--SKFFTDLR 232 (284)
T ss_dssp TEEEECCCTTCEESSC---CSCCCCCCSCCTTSCHHHHHCSCCC-THHHHHHHHHHHHHHHSCCSSHHHH--HHHHHHHH
T ss_pred CCEEECcchhheeccc---cccccccCCcccccChhhhccCCCc-chhhhHHHHHHHHHHHhcCCcchhH--HHHHHHhh
Confidence 9999999999876543 2234456799999999999887774 9999999999999999999997532 23344444
Q ss_pred cCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 232 KGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 232 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.+ ..+...++++.+||.+||+.||.+|||+.|+++++|...
T Consensus 233 ~~--~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~ 273 (284)
T 2a19_B 233 DG--IISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK 273 (284)
T ss_dssp TT--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred cc--cccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence 33 345668999999999999999999999999999988754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-47 Score=363.85 Aligned_cols=252 Identities=22% Similarity=0.297 Sum_probs=214.1
Q ss_pred cCCeEEee-EEeeeCceEEEEEEE--ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGK-IIGCGAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~-~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++.+ .||+|+||.||+|.+ ..+++.||+|++..... .......+.+|+.+++.++||||+++++++ ..+..
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~ 92 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESW 92 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCc
Confidence 46899998 999999999999954 56788999999976532 333467889999999999999999999999 56678
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+||||+.|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 172 (291)
T 1xbb_A 93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172 (291)
T ss_dssp EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence 999999999999999986 6799999999999999999999999999999999999999999999999999976533211
Q ss_pred C-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 171 D-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 171 ~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
. .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+..+. ...|...++++.+
T Consensus 173 ~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 251 (291)
T 1xbb_A 173 YYKAQTHGKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYD 251 (291)
T ss_dssp EEEC----CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cccccccCCCCceeeChHHhccCCCC-hhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 1 112234567899999999887775 89999999999999999 999999998888887777654 4567788999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcC
Q 014849 248 FIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h 269 (417)
+|.+||+.||.+|||+.++++.
T Consensus 252 li~~~l~~dp~~Rps~~~l~~~ 273 (291)
T 1xbb_A 252 LMNLCWTYDVENRPGFAAVELR 273 (291)
T ss_dssp HHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999863
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=381.24 Aligned_cols=253 Identities=25% Similarity=0.360 Sum_probs=207.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEc---cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNV---RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~---~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
..++|++.+.||+|+||.||+|++. .++..||||++.... .......+.+|+.+|+.++||||+++++++.+...
T Consensus 43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 120 (373)
T 2qol_A 43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP 120 (373)
T ss_dssp CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence 3568999999999999999999986 567789999997543 23345678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.|+||||++||+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus 121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 200 (373)
T 2qol_A 121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDD 200 (373)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccC
Confidence 9999999999999999976 47999999999999999999999999999999999999999999999999999765432
Q ss_pred CCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHH
Q 014849 169 RPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDL 245 (417)
Q Consensus 169 ~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 245 (417)
... .......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+. .+.|...++.+
T Consensus 201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 279 (373)
T 2qol_A 201 PEAAYTTRGGKIPIRWTSPEAIAYRKFT-SASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAAL 279 (373)
T ss_dssp -------------CTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCCCTTCBHHH
T ss_pred CccceeccCCCcCCCccChhhhccCCcC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 111 111223457889999999888775 89999999999999997 999999988888887776653 45566788999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+||.+||+.||.+|||+.++++.
T Consensus 280 ~~li~~cl~~dp~~RPs~~~i~~~ 303 (373)
T 2qol_A 280 YQLMLDCWQKDRNNRPKFEQIVSI 303 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhCcChhhCcCHHHHHHH
Confidence 999999999999999999999863
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-47 Score=364.42 Aligned_cols=251 Identities=24% Similarity=0.324 Sum_probs=203.8
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEE-EEeCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEV-LATKA 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~-~~~~~ 89 (417)
...+.++|++++.||+|+||.||+|++..+++.||+|++..... ..++.+|+.+++.++|++++..+.. .....
T Consensus 4 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~ 78 (296)
T 4hgt_A 4 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGD 78 (296)
T ss_dssp -------CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETT
T ss_pred ccccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCC
Confidence 34577899999999999999999999999999999998765532 2357789999999998876666555 47788
Q ss_pred EEEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeEEeeeeccee
Q 014849 90 KIYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAV 164 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vkl~DFGls~~ 164 (417)
..++||||+ +++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||++..
T Consensus 79 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~ 157 (296)
T 4hgt_A 79 YNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK 157 (296)
T ss_dssp EEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEE
T ss_pred ceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCcccee
Confidence 999999999 999999997 3689999999999999999999999999999999999999 7889999999999986
Q ss_pred ecccCCC-----CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHHHhcCCCC
Q 014849 165 KEQIRPD-----GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL---MAMYRKIYKGEYR 236 (417)
Q Consensus 165 ~~~~~~~-----~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~---~~~~~~i~~~~~~ 236 (417)
....... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+.+. ...+..+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 236 (296)
T 4hgt_A 158 YRDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMS 236 (296)
T ss_dssp CBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHH
T ss_pred ccCcccCccCCCCcccccCCCccccchHHhcCCCCC-chhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhccccc
Confidence 5433221 233467899999999999888774 999999999999999999999976322 1233333333322
Q ss_pred CC-----CCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 237 CP-----KWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 237 ~p-----~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.| ...++++.+||.+||+.||++|||++++++
T Consensus 237 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 237 TPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred chhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 33 567899999999999999999999999986
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-47 Score=365.05 Aligned_cols=251 Identities=24% Similarity=0.370 Sum_probs=201.7
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCcceEEEEEEe-
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR--LRHPNIVKLYEVLAT- 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~HpnIv~l~~~~~~- 87 (417)
...+.++|++.+.||+|+||+||+|.+ +|+.||||++.... .....+|.+++.. ++||||+++++++.+
T Consensus 3 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~ 74 (301)
T 3q4u_A 3 QRTVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRD------EKSWFRETELYNTVMLRHENILGFIASDMTS 74 (301)
T ss_dssp -CCCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEE
T ss_pred cccccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEecccc------chhhHHHHHHHHHhhccCcCeeeEEEeeccc
Confidence 456788999999999999999999988 79999999986542 3455667777766 799999999998644
Q ss_pred ---CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCeEE
Q 014849 88 ---KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH--------SRGVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 88 ---~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH--------~~givHrDlkp~NILl~~~~~vkl 156 (417)
...+|+||||+++|+|.+++..+.+++..+..++.||+.||.||| ++||+||||||+|||++.++.+||
T Consensus 75 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl 154 (301)
T 3q4u_A 75 RHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCI 154 (301)
T ss_dssp ETTEEEEEEEECCCTTCBHHHHHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEE
T ss_pred cCCCceeEEehhhccCCCHHHHHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEE
Confidence 356999999999999999998889999999999999999999999 999999999999999999999999
Q ss_pred eeeecceeecccCCC--CcccccccCccccccccccccCCC-----CChhhHHHHHHHHHHHHcC----------CCCCC
Q 014849 157 SDFGLSAVKEQIRPD--GMLHTLCGTPAYVAPEILAKKGYD-----GAKVDMWSCGVVLFVLNAG----------YLPFN 219 (417)
Q Consensus 157 ~DFGls~~~~~~~~~--~~~~~~~Gt~~y~APEvl~~~~y~-----~~~sDIwSlGvil~~ll~G----------~~Pf~ 219 (417)
+|||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||.
T Consensus 155 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~ 234 (301)
T 3q4u_A 155 ADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234 (301)
T ss_dssp CCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred eeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccc
Confidence 999999765432111 112345899999999999876332 2689999999999999999 88985
Q ss_pred CC-----CHHHHHHHHhcCC--CCCCCC-----CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 220 DP-----NLMAMYRKIYKGE--YRCPKW-----TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 220 ~~-----~~~~~~~~i~~~~--~~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.. ....+...+.... ...|.. .++++.+||.+||+.||++|||+.++++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~ 296 (301)
T 3q4u_A 235 DVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKT 296 (301)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred ccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 42 2222322222211 122211 24679999999999999999999999863
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=369.72 Aligned_cols=253 Identities=23% Similarity=0.338 Sum_probs=212.3
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTG----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
..++|++.+.||+|+||.||+|.+..++ ..||+|++.... .......+.+|+.+++.++||||+++++++.+.+
T Consensus 42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 119 (333)
T 1mqb_A 42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK 119 (333)
T ss_dssp CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 4578999999999999999999987654 459999997543 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..|+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~ 199 (333)
T 1mqb_A 120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED 199 (333)
T ss_dssp SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence 99999999999999999875 5799999999999999999999999999999999999999999999999999976543
Q ss_pred cCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChH
Q 014849 168 IRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPD 244 (417)
Q Consensus 168 ~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~ 244 (417)
.... .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|...++.
T Consensus 200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (333)
T 1mqb_A 200 DPEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSA 278 (333)
T ss_dssp -----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHH
T ss_pred ccccccccCCCCccccccCchhcccCCCC-chhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCCcccCCHH
Confidence 2111 112233568899999999887775 89999999999999998 99999998888888877765 35566778999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+||.+||+.||.+|||+.+++++
T Consensus 279 l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 279 IYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=386.07 Aligned_cols=253 Identities=27% Similarity=0.461 Sum_probs=210.3
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA- 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~- 89 (417)
...+.++|++.+.||+|+||+||+|++..+|+.||||++...... ...+.+.+|+.+|+.++||||+++++++...+
T Consensus 4 ~~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 81 (396)
T 4eut_A 4 QSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFL--RPVDVQMREFEVLKKLNHKNIVKLFAIEEETTT 81 (396)
T ss_dssp EECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGG--SCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTT
T ss_pred CCCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEecccccc--chHHHHHHHHHHHHhcCCCCCCeEEEeeccCCC
Confidence 345678999999999999999999999999999999999865432 23567789999999999999999999998765
Q ss_pred -EEEEEEeccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe----cCCCCeEEeeee
Q 014849 90 -KIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL----DENWDLKISDFG 160 (417)
Q Consensus 90 -~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl----~~~~~vkl~DFG 160 (417)
..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||+ +.++.+||+|||
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG 161 (396)
T 4eut_A 82 RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFG 161 (396)
T ss_dssp CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCC
Confidence 78999999999999999975 239999999999999999999999999999999999999 777789999999
Q ss_pred cceeecccCCCCcccccccCccccccccccc--------cCCCCChhhHHHHHHHHHHHHcCCCCCCC----CCHHHHHH
Q 014849 161 LSAVKEQIRPDGMLHTLCGTPAYVAPEILAK--------KGYDGAKVDMWSCGVVLFVLNAGYLPFND----PNLMAMYR 228 (417)
Q Consensus 161 ls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~--------~~y~~~~sDIwSlGvil~~ll~G~~Pf~~----~~~~~~~~ 228 (417)
++..... .......+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.. ....+...
T Consensus 162 ~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~-~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~ 237 (396)
T 4eut_A 162 AARELED---DEQFVSLYGTEEYLHPDMYERAVLRKDHQKKY-GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMY 237 (396)
T ss_dssp GCEECCC---GGGSSCSSSCCTTCCHHHHHHHCC--CHHHHH-HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHH
T ss_pred CceEccC---CCccccccCCccccCHHHhhccccccccccCC-CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHH
Confidence 9976542 223445789999999999865 334 4899999999999999999999963 22334455
Q ss_pred HHhcCCCC-------------------CC------CCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKGEYR-------------------CP------KWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~~~~-------------------~p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
++..+... .| ...++.+.++|.+||+.||++|||+.+++++
T Consensus 238 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~ 303 (396)
T 4eut_A 238 KIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE 303 (396)
T ss_dssp HHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred HHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence 55544321 11 1124567899999999999999999998654
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=377.36 Aligned_cols=254 Identities=24% Similarity=0.353 Sum_probs=211.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
...++|++.+.||+|+||.||+|.+ .+|+.||+|++.... ....+.+.+|+.+|+.++||||+++++++.+.+..|
T Consensus 36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCE
T ss_pred HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEE
Confidence 4678999999999999999999997 579999999987643 234677899999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 93 FVMEFAKGGELFAKISKG-----RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
+||||++||+|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 112 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 191 (321)
T 2qkw_B 112 LIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTE 191 (321)
T ss_dssp EEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSS
T ss_pred EEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 999999999999998652 489999999999999999999999999999999999999999999999999976544
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH------H-HHHhcCCC-----
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM------Y-RKIYKGEY----- 235 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~------~-~~i~~~~~----- 235 (417)
..........+||+.|+|||++.+..++ .++|||||||++|+|++|+.||......+. . .....+..
T Consensus 192 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 270 (321)
T 2qkw_B 192 LDQTHLSTVVKGTLGYIDPEYFIKGRLT-EKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270 (321)
T ss_dssp SSCCCCBCCCEEETTTCCHHHHHHCBCC-THHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSS
T ss_pred ccccccccccCCCccccCHHHhcCCCCC-cccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcC
Confidence 3333344556799999999999887775 999999999999999999999976432211 1 11111111
Q ss_pred -C----CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 236 -R----CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 236 -~----~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
. .+...+..+.+++.+||+.||++|||+.|++++..
T Consensus 271 ~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~ 311 (321)
T 2qkw_B 271 PNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLE 311 (321)
T ss_dssp SSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred hhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHH
Confidence 1 11123466889999999999999999999998743
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-47 Score=361.35 Aligned_cols=252 Identities=25% Similarity=0.331 Sum_probs=212.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...++|++.+.||+|+||.||+|.+.. ++..||+|++.... .......+.+|+.+++.++||||+++++++.+.
T Consensus 9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~- 85 (281)
T 3cc6_A 9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE- 85 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-
T ss_pred ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-
Confidence 346789999999999999999999754 34569999997653 223457788999999999999999999998755
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..|+||||+.|++|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 165 (281)
T 3cc6_A 86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165 (281)
T ss_dssp SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence 46899999999999999975 5699999999999999999999999999999999999999999999999999875443
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDL 245 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~ 245 (417)
.. ........||+.|+|||++.+..++ .++|||||||++|+|++ |..||...+.......+..+ ..+.|...++.+
T Consensus 166 ~~-~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 243 (281)
T 3cc6_A 166 ED-YYKASVTRLPIKWMSPESINFRRFT-TASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVL 243 (281)
T ss_dssp --------CCCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCCCTTCCHHH
T ss_pred cc-ccccccCCCCcceeCchhhccCCCC-chhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCCCCCCCHHH
Confidence 21 1122345678899999999887775 89999999999999998 99999877666666666554 345677789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++|.+||..||.+|||+.|++++
T Consensus 244 ~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 244 YTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCCchhCcCHHHHHHH
Confidence 999999999999999999999876
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=384.34 Aligned_cols=242 Identities=27% Similarity=0.441 Sum_probs=211.9
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC-EEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-KIY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-~~~ 92 (417)
-.++|++.+.||+|+||.||+|.+ +|+.||||++.... ....+.+|+.+|+.++||||+++++++.... .+|
T Consensus 191 ~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 263 (450)
T 1k9a_A 191 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 263 (450)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEE
T ss_pred ChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceE
Confidence 357899999999999999999988 47899999997643 3567889999999999999999999986655 799
Q ss_pred EEEeccCCCChHHHHhc-C--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 93 FVMEFAKGGELFAKISK-G--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
+||||+++|+|.+++.. + .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 264 iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~-- 341 (450)
T 1k9a_A 264 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS-- 341 (450)
T ss_dssp EEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc--
Confidence 99999999999999975 3 379999999999999999999999999999999999999999999999999875322
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~ 247 (417)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+ ....|...++++.+
T Consensus 342 ---~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 417 (450)
T 1k9a_A 342 ---TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYD 417 (450)
T ss_dssp --------CCCTTTSCHHHHHSSCCC-HHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ---cccCCCCCcceeCHHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 12334678999999999888875 99999999999999998 99999988777777777665 45678889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 014849 248 FIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~ 268 (417)
||.+||+.||.+|||+.++++
T Consensus 418 li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 418 VMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp HHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999975
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=362.63 Aligned_cols=253 Identities=23% Similarity=0.333 Sum_probs=211.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE-EeCC
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTG---QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL-ATKA 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~-~~~~ 89 (417)
-..+|++.+.||+|+||.||+|.+..++ ..||+|.+.... .......+.+|+.+++.++||||+++++++ .+.+
T Consensus 23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 100 (298)
T 3f66_A 23 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG 100 (298)
T ss_dssp GGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSS
T ss_pred cceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC--CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCC
Confidence 3568999999999999999999975433 468999987533 333467788999999999999999999985 5567
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..|+||||+.||+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 101 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~ 180 (298)
T 3f66_A 101 SPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 180 (298)
T ss_dssp CCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred ceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence 88999999999999999975 5689999999999999999999999999999999999999999999999999975432
Q ss_pred cC--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC-CCCCCCCh
Q 014849 168 IR--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY-RCPKWTSP 243 (417)
Q Consensus 168 ~~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~ 243 (417)
.. .........||+.|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+..+....+..+.. ..|...++
T Consensus 181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 259 (298)
T 3f66_A 181 KEYYSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPD 259 (298)
T ss_dssp GGGCBC-----CCBCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCTTCCH
T ss_pred cchhccccccCCCCCccccChHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCCccCCH
Confidence 21 11233455688999999999888775 89999999999999999 7788888776666666665554 44677899
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+.++|.+||+.||.+|||+.|+++.
T Consensus 260 ~l~~li~~~l~~~p~~Rps~~ell~~ 285 (298)
T 3f66_A 260 PLYEVMLKCWHPKAEMRPSFSELVSR 285 (298)
T ss_dssp HHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999999999999999864
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=364.14 Aligned_cols=256 Identities=27% Similarity=0.342 Sum_probs=209.1
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEcc-CCc--EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVR-TGQ--SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~--~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
....++|++.+.||+|+||.||+|++.. +++ .||+|++...........+.+.+|+.+++.++||||+++++++.+.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 14 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC
Confidence 4456799999999999999999998643 333 6999999876544455577889999999999999999999999877
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
. .++||||+.+++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 94 ~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~ 172 (291)
T 1u46_A 94 P-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 172 (291)
T ss_dssp S-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred C-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEcccccccccc
Confidence 6 8999999999999999875 579999999999999999999999999999999999999999999999999987654
Q ss_pred ccCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC--CCCCCCCC
Q 014849 167 QIRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE--YRCPKWTS 242 (417)
Q Consensus 167 ~~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~--~~~p~~~s 242 (417)
..... .......||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+.......+.... .+.+...+
T Consensus 173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~ 251 (291)
T 1u46_A 173 QNDDHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCP 251 (291)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCC
T ss_pred ccccchhhhccCCCCceeeCchhhcCCCCC-chhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCCCCcCcC
Confidence 32211 122345678899999999887775 89999999999999999 999999999888888887654 34556789
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+++.++|.+||..||.+|||+.+++++
T Consensus 252 ~~l~~li~~~l~~~p~~Rps~~~l~~~ 278 (291)
T 1u46_A 252 QDIYNVMVQCWAHKPEDRPTFVALRDF 278 (291)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=360.85 Aligned_cols=251 Identities=24% Similarity=0.368 Sum_probs=213.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE-
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI- 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~- 91 (417)
-+|++++.||+|+||.||+|.+..+++ .||+|++.... .....+.+.+|+.+++.++||||+++++++.+.+..
T Consensus 21 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 21 VVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred eEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCc
Confidence 367888999999999999999866655 79999986532 333457788999999999999999999999776655
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++||||+.+|+|.+++.. +.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 99 ~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~ 178 (298)
T 3pls_A 99 HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE 178 (298)
T ss_dssp EEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred EEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence 999999999999999976 579999999999999999999999999999999999999999999999999987543211
Q ss_pred --CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHH
Q 014849 170 --PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDL 245 (417)
Q Consensus 170 --~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 245 (417)
.........||+.|+|||++.+..++ .++|||||||++|+|++ |.+||...+.......+..+. ...|...++.+
T Consensus 179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 257 (298)
T 3pls_A 179 YYSVQQHRHARLPVKWTALESLQTYRFT-TKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSL 257 (298)
T ss_dssp GGCSCCSSCTTCGGGGSCHHHHTTCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCTTCCHHH
T ss_pred ccccccCcCCCCCccccChhhhccCCCC-hhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCCCccchHHH
Confidence 22233456789999999999887775 99999999999999999 566677777666666666554 45677789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+||.+||+.||.+|||+.++++.
T Consensus 258 ~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 258 YQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999999864
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-47 Score=360.61 Aligned_cols=243 Identities=26% Similarity=0.421 Sum_probs=206.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-CEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK-AKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~-~~~ 91 (417)
...++|++.+.||+|+||.||+|.+ +|+.||+|++.... ..+.+.+|+.+++.++||||+++++++.+. +..
T Consensus 18 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (278)
T 1byg_A 18 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGL 90 (278)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CC
T ss_pred CChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCce
Confidence 3468999999999999999999987 58899999987543 356788999999999999999999987544 578
Q ss_pred EEEEeccCCCChHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 92 YFVMEFAKGGELFAKISKG---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
|+||||+++++|.+++... .+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~- 169 (278)
T 1byg_A 91 YIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS- 169 (278)
T ss_dssp EEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------
T ss_pred EEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc-
Confidence 9999999999999999752 389999999999999999999999999999999999999999999999999875432
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLK 246 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~ 246 (417)
......+|+.|+|||++.+..++ .++|||||||++|+|++ |..||...+..+....+..+ ....|...++.+.
T Consensus 170 ----~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 244 (278)
T 1byg_A 170 ----TQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY 244 (278)
T ss_dssp ----------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHH
T ss_pred ----cccCCCccccccCHHHhCCCCCC-chhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCcccCCHHHH
Confidence 12345688999999999887775 89999999999999998 99999988877777777655 3456778899999
Q ss_pred HHHHHhccCCCCCCCCHHHHhc
Q 014849 247 WFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 247 ~li~~~L~~dP~~R~t~~eil~ 268 (417)
++|.+||..||.+|||+.++++
T Consensus 245 ~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 245 EVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp HHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhcCChhhCCCHHHHHH
Confidence 9999999999999999999976
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=382.91 Aligned_cols=255 Identities=27% Similarity=0.388 Sum_probs=199.9
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA 89 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~ 89 (417)
+..+.+.|.+.+.||+|+||+||.+. ..+|+.||||++..+. .+.+.+|+.+|+.+ +||||+++++++.+.+
T Consensus 10 ~~~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 82 (434)
T 2rio_A 10 EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDR 82 (434)
T ss_dssp SCSCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSS
T ss_pred hhhhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCC
Confidence 34567788899999999999998764 4689999999986543 45677899999876 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhcCCC--------CHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC----------
Q 014849 90 KIYFVMEFAKGGELFAKISKGRF--------SEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN---------- 151 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l--------~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~---------- 151 (417)
.+|+|||||. |+|.+++..... ++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 ~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~ 161 (434)
T 2rio_A 83 FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTG 161 (434)
T ss_dssp EEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTC
T ss_pred eEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccC
Confidence 9999999996 599999976432 233457899999999999999999999999999999754
Q ss_pred ---CCeEEeeeecceeecccCCC--CcccccccCccccccccccc------cCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 014849 152 ---WDLKISDFGLSAVKEQIRPD--GMLHTLCGTPAYVAPEILAK------KGYDGAKVDMWSCGVVLFVLNA-GYLPFN 219 (417)
Q Consensus 152 ---~~vkl~DFGls~~~~~~~~~--~~~~~~~Gt~~y~APEvl~~------~~y~~~~sDIwSlGvil~~ll~-G~~Pf~ 219 (417)
+.+||+|||++......... ......+||+.|+|||++.+ ....+.++|||||||++|+|++ |..||.
T Consensus 162 ~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~ 241 (434)
T 2rio_A 162 AENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241 (434)
T ss_dssp CCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred CCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCC
Confidence 47999999999865432111 12345689999999999875 1233599999999999999998 999998
Q ss_pred CCCHHHHHHHHhcCCCCCCC-------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 220 DPNLMAMYRKIYKGEYRCPK-------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 220 ~~~~~~~~~~i~~~~~~~p~-------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
+..... ..+..+.+..+. ..++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 242 ~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 242 DKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp STTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred CchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence 765433 234444433322 124789999999999999999999999999999754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-47 Score=385.76 Aligned_cols=250 Identities=23% Similarity=0.358 Sum_probs=197.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+|++.+.||+|+||+|+. ....+|+.||||++..+.. ....+|+.+|+.+ +|||||++++++.+....|+||
T Consensus 25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~ 97 (432)
T 3p23_A 25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAI 97 (432)
T ss_dssp EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEE
T ss_pred EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEE
Confidence 599999999999999774 4446899999999976542 2245899999999 7999999999999999999999
Q ss_pred eccCCCChHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----CCCeEEeeeecceeeccc
Q 014849 96 EFAKGGELFAKISKG--RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-----NWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 96 E~~~gg~L~~~i~~~--~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-----~~~vkl~DFGls~~~~~~ 168 (417)
|||. |+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++. ...+||+|||++......
T Consensus 98 E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~ 176 (432)
T 3p23_A 98 ELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVG 176 (432)
T ss_dssp ECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC---
T ss_pred ECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCC
Confidence 9996 4999999763 4666678899999999999999999999999999999953 235889999999765422
Q ss_pred C-CCCcccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCCCC---CCC
Q 014849 169 R-PDGMLHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEYRC---PKW 240 (417)
Q Consensus 169 ~-~~~~~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~~~---p~~ 240 (417)
. ........+||+.|+|||++.+ ..+ +.++|||||||++|+|++ |..||...........+....... +..
T Consensus 177 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~-t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 255 (432)
T 3p23_A 177 RHSFSRRSGVPGTEGWIAPEMLSEDCKENP-TYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKH 255 (432)
T ss_dssp ---------CCSCTTSCCGGGTSCC---CC-CTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCTTCH
T ss_pred CcceeeccccCCCcCccChhhhhcccccCC-CcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCcccc
Confidence 1 1123456789999999999974 333 579999999999999999 999997765444433332222221 222
Q ss_pred CChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 241 TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 241 ~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
.++.+.+||.+||+.||.+|||++|+++||||+..
T Consensus 256 ~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~~ 290 (432)
T 3p23_A 256 EDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290 (432)
T ss_dssp HHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCCH
T ss_pred ccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccCh
Confidence 35668999999999999999999999999999863
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=355.35 Aligned_cols=247 Identities=22% Similarity=0.364 Sum_probs=214.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++++.||+|+||.||+|.+. +++.||+|++..... ..+.+.+|+.+|+.++||||+++++++.+ +..|+
T Consensus 11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 84 (279)
T 1qpc_A 11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYI 84 (279)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEE
Confidence 4579999999999999999999984 677899999975432 25678899999999999999999999864 45899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+.|++|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~- 163 (279)
T 1qpc_A 85 ITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE- 163 (279)
T ss_dssp EEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-
T ss_pred EEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcc-
Confidence 9999999999999975 279999999999999999999999999999999999999999999999999997654221
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
........||+.|+|||++.+..++ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...++++.+|
T Consensus 164 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 242 (279)
T 1qpc_A 164 YTAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQL 242 (279)
T ss_dssp EECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred cccccCCCCccCccChhhhccCCCC-chhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCCCcccccHHHHHH
Confidence 1122344578899999999877774 89999999999999999 999999988888887776653 45567789999999
Q ss_pred HHHhccCCCCCCCCHHHHhc
Q 014849 249 IGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~ 268 (417)
|.+||..||++|||+.++++
T Consensus 243 i~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 243 MRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp HHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhccChhhCCCHHHHHH
Confidence 99999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-47 Score=373.78 Aligned_cols=253 Identities=17% Similarity=0.172 Sum_probs=201.8
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc---CCcEEEEEEeecccccc--------cchHHHHHHHHHHHHhCCCCCcceEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILR--------GGLTAHVKREISIMSRLRHPNIVKLYE 83 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~---~g~~vAiK~i~~~~~~~--------~~~~~~i~~Ei~il~~l~HpnIv~l~~ 83 (417)
.++|++++.||+|+||.||+|.+.. ++..+|+|++....... ......+.+|+.+++.++||||+++++
T Consensus 36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~ 115 (345)
T 2v62_A 36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG 115 (345)
T ss_dssp SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence 4689999999999999999999987 88899999997653210 011234667899999999999999999
Q ss_pred EEEe----CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC--CeEE
Q 014849 84 VLAT----KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW--DLKI 156 (417)
Q Consensus 84 ~~~~----~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~--~vkl 156 (417)
++.+ ....|+||||+ |++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||
T Consensus 116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kL 194 (345)
T 2v62_A 116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYL 194 (345)
T ss_dssp EEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSEEE
T ss_pred ccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcEEE
Confidence 9988 78999999999 9999999976 5899999999999999999999999999999999999999887 9999
Q ss_pred eeeecceeecccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC--CCHHHHHHH
Q 014849 157 SDFGLSAVKEQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND--PNLMAMYRK 229 (417)
Q Consensus 157 ~DFGls~~~~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~--~~~~~~~~~ 229 (417)
+|||++........ .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+ .+.......
T Consensus 195 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~ 273 (345)
T 2v62_A 195 ADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALS-RRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQTA 273 (345)
T ss_dssp CCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHHH
T ss_pred EeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCC-chhhHHHHHHHHHHHHhCCCCccccccccHHHHHH
Confidence 99999976543221 1223566899999999999887764 999999999999999999999965 333322222
Q ss_pred HhcCCCCCC---------CCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 230 IYKGEYRCP---------KWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 230 i~~~~~~~p---------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
........| ...++++.+||.+||..||++|||++++++.
T Consensus 274 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 322 (345)
T 2v62_A 274 KTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI 322 (345)
T ss_dssp HHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred HHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence 211111222 2678899999999999999999999999864
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=366.77 Aligned_cols=254 Identities=24% Similarity=0.324 Sum_probs=212.3
Q ss_pred ccccCCe-EEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 12 VNLFGKY-EVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 12 ~~~~~~y-~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
..+.++| ++++.||+|+||+||+|. +..+|+.||||++.... .......+.+|+.+|+.++||||+++++++.
T Consensus 26 ~~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 103 (318)
T 3lxp_A 26 TVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCE 103 (318)
T ss_dssp CBCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ceecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEe
Confidence 4577788 999999999999998775 44588999999997653 2334667899999999999999999999998
Q ss_pred e--CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 87 T--KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 87 ~--~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
+ ...+|+||||+++|+|.+++....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 104 DAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp ETTTTEEEEEECCCTTCBHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred cCCCceEEEEEecccCCcHHHHHhhCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 7 47899999999999999999988899999999999999999999999999999999999999999999999999986
Q ss_pred ecccCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHH
Q 014849 165 KEQIRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------------AMYR 228 (417)
Q Consensus 165 ~~~~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~ 228 (417)
....... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...... ....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 262 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFY-YASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTE 262 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCC-cHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHH
Confidence 5432111 123445688999999999887775 8999999999999999999999764322 1222
Q ss_pred HHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 229 KIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 229 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.+..+ ....|...++++.+||.+||+.||.+|||+.|+++
T Consensus 263 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 263 LLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 22222 34567778999999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=384.63 Aligned_cols=248 Identities=24% Similarity=0.357 Sum_probs=215.5
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||+||+|.+. ++..||||++.... ...+.+.+|+.+|+.++||||+++++++. ...+|+
T Consensus 186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 3568999999999999999999984 57889999997643 23678899999999999999999999986 567899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 260 v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~- 338 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE- 338 (454)
T ss_dssp EECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH-
T ss_pred EEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc-
Confidence 9999999999999975 379999999999999999999999999999999999999999999999999997643211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........+|+.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|...++++.+|
T Consensus 339 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 417 (454)
T 1qcf_A 339 YTAREGAKFPIKWTAPEAINFGSFT-IKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPENCPEELYNI 417 (454)
T ss_dssp HHTTCSSSSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTSCHHHHHH
T ss_pred eeccCCCcccccccCHHHhccCCCC-cHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 0112234567899999999887775 99999999999999999 99999999888888877765 355677889999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|.+||+.||.+|||+++|++.
T Consensus 418 i~~cl~~dp~~RPt~~~i~~~ 438 (454)
T 1qcf_A 418 MMRCWKNRPEERPTFEYIQSV 438 (454)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhHCcCHHHHHHH
Confidence 999999999999999999753
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=365.55 Aligned_cols=252 Identities=21% Similarity=0.292 Sum_probs=205.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE----eCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA----TKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~----~~~~ 90 (417)
.++|++.+.||+|+||.||+|.+..+|+.||+|++.... ......+.+|+.+++.++||||+++++++. ....
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHE---QQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHE 104 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCC---HHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCce
Confidence 468999999999999999999999999999999986542 234667889999999999999999999986 3458
Q ss_pred EEEEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
.|+||||+.+|+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 105 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 105 AWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred eEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 9999999999999998864 57999999999999999999999999999999999999999999999999988654
Q ss_pred cccCCC-------CcccccccCccccccccccccCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHHHHh-cC
Q 014849 166 EQIRPD-------GMLHTLCGTPAYVAPEILAKKGY--DGAKVDMWSCGVVLFVLNAGYLPFNDPNL--MAMYRKIY-KG 233 (417)
Q Consensus 166 ~~~~~~-------~~~~~~~Gt~~y~APEvl~~~~y--~~~~sDIwSlGvil~~ll~G~~Pf~~~~~--~~~~~~i~-~~ 233 (417)
...... .......||+.|+|||++....+ .+.++|||||||++|+|++|..||..... ......+. ..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 264 (317)
T 2buj_A 185 CIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQL 264 (317)
T ss_dssp CEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC-
T ss_pred ccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccC
Confidence 321111 01134568999999999875542 25899999999999999999999953110 01111111 22
Q ss_pred CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 234 EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 234 ~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.+...++++.+||.+||+.||.+|||+.+++++
T Consensus 265 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 300 (317)
T 2buj_A 265 SIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ 300 (317)
T ss_dssp -CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence 234455679999999999999999999999999987
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-47 Score=390.72 Aligned_cols=250 Identities=24% Similarity=0.390 Sum_probs=219.3
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
...+|++.+.||+|+||.||+|.+..++..||||++..... ..+.+.+|+.+|+.++||||+++++++.+...+|+
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~l 293 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI 293 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEE
Confidence 35679999999999999999999999999999999976432 25678899999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 294 v~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 372 (495)
T 1opk_A 294 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT- 372 (495)
T ss_dssp EEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC-
T ss_pred EEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc-
Confidence 9999999999999974 469999999999999999999999999999999999999999999999999997653211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........+|+.|+|||++....|+ .++|||||||++|+|++ |..||.+.+..+....+..+ ....|...++++.+|
T Consensus 373 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l 451 (495)
T 1opk_A 373 YTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 451 (495)
T ss_dssp EECCTTCCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eeecCCCcCCcceeCHhHHhcCCCC-cHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122334567899999999887775 99999999999999999 99999998877777766654 345677889999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|.+||+.||.+|||+.++++.
T Consensus 452 i~~cl~~dP~~RPs~~el~~~ 472 (495)
T 1opk_A 452 MRACWQWNPSDRPSFAEIHQA 472 (495)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCcChhHCcCHHHHHHH
Confidence 999999999999999999763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=366.57 Aligned_cols=251 Identities=24% Similarity=0.306 Sum_probs=212.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE--eC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA--TK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~--~~ 88 (417)
.++|++.+.||+|+||.||+|+ +..+++.||+|++.... ......+.+|+.+++.++||||+++++++. +.
T Consensus 22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~ 98 (327)
T 3lxl_A 22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYRGVSYGPGR 98 (327)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCC---HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSS
T ss_pred hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCC---HHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCC
Confidence 4699999999999999999999 56789999999997653 233567899999999999999999999886 56
Q ss_pred CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 89 AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
..+|+||||++|++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus 99 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 178 (327)
T 3lxl_A 99 QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP 178 (327)
T ss_dssp CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECC
T ss_pred ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecc
Confidence 789999999999999999975 569999999999999999999999999999999999999999999999999998654
Q ss_pred ccCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH---------------HHHHHH
Q 014849 167 QIRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM---------------AMYRKI 230 (417)
Q Consensus 167 ~~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~---------------~~~~~i 230 (417)
..... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||...... .....+
T Consensus 179 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 257 (327)
T 3lxl_A 179 LDKDYYVVREPGQSPIFWYAPESLSDNIFS-RQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELL 257 (327)
T ss_dssp TTCSEEECSSCCCSCGGGSCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHH
T ss_pred cCCccceeeccCCccccccCHHHhccCCCC-hHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHh
Confidence 32111 122345688999999999887774 8999999999999999999999654322 222233
Q ss_pred hcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 231 YKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 231 ~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+ ....|...++++.+||.+||++||.+|||+.|++++
T Consensus 258 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 297 (327)
T 3lxl_A 258 EEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ 297 (327)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 322 345677889999999999999999999999999765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-46 Score=374.48 Aligned_cols=252 Identities=16% Similarity=0.168 Sum_probs=200.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-----CcEEEEEEeeccccccc--------chHHHHHHHHHHHHhCCCCCcceE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-----GQSVAIKAVSKQKILRG--------GLTAHVKREISIMSRLRHPNIVKL 81 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-----g~~vAiK~i~~~~~~~~--------~~~~~i~~Ei~il~~l~HpnIv~l 81 (417)
.++|++++.||+|+||.||+|.+..+ ++.||||++........ .....+.+|+..++.++||||+++
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~ 113 (364)
T 3op5_A 34 AAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKY 113 (364)
T ss_dssp CCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCE
T ss_pred CCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeE
Confidence 34999999999999999999998764 58899999876532100 011234456677788899999999
Q ss_pred EEEEEeC----CEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCCC
Q 014849 82 YEVLATK----AKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD--ENWD 153 (417)
Q Consensus 82 ~~~~~~~----~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~--~~~~ 153 (417)
++++.+. ...|+||||+ |++|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++ .++.
T Consensus 114 ~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~~ 192 (364)
T 3op5_A 114 WGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQ 192 (364)
T ss_dssp EEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTTC
T ss_pred EeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCCe
Confidence 9998764 5689999999 9999999975 6799999999999999999999999999999999999999 8899
Q ss_pred eEEeeeecceeecccCCC-----CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Q 014849 154 LKISDFGLSAVKEQIRPD-----GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYR 228 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~-----~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~ 228 (417)
+||+|||++......... ......+||+.|+|||++.+..++ .++|||||||++|+|++|..||.+......+.
T Consensus 193 ~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~ 271 (364)
T 3op5_A 193 VYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPS-RRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV 271 (364)
T ss_dssp EEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred EEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCC-chhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence 999999999765432211 122456799999999999888774 99999999999999999999998532111111
Q ss_pred HHhc----CC-------CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 229 KIYK----GE-------YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 229 ~i~~----~~-------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.... .. ...+...++++.+++.+||..||.+|||+.+|++
T Consensus 272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 1110 00 0112557899999999999999999999999976
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=357.05 Aligned_cols=235 Identities=32% Similarity=0.592 Sum_probs=196.3
Q ss_pred ccccccCCeEEe-eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHH-HhCCCCCcceEEEEEEe
Q 014849 10 REVNLFGKYEVG-KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM-SRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 10 ~~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il-~~l~HpnIv~l~~~~~~ 87 (417)
....+.++|.+. +.||+|+||.||+|.+..+|+.||+|++... ....+|+.++ +.++||||+++++++.+
T Consensus 11 ~~~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~ 82 (299)
T 3m2w_A 11 KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYEN 82 (299)
T ss_dssp BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cccccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhh
Confidence 445678889887 8899999999999999999999999998642 3566888888 66799999999999987
Q ss_pred ----CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEe
Q 014849 88 ----KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKIS 157 (417)
Q Consensus 88 ----~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~ 157 (417)
...+|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++. ++.+||+
T Consensus 83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~ 162 (299)
T 3m2w_A 83 LYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLT 162 (299)
T ss_dssp EETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEEC
T ss_pred hcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEe
Confidence 7789999999999999999975 36999999999999999999999999999999999999998 7889999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH----HhcC
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK----IYKG 233 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~----i~~~ 233 (417)
|||++.... +..| +.++|||||||++|+|++|..||.+.+....... +..+
T Consensus 163 Dfg~a~~~~------------------------~~~~-~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~ 217 (299)
T 3m2w_A 163 DFGFAKETT------------------------GEKY-DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG 217 (299)
T ss_dssp CCTTCEECT------------------------TCGG-GGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTT
T ss_pred ccccccccc------------------------cccC-CchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhc
Confidence 999986432 1234 4899999999999999999999987654443221 2222
Q ss_pred CCCCC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 EYRCP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 ~~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
....| ...++++.+||.+||+.||.+|||++|+++||||++...
T Consensus 218 ~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~ 265 (299)
T 3m2w_A 218 QYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 265 (299)
T ss_dssp CCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGG
T ss_pred cccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhccccc
Confidence 33333 457999999999999999999999999999999987554
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-46 Score=364.16 Aligned_cols=251 Identities=22% Similarity=0.345 Sum_probs=201.7
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhC--CCCCcceEEEEEEeC
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL--RHPNIVKLYEVLATK 88 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l--~HpnIv~l~~~~~~~ 88 (417)
...+.++|++.+.||+|+||.||+|.+. |+.||||++.... .....+|..++..+ +||||+++++++...
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 103 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTE------EASWFRETEIYQTVLMRHENILGFIAADIKG 103 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEES
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccc------cchhhhHHHHHHHHhhcCCCeeeEEEEEccC
Confidence 3566789999999999999999999984 8999999986542 33445566666554 899999999999887
Q ss_pred ----CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc--------CCeecCCCCCcEEecCCCCeEE
Q 014849 89 ----AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR--------GVFHRDLKLENLLLDENWDLKI 156 (417)
Q Consensus 89 ----~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~--------givHrDlkp~NILl~~~~~vkl 156 (417)
..+|+||||+.||+|.+++..+.+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||
T Consensus 104 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 104 TGSWTQLYLITDYHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CGGGCEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CCCCCceEEEEeccCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 7899999999999999999888999999999999999999999999 9999999999999999999999
Q ss_pred eeeecceeecccCCC--CcccccccCccccccccccccCCCCC-----hhhHHHHHHHHHHHHcC----------CCCCC
Q 014849 157 SDFGLSAVKEQIRPD--GMLHTLCGTPAYVAPEILAKKGYDGA-----KVDMWSCGVVLFVLNAG----------YLPFN 219 (417)
Q Consensus 157 ~DFGls~~~~~~~~~--~~~~~~~Gt~~y~APEvl~~~~y~~~-----~sDIwSlGvil~~ll~G----------~~Pf~ 219 (417)
+|||++......... ....+.+||+.|+|||++.+..+... ++|||||||++|+|++| ..||.
T Consensus 184 ~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~ 263 (337)
T 3mdy_A 184 ADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263 (337)
T ss_dssp CCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTT
T ss_pred EeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHh
Confidence 999999754332211 11235689999999999987766532 49999999999999999 77775
Q ss_pred CC-----CHHHHHHHHhcCC--CCCCC-----CCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 220 DP-----NLMAMYRKIYKGE--YRCPK-----WTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 220 ~~-----~~~~~~~~i~~~~--~~~p~-----~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.. ........+.... ...|. ..++++.+||.+||+.||.+|||+.+++++
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp TTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred hhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence 42 2223333222222 22232 234568999999999999999999999986
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-46 Score=380.47 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=211.3
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ ..+|+
T Consensus 182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~i 255 (452)
T 1fmk_A 182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 255 (452)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEE
Confidence 35689999999999999999999964 46799999976532 24678899999999999999999999876 66899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+.+|+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 256 v~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~- 334 (452)
T 1fmk_A 256 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 334 (452)
T ss_dssp EECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------
T ss_pred EehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc-
Confidence 9999999999999964 469999999999999999999999999999999999999999999999999997654211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........+|+.|+|||++....++ .++|||||||++|+|++ |..||.+.+..+....+..+ ..+.|...++.+.+|
T Consensus 335 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 413 (452)
T 1fmk_A 335 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 413 (452)
T ss_dssp --------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHH
T ss_pred eecccCCcccccccCHhHHhcCCCC-ccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 1122344578899999999887775 99999999999999999 99999999888888887765 356678889999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|.+||+.||++|||++++++.
T Consensus 414 i~~cl~~dP~~Rpt~~~l~~~ 434 (452)
T 1fmk_A 414 MCQCWRKEPEERPTFEYLQAF 434 (452)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999863
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=372.85 Aligned_cols=243 Identities=18% Similarity=0.247 Sum_probs=201.4
Q ss_pred cCCeEEeeEEeeeCceEEEEE-----EEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHG-----RNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLA 86 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a-----~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~ 86 (417)
.++|++.+.||+|+||.||+| .+..+++.||+|++.... ...+.+|+.+++.++ ||||+++++++.
T Consensus 64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~ 137 (365)
T 3e7e_A 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHL 137 (365)
T ss_dssp SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEE
T ss_pred CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeee
Confidence 568999999999999999999 477899999999997543 456778888888887 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC----------
Q 014849 87 TKAKIYFVMEFAKGGELFAKIS------KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---------- 150 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~------~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---------- 150 (417)
..+..|+||||++||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 138 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~ 217 (365)
T 3e7e_A 138 FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD 217 (365)
T ss_dssp CSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred cCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence 9999999999999999999995 357999999999999999999999999999999999999998
Q ss_pred -CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Q 014849 151 -NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK 229 (417)
Q Consensus 151 -~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~ 229 (417)
++.+||+|||+|...............+||+.|+|||++.+..|+ .++|||||||++|+|++|+.||........
T Consensus 218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~pf~~~~~~~~--- 293 (365)
T 3e7e_A 218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWN-YQIDYFGVAATVYCMLFGTYMKVKNEGGEC--- 293 (365)
T ss_dssp -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBS-THHHHHHHHHHHHHHHHSSCCCEEEETTEE---
T ss_pred ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCC-ccccHHHHHHHHHHHHhCCCccccCCCCce---
Confidence 899999999999765544444556678999999999999988875 999999999999999999999965432100
Q ss_pred HhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 230 IYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 230 i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.........+.++.+.+++.+||+.+|.+|++..+.+.
T Consensus 294 -~~~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~ 331 (365)
T 3e7e_A 294 -KPEGLFRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLR 331 (365)
T ss_dssp -EECSCCTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHH
T ss_pred -eechhccccCcHHHHHHHHHHHcCCCCCCcchHHHHHH
Confidence 00011112245778899999999999999975444433
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-46 Score=363.51 Aligned_cols=250 Identities=27% Similarity=0.445 Sum_probs=188.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEE-------
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLA------- 86 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~------- 86 (417)
..+|++.+.||+|+||.||+|++..+|+.||+|++.... ......+.+|+.+++.+. ||||+++++++.
T Consensus 27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 103 (337)
T 3ll6_A 27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNE---EEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESD 103 (337)
T ss_dssp TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESS---HHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTST
T ss_pred CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCc---hHHHHHHHHHHHHHHHhccCCChhhccccccccccccc
Confidence 348999999999999999999999999999999986542 233567889999999996 999999999983
Q ss_pred -eCCEEEEEEeccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEecCCCCeEEeee
Q 014849 87 -TKAKIYFVMEFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 87 -~~~~~~lV~E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~~~~~vkl~DF 159 (417)
....+|+||||+. |+|.+++.. +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+||
T Consensus 104 ~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 104 TGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp TSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred cCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecC
Confidence 4456899999996 588887753 67999999999999999999999999 999999999999999999999999
Q ss_pred ecceeecccCCC----------CcccccccCccccccccc---cccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 014849 160 GLSAVKEQIRPD----------GMLHTLCGTPAYVAPEIL---AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAM 226 (417)
Q Consensus 160 Gls~~~~~~~~~----------~~~~~~~Gt~~y~APEvl---~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~ 226 (417)
|++......... ......+||+.|+|||++ .+..+ +.++|||||||++|+|++|..||........
T Consensus 183 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~~~Dv~slG~il~el~~g~~p~~~~~~~~~ 261 (337)
T 3ll6_A 183 GSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPI-GEKQDIWALGCILYLLCFRQHPFEDGAKLRI 261 (337)
T ss_dssp TTCBCCSSCC-------------------------------CCTTSCS-SHHHHHHHHHHHHHHHHHSSCCC--------
T ss_pred ccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCC-ChHHhHHHHHHHHHHHHhCCCCCcchhHHHh
Confidence 999765432111 112256799999999998 34444 5899999999999999999999987655443
Q ss_pred HHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 227 YRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 227 ~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
..... ....+...++.+.+||.+||+.||.+|||+.|++++.+
T Consensus 262 ~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~ 304 (337)
T 3ll6_A 262 VNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQ 304 (337)
T ss_dssp ----C--CCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred hcCcc--cCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence 33221 23344566788999999999999999999999999854
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=367.65 Aligned_cols=245 Identities=14% Similarity=0.191 Sum_probs=203.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC--------CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcce------
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT--------GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVK------ 80 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~--------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~------ 80 (417)
.++|++.+.||+|+||.||+|++..+ ++.||+|++... ..+.+|+.+++.++||||++
T Consensus 41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~ 112 (352)
T 2jii_A 41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLY 112 (352)
T ss_dssp SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhc
Confidence 47999999999999999999999874 889999998754 35678999999999999987
Q ss_pred ---------EEEEEEe-CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEE
Q 014849 81 ---------LYEVLAT-KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLL 147 (417)
Q Consensus 81 ---------l~~~~~~-~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NIL 147 (417)
+++++.. ....|+||||+ |++|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||
T Consensus 113 ~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl 191 (352)
T 2jii_A 113 STPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIF 191 (352)
T ss_dssp TCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEE
T ss_pred cCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEE
Confidence 6677765 78999999999 9999999975 57999999999999999999999999999999999999
Q ss_pred ecCCC--CeEEeeeecceeecccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 014849 148 LDENW--DLKISDFGLSAVKEQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND 220 (417)
Q Consensus 148 l~~~~--~vkl~DFGls~~~~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~ 220 (417)
++.++ .+||+|||++........ .......+||+.|+|||++.+..++ .++|||||||++|+|++|..||..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~pf~~ 270 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPS-RRSDLQSLGYCMLKWLYGFLPWTN 270 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSCCTTGG
T ss_pred EcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCC-chhhHHHHHHHHHHHHhCCCCccc
Confidence 99998 899999999976543221 1122445899999999999887774 999999999999999999999986
Q ss_pred C--CHHHHHHHH---hcCCCCCC------CCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 221 P--NLMAMYRKI---YKGEYRCP------KWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 221 ~--~~~~~~~~i---~~~~~~~p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
. +...+.... .......+ ...++++.+||.+||+.||++|||++++++.
T Consensus 271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 330 (352)
T 2jii_A 271 CLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN 330 (352)
T ss_dssp GTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred CCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence 5 333333222 22222221 2458999999999999999999999999864
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.93 Aligned_cols=241 Identities=29% Similarity=0.483 Sum_probs=199.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.++|++.+.||+|+||.||+|.+ .++.||+|++.... ....+.+|+.+|+.++||||+++++++.+. .|+
T Consensus 6 ~~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~l 76 (307)
T 2eva_A 6 DYKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLNP--VCL 76 (307)
T ss_dssp CGGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTT-----HHHHHHHHHHHHHHCCCTTBCCEEEBCTTT--TEE
T ss_pred CHhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChh-----HHHHHHHHHHHHhcCCCCCcCeEEEEEcCC--cEE
Confidence 357899999999999999999998 47899999986432 356788999999999999999999987743 799
Q ss_pred EEeccCCCChHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHH---cCCeecCCCCCcEEecCCCC-eEEeeeecceee
Q 014849 94 VMEFAKGGELFAKISKG----RFSEQLSRRYFQQLISAVEYCHS---RGVFHRDLKLENLLLDENWD-LKISDFGLSAVK 165 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~----~l~e~~~~~i~~ql~~aL~ylH~---~givHrDlkp~NILl~~~~~-vkl~DFGls~~~ 165 (417)
||||++||+|.+++... .+++..+..++.|++.||.|||+ +||+||||||+|||++.++. +||+|||++...
T Consensus 77 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~ 156 (307)
T 2eva_A 77 VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDI 156 (307)
T ss_dssp EEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC----
T ss_pred EEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccc
Confidence 99999999999999763 47899999999999999999999 89999999999999999887 799999998654
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--CHHHHHHHHhcC-CCCCCCCCC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--NLMAMYRKIYKG-EYRCPKWTS 242 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--~~~~~~~~i~~~-~~~~p~~~s 242 (417)
.. .....+||+.|+|||++.+..++ .++|||||||++|+|++|..||... ........+..+ ....+...+
T Consensus 157 ~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 230 (307)
T 2eva_A 157 QT-----HMTNNKGSAAWMAPEVFEGSNYS-EKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLP 230 (307)
T ss_dssp -------------CCTTSSCHHHHTCCCCC-THHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCCCCBTTCC
T ss_pred cc-----ccccCCCCCceEChhhhCCCCCC-cHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCCCcccccC
Confidence 32 22345799999999999887775 9999999999999999999999854 233333333333 345567789
Q ss_pred hHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 243 PDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 243 ~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+.+||.+||+.||.+|||+++++++
T Consensus 231 ~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 231 KPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999999999999999999999874
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.47 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=203.9
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTG---QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA-TKAKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~ 91 (417)
.+|++.+.||+|+||+||+|.+..++ ..||+|.+.... ......++.+|+.+|+.++||||+++++++. ..+..
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ 166 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 166 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS--CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCe
Confidence 36899999999999999999986543 468999986532 3344678899999999999999999999864 55688
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 167 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~ 246 (373)
T 3c1x_A 167 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 246 (373)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence 999999999999999975 468999999999999999999999999999999999999999999999999997543221
Q ss_pred CC--CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHH
Q 014849 170 PD--GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDL 245 (417)
Q Consensus 170 ~~--~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 245 (417)
.. .......||+.|+|||++.+..++ .++|||||||++|+|++ |.+||.+.+..+....+..+. ...|...++.+
T Consensus 247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p~~~~~~l 325 (373)
T 3c1x_A 247 FDSVHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPL 325 (373)
T ss_dssp -----------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCCCTTCCHHH
T ss_pred cccccccCCCCCcccccChHHhcCCCCC-cHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHH
Confidence 11 122345678899999999887775 99999999999999999 788998876666666666554 34567789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.++|.+||+.||.+|||+.|++++
T Consensus 326 ~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 326 YEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999999876
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-46 Score=360.90 Aligned_cols=249 Identities=25% Similarity=0.380 Sum_probs=205.0
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-cccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
.|..++.||+|+||.||+|.+ +++.||+|++..... ........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEE
Confidence 355669999999999999986 688999999976432 23345678899999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 96 EFAKGGELFAKISK----GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 96 E~~~gg~L~~~i~~----~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||++|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus 110 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 189 (307)
T 2nru_A 110 VYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189 (307)
T ss_dssp ECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred EecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence 99999999998863 46999999999999999999999999999999999999999999999999998765433222
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCCC-----------C
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM----AMYRKIYKGEY-----------R 236 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~~-----------~ 236 (417)
......+||+.|+|||++.+. + +.++|||||||++|+|++|..||...+.. .....+..... .
T Consensus 190 ~~~~~~~g~~~y~aPE~~~~~-~-~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 267 (307)
T 2nru_A 190 VMTSRIVGTTAYMAPEALRGE-I-TPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMND 267 (307)
T ss_dssp EECSSCCSCGGGCCHHHHTTE-E-CTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSC
T ss_pred ccccccCCCcCcCChHHhcCC-C-CccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccc
Confidence 233456899999999998754 4 58999999999999999999999865432 22222222111 1
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+...++.+.+++.+||+.||.+|||+.+++++
T Consensus 268 ~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 268 ADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp CCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred cchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 122235678999999999999999999999865
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=361.20 Aligned_cols=258 Identities=24% Similarity=0.298 Sum_probs=196.4
Q ss_pred cccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHH--HHHHHHhCCCCCcceEEEEEEe-
Q 014849 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR--EISIMSRLRHPNIVKLYEVLAT- 87 (417)
Q Consensus 11 ~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~--Ei~il~~l~HpnIv~l~~~~~~- 87 (417)
...-.++|++++.||+|+||.||+|++ +++.||||++.... ...... |+..++.++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~ 79 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERV 79 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred CCcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheeccccc
Confidence 345578999999999999999999976 78999999997543 223333 4444556899999999986532
Q ss_pred ----CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc---------CCeecCCCCCcEEecCCCCe
Q 014849 88 ----KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR---------GVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 88 ----~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~---------givHrDlkp~NILl~~~~~v 154 (417)
...+|+||||++||+|.+++.....++..+..++.||+.||.|||++ ||+||||||+|||++.++.+
T Consensus 80 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~ 159 (336)
T 3g2f_A 80 TADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTC 159 (336)
T ss_dssp CTTSCEEEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCE
T ss_pred ccCCCceEEEEEecCCCCcHHHHHhhcccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcE
Confidence 34689999999999999999888889999999999999999999999 99999999999999999999
Q ss_pred EEeeeecceeecccC------CCCcccccccCcccccccccccc-------CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 014849 155 KISDFGLSAVKEQIR------PDGMLHTLCGTPAYVAPEILAKK-------GYDGAKVDMWSCGVVLFVLNAGYLPFNDP 221 (417)
Q Consensus 155 kl~DFGls~~~~~~~------~~~~~~~~~Gt~~y~APEvl~~~-------~y~~~~sDIwSlGvil~~ll~G~~Pf~~~ 221 (417)
||+|||++....... ........+||+.|+|||++.+. .+ +.++|||||||++|+|++|..||...
T Consensus 160 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~-~~~~DiwslG~il~ell~g~~p~~~~ 238 (336)
T 3g2f_A 160 VISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA-LKQVDMYALGLIYWEIFMRCTDLFPG 238 (336)
T ss_dssp EECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHH-HHHHHHHHHHHHHHHHHTTBGGGSTT
T ss_pred EEeeccceeecccccccCccccccccccCCCccceeCchhhcCCccccccccc-ccccchHHHHHHHHHHHhcCCcCCCc
Confidence 999999997654221 12233456899999999998762 33 47899999999999999997766321
Q ss_pred ------------------CHHHHHHHHhcC--CCCCCCCC------ChHHHHHHHHhccCCCCCCCCHHHH------hcC
Q 014849 222 ------------------NLMAMYRKIYKG--EYRCPKWT------SPDLKWFIGRLLDTDPATRITVDEI------LRD 269 (417)
Q Consensus 222 ------------------~~~~~~~~i~~~--~~~~p~~~------s~~~~~li~~~L~~dP~~R~t~~ei------l~h 269 (417)
....+...+... ...+|... ++++.+||.+||+.||++|||+.|+ +.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~ 318 (336)
T 3g2f_A 239 ESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM 318 (336)
T ss_dssp SCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred cchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHH
Confidence 111221112111 22233322 3479999999999999999999999 446
Q ss_pred cccccccc
Q 014849 270 PWFKKDYK 277 (417)
Q Consensus 270 ~~f~~~~~ 277 (417)
+|-++...
T Consensus 319 ~~~~~~~~ 326 (336)
T 3g2f_A 319 IWERNKSV 326 (336)
T ss_dssp CCCC----
T ss_pred HHHhcccC
Confidence 66665443
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=365.95 Aligned_cols=255 Identities=23% Similarity=0.339 Sum_probs=206.9
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++.+.||+|+||.||+|++ .+|+.||+|++....... ....+.+|+.+++.++||||+++++++.+.+..
T Consensus 26 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 102 (326)
T 3uim_A 26 QVASDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQG--GELQFQTEVEMISMAVHRNLLRLRGFCMTPTER 102 (326)
T ss_dssp HTTTTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCC
T ss_pred HHHhhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCch--HHHHHHHHHHHHHhccCCCccceEEEEecCCce
Confidence 34578999999999999999999985 579999999997654322 233688999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHc---CCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 92 YFVMEFAKGGELFAKISKG-----RFSEQLSRRYFQQLISAVEYCHSR---GVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~-----~l~e~~~~~i~~ql~~aL~ylH~~---givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
++||||+.||+|.+++... .+++..+..++.|++.||.|||++ ||+||||||+|||++.++.+||+|||++.
T Consensus 103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 182 (326)
T 3uim_A 103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAK 182 (326)
T ss_dssp EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCE
T ss_pred EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccc
Confidence 9999999999999999752 399999999999999999999999 99999999999999999999999999997
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC--------CHHHHHHHHhcCC-
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP--------NLMAMYRKIYKGE- 234 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~--------~~~~~~~~i~~~~- 234 (417)
..... ........+||+.|+|||++.+..++ .++|||||||++|+|++|..||... .............
T Consensus 183 ~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 260 (326)
T 3uim_A 183 LMDYK-DTHVTTAVRGTIGHIAPEYLSTGKSS-EKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKK 260 (326)
T ss_dssp ECCSS-SSCEECCCCSCGGGCCHHHHHHSEEC-HHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCC
T ss_pred ccCcc-cccccccccCCcCccCHHHhccCCCC-ccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchh
Confidence 65432 22334456799999999999887774 9999999999999999999999521 1111111111110
Q ss_pred C----------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcc
Q 014849 235 Y----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPW 271 (417)
Q Consensus 235 ~----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~ 271 (417)
. ..+...++.+.+++.+||+.||.+|||+.|+++|.+
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~ 307 (326)
T 3uim_A 261 LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLE 307 (326)
T ss_dssp STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence 0 011112367899999999999999999999998854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=361.51 Aligned_cols=257 Identities=24% Similarity=0.320 Sum_probs=210.4
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEE----EccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEE
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGR----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYE 83 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~----~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~ 83 (417)
-.......++|++++.||+|+||.||+|+ +..+|+.||+|++.... ......+.+|+.+|+.++||||+++++
T Consensus 33 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~ 109 (326)
T 2w1i_A 33 RDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST---EEHLRDFEREIEILKSLQHDNIVKYKG 109 (326)
T ss_dssp ----CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCC---SHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cCccccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeeEEE
Confidence 33445567789999999999999999998 46789999999997642 334567899999999999999999999
Q ss_pred EEEeCC--EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeee
Q 014849 84 VLATKA--KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDF 159 (417)
Q Consensus 84 ~~~~~~--~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DF 159 (417)
++...+ .+|+||||++|++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus 110 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Df 189 (326)
T 2w1i_A 110 VCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDF 189 (326)
T ss_dssp EECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCC
T ss_pred EEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecC
Confidence 986544 78999999999999999976 46999999999999999999999999999999999999999999999999
Q ss_pred ecceeecccCCC-CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH--------------
Q 014849 160 GLSAVKEQIRPD-GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-------------- 224 (417)
Q Consensus 160 Gls~~~~~~~~~-~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-------------- 224 (417)
|++......... .......||+.|+|||++.+..++ .++|||||||++|+|++|..||......
T Consensus 190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~ 268 (326)
T 2w1i_A 190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFS-VASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 268 (326)
T ss_dssp TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHH
T ss_pred cchhhccccccccccccCCCCceeEECchhhcCCCCC-chhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhh
Confidence 999865432111 112334678889999999887775 8999999999999999999998653211
Q ss_pred --HHHHHHhc-CCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 225 --AMYRKIYK-GEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 225 --~~~~~i~~-~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.+...+.. ...+.|...++++.+||.+||+.||++|||+.|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 269 VFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 11122222 234567788999999999999999999999999975
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-45 Score=387.10 Aligned_cols=249 Identities=24% Similarity=0.352 Sum_probs=209.6
Q ss_pred CCeEEee-EEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGK-IIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~-~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
++|.+.+ .||+|+||.||+|.+. .++..||||++.... .....+.+.+|+.+|+.++|||||++++++.++ .+|
T Consensus 335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~-~~~ 411 (613)
T 2ozo_A 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 411 (613)
T ss_dssp TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESS-SEE
T ss_pred cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccC-CeE
Confidence 4556666 8999999999999876 356679999997653 233467899999999999999999999999774 589
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+||||+.||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus 412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~ 491 (613)
T 2ozo_A 412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491 (613)
T ss_dssp EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence 99999999999999964 5699999999999999999999999999999999999999999999999999975432111
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
........+|+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...++++.+
T Consensus 492 ~~~~~~~~~~~~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 570 (613)
T 2ozo_A 492 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 570 (613)
T ss_dssp ----------CCTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred eeeeccCCCCccceeCHhhhcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1112234467899999999888875 99999999999999998 999999988888888887764 4677889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhc
Q 014849 248 FIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~ 268 (417)
||.+||+.||.+|||+.++++
T Consensus 571 li~~cl~~dP~~RPs~~~l~~ 591 (613)
T 2ozo_A 571 LMSDCWIYKWEDRPDFLTVEQ 591 (613)
T ss_dssp HHHHTTCSSTTTSCCHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999999854
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-45 Score=357.43 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=207.7
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHh--CCCCCcceEEEEEEeCC
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR--LRHPNIVKLYEVLATKA 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~--l~HpnIv~l~~~~~~~~ 89 (417)
..+.++|++.+.||+|+||.||+|.+ +|+.||||++.... ...+.+|+.+++. ++||||+++++++....
T Consensus 38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 38 RTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred ccccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchh------HHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 34568999999999999999999998 68999999986542 4567789999988 78999999999998876
Q ss_pred ----EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------HcCCeecCCCCCcEEecCCCCeEEe
Q 014849 90 ----KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCH--------SRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 90 ----~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH--------~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
.+|+||||+.+|+|.+++..+++++..+..++.|++.||.||| ++||+||||||+|||++.++.+||+
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~ 189 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEEC
T ss_pred CccceeEEEEeecCCCcHHHHHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEE
Confidence 8999999999999999999889999999999999999999999 8999999999999999999999999
Q ss_pred eeecceeecccCCC--CcccccccCccccccccccccCCC-----CChhhHHHHHHHHHHHHcC----------CCCCCC
Q 014849 158 DFGLSAVKEQIRPD--GMLHTLCGTPAYVAPEILAKKGYD-----GAKVDMWSCGVVLFVLNAG----------YLPFND 220 (417)
Q Consensus 158 DFGls~~~~~~~~~--~~~~~~~Gt~~y~APEvl~~~~y~-----~~~sDIwSlGvil~~ll~G----------~~Pf~~ 220 (417)
|||++......... ......+||+.|+|||++.+.... +.++|||||||++|+|++| ..||..
T Consensus 190 Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~ 269 (342)
T 1b6c_B 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269 (342)
T ss_dssp CCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred ECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccc
Confidence 99999765432211 023456899999999998765322 2689999999999999999 889976
Q ss_pred C-----CHHHHHHHHhcCCC--CCCCC-----CChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 221 P-----NLMAMYRKIYKGEY--RCPKW-----TSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 221 ~-----~~~~~~~~i~~~~~--~~p~~-----~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
. ....+...+..... ..|.. .++.+.+||.+||+.||++|||+.+++++
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 270 LVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp TSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred cCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence 4 34455555443332 22221 13468899999999999999999999986
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-45 Score=388.72 Aligned_cols=246 Identities=23% Similarity=0.319 Sum_probs=209.4
Q ss_pred eeEEeeeCceEEEEEEE--ccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEecc
Q 014849 21 GKIIGCGAFAKVYHGRN--VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~--~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~ 98 (417)
.+.||+|+||.||+|.+ ..+++.||||++.... ........+.+|+.+|+.++|||||++++++.++ .+|+||||+
T Consensus 374 ~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~lv~E~~ 451 (635)
T 4fl3_A 374 DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMA 451 (635)
T ss_dssp EEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEEEcc
Confidence 45899999999999955 4577899999997653 2334467899999999999999999999999755 588999999
Q ss_pred CCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC-CCcccc
Q 014849 99 KGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP-DGMLHT 176 (417)
Q Consensus 99 ~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~-~~~~~~ 176 (417)
.+|+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........ ......
T Consensus 452 ~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~ 531 (635)
T 4fl3_A 452 ELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531 (635)
T ss_dssp TTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC----------
T ss_pred CCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccC
Confidence 99999999976 6799999999999999999999999999999999999999999999999999975432211 122334
Q ss_pred cccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhcc
Q 014849 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLD 254 (417)
Q Consensus 177 ~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~ 254 (417)
..||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..+....+..+. ...|...++++.+||.+||+
T Consensus 532 ~~~t~~y~APE~~~~~~~~-~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~ 610 (635)
T 4fl3_A 532 GKWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWT 610 (635)
T ss_dssp ---CGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTC
T ss_pred CCCceeeeChhhhcCCCCC-cHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcC
Confidence 4678899999999888875 99999999999999998 999999999888888887764 45788899999999999999
Q ss_pred CCCCCCCCHHHHhcC
Q 014849 255 TDPATRITVDEILRD 269 (417)
Q Consensus 255 ~dP~~R~t~~eil~h 269 (417)
.||++|||++++++.
T Consensus 611 ~dP~~RPs~~~l~~~ 625 (635)
T 4fl3_A 611 YDVENRPGFAAVELR 625 (635)
T ss_dssp SSTTTSCCHHHHHHH
T ss_pred CCHhHCcCHHHHHHH
Confidence 999999999999753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=373.95 Aligned_cols=245 Identities=20% Similarity=0.278 Sum_probs=200.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc-----ccchHHHHHHHHHHHHhCC---------CCCc
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL-----RGGLTAHVKREISIMSRLR---------HPNI 78 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----~~~~~~~i~~Ei~il~~l~---------HpnI 78 (417)
...++|++++.||+|+||+||+|++ +|+.||||++...... .......+.+|+.+|+.++ ||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3468999999999999999999998 7899999999876432 2233477889999999886 8888
Q ss_pred ceEEEEEE------------------------------eCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHH
Q 014849 79 VKLYEVLA------------------------------TKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAV 128 (417)
Q Consensus 79 v~l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL 128 (417)
+++.+++. +...+|+|||||.+|++.+.+.++.+++.+++.++.||+.||
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASL 174 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHH
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHH
Confidence 88877643 267899999999999888888778899999999999999999
Q ss_pred HHHH-HcCCeecCCCCCcEEecCCC--------------------CeEEeeeecceeecccCCCCcccccccCccccccc
Q 014849 129 EYCH-SRGVFHRDLKLENLLLDENW--------------------DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187 (417)
Q Consensus 129 ~ylH-~~givHrDlkp~NILl~~~~--------------------~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APE 187 (417)
.||| ++||+||||||+|||++.++ .+||+|||+|+.... .+.+||+.|+|||
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-------~~~~gt~~y~aPE 247 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-------GIVVFCDVSMDED 247 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-------TEEECCCCTTCSG
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-------CcEEEeecccChh
Confidence 9999 99999999999999999887 899999999986542 2468999999999
Q ss_pred cccccCCCCChhhHHHHHHH-HHHHHcCCCCCCCCCH-HHHHHHHhcC-CCC--C----CCCCChHHHHHHHHhccCCCC
Q 014849 188 ILAKKGYDGAKVDMWSCGVV-LFVLNAGYLPFNDPNL-MAMYRKIYKG-EYR--C----PKWTSPDLKWFIGRLLDTDPA 258 (417)
Q Consensus 188 vl~~~~y~~~~sDIwSlGvi-l~~ll~G~~Pf~~~~~-~~~~~~i~~~-~~~--~----p~~~s~~~~~li~~~L~~dP~ 258 (417)
++.+.. +.++||||+|++ .+++++|..||.+... ......+... ... . +...++++.+||++||+.|
T Consensus 248 ~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-- 323 (336)
T 2vuw_A 248 LFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-- 323 (336)
T ss_dssp GGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS--
T ss_pred hhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC--
Confidence 998765 589999998777 7789999999965321 1222333311 111 1 1235788999999999977
Q ss_pred CCCCHHHHh-cCcccc
Q 014849 259 TRITVDEIL-RDPWFK 273 (417)
Q Consensus 259 ~R~t~~eil-~h~~f~ 273 (417)
|++|+| +||||+
T Consensus 324 ---sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 324 ---SATDLLCQHSLFK 336 (336)
T ss_dssp ---SHHHHHHHCGGGC
T ss_pred ---CHHHHHhcCCCcC
Confidence 999999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-46 Score=376.63 Aligned_cols=248 Identities=15% Similarity=0.176 Sum_probs=197.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCc---------ce-----
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-PNI---------VK----- 80 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-pnI---------v~----- 80 (417)
..|++++.||+|+||.||+|++..+|+.||||++...........+.+.+|+.+++.++| +|. +.
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 157 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV 157 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence 358899999999999999999999999999999985544344446789999999999987 321 11
Q ss_pred -------EEEEEEe-----CCEEEEEEeccCCCChHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecC
Q 014849 81 -------LYEVLAT-----KAKIYFVMEFAKGGELFAKIS--------KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRD 140 (417)
Q Consensus 81 -------l~~~~~~-----~~~~~lV~E~~~gg~L~~~i~--------~~~l~e~~~~~i~~ql~~aL~ylH~~givHrD 140 (417)
+..++.. ...++++|+++ +++|.+++. .+.+++..+..++.||+.||.|||++||+|||
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD 236 (413)
T 3dzo_A 158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY 236 (413)
T ss_dssp ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 1111111 12467777776 579998884 24578889999999999999999999999999
Q ss_pred CCCCcEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccc----------cccCCCCChhhHHHHHHHHHH
Q 014849 141 LKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL----------AKKGYDGAKVDMWSCGVVLFV 210 (417)
Q Consensus 141 lkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl----------~~~~y~~~~sDIwSlGvil~~ 210 (417)
|||+|||++.++.+||+|||++..... ...+.+| +.|+|||++ .+..| +.++|||||||++|+
T Consensus 237 iKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~-~~~~DvwSlGvil~e 309 (413)
T 3dzo_A 237 LRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM-TFAFDTWTLGLAIYW 309 (413)
T ss_dssp CCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE-CHHHHHHHHHHHHHH
T ss_pred cccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC-CchhhHHHHHHHHHH
Confidence 999999999999999999999876432 2556788 999999999 33345 489999999999999
Q ss_pred HHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 211 LNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 211 ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|++|+.||...+.......+.. ....+++++.+||.+||+.||.+|||+.++++||||+..
T Consensus 310 lltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 310 IWCADLPNTDDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHSSCCCCTTGGGSCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHCCCCCCCcchhhhHHHHHh----hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 9999999988765444433332 223568999999999999999999999999999999864
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=381.99 Aligned_cols=248 Identities=24% Similarity=0.367 Sum_probs=215.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||.||+|.+.. +..||||++..... ..+.+.+|+.+|+.++||||+++++++.+ ..+|+
T Consensus 265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~l 338 (535)
T 2h8h_A 265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYI 338 (535)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEE
T ss_pred chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceE
Confidence 45789999999999999999999964 46799999976532 24678899999999999999999999876 66899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+.+|+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus 339 v~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~- 417 (535)
T 2h8h_A 339 VTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE- 417 (535)
T ss_dssp EECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH-
T ss_pred eeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc-
Confidence 9999999999999974 469999999999999999999999999999999999999999999999999997543211
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
........+|+.|+|||++....++ .++|||||||++|+|++ |..||.+....+....+..+ ....|..+++++.+|
T Consensus 418 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~l 496 (535)
T 2h8h_A 418 YTARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDL 496 (535)
T ss_dssp HHTTCSTTSCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred eecccCCcCcccccCHHHhccCCCC-chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHHH
Confidence 0111234567899999999887775 99999999999999999 99999999888888887765 345677889999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|.+||+.||++|||+++|++.
T Consensus 497 i~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 497 MCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999864
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=357.98 Aligned_cols=253 Identities=23% Similarity=0.365 Sum_probs=210.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
....++|++++.||+|+||.||+|.+.. .+|+|++..... .......+.+|+.+++.++||||+++++++.+...+
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERD-NEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSC-CCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCC-CHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 3456899999999999999999999853 499999976542 222345567899999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc-
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI- 168 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~- 168 (417)
|+||||+.|++|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++......
T Consensus 105 ~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~ 183 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQ 183 (319)
T ss_dssp EEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC------
T ss_pred EEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccc
Confidence 999999999999999986 3699999999999999999999999999999999999998 679999999998654321
Q ss_pred --CCCCcccccccCcccccccccccc--------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-
Q 014849 169 --RPDGMLHTLCGTPAYVAPEILAKK--------GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC- 237 (417)
Q Consensus 169 --~~~~~~~~~~Gt~~y~APEvl~~~--------~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~- 237 (417)
..........||+.|+|||++... ...+.++|||||||++|+|++|..||...+.......+..+..+.
T Consensus 184 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 263 (319)
T 2y4i_B 184 AGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL 263 (319)
T ss_dssp ----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC
T ss_pred ccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC
Confidence 122334456799999999998752 223589999999999999999999999998888887777665432
Q ss_pred -CCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 238 -PKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 238 -p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+...++++.++|.+||..||.+|||+.++++.
T Consensus 264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~ 296 (319)
T 2y4i_B 264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM 296 (319)
T ss_dssp CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 23468899999999999999999999999874
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=372.75 Aligned_cols=250 Identities=22% Similarity=0.286 Sum_probs=210.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-PNIVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~ 90 (417)
..+.++|++++.||+|+||.||+|.+..+|+.||||++..... ..++.+|+.+++.++| ++|..+..+......
T Consensus 3 ~~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~ 77 (483)
T 3sv0_A 3 PRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTK-----HPQLLYESKIYRILQGGTGIPNVRWFGVEGDY 77 (483)
T ss_dssp CEETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCS-----SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTE
T ss_pred CCcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccc-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCE
Confidence 4577899999999999999999999999999999999876542 2347789999999987 566667777788899
Q ss_pred EEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe---cCCCCeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL---DENWDLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl---~~~~~vkl~DFGls~~~ 165 (417)
.|+||||+ |++|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||| +.++.+||+|||++...
T Consensus 78 ~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~ 156 (483)
T 3sv0_A 78 NVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156 (483)
T ss_dssp EEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred EEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceec
Confidence 99999999 999999997 4789999999999999999999999999999999999999 68899999999999865
Q ss_pred cccCCC-----CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCC--
Q 014849 166 EQIRPD-----GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGEY-- 235 (417)
Q Consensus 166 ~~~~~~-----~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~-- 235 (417)
...... ......+||+.|+|||++.+..++ .++|||||||+||+|++|..||.+. .....+.++.....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s-~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~ 235 (483)
T 3sv0_A 157 RDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQS-RRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVAT 235 (483)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHS
T ss_pred cCCccccccccccccccCCCccccCHHHhcCCCCC-hHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccc
Confidence 432221 123367899999999999988875 9999999999999999999999864 33444444433322
Q ss_pred ---CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 236 ---RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 236 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..+..+++++.+||.+||+.||.+||++.+|++
T Consensus 236 ~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 236 SIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp CHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred cHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 223567899999999999999999999998864
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-44 Score=385.16 Aligned_cols=252 Identities=26% Similarity=0.365 Sum_probs=214.5
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccC---CcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~---g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
...++|++++.||+|+||+||+|.+..+ +..||+|.+.... .....+.+.+|+.+|+.++||||+++++++. .+
T Consensus 387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~ 463 (656)
T 2j0j_A 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-EN 463 (656)
T ss_dssp CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS
T ss_pred cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cC
Confidence 4467899999999999999999998654 4579999986542 2334577889999999999999999999985 45
Q ss_pred EEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 90 KIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
..|+||||++||+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus 464 ~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~ 543 (656)
T 2j0j_A 464 PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED 543 (656)
T ss_dssp SCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC
T ss_pred ceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCC
Confidence 68999999999999999975 3699999999999999999999999999999999999999999999999999976532
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHH
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDL 245 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 245 (417)
.. ........||+.|+|||++.+..|+ .++|||||||++|+|++ |..||.+.+..+....+..+. .+.|...++.+
T Consensus 544 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~-~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l 621 (656)
T 2j0j_A 544 ST-YYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTL 621 (656)
T ss_dssp -----------CCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCCCTTCCHHH
T ss_pred Cc-ceeccCCCCCcceeCHHHhcCCCCC-chhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCCCccccHHH
Confidence 21 1122345678899999999887775 89999999999999997 999999998888888887664 56788899999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhcC
Q 014849 246 KWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+||.+||..||.+|||+.++++.
T Consensus 622 ~~li~~~l~~dP~~RPs~~el~~~ 645 (656)
T 2j0j_A 622 YSLMTKCWAYDPSRRPRFTELKAQ 645 (656)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999999999999864
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=394.49 Aligned_cols=257 Identities=28% Similarity=0.402 Sum_probs=207.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe----
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT---- 87 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~---- 87 (417)
....++|++.+.||+|+||.||+|.+..+|+.||||++.... .......+.+|+.+|+.++||||+++++++..
T Consensus 10 g~~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~ 87 (676)
T 3qa8_A 10 TQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87 (676)
T ss_dssp -------CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCC
T ss_pred CCCCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccc
Confidence 345699999999999999999999999999999999987642 23346678899999999999999999998755
Q ss_pred --CCEEEEEEeccCCCChHHHHhc-C---CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC---eEEee
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK-G---RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD---LKISD 158 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~-~---~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~---vkl~D 158 (417)
.+..|+||||++||+|.+++.. + .+++..++.++.||+.||.|||++||+||||||+|||++.++. +||+|
T Consensus 88 ~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~D 167 (676)
T 3qa8_A 88 APNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIID 167 (676)
T ss_dssp CTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECS
T ss_pred cCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcc
Confidence 6778999999999999999975 2 6999999999999999999999999999999999999998775 99999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH---------
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRK--------- 229 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~--------- 229 (417)
||++..... .......+||+.|+|||++.+..++ .++||||+||++|+|++|..||........+..
T Consensus 168 FG~a~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~s-~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~ 243 (676)
T 3qa8_A 168 LGYAKELDQ---GELCTEFVGTLQYLAPELLEQKKYT-VTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEH 243 (676)
T ss_dssp CCCCCBTTS---CCCCCCCCSCCTTCSSCSSCCSCCS-TTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------
T ss_pred ccccccccc---ccccccccCCcccCChHHhccCCCC-chhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchh
Confidence 999976542 2334567899999999999887775 899999999999999999999976533221100
Q ss_pred -----HhcCCC------CCC----CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 230 -----IYKGEY------RCP----KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 230 -----i~~~~~------~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...+.. +.| ...++.+.+||.+||.+||.+|||+.++++||||+.
T Consensus 244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~ 303 (676)
T 3qa8_A 244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA 303 (676)
T ss_dssp CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence 011111 111 124578999999999999999999999999999975
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=344.24 Aligned_cols=231 Identities=16% Similarity=0.184 Sum_probs=194.8
Q ss_pred Cccccc-cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEE
Q 014849 7 DISREV-NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVL 85 (417)
Q Consensus 7 ~~~~~~-~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~ 85 (417)
.+..+. .+.++|++.+.||+|+||.||+|++..+|+.||||++.............+.+|+.+++.++||||+++++++
T Consensus 21 ~~~~g~~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~ 100 (286)
T 3uqc_A 21 QLVPGARIANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVV 100 (286)
T ss_dssp CCCTTCEETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred cCCCCCEEecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEE
Confidence 334444 5678999999999999999999999999999999999876554445567889999999999999999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
.+.+..|+||||++|++|.+++..+. ...++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|
T Consensus 101 ~~~~~~~lv~e~~~g~~L~~~l~~~~-~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----- 174 (286)
T 3uqc_A 101 HTRAGGLVVAEWIRGGSLQEVADTSP-SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----- 174 (286)
T ss_dssp EETTEEEEEEECCCEEEHHHHHTTCC-CHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC-----
T ss_pred EECCcEEEEEEecCCCCHHHHHhcCC-ChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc-----
Confidence 99999999999999999999997654 566788999999999999999999999999999999999999998543
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHH---HHhcCCCC----CC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYR---KIYKGEYR----CP 238 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~---~i~~~~~~----~p 238 (417)
|++| + +.++|||||||++|+|++|..||.+.+...... +...+... .+
T Consensus 175 -----------------~~~~-------~-~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (286)
T 3uqc_A 175 -----------------TMPD-------A-NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADID 229 (286)
T ss_dssp -----------------CCTT-------C-CHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHC
T ss_pred -----------------ccCC-------C-CchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcc
Confidence 3333 3 589999999999999999999998765332110 11122221 23
Q ss_pred CCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 239 ~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
...++++.+||.+||+.||.+| |+.|+++.
T Consensus 230 ~~~~~~l~~li~~~l~~dP~~R-s~~el~~~ 259 (286)
T 3uqc_A 230 RDIPFQISAVAARSVQGDGGIR-SASTLLNL 259 (286)
T ss_dssp TTSCHHHHHHHHHHHCTTSSCC-CHHHHHHH
T ss_pred cCCCHHHHHHHHHHcccCCccC-CHHHHHHH
Confidence 5678999999999999999999 99999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=380.87 Aligned_cols=247 Identities=25% Similarity=0.373 Sum_probs=204.0
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEcc-CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVR-TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK 88 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~-~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~ 88 (417)
.+..+.++|++.+.||+|+||.||+|.+.. +|+.||||++.... .......+.+|+.+|+.++||||+++++++...
T Consensus 74 ~g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 151 (681)
T 2pzi_A 74 PGDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHT 151 (681)
T ss_dssp TTCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEE
T ss_pred CCCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeec
Confidence 344667999999999999999999999976 79999999986542 233456788999999999999999999999876
Q ss_pred CE-----EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 89 AK-----IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 89 ~~-----~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
+. .|+||||++|++|.+.+.. .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++.
T Consensus 152 ~~~~~~~~~lv~E~~~g~~L~~~~~~-~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~ 229 (681)
T 2pzi_A 152 DRHGDPVGYIVMEYVGGQSLKRSKGQ-KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVS 229 (681)
T ss_dssp CTTSCEEEEEEEECCCCEECC----C-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCE
T ss_pred CCCCCceeEEEEEeCCCCcHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccch
Confidence 55 7999999999999988765 89999999999999999999999999999999999999886 89999999997
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCCh
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 243 (417)
.... ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+...... .........++
T Consensus 230 ~~~~------~~~~~gt~~y~aPE~~~~~-~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~------~~~~~~~~~~~ 295 (681)
T 2pzi_A 230 RINS------FGYLYGTPGFQAPEIVRTG-P-TVATDIYTVGRTLAALTLDLPTRNGRYVDGL------PEDDPVLKTYD 295 (681)
T ss_dssp ETTC------CSCCCCCTTTSCTTHHHHC-S-CHHHHHHHHHHHHHHHHSCCCEETTEECSSC------CTTCHHHHHCH
T ss_pred hccc------CCccCCCccccCHHHHcCC-C-CCceehhhhHHHHHHHHhCCCCCcccccccc------cccccccccCH
Confidence 6432 1456899999999998764 3 5899999999999999999999875321000 00000011357
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
.+.+||.+||++||.+||+..+.+.|+|+.-
T Consensus 296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 8999999999999999999999999999853
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-37 Score=323.90 Aligned_cols=231 Identities=13% Similarity=0.109 Sum_probs=162.0
Q ss_pred EEeeeCceEEEEEEEccCCcEEEEEEeecccccc-------cchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEEEEE
Q 014849 23 IIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR-------GGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 23 ~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~-------~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++.|++|.+..++..-+|+.+|+|++.++.... .....++.+|+++|+++ .|+||+++++++++.+..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 4667888888888888899999999998753221 12345688999999999 699999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||+|++|.++|.. +++++. +|+.||++||.|||++||+||||||+||||+.+|++||+|||+|+.... ....
T Consensus 321 MEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~--~~~~ 395 (569)
T 4azs_A 321 MEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ--DCSW 395 (569)
T ss_dssp EECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CC
T ss_pred EecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCC--CCcc
Confidence 999999999999987 677764 5899999999999999999999999999999999999999999976543 2334
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
..+.|||+.|||||++.+.. ..++|+||+|++++.|++|..|+ ...+.. .|.. ...+..+...++
T Consensus 396 ~~t~vGTp~YmAPE~l~g~~--~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~----~~~~-~~~~~~l~~~l~ 460 (569)
T 4azs_A 396 PTNLVQSFFVFVNELFAENK--SWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQ----EPVE-RWNFVLLLALFE 460 (569)
T ss_dssp SHHHHHHHHHHHHHHC-------------------CCCCTTHHHH--------HHHHHT----SCGG-GCSHHHHHHHHH
T ss_pred ccCceechhhccHHHhCCCC--CCcccccccccchhhhccccchh--------HHHhhc----CCCC-CCcHHHHHHHHh
Confidence 56789999999999997653 36799999999998887765443 111111 1111 113556677777
Q ss_pred cCCCCCCCCHHHHhcCcccc
Q 014849 254 DTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~ 273 (417)
..+|..|+.......++|..
T Consensus 461 ~~~~~~~~~~~~~~~~~~~~ 480 (569)
T 4azs_A 461 KKAKLPSAEQQRGATEQWII 480 (569)
T ss_dssp TGGGSCCGGGSSCCHHHHHH
T ss_pred CCCCCCCCChhhhccchhHH
Confidence 88888888777777777764
|
| >2zfd_B Putative uncharacterized protein T20L15_90; calcium binding protein, protein-protein complex, ATP-bindin kinase, nucleotide-binding; 1.20A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=220.39 Aligned_cols=112 Identities=50% Similarity=0.776 Sum_probs=98.7
Q ss_pred CCccCcchhhccCCCCCCCCCCccCCCCCCCccccceeecCCHHHHHHHHHHHHHhhcCCCceEEEEeeee-EEEEeecc
Q 014849 299 EKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKKEWG-AKLEGQNG 377 (417)
Q Consensus 299 ~~~~~~~~~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~ 377 (417)
+..+|||||||+|+|||||+||++..... +++||+|+.||++|+++||++|+.+ ||+|++++++ ...+|++|
T Consensus 3 ~~~lNAFdiIs~S~g~dLSgLFe~~~~~~---r~tRF~S~~~a~~ii~klEe~a~~l----g~~v~kk~~~~~~~~g~kG 75 (123)
T 2zfd_B 3 ARRMNAFDIISGSPGFNLSGLFGDARKYD---RVERFVSAWTAERVVERLEEIVSAE----NLTVAKKETWGMKIEGQKG 75 (123)
T ss_dssp -CCCCHHHHHHTSTTSSSGGGGGGGCSSC---CCEEEEESSCHHHHHHHHHHHHHHT----TCEEEEEETTEEEEEEGGG
T ss_pred cccccHHHHHHHCcCCCchHhcCcccccc---cceEEEeCCCHHHHHHHHHHHHHHC----CCEEEEcCCccccccCCCc
Confidence 45699999999999999999997643211 6899999999999999999999999 9999877763 34459999
Q ss_pred ceEEEEEEEEecCceEEEEEEecCCc---hhhhhccccccccC
Q 014849 378 NFTMVIGIDRLTDDLVVVEIKKSMRR---GEENWKDKLRPAAR 417 (417)
Q Consensus 378 ~~~~~~~~~~~~~~~~~v~~~~~~g~---~~~~~~~~~~~~~~ 417 (417)
.|++.||||||+|+++||||||++|| |++||.++|||+|+
T Consensus 76 ~l~v~~EVfev~p~l~vVEvrks~GD~lEy~~~~~~~L~~~L~ 118 (123)
T 2zfd_B 76 NFAMVVEINQLTDELVMIEVRKRQRAAASGRDLWTDTLRPFFV 118 (123)
T ss_dssp TEEEEEEEEECSSSCEEEEEEEEESCC---CCHHHHTHHHHHH
T ss_pred cEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHHHHHHHHHh
Confidence 99999999999999999999999999 99999989999884
|
| >2ehb_D CBL-interacting serine/threonine-protein kinase 2; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.9e-30 Score=221.02 Aligned_cols=113 Identities=29% Similarity=0.478 Sum_probs=102.3
Q ss_pred CCCccCcchhhccCCCCCCCCCCccCCCCCCCccccceeecCCHHHHHHHHHHHHHhhcCCCceEEEEeeeeEEEE----
Q 014849 298 SEKYLNAFDIISLSSGFNLSGLFDDFNNNDAPFCNERFLSNETPEKILEKVEEVARLVADGDRLAVTKKEWGAKLE---- 373 (417)
Q Consensus 298 ~~~~~~~~~~is~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---- 373 (417)
.|..+|||||||+|+|||||+||+..... ..+++||+|+.+|++|+++||++|+.+ ||+|++++++|+++
T Consensus 3 ~p~~lNAFdiIs~S~g~dLSgLFe~~~~~--~~r~tRF~s~~~a~~ii~klEe~a~~l----g~~V~kk~~~vkl~~~~~ 76 (143)
T 2ehb_D 3 GPLMMNAFEMITLSQGLNLSALFDRRQDF--VKRQTRFVSRREPSEIIANIEAVANSM----GFKSHTRNFKTRLEGLSS 76 (143)
T ss_dssp CCEECCHHHHHTTCTTTCGGGGGCSCCCS--CCCCCEEEECSCHHHHHHHHHHHHHHT----TEEEEESSSEEEEEECCS
T ss_pred CccccCHHHHHHHCcCCCchhhhcccccc--ccccceEEeCCCHHHHHHHHHHHHHhc----CcEEEEcCcEEEEEEecC
Confidence 45679999999999999999999765421 116899999999999999999999999 99998888899987
Q ss_pred eeccceEEEEEEEEecCceEEEEEEecCCc---hhhhhccccccccC
Q 014849 374 GQNGNFTMVIGIDRLTDDLVVVEIKKSMRR---GEENWKDKLRPAAR 417 (417)
Q Consensus 374 ~~~~~~~~~~~~~~~~~~~~~v~~~~~~g~---~~~~~~~~~~~~~~ 417 (417)
|++|.|++.||||||+|+++||||||++|| |++||+ +|||+|+
T Consensus 77 grkG~l~v~~EVfevapsl~vVEvrks~GD~lEy~k~~~-~Lr~~L~ 122 (143)
T 2ehb_D 77 IKAGQLAVVIEIYEVAPSLFMVDVRKAAGETLEYHKFYK-KLCSKLE 122 (143)
T ss_dssp SGGGCCEEEEEEEEEETTEEEEEEEEEESCHHHHHHHHH-HHHHHST
T ss_pred CCcceEEEEEEEEEecCCEEEEEEEecCCChHHHHHHHH-HHHHHhh
Confidence 689999999999999999999999999999 999777 9999985
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-31 Score=273.54 Aligned_cols=188 Identities=21% Similarity=0.224 Sum_probs=145.7
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc-----hHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG-----LTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~-----~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
...+.||+|+||.||+|. ..++.+++|........... ..+++.+|+.+|+.++||||+++..+..+.+..|+
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~l 416 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRI 416 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEE
Confidence 446789999999999994 47889999987654332221 23457899999999999999955555556777799
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC-
Q 014849 94 VMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG- 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~- 172 (417)
||||++|++|.+++.. +..++.|++.||.|||++||+||||||+|||++. ++||+|||+|+.........
T Consensus 417 VmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~ 487 (540)
T 3en9_A 417 MMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAV 487 (540)
T ss_dssp EEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHH
T ss_pred EEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccccc
Confidence 9999999999999876 6789999999999999999999999999999998 99999999998754321111
Q ss_pred ----cccccccCccccccccccc--cCCCCChhhHHHHHHHHHHHHcCCCCC
Q 014849 173 ----MLHTLCGTPAYVAPEILAK--KGYDGAKVDMWSCGVVLFVLNAGYLPF 218 (417)
Q Consensus 173 ----~~~~~~Gt~~y~APEvl~~--~~y~~~~sDIwSlGvil~~ll~G~~Pf 218 (417)
...+.+||+.|+|||++.. .+|. ..+|+||..+-..+-..++.+|
T Consensus 488 ~~~~~~~~~~GT~~y~APEv~~~~~~~Y~-~~~d~ws~vl~~l~~v~~r~rY 538 (540)
T 3en9_A 488 DLIVFKKAVLSTHHEKFDEIWERFLEGYK-SVYDRWEIILELMKDVERRARY 538 (540)
T ss_dssp HHHHHHHHHHHHCGGGHHHHHHHHHHHHH-HHCTTHHHHHHHHHHHHTCSCC
T ss_pred chhhhhhhhcCCCCcCCHHHHHHHHHHHH-HHHhHHHHHHHHHHHHHhcccc
Confidence 2346799999999999987 6775 7789999988877777666665
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.6e-27 Score=227.69 Aligned_cols=147 Identities=20% Similarity=0.214 Sum_probs=118.1
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---------------chHHHHHHHHHHHHhCCCCCcceE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---------------GLTAHVKREISIMSRLRHPNIVKL 81 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---------------~~~~~i~~Ei~il~~l~HpnIv~l 81 (417)
.|++++.||+|+||.||+|.+ .+|+.||+|++........ .....+.+|+.+|+.++| +++
T Consensus 91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~---~~v 166 (282)
T 1zar_A 91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQG---LAV 166 (282)
T ss_dssp CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTT---SSS
T ss_pred EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccC---CCc
Confidence 345559999999999999999 8999999999965432111 134568899999999994 555
Q ss_pred EEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeec
Q 014849 82 YEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGL 161 (417)
Q Consensus 82 ~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGl 161 (417)
++++.. +..|+||||++|++|.+ +.. ..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-----~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DFG~ 238 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-----ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQ 238 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-----SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCCTT
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-----hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEECCC
Confidence 554444 44699999999999988 422 23567999999999999999999999999999999 99999999999
Q ss_pred ceeecccCCCCcccccccCcccccccccc
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILA 190 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~ 190 (417)
|. .+..|.|||.+.
T Consensus 239 a~---------------~~~~~~a~e~l~ 252 (282)
T 1zar_A 239 SV---------------EVGEEGWREILE 252 (282)
T ss_dssp CE---------------ETTSTTHHHHHH
T ss_pred Ce---------------ECCCCCHHHHHH
Confidence 85 355689999875
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=5.4e-23 Score=194.78 Aligned_cols=140 Identities=19% Similarity=0.252 Sum_probs=110.4
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcE--EEEEEeeccccc-c--------------------cchHHHHHHHHHHHHhC
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQS--VAIKAVSKQKIL-R--------------------GGLTAHVKREISIMSRL 73 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~-~--------------------~~~~~~i~~Ei~il~~l 73 (417)
-|++++.||+|+||.||+|.+..+|+. ||||++...... . ......+.+|+.+|+.+
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 378999999999999999999889999 999997553211 0 01123678999999999
Q ss_pred CCCCc--ceEEEEEEeCCEEEEEEeccCC-C----ChHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-HcCCeecCCCCCc
Q 014849 74 RHPNI--VKLYEVLATKAKIYFVMEFAKG-G----ELFAKISKGRFSEQLSRRYFQQLISAVEYCH-SRGVFHRDLKLEN 145 (417)
Q Consensus 74 ~HpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH-~~givHrDlkp~N 145 (417)
.|+++ +.++.. ...++||||+.+ | .|.+.... .++..+..++.|++.||.||| ++||+||||||+|
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~N 201 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYN 201 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTS
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHH
Confidence 88864 444442 246899999942 3 66665432 345578899999999999999 9999999999999
Q ss_pred EEecCCCCeEEeeeeccee
Q 014849 146 LLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 146 ILl~~~~~vkl~DFGls~~ 164 (417)
||++. .++|+|||+|..
T Consensus 202 ILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 202 IMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp EEESS--SEEECCCTTCEE
T ss_pred EEEcC--cEEEEECccccc
Confidence 99998 899999999864
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.80 E-value=1.3e-19 Score=180.57 Aligned_cols=138 Identities=20% Similarity=0.228 Sum_probs=102.8
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc-----------ccc----h----HHHHHHHHHHHHhCCCCCc
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL-----------RGG----L----TAHVKREISIMSRLRHPNI 78 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~-----------~~~----~----~~~i~~Ei~il~~l~HpnI 78 (417)
|++++.||+|+||.||+|.+ .+|+.||||++...... ... . .....+|...|.++.++++
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp SEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 99999999999999999998 57999999998643211 000 0 0112467788888865554
Q ss_pred ceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC-----
Q 014849 79 VKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD----- 153 (417)
Q Consensus 79 v~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~----- 153 (417)
.-..-+.... .++||||++|++|..... ...+..++.||+.+|.+||++|||||||||.|||++.+|.
T Consensus 176 ~vp~p~~~~~--~~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~d~~ 248 (397)
T 4gyi_A 176 PVPEPIAQSR--HTIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAEDPS 248 (397)
T ss_dssp SCCCEEEEET--TEEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSSCTT
T ss_pred CCCeeeeccC--ceEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCccccc
Confidence 3222222222 379999999988865532 2245678999999999999999999999999999988773
Q ss_pred -----eEEeeeecce
Q 014849 154 -----LKISDFGLSA 163 (417)
Q Consensus 154 -----vkl~DFGls~ 163 (417)
+.|+||+.+.
T Consensus 249 ~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 249 SITLTPIIIXFPQMV 263 (397)
T ss_dssp SEEEEEEECCCTTCE
T ss_pred ccccceEEEEeCCcc
Confidence 8999999764
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.48 E-value=1.8e-13 Score=128.63 Aligned_cols=141 Identities=21% Similarity=0.166 Sum_probs=115.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
..+.|++...+|.|+++.||.+.. .|+.+++|+....... ....+.+|+.+|+.+. +..+.+++.+..+.+..|
T Consensus 12 ~l~~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~---~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~ 86 (263)
T 3tm0_A 12 LIEKYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKG---TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHTTSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTT---STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HhccceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCC---CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceE
Confidence 346799999999999999999975 4789999998753211 1345889999999985 677889999999999999
Q ss_pred EEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---------------------------------------
Q 014849 93 FVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS--------------------------------------- 133 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~--------------------------------------- 133 (417)
+||||++|.+|.+... +......++.++..+|..||+
T Consensus 87 lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (263)
T 3tm0_A 87 LLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDT 162 (263)
T ss_dssp EEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTC
T ss_pred EEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccc
Confidence 9999999999877632 122345788999999999999
Q ss_pred --------------------cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 --------------------RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 --------------------~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
..++|+|++|.|||+++++.+.|+||+.+.
T Consensus 163 ~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~ 212 (263)
T 3tm0_A 163 PFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG 212 (263)
T ss_dssp SSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred cCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence 458999999999999876556799999774
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.35 E-value=1.2e-12 Score=121.86 Aligned_cols=138 Identities=15% Similarity=0.163 Sum_probs=105.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEEEEeCCE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEVLATKAK 90 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~~~~~~~ 90 (417)
.....|.+..+.+.|+.+.||++.. .+|+.+++|+.... ....+.+|+.+|+.+.+.+ +.+++.+..+.+.
T Consensus 17 ~~~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~------~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~ 89 (264)
T 1nd4_A 17 ERLFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSG------ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGR 89 (264)
T ss_dssp TTTTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSC------TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC
T ss_pred HhcCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcc------cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCC
Confidence 3456688876666777799999965 56788999997543 1245678999999886544 5678888888888
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC-----------------------------------
Q 014849 91 IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG----------------------------------- 135 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~g----------------------------------- 135 (417)
.|+||||++|.+|. .. ..+ ...++.++...|..||+..
T Consensus 90 ~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (264)
T 1nd4_A 90 DWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEH 162 (264)
T ss_dssp EEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGG
T ss_pred CEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhc
Confidence 99999999998884 21 112 2356777888888888643
Q ss_pred -----------------------CeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 136 -----------------------VFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 136 -----------------------ivHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
++|+|++|.|||+++++.+.|+|||.+..
T Consensus 163 ~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 163 QGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 99999999999998876677999998753
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.23 E-value=1.9e-11 Score=120.33 Aligned_cols=141 Identities=21% Similarity=0.374 Sum_probs=107.7
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEee--cccccccchHHHHHHHHHHHHhCC--CCCcceEEEEEEeC---CEE
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVS--KQKILRGGLTAHVKREISIMSRLR--HPNIVKLYEVLATK---AKI 91 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~--~~~~~~~~~~~~i~~Ei~il~~l~--HpnIv~l~~~~~~~---~~~ 91 (417)
...+.|+.|.++.||++.. .+..+++|+.. ..... .....+.+|+.+|+.+. +..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEEC--SSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 3467889999999999876 34688888775 33211 12456789999999997 45588899888776 458
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS-------------------------------------- 133 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~-------------------------------------- 133 (417)
|+||||++|..+.+... ..+++.+...++.+++..|..||+
T Consensus 117 ~~vme~v~G~~l~~~~~-~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQSL-PGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIP 195 (359)
T ss_dssp EEEEECCCCBCCCCTTC-TTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCH
T ss_pred EEEEEecCCeecCCCcc-ccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCCh
Confidence 99999999987754221 347888889999999999999997
Q ss_pred --------------------cCCeecCCCCCcEEecCCCC--eEEeeeeccee
Q 014849 134 --------------------RGVFHRDLKLENLLLDENWD--LKISDFGLSAV 164 (417)
Q Consensus 134 --------------------~givHrDlkp~NILl~~~~~--vkl~DFGls~~ 164 (417)
.+++|+|++|.|||++.++. +.|.||+.+..
T Consensus 196 ~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 196 AMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998764 69999998864
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.1e-11 Score=119.27 Aligned_cols=186 Identities=18% Similarity=0.205 Sum_probs=124.7
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCC--cceEEEEEEeCC---EEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPN--IVKLYEVLATKA---KIYFV 94 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-Hpn--Iv~l~~~~~~~~---~~~lV 94 (417)
.+.++.|....||.+. ..+++|+.... .....+.+|..+|+.+. +.. +.+.+....+.. ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 4569999999999864 56889986433 23567889999998873 333 445555443333 35899
Q ss_pred EeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------------
Q 014849 95 MEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS----------------------------------------- 133 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~----------------------------------------- 133 (417)
|++++|..|.+... ..++..+...++.|+...+..||+
T Consensus 95 m~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 173 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKV 173 (304)
T ss_dssp EECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHH
T ss_pred EcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHH
Confidence 99999988865432 357888888999999999999996
Q ss_pred -----------------cCCeecCCCCCcEEecC--CCCeEEeeeecceeecccCCCCcccccccCccccccccc----c
Q 014849 134 -----------------RGVFHRDLKLENLLLDE--NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL----A 190 (417)
Q Consensus 134 -----------------~givHrDlkp~NILl~~--~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl----~ 190 (417)
..++|+|++|.||+++. ++.+.|+||+.+..-+.. ..+...+....-..|+.. .
T Consensus 174 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~---~Dl~~~~~~~~~~~~~~~~~~l~ 250 (304)
T 3sg8_A 174 DDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD---NDFISLMEDDEEYGMEFVSKILN 250 (304)
T ss_dssp HHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT---HHHHTTCCTTTSCCHHHHHHHHH
T ss_pred HHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH---HHHHHHHhhccccCHHHHHHHHH
Confidence 13699999999999998 456899999988653211 000000000000222221 1
Q ss_pred ccCCCC---------ChhhHHHHHHHHHHHHcCCCCCCC
Q 014849 191 KKGYDG---------AKVDMWSCGVVLFVLNAGYLPFND 220 (417)
Q Consensus 191 ~~~y~~---------~~sDIwSlGvil~~ll~G~~Pf~~ 220 (417)
..+... .-.+.|++|.++|.+.+|..||..
T Consensus 251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~ 289 (304)
T 3sg8_A 251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYE 289 (304)
T ss_dssp HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHH
T ss_pred HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHH
Confidence 111110 226899999999999999988643
|
| >3ose_A Serine/threonine-protein kinase MARK1; kinase associated-1(Ka1) domain, transferase, lipid binding membrane association; 1.70A {Homo sapiens} SCOP: d.129.6.1 PDB: 1ul7_A | Back alignment and structure |
|---|
Probab=98.87 E-value=6.7e-09 Score=86.05 Aligned_cols=79 Identities=14% Similarity=0.090 Sum_probs=67.9
Q ss_pred ceeecCCHHHHHHHHHHHHHhhcCCCceEEEEee-eeEEEEe----eccceEEEEEEEEec-CceEEEEEEecCCc---h
Q 014849 334 RFLSNETPEKILEKVEEVARLVADGDRLAVTKKE-WGAKLEG----QNGNFTMVIGIDRLT-DDLVVVEIKKSMRR---G 404 (417)
Q Consensus 334 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~-~~~~~v~~~~~~g~---~ 404 (417)
.-+|+.+|++|+..|+.+++.+ |+.+++++ |.+++.. ..+.+.+.+|||++. +++++|+|+|.+|| |
T Consensus 32 ~tTS~~~P~eIm~eI~rvL~~~----gi~~~~~g~y~l~C~~~~~~~~~~v~fElEVckl~~~~l~gV~~kRi~Gd~~~y 107 (120)
T 3ose_A 32 KTTSSMDPNDMMREIRKVLDAN----NCDYEQKERFLLFCVHGDARQDSLVQWEMEVCKLPRLSLNGVRFKRISGTSIAF 107 (120)
T ss_dssp CCEECSCHHHHHHHHHHHHHHT----TCEEEEEETTEEEEEESCTTTTCCEEEEEEEEEEGGGTEEEEEEEEEESCHHHH
T ss_pred cCcccCCHHHHHHHHHHHHHHC----CCEEEEcCCEEEEEEecCCCCCccEEEEEEEEEecCCCceeEEEEecCCCHHHH
Confidence 3578999999999999999999 99997665 7888882 245799999999996 89999999999999 9
Q ss_pred hhhhccccccccC
Q 014849 405 EENWKDKLRPAAR 417 (417)
Q Consensus 405 ~~~~~~~~~~~~~ 417 (417)
+++|. .+.+.|+
T Consensus 108 k~lc~-~il~~L~ 119 (120)
T 3ose_A 108 KNIAS-KIANELK 119 (120)
T ss_dssp HHHHH-HHHHHCC
T ss_pred HHHHH-HHHHHhc
Confidence 99999 6655553
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.71 E-value=2.1e-07 Score=89.53 Aligned_cols=134 Identities=16% Similarity=0.122 Sum_probs=98.3
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCC---CcceEEEEEE-eCCEEEEEEe
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP---NIVKLYEVLA-TKAKIYFVME 96 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hp---nIv~l~~~~~-~~~~~~lV~E 96 (417)
.+.++.|....||.. |..+++|+... ......+.+|..+|+.+.+. .+.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456889999999987 57788998532 22356788999999999752 3566666664 4456789999
Q ss_pred ccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc------------------------------------------
Q 014849 97 FAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR------------------------------------------ 134 (417)
Q Consensus 97 ~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~------------------------------------------ 134 (417)
+++|..|....- ..++..+...++.|+...|..||+.
T Consensus 94 ~i~G~~l~~~~~-~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l 172 (306)
T 3tdw_A 94 KVQGQILGEDGM-AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYL 172 (306)
T ss_dssp CCCSEECHHHHH-TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHH
T ss_pred ccCCeECchhhh-hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHH
Confidence 999988866321 2356666666667777766666642
Q ss_pred ------------------CCeecCCCCCcEEecC---CCCe-EEeeeecceee
Q 014849 135 ------------------GVFHRDLKLENLLLDE---NWDL-KISDFGLSAVK 165 (417)
Q Consensus 135 ------------------givHrDlkp~NILl~~---~~~v-kl~DFGls~~~ 165 (417)
.++|+|++|.|||++. ++.+ .|+||+.+..-
T Consensus 173 ~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 173 TLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 3499999999999987 4564 89999987653
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.62 E-value=4.5e-07 Score=84.89 Aligned_cols=132 Identities=17% Similarity=0.209 Sum_probs=96.8
Q ss_pred EeeeCc-eEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEEEEEeccCCC
Q 014849 24 IGCGAF-AKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 24 LG~G~f-g~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~lV~E~~~gg 101 (417)
+..|.. +.||.......+..+.+|+-... ....+.+|..+|+.+. +--+.+++.+..+.+..|+|||+++|.
T Consensus 32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred ccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 334444 47998887777788999986543 3567889999998885 323678888889999999999999998
Q ss_pred ChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc-----------------------------------------------
Q 014849 102 ELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR----------------------------------------------- 134 (417)
Q Consensus 102 ~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~----------------------------------------------- 134 (417)
++.+..... ......+..++...|.-||+.
T Consensus 106 ~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 182 (272)
T 4gkh_A 106 TAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKE 182 (272)
T ss_dssp EHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHH
T ss_pred cccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHH
Confidence 877654421 122334556666666666631
Q ss_pred -----------CCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 135 -----------GVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 135 -----------givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
.++|+|+.|.|||++.++.+-|.||+.+..
T Consensus 183 l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 183 MHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 279999999999999887677999998753
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=6.7e-07 Score=88.91 Aligned_cols=81 Identities=17% Similarity=0.133 Sum_probs=52.3
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccc-cc---cchHHHHHHHHHHHHhCCC--C-CcceEEEEEEeCCEEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI-LR---GGLTAHVKREISIMSRLRH--P-NIVKLYEVLATKAKIY 92 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~-~~---~~~~~~i~~Ei~il~~l~H--p-nIv~l~~~~~~~~~~~ 92 (417)
-.+.||.|.++.||++....+++.+++|....... .. ....+++.+|..+|+.+.. | .+.+++.+ +....+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 36789999999999997766778999998653211 01 1124566789999988742 3 34466644 344568
Q ss_pred EEEeccCCCC
Q 014849 93 FVMEFAKGGE 102 (417)
Q Consensus 93 lV~E~~~gg~ 102 (417)
+|||+++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.32 E-value=4.6e-07 Score=88.53 Aligned_cols=86 Identities=9% Similarity=0.078 Sum_probs=57.1
Q ss_pred EEeeEE-eeeCceEEEEEEEc--c----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-C--CCcceEEEEEEeC
Q 014849 19 EVGKII-GCGAFAKVYHGRNV--R----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-H--PNIVKLYEVLATK 88 (417)
Q Consensus 19 ~i~~~L-G~G~fg~Vy~a~~~--~----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-H--pnIv~l~~~~~~~ 88 (417)
...+.| +.|....+|..... . +++.+++|+..............+.+|+.+|+.+. + -.+.+++.+..+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~ 102 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTG 102 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSS
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCC
Confidence 445778 88999999988653 1 26789999865432000001245678888888874 2 3577788776655
Q ss_pred ---CEEEEEEeccCCCChH
Q 014849 89 ---AKIYFVMEFAKGGELF 104 (417)
Q Consensus 89 ---~~~~lV~E~~~gg~L~ 104 (417)
+..|+|||+++|..+.
T Consensus 103 ~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 103 DVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TTTSSCEEEEECCCCBCCC
T ss_pred CccCCceEEEEecCCCChh
Confidence 3568999999986653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.19 E-value=1.2e-05 Score=77.49 Aligned_cols=134 Identities=14% Similarity=0.158 Sum_probs=78.6
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----HPNIVKLY-E--VLATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~~ 92 (417)
.+.|+.|..+.||++.. . +..+++|+.... ...+..|..+++.|. .|.++... + +....+..|
T Consensus 37 ~~~l~gG~~n~~~~v~~-~-~~~~vlk~~~~~-------~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~ 107 (346)
T 2q83_A 37 IDVIQGNQMALVWKVHT-D-SGAVCLKRIHRP-------EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLF 107 (346)
T ss_dssp EEECC----CEEEEEEE-T-TEEEEEEEECSC-------HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEE
T ss_pred eeeccccccCcEEEEEe-C-CCCEEEEecCCC-------HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEE
Confidence 45567778899999876 2 345999988652 233445555555543 34444310 0 123567889
Q ss_pred EEEeccCCCChH-----------HH---Hhc--CCC--C-----------HH--------H-------------------
Q 014849 93 FVMEFAKGGELF-----------AK---ISK--GRF--S-----------EQ--------L------------------- 116 (417)
Q Consensus 93 lV~E~~~gg~L~-----------~~---i~~--~~l--~-----------e~--------~------------------- 116 (417)
++|+|++|..+. .. +.. ..+ + .. .
T Consensus 108 ~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~ 187 (346)
T 2q83_A 108 VVYDWIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQL 187 (346)
T ss_dssp EEEECCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHH
T ss_pred EEEEeecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHH
Confidence 999999986542 01 110 111 1 00 0
Q ss_pred ----HHHHHHHHHHHHHHHHH-------------cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 117 ----SRRYFQQLISAVEYCHS-------------RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 117 ----~~~i~~ql~~aL~ylH~-------------~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
...+..++..++.+|++ .++||+|++|.|||++.++.+.|+||+.+.
T Consensus 188 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 188 YLQEIDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS 251 (346)
T ss_dssp HHHHHHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred HHHHHHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence 11122233445666652 579999999999999888899999999764
|
| >1v5s_A MAP/microtubule affinity-regulating kinase 3; Ka1 domain, ELKL motif, MARK3, phosphorylation, structural genomics, NPPSFA; NMR {Mus musculus} SCOP: d.129.6.1 | Back alignment and structure |
|---|
Probab=98.12 E-value=2.2e-06 Score=71.00 Aligned_cols=73 Identities=10% Similarity=-0.004 Sum_probs=62.3
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEE-eeeeEEEE-e---eccceEEEEEEEEec-CceEEEEEEecCCc---hh
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTK-KEWGAKLE-G---QNGNFTMVIGIDRLT-DDLVVVEIKKSMRR---GE 405 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~---~~~~~~~~~~~~~~~-~~~~~v~~~~~~g~---~~ 405 (417)
-+|+.+|++|+..|..+.+.+ ++.+++ ..+.+++. + ....+.+.+||+.|. .+++.|.|||.+|| |+
T Consensus 33 tTSsk~P~eIm~EI~rvL~~~----~i~~k~~~~y~L~C~~~~~~~~~~vkfEiEVcKvp~l~l~GI~fKRisGd~w~YK 108 (126)
T 1v5s_A 33 QGSSGSSGDMMREIRKVLGAN----NCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIAFK 108 (126)
T ss_dssp CCCCSSHHHHHHHHHHHHHHT----TEEEEEEETTEEEEEECSSSTTTCEEEEEECCCCTTTCSCCCEEEEEESCHHHHH
T ss_pred eecCCCHHHHHHHHHHHHHHc----CCcEEEECCEEEEEEECCCCCCceEEEEEEEEEecCCCceeEEEeeccCchhHHH
Confidence 356889999999999999999 999965 56788886 2 235799999999995 79999999999999 99
Q ss_pred hhhccc
Q 014849 406 ENWKDK 411 (417)
Q Consensus 406 ~~~~~~ 411 (417)
++|.+-
T Consensus 109 ~lc~~I 114 (126)
T 1v5s_A 109 NIASKI 114 (126)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999843
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.0001 Score=71.10 Aligned_cols=76 Identities=12% Similarity=0.194 Sum_probs=61.0
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC---CCCcceEEEEEEeCCEEEEEEe
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR---HPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~---HpnIv~l~~~~~~~~~~~lV~E 96 (417)
-.+.|+.|....+|.... ++..+++|+.... ....+.+|...|+.|. ...+++.+.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457789999999999875 5678899987643 2566788999888884 3568888888888889999999
Q ss_pred ccCCCCh
Q 014849 97 FAKGGEL 103 (417)
Q Consensus 97 ~~~gg~L 103 (417)
|++|..+
T Consensus 112 ~l~G~~~ 118 (312)
T 3jr1_A 112 ALNKSKN 118 (312)
T ss_dssp CCCCCCC
T ss_pred eccCCCC
Confidence 9998764
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.81 E-value=5.7e-05 Score=75.58 Aligned_cols=78 Identities=15% Similarity=0.072 Sum_probs=46.4
Q ss_pred HcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccccccc--CccccccccccccCCC--CChhhHHHHHHHH
Q 014849 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCG--TPAYVAPEILAKKGYD--GAKVDMWSCGVVL 208 (417)
Q Consensus 133 ~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~G--t~~y~APEvl~~~~y~--~~~sDIwSlGvil 208 (417)
...++|+|++|.|||++.++ +.|.||+.+..-... ..+...++ ...|++|+......-. ....++.++...+
T Consensus 231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~---~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (420)
T 2pyw_A 231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG---FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQT 306 (420)
T ss_dssp CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH---HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHH
T ss_pred CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH---HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHH
Confidence 45799999999999999876 999999988643210 01111111 2346666654311110 1224445777777
Q ss_pred HHHHcC
Q 014849 209 FVLNAG 214 (417)
Q Consensus 209 ~~ll~G 214 (417)
+..+++
T Consensus 307 ~~~y~~ 312 (420)
T 2pyw_A 307 WNLFNK 312 (420)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 766543
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=97.77 E-value=0.00025 Score=64.42 Aligned_cols=120 Identities=15% Similarity=0.077 Sum_probs=80.8
Q ss_pred ChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCcccccc
Q 014849 102 ELFAKISK--GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLC 178 (417)
Q Consensus 102 ~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~ 178 (417)
+|.+.+.. ++++|++++.++.|.+.+|.-+-. +.-..+=+.|..|++..+|+|-+.+ +.+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~--------------~ 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD--------------A 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc--------------c
Confidence 68888874 799999999999999999877622 2222344567999999999998774 2211 1
Q ss_pred cCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhccC
Q 014849 179 GTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 179 Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L~~ 255 (417)
....+.|||... .-.+.+.=|+|||+++|.-+--.+|= .-+..+|+++.+||..|..-
T Consensus 99 ~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALDygL~e-----------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 99 GEPPPVAGKLGY--SQCMETEVIESLGIIIYKALDYGLKE-----------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp --------CCSS--SSSCHHHHHHHHHHHHHHHHTTTCCT-----------------TEEECCCHHHHHHHHHHTTC
T ss_pred cccCCCChhhcc--ccchHHHHHHHHHHHHHHHhhcCCCc-----------------ccchhhCHHHHHHHHHHHhc
Confidence 233567888763 22347889999999999776544431 22345799999999999865
|
| >4eai_A 5'-AMP-activated protein kinase catalytic subunit linker, 5'-AMP-activated protein...; AMPK, transferase; HET: AMP; 2.29A {Rattus norvegicus} PDB: 4eaj_A* 4eak_A* 4eal_A* | Back alignment and structure |
|---|
Probab=97.68 E-value=0.00018 Score=57.57 Aligned_cols=71 Identities=10% Similarity=0.091 Sum_probs=60.2
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEEe-eeeEEEEeec----cceEEEEEEEEecCceEEEEEEecCC-------
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTKK-EWGAKLEGQN----GNFTMVIGIDRLTDDLVVVEIKKSMR------- 402 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~v~~~~~~g------- 402 (417)
..|+..|.+||..|..+.+.+ |+.|++. .+.|++.-.+ ..+.+.+++|++.+..||+||++..|
T Consensus 12 IrS~~~P~eiM~eIyraLk~l----g~~Wk~~~~Y~lkcR~~~~~~~~~vK~~lQLYkv~~~~YLLDfq~i~g~~~~~~~ 87 (106)
T 4eai_A 12 IRSQSRPNDIMAEVCRAIKQL----DYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDGGGGGGG 87 (106)
T ss_dssp EEECSCHHHHHHHHHHHHHHH----TCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEECCSSCCCSSS
T ss_pred ceeCCCHHHHHHHHHHHHHHc----CCEEeeCCceEEEEEEcCCCCCceeEEEEEEEEecCCcEEEEEEeccCCCCCCCC
Confidence 357888999999999999999 9999654 6888887332 35889999999999999999999999
Q ss_pred -c---hhhhhc
Q 014849 403 -R---GEENWK 409 (417)
Q Consensus 403 -~---~~~~~~ 409 (417)
. |.++|.
T Consensus 88 ~~~~~F~d~ca 98 (106)
T 4eai_A 88 SHTIEFFEMCA 98 (106)
T ss_dssp CHHHHHHHHHH
T ss_pred cCcEeHHHHHH
Confidence 3 777777
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.59 E-value=9.3e-05 Score=71.37 Aligned_cols=135 Identities=14% Similarity=0.160 Sum_probs=71.5
Q ss_pred eeEEeeeCceE-EEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEEec
Q 014849 21 GKIIGCGAFAK-VYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKAKIYFVMEF 97 (417)
Q Consensus 21 ~~~LG~G~fg~-Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~E~ 97 (417)
.+.|+.|+... +|.... .+|+.+++|...... ...+..|+.+++.+.. -.+.+++.+..+.+ +++||+
T Consensus 23 ~~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~------~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~ 93 (333)
T 3csv_A 23 RTPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEE------GGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIED 93 (333)
T ss_dssp ECC--------CCEEEEC-TTCCEEEEEECCTTT------TCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECC
T ss_pred eeECCCCCCCceEEEEEc-CCCCeEEEEECCCCC------CccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEee
Confidence 34565555544 556543 236777777654321 1234467777776642 23556666543344 789999
Q ss_pred cCCCChHHHHhcC------------------------C---CCHHHHH-------H-HH------------HHHHHHHHH
Q 014849 98 AKGGELFAKISKG------------------------R---FSEQLSR-------R-YF------------QQLISAVEY 130 (417)
Q Consensus 98 ~~gg~L~~~i~~~------------------------~---l~e~~~~-------~-i~------------~ql~~aL~y 130 (417)
+.|..+.+.+... . ++..... . +. ..+...+..
T Consensus 94 l~~~~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~ 173 (333)
T 3csv_A 94 LGDALFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQ 173 (333)
T ss_dssp CCSCBHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHH
T ss_pred CCCcchHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHH
Confidence 9776664433211 1 1121110 0 00 011122223
Q ss_pred H------HHcCCeecCCCCCcEEecCC----CCeEEeeeeccee
Q 014849 131 C------HSRGVFHRDLKLENLLLDEN----WDLKISDFGLSAV 164 (417)
Q Consensus 131 l------H~~givHrDlkp~NILl~~~----~~vkl~DFGls~~ 164 (417)
+ +...++|||+.|.|||++.+ +.+.|.||+.+..
T Consensus 174 l~~~~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 174 ILSAQLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp HHHHHCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred HHHhcccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 3 13469999999999999874 6799999998764
|
| >2v8q_A 5'-AMP-activated protein kinase catalytic subunit; phosphorylation, nucleotide-binding, serine/threonine-protei kinase, magnesium, CBS domain; HET: AMP; 2.10A {Rattus norvegicus} SCOP: d.129.6.2 PDB: 2v92_A* 2v9j_A* 2y94_C* | Back alignment and structure |
|---|
Probab=97.58 E-value=0.00036 Score=59.18 Aligned_cols=67 Identities=10% Similarity=0.150 Sum_probs=56.4
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEEe-eeeEEEEeecc----ceEEEEEEEEecCceEEEEEEecCCc-hh
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTKK-EWGAKLEGQNG----NFTMVIGIDRLTDDLVVVEIKKSMRR-GE 405 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~----~~~~~~~~~~~~~~~~~v~~~~~~g~-~~ 405 (417)
..|+..|.+||..|..+.+.+ |+.|++. .|.|++.-.++ .+.|.+++|++.+..|||||++..|| |+
T Consensus 9 IrSrs~P~eIM~EVyRALk~L----g~eWK~~~pY~IkcRw~~~~~~~~vKm~LQLYkv~~~~YLLDFk~l~g~~~e 81 (157)
T 2v8q_A 9 IRSQSRPNDIMAEVCRAIKQL----DYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITE 81 (157)
T ss_dssp EEECSCHHHHHHHHHHHHHHT----TCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC---
T ss_pred cccCCCHHHHHHHHHHHHHHc----CCEEeeCCCeEEEEEEcCCCCCceEEEEEEEEEecCCCEEEEEEecCCCccc
Confidence 347889999999999999999 9999764 68888873333 48899999999999999999999998 65
|
| >2y8l_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, serine/threonine-protein KI; HET: ADP AMP; 2.50A {Rattus norvegicus} PDB: 2y8q_A* 2ya3_A* | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00048 Score=59.20 Aligned_cols=68 Identities=10% Similarity=0.160 Sum_probs=56.5
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEE-eeeeEEEEeecc----ceEEEEEEEEecCceEEEEEEecCCc-hhh
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTK-KEWGAKLEGQNG----NFTMVIGIDRLTDDLVVVEIKKSMRR-GEE 406 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~v~~~~~~g~-~~~ 406 (417)
..|+..|.+||..|..+.+.+ |+.|++ ..|.|++.-.++ .+.|.+++|++.+..|||||++..|| |+.
T Consensus 23 IrSrs~P~eIM~EVyRALk~L----g~eWK~i~pY~IkcRw~~~~~~~~vKmeLQLYKv~~~~YLLDFk~l~Gd~~e~ 96 (173)
T 2y8l_A 23 IRSQSRPNDIMAEVCRAIKQL----DYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDEITEA 96 (173)
T ss_dssp EEECSCHHHHHHHHHHHHHHT----TCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC----
T ss_pred cccCCCHHHHHHHHHHHHHHc----CCEEeeCCCeEEEEEEcCCCCCeeEEEEEEEEEEcCCCEEEEEEecCCCcccc
Confidence 348889999999999999999 999976 468888873333 48899999999999999999999998 653
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.51 E-value=0.00028 Score=67.04 Aligned_cols=131 Identities=15% Similarity=0.139 Sum_probs=75.2
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc-
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEFA- 98 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~- 98 (417)
.+.|+.|....+|++ +.+++|+....... .....+|+.+++.+...++ .+++.+ +...-++++||+
T Consensus 23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~----~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~ 90 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEE----YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIA 90 (301)
T ss_dssp CEEEESCSSEEEEEE------TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCT
T ss_pred eeEcCCcccccccee------eeEEEECCCCCccc----eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecC
Confidence 788999999999998 56888987643111 1123468777777643222 455554 333347899999
Q ss_pred CCCChHH---------------HHh---c-C-CCC-----HHHHHHHHHH--------------HHHHHHHHHH------
Q 014849 99 KGGELFA---------------KIS---K-G-RFS-----EQLSRRYFQQ--------------LISAVEYCHS------ 133 (417)
Q Consensus 99 ~gg~L~~---------------~i~---~-~-~l~-----e~~~~~i~~q--------------l~~aL~ylH~------ 133 (417)
+|..|.. .+. . + .++ ......+..+ +...+..+..
T Consensus 91 ~g~~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~ 170 (301)
T 3dxq_A 91 GAQTMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHP 170 (301)
T ss_dssp TCEECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSC
T ss_pred CCccCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcC
Confidence 6654421 010 0 0 010 1111111111 1111222211
Q ss_pred --cCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 134 --RGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 134 --~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 171 ~~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 171 LPLAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CCCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred CCceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 13799999999999 5667899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.49 E-value=0.00021 Score=68.30 Aligned_cols=137 Identities=15% Similarity=0.122 Sum_probs=78.0
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----CCCcceEE-E--EEEeCCEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----HPNIVKLY-E--VLATKAKI 91 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----HpnIv~l~-~--~~~~~~~~ 91 (417)
-.+.|+.|....+|+... ..| .+++|+..... ....+..|..+++.+. -|.++... + +....+..
T Consensus 26 ~~~~i~~G~~n~~~~v~~-~~g-~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~ 98 (322)
T 2ppq_A 26 SYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRP 98 (322)
T ss_dssp EEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEE
T ss_pred EeeccCCCcccceEEEEe-CCc-cEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEE
Confidence 355677888899999876 233 68899886521 1234567777777664 23333210 0 11234678
Q ss_pred EEEEeccCCCChHH-----------H---Hhc--CCC--------CHHHHHHH---------------HHHHHHHHHHHH
Q 014849 92 YFVMEFAKGGELFA-----------K---ISK--GRF--------SEQLSRRY---------------FQQLISAVEYCH 132 (417)
Q Consensus 92 ~lV~E~~~gg~L~~-----------~---i~~--~~l--------~e~~~~~i---------------~~ql~~aL~ylH 132 (417)
+++++|++|..+.. . +.. ..+ ....-... -..+...+.+++
T Consensus 99 ~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~ 178 (322)
T 2ppq_A 99 AALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLA 178 (322)
T ss_dssp EEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHH
T ss_pred EEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHH
Confidence 99999999865311 0 110 011 10000000 011344555555
Q ss_pred H-------cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 133 S-------RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 133 ~-------~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 179 ~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~ 216 (322)
T 2ppq_A 179 AHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 216 (322)
T ss_dssp HHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred hhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence 3 479999999999999987656899999775
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.29 E-value=0.00053 Score=68.96 Aligned_cols=75 Identities=17% Similarity=0.191 Sum_probs=50.7
Q ss_pred EeeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEE
Q 014849 20 VGKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKI 91 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~ 91 (417)
-.+.|+.|....||++.... .++.+.+|+..... ..+.+.+|..+++.+...++ .++++.+. +
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-----~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~-- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-----TESHLVAESVIFTLLSERHLGPKLYGIFS--G-- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-----CHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-----cHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence 35678888889999998643 35789999874321 12455579999888853333 56776553 2
Q ss_pred EEEEeccCCCCh
Q 014849 92 YFVMEFAKGGEL 103 (417)
Q Consensus 92 ~lV~E~~~gg~L 103 (417)
.+|+||++|..|
T Consensus 148 g~v~e~l~G~~l 159 (429)
T 1nw1_A 148 GRLEEYIPSRPL 159 (429)
T ss_dssp EEEECCCCEEEC
T ss_pred CEEEEEeCCccc
Confidence 389999987443
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.25 E-value=0.0044 Score=58.22 Aligned_cols=79 Identities=13% Similarity=0.090 Sum_probs=56.2
Q ss_pred CeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC---CCcceEEEEEEeCCEEEE
Q 014849 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH---PNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 17 ~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H---pnIv~l~~~~~~~~~~~l 93 (417)
+..-.+.+|.|..+.||+.+. .+|+.|.+|+...... .....+.+|...|+.|.. --+.+.+.+ +. -++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~---~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAP---ALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCC---CCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCc---chhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceE
Confidence 566688899999999999986 6789999998754432 123456789999988842 134555554 23 278
Q ss_pred EEeccCCCCh
Q 014849 94 VMEFAKGGEL 103 (417)
Q Consensus 94 V~E~~~gg~L 103 (417)
||||+.++..
T Consensus 88 v~e~l~~~~~ 97 (288)
T 3f7w_A 88 AMEWVDERPP 97 (288)
T ss_dssp EEECCCCCCC
T ss_pred EEEeecccCC
Confidence 9999987653
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.19 E-value=0.00083 Score=64.29 Aligned_cols=76 Identities=11% Similarity=0.151 Sum_probs=48.8
Q ss_pred eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC--cceEEEE-----EEeCCEEEEE
Q 014849 22 KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN--IVKLYEV-----LATKAKIYFV 94 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn--Iv~l~~~-----~~~~~~~~lV 94 (417)
+.|+ |....||.+.. .+|+.+++|+...... ....+..|..+++.+.... +++++.. ....+..+++
T Consensus 32 ~~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~----~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l 105 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQD-EDRRRFVVKFYRPERW----TADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAV 105 (328)
T ss_dssp EEEC-CSSSEEEEECC-TTCCCEEEEEECTTTS----CHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEE
T ss_pred Eeec-CcccceEEEEc-CCCCEEEEEEcCCCCC----CHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEE
Confidence 4566 88889998765 4567899999864321 2456777888887774211 3333332 2235677899
Q ss_pred EeccCCCCh
Q 014849 95 MEFAKGGEL 103 (417)
Q Consensus 95 ~E~~~gg~L 103 (417)
+++++|..+
T Consensus 106 ~~~i~G~~~ 114 (328)
T 1zyl_A 106 FPSVGGRQF 114 (328)
T ss_dssp EECCCCEEC
T ss_pred EEecCCCCC
Confidence 999988543
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.17 E-value=0.001 Score=65.75 Aligned_cols=136 Identities=15% Similarity=0.113 Sum_probs=83.2
Q ss_pred eeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
.+.|..|-...+|++.... .++.+.+++..... .....+.+|..+++.+. +.-..+++..+.+ .
T Consensus 55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~----~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g 126 (379)
T 3feg_A 55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL----QGVDSLVLESVMFAILAERSLGPQLYGVFPE----G 126 (379)
T ss_dssp CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----E
T ss_pred EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc----chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----c
Confidence 3567778888899988642 35789999863311 12456678999998885 3223566665543 2
Q ss_pred EEEeccCCCChHH--------------HHh---c-----CC-C--CHHHHHHHHHHHHH-------------------HH
Q 014849 93 FVMEFAKGGELFA--------------KIS---K-----GR-F--SEQLSRRYFQQLIS-------------------AV 128 (417)
Q Consensus 93 lV~E~~~gg~L~~--------------~i~---~-----~~-l--~e~~~~~i~~ql~~-------------------aL 128 (417)
+||||++|..|.. .+. . ++ . -..++.++..|+-. .+
T Consensus 127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~ 206 (379)
T 3feg_A 127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM 206 (379)
T ss_dssp EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence 8999999865421 111 1 11 1 13455666655432 23
Q ss_pred HHHHH--------cCCeecCCCCCcEEecCC----CCeEEeeeeccee
Q 014849 129 EYCHS--------RGVFHRDLKLENLLLDEN----WDLKISDFGLSAV 164 (417)
Q Consensus 129 ~ylH~--------~givHrDlkp~NILl~~~----~~vkl~DFGls~~ 164 (417)
..|.+ ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 44432 258999999999999876 7899999998764
|
| >4eag_A EG:132E8.2 protein; AMPK, transferase; HET: ATP TAM; 2.70A {Drosophila melanogaster} | Back alignment and structure |
|---|
Probab=97.15 E-value=0.0018 Score=53.23 Aligned_cols=64 Identities=13% Similarity=0.187 Sum_probs=53.1
Q ss_pred eecCCHHHHHHHHHHHHHhhcCCCceEEEEe-eeeEEEEee---cc-ceEEEEEEEEecCceEEEEEEecCCc
Q 014849 336 LSNETPEKILEKVEEVARLVADGDRLAVTKK-EWGAKLEGQ---NG-NFTMVIGIDRLTDDLVVVEIKKSMRR 403 (417)
Q Consensus 336 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~-~~~~~~~~~~~~~~~~~v~~~~~~g~ 403 (417)
.|+..|.+||..|..+.+.+ |+.|++. .+.|++.-. .+ .+.|.+++|+|.+..||+||++..||
T Consensus 13 rS~~~P~eIM~EVyrALk~L----g~eWK~~~pY~vkcR~~n~~~~~~vKm~LQLYqv~~~~YLLDfk~~~~~ 81 (130)
T 4eag_A 13 RSQSKPNDIMLEVYRAMKAL----SYEWKIINPYHVRVRRQNVKTGKFSKMSLQLYQVDAKSYLLDFKSLTND 81 (130)
T ss_dssp CCCSCHHHHHHHHHHHHHHT----TCEEEEEETTEEEEEEECTTTCCEEEEEEEEEESSSSCEEEEEEECC--
T ss_pred ecCCCHHHHHHHHHHHHHHC----CCEEeeCCCEEEEEEecCCCCCceeEEEEEEEEecCCcEEEEeccCCcc
Confidence 36778999999999999999 9999665 688888722 22 57799999999999999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0012 Score=64.67 Aligned_cols=75 Identities=13% Similarity=0.093 Sum_probs=45.5
Q ss_pred eeEEeeeCceEEEEEEEcc--------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR--------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAKI 91 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~--------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~ 91 (417)
.+.++.|....+|++.... .++.+++|+...... . .....+|..+++.+...+ +.+++... .+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~---~-~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~-- 109 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD---E-LYNTISEFEVYKTMSKYKIAPQLLNTF--NG-- 109 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG---G-TSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc---c-eecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence 5667888888999998643 136899998754321 1 112357888888775333 44666544 33
Q ss_pred EEEEeccCCCCh
Q 014849 92 YFVMEFAKGGEL 103 (417)
Q Consensus 92 ~lV~E~~~gg~L 103 (417)
++|+||++|..+
T Consensus 110 ~~v~e~i~G~~l 121 (369)
T 3c5i_A 110 GRIEEWLYGDPL 121 (369)
T ss_dssp EEEEECCCSEEC
T ss_pred cEEEEEecCCcC
Confidence 689999988543
|
| >2qrd_A SNF1-like protein kinase SSP2; AMPK, ADP, ATP-binding, kinase, nucleotide-binding, serine/T protein kinase, transferase, CBS domain; HET: ADP ATP; 2.41A {Schizosaccharomyces pombe} SCOP: d.129.6.2 PDB: 2ooy_A* 2qr1_A* 2qrc_A* 2oox_A* 2qre_A* | Back alignment and structure |
|---|
Probab=97.13 E-value=0.0012 Score=55.43 Aligned_cols=64 Identities=9% Similarity=0.017 Sum_probs=54.7
Q ss_pred eecCCHHHHHHHHHHHHHhhcCCCceEEEEe----------eeeEEEEeecc---------ceEEEEEEEEecCceEEEE
Q 014849 336 LSNETPEKILEKVEEVARLVADGDRLAVTKK----------EWGAKLEGQNG---------NFTMVIGIDRLTDDLVVVE 396 (417)
Q Consensus 336 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~v~ 396 (417)
.|+..|.+||..|..+.+.+ |+.|++. .|.|++.-.++ .+.|.+++|++.+..||||
T Consensus 18 RSrs~P~eIM~EVyrALk~L----g~eWk~~~~~~~~~~~~~y~Ik~R~~~~~~~~~~~~~~vkm~iQLYqv~~~~YLlD 93 (137)
T 2qrd_A 18 RCRGDAPEILLAVYRALQRA----GAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFMLD 93 (137)
T ss_dssp EEESCHHHHHHHHHHHHHHH----TCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEEE
T ss_pred ccCCCHHHHHHHHHHHHHHC----CCEEEeccccccccCCCceEEEEEEecCCCccccCCceEEEEEEEEEecCCcEEEE
Confidence 48889999999999999999 9999654 47788773222 4889999999999999999
Q ss_pred EEecCCc
Q 014849 397 IKKSMRR 403 (417)
Q Consensus 397 ~~~~~g~ 403 (417)
|+..+|+
T Consensus 94 Fk~~~~~ 100 (137)
T 2qrd_A 94 VKSNGYK 100 (137)
T ss_dssp EEEEEEE
T ss_pred EEecCCc
Confidence 9999886
|
| >3t4n_A Carbon catabolite-derepressing protein kinase; CBS domain, nucleotide binding, cytosol, protein binding; HET: ADP; 2.30A {Saccharomyces cerevisiae} SCOP: d.129.6.2 PDB: 3tdh_A* 3te5_A* 2qlv_A | Back alignment and structure |
|---|
Probab=96.97 E-value=0.0026 Score=55.11 Aligned_cols=63 Identities=17% Similarity=0.194 Sum_probs=52.9
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEEe----eeeEEEEeec-------------cceEEEEEEEEecCceEEEEE
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTKK----EWGAKLEGQN-------------GNFTMVIGIDRLTDDLVVVEI 397 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~v~~ 397 (417)
..|+..|.+||..|..+.+.+ |+.|++. .|.|++.-.. ..+.|.+++|++.++.|||||
T Consensus 55 IrS~~~P~eIM~EVyrALk~L----g~~WKk~~~~~pY~IkcRw~~~~~~~~~~~~~~p~~vKmeLQLYkv~~~~YLLDf 130 (179)
T 3t4n_A 55 IRSRSYPLDVMGEIYIALKNL----GAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDF 130 (179)
T ss_dssp EEECSCHHHHHHHHHHHHHHH----TCEEECCCGGGTTEEEEEECC-----------CCCEEEEEEEEEEEETTEEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHc----CCEEeeCCCCCceEEEEEEeCCCCcccccccCCCceeEEEEEEEEecCCceEEEE
Confidence 347899999999999999999 9999774 5788887111 238899999999999999999
Q ss_pred EecCC
Q 014849 398 KKSMR 402 (417)
Q Consensus 398 ~~~~g 402 (417)
+ ..|
T Consensus 131 k-~~G 134 (179)
T 3t4n_A 131 K-FDG 134 (179)
T ss_dssp E-EEE
T ss_pred E-ecc
Confidence 9 667
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.96 E-value=0.0034 Score=60.82 Aligned_cols=31 Identities=19% Similarity=0.295 Sum_probs=27.6
Q ss_pred cCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 134 ~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..++|+|+.|.||+++.++.+.|.||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 3689999999999999888899999987764
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.73 E-value=0.03 Score=56.60 Aligned_cols=76 Identities=21% Similarity=0.229 Sum_probs=49.6
Q ss_pred EeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc-ceEEEEEEeCCEEEEEEecc
Q 014849 20 VGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI-VKLYEVLATKAKIYFVMEFA 98 (417)
Q Consensus 20 i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI-v~l~~~~~~~~~~~lV~E~~ 98 (417)
-.+.|+.|-...+|++.....+..+++|+..... .... ...+|..+|+.|...++ .+++.++. + .+|+||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 3567888889999999875445789999875421 1111 12589999998875444 56777663 3 2599999
Q ss_pred CCCCh
Q 014849 99 KGGEL 103 (417)
Q Consensus 99 ~gg~L 103 (417)
+|..|
T Consensus 184 ~G~~l 188 (458)
T 2qg7_A 184 DGYAL 188 (458)
T ss_dssp CSEEC
T ss_pred CCccC
Confidence 87544
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.70 E-value=0.022 Score=56.94 Aligned_cols=75 Identities=17% Similarity=0.135 Sum_probs=48.3
Q ss_pred eeEEeeeCceEEEEEEEccC-------CcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRT-------GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~-------g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~ 92 (417)
.+.|..|-...+|++..... ++.+++++..... .. .....+|..+++.+. +.-..++++.+ .+ +
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~-~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--~ 146 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GK-FYDSKVELDVFRYLSNINIAPNIIADF--PE--G 146 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----C-CCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--E
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---ch-hcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--C
Confidence 45667788889999887421 6789999864421 11 122457888888875 32244566533 33 7
Q ss_pred EEEeccCCCCh
Q 014849 93 FVMEFAKGGEL 103 (417)
Q Consensus 93 lV~E~~~gg~L 103 (417)
.|+||++|..|
T Consensus 147 ~I~efI~G~~l 157 (424)
T 3mes_A 147 RIEEFIDGEPL 157 (424)
T ss_dssp EEEECCCSEEC
T ss_pred EEEEEeCCccC
Confidence 89999998654
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=93.08 E-value=0.33 Score=43.69 Aligned_cols=114 Identities=14% Similarity=0.189 Sum_probs=79.4
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCC
Q 014849 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWD 153 (417)
Q Consensus 74 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~ 153 (417)
.||+.+.. .+-.+.+.+.+.++.-+.+--+..+. .++..+.++++.+|+....+++ .=+|=-|+|+||+++.++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~ik--~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL~f~~~~~ 117 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNIK--SFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDELFFTRDGL 117 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGGG--GSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGEEECTTSC
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHHHH--hcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceEEEcCCCC
Confidence 68999976 67777787777666655433344444 4788889999999998885443 3477789999999999999
Q ss_pred eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHH-HHHHHHHHHHcCCCCC
Q 014849 154 LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMW-SCGVVLFVLNAGYLPF 218 (417)
Q Consensus 154 vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIw-SlGvil~~ll~G~~Pf 218 (417)
+++.-.|+-.. ++|. .-...|.| ..=|++..+++++..|
T Consensus 118 p~i~~RGik~~-------------------l~P~-------~~~ee~fL~qyKAliiall~~K~~F 157 (215)
T 4ann_A 118 PIAKTRGLQNV-------------------VDPL-------PVSEAEFLTRYKALVICAFNEKQSF 157 (215)
T ss_dssp EEESCCEETTT-------------------BSCC-------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred EEEEEccCccC-------------------CCCC-------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence 99998886321 1222 11223333 4557888888998886
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=91.52 E-value=0.06 Score=53.19 Aligned_cols=29 Identities=34% Similarity=0.469 Sum_probs=25.2
Q ss_pred CeecCCCCCcEEe------cCCCCeEEeeeeccee
Q 014849 136 VFHRDLKLENLLL------DENWDLKISDFGLSAV 164 (417)
Q Consensus 136 ivHrDlkp~NILl------~~~~~vkl~DFGls~~ 164 (417)
+||+|+.+.|||+ ++++.+.++||-+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4566799999998864
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=90.63 E-value=0.7 Score=41.68 Aligned_cols=113 Identities=16% Similarity=0.177 Sum_probs=80.2
Q ss_pred CCCCcceEEEEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHHcCCeecCCCCCcEEecCCC
Q 014849 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVE-YCHSRGVFHRDLKLENLLLDENW 152 (417)
Q Consensus 74 ~HpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~-ylH~~givHrDlkp~NILl~~~~ 152 (417)
.||++ -..+-.+.+.+.+.++.-+++.-+..+. .++..+.++++.+|+.... +++ .-+|=-|+|+||+++.++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i~--~~~~~eKlrll~nl~~L~~~~~~--~r~tf~l~P~NL~f~~~~ 121 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAIR--KTTLLSRIRAAIHLVSKVKHHSA--RRLIFIVCPENLMFNRAL 121 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHHH--TSCHHHHHHHHHHHHHHHSSCCS--SSEECCCCGGGEEECTTC
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHHH--hcCHHHHHHHHHHHHHHHHHhhh--CceeEEEeCceEEEeCCC
Confidence 68888 5556688888888888776655566654 5888889999999888776 443 346778999999999999
Q ss_pred CeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHH-HHHHHHHHHHcCCCCC
Q 014849 153 DLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMW-SCGVVLFVLNAGYLPF 218 (417)
Q Consensus 153 ~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIw-SlGvil~~ll~G~~Pf 218 (417)
.+++.-.|+-. -++|..+ ...|.| +.=|++..++.++..|
T Consensus 122 ~p~i~hRGi~~-------------------~lpP~e~-------~ee~fl~qyKali~all~~K~~F 162 (219)
T 4ano_A 122 EPFFLHVGVKE-------------------SLPPDEW-------DDERLLREVKATVLALTEGEYRF 162 (219)
T ss_dssp CEEESCCEETT-------------------TBSSCSC-------CHHHHHHHHHHHHHHHTTCSSCH
T ss_pred cEEEEEcCCcc-------------------cCCCCCC-------CHHHHHHHHHHHHHHHHcCCCCH
Confidence 99999888632 1233221 223333 4557777888887765
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.61 E-value=0.071 Score=53.89 Aligned_cols=64 Identities=8% Similarity=0.128 Sum_probs=18.2
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEE------EEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAI------KAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAi------K~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
.+.+.|| ||.||.+.......+||+ |.+...... .+....+.+|..+++.++|||+++.|.+-.
T Consensus 145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~-~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVS-EKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp CSTTTSS---BCCC---------CCBGGGC------------------------------------CBCCCEEE
T ss_pred cccccCC---chhhhcccccccCCchhhhhccCcccccccccc-ccccccccccccccccccccccCCCcceEE
Confidence 3445566 999999998665668888 655432221 122345677889999999999999988754
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 417 | ||||
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-91 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-88 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 3e-87 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-85 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 4e-85 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 7e-85 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-84 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-82 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 5e-82 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-81 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-80 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 7e-80 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 2e-78 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 3e-77 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-76 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 5e-76 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 9e-76 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-75 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-74 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 2e-74 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-73 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-73 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-72 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-71 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-69 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-67 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-66 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 1e-65 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-65 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 1e-64 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-64 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-64 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-64 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-64 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 5e-64 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 7e-64 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 7e-64 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-63 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-63 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-62 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 5e-62 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-61 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 5e-61 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-61 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-60 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 4e-60 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 7e-60 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 9e-60 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-59 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-58 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-56 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-56 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 5e-56 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 7e-56 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 5e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-53 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-52 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 1e-49 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-44 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-23 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 274 bits (702), Expect = 3e-91
Identities = 90/260 (34%), Positives = 146/260 (56%), Gaps = 6/260 (2%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+E+G+ +G G F VY R ++ +A+K + K ++ + G+ ++RE+ I S LRHP
Sbjct: 7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHP 66
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG 135
NI++LY ++Y ++E+A G ++ ++ K +F EQ + Y +L +A+ YCHS+
Sbjct: 67 NILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR 126
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V HRD+K ENLLL +LKI+DFG S P TLCGT Y+ PE++ + +D
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHD 182
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
KVD+WS GV+ + G PF Y++I + E+ P + + + I RLL
Sbjct: 183 -EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLLKH 241
Query: 256 DPATRITVDEILRDPWFKKD 275
+P+ R + E+L PW +
Sbjct: 242 NPSQRPMLREVLEHPWITAN 261
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 266 bits (681), Expect = 8e-88
Identities = 94/264 (35%), Positives = 146/264 (55%), Gaps = 8/264 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
++ GKI+G G+F+ V R + T + AIK + K+ I++ +V RE +MSRL HP
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG 135
VKLY K+YF + +AK GEL I K G F E +R Y +++SA+EY H +G
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
+ HRDLK EN+LL+E+ ++I+DFG + V ++ GT YV+PE+L +K
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
D+W+ G +++ L AG PF N +++KI K EY P+ P + + +LL
Sbjct: 189 -KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVL 247
Query: 256 DPATRITVDE------ILRDPWFK 273
D R+ +E + P+F+
Sbjct: 248 DATKRLGCEEMEGYGPLKAHPFFE 271
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 264 bits (676), Expect = 3e-87
Identities = 92/267 (34%), Positives = 147/267 (55%), Gaps = 6/267 (2%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+++ + +G GA+ +V N T ++VA+K V ++ + ++K+EI I L H
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNH 62
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSR 134
N+VK Y Y +E+ GGELF +I E ++R+F QL++ V Y H
Sbjct: 63 ENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGI 122
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY 194
G+ HRD+K ENLLLDE +LKISDFGL+ V + +L+ +CGT YVAPE+L ++ +
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182
Query: 195 DGAKVDMWSCGVVLFVLNAGYLPFNDPN-LMAMYRKIYKGEYRCPKWT--SPDLKWFIGR 251
VD+WSCG+VL + AG LP++ P+ Y + + W + +
Sbjct: 183 HAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHK 242
Query: 252 LLDTDPATRITVDEILRDPWFKKDYKE 278
+L +P+ RIT+ +I +D W+ K K+
Sbjct: 243 ILVENPSARITIPDIKKDRWYNKPLKK 269
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 263 bits (672), Expect = 1e-85
Identities = 79/274 (28%), Positives = 139/274 (50%), Gaps = 15/274 (5%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+++ Y++ + +G GAF V+ TG+ K ++ L VK EISIM++
Sbjct: 26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLD---KYTVKNEISIMNQ 82
Query: 73 LRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEY 130
L HP ++ L++ K ++ ++EF GGELF +I+ + SE Y +Q +++
Sbjct: 83 LHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH 142
Query: 131 CHSRGVFHRDLKLENLLLDENWD--LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEI 188
H + H D+K EN++ + +KI DFGL+ ++ PD ++ T + APEI
Sbjct: 143 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLA---TKLNPDEIVKVTTATAEFAAPEI 199
Query: 189 LAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTSPD 244
+ ++ DMW+ GV+ +VL +G PF + + + + + ++ + SP+
Sbjct: 200 VDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 258
Query: 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
K FI LL +P R+TV + L PW K D+
Sbjct: 259 AKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSN 292
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 259 bits (663), Expect = 4e-85
Identities = 78/280 (27%), Positives = 134/280 (47%), Gaps = 14/280 (5%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREI 67
++R++N +E+ +G GAF KVY +N T A K + + EI
Sbjct: 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEI 60
Query: 68 SIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLI 125
I++ HPNIVKL + + ++ ++EF GG + A + + +E + +Q +
Sbjct: 61 DILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
A+ Y H + HRDLK N+L + D+K++DFG+S + R + GTP ++A
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVS--AKNTRTIQRRDSFIGTPYWMA 178
Query: 186 PEIL----AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RCP 238
PE++ +K K D+WS G+ L + P ++ N M + KI K E P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238
Query: 239 KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278
S + K F+ + L+ + R T ++L+ P+ D +
Sbjct: 239 SRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNK 278
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 259 bits (663), Expect = 7e-85
Identities = 70/294 (23%), Positives = 121/294 (41%), Gaps = 11/294 (3%)
Query: 4 NTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHV 63
+ ++ + + + + IG G+F VY R+VR + VAIK +S +
Sbjct: 3 DVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62
Query: 64 KREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQ 122
+E+ + +LRHPN ++ + + VME+ G K E
Sbjct: 63 IKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTH 122
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
+ + Y HS + HRD+K N+LL E +K+ DFG + ++ GTP
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA------SIMAPANSFVGTPY 176
Query: 183 YVAPEILA--KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW 240
++APE++ +G KVD+WS G+ L P + N M+ I + E +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236
Query: 241 T--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSV 292
S + F+ L P R T + +L+ + ++ KD+V
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAV 290
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 256 bits (656), Expect = 5e-84
Identities = 77/262 (29%), Positives = 130/262 (49%), Gaps = 9/262 (3%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
KY + IG GA VY +V TGQ VAI+ ++ Q+ + + EI +M ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKN 76
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
PNIV + +++ VME+ GG L +++ E ++ + A+E+ HS
Sbjct: 77 PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQ 136
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V HRD+K +N+LL + +K++DFG + T+ GTP ++APE++ +K Y
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFC--AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLKWFIGRL 252
KVD+WS G++ + G P+ + N + I E + P+ S + F+ R
Sbjct: 195 -PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLNRC 253
Query: 253 LDTDPATRITVDEILRDPWFKK 274
LD D R + E+L+ + K
Sbjct: 254 LDMDVEKRGSAKELLQHQFLKI 275
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 255 bits (651), Expect = 1e-82
Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 15/281 (5%)
Query: 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISI 69
+ ++ Y++ + +G GAF V+ TG + A K V V++EI
Sbjct: 20 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQT 76
Query: 70 MSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISA 127
MS LRHP +V L++ ++ + EF GGELF K++ + SE + Y +Q+
Sbjct: 77 MSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKG 136
Query: 128 VEYCHSRGVFHRDLKLENLLL--DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+ + H H DLK EN++ + +LK+ DFGL+A + P + GT + A
Sbjct: 137 LCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA---HLDPKQSVKVTTGTAEFAA 193
Query: 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR----CPKWT 241
PE+ K G DMWS GV+ ++L +G PF N R + ++
Sbjct: 194 PEVAEGKPV-GYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGI 252
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFP 282
S D K FI +LL DP TR+T+ + L PW +
Sbjct: 253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 252 bits (644), Expect = 5e-82
Identities = 112/302 (37%), Positives = 171/302 (56%), Gaps = 16/302 (5%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
Y+ ++G GAF++V + RT + VAIK ++K+ + G ++ EI+++ +++HP
Sbjct: 10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHP 67
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIV L ++ + +Y +M+ GGELF +I KG ++E+ + R Q++ AV+Y H G
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG 127
Query: 136 VFHRDLKLENLLL---DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
+ HRDLK ENLL DE+ + ISDFGLS + P +L T CGTP YVAPE+LA+K
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLS---KMEDPGSVLSTACGTPGYVAPEVLAQK 184
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWT--SPDLKWF 248
Y VD WS GV+ ++L GY PF D N ++ +I K EY P W S K F
Sbjct: 185 PYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF 243
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDII 308
I L++ DP R T ++ L+ PW D K H+ + + + N K+ AF+
Sbjct: 244 IRHLMEKDPEKRFTCEQALQHPWIAGDTALDKNIHQ--SVSEQIKKNFAKSKWKQAFNAT 301
Query: 309 SL 310
++
Sbjct: 302 AV 303
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 248 bits (635), Expect = 3e-81
Identities = 82/268 (30%), Positives = 132/268 (49%), Gaps = 17/268 (6%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
YEV IG G++ + R G+ + K + + + E++++ L+HP
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63
Query: 77 NIVKLYEVL--ATKAKIYFVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVE 129
NIV+ Y+ + T +Y VME+ +GG+L + I+K E+ R QL A++
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 130 YCHSRG-----VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
CH R V HRDLK N+ LD ++K+ DFGL+ + GTP Y+
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA--RILNHDTSFAKAFVGTPYYM 181
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSP 243
+PE + + Y+ K D+WS G +L+ L A PF + + KI +G++ R P S
Sbjct: 182 SPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRYSD 240
Query: 244 DLKWFIGRLLDTDPATRITVDEILRDPW 271
+L I R+L+ R +V+EIL +P
Sbjct: 241 ELNEIITRMLNLKDYHRPSVEEILENPL 268
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 247 bits (631), Expect = 6e-80
Identities = 75/272 (27%), Positives = 128/272 (47%), Gaps = 16/272 (5%)
Query: 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
L+ KY + + +G G F V+ + ++ K V + + VK+EISI++
Sbjct: 3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQ----VLVKKEISILNIA 58
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYC 131
RH NI+ L+E + ++ + EF G ++F +I S +E+ Y Q+ A+++
Sbjct: 59 RHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 132 HSRGVFHRDLKLENLLLD--ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL 189
HS + H D++ EN++ + +KI +FG + Q++P L P Y APE+
Sbjct: 119 HSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQA---RQLKPGDNFRLLFTAPEYYAPEVH 175
Query: 190 AKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSPDL 245
DMWS G +++VL +G PF + I EY K S +
Sbjct: 176 QHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA 234
Query: 246 KWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
F+ RLL + +R+T E L+ PW K+ +
Sbjct: 235 MDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 245 bits (627), Expect = 7e-80
Identities = 90/277 (32%), Positives = 140/277 (50%), Gaps = 20/277 (7%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG------GLTAHVKREIS 68
+ YE +I+G G + V + T + A+K + L +E+
Sbjct: 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 61
Query: 69 IMSRLR-HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLIS 126
I+ ++ HPNI++L + T + V + K GELF + K SE+ +R+ + L+
Sbjct: 62 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLE 121
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+ H + HRDLK EN+LLD++ ++K++DFG S Q+ P L +CGTP+Y+AP
Sbjct: 122 VICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC---QLDPGEKLREVCGTPSYLAP 178
Query: 187 EILAKKGYD-----GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--CPK 239
EI+ D G +VDMWS GV+++ L AG PF M M R I G Y+ P+
Sbjct: 179 EIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE 238
Query: 240 WT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
W S +K + R L P R T +E L P+F++
Sbjct: 239 WDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 243 bits (622), Expect = 2e-78
Identities = 85/260 (32%), Positives = 142/260 (54%), Gaps = 6/260 (2%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR-LRHP 76
+ + K++G G+F KV+ +T Q AIKA+ K +L E ++S HP
Sbjct: 4 FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+ ++ TK ++FVME+ GG+L I S +F + Y ++I +++ HS+G
Sbjct: 64 FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
+ +RDLKL+N+LLD++ +KI+DFG+ KE + D +T CGTP Y+APEIL + Y+
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMC--KENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
VD WS GV+L+ + G PF+ + ++ I P+W + K + +L
Sbjct: 182 -HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVR 240
Query: 256 DPATRITV-DEILRDPWFKK 274
+P R+ V +I + P F++
Sbjct: 241 EPEKRLGVRGDIRQHPLFRE 260
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 239 bits (612), Expect = 3e-77
Identities = 86/263 (32%), Positives = 153/263 (58%), Gaps = 12/263 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+++ + +G G+F +V+ R+ G+ A+K + K+ ++R H E ++S + HP
Sbjct: 6 FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHSRGV 136
I++++ +I+ +M++ +GGELF+ RF +++ Y ++ A+EY HS+ +
Sbjct: 66 IIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125
Query: 137 FHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDG 196
+RDLK EN+LLD+N +KI+DFG + + +TLCGTP Y+APE+++ K Y+
Sbjct: 126 IYRDLKPENILLDKNGHIKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYN- 179
Query: 197 AKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDTD 256
+D WS G++++ + AGY PF D N M Y KI E R P + + D+K + RL+ D
Sbjct: 180 KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRD 239
Query: 257 PATRI-----TVDEILRDPWFKK 274
+ R+ +++ PWFK+
Sbjct: 240 LSQRLGNLQNGTEDVKNHPWFKE 262
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 238 bits (608), Expect = 2e-76
Identities = 97/263 (36%), Positives = 145/263 (55%), Gaps = 9/263 (3%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
++ K++G G F KV R TG+ A+K + K+ I+ AH E ++ RHP
Sbjct: 6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEYCHSRG 135
+ L T ++ FVME+A GGELF +S+ F+E+ +R Y +++SA+EY HSR
Sbjct: 66 FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V +RD+KLENL+LD++ +KI+DFGL KE I + T CGTP Y+APE+L Y
Sbjct: 126 VVYRDIKLENLMLDKDGHIKITDFGLC--KEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
VD W GVV++ + G LPF + + ++ I E R P+ SP+ K + LL
Sbjct: 184 -RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLLKK 242
Query: 256 DPATRI-----TVDEILRDPWFK 273
DP R+ E++ +F
Sbjct: 243 DPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 235 bits (601), Expect = 5e-76
Identities = 76/266 (28%), Positives = 127/266 (47%), Gaps = 18/266 (6%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAH---VKREISIMSR 72
+Y+VG ++G G F VY G V VAIK V K +I G + V E+ ++ +
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 73 LR--HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAV 128
+ +++L + ++E + + +G E+L+R +F Q++ AV
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAV 123
Query: 129 EYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPE 187
+CH+ GV HRD+K EN+L+D N +LK+ DFG A+ + D + GT Y PE
Sbjct: 124 RHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK----DTVYTDFDGTRVYSPPE 179
Query: 188 ILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKW 247
+ Y G +WS G++L+ + G +PF +I +G+ + S + +
Sbjct: 180 WIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSECQH 233
Query: 248 FIGRLLDTDPATRITVDEILRDPWFK 273
I L P+ R T +EI PW +
Sbjct: 234 LIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 234 bits (599), Expect = 9e-76
Identities = 65/270 (24%), Positives = 128/270 (47%), Gaps = 19/270 (7%)
Query: 16 GKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
G++ + IG G+F VY G + T VA + +K+ + K E ++ L+
Sbjct: 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEMLKGLQ 66
Query: 75 HPNIVKLYEVLATKAK----IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVE 129
HPNIV+ Y+ + K I V E G L + + ++ R + +Q++ ++
Sbjct: 67 HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQ 126
Query: 130 YCHSRG--VFHRDLKLENLLL-DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+ H+R + HRDLK +N+ + +KI D GL+ ++ + GTP ++AP
Sbjct: 127 FLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA----TLKRASFAKAVIGTPEFMAP 182
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGEY--RCPKWTSP 243
E+ ++ YD VD+++ G+ + + P+++ N +YR++ G K P
Sbjct: 183 EMY-EEKYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIP 240
Query: 244 DLKWFIGRLLDTDPATRITVDEILRDPWFK 273
++K I + + R ++ ++L +F+
Sbjct: 241 EVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 236 bits (602), Expect = 1e-75
Identities = 65/308 (21%), Positives = 121/308 (39%), Gaps = 53/308 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+E +G G V+ + +G +A K + + ++ + + RE+ ++ P
Sbjct: 7 DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSR- 134
IV Y + +I ME GG L + K GR EQ+ + +I + Y +
Sbjct: 65 YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY 194
+ HRD+K N+L++ ++K+ DFG+S D M ++ GT +Y++PE L Y
Sbjct: 125 KIMHRDVKPSNILVNSRGEIKLCDFGVS----GQLIDSMANSFVGTRSYMSPERLQGTHY 180
Query: 195 DGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYR--------------- 236
+ D+WS G+ L + G P P+ L M+ +G+
Sbjct: 181 S-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239
Query: 237 --------------------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDP 270
S + + F+ + L +PA R + +++
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA 299
Query: 271 WFKKDYKE 278
+ K+ E
Sbjct: 300 FIKRSDAE 307
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (593), Expect = 1e-74
Identities = 90/279 (32%), Positives = 140/279 (50%), Gaps = 16/279 (5%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---RGGLTAHVK 64
+ R+ N+ Y+ G+ +G G FA V R TG A K + K++ RG ++
Sbjct: 2 VFRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIE 61
Query: 65 REISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQ 123
RE+SI+ ++HPN++ L+EV K + ++E GGELF K +E+ + + +Q
Sbjct: 62 REVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQ 121
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWD----LKISDFGLSAVKEQIRPDGMLHTLCG 179
+++ V Y HS + H DLK EN++L + +KI DFGL+ +I + G
Sbjct: 122 ILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA---HKIDFGNEFKNIFG 178
Query: 180 TPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR--- 236
TP +VAPEI+ + + DMWS GV+ ++L +G PF + Y
Sbjct: 179 TPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED 237
Query: 237 -CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
TS K FI RLL DP R+T+ + L+ PW K
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 233 bits (596), Expect = 2e-74
Identities = 89/292 (30%), Positives = 140/292 (47%), Gaps = 26/292 (8%)
Query: 14 LFGKYEV-GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+ Y+V +++G G KV N RT + A+K + R RE+ + R
Sbjct: 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKAR--------REVELHWR 60
Query: 73 L-RHPNIVKLYEVL----ATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQL 124
+ P+IV++ +V A + + VME GGELF++I F+E+ + + +
Sbjct: 61 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
A++Y HS + HRD+K ENLL I ++ L T C TP YV
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMA----MYRKIYKGEYR--CP 238
APE+L + YD DMWS GV++++L GY PF + +A M +I G+Y P
Sbjct: 181 APEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNP 239
Query: 239 KWT--SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDL 288
+W+ S ++K I LL T+P R+T+ E + PW + K + P +
Sbjct: 240 EWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRV 291
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 229 bits (585), Expect = 1e-73
Identities = 66/264 (25%), Positives = 118/264 (44%), Gaps = 15/264 (5%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
G+ VG+ IG G+F VY G+ VA+K ++ L K E+ ++ + R
Sbjct: 7 DGQITVGQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQL-QAFKNEVGVLRKTR 62
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYCH 132
H NI+ +T ++ V ++ +G L+ + + +F +Q ++Y H
Sbjct: 63 HVNILLFMGY-STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEIL--A 190
++ + HRDLK N+ L E+ +KI DFGL+ VK + L G+ ++APE++
Sbjct: 122 AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT------SPD 244
K + D+++ G+VL+ L G LP+++ N + Y P +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241
Query: 245 LKWFIGRLLDTDPATRITVDEILR 268
+K + L R +IL
Sbjct: 242 MKRLMAECLKKKRDERPLFPQILA 265
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 232 bits (592), Expect = 2e-73
Identities = 84/268 (31%), Positives = 131/268 (48%), Gaps = 16/268 (5%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE---ISIMSRLR 74
+ V +IIG G F +VY R TG+ A+K + K++I E +S++S
Sbjct: 6 FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS 133
P IV + T K+ F+++ GG+L +S+ G FSE R Y ++I +E+ H+
Sbjct: 66 CPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHN 125
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
R V +RDLK N+LLDE+ ++ISD GL+ + +P H GT Y+APE+L K
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP----HASVGTHGYMAPEVLQKGV 181
Query: 194 YDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIG 250
+ D +S G +LF L G+ PF + + R P SP+L+ +
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLE 241
Query: 251 RLLDTDPATRITV-----DEILRDPWFK 273
LL D R+ E+ P+F+
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 225 bits (574), Expect = 5e-72
Identities = 63/271 (23%), Positives = 120/271 (44%), Gaps = 11/271 (4%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+L +YE+G+I+G G ++V+ R++R + VA+K + +RE +
Sbjct: 4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA 63
Query: 73 LRHPNIVKLYEVLATKAK----IYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISA 127
L HP IV +Y+ + Y VME+ G L + G + + + A
Sbjct: 64 LNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQA 123
Query: 128 VEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA-VKEQIRPDGMLHTLCGTPAYVAP 186
+ + H G+ HRD+K N+++ +K+ DFG++ + + + GT Y++P
Sbjct: 124 LNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP 183
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTS 242
E D A+ D++S G VL+ + G PF + +++ + + + P + S
Sbjct: 184 EQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS 242
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
DL + + L +P R +R +
Sbjct: 243 ADLDAVVLKALAKNPENRYQTAAEMRADLVR 273
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 226 bits (578), Expect = 1e-71
Identities = 93/264 (35%), Positives = 143/264 (54%), Gaps = 12/264 (4%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+++ K +G G+F +V ++ +G A+K + KQK+++ H E I+ + P
Sbjct: 42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFP 101
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG 135
+VKL + +Y VME+ GGE+F+ + + GRFSE +R Y Q++ EY HS
Sbjct: 102 FLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD 161
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
+ +RDLK ENLL+D+ ++++DFG + R G TLCGTP +APEI+ KGY+
Sbjct: 162 LIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLLDT 255
VD W+ GV+++ + AGY PF + +Y KI G+ R P S DLK + LL
Sbjct: 217 -KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQV 275
Query: 256 DPATRI-----TVDEILRDPWFKK 274
D R V++I WF
Sbjct: 276 DLTKRFGNLKNGVNDIKNHKWFAT 299
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 221 bits (564), Expect = 1e-69
Identities = 70/303 (23%), Positives = 112/303 (36%), Gaps = 38/303 (12%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+Y IG GA+ V + VAIK +S + REI I+ R RH
Sbjct: 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRH 65
Query: 76 PNIVKLYEVLATKA----KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
NI+ + +++ K +++ G +L+ + S + Q++ ++Y
Sbjct: 66 ENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYI 125
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH-TLCGTPAYVAPEILA 190
HS V HRDLK NLLL+ DLKI DFGL+ V + T Y APEI+
Sbjct: 126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI-------------------- 230
+D+WS G +L + + F + + I
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 245
Query: 231 YKGEYRCPKWT-----------SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKER 279
P + ++L +P RI V++ L P+ ++ Y
Sbjct: 246 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPS 305
Query: 280 KFP 282
P
Sbjct: 306 DEP 308
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 215 bits (547), Expect = 1e-67
Identities = 77/290 (26%), Positives = 110/290 (37%), Gaps = 33/290 (11%)
Query: 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI--LRGGLTAHVKREISIMSRLRHP 76
E +G G FA VY R+ T Q VAIK + + G+ REI ++ L HP
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHSRG 135
NI+ L + K+ I V +F + + + Y + +EY H
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
+ HRDLK NLLLDEN LK++DFGL+ K P+ T Y APE+L
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLA--KSFGSPNRAYTHQVVTRWYRAPELLFGARMY 178
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-------------------- 235
G VDMW+ G +L L + + +I++
Sbjct: 179 GVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238
Query: 236 --------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
DL I L +P RIT + L+ +F
Sbjct: 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 288
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (539), Expect = 3e-66
Identities = 75/303 (24%), Positives = 115/303 (37%), Gaps = 44/303 (14%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
KYE IG G F +V+ R+ +TGQ VA+K V + + G REI I+ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQLLKH 68
Query: 76 PNIVKLYEVLATKA--------KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLIS 126
N+V L E+ TKA IY V +F + + +F+ +R Q L++
Sbjct: 69 ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD--GMLHTLCGTPAYV 184
+ Y H + HRD+K N+L+ + LK++DFGL+ + T Y
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188
Query: 185 APEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT--- 241
PE+L + G +D+W G ++ + I +
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248
Query: 242 -----------------------------SPDLKWFIGRLLDTDPATRITVDEILRDPWF 272
P I +LL DPA RI D+ L +F
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308
Query: 273 KKD 275
D
Sbjct: 309 WSD 311
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (530), Expect = 1e-65
Identities = 65/264 (24%), Positives = 113/264 (42%), Gaps = 20/264 (7%)
Query: 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
+N+ + ++ + IG G F V G G VA+K + + E S+M
Sbjct: 3 ALNM-KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQ-----AFLAEASVM 54
Query: 71 SRLRHPNIVKLYEVLA-TKAKIYFVMEFAKGGELFAKI---SKGRFSEQLSRRYFQQLIS 126
++LRH N+V+L V+ K +Y V E+ G L + + ++ +
Sbjct: 55 TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
A+EY HRDL N+L+ E+ K+SDFGL+ + T + AP
Sbjct: 115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAP 169
Query: 187 EILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPD 244
E L +K + K D+WS G++L+ + + G +P+ L + ++ KG P P
Sbjct: 170 EALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPA 228
Query: 245 LKWFIGRLLDTDPATRITVDEILR 268
+ + D A R + ++
Sbjct: 229 VYEVMKNCWHLDAAMRPSFLQLRE 252
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (534), Expect = 5e-65
Identities = 77/313 (24%), Positives = 123/313 (39%), Gaps = 50/313 (15%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
Y K+IG G+F VY + +G+ VAIK V + K + RE+ IM +L H N
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMRKLDHCN 74
Query: 78 IVKLYEVLATKAK------IYFVMEFAKGGEL----FAKISKGRFSEQLSRRYFQQLISA 127
IV+L + + + V+++ +K + Y QL +
Sbjct: 75 IVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRS 134
Query: 128 VEYCHSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+ Y HS G+ HRD+K +NLLLD + LK+ DFG + +Q+ + + Y AP
Sbjct: 135 LAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSA---KQLVRGEPNVSYICSRYYRAP 191
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYK-------------- 232
E++ + +D+WS G VL L G F + + +I K
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 233 ---GEYRCPKW------------TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
E++ P+ T P+ RLL+ P R+T E +F +
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311
Query: 278 ERKFPHEDFDLKD 290
D
Sbjct: 312 PNVKLPNGRDTPA 324
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 206 bits (525), Expect = 1e-64
Identities = 77/288 (26%), Positives = 123/288 (42%), Gaps = 34/288 (11%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KY + IG G + VY +N G++ A+K + +K G + REISI+ L+H
Sbjct: 3 KYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIP-STTIREISILKELKHS 60
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFA-KISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIVKLY+V+ TK ++ V E + +G ++ + QL++ + YCH R
Sbjct: 61 NIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR 120
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V HRDLK +NLL++ +LKI+DFGL+ + P T Y AP++L
Sbjct: 121 VLHRDLKPQNLLINREGELKIADFGLA--RAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178
Query: 196 GAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-------------------- 235
+D+WS G + + G F + +I++
Sbjct: 179 STTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF 238
Query: 236 ---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
K + ++L DP RIT + L +FK+
Sbjct: 239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-64
Identities = 81/273 (29%), Positives = 133/273 (48%), Gaps = 15/273 (5%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSR 72
+E+ K++G GA+ KV+ R + TG+ A+K + K I+ + T H + E ++
Sbjct: 25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 84
Query: 73 LRH-PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKG-RFSEQLSRRYFQQLISAVEY 130
+R P +V L+ T+ K++ ++++ GGELF +S+ RF+E + Y +++ A+E+
Sbjct: 85 IRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEH 144
Query: 131 CHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILA 190
H G+ +RD+KLEN+LLD N + ++DFGLS + +
Sbjct: 145 LHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRG 204
Query: 191 KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCPKWTSPDLK 246
VD WS GV+++ L G PF + R+I K E P+ S K
Sbjct: 205 GDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAK 264
Query: 247 WFIGRLLDTDPATRI-----TVDEILRDPWFKK 274
I RLL DP R+ DEI +F+K
Sbjct: 265 DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 4e-64
Identities = 67/268 (25%), Positives = 105/268 (39%), Gaps = 15/268 (5%)
Query: 17 KYEVGKI-IGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL 73
+ I +GCG F V G R + VAIK + + T + RE IM +L
Sbjct: 9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQL 66
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYC 131
+P IV+L V + VME A GG L + + Q+ ++Y
Sbjct: 67 DNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYL 125
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILA 190
+ HRDL N+LL KISDFGLS A+ + APE +
Sbjct: 126 EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECIN 185
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWF 248
+ + ++ D+WS GV ++ L+ G P+ + I +G+ CP P+L
Sbjct: 186 FRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYAL 244
Query: 249 IGRLLDTDPATRITVDEI---LRDPWFK 273
+ R + +R ++
Sbjct: 245 MSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 4e-64
Identities = 66/258 (25%), Positives = 98/258 (37%), Gaps = 9/258 (3%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRT---GQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR 74
+ + +G G+F V G SVA+K + + + RE++ M L
Sbjct: 10 LRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD 69
Query: 75 HPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCH 132
H N+++LY V+ T + V E A G L ++ K G F RY Q+ + Y
Sbjct: 70 HRNLIRLYGVVLTP-PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLE 128
Query: 133 SRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
S+ HRDL NLLL +KI DFGL Q ++ P K
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188
Query: 193 GYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWFI 249
D W GV L+ + G P+ N + KI K R P+ D+ +
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIYNVM 248
Query: 250 GRLLDTDPATRITVDEIL 267
+ P R T +
Sbjct: 249 VQCWAHKPEDRPTFVALR 266
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 206 bits (526), Expect = 5e-64
Identities = 75/318 (23%), Positives = 123/318 (38%), Gaps = 47/318 (14%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+ Y + +G GA+ V + RTG VAIK + + RE+ ++
Sbjct: 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-PFQSELFAKRAYRELRLLKH 73
Query: 73 LRHPNIVKLYEV------LATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126
+RH N++ L +V L Y VM F G +L + + E + Q++
Sbjct: 74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLK 132
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+ Y H+ G+ HRDLK NL ++E+ +LKI DFGL+ + D + T Y AP
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA-----RQADSEMTGYVVTRWYRAP 187
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKW------ 240
E++ VD+WS G ++ + G F + + ++I K P
Sbjct: 188 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247
Query: 241 -------------------------TSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275
SP + ++L D R+T E L P+F+
Sbjct: 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307
Query: 276 YK---ERKFPHEDFDLKD 290
+ E + D D
Sbjct: 308 HDTEDEPQVQKYDDSFDD 325
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 205 bits (522), Expect = 5e-64
Identities = 82/292 (28%), Positives = 126/292 (43%), Gaps = 34/292 (11%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
++ + IG G + VY RN TG+ VA+K + G + REIS++ L HP
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVP-STAIREISLLKELNHP 61
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
NIVKL +V+ T+ K+Y V EF + + L + Y QL+ + +CHS
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGY 194
V HRDLK +NLL++ +K++DFGL+ + P T Y APEIL Y
Sbjct: 122 RVLHRDLKPQNLLINTEGAIKLADFGLA--RAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 195 DGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG------------------EYR 236
VD+WS G + + F + + +I++ +
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 237 CPKWT-----------SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277
PKW D + + ++L DP RI+ L P+F+ K
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 7e-64
Identities = 61/261 (23%), Positives = 107/261 (40%), Gaps = 12/261 (4%)
Query: 22 KIIGCGAFAKVYHG--RNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIV 79
K +G G F V G + + ++VA+K + K + L + E ++M +L +P IV
Sbjct: 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQLDNPYIV 71
Query: 80 KLYEVLATKAKIYFVMEFAKGGELFAKI-SKGRFSEQLSRRYFQQLISAVEYCHSRGVFH 138
++ + + VME A+ G L + ++ Q+ ++Y H
Sbjct: 72 RMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVH 130
Query: 139 RDLKLENLLLDENWDLKISDFGLS-AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGA 197
RDL N+LL KISDFGLS A++ + APE + + +
Sbjct: 131 RDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFS-S 189
Query: 198 KVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDT 255
K D+WS GV+++ + G P+ + + KGE CP ++ +
Sbjct: 190 KSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249
Query: 256 DPATRITVDEI---LRDPWFK 273
D R + LR+ ++
Sbjct: 250 DVENRPGFAAVELRLRNYYYD 270
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 204 bits (521), Expect = 7e-64
Identities = 64/275 (23%), Positives = 115/275 (41%), Gaps = 16/275 (5%)
Query: 5 TGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLT---- 60
+ ++E+++ ++ ++IG G F +V G G+ A+ K L+ G T
Sbjct: 16 VREFAKEIDI-SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAI---KTLKSGYTEKQR 71
Query: 61 AHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSR 118
E SIM + HPN++ L V+ + + EF + G L F + + G+F+
Sbjct: 72 RDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLV 131
Query: 119 RYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT-- 176
+ + + ++Y HRDL N+L++ N K+SDFGLS E D +
Sbjct: 132 GMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSAL 191
Query: 177 -LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGE 234
+ APE + + + D+WS G+V++ V++ G P+ D + I +
Sbjct: 192 GGKIPIRWTAPEAIQYRKFTS-ASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDY 250
Query: 235 YR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
P L + D R +I+
Sbjct: 251 RLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVN 285
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-63
Identities = 60/256 (23%), Positives = 104/256 (40%), Gaps = 11/256 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
K +G G F V +G+ R VAIK + + + E +M L H
Sbjct: 6 LTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSMSE----DEFIEEAKVMMNLSHEK 60
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+V+LY V + I+ + E+ G L + + RF Q + + A+EY S+
Sbjct: 61 LVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
HRDL N L+++ +K+SDFGLS + + + PE+L +
Sbjct: 121 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS-KFPVRWSPPEVLMYSKFS 179
Query: 196 GAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLL 253
+K D+W+ GV+++ + + G +P+ I +G P S + +
Sbjct: 180 -SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYSCW 238
Query: 254 DTDPATRITVDEILRD 269
R T +L +
Sbjct: 239 HEKADERPTFKILLSN 254
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 3e-63
Identities = 58/297 (19%), Positives = 111/297 (37%), Gaps = 37/297 (12%)
Query: 3 DNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GL 59
D + RE E GK++G GAF KV + ++ V+ + +
Sbjct: 29 DLKWEFPRE-----NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSE 83
Query: 60 TAHVKREISIMSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--------- 109
+ E+ +M++L H NIV L IY + E+ G+L +
Sbjct: 84 REALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 143
Query: 110 ---------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDL 154
+ + + Q+ +E+ + HRDL N+L+ +
Sbjct: 144 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 203
Query: 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNA 213
KI DFGL+ + ++APE L + Y K D+WS G++L+ + +
Sbjct: 204 KICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSL 262
Query: 214 GYLPFNDPNLMAMYRKIYKGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
G P+ + A + K+ + ++ P + + ++ + D R + +
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (514), Expect = 2e-62
Identities = 56/279 (20%), Positives = 113/279 (40%), Gaps = 9/279 (3%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ--KILRGGLTAHVKREISIMSRLRH 75
++ K++G GAF VY G + G+ V I K+ + + E +M+ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 76 PNIVKLYEVLATKAKIYFVMEFAKGGELFAKI--SKGRFSEQLSRRYFQQLISAVEYCHS 133
P++ +L + T + + + G L + K Q + Q+ + Y
Sbjct: 71 PHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKG 193
R + HRDL N+L+ +KI+DFGL+ + + ++A E + +
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 194 YDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIGR 251
Y + D+WS GV ++ ++ G P++ + + KGE P + D+ + +
Sbjct: 190 YT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIMVK 248
Query: 252 LLDTDPATRITVDEILRDP-WFKKDYKERKFPHEDFDLK 289
D +R E++ + +D + D +
Sbjct: 249 CWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 202 bits (513), Expect = 5e-62
Identities = 63/302 (20%), Positives = 118/302 (39%), Gaps = 42/302 (13%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+Y+ +G GA+ V + +TG VA+K +S+ RE+ ++ ++H
Sbjct: 19 RYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA-KRTYRELRLLKHMKHE 77
Query: 77 NIVKLYEVLATKAKI-----YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
N++ L +V + +++ G +L + + ++ + Q++ ++Y
Sbjct: 78 NVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYI 137
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAK 191
HS + HRDLK NL ++E+ +LKI DFGL+ D + T Y APEI+
Sbjct: 138 HSADIIHRDLKPSNLAVNEDCELKILDFGLA-----RHTDDEMTGYVATRWYRAPEIMLN 192
Query: 192 KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWT---------- 241
+ VD+WS G ++ L G F + + + I +
Sbjct: 193 WMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESAR 252
Query: 242 ---------------------SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERK 280
+P + ++L D RIT + L +F + +
Sbjct: 253 NYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312
Query: 281 FP 282
P
Sbjct: 313 EP 314
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 197 bits (502), Expect = 2e-61
Identities = 63/255 (24%), Positives = 105/255 (41%), Gaps = 11/255 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
+ IG G F V+ G VAIK + + + E +M +L HP
Sbjct: 7 LTFVQEIGSGQFGLVHLGYW-LNKDKVAIKTIREGAMSE----EDFIEEAEVMMKLSHPK 61
Query: 78 IVKLYEVLATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
+V+LY V +A I V EF + G L + + +G F+ + + + Y
Sbjct: 62 LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V HRDL N L+ EN +K+SDFG++ + +PE+ + Y
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD-DQYTSSTGTKFPVKWASPEVFSFSRYS 180
Query: 196 GAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTSPDLKWFIGRLL 253
+K D+WS GV+++ V + G +P+ + + + I G P+ S + +
Sbjct: 181 -SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCW 239
Query: 254 DTDPATRITVDEILR 268
P R +LR
Sbjct: 240 KERPEDRPAFSRLLR 254
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 197 bits (502), Expect = 5e-61
Identities = 66/276 (23%), Positives = 119/276 (43%), Gaps = 19/276 (6%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
+ +G G + +VY G + +VA+K + + + +E ++M ++HP
Sbjct: 18 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV----EEFLKEAAVMKEIKHP 73
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGELFAKI---SKGRFSEQLSRRYFQQLISAVEYCHS 133
N+V+L V + Y + EF G L + ++ S + Q+ SA+EY
Sbjct: 74 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 133
Query: 134 RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT---PAYVAPEILA 190
+ HRDL N L+ EN +K++DFGLS ++ G + APE LA
Sbjct: 134 KNFIHRDLAARNCLVGENHLVKVADFGLS----RLMTGDTYTAHAGAKFPIKWTAPESLA 189
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248
+ K D+W+ GV+L+ + G P+ +L +Y + K P+ +
Sbjct: 190 YNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYEL 248
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHE 284
+ +P+ R + EI + F+ ++E E
Sbjct: 249 MRACWQWNPSDRPSFAEIHQ--AFETMFQESSISDE 282
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (503), Expect = 5e-61
Identities = 59/305 (19%), Positives = 111/305 (36%), Gaps = 24/305 (7%)
Query: 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL- 73
+ + +IG G F +V R + G + ++ E+ ++ +L
Sbjct: 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLG 68
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-----------------GRFSEQL 116
HPNI+ L + +Y +E+A G L + K S Q
Sbjct: 69 HHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 128
Query: 117 SRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT 176
+ + ++Y + HRDL N+L+ EN+ KI+DFGLS
Sbjct: 129 LLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS---RGQEVYVKKTM 185
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY 235
++A E L D+WS GV+L+ +++ G P+ +Y K+ +G
Sbjct: 186 GRLPVRWMAIESL-NYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 244
Query: 236 -RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGC 294
P ++ + + P R + +IL + ++ ++ G
Sbjct: 245 LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTYVNTTLYEKFTYAGI 304
Query: 295 NVGSE 299
+ +E
Sbjct: 305 DCSAE 309
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 2e-60
Identities = 74/289 (25%), Positives = 124/289 (42%), Gaps = 34/289 (11%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHP 76
KYE + IG G + V+ +N T + VA+K V G + + REI ++ L+H
Sbjct: 3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEG-VPSSALREICLLKELKHK 61
Query: 77 NIVKLYEVLATKAKIYFVMEFAKGGEL-FAKISKGRFSEQLSRRYFQQLISAVEYCHSRG 135
NIV+L++VL + K+ V EF + G ++ + + QL+ + +CHSR
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121
Query: 136 VFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYD 195
V HRDLK +NLL++ N +LK+++FGL+ P T Y P++L
Sbjct: 122 VLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRCYSAEVVTLWYRPPDVLFGAKLY 179
Query: 196 GAKVDMWSCGVVLFVLNAGYLP-FNDPNLMAMYRKIYKGEY------------------- 235
+DMWS G + L P F ++ ++I++
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY 239
Query: 236 ----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274
+ + + LL +P RI+ +E L+ P+F
Sbjct: 240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (495), Expect = 3e-60
Identities = 60/273 (21%), Positives = 115/273 (42%), Gaps = 20/273 (7%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
++ RE ++ + +G G F +V+ G VA+K++ + + E
Sbjct: 9 EVPRE-----TLKLVERLGAGQFGEVWMGYY-NGHTKVAVKSLKQGSMSP----DAFLAE 58
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI---SKGRFSEQLSRRYFQQ 123
++M +L+H +V+LY V+ T+ IY + E+ + G L + S + + Q
Sbjct: 59 ANLMKQLQHQRLVRLYAVV-TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQ 117
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
+ + + R HRDL+ N+L+ + KI+DFGL+ + E +
Sbjct: 118 IAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED-NEYTAREGAKFPIKW 176
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWT 241
APE + G K D+WS G++L ++ G +P+ + + + +G P
Sbjct: 177 TAPEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNC 235
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILR--DPWF 272
+L + P R T D + + +F
Sbjct: 236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 4e-60
Identities = 71/295 (24%), Positives = 123/295 (41%), Gaps = 43/295 (14%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-- 73
+YE IG GA+ KV+ R+++ G+ VA+K V Q G+ RE++++ L
Sbjct: 8 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLET 66
Query: 74 -RHPNIVKLYEVLAT-----KAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLI 125
HPN+V+L++V + K+ V E K+ + + + QL+
Sbjct: 67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126
Query: 126 SAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVA 185
+++ HS V HRDLK +N+L+ + +K++DFGL+ + L ++ T Y A
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVVVTLWYRA 183
Query: 186 PEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---------- 235
PE+L + Y VD+WS G + + F + + KI
Sbjct: 184 PEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242
Query: 236 -----------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
+ K + + L +PA RI+ L P+F+
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQ 297
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-60
Identities = 67/267 (25%), Positives = 109/267 (40%), Gaps = 13/267 (4%)
Query: 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAV-SKQKILRGGLTAHVKRE 66
I RE + E+G+ IG G F V+ G + A+ + + + +E
Sbjct: 4 IQRE-----RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQE 58
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQL 124
M + HP+IVKL V+ T+ ++ +ME GEL + + Y QL
Sbjct: 59 ALTMRQFDHPHIVKLIGVI-TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 125 ISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYV 184
+A+ Y S+ HRD+ N+L+ N +K+ DFGLS E ++
Sbjct: 118 STALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED-STYYKASKGKLPIKWM 176
Query: 185 APEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWTS 242
APE + + + D+W GV ++ +L G PF + +I GE P
Sbjct: 177 APESINFRRFTS-ASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCP 235
Query: 243 PDLKWFIGRLLDTDPATRITVDEILRD 269
P L + + DP+ R E+
Sbjct: 236 PTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 9e-60
Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 21/286 (7%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKRE 66
+I RE + +G G F +V+ G T + VAIK + + +E
Sbjct: 13 EIPRE-----SLRLEVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSP----EAFLQE 62
Query: 67 ISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI---SKGRFSEQLSRRYFQQ 123
+M +LRH +V+LY V+ ++ IY V E+ G L + + Q
Sbjct: 63 AQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQ 121
Query: 124 LISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAY 183
+ S + Y HRDL+ N+L+ EN K++DFGL+ + E +
Sbjct: 122 IASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIED-NEYTARQGAKFPIKW 180
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWT 241
APE + K D+WS G++L + G +P+ + ++ +G CP
Sbjct: 181 TAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPEC 239
Query: 242 SPDLKWFIGRLLDTDPATRITVDEILR--DPWFKKDYKERKFPHED 285
L + + +P R T + + + +F + + P E+
Sbjct: 240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS-TEPQYQPGEN 284
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 194 bits (493), Expect = 3e-59
Identities = 66/299 (22%), Positives = 121/299 (40%), Gaps = 53/299 (17%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-H 75
Y++ + +G G +++V+ N+ + V +K + K +KREI I+ LR
Sbjct: 36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGG 89
Query: 76 PNIVKLYEVLATKAK--IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS 133
PNI+ L +++ V E + ++ R Y +++ A++YCHS
Sbjct: 90 PNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHS 147
Query: 134 RGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKK 192
G+ HRD+K N+++D E+ L++ D+GL+ E P + + + PE+L
Sbjct: 148 MGIMHRDVKPHNVMIDHEHRKLRLIDWGLA---EFYHPGQEYNVRVASRYFKGPELLVDY 204
Query: 193 GYDGAKVDMWSCGVVLFVLNAGYLPF----NDPNLMAMYRKIYKGEYRCPKWT------- 241
+DMWS G +L + PF ++ + + K+ E
Sbjct: 205 QMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD 264
Query: 242 ---------------------------SPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273
SP+ F+ +LL D +R+T E + P+F
Sbjct: 265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (486), Expect = 1e-58
Identities = 65/284 (22%), Positives = 106/284 (37%), Gaps = 35/284 (12%)
Query: 17 KYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
E + IG GAF +V+ R VA+K + ++ + A +RE ++M+
Sbjct: 14 NIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA 71
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-------------------- 111
+PNIVKL V A + + E+ G+L +
Sbjct: 72 EFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131
Query: 112 -----FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166
S +Q+ + + Y R HRDL N L+ EN +KI+DFGLS
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191
Query: 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMA 225
++ PE + Y + D+W+ GVVL+ + + G P+
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250
Query: 226 MYRKIYKGEYR-CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
+ + G CP+ +L + PA R + I R
Sbjct: 251 VIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 185 bits (471), Expect = 3e-56
Identities = 58/280 (20%), Positives = 104/280 (37%), Gaps = 31/280 (11%)
Query: 17 KYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
+ GK +G GAF KV +VA+K + L + E+ ++S
Sbjct: 24 RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTE--REALMSELKVLS 81
Query: 72 RL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISK-------------------GR 111
L H NIV L + E+ G+L + +
Sbjct: 82 YLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELA 141
Query: 112 FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171
+ + Q+ + + S+ HRDL N+LL KI DFGL+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNY 201
Query: 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKI 230
+ ++APE + + D+WS G+ L+ + + G P+ + + + K+
Sbjct: 202 VVKGNARLPVKWMAPESI-FNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM 260
Query: 231 YKGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
K +R P+ ++ + D DP R T +I++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 185 bits (469), Expect = 4e-56
Identities = 62/289 (21%), Positives = 106/289 (36%), Gaps = 27/289 (9%)
Query: 11 EVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIM 70
E+ + +Y +G+ IG G+F +Y G ++ G+ VAIK + + E I
Sbjct: 2 ELRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIY 56
Query: 71 SRLRHPNIVK-LYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAV 128
++ + + A VME R FS + Q+IS +
Sbjct: 57 KMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRI 116
Query: 129 EYCHSRGVFHRDLKLENLL---LDENWDLKISDFGLS-----AVKEQIRPDGMLHTLCGT 180
EY HS+ HRD+K +N L + + I DFGL+ A Q P L GT
Sbjct: 117 EYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGT 176
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRC 237
Y + + D+ S G VL N G LP+ Y +I + +
Sbjct: 177 ARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235
Query: 238 P-----KWTSPDLKWFIGRLLDTDPATRIT---VDEILRDPWFKKDYKE 278
P K + ++ + + ++ R+ + ++ +
Sbjct: 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFSY 284
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (468), Expect = 5e-56
Identities = 60/280 (21%), Positives = 115/280 (41%), Gaps = 30/280 (10%)
Query: 17 KYEVGKIIGCGAFAKVYHGRNVRTGQS-------VAIKAVSKQKILRGGLTAHVKREISI 69
+ +GK +G GAF +V + + VA+K + + + + E+ +
Sbjct: 14 RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD--LSDLISEMEM 71
Query: 70 MSRL-RHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKI-----------------SKGR 111
M + +H NI+ L +Y ++E+A G L + + +
Sbjct: 72 MKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131
Query: 112 FSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171
S + Q+ +EY S+ HRDL N+L+ E+ +KI+DFGL+ I
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191
Query: 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKI 230
++APE L + Y + D+WS GV+L+ + G P+ + +++ +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL 250
Query: 231 YKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269
+G P + +L + P+ R T +++ D
Sbjct: 251 KEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 7e-56
Identities = 60/258 (23%), Positives = 113/258 (43%), Gaps = 13/258 (5%)
Query: 21 GKIIGCGAFAKVYHGRNVR---TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN 77
++IG G F VYHG + A+K++++ I G + E IM HPN
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 78 IVKLYEV-LATKAKIYFVMEFAKGGEL--FAKISKGRFSEQLSRRYFQQLISAVEYCHSR 134
++ L + L ++ V+ + K G+L F + + + + Q+ +++ S+
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASK 149
Query: 135 GVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHT--LCGTPAYVAPEILAKK 192
HRDL N +LDE + +K++DFGL+ D + + ++A E L +
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL-QT 208
Query: 193 GYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR-CPKWTSPDLKWFIG 250
K D+WS GV+L+ ++ G P+ D N + + +G P++ L +
Sbjct: 209 QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEVML 268
Query: 251 RLLDTDPATRITVDEILR 268
+ R + E++
Sbjct: 269 KCWHPKAEMRPSFSELVS 286
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (459), Expect = 5e-54
Identities = 69/327 (21%), Positives = 122/327 (37%), Gaps = 55/327 (16%)
Query: 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSR 72
+ +Y+ K IG GA V + ++VAIK +S+ RE+ +M
Sbjct: 14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLMKC 72
Query: 73 LRHPNIVKLYEVLATKAK------IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLIS 126
+ H NI+ L V + +Y VME ++ + + Q++
Sbjct: 73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLC--QVIQMELDHERMSYLLYQMLC 130
Query: 127 AVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAP 186
+++ HS G+ HRDLK N+++ + LKI DFGL+ M+ T Y AP
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYYRAP 187
Query: 187 EILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP-------- 238
E++ GY VD+WS G ++ + + F + + + K+ +
Sbjct: 188 EVILGMGYKE-NVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ 246
Query: 239 ----------------------------------KWTSPDLKWFIGRLLDTDPATRITVD 264
K + + + ++L DPA RI+VD
Sbjct: 247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVD 306
Query: 265 EILRDPWFKKDYKERKFPHEDFDLKDS 291
+ L+ P+ Y + + D
Sbjct: 307 DALQHPYINVWYDPAEVEAPPPQIYDK 333
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 1e-53
Identities = 58/260 (22%), Positives = 108/260 (41%), Gaps = 12/260 (4%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQS----VAIKAVSKQKILRGGLTAHVKREISIMSRL 73
K+IG G F +VY G + VAIK + + E IM +
Sbjct: 9 VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ--RVDFLGEAGIMGQF 66
Query: 74 RHPNIVKLYEVLATKAKIYFVMEFAKGG--ELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
H NI++L V++ + + E+ + G + F + G FS + + + ++Y
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYL 126
Query: 132 HSRGVFHRDLKLENLLLDENWDLKISDFGLSA-VKEQIRPDGMLHTLCGTPAYVAPEILA 190
+ HRDL N+L++ N K+SDFGLS +++ + APE ++
Sbjct: 127 ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAIS 186
Query: 191 KKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248
+ + D+WS G+V++ V+ G P+ + + + + I G P +
Sbjct: 187 YRKFTS-ASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIYQL 245
Query: 249 IGRLLDTDPATRITVDEILR 268
+ + + A R +I+
Sbjct: 246 MMQCWQQERARRPKFADIVS 265
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 4e-53
Identities = 58/282 (20%), Positives = 108/282 (38%), Gaps = 27/282 (9%)
Query: 17 KYEVGKIIGCGAFAKVYHGRN-----VRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS 71
K + + +G G+F VY G VAIK V++ +R E S+M
Sbjct: 21 KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRE--RIEFLNEASVMK 78
Query: 72 RLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-----------FSEQLSRRY 120
++V+L V++ +ME G+L + + R S +
Sbjct: 79 EFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138
Query: 121 FQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGT 180
++ + Y ++ HRDL N ++ E++ +KI DFG++ +
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198
Query: 181 PAYVAPEILAKKGYDGAKVDMWSCGVVLF-VLNAGYLPFNDPNLMAMYRKIYKGEYR-CP 238
+++PE L + D+WS GVVL+ + P+ + + R + +G P
Sbjct: 199 VRWMSPESLKDGVFTT-YSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP 257
Query: 239 KWTSPDLKWFIGRLLDTDPATRITVDEILR------DPWFKK 274
L + +P R + EI+ +P F++
Sbjct: 258 DNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (448), Expect = 5e-53
Identities = 59/294 (20%), Positives = 115/294 (39%), Gaps = 47/294 (15%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+ + IG G F +V+ G+ G+ VA+K S ++ + EI LRH
Sbjct: 3 RTIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERS----WFREAEIYQTVMLRH 56
Query: 76 PNIVKLYEVL----ATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYC 131
NI+ T +++ V ++ + G LF +++ + + + S + +
Sbjct: 57 ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 132 HS--------RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP--DGMLHTLCGTP 181
H + HRDLK +N+L+ +N I+D GL+ + D + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 182 AYVAPEIL-----AKKGYDGAKVDMWSCGVVLFVLNAGYLPFN---------------DP 221
Y+APE+L K + D+++ G+V + + DP
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 236
Query: 222 NLMAMYRKIYKGEYRCP---KWTSPD----LKWFIGRLLDTDPATRITVDEILR 268
++ M + + + + R +W S + + + + A R+T I +
Sbjct: 237 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 176 bits (446), Expect = 1e-52
Identities = 54/293 (18%), Positives = 100/293 (34%), Gaps = 29/293 (9%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
Y+VG+ IG G+F ++ G N+ Q VAIK ++ ++ E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAG 59
Query: 76 -PNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGR-FSEQLSRRYFQQLISAVEYCHS 133
I +Y V++ GR FS + +Q+++ V+ H
Sbjct: 60 CTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 119
Query: 134 RGVFHRDLKLENLLLDE-----NWDLKISDFGLSAVKE-----QIRPDGMLHTLCGTPAY 183
+ + +RD+K +N L+ + + DFG+ Q P L GT Y
Sbjct: 120 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 179
Query: 184 VAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF---NDPNLMAMYRKIYKGEYRCP-- 238
++ + + D+ + G V G LP+ Y +I + + P
Sbjct: 180 MSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLR 238
Query: 239 ---KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHED-FD 287
+ ++ + D + F K + ++ FD
Sbjct: 239 ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG--LFSKVLERLNTTEDENFD 289
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (424), Expect = 1e-49
Identities = 62/288 (21%), Positives = 114/288 (39%), Gaps = 33/288 (11%)
Query: 7 DISREVNLFGKYEVGKIIGCGAFAKVYHGR-----NVRTGQSVAIKAVSKQKILRGGLTA 61
+ R+ + ++GK +G GAF +V T ++VA+K + + A
Sbjct: 9 EFPRD-----RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT-HSEHRA 62
Query: 62 HVKREISIMSRLRHPNIVKLYEV-LATKAKIYFVMEFAKGGELFAKI------------- 107
+ ++ H N+V L + ++EF K G L +
Sbjct: 63 LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 122
Query: 108 ----SKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163
K + + Y Q+ +E+ SR HRDL N+LL E +KI DFGL+
Sbjct: 123 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 182
Query: 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY-LPFNDPN 222
+ ++APE + + Y + D+WS GV+L+ + + P+
Sbjct: 183 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVK 241
Query: 223 LMAMYRKIYKGEYR--CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268
+ + + K R P +T+P++ + +P+ R T E++
Sbjct: 242 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE 289
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 156 bits (395), Expect = 1e-44
Identities = 59/374 (15%), Positives = 117/374 (31%), Gaps = 93/374 (24%)
Query: 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH 75
+Y + + +G G F+ V+ +++ VA+K V K+ + EI ++ R+
Sbjct: 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVND 68
Query: 76 PNIVKL-------------YEVLATKAKIYFVMEFAKGG----ELFAKISKGRFSEQLSR 118
+ K + ++ VM F G L K +
Sbjct: 69 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK 128
Query: 119 RYFQQLISAVEYC-HSRGVFHRDLKLENLLLD-ENWDLKISDFGLSAVKEQIRPDGMLHT 176
+ +QL+ ++Y G+ H D+K EN+L++ + + ++ + D
Sbjct: 129 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN 188
Query: 177 LCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY--------- 227
T Y +PE+L + D+WS ++F L G F +
Sbjct: 189 SIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI 247
Query: 228 ---------------------------------------RKIYKGEYRCPKWTSPDLKWF 248
+ +Y+ K + ++ F
Sbjct: 248 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307
Query: 249 IGRLLDTDPATRITVDEILRDPWFKKDYKERKFPHEDFDLKDSVGCNVGSEKYLNAFDII 308
+ +L DP R ++ PW K + D +L
Sbjct: 308 LSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPDREL-------------------- 347
Query: 309 SLSSGFNLSGLFDD 322
SG ++ G F++
Sbjct: 348 -YGSGSDIPGWFEE 360
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 95.2 bits (236), Expect = 1e-23
Identities = 32/209 (15%), Positives = 64/209 (30%), Gaps = 35/209 (16%)
Query: 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKI---------------LRGGLTAH 62
+GK++G G + V++ + +K
Sbjct: 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRS 60
Query: 63 VKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQ 122
+ E + +L+ + K+Y +ME EL+ R +
Sbjct: 61 ARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELY------RVRVENPDEVLD 110
Query: 123 QLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPA 182
++ V + RG+ H DL N+L+ E + I DF S + +L
Sbjct: 111 MILEEVAKFYHRGIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDV---- 165
Query: 183 YVAPEILAKKGYDGAKVDMWSCGVVLFVL 211
++ + D+ S + +L
Sbjct: 166 RNIITYFSRTY--RTEKDINS--AIDRIL 190
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 417 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1ul7a_ | 102 | Map/microtubule affinity-regulating kinase 3 {Mous | 99.14 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.58 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.97 | |
| d2v8qa1 | 153 | 5'-AMP-activated protein kinase catalytic subunit | 97.46 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.05 | |
| d2qrda1 | 127 | Snf1-like protein kinase ssp2 {Schizosaccharomyces | 96.92 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.83 | |
| d2qlva1 | 171 | Carbon catabolite-derepressing protein kinase SNF1 | 96.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.0 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-66 Score=494.99 Aligned_cols=256 Identities=35% Similarity=0.696 Sum_probs=240.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|+++.+|+.||+|++.+....+......+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 46899999999999999999999999999999999887766666678899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||+||+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+|++||+|||+|.... ...
T Consensus 85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~----~~~ 160 (263)
T d2j4za1 85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSR 160 (263)
T ss_dssp EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCC----CCC
T ss_pred EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecC----CCc
Confidence 999999999999976 789999999999999999999999999999999999999999999999999997543 234
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
....+||+.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.++.++.+..|...|+++++||.+||
T Consensus 161 ~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 239 (263)
T d2j4za1 161 RTTLCGTLDYLPPEMIEGRMHD-EKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLISRLL 239 (263)
T ss_dssp CEETTEEGGGCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCTTSCHHHHHHHHHHT
T ss_pred ccccCCCCcccCHHHHcCCCCC-chhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHHc
Confidence 4677899999999999998885 999999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCCHHHHhcCcccccc
Q 014849 254 DTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 254 ~~dP~~R~t~~eil~h~~f~~~ 275 (417)
++||++|||++|+++||||+.+
T Consensus 240 ~~dp~~R~t~~eil~hp~~~~~ 261 (263)
T d2j4za1 240 KHNPSQRPMLREVLEHPWITAN 261 (263)
T ss_dssp CSSGGGSCCHHHHHTCHHHHHH
T ss_pred cCCHhHCcCHHHHHcCcCcCCc
Confidence 9999999999999999999864
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-66 Score=494.70 Aligned_cols=263 Identities=35% Similarity=0.612 Sum_probs=228.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.+.++|++++.||+|+||+||+|+++.+|+.||||++++.... ...+.+.+|+.+|+.++|||||++++++.+++.+|
T Consensus 2 Pf~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ 79 (271)
T d1nvra_ 2 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQY 79 (271)
T ss_dssp TTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred CCCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcc--hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeE
Confidence 4678999999999999999999999999999999999876432 23457889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 93 FVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
+|||||+||+|.+++.. +.+++.+++.++.||++||+|||++||+||||||+|||++.++++||+|||+|.........
T Consensus 80 ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~ 159 (271)
T d1nvra_ 80 LFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159 (271)
T ss_dssp EEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred EEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence 99999999999999976 68999999999999999999999999999999999999999999999999999876544444
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCCCCC--CCCChHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEYRCP--KWTSPDLKWF 248 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~~~p--~~~s~~~~~l 248 (417)
....+.+||+.|||||++.+..|++.++|||||||++|+|++|++||...+.. ..+..+.......+ ...|+++.+|
T Consensus 160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l 239 (271)
T d1nvra_ 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPLAL 239 (271)
T ss_dssp CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTSTTGGGSCHHHHHH
T ss_pred ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCCCccccCCHHHHHH
Confidence 55667899999999999999888778899999999999999999999765433 33444444333322 4569999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
|.+||+.||++|||++|+++||||++..+
T Consensus 240 i~~~L~~dP~~R~t~~eil~hpwf~~~l~ 268 (271)
T d1nvra_ 240 LHKILVENPSARITIPDIKKDRWYNKPLK 268 (271)
T ss_dssp HHHHSCSSTTTSCCHHHHTTCTTTTCCCC
T ss_pred HHHHcCCChhHCcCHHHHhcCHhhCcCCC
Confidence 99999999999999999999999987554
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-65 Score=494.92 Aligned_cols=260 Identities=36% Similarity=0.635 Sum_probs=236.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++++.||+|+||+||+|+++.+|+.||||++.+....+......+.+|+.+|++++|||||++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 34689999999999999999999999999999999988766556667889999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||||+||+|.+++.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..........
T Consensus 86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~ 165 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA 165 (288)
T ss_dssp EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence 9999999999998875 899999999999999999999999999999999999999999999999999998765544455
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+++.++.++.+.+|..+|+++++||++|
T Consensus 166 ~~~~~~GT~~Y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 244 (288)
T d1uu3a_ 166 RANSFVGTAQYVSPELLTEKSAC-KSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKL 244 (288)
T ss_dssp ----CCCCGGGCCHHHHHTCCCC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCTTCCHHHHHHHHTT
T ss_pred ccccccCCccccCceeeccCCCC-cccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCCccCCHHHHHHHHHH
Confidence 56678999999999999998885 89999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCHHH------HhcCccccc
Q 014849 253 LDTDPATRITVDE------ILRDPWFKK 274 (417)
Q Consensus 253 L~~dP~~R~t~~e------il~h~~f~~ 274 (417)
|+.||++|||++| |++||||+.
T Consensus 245 L~~dP~~R~t~~e~~~~~~i~~Hpff~~ 272 (288)
T d1uu3a_ 245 LVLDATKRLGCEEMEGYGPLKAHPFFES 272 (288)
T ss_dssp SCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred ccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence 9999999999988 588999975
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-64 Score=494.79 Aligned_cols=257 Identities=37% Similarity=0.646 Sum_probs=241.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|+++.+|+.||||++++..........++.+|+.+|+.++||||+++++++.+...+|+|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccc
Confidence 56899999999999999999999999999999999987665566678899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||+||+|.+++.+ +.++|..++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|+.... ....
T Consensus 84 ~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~--~~~~ 161 (337)
T d1o6la_ 84 MEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS--DGAT 161 (337)
T ss_dssp EECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC--TTCC
T ss_pred eeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeeccccccccc--CCcc
Confidence 999999999999986 8899999999999999999999999999999999999999999999999999975432 2345
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
..+.||||.|+|||++.+.+|+ .++|||||||++|+|++|++||.+.+..+++.++..+.+.+|..+|+++++||++||
T Consensus 162 ~~~~~GT~~Y~aPE~~~~~~y~-~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~L 240 (337)
T d1o6la_ 162 MKTFCGTPEYLAPEVLEDNDYG-RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240 (337)
T ss_dssp BCCCEECGGGCCGGGGSSSCBC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccceeCHHHhhhhhccCCCCC-hhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHhhc
Confidence 6678999999999999999995 899999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCCC-----HHHHhcCccccc
Q 014849 254 DTDPATRIT-----VDEILRDPWFKK 274 (417)
Q Consensus 254 ~~dP~~R~t-----~~eil~h~~f~~ 274 (417)
++||.+|++ ++|+++||||+.
T Consensus 241 ~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 241 KKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred cCCchhhcccccccHHHHHcCccccc
Confidence 999999994 999999999986
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-64 Score=487.25 Aligned_cols=255 Identities=31% Similarity=0.480 Sum_probs=230.4
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||+||+|+++.+|+.||||++...... ..+.+.+|+.+|+.++|||||++++++.+.+.+|+
T Consensus 18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~i 94 (293)
T d1yhwa1 18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWV 94 (293)
T ss_dssp TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccCh---HHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEE
Confidence 346899999999999999999999999999999999865432 35678999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 94 VMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||||+||+|.+++.++.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... ....
T Consensus 95 vmEy~~gg~L~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~--~~~~ 172 (293)
T d1yhwa1 95 VMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP--EQSK 172 (293)
T ss_dssp EEECCTTCBHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--TTCC
T ss_pred EEEecCCCcHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecc--cccc
Confidence 99999999999999888999999999999999999999999999999999999999999999999999986543 2334
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---CCCCCCCCChHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---EYRCPKWTSPDLKWFIG 250 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---~~~~p~~~s~~~~~li~ 250 (417)
....+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+....+... .+..|..+|+++++||.
T Consensus 173 ~~~~~gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~ 251 (293)
T d1yhwa1 173 RSTMVGTPYWMAPEVVTRKAYG-PKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFRDFLN 251 (293)
T ss_dssp BCCCCSCGGGCCHHHHSSSCBC-THHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCSSGGGSCHHHHHHHH
T ss_pred ccccccCCCccChhhhcCCCCC-chhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCCCCcccCCHHHHHHHH
Confidence 5677899999999999998885 8999999999999999999999998877766655543 34456778999999999
Q ss_pred HhccCCCCCCCCHHHHhcCccccc
Q 014849 251 RLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 251 ~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
+||++||.+|||++|+|+||||+.
T Consensus 252 ~~L~~dP~~R~s~~eil~Hp~~~~ 275 (293)
T d1yhwa1 252 RCLDMDVEKRGSAKELLQHQFLKI 275 (293)
T ss_dssp HHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred HHccCChhHCcCHHHHhcCHhhCC
Confidence 999999999999999999999974
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-63 Score=485.15 Aligned_cols=260 Identities=39% Similarity=0.725 Sum_probs=217.7
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
....+.++|++++.||+|+||+||+|+++.+|+.||||++.++.... ....+.+|+.+|+.++|||||++++++.+++
T Consensus 3 ~~edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~ 80 (307)
T d1a06a_ 3 QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGG 80 (307)
T ss_dssp ECSCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSS
T ss_pred CCCCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECC
Confidence 34467789999999999999999999999999999999998765432 2456789999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec---CCCCeEEeeeecceee
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD---ENWDLKISDFGLSAVK 165 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~---~~~~vkl~DFGls~~~ 165 (417)
.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||+. .++.+||+|||+|...
T Consensus 81 ~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 81 HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp EEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEc
Confidence 99999999999999999976 7899999999999999999999999999999999999994 5789999999999765
Q ss_pred cccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWT 241 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~ 241 (417)
. ......+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+....+.++.+..+ ..+
T Consensus 161 ~---~~~~~~~~~GT~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 236 (307)
T d1a06a_ 161 D---PGSVLSTACGTPGYVAPEVLAQKPYS-KAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDI 236 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTS
T ss_pred c---CCCeeeeeeeCccccCcHHHcCCCCC-cHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCC
Confidence 4 23445678999999999999998885 999999999999999999999999999999999988876543 457
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|+++++||.+||++||++|||++|+++||||+..
T Consensus 237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 270 (307)
T d1a06a_ 237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD 270 (307)
T ss_dssp CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 8999999999999999999999999999999854
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.6e-63 Score=482.60 Aligned_cols=255 Identities=34% Similarity=0.689 Sum_probs=238.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+.|++++.||+|+||+||+|+++.+|+.||||++.+....+....+.+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35799999999999999999999999999999999887665556678899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||.||+|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..... .
T Consensus 83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~-----~ 157 (316)
T d1fota_ 83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-----V 157 (316)
T ss_dssp ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-----C
T ss_pred eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecc-----c
Confidence 999999999998876 6899999999999999999999999999999999999999999999999999976542 3
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHhc
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRLL 253 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 253 (417)
..+.|||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+.+.++..+....|...|++++++|.+||
T Consensus 158 ~~~~~Gt~~Y~APE~l~~~~y~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~L 236 (316)
T d1fota_ 158 TYTLCGTPDYIAPEVVSTKPYN-KSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLI 236 (316)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBC-TTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHT
T ss_pred cccccCcccccCHHHHcCCCCC-chhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCCCCCCHHHHHHHHHHh
Confidence 4568999999999999998886 899999999999999999999999999999999999999999999999999999999
Q ss_pred cCCCCCCC-----CHHHHhcCcccccc
Q 014849 254 DTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 254 ~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
++||.+|+ |++++++||||++.
T Consensus 237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i 263 (316)
T d1fota_ 237 TRDLSQRLGNLQNGTEDVKNHPWFKEV 263 (316)
T ss_dssp CSCTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred hhCHHhccccchhhHHHHHcCcccccC
Confidence 99999996 99999999999863
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-63 Score=479.82 Aligned_cols=262 Identities=30% Similarity=0.480 Sum_probs=231.0
Q ss_pred ccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe
Q 014849 8 ISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT 87 (417)
Q Consensus 8 ~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~ 87 (417)
+.+.....+.|++++.||+|+||+||+|+++.+|+.||||++++.. ....+.+.+|+++|+.++|||||++++++.+
T Consensus 4 ~~r~~~p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~ 80 (288)
T d2jfla1 4 VTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYY 80 (288)
T ss_dssp CEESSCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred ccCCCCcccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence 3444555678999999999999999999999999999999997653 2235678899999999999999999999999
Q ss_pred CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 88 KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
++.+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|...
T Consensus 81 ~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~ 160 (288)
T d2jfla1 81 ENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN 160 (288)
T ss_dssp TTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhcc
Confidence 9999999999999999998754 57999999999999999999999999999999999999999999999999999754
Q ss_pred cccCCCCcccccccCcccccccccc-----ccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC---CC
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILA-----KKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY---RC 237 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~-----~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~---~~ 237 (417)
... .....+.+||+.|+|||++. +.+| +.++|||||||++|+|++|.+||.+.+..+.+.++..+.. ..
T Consensus 161 ~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y-~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (288)
T d2jfla1 161 TRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPY-DYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ 237 (288)
T ss_dssp HHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSST-TTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS
T ss_pred CCC--cccccccccccccCCHHHHhhcccCCCCC-ChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 321 12345678999999999984 3445 4899999999999999999999999888888888887754 33
Q ss_pred CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 238 PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 238 p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|...|+++++||++||++||++|||++|+++||||+..
T Consensus 238 ~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~ 275 (288)
T d2jfla1 238 PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD 275 (288)
T ss_dssp GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 56789999999999999999999999999999999754
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-62 Score=472.68 Aligned_cols=262 Identities=33% Similarity=0.558 Sum_probs=236.5
Q ss_pred ccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc---chHHHHHHHHHHHHhCCCCCcceEEEEEE
Q 014849 10 REVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG---GLTAHVKREISIMSRLRHPNIVKLYEVLA 86 (417)
Q Consensus 10 ~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~---~~~~~i~~Ei~il~~l~HpnIv~l~~~~~ 86 (417)
+...+.++|++++.||+|+||+||+|+++.+|+.||||++.+...... ...+.+.+|+.+|++++|||||++++++.
T Consensus 4 ~~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~ 83 (293)
T d1jksa_ 4 RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83 (293)
T ss_dssp BCSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred cCCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence 345577899999999999999999999999999999999987654322 23678999999999999999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC----CeEEeeeec
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW----DLKISDFGL 161 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~----~vkl~DFGl 161 (417)
+++.+|+|||||+||+|.+++.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++ .+|++|||+
T Consensus 84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999999999976 7899999999999999999999999999999999999998876 499999999
Q ss_pred ceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC---
Q 014849 162 SAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP--- 238 (417)
Q Consensus 162 s~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 238 (417)
|.... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.++..+.+..+
T Consensus 164 a~~~~---~~~~~~~~~~t~~y~APE~~~~~~~~-~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 239 (293)
T d1jksa_ 164 AHKID---FGNEFKNIFGTPEFVAPEIVNYEPLG-LEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEY 239 (293)
T ss_dssp CEECT---TSCBCSCCCCCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHH
T ss_pred hhhcC---CCccccccCCCCcccCHHHHcCCCCC-CcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchh
Confidence 97654 23445677899999999999988774 999999999999999999999999999999999988877654
Q ss_pred -CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 239 -KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 239 -~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...|+++++||++||++||++|||++|+++||||+..
T Consensus 240 ~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~ 277 (293)
T d1jksa_ 240 FSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK 277 (293)
T ss_dssp HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred cCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 5679999999999999999999999999999999853
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.9e-62 Score=483.42 Aligned_cols=256 Identities=36% Similarity=0.651 Sum_probs=239.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
-.++|++++.||+|+||+||+|+++.+|+.||||++.+....+......+.+|+.+|+.++|||||++++++.+...+|+
T Consensus 39 ~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 118 (350)
T d1rdqe_ 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccc
Confidence 35899999999999999999999999999999999988766555667789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+.||+|...+.. +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|++||+|||+|.... .
T Consensus 119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~-----~ 193 (350)
T d1rdqe_ 119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----G 193 (350)
T ss_dssp EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECS-----S
T ss_pred ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecc-----c
Confidence 9999999999999876 789999999999999999999999999999999999999999999999999998653 2
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
...+.+||+.|||||++.+.+|+ .++|||||||++|+|++|++||.+.+...++.++..+.+..|..+++++.+||++|
T Consensus 194 ~~~~~~Gt~~Y~APE~~~~~~~~-~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 272 (350)
T d1rdqe_ 194 RTWTLCGTPEALAPEIILSKGYN-KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNL 272 (350)
T ss_dssp CBCCCEECGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTCCHHHHHHHHHH
T ss_pred ccccccCccccCCHHHHcCCCCC-ccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCCccCCHHHHHHHHHH
Confidence 34567899999999999998886 99999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCC-----CHHHHhcCcccccc
Q 014849 253 LDTDPATRI-----TVDEILRDPWFKKD 275 (417)
Q Consensus 253 L~~dP~~R~-----t~~eil~h~~f~~~ 275 (417)
|++||.+|+ |++++++||||+..
T Consensus 273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~ 300 (350)
T d1rdqe_ 273 LQVDLTKRFGNLKNGVNDIKNHKWFATT 300 (350)
T ss_dssp SCSCTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred hhhCHHhccccccccHHHHHcCccccCC
Confidence 999999995 99999999999863
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3.2e-62 Score=483.38 Aligned_cols=259 Identities=31% Similarity=0.543 Sum_probs=235.4
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..+.++|++++.||+|+||+||+|+++.+|+.||||++.+.... ....+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~ 101 (352)
T d1koba_ 25 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEM 101 (352)
T ss_dssp SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEE
T ss_pred CCcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence 45678999999999999999999999999999999999875422 246788999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCCCeEEeeeecceeecc
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD--ENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~--~~~~vkl~DFGls~~~~~ 167 (417)
|+|||||+||+|++.+.. .++++.+++.++.||+.||.|||++||+||||||+||||+ .++.+||+|||+|....
T Consensus 102 ~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~- 180 (352)
T d1koba_ 102 VLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLN- 180 (352)
T ss_dssp EEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECC-
T ss_pred EEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecC-
Confidence 999999999999998765 4799999999999999999999999999999999999998 67899999999998654
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCh
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSP 243 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~ 243 (417)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..+.+.++..+.+..| ..+|+
T Consensus 181 --~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 257 (352)
T d1koba_ 181 --PDEIVKVTTATAEFAAPEIVDREPVG-FYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSP 257 (352)
T ss_dssp --TTSCEEEECSSGGGCCHHHHTTCCBC-HHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCH
T ss_pred --CCCceeeccCcccccCHHHHcCCCCC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCH
Confidence 34556778999999999999998885 999999999999999999999999999999999988876654 45799
Q ss_pred HHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 244 DLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
++.+||.+||++||.+|||++|+|+||||+....
T Consensus 258 ~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~ 291 (352)
T d1koba_ 258 EAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHS 291 (352)
T ss_dssp HHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCT
T ss_pred HHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcc
Confidence 9999999999999999999999999999987543
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-63 Score=470.53 Aligned_cols=254 Identities=32% Similarity=0.573 Sum_probs=217.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe--CCEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--KAKIY 92 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--~~~~~ 92 (417)
.+.|++.+.||+|+||+||+|+++.+|+.||+|++.+.... ....+.+.+|+++|++++|||||++++++.+ .+.+|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEE
Confidence 46899999999999999999999999999999999876543 3345678899999999999999999999864 45689
Q ss_pred EEEeccCCCChHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHcC-----CeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 93 FVMEFAKGGELFAKISK-----GRFSEQLSRRYFQQLISAVEYCHSRG-----VFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~-----~~l~e~~~~~i~~ql~~aL~ylH~~g-----ivHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
+|||||+||+|.+++.+ +.+++..++.++.||+.||.|||++| |+||||||+|||++.++.+||+|||+|
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a 161 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA 161 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHH
T ss_pred EEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccce
Confidence 99999999999998853 57999999999999999999999987 999999999999999999999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-CCCCCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY-RCPKWT 241 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~ 241 (417)
..... ......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|.+||.+.+..++..++..+.+ ..|..+
T Consensus 162 ~~~~~--~~~~~~~~~gt~~Y~APE~l~~~~~~-~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~ 238 (269)
T d2java1 162 RILNH--DTSFAKAFVGTPYYMSPEQMNRMSYN-EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYRY 238 (269)
T ss_dssp HHC-------------CCCSCCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCCTTS
T ss_pred eeccc--CCCccccCCCCcccCCHHHHcCCCCC-hHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCccc
Confidence 76543 22344568999999999999988885 999999999999999999999999999999999988876 467778
Q ss_pred ChHHHHHHHHhccCCCCCCCCHHHHhcCccc
Q 014849 242 SPDLKWFIGRLLDTDPATRITVDEILRDPWF 272 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~t~~eil~h~~f 272 (417)
|+++.+||.+||++||.+|||++|+++|||+
T Consensus 239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 239 SDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 9999999999999999999999999999995
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=4.2e-62 Score=482.18 Aligned_cols=258 Identities=32% Similarity=0.534 Sum_probs=234.0
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+... ...+.+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~---~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 99 (350)
T d1koaa2 23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHE---SDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMV 99 (350)
T ss_dssp CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSH---HHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEE
T ss_pred CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccch---hhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 466899999999999999999999999999999999976532 23567889999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec--CCCCeEEeeeecceeeccc
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD--ENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~--~~~~vkl~DFGls~~~~~~ 168 (417)
+|||||+||+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+|....
T Consensus 100 ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~-- 177 (350)
T d1koaa2 100 MIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLD-- 177 (350)
T ss_dssp EEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECC--
T ss_pred EEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecc--
Confidence 99999999999999953 6799999999999999999999999999999999999995 46789999999998654
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCChH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCP----KWTSPD 244 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~ 244 (417)
......+.+||+.|||||++.+.+|+ .++|||||||++|+|++|.+||.+.+..+.+.++..+.+..+ ..+|++
T Consensus 178 -~~~~~~~~~gT~~Y~aPEv~~~~~~~-~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 255 (350)
T d1koaa2 178 -PKQSVKVTTGTAEFAAPEVAEGKPVG-YYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISED 255 (350)
T ss_dssp -TTSCEEEECSCTTTCCHHHHHTCCBC-HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHH
T ss_pred -cccccceecCcccccCHHHHcCCCCC-hhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHH
Confidence 33455678999999999999998885 999999999999999999999999999999999988876654 357999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+++||++||++||++|||++|+|+||||+....
T Consensus 256 ~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~ 288 (350)
T d1koaa2 256 GKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 288 (350)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTC
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence 999999999999999999999999999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-61 Score=462.66 Aligned_cols=255 Identities=26% Similarity=0.524 Sum_probs=222.5
Q ss_pred ccccCCe-EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe---
Q 014849 12 VNLFGKY-EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT--- 87 (417)
Q Consensus 12 ~~~~~~y-~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~--- 87 (417)
....||| ++.+.||+|+||+||+|++..+++.||+|++...... ....+.+.+|+++|++++|||||++++++.+
T Consensus 4 ~~~~gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 82 (270)
T d1t4ha_ 4 MSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82 (270)
T ss_dssp ECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESS
T ss_pred cCCCCCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccc
Confidence 3456677 7888999999999999999999999999999876543 2345678999999999999999999999865
Q ss_pred -CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcC--CeecCCCCCcEEec-CCCCeEEeeeecc
Q 014849 88 -KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRG--VFHRDLKLENLLLD-ENWDLKISDFGLS 162 (417)
Q Consensus 88 -~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~g--ivHrDlkp~NILl~-~~~~vkl~DFGls 162 (417)
+..+|+|||||+||+|.+++.+ +.+++.+++.++.||+.||+|||++| |+||||||+|||++ .++.+||+|||+|
T Consensus 83 ~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla 162 (270)
T d1t4ha_ 83 GKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA 162 (270)
T ss_dssp SCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGG
T ss_pred cCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcc
Confidence 4578999999999999999976 78999999999999999999999999 99999999999996 5789999999999
Q ss_pred eeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHHHHhcCCCC--CCC
Q 014849 163 AVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP-NLMAMYRKIYKGEYR--CPK 239 (417)
Q Consensus 163 ~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~-~~~~~~~~i~~~~~~--~p~ 239 (417)
.... .....+.+|||.|+|||++.+ +|+ .++|||||||++|+|++|++||.+. +...++..+..+..+ .+.
T Consensus 163 ~~~~----~~~~~~~~GT~~Y~aPE~~~~-~~~-~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~~~~~ 236 (270)
T d1t4ha_ 163 TLKR----ASFAKAVIGTPEFMAPEMYEE-KYD-ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDK 236 (270)
T ss_dssp GGCC----TTSBEESCSSCCCCCGGGGGT-CCC-THHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCGGGGG
T ss_pred eecc----CCccCCcccCccccCHHHhCC-CCC-CcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCcccCc
Confidence 7543 234567899999999999875 464 9999999999999999999999764 556677777665432 345
Q ss_pred CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccc
Q 014849 240 WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFK 273 (417)
Q Consensus 240 ~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~ 273 (417)
..++++++||.+||++||++|||++|+++||||+
T Consensus 237 ~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 237 VAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp CCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred cCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 6789999999999999999999999999999996
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-62 Score=475.36 Aligned_cols=257 Identities=32% Similarity=0.602 Sum_probs=235.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHH-hCCCCCcceEEEEEEeCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS-RLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~l 93 (417)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+|+.++. .++|||||++++++.+++.+|+
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 368999999999999999999999999999999998876555555666777777765 6899999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||||+||+|.+++.. +++++.+++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++..... ...
T Consensus 81 vmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~--~~~ 158 (320)
T d1xjda_ 81 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML--GDA 158 (320)
T ss_dssp EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC--TTC
T ss_pred EEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccc--ccc
Confidence 9999999999999976 7899999999999999999999999999999999999999999999999999975432 233
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChHHHHHHHHh
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPDLKWFIGRL 252 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~~ 252 (417)
.....+||+.|+|||++.+.+|+ .++|||||||++|+|++|+.||.+.+..+++.++..+.+..|..+|+++.+||++|
T Consensus 159 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p~~~s~~~~dli~~~ 237 (320)
T d1xjda_ 159 KTNTFCGTPDYIAPEILLGQKYN-HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 237 (320)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBC-THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCTTSCHHHHHHHHHH
T ss_pred cccccCCCCCcCCHHHHcCCCCC-chhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCccCCHHHHHHHHHh
Confidence 44567899999999999998886 89999999999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCCCCHH-HHhcCccccc
Q 014849 253 LDTDPATRITVD-EILRDPWFKK 274 (417)
Q Consensus 253 L~~dP~~R~t~~-eil~h~~f~~ 274 (417)
|++||.+|||+. ++++||||++
T Consensus 238 L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 238 FVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SCSSGGGSBTTBSCGGGSGGGTT
T ss_pred cccCCCCCcCHHHHHHhCchhcc
Confidence 999999999995 8999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.8e-62 Score=473.91 Aligned_cols=254 Identities=26% Similarity=0.405 Sum_probs=227.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
..+|++.+.||+|+||+||+|++..+|+.||||++.+...........+.+|+.+|+.++|||||++++++.+++.+|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEE
Confidence 34699999999999999999999999999999999877655555567889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||||.||+|..++.. +++++.+++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|.....
T Consensus 94 ~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------ 167 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ 167 (309)
T ss_dssp EECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------
T ss_pred EEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC------
Confidence 999999999876654 7899999999999999999999999999999999999999999999999999975432
Q ss_pred ccccccCccccccccccc---cCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC--CCCCChHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAK---KGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC--PKWTSPDLKWF 248 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~---~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~l 248 (417)
..+.+||+.|+|||++.+ ..| +.++|||||||++|+|++|..||.+.+..+...++..+..+. +..+|+++++|
T Consensus 168 ~~~~~GT~~Y~APE~~~~~~~~~y-~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~s~~~~~l 246 (309)
T d1u5ra_ 168 ANSFVGTPYWMAPEVILAMDEGQY-DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRNF 246 (309)
T ss_dssp BCCCCSCGGGCCHHHHTTTTSCCB-CTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCCSCTTSCHHHHHH
T ss_pred CCccccCccccCHHHHhccCCCCc-CchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCCCCCCHHHHHH
Confidence 345789999999999864 235 489999999999999999999999998888888877766543 34579999999
Q ss_pred HHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 249 IGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
|.+||+.||++|||++|+++||||++.
T Consensus 247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 247 VDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 999999999999999999999999864
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-62 Score=479.03 Aligned_cols=256 Identities=24% Similarity=0.433 Sum_probs=218.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~l 93 (417)
..++|++.+.||+|+||+||+|+++.+|+.||+|++.++. ......++.+|+.+|+.++|||||++++++.+++.+|+
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i 81 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 81 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 3578999999999999999999999999999999997653 34456789999999999999999999999999999999
Q ss_pred EEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 94 VMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
|||||+||+|.+++.+ +++++.+++.++.||+.||.|||+ +||+||||||+|||++.+|++||+|||+|.....
T Consensus 82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~---- 157 (322)
T d1s9ja_ 82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID---- 157 (322)
T ss_dssp EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH----
T ss_pred EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCC----
Confidence 9999999999999975 789999999999999999999997 5999999999999999999999999999986533
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH------------------------
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMY------------------------ 227 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~------------------------ 227 (417)
....+.+||+.|+|||++.+..|+ .++||||+||++|+|++|+.||.+.+.....
T Consensus 158 ~~~~~~~GT~~Y~APEvl~~~~y~-~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (322)
T d1s9ja_ 158 SMANSFVGTRSYMSPERLQGTHYS-VQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236 (322)
T ss_dssp HTC---CCSSCCCCHHHHHCSCCC-TTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred CccccccCCccccCchHHcCCCCC-cHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence 233567999999999999998885 9999999999999999999999765432211
Q ss_pred ------------------HHHhcCC-CCCC-CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 228 ------------------RKIYKGE-YRCP-KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 228 ------------------~~i~~~~-~~~p-~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
..+.... ...| ...|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 0111111 1111 12478999999999999999999999999999998643
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=3.8e-61 Score=460.60 Aligned_cols=258 Identities=33% Similarity=0.559 Sum_probs=231.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccccc------chHHHHHHHHHHHHhCC-CCCcceEEEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRG------GLTAHVKREISIMSRLR-HPNIVKLYEVLA 86 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~------~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~ 86 (417)
+.++|++.+.||+|+||+||+|++..+|+.||||++++...... ...+++.+|+.+|+.++ |||||++++++.
T Consensus 1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~ 80 (277)
T d1phka_ 1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 80 (277)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence 46899999999999999999999999999999999987654321 23456889999999997 999999999999
Q ss_pred eCCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceee
Q 014849 87 TKAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVK 165 (417)
Q Consensus 87 ~~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~ 165 (417)
+++.+|+|||||+||+|.+++.. +.+++.+++.|+.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus 81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~ 160 (277)
T d1phka_ 81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 160 (277)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence 99999999999999999999975 89999999999999999999999999999999999999999999999999999865
Q ss_pred cccCCCCcccccccCcccccccccccc-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC-
Q 014849 166 EQIRPDGMLHTLCGTPAYVAPEILAKK-----GYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK- 239 (417)
Q Consensus 166 ~~~~~~~~~~~~~Gt~~y~APEvl~~~-----~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~- 239 (417)
.. .......+||+.|+|||++.+. ...+.++||||+||++|+|++|++||.+.+.......+..+.+..+.
T Consensus 161 ~~---~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (277)
T d1phka_ 161 DP---GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP 237 (277)
T ss_dssp CT---TCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred cC---CCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence 43 3344567899999999998632 22368999999999999999999999999999999988888765433
Q ss_pred ---CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 240 ---WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 240 ---~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..|+++++||.+||++||++|||++|+++||||++
T Consensus 238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~ 275 (277)
T d1phka_ 238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275 (277)
T ss_dssp TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred ccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence 57999999999999999999999999999999975
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-61 Score=471.37 Aligned_cols=257 Identities=28% Similarity=0.474 Sum_probs=234.2
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
.+++||++++.||+|+||+||+|+++.+|+.||||++++... ....+.+|+.+|+.++|||||++++++.+.+.+|
T Consensus 2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ 77 (321)
T d1tkia_ 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELV 77 (321)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEE
T ss_pred CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcc----cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence 578999999999999999999999999999999999977542 2356789999999999999999999999999999
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC--CCeEEeeeecceeeccc
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN--WDLKISDFGLSAVKEQI 168 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~--~~vkl~DFGls~~~~~~ 168 (417)
+|||||+||+|.+++.. +++++.+++.|+.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus 78 lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~-- 155 (321)
T d1tkia_ 78 MIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLK-- 155 (321)
T ss_dssp EEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECC--
T ss_pred EEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccc--
Confidence 99999999999999975 379999999999999999999999999999999999999854 479999999997643
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC----CCChH
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK----WTSPD 244 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~ 244 (417)
......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|..||.+.+..+.+.+|.++.+.+|. .+|++
T Consensus 156 -~~~~~~~~~~t~~y~ape~~~~~~~~-~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~ 233 (321)
T d1tkia_ 156 -PGDNFRLLFTAPEYYAPEVHQHDVVS-TATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIE 233 (321)
T ss_dssp -TTCEEEEEESCGGGSCHHHHTTCEEC-HHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHH
T ss_pred -cCCcccccccccccccchhccCCCCC-chhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHH
Confidence 34456778999999999999888875 9999999999999999999999999999999999998877663 67999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
+++||++||++||.+|||++|+++||||++...
T Consensus 234 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~ 266 (321)
T d1tkia_ 234 AMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266 (321)
T ss_dssp HHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGG
T ss_pred HHHHHHHHccCChhHCcCHHHHhcCHhhccCcc
Confidence 999999999999999999999999999986543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=7.5e-61 Score=475.63 Aligned_cols=257 Identities=32% Similarity=0.467 Sum_probs=225.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHH---HHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKR---EISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~---Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++++.||+|+||+||+|+++.+|+.||||++.+...........+.+ |+++++.++|||||++++++.+.+.+
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEE
Confidence 468999999999999999999999999999999998766544333334444 46777778899999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 92 YFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
|+|||||+||+|.+++.+ +.+++.+++.|+.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 83 ~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~--- 159 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK--- 159 (364)
T ss_dssp EEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSS---
T ss_pred EEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCC---
Confidence 999999999999999976 7899999999999999999999999999999999999999999999999999986543
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCC---HHHHHHHHhcCCCCCCCCCChHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPN---LMAMYRKIYKGEYRCPKWTSPDLKW 247 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~---~~~~~~~i~~~~~~~p~~~s~~~~~ 247 (417)
....+.+||+.|+|||++....+.+.++|||||||++|+|++|+.||.+.+ ...+...+.......|..+|+++++
T Consensus 160 -~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~ 238 (364)
T d1omwa3 160 -KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRS 238 (364)
T ss_dssp -SCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSSCCCCCCSSSCHHHHH
T ss_pred -CcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCCCCCCCHHHHH
Confidence 334567899999999999755444599999999999999999999998643 3445556666677788889999999
Q ss_pred HHHHhccCCCCCCCC-----HHHHhcCcccccc
Q 014849 248 FIGRLLDTDPATRIT-----VDEILRDPWFKKD 275 (417)
Q Consensus 248 li~~~L~~dP~~R~t-----~~eil~h~~f~~~ 275 (417)
||.+||++||++||| ++|+++||||+..
T Consensus 239 li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 239 LLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp HHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 999999999999999 7999999999863
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-61 Score=458.58 Aligned_cols=254 Identities=31% Similarity=0.587 Sum_probs=225.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccc---hHHHHHHHHHHHHhCC--CCCcceEEEEEEe
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGG---LTAHVKREISIMSRLR--HPNIVKLYEVLAT 87 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~---~~~~i~~Ei~il~~l~--HpnIv~l~~~~~~ 87 (417)
.+.++|++++.||+|+||+||+|++..+|+.||||++.+....... ...++.+|+.+|++++ |||||++++++.+
T Consensus 1 pl~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~ 80 (273)
T d1xwsa_ 1 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 80 (273)
T ss_dssp CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CCCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee
Confidence 3678999999999999999999999999999999999876543322 1234668999999987 8999999999999
Q ss_pred CCEEEEEEeccCC-CChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCC-CCeEEeeeeccee
Q 014849 88 KAKIYFVMEFAKG-GELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDEN-WDLKISDFGLSAV 164 (417)
Q Consensus 88 ~~~~~lV~E~~~g-g~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~-~~vkl~DFGls~~ 164 (417)
++.+|+||||+.+ +++.+++.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|..
T Consensus 81 ~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~ 160 (273)
T d1xwsa_ 81 PDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 160 (273)
T ss_dssp SSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred CCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccccee
Confidence 9999999999976 577888765 789999999999999999999999999999999999999854 7899999999976
Q ss_pred ecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCCCChH
Q 014849 165 KEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPKWTSPD 244 (417)
Q Consensus 165 ~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~ 244 (417)
.. .....+.+||+.|+|||++.+..|++.++|||||||++|+|++|+.||.+.+ .+.++...++..+|++
T Consensus 161 ~~----~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~~~~s~~ 230 (273)
T d1xwsa_ 161 LK----DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFRQRVSSE 230 (273)
T ss_dssp CC----SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCSSCCCHH
T ss_pred cc----cccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCCCCCCHH
Confidence 43 2345678899999999999988887788999999999999999999998642 4667788889999999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+++||++||++||++|||++|+++||||++..
T Consensus 231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred HHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999999999999999999999999998754
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-60 Score=456.64 Aligned_cols=256 Identities=30% Similarity=0.408 Sum_probs=216.8
Q ss_pred EEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccc--cchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEe
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILR--GGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVME 96 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~--~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E 96 (417)
|.+++||+|+||+||+|+++.+|+.||||++....... ......+.+|+.+|+.++|||||++++++.+++.+|+|||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE 80 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFD 80 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhh
Confidence 45789999999999999999999999999997654322 2234578899999999999999999999999999999999
Q ss_pred ccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCccc
Q 014849 97 FAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGMLH 175 (417)
Q Consensus 97 ~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~~~ 175 (417)
|+.|+++...+.. +.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|..... ......
T Consensus 81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~--~~~~~~ 158 (299)
T d1ua2a_ 81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS--PNRAYT 158 (299)
T ss_dssp CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTS--CCCCCC
T ss_pred hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCC--Cccccc
Confidence 9999888777764 6799999999999999999999999999999999999999999999999999975433 233455
Q ss_pred ccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCC-------------------
Q 014849 176 TLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYR------------------- 236 (417)
Q Consensus 176 ~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~------------------- 236 (417)
+.+||+.|+|||++....+++.++||||+||++|+|++|.+||.+.+..+...++.+....
T Consensus 159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~ 238 (299)
T d1ua2a_ 159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK 238 (299)
T ss_dssp CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence 6789999999999976665569999999999999999999999999888877776532100
Q ss_pred -C--------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 237 -C--------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 237 -~--------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
. ....++++.+||++||+.||++|||++|+|+||||++..
T Consensus 239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p 287 (299)
T d1ua2a_ 239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRP 287 (299)
T ss_dssp CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSS
T ss_pred cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCC
Confidence 0 123578999999999999999999999999999998644
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-59 Score=452.62 Aligned_cols=261 Identities=31% Similarity=0.476 Sum_probs=221.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|+++.+|+.||||++..... ......++.+|+.+|++++|||||++++++.+++.+|+|
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv 79 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLV 79 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEE
Confidence 3689999999999999999999999999999999976543 333467889999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
|||+.|+.+...... +++++.+++.++.||+.||.|||++||+||||||+|||++.++++||+|||+|..... ...
T Consensus 80 ~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~--~~~ 157 (298)
T d1gz8a_ 80 FEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGV--PVR 157 (298)
T ss_dssp EECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCC--CSB
T ss_pred EeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccC--Ccc
Confidence 999977544444332 6799999999999999999999999999999999999999999999999999975432 334
Q ss_pred cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------------
Q 014849 173 MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------------- 235 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------------- 235 (417)
.....+||+.|+|||++....+.+.++||||+||++|+|++|+.||.+.+..+...++.+...
T Consensus 158 ~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 237 (298)
T d1gz8a_ 158 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237 (298)
T ss_dssp CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCC
T ss_pred cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccc
Confidence 456678999999999999888888999999999999999999999999887776655532100
Q ss_pred -CCC-----------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 236 -RCP-----------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 236 -~~p-----------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
..+ ...|+++.+||++||++||++|||++|+++||||++...+
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p 292 (298)
T d1gz8a_ 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP 292 (298)
T ss_dssp TTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred cccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence 011 2347889999999999999999999999999999875443
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-59 Score=462.49 Aligned_cols=254 Identities=34% Similarity=0.616 Sum_probs=217.2
Q ss_pred cccccCCeEEe-eEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHH-hCCCCCcceEEEEEEe-
Q 014849 11 EVNLFGKYEVG-KIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMS-RLRHPNIVKLYEVLAT- 87 (417)
Q Consensus 11 ~~~~~~~y~i~-~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~-~l~HpnIv~l~~~~~~- 87 (417)
...+.++|++. ++||+|+||+||+|++..+|+.||||++++. ..+.+|+.++. ..+|||||++++++.+
T Consensus 6 ~~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~ 77 (335)
T d2ozaa1 6 KNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENL 77 (335)
T ss_dssp CSCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEE
T ss_pred CCCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeec
Confidence 34567899986 5799999999999999999999999998643 45678999865 4589999999999976
Q ss_pred ---CCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEee
Q 014849 88 ---KAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISD 158 (417)
Q Consensus 88 ---~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~D 158 (417)
...+|+|||||+||+|++++.. .++++.+++.|+.||+.||+|||++||+||||||+|||++. ++.+||+|
T Consensus 78 ~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~D 157 (335)
T d2ozaa1 78 YAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTD 157 (335)
T ss_dssp ETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECC
T ss_pred ccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccc
Confidence 4679999999999999999975 36999999999999999999999999999999999999985 56799999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH----HHHHHHhcCC
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM----AMYRKIYKGE 234 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~----~~~~~i~~~~ 234 (417)
||+|+.... .....+.+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+.. .+...+..+.
T Consensus 158 FG~a~~~~~---~~~~~~~~gt~~y~aPE~~~~~~y~-~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~ 233 (335)
T d2ozaa1 158 FGFAKETTS---HNSLTTPCYTPYYVAPEVLGPEKYD-KSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ 233 (335)
T ss_dssp CTTCEECCC---CCCCCCCSCCCSSCCCCCCCGGGGS-HHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCS
T ss_pred cceeeeccC---CCccccccCCcccCCcHHHcCCCCC-HHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCC
Confidence 999976543 3445678999999999999998886 9999999999999999999999776533 3344555556
Q ss_pred CCCCC----CCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 235 YRCPK----WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 235 ~~~p~----~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
+.+|. .+|+++.+||++||+.||++|||++|+++||||++..
T Consensus 234 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 279 (335)
T d2ozaa1 234 YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQST 279 (335)
T ss_dssp SSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTT
T ss_pred CCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCC
Confidence 65553 3689999999999999999999999999999997643
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-58 Score=442.11 Aligned_cols=256 Identities=30% Similarity=0.461 Sum_probs=219.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.+||++.+.||+|+||+||+|+++ +|+.||||++..... ......++.+|+.+|++++|||||++++++.+.+..|++
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~ 78 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLV 78 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEE
Confidence 369999999999999999999995 889999999987654 344467899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+||+.++.+...... +.+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||+|..... ....
T Consensus 79 ~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~--~~~~ 156 (286)
T d1ob3a_ 79 FEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI--PVRK 156 (286)
T ss_dssp EECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred EEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceeccc--Cccc
Confidence 999998887777764 7899999999999999999999999999999999999999999999999999876432 2233
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY------------------ 235 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~------------------ 235 (417)
....+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+..+...++.....
T Consensus 157 ~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~ 236 (286)
T d1ob3a_ 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236 (286)
T ss_dssp -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred cceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhccc
Confidence 45567999999999998877778999999999999999999999999887777666542100
Q ss_pred -----------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 236 -----------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 236 -----------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
..+...++++.+||++||++||++|||++|+++||||++
T Consensus 237 ~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE 286 (286)
T ss_dssp TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred ccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence 112345889999999999999999999999999999984
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=1.5e-58 Score=442.07 Aligned_cols=260 Identities=25% Similarity=0.417 Sum_probs=219.8
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC--
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA-- 89 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~-- 89 (417)
..+.+||++.+.||+|+||+||+|++..+|+.||||++.++...+.....++.+|+.+|+.++|||||++++++.+.+
T Consensus 3 ~~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~ 82 (277)
T d1o6ya_ 3 SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPA 82 (277)
T ss_dssp SEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSS
T ss_pred cCccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCC
Confidence 467899999999999999999999999999999999998876656666778999999999999999999999987654
Q ss_pred --EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 --KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 --~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+|+|||||+|++|.+.+.. +.+++.+++.++.||+.||.|||++||+||||||+|||++.++.++++|||.+....
T Consensus 83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~ 162 (277)
T d1o6ya_ 83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 162 (277)
T ss_dssp SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence 48999999999999998875 789999999999999999999999999999999999999999999999999986543
Q ss_pred cc-CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC----CCCC
Q 014849 167 QI-RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC----PKWT 241 (417)
Q Consensus 167 ~~-~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----p~~~ 241 (417)
.. .......+.+||+.|+|||++.+..|+ .++|||||||++|+|++|++||.+.+..+...++....... +..+
T Consensus 163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~-~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~ 241 (277)
T d1o6ya_ 163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVD-ARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241 (277)
T ss_dssp ----------------TTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSC
T ss_pred cccccccccccccCcccccCHHHHcCCCCC-cceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCC
Confidence 22 222345567899999999999988885 89999999999999999999999999888888777766543 3457
Q ss_pred ChHHHHHHHHhccCCCCCCC-CHHHHhcCcccc
Q 014849 242 SPDLKWFIGRLLDTDPATRI-TVDEILRDPWFK 273 (417)
Q Consensus 242 s~~~~~li~~~L~~dP~~R~-t~~eil~h~~f~ 273 (417)
|+++.+||.+||++||++|| |++++ .|+|.+
T Consensus 242 s~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~r 273 (277)
T d1o6ya_ 242 SADLDAVVLKALAKNPENRYQTAAEM-RADLVR 273 (277)
T ss_dssp CHHHHHHHHHHTCSSGGGSCSSHHHH-HHHHHH
T ss_pred CHHHHHHHHHHccCCHhHCHhHHHHH-HHHHHH
Confidence 89999999999999999999 55555 466654
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-57 Score=441.43 Aligned_cols=256 Identities=27% Similarity=0.405 Sum_probs=216.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccC-CcEEEEEEeecccccccchHHHHHHHHHHHHhC---CCCCcceEEEEEEe---
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRT-GQSVAIKAVSKQKILRGGLTAHVKREISIMSRL---RHPNIVKLYEVLAT--- 87 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~-g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l---~HpnIv~l~~~~~~--- 87 (417)
.++|++++.||+|+||+||+|++..+ ++.||||++...... ......+.+|+.+|+.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence 57999999999999999999999766 567999999775432 22234556788877766 79999999999853
Q ss_pred --CCEEEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
...+|++|||+.++.+...... ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~ 164 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 164 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence 3579999999999877555433 679999999999999999999999999999999999999999999999999987
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC---------
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE--------- 234 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~--------- 234 (417)
.... .....+.+||+.|+|||++.+.+|+ .++||||+||++|+|++|++||.+.+..+...++....
T Consensus 165 ~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~-~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~ 240 (305)
T d1blxa_ 165 IYSF---QMALTSVVVTLWYRAPEVLLQSSYA-TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 240 (305)
T ss_dssp CCCG---GGGGCCCCCCCTTCCHHHHTTCCCC-THHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred hhcc---cccCCCcccChhhcCcchhcCCCCC-hhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence 5432 2345678999999999999998886 99999999999999999999999998887777664310
Q ss_pred ------------------CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 235 ------------------YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 235 ------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
...+...++.+.+||++||++||++|||++|+|+||||++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i 299 (305)
T d1blxa_ 241 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299 (305)
T ss_dssp TTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred ccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence 01234568899999999999999999999999999999864
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-57 Score=442.65 Aligned_cols=263 Identities=28% Similarity=0.389 Sum_probs=218.2
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT------ 87 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------ 87 (417)
-.+||++++.||+|+||+||+|++..+|+.||||++.++.. ......++.+|+.+|+.++||||+++++++.+
T Consensus 8 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp BGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC------
T ss_pred ccCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccc
Confidence 36999999999999999999999999999999999977654 33456778899999999999999999999855
Q ss_pred --CCEEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 88 --KAKIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 88 --~~~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
+..+|+||||+.++.+...... +.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus 87 ~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~ 166 (318)
T d3blha1 87 RCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA 166 (318)
T ss_dssp ----CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeee
Confidence 4468999999988776655544 6899999999999999999999999999999999999999999999999999975
Q ss_pred ecccC--CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCC---
Q 014849 165 KEQIR--PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRCPK--- 239 (417)
Q Consensus 165 ~~~~~--~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~p~--- 239 (417)
..... ......+.+||+.|+|||++.+..+++.++||||+||++|+|++|++||.+.+.......+.......+.
T Consensus 167 ~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~ 246 (318)
T d3blha1 167 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246 (318)
T ss_dssp CCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred cccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhc
Confidence 44221 2334456789999999999987655569999999999999999999999998877776665442211110
Q ss_pred -----------------------------CCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 240 -----------------------------WTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 240 -----------------------------~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
..++++.+||.+||++||++|||++|+|+||||+....
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~ 313 (318)
T d3blha1 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPM 313 (318)
T ss_dssp TTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSC
T ss_pred cccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCC
Confidence 02678899999999999999999999999999996543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-57 Score=447.46 Aligned_cols=256 Identities=27% Similarity=0.431 Sum_probs=218.4
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC---
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA--- 89 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~--- 89 (417)
.+.++|++++.||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|+.++|||||++++++.+.+
T Consensus 15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~ 93 (346)
T d1cm8a_ 15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 93 (346)
T ss_dssp CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTT
T ss_pred ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCcccc
Confidence 367899999999999999999999999999999999976543 3445678899999999999999999999997654
Q ss_pred ---EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeec
Q 014849 90 ---KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKE 166 (417)
Q Consensus 90 ---~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~ 166 (417)
.+|+||||+ |.+|...+..+++++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||+|....
T Consensus 94 ~~~~~~lv~e~~-~~~l~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~ 172 (346)
T d1cm8a_ 94 DFTDFYLVMPFM-GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD 172 (346)
T ss_dssp TCCCCEEEEECC-SEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred ccceEEEEEecc-cccHHHHHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceeccC
Confidence 579999999 6688888888999999999999999999999999999999999999999999999999999997643
Q ss_pred ccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC-----------
Q 014849 167 QIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEY----------- 235 (417)
Q Consensus 167 ~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~----------- 235 (417)
......+||+.|+|||++.+..+.+.++||||+||++|+|++|++||.+.+.......+.....
T Consensus 173 -----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 247 (346)
T d1cm8a_ 173 -----SEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 247 (346)
T ss_dssp -----SSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred -----CccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence 3345678999999999998877777999999999999999999999998887666554432110
Q ss_pred --------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 236 --------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 236 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
..+...++++.+||++||+.||++|||++|+|+||||+..
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL 307 (346)
T ss_dssp CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence 1234568999999999999999999999999999999864
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-57 Score=445.19 Aligned_cols=251 Identities=23% Similarity=0.351 Sum_probs=216.0
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc-----EEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCC
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ-----SVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKA 89 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~-----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~ 89 (417)
++|++++.||+|+||+||+|++..+++ .||+|.+.... .......+.+|+.+|+++ +|||||++++++.+.+
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~ 114 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSG 114 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred HHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCC
Confidence 689999999999999999999876654 69999987543 223356788999999988 8999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCc
Q 014849 90 KIYFVMEFAKGGELFAKISK------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLEN 145 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~N 145 (417)
.+|+|||||+||+|.+++.. +.+++.+++.|+.||+.||.|||++||+||||||+|
T Consensus 115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N 194 (325)
T d1rjba_ 115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194 (325)
T ss_dssp SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence 99999999999999999864 248999999999999999999999999999999999
Q ss_pred EEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 014849 146 LLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLM 224 (417)
Q Consensus 146 ILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~ 224 (417)
||++.++++||+|||+|+............+.+||+.|||||++.+..|+ .++|||||||++|+|++ |.+||.+.+..
T Consensus 195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYT-IKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCC-cceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999876544333345567899999999999988885 99999999999999997 89999887655
Q ss_pred HHHHHHhcCC--CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 225 AMYRKIYKGE--YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 225 ~~~~~i~~~~--~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
..+.++.... ++.|...|+++.+||.+||+.||++|||++||++|
T Consensus 274 ~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~ 320 (325)
T d1rjba_ 274 ANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 5555555443 45678899999999999999999999999999876
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=442.29 Aligned_cols=263 Identities=27% Similarity=0.421 Sum_probs=218.7
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA---- 89 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~---- 89 (417)
+..||++++.||+|+||+||+|+++.+|+.||||++++.. ......++.+|+.+|+.++||||+++++++....
T Consensus 6 i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~ 83 (345)
T d1pmea_ 6 VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQM 83 (345)
T ss_dssp CCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTC
T ss_pred cCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecccccc
Confidence 4579999999999999999999999999999999997643 3344678889999999999999999999987653
Q ss_pred EEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 90 KIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
..+++++|+.||+|.+++..+++++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|.......
T Consensus 84 ~~~~l~~~~~~g~L~~~l~~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~ 163 (345)
T d1pmea_ 84 KDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH 163 (345)
T ss_dssp CCEEEEEECCCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGG
T ss_pred ceEEEEEeecCCchhhhhhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCC
Confidence 23444556679999999988899999999999999999999999999999999999999999999999999997654332
Q ss_pred -CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------------
Q 014849 170 -PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGE-------------- 234 (417)
Q Consensus 170 -~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~-------------- 234 (417)
......+.+||+.|+|||++....+++.++||||+||++|+|++|+.||.+.+..+.........
T Consensus 164 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 243 (345)
T d1pmea_ 164 DHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 243 (345)
T ss_dssp CBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCH
T ss_pred ccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhh
Confidence 22345677899999999999766666799999999999999999999999887665544432110
Q ss_pred --------C---------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccccc
Q 014849 235 --------Y---------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYKE 278 (417)
Q Consensus 235 --------~---------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~~ 278 (417)
. ......|+++.+||.+||+.||++|||++|+|+||||+....+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~ 304 (345)
T d1pmea_ 244 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 304 (345)
T ss_dssp HHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred hhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence 0 0123467899999999999999999999999999999866544
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=3.9e-57 Score=434.80 Aligned_cols=262 Identities=24% Similarity=0.365 Sum_probs=224.8
Q ss_pred CCCCCCCccccccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcce
Q 014849 1 MGDNTGDISREVNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVK 80 (417)
Q Consensus 1 ~~~~~~~~~~~~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~ 80 (417)
|--++|+..+=..-.++|++++.||+|+||+||+|++..+|+.||||++..+.. ..+++.+|+.+|+.++|||||+
T Consensus 2 ~~p~~p~~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~ 77 (287)
T d1opja_ 2 MDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQ 77 (287)
T ss_dssp CCTTSTTCCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCC
T ss_pred cCCCCCCCcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEec
Confidence 444566655433445789999999999999999999999999999999976532 2567899999999999999999
Q ss_pred EEEEEEeCCEEEEEEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEe
Q 014849 81 LYEVLATKAKIYFVMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKIS 157 (417)
Q Consensus 81 l~~~~~~~~~~~lV~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~ 157 (417)
+++++.+++.+|+|||||++|+|.+++.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++++||+
T Consensus 78 ~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~ 157 (287)
T d1opja_ 78 LLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVA 157 (287)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred CCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEc
Confidence 99999999999999999999999999864 579999999999999999999999999999999999999999999999
Q ss_pred eeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCC-CCCCCCHHHHHHHHhcC-CC
Q 014849 158 DFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYL-PFNDPNLMAMYRKIYKG-EY 235 (417)
Q Consensus 158 DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~-Pf~~~~~~~~~~~i~~~-~~ 235 (417)
|||+|+..... .........||+.|+|||++.+..|+ .++||||+||++|+|++|.. ||.+.+...++..+..+ ..
T Consensus 158 DFG~a~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~-~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~ 235 (287)
T d1opja_ 158 DFGLSRLMTGD-TYTAHAGAKFPIKWTAPESLAYNKFS-IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM 235 (287)
T ss_dssp CCCCTTTCCSS-SSEEETTEEECGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred cccceeecCCC-CceeeccccccccccChHHHcCCCCC-chhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCC
Confidence 99999765432 11223345689999999999988885 99999999999999999654 55666777777666554 35
Q ss_pred CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 236 RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 236 ~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
+.|...++++.+||.+||+.||++|||++||++
T Consensus 236 ~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 236 ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 677889999999999999999999999999965
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-57 Score=433.09 Aligned_cols=250 Identities=25% Similarity=0.430 Sum_probs=206.1
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|+.. ..||||++..... .......+.+|+.+|++++|||||++++++.+ ..+|+|
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv 81 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIV 81 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEE
Confidence 578999999999999999999753 4699999976543 33346788999999999999999999998654 568999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCC
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDG 172 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~ 172 (417)
||||+||+|.+++.. +++++..+..++.||+.||+|||++||+||||||+||||+.++++||+|||+|..........
T Consensus 82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~ 161 (276)
T d1uwha_ 82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH 161 (276)
T ss_dssp EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence 999999999999864 679999999999999999999999999999999999999999999999999998765544444
Q ss_pred cccccccCccccccccccccC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH-HHHHHHhcCCC-----CCCCCCChH
Q 014849 173 MLHTLCGTPAYVAPEILAKKG--YDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM-AMYRKIYKGEY-----RCPKWTSPD 244 (417)
Q Consensus 173 ~~~~~~Gt~~y~APEvl~~~~--y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~-~~~~~i~~~~~-----~~p~~~s~~ 244 (417)
...+.+||+.|||||++.+.. ..+.++||||+||++|||++|+.||.+.+.. .+...+.++.. ..+..++++
T Consensus 162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~ 241 (276)
T d1uwha_ 162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA 241 (276)
T ss_dssp ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence 566788999999999986432 2258999999999999999999999886544 44444444322 235567899
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+||.+||+.||++|||++||+++
T Consensus 242 l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 242 MKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999987
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.9e-56 Score=425.23 Aligned_cols=257 Identities=29% Similarity=0.475 Sum_probs=223.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
++||++++.||+|+||+||+|++..+|+.||||+++.... ......++.+|+.+|+.++||||+++++++.+....++|
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv 79 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEE
Confidence 4699999999999999999999999999999999977643 445578899999999999999999999999999999999
Q ss_pred EeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 95 MEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
+|++.|++|..++.. +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.|..... ....
T Consensus 80 ~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~--~~~~ 157 (292)
T d1unla_ 80 FEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI--PVRC 157 (292)
T ss_dssp EECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCS--CCSC
T ss_pred eeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccC--CCcc
Confidence 999999999888776 7899999999999999999999999999999999999999999999999999976543 2233
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHHHHhcCC------------------
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPF-NDPNLMAMYRKIYKGE------------------ 234 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf-~~~~~~~~~~~i~~~~------------------ 234 (417)
.....+++.|+|||++....+.+.++||||+||++|+|++|..|| .+.+..+...++....
T Consensus 158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 237 (292)
T d1unla_ 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK 237 (292)
T ss_dssp CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence 445567899999999988877679999999999999999999885 5556566555543210
Q ss_pred -----------CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccc
Q 014849 235 -----------YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKK 274 (417)
Q Consensus 235 -----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~ 274 (417)
...+...++.+.+||++||++||.+|||++|+|+||||++
T Consensus 238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~ 288 (292)
T d1unla_ 238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSD 288 (292)
T ss_dssp CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSS
T ss_pred ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcC
Confidence 1122345789999999999999999999999999999975
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.8e-56 Score=432.64 Aligned_cols=252 Identities=24% Similarity=0.358 Sum_probs=209.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCc---EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQ---SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~---~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++.+.||+|+||+||+|+++.+|+ .||||.+.... .......+.+|+.+|++++|||||++++++.+++.+
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence 5789999999999999999999987765 58899886543 223456789999999999999999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+|||||+||+|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||||+.++++||+|||+|+......
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~ 182 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 182 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred EEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCC
Confidence 999999999999998875 579999999999999999999999999999999999999999999999999998654322
Q ss_pred CCC---cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChH
Q 014849 170 PDG---MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPD 244 (417)
Q Consensus 170 ~~~---~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~ 244 (417)
... .....+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..++...+..+. .+.|...+++
T Consensus 183 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~-~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~ 261 (299)
T d1jpaa_ 183 SDPTYTSALGGKIPIRWTAPEAIQYRKFT-SASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSA 261 (299)
T ss_dssp -------------CGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCCHH
T ss_pred CcceeeecccccCCccccCHHHHhcCCCC-cccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccchHH
Confidence 211 11234689999999999888875 89999999999999998 899999999888888887664 5667778999
Q ss_pred HHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 245 LKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 245 ~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
+.+||.+||+.||++|||+.||+++
T Consensus 262 l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 262 LHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999999875
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-56 Score=429.71 Aligned_cols=248 Identities=23% Similarity=0.337 Sum_probs=211.6
Q ss_pred eEEeeeCceEEEEEEEc--cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEEeccC
Q 014849 22 KIIGCGAFAKVYHGRNV--RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVMEFAK 99 (417)
Q Consensus 22 ~~LG~G~fg~Vy~a~~~--~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~E~~~ 99 (417)
+.||+|+||+||+|.+. .+++.||||++..+.. +....+.+.+|+.+|++++|||||++++++.++ ..|+|||||+
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~-~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESS-SEEEEEECCT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEeccC-CEEEEEEcCC
Confidence 57999999999999864 4567899999976542 344567899999999999999999999999765 4689999999
Q ss_pred CCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC-CCccccc
Q 014849 100 GGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP-DGMLHTL 177 (417)
Q Consensus 100 gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~-~~~~~~~ 177 (417)
||+|.+++.. +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|........ .......
T Consensus 91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~ 170 (277)
T d1xbba_ 91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG 170 (277)
T ss_dssp TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence 9999999876 6799999999999999999999999999999999999999999999999999976543211 1122345
Q ss_pred ccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHHhccC
Q 014849 178 CGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGRLLDT 255 (417)
Q Consensus 178 ~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~~L~~ 255 (417)
+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..++...+.++. ++.|..+++++.+||.+||+.
T Consensus 171 ~gt~~y~APE~l~~~~~~-~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~ 249 (277)
T d1xbba_ 171 KWPVKWYAPECINYYKFS-SKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNLCWTY 249 (277)
T ss_dssp CCCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceecCchhhcCCCCC-chhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCC
Confidence 799999999999888875 89999999999999997 999999999888888888764 567888999999999999999
Q ss_pred CCCCCCCHHHHh---cCccc
Q 014849 256 DPATRITVDEIL---RDPWF 272 (417)
Q Consensus 256 dP~~R~t~~eil---~h~~f 272 (417)
||++|||+++|+ +|+|+
T Consensus 250 dp~~RPs~~~i~~~L~~~~~ 269 (277)
T d1xbba_ 250 DVENRPGFAAVELRLRNYYY 269 (277)
T ss_dssp STTTSCCHHHHHHHHHHHHH
T ss_pred CHhHCcCHHHHHHHhhCHHh
Confidence 999999999984 56554
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-56 Score=430.52 Aligned_cols=254 Identities=25% Similarity=0.371 Sum_probs=220.0
Q ss_pred CCeEEeeE-EeeeCceEEEEEEEcc--CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEE
Q 014849 16 GKYEVGKI-IGCGAFAKVYHGRNVR--TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIY 92 (417)
Q Consensus 16 ~~y~i~~~-LG~G~fg~Vy~a~~~~--~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 92 (417)
++|.+... ||+|+||+||+|.++. ++..||||+++... .....+.+.+|+++|++++|||||++++++.++ .+|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~-~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE-ALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-eEE
Confidence 56888885 9999999999998764 45579999997643 233467889999999999999999999998765 589
Q ss_pred EEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 93 FVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 93 lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
+|||||+||+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+.......
T Consensus 85 lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 164 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 164 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred EEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccccc
Confidence 99999999999998754 5799999999999999999999999999999999999999999999999999986543221
Q ss_pred -CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 171 -DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 171 -~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
.......+||+.|+|||++....|+ .++|||||||++|||+| |..||.+.+..++...+..+. .+.|+..++++.+
T Consensus 165 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~ 243 (285)
T d1u59a_ 165 YYTARSAGKWPLKWYAPECINFRKFS-SRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA 243 (285)
T ss_dssp EECCCCSSCCCGGGCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred ccccccccccCccccChHHHhCCCCC-ccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCCcCCHHHHH
Confidence 1223456799999999999888875 99999999999999998 999999988888888888765 5678889999999
Q ss_pred HHHHhccCCCCCCCCHHHH---hcCcccc
Q 014849 248 FIGRLLDTDPATRITVDEI---LRDPWFK 273 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~ei---l~h~~f~ 273 (417)
||.+||+.||++|||+.+| |+|+|+.
T Consensus 244 li~~cl~~~p~~RPs~~~i~~~L~~~~~~ 272 (285)
T d1u59a_ 244 LMSDCWIYKWEDRPDFLTVEQRMRACYYS 272 (285)
T ss_dssp HHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence 9999999999999999888 6677774
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-56 Score=424.36 Aligned_cols=247 Identities=25% Similarity=0.397 Sum_probs=210.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
++|++++.||+|+||+||+|++. +++.||||++..... ..+++.+|+.+|+.++|||||++++++.+++.+|+||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~ 79 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVF 79 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEE
Confidence 57999999999999999999985 678899999976432 2467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
|||++|+|.+++.. ..+++..+..++.||+.||.|||+++|+||||||+|||++.++++||+|||+|+...... ...
T Consensus 80 E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~-~~~ 158 (263)
T d1sm2a_ 80 EFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ-YTS 158 (263)
T ss_dssp ECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred EecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCC-cee
Confidence 99999999998865 568999999999999999999999999999999999999999999999999997654322 223
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 251 (417)
....+||+.|+|||++.+..|+ .++||||+||++|||++ |.+||...+..++...+..+. ...|...++++.+||.+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~-~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 237 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYS-SKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVYQIMNH 237 (263)
T ss_dssp ------CTTSCCHHHHTTCCCC-HHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCCCTTSCHHHHHHHHH
T ss_pred ecceecCcccCChHHhcCCCCC-chhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCCccccCHHHHHHHHH
Confidence 3456799999999999988886 89999999999999998 688888888888888887764 45677889999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||+.||++|||++||++|
T Consensus 238 cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 238 CWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp HTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999986
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-56 Score=425.73 Aligned_cols=252 Identities=22% Similarity=0.376 Sum_probs=219.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|++. +++.||||++..... ..+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEE
Confidence 468999999999999999999984 678999999976432 24678999999999999999999998754 557999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||++|+|.+++.. .++++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+...... .
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~-~ 164 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE-Y 164 (272)
T ss_dssp EECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC-E
T ss_pred EEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCc-c
Confidence 999999999997754 369999999999999999999999999999999999999999999999999998754321 1
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li 249 (417)
.......||+.|+|||++.+..|+ .++||||+||++|+|+| |.+||...+..+....+..+. ...|...++++.+||
T Consensus 165 ~~~~~~~gt~~y~APE~~~~~~~~-~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li 243 (272)
T d1qpca_ 165 TAREGAKFPIKWTAPEAINYGTFT-IKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELYQLM 243 (272)
T ss_dssp ECCTTCCCCTTTSCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHH
T ss_pred ccccccCCcccccChHHHhCCCCC-chhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCcccChHHHHHHH
Confidence 233456799999999999888775 99999999999999999 567778888888888887764 566788999999999
Q ss_pred HHhccCCCCCCCCHHHHhc--Cccccc
Q 014849 250 GRLLDTDPATRITVDEILR--DPWFKK 274 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~--h~~f~~ 274 (417)
.+||+.||++|||++||++ |+||..
T Consensus 244 ~~cl~~~P~~Rpt~~ei~~~L~~~fts 270 (272)
T d1qpca_ 244 RLCWKERPEDRPTFDYLRSVLEDFFTA 270 (272)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred HHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence 9999999999999999998 788853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-56 Score=436.37 Aligned_cols=253 Identities=29% Similarity=0.404 Sum_probs=212.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe------C
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT------K 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------~ 88 (417)
.-+|+.+++||+|+||+||+|++..+|+.||||++.++... ..+|+.+|+.++||||+++++++.. .
T Consensus 19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~-------~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~ 91 (350)
T d1q5ka_ 19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDE 91 (350)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSS-------CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSC
T ss_pred cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchH-------HHHHHHHHHhcCCCCCCcEEEEEEecCccCCc
Confidence 44799999999999999999999999999999999765421 2379999999999999999999854 3
Q ss_pred CEEEEEEeccCCCChHHHH---h-cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecce
Q 014849 89 AKIYFVMEFAKGGELFAKI---S-KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSA 163 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i---~-~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~ 163 (417)
..+|+|||||+++.+.... . ...+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.
T Consensus 92 ~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 92 VYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp CEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred eEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchh
Confidence 4689999999876443332 2 25799999999999999999999999999999999999999875 89999999997
Q ss_pred eecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC----------
Q 014849 164 VKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG---------- 233 (417)
Q Consensus 164 ~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~---------- 233 (417)
.... .....+.+||+.|+|||++.+..+.+.++||||+||++|+|++|..||...+..+.+.++.+.
T Consensus 172 ~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~ 248 (350)
T d1q5ka_ 172 QLVR---GEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248 (350)
T ss_dssp ECCT---TSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred hccC---CcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhh
Confidence 6542 334566789999999999887655569999999999999999999999988877766665421
Q ss_pred -------CCC------------CCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 -------EYR------------CPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 -------~~~------------~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
... .....++++.+||.+||++||++|||+.|+|+||||++...
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~ 311 (350)
T d1q5ka_ 249 EMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD 311 (350)
T ss_dssp HHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred hhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence 111 12346899999999999999999999999999999986543
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-56 Score=419.47 Aligned_cols=247 Identities=24% Similarity=0.359 Sum_probs=222.3
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV~ 95 (417)
+.|++++.||+|+||+||+|++ .+++.||||++++... ..+.+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~-~~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~ 78 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKW-RGQYDVAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIIT 78 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEE-TTTEEEEEEEEESSSS----CHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEE
T ss_pred HHCEEeEEEecCCCeEEEEEEE-CCCCEEEEEEECcCcC----CHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEE
Confidence 5789999999999999999998 4888999999987543 2467889999999999999999999999999999999
Q ss_pred eccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCCCc
Q 014849 96 EFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPDGM 173 (417)
Q Consensus 96 E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~~~ 173 (417)
||+.+|+|..++.. +.+++..+.+++.|+++||.|||++||+||||||+|||++.++.+||+|||+|....... ...
T Consensus 79 Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~-~~~ 157 (258)
T d1k2pa_ 79 EYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE-YTS 157 (258)
T ss_dssp ECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS-CCC
T ss_pred EccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCC-cee
Confidence 99999999998754 679999999999999999999999999999999999999999999999999997654332 223
Q ss_pred ccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHHHHHH
Q 014849 174 LHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKWFIGR 251 (417)
Q Consensus 174 ~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~ 251 (417)
....+||+.|+|||++.+..|+ .++||||+||++|+|+| |+.||.+.+..++..++..+. ...|...++++.+||++
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~-~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~~~~~~l~~li~~ 236 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFS-SKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVYTIMYS 236 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHH
T ss_pred ecccCCCCCcCCcHHhcCCCCC-cceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCCcccccHHHHHHHHH
Confidence 3456799999999999988886 89999999999999998 899999999999999888764 46678889999999999
Q ss_pred hccCCCCCCCCHHHHhcC
Q 014849 252 LLDTDPATRITVDEILRD 269 (417)
Q Consensus 252 ~L~~dP~~R~t~~eil~h 269 (417)
||+.||++|||+++|++|
T Consensus 237 cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 237 CWHEKADERPTFKILLSN 254 (258)
T ss_dssp TTCSSGGGSCCHHHHHHH
T ss_pred HccCCHhHCcCHHHHHHH
Confidence 999999999999999987
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-56 Score=439.79 Aligned_cols=257 Identities=24% Similarity=0.359 Sum_probs=220.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeC-----
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATK----- 88 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~----- 88 (417)
+.+||++++.||+|+||+||+|+++.+|+.||||++.+... ......++.+|+.+|+.++|||||++++++...
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~ 94 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 94 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTT
T ss_pred CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeecccccc
Confidence 35799999999999999999999999999999999986543 333456788999999999999999999998643
Q ss_pred CEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 89 AKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
...+++++|+.||+|.+++..+++++.+++.++.||+.||+|||++||+||||||+|||++.+|.+|++|||+|....
T Consensus 95 ~~~~~i~~~~~gg~L~~~~~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-- 172 (348)
T d2gfsa1 95 FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-- 172 (348)
T ss_dssp CCCCEEEEECCSEEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT--
T ss_pred CceEEEEEeecCCchhhhcccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC--
Confidence 344666778889999999988899999999999999999999999999999999999999999999999999986543
Q ss_pred CCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCC-----------
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKGEYRC----------- 237 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~~~~~----------- 237 (417)
....+.+||+.|+|||++.+..+.+.++|||||||++|+|++|.+||.+.+.......+.......
T Consensus 173 ---~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 249 (348)
T d2gfsa1 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249 (348)
T ss_dssp ---GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCH
T ss_pred ---cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccch
Confidence 344567899999999998888877899999999999999999999999988777766664322111
Q ss_pred --------------------CCCCChHHHHHHHHhccCCCCCCCCHHHHhcCccccccc
Q 014849 238 --------------------PKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDY 276 (417)
Q Consensus 238 --------------------p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~ 276 (417)
....++++++||++||+.||.+|||++|+|+||||++..
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~ 308 (348)
T d2gfsa1 250 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH 308 (348)
T ss_dssp HHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred hhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCC
Confidence 124689999999999999999999999999999998653
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.6e-56 Score=432.13 Aligned_cols=259 Identities=34% Similarity=0.560 Sum_probs=225.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEE---ccCCcEEEEEEeeccccc-ccchHHHHHHHHHHHHhCCC-CCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRN---VRTGQSVAIKAVSKQKIL-RGGLTAHVKREISIMSRLRH-PNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~---~~~g~~vAiK~i~~~~~~-~~~~~~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~ 89 (417)
.++|++++.||+|+||+||+|++ ..+|+.||||++++.... +....+.+.+|+.+|++++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCC
Confidence 47899999999999999999997 447999999999876543 23345678899999999977 89999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 90 KIYFVMEFAKGGELFAKISK-GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
.+|+||||+.||+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|......
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~ 182 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD 182 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred ceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccc
Confidence 99999999999999999876 78999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCCcccccccCccccccccccccC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC----HHHHHHHHhcCCCCCCCCCCh
Q 014849 169 RPDGMLHTLCGTPAYVAPEILAKKG-YDGAKVDMWSCGVVLFVLNAGYLPFNDPN----LMAMYRKIYKGEYRCPKWTSP 243 (417)
Q Consensus 169 ~~~~~~~~~~Gt~~y~APEvl~~~~-y~~~~sDIwSlGvil~~ll~G~~Pf~~~~----~~~~~~~i~~~~~~~p~~~s~ 243 (417)
......+.+||+.|+|||.+.+.. +.+.++|||||||+||+|++|..||.+.+ ...+.........+.|...|+
T Consensus 183 -~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~ 261 (322)
T d1vzoa_ 183 -ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA 261 (322)
T ss_dssp -GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred -ccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence 233456788999999999997654 34689999999999999999999997654 334455555667788888999
Q ss_pred HHHHHHHHhccCCCCCCC-----CHHHHhcCccccc
Q 014849 244 DLKWFIGRLLDTDPATRI-----TVDEILRDPWFKK 274 (417)
Q Consensus 244 ~~~~li~~~L~~dP~~R~-----t~~eil~h~~f~~ 274 (417)
++.+||++||++||++|| |++|+++||||+.
T Consensus 262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred HHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 999999999999999999 5899999999986
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.1e-55 Score=428.53 Aligned_cols=251 Identities=25% Similarity=0.447 Sum_probs=211.0
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeC--CE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATK--AK 90 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~--~~ 90 (417)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. ..++.+|+.+|+.++ ||||+++++++... ..
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 3478999999999999999999999999999999997543 467889999999995 99999999999744 56
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCC-CeEEeeeecceeecccC
Q 014849 91 IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENW-DLKISDFGLSAVKEQIR 169 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~-~vkl~DFGls~~~~~~~ 169 (417)
+|+|||||.+++|.... +++++.+++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||+|.....
T Consensus 107 ~~~v~e~~~~~~L~~~~--~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~-- 182 (328)
T d3bqca1 107 PALVFEHVNNTDFKQLY--QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 182 (328)
T ss_dssp EEEEEECCCSCBGGGTT--TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCT--
T ss_pred eeEEEeecCCCcHHHHh--cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccC--
Confidence 99999999999997764 4699999999999999999999999999999999999998765 599999999986543
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHHHHhc-------------CCC
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNL-MAMYRKIYK-------------GEY 235 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~-~~~~~~i~~-------------~~~ 235 (417)
.......+||+.|+|||++.+....+.++||||+||++|+|++|..||...+. ......+.. ...
T Consensus 183 -~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~ 261 (328)
T d3bqca1 183 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 261 (328)
T ss_dssp -TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred -CCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence 33456778999999999988766556999999999999999999999976432 222211110 000
Q ss_pred ------------------------CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccc
Q 014849 236 ------------------------RCPKWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKD 275 (417)
Q Consensus 236 ------------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~ 275 (417)
......|+++.+||++||++||++|||++|+|+||||+.-
T Consensus 262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 0112358899999999999999999999999999999864
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-55 Score=420.73 Aligned_cols=250 Identities=26% Similarity=0.374 Sum_probs=208.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG---QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++++.||+|+||+||+|++..++ ..||||.+.... .......+.+|+.+|++++|||||++++++. .+.+
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeE
Confidence 468999999999999999999986543 468888885433 3344677899999999999999999999985 4678
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
|+||||+++|+|.+++.. +.+++..++.++.||++||.|||++||+||||||+|||++.++.+||+|||+|+.....
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~- 161 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDS- 161 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred EEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCC-
Confidence 999999999999988754 57999999999999999999999999999999999999999999999999999765432
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
........+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+++.++..+. .+.|+.+|+++.+
T Consensus 162 ~~~~~~~~~gt~~y~apE~l~~~~~~-~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~ 240 (273)
T d1mp8a_ 162 TYYKASKGKLPIKWMAPESINFRRFT-SASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS 240 (273)
T ss_dssp ---------CCGGGCCHHHHHHCCCS-HHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHH
T ss_pred cceeccceecCcccchhhHhccCCCC-CccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCCCCHHHHH
Confidence 22233456789999999999988885 89999999999999997 899999998888888888775 5678889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcC
Q 014849 248 FIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h 269 (417)
||.+||+.||++|||++||++|
T Consensus 241 li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 241 LMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999999999999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-55 Score=426.50 Aligned_cols=251 Identities=22% Similarity=0.359 Sum_probs=212.2
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCc----EEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQ----SVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~----~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
..|+++++||+|+||+||+|.+..+|+ .||+|.+.... ......++.+|+.+|++++|||||++++++.++. .
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~-~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST-V 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-e
Confidence 569999999999999999999988887 47777775432 3334678999999999999999999999998765 6
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++++||+.+|+|.+.+.. ..+++..++.++.||+.||.|||++||+||||||+||||+.++++||+|||+|.......
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~ 165 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE 165 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence 788999999999988764 579999999999999999999999999999999999999999999999999998765433
Q ss_pred CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCC-CCCCCCCChHHHH
Q 014849 170 PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDLKW 247 (417)
Q Consensus 170 ~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~ 247 (417)
.........||+.|+|||++.+..|+ .++|||||||++|+|+| |.+||.+.+..++...+..+. .+.|...++++.+
T Consensus 166 ~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~~~~~~~~~ 244 (317)
T d1xkka_ 166 KEYHAEGGKVPIKWMALESILHRIYT-HQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYM 244 (317)
T ss_dssp C--------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCCCTTBCHHHHH
T ss_pred ccccccccccCccccChHHHhcCCCC-hhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCcccCHHHHH
Confidence 33344455789999999999988875 99999999999999998 899999988778887777765 5677889999999
Q ss_pred HHHHhccCCCCCCCCHHHHhcCc
Q 014849 248 FIGRLLDTDPATRITVDEILRDP 270 (417)
Q Consensus 248 li~~~L~~dP~~R~t~~eil~h~ 270 (417)
||.+||+.||.+|||+.||++|.
T Consensus 245 li~~cl~~dP~~RPs~~eil~~l 267 (317)
T d1xkka_ 245 IMVKCWMIDADSRPKFRELIIEF 267 (317)
T ss_dssp HHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHHHhCCCChhhCcCHHHHHHHH
Confidence 99999999999999999999984
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-55 Score=432.80 Aligned_cols=257 Identities=27% Similarity=0.455 Sum_probs=207.6
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe------
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT------ 87 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~------ 87 (417)
+..+|++++.||+|+||+||+|+++.||+.||||++.+... ......++.+|+.+|+.++|||||++++++.+
T Consensus 15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTT
T ss_pred ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEeccccccc
Confidence 56899999999999999999999999999999999987653 33345678899999999999999999999953
Q ss_pred CCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecc
Q 014849 88 KAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQ 167 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~ 167 (417)
.+.+|+|||||.|+.+ ..+ .+.+++.+++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++.....
T Consensus 94 ~~~~~iv~Ey~~~~l~-~~~-~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~ 171 (355)
T d2b1pa1 94 FQDVYLVMELMDANLC-QVI-QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_dssp CCEEEEEEECCSEEHH-HHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred CceeEEEEeccchHHH-Hhh-hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhcccc
Confidence 4789999999977544 444 35799999999999999999999999999999999999999999999999999875442
Q ss_pred cCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--------------
Q 014849 168 IRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKIYKG-------------- 233 (417)
Q Consensus 168 ~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i~~~-------------- 233 (417)
.......+||+.|+|||++.+..|+ .++||||+||++|+|++|++||.+.+......++...
T Consensus 172 ---~~~~~~~~~t~~y~aPE~l~~~~~~-~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~ 247 (355)
T d2b1pa1 172 ---SFMMTPYVVTRYYRAPEVILGMGYK-ENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP 247 (355)
T ss_dssp ------------CCTTCCHHHHTTCCCC-TTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred ---ccccccccccccccChhhhcCCCCC-CCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence 3344567899999999999988775 8999999999999999999999988877666554321
Q ss_pred --------CCCC--------------C------CCCChHHHHHHHHhccCCCCCCCCHHHHhcCcccccccc
Q 014849 234 --------EYRC--------------P------KWTSPDLKWFIGRLLDTDPATRITVDEILRDPWFKKDYK 277 (417)
Q Consensus 234 --------~~~~--------------p------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~f~~~~~ 277 (417)
.... + ...|+++.+||++||++||++|||++|+|+||||+....
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD 319 (355)
T ss_dssp HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence 1000 0 012577899999999999999999999999999997543
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-54 Score=414.62 Aligned_cols=251 Identities=23% Similarity=0.329 Sum_probs=209.4
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCC----cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTG----QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAK 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g----~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~ 90 (417)
.+.|++.++||+|+||+||+|.++.++ ..||||++..... .....++.+|+.+|++++|||||++++++.+...
T Consensus 6 ~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~ 83 (283)
T d1mqba_ 6 PSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKP 83 (283)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred HHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccC--hHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCc
Confidence 357999999999999999999987655 4799999975432 2335678899999999999999999999999999
Q ss_pred EEEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeeccc
Q 014849 91 IYFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQI 168 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~ 168 (417)
+|+|||||.+++|.+.+.. +.+++.++..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.....
T Consensus 84 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 163 (283)
T d1mqba_ 84 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 163 (283)
T ss_dssp EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCC
Confidence 9999999999999988764 67999999999999999999999999999999999999999999999999999865432
Q ss_pred CC-CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCC-CCCCCCCChHH
Q 014849 169 RP-DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGE-YRCPKWTSPDL 245 (417)
Q Consensus 169 ~~-~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~ 245 (417)
.. .......+||+.|+|||++.+..|+ .++|||||||++|||++| .+||...+..+++..+..+. .+.|...++++
T Consensus 164 ~~~~~~~~~~~gt~~Y~APE~l~~~~~~-~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l 242 (283)
T d1mqba_ 164 PEATYTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTPMDCPSAI 242 (283)
T ss_dssp ----------CCCGGGSCHHHHHSCCCC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCTTCBHHH
T ss_pred CccceEeccCCCCccccCHHHHccCCCC-CcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCCchhhHHHH
Confidence 22 1223345789999999999888876 899999999999999984 66677777788888777653 46677789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 014849 246 KWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.+||.+||+.||++|||+.||++
T Consensus 243 ~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 243 YQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHHHHHHCcCCHhHCcCHHHHHH
Confidence 99999999999999999999987
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-54 Score=414.93 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=214.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKIYFV 94 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lV 94 (417)
.++|++++.||+|+||+||+|++..+ +.||||++..... ..+.+.+|+.+|++++|||||++++++.+ +.+|+|
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~----~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv 89 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIV 89 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccC----CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEE
Confidence 47899999999999999999999655 6799999976542 24678999999999999999999999855 458999
Q ss_pred EeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCCC
Q 014849 95 MEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRPD 171 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~~ 171 (417)
||||++|+|..++.. +.+++.+++.++.||+.||+|||++||+||||||+||||+.++++||+|||+|+...... .
T Consensus 90 ~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~-~ 168 (285)
T d1fmka3 90 TEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE-Y 168 (285)
T ss_dssp ECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred EEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCC-c
Confidence 999999999988753 579999999999999999999999999999999999999999999999999997654321 2
Q ss_pred CcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHHH
Q 014849 172 GMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWFI 249 (417)
Q Consensus 172 ~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li 249 (417)
......+||+.|+|||++....++ .++||||+||++|+|++ |.+||...+..+++..+.++ ..+.|...++++.+||
T Consensus 169 ~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li 247 (285)
T d1fmka3 169 TARQGAKFPIKWTAPEAALYGRFT-IKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLM 247 (285)
T ss_dssp -------CCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCCTTSCHHHHHHH
T ss_pred eeeccccccccccChHHHhCCCCC-cHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCcccCHHHHHHH
Confidence 233456799999999999988885 99999999999999999 56667778888888887765 3567888999999999
Q ss_pred HHhccCCCCCCCCHHHHhc--Ccccccc
Q 014849 250 GRLLDTDPATRITVDEILR--DPWFKKD 275 (417)
Q Consensus 250 ~~~L~~dP~~R~t~~eil~--h~~f~~~ 275 (417)
.+||+.||++|||+++|++ ++||...
T Consensus 248 ~~cl~~dP~~Rps~~~i~~~L~~~~~~~ 275 (285)
T d1fmka3 248 CQCWRKEPEERPTFEYLQAFLEDYFTST 275 (285)
T ss_dssp HHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred HHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence 9999999999999999987 7888653
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.4e-54 Score=416.72 Aligned_cols=251 Identities=25% Similarity=0.335 Sum_probs=220.7
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++++.||+|+||+||+|+.+ .+++.||||+++... ......++.+|+.+|+.++||||+++++++.+.+
T Consensus 12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 89 (301)
T d1lufa_ 12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGK 89 (301)
T ss_dssp GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc--ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCC
Confidence 457999999999999999999975 366889999997643 2334677899999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-------------------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCC
Q 014849 90 KIYFVMEFAKGGELFAKISK-------------------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLE 144 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-------------------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~ 144 (417)
..++||||+.+|+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~ 169 (301)
T d1lufa_ 90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 169 (301)
T ss_dssp SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence 99999999999999998853 13889999999999999999999999999999999
Q ss_pred cEEecCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCC-CCCCCCCH
Q 014849 145 NLLLDENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGY-LPFNDPNL 223 (417)
Q Consensus 145 NILl~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~-~Pf~~~~~ 223 (417)
||||+.++++||+|||+|+............+.+||+.|+|||++.+..|+ .++|||||||++|||++|. +||.+.+.
T Consensus 170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t-~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYT-TESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCC-hhhhhccchhhHHHHHccCCCCCCCCCH
Confidence 999999999999999999866544444455678899999999999998886 9999999999999999984 78999999
Q ss_pred HHHHHHHhcCCC-CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 224 MAMYRKIYKGEY-RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 224 ~~~~~~i~~~~~-~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.++...+..+.. ..|...++++.+||.+||+.||++|||+.||++
T Consensus 249 ~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~ 294 (301)
T d1lufa_ 249 EEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294 (301)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999888764 467788999999999999999999999999964
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-54 Score=413.37 Aligned_cols=252 Identities=23% Similarity=0.371 Sum_probs=219.1
Q ss_pred ccCCeEEeeEEeeeCceEEEEEEEccCC-------cEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEE
Q 014849 14 LFGKYEVGKIIGCGAFAKVYHGRNVRTG-------QSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVL 85 (417)
Q Consensus 14 ~~~~y~i~~~LG~G~fg~Vy~a~~~~~g-------~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~ 85 (417)
-.++|++++.||+|+||.||+|++..++ ..||||++.++.. ......+.+|...++++ +|||||++++++
T Consensus 11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~ 88 (299)
T d1fgka_ 11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC 88 (299)
T ss_dssp CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEeccccc
Confidence 3579999999999999999999986655 4799999976542 23356788898888888 799999999999
Q ss_pred EeCCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEe
Q 014849 86 ATKAKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLL 148 (417)
Q Consensus 86 ~~~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl 148 (417)
.++..+|+|||||++|+|.+++.. ..+++.++..++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl 168 (299)
T d1fgka_ 89 TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 168 (299)
T ss_dssp CSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred ccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceee
Confidence 999999999999999999999964 248999999999999999999999999999999999999
Q ss_pred cCCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 014849 149 DENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMY 227 (417)
Q Consensus 149 ~~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~ 227 (417)
+.++.+||+|||++...............+||+.|+|||++.+..|+ .++|||||||++|+|++ |.+||.+.+..+++
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~-~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~ 247 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT-HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 247 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCC-chhhhHHhHHHHHHhccCCCCCCCCCCHHHHH
Confidence 99999999999999877665555556677899999999999988886 99999999999999997 79999999999888
Q ss_pred HHHhcCC-CCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 228 RKIYKGE-YRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 228 ~~i~~~~-~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..+..+. +..|.+.++++.+||.+||+.||++|||+.||++
T Consensus 248 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 248 KLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp HHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 8887653 5678889999999999999999999999999986
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-54 Score=412.32 Aligned_cols=252 Identities=28% Similarity=0.351 Sum_probs=207.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-CC--cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-TG--QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-~g--~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++.+.||+|+||+||+|+... ++ ..||||++.+.........+.+.+|+.+|+.++|||||++++++.++ .+
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~-~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP-PM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SC
T ss_pred hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeec-ch
Confidence 4679999999999999999998643 33 36899999877665666677899999999999999999999999765 57
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccC
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIR 169 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~ 169 (417)
++||||+++|+|.+.+.. +.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~ 165 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND 165 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-C
T ss_pred heeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccCC
Confidence 899999999999987764 679999999999999999999999999999999999999999999999999998754332
Q ss_pred CCC-cccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcCCC--CCCCCCChHH
Q 014849 170 PDG-MLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKGEY--RCPKWTSPDL 245 (417)
Q Consensus 170 ~~~-~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~~~--~~p~~~s~~~ 245 (417)
... .....+||+.|+|||++.+..|+ .++|||||||++|||++ |.+||.+.+..+...++.+... +.|..+++++
T Consensus 166 ~~~~~~~~~~~~~~~~aPE~~~~~~~~-~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~l 244 (273)
T d1u46a_ 166 DHYVMQEHRKVPFAWCAPESLKTRTFS-HASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDI 244 (273)
T ss_dssp CEEEC-----CCGGGCCHHHHHHCEEE-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCCTTCCHHH
T ss_pred CcceecCccccCcccCCHHHHhCCCCC-cchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCcccccHHH
Confidence 222 23345688899999999988775 99999999999999998 8999999999999888877654 4566789999
Q ss_pred HHHHHHhccCCCCCCCCHHHHhc
Q 014849 246 KWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 246 ~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.+||.+||+.||++|||++||++
T Consensus 245 ~~li~~cl~~dp~~RPt~~ei~~ 267 (273)
T d1u46a_ 245 YNVMVQCWAHKPEDRPTFVALRD 267 (273)
T ss_dssp HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHcCCChhHCcCHHHHHH
Confidence 99999999999999999999963
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-54 Score=415.39 Aligned_cols=252 Identities=25% Similarity=0.374 Sum_probs=203.5
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEe-
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLAT- 87 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~- 87 (417)
.++|++++.||+|+||+||+|++.. +++.||||++..... ......+.+|+.++.++ +||||+++++++.+
T Consensus 12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~--~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~ 89 (299)
T d1ywna1 12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 89 (299)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----C--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccC--cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC
Confidence 3689999999999999999999754 457899999875432 22345667777777766 68999999998765
Q ss_pred CCEEEEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC
Q 014849 88 KAKIYFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE 150 (417)
Q Consensus 88 ~~~~~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~ 150 (417)
...+|+|||||+||+|.+++.. ..+++.++..++.||++||.|||++||+||||||+||||+.
T Consensus 90 ~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~ 169 (299)
T d1ywna1 90 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 169 (299)
T ss_dssp TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECG
T ss_pred CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECC
Confidence 4568999999999999999853 24899999999999999999999999999999999999999
Q ss_pred CCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHH-HHH
Q 014849 151 NWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMA-MYR 228 (417)
Q Consensus 151 ~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~-~~~ 228 (417)
++++||+|||+|+............+.+||+.|+|||++.+..|+ .++||||+||++|+|++| .+||.+.+..+ ...
T Consensus 170 ~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~-~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~ 248 (299)
T d1ywna1 170 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYT-IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248 (299)
T ss_dssp GGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHH
T ss_pred CCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCC-cccceeehHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 999999999999865544444445567899999999999988875 999999999999999986 57887765443 344
Q ss_pred HHhcC-CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 229 KIYKG-EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 229 ~i~~~-~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..+ .+..|...++++.+||.+||+.||++|||++||++|
T Consensus 249 ~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~ 290 (299)
T d1ywna1 249 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290 (299)
T ss_dssp HHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 44443 356778899999999999999999999999999987
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-53 Score=413.83 Aligned_cols=249 Identities=24% Similarity=0.394 Sum_probs=215.2
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcE--EEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeCCEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQS--VAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATKAKI 91 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~--vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~~~~ 91 (417)
.++|++++.||+|+||+||+|+++.+|.. ||||.+.... .....+.+.+|+.+|+++ +|||||++++++.+++.+
T Consensus 9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~ 86 (309)
T d1fvra_ 9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 86 (309)
T ss_dssp GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEE
T ss_pred HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCee
Confidence 46899999999999999999999988875 6677665332 233356789999999998 799999999999999999
Q ss_pred EEEEeccCCCChHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCe
Q 014849 92 YFVMEFAKGGELFAKISK-----------------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDL 154 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~-----------------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~v 154 (417)
|+||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus 87 ~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 87 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 166 (309)
T ss_dssp EEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCE
T ss_pred EEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCce
Confidence 999999999999998853 469999999999999999999999999999999999999999999
Q ss_pred EEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcC
Q 014849 155 KISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKG 233 (417)
Q Consensus 155 kl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~ 233 (417)
||+|||+|...... ......+||+.|+|||.+.+..|+ .++|||||||++|+|++| .+||.+.+..+++..+..+
T Consensus 167 kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~-~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~ 242 (309)
T d1fvra_ 167 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYT-TNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG 242 (309)
T ss_dssp EECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEEC-HHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred EEcccccccccccc---ccccceecCCcccchHHhccCCCC-ccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999754432 223456799999999999988885 899999999999999996 5689999999999988776
Q ss_pred -CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 234 -EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 234 -~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
.+..|...++++.+||.+||+.||++|||++||+++
T Consensus 243 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 279 (309)
T d1fvra_ 243 YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279 (309)
T ss_dssp CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 456677889999999999999999999999999987
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-53 Score=405.50 Aligned_cols=242 Identities=26% Similarity=0.438 Sum_probs=207.6
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEE-eCCEEEE
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLA-TKAKIYF 93 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~-~~~~~~l 93 (417)
.++|++++.||+|+||.||+|++ +|+.||||+++++. ..+.+.+|+.+|++++||||+++++++. +++.+|+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~l 78 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYI 78 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEE
T ss_pred HHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEE
Confidence 45799999999999999999998 57899999997543 3567899999999999999999999885 4566899
Q ss_pred EEeccCCCChHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC
Q 014849 94 VMEFAKGGELFAKISK---GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP 170 (417)
Q Consensus 94 V~E~~~gg~L~~~i~~---~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~ 170 (417)
||||+++|+|.+++.. ..+++..++.++.||+.||.|||+++|+||||||+|||++.++++||+|||++....
T Consensus 79 v~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~---- 154 (262)
T d1byga_ 79 VTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS---- 154 (262)
T ss_dssp EECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecC----
Confidence 9999999999999865 259999999999999999999999999999999999999999999999999997543
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHHHHhcC-CCCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYRKIYKG-EYRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~l 248 (417)
....+.++|+.|+|||++.+..|+ .++||||+||++|||++ |.+||...+..++...+..+ .++.|...++++.+|
T Consensus 155 -~~~~~~~~~~~y~aPE~l~~~~~t-~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~l 232 (262)
T d1byga_ 155 -STQDTGKLPVKWTAPEALREKKFS-TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVYEV 232 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCCCTTCCHHHHHH
T ss_pred -CCCccccccccCCChHHHhCCCCC-hHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHH
Confidence 233456789999999999888875 99999999999999998 79999998888888888765 456788899999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|++||+.||.+|||+.+++++
T Consensus 233 i~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 233 MKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcccCHhHCcCHHHHHHH
Confidence 999999999999999999874
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-53 Score=411.07 Aligned_cols=251 Identities=22% Similarity=0.286 Sum_probs=222.0
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEcc-----CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVR-----TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA 89 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~-----~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~ 89 (417)
.++|++++.||+|+||+||+|.+.. +++.||||+++... .......+.+|+.+|++++|||||++++++..+.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCC
Confidence 4899999999999999999998853 46789999997643 2233567889999999999999999999999999
Q ss_pred EEEEEEeccCCCChHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEee
Q 014849 90 KIYFVMEFAKGGELFAKISK-----------GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISD 158 (417)
Q Consensus 90 ~~~lV~E~~~gg~L~~~i~~-----------~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~D 158 (417)
..++||||+.+|+|.+++.. ..+++..+..++.|++.||.|||+++|+||||||+|||++.++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred ceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEee
Confidence 99999999999999998742 2478899999999999999999999999999999999999999999999
Q ss_pred eecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHHHHhcCCC-C
Q 014849 159 FGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAG-YLPFNDPNLMAMYRKIYKGEY-R 236 (417)
Q Consensus 159 FGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G-~~Pf~~~~~~~~~~~i~~~~~-~ 236 (417)
||+|...............+||+.|+|||.+.+..|+ .++||||+||++|+|++| .+||.+.+..+.+..+.++.. +
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~-~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~ 255 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFT-TYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD 255 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred cccceeccCCcceeeccceecccccCCHHHHccCCCC-cccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC
Confidence 9999866544443344556799999999999988875 899999999999999998 689999999999988887664 5
Q ss_pred CCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 237 CPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 237 ~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
.|...++.+.+||.+||+.||++|||+++|++
T Consensus 256 ~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~ 287 (308)
T d1p4oa_ 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 287 (308)
T ss_dssp CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 67889999999999999999999999999997
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=407.51 Aligned_cols=251 Identities=23% Similarity=0.335 Sum_probs=215.9
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEc-----cCCcEEEEEEeecccccccchHHHHHHHHHHHHhC-CCCCcceEEEEEEeC
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNV-----RTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRL-RHPNIVKLYEVLATK 88 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~-----~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l-~HpnIv~l~~~~~~~ 88 (417)
.++|++++.||+|+||+||+|++. .+++.||||++..... ......+.+|+.+++.+ +|||||++++++.++
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~ 99 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIG 99 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC
Confidence 479999999999999999999863 5778999999976542 33456788999999999 699999999999999
Q ss_pred CEEEEEEeccCCCChHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEec
Q 014849 89 AKIYFVMEFAKGGELFAKISKG-------------------RFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLD 149 (417)
Q Consensus 89 ~~~~lV~E~~~gg~L~~~i~~~-------------------~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~ 149 (417)
..+|+|||||++|+|.+++... .+++..+..++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~ 179 (311)
T d1t46a_ 100 GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLT 179 (311)
T ss_dssp SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEE
T ss_pred CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccc
Confidence 9999999999999999998542 589999999999999999999999999999999999999
Q ss_pred CCCCeEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHH
Q 014849 150 ENWDLKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNA-GYLPFNDPNLMAMYR 228 (417)
Q Consensus 150 ~~~~vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~-G~~Pf~~~~~~~~~~ 228 (417)
.++++|++|||++...............+||+.|+|||++.+..++ .++|||||||++|+|++ |.+||...+..+.+.
T Consensus 180 ~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 180 HGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYT-FESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp TTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred ccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCC-CcccccchHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999876544333444557899999999999887775 99999999999999998 777787766555554
Q ss_pred HHhcC--CCCCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 229 KIYKG--EYRCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 229 ~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
++... ....|...++++.+||.+||++||.+|||++||++
T Consensus 259 ~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~ 300 (311)
T d1t46a_ 259 KMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (311)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 44433 34456778999999999999999999999999986
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-50 Score=394.15 Aligned_cols=248 Identities=23% Similarity=0.316 Sum_probs=205.9
Q ss_pred EEeeEEeeeCceEEEEEEEccCC---cEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEe-CCEEEEE
Q 014849 19 EVGKIIGCGAFAKVYHGRNVRTG---QSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLAT-KAKIYFV 94 (417)
Q Consensus 19 ~i~~~LG~G~fg~Vy~a~~~~~g---~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lV 94 (417)
...++||+|+||+||+|++..++ ..||||++++.. ......++.+|+.+|++++|||||++++++.+ +...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCC--CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECccc--CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEE
Confidence 34689999999999999986654 369999997532 34446789999999999999999999999765 5689999
Q ss_pred EeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecceeecccCC--
Q 014849 95 MEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLSAVKEQIRP-- 170 (417)
Q Consensus 95 ~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls~~~~~~~~-- 170 (417)
||||++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+||||++++.+||+|||++........
T Consensus 108 ~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~ 187 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDS 187 (311)
T ss_dssp EECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCC
T ss_pred EEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccc
Confidence 999999999998875 4688889999999999999999999999999999999999999999999999986543221
Q ss_pred CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHHHHhcCC-CCCCCCCChHHHHH
Q 014849 171 DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFND-PNLMAMYRKIYKGE-YRCPKWTSPDLKWF 248 (417)
Q Consensus 171 ~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~-~~~~~~~~~i~~~~-~~~p~~~s~~~~~l 248 (417)
........||+.|+|||++....|+ .++|||||||++|||++|..||.. .+..+....+..+. +..|...++++.+|
T Consensus 188 ~~~~~~~~gt~~y~aPE~~~~~~~~-~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~~~~~~l~~l 266 (311)
T d1r0pa_ 188 VHNKTGAKLPVKWMALESLQTQKFT-TKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLYEV 266 (311)
T ss_dssp TTCTTCSSCCGGGSCHHHHHHCCCC-HHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCCCTTCCHHHHHH
T ss_pred ceecccccccccccChHHHhcCCCC-ChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcccCcHHHHHH
Confidence 1223345789999999999888775 999999999999999997666654 44555666666554 45678889999999
Q ss_pred HHHhccCCCCCCCCHHHHhcC
Q 014849 249 IGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 249 i~~~L~~dP~~R~t~~eil~h 269 (417)
|.+||+.||++|||+.||++|
T Consensus 267 i~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 267 MLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCHhHCcCHHHHHHH
Confidence 999999999999999999987
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.1e-51 Score=394.19 Aligned_cols=259 Identities=22% Similarity=0.291 Sum_probs=206.6
Q ss_pred ccccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCE
Q 014849 12 VNLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAK 90 (417)
Q Consensus 12 ~~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~ 90 (417)
.++.+||++++.||+|+||+||+|++..+|+.||||++..... ..++.+|+++++.++|+| |+.+..++.+.+.
T Consensus 3 ~~vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~ 77 (299)
T d1ckia_ 3 LRVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDY 77 (299)
T ss_dssp CEETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT-----SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTE
T ss_pred CeECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhcc-----CHHHHHHHHHHHHccCCCcccEEEEEEecCCE
Confidence 4566899999999999999999999999999999999876532 235678999999998766 5556666788999
Q ss_pred EEEEEeccCCCChHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC---CCCeEEeeeecceee
Q 014849 91 IYFVMEFAKGGELFAKIS--KGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE---NWDLKISDFGLSAVK 165 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~--~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~---~~~vkl~DFGls~~~ 165 (417)
.++||||+. ++|.+.+. .+.+++..+..++.|++.||+|||++||+||||||+|||++. +..+||+|||+|...
T Consensus 78 ~~ivme~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 78 NVMVMELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EEEEEECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEEEEEEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceec
Confidence 999999995 46666554 368999999999999999999999999999999999999854 457999999999876
Q ss_pred cccCC-----CCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH---hcCCC--
Q 014849 166 EQIRP-----DGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLMAMYRKI---YKGEY-- 235 (417)
Q Consensus 166 ~~~~~-----~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~~~~~~i---~~~~~-- 235 (417)
..... .....+.+||+.|+|||++.+.+|+ .++|||||||++|+|++|.+||...+.......+ .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~ 235 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQS-RRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST 235 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCC-HHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHS
T ss_pred cccccccceeccccCCcCCCccccCHHHHhCCCCC-ChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCC
Confidence 54322 1233566899999999999998885 9999999999999999999999876544333222 11111
Q ss_pred ---CCCCCCChHHHHHHHHhccCCCCCCCCHHH---HhcCcccccccc
Q 014849 236 ---RCPKWTSPDLKWFIGRLLDTDPATRITVDE---ILRDPWFKKDYK 277 (417)
Q Consensus 236 ---~~p~~~s~~~~~li~~~L~~dP~~R~t~~e---il~h~~f~~~~~ 277 (417)
..+..+|+++.+||.+||+.||++||++++ +|+|+|.+....
T Consensus 236 ~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~~~~ 283 (299)
T d1ckia_ 236 PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283 (299)
T ss_dssp CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHcCCC
Confidence 123567899999999999999999999874 567777655443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=8e-50 Score=384.57 Aligned_cols=249 Identities=19% Similarity=0.252 Sum_probs=209.1
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-CCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-PNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-pnIv~l~~~~~~~~~~ 91 (417)
.+.++|++++.||+|+||+||+|++..+|+.||||++..... ...+.+|+++++.++| ||++.+++++.+....
T Consensus 2 vig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 76 (293)
T d1csna_ 2 VVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 76 (293)
T ss_dssp EETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred CCCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCcc
Confidence 356899999999999999999999999999999999866432 3356789999999976 8999999999999999
Q ss_pred EEEEeccCCCChHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecC-----CCCeEEeeeeccee
Q 014849 92 YFVMEFAKGGELFAKISK--GRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDE-----NWDLKISDFGLSAV 164 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~--~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~-----~~~vkl~DFGls~~ 164 (417)
|+||||+ |++|.+.+.. +.+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+|+.
T Consensus 77 ~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 77 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEE
Confidence 9999999 6799888864 57999999999999999999999999999999999999974 57899999999987
Q ss_pred ecccC-----CCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHHHHhcCCC-
Q 014849 165 KEQIR-----PDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDP---NLMAMYRKIYKGEY- 235 (417)
Q Consensus 165 ~~~~~-----~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~---~~~~~~~~i~~~~~- 235 (417)
..... +.....+.+||+.|||||++.+..|+ .++|||||||++|+|++|.+||.+. +....+.++.....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~-~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~ 234 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQS-RRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS 234 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCC-HHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred cccCccccceeecccCceEEchhhcCHHHhcCCCCC-hHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence 54322 12234567899999999999988875 9999999999999999999999753 33444444432221
Q ss_pred ----CCCCCCChHHHHHHHHhccCCCCCCCCHHHHhc
Q 014849 236 ----RCPKWTSPDLKWFIGRLLDTDPATRITVDEILR 268 (417)
Q Consensus 236 ----~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 268 (417)
..++.+++++.+++..|+..+|++||+.+.+.+
T Consensus 235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~ 271 (293)
T d1csna_ 235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQG 271 (293)
T ss_dssp SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 123557899999999999999999999877754
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-49 Score=382.95 Aligned_cols=249 Identities=22% Similarity=0.295 Sum_probs=196.3
Q ss_pred cCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCcceEEEEEEeCC----E
Q 014849 15 FGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNIVKLYEVLATKA----K 90 (417)
Q Consensus 15 ~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnIv~l~~~~~~~~----~ 90 (417)
..+|.+.+.||+|+||.||+|+. +|+.||||+++.+.. ......+|+..++.++|||||++++++.+.+ .
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~----~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~ 75 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREE----RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 75 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGH----HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccch----hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceE
Confidence 45799999999999999999986 789999999965431 1122234555666789999999999987654 7
Q ss_pred EEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------cCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 91 IYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS--------RGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 91 ~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~--------~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
+|+|||||++|+|.+++.+.++++..+..++.|++.||.|+|+ +||+||||||+||||+.++++||+|||++
T Consensus 76 ~~lv~Ey~~~g~L~~~l~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~ 155 (303)
T d1vjya_ 76 LWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred EEEEEecccCCCHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence 8999999999999999998899999999999999999999996 59999999999999999999999999999
Q ss_pred eeecccCC--CCcccccccCccccccccccccCC-----CCChhhHHHHHHHHHHHHcCCCCCCC---------------
Q 014849 163 AVKEQIRP--DGMLHTLCGTPAYVAPEILAKKGY-----DGAKVDMWSCGVVLFVLNAGYLPFND--------------- 220 (417)
Q Consensus 163 ~~~~~~~~--~~~~~~~~Gt~~y~APEvl~~~~y-----~~~~sDIwSlGvil~~ll~G~~Pf~~--------------- 220 (417)
........ .......+||+.|+|||++.+... .+.++|||||||+||||++|..||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~ 235 (303)
T d1vjya_ 156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD 235 (303)
T ss_dssp EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence 87643221 123456789999999999876432 24689999999999999999887732
Q ss_pred CCHHHHHHHHhcCCC--CCCCCC-----ChHHHHHHHHhccCCCCCCCCHHHHhcC
Q 014849 221 PNLMAMYRKIYKGEY--RCPKWT-----SPDLKWFIGRLLDTDPATRITVDEILRD 269 (417)
Q Consensus 221 ~~~~~~~~~i~~~~~--~~p~~~-----s~~~~~li~~~L~~dP~~R~t~~eil~h 269 (417)
............... .+|... ...+.+|+.+||+.||++|||+.||+++
T Consensus 236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 233333333333332 222211 2348899999999999999999999774
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.8e-48 Score=384.49 Aligned_cols=251 Identities=24% Similarity=0.443 Sum_probs=198.4
Q ss_pred CCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-----------CCCcceEEEE
Q 014849 16 GKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-----------HPNIVKLYEV 84 (417)
Q Consensus 16 ~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-----------HpnIv~l~~~ 84 (417)
+||++++.||+|+||+||+|+++.+|+.||||+++++.. ..+.+.+|+.+|+.++ ||||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 689999999999999999999999999999999976532 2456778999988875 5789999988
Q ss_pred EE--eCCEEEEEEeccCCCChHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHH-cCCeecCCCCCcEEecCCCC----
Q 014849 85 LA--TKAKIYFVMEFAKGGELFAKIS----KGRFSEQLSRRYFQQLISAVEYCHS-RGVFHRDLKLENLLLDENWD---- 153 (417)
Q Consensus 85 ~~--~~~~~~lV~E~~~gg~L~~~i~----~~~l~e~~~~~i~~ql~~aL~ylH~-~givHrDlkp~NILl~~~~~---- 153 (417)
+. .....+++++++..+....... ...+++..++.++.||+.||+|||+ +||+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence 75 4567788888776655433322 2679999999999999999999998 89999999999999987654
Q ss_pred --eEEeeeecceeecccCCCCcccccccCccccccccccccCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH------H
Q 014849 154 --LKISDFGLSAVKEQIRPDGMLHTLCGTPAYVAPEILAKKGYDGAKVDMWSCGVVLFVLNAGYLPFNDPNLM------A 225 (417)
Q Consensus 154 --vkl~DFGls~~~~~~~~~~~~~~~~Gt~~y~APEvl~~~~y~~~~sDIwSlGvil~~ll~G~~Pf~~~~~~------~ 225 (417)
+|++|||.|..... .....+||+.|+|||++...+|+ .++||||+||++++|++|+.||...+.. .
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~ 242 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWG-CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD 242 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCC-THHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred ceeeEeeccccccccc-----ccccccccccccChhhccccCCC-ccccccchHHHHHHHHHCCCCCCCCccccccchhH
Confidence 99999999875432 23567899999999999988886 8999999999999999999999754321 1
Q ss_pred HHHHHhc--C----------------------------------------CCCCCCCCChHHHHHHHHhccCCCCCCCCH
Q 014849 226 MYRKIYK--G----------------------------------------EYRCPKWTSPDLKWFIGRLLDTDPATRITV 263 (417)
Q Consensus 226 ~~~~i~~--~----------------------------------------~~~~p~~~s~~~~~li~~~L~~dP~~R~t~ 263 (417)
....... + .+..+...++++.+||.+||++||.+|||+
T Consensus 243 ~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta 322 (362)
T d1q8ya_ 243 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA 322 (362)
T ss_dssp HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred HHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCH
Confidence 1111000 0 001112235778999999999999999999
Q ss_pred HHHhcCccccccc
Q 014849 264 DEILRDPWFKKDY 276 (417)
Q Consensus 264 ~eil~h~~f~~~~ 276 (417)
+|+|+||||++-.
T Consensus 323 ~e~L~Hp~f~~~~ 335 (362)
T d1q8ya_ 323 GGLVNHPWLKDTL 335 (362)
T ss_dssp HHHHTCGGGTTCT
T ss_pred HHHhcCcccCCCC
Confidence 9999999999543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=2.8e-27 Score=212.04 Aligned_cols=137 Identities=20% Similarity=0.235 Sum_probs=109.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeeccccc---------------ccchHHHHHHHHHHHHhCCCCCcceEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKIL---------------RGGLTAHVKREISIMSRLRHPNIVKLY 82 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~---------------~~~~~~~i~~Ei~il~~l~HpnIv~l~ 82 (417)
|.+++.||+|+||+||+|++ .+|+.||||++...... .........+|...|.++.|++++..+
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~ 80 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY 80 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence 56899999999999999998 57999999987542211 001123456789999999999999988
Q ss_pred EEEEeCCEEEEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCeecCCCCCcEEecCCCCeEEeeeecc
Q 014849 83 EVLATKAKIYFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHSRGVFHRDLKLENLLLDENWDLKISDFGLS 162 (417)
Q Consensus 83 ~~~~~~~~~~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~~givHrDlkp~NILl~~~~~vkl~DFGls 162 (417)
++. . .+++|||+++..+.. +++..+..++.|++.+|.|||++||+||||||+|||+++++ ++|+|||+|
T Consensus 81 ~~~--~--~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liDFG~a 149 (191)
T d1zara2 81 AWE--G--NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQS 149 (191)
T ss_dssp EEE--T--TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECCCTTC
T ss_pred Eec--C--CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEECCCc
Confidence 753 2 279999998865432 45566788999999999999999999999999999999765 999999998
Q ss_pred eeec
Q 014849 163 AVKE 166 (417)
Q Consensus 163 ~~~~ 166 (417)
....
T Consensus 150 ~~~~ 153 (191)
T d1zara2 150 VEVG 153 (191)
T ss_dssp EETT
T ss_pred ccCC
Confidence 6543
|
| >d1ul7a_ d.129.6.1 (A:) Map/microtubule affinity-regulating kinase 3 {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Kinase associated domain 1, KA1 domain: Map/microtubule affinity-regulating kinase 3 species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.14 E-value=4.2e-11 Score=94.30 Aligned_cols=79 Identities=10% Similarity=0.031 Sum_probs=68.1
Q ss_pred cceeecCCHHHHHHHHHHHHHhhcCCCceEEEEe-eeeEEEE----eeccceEEEEEEEEec-CceEEEEEEecCCc---
Q 014849 333 ERFLSNETPEKILEKVEEVARLVADGDRLAVTKK-EWGAKLE----GQNGNFTMVIGIDRLT-DDLVVVEIKKSMRR--- 403 (417)
Q Consensus 333 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~----~~~~~~~~~~~~~~~~-~~~~~v~~~~~~g~--- 403 (417)
-.-||+.+|++|+..|+++++.+ |+.++++ ++.++++ ++++.|.+++||++|. +++++|+|+|..||
T Consensus 13 v~tTS~~~P~eIm~eI~rvL~~l----gv~~~~~g~y~l~c~~~~~~~~~~v~fEieV~kv~~~~l~gv~~kR~~Gd~~~ 88 (102)
T d1ul7a_ 13 MKTTSSMDPSDMMREIRKVLGAN----NCDYEQRERFLLFCVHGDGHAENLVQWEMEVCKLPRLSLNGVRFKRISGTSIA 88 (102)
T ss_dssp CCCCBCSCHHHHHHHHHHHHHHT----TCEEEECSTTCEEEEECSSCGGGCEEEEEEEEECSSSSSEEEEEEEEESCHHH
T ss_pred eecCcCCCHHHHHHHHHHHHHHc----CcEEEEcCCEEEEEEecCCCCCceEEEEEEEEEcCCCceEEEEEEEccCCHHH
Confidence 34579999999999999999999 9999655 6899998 4567899999999995 79999999999999
Q ss_pred hhhhhcccccccc
Q 014849 404 GEENWKDKLRPAA 416 (417)
Q Consensus 404 ~~~~~~~~~~~~~ 416 (417)
|+++|. ++-..|
T Consensus 89 yk~l~~-~il~~l 100 (102)
T d1ul7a_ 89 FKNIAS-KIANEL 100 (102)
T ss_dssp HHHHHH-HHHHHC
T ss_pred HHHHHH-HHHHhc
Confidence 999998 444333
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.58 E-value=1.1e-07 Score=86.28 Aligned_cols=143 Identities=20% Similarity=0.169 Sum_probs=99.3
Q ss_pred cccCCeEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCC-CCCcceEEEEEEeCCEE
Q 014849 13 NLFGKYEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLR-HPNIVKLYEVLATKAKI 91 (417)
Q Consensus 13 ~~~~~y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~-HpnIv~l~~~~~~~~~~ 91 (417)
.+...|+..+..+.++.+.||... ..++.+.+|....... .....+.+|...++.+. +=-+.+++.+..+++..
T Consensus 11 ~~~~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~---~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~ 85 (263)
T d1j7la_ 11 KLIEKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYK---GTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWS 85 (263)
T ss_dssp HHHTTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGT---TSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEE
T ss_pred HhhhceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcc---cchhhHHHHHHHHHHHhccCCCCcEEEEEecCCce
Confidence 456789988887777778999875 3667788888765432 22445678888888774 33367888888889999
Q ss_pred EEEEeccCCCChHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH--------------------------------------
Q 014849 92 YFVMEFAKGGELFAKISKGRFSEQLSRRYFQQLISAVEYCHS-------------------------------------- 133 (417)
Q Consensus 92 ~lV~E~~~gg~L~~~i~~~~l~e~~~~~i~~ql~~aL~ylH~-------------------------------------- 133 (417)
|+||++++|..+.+......- ...++.++...+..||+
T Consensus 86 ~lv~~~l~G~~~~~~~~~~~~----~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (263)
T d1j7la_ 86 NLLMSEADGVLCSEEYEDEQS----PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEED 161 (263)
T ss_dssp EEEEECCSSEEHHHHTTTCSC----HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTT
T ss_pred EEEEEeccccccccccccccc----HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhccccc
Confidence 999999999887654322111 12223333333333332
Q ss_pred ---------------------cCCeecCCCCCcEEecCCCCeEEeeeeccee
Q 014849 134 ---------------------RGVFHRDLKLENLLLDENWDLKISDFGLSAV 164 (417)
Q Consensus 134 ---------------------~givHrDlkp~NILl~~~~~vkl~DFGls~~ 164 (417)
..++|+|+.|.|||+++++.+-|.||+.+..
T Consensus 162 ~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 162 TPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp CSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred ccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 1379999999999999876667999998753
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=4.7e-06 Score=74.84 Aligned_cols=139 Identities=14% Similarity=0.146 Sum_probs=84.4
Q ss_pred eEEeeEEeeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC--CCcceEEEEEEeCCEEEEEE
Q 014849 18 YEVGKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH--PNIVKLYEVLATKAKIYFVM 95 (417)
Q Consensus 18 y~i~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H--pnIv~l~~~~~~~~~~~lV~ 95 (417)
++....-+..+-+.||+... ..+..+.+|.-.... ...+.+|...|+.+.. -.+.+++.+..+++..|+||
T Consensus 13 ~~~~~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~------~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~ 85 (255)
T d1nd4a_ 13 YDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLL 85 (255)
T ss_dssp CEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEE
T ss_pred CceEEcCCcccCCeEEEEEe-CCCCEEEEEeCCccC------HhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEE
Confidence 44433333333478998876 567778889764432 3346678888877643 33677888888888999999
Q ss_pred eccCCCChHHH--------------Hhc-C-------CCC--HHHHH-----HHH---------------HHHHHHHHHH
Q 014849 96 EFAKGGELFAK--------------ISK-G-------RFS--EQLSR-----RYF---------------QQLISAVEYC 131 (417)
Q Consensus 96 E~~~gg~L~~~--------------i~~-~-------~l~--e~~~~-----~i~---------------~ql~~aL~yl 131 (417)
++++|.++.+. +.+ . ++. ..... .+. ......+..+
T Consensus 86 ~~i~G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 165 (255)
T d1nd4a_ 86 GEVPGQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARL 165 (255)
T ss_dssp ECCSSEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHH
T ss_pred EeeeccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHH
Confidence 99988665321 000 0 000 00000 000 0011223333
Q ss_pred HHc-------CCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 132 HSR-------GVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 132 H~~-------givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
... .++|+|+.|.|||+++++.+-|+||+.+.
T Consensus 166 ~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~ 204 (255)
T d1nd4a_ 166 KARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG 204 (255)
T ss_dssp HHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence 322 37999999999999987667899999775
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.97 E-value=1.2e-05 Score=77.74 Aligned_cols=81 Identities=19% Similarity=0.168 Sum_probs=52.0
Q ss_pred eeEEeeeCceEEEEEEEccCCcEEEEEEeecc-cccc---cchHHHHHHHHHHHHhCC-C--CCcceEEEEEEeCCEEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVRTGQSVAIKAVSKQ-KILR---GGLTAHVKREISIMSRLR-H--PNIVKLYEVLATKAKIYF 93 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~~g~~vAiK~i~~~-~~~~---~~~~~~i~~Ei~il~~l~-H--pnIv~l~~~~~~~~~~~l 93 (417)
.+.+|.|....||++.+..+|+.+++|.-... +... .....+..+|..+|+.+. + ..+++++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 55789999999999998778889999975432 1111 112456677888888763 2 346666654 4445578
Q ss_pred EEeccCCCCh
Q 014849 94 VMEFAKGGEL 103 (417)
Q Consensus 94 V~E~~~gg~L 103 (417)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d2v8qa1 d.129.6.2 (A:396-548) 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: 5'-AMP-activated protein kinase catalytic subunit alpha-1, AMPK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=97.46 E-value=0.00027 Score=57.46 Aligned_cols=65 Identities=8% Similarity=0.143 Sum_probs=56.1
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEE-eeeeEEEEee----ccceEEEEEEEEecCceEEEEEEecCCc
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTK-KEWGAKLEGQ----NGNFTMVIGIDRLTDDLVVVEIKKSMRR 403 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~v~~~~~~g~ 403 (417)
..|+..|.+||..|..+.+.+ |+.|++ ..|.|++.-. ...+.|..++|+|.+..||||||...|+
T Consensus 5 IrS~s~P~dIM~eVyrALk~L----~~eWk~~~~y~ir~R~~~~~~~~~~Km~lQLYqv~~~~YLLDfk~i~~~ 74 (153)
T d2v8qa1 5 IRSQSRPNDIMAEVCRAIKQL----DYEWKVVNPYYLRVRRKNPVTSTFSKMSLQLYQVDSRTYLLDFRSIDDE 74 (153)
T ss_dssp EEECSCHHHHHHHHHHHHHHT----TCEEEEEETTEEEEEEECTTTCCEEEEEEEEEECSSSCEEEEEEEECCC
T ss_pred cccCCCHHHHHHHHHHHHHHc----CCeEEecCceEEEEEEECCCCCceeEEEEEEEEEcCCceEEEeeecCcc
Confidence 357889999999999999999 999965 4688888732 2367899999999999999999999886
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.05 E-value=0.00044 Score=64.37 Aligned_cols=128 Identities=13% Similarity=0.147 Sum_probs=76.3
Q ss_pred ceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCCc--ceEE-----EEEEeCCEEEEEEeccCCC
Q 014849 29 FAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPNI--VKLY-----EVLATKAKIYFVMEFAKGG 101 (417)
Q Consensus 29 fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~HpnI--v~l~-----~~~~~~~~~~lV~E~~~gg 101 (417)
--.||++.. ++|+.|++|+..... ...+++..|...|..|...++ +... ..+......+.+++++.|.
T Consensus 35 EN~vy~v~~-~dg~~~VlK~~rp~~----~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~ 109 (325)
T d1zyla1 35 ENRVYQFQD-EDRRRFVVKFYRPER----WTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGR 109 (325)
T ss_dssp SSEEEEECC-TTCCCEEEEEECTTT----SCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCE
T ss_pred cceeEEEEc-CCCCEEEEEEeCCCC----CCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCc
Confidence 357999887 688999999986542 135678889888877752221 1111 1234567889999999875
Q ss_pred ChHH-----------HH-------hcC------C-------------------CCHHHHHHHHHHHHHHHHHHHH-----
Q 014849 102 ELFA-----------KI-------SKG------R-------------------FSEQLSRRYFQQLISAVEYCHS----- 133 (417)
Q Consensus 102 ~L~~-----------~i-------~~~------~-------------------l~e~~~~~i~~ql~~aL~ylH~----- 133 (417)
.+.. .+ ... . ++......+...+-..++.+..
T Consensus 110 ~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~ 189 (325)
T d1zyla1 110 QFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWRED 189 (325)
T ss_dssp ECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSC
T ss_pred CCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcccc
Confidence 4310 00 000 0 1111111222222333333332
Q ss_pred --cCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 134 --RGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 134 --~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
.++||+|+.|.|||++++ ..+.||+.+.
T Consensus 190 ~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~ 219 (325)
T d1zyla1 190 FTVLRLHGDCHAGNILWRDG--PMFVDLDDAR 219 (325)
T ss_dssp SCCEECCSSCSGGGEEESSS--EEECCCTTCC
T ss_pred CCceeecCCCCcccEEEeCC--ceEEechhcc
Confidence 368999999999999743 5689999775
|
| >d2qrda1 d.129.6.2 (A:450-576) Snf1-like protein kinase ssp2 {Schizosaccharomyces pombe [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Snf1-like protein kinase ssp2 species: Schizosaccharomyces pombe [TaxId: 4896]
Probab=96.92 E-value=0.0013 Score=52.14 Aligned_cols=60 Identities=12% Similarity=0.084 Sum_probs=50.2
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEEee----------eeEEEEee---------ccceEEEEEEEEecCceEEE
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTKKE----------WGAKLEGQ---------NGNFTMVIGIDRLTDDLVVV 395 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~~~~---------~~~~~~~~~~~~~~~~~~~v 395 (417)
.-|+..|-+||..|..+.+.+ |+.|++.+ +.|++.-. ...+.|.+++|+|.++.|||
T Consensus 7 IRSrs~P~eiM~eVYrALk~L----g~eWk~~~~~~~~~~~d~y~Ir~R~~~~~~~~~~~~~~vkm~iQLYqve~~~YLl 82 (127)
T d2qrda1 7 VRCRGDAPEILLAVYRALQRA----GAQFTVPKPVNGKYRSDMYTIKSRWEIPHCKREGKNTYAYIELQLYEVMPGCFML 82 (127)
T ss_dssp EEEESCHHHHHHHHHHHHHHH----TCEECCCCCBTTBCCGGGGEEEEEEECHHHHHTTCCEEEEEEEEEEEEETTEEEE
T ss_pred cccCCChHHHHHHHHHHHHHc----CCEEeecCcccccccCCceEEEEEeecCCccccCCCceEEEEEEEEEEcCCcEEE
Confidence 358999999999999999999 99996543 67887611 12478999999999999999
Q ss_pred EEE
Q 014849 396 EIK 398 (417)
Q Consensus 396 ~~~ 398 (417)
|||
T Consensus 83 DFK 85 (127)
T d2qrda1 83 DVK 85 (127)
T ss_dssp EEE
T ss_pred EEc
Confidence 998
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.83 E-value=0.0021 Score=61.20 Aligned_cols=74 Identities=18% Similarity=0.153 Sum_probs=50.6
Q ss_pred eeEEeeeCceEEEEEEEcc-------CCcEEEEEEeecccccccchHHHHHHHHHHHHhCCCCC-cceEEEEEEeCCEEE
Q 014849 21 GKIIGCGAFAKVYHGRNVR-------TGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRHPN-IVKLYEVLATKAKIY 92 (417)
Q Consensus 21 ~~~LG~G~fg~Vy~a~~~~-------~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~Hpn-Iv~l~~~~~~~~~~~ 92 (417)
++.|+.|-.=.+|++.... ..+.|.+++.-.. . ......+|..+++.+.-.+ ..+++.++.. .
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~-~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g 117 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----E-TESHLVAESVIFTLLSERHLGPKLYGIFSG----G 117 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----C-CHHHHHHHHHHHHHHHHTTSSSCEEEEETT----E
T ss_pred EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----c-hhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----c
Confidence 4678888889999998643 3456778776422 1 1345668999999885334 4577776642 6
Q ss_pred EEEeccCCCCh
Q 014849 93 FVMEFAKGGEL 103 (417)
Q Consensus 93 lV~E~~~gg~L 103 (417)
+|+||++|..|
T Consensus 118 ~I~efi~g~~l 128 (395)
T d1nw1a_ 118 RLEEYIPSRPL 128 (395)
T ss_dssp EEECCCCEEEC
T ss_pred eEEEEeccccC
Confidence 89999987544
|
| >d2qlva1 d.129.6.2 (A:460-630) Carbon catabolite-derepressing protein kinase SNF1 {Saccharomyces cerevisiae [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: TBP-like superfamily: KA1-like family: Ssp2 C-terminal domain-like domain: Carbon catabolite-derepressing protein kinase SNF1 species: Saccharomyces cerevisiae [TaxId: 4932]
Probab=96.04 E-value=0.0064 Score=50.53 Aligned_cols=61 Identities=20% Similarity=0.264 Sum_probs=47.4
Q ss_pred eeecCCHHHHHHHHHHHHHhhcCCCceEEEEee----eeEEEEee---------c----cceEEEEEEEEecCceEEEEE
Q 014849 335 FLSNETPEKILEKVEEVARLVADGDRLAVTKKE----WGAKLEGQ---------N----GNFTMVIGIDRLTDDLVVVEI 397 (417)
Q Consensus 335 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~---------~----~~~~~~~~~~~~~~~~~~v~~ 397 (417)
.-|+..|-+||..|..+.+.+ |++|++.+ |.|++.-. + ..+.|.+++|+|.++.|||||
T Consensus 50 IRSrs~P~eiM~evykALk~L----g~eWk~~~~~~~~~ir~Rwk~~~~~~~~~~~~~~~~vk~~iQLYqv~~~~YLlDF 125 (171)
T d2qlva1 50 IRSRSYPLDVMGEIYIALKNL----GAEWAKPSEEDLWTIKLRWKYDIGNKTNTNEKIPDLMKMVIQLFQIETNNYLVDF 125 (171)
T ss_dssp EEECSCHHHHHHHHHHHHHHH----TCEECCCC---CCEEEEEEC--------------CEEEEEEEEEC---CCEEEEE
T ss_pred cccCCCHHHHHHHHHHHHHHc----CCEEeecCCCCceEEEEEeecCCCcccccCCCCCceEEEEEEEEEEcCCceEEEE
Confidence 349999999999999999999 99996543 77887611 1 237899999999999999999
Q ss_pred Ee
Q 014849 398 KK 399 (417)
Q Consensus 398 ~~ 399 (417)
|-
T Consensus 126 K~ 127 (171)
T d2qlva1 126 KF 127 (171)
T ss_dssp EE
T ss_pred ec
Confidence 84
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.00 E-value=0.0068 Score=55.33 Aligned_cols=143 Identities=15% Similarity=0.165 Sum_probs=76.4
Q ss_pred ccCCeEEeeEE-----eeeCceEEEEEEEccCCcEEEEEEeecccccccchHHHHHHHHHHHHhCCC-----CCcceEE-
Q 014849 14 LFGKYEVGKII-----GCGAFAKVYHGRNVRTGQSVAIKAVSKQKILRGGLTAHVKREISIMSRLRH-----PNIVKLY- 82 (417)
Q Consensus 14 ~~~~y~i~~~L-----G~G~fg~Vy~a~~~~~g~~vAiK~i~~~~~~~~~~~~~i~~Ei~il~~l~H-----pnIv~l~- 82 (417)
+..+|.+++.. ..|---+.|+... ..| .+++|++.... . .+.+..|+.+|..|.. |..+...
T Consensus 11 ~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t-~~g-~yVLri~~~~~--~---~~~l~~~~~~l~~L~~~g~pvp~pi~~~~ 83 (316)
T d2ppqa1 11 FLTQYDVGSLTSYKGIAEGVENSNFLLHT-TKD-PLILTLYEKRV--E---KNDLPFFLGLMQHLAAKGLSCPLPLPRKD 83 (316)
T ss_dssp HHTTBCCCCEEEEEEECC---EEEEEEEE-SSC-CEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTT
T ss_pred HHHhCCCCCceEeecCCCCcccCeEEEEE-CCC-cEEEEEcCCCC--C---HHHHHHHHHHHHhhhhccccccccceecC
Confidence 34556665444 3555567899876 344 58999886532 1 3455667777777643 2222110
Q ss_pred --EEEEeCCEEEEEEeccCCCChHH--------------HHh---c-------CCCCH------------------HHHH
Q 014849 83 --EVLATKAKIYFVMEFAKGGELFA--------------KIS---K-------GRFSE------------------QLSR 118 (417)
Q Consensus 83 --~~~~~~~~~~lV~E~~~gg~L~~--------------~i~---~-------~~l~e------------------~~~~ 118 (417)
.+.........++.+..|..... .+. . ..... ....
T Consensus 84 g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (316)
T d2ppqa1 84 GELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLR 163 (316)
T ss_dssp CCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHH
T ss_pred CCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHH
Confidence 01233456777777776643311 000 0 00000 0111
Q ss_pred HHHHHHHHHHHHHH----HcCCeecCCCCCcEEecCCCCeEEeeeecce
Q 014849 119 RYFQQLISAVEYCH----SRGVFHRDLKLENLLLDENWDLKISDFGLSA 163 (417)
Q Consensus 119 ~i~~ql~~aL~ylH----~~givHrDlkp~NILl~~~~~vkl~DFGls~ 163 (417)
..+..+...+.-.+ ..|+||+|+.+.||+++.+...-|.||+.+.
T Consensus 164 ~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~ 212 (316)
T d2ppqa1 164 EEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC 212 (316)
T ss_dssp HHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred HHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence 22222233222222 2489999999999999988777899999875
|